Citrus Sinensis ID: 017231
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 375 | 2.2.26 [Sep-21-2011] | |||||||
| Q39024 | 376 | Mitogen-activated protein | yes | no | 0.989 | 0.986 | 0.887 | 0.0 | |
| Q40353 | 371 | Mitogen-activated protein | N/A | no | 0.981 | 0.991 | 0.865 | 0.0 | |
| Q5J4W4 | 394 | Mitogen-activated protein | yes | no | 0.962 | 0.916 | 0.842 | 0.0 | |
| Q9LMM5 | 369 | Mitogen-activated protein | no | no | 0.949 | 0.964 | 0.873 | 0.0 | |
| Q336X9 | 376 | Mitogen-activated protein | no | no | 0.962 | 0.960 | 0.847 | 0.0 | |
| Q8GYQ5 | 372 | Mitogen-activated protein | no | no | 0.954 | 0.962 | 0.826 | 1e-179 | |
| Q39025 | 376 | Mitogen-activated protein | no | no | 0.986 | 0.984 | 0.778 | 1e-176 | |
| Q40531 | 371 | Mitogen-activated protein | N/A | no | 0.954 | 0.964 | 0.768 | 1e-169 | |
| Q9LQQ9 | 363 | Mitogen-activated protein | no | no | 0.941 | 0.972 | 0.753 | 1e-162 | |
| Q40532 | 393 | Mitogen-activated protein | N/A | no | 0.946 | 0.903 | 0.733 | 1e-162 |
| >sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 695 bits (1793), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/372 (88%), Positives = 350/372 (94%), Gaps = 1/372 (0%)
Query: 1 MSGESSSGS-GDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAA 59
MS ES GS GD + KGV THGG YVQYNVYGNLFEVSRKYVPP+RP+GRGAYGIVCAA
Sbjct: 1 MSAESCFGSSGDQSSSKGVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAA 60
Query: 60 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119
NSET EEVAIKKIGNAFDN IDAKRTLREIKLL+HMDHEN+IA+KDII+PPQRE FNDV
Sbjct: 61 TNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDV 120
Query: 120 YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 179
YIVYELMDTDLHQIIRS+Q LTDDHCR+FLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN
Sbjct: 121 YIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 180
Query: 180 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 239
CDLK+GDFGLART SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE MTR
Sbjct: 181 CDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTR 240
Query: 240 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 299
+PLFPGKDYVHQLRLITELIGSPD++SLGFLRSDNARRYVR LPQ+P+QNF+ARFPN S
Sbjct: 241 EPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSA 300
Query: 300 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 359
GAVDLLEKMLVFDP+RRITVDEALCHPYLAPLHDINEEPVC RPF+FDFE P+ TEENIK
Sbjct: 301 GAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIK 360
Query: 360 ELIYRESVKFNP 371
ELIYRE+VKFNP
Sbjct: 361 ELIYRETVKFNP 372
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q40353|MMK2_MEDSA Mitogen-activated protein kinase homolog MMK2 OS=Medicago sativa GN=MMK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 686 bits (1771), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 323/373 (86%), Positives = 353/373 (94%), Gaps = 5/373 (1%)
Query: 1 MSGESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAM 60
MS ES+ + ++GVPTHGGRY+QYN+YGNLFEVSRKYVPPIR VGRGAYGIVCAA+
Sbjct: 1 MSVESAENN-----IRGVPTHGGRYLQYNIYGNLFEVSRKYVPPIRSVGRGAYGIVCAAV 55
Query: 61 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120
N+ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN+++IKDIIRPPQ+E FN VY
Sbjct: 56 NAETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVMSIKDIIRPPQKENFNHVY 115
Query: 121 IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180
IV ELMDTDLHQIIRS+Q +TDDHCRYF+YQLLRGLKYVHSANVLHRDLKPSNLLLNANC
Sbjct: 116 IVSELMDTDLHQIIRSNQPMTDDHCRYFVYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 175
Query: 181 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 240
DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS+YTAAIDIWSVGCILGEI+TRQ
Sbjct: 176 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSDYTAAIDIWSVGCILGEIVTRQ 235
Query: 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 300
PLFPG+DYVHQLRL+TELIGSPD+ SLGFLRS+NARRYVR LPQ+PKQNFSARFPN SPG
Sbjct: 236 PLFPGRDYVHQLRLVTELIGSPDDASLGFLRSENARRYVRQLPQYPKQNFSARFPNMSPG 295
Query: 301 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 360
AVDLLEKML+FDP++RI VDEALCHPY+APLHDINEEPVC RPFSFDFE P FTEE+IKE
Sbjct: 296 AVDLLEKMLIFDPSKRIKVDEALCHPYMAPLHDINEEPVCARPFSFDFEEPMFTEEDIKE 355
Query: 361 LIYRESVKFNPDP 373
LI++ESV+FNPDP
Sbjct: 356 LIWKESVRFNPDP 368
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5J4W4|MPK2_ORYSJ Mitogen-activated protein kinase 2 OS=Oryza sativa subsp. japonica GN=MPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 654 bits (1687), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 304/361 (84%), Positives = 339/361 (93%)
Query: 15 VKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIG 74
+KG THGGRYVQYNVYGNLFEVS KYVPPIRPVGRGA GI+CA +N++TR+EVAIKKIG
Sbjct: 34 IKGTLTHGGRYVQYNVYGNLFEVSSKYVPPIRPVGRGACGIICAVVNAQTRQEVAIKKIG 93
Query: 75 NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII 134
NAFDN+IDAKRTLREIKLLRHMDH+N+I+IKDIIRPP+RE FNDVYIVYELMDTDLH ++
Sbjct: 94 NAFDNQIDAKRTLREIKLLRHMDHDNVISIKDIIRPPRRENFNDVYIVYELMDTDLHHLL 153
Query: 135 RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194
RS+Q LTDDHC+YFLYQ+LRGLKYVHSANVLHRDL+PSNLLLNA CDLKIGDFGLARTT+
Sbjct: 154 RSNQPLTDDHCQYFLYQVLRGLKYVHSANVLHRDLRPSNLLLNAKCDLKIGDFGLARTTN 213
Query: 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRL 254
ETDFM EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI+TR+PLFPGKDYVHQLRL
Sbjct: 214 ETDFMMEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIVTREPLFPGKDYVHQLRL 273
Query: 255 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN 314
ITELIGSPD++SLGFLRSDNARRYVR LPQ+PKQ F ARFP S GA+DLLE+MLVFDP+
Sbjct: 274 ITELIGSPDDSSLGFLRSDNARRYVRSLPQYPKQQFRARFPTMSSGAMDLLERMLVFDPS 333
Query: 315 RRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDPT 374
+RITVDEALCHPYLA LH+I +EPVCP PFSFDFE PS TEE+IKE+I+RE++KFNP+P
Sbjct: 334 KRITVDEALCHPYLASLHEIYDEPVCPAPFSFDFEQPSLTEEDIKEIIWREALKFNPEPI 393
Query: 375 H 375
H
Sbjct: 394 H 394
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LMM5|MPK11_ARATH Mitogen-activated protein kinase 11 OS=Arabidopsis thaliana GN=MPK11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 650 bits (1676), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 311/356 (87%), Positives = 332/356 (93%)
Query: 16 KGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGN 75
+GV +GGRYVQYNVYGNLFEVS+KYVPP+RP+GRGA GIVCAA NSET EEVAIKKIGN
Sbjct: 14 RGVSINGGRYVQYNVYGNLFEVSKKYVPPLRPIGRGASGIVCAAWNSETGEEVAIKKIGN 73
Query: 76 AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR 135
AF N IDAKRTLREIKLL+HMDH+N+IAI DIIRPPQ + FNDV+IVYELMDTDLH IIR
Sbjct: 74 AFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIR 133
Query: 136 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195
S+Q LTDDH R+FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART SE
Sbjct: 134 SNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTKSE 193
Query: 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 255
TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR+PLFPG+DYV QLRLI
Sbjct: 194 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLI 253
Query: 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 315
TELIGSPD++SLGFLRSDNARRYVR LPQ+P+QNF+ARFPN S AVDLL+KMLVFDPNR
Sbjct: 254 TELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDPNR 313
Query: 316 RITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
RITVDEALCHPYLAPLH+ NEEPVC RPF FDFE PS TEENIKELIYRESVKFNP
Sbjct: 314 RITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLTEENIKELIYRESVKFNP 369
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q336X9|MPK6_ORYSJ Mitogen-activated protein kinase 6 OS=Oryza sativa subsp. japonica GN=MPK6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 647 bits (1670), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 306/361 (84%), Positives = 333/361 (92%)
Query: 15 VKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIG 74
+KG+ THGGRYV YNVYGN FEVS KY PPIRP+GRGAYGIVCAA+NSE EEVAIKKIG
Sbjct: 16 IKGMGTHGGRYVLYNVYGNFFEVSSKYAPPIRPIGRGAYGIVCAAVNSENGEEVAIKKIG 75
Query: 75 NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII 134
NAFDN IDAKRTLREIKLLRHMDHENIIAIKDIIRPP+R+ FNDVYIV ELMDTDLHQII
Sbjct: 76 NAFDNHIDAKRTLREIKLLRHMDHENIIAIKDIIRPPRRDNFNDVYIVSELMDTDLHQII 135
Query: 135 RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194
RS+Q LTDDHC+YFLYQLLRGLKYVHSANVLHRDLKPSNL LNANCDLKI DFGLARTT+
Sbjct: 136 RSNQPLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLFLNANCDLKIADFGLARTTT 195
Query: 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRL 254
ETD MTEYVVTRWYRAPELLLNCS+YTAAID+WSVGCILGEI+TRQPLFPG+DY+ QL+L
Sbjct: 196 ETDLMTEYVVTRWYRAPELLLNCSQYTAAIDVWSVGCILGEIVTRQPLFPGRDYIQQLKL 255
Query: 255 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN 314
ITELIGSPD++SLGFLRSDNARRY++ LPQ+P+Q+F RF N S GAVDLLEKMLVFDP+
Sbjct: 256 ITELIGSPDDSSLGFLRSDNARRYMKQLPQYPRQDFRLRFRNMSAGAVDLLEKMLVFDPS 315
Query: 315 RRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDPT 374
RRITVDEAL HPYLA LHDINEEP CP PFSFDFE PSFTEE+IKELI+RES+ FNPDP
Sbjct: 316 RRITVDEALHHPYLASLHDINEEPTCPAPFSFDFEQPSFTEEHIKELIWRESLAFNPDPP 375
Query: 375 H 375
+
Sbjct: 376 Y 376
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q8GYQ5|MPK12_ARATH Mitogen-activated protein kinase 12 OS=Arabidopsis thaliana GN=MPK12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1615), Expect = e-179, Method: Compositional matrix adjust.
Identities = 296/358 (82%), Positives = 327/358 (91%)
Query: 15 VKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIG 74
+K VPTHGGRYVQYNVYG LFEVSRKYVPPIRP+GRGA GIVCAA+NS T E+VAIKKIG
Sbjct: 14 IKVVPTHGGRYVQYNVYGQLFEVSRKYVPPIRPIGRGACGIVCAAVNSVTGEKVAIKKIG 73
Query: 75 NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII 134
NAFDN IDAKRTLREIKLLRHMDHEN+I IKDI+RPPQR+ FNDVYIVYELMDTDL +I+
Sbjct: 74 NAFDNIIDAKRTLREIKLLRHMDHENVITIKDIVRPPQRDIFNDVYIVYELMDTDLQRIL 133
Query: 135 RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194
RS+Q LT D CR+ +YQLLRGLKYVHSAN+LHRDL+PSN+LLN+ +LKIGDFGLARTTS
Sbjct: 134 RSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNVLLNSKNELKIGDFGLARTTS 193
Query: 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRL 254
+TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT QPLFPGKDYVHQLRL
Sbjct: 194 DTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTGQPLFPGKDYVHQLRL 253
Query: 255 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN 314
ITEL+GSPD +SLGFLRSDNARRYVR LP++PKQ F+ARFP A+DLLE+MLVFDPN
Sbjct: 254 ITELVGSPDNSSLGFLRSDNARRYVRQLPRYPKQQFAARFPKMPTTAIDLLERMLVFDPN 313
Query: 315 RRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPD 372
RRI+VDEAL H YL+P HD+ +EPVC PFSFDFEHPS TEE+IKELIY+ESVKFNPD
Sbjct: 314 RRISVDEALGHAYLSPHHDVAKEPVCSTPFSFDFEHPSCTEEHIKELIYKESVKFNPD 371
|
Negative regulator of the auxin transduction signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q39025|MPK5_ARATH Mitogen-activated protein kinase 5 OS=Arabidopsis thaliana GN=MPK5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 619 bits (1595), Expect = e-176, Method: Compositional matrix adjust.
Identities = 289/371 (77%), Positives = 332/371 (89%), Gaps = 1/371 (0%)
Query: 4 ESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE 63
ES++ GD T +KGV HGGRY QYNVYGNLFEVS KYVPPIRP+GRGAYG VCAA++SE
Sbjct: 6 ESATDLGD-TNIKGVLVHGGRYFQYNVYGNLFEVSNKYVPPIRPIGRGAYGFVCAAVDSE 64
Query: 64 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123
T EE+AIKKIG AFDN++DAKRTLREIKLLRH++HEN++ IKDIIRPP++E F DVYIV+
Sbjct: 65 THEEIAIKKIGKAFDNKVDAKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVDVYIVF 124
Query: 124 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 183
ELMDTDLHQIIRS+Q L DDHC+YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN+NCDLK
Sbjct: 125 ELMDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNCDLK 184
Query: 184 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 243
I DFGLARTTSET++MTEYVVTRWYRAPELLLN SEYT+AID+WSVGCI EIMTR+PLF
Sbjct: 185 ITDFGLARTTSETEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTREPLF 244
Query: 244 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 303
PGKDYVHQL+LITELIGSPD SL FLRS NAR+YV+ LP+FP+QNFSARFP+ + A+D
Sbjct: 245 PGKDYVHQLKLITELIGSPDGASLEFLRSANARKYVKELPKFPRQNFSARFPSMNSTAID 304
Query: 304 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 363
LLEKMLVFDP +RITV+EALC+PYL+ LHD+N+EPVC FSF FE PS TEE IKEL++
Sbjct: 305 LLEKMLVFDPVKRITVEEALCYPYLSALHDLNDEPVCSNHFSFHFEDPSSTEEEIKELVW 364
Query: 364 RESVKFNPDPT 374
ESVKFNP P+
Sbjct: 365 LESVKFNPLPS 375
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q40531|NTF6_TOBAC Mitogen-activated protein kinase homolog NTF6 OS=Nicotiana tabacum GN=NTF6 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 593 bits (1528), Expect = e-169, Method: Compositional matrix adjust.
Identities = 275/358 (76%), Positives = 318/358 (88%)
Query: 15 VKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIG 74
+KG+PTH G+YV+YNV GN FEV+ KY+PPI+PVGRGAYG+VC A NSET+EEVAIKKIG
Sbjct: 11 IKGIPTHEGKYVEYNVLGNFFEVTSKYIPPIQPVGRGAYGMVCCATNSETKEEVAIKKIG 70
Query: 75 NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII 134
NAF+NRIDAKRTLREIKLL HMDHENII IKDI+RPP RE FNDVYIVYELMDTDLHQII
Sbjct: 71 NAFENRIDAKRTLREIKLLSHMDHENIIKIKDIVRPPDREEFNDVYIVYELMDTDLHQII 130
Query: 135 RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194
RS Q LTDDHC+YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI DFGLARTTS
Sbjct: 131 RSSQALTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 190
Query: 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRL 254
E DFMTEYVVTRWYRAPELLLNC+EYTAAIDIWSVGCIL E++ R+PLFPG+DY QL L
Sbjct: 191 EADFMTEYVVTRWYRAPELLLNCTEYTAAIDIWSVGCILMELIKREPLFPGRDYAQQLGL 250
Query: 255 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN 314
I L+GSP+++ LGFLRSDNAR+YV+ LP+ P+ FS +FP+ SP A+DL E+MLVFDP
Sbjct: 251 IIALLGSPEDSDLGFLRSDNARKYVKHLPRVPRHPFSQKFPDVSPLALDLAERMLVFDPA 310
Query: 315 RRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPD 372
+RITV++AL HP+L LH+INEEPVC PF+FDFE S +E++IKELI+ E++KF+P+
Sbjct: 311 KRITVEDALNHPFLISLHEINEEPVCDSPFNFDFEQASLSEDDIKELIWNEALKFDPN 368
|
Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9LQQ9|MPK13_ARATH Mitogen-activated protein kinase 13 OS=Arabidopsis thaliana GN=MPK13 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 572 bits (1475), Expect = e-162, Method: Compositional matrix adjust.
Identities = 266/353 (75%), Positives = 304/353 (86%)
Query: 17 GVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA 76
G+ T+ GRYV YNV GN+FE+S KY+PPI P+GRGAYGIVC A NSET EEVAIKKI NA
Sbjct: 8 GILTYDGRYVMYNVLGNIFELSSKYIPPIEPIGRGAYGIVCCATNSETNEEVAIKKIANA 67
Query: 77 FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS 136
FDNR+DAKRTLREIKLL HMDH+N+I IKDII P++E F DVYIVYELMDTDLHQIIRS
Sbjct: 68 FDNRVDAKRTLREIKLLSHMDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRS 127
Query: 137 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196
Q LTDDHC+YFLYQ+LRGLKY+HSANVLHRDLKPSNL+LN NCDLKI DFGLART++ET
Sbjct: 128 TQTLTDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNET 187
Query: 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLIT 256
+ MTEYVVTRWYRAPELLLN SEYT AIDIWSVGCI EI+ R+ LFPGKDYV QL+LIT
Sbjct: 188 EIMTEYVVTRWYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLIT 247
Query: 257 ELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
EL+GSPD++ L FLRSDNAR+YV+ LP KQ+F +FPN SP A+DL EKMLVFDP++R
Sbjct: 248 ELLGSPDDSDLDFLRSDNARKYVKQLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKR 307
Query: 317 ITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKF 369
ITVDEAL PYLA LH+INEEP CP PFSFDFE + E++IKEL++RES+ F
Sbjct: 308 ITVDEALKQPYLASLHEINEEPTCPTPFSFDFEETALDEQDIKELVWRESLHF 360
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q40532|NTF4_TOBAC Mitogen-activated protein kinase homolog NTF4 OS=Nicotiana tabacum GN=NTF4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 571 bits (1472), Expect = e-162, Method: Compositional matrix adjust.
Identities = 261/356 (73%), Positives = 312/356 (87%), Gaps = 1/356 (0%)
Query: 20 THGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN 79
+HGGR++QYN++GN+FEV+ KY PPI P+G+GAYGIVC+A+NSET E VAIKKI NAFDN
Sbjct: 38 SHGGRFIQYNIFGNIFEVTAKYKPPIMPIGKGAYGIVCSALNSETNEHVAIKKIANAFDN 97
Query: 80 RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD 139
+IDAKRTLREIKLLRHMDHENI+AI+DII PPQRE FNDVYI YELMDTDLHQIIRS+Q
Sbjct: 98 KIDAKRTLREIKLLRHMDHENIVAIRDIIPPPQREAFNDVYIAYELMDTDLHQIIRSNQG 157
Query: 140 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199
L+++HC+YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLNANCDLKI DFGLAR TSETDFM
Sbjct: 158 LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 217
Query: 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 259
TEYVVTRWYRAPELLLN S+YTAAID+WSVGCI E+M R+PLFPG+D+VHQLRL+ ELI
Sbjct: 218 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELI 277
Query: 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 319
G+P E + FL ++NA+RY+R LP + +Q+F +FP+ +P A+DL+EKML FDP RRITV
Sbjct: 278 GTPSEAEMEFL-NENAKRYIRQLPLYRRQSFVEKFPHVNPAAIDLVEKMLTFDPRRRITV 336
Query: 320 DEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDPTH 375
++AL HPYL LHDI++EPVC PF+FDFE + TEE +KELIYRE + FNP+ H
Sbjct: 337 EDALAHPYLTSLHDISDEPVCMTPFNFDFEQHALTEEQMKELIYREGLAFNPEYQH 392
|
Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 375 | ||||||
| 25052804 | 374 | mitogen-activated protein kinase 4 [Petr | 0.984 | 0.986 | 0.924 | 0.0 | |
| 350528643 | 373 | mitogen-activated protein kinase 1 [Prun | 0.986 | 0.991 | 0.919 | 0.0 | |
| 315258227 | 373 | mitogen-activated protein kinase 4 [Nico | 0.989 | 0.994 | 0.900 | 0.0 | |
| 359489658 | 375 | PREDICTED: mitogen-activated protein kin | 0.992 | 0.992 | 0.908 | 0.0 | |
| 225426166 | 375 | PREDICTED: mitogen-activated protein kin | 1.0 | 1.0 | 0.893 | 0.0 | |
| 255541680 | 370 | big map kinase/bmk, putative [Ricinus co | 0.984 | 0.997 | 0.902 | 0.0 | |
| 78096654 | 373 | mitogen-activated protein kinase [Nicoti | 0.984 | 0.989 | 0.891 | 0.0 | |
| 224067920 | 372 | predicted protein [Populus trichocarpa] | 0.992 | 1.0 | 0.900 | 0.0 | |
| 363808060 | 373 | uncharacterized protein LOC100815697 [Gl | 0.986 | 0.991 | 0.890 | 0.0 | |
| 312281951 | 375 | unnamed protein product [Thellungiella h | 0.986 | 0.986 | 0.892 | 0.0 |
| >gi|25052804|gb|AAN65180.1| mitogen-activated protein kinase 4 [Petroselinum crispum] | Back alignment and taxonomy information |
|---|
Score = 720 bits (1859), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/369 (92%), Positives = 357/369 (96%)
Query: 5 SSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSET 64
SS+ + DHT +KGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNS+T
Sbjct: 4 SSAATADHTHIKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSDT 63
Query: 65 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 124
REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM+HEN+IAIKDIIRPPQ E+FNDVYIVYE
Sbjct: 64 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMNHENVIAIKDIIRPPQIESFNDVYIVYE 123
Query: 125 LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 184
LMDTDLHQIIRS+Q LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI
Sbjct: 124 LMDTDLHQIIRSNQQLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 183
Query: 185 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 244
GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE+MTRQPLFP
Sbjct: 184 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEVMTRQPLFP 243
Query: 245 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDL 304
GKDYVHQLRLITELIGSPD+ SLGFLRSDNARRYVR LPQ+PKQ FSARF NKSPGA+DL
Sbjct: 244 GKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPQYPKQQFSARFLNKSPGALDL 303
Query: 305 LEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYR 364
LEKML+FDPNRRITVDEALCHPYLA LHDINEEPVCPRPFSFDFE P+ TEENIKELI++
Sbjct: 304 LEKMLIFDPNRRITVDEALCHPYLAALHDINEEPVCPRPFSFDFEQPTCTEENIKELIWK 363
Query: 365 ESVKFNPDP 373
ESVKFNPDP
Sbjct: 364 ESVKFNPDP 372
|
Source: Petroselinum crispum Species: Petroselinum crispum Genus: Petroselinum Family: Apiaceae Order: Apiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|350528643|gb|AEQ28763.1| mitogen-activated protein kinase 1 [Prunus salicina] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1848), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 341/371 (91%), Positives = 357/371 (96%), Gaps = 1/371 (0%)
Query: 5 SSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSET 64
SS+ +GDH I KGVP HGGRYVQYNVYGN FEVSRKYVPPIRPVGRGAYGIVCAA+N+ET
Sbjct: 4 SSASAGDHNI-KGVPAHGGRYVQYNVYGNFFEVSRKYVPPIRPVGRGAYGIVCAAVNAET 62
Query: 65 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 124
REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN+IAIKDIIRPPQ+E FNDVYIVYE
Sbjct: 63 REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIAIKDIIRPPQKENFNDVYIVYE 122
Query: 125 LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 184
LMDTDLHQIIRS+Q L DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL+NANCDLKI
Sbjct: 123 LMDTDLHQIIRSNQPLNDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLMNANCDLKI 182
Query: 185 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 244
GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR+PLFP
Sbjct: 183 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRRPLFP 242
Query: 245 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDL 304
GKDYVHQLRLITEL+GSPD++SLGFLRSDNARRYVR LPQ+PKQ+FSA FPN SPGAVDL
Sbjct: 243 GKDYVHQLRLITELLGSPDDSSLGFLRSDNARRYVRQLPQYPKQSFSAGFPNMSPGAVDL 302
Query: 305 LEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYR 364
LEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCP PF+FDFE PSFTEENIKELI+R
Sbjct: 303 LEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPMPFNFDFEQPSFTEENIKELIWR 362
Query: 365 ESVKFNPDPTH 375
ESVKFNPDP H
Sbjct: 363 ESVKFNPDPIH 373
|
Source: Prunus salicina Species: Prunus salicina Genus: Prunus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|315258227|gb|ADT91692.1| mitogen-activated protein kinase 4 [Nicotiana attenuata] | Back alignment and taxonomy information |
|---|
Score = 711 bits (1835), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/373 (90%), Positives = 358/373 (95%), Gaps = 2/373 (0%)
Query: 4 ESSSG-SGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNS 62
E+SSG G + KG+PTHGGRYVQYNVYGNLFEVS+KYVP +RPVGRGAYGIVCAAMNS
Sbjct: 2 EASSGDQGVQSNFKGIPTHGGRYVQYNVYGNLFEVSKKYVP-LRPVGRGAYGIVCAAMNS 60
Query: 63 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122
ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH+N+IAIKDIIRPPQ E FNDVYIV
Sbjct: 61 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHDNVIAIKDIIRPPQTENFNDVYIV 120
Query: 123 YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 182
YELMDTDLHQIIRS+Q LTDDHCRYFLYQ+LRGLKY+HSANVLHRDLKPSNLLLNANCDL
Sbjct: 121 YELMDTDLHQIIRSNQQLTDDHCRYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 180
Query: 183 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 242
K+GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE+MTRQPL
Sbjct: 181 KVGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEMMTRQPL 240
Query: 243 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 302
FPGKDYVHQLRLITELIGSPD+ SLGFLRSDNARRYVR LPQ+P+Q F+ARFPN SPGAV
Sbjct: 241 FPGKDYVHQLRLITELIGSPDDASLGFLRSDNARRYVRQLPQYPRQQFAARFPNSSPGAV 300
Query: 303 DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELI 362
DLLEKMLVFDP+RR+TVD+ALCHPYLAPLHDINEEP+CP+PFSFDFE PSFTEENIKELI
Sbjct: 301 DLLEKMLVFDPSRRVTVDQALCHPYLAPLHDINEEPICPKPFSFDFEQPSFTEENIKELI 360
Query: 363 YRESVKFNPDPTH 375
+RESVKFNPDPTH
Sbjct: 361 WRESVKFNPDPTH 373
|
Source: Nicotiana attenuata Species: Nicotiana attenuata Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359489658|ref|XP_003633959.1| PREDICTED: mitogen-activated protein kinase homolog MMK2-like [Vitis vinifera] gi|147786894|emb|CAN75543.1| hypothetical protein VITISV_000466 [Vitis vinifera] gi|297745345|emb|CBI40425.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 707 bits (1824), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 339/373 (90%), Positives = 355/373 (95%), Gaps = 1/373 (0%)
Query: 1 MSGESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAM 60
MS ESS+GS + I +GV THGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAM
Sbjct: 1 MSMESSAGSVEGNI-RGVSTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAM 59
Query: 61 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120
NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN+I +KDIIRPP+RE FNDVY
Sbjct: 60 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIVLKDIIRPPKRENFNDVY 119
Query: 121 IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180
IVYELMDTDLHQIIRS+Q L DDHCRYFLYQ+LRGLKYVHSANVLHRDLKPSNLLLNANC
Sbjct: 120 IVYELMDTDLHQIIRSNQPLNDDHCRYFLYQVLRGLKYVHSANVLHRDLKPSNLLLNANC 179
Query: 181 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 240
DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ
Sbjct: 180 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 239
Query: 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 300
PLFPG+DYVHQLRLITELIGSPD++SLGFLRSDNARRYVR LPQ+P+Q F ARFPN SPG
Sbjct: 240 PLFPGRDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQQFQARFPNMSPG 299
Query: 301 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 360
A+DLLEKMLVFDPNRRITV+ AL HPYLAPLHDINEEPVCPRPF FDFE PSFTEENIKE
Sbjct: 300 AIDLLEKMLVFDPNRRITVEGALSHPYLAPLHDINEEPVCPRPFVFDFEQPSFTEENIKE 359
Query: 361 LIYRESVKFNPDP 373
LI+RESVKFNPDP
Sbjct: 360 LIWRESVKFNPDP 372
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225426166|ref|XP_002278860.1| PREDICTED: mitogen-activated protein kinase homolog MMK2 [Vitis vinifera] gi|297742231|emb|CBI34380.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 706 bits (1821), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 335/375 (89%), Positives = 354/375 (94%)
Query: 1 MSGESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAM 60
MS ++SSGSGD +KGVPTHGGRYV+YNVYGN FEVS KYVPPIRPVGRGAYGIVCAA+
Sbjct: 1 MSMDASSGSGDGGNIKGVPTHGGRYVRYNVYGNFFEVSAKYVPPIRPVGRGAYGIVCAAV 60
Query: 61 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120
NSET EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN+IAIKDIIRPP++ETFNDVY
Sbjct: 61 NSETHEEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIAIKDIIRPPKKETFNDVY 120
Query: 121 IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180
IVYELMDTDLHQII S+Q LTDDHC+YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC
Sbjct: 121 IVYELMDTDLHQIICSNQSLTDDHCQYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180
Query: 181 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 240
DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR+
Sbjct: 181 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRE 240
Query: 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 300
PLFPGKDYVHQLRLITEL+GSPD+ SLGFLRS+NARRYVR LPQ+PKQ SARFPN SP
Sbjct: 241 PLFPGKDYVHQLRLITELLGSPDDASLGFLRSNNARRYVRQLPQYPKQQISARFPNMSPS 300
Query: 301 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 360
AVDLLEKMLVFDP +RITVDEALCHPYL+ LHDIN+EPVCP PFSFDFE S TEENIKE
Sbjct: 301 AVDLLEKMLVFDPTKRITVDEALCHPYLSSLHDINDEPVCPSPFSFDFEQSSITEENIKE 360
Query: 361 LIYRESVKFNPDPTH 375
LI+RESVKFNPDPTH
Sbjct: 361 LIWRESVKFNPDPTH 375
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541680|ref|XP_002511904.1| big map kinase/bmk, putative [Ricinus communis] gi|223549084|gb|EEF50573.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1817), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 334/370 (90%), Positives = 354/370 (95%), Gaps = 1/370 (0%)
Query: 4 ESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE 63
ESS+GS +H V+G+PTHGGRYVQYN+YGNLFEVSRKYVPPIRPVGRGA GIVCAA N+E
Sbjct: 2 ESSAGSSEHN-VRGLPTHGGRYVQYNIYGNLFEVSRKYVPPIRPVGRGANGIVCAAKNAE 60
Query: 64 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123
T+EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI+AIKDIIRPPQ+E FNDVYIV
Sbjct: 61 TQEEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIVAIKDIIRPPQKENFNDVYIVS 120
Query: 124 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 183
ELMDTDLH IIRS+Q LTDDHCRYFLYQLLRGLKYVHSA+VLHRDLKPSNLLLNANCDLK
Sbjct: 121 ELMDTDLHHIIRSNQSLTDDHCRYFLYQLLRGLKYVHSAHVLHRDLKPSNLLLNANCDLK 180
Query: 184 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 243
I DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF
Sbjct: 181 IADFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 240
Query: 244 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 303
PGKDYVHQLRLITELIGSPD+ SLGFLRSDNARRYVR LPQ+P++NF+ RFPN S GA+D
Sbjct: 241 PGKDYVHQLRLITELIGSPDDNSLGFLRSDNARRYVRQLPQYPRKNFATRFPNMSSGAID 300
Query: 304 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 363
LLE+MLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPF+FDFE PSFTEENIKELI+
Sbjct: 301 LLERMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFNFDFEQPSFTEENIKELIW 360
Query: 364 RESVKFNPDP 373
RESVKFNPDP
Sbjct: 361 RESVKFNPDP 370
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|78096654|dbj|BAE46985.1| mitogen-activated protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 703 bits (1815), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 330/370 (89%), Positives = 351/370 (94%), Gaps = 1/370 (0%)
Query: 6 SSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETR 65
S G + KGVPTHGGRY QYNVYGNLFEVS+KYVP +RPVGRGAYGIVCAAMNSETR
Sbjct: 5 SGDQGVQSNFKGVPTHGGRYAQYNVYGNLFEVSKKYVP-LRPVGRGAYGIVCAAMNSETR 63
Query: 66 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 125
EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH+N+IA KDIIRPPQ E FNDVYIVYEL
Sbjct: 64 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHDNVIATKDIIRPPQTENFNDVYIVYEL 123
Query: 126 MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 185
MDTDLHQIIRS+Q LTDDHCRYFLYQ+LRGLKY+HSANVLHRDLKPSNL LNANCDLK+G
Sbjct: 124 MDTDLHQIIRSNQQLTDDHCRYFLYQILRGLKYIHSANVLHRDLKPSNLFLNANCDLKVG 183
Query: 186 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 245
DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE+MTRQPLFPG
Sbjct: 184 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEMMTRQPLFPG 243
Query: 246 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 305
KDYVHQL+LITELIGSPD+ SLGFLRSDNARRYVR LPQ+P+Q F+ARFPN SPGAVDLL
Sbjct: 244 KDYVHQLKLITELIGSPDDASLGFLRSDNARRYVRQLPQYPRQQFAARFPNSSPGAVDLL 303
Query: 306 EKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRE 365
EKMLVFDP+RR+TVD+ALCHPYLAPLHDINEEP+CP+PFSFDFE PSFTEENIKELI+RE
Sbjct: 304 EKMLVFDPSRRVTVDQALCHPYLAPLHDINEEPICPKPFSFDFEQPSFTEENIKELIWRE 363
Query: 366 SVKFNPDPTH 375
SVKFNPDPTH
Sbjct: 364 SVKFNPDPTH 373
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224067920|ref|XP_002302599.1| predicted protein [Populus trichocarpa] gi|222844325|gb|EEE81872.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 702 bits (1811), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/373 (90%), Positives = 350/373 (93%), Gaps = 1/373 (0%)
Query: 1 MSGESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAM 60
MS SS GD I KG+PTHGGRYVQYNVYGNLFEVS KYVPPIRPVGRGAYGIVCAA+
Sbjct: 1 MSSLESSSGGDPNI-KGIPTHGGRYVQYNVYGNLFEVSMKYVPPIRPVGRGAYGIVCAAV 59
Query: 61 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120
N+ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN+IAIKDIIRPPQ E FNDVY
Sbjct: 60 NAETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENVIAIKDIIRPPQTENFNDVY 119
Query: 121 IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180
IVYELMDTDLHQIIRS+Q LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNL LNANC
Sbjct: 120 IVYELMDTDLHQIIRSNQQLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLFLNANC 179
Query: 181 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 240
DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI+TRQ
Sbjct: 180 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEILTRQ 239
Query: 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 300
PLFPGKDYVHQLRL+TELIGSPD++ LGFLRS+NARRYVR LPQ+P+QNF+ARFPN S G
Sbjct: 240 PLFPGKDYVHQLRLVTELIGSPDDSCLGFLRSENARRYVRQLPQYPRQNFAARFPNISAG 299
Query: 301 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 360
A DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPF FDFE PSFTEENIKE
Sbjct: 300 AADLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFLFDFEQPSFTEENIKE 359
Query: 361 LIYRESVKFNPDP 373
LI+ ESV FNP P
Sbjct: 360 LIWMESVNFNPGP 372
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363808060|ref|NP_001242213.1| uncharacterized protein LOC100815697 [Glycine max] gi|255640002|gb|ACU20292.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1799), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/373 (89%), Positives = 352/373 (94%), Gaps = 3/373 (0%)
Query: 1 MSGESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAM 60
M+ ES+ S D ++GV THGGRYVQYN+YGNLFEVSRKYVPPIRPVGRGAYGIVCAA+
Sbjct: 1 MALESAPASAD---IRGVHTHGGRYVQYNIYGNLFEVSRKYVPPIRPVGRGAYGIVCAAV 57
Query: 61 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120
N+ETREEVAIKK+GNAFDNRIDAKRTLREIKLLRHMDHEN+IA+KDIIRPPQR+ FNDVY
Sbjct: 58 NAETREEVAIKKVGNAFDNRIDAKRTLREIKLLRHMDHENVIALKDIIRPPQRDNFNDVY 117
Query: 121 IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180
IVYELMDTDLHQIIRS+Q LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC
Sbjct: 118 IVYELMDTDLHQIIRSNQQLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 177
Query: 181 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 240
DLKI DFGLAR TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI+TRQ
Sbjct: 178 DLKIADFGLARATSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIITRQ 237
Query: 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 300
PLFPGKDYVHQLRLITELIGSPD+ SLGFLRSDNARRYVR LPQ+P+Q F+ RFP+ SPG
Sbjct: 238 PLFPGKDYVHQLRLITELIGSPDDHSLGFLRSDNARRYVRQLPQYPRQQFATRFPSMSPG 297
Query: 301 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 360
AVDLLEKMLVFDPNRRITV EALCHPYLAPLHDINEEPVC RPFSFDFE PSFTEE+IKE
Sbjct: 298 AVDLLEKMLVFDPNRRITVKEALCHPYLAPLHDINEEPVCVRPFSFDFEQPSFTEEDIKE 357
Query: 361 LIYRESVKFNPDP 373
LI+RESV FNPDP
Sbjct: 358 LIWRESVLFNPDP 370
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|312281951|dbj|BAJ33841.1| unnamed protein product [Thellungiella halophila] | Back alignment and taxonomy information |
|---|
Score = 695 bits (1794), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/372 (89%), Positives = 352/372 (94%), Gaps = 2/372 (0%)
Query: 1 MSGESS-SGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAA 59
MS ES GSGD + KG+PTHGGRYVQYNVYGNLFEVSRKYVPP+RP+GRGAYGIVCAA
Sbjct: 1 MSAESCFGGSGDQS-TKGLPTHGGRYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAA 59
Query: 60 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119
+SET EEVAIKKIGNAFDN IDAKRTLREIKLL+HMDHEN+IA+KDIIRPPQRE FNDV
Sbjct: 60 TDSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIRPPQRENFNDV 119
Query: 120 YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 179
YIVYELMDTDLHQIIRS+Q LTDDHCR+FLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN
Sbjct: 120 YIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 179
Query: 180 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 239
CDLK+GDFGLART SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE MTR
Sbjct: 180 CDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTR 239
Query: 240 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 299
+PLFPGKDYVHQLRLITELIGSPD++SLGFLRSDNARRYVR LPQ+P+QNF+ARFPN S
Sbjct: 240 EPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSA 299
Query: 300 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 359
GAVDLLEKMLVFDP+RRITVDEALCHPYLAPLHDINEEPVC RPF+FDFE PS TEENIK
Sbjct: 300 GAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPSLTEENIK 359
Query: 360 ELIYRESVKFNP 371
ELIYRE+VKFNP
Sbjct: 360 ELIYRETVKFNP 371
|
Source: Thellungiella halophila Species: Eutrema halophilum Genus: Eutrema Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 375 | ||||||
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.989 | 0.986 | 0.887 | 1.1e-181 | |
| TAIR|locus:2025341 | 369 | MPK11 "MAP kinase 11" [Arabido | 0.949 | 0.964 | 0.873 | 1.5e-170 | |
| TAIR|locus:2062897 | 372 | MPK12 "mitogen-activated prote | 0.989 | 0.997 | 0.825 | 6.6e-168 | |
| TAIR|locus:2128263 | 376 | MPK5 "MAP kinase 5" [Arabidops | 0.986 | 0.984 | 0.778 | 8.4e-161 | |
| TAIR|locus:2026484 | 363 | ATMPK13 [Arabidopsis thaliana | 0.941 | 0.972 | 0.753 | 2.4e-147 | |
| TAIR|locus:2043904 | 395 | MPK6 "MAP kinase 6" [Arabidops | 0.952 | 0.903 | 0.714 | 1.5e-145 | |
| TAIR|locus:2085632 | 370 | MPK3 "mitogen-activated protei | 0.976 | 0.989 | 0.666 | 4.3e-141 | |
| TAIR|locus:2080457 | 393 | MPK10 "MAP kinase 10" [Arabido | 0.957 | 0.913 | 0.654 | 3.9e-131 | |
| TAIR|locus:2053119 | 368 | MPK7 "MAP kinase 7" [Arabidops | 0.938 | 0.956 | 0.563 | 1.4e-110 | |
| TAIR|locus:2012808 | 370 | MPK1 "mitogen-activated protei | 0.936 | 0.948 | 0.561 | 6.1e-110 |
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1763 (625.7 bits), Expect = 1.1e-181, P = 1.1e-181
Identities = 330/372 (88%), Positives = 350/372 (94%)
Query: 1 MSGESSSGS-GDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAA 59
MS ES GS GD + KGV THGG YVQYNVYGNLFEVSRKYVPP+RP+GRGAYGIVCAA
Sbjct: 1 MSAESCFGSSGDQSSSKGVATHGGSYVQYNVYGNLFEVSRKYVPPLRPIGRGAYGIVCAA 60
Query: 60 MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119
NSET EEVAIKKIGNAFDN IDAKRTLREIKLL+HMDHEN+IA+KDII+PPQRE FNDV
Sbjct: 61 TNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAVKDIIKPPQRENFNDV 120
Query: 120 YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 179
YIVYELMDTDLHQIIRS+Q LTDDHCR+FLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN
Sbjct: 121 YIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 180
Query: 180 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 239
CDLK+GDFGLART SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE MTR
Sbjct: 181 CDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGETMTR 240
Query: 240 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 299
+PLFPGKDYVHQLRLITELIGSPD++SLGFLRSDNARRYVR LPQ+P+QNF+ARFPN S
Sbjct: 241 EPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSA 300
Query: 300 GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIK 359
GAVDLLEKMLVFDP+RRITVDEALCHPYLAPLHDINEEPVC RPF+FDFE P+ TEENIK
Sbjct: 301 GAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPVCVRPFNFDFEQPTLTEENIK 360
Query: 360 ELIYRESVKFNP 371
ELIYRE+VKFNP
Sbjct: 361 ELIYRETVKFNP 372
|
|
| TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1658 (588.7 bits), Expect = 1.5e-170, P = 1.5e-170
Identities = 311/356 (87%), Positives = 332/356 (93%)
Query: 16 KGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGN 75
+GV +GGRYVQYNVYGNLFEVS+KYVPP+RP+GRGA GIVCAA NSET EEVAIKKIGN
Sbjct: 14 RGVSINGGRYVQYNVYGNLFEVSKKYVPPLRPIGRGASGIVCAAWNSETGEEVAIKKIGN 73
Query: 76 AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIR 135
AF N IDAKRTLREIKLL+HMDH+N+IAI DIIRPPQ + FNDV+IVYELMDTDLH IIR
Sbjct: 74 AFGNIIDAKRTLREIKLLKHMDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIR 133
Query: 136 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195
S+Q LTDDH R+FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART SE
Sbjct: 134 SNQPLTDDHSRFFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTKSE 193
Query: 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 255
TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR+PLFPG+DYV QLRLI
Sbjct: 194 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLI 253
Query: 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 315
TELIGSPD++SLGFLRSDNARRYVR LPQ+P+QNF+ARFPN S AVDLL+KMLVFDPNR
Sbjct: 254 TELIGSPDDSSLGFLRSDNARRYVRQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDPNR 313
Query: 316 RITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
RITVDEALCHPYLAPLH+ NEEPVC RPF FDFE PS TEENIKELIYRESVKFNP
Sbjct: 314 RITVDEALCHPYLAPLHEYNEEPVCVRPFHFDFEQPSLTEENIKELIYRESVKFNP 369
|
|
| TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1633 (579.9 bits), Expect = 6.6e-168, P = 6.6e-168
Identities = 307/372 (82%), Positives = 338/372 (90%)
Query: 1 MSGESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAM 60
MSGESSSGS +H I K VPTHGGRYVQYNVYG LFEVSRKYVPPIRP+GRGA GIVCAA+
Sbjct: 1 MSGESSSGSTEHCI-KVVPTHGGRYVQYNVYGQLFEVSRKYVPPIRPIGRGACGIVCAAV 59
Query: 61 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120
NS T E+VAIKKIGNAFDN IDAKRTLREIKLLRHMDHEN+I IKDI+RPPQR+ FNDVY
Sbjct: 60 NSVTGEKVAIKKIGNAFDNIIDAKRTLREIKLLRHMDHENVITIKDIVRPPQRDIFNDVY 119
Query: 121 IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180
IVYELMDTDL +I+RS+Q LT D CR+ +YQLLRGLKYVHSAN+LHRDL+PSN+LLN+
Sbjct: 120 IVYELMDTDLQRILRSNQTLTSDQCRFLVYQLLRGLKYVHSANILHRDLRPSNVLLNSKN 179
Query: 181 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 240
+LKIGDFGLARTTS+TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT Q
Sbjct: 180 ELKIGDFGLARTTSDTDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTGQ 239
Query: 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 300
PLFPGKDYVHQLRLITEL+GSPD +SLGFLRSDNARRYVR LP++PKQ F+ARFP
Sbjct: 240 PLFPGKDYVHQLRLITELVGSPDNSSLGFLRSDNARRYVRQLPRYPKQQFAARFPKMPTT 299
Query: 301 AVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKE 360
A+DLLE+MLVFDPNRRI+VDEAL H YL+P HD+ +EPVC PFSFDFEHPS TEE+IKE
Sbjct: 300 AIDLLERMLVFDPNRRISVDEALGHAYLSPHHDVAKEPVCSTPFSFDFEHPSCTEEHIKE 359
Query: 361 LIYRESVKFNPD 372
LIY+ESVKFNPD
Sbjct: 360 LIYKESVKFNPD 371
|
|
| TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1566 (556.3 bits), Expect = 8.4e-161, P = 8.4e-161
Identities = 289/371 (77%), Positives = 332/371 (89%)
Query: 4 ESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE 63
ES++ GD T +KGV HGGRY QYNVYGNLFEVS KYVPPIRP+GRGAYG VCAA++SE
Sbjct: 6 ESATDLGD-TNIKGVLVHGGRYFQYNVYGNLFEVSNKYVPPIRPIGRGAYGFVCAAVDSE 64
Query: 64 TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123
T EE+AIKKIG AFDN++DAKRTLREIKLLRH++HEN++ IKDIIRPP++E F DVYIV+
Sbjct: 65 THEEIAIKKIGKAFDNKVDAKRTLREIKLLRHLEHENVVVIKDIIRPPKKEDFVDVYIVF 124
Query: 124 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 183
ELMDTDLHQIIRS+Q L DDHC+YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN+NCDLK
Sbjct: 125 ELMDTDLHQIIRSNQSLNDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNSNCDLK 184
Query: 184 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 243
I DFGLARTTSET++MTEYVVTRWYRAPELLLN SEYT+AID+WSVGCI EIMTR+PLF
Sbjct: 185 ITDFGLARTTSETEYMTEYVVTRWYRAPELLLNSSEYTSAIDVWSVGCIFAEIMTREPLF 244
Query: 244 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 303
PGKDYVHQL+LITELIGSPD SL FLRS NAR+YV+ LP+FP+QNFSARFP+ + A+D
Sbjct: 245 PGKDYVHQLKLITELIGSPDGASLEFLRSANARKYVKELPKFPRQNFSARFPSMNSTAID 304
Query: 304 LLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIY 363
LLEKMLVFDP +RITV+EALC+PYL+ LHD+N+EPVC FSF FE PS TEE IKEL++
Sbjct: 305 LLEKMLVFDPVKRITVEEALCYPYLSALHDLNDEPVCSNHFSFHFEDPSSTEEEIKELVW 364
Query: 364 RESVKFNPDPT 374
ESVKFNP P+
Sbjct: 365 LESVKFNPLPS 375
|
|
| TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1439 (511.6 bits), Expect = 2.4e-147, P = 2.4e-147
Identities = 266/353 (75%), Positives = 304/353 (86%)
Query: 17 GVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA 76
G+ T+ GRYV YNV GN+FE+S KY+PPI P+GRGAYGIVC A NSET EEVAIKKI NA
Sbjct: 8 GILTYDGRYVMYNVLGNIFELSSKYIPPIEPIGRGAYGIVCCATNSETNEEVAIKKIANA 67
Query: 77 FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS 136
FDNR+DAKRTLREIKLL HMDH+N+I IKDII P++E F DVYIVYELMDTDLHQIIRS
Sbjct: 68 FDNRVDAKRTLREIKLLSHMDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRS 127
Query: 137 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196
Q LTDDHC+YFLYQ+LRGLKY+HSANVLHRDLKPSNL+LN NCDLKI DFGLART++ET
Sbjct: 128 TQTLTDDHCQYFLYQILRGLKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNET 187
Query: 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLIT 256
+ MTEYVVTRWYRAPELLLN SEYT AIDIWSVGCI EI+ R+ LFPGKDYV QL+LIT
Sbjct: 188 EIMTEYVVTRWYRAPELLLNSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLIT 247
Query: 257 ELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
EL+GSPD++ L FLRSDNAR+YV+ LP KQ+F +FPN SP A+DL EKMLVFDP++R
Sbjct: 248 ELLGSPDDSDLDFLRSDNARKYVKQLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKR 307
Query: 317 ITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKF 369
ITVDEAL PYLA LH+INEEP CP PFSFDFE + E++IKEL++RES+ F
Sbjct: 308 ITVDEALKQPYLASLHEINEEPTCPTPFSFDFEETALDEQDIKELVWRESLHF 360
|
|
| TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1422 (505.6 bits), Expect = 1.5e-145, P = 1.5e-145
Identities = 258/361 (71%), Positives = 312/361 (86%)
Query: 15 VKGVP---THGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIK 71
++ +P +HGGR++QYN++GN+FEV+ KY PPI P+G+GAYGIVC+AMNSET E VAIK
Sbjct: 33 IENIPATLSHGGRFIQYNIFGNIFEVTAKYKPPIMPIGKGAYGIVCSAMNSETNESVAIK 92
Query: 72 KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLH 131
KI NAFDN+IDAKRTLREIKLLRHMDHENI+AI+DII PP R FNDVYI YELMDTDLH
Sbjct: 93 KIANAFDNKIDAKRTLREIKLLRHMDHENIVAIRDIIPPPLRNAFNDVYIAYELMDTDLH 152
Query: 132 QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191
QIIRS+Q L+++HC+YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLNANCDLKI DFGLAR
Sbjct: 153 QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 212
Query: 192 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 251
TSE+DFMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI E+M R+PLFPG+D+VHQ
Sbjct: 213 VTSESDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 272
Query: 252 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVF 311
LRL+ ELIG+P E L FL ++NA+RY+R LP +P+Q+ + +FP P A+DL+EKML F
Sbjct: 273 LRLLMELIGTPSEEELEFL-NENAKRYIRQLPPYPRQSITDKFPTVHPLAIDLIEKMLTF 331
Query: 312 DPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
DP RRITV +AL HPYL LHDI++EP C PF+FDFE+ + +EE +KELIYRE++ FNP
Sbjct: 332 DPRRRITVLDALAHPYLNSLHDISDEPECTIPFNFDFENHALSEEQMKELIYREALAFNP 391
Query: 372 D 372
+
Sbjct: 392 E 392
|
|
| TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1380 (490.8 bits), Expect = 4.3e-141, P = 4.3e-141
Identities = 244/366 (66%), Positives = 309/366 (84%)
Query: 6 SSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETR 65
++G G +T V THGG+++ Y+++G+LFE++ KY PPI P+GRGAYGIVC+ +++ET
Sbjct: 2 NTGGGQYTDFPAVETHGGQFISYDIFGSLFEITSKYRPPIIPIGRGAYGIVCSVLDTETN 61
Query: 66 EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 125
E VA+KKI NAFDN +DAKRTLREIKLLRH+DHENIIAI+D++ PP R F+DVYI EL
Sbjct: 62 ELVAMKKIANAFDNHMDAKRTLREIKLLRHLDHENIIAIRDVVPPPLRRQFSDVYISTEL 121
Query: 126 MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 185
MDTDLHQIIRS+Q L+++HC+YFLYQLLRGLKY+HSAN++HRDLKPSNLLLNANCDLKI
Sbjct: 122 MDTDLHQIIRSNQSLSEEHCQYFLYQLLRGLKYIHSANIIHRDLKPSNLLLNANCDLKIC 181
Query: 186 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 245
DFGLAR TSE DFMTEYVVTRWYRAPELLLN S+YTAAID+WSVGCI E+M R+PLFPG
Sbjct: 182 DFGLARPTSENDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMNRKPLFPG 241
Query: 246 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 305
KD+VHQ+RL+TEL+G+P E+ LGF +++A+RY+R LP FP+Q + F + +P A+DL+
Sbjct: 242 KDHVHQMRLLTELLGTPTESDLGFTHNEDAKRYIRQLPNFPRQPLAKLFSHVNPMAIDLV 301
Query: 306 EKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRE 365
++ML FDPNRRITV++AL H YLA LHD N+EP+C +PFSF+FE EE IKE+IY+E
Sbjct: 302 DRMLTFDPNRRITVEQALNHQYLAKLHDPNDEPICQKPFSFEFEQQPLDEEQIKEMIYQE 361
Query: 366 SVKFNP 371
++ NP
Sbjct: 362 AIALNP 367
|
|
| TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
Identities = 237/362 (65%), Positives = 295/362 (81%)
Query: 15 VKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIG 74
+ G +H GRY+QYN++G++FE+ KY PPIRP+GRGA GIVC+A++SET E+VAIKKI
Sbjct: 33 IPGTLSHDGRYIQYNLFGHIFELPAKYKPPIRPIGRGACGIVCSAVDSETNEKVAIKKIT 92
Query: 75 NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII 134
FDN I+AKRTLREIKLLRH DHENI+AI+D+I PPQR++F DVYIV ELM+ DL++ +
Sbjct: 93 QVFDNTIEAKRTLREIKLLRHFDHENIVAIRDVILPPQRDSFEDVYIVNELMEFDLYRTL 152
Query: 135 RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194
+S Q+LT DH YF+YQ+LRGLKY+HSANVLHRDLKPSNLLL+ CDLKI DFGLAR T
Sbjct: 153 KSDQELTKDHGMYFMYQILRGLKYIHSANVLHRDLKPSNLLLSTQCDLKICDFGLARATP 212
Query: 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRL 254
E++ MTEYVVTRWYRAPELLL S+YTAAID+WSVGCI EIM R+PLFPGKD V+QLRL
Sbjct: 213 ESNLMTEYVVTRWYRAPELLLGSSDYTAAIDVWSVGCIFMEIMNREPLFPGKDQVNQLRL 272
Query: 255 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN 314
+ ELIG+P E LG L S+ A+RY+R LP P+Q+F+ +FPN P A+DL+EKML FDP
Sbjct: 273 LLELIGTPSEEELGSL-SEYAKRYIRQLPTLPRQSFTEKFPNVPPLAIDLVEKMLTFDPK 331
Query: 315 RRITVDEALCHPYLAPLHDINEEPVCPRPFSFDF-EHPSFTEENIKELIYRESVKFNPDP 373
+RI+V EAL HPYL+ HDI +EP C PF+FD EHP F+EE +ELIY E++ FNP+
Sbjct: 332 QRISVKEALAHPYLSSFHDITDEPECSEPFNFDLDEHP-FSEEQFRELIYCEALAFNPET 390
Query: 374 TH 375
++
Sbjct: 391 SN 392
|
|
| TAIR|locus:2053119 MPK7 "MAP kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1092 (389.5 bits), Expect = 1.4e-110, P = 1.4e-110
Identities = 201/357 (56%), Positives = 269/357 (75%)
Query: 17 GVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA 76
G+ G Y Y+++ LFE+ KYVP I+P+GRGAYG+VC+++N ET E VAIKKI N
Sbjct: 10 GIKQQGKHY--YSMWQTLFEIDTKYVP-IKPIGRGAYGVVCSSINRETNERVAIKKIHNV 66
Query: 77 FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS 136
F+NR+DA RTLRE+KLLRH+ HEN+IA+KD++ P R +F DVY+VYELMDTDLHQII+S
Sbjct: 67 FENRVDALRTLRELKLLRHVRHENVIALKDVMLPANRSSFKDVYLVYELMDTDLHQIIKS 126
Query: 137 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196
Q L+DDHC+YFL+QLLRGLKY+HSAN+LHRDLKP NLL+NANCDLKI DFGLART+
Sbjct: 127 SQSLSDDHCKYFLFQLLRGLKYLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSQGN 186
Query: 197 D-FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 255
+ FMTEYVVTRWYRAPELLL C Y +ID+WSVGCI EI+ R+P+FPG + ++QL+LI
Sbjct: 187 EQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLI 246
Query: 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 315
++GS E+ + F+ + ARR+++ LP + S +P +P A+DLL++MLVFDP +
Sbjct: 247 INVVGSQQESDIRFIDNPKARRFIKSLPYSRGTHLSNLYPQANPLAIDLLQRMLVFDPTK 306
Query: 316 RITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPD 372
RI+V +AL HPY+A L D P P S D + + E I+E+++ E + ++P+
Sbjct: 307 RISVTDALLHPYMAGLFDPGSNPPAHVPISLDIDE-NMEEPVIREMMWNEMLYYHPE 362
|
|
| TAIR|locus:2012808 MPK1 "mitogen-activated protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1086 (387.4 bits), Expect = 6.1e-110, P = 6.1e-110
Identities = 200/356 (56%), Positives = 270/356 (75%)
Query: 17 GVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA 76
G+ G Y ++++ LFE+ KY+P I+P+GRGAYG+VC+++NS+T E+VAIKKI N
Sbjct: 10 GIRNEGKHY--FSMWQTLFEIDTKYMP-IKPIGRGAYGVVCSSVNSDTNEKVAIKKIHNV 66
Query: 77 FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS 136
++NRIDA RTLRE+KLLRH+ HEN+IA+KD++ P + +F DVY+VYELMDTDLHQII+S
Sbjct: 67 YENRIDALRTLRELKLLRHLRHENVIALKDVMMPIHKMSFKDVYLVYELMDTDLHQIIKS 126
Query: 137 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-E 195
Q L++DHC+YFL+QLLRGLKY+HSAN+LHRDLKP NLL+NANCDLKI DFGLAR ++ +
Sbjct: 127 SQVLSNDHCQYFLFQLLRGLKYIHSANILHRDLKPGNLLVNANCDLKICDFGLARASNTK 186
Query: 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 255
FMTEYVVTRWYRAPELLL C Y +ID+WSVGCI E++ R+P+F G + ++QL+LI
Sbjct: 187 GQFMTEYVVTRWYRAPELLLCCDNYGTSIDVWSVGCIFAELLGRKPIFQGTECLNQLKLI 246
Query: 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 315
++GS E L F+ + A+RY+R LP P + S +P A+DLL+KMLVFDP++
Sbjct: 247 VNILGSQREEDLEFIDNPKAKRYIRSLPYSPGMSLSRLYPGAHVLAIDLLQKMLVFDPSK 306
Query: 316 RITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
RI+V EAL HPY+APL+D N P P D + EE I+E+++ E + ++P
Sbjct: 307 RISVSEALQHPYMAPLYDPNANPPAQVPIDLDVDE-DLREEMIREMMWNEMLHYHP 361
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| Q336X9 | MPK6_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8476 | 0.9626 | 0.9601 | no | no |
| Q8GYQ5 | MPK12_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8268 | 0.9546 | 0.9623 | no | no |
| Q40884 | MAPK_PETHY | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5882 | 0.9386 | 0.9166 | N/A | no |
| Q9LMM5 | MPK11_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8735 | 0.9493 | 0.9647 | no | no |
| Q9LQQ9 | MPK13_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7535 | 0.9413 | 0.9724 | no | no |
| Q84UI5 | MPK1_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7290 | 0.952 | 0.8969 | no | no |
| Q06060 | MAPK_PEA | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7308 | 0.9386 | 0.8934 | N/A | no |
| Q5J4W4 | MPK2_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8421 | 0.9626 | 0.9162 | yes | no |
| P0CP67 | CPK1_CRYNB | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5352 | 0.8613 | 0.8825 | N/A | no |
| P42525 | ERK1_DICDI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5787 | 0.9226 | 0.6540 | yes | no |
| O42781 | MAPK2_PNECA | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5236 | 0.9093 | 0.9715 | N/A | no |
| Q40531 | NTF6_TOBAC | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7681 | 0.9546 | 0.9649 | N/A | no |
| Q40532 | NTF4_TOBAC | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7331 | 0.9466 | 0.9033 | N/A | no |
| P0CP66 | CPK1_CRYNJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5352 | 0.8613 | 0.8825 | yes | no |
| Q40517 | NTF3_TOBAC | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5854 | 0.9386 | 0.9462 | N/A | no |
| Q00859 | MAPK_FUSSO | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5592 | 0.8506 | 0.8985 | N/A | no |
| P26696 | MK01_XENLA | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5202 | 0.904 | 0.9390 | N/A | no |
| Q39026 | MPK6_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7223 | 0.9386 | 0.8911 | no | no |
| Q39025 | MPK5_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7789 | 0.9866 | 0.9840 | no | no |
| Q39024 | MPK4_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8870 | 0.9893 | 0.9867 | yes | no |
| A2XFC8 | MPK5_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.6742 | 0.9413 | 0.9566 | N/A | no |
| P39745 | SUR1_CAEEL | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5278 | 0.8906 | 0.7522 | yes | no |
| P27638 | SPK1_SCHPO | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5348 | 0.8613 | 0.8682 | yes | no |
| Q07176 | MMK1_MEDSA | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7262 | 0.952 | 0.9224 | N/A | no |
| Q40353 | MMK2_MEDSA | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8659 | 0.9813 | 0.9919 | N/A | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00026919001 | SubName- Full=Putative uncharacterized protein (Chromosome chr15 scaffold_40, whole genome shotgun sequence); (375 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| GSVIVG00015318001 | SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (563 aa) | • | • | • | 0.817 | ||||||
| GSVIVG00016514001 | SubName- Full=Chromosome chr11 scaffold_13, whole genome shotgun sequence; (354 aa) | • | • | • | 0.814 | ||||||
| GSVIVG00016645001 | SubName- Full=Putative uncharacterized protein (Chromosome chr11 scaffold_13, whole genome shot [...] (354 aa) | • | • | • | 0.812 | ||||||
| GSVIVG00023994001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (533 aa) | • | 0.800 | ||||||||
| GSVIVG00005840001 | SubName- Full=Chromosome chr12 scaffold_159, whole genome shotgun sequence; (552 aa) | • | • | 0.800 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 375 | |||
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-176 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-169 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-158 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-153 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-143 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-133 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-127 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-123 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-122 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-121 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-119 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-114 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-114 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-109 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-107 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-101 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-97 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-95 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-92 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-91 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-87 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-87 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-87 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-86 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-85 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-82 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-80 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-79 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-77 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-77 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-75 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-75 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-74 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-73 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-72 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-70 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-70 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-69 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-68 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-68 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-66 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-65 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-64 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-64 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-62 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-59 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-57 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-57 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-55 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-54 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-52 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-48 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-47 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-47 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-46 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-45 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-42 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-38 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-37 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-33 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-32 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-31 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-31 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-28 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-28 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-27 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-26 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 8e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-25 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-24 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-24 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-23 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-22 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-21 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-18 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-17 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-17 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-17 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-16 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-16 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-15 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-15 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-14 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-14 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-14 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-13 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 4e-04 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 693 bits (1790), Expect = 0.0
Identities = 261/338 (77%), Positives = 296/338 (87%), Gaps = 2/338 (0%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
FEV KYVP P+GRGAYGIVC+A NSET E+VAIKKI NAFDNRIDAKRTLREIKLLR
Sbjct: 1 FEVDTKYVPIK-PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR 59
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLR 154
H+DHEN+IAIKDI+ PP RE FNDVYIVYELMDTDLHQIIRS Q L+DDHC+YFLYQLLR
Sbjct: 60 HLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 155 GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPEL 213
GLKY+HSANVLHRDLKPSNLLLNANCDLKI DFGLARTTSE DFMTEYVVTRWYRAPEL
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPEL 179
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
LLNCSEYT AID+WSVGCI E++ R+PLFPGKDYVHQL+LITEL+GSP E LGF+R++
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239
Query: 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333
ARRY+R LP P+Q+F+ FP+ +P A+DLLEKMLVFDP++RITV+EAL HPYLA LHD
Sbjct: 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299
Query: 334 INEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
++EPVC PFSFDFE + TEE+IKELIY E + ++P
Sbjct: 300 PSDEPVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 574 bits (1481), Expect = 0.0
Identities = 212/327 (64%), Positives = 255/327 (77%), Gaps = 5/327 (1%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
++P+G GAYG+VC+A++ T +VAIKKI N FD+ IDAKR LREIKLLRH+ HENII
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 104 IKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
+ DI+RPP E FNDVYIV ELM+TDLH++I+S Q LTDDH +YFLYQ+LRGLKY+HSAN
Sbjct: 64 LLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN 123
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTT----SETDFMTEYVVTRWYRAPELLLNCSE 219
V+HRDLKPSN+L+N+NCDLKI DFGLAR E F+TEYVVTRWYRAPELLL+ S
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSR 183
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
YT AIDIWSVGCI E++TR+PLFPG+DY+ QL LI E++G+P E L F+ S+ AR Y+
Sbjct: 184 YTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYL 243
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 339
+ LP+ PK+ S FP SP A+DLLEKMLVFDP +RIT DEAL HPYLA LHD +EPV
Sbjct: 244 KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPV 303
Query: 340 CPRPFSFDFEHPS-FTEENIKELIYRE 365
PF FDF TEE +KELIY E
Sbjct: 304 AKPPFDFDFFDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 493 bits (1271), Expect = e-176
Identities = 195/339 (57%), Positives = 251/339 (74%), Gaps = 8/339 (2%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
F+V +Y + +G GAYG+VC+A + T +VAIKKI + F+++ +RTLREIK+LR
Sbjct: 1 FDVGPRYQN-LSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRTLREIKILR 58
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLR 154
HENII I DIIRPP E+FNDVYIV ELM+TDL+++I++ Q L++DH +YFLYQ+LR
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILR 117
Query: 155 GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE----TDFMTEYVVTRWYRA 210
GLKY+HSANVLHRDLKPSNLLLN NCDLKI DFGLAR T F+TEYV TRWYRA
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270
PE++LN YT AIDIWSVGCIL E+++ +PLFPGKDY+HQL LI ++G+P + L +
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237
Query: 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330
S AR Y++ LP PK ++ FPN P A+DLL+KML F+P++RITV+EAL HPYL
Sbjct: 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ 297
Query: 331 LHDINEEPVCPRPFSFDFE-HPSFTEENIKELIYRESVK 368
HD ++EPV PF FDFE +E +KELI+ E ++
Sbjct: 298 YHDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIMR 336
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 474 bits (1222), Expect = e-169
Identities = 196/336 (58%), Positives = 255/336 (75%), Gaps = 7/336 (2%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
F+V +Y PI +G GAYG+VC+A+++ + ++VAIKKI +AFD AKRTLRE+K+LR
Sbjct: 1 FDVGSRY-KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILR 59
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLR 154
H H+NIIAI+DI+RPP + F DVY+V +LM++DLH II S Q LT++H RYFLYQLLR
Sbjct: 60 HFKHDNIIAIRDILRPPGAD-FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLR 118
Query: 155 GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR--TTSETD---FMTEYVVTRWYR 209
GLKY+HSANV+HRDLKPSNLL+N +C+L+IGDFG+AR ++S T+ FMTEYV TRWYR
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 210 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269
APELLL+ EYT AID+WSVGCI E++ R+ LFPGK+YVHQL+LI ++GSP E L
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
+ SD R+Y++ LP+ +S FP SP A+DLL +ML FDP RITV++AL HP+LA
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298
Query: 330 PLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRE 365
HD ++EP CP PF FDFE + E +KE I +E
Sbjct: 299 QYHDPDDEPTCPPPFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 448 bits (1155), Expect = e-158
Identities = 175/348 (50%), Positives = 241/348 (69%), Gaps = 6/348 (1%)
Query: 25 YVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK 84
+ + + ++EV +Y + PVG GAYG VC+A +++T +VAIKK+ F + I AK
Sbjct: 1 FYRQELNKTVWEVPDRYQN-LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK 59
Query: 85 RTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMDTDLHQIIRSHQDLTDD 143
RT RE++LL+HMDHEN+I + D+ P E F DVY+V LM DL+ I++ Q L+DD
Sbjct: 60 RTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDD 118
Query: 144 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 203
H ++ +YQ+LRGLKY+HSA ++HRDLKPSN+ +N +C+LKI DFGLAR T + MT YV
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYV 176
Query: 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263
TRWYRAPE++LN Y +DIWSVGCI+ E++T + LFPG D++ QL+ I L+G+PD
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
E L + S++AR Y++ LPQ PK++F F +P A+DLLEKMLV DP++RIT EAL
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296
Query: 324 CHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
HPYLA HD +EPV P P+ FE T + KEL+Y+E + F P
Sbjct: 297 AHPYLAEYHDPEDEPVAP-PYDQSFESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 433 bits (1115), Expect = e-153
Identities = 190/331 (57%), Positives = 242/331 (73%), Gaps = 14/331 (4%)
Query: 45 IRPVGRGAYGIVCAAMNSETREE--VAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENI 101
I+ +G+GAYGIVC+A N+ET EE VAIKKI N F +I AKR LRE+KLLRH H+NI
Sbjct: 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI 64
Query: 102 IAI--KDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
+ DI+ P FN++Y+ ELM+ DLHQIIRS Q LTD H + F+YQ+L GLKY+
Sbjct: 65 TCLYDMDIVFPGN---FNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-----TDFMTEYVVTRWYRAPELL 214
HSANVLHRDLKP NLL+NA+C+LKI DFGLAR SE FMTEYV TRWYRAPE++
Sbjct: 122 HSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181
Query: 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
L+ YT AID+WSVGCIL E++ R+P+F GKDYV QL I +++G+PDE +L + S
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334
A+ Y+R LP PK+ F + FPN +P A+DLLEK+L FDP +RI+V+EAL HPYLA HD
Sbjct: 242 AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301
Query: 335 NEEPVCPRPFSFDFEHPSFTEENIKELIYRE 365
++EPVC +PF F FE EE ++++I E
Sbjct: 302 DDEPVCQKPFDFSFESEDSMEE-LRDMIIEE 331
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 408 bits (1050), Expect = e-143
Identities = 172/334 (51%), Positives = 237/334 (70%), Gaps = 13/334 (3%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G+YG+VC+A+++ T E+VAIKKI + F++ DA R LREIKLLR + H +I+ IK I
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 108 IRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHR 167
+ PP R F D+Y+V+ELM++DLHQ+I+++ DLT +H ++FLYQLLR LKY+H+ANV HR
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHR 127
Query: 168 DLKPSNLLLNANCDLKIGDFGLART----TSETDFMTEYVVTRWYRAPELLLNC----SE 219
DLKP N+L NA+C LKI DFGLAR T F T+YV TRWYRAPEL C S+
Sbjct: 128 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL---CGSFFSK 184
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
YT AIDIWS+GCI E++T +PLFPGK+ VHQL LIT+L+G+P ++ +R++ ARRY+
Sbjct: 185 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYL 244
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 339
+ + FS +FPN P A+ LLE++L FDP R T +EAL PY L + EP
Sbjct: 245 SSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPS 304
Query: 340 C-PRP-FSFDFEHPSFTEENIKELIYRESVKFNP 371
P F+FE T+E+++ELIYRE ++++P
Sbjct: 305 AQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 383 bits (986), Expect = e-133
Identities = 154/338 (45%), Positives = 223/338 (65%), Gaps = 13/338 (3%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH 95
+ RKY ++ +G+GAYGIV A++ T+E VA+KKI +AF N DA+RT REI L+
Sbjct: 4 HILRKY-EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQE 62
Query: 96 M-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLR 154
+ DH NI+ + ++I+ E D+Y+V+E M+TDLH +IR L D H RY +YQLL+
Sbjct: 63 LGDHPNIVKLLNVIKA---ENDKDIYLVFEYMETDLHAVIR-ANILEDVHKRYIMYQLLK 118
Query: 155 GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD------FMTEYVVTRWY 208
LKY+HS NV+HRDLKPSN+LLN++C +K+ DFGLAR+ SE + +T+YV TRWY
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268
RAPE+LL + YT +D+WSVGCILGE++ +PLFPG ++QL I E+IG P +
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238
Query: 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
++S A + LP P++ P S A+DLL+K+LVF+PN+R+T +EAL HPY+
Sbjct: 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYV 298
Query: 329 APLHDINEEPVCPRPFSFDF-EHPSFTEENIKELIYRE 365
A H+ ++EPV P P + ++ + + +Y E
Sbjct: 299 AQFHNPSDEPVLPYPITIPLDDNVKLSVAEYRNKLYEE 336
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 369 bits (949), Expect = e-127
Identities = 168/336 (50%), Positives = 228/336 (67%), Gaps = 8/336 (2%)
Query: 30 VYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLRE 89
++G +FE++ +YV ++PVG GA+G+VC+A + T + VAIKKI F + AKRT RE
Sbjct: 1 IFGTVFEITNRYVD-LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE 59
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFL 149
+KLL+H+ HENII++ DI P D+Y V EL+ TDLH+++ S + L +YFL
Sbjct: 60 LKLLKHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFL 114
Query: 150 YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYR 209
YQ+LRGLKYVHSA V+HRDLKPSN+L+N NCDLKI DFGLAR MT YV TR+YR
Sbjct: 115 YQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYR 172
Query: 210 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269
APE++L +Y +DIWS GCI E++ +PLFPGKD+V+Q +IT+L+G+P + +
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232
Query: 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
+ S+N R+V+ LP+ FS +F N P A+DLLEKMLVFDP +RI+ EAL HPYLA
Sbjct: 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292
Query: 330 PLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRE 365
P HD +EPV F + F + K ++Y E
Sbjct: 293 PYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 355 bits (913), Expect = e-123
Identities = 134/286 (46%), Positives = 178/286 (62%), Gaps = 8/286 (2%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G G YG+V A + T E VAIKKI F++ K LREIKLL+ ++H NII +
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKL 63
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSAN 163
D+ R D+Y+V+E MDTDL+++I+ Q L + + +LYQLL+GL + HS
Sbjct: 64 LDVFRHKG-----DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTA 222
+LHRDLKP NLL+N LK+ DFGLAR+ S T YVVTRWYRAPELLL Y+
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178
Query: 223 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282
+DIWSVGCI E+++R+PLFPGK + QL I +G+PD S AR Y
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-LARNYKFSF 237
Query: 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+ FPN SP A+DLL +ML +DP++RIT ++AL HPY
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 355 bits (912), Expect = e-122
Identities = 170/339 (50%), Positives = 230/339 (67%), Gaps = 6/339 (1%)
Query: 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLL 93
++EV +Y + PVG GAYG VCAA +++T VA+KK+ F + I AKRT RE++LL
Sbjct: 12 IWEVPERY-QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 94 RHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQL 152
+HM HEN+I + D+ P + E FNDVY+V LM DL+ I++ Q LTDDH ++ +YQ+
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQI 129
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 212
LRGLKY+HSA+++HRDLKPSNL +N +C+LKI DFGLAR T + MT YV TRWYRAPE
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPE 187
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272
++LN Y +DIWSVGCI+ E++T + LFPG D++ QL+LI L+G+P L + S
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247
Query: 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332
++AR Y++ L Q PK NF+ F +P AVDLLEKMLV D ++RIT +AL H Y A H
Sbjct: 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307
Query: 333 DINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
D ++EPV P+ FE + K L Y E + F P
Sbjct: 308 DPDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 352 bits (905), Expect = e-121
Identities = 161/339 (47%), Positives = 227/339 (66%), Gaps = 6/339 (1%)
Query: 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLL 93
++EV +Y + PVG GAYG VC+A ++ R++VA+KK+ F + I A+RT RE++LL
Sbjct: 10 VWEVPERY-QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68
Query: 94 RHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQL 152
+HM HEN+I + D+ P E FN+VY+V LM DL+ I++ Q L+D+H ++ +YQL
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQL 127
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 212
LRGLKY+HSA ++HRDLKPSN+ +N +C+L+I DFGLAR D MT YV TRWYRAPE
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEMTGYVATRWYRAPE 185
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272
++LN Y +DIWSVGCI+ E++ + LFPG DY+ QL+ I E++G+P L + S
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332
++AR+Y++ LP P+Q+ F +P A+DLLEKMLV D ++RI+ EAL HPY + H
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305
Query: 333 DINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
D +EP P+ E+ T E KEL Y E F P
Sbjct: 306 DPEDEPEAE-PYDESPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 349 bits (898), Expect = e-119
Identities = 153/339 (45%), Positives = 215/339 (63%), Gaps = 7/339 (2%)
Query: 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLL 93
++E+ +Y + VG GAYG VC+A++ T E+VAIKK+ F + I AKR RE+ LL
Sbjct: 10 VWELPERYTSL-KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLL 68
Query: 94 RHMDHENIIAIKDIIRP-PQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQL 152
+HM HEN+I + D+ + F D Y+V M TDL +I+ L++D +Y +YQ+
Sbjct: 69 KHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHP--LSEDKVQYLVYQM 126
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 212
L GLKY+HSA ++HRDLKP NL +N +C+LKI DFGLAR MT YVVTRWYRAPE
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPE 184
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272
++LN Y +DIWSVGCI+ E++T + LF GKDY+ QL I ++ G P + L
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244
Query: 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332
A+ Y++ LP++P+++FS FP SP AVDLLEKML D ++R+T EAL HPY
Sbjct: 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304
Query: 333 DINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
D +EE +P+ E+ + + K+ IY+E F+P
Sbjct: 305 DADEETE-QQPYDDSLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 337 bits (865), Expect = e-114
Identities = 156/348 (44%), Positives = 229/348 (65%), Gaps = 6/348 (1%)
Query: 25 YVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK 84
Y + V ++EV +Y ++ VG GAYG VC+A++ T +VAIKK+ F + + AK
Sbjct: 1 YYRQEVNKTIWEVPDRY-RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAK 59
Query: 85 RTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDD 143
R RE++LL+HM HEN+I + D+ P + F+D Y+V M TDL ++++ H+ L++D
Sbjct: 60 RAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSED 118
Query: 144 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 203
++ +YQ+L+GLKY+H+A ++HRDLKP NL +N +C+LKI DFGLAR T MT YV
Sbjct: 119 RIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYV 176
Query: 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263
VTRWYRAPE++LN YT +DIWSVGCI+ E++T +PLF G D++ QL I ++ G+P
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236
Query: 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
+ + L+S++A+ YV+ LP+F K++F + PN +P AV++LEKMLV D RIT EAL
Sbjct: 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296
Query: 324 CHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
HPY HD +E P P+ F+ + E K L + E + F P
Sbjct: 297 AHPYFEEFHDPEDETEAP-PYDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 336 bits (864), Expect = e-114
Identities = 143/348 (41%), Positives = 211/348 (60%), Gaps = 27/348 (7%)
Query: 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI 101
V P RP+G GA+G+V + + + VA+KK+ N F N + KR RE+K+L H+N+
Sbjct: 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV 61
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
++ DI++PP + F ++Y+V ELM +DLH+II S Q L+ DH + FLYQ+LRGLKY+HS
Sbjct: 62 LSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS--ETDFMTEYVVTRWYRAPELLLNCSE 219
A +LHRD+KP NLL+N+NC LKI DFGLAR E+ MT+ VVT++YRAPE+L+
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRH 181
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
YT+A+DIWSVGCI E++ R+ LF + + QL LIT+L+G+P ++ AR ++
Sbjct: 182 YTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GARAHI 240
Query: 280 RMLPQFPKQNFSARFPNKSPG---AVDLLEKMLVFDPNRRITVDEALCHPYL-------- 328
P P + + S AV LL +MLVFDP++RI+ +AL HPYL
Sbjct: 241 LRGPHKPP-SLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYH 299
Query: 329 ------------APLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYR 364
++ + EP PF ++E + +KE +++
Sbjct: 300 TCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQ 347
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 321 bits (826), Expect = e-109
Identities = 120/290 (41%), Positives = 167/290 (57%), Gaps = 23/290 (7%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENI 101
+G G YG+V A + +T E VA+KKI R+D + LREI LL+ + H NI
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKI------RLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVH 160
+ + D+I T +Y+V+E D DL + + L+ + + +YQLLRGL Y H
Sbjct: 61 VKLLDVIH-----TERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSE 219
S +LHRDLKP N+L+N + LK+ DFGLAR T VVT WYRAPE+LL
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS-LGFLRSDNARRY 278
Y+ A+DIWSVGCI E++T +PLFPG + QL I +++G+P E S G + + Y
Sbjct: 176 YSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD---Y 232
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+FP ++ P P +DLL KML ++P +RI+ EAL HPY
Sbjct: 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 317 bits (815), Expect = e-107
Identities = 151/346 (43%), Positives = 213/346 (61%), Gaps = 20/346 (5%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
F V ++Y ++P+G GA GIVCAA ++ T + VAIKK+ F N AKR RE+ L++
Sbjct: 12 FTVLKRYQN-LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMK 70
Query: 95 HMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLL 153
++H+NII + ++ P + E F DVY+V ELMD +L Q+I DL + Y LYQ+L
Sbjct: 71 LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQML 128
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 213
G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART + MT YVVTR+YRAPE+
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 188
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
+L Y +DIWSVGCI+GE++ LFPG D++ Q I E +G+P + + L+
Sbjct: 189 ILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP- 246
Query: 274 NARRYVRMLPQFPKQNFSARFP-------------NKSPGAVDLLEKMLVFDPNRRITVD 320
R YV P++ +F FP K+ A DLL KMLV DP +RI+VD
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 321 EALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSFTEENIKELIYRE 365
+AL HPY+ +D +E E P P+ + T E KELIY+E
Sbjct: 307 DALQHPYINVWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYKE 352
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = e-101
Identities = 117/301 (38%), Positives = 168/301 (55%), Gaps = 36/301 (11%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDH 98
I +G G YG V A N +T E VA+KKI R++ ++ +REIKLL+ + H
Sbjct: 4 IAQIGEGTYGQVYKARNKKTGELVALKKI------RMENEKEGFPITAIREIKLLQKLRH 57
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLK 157
NI+ +K+I+ + +Y+V+E MD DL ++ S + T+ + ++ QLL GL+
Sbjct: 58 PNIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQ 114
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS--ETDFMTEYVVTRWYRAPELLL 215
Y+HS +LHRD+K SN+L+N + LK+ DFGLAR + + T V+T WYR PELLL
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLL 174
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+ Y +D+WSVGCIL E+ +P+F G + QL I EL GSP D
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPT---------DEN 225
Query: 276 RRYVRMLPQF----PKQNFSARFPNK-----SPGAVDLLEKMLVFDPNRRITVDEALCHP 326
V LP F PK+ + R P A+DLL+K+L DP +RI+ D+AL H
Sbjct: 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE 285
Query: 327 Y 327
Y
Sbjct: 286 Y 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 288 bits (740), Expect = 5e-97
Identities = 103/285 (36%), Positives = 157/285 (55%), Gaps = 35/285 (12%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G G++G V A + +T + VAIK I + D +R LREIK+L+ + H NI+ +
Sbjct: 4 LEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKK-DRERILREIKILKKLKHPNIVRL 62
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
D+ E + +Y+V E + DL +++ L++D R++L Q+L L+Y+HS
Sbjct: 63 YDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAA 223
++HRDLKP N+LL+ + +K+ DFGLAR + +T +V T Y APE+LL Y A
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL-GKGYGKA 176
Query: 224 IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 283
+DIWS+G IL E++T +P FPG D QL + + IG P
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKPP------------------ 215
Query: 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
F + SP A DL+ K+LV DP +R+T +EAL HP+
Sbjct: 216 ------FPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 287 bits (736), Expect = 3e-95
Identities = 135/346 (39%), Positives = 205/346 (59%), Gaps = 20/346 (5%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
F++ +Y+ +RP+G G+ G+V +A++S+ + VA+KKI + K LREIK++R
Sbjct: 1 FDLGSRYMD-LRPLGCGSNGLVFSAVDSDCDKRVAVKKI--VLTDPQSVKHALREIKIIR 57
Query: 95 HMDHENIIAIKDIIRPPQRE---------TFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 145
+DH+NI+ + +++ P + N VYIV E M+TDL ++ L+++H
Sbjct: 58 RLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVL-EQGPLSEEHA 116
Query: 146 RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTT----SETDFMT 200
R F+YQLLRGLKY+HSANVLHRDLKP+N+ +N + LKIGDFGLAR S +++
Sbjct: 117 RLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS 176
Query: 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 260
E +VT+WYR+P LLL+ + YT AID+W+ GCI E++T +PLF G + Q++LI E +
Sbjct: 177 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236
Query: 261 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD 320
E L + +VR P++ P +P A+D LE++L F+P R+T +
Sbjct: 237 VVREEDRNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295
Query: 321 EALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTE-ENIKELIYRE 365
EAL HPY++ +EPV PF + E I +IY
Sbjct: 296 EALMHPYMSCYSCPFDEPVSLHPFHIEDELDDILLMTEIHSIIYNW 341
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 6e-92
Identities = 123/295 (41%), Positives = 168/295 (56%), Gaps = 18/295 (6%)
Query: 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK----RT-LREIKLLR 94
+Y + +G G Y +V A + ET VAIKKI R +AK T LREIKLL+
Sbjct: 1 RYEK-GKKLGEGTYAVVYKARDKETGRIVAIKKIKL--GERKEAKDGINFTALREIKLLQ 57
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLL 153
+ H NII + D+ + +V+E M+TDL ++I+ LT + ++ L
Sbjct: 58 ELKHPNIIGLLDVFGHKSN-----INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTL 112
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPE 212
RGL+Y+HS +LHRDLKP+NLL+ ++ LK+ DFGLAR+ S MT VVTRWYRAPE
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPE 172
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272
LL Y +D+WSVGCI E++ R P PG + QL I E +G+P E + + S
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232
Query: 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
YV P FP FP S A+DLL+++L +PN+RIT +AL HPY
Sbjct: 233 LP--DYVEFKP-FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 277 bits (710), Expect = 4e-91
Identities = 151/359 (42%), Positives = 216/359 (60%), Gaps = 23/359 (6%)
Query: 23 GRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRID 82
++ V + F V ++Y ++P+G GA GIVCAA ++ VA+KK+ F N+
Sbjct: 5 SQFYSVQVADSTFTVLKRY-QQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 63
Query: 83 AKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLT 141
AKR RE+ LL+ ++H+NII++ ++ P + E F DVY+V ELMD +L Q+I H +L
Sbjct: 64 AKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--HMELD 121
Query: 142 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 201
+ Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART MT
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181
Query: 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 261
YVVTR+YRAPE++L Y +DIWSVGCI+GE++ +F G D++ Q + E +G+
Sbjct: 182 YVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240
Query: 262 PDETSLGFLRS--DNARRYVRMLPQFPKQNFSARFPN------------KSPGAVDLLEK 307
P S F+ R YV PQ+P +F FP+ K+ A DLL K
Sbjct: 241 P---SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSK 297
Query: 308 MLVFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSFTEENIKELIYRE 365
MLV DP++RI+VDEAL HPY+ +D E E P+ + E E KELIY+E
Sbjct: 298 MLVIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKE 356
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 268 bits (685), Expect = 2e-87
Identities = 149/345 (43%), Positives = 214/345 (62%), Gaps = 19/345 (5%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
F V ++Y ++P+G GA GIVCAA ++ VAIKK+ F N+ AKR RE+ L++
Sbjct: 13 FTVLKRY-QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 95 HMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLL 153
++H+NII++ ++ P + E F DVY+V ELMD +L Q+I+ +L + Y LYQ+L
Sbjct: 72 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQML 129
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 213
G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART + MT YVVTR+YRAPE+
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
+L Y +DIWSVGCI+GE++ + LFPG+DY+ Q + E +G+P + L+
Sbjct: 190 ILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP- 247
Query: 274 NARRYVRMLPQFPKQNFSARFPN------------KSPGAVDLLEKMLVFDPNRRITVDE 321
R YV P++ F FP+ K+ A DLL KMLV DP +RI+VDE
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307
Query: 322 ALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSFTEENIKELIYRE 365
AL HPY+ +D E E P+ + + T E KELIY+E
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE 352
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 7e-87
Identities = 148/345 (42%), Positives = 212/345 (61%), Gaps = 19/345 (5%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
F V ++Y ++P+G GA GIVCAA ++ VAIKK+ F N+ AKR RE+ L++
Sbjct: 20 FTVLKRY-QNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 95 HMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLL 153
++H+NII + ++ P + E F DVYIV ELMD +L Q+I+ +L + Y LYQ+L
Sbjct: 79 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQML 136
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 213
G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART + MT YVVTR+YRAPE+
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 196
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
+L Y +DIWSVGCI+GE++ LFPG D++ Q + E +G+P + L+
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP- 254
Query: 274 NARRYVRMLPQFPKQNFSARFPN------------KSPGAVDLLEKMLVFDPNRRITVDE 321
R YV P++ +F FP+ K+ A DLL KMLV D ++RI+VDE
Sbjct: 255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 314
Query: 322 ALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSFTEENIKELIYRE 365
AL HPY+ +D +E E P+ + T E KELIY+E
Sbjct: 315 ALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKE 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 263 bits (675), Expect = 9e-87
Identities = 113/297 (38%), Positives = 171/297 (57%), Gaps = 30/297 (10%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIA 103
I+ +G G +G V A N ET E VAIKK+ F + + LRE+K LR + +H NI+
Sbjct: 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPNIVK 62
Query: 104 IKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHS 161
+K++ R +++Y V+E M+ +L+Q+++ + ++ R +YQ+L+GL ++H
Sbjct: 63 LKEVFR-----ENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
HRDLKP NLL++ +KI DFGLAR T+YV TRWYRAPE+LL + Y+
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYS 177
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE----------TSLGFLR 271
+ +DIW++GCI+ E+ T +PLFPG + QL I ++G+P + + LGF
Sbjct: 178 SPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF-- 235
Query: 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
PQF + PN SP A+DL++ ML +DP +R T +AL HPY
Sbjct: 236 ---------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 2e-86
Identities = 109/292 (37%), Positives = 167/292 (57%), Gaps = 25/292 (8%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G GA+GIV A + ET E VA+KK+ + LREIK L+ H ++ + D+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 108 IRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLH 166
+V E M +DL +++R + L + + ++ LL+G+ Y+H+ ++H
Sbjct: 68 FPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMH 122
Query: 167 RDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAI 224
RDLKP+NLL++A+ LKI DFGLAR SE + + V TRWYRAPELL +Y +
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV 182
Query: 225 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 284
D+W+VGCI E++ PLFPG++ + QL ++ +G+P+E + L S LP
Sbjct: 183 DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS---------LPD 233
Query: 285 FPKQNFSAR--------FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ K F FP+ SP A+DLL+ +LV+DP++R++ EAL HPY
Sbjct: 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 257 bits (660), Expect = 8e-85
Identities = 96/286 (33%), Positives = 154/286 (53%), Gaps = 31/286 (10%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+R +G G++G V A + T + VA+K + + + REI++LR + H NI+ +
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
D E + +Y+V E + DL + L++D + Q+LRGL+Y+HS
Sbjct: 64 IDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG 118
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCSEYTA 222
++HRDLKP N+LL+ N +KI DFGLA+ ++ +T +V T WY APE+LL + Y
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178
Query: 223 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282
+D+WS+G IL E++T +P F G++ + QL+LI I P
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLI-RRILGPP------------------- 218
Query: 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+F + +S + S A DL++K L DP++R T +E L HP+
Sbjct: 219 LEFDEPKWS----SGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 9e-82
Identities = 112/291 (38%), Positives = 166/291 (57%), Gaps = 28/291 (9%)
Query: 51 GAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENIIAI 104
G YG+V A + +T E VA+KK+ +++ ++ +LREI +L + H NI+ +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKL------KMEKEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
K+++ + +Y+V E ++ DL ++ Q + + QLL G+ ++H
Sbjct: 70 KEVV---VGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW 126
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCSEYTA 222
+LHRDLK SNLLLN LKI DFGLAR T+ VVT WYRAPELLL EY+
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYST 186
Query: 223 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRM 281
AID+WSVGCI E++T++PLFPGK + QL I +L+G+P E GF A++
Sbjct: 187 AIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKK--- 243
Query: 282 LPQFPKQNFS---ARFPNKSPG--AVDLLEKMLVFDPNRRITVDEALCHPY 327
F K ++ +FP S DLL ++L +DP +RI+ ++AL HPY
Sbjct: 244 --TFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 247 bits (632), Expect = 3e-80
Identities = 109/285 (38%), Positives = 162/285 (56%), Gaps = 9/285 (3%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
VG GAYG+V N T E VAIKK + D+ K LRE+K+LR + HENI+ +K+
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 108 IRPPQRETFNDVYIVYELMDTDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLH 166
R R +Y+V+E ++ L +++ S L D R +++QLL+ + Y HS N++H
Sbjct: 69 FRRKGR-----LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIH 123
Query: 167 RDLKPSNLLLNANCDLKIGDFGLARTTSE--TDFMTEYVVTRWYRAPELLLNCSEYTAAI 224
RD+KP N+L++ + LK+ DFG AR +T+YV TRWYRAPELL+ + Y +
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPV 183
Query: 225 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 284
D+W++GCI+ E++ +PLFPG + QL LI + +G + S+ V
Sbjct: 184 DVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEP 243
Query: 285 FPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
++ R+P K S A+D L+ L DP R+T DE L HPY
Sbjct: 244 SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 244 bits (625), Expect = 2e-79
Identities = 118/297 (39%), Positives = 167/297 (56%), Gaps = 36/297 (12%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENI 101
+G G YG+V A + T E VA+KKI R++ + +REI LL+ ++H NI
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI------RLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYV 159
+ + D++ + +Y+V+E +D DL + + S L + +LYQLL+G+ Y
Sbjct: 61 VRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF------MTEYVVTRWYRAPEL 213
HS VLHRDLKP NLL++ LK+ DFGLAR F T VVT WYRAPE+
Sbjct: 116 HSHRVLHRDLKPQNLLIDREGALKLADFGLARA-----FGVPVRTYTHEVVTLWYRAPEI 170
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS- 272
LL +Y+ +DIWS+GCI E++ R+PLFPG + QL I +G+PDE + S
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230
Query: 273 -DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
D Y P++ +Q+ S PN +DLL KMLV+DP +RI+ AL HPY
Sbjct: 231 PD----YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 1e-77
Identities = 110/296 (37%), Positives = 161/296 (54%), Gaps = 30/296 (10%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMD---H 98
+G GAYG V A + T VA+KK+ R+ TLREI LL+ ++ H
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV------RVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGL 156
NI+ + D+ P+ + + +V+E +D DL + L + + + QLLRG+
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 216
++HS ++HRDLKP N+L+ ++ +KI DFGLAR S +T VVT WYRAPE+LL
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ 180
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET----SLGFLRS 272
S Y +D+WSVGCI E+ R+PLF G QL I ++IG P E ++ RS
Sbjct: 181 SS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239
Query: 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P + ++F + P +DLL+KML F+P++RI+ EAL HPY
Sbjct: 240 S--------FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 239 bits (612), Expect = 6e-77
Identities = 117/289 (40%), Positives = 172/289 (59%), Gaps = 20/289 (6%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENI 101
+G G YGIV A ++ + E VA+KK+ R+D +R +LREI LL ++ H NI
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVH 160
+ +K+++ + + +++V E + DL ++ + ++ + + QLLRGL+Y+H
Sbjct: 69 VELKEVV---VGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCSE 219
++HRDLK SNLLL LKI DFGLART MT VVT WYRAPELLL C+
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTT 185
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRY 278
YT AID+W+VGCIL E++ +PL PGK + QL LI +L+G+P+E+ GF ++
Sbjct: 186 YTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
LP+ P N +FP S + LL +L++DP +R T +EAL Y
Sbjct: 246 T--LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 233 bits (597), Expect = 4e-75
Identities = 113/290 (38%), Positives = 164/290 (56%), Gaps = 24/290 (8%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR-----TLREIKLLRHMDHENII 102
+G G Y V N T E VA+K+I +DA+ +REI L++ + HENI+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEI------HLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYV 159
+ D+I T N + +V+E MD DL + + +H L + + F YQLL+G+ +
Sbjct: 62 RLHDVI-----HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLART--TSETDFMTEYVVTRWYRAPELLLNC 217
H VLHRDLKP NLL+N +LK+ DFGLAR F E VVT WYRAP++LL
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRAPDVLLGS 175
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
Y+ +IDIWSVGCI+ E++T +PLFPG + QL I ++G+P E++
Sbjct: 176 RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWP--GISQLPE 233
Query: 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
Y P++P Q+ FP+ P +DLL ++L +P RI+ +AL HP+
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 6e-75
Identities = 102/286 (35%), Positives = 158/286 (55%), Gaps = 19/286 (6%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDI 107
G G + V A + +T + AIK + F + ++ LREI+ LR + H NI+ + ++
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 108 I--RPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANV 164
+ R R V+ELMD +L+++I+ + L + + ++YQLL+ L ++H +
Sbjct: 67 LFDRKTGRLAL-----VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121
Query: 165 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI 224
HRD+KP N+L+ + LK+ DFG R TEY+ TRWYRAPE LL Y +
Sbjct: 122 FHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKM 180
Query: 225 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 284
DIW+VGC+ EI++ PLFPG + + Q+ I +++G+PD L R+ M
Sbjct: 181 DIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF-----RKSRHMNYN 235
Query: 285 FPKQN---FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
FP + PN S +DLL+K+L +DP+ RIT +AL HPY
Sbjct: 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 231 bits (590), Expect = 4e-74
Identities = 118/298 (39%), Positives = 167/298 (56%), Gaps = 34/298 (11%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDH 98
+ +G G YG+V A N T E VA+KKI R+D + +REI LL+ ++H
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKI------RLDTETEGVPSTAIREISLLKELNH 58
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGL 156
NI+ + D+I T N +Y+V+E + DL + + + + + +L+QLL+GL
Sbjct: 59 PNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLL 215
+ HS VLHRDLKP NLL+N +K+ DFGLAR T VVT WYRAPE+LL
Sbjct: 114 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE------TSLGF 269
C Y+ A+DIWS+GCI E++TR+ LFPG + QL I +G+PDE TSL
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD 233
Query: 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+ P++ +Q+FS P DLL +ML +DPN+RI+ AL HP+
Sbjct: 234 YKPS--------FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 229 bits (587), Expect = 3e-73
Identities = 108/304 (35%), Positives = 156/304 (51%), Gaps = 35/304 (11%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108
G G +G V A +T VA+KKI + LREIK+L+ + H N++ + D+
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMA 76
Query: 109 --RPPQ-RETFNDVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANV 164
RP + + VY+V MD DL ++ + LT+ + ++ QLL G+ Y+H ++
Sbjct: 77 VERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHI 136
Query: 165 LHRDLKPSNLLLNANCDLKIGDFGLAR-------------TTSETDFMTEYVVTRWYRAP 211
LHRD+K +N+L++ LKI DFGLAR + T VVTRWYR P
Sbjct: 137 LHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY-TNLVVTRWYRPP 195
Query: 212 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271
ELLL YT A+DIW +GC+ E+ TR+P+ GK + QL LI +L G+P E + R
Sbjct: 196 ELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWR 255
Query: 272 SDNARRYVRMLPQFPKQNFSARFPNK--------SPGAVDLLEKMLVFDPNRRITVDEAL 323
S LP + +P P +DLL K+L DP +R+T +AL
Sbjct: 256 S---------LPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306
Query: 324 CHPY 327
HPY
Sbjct: 307 EHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 8e-72
Identities = 115/291 (39%), Positives = 167/291 (57%), Gaps = 11/291 (3%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G G YG+V A + T E +A+KKI ++ +REI LL+ M H NI+ ++D+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 108 IRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH--CRYFLYQLLRGLKYVHSANVL 165
+ +R +Y+V+E +D DL + + S D + + +LYQ+LRG+ Y HS VL
Sbjct: 70 VHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL 124
Query: 166 HRDLKPSNLLLNANCD-LKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAA 223
HRDLKP NLL++ + LK+ DFGLAR T VVT WYRAPE+LL Y+
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTP 184
Query: 224 IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 283
+DIWSVGCI E++ ++PLFPG + +L I ++G+P+E + + S Y P
Sbjct: 185 VDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS--LPDYKSAFP 242
Query: 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334
++P ++ + P P VDLL KML DP++RIT AL H Y L D
Sbjct: 243 KWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293
|
Length = 294 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 1e-70
Identities = 114/320 (35%), Positives = 173/320 (54%), Gaps = 35/320 (10%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGN-AFDNRIDAKR-------- 85
F +S +Y+ +G G YG V A ++ T + VAIKK+ N + R
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 86 ---TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTD 142
TLRE+K++ + HENI+ + D+ + + N +V ++M +DL +++ LT+
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVY--VEGDFIN---LVMDIMASDLKKVVDRKIRLTE 118
Query: 143 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR----------- 191
+ L Q+L GL +H +HRDL P+N+ +N+ KI DFGLAR
Sbjct: 119 SQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 192 ----TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 247
T + MT VVT WYRAPELL+ +Y A+D+WSVGCI E++T +PLFPG++
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
Query: 248 YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEK 307
+ QL I EL+G+P+E + + ++ Y P+ PK + FPN S A+DLL+
Sbjct: 239 EIDQLGRIFELLGTPNEDN--WPQAKKLPLYTEFTPRKPK-DLKTIFPNASDDAIDLLQS 295
Query: 308 MLVFDPNRRITVDEALCHPY 327
+L +P RI+ EAL H Y
Sbjct: 296 LLKLNPLERISAKEALKHEY 315
|
Length = 335 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 7e-70
Identities = 110/287 (38%), Positives = 156/287 (54%), Gaps = 12/287 (4%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G G YG V A N ET E VA+K++ D+ LREI LL+ + H+NI+ +
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH-CRYFLYQLLRGLKYVHSAN 163
D++ ++ T +V+E D DL + S D + F++QLL+GL + HS N
Sbjct: 65 YDVLHSDKKLT-----LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLART--TSETDFMTEYVVTRWYRAPELLLNCSEYT 221
VLHRDLKP NLL+N N +LK+ DFGLAR + E VVT WYR P++L Y+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYS 178
Query: 222 AAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
+ID+WS GCI E+ +PLFPG D QL+ I L+G+P E S + Y
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV--SKLPDYKP 236
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+ P + DLL+ +LV +P +RI+ +EAL HPY
Sbjct: 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 4e-69
Identities = 109/292 (37%), Positives = 161/292 (55%), Gaps = 13/292 (4%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN-IIA 103
+ +G G YG V A + T + VA+KK D LREI LL+ + I+
Sbjct: 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 104 IKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-----QDLTDDHCRYFLYQLLRGLKY 158
+ D+ ++ +Y+V+E +D+DL + + S+ + L + F+YQLL+G+ +
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 159 VHSANVLHRDLKPSNLLLNANCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 216
H V+HRDLKP NLL++ LKI D GL R + T +VT WYRAPE+LL
Sbjct: 126 CHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG 185
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNA 275
+ Y+ +DIWSVGCI E+ +QPLFPG + QL I +L+G+P E G + +
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDW 245
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+ PQ+ Q+ S P+ SP +DLL+KML +DP +RI+ AL HPY
Sbjct: 246 HEF----PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 2e-68
Identities = 121/306 (39%), Positives = 169/306 (55%), Gaps = 37/306 (12%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDH 98
I +G G YG V A + +T E VA+KK+ R+D ++ +REIK+LR ++H
Sbjct: 12 IGQIGEGTYGQVYKARDKDTGELVALKKV------RLDNEKEGFPITAIREIKILRQLNH 65
Query: 99 ENIIAIKDIIRPPQ-----RETFNDVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQL 152
NI+ +K+I+ Q ++ Y+V+E MD DL ++ S ++DH + F+ QL
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRA 210
L GL Y H N LHRD+K SN+LLN +K+ DFGLAR + E+ T V+T WYR
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRP 185
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270
PELLL Y AID+WS GCILGE+ T++P+F + QL LI+ L GSP
Sbjct: 186 PELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA----- 240
Query: 271 RSDNARRYVRMLPQF----PKQNFSAR----FPNKSPGAVDLLEKMLVFDPNRRITVDEA 322
V LP F PK+ + R F A+DLL+ ML DP++R T +EA
Sbjct: 241 ----VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA 296
Query: 323 LCHPYL 328
L P+L
Sbjct: 297 LNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 4e-68
Identities = 109/293 (37%), Positives = 159/293 (54%), Gaps = 24/293 (8%)
Query: 47 PVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR-----TLREIKLLRHMDHENI 101
+G G+Y V + T + VA+K+I R++ + +RE LL+ + H NI
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH-CRYFLYQLLRGLKYVH 160
+ + DII + T V+E +DTDL Q + H R FL+QLLRGL Y H
Sbjct: 66 VTLHDIIHTKKTLTL-----VFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSE 219
VLHRDLKP NLL++ +LK+ DFGLAR S + + VVT WYR P++LL +E
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSP-DETSLGFLRSDNARR 277
Y+ ++D+W VGCI E+ T +PLFPG D QL I ++G+P +ET G + +
Sbjct: 181 YSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240
Query: 278 YVRMLPQFPKQNFSARFP--NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
Y P +P + P ++ P +L K L ++P +RI+ EA+ HPY
Sbjct: 241 Y--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 2e-66
Identities = 107/294 (36%), Positives = 161/294 (54%), Gaps = 23/294 (7%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I +G G YG+V N +T + VA+KKI + +REI LL+ + H NI+ +
Sbjct: 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLHQI---IRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
+D++ R +Y+++E + DL + + Q + + + +LYQ+L+G+ + HS
Sbjct: 65 QDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEY 220
VLHRDLKP NLL++ +K+ DFGLAR T VVT WYRAPE+LL Y
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE------TSLGFLRSDN 274
+ +DIWS+G I E+ T++PLF G + QL I ++G+P E TSL
Sbjct: 180 STPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL------- 232
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
Y P++ K + + N +DLLEKML++DP +RI+ +AL HPY
Sbjct: 233 -PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 1e-65
Identities = 107/302 (35%), Positives = 158/302 (52%), Gaps = 34/302 (11%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR-----IDAKRTLREIKLLRHMDHENII 102
+G+G +G V A + +T++ VA+KK+ +N I A LREIK+L+ + HEN++
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITA---LREIKILQLLKHENVV 74
Query: 103 AIKDIIRPPQRETFN---DVYIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKY 158
+ +I R Y+V+E + DL ++ + + T + + LL GL Y
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-----DFMTEYVVTRWYRAPEL 213
+H +LHRD+K +N+L+ + LK+ DFGLAR S + + T VVT WYR PEL
Sbjct: 135 IHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL 194
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS------PDETSL 267
LL +Y ID+W GCI+ E+ TR P+ G HQL LI++L GS P L
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKL 254
Query: 268 GFLRSDNARRYVRMLPQFPKQNFSARFP--NKSPGAVDLLEKMLVFDPNRRITVDEALCH 325
+ LPQ K+ R K P A+DL++K+LV DP +RI D AL H
Sbjct: 255 ELFK-------KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307
Query: 326 PY 327
+
Sbjct: 308 DF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 206 bits (525), Expect = 3e-64
Identities = 92/282 (32%), Positives = 163/282 (57%), Gaps = 7/282 (2%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G G+YG+V N ET + VAIKK + D+ + K LREI++L+ + H N++ + ++
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLH 166
R ++ +++V+E D T L+++ ++ + + + + ++Q L+ + + H N +H
Sbjct: 69 FRRKRK-----LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123
Query: 167 RDLKPSNLLLNANCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCSEYTAAID 225
RD+KP N+L+ +K+ DFG AR + T+YV TRWYRAPELL+ ++Y +D
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVD 183
Query: 226 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 285
+W++GC+ E++T QPL+PGK V QL LI + +G ++ + + +
Sbjct: 184 VWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPE 243
Query: 286 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
++ ++FPN S A+ L+ L DP R++ +E L HPY
Sbjct: 244 TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 7e-64
Identities = 108/316 (34%), Positives = 165/316 (52%), Gaps = 44/316 (13%)
Query: 48 VGRGAYGIVCAAMNSETR--EEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+GRG YG V A + +E AIKK G+ ++ REI LLR + HEN++++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-----LTDDHCRYFLYQLLRGLKYV 159
++ ++ VY++++ + DL QII+ H+ + + L+Q+L G+ Y+
Sbjct: 68 VEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 160 HSANVLHRDLKPSNLLLNANCD----LKIGDFGLAR-------TTSETDFMTEYVVTRWY 208
HS VLHRDLKP+N+L+ +KIGD GLAR ++ D VVT WY
Sbjct: 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD---PVVVTIWY 181
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD---------YVHQLRLITELI 259
RAPELLL YT AIDIW++GCI E++T +P+F G++ QL I E++
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241
Query: 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA--------RFPNKSPGAVDLLEKMLVF 311
G+P E ++ Y ++ F + + + + DLL K+L +
Sbjct: 242 GTPTEKDWPDIK--KMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 312 DPNRRITVDEALCHPY 327
DP +RIT +EAL HPY
Sbjct: 300 DPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 5e-62
Identities = 103/286 (36%), Positives = 174/286 (60%), Gaps = 15/286 (5%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
VG G+YG+V + ET + VAIKK + D+++ K +REI++L+ + HEN++ + ++
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLH 166
R +R +Y+V+E +D T L + + L + R +L+Q+LRG+++ HS N++H
Sbjct: 69 FRRKKR-----LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123
Query: 167 RDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAID 225
RD+KP N+L++ + +K+ DFG ART + + T+YV TRWYRAPELL+ ++Y A+D
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVD 183
Query: 226 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG--SPDETSLGFLRSDNARRYVRM-L 282
IW+VGC++ E++T +PLFPG + QL I + +G P + F ++ + M L
Sbjct: 184 IWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEI-FQKN---PLFAGMRL 239
Query: 283 PQFPK-QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
P+ + + RFP S +DL ++ L DP+ R + + L H +
Sbjct: 240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 194 bits (493), Expect = 1e-59
Identities = 109/285 (38%), Positives = 161/285 (56%), Gaps = 13/285 (4%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT-LREIKLLRHMDHENIIAIKD 106
+G G Y V + T VA+K+I ++ A T +RE+ LL+++ H NI+ + D
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 107 IIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH-CRYFLYQLLRGLKYVHSANVL 165
II T + +V+E +D+DL Q + + +L H + F++QLLRGL Y H +L
Sbjct: 71 II-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAI 224
HRDLKP NLL+N +LK+ DFGLAR S T + VVT WYR P++LL +EY+ I
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 225 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYVRMLP 283
D+W VGCIL E+ T +P+FPG +L LI L+G+P E + G ++ R Y + P
Sbjct: 186 DMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY--LFP 243
Query: 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
Q+ Q P +DLL +L+++ RI+ + AL H Y
Sbjct: 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 189 bits (480), Expect = 2e-57
Identities = 110/288 (38%), Positives = 159/288 (55%), Gaps = 13/288 (4%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT-LREIKLLRHMDHENIIAIKD 106
+G G Y V + T VA+K+I ++ A T +RE+ LL+ + H NI+ + D
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEI--RLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 107 IIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH-CRYFLYQLLRGLKYVHSANVL 165
II T + +V+E +D DL Q + + + H + FL+QLLRGL Y H VL
Sbjct: 72 II-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAI 224
HRDLKP NLL+N +LK+ DFGLAR S T + VVT WYR P++LL ++Y+ I
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQI 186
Query: 225 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP-DETSLGFLRSDNARRYVRMLP 283
D+W VGCI E+ T +PLFPG QL I ++G+P +ET G L ++ + Y P
Sbjct: 187 DMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY--NYP 244
Query: 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331
++ P +LL K+L F+ +RI+ +EA+ HPY L
Sbjct: 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 3e-57
Identities = 103/283 (36%), Positives = 165/283 (58%), Gaps = 10/283 (3%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
VG GAYG+V + ET+E VAIKK ++ +N + TLRE+K+LR + ENI+ +K+
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 108 IRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLH 166
R + +Y+V+E ++ ++ +++ + + + R ++YQL++ + + H +++H
Sbjct: 69 FRRRGK-----LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVH 123
Query: 167 RDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAI 224
RD+KP NLL++ N LK+ DFG AR SE TEYV TRWYR+PELLL + Y A+
Sbjct: 124 RDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG-APYGKAV 182
Query: 225 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 284
D+WSVGCILGE+ QPLFPG+ + QL I +++G + S+ +R
Sbjct: 183 DMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242
Query: 285 FPKQNFSARFPNKSPGA-VDLLEKMLVFDPNRRITVDEALCHP 326
Q+ R+ G +DL++ +L +P R ++ L HP
Sbjct: 243 NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 8e-56
Identities = 110/288 (38%), Positives = 159/288 (55%), Gaps = 13/288 (4%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT-LREIKLLRHMDHENIIAIKD 106
+G G Y V + T VA+K+I ++ A T +RE+ LL+ + H NI+ + D
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEI--RLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 107 IIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDH-CRYFLYQLLRGLKYVHSANVL 165
I+ T + +V+E +D DL Q + ++ H + FLYQ+LRGL Y H VL
Sbjct: 72 IV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAI 224
HRDLKP NLL+N +LK+ DFGLAR S T + VVT WYR P++LL SEY+ I
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 225 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP-DETSLGFLRSDNARRYVRMLP 283
D+W VGCI E+ + +PLFPG +L LI L+G+P +ET G +D + Y P
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY--NFP 244
Query: 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331
++ Q P ++LL K L ++ +RI+ +EA+ H Y L
Sbjct: 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-55
Identities = 69/193 (35%), Positives = 113/193 (58%), Gaps = 10/193 (5%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G G +G V A + +T ++VAIK I D+ + LREI++L+ ++H NI+ + +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVL 165
E N +Y+V E + L +++ + L++D L Q+L GL+Y+HS ++
Sbjct: 60 F-----EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 166 HRDLKPSNLLLNANCD-LKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAA 223
HRDLKP N+LL+++ +K+ DFGL++ TS+ + V T Y APE+LL Y+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 224 IDIWSVGCILGEI 236
DIWS+G IL E+
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 1e-54
Identities = 104/288 (36%), Positives = 158/288 (54%), Gaps = 10/288 (3%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G G+Y V ++ + VA+K I + + +RE LL+ + H NI+ +
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFT-AIREASLLKGLKHANIVLL 68
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSAN 163
DII + TF V+E M TDL Q + H L + R F++QLLRGL Y+H +
Sbjct: 69 HDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSEYTA 222
+LHRDLKP NLL++ +LK+ DFGLAR S + + VVT WYR P++LL ++Y++
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 223 AIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSP-DETSLGFLRSDNARRYVR 280
A+DIW GCI E++ QP FPG D QL I ++G P ++T G + N +
Sbjct: 184 ALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ + + + ++ P A DL +ML+ P RI+ +AL HPY
Sbjct: 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 7e-54
Identities = 86/287 (29%), Positives = 139/287 (48%), Gaps = 36/287 (12%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+GRG++G V A++ +T E +A+K + + D+ + + REI++L + H NI+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
R ++ T N I E + L +++ L + R + Q+L GL Y+HS +
Sbjct: 66 GSERDEEKNTLN---IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGI 122
Query: 165 LHRDLKPSNLLLNANCDLKIGDFGLART--TSETDFMTEYVV-TRWYRAPELLLNCSEYT 221
+HRD+K +N+L++++ +K+ DFG A+ ET T V T ++ APE ++ EY
Sbjct: 123 VHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYG 181
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281
A DIWS+GC + E+ T +P + IGS E
Sbjct: 182 RAADIWSLGCTVIEMATGKPPWSELGNPMAALY---KIGSSGE----------------- 221
Query: 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+ P+ + S A D L K L DP +R T DE L HP+L
Sbjct: 222 PPEIPE--------HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 175 bits (444), Expect = 3e-52
Identities = 105/298 (35%), Positives = 153/298 (51%), Gaps = 26/298 (8%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR---HMDHEN 100
P+ +G GAYG V A + + VA+K + + T+RE+ LL+ DH N
Sbjct: 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKY 158
I+ + D+ + + V +V+E +D DL + L + + + Q LRGL +
Sbjct: 64 IVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 218
+H+ ++HRDLKP N+L+ + +K+ DFGLAR S +T VVT WYRAPE+LL S
Sbjct: 124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ-S 182
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278
Y +D+WSVGCI E+ R+PLF G QL I +LIG P E D+ R
Sbjct: 183 TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE--------DDWPRD 234
Query: 279 VRMLPQFPKQNFSAR--------FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
V + P+ FS R P LL +ML F+P++RI+ AL HP+
Sbjct: 235 VTL----PRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 8e-48
Identities = 81/298 (27%), Positives = 141/298 (47%), Gaps = 49/298 (16%)
Query: 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE 99
KY I+ +G+G++G V + +K+I + + + + L E+K+L+ ++H
Sbjct: 1 KYEI-IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHP 59
Query: 100 NIIAIKDIIRPPQRETFND---VYIVYELMD-TDLHQIIRSHQD----LTDDHCRYFLYQ 151
NII E+F + + IV E D DL Q I+ + ++ + Q
Sbjct: 60 NIIKY--------YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ 111
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-TRWYRA 210
L LKY+HS +LHRD+KP N+ L +N +K+GDFG+++ S T + + VV T +Y +
Sbjct: 112 LCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270
PEL N Y DIWS+GC+L E+ T + F G+ + L L +++
Sbjct: 172 PELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGE---NLLELALKIL----------- 216
Query: 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ +P +S+ +L+ +L DP R ++ + L P++
Sbjct: 217 -----KGQYPPIP----SQYSSEL-------RNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 165 bits (418), Expect = 2e-47
Identities = 83/324 (25%), Positives = 143/324 (44%), Gaps = 42/324 (12%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDHE-NII 102
+R +G G++G V A + R+ VA+K + +++ +R LREI++L ++H NI+
Sbjct: 5 LRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 103 AIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKY 158
+ D + +Y+V E +D L +++ L++ + L Q+L L+Y
Sbjct: 62 KLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 159 VHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETD-------FMTEYVVTRWYRA 210
+HS ++HRD+KP N+LL+ + +K+ DFGLA+ + + V T Y A
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 211 PELLL--NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268
PE+LL + + +++ DIWS+G L E++T P F G+ ++I
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII--------- 227
Query: 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P + S A DLL+K+L DP R++ L H L
Sbjct: 228 ---------LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL 278
Query: 329 APLHDINEEPVCPRPFSFDFEHPS 352
A L +
Sbjct: 279 AHLKLKESDLSDLLKPDDSAPLRL 302
|
Length = 384 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 2e-47
Identities = 101/294 (34%), Positives = 154/294 (52%), Gaps = 19/294 (6%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREE-VAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HE 99
+ +G GAYG V A + + VA+K++ T+RE+ +LRH++ H
Sbjct: 5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHP 64
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLK 157
N++ + D+ + + + +V+E +D DL + + + + + ++QLLRGL
Sbjct: 65 NVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217
++HS V+HRDLKP N+L+ ++ +K+ DFGLAR S +T VVT WYRAPE+LL
Sbjct: 125 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ- 183
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE----TSLGFLRSD 273
S Y +D+WSVGCI E+ R+PLF G V QL I ++IG P E + R
Sbjct: 184 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 243
Query: 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+ P + F + DLL K L F+P +RI+ AL HPY
Sbjct: 244 FHSK-----SAQPIEKF---VTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 104/327 (31%), Positives = 173/327 (52%), Gaps = 28/327 (8%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G G++G+V A+ +T E+VAIKK+ D + RE+ ++++++H NII +KD
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQ------DPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 108 -----IRPPQRETFNDVYIVYELMDTDLHQII----RSHQDLTDDHCRYFLYQLLRGLKY 158
+ ++ F +V V E + +H+ + R++ L + + YQL R L Y
Sbjct: 128 YYTECFKKNEKNIFLNV--VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY 185
Query: 159 VHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217
+HS + HRDLKP NLL++ N LK+ DFG A+ Y+ +R+YRAPEL+L
Sbjct: 186 IHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
+ YT ID+WS+GCI+ E++ P+F G+ V QL I +++G+P E L + + A
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYAD- 304
Query: 278 YVRMLPQFPKQNFSARFPNKSP-GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336
P ++ FP +P A++ + + L ++P +R+ EAL P+ L D
Sbjct: 305 --IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD--- 359
Query: 337 EPVCPRPFSFDF--EHPSFTEENIKEL 361
P P D + +F + IKE+
Sbjct: 360 -PCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 3e-45
Identities = 106/307 (34%), Positives = 156/307 (50%), Gaps = 42/307 (13%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI------GNAFDNRIDAKRTLREIKLLRHMDH 98
+ +G G+Y V + + VA+K I G F +RE LL+ + H
Sbjct: 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT-------AIREASLLKGLKH 62
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLK 157
NI+ + DII +ET +V+E + TDL Q + H L ++ + FL+QLLRGL
Sbjct: 63 ANIVLLHDIIH--TKETLT---LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLN 216
Y+H +LHRDLKP NLL++ +LK+ DFGLAR S + + VVT WYR P++LL
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG 177
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+EY+ +D+W VGCI E++ FPG KD QL I ++G+P+E + + S
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS--- 234
Query: 276 RRYVRMLPQFPKQNFSARFPNKS-----------PGAVDLLEKMLVFDPNRRITVDEALC 324
LP F + F+ + K+ A DL K+L P R++ AL
Sbjct: 235 ------LPHFKPERFTL-YSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287
Query: 325 HPYLAPL 331
H Y + L
Sbjct: 288 HEYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 3e-45
Identities = 78/293 (26%), Positives = 135/293 (46%), Gaps = 46/293 (15%)
Query: 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN 100
+ +G+G +G V A + T +EVAIK I +++ ++ + EI++L+ H N
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--KLESKEKKEKIINEIQILKKCKHPN 58
Query: 101 IIA-IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLK 157
I+ ++ ++++IV E L +++S Q LT+ Y +LL+GL+
Sbjct: 59 IVKYYGSYLKK------DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE 112
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217
Y+HS ++HRD+K +N+LL ++ ++K+ DFGL+ S+T V T ++ APE ++N
Sbjct: 113 YLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE-VING 171
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
Y DIWS+G E+ +P P + L A
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKP--PYSE----------------------LPPMKALF 207
Query: 278 YVRMLPQFPKQNFSARFPNK---SPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+ P N S D L+K L +P +R T ++ L HP+
Sbjct: 208 KIATNG-PPG------LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 3e-42
Identities = 86/296 (29%), Positives = 137/296 (46%), Gaps = 62/296 (20%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G GA G V A + T +EVAIKK+ N+ + + EI +++ H NI+ D
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK---ELIINEILIMKDCKHPNIV---DY 80
Query: 108 IRPPQRETF---NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
+++ +++++V E MD TD+ I ++ + + Y ++L+GL+Y+H
Sbjct: 81 Y-----DSYLVGDELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
S NV+HRD+K N+LL+ + +K+ DFG A+ T E V T ++ APE++ +
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KD 192
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI-GSP---DETSLG--FLRSD 273
Y +DIWS+G IM E+ G P E L FL +
Sbjct: 193 YGPKVDIWSLG-----IMCI-----------------EMAEGEPPYLREPPLRALFLITT 230
Query: 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
+P SP D L K LV DP +R + +E L HP+L
Sbjct: 231 KG------IPPLKNPE------KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 8e-41
Identities = 86/285 (30%), Positives = 136/285 (47%), Gaps = 42/285 (14%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+GRGA+G+V +N ET + VAIK+I K ++EI LL+++ H NI+
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 108 IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLH 166
I ET + +YI+ E + L QII+ + ++YQ+L+GL Y+H V+H
Sbjct: 68 I-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIH 122
Query: 167 RDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCSEYTAAID 225
RD+K +N+L + +K+ DFG+A ++ VV T ++ APE++ S + A D
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-SGASTASD 181
Query: 226 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL--IGSPDETSLGFLRSDNARRYVRMLP 283
IWS+GC + E++T P + + L + L I D P
Sbjct: 182 IWSLGCTVIELLTGNPPY------YDLNPMAALFRIVQDDH------------------P 217
Query: 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+ SP D L + DPN R T + L HP++
Sbjct: 218 PLPE--------GISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 77/287 (26%), Positives = 134/287 (46%), Gaps = 45/287 (15%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G+G++G V +T + A+K + + + + TL E +L ++H I+ +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK-EVEHTLTERNILSRINHPFIVKLH 59
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
+T +Y+V E +L + +++ R++ +++ L+Y+HS +
Sbjct: 60 YAF-----QTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 165 LHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAA 223
++RDLKP N+LL+A+ +K+ DFGLA+ +SE + T Y APE+LL Y A
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKA 173
Query: 224 IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 283
+D WS+G +L E++T +P F +D I E I L+
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKI----------LKDP---------L 210
Query: 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC---HPY 327
+FP SP A DL+ +L DP +R+ A HP+
Sbjct: 211 RFP--------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 67/217 (30%), Positives = 109/217 (50%), Gaps = 26/217 (11%)
Query: 45 IRPVGRGAYGIVCAAM----NSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHE 99
+ +G GA+G V + + EVA+K + +A + +I + LRE +++R +DH
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLK 157
N++ + + + +YIV E M+ DL +R ++ L+ F Q+ RG++
Sbjct: 62 NVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAP 211
Y+ S N +HRDL N L+ N +KI DFGL+R + D Y RW AP
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRWM-AP 172
Query: 212 ELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKD 247
E L ++T+ D+WS G +L EI T + +PG
Sbjct: 173 ESLKE-GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS 208
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 2e-38
Identities = 68/218 (31%), Positives = 106/218 (48%), Gaps = 27/218 (12%)
Query: 45 IRPVGRGAYGIVCAAM----NSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHE 99
+ +G GA+G V EVA+K + +A + +I + LRE +++R +DH
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD--LTDDHCRYFLYQLLRGL 156
NI+ + + + + IV E M DL +R ++ L+ F Q+ RG+
Sbjct: 62 NIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT------RWYRA 210
+Y+ S N +HRDL N L+ N +KI DFGL+R + D Y V RW A
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWM-A 172
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKD 247
PE L ++T+ D+WS G +L EI T + +PG
Sbjct: 173 PESLKE-GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS 209
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 104/326 (31%), Positives = 159/326 (48%), Gaps = 62/326 (19%)
Query: 48 VGRGAYGIVCAAMNSETREE--VAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
VGRG YG V A + ++E A+K+I G + REI LLR + H N+IA+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIAL 63
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ---------DLTDDHCRYFLYQLLRG 155
+ + + V+++++ + DL II+ H+ L + LYQ+L G
Sbjct: 64 QKVF---LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCD----LKIGDFGLARTTSET----DFMTEYVVTRW 207
+ Y+H+ VLHRDLKP+N+L+ +KI D G AR + + VVT W
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD---------YVHQLRLITEL 258
YRAPELLL YT AIDIW++GCI E++T +P+F + + QL I +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240
Query: 259 IGSPDETSLGFLRSDNARRYVRMLPQFP--KQNF-SARFPNKS-------------PGAV 302
+G P +D +R +P++P +++F + N S
Sbjct: 241 MGFP---------ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVF 291
Query: 303 DLLEKMLVFDPNRRITVDEALCHPYL 328
LL+K+L DP +RIT ++AL PY
Sbjct: 292 LLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 4e-38
Identities = 78/292 (26%), Positives = 132/292 (45%), Gaps = 46/292 (15%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII-- 102
++ +G+G+ G+V + T + A+KKI + + K+ LRE+K LR + ++
Sbjct: 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 103 --AIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
A + + + IV E MD L +++ + + Y Q+L+GL Y+
Sbjct: 65 YGAF---YKEGE------ISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYL 115
Query: 160 HS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNC 217
H+ +++HRD+KPSNLL+N+ ++KI DFG+++ T +V T Y +PE +
Sbjct: 116 HTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE-RIQG 174
Query: 218 SEYTAAIDIWSVGCILGE-IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
Y+ A DIWS+G L E + + P P L+ + P
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-FFELMQAICDGP-------------- 219
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P P + FS F D + L DP +R + E L HP++
Sbjct: 220 -----PPSLPAEEFSPEF-------RDFISACLQKDPKKRPSAAELLQHPFI 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 1e-37
Identities = 80/288 (27%), Positives = 137/288 (47%), Gaps = 44/288 (15%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL----REIKLLRHMDHENIIA 103
+G G++G V +N + + A+K++ + D+ + + +EI LL + H NI+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEV-SLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+RE N +YI EL+ L ++++ + + R + Q+L GL+Y+H
Sbjct: 67 Y----LGTEREEDN-LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR 121
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA 222
N +HRD+K +N+L++ N +K+ DFG+A+ E F + + ++ APE++ Y
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGL 181
Query: 223 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL--IGSPDETSLGFLRSDNARRYVR 280
A DIWS+GC + E+ T +P + QL + + IG E
Sbjct: 182 AADIWSLGCTVLEMATGKPPW------SQLEGVAAVFKIGRSKE---------------- 219
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
LP P + S A D + K L DP+ R T E L HP++
Sbjct: 220 -LPPIPD--------HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 42/290 (14%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G G +G V A+N +T E +A+K+I ++ K E+K+L + H N++ +
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHC-RYFLYQLLRGLKYVHSANVL 165
RE VYI E L +++ H + D+H R + QLL GL Y+HS ++
Sbjct: 68 --EVHRE---KVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLA-----RTTSETDFMTEYVVTRWYRAPELLLN--CS 218
HRD+KP+N+ L+ N +K+GDFG A TT+ + + T Y APE++
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278
+ A DIWS+GC++ E+ T + + D Q I +G+
Sbjct: 182 GHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFHVGA----------------- 221
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P P SP D L++ L DP +R T E L HP++
Sbjct: 222 -GHKPPIPDSL------QLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 8e-36
Identities = 99/319 (31%), Positives = 157/319 (49%), Gaps = 48/319 (15%)
Query: 48 VGRGAYGIVCAAMNSETREE--VAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
VGRG YG V A + +++ A+K+I G + REI LLR + H N+I++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISL 63
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ---------DLTDDHCRYFLYQLLRG 155
+ + V+++++ + DL II+ H+ L + LYQ+L G
Sbjct: 64 QKVF---LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCD----LKIGDFGLARTTSET----DFMTEYVVTRW 207
+ Y+H+ VLHRDLKP+N+L+ +KI D G AR + + VVT W
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD--------YVH-QLRLITEL 258
YRAPELLL YT AIDIW++GCI E++T +P+F + Y H QL I +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240
Query: 259 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS----ARFPNK-----SPGAVDLLEKML 309
+G P + ++ + ++ F + ++ ++ K A LL+K+L
Sbjct: 241 MGFPADKDWEDIK--KMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLL 298
Query: 310 VFDPNRRITVDEALCHPYL 328
DP +RIT ++A+ PY
Sbjct: 299 TMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 8e-34
Identities = 82/294 (27%), Positives = 140/294 (47%), Gaps = 49/294 (16%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT--LREIKLLRHMDHENIIAIK 105
+G+G++G V + + K+I + N + ++ + E+ +LR + H NI+
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQII----RSHQDLTDDHCRYFLYQLLRGLKYVH 160
D I +T +YIV E + DL Q+I + + + ++ L QLL L H
Sbjct: 66 DRIIDRSNQT---LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 161 -----SANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELL 214
VLHRDLKP+N+ L+AN ++K+GDFGLA+ ++ F YV T +Y +PE L
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL 182
Query: 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
+ Y DIWS+GC++ E+ P F ++ QL+L ++ ++
Sbjct: 183 NH-MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASK------------IKEGK 226
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
RR +P S ++++ ML DP++R + +E L P +
Sbjct: 227 FRR----IPYR-----------YSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 122 bits (310), Expect = 8e-33
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 45 IRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN 100
+ +G GA+G V T +VA+K + + + L E +++ + H N
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE-EREEFLEEASIMKKLSHPN 62
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKY 158
I+ + + + +YIV E M DL +R H + LT Q+ +G++Y
Sbjct: 63 IVRLLGVCTQGEP-----LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEY 117
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAP 211
+ S N +HRDL N L+ N +KI DFGL+R E D Y +W AP
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWM-AP 173
Query: 212 ELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKD 247
E L + ++T+ D+WS G +L EI T QP +PG
Sbjct: 174 ESLKDG-KFTSKSDVWSFGVLLWEIFTLGEQP-YPGMS 209
|
Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 88/323 (27%), Positives = 135/323 (41%), Gaps = 87/323 (26%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK----------LL 93
+ +G G++ V A ET +E AIK +D ++ ++E K L
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIK--------ILDKRQLIKEKKVKYVKIEKEVLT 56
Query: 94 RHMDHENIIAIKDIIRPPQRETFND---VYIVYELM-DTDLHQIIRSHQDLTDDHCRYFL 149
R H II + TF D +Y V E + +L Q IR + L + R++
Sbjct: 57 RLNGHPGIIKLYY--------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYA 108
Query: 150 YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-------- 201
++L L+Y+HS ++HRDLKP N+LL+ + +KI DFG A+
Sbjct: 109 AEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 202 -------------YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY 248
+V T Y +PELL + D+W++GCI+ +++T +P F G +
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNE 227
Query: 249 VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKM 308
+ I +L FP PN P A DL+EK+
Sbjct: 228 YLTFQKILKL-----------------------EYSFP--------PNFPPDAKDLIEKL 256
Query: 309 LVFDPNRRITV----DEALCHPY 327
LV DP R+ V DE HP+
Sbjct: 257 LVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-32
Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 34/234 (14%)
Query: 46 RPVGRGAYGIVCAAM---NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII 102
+ +G GA+G V EVA+K + + + K L+E ++++ + H N++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 103 AIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCR---------YFLYQL 152
+ + + +Y+V E M+ DL +R + + + F Q+
Sbjct: 60 RLLGVCTEEEP-----LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT------- 205
+G++Y+ S +HRDL N L+ + +KI DFGL+R + D+ Y
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPI 171
Query: 206 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR--QPLFPGKDYVHQLRLITE 257
RW APE L + +T+ D+WS G +L EI T P +PG L + +
Sbjct: 172 RWM-APESLKD-GIFTSKSDVWSFGVLLWEIFTLGATP-YPGLSNEEVLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 6e-31
Identities = 71/213 (33%), Positives = 114/213 (53%), Gaps = 25/213 (11%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK---RTLREIKLLRHMDHENII 102
+ +G+G + +V A+ VA+KK+ F+ +DAK L+EI LL+ +DH N+I
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKV-QIFE-MMDAKARQDCLKEIDLLKQLDHPNVI 65
Query: 103 AIKDIIRPPQRETF---NDVYIVYELMDT-DLHQII---RSHQDLTDDHC--RYFLYQLL 153
+F N++ IV EL D DL ++I + + L + +YF QL
Sbjct: 66 KYLA--------SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYF-VQLC 116
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPE 212
L+++HS ++HRD+KP+N+ + A +K+GD GL R +S+T V T +Y +PE
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 245
+ + Y DIWS+GC+L E+ Q F G
Sbjct: 177 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 9e-31
Identities = 81/304 (26%), Positives = 140/304 (46%), Gaps = 56/304 (18%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNA---FDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +GAYG V A T + AIK I A N++D T R+I L ++ +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL 58
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
+ ++Y+V E + DL ++ + L +D R ++ +++ L+Y+HS
Sbjct: 59 YYSFQ-----GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLART--TSETDFM-------TEYVVTRWYRAPELL 214
++HRDLKP N+L+++N LK+ DFGL++ + V T Y APE++
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
L ++ +D WS+GCIL E + P F G+ +P+E L
Sbjct: 174 LG-QGHSKTVDWWSLGCILYEFLVGIPPFHGE--------------TPEEIFQNIL---- 214
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLAPL 331
+ ++P+ S A+DL+ K+LV DP +R+ +++E HP+
Sbjct: 215 NGKI-----EWPE------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFK-- 261
Query: 332 HDIN 335
I+
Sbjct: 262 -GID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 85/294 (28%), Positives = 131/294 (44%), Gaps = 61/294 (20%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKK--IGNAFDNRIDAKRTLREIKLLRHMDHENIIA-- 103
+G G+YG V A++ ET + VAIK + I +EI +L+ D I+
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII------KEISILKQCDSPYIVKYY 64
Query: 104 ---IKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
K+ D++IV E +D+ +I LT++ LYQ L+GL
Sbjct: 65 GSYFKN----------TDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGL 112
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLL 215
+Y+HS +HRD+K N+LLN K+ DFG++ ++T V+ T ++ APE++
Sbjct: 113 EYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
Y DIWS+G E+ +P P D +H +R I
Sbjct: 173 E-IGYNNKADIWSLGITAIEMAEGKP--PYSD-IHPMRAIF------------------- 209
Query: 276 RRYVRMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
M+P P S P K SP D ++K LV DP R + + L HP++
Sbjct: 210 -----MIPNKPPPTLSD--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-30
Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 43/293 (14%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKI-------GNAFDNRIDAKRTLR-EIKLLRHMDHE 99
+G+G YG V A+N T E +A+K++ G + D + LR EI+ L+ +DH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
NI+ T + I E + + +R++ + R+F Q+L GL Y
Sbjct: 69 NIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY 123
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLL 215
+HS +LHRDLK NLL++A+ KI DFG+++ + + D + ++ APE++
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183
Query: 216 NCSE-YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
+ S+ Y+A +DIWS+GC++ E +F G+ I + LG RS
Sbjct: 184 SYSQGYSAKVDIWSLGCVVLE------MFAGRRPWSDEEAIAAMF------KLGNKRS-- 229
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
P P N SP A+D L +P+ R T E L HP+
Sbjct: 230 -------APPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 80/291 (27%), Positives = 127/291 (43%), Gaps = 54/291 (18%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108
G+G+YG V + A+K++ ++ + + + EI++L ++H NII+ K
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK--- 65
Query: 109 RPPQRETF---NDVYIVYELMD-TDLHQIIRSHQDL-----TDDHCRYFLYQLLRGLKYV 159
E F N + IV E DL + I + + R F+ QLLRGL+ +
Sbjct: 66 -----EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGLQAL 119
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
H +LHRDLK +N+LL AN +KIGD G+++ + T+ + T Y APE+
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPEVWKG-RP 177
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
Y+ DIWS+GC+L E+ T P F + + +L RY
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARS-------MQDL------------------RYK 212
Query: 280 RMLPQFPK--QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
++P +S N + ML P R D+ L P +
Sbjct: 213 VQRGKYPPIPPIYSQDLQN-------FIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 73/289 (25%), Positives = 139/289 (48%), Gaps = 45/289 (15%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLR----EIKLLRHMDHENIIA 103
+G+GA+G V + +T E+A+K++ D+ + K+ + EI+LL+++ HE I+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSP-ETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+R + + I E M + ++++ LT+ R + Q+L G++Y+HS
Sbjct: 69 YYGCLRDDET-----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPELLLNCS 218
++HRD+K +N+L ++ ++K+GDFG L S M T ++ +PE +++
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISGE 182
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278
Y D+WSVGC + E++T +P P ++ + I ++ P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKP--PWAEF-EAMAAIFKIATQPTN-------------- 225
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
PQ P + SP A + L + V + +R + +E L H +
Sbjct: 226 ----PQLP--------SHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 77/292 (26%), Positives = 128/292 (43%), Gaps = 46/292 (15%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
PIR +G+GA+G +E V K++ + + + L EI +L + H NIIA
Sbjct: 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIA 63
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYV 159
+ N + I E + L+ I Q ++ ++L+Q++ + Y+
Sbjct: 64 YYN-----HFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYI 117
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCS 218
H A +LHRD+K N+ L +K+GDFG+++ M E VV T +Y +PEL C
Sbjct: 118 HKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL---CQ 174
Query: 219 --EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
+Y DIW++GC+L E++T + F + L L+ +++ +
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGN--------YTPVVS 223
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
Y S + L+ +L DP +R T DE L P L
Sbjct: 224 VY-------------------SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-27
Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 51/296 (17%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
+ +G G G+V ++ T + +A+K I + I K+ LRE+ +L + I+
Sbjct: 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ-KQILRELDILHKCNSPYIV- 62
Query: 104 IKDIIRPPQRETF-------NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFL-YQLLR 154
F D+ I E MD L +I++ Q + + +L+
Sbjct: 63 -----------GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLK 111
Query: 155 GLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPEL 213
GL Y+H ++HRD+KPSN+L+N+ +K+ DFG++ + T +V T Y APE
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE- 169
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
+ ++Y+ DIWS+G L E+ T + FP ++ G +
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR--FP--------------YPPENDPPDGIF--E 211
Query: 274 NARRYVRM-LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ V P+ P FS F D + L+ DP R + E L HP++
Sbjct: 212 LLQYIVNEPPPRLPSGKFSPDF-------QDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 82/298 (27%), Positives = 142/298 (47%), Gaps = 55/298 (18%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKK-----IGNAFDNRIDAKRTL-----REIKLLRHMD 97
+G G++G V MN+ + E +A+K+ + + +R KR++ REI LL+ +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDR---KRSMLDALAREIALLKELQ 64
Query: 98 HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
HENI+ ++++ Y + + ++ ++ + R F+ Q+L+GL
Sbjct: 65 HENIVQYLG---SSLDADHLNIFLEY-VPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR-------WYRA 210
Y+H+ ++HRD+K +N+L++ +KI DFG+++ T+ R ++ A
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270
PE++ S YT DIWS+GC++ E++T + FP QL+ I + IG
Sbjct: 181 PEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCT---QLQAIFK-IGE--------- 226
Query: 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+ P N S A+D LEK D N+R T E L HP+L
Sbjct: 227 ---------NASPEIPS--------NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 62/301 (20%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++P+ +GA+G V A T + AIK + + + AK + +K R +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKS---DMIAKNQVTNVKAERAIMMI----- 52
Query: 105 KDIIRPPQRE---------TFND---VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQ 151
Q E +F +Y+V E ++ D +I++ L +D + ++ +
Sbjct: 53 -------QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAE 105
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 211
++ G++ +H ++HRD+KP NLL++ LK+ DFGL+R E ++V T Y AP
Sbjct: 106 VVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---KKFVGTPDYLAP 162
Query: 212 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271
E +L + D WS+GC++ E + P F +PD L
Sbjct: 163 ETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHA--------------ETPDAVFDNILS 207
Query: 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYL 328
+P++ SP AVDL+ ++L DP +R+ E HP+
Sbjct: 208 RR---------INWPEEVKEF----CSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
Query: 329 A 329
Sbjct: 255 K 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 69/295 (23%), Positives = 132/295 (44%), Gaps = 52/295 (17%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT----LREIKLLRHMDHEN 100
+R +G+GA+G VC +T++ A+K + + K + L E ++L+ ++H
Sbjct: 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ---KCVEKGSVRNVLNERRILQELNHPF 61
Query: 101 IIAIKDIIRPPQRETFND---VYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
++ + +F D +Y+V +L+ DL + +++ ++++ +++ L
Sbjct: 62 LVNL--------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLAL 113
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 216
+Y+HS ++HRD+KP N+LL+ + I DF +A + T T Y APE +L
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE-VLC 172
Query: 217 CSEYTAAIDIWSVGCILGE-IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
Y+ A+D WS+G E + ++P + G R I + I
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP-YRGHS-----RTIRDQI---------------R 211
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI--TVDEALCHPYL 328
+ +P S A+D + K+L DP +R+ + + HPY
Sbjct: 212 AKQETADVLYP--------ATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 61/197 (30%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G++G+V + + A+K+I + NR + + + E ++L +D II +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 108 IRPPQRETFNDVYIVYELMDT-DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANV 164
+ + IV E + DLH++++ + L +D F Q+L GL ++HS +
Sbjct: 68 FLDKGK-----LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKI 122
Query: 165 LHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTEYVVTRWYRAPELLLNCSE--YT 221
LHRD+K NL L+A ++KIGD G+A+ S T+F V T +Y +PEL C + Y
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL---CEDKPYN 179
Query: 222 AAIDIWSVGCILGEIMT 238
D+W++G +L E T
Sbjct: 180 EKSDVWALGVVLYECCT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 74/293 (25%), Positives = 124/293 (42%), Gaps = 59/293 (20%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIG--NAFDNRIDAKRTLREIKLLRHMDHENII--- 102
+G+G++G V A++ T + VAIK I A D D +EI+ L I
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIED---IQQEIQFLSQCRSPYITKYY 65
Query: 103 --AIKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
+K + ++I+ E DL + + L + + + L ++L GL
Sbjct: 66 GSFLKG----------SKLWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLLGL 111
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLL 215
+Y+H +HRD+K +N+LL+ D+K+ DFG++ + TS +V T ++ APE++
Sbjct: 112 EYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
S Y DIWS+G E+ +P P D H +R++ + +
Sbjct: 172 Q-SGYDEKADIWSLGITAIELAKGEP--PLSDL-HPMRVLFLIPKNNP------------ 215
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P FS F D + L DP R + E L H ++
Sbjct: 216 -------PSLEGNKFSKPFK-------DFVSLCLNKDPKERPSAKELLKHKFI 254
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 47/292 (16%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+R VG+G+YG V + ++ IKK+ +R + K +E +LL + H NI+A
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 105 KDIIRPPQRETFND----VYIVYELMDT-DLHQIIRSHQD--LTDDHCRYFLYQLLRGLK 157
RE++ +YIV + DL+ ++ + L ++ + Q+ L+
Sbjct: 65 --------RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 216
Y+H ++LHRDLK N+ L +K+GD G+AR ++ D + + T +Y +PEL N
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN 176
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
Y D+W++GC + E+ T + F KD + I E
Sbjct: 177 -KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE------------------- 216
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
LP PK + SP +L+ ML P +R +V L PY+
Sbjct: 217 ---GKLPPMPK--------DYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNA--FDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G G +G V A+K + + + E ++L +H I+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVK-- 57
Query: 106 DIIRPPQRETFNDVYIVYELMDT----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
TF D +Y LM+ +L I+R + R+++ ++ +Y+H+
Sbjct: 58 ------LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+++RDLKP NLLL++N +K+ DFG A+ + T Y APE++LN Y
Sbjct: 112 RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN-KGYD 170
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKD 247
++D WS+G +L E++T +P F D
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 77/295 (26%), Positives = 136/295 (46%), Gaps = 61/295 (20%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL--REIKLLRHMDHENIIAIK 105
+G G+ GIVC A + T +VA+KK+ D R +R L E+ ++R H NI+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM----DLRKQQRRELLFNEVVIMRDYQHPNIV--- 79
Query: 106 DIIRPPQRETFN------DVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRG 155
E ++ ++++V E ++ TD I +H + ++ +L+
Sbjct: 80 --------EMYSSYLVGDELWVVMEFLEGGALTD----IVTHTRMNEEQIATVCLAVLKA 127
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELL 214
L ++H+ V+HRD+K ++LL ++ +K+ DFG A+ + E V T ++ APE++
Sbjct: 128 LSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
Y +DIWS+G ++ E++ +P + + + ++ I +
Sbjct: 188 SR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD----------------- 229
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
LP K SP L++MLV DP +R T E L HP+LA
Sbjct: 230 ------NLPPKLKNLHKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-24
Identities = 69/212 (32%), Positives = 106/212 (50%), Gaps = 15/212 (7%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENII 102
+R VG G++G + + ++ A+K+I + D+++ E LL M H NI+
Sbjct: 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIV 61
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYV 159
A K+ E +YIV E D DL Q I+ + +D + Q+ G++++
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCS 218
H VLHRD+K N+ L N +K+GDFG AR TS + YV T +Y PE+ N
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP 176
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH 250
Y DIWS+GCIL E+ T + F + +
Sbjct: 177 -YNNKSDIWSLGCILYELCTLKHPFQANSWKN 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-24
Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 12/215 (5%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I+ +G G++G + A E IK+I + + + +E+ LL M H NI+
Sbjct: 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF 64
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDL--TDDHCRYFLYQLLRGLKYVHS 161
+ R ++IV E D DL + I + + ++D + Q+ GLK++H
Sbjct: 65 FASFQENGR-----LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 162 ANVLHRDLKPSNLLLNANCDL-KIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCSE 219
+LHRD+K N+ L+ N + K+GDFG+AR +++ + V T +Y +PE+ N
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN-RP 178
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRL 254
Y DIWS+GC+L E+ T + F G + HQL L
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFEGNNL-HQLVL 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 82/300 (27%), Positives = 138/300 (46%), Gaps = 57/300 (19%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENI----- 101
+G G YG V A + +T + VAIK + D + K E +LR +H NI
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPNIATFYG 70
Query: 102 --IAIKDIIRPPQRETFNDVYIVYELMD----TDLHQ-IIRSHQDLTDDHCRYFLYQLLR 154
I Q +++V EL TDL + + + + L ++ Y L + LR
Sbjct: 71 AFIKKNPPGNDDQ------LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124
Query: 155 GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPEL 213
GL Y+H V+HRD+K N+LL N ++K+ DFG++ T ++ T ++ APE+
Sbjct: 125 GLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV 184
Query: 214 LLNCSE-----YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268
+ C E Y A D+WS+G E+ +P P D +H +R + ++ +P T
Sbjct: 185 IA-CDEQPDASYDARSDVWSLGITAIELADGKP--PLCD-MHPMRALFKIPRNPPPT--- 237
Query: 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
L+S +N+S +F D + + L+ + +R ++E L HP++
Sbjct: 238 -LKS--------------PENWSKKF-------NDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 83/290 (28%), Positives = 133/290 (45%), Gaps = 42/290 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I+ +G G YG V A + T E VAIK I + D + +EI +L+ H NI+A
Sbjct: 8 IQRIGSGTYGDVYKARDIATGELVAIKVI--KLEPGDDFEIIQQEISMLKECRHPNIVAY 65
Query: 105 KDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
R + ++IV E D++Q+ R L++ Y + L+GL Y+H
Sbjct: 66 ---FGSYLRR--DKLWIVMEYCGGGSLQDIYQVTRGP--LSELQIAYVCRETLKGLAYLH 118
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
+HRD+K +N+LL + D+K+ DFG+ A+ T+ ++ T ++ APE+ +
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERK 178
Query: 220 --YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
Y DIW++G E+ QP P D +H +R + FL S
Sbjct: 179 GGYDGKCDIWALGITAIELAELQP--PMFD-LHPMRAL-------------FLIS----- 217
Query: 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+ PK ++ SP D ++K L DP +R T + L HP+
Sbjct: 218 --KSNFPPPKLKDKEKW---SPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-23
Identities = 80/293 (27%), Positives = 143/293 (48%), Gaps = 41/293 (13%)
Query: 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL--REIKLLRHM 96
R+Y+ +G G+ GIVC A T ++VA+KK+ D R +R L E+ ++R
Sbjct: 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM----DLRKQQRRELLFNEVVIMRDY 76
Query: 97 DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
HEN++ + + +++++V E ++ I +H + ++ +LR L
Sbjct: 77 HHENVVDMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRAL 131
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 215
Y+H+ V+HRD+K ++LL ++ +K+ DFG A+ + E V T ++ APE++
Sbjct: 132 SYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS 191
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
Y +DIWS+G ++ E++ +P + + + +R I DN
Sbjct: 192 RLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI----------------RDN- 233
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
LP P+ S + + G +DL MLV +P++R T E L HP+L
Sbjct: 234 ------LP--PRVKDSHKVSSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-23
Identities = 78/253 (30%), Positives = 126/253 (49%), Gaps = 47/253 (18%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR---TLREIKLLRHMDHENII 102
+ +GRG + V A R+ VA+KK+ F+ +DAK ++EI LL+ ++H N+I
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKV-QIFE-MMDAKARQDCVKEIDLLKQLNHPNVI 65
Query: 103 AIKDIIRPPQRETF---NDVYIVYELMDT-DLHQII---RSHQDLTDDHC--RYFLYQLL 153
D +F N++ IV EL D DL Q+I + + L + +YF+ QL
Sbjct: 66 KYLD--------SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV-QLC 116
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPE 212
++++HS V+HRD+KP+N+ + A +K+GD GL R +S+T V T +Y +PE
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQ----------------------PLFPGKDYVH 250
++ + Y DIWS+GC+L E+ Q P P + Y
Sbjct: 177 -RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSE 235
Query: 251 QLRLITELIGSPD 263
+LR + + PD
Sbjct: 236 KLRELVSMCIYPD 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-23
Identities = 71/299 (23%), Positives = 128/299 (42%), Gaps = 54/299 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I +G GA +V AA+ E+VAIK+I + + +E++ + +H N++
Sbjct: 6 IEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHPNVVK- 63
Query: 105 KDIIRPPQRETF---NDVYIVYELMDT-DLHQIIRS--HQDLTDDHC-RYFLYQLLRGLK 157
+F +++++V + L I++S + D+ L ++L+GL+
Sbjct: 64 -------YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-----YVVTRWYRAPE 212
Y+HS +HRD+K N+LL + +KI DFG++ + ++ T +V T + APE
Sbjct: 117 YLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272
++ Y DIWS G E+ T P Y P + + L++
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGAA--PYSKY------------PPMKVLMLTLQN 222
Query: 273 DNARRYVRMLPQFP----KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
D P + +S F ++ L DP++R T +E L H +
Sbjct: 223 DP--------PSLETGADYKKYSKSFR-------KMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 7e-23
Identities = 84/305 (27%), Positives = 128/305 (41%), Gaps = 57/305 (18%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
I +GRGAYG+V + T +A+K+I A N + KR L ++ +
Sbjct: 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQEQKRLLMDLDISMRSVD----- 58
Query: 104 IKDIIRPPQRETF-------NDVYIVYELMDTDLH----QIIRSHQDLTDDHCRYFLYQL 152
P TF DV+I E+MDT L ++ + +D +
Sbjct: 59 ------CPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSI 112
Query: 153 LRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 211
++ L+Y+HS +V+HRD+KPSN+L+N N +K+ DFG++ ++ T + Y AP
Sbjct: 113 VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAP 172
Query: 212 ELL---LNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSL 267
E + LN Y D+WS+G + E+ T R P K QL+ + E E S
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE------EPS- 225
Query: 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
PQ P + FS F D + K L + R E L HP+
Sbjct: 226 ---------------PQLPAEKFSPEF-------QDFVNKCLKKNYKERPNYPELLQHPF 263
Query: 328 LAPLH 332
Sbjct: 264 FELHL 268
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 8e-23
Identities = 60/211 (28%), Positives = 111/211 (52%), Gaps = 17/211 (8%)
Query: 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE 99
KYV ++ +G G++G + E ++ IK+I + + + + + +E+ +L +M H
Sbjct: 1 KYVK-VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHP 59
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDL--TDDHCRYFLYQLL 153
NI+ +E+F + +Y +MD DL++ I + + + +D + Q+
Sbjct: 60 NIVQY--------QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPE 212
LK+VH +LHRD+K N+ L + +K+GDFG+AR + T + + T +Y +PE
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE 171
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 243
+ N Y DIW++GC+L E+ T + F
Sbjct: 172 ICEN-RPYNNKSDIWALGCVLYEMCTLKHAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 9e-23
Identities = 74/297 (24%), Positives = 136/297 (45%), Gaps = 47/297 (15%)
Query: 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL--REIKLLRHM 96
R Y+ +G G+ GIVC A + + VA+KK+ D R +R L E+ ++R
Sbjct: 19 RTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKM----DLRKQQRRELLFNEVVIMRDY 74
Query: 97 DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
HEN++ + + +++++V E ++ I +H + ++ +L+ L
Sbjct: 75 QHENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKAL 129
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 215
+H+ V+HRD+K ++LL + +K+ DFG A+ + E V T ++ APEL+
Sbjct: 130 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS 189
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
Y +DIWS+G ++ E++ +P + + + +++I
Sbjct: 190 RLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------------- 228
Query: 276 RRYVRMLPQFPKQNFSARFPNK---SPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
+ N + N SP L+++LV DP +R T E L HP+LA
Sbjct: 229 -----------RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 83/296 (28%), Positives = 137/296 (46%), Gaps = 58/296 (19%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLR----EIKLLRHMDHENIIAI 104
G GA+G V A + ET A K I +I+++ L EI +L H NI+ +
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKII------QIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 105 KDIIRPPQRETF---NDVYIVYELMDTD-LHQII-RSHQDLTDDHCRYFLYQLLRGLKYV 159
E + N ++I+ E D L I+ + LT+ RY Q+L L ++
Sbjct: 68 --------YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFL 119
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNC- 217
HS V+HRDLK N+LL + D+K+ DFG+ A+ S ++ T ++ APE ++ C
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE-VVACE 178
Query: 218 ----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
+ Y DIWS+G L E+ +P P + ++ +R++ +++ S T D
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRVLLKILKSEPPT------LD 229
Query: 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
++ +F+ D L+ LV DP+ R T E L HP+++
Sbjct: 230 QPSKWSS--------SFN-----------DFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 1e-22
Identities = 74/275 (26%), Positives = 137/275 (49%), Gaps = 32/275 (11%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLRE-------IKLLRHMDHEN 100
+G+GA+G V +++T E+A+K++ FD ++ T +E I+LL+++ HE
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQV--QFDP--ESPETSKEVNALECEIQLLKNLLHER 65
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
I+ +R P T + I E M + ++S+ LT++ R + Q+L G+ Y+
Sbjct: 66 IVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLL 215
HS ++HRD+K +N+L ++ ++K+GDFG ++ M T ++ +PE ++
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE-VI 181
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+ Y DIWSVGC + E++T +P P ++ + I ++ P L SD+
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKP--PWAEF-EAMAAIFKIATQPTNPVLPPHVSDHC 238
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLV 310
R +++ + K P A +LL V
Sbjct: 239 RDFLKRIFVEAKLR---------PSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 3e-22
Identities = 79/289 (27%), Positives = 122/289 (42%), Gaps = 46/289 (15%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
IR VGRGA+GIV ++ V IK+I + + E ++L+ + H NII
Sbjct: 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 105 KDIIRPPQRETF---NDVYIVYELMDT-DLHQII--RSHQDLTDDHCRYFLYQLLRGLKY 158
E F + IV E L + I R + L +D +F Q+L L +
Sbjct: 65 --------YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 159 VHSANVLHRDLKPSNLLLNANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217
VH+ +LHRDLK N+LL+ + +KIGDFG+++ S V T Y +PE L
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE-LCEG 175
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
Y DIW++GC+L E+ + + F + + I +P SD
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP--------ISDRYSP 227
Query: 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
+R L+ ML DP++R + + + P
Sbjct: 228 DLRQ----------------------LILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 7e-22
Identities = 64/212 (30%), Positives = 106/212 (50%), Gaps = 29/212 (13%)
Query: 45 IRPVGRGAYGIVCAA----MNSETREEVAIKKIGNAFDN--RIDAKRTLREIKLLRHMDH 98
I+ +G G +G V + T E+VA+K + ++ + R D +R EI++LR +DH
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---EIEILRTLDH 65
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRG 155
ENI+ K + P + ++ E L L ++ H+D + R L+ Q+ +G
Sbjct: 66 ENIVKYKGVCEKPGG---RSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKG 121
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR--------W 207
+ Y+ S +HRDL N+L+ + +KI DFGLA+ E +Y + W
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK---DYYYVKEPGESPIFW 178
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 239
Y APE L ++++A D+WS G L E+ T
Sbjct: 179 Y-APECLRTS-KFSSASDVWSFGVTLYELFTY 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
R +G G +G V + VAIK + + D+ + + +E++ L+ + H+++I++
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVR-VAIKILKS--DDLLKQQDFQKEVQALKRLRHKHLISLF 68
Query: 106 DII---RPPQRETFNDVYIVYELMDT-DLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYV 159
+ P VYI+ ELM+ L +RS Q L Q+ G+ Y+
Sbjct: 69 AVCSVGEP--------VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAPELLLNC 217
N +HRDL N+L+ + K+ DFGLAR E +++ + +W APE +
Sbjct: 121 EEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPE-AASH 178
Query: 218 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITE 257
++ D+WS G +L E+ T Q +PG + IT
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA 219
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-21
Identities = 67/248 (27%), Positives = 136/248 (54%), Gaps = 25/248 (10%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLRE-------IKLLRHMDHEN 100
+GRGA+G V +++T E+A+K++ FD D++ T +E I+LL+++ H+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQV--PFDP--DSQETSKEVNALECEIQLLKNLRHDR 65
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
I+ +R P+ + + I E M + ++++ LT++ R + Q+L+G+ Y+
Sbjct: 66 IVQYYGCLRDPEEKKLS---IFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRAPELL 214
HS ++HRD+K +N+L ++ ++K+GDFG ++ +T M+ + T ++ +PE +
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSGTGIKSVTGTPYWMSPE-V 180
Query: 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
++ Y D+WSV C + E++T +P P +Y + I ++ P + L SD
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKP--PWAEY-EAMAAIFKIATQPTKPMLPDGVSDA 237
Query: 275 ARRYVRML 282
R +++ +
Sbjct: 238 CRDFLKQI 245
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 71/292 (24%), Positives = 126/292 (43%), Gaps = 77/292 (26%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIK-----KIGNAFDNRIDAKR---TLREIKLLRHM 96
I+ +G G++G V + + + A+K KI + K+ L E ++L+ +
Sbjct: 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-------VKLKQVEHVLNEKRILQSI 58
Query: 97 DHENIIAIKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQL 152
H ++ + +F D +Y +M+ +L +R + R++ Q+
Sbjct: 59 RHPFLVNLYG--------SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR-W---- 207
+ L+Y+HS ++++RDLKP NLLL+++ +KI DFG A+ V R +
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK----------RVKGRTYTLCG 160
Query: 208 ---YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 264
Y APE++L+ Y A+D W++G ++ E++ P F + I E I
Sbjct: 161 TPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPF----FDDNPIQIYEKILE--- 212
Query: 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
G +R FP SP A DL+ +L D +R
Sbjct: 213 ---GKVR-------------FPS--------FFSPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 20/217 (9%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLL---RHMDHENIIA- 103
+GRGAYG V + T VA+K I N D RE+ LL R NI
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKII-NLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 104 ----IKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
+K ++I+ E + + + + + + + ++L LKY+
Sbjct: 68 YGSYLKG----------PRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYI 117
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCS 218
H V+HRD+K +N+L+ ++K+ DFG+ A + + +V T ++ APE++
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 255
Y DIWS+G + E+ T P + D + LI
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-21
Identities = 73/293 (24%), Positives = 128/293 (43%), Gaps = 41/293 (13%)
Query: 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL--REIKLLRHM 96
R + +G G+ GIVC A + +VA+K + D R +R L E+ ++R
Sbjct: 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMM----DLRKQQRRELLFNEVVIMRDY 75
Query: 97 DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
H+N++ + +++++ E + I S L ++ +L+ L
Sbjct: 76 QHQNVVEMYK-----SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQAL 130
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 215
Y+HS V+HRD+K ++LL + +K+ DFG A+ + + V T ++ APE++
Sbjct: 131 CYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 190
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+ Y +DIWS+G ++ E++ +P + V A
Sbjct: 191 R-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV------------------------QA 225
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ +R P +N SP D LE+ML +P R T E L HP+L
Sbjct: 226 MKRLRDSPPPKLKNAH----KISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 5e-21
Identities = 74/294 (25%), Positives = 131/294 (44%), Gaps = 51/294 (17%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL----REIKLLRHMDHENIIA 103
+G GA+ A + +T +A+K++ + + + + +EI+L+ ++H +II
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 104 IKDIIRPPQRETFNDVYIVYELM-----DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+ + FN + E M L + + + ++ QLLRGL Y
Sbjct: 68 MLGATC--EDSHFN---LFVEWMAGGSVSHLLSKYGAFKEAVIINYTE----QLLRGLSY 118
Query: 159 VHSANVLHRDLKPSNLLLNANC-DLKIGDFGLA-----RTTSETDFMTEYVVTRWYRAPE 212
+H ++HRD+K +NLL+++ L+I DFG A + T +F + + T + APE
Sbjct: 119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272
+L +Y + D+WSVGC++ E+ T +P + + + + L LI + I S
Sbjct: 179 VLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK-IASATTA------- 229
Query: 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
P P+ + SPG D+ + L P R E L HP
Sbjct: 230 ----------PSIPE--------HLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-21
Identities = 77/296 (26%), Positives = 133/296 (44%), Gaps = 51/296 (17%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
VG+G YG V A +T E VA+K++ K L ++ +RH+ E +DI
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRM---------KKSLLFKLNEVRHVLTE-----RDI 54
Query: 108 IRPPQRE-------TFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
+ + E F D +Y M+ D ++ + L++DH R+++ ++ +
Sbjct: 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV 114
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 216
+H +HRDLKP N L++A+ +K+ DFGL++ + V + Y APE +L
Sbjct: 115 DALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPE-VLR 171
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
Y +D WS+GC+L E + P F G +P+ET +N +
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGS--------------TPNET------WENLK 211
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332
+ L Q P + N S A DL+ K++ R ++++ HP+ +
Sbjct: 212 YWKETL-QRP--VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 8e-21
Identities = 76/278 (27%), Positives = 130/278 (46%), Gaps = 24/278 (8%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDHENIIAIKD 106
+G G++G V A NS T E VA+KK+ + + + ++E+K L+ + H N I K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 107 IIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVL 165
+ ++V E ++ H+ L + + L+GL Y+HS N++
Sbjct: 89 CYLKE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--YTAA 223
HRD+K N+LL +K+ DFG A +S + +V T ++ APE++L E Y
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQYDGK 200
Query: 224 IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 283
+D+WS+G E+ R+P + + L I + SP S + +D+ R +V
Sbjct: 201 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NDSPTLQSNEW--TDSFRGFVDYCL 257
Query: 284 QFPKQNFSARFPNKSPGAVDLLEKMLVF-DPNRRITVD 320
Q + P + P + +LL V D R+ +D
Sbjct: 258 Q--------KIPQERPASAELLRHDFVRRDRPARVLID 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 8e-21
Identities = 76/296 (25%), Positives = 132/296 (44%), Gaps = 48/296 (16%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR----TLREIKLLRHMDHENIIA 103
+G+G +G VCA T + A KK+ R+ ++ L E K+L + I++
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDK---KRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLY--QLLRGLKYVH 160
+ ET +D+ +V LM+ DL I + + R Y Q++ GL+++H
Sbjct: 58 LAYAF-----ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY 220
+++RDLKP N+LL+ + +++I D GLA + T Y APE+L Y
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVY 171
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
++D +++GC L E++ + P + ++ + + RR +
Sbjct: 172 DFSVDWFALGCTLYEMIAGRS--PFRQRKEKVE-----------------KEELKRRTLE 212
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPL 331
M ++P + SP A DL E +L DP +R+ + DE HP L
Sbjct: 213 MAVEYPDKF--------SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 9e-21
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 16/204 (7%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G YGIV AA + T+ +AIK+I + EI L ++ H NI+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSR--YVQPLHEEIALHSYLKHRNIV----- 68
Query: 108 IRPPQRETFNDVYIVY--ELMDTDLHQIIRSHQDLTDDH---CRYFLYQLLRGLKYVHSA 162
+ ++ N + ++ ++ L ++RS D+ ++ Q+L GLKY+H
Sbjct: 69 -QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN 127
Query: 163 NVLHRDLKPSNLLLNANCD-LKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSE- 219
++HRD+K N+L+N +KI DFG ++ + + TE + T Y APE++
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 220 YTAAIDIWSVGCILGEIMTRQPLF 243
Y A DIWS+GC + E+ T +P F
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 64/206 (31%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDHENIIA 103
+R +G G++G V A + T E VAIKK+ + + + ++E++ L+ + H N I
Sbjct: 20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 104 IKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSA 162
K RE ++V E I+ H+ L + + L+GL Y+HS
Sbjct: 80 YKGCY---LREH--TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--Y 220
+HRD+K N+LL +K+ DFG A S + +V T ++ APE++L E Y
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMDEGQY 191
Query: 221 TAAIDIWSVG--CILGEIMTRQ-PLF 243
+D+WS+G CI E+ R+ PLF
Sbjct: 192 DGKVDVWSLGITCI--ELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 78/255 (30%), Positives = 124/255 (48%), Gaps = 51/255 (20%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR---TLREIKLLRHMDHENII 102
+ +GRG + V A VA+KK+ FD +DAK ++EI LL+ ++H N+I
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKV-QIFD-LMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 103 A-----IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIR---SHQDLTDDHC--RYFLYQ 151
I+D N++ IV EL D DL ++I+ + L + +YF+ Q
Sbjct: 66 KYYASFIED----------NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV-Q 114
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRA 210
L L+++HS V+HRD+KP+N+ + A +K+GD GL R +S+T V T +Y +
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 174
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMTRQ----------------------PLFPGKDY 248
PE ++ + Y DIWS+GC+L E+ Q P P Y
Sbjct: 175 PE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHY 233
Query: 249 VHQLRLITELIGSPD 263
+LR + + +PD
Sbjct: 234 SEELRQLVNMCINPD 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 2e-20
Identities = 74/298 (24%), Positives = 132/298 (44%), Gaps = 57/298 (19%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLR----EIKLLRHMDHENIIA 103
+G+GAYG V + + + +A+K++ N + A++ E+ LL+ + H NI+
Sbjct: 8 LGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 104 -----IKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
+ D N + I E + + I+ L + + Q+L G+
Sbjct: 67 YLGTCLDD----------NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA 116
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRA 210
Y+H+ V+HRD+K +N++L N +K+ DFG AR + ++ + T ++ A
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270
PE ++N S Y DIWS+GC + E+ T +P D + + I G
Sbjct: 177 PE-VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------------GAH 223
Query: 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
R ++P+ P +FSA A+D + L D + R + + L H +L
Sbjct: 224 RG--------LMPRLP-DSFSA-------AAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-20
Identities = 69/238 (28%), Positives = 108/238 (45%), Gaps = 42/238 (17%)
Query: 36 EVSRKYVPPIRPVGRGAYGIV-----CAAMNSETREEVAIKKIGNAFDNRIDAKRTL-RE 89
V R + R +G GA+G V +E VA+K + N DA++ RE
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFERE 58
Query: 90 IKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVYELMDT-DLHQIIRSH-------- 137
+LL + HENI+ + PP +V+E M+ DL++ +RSH
Sbjct: 59 AELLTNFQHENIVKFYGVCTEGDPP--------IMVFEYMEHGDLNKFLRSHGPDAAFLK 110
Query: 138 ------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191
+LT Q+ G+ Y+ S + +HRDL N L+ + +KIGDFG++R
Sbjct: 111 SPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
Query: 192 TTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLF 243
TD+ + RW PE ++ ++T D+WS G +L EI T +QP +
Sbjct: 171 DVYTTDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 5e-20
Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 25/213 (11%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR--TLREIKLLRHMDHENII 102
+ +G GA G V ++ T A+K I + N D R REI++LR ++H N++
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEILRDVNHPNVV 135
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDT---DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
D+ + ++ ++ E MD + I L D Q+L G+ Y+
Sbjct: 136 KCHDMF-----DHNGEIQVLLEFMDGGSLEGTHIADEQF-LAD-----VARQILSGIAYL 184
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELL---L 215
H +++HRD+KPSNLL+N+ ++KI DFG++R ++T D V T Y +PE + L
Sbjct: 185 HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL 244
Query: 216 NCSEYTA-AIDIWSVG-CILGEIMTRQPLFPGK 246
N Y A DIWS+G IL + R P G+
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 45/291 (15%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKD 106
+G+G++G V +T+ A+K I A +R + TL E +L ++ I+ +K
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 107 IIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVL 165
+ P++ +Y+V ++ +L ++ R++ +LL L+ +H NV+
Sbjct: 61 SFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAI 224
+RDLKP N+LL+ + + DFGL + + D + T Y APELLL YT A+
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAV 174
Query: 225 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 284
D W++G +L E++T P F +N R + Q
Sbjct: 175 DWWTLGVLLYEMLTGLPPF---------------------------YDENVNEMYRKILQ 207
Query: 285 FPKQNFSARFP-NKSPGAVDLLEKMLVFDPNRRITV---DEALCHPYLAPL 331
P RFP A DLL +L DP RR+ E HP+ + L
Sbjct: 208 EP-----LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 64/256 (25%), Positives = 131/256 (51%), Gaps = 21/256 (8%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLRE-------IKLLRHMDHEN 100
+G+GA+G V + +T E+A K++ FD ++ T +E I+LL+++ HE
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQV--QFDP--ESPETSKEVSALECEIQLLKNLQHER 65
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
I+ +R +T +++ Y + + ++++ LT+ R + Q+L G+ Y+H
Sbjct: 66 IVQYYGCLRDRAEKTLT-IFMEY-MPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH 123
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----MTEYVVTRWYRAPELLLN 216
S ++HRD+K +N+L ++ ++K+GDFG ++ + T ++ +PE +++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE-VIS 182
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
Y D+WS+GC + E++T +P P +Y + I ++ P L S++AR
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKP--PWAEY-EAMAAIFKIATQPTNPQLPSHISEHAR 239
Query: 277 RYVRMLPQFPKQNFSA 292
++ + + SA
Sbjct: 240 DFLGCIFVEARHRPSA 255
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDH 98
K +R +G G++G V A + T E VAIKK+ + + + ++E+K L+ + H
Sbjct: 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLK 157
N I K RE + ++V E ++ H+ L + + L+GL
Sbjct: 85 PNSIEYKGCY---LRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 139
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217
Y+HS N++HRD+K N+LL +K+ DFG A S + +V T ++ APE++L
Sbjct: 140 YLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAM 196
Query: 218 SE--YTAAIDIWSVGCILGEIMTRQP 241
E Y +D+WS+G E+ R+P
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 2e-19
Identities = 76/288 (26%), Positives = 134/288 (46%), Gaps = 42/288 (14%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLR---EIKLLRHMDHENIIAI 104
+G+G++G V + + E +K + ++ T++ E +LL +DH I+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 105 KDIIRPPQRETFNDVYIVYELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+R+ F + E D D L ++ + + L+++ + QLL G+ Y+H
Sbjct: 68 HASFL--ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+LHRDLK N+ L N LKIGDFG++R D T + T +Y +PE L + Y
Sbjct: 126 RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYD 183
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281
+ DIWS+GCIL E+ F G+++ L ++ ++ P +
Sbjct: 184 SKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPS---------------- 224
Query: 282 LPQ-FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
LP+ + +Q S +++ ML DP+ R + E L +P++
Sbjct: 225 LPETYSRQLNS------------IMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-19
Identities = 51/165 (30%), Positives = 84/165 (50%), Gaps = 19/165 (11%)
Query: 89 EIKLLR-HMDHENIIAIKDIIRPPQRETF--ND-VYIVYELMD-TDLHQIIRS----HQD 139
E+ +++ + H NI+ +TF ND +YIV +L++ L + S Q
Sbjct: 58 EVTIIKEQLRHPNIVRY--------YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQR 109
Query: 140 LTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198
T++ Q++ L+Y+H ++HRDL P+N++L + + I DFGLA+
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK 169
Query: 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 243
+T V T Y PE++ N Y D+W+ GCIL ++ T QP F
Sbjct: 170 LTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 43/221 (19%)
Query: 40 KYVPPIRPVGRGAYGIVCAAM---NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLR 94
YV + +G G +G VC + +VAIK K G++ R+D L E ++
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEASIMG 60
Query: 95 HMDHENIIAIKDII---RPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLY 150
DH NII ++ ++ RP V I+ E M+ L + +R + ++ +
Sbjct: 61 QFDHPNIIRLEGVVTKSRP--------VMIITEYMENGSLDKFLRENDG------KFTVG 106
Query: 151 QLLR-------GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 203
QL+ G+KY+ N +HRDL N+L+N+N K+ DFGL+R +++ Y
Sbjct: 107 QLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYT 164
Query: 204 VT------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
RW APE + ++T+A D+WS G ++ E+M+
Sbjct: 165 TKGGKIPIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 59/206 (28%), Positives = 104/206 (50%), Gaps = 12/206 (5%)
Query: 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDA-KRTLREIKLLRHMDH 98
K +R +G G++G V A + E VAIKK+ + + + ++E++ L+ + H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLK 157
N I + RE + ++V E ++ H+ L + + L+GL
Sbjct: 75 PNTIQYRGCY---LRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217
Y+HS N++HRD+K N+LL+ +K+GDFG A + + +V T ++ APE++L
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAM 186
Query: 218 SE--YTAAIDIWSVGCILGEIMTRQP 241
E Y +D+WS+G E+ R+P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 81/313 (25%), Positives = 134/313 (42%), Gaps = 55/313 (17%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREE---VAIKKIGNAFDNRIDAKRTLREIK 91
+E+ R+ + R +G G +G V + E VA+K N ++ L+E
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS-VREKFLQEAY 59
Query: 92 LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFL 149
++R DH +I+ + +I T N V+IV EL +L ++ ++ L +
Sbjct: 60 IMRQFDHPHIVKLIGVI------TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113
Query: 150 YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV---TR 206
YQL L Y+ S +HRD+ N+L+++ +K+GDFGL+R + + +
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK 173
Query: 207 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR--QPLFPGKDYVHQLRLITELIGSPDE 264
W APE +N +T+A D+W G + EI+ +P K+ ++IG
Sbjct: 174 WM-APE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN--------NDVIG---- 219
Query: 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324
R +N R LP P PN P L+ K +DP++R E
Sbjct: 220 ------RIENGER----LPM-P--------PNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260
Query: 325 HPYLAPLHDINEE 337
L DI +E
Sbjct: 261 Q-----LSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 3e-18
Identities = 77/295 (26%), Positives = 132/295 (44%), Gaps = 46/295 (15%)
Query: 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH 98
+KY +G+GA G V A++ T +EVAIK++ + + + EI ++R H
Sbjct: 19 KKYTR-FEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRENKH 75
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLR 154
NI+ D +++++V E + TD+ + CR + L+
Sbjct: 76 PNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR----ECLQ 126
Query: 155 GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPEL 213
L+++HS V+HRD+K N+LL + +K+ DFG A+ T E + V T ++ APE+
Sbjct: 127 ALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
+ Y +DIWS+G + E++ +P + ++ + L LI G+P+
Sbjct: 187 VTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------- 234
Query: 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
L K S D L + L D +R + E L HP+L
Sbjct: 235 --------LQNPEKL---------SAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-18
Identities = 83/298 (27%), Positives = 139/298 (46%), Gaps = 46/298 (15%)
Query: 39 RKYVPPIRPVGRGAYGIV--CA--AMNSETREEVAIK--KIGNAFDNRIDAKRTLREIKL 92
++++ IR +G G +G V C T E+VA+K K + ++ D K+ EI++
Sbjct: 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEI 59
Query: 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQII---RSHQDLTDDHCRYF 148
LR++ HENI+ K I + N + ++ E + + L + + ++ +L +Y
Sbjct: 60 LRNLYHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQL-KYA 115
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR-- 206
+ Q+ +G+ Y+ S +HRDL N+L+ + +KIGDFGL + ETD EY +
Sbjct: 116 V-QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETD--KEYYTVKDD 171
Query: 207 ------WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 260
WY APE L+ Y A+ D+WS G L E++T + + + L ++IG
Sbjct: 172 LDSPVFWY-APECLIQSKFYIAS-DVWSFGVTLYELLT----YCDSES-SPMTLFLKMIG 224
Query: 261 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 318
P + R + LP R PN L+ K F P++R T
Sbjct: 225 -PTHGQMTVTRLVRVLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTT 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 9e-18
Identities = 73/282 (25%), Positives = 131/282 (46%), Gaps = 37/282 (13%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+GA G V A++ T +EVAIK++ + + + EI ++R + NI+ D
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD- 83
Query: 108 IRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHR 167
+++++V E + + + + + + L+ L ++HS V+HR
Sbjct: 84 ----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHR 139
Query: 168 DLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 226
D+K N+LL + +K+ DFG A+ T E + V T ++ APE++ Y +DI
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 198
Query: 227 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 286
WS+G + E++ +P + ++ + L LI G+P+ Q P
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPEL-------------------QNP 238
Query: 287 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
++ SA F D L + L D +RR + E L HP+L
Sbjct: 239 ER-LSAVFR-------DFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 81/356 (22%), Positives = 140/356 (39%), Gaps = 92/356 (25%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
I+ +GRGA+G V + +T + A+K LR+ +++ ++ A
Sbjct: 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKV--------------LRKSDMIKRNQIAHVRA 50
Query: 104 IKDIIRPPQRE-------TFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQL 152
+DI+ +F D +Y +M+ DL ++ ++ R+++ +L
Sbjct: 51 ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAEL 110
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA------------RTTSETDFMT 200
+ L VH +HRD+KP N+L++A+ +K+ DFGL S
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 201 EYVVTRW------------------YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 242
+ V+ R Y APE+L + Y D WS+G IL E++ P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPP 229
Query: 243 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 302
F + ET + + N + +R FP P SP A+
Sbjct: 230 FYSD--------------TLQET---YNKIINWKESLR----FPPD------PPVSPEAI 262
Query: 303 DLLEKMLVFDPNRRIT-VDEALCHPYLAPL---HDINEEPVCPRPFSFDFEHPSFT 354
DL+ + L+ DP R+ +E HP+ + + +P PF + P T
Sbjct: 263 DLICR-LLCDPEDRLGSFEEIKSHPFFKGIDWENLRETKP----PFVPELSSPLDT 313
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 1e-17
Identities = 62/238 (26%), Positives = 110/238 (46%), Gaps = 41/238 (17%)
Query: 36 EVSRKYVPPIRPVGRGAYGIV---CAA--MNSETREEVAIKKIGNAFDNRIDAKRT--LR 88
E+ R+ + IR +G+G++G+V A + E VAIK + +N +R L
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTV---NENASMRERIEFLN 58
Query: 89 EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHC-- 145
E +++ + +++ + ++ Q +V ELM DL +RS + +++
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQP-----TLVVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 146 ------RYFLY--QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197
++ ++ G+ Y+ + +HRDL N ++ + +KIGDFG+ R ETD
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
Query: 198 FMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGK 246
+ Y RW APE L + +T D+WS G +L E+ T QP + G
Sbjct: 174 Y---YRKGGKGLLPVRWM-APESLKD-GVFTTKSDVWSFGVVLWEMATLAEQP-YQGL 225
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-17
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 39 RKYVPPIRPVGRGAYGIVCA----AMNSETREEVAIK--KIGNAFDNRIDAKRTLREIKL 92
++Y+ IR +G G +G V N T E VA+K K N K+ EI +
Sbjct: 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINI 59
Query: 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQL 152
L+ + HENI+ K Q + + Y + + + + +L F Q+
Sbjct: 60 LKTLYHENIVKYKGCCSE-QGGKGLQLIMEYVPLGSLRDYLPKHKLNLA--QLLLFAQQI 116
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR------ 206
G+ Y+HS + +HRDL N+LL+ + +KIGDFGLA+ E EY R
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSP 173
Query: 207 --WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 239
WY A E L A+ D+WS G L E++T
Sbjct: 174 VFWY-AVECLKENKFSYAS-DVWSFGVTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 2e-17
Identities = 57/217 (26%), Positives = 110/217 (50%), Gaps = 10/217 (4%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+GA G V AM+ T +EVAI+++ + + + EI ++R + NI+ D
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPNIVNYLD- 84
Query: 108 IRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHR 167
+++++V E + + + + + + L+ L+++HS V+HR
Sbjct: 85 ----SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHR 140
Query: 168 DLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 226
D+K N+LL + +K+ DFG A+ T E + V T ++ APE++ Y +DI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 199
Query: 227 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263
WS+G + E++ +P + ++ + L LI G+P+
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE 235
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 10/205 (4%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAI 104
R +G+G +G VCA T + A K++ R L E ++L ++ + ++ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 105 KDIIRPPQRETFNDVYIVYELM---DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
ET + + +V +M D H + ++ ++ ++L GL+ +H
Sbjct: 66 A-----YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
N ++RDLKP N+LL+ ++I D GLA E + + V T Y APE+L N YT
Sbjct: 121 ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-QRYT 179
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGK 246
+ D W +GC++ E++ Q F G+
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-17
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I +G GA+G V A N ET A K I + ++ + EI +L DH NI+ +
Sbjct: 10 IGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELE--DYMVEIDILASCDHPNIVKL 67
Query: 105 KDIIRPPQRETFNDVYIVYEL-----MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
D N+++I+ E +D + ++ R LT+ R Q L L Y+
Sbjct: 68 LDAFYYE-----NNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYL 119
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCS 218
H ++HRDLK N+L + D+K+ DFG+ A+ T ++ T ++ APE+++ C
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVM-CE 178
Query: 219 E-----YTAAIDIWSVGCILGEIMTRQP 241
Y D+WS+G L E+ +P
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 81/308 (26%), Positives = 134/308 (43%), Gaps = 42/308 (13%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I+ + G+ G V A + + + KIG TL E LL++++H ++I +
Sbjct: 71 IKTLTPGSEGRVFVA-TKPGQPDPVVLKIGQK-------GTTLIEAMLLQNVNHPSVIRM 122
Query: 105 KD-IIRPPQRETFNDVYIVYELMDTDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
KD ++ +V +DL+ + + + L D Q+L GL+Y+H+
Sbjct: 123 KDTLVSGAI------TCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ 176
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
++HRD+K N+ +N + IGD G A+ F+ T APE+L +Y
Sbjct: 177 RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVETNAPEVLAR-DKYN 234
Query: 222 AAIDIWSVGCILGEIMT------RQPLFPGKDYV-----HQLRLITELIGSPDETSLGFL 270
+ DIWS G +L E++ P ++YV H L++I+ L P+E F
Sbjct: 235 SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE----FP 290
Query: 271 RSDNAR------RYVRMLPQ-FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
R +R Y + Q + + R G L+ KML FD R + +E L
Sbjct: 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEF-LVHKMLTFDAAMRPSAEEIL 349
Query: 324 CHPYLAPL 331
+P A L
Sbjct: 350 NYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 66/246 (26%), Positives = 109/246 (44%), Gaps = 36/246 (14%)
Query: 129 DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188
DL I+S + R++ +++ GL+++H +++RDLK N+LL+ + +KI DFG
Sbjct: 82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141
Query: 189 LARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 247
+ + + + T Y APE+L +Y ++D WS G +L E++ Q F G+D
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
Query: 248 YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEK 307
EL S + +D P FP+ S A D L K
Sbjct: 201 E-------DELFDS--------ILNDR--------PHFPRW--------ISKEAKDCLSK 229
Query: 308 MLVFDPNRRITVDEAL-CHPYLAPLH-DINEEPVCPRPFSFDFEHPSFTEENIKELIYRE 365
+ DP +R+ VD + HP+ + + E+ P PF + PS N E
Sbjct: 230 LFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDA-SNFDREFTNE 288
Query: 366 SVKFNP 371
V+ +P
Sbjct: 289 KVRLSP 294
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 64/271 (23%), Positives = 122/271 (45%), Gaps = 41/271 (15%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G +G V +TR A+K + K + + ++ + NI+ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK--------KEIVAKKEVAHTIGERNILVRTLL 52
Query: 108 IRPP-------QRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
P +T +D+Y+V + M +L ++ ++D ++++ +L+ L+++
Sbjct: 53 DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHL 112
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMTEYVVTRWYRAPELLLNCS 218
H ++++RDLKP N+LL+A + + DFGL++ ++ + T Y APE+LL+
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR------S 272
YT +D WS+G ++ E+ F +D R I + G +R S
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI----------AFGKVRFPKNVLS 222
Query: 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVD 303
D R++V+ L R P GA
Sbjct: 223 DEGRQFVKGLLN--------RNPQHRLGAHR 245
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-17
Identities = 70/279 (25%), Positives = 124/279 (44%), Gaps = 43/279 (15%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR----TLREIKLLRHMDHENI 101
R +G+G +G VCA T + A KK+ RI ++ L E ++L ++ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFV 62
Query: 102 IAIKDIIRPPQRETFNDVYIVYELM---DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+++ ET + + +V LM D H + ++ ++ GL+
Sbjct: 63 VSLA-----YAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLED 117
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 218
+H +++RDLKP N+LL+ + ++I D GLA E + V T Y APE++ N
Sbjct: 118 LHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-E 176
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278
YT + D W++GC+L E++ Q SP + ++ + R
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQ--------------------SPFQQRKKKIKREEVERL 216
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 317
V+ + + +S +F SP A L + +L DP R+
Sbjct: 217 VKEVQ----EEYSEKF---SPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 9e-17
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 30/219 (13%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-NSETREE--VAIK--KIGNAFDNRIDAKRTLREI 90
E+ ++ + +G G +G V + R+E VAIK K G R D L E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD---FLSEA 57
Query: 91 KLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQDLTDDHCRYFL 149
++ H NII ++ ++ F I+ E M+ L + +R H + Y L
Sbjct: 58 SIMGQFSHHNIIRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQL 109
Query: 150 YQLLRG----LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT 205
+LRG +KY+ N +HRDL N+L+N+N + K+ DFGL+R E D Y +
Sbjct: 110 VGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTS 168
Query: 206 ------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
RW APE + ++T+A D+WS G ++ E+M+
Sbjct: 169 GGKIPIRW-TAPE-AIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 9e-17
Identities = 80/318 (25%), Positives = 135/318 (42%), Gaps = 59/318 (18%)
Query: 51 GAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR--TLREIKLLRHMDHENIIAIKDII 108
GA G A ++++T E V IK +R T E +LR ++H +II +K
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA----------GQRGGTATEAHILRAINHPSIIQLKGTF 152
Query: 109 RPPQRETFNDVY-IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHR 167
T+N ++ TDL+ + + +++ +LR ++Y+H ++HR
Sbjct: 153 ------TYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHR 206
Query: 168 DLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWY--------RAPELLLNCSE 219
D+K N+ +N D+ +GDFG A F + ++Y APELL
Sbjct: 207 DIKAENIFINHPGDVCLGDFGAAC------FPVDINANKYYGWAGTIATNAPELLAR-DP 259
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYV-------HQLRLITELIGS-PDETSLGFLR 271
Y A+DIWS G +L E+ T KD + Q++LI G+ P+E + +
Sbjct: 260 YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID-AQ 318
Query: 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLE----------KMLVFDPNRRITVDE 321
++ Y+ + + S+R P P +L E KML FD + R + +
Sbjct: 319 ANLDEIYIGLAKK------SSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEA 372
Query: 322 ALCHPYLAPLHDINEEPV 339
L + D P+
Sbjct: 373 LLDFAAFQDIPDPYPNPM 390
|
Length = 391 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 36/224 (16%)
Query: 46 RPVGRGAYGIV----CAAMNSETRE-EVAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHE 99
R +G GA+G V C + E + VA+K + +A DN A++ RE +LL ++ HE
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDN---ARKDFHREAELLTNLQHE 67
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-------------QDLTDDHC 145
+I+ + + + +V+E M DL++ +R+H +LT
Sbjct: 68 HIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122
Query: 146 RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT----E 201
+ Q+ G+ Y+ S + +HRDL N L+ N +KIGDFG++R TD+
Sbjct: 123 LHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLF 243
+ RW PE ++ ++T D+WS+G +L EI T +QP +
Sbjct: 183 MLPIRWM-PPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 1e-16
Identities = 72/283 (25%), Positives = 131/283 (46%), Gaps = 39/283 (13%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+GA G V A++ T +EVAIK+I + + + EI +++ + + NI+ D
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPNIVNFLD- 83
Query: 108 IRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHR 167
+++++V E + + + + + + L+ L+++H+ V+HR
Sbjct: 84 ----SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHR 139
Query: 168 DLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDI 226
D+K N+LL + +K+ DFG A+ T E + V T ++ APE++ Y +DI
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDI 198
Query: 227 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 286
WS+G + E++ +P + ++ + L LI G+P+
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE----------------------- 234
Query: 287 KQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
QN P K SP D L + L D +R + E L HP+L
Sbjct: 235 LQN-----PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 65/245 (26%), Positives = 116/245 (47%), Gaps = 19/245 (7%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR----TLREIKLLRHMDHENI 101
R +G+G +G VCA T + A KK+ RI ++ L E ++L ++ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFV 62
Query: 102 IAIKDIIRPPQRETFNDVYIVYELM---DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+++ ET + + +V LM D H + ++ ++ ++ GL+
Sbjct: 63 VSLA-----YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 218
+H +++RDLKP N+LL+ ++I D GLA E + + V T Y APE++ N
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN-E 176
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
YT + D W +GC++ E++ + F K+ V + + + +E S F S+ AR
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKF--SEAARS 234
Query: 278 YVRML 282
R L
Sbjct: 235 ICRQL 239
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 84/325 (25%), Positives = 145/325 (44%), Gaps = 65/325 (20%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK----RTLREIKLLRHMDHENIIA 103
+G+G +G V T + A+K + I AK TL E ++L++ H + A
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEV---IIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+K + R F V E + +L + + ++D R++ +++ L Y+HS
Sbjct: 60 LKYSFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC 114
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+V++RDLK NL+L+ + +KI DFGL + S+ M + T Y APE+L + ++Y
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYG 173
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITELIGSPDETSLGFLRSDNARRYV 279
A+D W +G ++ E+M + F +D+ + +L L+ E+
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI--------------------- 212
Query: 280 RMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPL-- 331
RFP SP A LL +L DP +R+ E + H + A +
Sbjct: 213 -------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259
Query: 332 HDINEEPVCPRPFSFDFEHPSFTEE 356
D+ ++ + P PF P T E
Sbjct: 260 QDVVQKKLEP-PFK-----PQVTSE 278
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 3e-16
Identities = 66/221 (29%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-NSETREEVAIK--KIGNAFDNRIDAKRTLREIKL 92
E+ R+ + R +G G +G V N T +VA+K K G + + L+E ++
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGT-----MSPEAFLQEAQI 54
Query: 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH--QDLTDDHCRYFL 149
++ + H+ ++ + + + E YIV E M L ++S + L
Sbjct: 55 MKKLRHDKLVQLYAVCS--EEEPI---YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA 109
Query: 150 YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 207
Q+ G+ Y+ S N +HRDL N+L+ N KI DFGLAR E D T ++
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI-EDDEYTAREGAKFPI 168
Query: 208 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+ APE N +T D+WS G +L EI+T R P +PG
Sbjct: 169 KWTAPE-AANYGRFTIKSDVWSFGILLTEIVTYGRVP-YPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 68/304 (22%), Positives = 130/304 (42%), Gaps = 59/304 (19%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLL-RHMDHENIIA 103
+R +G GAYG V ++K+G ++ A + L++ ++ + E+
Sbjct: 5 LRVLGTGAYGKV-----------FLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT 53
Query: 104 IKDIIRPPQRETFNDVYIVYELM-DTDLHQIIR------------SHQDLTDDHCRYFLY 150
+ ++ +R F V + Y DT LH I+ + T+ R ++
Sbjct: 54 ERQVLEAVRRCPFL-VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA 112
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR--TTSETDFMTEYVVTRWY 208
+++ L ++H +++RD+K N+LL++ + + DFGL++ E + + T Y
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172
Query: 209 RAPELLLNCSE-YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267
APE++ S + A+D WS+G + E++T F +
Sbjct: 173 MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---------------- 216
Query: 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALC 324
+S+ +RR ++ P FP S A D ++K+L DP +R+ DE
Sbjct: 217 ---QSEISRRILKSKPPFP--------KTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265
Query: 325 HPYL 328
HP+
Sbjct: 266 HPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 28/210 (13%)
Query: 45 IRPVGRGAYGIV--CA--AMNSETREEVAIKKIGNAFDNRI-DAKRTLREIKLLRHMDHE 99
I+ +G+G +G V C + T E VA+KK+ ++ + D +R EI++L+ + H+
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER---EIEILKSLQHD 65
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLY--QLLRGL 156
NI+ K + R ++ +V E L L ++ H++ D H + LY Q+ +G+
Sbjct: 66 NIVKYKGVCYSAGR---RNLRLVMEYLPYGSLRDYLQKHRERLD-HRKLLLYASQICKGM 121
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR--------WY 208
+Y+ S +HRDL N+L+ + +KIGDFGL + + EY R WY
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD---KEYYKVREPGESPIFWY 178
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
APE L S+++ A D+WS G +L E+ T
Sbjct: 179 -APE-SLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 64/212 (30%), Positives = 105/212 (49%), Gaps = 33/212 (15%)
Query: 46 RPVGRGAYG-IVCAAMNSETREEVAIK---KIGNAFDNRIDAKRTLREIKLLRHM-DHEN 100
+ +G GA+G +V A ++ + +K K+ + + + + E+K++ H+ +HEN
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 101 IIAIKD--IIRPPQRETFNDVYIVYEL-MDTDLHQIIRSHQD--LTDDHCRYFLYQLLRG 155
I+ + I P + ++ E DL +R ++ LT + F YQ+ +G
Sbjct: 101 IVNLLGACTIGGP-------ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE--YVV-------TR 206
+ ++ S N +HRDL N+LL +KI DFGLAR D M + YVV +
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNARLPVK 208
Query: 207 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
W APE + NC YT D+WS G +L EI +
Sbjct: 209 WM-APESIFNCV-YTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 4e-16
Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK-LLRHMDHENIIAIKD 106
+GRGA+G V ++ + +A+K+I + D + + KR L ++ ++R D I+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEK-EQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 107 IIRPPQRETFN--DVYIVYELMDTDL-------HQIIRSHQDLTDDHCRYFLYQLLRGLK 157
+ F D +I ELMD L +++++S + ++ ++ L
Sbjct: 71 AL-------FREGDCWICMELMDISLDKFYKYVYEVLKSV--IPEEILGKIAVATVKALN 121
Query: 158 YVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 216
Y+ ++HRD+KPSN+LL+ N ++K+ DFG++ ++ T R Y APE +
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 181
Query: 217 CSE--YTAAIDIWSVGCILGEIMT 238
+ Y D+WS+G L E+ T
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVAT 205
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 5e-16
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 42/215 (19%)
Query: 46 RPVGRGAYGIVCAA-MNSETREE--VAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHEN 100
+ +G G +G VC+ + + E VAIK K G R D L E ++ DH N
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD---FLSEASIMGQFDHPN 66
Query: 101 IIAIKDII---RPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQL---L 153
II ++ ++ +P V IV E M+ L +R H ++ + QL L
Sbjct: 67 IIHLEGVVTKSKP--------VMIVTEYMENGSLDAFLRKHDG------QFTVIQLVGML 112
Query: 154 RG----LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---- 205
RG +KY+ +HRDL N+L+N+N K+ DFGL+R E D Y
Sbjct: 113 RGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGKI 171
Query: 206 --RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
RW APE + ++T+A D+WS G ++ E+M+
Sbjct: 172 PIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-16
Identities = 61/225 (27%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIV-CAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLL 93
+E+ R+ + + +G G +G V A N T+ V K G+ + + L E ++
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVM 55
Query: 94 RHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ-------DLTDDHC 145
+ + H+ ++ + ++ T +YI+ E M L ++S + L D
Sbjct: 56 KTLQHDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLID--- 106
Query: 146 RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE---Y 202
F Q+ G+ ++ N +HRDL+ +N+L++A+ KI DFGLAR + ++
Sbjct: 107 --FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 164
Query: 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W APE +N +T D+WS G +L EI+T R P +PG
Sbjct: 165 FPIKW-TAPE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 206
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 90/361 (24%), Positives = 146/361 (40%), Gaps = 57/361 (15%)
Query: 28 YNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL 87
Y V G +VS + + +G G +G V A + + +E A+K + N DAK +
Sbjct: 117 YVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEI 176
Query: 88 REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY 147
+ ++ +R D + + I R Q ET + IV L I H + H
Sbjct: 177 QFMEKVRQADPADRFPLMKIQRYFQNET-GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQ 235
Query: 148 FLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNAN----------------CDLKIGDFGLA 190
++Q L Y H+ +++H DLKP N+L+ + C ++I D G
Sbjct: 236 IIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG-- 293
Query: 191 RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH 250
E T V TR YR+PE++L + + D+WS+GCI+ E+ T + L+ D +
Sbjct: 294 GCCDERHSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352
Query: 251 QLRLITELIGS-PDE--------------TSLGFLR----SDNARRYVRMLPQFPKQNFS 291
L L+ + +G P E S G LR + R R P
Sbjct: 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARP-------- 404
Query: 292 ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL---------APLHDINEEPVCPR 342
R + DL+ +L +D +R+ + HPY+ P + N + P
Sbjct: 405 VREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYPDNRSMLRPT 464
Query: 343 P 343
P
Sbjct: 465 P 465
|
Length = 467 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 42/230 (18%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAM-NSETREEVAIK--KIGNAFDNRIDAKRTLREIK 91
+E+ R + +R +G G +G V + N+ T VA+K K G D K L E +
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTM-----DPKDFLAEAQ 53
Query: 92 LLRHMDHENII---AIKDIIRPPQRETFNDVYIVYELMD-----TDLHQIIRSH---QDL 140
+++ + H +I A+ + P +YIV ELM L L
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEP--------IYIVTELMKYGSLLEYLQGGAGRALKLPQL 105
Query: 141 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200
D Q+ G+ Y+ + N +HRDL N+L+ N K+ DFGLAR E +
Sbjct: 106 ID-----MAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E 159
Query: 201 EYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
++ + APE + ++ D+WS G +L EI+T R P +PG
Sbjct: 160 AREGAKFPIKWTAPE-AALYNRFSIKSDVWSFGILLTEIVTYGRMP-YPG 207
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 69/284 (24%), Positives = 126/284 (44%), Gaps = 42/284 (14%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIG--NAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G+G++G V +++ T++ VAIK I A D D ++ EI +L D +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVTKYY 68
Query: 106 DIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVL 165
+ ++I+ E + + + L ++L+GL Y+HS +
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKI 123
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTAAI 224
HRD+K +N+LL+ D+K+ DFG+A ++T +V T ++ APE++ S Y +
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ-SAYDSKA 182
Query: 225 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 284
DIWS+G E+ +P P D +H +R++ ++P+
Sbjct: 183 DIWSLGITAIELAKGEP--PNSD-MHPMRVLF------------------------LIPK 215
Query: 285 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ F S + ++ L DP+ R T E L H ++
Sbjct: 216 NNPPTLTGEF---SKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 43/235 (18%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAM-----NSETREEVAIKKI-GNAFDNRIDAKRTLR 88
+E+ R + +P+G GA+G V A N VA+K + +A + D +
Sbjct: 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVS 64
Query: 89 EIKLLRHM-DHENIIAIKDIIR---PPQRETFNDVYIVYELMDT-DLHQIIRSH------ 137
E+++++ + H+NII + + P Y+V E +L +R+
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPL--------YVVVEYAAHGNLRDFLRARRPPGEY 116
Query: 138 ----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 187
+ LT F YQ+ RG++++ S +HRDL N+L+ + +KI DF
Sbjct: 117 ASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADF 176
Query: 188 GLARTTSETDFMTEYVVTR----WYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
GLAR D+ + R W APE L + YT D+WS G +L EI T
Sbjct: 177 GLARDIHHIDYYRKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 68/296 (22%), Positives = 123/296 (41%), Gaps = 44/296 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G GA G V T A+K I N K+ LRE+++ + I+
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKY 64
Query: 105 KDIIRPPQRETFNDVYIVYELMDT----DLHQIIRSHQDLTDDHCRYFLYQ-LLRGLKYV 159
+ + I E + +++ ++ + + + +L+GL Y+
Sbjct: 65 YGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
HS ++HRD+KPSN+LL +K+ DFG++ + T + T +Y APE +
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-FTGTSFYMAPERIQG-KP 179
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFP--GKDYVHQLRLITELIGSP-----DETSLGFLRS 272
Y+ D+WS+G L E+ + FP G+ + + L++ ++ P DE G S
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239
Query: 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ + D +++ L DP RR T + L HP++
Sbjct: 240 EEFK--------------------------DFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 78/287 (27%), Positives = 125/287 (43%), Gaps = 37/287 (12%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I+ VG G YG V A N T E A+K I + D +EI +++ H NI+A
Sbjct: 14 IQRVGSGTYGDVYKARNLHTGELAAVKII--KLEPGDDFSLIQQEIFMVKECKHCNIVAY 71
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
++ ++I E L I L++ Y + L+GL Y+HS
Sbjct: 72 FGSYLSREK-----LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPEL--LLNCSEY 220
+HRD+K +N+LL N D+K+ DFG+ A+ T+ ++ T ++ APE+ + Y
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
DIW+VG E+ QP P D +H +R + FL S +
Sbjct: 187 NQLCDIWAVGITAIELAELQP--PMFD-LHPMRAL-------------FLMSKSNF---- 226
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
Q PK ++ S + ++ L +P +R T + L H +
Sbjct: 227 ---QPPKLKDKTKW---SSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 79/316 (25%), Positives = 116/316 (36%), Gaps = 48/316 (15%)
Query: 27 QYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT 86
QYN+ +L S V VC E R++V +K + K
Sbjct: 93 QYNILSSLTPGSEGEV------------FVCTKHGDEQRKKVIVKAV-------TGGKTP 133
Query: 87 LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 146
REI +L+ + H II + R + V +V DL + L +
Sbjct: 134 GREIDILKTISHRAIINLIHAYRWK-----STVCMVMPKYKCDLFTYVDRSGPLPLEQAI 188
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE---YV 203
+LL L Y+H ++HRD+K N+ L+ + +GDFG A + +
Sbjct: 189 TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS 248
Query: 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLF--PGKDYVHQLRLITELIG 260
T +PELL Y A DIWS G +L E+ LF K QLR I I
Sbjct: 249 GTLETNSPELLA-LDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI---IR 304
Query: 261 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD----------LLEKMLV 310
L F ++ + + F + R P P + L+ KML
Sbjct: 305 CMQVHPLEFPQNGST----NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLT 360
Query: 311 FDPNRRITVDEALCHP 326
FD R + + L P
Sbjct: 361 FDQEFRPSAQDILSLP 376
|
Length = 392 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-15
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 38/215 (17%)
Query: 46 RPVGRGAYGIVCAAM---NSETREEVAIKKIGNAFDNRI----DAKRTLREIKLLRHMDH 98
R +G+G +G V + + A+K + NRI + ++ L+E +++ H
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL-----NRITDLEEVEQFLKEGIIMKDFSH 55
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ------DLTDDHCRYFLYQL 152
N++++ I P E V + Y + DL IRS DL F Q+
Sbjct: 56 PNVLSLLGICLPS--EGSPLVVLPY-MKHGDLRNFIRSETHNPTVKDLIG-----FGLQV 107
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 212
+G++Y+ S +HRDL N +L+ + +K+ DFGLAR + EY + +
Sbjct: 108 AKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD----KEYYSVHNHTGAK 163
Query: 213 L--------LLNCSEYTAAIDIWSVGCILGEIMTR 239
L L ++T D+WS G +L E+MTR
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 198
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 21/202 (10%)
Query: 46 RPVGRGAYGIVC-AAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+G+G +G V + T EVA+K + ++ L+E ++L+ DH NI+ +
Sbjct: 1 EKIGKGNFGDVYKGVLKGNT--EVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKL 57
Query: 105 KDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSA 162
+ Q++ +YIV EL+ L +R ++ LT G++Y+ S
Sbjct: 58 IGVC--VQKQP---IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM------TEYVVTRWYRAPELLLN 216
N +HRDL N L+ N LKI DFG++R E + + + +W APE LN
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKW-TAPE-ALN 168
Query: 217 CSEYTAAIDIWSVGCILGEIMT 238
YT+ D+WS G +L E +
Sbjct: 169 YGRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 67/281 (23%), Positives = 123/281 (43%), Gaps = 53/281 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLR---EIKLLRHMDHENI 101
I+ VG G +G V + + A+K + A I K+ E ++L+ + H I
Sbjct: 6 IKTVGTGTFGRVHLVRDRISEHYYALKVM--AIPEVIRLKQEQHVHNEKRVLKEVSHPFI 63
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
I + T +D +Y LM+ +L +R+ ++ ++ +++ L+
Sbjct: 64 IRLF--------WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE 115
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217
Y+HS +++RDLKP N+LL+ +K+ DFG A+ D T Y APE++ +
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPEVIQS- 172
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
+ A+D W++G ++ E++ P F + G ++ G L
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDN----------PFGIYEKILAGKLE------ 216
Query: 278 YVRMLPQFPKQ-NFSARFPNKSPGAVDLLEKMLVFDPNRRI 317
FP+ + A+ DL++K+LV D RR+
Sbjct: 217 -------FPRHLDLYAK---------DLIKKLLVVDRTRRL 241
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 4e-15
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 20/217 (9%)
Query: 46 RPVGRGAYGIVCAA---MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII 102
R +G+G +G V A + ++VA+K + + D + LRE ++ DH N+I
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 103 AIKDII---RPPQRETFNDVYIVYELMDTDLHQIIRSHQ------DLTDDHCRYFLYQLL 153
+ + R R V + + + DLH + + L F+ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPF-MKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----RWYR 209
G++Y+ S N +HRDL N +LN N + + DFGL++ D+ + + +W
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 210 APELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPG 245
L N YT D+W+ G + EIMTR Q + G
Sbjct: 184 LESLADNV--YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 68/249 (27%), Positives = 123/249 (49%), Gaps = 28/249 (11%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR----TLRE---IKLLRHMDHEN 100
+GRG +G V ++T + A+K + RI K+ L E + L+ D
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
I+ + P + F + +LM+ DLH + H ++ R++ +++ GL+++
Sbjct: 59 IVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHM 113
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
H+ V++RDLKP+N+LL+ + ++I D GLA S+ V T Y APE+L +
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGTA 172
Query: 220 YTAAIDIWSVGCILGEIMT-----RQPLFPGKDYVHQLRLITEL----IGSPDETSL--G 268
Y ++ D +S+GC+L +++ RQ K + ++ L + SP+ SL G
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG 232
Query: 269 FLRSDNARR 277
L+ D ++R
Sbjct: 233 LLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G GA+G V A N ET A K I + + + + EI++L +H I+ +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 108 IRPPQRETFNDVYIVYEL-----MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
++I+ E +D + ++ R LT+ + Q+L L+Y+HS
Sbjct: 78 FYWD-----GKLWIMIEFCPGGAVDAIMLELDRG---LTEPQIQVICRQMLEALQYLHSM 129
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLNC---- 217
++HRDLK N+LL + D+K+ DFG+ A+ ++ T ++ APE+++ C
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVM-CETMK 188
Query: 218 -SEYTAAIDIWSVGCILGEIMTRQP 241
+ Y DIWS+G L E+ +P
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 73/274 (26%), Positives = 128/274 (46%), Gaps = 27/274 (9%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIG--NAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G+G++G V +++ T+E VAIK I A D D ++ EI +L D I
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYITRYY 68
Query: 106 DIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVL 165
+ ++I+ E + + L + + L ++L+GL Y+HS +
Sbjct: 69 GSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKI 123
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCSEYTAAI 224
HRD+K +N+LL+ D+K+ DFG+A ++T +V T ++ APE++ S Y
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDFKA 182
Query: 225 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV----- 279
DIWS+G E+ +P P D +H +R++ LI +L S + +V
Sbjct: 183 DIWSLGITAIELAKGEP--PNSD-LHPMRVLF-LIPKNSPPTLEGQYSKPFKEFVEACLN 238
Query: 280 ---RMLP---QFPKQNFSARFPNKSPGAVDLLEK 307
R P + K F R+ K+ +L+++
Sbjct: 239 KDPRFRPTAKELLKHKFITRYTKKTSFLTELIDR 272
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 5e-15
Identities = 75/288 (26%), Positives = 122/288 (42%), Gaps = 39/288 (13%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA- 103
I+ +G G YG V A N T E AIK I + D +EI +++ H NI+A
Sbjct: 14 IQRIGSGTYGDVYKARNVNTGELAAIKVI--KLEPGEDFAVVQQEIIMMKDCKHSNIVAY 71
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+R + ++I E L I L++ Y + L+GL Y+HS
Sbjct: 72 FGSYLRR------DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPEL--LLNCSE 219
+HRD+K +N+LL N +K+ DFG+ A+ T+ ++ T ++ APE+ +
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
Y DIW+VG E+ QP + L L+T+ P + S++ +V
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+M L +P +R T ++ L HP+
Sbjct: 246 KM--------------------------ALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 85/311 (27%), Positives = 127/311 (40%), Gaps = 49/311 (15%)
Query: 51 GAYG--IVCAAMNS----ETREEVAIKKIGNAFDNRIDAKR---TLR-------EIKLLR 94
GA+G +CA S E R V G R+ AKR R EI L
Sbjct: 159 GAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALG 218
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-DLTDD----HCRYFL 149
++HENI+ I++I+R + Y++ + D DL+ + D D R +
Sbjct: 219 RLNHENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIM 273
Query: 150 YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY--VVTRW 207
QLL ++Y+H ++HRD+K N+ LN + + +GDFG A + +Y V T
Sbjct: 274 KQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVA 333
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP----GKDYVHQLRLITELIGSPD 263
+PE+L Y DIWS G IL ++++ P G QL I + + D
Sbjct: 334 TNSPEILAGDG-YCEITDIWSCGLILLDMLSHD-FCPIGDGGGKPGKQLLKIIDSLSVCD 391
Query: 264 E-------TSLGFLRSDNARRYVRMLPQFPKQ-NFSARFPNKSPGAVDLLEKMLVFDPNR 315
E ++ S +P + A F + P L KML FD +
Sbjct: 392 EEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADF--EYP-----LVKMLTFDWHL 444
Query: 316 RITVDEALCHP 326
R E L P
Sbjct: 445 RPGAAELLALP 455
|
Length = 501 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 69/249 (27%), Positives = 121/249 (48%), Gaps = 33/249 (13%)
Query: 48 VGRGAYGIVCAAMNSET---------REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH 98
+G+G +G V T R+EV I K + T+ E ++L++ H
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD--------EVAHTVTESRVLQNTRH 54
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
+ A+K + R F V E + +L + + T++ R++ +++ L+
Sbjct: 55 PFLTALKYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 109
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 216
Y+HS +V++RD+K NL+L+ + +KI DFGL + S+ M + T Y APE+L +
Sbjct: 110 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED 169
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI-TELIG-----SPDETSL--G 268
++Y A+D W +G ++ E+M + F +D+ LI E I SP+ SL G
Sbjct: 170 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 228
Query: 269 FLRSDNARR 277
L+ D +R
Sbjct: 229 LLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-15
Identities = 52/210 (24%), Positives = 95/210 (45%), Gaps = 38/210 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +G G +G+V + VAIK I + D + E K++ + H N++ +
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDD---FIEEAKVMMKLSHPNLVQL 64
Query: 105 KDII---RPPQRETFNDVYIVYELMDTD-LHQIIRSHQDLTD-----DHCRYFLYQLLRG 155
+ RP ++IV E M L +R + D C +
Sbjct: 65 YGVCTKQRP--------IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS----DVCEA 112
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-------TTSETDFMTEYVVTRWY 208
++Y+ S +HRDL N L+ + +K+ DFGLAR T+S+ T++ V +W
Sbjct: 113 MEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG---TKFPV-KW- 167
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
AP + + S +++ D+WS G ++ E+ +
Sbjct: 168 -APPEVFDYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 9e-15
Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 21/226 (9%)
Query: 46 RPVGRGAYGIVCAAM--NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
+ +G G +G V ++ +VA+K + A R + + L E ++ DH N++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 104 IKDI-IRPPQRETFNDVYIVYELMD-TDLHQII------RSHQDLTDDHCRYFLYQLLRG 155
+ + ++ + E + ++ M DLH + Q L F+ + G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPE 212
++Y+ S + +HRDL N +LN N ++ + DFGL++ D+ + + + + A E
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPG------KDYVHQ 251
L + YT D+WS G + EI TR Q +PG DY+ Q
Sbjct: 185 SLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 1e-14
Identities = 75/318 (23%), Positives = 141/318 (44%), Gaps = 51/318 (16%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKD 106
+G+G +G V + + A+K + + + TL E ++L++ H + ++K
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 107 IIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLH 166
+ R F Y+ +L + + ++D R++ +++ L Y+HS +++
Sbjct: 63 SFQTKDRLCFVMEYV----NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVY 118
Query: 167 RDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAID 225
RDLK NL+L+ + +KI DFGL + ++ M + T Y APE+L + ++Y A+D
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED-NDYGRAVD 177
Query: 226 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 285
W +G ++ E+M + F +D+ LI L D +F
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------------LMED---------IKF 214
Query: 286 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH--DINEEP 338
P+ S A LL +L+ DPN+R+ E + H + ++ D+ ++
Sbjct: 215 PR--------TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKK 266
Query: 339 VCPRPFSFDFEHPSFTEE 356
+ P PF P T E
Sbjct: 267 LVP-PFK-----PQVTSE 278
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 41/228 (17%)
Query: 126 MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 185
M T L+Q + ++D R++ +++ L+++H +++RD+K N+LL++ + +
Sbjct: 92 MFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLT 147
Query: 186 DFGLART--TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 243
DFGL++ + E + + T Y APE++ + A+D WS+G ++ E++T F
Sbjct: 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
Query: 244 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 303
L G + +S+ +RR ++ P FP P A D
Sbjct: 208 -------------TLEGERNT------QSEVSRRILKCDPPFP--------SFIGPEAQD 240
Query: 304 LLEKMLVFDPNRRI-----TVDEALCHPYLAPLH--DINEEPVCPRPF 344
LL K+L DP +R+ E HP+ L + V PF
Sbjct: 241 LLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKV-NPPF 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-14
Identities = 67/227 (29%), Positives = 105/227 (46%), Gaps = 44/227 (19%)
Query: 48 VGRGAYGIV----CAAMNSET-REEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENI 101
+G GA+G V C + E + VA+K + A ++ R D +R E +LL + H++I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69
Query: 102 IAIKDII---RPPQRETFNDVYIVYELM-DTDLHQIIRSHQ---------------DLTD 142
+ + RP + +V+E M DL++ +RSH LT
Sbjct: 70 VRFYGVCTEGRP--------LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTL 121
Query: 143 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--- 199
Q+ G+ Y+ S + +HRDL N L+ +KIGDFG++R TD+
Sbjct: 122 GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 200 -TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLF 243
+ RW PE +L ++T DIWS G +L EI T +QP +
Sbjct: 182 GRTMLPIRWM-PPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 79/308 (25%), Positives = 141/308 (45%), Gaps = 38/308 (12%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR----TLREIKLLRHMDHENI 101
R +G+G +G VCA T + A KK+ RI ++ L E ++L ++ +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFV 62
Query: 102 IAIKDIIRPPQRETFNDVYIVYELM---DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+++ ET + + +V +M D H + + ++ +L GL+
Sbjct: 63 VSLA-----YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLED 117
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 218
+ +++RDLKP N+LL+ ++I D GLA E + + V T Y APE++ N
Sbjct: 118 LQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN-E 176
Query: 219 EYTAAIDIWSVGCILGEIMTRQ-PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
+YT + D W +GC++ E++ Q P K+ V + + + +E S F S++A+
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKF--SEDAKS 234
Query: 278 YVRM-LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN-RRITVDEALCHPYLAPLHDIN 335
RM L + PK+ R GA + + + + N +R+ EA ++
Sbjct: 235 ICRMLLTKNPKERLGCR----GNGAAGVKQHPIFKNINFKRL---EA----------NML 277
Query: 336 EEPVCPRP 343
E P CP P
Sbjct: 278 EPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 30/224 (13%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAM-NSETREEVAIKKIGNAFDNRIDAKRTLREIKLL 93
+E+ R+ + ++ +G G +G V N+ T+ V K G + + L E L+
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLM 55
Query: 94 RHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQ-------DLTDDHC 145
+ + H+ ++ + ++ + +YI+ E M L ++S + L D
Sbjct: 56 KTLQHDKLVRLYAVVTKEE-----PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLID--- 107
Query: 146 RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE---Y 202
F Q+ G+ Y+ N +HRDL+ +N+L++ + KI DFGLAR + ++
Sbjct: 108 --FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAK 165
Query: 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 245
+W APE +N +T D+WS G +L EI+T + +PG
Sbjct: 166 FPIKW-TAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 34/208 (16%)
Query: 114 ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 172
+T +++ V E ++ DL I+S ++ +++ GL+++HS +++RDLK
Sbjct: 66 QTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLD 125
Query: 173 NLLLNANCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 231
N+LL+ + +KI DFG+ + D T + T Y APE+LL +Y ++D WS G
Sbjct: 126 NILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGV 184
Query: 232 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 291
+L E++ Q F G D +E +R DN P +P
Sbjct: 185 LLYEMLIGQSPFHGHD---------------EEELFQSIRMDN--------PCYP----- 216
Query: 292 ARFPNKSPGAVDLLEKMLVFDPNRRITV 319
R+ + A D+L K+ V +P RR+ V
Sbjct: 217 -RWLTRE--AKDILVKLFVREPERRLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 59/281 (20%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA---- 103
+G G++G V A + T E AIK KR + ++K ++H+ E I
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIK---------CLKKREILKMKQVQHVAQEKSILMELS 76
Query: 104 ---IKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
I +++ Q E N VY + E ++ +L +R +D +++ +L+ +Y+
Sbjct: 77 HPFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
HS ++++RDLKP NLLL+ +K+ DFG A+ + F T Y APE ++
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT--LCGTPEYLAPE-VIQSKG 191
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
+ A+D W++G +L E + P F D+T R Y
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPF------------------FDDTPF--------RIYE 225
Query: 280 RMLP---QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 317
++L +FP F R A DL++ +L D +R+
Sbjct: 226 KILAGRLKFPNW-FDGR-------ARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 72/276 (26%), Positives = 127/276 (46%), Gaps = 30/276 (10%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIG--NAFDNRIDAKRTLREIKLLRHM-DHENI 101
I +G+G YG V N + A+K + + D I+A E +L+ + +H N+
Sbjct: 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA-----EYNILQSLPNHPNV 81
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMD----TDLHQ-IIRSHQDLTDDHCRYFLYQLLRGL 156
+ + + +++V EL + T+L + ++ Q L + Y LY L GL
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 215
+++H+ ++HRD+K +N+LL +K+ DFG+ A+ TS V T ++ APE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 201
Query: 216 NCSE-----YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270
C + Y A D+WS+G E+ P P D +H ++ + ++ +P T L
Sbjct: 202 -CEQQYDYSYDARCDVWSLGITAIELGDGDP--PLFD-MHPVKTLFKIPRNPPPTLL--- 254
Query: 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLE 306
+ ++ R F Q F P LLE
Sbjct: 255 ---HPEKWCRSFNHFISQCLIKDF-EARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 70/311 (22%), Positives = 126/311 (40%), Gaps = 76/311 (24%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+ +G+G++G V A T E A+K L++ +L+ D E + K
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVK--------------VLKKDVILQDDDVECTMTEK 46
Query: 106 DIIRPPQR-----------ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLL 153
++ + +T + ++ V E ++ DL I+ + R++ +++
Sbjct: 47 RVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIV 106
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW------ 207
GL+++H +++RDLK N+LL++ +KI DFG+ + + + V T
Sbjct: 107 LGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCK-----EGILGGVTTSTFCGTPD 161
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267
Y APE+L Y A+D W++G +L E++ Q F G D ++
Sbjct: 162 YIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDD---------------EDELF 205
Query: 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+ D RY R L S A +L+ L +P +R+ C P
Sbjct: 206 QSILEDEV-RYPRWL---------------SKEAKSILKSFLTKNPEKRLG-----CLPT 244
Query: 328 LAPLHDINEEP 338
DI P
Sbjct: 245 GE--QDIKGHP 253
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 61/232 (26%), Positives = 102/232 (43%), Gaps = 31/232 (13%)
Query: 117 NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKY---VHSANVLHRDLKPS 172
++ I E MD L Q+++ + ++ +LRGL Y H ++HRD+KPS
Sbjct: 72 GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPS 129
Query: 173 NLLLNANCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 231
N+L+N+ ++K+ DFG++ D M +V TR Y +PE L + YT DIWS+G
Sbjct: 130 NILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQG-THYTVQSDIWSLGL 186
Query: 232 ILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS--DNARRYVRML------ 282
L E+ R P+ P + + + S + ++ R + +
Sbjct: 187 SLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYI 246
Query: 283 -----PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
P+ P FS F D ++K L +P R + E HP++
Sbjct: 247 VNEPPPKLPSGAFSDEF-------QDFVDKCLKKNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 70/236 (29%), Positives = 115/236 (48%), Gaps = 39/236 (16%)
Query: 37 VSRKYVPPIRPVGRGAYGIVCAAMN---SETREE--VAIKKIGNAFDNRIDAKRTL-REI 90
+ R+ + R +G GA+G V A S T+++ VA+K + D + A++ RE
Sbjct: 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK---DPTLAARKDFQREA 58
Query: 91 KLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD----LTDDHC 145
+LL ++ HE+I+ + + + +V+E M DL++ +R+H L D
Sbjct: 59 ELLTNLQHEHIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113
Query: 146 R------------YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193
R + Q+ G+ Y+ S + +HRDL N L+ AN +KIGDFG++R
Sbjct: 114 RQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 173
Query: 194 SETDFMT----EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLF 243
TD+ + RW PE ++ ++T D+WS G IL EI T +QP F
Sbjct: 174 YSTDYYRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 64/244 (26%), Positives = 121/244 (49%), Gaps = 18/244 (7%)
Query: 45 IRPVGRGAYG---IVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI 101
++ +G+G++G +V + + A+K + A D RT E +L ++H I
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 102 IAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
+ + +T +Y++ + L DL + T++ +++L +L L ++H
Sbjct: 61 VKLHYAF-----QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCSE 219
S +++RDLKP N+LL+ +K+ DFGL++ + + + + T Y APE ++N
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRG 174
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRY 278
+T + D WS G ++ E++T F GKD + +I + +G P FL S A+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ-----FL-SPEAQSL 228
Query: 279 VRML 282
+R L
Sbjct: 229 LRAL 232
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 3e-14
Identities = 81/301 (26%), Positives = 133/301 (44%), Gaps = 64/301 (21%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK--RTLREIKLLRHMDHENIIAIK 105
+G+G YG V ++ T +A+K+I D ++K + + E+ +L I+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD---ESKFNQIIMELDILHKAVSPYIV--- 62
Query: 106 DIIRPPQRETFNDVYIVYELMDT----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
D E VY+ E MD L+ + + + +D R Y +++GLK++
Sbjct: 63 DFYGAFFIE--GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 162 A-NVLHRDLKPSNLLLNANCDLKIGDFG----LARTTSETDFMTEYVVTRWYRAPELL-- 214
N++HRD+KP+N+L+N N +K+ DFG L + ++T+ + + Y APE +
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPERIKS 175
Query: 215 LNCSE---YTAAIDIWSVG-CILGEIMTRQPLFPGKDYVH---QLRLITELIGSPDETSL 267
++ YT D+WS+G IL + R P +P + Y + QL I + G P
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGRYP-YPPETYANIFAQLSAIVD--GDP----- 227
Query: 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
P P S A D + K L PNRR T + L HP+
Sbjct: 228 ---------------PTLP--------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264
Query: 328 L 328
L
Sbjct: 265 L 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 70/250 (28%), Positives = 123/250 (49%), Gaps = 30/250 (12%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR----TLRE---IKLLRHMDHEN 100
+GRG +G V ++T + A+K + RI K+ L E + L+ D
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
I+ + P + +F + +LM+ DLH + H ++ R++ +++ GL+++
Sbjct: 59 IVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHM 113
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
H+ V++RDLKP+N+LL+ + ++I D GLA S+ V T Y APE+L
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQKGVA 172
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPG---KDYVHQLRLITELI-------GSPDETSL-- 267
Y ++ D +S+GC+L +++ F KD H++ +T + SP+ SL
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLE 231
Query: 268 GFLRSDNARR 277
G L+ D RR
Sbjct: 232 GLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 72/311 (23%), Positives = 132/311 (42%), Gaps = 75/311 (24%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENII 102
I+ +G+G G V T + A+K + R KR L E ++L +DH +
Sbjct: 5 KIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLP 64
Query: 103 AIKDIIRPPQRETFNDVYIVYELMD----TDLHQII--RSHQDLTDDHCRYFLYQLLRGL 156
+ Q ET+ + +MD +L +++ + + L+++ R++ ++L L
Sbjct: 65 TLYASF---QTETY-----LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS---------------------- 194
+Y+H +++RDLKP N+LL+ + + + DF L++ +
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 195 -------ETDFMT-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 246
E F + +V T Y APE++ + +A+D W++G +L E++ F G
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGS 235
Query: 247 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLE 306
+ DET L+ + FP P S A DL+
Sbjct: 236 --------------NRDETFSNILKKE---------VTFPGS------PPVSSSARDLIR 266
Query: 307 KMLVFDPNRRI 317
K+LV DP++R+
Sbjct: 267 KLLVKDPSKRL 277
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 30/204 (14%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G G +G V T ++VA+K I + A+ L E ++ + H+N++ + +
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 108 IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLR-------GLKYV 159
I N +YIV ELM +L +R+ + QLL+ G++Y+
Sbjct: 68 I------LHNGLYIVMELMSKGNLVNFLRTRGRALVS-----VIQLLQFSLDVAEGMEYL 116
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
S ++HRDL N+L++ + K+ DFGLAR S ++ V +W APE L + +
Sbjct: 117 ESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-KW-TAPEALKH-KK 173
Query: 220 YTAAIDIWSVGCILGEIMT--RQP 241
+++ D+WS G +L E+ + R P
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 66/253 (26%), Positives = 117/253 (46%), Gaps = 33/253 (13%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVC-----AAMNSETREEVAIKKIGNAFDNRIDAKRTLRE 89
+EV+R+ + R +G+G++G+V + E VAIK + A R + L E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 59
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYF 148
+++ + +++ + ++ Q ++ ELM DL +RS + +++
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQ-----PTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 149 LYQLLR----------GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198
L + G+ Y+++ +HRDL N ++ + +KIGDFG+ R ETD+
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174
Query: 199 MTE----YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQL 252
+ + RW +PE L + +T D+WS G +L EI T QP + G L
Sbjct: 175 YRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQP-YQGMSNEQVL 231
Query: 253 RLITE--LIGSPD 263
R + E L+ PD
Sbjct: 232 RFVMEGGLLDKPD 244
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 76/298 (25%), Positives = 136/298 (45%), Gaps = 48/298 (16%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIG--NAFDNRIDAKRTLREIKLLRHM-DHENI 101
I +G+G YG V +N + + A+K + + D I+A E +L+ + DH N+
Sbjct: 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA-----EYNILKALSDHPNV 77
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMD----TDLHQ-IIRSHQDLTDDHCRYFLYQLLRGL 156
+ + + + +++V EL + TDL + ++ + + + Y L++ L GL
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLL 215
+++H +HRD+K +N+LL +K+ DFG+ A+ TS V T ++ APE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197
Query: 216 NC-----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270
C S Y A D+WS+G E+ P P D +H +R + ++ +P T L
Sbjct: 198 -CEQQLDSTYDARCDVWSLGITAIELGDGDP--PLAD-LHPMRALFKIPRNPPPT----L 249
Query: 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+ F+ D + K L D +R TV + L H ++
Sbjct: 250 HQ----------PELWSNEFN-----------DFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 58/196 (29%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G +G V + + VA+K + K L E ++L+ DH NI+ + +
Sbjct: 3 LGKGNFGEVFKG-TLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 108 IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVL 165
QR+ +YIV EL+ D +R +D L F G+ Y+ S N +
Sbjct: 61 C--TQRQP---IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT---EYVVTRWYRAPELLLNCSEYTA 222
HRDL N L+ N LKI DFG++R + + + + + +W APE LN Y++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAPE-ALNYGRYSS 173
Query: 223 AIDIWSVGCILGEIMT 238
D+WS G +L E +
Sbjct: 174 ESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 63/215 (29%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIGNAF-------DNRIDAKRTLREIKLLRHMDHENI 101
GRG +G V A +T E AIK + ++ + KR RH N+
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNL 67
Query: 102 IAIKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYV 159
A +T + V V E DL I H D ++ ++ ++ GL+Y+
Sbjct: 68 FAC--------FQTEDHVCFVMEYAAGGDLMMHI--HTDVFSEPRAVFYAACVVLGLQYL 117
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-------TTSETDFMTEYVVTRWYRAPE 212
H +++RDLK NLLL+ +KI DFGL + TS + T + APE
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS------TFCGTPEFLAPE 171
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 247
+L S YT A+D W +G ++ E++ + FPG D
Sbjct: 172 VLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-14
Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 38/212 (17%)
Query: 48 VGRGAYGIVCAA-MNSETREE--VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+G G +G VC + + E VAIK + + + + + L E ++ DH NII +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASIMGQFDHPNIIHL 70
Query: 105 KDII---RPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQL---LRG-- 155
+ ++ RP V I+ E M+ L +R + ++ + QL LRG
Sbjct: 71 EGVVTKSRP--------VMIITEFMENGALDSFLRQNDG------QFTVIQLVGMLRGIA 116
Query: 156 --LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-------TDFMTEYVVTR 206
+KY+ N +HRDL N+L+N+N K+ DFGL+R + T + + R
Sbjct: 117 AGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR 176
Query: 207 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
W APE + ++T+A D+WS G ++ E+M+
Sbjct: 177 W-TAPE-AIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 58/219 (26%), Positives = 106/219 (48%), Gaps = 21/219 (9%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
+EV R+ + ++ +G G +G V + + VAIK + + + L E L++
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLK---QGSMSPEAFLAEANLMK 56
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ--DLTDDHCRYFLYQ 151
+ H ++ + ++ T +YI+ E M+ L +++ + LT + Q
Sbjct: 57 QLQHPRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ 110
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE---YVVTRWY 208
+ G+ ++ N +HRDL+ +N+L++ KI DFGLAR + ++ +W
Sbjct: 111 IAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW- 169
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
APE +N +T D+WS G +L EI+T R P +PG
Sbjct: 170 TAPE-AINYGTFTIKSDVWSFGILLTEIVTYGRIP-YPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 70/266 (26%), Positives = 115/266 (43%), Gaps = 56/266 (21%)
Query: 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAA----MNSETREE---VAIKKI-GNAFDNRID 82
+E R + +P+G G +G V A ++ ++ VA+K + NA D D
Sbjct: 3 LDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDK--D 60
Query: 83 AKRTLREIKLLRHMD-HENIIAIKDII-------------------------RPPQRETF 116
+ E++L++ + H+NII + + RPP +
Sbjct: 61 LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYT 120
Query: 117 NDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 176
D+ T + + S +DL C YQ+ RG++Y+ S +HRDL N+L+
Sbjct: 121 FDI--------TKVPEEQLSFKDLVS--C---AYQVARGMEYLESRRCIHRDLAARNVLV 167
Query: 177 NANCDLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCIL 233
+ +KI DFGLAR + D+ + R + APE L + YT D+WS G ++
Sbjct: 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILM 226
Query: 234 GEIMTR--QPLFPGKDYVHQLRLITE 257
EI T P +PG +L+ E
Sbjct: 227 WEIFTLGGSP-YPGIPVEELFKLLRE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 80/337 (23%), Positives = 148/337 (43%), Gaps = 64/337 (18%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G++G V A + + A+K + K+ + + K +H+ E + +K++
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVL---------QKKAILKKKEEKHIMSERNVLLKNV 53
Query: 108 IRP------PQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
P +T + +Y V + ++ +L ++ + + R++ ++ L Y+H
Sbjct: 54 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 113
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSE 219
S N+++RDLKP N+LL++ + + DFGL + E + T + T Y APE +L+
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPE-VLHKQP 172
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
Y +D W +G +L E++ P F + + A Y
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSR--------------------------NTAEMYD 206
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD----EALCHPYLAPLH--D 333
+L + P Q PN + A LLE +L D +R+ E H + +P++ D
Sbjct: 207 NILNK-PLQ----LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261
Query: 334 INEEPVCPRPFS------FDFEH--PSFTEENIKELI 362
+ + + P PF+ D H P FTEE + I
Sbjct: 262 LINKKITP-PFNPNVSGPNDLRHFDPEFTEEPVPNSI 297
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 57/218 (26%), Positives = 108/218 (49%), Gaps = 29/218 (13%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR------HMDH 98
++ +G+G YG V ++K+ A +I A + L++ ++R H
Sbjct: 1 LKVLGKGGYGKV-----------FQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA 49
Query: 99 E-NIIA------IKDIIRPPQRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLY 150
E NI+ I D+I Q T +Y++ E L +L + +D ++L
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQ--TGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYR 209
++ L+++H +++RDLKP N+LL+A +K+ DFGL + + +T + T Y
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYM 167
Query: 210 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 247
APE+L+ + A+D WS+G ++ +++T P F ++
Sbjct: 168 APEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 70/249 (28%), Positives = 108/249 (43%), Gaps = 35/249 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I+ +G G +G V + T+E K I + + + E+ ++R + H+NI+
Sbjct: 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDL---TDDHCRY-FLYQLLRGLKYV 159
D + +YI+ E D DL + I+ + ++H QLL L Y
Sbjct: 78 IDRFLNKANQK---LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 160 HS-------ANVLHRDLKPSNLLL-----------------NANCDLKIGDFGLARTTSE 195
H+ VLHRDLKP N+ L N KIGDFGL++
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 196 TDFMTEYVVTRWYRAPELLLN-CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRL 254
V T +Y +PELLL+ Y D+W++GCI+ E+ + + F + Q L
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ--L 252
Query: 255 ITELIGSPD 263
I+EL PD
Sbjct: 253 ISELKRGPD 261
|
Length = 1021 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 8e-14
Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 41/200 (20%)
Query: 68 VAIKKIG-NAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIR--PPQRETFNDVYIVY 123
VA+K + +A DN R D L+E+K+L + NI + + PP + ++
Sbjct: 49 VAVKVLRPDASDNARED---FLKEVKILSRLSDPNIARLLGVCTVDPP-------LCMIM 98
Query: 124 ELMDT-DLHQIIRSHQDLTDDHCRY--------FLY---QLLRGLKYVHSANVLHRDLKP 171
E M+ DL+Q ++ H T LY Q+ G++Y+ S N +HRDL
Sbjct: 99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158
Query: 172 SNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-------TRWYRAPELLLNCSEYTAAI 224
N L+ N +KI DFG++R +D+ Y V RW +LL ++T
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLL--GKFTTKS 213
Query: 225 DIWSVGCILGEIMT---RQP 241
D+W+ G L EI+T QP
Sbjct: 214 DVWAFGVTLWEILTLCREQP 233
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-14
Identities = 76/297 (25%), Positives = 134/297 (45%), Gaps = 54/297 (18%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA---- 103
VG G YG V + +T + AIK + D + K+ EI +L+ H IA
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIATYYG 70
Query: 104 --IKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
IK PP + + +++V E TDL + + + L ++ Y ++LRGL
Sbjct: 71 AFIKK--NPPGMD--DQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLS 125
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLN 216
++H V+HRD+K N+LL N ++K+ DFG++ T ++ T ++ APE++
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIA- 184
Query: 217 CSE-----YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271
C E Y D+WS+G E+ P P D +H +R + + +P
Sbjct: 185 CDENPDATYDFKSDLWSLGITAIEMAEGAP--PLCD-MHPMRALFLIPRNP--------- 232
Query: 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+ + +S +F + +E LV + ++R T ++ + HP++
Sbjct: 233 ----------APRLKSKKWSKKFQS-------FIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 9e-14
Identities = 56/205 (27%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIG--NAFDNRIDAKRTLREIKLLRHMDHENII 102
+ +G+G++G V +++ T++ VAIK I A D D ++ EI +L D +
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ---EITVLSQCDSPYVT 65
Query: 103 A-----IKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
+KD ++I+ E + + L + L ++L+GL
Sbjct: 66 KYYGSYLKD----------TKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLD 115
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM-TEYVVTRWYRAPELLLN 216
Y+HS +HRD+K +N+LL+ + ++K+ DFG+A ++T +V T ++ APE++
Sbjct: 116 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 175
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQP 241
S Y + DIWS+G E+ +P
Sbjct: 176 -SAYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 86/368 (23%), Positives = 138/368 (37%), Gaps = 101/368 (27%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I+ +G GA+G VC +T A+K TLR+ +L ++ A
Sbjct: 6 IKTIGIGAFGEVCLVRKVDTNALYAMK--------------TLRKADVLMRNQAAHVKAE 51
Query: 105 KDIIRPPQRE-------TFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLL 153
+DI+ E +F D +Y +MD D+ ++ +D R+++ +L
Sbjct: 52 RDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELT 111
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA---RTTSET-------------- 196
++ VH +HRD+KP N+L++ + +K+ DFGL R T ++
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171
Query: 197 DFMTEY---------------------------VVTRWYRAPELLLNCSEYTAAIDIWSV 229
+ E+ V T Y APE+LL + YT D WSV
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSV 230
Query: 230 GCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN 289
G IL E++ QP F L +P ET L+ N + + Q
Sbjct: 231 GVILYEMLVGQPPF--------------LADTPAETQ---LKVINWETTLHIPSQ----- 268
Query: 290 FSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLAPLHDINEEPVCPRPFSF 346
S A DL+ + L R+ DE HP+ + + P+
Sbjct: 269 -----AKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAPYIP 322
Query: 347 DFEHPSFT 354
HP+ T
Sbjct: 323 KITHPTDT 330
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 51/223 (22%), Positives = 93/223 (41%), Gaps = 32/223 (14%)
Query: 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREE-----VAIKKIGNAFDNRIDAKRTL---R 88
R + I +GRG +G V A EE V +K A D R
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVK----ALQKTKDENLQSEFRR 57
Query: 89 EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIR---------SHQ 138
E+ + R + H+N++ + + R + E Y++ E D DL Q +R
Sbjct: 58 ELDMFRKLSHKNVVRLLGLCR--EAEPH---YMILEYTDLGDLKQFLRATKSKDEKLKPP 112
Query: 139 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197
L+ Q+ G+ ++ +A +HRDL N L+++ ++K+ L++ ++
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172
Query: 198 --FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
+ RW APE + +++ D+WS G ++ E+ T
Sbjct: 173 YKLRNALIPLRWL-APEAVQE-DDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 90/372 (24%), Positives = 142/372 (38%), Gaps = 105/372 (28%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I+ +G GA+G VC A +T + A +TLR+ +L ++ A
Sbjct: 6 IKTLGIGAFGEVCLARKVDT--------------KALYAMKTLRKKDVLLRNQVAHVKAE 51
Query: 105 KDIIRPPQRE-------TFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLL 153
+DI+ E +F D +Y +MD D+ ++ +D R+++ +L
Sbjct: 52 RDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELT 111
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA---RTTSET-------------- 196
++ VH +HRD+KP N+L++ + +K+ DFGL R T ++
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 197 DFMTEY-------------------------------VVTRWYRAPELLLNCSEYTAAID 225
DF E+ V T Y APE+LL + YT D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCD 230
Query: 226 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 285
WSVG IL E++ QP F L +P ET + + +
Sbjct: 231 WWSVGVILYEMLVGQPPF--------------LAQTPLETQMKVINWQTSL-------HI 269
Query: 286 PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLAPLHDINEEPVCPR 342
P Q SP A DL+ K L P R+ DE HP+ + ++
Sbjct: 270 PPQ------AKLSPEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSA 322
Query: 343 PFSFDFEHPSFT 354
P+ HP+ T
Sbjct: 323 PYIPKITHPTDT 334
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 72/314 (22%), Positives = 129/314 (41%), Gaps = 48/314 (15%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKD 106
+G+G +G V A T + A KK+ R + + E ++L + I+++
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 107 IIRPPQRETFNDVYIVYELMDT-DL----HQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
+T D+ +V +M+ DL + + + + ++ Q++ GL+++H
Sbjct: 61 AF-----QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ 115
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEY 220
+++RDLKP N+LL+ + +++I D GLA + T+ Y T + APELL EY
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEY 174
Query: 221 TAAIDIWSVGCILGE-IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
++D +++G L E I R P + V L ++
Sbjct: 175 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS----------------- 217
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH-D 333
+ +F SP + E +L DP +R+ D HP L+
Sbjct: 218 --------VTYPDKF---SPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266
Query: 334 INEEPVCPRPFSFD 347
E + P PF D
Sbjct: 267 QLEAGMLPPPFVPD 280
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 52/203 (25%), Positives = 89/203 (43%), Gaps = 22/203 (10%)
Query: 48 VGRGAYGIVCAA---MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+G G +G V M S EVA+K + K LRE ++ +DH I+ +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE-HIAAGKKEFLREASVMAQLDHPCIVRL 61
Query: 105 KDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
+ + + +V EL L + ++ +++ + +Q+ G+ Y+ S +
Sbjct: 62 IGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH 115
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLN 216
+HRDL N+LL KI DFG++R Y T +WY APE +N
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS--DYYRATTAGRWPLKWY-APE-CIN 171
Query: 217 CSEYTAAIDIWSVGCILGEIMTR 239
++++ D+WS G L E +
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSY 194
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 52/213 (24%), Positives = 105/213 (49%), Gaps = 19/213 (8%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G++G V A K G + ++ K+ + K +H+ E + +K++
Sbjct: 3 IGKGSFGKVLLAKR---------KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV 53
Query: 108 IRP------PQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
P +T +Y V + ++ +L ++ + + R++ ++ L Y+H
Sbjct: 54 KHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSE 219
S N+++RDLKP N+LL++ + + DFGL + +++D T + T Y APE++
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QP 172
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL 252
Y +D W +G +L E++ P F +D V ++
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKD 106
+G+G +G VCA T + A KK+ + K L E ++L ++ I+ +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 107 IIRPPQRETFNDVYIVYELM---DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
E+ + +V LM D H + L + ++ Q+ G+ ++HS +
Sbjct: 61 AF-----ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAA 223
+++RD+KP N+LL+ + ++ D GLA + +T+ T Y APE+L Y+
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE-EPYSYP 174
Query: 224 IDIWSVGCILGEIMTRQPLFPGKDY 248
+D +++GC + E++ + P KD+
Sbjct: 175 VDWFAMGCSIYEMVAGRT--PFKDH 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 17/205 (8%)
Query: 45 IRPVGRGAYG-IVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENII 102
IR +G G++G ++ A +E VAIK+ + + E K+L +++H +
Sbjct: 35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 103 AIKDIIRPPQRETFND---VYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+ +F D +Y+V E ++ + +R ++ +D ++ Q++ +Y
Sbjct: 95 NLYG--------SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 218
+ S N+++RDLKP NLLL+ + +K+ DFG A+ + T Y APE+LLN
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYIAPEILLNVG 204
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLF 243
AA D W++G + EI+ P F
Sbjct: 205 HGKAA-DWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI- 104
R +G GA G V A E A+K + + D R E+ L + D +I+
Sbjct: 38 RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCH 97
Query: 105 KDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTD---DHCRYFLY-QLLRGL 156
+D + R N V ++ ++D DL Q I+S +H L+ Q+L +
Sbjct: 98 EDFAKKDPRNPEN-VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPEL 213
+VHS +++HRD+K +N+LL +N +K+GDFG ++ + T D + T +Y APE+
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEI 216
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 247
Y+ D++S+G +L E++T + F G++
Sbjct: 217 WRRKP-YSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 2e-13
Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 42/228 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I+ + GAYG V + ETR+ A+KKI K+ L +LR+ + +
Sbjct: 6 IKLISNGAYGAVYLVRHKETRQRFAMKKIN---------KQNL----ILRNQIQQ-VFVE 51
Query: 105 KDIIRPPQR----------ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLL 153
+DI+ + ET + +V E ++ D ++++ L D R + + +
Sbjct: 52 RDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETV 111
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR------TTS------ETD---F 198
L+Y+H+ ++HRDLKP NLL+ + +K+ DFGL++ TT+ E D F
Sbjct: 112 LALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 199 MTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 245
+ + V T Y APE++L Y +D W++G IL E + F G
Sbjct: 172 LDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 87/368 (23%), Positives = 136/368 (36%), Gaps = 103/368 (27%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I+ +G GA+G VC A +T A+K TLR+ +L ++ A
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMK--------------TLRKKDVLNRNQVAHVKAE 51
Query: 105 KDIIRPPQRE-------TFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLL 153
+DI+ E +F D +Y +MD D+ ++ + + R+++ +L
Sbjct: 52 RDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELT 111
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL------------------------ 189
++ VH +HRD+KP N+L++ + +K+ DFGL
Sbjct: 112 LAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171
Query: 190 ------------------------ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAID 225
A + V T Y APE+LL YT D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCD 230
Query: 226 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 285
WSVG IL E++ QP F L +P ET L + +N
Sbjct: 231 WWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTL-------HI 269
Query: 286 PKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLHDINEEPVCPRP 343
P Q SP AVDL+ K+ R R D+ HP+ + + ++ P P
Sbjct: 270 PPQ------VKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAP 323
Query: 344 FSFDFEHP 351
+ HP
Sbjct: 324 YVPKISHP 331
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 58/223 (26%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G++G V A T E AIK L++ +++ D E + K +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK--------------ILKKDVIIQDDDVECTMVEKRV 53
Query: 108 IRPPQRETF-----------NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRG 155
+ P + F + +Y V E ++ DL I+ + H ++ ++ G
Sbjct: 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG 113
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELL 214
L ++HS +++RDLK N++L+A +KI DFG+ + T + T Y APE++
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 257
Y ++D W+ G +L E++ QP F G+D + I E
Sbjct: 174 AY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 58/251 (23%), Positives = 111/251 (44%), Gaps = 37/251 (14%)
Query: 84 KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQDLTD 142
K+ LRE++++ I++ E N++ + E MD L +I + +
Sbjct: 48 KQILRELQIMHECRSPYIVSFYGAF---LNE--NNICMCMEFMDCGSLDRIYKKGGPIPV 102
Query: 143 DHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNLLLNANCDLKIGDFG----LARTTSETD 197
+ ++ GL Y+++ + ++HRD+KPSN+L+N+ +K+ DFG L + ++T
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT- 161
Query: 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 257
+V T Y +PE + +YT D+WS+G + E+ + FP +
Sbjct: 162 ----FVGTSTYMSPE-RIQGGKYTVKSDVWSLGISIIELALGK--FPFAF--------SN 206
Query: 258 LIGSPDETSLGFLRSDNARRYVRM-LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
+ + +G L D ++ V+ P+ P +F D ++ L+ DP R
Sbjct: 207 IDDDGQDDPMGIL--DLLQQIVQEPPPRLPSSDF-------PEDLRDFVDACLLKDPTER 257
Query: 317 ITVDEALCHPY 327
T + P
Sbjct: 258 PTPQQLCAMPP 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 37/198 (18%)
Query: 68 VAIKKIGNAFDNRIDAKRT-----LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122
VA+K + R DA + L+EIK++ + NII + + T + + ++
Sbjct: 49 VAVKML------REDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMI 97
Query: 123 YELMDT-DLHQIIRSHQ---DLTDDHCRYFLY--------QLLRGLKYVHSANVLHRDLK 170
E M+ DL+Q + H+ Y Q+ G+KY+ S N +HRDL
Sbjct: 98 TEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLA 157
Query: 171 PSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDI 226
N L+ N +KI DFG++R D+ + RW +LL ++T A D+
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDV 215
Query: 227 WSVGCILGEIMT---RQP 241
W+ G L EI+T QP
Sbjct: 216 WAFGVTLWEILTLCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 33/225 (14%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIV-CAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLL 93
+E+ R+ + +G+G +G V N TR VAIK + + + L+E +++
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLKPG---TMSPEAFLQEAQVM 55
Query: 94 RHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT---------DLHQIIRSHQDLTDDH 144
+ + HE ++ + ++ + +YIV E M ++ + +R Q L D
Sbjct: 56 KKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ-LVD-- 106
Query: 145 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY-- 202
Q+ G+ YV N +HRDL+ +N+L+ N K+ DFGLAR + ++
Sbjct: 107 ---MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163
Query: 203 -VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 245
+W APE L +T D+WS G +L E+ T+ + +PG
Sbjct: 164 KFPIKW-TAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 79/300 (26%), Positives = 134/300 (44%), Gaps = 54/300 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA- 103
+ VG G YG V + +T + AIK + D + K EI +L+ H IA
Sbjct: 21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL---EINMLKKYSHHRNIAT 77
Query: 104 -----IKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLR 154
IK PP + + +++V E TDL + + + L +D Y ++LR
Sbjct: 78 YYGAFIKK--SPPGHD--DQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILR 132
Query: 155 GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPEL 213
GL ++H+ V+HRD+K N+LL N ++K+ DFG++ T ++ T ++ APE+
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEV 192
Query: 214 LLNCSE-----YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268
+ C E Y DIWS+G E+ P P D +H +R + + +P
Sbjct: 193 IA-CDENPDATYDYRSDIWSLGITAIEMAEGAP--PLCD-MHPMRALFLIPRNPP----- 243
Query: 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+ + +S +F +D +E LV + R + ++ L HP++
Sbjct: 244 --------------PKLKSKKWSKKF-------IDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 55/193 (28%), Positives = 95/193 (49%), Gaps = 18/193 (9%)
Query: 48 VGRGAYGIVCAAMNSETR-EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKD 106
+G+G +G V M + R ++VA+K + D+ A+ L E ++ + H N++ +
Sbjct: 14 IGKGEFGDV---MLGDYRGQKVAVKCLK---DDSTAAQAFLAEASVMTTLRHPNLVQLLG 67
Query: 107 IIRPPQRETFNDVYIVYELMDT-DLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSAN 163
++ N +YIV E M L +RS +T F + G++Y+ N
Sbjct: 68 VVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAA 223
+HRDL N+L++ + K+ DFGLA+ S+ + V +W APE L +++
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-KW-TAPEALRE-KKFSTK 179
Query: 224 IDIWSVGCILGEI 236
D+WS G +L EI
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-13
Identities = 59/246 (23%), Positives = 117/246 (47%), Gaps = 26/246 (10%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G++G V A + + A+K + K+ + + K +H+ E + +K++
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVK---------VLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 108 IRP------PQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
P +T + +Y V + ++ +L ++ + + R++ ++ L Y+H
Sbjct: 54 KHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCSE 219
S N+++RDLKP N+LL++ + + DFGL + E + + + T Y APE+L
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QP 172
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDY-------VHQ-LRLITELIGSPDETSLGFLR 271
Y +D W +G +L E++ P F +D +++ LRL + S G L+
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQ 232
Query: 272 SDNARR 277
D +R
Sbjct: 233 KDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-13
Identities = 51/192 (26%), Positives = 86/192 (44%), Gaps = 32/192 (16%)
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 211
+++GL Y+ S +LHRD+KPSN+L+N +K+ DFG++ + YV T Y AP
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAP 162
Query: 212 ELLLNCSEYTAAIDIWSVGCILGEI-MTRQP---LFPGKDYVHQLRLITELIGSPDETSL 267
E + +Y D+WS+G E+ + R P + + + L+L+ ++ DE
Sbjct: 163 ERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV---DEDP- 217
Query: 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
P P FS +F V + + + P R + + HP+
Sbjct: 218 ---------------PVLPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPF 255
Query: 328 LAPLHDINEEPV 339
+ +D N E V
Sbjct: 256 IVQYNDGNAEVV 267
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-13
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 35/226 (15%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAM-NSETREEVAIKKIGNAFDNRIDAKRTLREIKLL 93
+E+ R+ + I+ +G G +G V N T+ V K G + + L E +++
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-----MSPESFLEEAQIM 55
Query: 94 RHMDHENIIAIKDII-RPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYF---- 148
+ + H+ ++ + ++ P +YIV E M L D R
Sbjct: 56 KKLRHDKLVQLYAVVSEEP-------IYIVTEYMSKGSLLDF-----LKDGEGRALKLPN 103
Query: 149 ----LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY-- 202
Q+ G+ Y+ N +HRDL+ +N+L+ KI DFGLAR + ++
Sbjct: 104 LVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA 163
Query: 203 -VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W APE L +T D+WS G +L E++T R P +PG
Sbjct: 164 KFPIKW-TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVP-YPG 206
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 47/218 (21%), Positives = 89/218 (40%), Gaps = 22/218 (10%)
Query: 46 RPVGRGAYGIVCAAMNSE---TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII 102
+ +G G +G V S+ ++ +VA+K + + + L E ++ DH N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 103 AIKDI-IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLL------- 153
+ + + ++ M DLH + + Q L
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVDI 122
Query: 154 -RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----RWY 208
G++Y+ + N +HRDL N +L + + + DFGL++ D+ + + +W
Sbjct: 123 ALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPG 245
L YT+ D+W+ G + EI TR Q +PG
Sbjct: 183 AIESLADRV--YTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 7e-13
Identities = 82/321 (25%), Positives = 139/321 (43%), Gaps = 56/321 (17%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIKD 106
+G+G +G V T A+K + + + TL E ++L++ H + A+K
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 107 IIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NV 164
+ R F V E + +L + + ++D R++ +++ L Y+HS NV
Sbjct: 63 SFQTHDRLCF-----VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 165 LHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAA 223
++RDLK NL+L+ + +KI DFGL + + M + T Y APE+L + ++Y A
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRA 176
Query: 224 IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 283
+D W +G ++ E+M + F +D+ LI L +
Sbjct: 177 VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------------LMEE---------- 212
Query: 284 QFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPL--HDIN 335
RFP SP A LL +L DP +R+ E + H + A + D+
Sbjct: 213 --------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVY 264
Query: 336 EEPVCPRPFSFDFEHPSFTEE 356
E+ + P PF P T E
Sbjct: 265 EKKLVP-PFK-----PQVTSE 279
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 7e-13
Identities = 63/233 (27%), Positives = 93/233 (39%), Gaps = 52/233 (22%)
Query: 63 ETREEVAIKKIGNAFDNRIDA-------KRTLREIKLLRHMDHENIIAIKDI-IRPPQRE 114
T EVAIK + R DA R RE L + H NI+A+ D PP
Sbjct: 1 MTGHEVAIKLL------RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL- 53
Query: 115 TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 173
++ V+E + L +++ + L + Q+L L H+ ++HRDLKP N
Sbjct: 54 ----LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQN 109
Query: 174 LLLNANCD---LKIGDFGL------------ARTTSETDFMTEYVVTRWYRAPELLLNCS 218
++++ K+ DFG+ A T TE + T Y APE L
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT----TEVLGTPTYCAPEQLRG-E 164
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKD----YVHQLRLITELIGSPDETSL 267
T D+++ G I E +T Q + G QL SP + SL
Sbjct: 165 PVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQL--------SPVDVSL 209
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 7e-13
Identities = 50/195 (25%), Positives = 99/195 (50%), Gaps = 14/195 (7%)
Query: 48 VGRGAYGIVCAAM--NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G G +G V M ++ + VA+K + N ++ LRE +++ +D+ I+ +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 106 DIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVL 165
I + E++ V + EL L++ ++ ++ +T+ + ++Q+ G+KY+ N +
Sbjct: 63 GIC---EAESWMLVMELAEL--GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-----RWYRAPELLLNCSEY 220
HRDL N+LL KI DFGL++ + + +WY APE +N ++
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY-APE-CMNYYKF 175
Query: 221 TAAIDIWSVGCILGE 235
++ D+WS G ++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 39/123 (31%), Positives = 65/123 (52%), Gaps = 4/123 (3%)
Query: 126 MDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 185
++ + Q ++ H + YQ++ L VHS ++HRDLK +N+ L +K+G
Sbjct: 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211
Query: 186 DFGLARTTSET---DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 242
DFG ++ S++ D + + T +Y APEL Y+ D+WS+G IL E++T
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRP 270
Query: 243 FPG 245
F G
Sbjct: 271 FKG 273
|
Length = 478 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 65/252 (25%), Positives = 115/252 (45%), Gaps = 36/252 (14%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREE-------VAIKKIGNAFDNRIDAKRTL 87
+E+SR + +P+G G +G V A ++ VA+K + + ++ D +
Sbjct: 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDK-DLSDLV 65
Query: 88 REIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ----DLT 141
E+++++ + H+NII + +Y++ E +L + +R+ + D +
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQD-----GPLYVLVEYASKGNLREYLRARRPPGMDYS 120
Query: 142 DDHCRY------------FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189
D C+ YQ+ RG++Y+ S +HRDL N+L+ + +KI DFGL
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGL 180
Query: 190 ARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 245
AR D+ + R + APE L + YT D+WS G +L EI T +PG
Sbjct: 181 ARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
Query: 246 KDYVHQLRLITE 257
+L+ E
Sbjct: 240 IPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 23/206 (11%)
Query: 45 IRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN 100
I+ +G GA+G V + + + VAIK + K L E ++ +DH +
Sbjct: 12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPH 70
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKY 158
++ + I Q V ++ +LM L +R+H+D + + + Q+ +G+ Y
Sbjct: 71 VVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT------RWYRAPE 212
+ ++HRDL N+L+ +KI DFGLA+ + EY +W A E
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVPIKWM-ALE 181
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMT 238
+L+ YT D+WS G + E+MT
Sbjct: 182 SILH-RIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 77/295 (26%), Positives = 124/295 (42%), Gaps = 55/295 (18%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKI---GNAFDNRIDAKRTLR--EIKLLRHMDHENII 102
+G G G V +T +A+K++ GN +N KR L ++ L H D I+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN----KRILMDLDVVLKSH-DCPYIV 77
Query: 103 -AIKDIIRPPQRETFNDVYIVYELMDTDLHQI-IRSHQDLTDD---HCRYFLYQLLRGLK 157
I DV+I ELM T L ++ R + +D + + L LK
Sbjct: 78 KCYGYFITDS------DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL--- 214
H V+HRD+KPSN+LL+A+ ++K+ DFG++ ++ T Y APE +
Sbjct: 132 EKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPP 189
Query: 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
+Y D+WS+G L E+ T Q FP K+ + ++T+++
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEE------------ 235
Query: 275 ARRYVRMLPQFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P P + FS F ++ L D +R E L HP++
Sbjct: 236 -------PPSLPPNEGFSPDF-------CSFVDLCLTKDHRKRPKYRELLQHPFI 276
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 56/201 (27%), Positives = 96/201 (47%), Gaps = 12/201 (5%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENIIAI 104
+G+G++G V A T E AIK + D+ +D T + I L H + A+
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRI-LALAAKHPFLTAL 61
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
+ R ++ V E ++ DL I+ + + R++ ++ L ++H
Sbjct: 62 HCCFQTKDR-----LFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTA 222
V++RDLK N+LL+A K+ DFG+ + T + T Y APE+L EY
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGP 175
Query: 223 AIDIWSVGCILGEIMTRQPLF 243
++D W++G ++ E+M QP F
Sbjct: 176 SVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 83/347 (23%), Positives = 147/347 (42%), Gaps = 69/347 (19%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G++G V A K G+ + ++ K+T+ + K H+ E + +K++
Sbjct: 3 IGKGSFGKVLLAKR---------KSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL 53
Query: 108 IRP---PQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
P +F +Y ++D +L ++ + + R++ ++ + Y+H
Sbjct: 54 KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH 113
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSE 219
S N+++RDLKP N+LL++ + + DFGL + E + T + T Y APE+L
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EP 172
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
Y +D W +G +L E++ P F +D V Q+ DN
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQM-------------------YDNILHKP 212
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD----EALCHPYLAPLH--D 333
LP K+ A DLL +L D RR+ E H + +P++ D
Sbjct: 213 LQLP-----------GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDD 261
Query: 334 INEEPVCPRPFS------FDFEH--PSFTEENIKELIYRESVKFNPD 372
+ + + P P++ D H P FT+E + SV PD
Sbjct: 262 LYHKRITP-PYNPNVAGPADLRHFDPEFTQEAVS-----SSVGQTPD 302
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 57/208 (27%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIK----KIGNAFDNRIDAKRTLREIKLLRHMDHE 99
I +G G G+V + + +A K +I A N+I +RE+++L +
Sbjct: 9 RISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI-----IRELQVLHECNSP 63
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
I+ + ++ I E MD L Q+++ + + ++ +LRGL Y
Sbjct: 64 YIVGFYGAFY-----SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAY 118
Query: 159 VHSAN-VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217
+ + ++HRD+KPSN+L+N+ ++K+ DFG++ ++ +V TR Y +PE L
Sbjct: 119 LREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQG 176
Query: 218 SEYTAAIDIWSVGCILGEI-MTRQPLFP 244
+ Y+ DIWS+G L E+ + R P+ P
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMDHENII 102
I+ +GRGA+G V + +++ A+K + + F+ R D+ E ++ H + E I+
Sbjct: 48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLL-SKFEMIKRSDSAFFWEERDIMAHANSEWIV 106
Query: 103 AIKDIIRPPQRETFND---VYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+ F D +Y+V E M DL ++ S+ D+ + R++ +++ L
Sbjct: 107 QL--------HYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDA 157
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAPELLLN 216
+HS +HRD+KP N+LL+ + LK+ DFG + V T Y +PE+L +
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217
Query: 217 ---CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 249
Y D WSVG L E++ F V
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 49/293 (16%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
VGRG +G V T + A+K + L + + + +I++I +
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVM--------KKSVLLAQETVSFFEEERDILSISNS 60
Query: 108 IRPPQRE-TFNDVYIVYELMD----TDLHQIIRSHQDLTD-DHCRYFLYQLLRGLKYVHS 161
PQ + F D +Y +M+ DL ++ ++D D D +++L +L+ + VH
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLLNCSE 219
+HRD+KP N+L++ +K+ DFG A T ++ V T Y APE+L +
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 220 YTAAI-----DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
D WS+G I E++ + F ++ + N
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRSPF-----------------HEGTSAKTYNNIMN 223
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+R+++ FP+ P S +DL++ +L R+ + CHP+
Sbjct: 224 FQRFLK----FPED------PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 42/217 (19%)
Query: 48 VGRGAYGIVCAAMNSE---TREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENII 102
+G G++G+V S VA+K K D D L+E ++ +DHEN+I
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD---FLKEAAIMHSLDHENLI 59
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLY--------QLL 153
+ ++ + +V EL + S D L D +FL Q+
Sbjct: 60 RLYGVVLTHP------LMMVTELAP------LGSLLDRLRKDALGHFLISTLCDYAVQIA 107
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYR---- 209
G++Y+ S +HRDL N+LL ++ +KIGDFGL R + + ++ V +
Sbjct: 108 NGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE---DHYVMEEHLKVPF 164
Query: 210 ---APELLLNCSEYTAAIDIWSVGCILGEIMT--RQP 241
APE L ++ A D+W G L E+ T +P
Sbjct: 165 AWCAPE-SLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 26/200 (13%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+GRG +G V + VA+K + AK L+E ++L+ H NI+ + +
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61
Query: 108 IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLR-------GLKYV 159
Q +YIV EL+ D +R+ + R + +L++ G++Y+
Sbjct: 62 CTQKQ-----PIYIVMELVQGGDFLTFLRT------EGPRLKVKELIQMVENAAAGMEYL 110
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELLL 215
S + +HRDL N L+ LKI DFG++R + + + + + +W APE L
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPE-AL 168
Query: 216 NCSEYTAAIDIWSVGCILGE 235
N Y++ D+WS G +L E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 150 YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-- 207
YQ+ RG++Y+ S +HRDL N+L+ N +KI DFGLAR + D+ + R
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 208 -YRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
+ APE L + YT D+WS G ++ EI T
Sbjct: 204 KWMAPEALFD-RVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 52/232 (22%), Positives = 108/232 (46%), Gaps = 52/232 (22%)
Query: 128 TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 187
T L Q R + + + +++ L+++H +++RD+K N+LL++N + + DF
Sbjct: 94 THLSQRER----FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 149
Query: 188 GLART--TSETDFMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFP 244
GL++ E + + T Y AP+++ + A+D WS+G ++ E++T
Sbjct: 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG----- 204
Query: 245 GKDYVHQLRLITELIGSP-----DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 299
SP ++ S +++ +RR ++ P +P++ S
Sbjct: 205 ---------------ASPFTVDGEKNS----QAEISRRILKSEPPYPQE--------MSA 237
Query: 300 GAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH--DINEEPVCPRPF 344
A D+++++L+ DP +R+ DE HP+ ++ D+ + V P PF
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKV-PAPF 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 75/342 (21%), Positives = 148/342 (43%), Gaps = 48/342 (14%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENII 102
R +GRG+Y V +T A+K + D ID +T + + + +H ++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLV 59
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
+ + R ++ V E ++ DL ++ + L ++H R++ ++ L Y+H
Sbjct: 60 GLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEY 220
+++RDLK N+LL++ +K+ D+G+ + D + + T Y APE+L +Y
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDY 173
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS---PDETSLGFLRSDNARR 277
++D W++G ++ E+M + F +++GS PD+ + +L +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF-------------DIVGSSDNPDQNTEDYLFQVILEK 220
Query: 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV------DEALCHPYLAPL 331
+R+ P+ + S A +L+ L DP R+ + HP+ +
Sbjct: 221 QIRI----PR--------SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268
Query: 332 H-DINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPD 372
D+ E+ PF + F +N E V+ PD
Sbjct: 269 DWDLMEQKQVVPPFKPNISG-EFGLDNFDAQFTNEPVQLTPD 309
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 51/216 (23%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM 96
+ K + ++ +G G +G+V + +VAIK I + + + E K++ +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYG-KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKL 56
Query: 97 DHENIIAIKDII---RPPQRETFNDVYIVYELMDTD-LHQIIRSHQD-LTDDHCRYFLYQ 151
HE ++ + + RP +YIV E M L +R H
Sbjct: 57 SHEKLVQLYGVCTKQRP--------IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRW 207
+ G+ Y+ S +HRDL N L++ +K+ DFGL+R + ++ +++ V RW
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV-RW 167
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQP 241
PE+LL ++++ D+W+ G ++ E+ + + P
Sbjct: 168 -SPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 53/198 (26%), Positives = 82/198 (41%), Gaps = 35/198 (17%)
Query: 54 GIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113
IV A + T VA+KKI ++ D K +EI R + H NI+ P
Sbjct: 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL--------PYV 65
Query: 114 ETF---NDVYIVYELMDTDLHQIIRSHQDLTDDHC---------RYFLYQLLRGLKYVHS 161
+F +++Y+V LM S +DL H + L +L L Y+HS
Sbjct: 66 TSFIVDSELYVVSPLMAYG------SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLA--------RTTSETDFMTEYVVTRWYRAPEL 213
+HR +K S++LL+ + + + + R DF V + +PE+
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEV 179
Query: 214 L-LNCSEYTAAIDIWSVG 230
L N Y DI+SVG
Sbjct: 180 LQQNLQGYNEKSDIYSVG 197
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 77/338 (22%), Positives = 130/338 (38%), Gaps = 98/338 (28%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
I+ +GRGA+G V +T I A + LR+ ++L ++ A
Sbjct: 5 SIKVIGRGAFGEVRLVQKKDT--------------GHIYAMKKLRKSEMLEKEQVAHVRA 50
Query: 104 IKDIIRPPQRE-------TFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQL 152
+DI+ +F D +Y +M+ D+ ++ T++ R+++ +
Sbjct: 51 ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAET 110
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY---------- 202
+ + +H +HRD+KP NLLL+A +K+ DFGL T + TE+
Sbjct: 111 ILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC-TGLKKSHRTEFYRILSHALPS 169
Query: 203 ------------------------------VVTRWYRAPELLLNCSEYTAAIDIWSVGCI 232
V T Y APE+ L + Y D WS+G I
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVI 228
Query: 233 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSA 292
+ E++ P F + P ET + N + + QFP +
Sbjct: 229 MYEMLVGYPPFCSDN--------------PQETYRKII---NWKETL----QFPDE---- 263
Query: 293 RFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPY 327
SP A DL+++ L + RR+ V+E HP+
Sbjct: 264 --VPLSPEAKDLIKR-LCCEAERRLGNNGVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 41/109 (37%), Positives = 58/109 (53%), Gaps = 19/109 (17%)
Query: 148 FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE--YVV- 204
F Q+ +G+ ++ S N +HRD+ N+LL KI DFGLAR D M + YVV
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVK 271
Query: 205 ------TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W APE + +C YT D+WS G +L EI + + P +PG
Sbjct: 272 GNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP-YPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-12
Identities = 66/236 (27%), Positives = 111/236 (47%), Gaps = 36/236 (15%)
Query: 48 VGRGAYGIVCAAM------NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI 101
+G GA+G V VA+K + ++ + K L+E L+ + +H NI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQ-EKKEFLKEAHLMSNFNHPNI 61
Query: 102 IAIKDIIRPPQRETFND-VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLL------ 153
+ + + N+ YI+ ELM+ DL +R + L +LL
Sbjct: 62 VKLLGVC------LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115
Query: 154 -RGLKYVHSANVLHRDLKPSNLLLNA---NCD--LKIGDFGLARTTSETDFMTE----YV 203
+G Y+ + +HRDL N L++ + D +KIGDFGLAR ++D+ + +
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITE 257
RW APE LL+ ++T D+WS G ++ EI+T +QP +P + L+ +T
Sbjct: 176 PVRWM-APESLLD-GKFTTQSDVWSFGVLMWEILTLGQQP-YPALNNQEVLQHVTA 228
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-12
Identities = 51/223 (22%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +G G +G+V + +VAIK I + D + E K++ + H ++ +
Sbjct: 9 MKELGSGQFGVVHLG-KWRAQIKVAIKAINEGAMSEED---FIEEAKVMMKLSHPKLVQL 64
Query: 105 KDII---RPPQRETFNDVYIVYELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
+ +P +YIV E M+ L+ + + L+ D + G++Y+
Sbjct: 65 YGVCTQQKP--------LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL 116
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY---VVTRWYRAPELLLN 216
+ +HRDL N L+++ +K+ DFG+ R + ++ + +W PE + N
Sbjct: 117 ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPE-VFN 174
Query: 217 CSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITE 257
S+Y++ D+WS G ++ E+ T + P F K + +I+
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMP-FEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-12
Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 35/232 (15%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
+E+ R + +G G YG V + + VA+K + ++ ++ + L+E +++
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMK 57
Query: 95 HMDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRS--HQDLTDDHCRYFL 149
+ H N++ + + PP YI+ E M +L +R Q++ Y
Sbjct: 58 EIKHPNLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMA 110
Query: 150 YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---- 205
Q+ ++Y+ N +HRDL N L+ N +K+ DFGL+R MT T
Sbjct: 111 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR------LMTGDTYTAHAG 164
Query: 206 -----RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVH 250
+W APE L ++++ D+W+ G +L EI T P +PG D
Sbjct: 165 AKFPIKW-TAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 33/174 (18%)
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVT 205
++ +++ GL+++HS +++RDLK N++L+ + +KI DFG+ + D + + T
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159
Query: 206 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 265
Y APE+L +YT ++D WS G +L E++ Q F G D EL S
Sbjct: 160 PDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFES---- 207
Query: 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 319
+R D P +P R+ K + D+LEK+ DP RR+ V
Sbjct: 208 ----IRVDT--------PHYP------RWITKE--SKDILEKLFERDPTRRLGV 241
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 66/241 (27%), Positives = 107/241 (44%), Gaps = 53/241 (21%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAA----MNSETRE---EVAIKKIGNAFDNRIDAKRTL 87
+EV R + +P+G G +G V A ++ E +VA+K + + + D +
Sbjct: 13 WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEK-DLSDLI 71
Query: 88 REIKLLRHM-DHENIIAI-----KD--------------------IIRPPQRE-TFNDVY 120
E+++++ + H+NII + +D RPP E +N
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQ 131
Query: 121 IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180
+ E + S +DL C Y Q+ RG++Y+ S +HRDL N+L+ +
Sbjct: 132 VPEEQL---------SFKDLVS--CAY---QVARGMEYLASKKCIHRDLAARNVLVTEDN 177
Query: 181 DLKIGDFGLARTTSETDFMTEYVVTRW---YRAPELLLNCSEYTAAIDIWSVGCILGEIM 237
+KI DFGLAR D+ + R + APE L + YT D+WS G +L EI
Sbjct: 178 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 236
Query: 238 T 238
T
Sbjct: 237 T 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 47/140 (33%), Positives = 70/140 (50%), Gaps = 19/140 (13%)
Query: 106 DIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVL 165
D R + ++ D + E+++ D ++ +DL F YQ+ +G+ ++ S N +
Sbjct: 184 DKRRSVRSGSYIDQDVTSEILEED--ELALDTEDLLS-----FSYQVAKGMSFLASKNCI 236
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-------TRWYRAPELLLNCS 218
HRDL N+LL KI DFGLAR D + YVV +W APE + NC
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLARDIR-ND--SNYVVKGNARLPVKWM-APESIFNCV 292
Query: 219 EYTAAIDIWSVGCILGEIMT 238
YT D+WS G +L EI +
Sbjct: 293 -YTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 52/202 (25%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENII 102
R +GRG+Y V +TR A+K I D ID +T + + +H ++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHV-FETASNHPFLV 59
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
+ + R ++ V E + DL ++ + L ++H R++ ++ L ++H
Sbjct: 60 GLHSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEY 220
+++RDLK N+LL+A +K+ D+G+ + D + + T Y APE+L +Y
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDY 173
Query: 221 TAAIDIWSVGCILGEIMT-RQP 241
++D W++G ++ E+M R P
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 74/352 (21%), Positives = 150/352 (42%), Gaps = 63/352 (17%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +GRGA+G EVA+ K+ NA +++ A + L + ++L+ +
Sbjct: 6 LKVIGRGAFG------------EVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREE 51
Query: 105 KDIIRPPQRE-------TFNDVYIVYELMD----TDLHQIIRSHQD-LTDDHCRYFLYQL 152
+D++ + F D +Y +MD DL ++ +D L +D R++L ++
Sbjct: 52 RDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEM 111
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--TRWYRA 210
+ + VH + +HRD+KP N+L++ N +++ DFG E + V T Y +
Sbjct: 112 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171
Query: 211 PELLLNCSE----YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS 266
PE+L + Y D WS+G + E++ + F + V
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------------- 216
Query: 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALC 324
Y +++ + F A+ + S A DL+ +++ +R + +++
Sbjct: 217 -----------YGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265
Query: 325 HPYLAPLHDINEEPVCPRPFSFDFEHPSFTEE-NIKELIYRESVKFNPDPTH 375
HP+ + D + C P+ + P+ T ++ + + S P P+H
Sbjct: 266 HPFFTGI-DWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETM-PPPSH 315
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G++G V A T E AIK L++ +++ D E + K +
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIK--------------ILKKDVVIQDDDVECTMVEKRV 53
Query: 108 I----RPPQR-------ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRG 155
+ +PP +T + +Y V E ++ DL I+ + H ++ ++ G
Sbjct: 54 LALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG 113
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELL 214
L ++HS +++RDLK N++L++ +KI DFG+ + T+ + T Y APE +
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPE-I 172
Query: 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 247
+ Y ++D W+ G +L E++ Q F G+D
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 39/207 (18%)
Query: 127 DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-LKIG 185
D DL +++ L++ + + QL+ L +H N++H D+K N+L + D + +
Sbjct: 93 DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152
Query: 186 DFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 242
D+GL + T S D +Y +PE + Y + D W+VG + E++T +
Sbjct: 153 DYGLCKIIGTPSCYDGTLDYF------SPE-KIKGHNYDVSFDWWAVGVLTYELLTGK-- 203
Query: 243 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 302
P K+ DE +R + LP F K N S A
Sbjct: 204 HPFKE-------------DEDEE---LDLESLLKRQQKKLP-FIK--------NVSKNAN 238
Query: 303 DLLEKMLVFDPNRR-ITVDEALCHPYL 328
D ++ ML ++ N R +E + HP+L
Sbjct: 239 DFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 2e-11
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 26/201 (12%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G G +G+V E R+ VAIK I + D E +++ + H ++ + +
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIE---EAQVMMKLSHPKLVQLYGV 67
Query: 108 I--RPPQRETFNDVYIVYELMDTD-LHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSAN 163
R P + +V+E M+ L +R+ + + + + G+ Y+ S+N
Sbjct: 68 CTERSP-------ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN 120
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLART------TSETDFMTEYVVTRWYRAPELLLNC 217
V+HRDL N L+ N +K+ DFG+ R TS T T++ V +W +PE + +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG--TKFPV-KW-SSPE-VFSF 175
Query: 218 SEYTAAIDIWSVGCILGEIMT 238
S+Y++ D+WS G ++ E+ +
Sbjct: 176 SKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 22/221 (9%)
Query: 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETR-EEVAIKKIGNAFDNRIDAKRTLREIKLLRH 95
++ K + ++ +G+G +G V M + R +VA+K I N A+ L E ++
Sbjct: 3 LNMKELKLLQTIGKGEFGDV---MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQ 55
Query: 96 MDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSH--QDLTDDHCRYFLYQL 152
+ H N++ + +I E +YIV E M L +RS L D F +
Sbjct: 56 LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 212
++Y+ + N +HRDL N+L++ + K+ DFGL + S T + V +W APE
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KW-TAPE 169
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMT----RQPLFPGKDYV 249
L +++ D+WS G +L EI + P P KD V
Sbjct: 170 ALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 42/135 (31%), Positives = 69/135 (51%), Gaps = 6/135 (4%)
Query: 108 IRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHR 167
I E+ D Y+ T +I L+ F YQ+ G++++ S N +HR
Sbjct: 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263
Query: 168 DLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTE---YVVTRWYRAPELLLNCSEYTAA 223
DL N+L+ +KI DFGLAR +++++++ ++ +W APE + N + YT
Sbjct: 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-APESIFN-NLYTTL 321
Query: 224 IDIWSVGCILGEIMT 238
D+WS G +L EI T
Sbjct: 322 SDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 32/219 (14%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENII 102
+ +G+G++G V A T E AIK + + D + T+ E ++L D
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD----- 58
Query: 103 AIKDIIRPPQR-------ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLR 154
+PP +T + +Y V E ++ DL I+ + ++ ++
Sbjct: 59 ------KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV 112
Query: 155 GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW------Y 208
GL ++H +++RDLK N++L++ +KI DFG+ + + M + V TR Y
Sbjct: 113 GLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGTPDY 167
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 247
APE++ Y ++D W+ G +L E++ QP F G+D
Sbjct: 168 IAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 45/198 (22%)
Query: 68 VAIKKIGNAFDNRIDAKRT-----LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122
VA+K + R D +T L+EIK++ + + NII + + + + ++
Sbjct: 47 VAVKML------RADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMI 95
Query: 123 YELMDT-DLHQIIR-----------------SHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
E M+ DL+Q + S +L Y Q+ G+KY+ S N
Sbjct: 96 TEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL-----YMAVQIASGMKYLASLNF 150
Query: 165 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEY 220
+HRDL N L+ + +KI DFG++R D+ + RW +LL ++
Sbjct: 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKF 208
Query: 221 TAAIDIWSVGCILGEIMT 238
T A D+W+ G L E+ T
Sbjct: 209 TTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 44/229 (19%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
IR +G+G G V A + VA+KKI + +N + KR LRE K+ + H I+
Sbjct: 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 104 IKDIIRPPQRETFNDVYIVYELM----DTDLHQIIRS---HQDLTDDH-----CRYFL-- 149
+ I +D VY M L +++S + L+ + FL
Sbjct: 67 VYSI--------CSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI 118
Query: 150 -YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT--------------- 193
+++ ++YVHS VLHRDLKP N+LL ++ I D+G A
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 194 ----SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
S + V T Y APE LL + + DI+++G IL +++T
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 48/182 (26%), Positives = 94/182 (51%), Gaps = 20/182 (10%)
Query: 114 ETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 172
+T + +++V E ++ DL ++ + L ++H R++ ++ L ++H +++RDLK
Sbjct: 66 QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLD 125
Query: 173 NLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 231
N+LL+A+ +K+ D+G+ + D + + T Y APE+L EY ++D W++G
Sbjct: 126 NVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGV 184
Query: 232 ILGEIM---------TRQPLFPGKDYVHQLRLITELIGSPDETSL-------GFLRSDNA 275
++ E+M T P +DY+ Q+ ++ + I P S+ GFL D
Sbjct: 185 LMFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASHVLKGFLNKDPK 243
Query: 276 RR 277
R
Sbjct: 244 ER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-11
Identities = 63/252 (25%), Positives = 107/252 (42%), Gaps = 49/252 (19%)
Query: 48 VGRGAYGIV-----CAAMNSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHEN 100
+G GA+G V + VAIK K + + ++ E +L+ + H N
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ---EAELMSDLQHPN 69
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY------------ 147
I+ + + Q +++E + DLH+ + + +D
Sbjct: 70 IVCLLGVCTKEQ-----PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 148 -FL---YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 203
FL Q+ G++Y+ S + +HRDL N L+ +KI DFGL+R D+ Y
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY---YR 181
Query: 204 V-------TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR--QPL--FPGKDYVHQL 252
V RW PE +L ++T DIWS G +L EI + QP F ++ + +
Sbjct: 182 VQSKSLLPVRWM-PPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239
Query: 253 RLITELIGSPDE 264
R +L+ P++
Sbjct: 240 R-SRQLLPCPED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 58/229 (25%), Positives = 109/229 (47%), Gaps = 30/229 (13%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIKKIGNAFDNRIDAKRTLRE 89
+EVSR+ + +R +G+G++G+V + E VA+K + + R + L E
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR-ERIEFLNE 59
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDD----- 143
+++ +++ + ++ Q +V ELM DL +RS + ++
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQ-----PTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 144 --HCRYFLY---QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198
+ + ++ G+ Y+++ +HRDL N ++ + +KIGDFG+ R ETD+
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY 174
Query: 199 MTE----YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQP 241
+ + RW APE L + +T + D+WS G +L EI + QP
Sbjct: 175 YRKGGKGLLPVRWM-APESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 26/173 (15%)
Query: 148 FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YV 203
F +Q+ RG++Y+ ++HRDL N+L+ +KI DFGL+R E D + +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191
Query: 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQLRLITELIGS 261
+W A E L + YT D+WS G +L EI+T P +PG + RL L
Sbjct: 192 PVKWM-AIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNP-YPG---IAPERLFNLL--- 242
Query: 262 PDETSLGFLRSDNARRYV-RMLPQFPKQNFSARFPNKSPGAVDL---LEKMLV 310
+T R +N + ++ KQ P+K P D+ LEKM+V
Sbjct: 243 --KTGYRMERPENCSEEMYNLMLTCWKQE-----PDKRPTFADISKELEKMMV 288
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 52/247 (21%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIK--KIGNAFDNRIDAKRTLR 88
E R + +R +G+GA+G V A + E VA+K K + D + D +R
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR--- 57
Query: 89 EIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVYELMDT-DLHQIIRSHQ------ 138
E L+ DH NI+ + + +P + +++E M DL++ +R
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKP--------MCLLFEYMAYGDLNEFLRHRSPRAQCS 109
Query: 139 ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 182
L+ Q+ G+ Y+ +HRDL N L+ N +
Sbjct: 110 LSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 169
Query: 183 KIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
KI DFGL+R D+ + + RW + N YT D+W+ G +L EI +
Sbjct: 170 KIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFS 227
Query: 239 R--QPLF 243
QP +
Sbjct: 228 YGMQPYY 234
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 20/213 (9%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVC-AAMNSETREE--VAIKKIGNAFDNRIDAKRT--LREI 90
E+ K + R +G G +G +C + ++ E VAI + D +R L E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLR---AGCSDKQRRGFLAEA 57
Query: 91 KLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQ-DLTDDHCRYF 148
L DH NI+ ++ +I N + IV E M L +R H+ L
Sbjct: 58 LTLGQFDHSNIVRLEGVI-----TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG-LARTTSETDF--MTEYVVT 205
L L G+KY+ +H+ L +L+N++ KI F L SE + M+
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPV 172
Query: 206 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
W APE + +++A D+WS G ++ E+M+
Sbjct: 173 LW-AAPE-AIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 25/221 (11%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIV-CAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLL 93
+E+ R+ + +G+G +G V N T+ VAIK + + + L+E +++
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTK--VAIKTLKPG---TMMPEAFLQEAQIM 55
Query: 94 RHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRY-----F 148
+ + H+ ++ + ++ + +YIV E M ++ ++ + +
Sbjct: 56 KKLRHDKLVPLYAVV------SEEPIYIVTEFMGKG--SLLDFLKEGDGKYLKLPQLVDM 107
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY---VVT 205
Q+ G+ Y+ N +HRDL+ +N+L+ N KI DFGLAR + ++
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI 167
Query: 206 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPG 245
+W APE L +T D+WS G +L E++T+ + +PG
Sbjct: 168 KW-TAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 37/103 (35%), Positives = 62/103 (60%), Gaps = 7/103 (6%)
Query: 148 FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTE---YV 203
F YQ+ RG++++ S N +HRDL N+LL +KI DFGLAR +++++++ ++
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL 301
Query: 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPG 245
+W APE + + + YT D+WS G +L EI + +PG
Sbjct: 302 PVKWM-APESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 55/204 (26%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 45 IRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN 100
I+ +G GA+G V + + + VAIK++ A + + K L E ++ +D+ +
Sbjct: 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 70
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKY 158
+ + I + V ++ +LM L +R H+D + + + Q+ +G+ Y
Sbjct: 71 VCRLLGICLT------STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR--TTSETDFMTE--YVVTRWYRAPELL 214
+ ++HRDL N+L+ +KI DFGLA+ E ++ E V +W A E +
Sbjct: 125 LEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM-ALESI 183
Query: 215 LNCSEYTAAIDIWSVGCILGEIMT 238
L+ YT D+WS G + E+MT
Sbjct: 184 LHRI-YTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 22/218 (10%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMDHENII 102
I+ +GRGA+G V A + + E + KI N ++ R + E +L + D + I
Sbjct: 6 IKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWIT 64
Query: 103 AIKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLK 157
+ F D +Y +MD DL ++ +D L +D R+++ +++ +
Sbjct: 65 TL--------HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLL 215
+H + +HRD+KP N+LL+ N +++ DFG L T + V T Y +PE+L
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQ 176
Query: 216 ----NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 249
+Y D WS+G + E++ + F + V
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 32/200 (16%)
Query: 152 LLRGLKYVHSAN-VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 210
+++GL Y+ + ++HRD+KPSN+L+N+ ++K+ DFG++ ++ +V TR Y +
Sbjct: 112 VIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMS 170
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEI-MTRQPLFPGKDYVHQLRLITELIGSPDETSL-- 267
PE L + Y+ DIWS+G L E+ + R P+ P +L + G P E+
Sbjct: 171 PE-RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSP 229
Query: 268 --------GFLRSDNARRYVRML-----------PQFPKQNFSARFPNKSPGAVDLLEKM 308
++R + + P+ P F A F D + K
Sbjct: 230 RPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQ-------DFVNKC 282
Query: 309 LVFDPNRRITVDEALCHPYL 328
L+ +P R + + + H ++
Sbjct: 283 LIKNPAERADLKQLMVHAFI 302
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 86 TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII-RSHQDLTDDH 144
++ E +LLR + H ++A+ D+ R T +V +DL+ + + L
Sbjct: 207 SVHEARLLRRLSHPAVLALLDV-RVVGGLTC----LVLPKYRSDLYTYLGARLRPLGLAQ 261
Query: 145 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG---LARTTSETDFMTE 201
QLL + Y+H ++HRD+K N+L+N D+ +GDFG AR + T F
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 235
T APE+L YT ++DIWS G ++ E
Sbjct: 322 IAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 29/207 (14%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108
GR YGI+ + EEV +K + + + I L+E LL + H+NI+ I +
Sbjct: 20 GRIFYGILIDEKPGKE-EEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVC 77
Query: 109 ----RPPQRETFNDVYIVYELMD-TDLHQIIR--------SHQDLTDDHCRYFLYQLLRG 155
PP +++Y M+ +L ++ + Q L+ + Q+ G
Sbjct: 78 IEDGEPP--------FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAP 211
+ Y+H V+H+D+ N +++ +KI D L+R D+ E +W A
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM-AL 188
Query: 212 ELLLNCSEYTAAIDIWSVGCILGEIMT 238
E L+N EY++A D+WS G +L E+MT
Sbjct: 189 ESLVN-KEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 35/103 (33%), Positives = 59/103 (57%), Gaps = 6/103 (5%)
Query: 140 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDF 198
LT + + +Q+ +G++++ S +HRDL N+LL+ N +KI DFGLAR + D+
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235
Query: 199 MTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
+ + + +W APE + + YT D+WS G +L EI +
Sbjct: 236 VRKGDARLPLKWM-APETIFD-RVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 48/197 (24%), Positives = 93/197 (47%), Gaps = 12/197 (6%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENII 102
R +G+G++G V A E+ A+K + D+ ++ T + I L +H +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLT 59
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
+ + P R ++ V E ++ DL I+ + + R++ ++ L ++H
Sbjct: 60 QLYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEY 220
+++RDLK N+LL+ K+ DFG+ + T + T Y APE+L Y
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLY 173
Query: 221 TAAIDIWSVGCILGEIM 237
++D W++G +L E++
Sbjct: 174 GPSVDWWAMGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +GRGA+G ++ + + ++ A + L + ++++ D
Sbjct: 48 VKVIGRGAFG--------------EVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 105 KDIIRPPQRE-------TFND---VYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLL 153
+DI+ F D +Y+V E M DL ++ S+ D+ + +++ +++
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVV 152
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAP 211
L +HS ++HRD+KP N+LL+ + LK+ DFG ET + V T Y +P
Sbjct: 153 LALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISP 212
Query: 212 ELLLNC---SEYTAAIDIWSVGCILGEIM 237
E+L + Y D WSVG L E++
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 34/95 (35%), Positives = 56/95 (58%), Gaps = 6/95 (6%)
Query: 148 FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFM---TEYV 203
+ +Q+ RG++++ S +HRDL N+LL+ N +KI DFGLAR + D++ + +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238
Query: 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
+W APE + + YT D+WS G +L EI +
Sbjct: 239 PLKWM-APESIFD-KVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 43/140 (30%), Positives = 73/140 (52%), Gaps = 20/140 (14%)
Query: 140 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199
LT + + +Q+ RG++++ S +HRDL N+LL+ N +KI DFGLAR +
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD--- 226
Query: 200 TEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG----K 246
+YV +W APE + + YT D+WS G +L EI + P +PG +
Sbjct: 227 PDYVRKGDARLPLKWM-APESIFD-KVYTTQSDVWSFGVLLWEIFSLGASP-YPGVQIDE 283
Query: 247 DYVHQLRLITELIGSPDETS 266
++ +L+ T + +P+ +
Sbjct: 284 EFCRRLKEGTRM-RAPEYAT 302
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 51/209 (24%), Positives = 96/209 (45%), Gaps = 31/209 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +GRGA+G ++ + + ++ A + L + ++++ D
Sbjct: 48 VKVIGRGAFG--------------EVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 105 KDIIRPPQRE-------TFND---VYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLL 153
+DI+ F D +Y+V E M DL ++ S+ D+ + R++ +++
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVV 152
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRWYRAP 211
L +HS +HRD+KP N+LL+ + LK+ DFG ++ + V T Y +P
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212
Query: 212 ELLLNC---SEYTAAIDIWSVGCILGEIM 237
E+L + Y D WSVG L E++
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 35/246 (14%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-----NSETREEVAIKKIGNAFDNRIDAKRTLREI 90
EV R + +R +G GA+G V + +VA+K + + + D L E
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEA 60
Query: 91 KLLRHMDHENIIAI--KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRY 147
++ +H+NI+ + R P+ +I+ ELM DL +R ++ +
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPR-------FILLELMAGGDLKSFLRENRPRPERPSSL 113
Query: 148 FLYQLLR-------GLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSETD 197
+ LL G KY+ + +HRD+ N LL KI DFG+AR
Sbjct: 114 TMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRAS 173
Query: 198 FMTE----YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKDYVHQ 251
+ + + +W PE L+ +T+ D+WS G +L EI + P +PG+
Sbjct: 174 YYRKGGRAMLPIKWM-PPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMP-YPGRTNQEV 230
Query: 252 LRLITE 257
+ +T
Sbjct: 231 MEFVTG 236
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 36/187 (19%)
Query: 80 RIDAKRT-----LREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQI 133
R DA + L+E+K+L + NII + + + + ++ E M+ DL+Q
Sbjct: 55 RPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE-----DPLCMITEYMENGDLNQF 109
Query: 134 IRSHQ----------DLTDDHCR---------YFLYQLLRGLKYVHSANVLHRDLKPSNL 174
+ SH + HC + Q+ G+KY+ S N +HRDL N
Sbjct: 110 LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNC 169
Query: 175 LLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 230
L+ N +KI DFG++R D+ + RW A E +L ++T A D+W+ G
Sbjct: 170 LVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWM-AWECIL-MGKFTTASDVWAFG 227
Query: 231 CILGEIM 237
L EI+
Sbjct: 228 VTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIK---KIGNAFDNRIDAKRTLREIKLLRHMDHENI 101
++ +G GA+G V + E V I KI N + E ++ MDH ++
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 71
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYV 159
+ + + P + +V +LM L + H+D + + Q+ +G+ Y+
Sbjct: 72 VRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS--ETDFMTE--YVVTRWYRAPELLL 215
++HRDL N+L+ + +KI DFGLAR E ++ + + +W + L
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW-----MAL 180
Query: 216 NCSEY---TAAIDIWSVGCILGEIMTRQPLFPGKDY 248
C Y T D+WS G + E+MT F GK Y
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMT----FGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 55/241 (22%), Positives = 105/241 (43%), Gaps = 52/241 (21%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +GRGA+G V V K G+ + +I K + E + + H+ E I +
Sbjct: 6 LKVIGRGAFGEV---------RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILV 56
Query: 105 K--DIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+ + +F D +Y +M+ D+ ++ LT++ ++++ + + +
Sbjct: 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLA-------RT--------TSETDFMTEYV 203
+H +HRD+KP NLLL++ +K+ DFGL RT + +DF + +
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176
Query: 204 VTR-----WYR----------------APELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 242
++ W R APE+ + + Y D WS+G I+ E++ P
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 243 F 243
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 36/138 (26%), Positives = 64/138 (46%), Gaps = 18/138 (13%)
Query: 121 IVYELMDT-DLHQIIRSHQDLTDDHCRYFLY----QLLRGLKYVHSANVLHRDLKPSNLL 175
+V+E + DL + Q + L ++ G+ ++H N LH DL N
Sbjct: 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131
Query: 176 LNANCDLKIGDFGLARTTSETDFMT----EYVVTRWYRAPELL------LNCSEYTAAID 225
L ++ +K+GD+G+ + + D++ + V RW APEL+ L +E T +
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEFHGGLITAEQTKPSN 190
Query: 226 IWSVGCILGEIM--TRQP 241
+W++G L E+ QP
Sbjct: 191 VWALGVTLWELFENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 56/246 (22%), Positives = 102/246 (41%), Gaps = 62/246 (25%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +GRGA+G V +T I A + LR+ +L +I A
Sbjct: 6 LKVIGRGAFGEVRLVQKKDT--------------GHIYAMKILRKADMLEKEQVAHIRAE 51
Query: 105 KDIIRPPQRE-------TFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLL 153
+DI+ +F D +Y +M+ D+ ++ L+++ ++++ + +
Sbjct: 52 RDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV 111
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA-------RT--------TSETDF 198
+ +H +HRD+KP NLLL+A +K+ DFGL RT +DF
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 199 MTEYVVTR-----W----------------YRAPELLLNCSEYTAAIDIWSVGCILGEIM 237
+ + ++ W Y APE+ + + Y D WS+G I+ E++
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEML 230
Query: 238 TRQPLF 243
P F
Sbjct: 231 IGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 48/180 (26%), Positives = 86/180 (47%), Gaps = 31/180 (17%)
Query: 88 REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQ--IIRS-HQDL--- 140
+E L+ + H NI+ + ++ Q V +++E ++ DLH+ I+RS H D+
Sbjct: 56 QEASLMAELHHPNIVCLLGVVTQEQ-----PVCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110
Query: 141 ---------TDDHCRYF--LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189
+ DH + Q+ G++Y+ S +H+DL N+L+ +KI D GL
Sbjct: 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL 170
Query: 190 ARTTSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLF 243
+R D+ + RW PE ++ ++++ DIWS G +L EI + QP +
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWM-PPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 26/192 (13%)
Query: 67 EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 126
+VAIK + N + + +RE +++ +D+ I+ + I + E + +V E+
Sbjct: 24 DVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRM---IGVCEAEA---LMLVMEMA 76
Query: 127 DTD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 184
L++ + +D +T + ++Q+ G+KY+ N +HRDL N+LL KI
Sbjct: 77 SGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKI 136
Query: 185 GDFGLARTTSETDFMTEYVVTR--------WYRAPELLLNCSEYTAAIDIWSVGCILGEI 236
DFGL++ D Y R WY APE +N ++++ D+WS G + E
Sbjct: 137 SDFGLSKALGADD---SYYKARSAGKWPLKWY-APE-CINFRKFSSRSDVWSYGITMWEA 191
Query: 237 MTRQPLFPGKDY 248
+ + K Y
Sbjct: 192 FS----YGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 150 YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE----YVVT 205
++ GL ++H N +H DL N LL A+ +KIGD+GL+ + D+ +V
Sbjct: 107 CEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166
Query: 206 RWYRAPELL------LNCSEYTAAIDIWSVGCILGEI 236
RW APEL+ L + T ++WS+G + E+
Sbjct: 167 RWI-APELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 34/105 (32%), Positives = 49/105 (46%), Gaps = 3/105 (2%)
Query: 135 RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194
+ L+ +F + RG+ Y+ +HRDL N+L+ N KI DFGL+R
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 175
Query: 195 ETDFMTE-YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
T + RW LN S YT D+WS G +L EI++
Sbjct: 176 VYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 39/160 (24%), Positives = 80/160 (50%), Gaps = 25/160 (15%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++P+ RGA+G V + A+K + A + I+ ++M H+ + A
Sbjct: 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA--DMIN-----------KNMVHQ-VQAE 54
Query: 105 KDII---RPP-------QRETFNDVYIVYE-LMDTDLHQIIRSHQDLTDDHCRYFLYQLL 153
+D + + P ++ N+VY+V E L+ D+ ++ + ++ ++ ++
Sbjct: 55 RDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVA 114
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193
L Y+H ++HRDLKP N+L++ +K+ DFGL++ T
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 33/98 (33%), Positives = 48/98 (48%), Gaps = 14/98 (14%)
Query: 151 QLLR-------GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY- 202
QLL G+ Y+ +HRDL N+L+ N KI DFGL+R + ++ +
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM 170
Query: 203 --VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
+ RW LN S YT D+WS G +L EI++
Sbjct: 171 GRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 39/126 (30%), Positives = 66/126 (52%), Gaps = 8/126 (6%)
Query: 119 VYIVYELMDTD-LHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 176
V +V +LM L +R ++D + + Q+ +G+ Y+ ++HRDL N+L+
Sbjct: 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142
Query: 177 NANCDLKIGDFGLAR--TTSETDFMTE--YVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 232
+ +KI DFGLAR ET++ + V +W A E +L+ +T D+WS G
Sbjct: 143 KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM-ALESILH-RRFTHQSDVWSYGVT 200
Query: 233 LGEIMT 238
+ E+MT
Sbjct: 201 VWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 33/94 (35%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 155 GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT----EYVVTRWYRA 210
GL ++H A+ +H DL N L A+ +KIGD+GLA D+ V RW A
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL-A 170
Query: 211 PELL------LNCSEYTAAIDIWSVGCILGEIMT 238
PEL+ L + T +IWS+G + E+ T
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 34/102 (33%), Positives = 50/102 (49%), Gaps = 7/102 (6%)
Query: 140 LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199
LT F + G++Y+ +HRDL N+L+ N KI DFGL+R E ++
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV 173
Query: 200 TEY---VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
+ + RW LN S YT D+WS G +L EI++
Sbjct: 174 KKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 52/216 (24%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 63 ETREEVAIKKIGNAFDNRIDAKRTLREIKLLR-HMDHENIIAIKDIIRPPQRETFNDVYI 121
E + VAIK + + + + + ++R + H NI+ + ++ Q + Y
Sbjct: 33 EQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYC 90
Query: 122 VYELMDTDLHQ--IIRS-HQDL--TDDHCR-----------YFLYQLLRGLKYVHSANVL 165
+ +DLH+ ++RS H D+ TDD + + Q+ G++++ S +V+
Sbjct: 91 SH----SDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV 146
Query: 166 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELLLNCSEYT 221
H+DL N+L+ ++KI D GL R D+ + RW +PE ++ +++
Sbjct: 147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWM-SPEAIMY-GKFS 204
Query: 222 AAIDIWSVGCILGEIMTR--QPL--FPGKDYVHQLR 253
DIWS G +L E+ + QP + +D + +R
Sbjct: 205 IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 35/157 (22%), Positives = 77/157 (49%), Gaps = 25/157 (15%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +G+GA+G E R ++K +I A +TL + ++ + ++ A
Sbjct: 6 VKVIGKGAFG--------EVR---LVQKKD---TGKIYAMKTLLKSEMFKKDQLAHVKAE 51
Query: 105 KDIIRPPQRE-------TFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLL 153
+D++ +F D +Y +M+ DL ++ + ++D R+++ + +
Sbjct: 52 RDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECV 111
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190
++ VH +HRD+KP N+L++ +K+ DFGL+
Sbjct: 112 LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMDHENII 102
++ +GRGA+G V T +V KI N ++ R + E +L + D I
Sbjct: 6 LKVIGRGAFGEVAVVKMKNT-GQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWIT 64
Query: 103 AIKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLK 157
+ F D +Y +MD DL ++ +D L +D R++L +++ +
Sbjct: 65 NL--------HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID 116
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFG--LARTTSETDFMTEYVVTRWYRAPELLL 215
VH +HRD+KP N+LL+ N +++ DFG L T V T Y +PE+L
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQ 176
Query: 216 NCSE----YTAAIDIWSVGCILGEIM 237
+ Y D WS+G + E++
Sbjct: 177 AMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 3/92 (3%)
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 210
+++ L +H ++ RDL P+N+LL+ +++ F R + D V Y A
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENMYCA 150
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 242
PE+ SE T A D WS+G IL E++T + L
Sbjct: 151 PEVG-GISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 14/170 (8%)
Query: 86 TLREIKLLRHMDHENIIAIK----DIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQDL 140
T EIK LR +D NI+ I DI+ R + ++ E L +++ +DL
Sbjct: 65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPR-----LSLILEYCTRGYLREVLDKEKDL 119
Query: 141 TDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199
+ +GL ++ N +++L + L+ N LKI GL + S F
Sbjct: 120 SFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF- 178
Query: 200 TEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDY 248
+ V Y + ++L + SEYT DI+S+G +L EI T + F
Sbjct: 179 -KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227
|
Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 45 IRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---- 96
++ +G G +G V + + VAIK I + ++T +EI HM
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-----SGRQTFQEIT--DHMLAMG 64
Query: 97 --DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLL 153
DH I+ + I + + + L+D +R H+D L + Q+
Sbjct: 65 SLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDH-----VRQHRDSLDPQRLLNWCVQIA 119
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRA 210
+G+ Y+ ++HR+L N+LL ++ ++I DFG+A D F +E+ + A
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMT 238
E +L YT D+WS G + E+M+
Sbjct: 180 LESIL-FGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 19/42 (45%), Positives = 29/42 (69%)
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190
+ Q+L GL+ +H ++HRD+KP NLL+ + +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 30/124 (24%), Positives = 55/124 (44%), Gaps = 17/124 (13%)
Query: 76 AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY---IVYELMD-TDLH 131
D RI +RT RE +++ + + + + F D IV E ++ L
Sbjct: 36 ELDERIRRERTRREARIM-SRARKAGVNVPAVY-------FVDPENFIIVMEYIEGEPLK 87
Query: 132 QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191
+I S+ + R + + +HSA ++H DL SN++L+ + + DFGLA
Sbjct: 88 DLINSNGMEELELSREIGRLVGK----LHSAGIIHGDLTTSNMILSGG-KIYLIDFGLAE 142
Query: 192 TTSE 195
+ +
Sbjct: 143 FSKD 146
|
Length = 211 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 24/120 (20%), Positives = 48/120 (40%), Gaps = 17/120 (14%)
Query: 78 DNRIDAKRTLREIKLLRHMDHENIIA--IKDIIRPPQRETFNDVYIVYELMDTDLHQIIR 135
D R+ +RT E +LL + I D+ + ++ + DL ++
Sbjct: 375 DERLRTERTRAEARLLSEARRAGVPTPVIYDV------DPEEKTIVMEYIGGKDLKDVLE 428
Query: 136 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195
+ R ++ + +H A ++H DL SN ++ + L + DFGL + +
Sbjct: 429 G----NPELVR----KVGEIVAKLHKAGIVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDL 479
|
Length = 535 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.002
Identities = 28/121 (23%), Positives = 50/121 (41%), Gaps = 16/121 (13%)
Query: 77 FDNRIDAKRTLREIKLLR--HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII 134
D RI +RT E +LL N + D+ + N ++ + L +I
Sbjct: 35 LDERIRRERTRNEARLLSRARKAGVNTPVVYDV------DPDNKTIVMEYIEGKPLKDVI 88
Query: 135 RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194
D+ R + + +H A ++H DL SN+++ + L + DFGL + +
Sbjct: 89 EE---GNDELLREIGRLVGK----LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSD 140
Query: 195 E 195
E
Sbjct: 141 E 141
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.002
Identities = 29/125 (23%), Positives = 55/125 (44%), Gaps = 26/125 (20%)
Query: 78 DNRIDAKRTLREIKLLRHMDHENIIAIKDI-IRPPQRETFNDVYIVYELMDTDLHQIIRS 136
D ++ +RT RE ++L ++ + P IVY++ D D I+
Sbjct: 38 DEKLRRERTRREARILAKA--------REAGVPVP---------IVYDV-DPDNGLIVME 79
Query: 137 H------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190
+ +D ++ L ++ R + +H A ++H DL SN++L+ + DFGL
Sbjct: 80 YIEGELLKDALEEARPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLG 138
Query: 191 RTTSE 195
+ E
Sbjct: 139 EFSDE 143
|
Length = 204 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 375 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.58 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.18 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.1 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.07 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.06 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.77 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.66 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.52 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.33 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.11 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.09 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.07 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.07 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.05 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.98 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.85 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.82 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.81 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.57 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.56 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.52 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.5 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.49 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.47 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.39 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.37 | |
| PLN02236 | 344 | choline kinase | 97.28 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.24 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.18 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.16 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.92 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.78 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.77 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.7 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.53 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.34 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.15 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.11 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.9 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.26 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.01 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.9 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.63 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.87 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-61 Score=420.95 Aligned_cols=346 Identities=69% Similarity=1.175 Sum_probs=325.4
Q ss_pred eEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeee
Q 017231 25 YVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104 (375)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 104 (375)
|.++..+...|++...|. .++.||.|++|.|+.+.++.+|+.||||.+...+.+...+.+..+|+.+|+.++|+||+.+
T Consensus 8 ~~~~~~~~~~~~i~~~y~-~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l 86 (359)
T KOG0660|consen 8 YYDYEVFGELFEIPRYYV-LIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGL 86 (359)
T ss_pred ceEEEeeeeEEeccceec-ccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceE
Confidence 888999999999999999 5999999999999999999999999999998888888899999999999999999999999
Q ss_pred ceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEE
Q 017231 105 KDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 184 (375)
Q Consensus 105 ~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l 184 (375)
.+++..+..+.++.+|+|+|+|+.+|...++.+..++...+..++.||+.||.|+|+.|++|||+||.|++++.+..+|+
T Consensus 87 ~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI 166 (359)
T KOG0660|consen 87 LDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKI 166 (359)
T ss_pred EeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEe
Confidence 99999876677788999999999999999999988999999999999999999999999999999999999999999999
Q ss_pred eecccccccCC---CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCC
Q 017231 185 GDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 261 (375)
Q Consensus 185 ~Df~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 261 (375)
+|||+++.... .........|..|.|||++.+...|+.+.||||.|||+.||++|++.|.+.+...++..|....|.
T Consensus 167 ~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGt 246 (359)
T KOG0660|consen 167 CDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGT 246 (359)
T ss_pred ccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCC
Confidence 99999988764 333455667999999999998899999999999999999999999999999999999999999999
Q ss_pred CCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 017231 262 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCP 341 (375)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~ 341 (375)
+++.......+..+..++..++..+.+.+...+++.++...+++.+||..||.+|+|++|+|+||||..+++.++||+|.
T Consensus 247 P~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~ 326 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQ 326 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 017231 342 RPFSFDFEHPSFTEENIKELIYRESVKFNPDP 373 (375)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (375)
..|.. +... ...+.+++..+++.+.|+|+.
T Consensus 327 ~~~~~-~~~~-~~~~~~r~~i~~e~~~~~~~~ 356 (359)
T KOG0660|consen 327 PIFDS-FEHE-LTEEELRELIYKEILDFHPDV 356 (359)
T ss_pred CCCcc-cccc-ccHHHHHHHHHHHHHhhCccc
Confidence 98886 3333 889999999999999999974
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-55 Score=403.32 Aligned_cols=260 Identities=33% Similarity=0.528 Sum_probs=237.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCc-ccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
..+.||+|||+.||.+++..+|+.||+|++.+. .......+++.+|+++.++|+|||||+++++|.+. .++|||
T Consensus 22 ~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-----~nVYiv 96 (592)
T KOG0575|consen 22 RGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-----NNVYIV 96 (592)
T ss_pred eeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-----CceEEE
Confidence 599999999999999999999999999999764 35556778899999999999999999999999555 779999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMT 200 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~ 200 (375)
+|+|. ++|..++++.+.++|.+++.+++||+.||.|||+++|+|||||..|+|++++.++||+|||+|...... ....
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence 99997 899999999999999999999999999999999999999999999999999999999999999887744 6678
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
+.||||+|+|||++.. ..++..+||||+||+||.|+.|++||...+..++...|....-..|
T Consensus 177 TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P----------------- 238 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMP----------------- 238 (592)
T ss_pred eecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccc-----------------
Confidence 9999999999999987 8899999999999999999999999999999999998887543332
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC 340 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~ 340 (375)
..+|.++++||.+||+.||.+|||+++||.|+||+........|..
T Consensus 239 --------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~ 284 (592)
T KOG0575|consen 239 --------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSS 284 (592)
T ss_pred --------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCcc
Confidence 3579999999999999999999999999999999777777766663
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-56 Score=393.56 Aligned_cols=269 Identities=33% Similarity=0.543 Sum_probs=227.7
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch-----HHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR-----IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
.++++.+.+.||+|+||.|-+|..+++|+.||||++.+..... .......+|+++|++|+||+||+++++|..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~- 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP- 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-
Confidence 4555669999999999999999999999999999997653222 1233457999999999999999999999665
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC---CCEEEeecc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFG 188 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~---~~i~l~Df~ 188 (375)
...|+||||++ |.|.+.+-.++.+.+..-..++.||+.|+.|||+.||+||||||+|||+..+ -.+||+|||
T Consensus 249 ----ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 249 ----DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ----CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 55799999997 7999999999999999999999999999999999999999999999999776 569999999
Q ss_pred cccccCCCCccccccccccccCchhcccC--CCCCccchhHHHHHHHHHHhhCCCCCCCCChhH-HHHHHHHHhCCCCcc
Q 017231 189 LARTTSETDFMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH-QLRLITELIGSPDET 265 (375)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~ 265 (375)
+++..+......+.|||+.|.|||++.+. ..+..++|+|||||++|.+++|.+||....... ..++|....-...+.
T Consensus 325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 99999888888999999999999999762 234458899999999999999999998765444 444554432222222
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 338 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~ 338 (375)
. |..+|++..++|.+||..||++|||++|+|+||||+..++.+.+.
T Consensus 405 ~---------------------------w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s~~~ 450 (475)
T KOG0615|consen 405 Q---------------------------WDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLSKQD 450 (475)
T ss_pred h---------------------------hhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccchHH
Confidence 2 245799999999999999999999999999999999887666444
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-54 Score=375.60 Aligned_cols=265 Identities=27% Similarity=0.401 Sum_probs=228.7
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
..+....++.++.||+|..|+||+++|+.+++.+|+|++... .+.+....+.+|+++++.++|||||.+|+.|..+.
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~-- 150 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG-- 150 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC--
Confidence 345556888999999999999999999999999999999443 45556788999999999999999999999997652
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..++|+||||+ |+|.+++...+.+++.....|+.+|++||.|||. ++|+||||||+|||++..|++||||||.+..
T Consensus 151 --~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 151 --EEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred --ceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 14899999998 7999999998999999999999999999999995 8999999999999999999999999999987
Q ss_pred cCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCC-----ChhHHHHHHHHHhCCCCcccc
Q 017231 193 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK-----DYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 193 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~ 267 (375)
.... ...+..||..|||||.+.+ ..|+.++||||||+.++|+.+|+.||... +..+++..|.... +|....
T Consensus 229 lvnS-~a~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p--pP~lP~ 304 (364)
T KOG0581|consen 229 LVNS-IANTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP--PPRLPE 304 (364)
T ss_pred hhhh-hcccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC--CCCCCc
Confidence 6666 6788999999999999999 78999999999999999999999999774 3444444444321 111111
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
...|+++++||..||++||.+||++.+|++|||+++....+
T Consensus 305 ---------------------------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 305 ---------------------------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN 345 (364)
T ss_pred ---------------------------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence 02699999999999999999999999999999999875544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-54 Score=388.25 Aligned_cols=285 Identities=39% Similarity=0.689 Sum_probs=252.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++||.|.||.||+|+.+.++..||||.+++....-.+. .-.+|+..|++|+ ||||+++.+++.+++ ..+++|
T Consensus 14 ~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~----~~L~fV 88 (538)
T KOG0661|consen 14 VIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDND----RILYFV 88 (538)
T ss_pred HHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccC----ceEeee
Confidence 8999999999999999999999999999998765543222 3457999999998 999999999998774 379999
Q ss_pred EeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccc
Q 017231 123 YELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 201 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~ 201 (375)
||||+.+|.++|+.. +.+++..++.|+.||++||+|+|++|+.|||+||+|||+..+..+||+|||+++..........
T Consensus 89 fE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTe 168 (538)
T KOG0661|consen 89 FEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTE 168 (538)
T ss_pred HHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcch
Confidence 999999999999765 5599999999999999999999999999999999999999888999999999999888888888
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
...|..|+|||++.....|+.+.|+|++|||++|+.+-++.|++.++.+++.+|.+.+|.+....+..- ..-+....-.
T Consensus 169 YVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg-~~La~~mnf~ 247 (538)
T KOG0661|consen 169 YVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG-YNLASAMNFR 247 (538)
T ss_pred hhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH-HHHHHHhccC
Confidence 888999999999988789999999999999999999999999999999999999999999877655432 1223344445
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
+++.....+....+..+.++.++|.+||++||.+||||.++|+||||+.-...
T Consensus 248 ~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~ 300 (538)
T KOG0661|consen 248 FPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRAS 300 (538)
T ss_pred CCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccc
Confidence 66666667777778899999999999999999999999999999999976544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-53 Score=363.14 Aligned_cols=286 Identities=34% Similarity=0.649 Sum_probs=245.4
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
|+.+.++|+|+||+||+++++.||+.||||.+..+.++....+-.++|+++|++++|+|+|.++++|... ..+++
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-----rklhL 78 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-----RKLHL 78 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-----ceeEE
Confidence 3468899999999999999999999999999988888888888899999999999999999999999765 56899
Q ss_pred EEeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC-CCCcc
Q 017231 122 VYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFM 199 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~-~~~~~ 199 (375)
|+|||+.++.+.+...+ +++...+..++.|++.|+.|+|+++++||||||+||+|+.+|.+||||||.++... ..+..
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 99999988888887764 59999999999999999999999999999999999999999999999999998766 44445
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
.....|..|.|||.+.+...|+..+||||+||++.||++|.+.|++.+..+++..|....|...+.-..-+.....-.-+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 56677999999999999889999999999999999999999999999999999999999988765433332222211111
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
+.....-...+...++.++.-+.+++..||+.||++|++.+++|.|++|.++-
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 11111122345666788999999999999999999999999999999997653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=366.52 Aligned_cols=278 Identities=26% Similarity=0.435 Sum_probs=239.1
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
.+.+++++.||+|+||+||+++.+.+++.||+|++++.. ....+.+....|..+|.+++||.||+++..|.+. .
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~-----~ 98 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE-----E 98 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC-----C
Confidence 455568999999999999999999999999999998754 4445678899999999999999999999999555 6
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc-cCC
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSE 195 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~-~~~ 195 (375)
.+|+|+||+. |.|...|++.+.+++..++-++..|+.||.|||++||+||||||+|||+|.+|+++|+|||+++. ...
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 7999999996 69999999999999999999999999999999999999999999999999999999999999985 444
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
.....+.+||+.|+|||++.+ .+++.++|+||||+++|+|++|.+||.+.+.....+.|.......++
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p----------- 246 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP----------- 246 (357)
T ss_pred CCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-----------
Confidence 456677899999999999999 79999999999999999999999999999988888888764422111
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC----CHHHHhcCCCCCCCCCCC-CCCCCCCCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI----TVDEALCHPYLAPLHDIN-EEPVCPRPFSFDFEH 350 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp----s~~ell~~~~f~~~~~~~-~~~~~~~~~~~~~~~ 350 (375)
..++.+.+++|+++|+.||++|. .+.+|-+||||..++=.. ....-..+|.+....
T Consensus 247 -------------------~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~ 307 (357)
T KOG0598|consen 247 -------------------GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTG 307 (357)
T ss_pred -------------------ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCC
Confidence 13688999999999999999995 788999999999985221 111122267766666
Q ss_pred CC
Q 017231 351 PS 352 (375)
Q Consensus 351 ~~ 352 (375)
.+
T Consensus 308 ~~ 309 (357)
T KOG0598|consen 308 LE 309 (357)
T ss_pred cc
Confidence 54
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=374.78 Aligned_cols=328 Identities=52% Similarity=0.957 Sum_probs=266.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|++|.||++.++.++..||||.+............+.+|+.++++++||||+++++++..........+++||
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 68999999999999999999999999999875444444456788999999999999999999988765444446689999
Q ss_pred eCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC----cc
Q 017231 124 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----FM 199 (375)
Q Consensus 124 e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~----~~ 199 (375)
||++++|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 163 (338)
T cd07859 84 ELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFW 163 (338)
T ss_pred ecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999986543221 12
Q ss_pred ccccccccccCchhcccC-CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 200 TEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
....++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+.......+....+.++..............+
T Consensus 164 ~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 243 (338)
T cd07859 164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRY 243 (338)
T ss_pred cCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHH
Confidence 345688999999998652 4678899999999999999999999999888777777777777766554444444444444
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCHH
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCP--RPFSFDFEHPSFTEE 356 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 356 (375)
...+.......+...++.+++.+.++|.+||+.||++|||++|+++||||+.+......+.+. +...+.+....++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (338)
T cd07859 244 LSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLTKE 323 (338)
T ss_pred HHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhcCHH
Confidence 444444444444555677889999999999999999999999999999999887655444333 234444445558888
Q ss_pred HHHHHHHHHHhhcCC
Q 017231 357 NIKELIYRESVKFNP 371 (375)
Q Consensus 357 ~~~~~~~~~~~~~~~ 371 (375)
..+...+++-+.++|
T Consensus 324 ~~~~~~~~~~~~~~~ 338 (338)
T cd07859 324 DVRELIYREILEYHP 338 (338)
T ss_pred HHHHHHHHHHHhcCC
Confidence 999999898888876
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=367.32 Aligned_cols=285 Identities=40% Similarity=0.640 Sum_probs=243.5
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+.++.+++||+|.||.||+|++..+|+.||+|.+...........-..+|+.+|++|+||||+++.++...... +.+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~---~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS---GSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC---ceE
Confidence 33557999999999999999999999999999997665445455566799999999999999999999877632 679
Q ss_pred EEEEeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 120 YIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 120 ~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
|+|+|||+.+|.-++... -.+++.++..++.||+.||+|+|++|+.|||||..|||||.+|.+||+|||++.......
T Consensus 194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 999999999999998874 469999999999999999999999999999999999999999999999999998655543
Q ss_pred -ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 198 -FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 198 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
.......|..|.|||++.|...|+.+.|+||.||||.||++|++.|.+..+.+++..|-.++|++.+..|.. ....
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~-~kLP-- 350 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV-SKLP-- 350 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc-ccCC--
Confidence 345567799999999999989999999999999999999999999999999999999999999998887761 1111
Q ss_pred HHhhhCC-CCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 277 RYVRMLP-QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 277 ~~~~~~~-~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
.+...-+ +.-.+.+.+.+..+++...+|+..||..||++|.||.++|.++||..
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 0111111 11134455567889999999999999999999999999999999943
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=368.71 Aligned_cols=336 Identities=78% Similarity=1.304 Sum_probs=286.0
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|++.++|. +.+.||.|++|+||++.+..+++.||||.+............+..|+.+++.++|+|++++++++......
T Consensus 1 ~~~~~~y~-~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 1 FEVDTKYV-PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE 79 (337)
T ss_pred Ccccccee-EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence 45556655 78999999999999999999999999999876544444456677899999999999999999988765544
Q ss_pred CcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 115 TFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 115 ~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
.....++++||++++|.+++...+.+++..++.++.||+.||.+||+++++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 80 AFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred ccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 44668999999999999999988889999999999999999999999999999999999999999999999999987654
Q ss_pred CC-CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 195 ET-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 195 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
.. .......++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+....+.............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 160 EKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred CCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 43 22234456888999999876456889999999999999999999999988888888888888777766666555555
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSF 353 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (375)
....+...+............+.+++++.++|++||+.+|++|||++++++||||..+......++++.+|.+|+.+.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQTPFSFDFEEDAL 319 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCCccchhhhhhhc
Confidence 55555555554444444455567899999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHHHHhhcCC
Q 017231 354 TEENIKELIYRESVKFNP 371 (375)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~ 371 (375)
+.+.+++..+.+-+.|.|
T Consensus 320 ~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 320 TEEDIKELIYNEMLAYHP 337 (337)
T ss_pred CHHHHHHHHHHHHhhcCC
Confidence 999999999999888765
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=333.62 Aligned_cols=285 Identities=40% Similarity=0.693 Sum_probs=247.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
.+++||+|.||+||+|++..+|+.||||.++.............+|+..|+.++|+||+.++++|... +.+.+|+
T Consensus 6 ~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l~lVf 80 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNLSLVF 80 (318)
T ss_pred hhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----CceEEEE
Confidence 68999999999999999999999999999976544433455678999999999999999999999554 6689999
Q ss_pred eCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc-c
Q 017231 124 ELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-E 201 (375)
Q Consensus 124 e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~-~ 201 (375)
||++.+|...++.. ..++..++..++.+++.|++|||++.|.||||||.|++|+.+|.+||+|||++.......... .
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 99999999999765 459999999999999999999999999999999999999999999999999998876654322 2
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
...|..|.|||.+.|.+.|+...|+||.||++.||+.|.+.|.+.+..+++..|-..+|.+.+..|..+..-..---..
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~- 239 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ- 239 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh-
Confidence 3678999999999999999999999999999999999999999999999999999999999888887766554433333
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
+.+.......++..+.++.+++.+||..||.+|+++.|+|+|+||++.+.+..
T Consensus 240 --~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~ 292 (318)
T KOG0659|consen 240 --QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP 292 (318)
T ss_pred --cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence 23333344467888999999999999999999999999999999997654443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-50 Score=364.09 Aligned_cols=284 Identities=24% Similarity=0.398 Sum_probs=240.2
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
+-.+.-+.+++++.||+|+||.||+|+.+.||+.||+|+++++. ........++.|-.+|....+|.+|+++..|.+.
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~- 213 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK- 213 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC-
Confidence 33566777889999999999999999999999999999998864 4455678889999999999999999999999665
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.++||||||++ |++..+|.+.+.|++..++.++.+++.||..||+.|++|+||||+|+|||..|++||+|||++.
T Consensus 214 ----~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 214 ----EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred ----CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccc
Confidence 67999999997 6999999999999999999999999999999999999999999999999999999999999984
Q ss_pred ccCC----------------------C--C------------------------ccccccccccccCchhcccCCCCCcc
Q 017231 192 TTSE----------------------T--D------------------------FMTEYVVTRWYRAPELLLNCSEYTAA 223 (375)
Q Consensus 192 ~~~~----------------------~--~------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 223 (375)
-... . . ...+..|||.|+|||++.+ ++|+..
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~ 368 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKE 368 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCcc
Confidence 2110 0 0 0013568999999999999 789999
Q ss_pred chhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHH
Q 017231 224 IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 303 (375)
Q Consensus 224 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 303 (375)
+|+||||||+|||+.|.+||.+.+..++++.|+.+.....-+.. ..++++..+
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~---------------------------~~~s~eA~D 421 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE---------------------------VDLSDEAKD 421 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc---------------------------CcccHHHHH
Confidence 99999999999999999999999999999999987543322111 346899999
Q ss_pred HHHHhcCcCCCCCC---CHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 304 LLEKMLVFDPNRRI---TVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPS 352 (375)
Q Consensus 304 li~~~L~~dP~~Rp---s~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 352 (375)
||.+||. ||++|. +++||-.||||+.++=.+-.... .+|.++...+.
T Consensus 422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~-apfvP~v~~~~ 471 (550)
T KOG0605|consen 422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMP-APFVPQVNSEL 471 (550)
T ss_pred HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCC-CCCCCCCCCcc
Confidence 9999999 999998 48999999999999643322222 45666655554
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-50 Score=366.30 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=229.0
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchH-HHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCc
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRI-DAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
++.+++.||+|+|++|++|+++.+++.||||++.+..--++ .......|-.+|.+| .||.|++++..|.+. ..
T Consensus 74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-----~s 148 (604)
T KOG0592|consen 74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-----ES 148 (604)
T ss_pred hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc-----cc
Confidence 44489999999999999999999999999999976532222 234566788999999 799999999999765 56
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
+|+|+||++ |+|.++|.+.+.+++..++.++.+|+.||+|||++||+||||||+|||+|.+|+++|+|||.++......
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 999999997 8999999999999999999999999999999999999999999999999999999999999997654331
Q ss_pred c--------------cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 198 F--------------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 198 ~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
. ..++.||-.|.+||++.. ...++.+|||+|||++|+|+.|.+||.+.++-.+.+.|+...-..+
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 1 145789999999999988 7899999999999999999999999999999999999998765544
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
++.++.+.+||+++|..||.+|+|+.+|-+||||.+++=.+
T Consensus 308 -------------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 308 -------------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred -------------------------------CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 35688999999999999999999999999999999997554
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=341.68 Aligned_cols=287 Identities=38% Similarity=0.636 Sum_probs=244.8
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++.+..|++|.||+||.|+|+.+++.||+|.++-+....--.-...+|+.+|.+++|||||.+-++...... +.+|+
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d~iy~ 154 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---DKIYI 154 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---ceeee
Confidence 347899999999999999999999999999997654222222345789999999999999999999876543 66999
Q ss_pred EEeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cc
Q 017231 122 VYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
|||||+.+|..++.+.+ +++..++..++.|++.|++|||.+.|+|||||++|++++..|.+|++|||+++..+... ..
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 99999999999998876 79999999999999999999999999999999999999999999999999998877663 34
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....-|..|.|||.+.+...|+.+.|+||+|||+.||+++++.|.+..+.+++..|-...|.+.+..|..+.........
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 55667999999999999999999999999999999999999999999999999999999999998888776655543322
Q ss_pred hhCCCCCCCCccccCCC--CCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPN--KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~--~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
... .-+...+...++. ++....+++..+|..||.+|.||+|.|+|.||...+
T Consensus 315 ~f~-~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P 368 (419)
T KOG0663|consen 315 TFS-EHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP 368 (419)
T ss_pred ccC-CCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence 211 1222233333333 458999999999999999999999999999999854
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=337.88 Aligned_cols=254 Identities=26% Similarity=0.446 Sum_probs=229.8
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+.+++++.||.|+||.|.+++++.+|..||+|++.+.. ..-...+...+|..+|+.+.||.++++++.+.+. ..
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-----~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-----SN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-----Ce
Confidence 44668999999999999999999999999999997643 3344567788999999999999999999999766 66
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
+++||||++ |.|.+++++.+++++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||.++.....
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999997 699999999999999999999999999999999999999999999999999999999999999887765
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
..+.|||+.|+|||++.. ++++.++|+||||+++|||+.|.+||...+...+..+|.+..-..|
T Consensus 198 -T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP-------------- 261 (355)
T KOG0616|consen 198 -TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP-------------- 261 (355)
T ss_pred -EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC--------------
Confidence 678999999999999998 8999999999999999999999999999998888888877544433
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCC-----CCHHHHhcCCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR-----ITVDEALCHPYLAPLH 332 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R-----ps~~ell~~~~f~~~~ 332 (375)
...++++++||.++|+.|-++| ....+|..||||+++.
T Consensus 262 -----------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 262 -----------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred -----------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 2468899999999999999999 3678999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-49 Score=348.71 Aligned_cols=255 Identities=32% Similarity=0.499 Sum_probs=225.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|+||+||+|+++.++..||||.+.+.....+..+.+..|+.+|+.++|||||.+++++... +.+|+||
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~~i~lVM 88 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----DFIYLVM 88 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----CeEEEEE
Confidence 67889999999999999999999999999987766777888899999999999999999999999665 6799999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC------CCEEEeecccccccCCC
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN------CDLKIGDFGLARTTSET 196 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~------~~i~l~Df~~~~~~~~~ 196 (375)
|||+ |+|.+++++.+.+++..++.++.||+.||++||+++|+||||||+|||++.. -.+||+|||+++.....
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 9997 7999999999999999999999999999999999999999999999999875 45899999999999988
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
....+.+|++.|||||++.. ..|+-|+|+||+|+++|+|++|+.||......+....+.......+...
T Consensus 169 ~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~---------- 237 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLP---------- 237 (429)
T ss_pred hHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchh----------
Confidence 88999999999999999987 7899999999999999999999999999888777765444222221111
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
...+..+.+++...|..+|..|.+..+-+.|+++..-.
T Consensus 238 ------------------~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 238 ------------------AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ------------------hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 12466677888889999999999999999998887654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=369.15 Aligned_cols=259 Identities=30% Similarity=0.451 Sum_probs=234.5
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCc-ccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++++.||.|+.|.|-+|.+..||+..|||++.+. .........+.+|+.+|+.+.|||++++++++ ++..++|+
T Consensus 15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~lyl 89 (786)
T KOG0588|consen 15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQHLYL 89 (786)
T ss_pred eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCceEEE
Confidence 4789999999999999999999999999999775 34455567788999999999999999999999 44477999
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
|.||++ |.|.+++...+++++.++.+++.||+.|+.|+|..+|+|+|+||+|++++..++|||+|||.|..........
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 999996 7999999999999999999999999999999999999999999999999999999999999999998888899
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
+.||++.|.|||+++|....+.++||||+|+|+|.|++|+.||++.+...++.++....-..|
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----------------- 232 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----------------- 232 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC-----------------
Confidence 999999999999999966668999999999999999999999998888777776655322221
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 337 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~ 337 (375)
..+++++++||++||.+||++|.|.+||++|||+.+.......
T Consensus 233 --------------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 233 --------------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred --------------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 4689999999999999999999999999999999998766654
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=359.29 Aligned_cols=334 Identities=48% Similarity=0.918 Sum_probs=265.7
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..|++.++|. +++.||.|+||.||++.+..+++.||+|.+............+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07878 9 TVWEVPERYQ-NLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87 (343)
T ss_pred HHhhhhhhhh-hheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccc
Confidence 3466766666 899999999999999999999999999998765444445566778999999999999999999886542
Q ss_pred -CCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 113 -RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 113 -~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.......++++++++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 88 SIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred cccccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccce
Confidence 123355799999998899887754 569999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 192 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 192 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
..... .....++..|+|||++.+...++.++|||||||++|+|++|..||...+....+..+....+...........
T Consensus 167 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 167 QADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred ecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 65433 2345678999999998875678899999999999999999999999888888888877777665554444444
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHP 351 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~ 351 (375)
......+...++..+...+...+...++.+.++|.+||+.||.+|||+.|+|.||||.........+... .+...-...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~-~~~~~~~~~ 323 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAE-PYDESPENK 323 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccC-ccccchhhh
Confidence 4444445555555554445555566788899999999999999999999999999999887655444332 333333333
Q ss_pred CCCHHHHHHHHHHHHhhcCC
Q 017231 352 SFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~ 371 (375)
.-..+.+++..+.....|.|
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07878 324 ERTIEEWKELTYEEVSSFKP 343 (343)
T ss_pred hccHHHHHHHHHHHHHhcCC
Confidence 46667888888888877766
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=341.07 Aligned_cols=248 Identities=31% Similarity=0.467 Sum_probs=215.6
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeece-eecCCCCCCc
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKD-IIRPPQRETF 116 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~~~~ 116 (375)
....++|.++||+|.||.||++++..+|..+|+|.++...-+....+....|+.+|++|+|||||++++ .|.+..
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~---- 92 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN---- 92 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc----
Confidence 344556899999999999999999999999999999877777778889999999999999999999998 443321
Q ss_pred CcEEEEEeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCceEEecCCCEEEeec
Q 017231 117 NDVYIVYELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHS--AN--VLHRDLKPSNLLLNANCDLKIGDF 187 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~--~~--i~H~di~p~NIli~~~~~i~l~Df 187 (375)
.-++||||+|+ |+|...++. .+.+++..+|+++.|++.||.++|. .+ +.||||||.||+++.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 33789999997 899998864 3459999999999999999999998 44 999999999999999999999999
Q ss_pred ccccccCCCC-ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccc
Q 017231 188 GLARTTSETD-FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS 266 (375)
Q Consensus 188 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 266 (375)
|+++...... ...+..|||.|++||++.+ .+|+.++|||||||++|||+.-.+||.+.+..++..+|.....++ .+
T Consensus 173 GL~r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~--~p 249 (375)
T KOG0591|consen 173 GLGRFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP--LP 249 (375)
T ss_pred hhHhHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC--Cc
Confidence 9998877664 3457889999999999998 899999999999999999999999999999888888887642211 00
Q ss_pred ccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH
Q 017231 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 319 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~ 319 (375)
. ..+|.++..+|..|+.+||+.||+.
T Consensus 250 ~---------------------------~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 D---------------------------EHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred H---------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence 0 2578999999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=359.37 Aligned_cols=251 Identities=35% Similarity=0.518 Sum_probs=220.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc---hHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN---RIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++.||+|+||+|+++++..++..||+|++.+.... ....+.+.+|+.+++++. ||||+++++++... ..+
T Consensus 21 ~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~-----~~~ 95 (370)
T KOG0583|consen 21 LGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP-----TKI 95 (370)
T ss_pred eeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-----CeE
Confidence 699999999999999999999999999987664211 133456678999999998 99999999999655 559
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC-CCEEEeeccccccc-CCC
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTT-SET 196 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~-~~i~l~Df~~~~~~-~~~ 196 (375)
++||||+. |+|.+++...+++++.+++.+++||+.|++|||++||+||||||+||+++.+ +++||+|||++... ...
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~ 175 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED 175 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC
Confidence 99999997 5999999998999999999999999999999999999999999999999999 99999999999888 566
Q ss_pred CccccccccccccCchhcccCC-CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 197 DFMTEYVVTRWYRAPELLLNCS-EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
....+.+|++.|+|||++.+.. ....++||||+|+++|.|++|..||...+...+...|....-..+
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p------------ 243 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIP------------ 243 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCC------------
Confidence 7788999999999999999844 336899999999999999999999999877777766544322211
Q ss_pred HHHhhhCCCCCCCCccccCCCC-CchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~-s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
..+ |++++++|.+||..||.+|+++.+++.||||+.
T Consensus 244 -------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 244 -------------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 234 899999999999999999999999999999997
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=345.69 Aligned_cols=283 Identities=37% Similarity=0.662 Sum_probs=239.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
-.+.+|.|+||.||.+....+++.||||.+-....- -.+|+++|+.+.|||||++..+|......+.-...+||
T Consensus 28 ~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 28 AVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred eeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 589999999999999999999999999988543221 23799999999999999999888765433234567899
Q ss_pred eCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC-CCEEEeecccccccCCCCc
Q 017231 124 ELMDTDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 124 e~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~-~~i~l~Df~~~~~~~~~~~ 198 (375)
||++.+|...++. +..++.-.++.+..||+.||.|||+.||+||||||+|+|+|.+ |.+||||||+|+.......
T Consensus 102 eymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 102 EYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred HhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 9999999999874 5779999999999999999999999999999999999999986 8999999999999888888
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
..+...|..|+|||.+.+...|+.+.||||.||++.||+.|++.|++.+...++..|....|.+........+..-.
T Consensus 182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~--- 258 (364)
T KOG0658|consen 182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT--- 258 (364)
T ss_pred ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc---
Confidence 88888899999999999999999999999999999999999999999999999999999999887654443332211
Q ss_pred hhhCCCCCCCCccc-cCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSA-RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 279 ~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
....++.....+.. .....++++.+|+.++|..+|.+|.++.|++.||||..+.+.+
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 11111222222222 3456899999999999999999999999999999999987664
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=360.69 Aligned_cols=275 Identities=33% Similarity=0.532 Sum_probs=242.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|.||.||+++.+.+.+.||||.+.+....+.+...+.+|+++++.++||||+.+++.| +...++++|+
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~~vVt 80 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHLWVVT 80 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceEEEEe
Confidence 78999999999999999999999999999999888888899999999999999999999999999 5558899999
Q ss_pred eCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-cccc
Q 017231 124 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEY 202 (375)
Q Consensus 124 e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~-~~~~ 202 (375)
||+.|+|..++...+.++++.++.++.+++.||.|||+.+|.|+|+||+||++...|.+|+||||+++.+..... ....
T Consensus 81 e~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsi 160 (808)
T KOG0597|consen 81 EYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSI 160 (808)
T ss_pred hhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeeec
Confidence 999999999999999999999999999999999999999999999999999999999999999999988777643 4567
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
.||+.|+|||++.+ .+++..+|+|||||++|||+.|++||......+..+.|..-...++
T Consensus 161 kGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p------------------- 220 (808)
T KOG0597|consen 161 KGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP------------------- 220 (808)
T ss_pred cCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc-------------------
Confidence 89999999999998 8999999999999999999999999988887777777766433332
Q ss_pred CCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCC---CCCCCCCCCCCCCCCHH
Q 017231 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV---CPRPFSFDFEHPSFTEE 356 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 356 (375)
...+..+.+||+.+|.+||.+|.+..+++.|||.++--...+.+. ..++|.. -..|++.+-
T Consensus 221 ------------~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn-~~Ppe~kek 284 (808)
T KOG0597|consen 221 ------------STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTN-NTPPEYKEK 284 (808)
T ss_pred ------------ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCcccc-CCChHHHHh
Confidence 246888999999999999999999999999999998765554443 3444543 224544443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=337.57 Aligned_cols=292 Identities=39% Similarity=0.719 Sum_probs=248.4
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCC-eeeeceeecCCC-CCCcCcE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN-IIAIKDIIRPPQ-RETFNDV 119 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~-~~~~~~~ 119 (375)
++.+++||+|+||+||+|+++.+|+.||+|.+.-+...+-......+|+.+++.++|+| |+.+++++.... .+....+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 34678899999999999999999999999999765443334455679999999999999 999999987654 2344578
Q ss_pred EEEEeCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 120 YIVYELMDTDLHQIIRSHQ----DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 120 ~lv~e~~~g~L~~~l~~~~----~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
++|+||++-+|..++.... +++...++.++.||+.||+|||+++|+||||||+||+|+..|.+||+|||++.....
T Consensus 93 ~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~i 172 (323)
T KOG0594|consen 93 YLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSI 172 (323)
T ss_pred EEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcC
Confidence 9999999999999998765 588899999999999999999999999999999999999999999999999986663
Q ss_pred C-CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 196 T-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 196 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
. ........|..|+|||++.++..|+...||||+|||++||++++..|++..+.+++..|-...+.+.+..|..+....
T Consensus 173 p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~ 252 (323)
T KOG0594|consen 173 PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLP 252 (323)
T ss_pred CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccc
Confidence 3 335566789999999999998899999999999999999999999999999999999999999999888887665443
Q ss_pred hHHHhhhCCCCC-CCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 275 ARRYVRMLPQFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 275 ~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
.-.. ...... ...+....+..++...+++.+||+.+|.+|.|++.+|.||||..+....
T Consensus 253 ~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 253 DYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS 312 (323)
T ss_pred cccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence 3222 222222 4455556667778999999999999999999999999999999875444
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=355.95 Aligned_cols=326 Identities=43% Similarity=0.746 Sum_probs=252.5
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++++.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++|+||+++++++...........++
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 81 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV 81 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence 35789999999999999999999999999998765444455677889999999999999999999987664334457899
Q ss_pred EEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--cc
Q 017231 122 VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FM 199 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--~~ 199 (375)
|+||+.++|.+.+.....+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 82 v~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~ 161 (372)
T cd07853 82 VTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM 161 (372)
T ss_pred EeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccccC
Confidence 9999999999999888889999999999999999999999999999999999999999999999999886543321 22
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+....+.+.................
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 241 (372)
T cd07853 162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHIL 241 (372)
T ss_pred CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHH
Confidence 33456888999999987566889999999999999999999999999888888888887776554332221111111111
Q ss_pred hhCCCCCC-CCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC--------------------CCCCC
Q 017231 280 RMLPQFPK-QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD--------------------INEEP 338 (375)
Q Consensus 280 ~~~~~~~~-~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~--------------------~~~~~ 338 (375)
......+. ..........++++.++|.+||+.||.+|||+.|+++||||++... ...++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (372)
T cd07853 242 RGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCMCKCCYTTSGGRVYTSDFEP 321 (372)
T ss_pred hCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCcchhccccccccccccccccCCcccCC
Confidence 11111110 0111122456889999999999999999999999999999998431 22344
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHh
Q 017231 339 VCPRPFSFDFEHPSFTEENIKELIYRESV 367 (375)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (375)
.+...+..++..+..+....++.......
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (372)
T cd07853 322 SANPPFDDEYEKNLTSVRQVKEELHQFIL 350 (372)
T ss_pred CCCCCCCcccccccCCHHHHHHHHHHHHH
Confidence 45556666666666666666666555444
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=352.35 Aligned_cols=319 Identities=60% Similarity=1.066 Sum_probs=266.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||.|++|.||++.++.+++.|++|.+............+..|+.++++++||||+++++++.... ......++|+
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~lv~ 87 (334)
T cd07855 9 PIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDVYVVM 87 (334)
T ss_pred eeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceEEEEE
Confidence 789999999999999999999999999998765444445567788999999999999999999876543 3335789999
Q ss_pred eCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-----c
Q 017231 124 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-----F 198 (375)
Q Consensus 124 e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-----~ 198 (375)
||++++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 88 e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 167 (334)
T cd07855 88 DLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167 (334)
T ss_pred ehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcc
Confidence 99999999999888889999999999999999999999999999999999999999999999999886543321 1
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....++..|+|||.+.+...++.++|+|||||++|+|++|+.||...+....+..+....+.++...............
T Consensus 168 ~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 247 (334)
T cd07855 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKY 247 (334)
T ss_pred cccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHH
Confidence 12346788899999987645688999999999999999999999999888888888888777766555444433333333
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHH
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENI 358 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 358 (375)
...........+....+..++++.++|++||+.+|++||++.+++.||||++......++.|..+++.++..-++..|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (334)
T cd07855 248 IQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPPPFDFDFEAIELSREQL 327 (334)
T ss_pred HhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCCCCCCChhhhhcChhhH
Confidence 33333333333334446679999999999999999999999999999999999999999999999999999999999988
Q ss_pred HHHHH
Q 017231 359 KELIY 363 (375)
Q Consensus 359 ~~~~~ 363 (375)
.+...
T Consensus 328 ~~~~~ 332 (334)
T cd07855 328 KEAIV 332 (334)
T ss_pred HHHhh
Confidence 87653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=355.57 Aligned_cols=278 Identities=33% Similarity=0.583 Sum_probs=228.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-C-----CCeeeeceeecCCCCCCcC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-H-----ENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~~~~~~~~~~~~~~~ 117 (375)
|.+.||+|+||+|.+|++..|++.||||+++.. ..-......|+.+|..|+ | -|+|+++++|... +
T Consensus 190 V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr-----~ 261 (586)
T KOG0667|consen 190 VLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR-----N 261 (586)
T ss_pred EEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-----c
Confidence 799999999999999999999999999999764 233456678999999996 3 4899999999655 7
Q ss_pred cEEEEEeCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC--CEEEeeccccccc
Q 017231 118 DVYIVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC--DLKIGDFGLARTT 193 (375)
Q Consensus 118 ~~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~--~i~l~Df~~~~~~ 193 (375)
++|||+|.++.+|.++++.++ +++...++.++.||+.||.+||+.||+|+||||+|||+...+ .|||+|||++...
T Consensus 262 HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred ceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 899999999999999999874 599999999999999999999999999999999999997644 6999999999776
Q ss_pred CCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
..... +...+..|.|||++.+ .+|+.+.|+||||||+.||++|.+.|++.++.++++.|++.+|.++..........
T Consensus 342 ~q~vy--tYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~ 418 (586)
T KOG0667|consen 342 SQRVY--TYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA 418 (586)
T ss_pred CCcce--eeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence 65543 6778999999999999 88999999999999999999999999999999999999999998876544321111
Q ss_pred hhHHHhhh-----------------------------CCC--C--CCCCccccCC-CCCchHHHHHHHhcCcCCCCCCCH
Q 017231 274 NARRYVRM-----------------------------LPQ--F--PKQNFSARFP-NKSPGAVDLLEKMLVFDPNRRITV 319 (375)
Q Consensus 274 ~~~~~~~~-----------------------------~~~--~--~~~~~~~~~~-~~s~~l~~li~~~L~~dP~~Rps~ 319 (375)
..+... ... . ....+....+ .....+.+||.+||.+||.+|+|+
T Consensus 419 --~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 419 --HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred --ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 001100 000 0 0111122222 234568999999999999999999
Q ss_pred HHHhcCCCCCCCCCC
Q 017231 320 DEALCHPYLAPLHDI 334 (375)
Q Consensus 320 ~ell~~~~f~~~~~~ 334 (375)
.+.|+||||......
T Consensus 497 ~qal~Hpfl~~~~~~ 511 (586)
T KOG0667|consen 497 AQALNHPFLTGTSLE 511 (586)
T ss_pred HHHhcCccccccccc
Confidence 999999999966444
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=347.98 Aligned_cols=287 Identities=46% Similarity=0.816 Sum_probs=224.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC-CCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv 122 (375)
+++.||+|+||.||++.+..+|..||+|++............+.+|+.+++.++||||+++++++.... ......+++|
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence 699999999999999999999999999999765545555677889999999999999999999986543 1233468999
Q ss_pred EeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccccc
Q 017231 123 YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 202 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~ 202 (375)
|||++++|.+.+.. .+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||++............
T Consensus 105 ~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 182 (359)
T cd07876 105 MELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPY 182 (359)
T ss_pred EeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCC
Confidence 99999988887753 5899999999999999999999999999999999999999999999999998765444334456
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
.++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....+.+.......... ....+....
T Consensus 183 ~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 260 (359)
T cd07876 183 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP-TVRNYVENR 260 (359)
T ss_pred cccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH-HHHHHHhhC
Confidence 77899999999987 6789999999999999999999999998887777666666655544322111110 011111111
Q ss_pred CCCCCCC------------ccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 283 PQFPKQN------------FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 283 ~~~~~~~------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
+..+... ........+++++++|.+||..||++|||+.|+|+||||+.....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 324 (359)
T cd07876 261 PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP 324 (359)
T ss_pred CCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence 1111100 011112346789999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-47 Score=339.92 Aligned_cols=275 Identities=25% Similarity=0.354 Sum_probs=227.2
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|-+..+.|++.+.||.|..++||+|+...+++.||||++..+..+.. .+.+.+|++.++.++||||++++..|...
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~--- 96 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVD--- 96 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEec---
Confidence 44445555579999999999999999999999999999987765554 78899999999999999999999999776
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
..+|+||.||. |++.++++.. .++++..+..|.++++.||.|||++|.+|||||+.||||+.+|.|+|+|||.+.
T Consensus 97 --~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 97 --SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred --ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence 55999999997 8999999874 459999999999999999999999999999999999999999999999999764
Q ss_pred ccCCCC----cc-ccccccccccCchh-cccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 192 TTSETD----FM-TEYVVTRWYRAPEL-LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 192 ~~~~~~----~~-~~~~~~~~y~aPE~-~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
..-... .. .+..|+++|+|||+ ......|+.|+||||||++..||.+|..||.......++ ++.+.+.++-.
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~ 252 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTL 252 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCc
Confidence 432221 11 56789999999999 445578999999999999999999999999887766554 44444444422
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
.......+ ....++..++.+|..||..||++|||++++|+|+||++......
T Consensus 253 ~t~~~~~d-------------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~ 304 (516)
T KOG0582|consen 253 LTSGLDKD-------------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEY 304 (516)
T ss_pred ccccCChH-------------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhh
Confidence 21111111 11345778999999999999999999999999999999866553
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=360.45 Aligned_cols=298 Identities=23% Similarity=0.368 Sum_probs=252.5
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQR 113 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 113 (375)
.+..+.+.++++||+|.||+|+++..+.+++.||||++++.. ..+.+.+..+.|.+++...+ ||.++.++.+|..
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT--- 440 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT--- 440 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc---
Confidence 555666778999999999999999999999999999998753 55667788899999999885 9999999999954
Q ss_pred CCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 114 ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 114 ~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
..++|+||||+.|.-.-.+...+.+++..++.++..|+.||.|||++||+|||||.+|||+|.+|.+||+|||+++..
T Consensus 441 --~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 441 --KEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred --CCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 478999999997533444455578999999999999999999999999999999999999999999999999999864
Q ss_pred C-CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 194 S-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 194 ~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
. ....+++.+||+.|+|||++.+ ..|+.++|+|||||+||+|+.|..||.+.++++..+.|.......|
T Consensus 519 m~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP--------- 588 (694)
T KOG0694|consen 519 MGQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP--------- 588 (694)
T ss_pred CCCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC---------
Confidence 4 5567889999999999999998 8899999999999999999999999999999999988877322211
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC-CCCCCCCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH-DINEEPVCPRPFSF 346 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~-~~~~~~~~~~~~~~ 346 (375)
..+|.+..++++++|..+|++|.. +++|..||||++++ +.-....-..+|++
T Consensus 589 ----------------------~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P 646 (694)
T KOG0694|consen 589 ----------------------RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVP 646 (694)
T ss_pred ----------------------CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCc
Confidence 247999999999999999999995 57999999999996 33333445556888
Q ss_pred CCCCCCCCHHHHHHHHHHHHhhcCC
Q 017231 347 DFEHPSFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (375)
....|. --.|+++...++...+.|
T Consensus 647 ~i~~~~-D~snFd~eFt~e~p~Lt~ 670 (694)
T KOG0694|consen 647 TIKGPE-DVSNFDEEFTSEKPALTP 670 (694)
T ss_pred ccCChh-hhcccchhhhcCCCccCC
Confidence 887774 344677777776666663
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=341.82 Aligned_cols=278 Identities=36% Similarity=0.691 Sum_probs=225.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||.|+||.||++.++.++..||+|++...... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 81 (288)
T cd07871 8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTE-----RCLTLV 81 (288)
T ss_pred eEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-----CeEEEE
Confidence 3689999999999999999999999999998654222 2234567899999999999999999998554 568999
Q ss_pred EeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-ccc
Q 017231 123 YELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMT 200 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~ 200 (375)
|||++++|.+++...+ .+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||++....... ...
T Consensus 82 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 82 FEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred EeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 9999999999987654 48999999999999999999999999999999999999999999999999886543322 223
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...+....... .+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 239 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE--EFRS 239 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch--hhhc
Confidence 45678899999998765678999999999999999999999999988888888888877776665554332211 1111
Q ss_pred -hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 281 -MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 281 -~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..+...........+.+++++.++|.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 111122222233345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=347.33 Aligned_cols=319 Identities=45% Similarity=0.759 Sum_probs=238.6
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC-CCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv 122 (375)
+.+.||+|+||.||++.+..+++.||||++............+.+|+.+++.++||||+++++++.... .+....+++|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEE
Confidence 699999999999999999999999999999765555555677889999999999999999999886543 1233568999
Q ss_pred EeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccccc
Q 017231 123 YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 202 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~ 202 (375)
|||++++|.+.+.. .++...++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++............
T Consensus 108 ~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 185 (364)
T cd07875 108 MELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 185 (364)
T ss_pred EeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCC
Confidence 99999999888864 4889999999999999999999999999999999999999999999999999776554444556
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
.++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....+.+........... ...+....
T Consensus 186 ~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 263 (364)
T cd07875 186 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT-VRTYVENR 263 (364)
T ss_pred cccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHH-HHHHHhhC
Confidence 78999999999987 67899999999999999999999999998887777777766665443222111111 01111111
Q ss_pred CCCCCCC------------ccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCC-CCCCC
Q 017231 283 PQFPKQN------------FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPF-SFDFE 349 (375)
Q Consensus 283 ~~~~~~~------------~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~-~~~~~ 349 (375)
+...... ........+.+++++|.+||+.||.+|||+.++|+||||............+..+ ..+.+
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~ 343 (364)
T cd07875 264 PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLD 343 (364)
T ss_pred CCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCCCCCCCCCccch
Confidence 1100000 0011122456789999999999999999999999999998765544433222211 11222
Q ss_pred CCCCCHHHHHHHHHHHH
Q 017231 350 HPSFTEENIKELIYRES 366 (375)
Q Consensus 350 ~~~~~~~~~~~~~~~~~ 366 (375)
..+-..+.+++..+.+.
T Consensus 344 ~~~~~~~~~~~~~~~~~ 360 (364)
T cd07875 344 EREHTIEEWKELIYKEV 360 (364)
T ss_pred hhhccHHHHHHHHHHHH
Confidence 22344445665554443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=348.77 Aligned_cols=334 Identities=52% Similarity=0.970 Sum_probs=278.1
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..|++.++|. +++.||+|++|.||++.+..+++.||+|.+............+..|+.+++++.|+|++++++++....
T Consensus 9 ~~~~~~~~y~-~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07851 9 TVWEVPDRYQ-NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPAS 87 (343)
T ss_pred ceecccCceE-EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccc
Confidence 4566777765 899999999999999999999999999998655434444566778999999999999999999876543
Q ss_pred C-CCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 113 R-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 113 ~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
. ......++|+||++++|.+++.. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 88 ~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 88 SLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred cccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 2 33355899999999899998876 569999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 192 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 192 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
..... .....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+.......+....+..++.......
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 65433 2334567889999998764567899999999999999999999998888777777777776666655555555
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHP 351 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~ 351 (375)
......+...+.......+...+..+++.+.++|.+||+.||++|||+.+|++||||++......++. ...+..++..-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~-~~~~~~~~~~~ 323 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPV-APPYDQSFESR 323 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCccccc-ccccCcchhhh
Confidence 55555666555555555555555667999999999999999999999999999999999987777665 67788888888
Q ss_pred CCCHHHHHHHHHHHHhhcCC
Q 017231 352 SFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~~ 371 (375)
.+..+.++...+++.-+|+|
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 324 DLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred hcCHHHHHHHhHHHHHhccC
Confidence 89999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-48 Score=353.36 Aligned_cols=257 Identities=28% Similarity=0.483 Sum_probs=222.6
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
...++...++||+|+.|.||.|....+++.||||.+....... .+.+.+|+.+|+..+|+|||.+++.|... +
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----d 343 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVG-----D 343 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhccc-----c
Confidence 4556778899999999999999999999999999997664443 56688999999999999999999999776 5
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
.+++||||++ |+|.+.+... .+++.++..|+++++.||+|||.+||+|+|||.+||+++.+|.+||+|||++......
T Consensus 344 eLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 5899999997 5888777654 4999999999999999999999999999999999999999999999999977665544
Q ss_pred -CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 197 -DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 197 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
....+..||++|+|||++.. +.|+++.||||||++++||+-|++||-+.+....+..|....... .
T Consensus 423 ~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~-l----------- 489 (550)
T KOG0578|consen 423 QSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPK-L----------- 489 (550)
T ss_pred cCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCC-c-----------
Confidence 35678899999999999987 889999999999999999999999998877777776665532211 1
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.....+|+.+++||.+||..|+++|++|.|||+||||+..
T Consensus 490 ----------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 490 ----------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred ----------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 1114579999999999999999999999999999999643
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=343.71 Aligned_cols=318 Identities=59% Similarity=1.010 Sum_probs=253.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|++|.||++.+..+|+.||+|.+.... .......+..|+.++++++|+|++++++++...........++++
T Consensus 9 i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 87 (336)
T cd07849 9 NLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQ 87 (336)
T ss_pred EEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEe
Confidence 7999999999999999999999999999985422 223456678899999999999999999988765544556789999
Q ss_pred eCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc----c
Q 017231 124 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----M 199 (375)
Q Consensus 124 e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~----~ 199 (375)
||++++|.+.+.. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 88 e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 166 (336)
T cd07849 88 ELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166 (336)
T ss_pred hhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCc
Confidence 9999999888754 5699999999999999999999999999999999999999999999999998865433221 1
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+.......+....+.................+.
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (336)
T cd07849 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYI 246 (336)
T ss_pred CCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHH
Confidence 23467888999998766467889999999999999999999999988877777777776665544333332222333333
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHH
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPS-FTEENI 358 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 358 (375)
..........+....+.+++++.++|.+||+.||++|||+.++++||||+.+.....++.....+-+|+..+. ...+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (336)
T cd07849 247 KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELFDDLPKEKL 326 (336)
T ss_pred hhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccccccCHHHH
Confidence 3333333333333445678999999999999999999999999999999999988888888777777776654 556666
Q ss_pred HHHHH
Q 017231 359 KELIY 363 (375)
Q Consensus 359 ~~~~~ 363 (375)
++...
T Consensus 327 ~~~~~ 331 (336)
T cd07849 327 KELIF 331 (336)
T ss_pred HHHHH
Confidence 66554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=338.52 Aligned_cols=281 Identities=35% Similarity=0.594 Sum_probs=221.0
Q ss_pred CCeeeccCCcceEEEEEEeCC-CCcEEEEEEecCcccchHHHHHHHHHHHHHHhc---CCCCeeeeceeecCCCCCCcCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNSE-TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
++++.||+|+||.||+|++.. ++..||+|.+............+.+|+.+++.+ .||||+++++++..........
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~ 83 (290)
T cd07862 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 83 (290)
T ss_pred ceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCc
Confidence 378999999999999999854 567899999865443333334455677776665 6999999999886543334467
Q ss_pred EEEEEeCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 119 VYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 119 ~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
+++||||++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+......
T Consensus 84 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T cd07862 84 LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 163 (290)
T ss_pred EEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC
Confidence 8999999999999999764 45899999999999999999999999999999999999999999999999998765544
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
.......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+....+.+..+....+.+....+........
T Consensus 164 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~- 241 (290)
T cd07862 164 MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR- 241 (290)
T ss_pred cccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccc-
Confidence 44455678999999999977 6789999999999999999999999999888888888877666544332211100000
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..+.......+....+.+++.++++|.+||+.||++|||+.++|+||||
T Consensus 242 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 242 ---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred ---hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0111111222223345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=333.77 Aligned_cols=265 Identities=25% Similarity=0.376 Sum_probs=230.3
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
+.-.|.-+.+++++.||.|.-|+||+++.+.++..+|+|++.+.. .......+...|-+||..+.||.++.+|+.|.
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-- 147 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE-- 147 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee--
Confidence 556777888899999999999999999999999999999998754 34556677889999999999999999999994
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
.....|++||||+ |+|..+.++++ .+++..++.++..|+.||+|||-.||++|||||+||||.++|+|.|+||+
T Consensus 148 ---t~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 148 ---TDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred ---ccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecc
Confidence 4477899999997 69999988764 49999999999999999999999999999999999999999999999999
Q ss_pred cccccCC-----------------------------------C----------------------CccccccccccccCc
Q 017231 189 LARTTSE-----------------------------------T----------------------DFMTEYVVTRWYRAP 211 (375)
Q Consensus 189 ~~~~~~~-----------------------------------~----------------------~~~~~~~~~~~y~aP 211 (375)
++..... . ...+++.||-.|+||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 8732110 0 011235678889999
Q ss_pred hhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCcc
Q 017231 212 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFS 291 (375)
Q Consensus 212 E~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (375)
|++.+ ...+.++|+|+||+++|||+.|..||.+.+..+++..|.......+..
T Consensus 305 EvI~G-~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~-------------------------- 357 (459)
T KOG0610|consen 305 EVIRG-EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEE-------------------------- 357 (459)
T ss_pred eeeec-CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCC--------------------------
Confidence 99999 789999999999999999999999999999999998887755444332
Q ss_pred ccCCCCCchHHHHHHHhcCcCCCCCCC----HHHHhcCCCCCCCC
Q 017231 292 ARFPNKSPGAVDLLEKMLVFDPNRRIT----VDEALCHPYLAPLH 332 (375)
Q Consensus 292 ~~~~~~s~~l~~li~~~L~~dP~~Rps----~~ell~~~~f~~~~ 332 (375)
+.++..+++||+++|.+||++|.. |.||-+||||++++
T Consensus 358 ---~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 358 ---PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred ---CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence 346788999999999999999998 99999999999986
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=344.90 Aligned_cols=317 Identities=45% Similarity=0.786 Sum_probs=236.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC-CCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv 122 (375)
+++.||+|+||.||++.+..+++.||+|.+............+.+|+.+++.++||||+++++++.... .+.....+++
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 689999999999999999999999999999766555556677889999999999999999999886543 1233568999
Q ss_pred EeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccccc
Q 017231 123 YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 202 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~ 202 (375)
|||++++|.+.+.. .++...++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++............
T Consensus 101 ~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (355)
T cd07874 101 MELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178 (355)
T ss_pred hhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCc
Confidence 99999999888754 5899999999999999999999999999999999999999999999999999776555444556
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
.++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+....+.+........... ...+....
T Consensus 179 ~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 256 (355)
T cd07874 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT-VRNYVENR 256 (355)
T ss_pred cccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHH-HHHHHhcC
Confidence 78999999999987 67899999999999999999999999988877776666665554432222111110 11111111
Q ss_pred CCCC--------CCC----ccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCC-CCCCCCCCCCC
Q 017231 283 PQFP--------KQN----FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP-VCPRPFSFDFE 349 (375)
Q Consensus 283 ~~~~--------~~~----~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~-~~~~~~~~~~~ 349 (375)
+... ... ........+.++.++|.+||+.||++|||+.|+|+||||....+..... ..+..+..+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~ 336 (355)
T cd07874 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDPAEVEAPPPQIYDKQLD 336 (355)
T ss_pred CccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccChhhccCCCccccccchh
Confidence 0000 000 0011123466789999999999999999999999999998765433222 22222333333
Q ss_pred CCCCCHHHHHHHHHH
Q 017231 350 HPSFTEENIKELIYR 364 (375)
Q Consensus 350 ~~~~~~~~~~~~~~~ 364 (375)
...-+.+.+++...+
T Consensus 337 ~~~~~~~~~~~~~~~ 351 (355)
T cd07874 337 EREHTIEEWKELIYK 351 (355)
T ss_pred hhhccHHHHHHHHHH
Confidence 333344445544443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=336.23 Aligned_cols=258 Identities=31% Similarity=0.445 Sum_probs=211.7
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+...+.||+|+||.||++.+.++|...|+|.+.... ....+.+.+|+.+|++++|||||++++....... ..+++
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i 93 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI 93 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence 447899999999999999999999999999986652 1226778999999999999999999997544321 36899
Q ss_pred EEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-CCCEEEeecccccccCC---
Q 017231 122 VYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSE--- 195 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-~~~i~l~Df~~~~~~~~--- 195 (375)
+|||+. |+|.+++...+ .+++..++.+.+||++||.|||++|++|+||||+|||++. ++.+||+|||++.....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999997 79999999887 7999999999999999999999999999999999999999 79999999998876653
Q ss_pred -CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCC-ChhHHHHHHHHHhCCCCcccccccccc
Q 017231 196 -TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK-DYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 196 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
........||+.|+|||++.+......++|||||||++.||+||+.||... .....+-.+.... ..|
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-~~P---------- 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-SLP---------- 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-CCC----------
Confidence 222445789999999999985233446999999999999999999999773 2222222222111 011
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.....+|++.++||.+||..||++||||+++|+|||.+.-..
T Consensus 243 ------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 243 ------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 111347899999999999999999999999999999987544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=336.12 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=231.1
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+.+++.+.||+|.||+|-+|++...|+.||||.+.+.. .++.+.-.+++|+++++.|+||||+.++++| ++.+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCce
Confidence 34558999999999999999999999999999998754 5666788899999999999999999999999 55578
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
++|||||.. |.|++++...+.+++.+++.+++||..|+.|+|+++++|+|||.+||++|.++++||.|||++.......
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 999999996 7999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
...++||++.|.+||++.+...-.+.+|.||||+++|.|..|.+||++.+...+.++|.......+
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-------------- 273 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-------------- 273 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC--------------
Confidence 999999999999999999955558999999999999999999999999999888888766433322
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
.-+....-+|+.||-++|++|.|+++|-+|=|+.=
T Consensus 274 ------------------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 274 ------------------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred ------------------CCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 33566889999999999999999999999988864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=343.51 Aligned_cols=321 Identities=65% Similarity=1.128 Sum_probs=271.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||.|++|.||++.+..+++.|++|.+............+..|+.+++.++|+|++++++++.....+....++++|
T Consensus 4 i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 83 (330)
T cd07834 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVT 83 (330)
T ss_pred eeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEe
Confidence 68999999999999999999999999999876544455567788999999999999999999998776544556789999
Q ss_pred eCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC----cc
Q 017231 124 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----FM 199 (375)
Q Consensus 124 e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~----~~ 199 (375)
||++++|.+++.....+++..++.++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 84 e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~ 163 (330)
T cd07834 84 ELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163 (330)
T ss_pred cchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999987655442 23
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+..+....+....+.+...............+.
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 243 (330)
T cd07834 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYL 243 (330)
T ss_pred cccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHH
Confidence 34466888999999988447899999999999999999999999999988888888888777766655544445555555
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHH
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSF-DFEHPSFTEENI 358 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 358 (375)
..........+....+.+++++.++|.+||+.+|++||++++++.||||+++.....++.....++. .+..-+++++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (330)
T cd07834 244 KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFDDDELTEEEL 323 (330)
T ss_pred hhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCcccccccchhhcCHHHH
Confidence 5555544455555566789999999999999999999999999999999999999998888888877 455566888887
Q ss_pred HHHHHH
Q 017231 359 KELIYR 364 (375)
Q Consensus 359 ~~~~~~ 364 (375)
++..+.
T Consensus 324 ~~~~~~ 329 (330)
T cd07834 324 KELIYE 329 (330)
T ss_pred hHHhhc
Confidence 776653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=337.69 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=213.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++++.||+|+||.||++.++.+++.||+|++.... ........+.+|+.++++++||||+++++.+... ..+++
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~l 78 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RFLYM 78 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----CeEEE
Confidence 37899999999999999999999999999986532 2223456688999999999999999999887543 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
||||+. |+|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~ 156 (291)
T cd05612 79 LMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TW 156 (291)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cc
Confidence 999997 699999998889999999999999999999999999999999999999999999999999998765432 23
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 157 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~------------------ 217 (291)
T cd05612 157 TLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF------------------ 217 (291)
T ss_pred cccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCC------------------
Confidence 4568999999999987 678999999999999999999999998877655555443311100
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH 332 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~ 332 (375)
...+++.++++|++||+.||.+||+ ++++++||||+.+.
T Consensus 218 -------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 218 -------------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred -------------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 0235788999999999999999995 99999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=345.35 Aligned_cols=250 Identities=27% Similarity=0.430 Sum_probs=211.9
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEe
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 124 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 124 (375)
+.||+|+||.||++.++.+|+.||+|++.... ........+..|+.++++++||||+++++.+... ..+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-----DRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-----CEEEEEEe
Confidence 46999999999999999999999999987543 2233456678899999999999999999988554 56899999
Q ss_pred CCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCccccc
Q 017231 125 LMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEY 202 (375)
Q Consensus 125 ~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~~ 202 (375)
|++ |+|.+++...+.+++..++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||++..... .......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 155 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccce
Confidence 997 69999999888999999999999999999999999999999999999999999999999998865322 2223456
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
.|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~-------------------- 214 (323)
T cd05571 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF-------------------- 214 (323)
T ss_pred ecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCC--------------------
Confidence 78999999999987 778999999999999999999999998877655554443211100
Q ss_pred CCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
...+++++.++|.+||+.||++|| ++.++++||||+++.
T Consensus 215 -----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~ 258 (323)
T cd05571 215 -----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258 (323)
T ss_pred -----------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 024688999999999999999999 899999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=336.34 Aligned_cols=280 Identities=36% Similarity=0.662 Sum_probs=218.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|++|.||+++++.+++.||+|++............+..|+.+++.++||||+++++++... ...++|
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv 78 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-----GKLYLV 78 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-----CEEEEE
Confidence 379999999999999999999999999999976544444566788999999999999999999998543 568999
Q ss_pred EeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--cc
Q 017231 123 YELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FM 199 (375)
Q Consensus 123 ~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--~~ 199 (375)
|||+++++.+.+.. ...+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+....... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccc
Confidence 99998766565544 4569999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+....+..+..............-.
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 34567899999999987 67899999999999999999999999988777776667666665544322211111000000
Q ss_pred h-hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 280 R-MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 280 ~-~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
. ................++.++.++|++||+.||++|||++++|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 000000000011123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=338.27 Aligned_cols=284 Identities=34% Similarity=0.585 Sum_probs=215.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|+||.||+|+++.+++.||+|++...... .....+.+|+.+++.++||||+++++++... ...++|
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 81 (303)
T cd07869 8 EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETLTLV 81 (303)
T ss_pred eEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecC-----CeEEEE
Confidence 3799999999999999999999999999998654322 2234567899999999999999999998654 568999
Q ss_pred EeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cccc
Q 017231 123 YELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMT 200 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~ 200 (375)
|||++++|.+++... +.+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++...... ....
T Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 82 FEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred EECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 999999999988764 56999999999999999999999999999999999999999999999999988653322 2223
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC-hhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
...+++.|+|||++.+...++.++|||||||++|+|++|..||.+.. ....+..+....+.+....+........ ...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 240 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH-FKP 240 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc-ccc
Confidence 45678899999998775668899999999999999999999998753 3444555554444433222211110000 000
Q ss_pred hhCCCCCCCCccccC--CCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARF--PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
..........+...+ ..+++.+.++|.+||+.||.+|||+.++++||||++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 241 ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 000000011111111 134678999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=334.47 Aligned_cols=280 Identities=35% Similarity=0.600 Sum_probs=220.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc---CCCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++.||+|++|+||+++++.+++.||+|.+...............|+.+++.+ +||||+++++++.....+....++
T Consensus 4 ~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~ 83 (288)
T cd07863 4 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVT 83 (288)
T ss_pred EeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEE
Confidence 68999999999999999999999999999865432222233445666666655 699999999998765434446689
Q ss_pred EEEeCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 121 IVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
+++|+++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+........
T Consensus 84 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd07863 84 LVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA 163 (288)
T ss_pred EEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCccc
Confidence 99999999999998764 3489999999999999999999999999999999999999999999999999876654443
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........+....+......+........
T Consensus 164 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 239 (288)
T cd07863 164 LTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR--- 239 (288)
T ss_pred CCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc---
Confidence 445567889999999987 6789999999999999999999999988877777777776655443322211100000
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
...............+.++..+.++|.+||+.||++|||+.+++.||||
T Consensus 240 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 -GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred -cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0011111122233345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=318.80 Aligned_cols=262 Identities=29% Similarity=0.473 Sum_probs=227.7
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
.+.+++.+.||+|.|+.|+.+.+..+|+.+++|++.-........+++.+|+++-+.|+||||+++++.+... +.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-----~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-----ce
Confidence 3445589999999999999999999999999999876554455778899999999999999999999988443 66
Q ss_pred EEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec---CCCEEEeecccccccC
Q 017231 119 VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTS 194 (375)
Q Consensus 119 ~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~---~~~i~l~Df~~~~~~~ 194 (375)
.|+|+|++.| +|..-+-..--+++..+...++||++||.|+|.+||+|||+||+|+++-. ..-+||+|||++....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 8999999974 88776655566899999999999999999999999999999999999943 3359999999998877
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
.........||+.|+|||++.. .+++..+|||+.|+++|-|+.|.+||.+.+.....+.|+...-..+...
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~-------- 235 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPE-------- 235 (355)
T ss_pred CccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcc--------
Confidence 6666677889999999999988 7899999999999999999999999999888888888877554444333
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
|++++++.+++|++||..||.+|.|+.|.|+|||+.+-..
T Consensus 236 -------------------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 236 -------------------WDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred -------------------cCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence 3678999999999999999999999999999999987543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=353.03 Aligned_cols=286 Identities=33% Similarity=0.583 Sum_probs=220.7
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC---CCC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ---RET 115 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~ 115 (375)
...+++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++.... .+.
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 334558999999999999999999999999999885431 22347999999999999999988765432 112
Q ss_pred cCcEEEEEeCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-CEEEeecccc
Q 017231 116 FNDVYIVYELMDTDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLA 190 (375)
Q Consensus 116 ~~~~~lv~e~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-~i~l~Df~~~ 190 (375)
...+++||||++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 234779999999998887753 45699999999999999999999999999999999999998765 6999999999
Q ss_pred cccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 191 RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 191 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
.............+++.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+.+........
T Consensus 219 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~ 298 (440)
T PTZ00036 219 KNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEM 298 (440)
T ss_pred hhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 76655444445677999999999877567899999999999999999999999998877777777777665543222111
Q ss_pred ccchhHHHhhhCCCCCCCCccccC-CCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARF-PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
..... ....+......+...+ ...++++.+||.+||..||.+|||+.|+|+||||..+..
T Consensus 299 ~~~~~---~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 299 NPNYA---DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred chhhh---cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 00000 0000011111111111 246788999999999999999999999999999998754
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=345.69 Aligned_cols=286 Identities=24% Similarity=0.328 Sum_probs=219.7
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
...|++++.||+|++|.||++.+..+++.||+|... ...+.+|+.++++++||||+++++++... ..
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 157 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYN-----KF 157 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----Ce
Confidence 334558999999999999999999999999999752 23467899999999999999999998654 55
Q ss_pred EEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC--
Q 017231 119 VYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-- 196 (375)
Q Consensus 119 ~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-- 196 (375)
.++++|++.++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 158 ~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 158 TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred eEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 899999999999999988888999999999999999999999999999999999999999999999999998643222
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCC-------ChhHHHHHHHHHhCCCCcccccc
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK-------DYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||... +....+..+....+..+......
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 12234578999999999987 67899999999999999999999876432 23445556665555543321111
Q ss_pred cccchhHHHhhhCC---CCCC-CCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 017231 270 LRSDNARRYVRMLP---QFPK-QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 338 (375)
Q Consensus 270 ~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~ 338 (375)
........+..... ..+. .........++.++.++|.+||+.||.+|||++|+|+||||+.+......|
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~~~ 389 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYPNP 389 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCCCC
Confidence 11111111111111 0000 000111224577899999999999999999999999999999876654443
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=318.37 Aligned_cols=256 Identities=32% Similarity=0.540 Sum_probs=226.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc------cchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCc
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF------DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 116 (375)
..+.||+|..++|..+.++.+|+.+++|++.... ......+....|+.+|+++ .||+|+++.+.|..+
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~----- 95 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD----- 95 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc-----
Confidence 6889999999999999999999999999985321 1222345567899999999 599999999999544
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
..+++|+|.|+ |.|.|++.+.-.+|+...+.|++|++++++|||.++|+|+||||+||+++.+.+++|+|||.+.....
T Consensus 96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 66899999997 89999999988999999999999999999999999999999999999999999999999999999888
Q ss_pred CCccccccccccccCchhcc-----cCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 196 TDFMTEYVVTRWYRAPELLL-----NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
.......|||+.|+|||.+. +...|+...|+|++|++||.|+.|.+||....-.-+++.|++..-+...+.
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~spe---- 251 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPE---- 251 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcc----
Confidence 88888899999999999985 345788999999999999999999999998888888888887655544433
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
|.++|...+++|.+||++||++|.|++|+|.||||..+
T Consensus 252 -----------------------Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 252 -----------------------WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred -----------------------hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 35789999999999999999999999999999999765
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=336.00 Aligned_cols=333 Identities=46% Similarity=0.872 Sum_probs=266.4
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
.|++.++|. +++.||+|++|.||++.+..++..||+|.+............+..|+.++++++|+||+++++++.....
T Consensus 10 ~~~~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 10 IWEVPDRYR-DLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhccccceE-EEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 355555554 7999999999999999999999999999986654444455678899999999999999999998865431
Q ss_pred -CCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 114 -ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 114 -~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
.....+++|+++++++|.+++.. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 89 ~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 89 LDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred ccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 22245789999998889888764 5699999999999999999999999999999999999999999999999998876
Q ss_pred cCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 193 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 193 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
.... .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+.......+.........
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07880 168 TDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS 245 (343)
T ss_pred cccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence 5432 22345688899999987644578999999999999999999999988877666666666555544333333333
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPS 352 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 352 (375)
.....+...++......+....+.+++++.++|.+||+.||++|||+.+++.||||+.......++... +|.-+++.-+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 324 (343)
T cd07880 246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP-PYDDSFDEVD 324 (343)
T ss_pred hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCC-CccccHHhhc
Confidence 333344444444433334444567889999999999999999999999999999999987776666444 4777888888
Q ss_pred CCHHHHHHHHHHHHhhcCC
Q 017231 353 FTEENIKELIYRESVKFNP 371 (375)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~ 371 (375)
-.-+-++.+...+.+.|+|
T Consensus 325 ~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 325 QSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred cchHHHHHHHHHHHHhcCC
Confidence 8899999999999999987
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=333.08 Aligned_cols=272 Identities=27% Similarity=0.425 Sum_probs=223.9
Q ss_pred EEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc------------chHHHHHHHHHHHHH
Q 017231 26 VQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD------------NRIDAKRTLREIKLL 93 (375)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------------~~~~~~~~~~e~~~l 93 (375)
.+++...++..|. . |++++.||+|.||+|.+|++..+++.||||++.+... .....++..+|+.+|
T Consensus 85 ~~~~~~~~~k~lN-q-y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIail 162 (576)
T KOG0585|consen 85 VRYDDDQDRKQLN-Q-YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAIL 162 (576)
T ss_pred eeecCcccceehh-h-eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHH
Confidence 3444445555443 3 3479999999999999999999999999999964321 111235788999999
Q ss_pred HhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 017231 94 RHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 172 (375)
Q Consensus 94 ~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~ 172 (375)
+++.|||||+++++..++.. ..+|+|+|||...-..+....+. +++.+++.++++++.||+|||.+||+||||||+
T Consensus 163 Kkl~H~nVV~LiEvLDDP~s---~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPs 239 (576)
T KOG0585|consen 163 KKLHHPNVVKLIEVLDDPES---DKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPS 239 (576)
T ss_pred HhcCCcCeeEEEEeecCccc---CceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchh
Confidence 99999999999999876543 78999999997433334444455 999999999999999999999999999999999
Q ss_pred ceEEecCCCEEEeeccccccc------CCCCccccccccccccCchhcccC---CCCCccchhHHHHHHHHHHhhCCCCC
Q 017231 173 NLLLNANCDLKIGDFGLARTT------SETDFMTEYVVTRWYRAPELLLNC---SEYTAAIDIWSVGCILGEIMTRQPLF 243 (375)
Q Consensus 173 NIli~~~~~i~l~Df~~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~~g~~pf 243 (375)
|+|++.+|++||+|||.+... +.........||+.|+|||...+. ...+.+.||||||++||.|+.|+.||
T Consensus 240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 999999999999999988755 222334457899999999998762 23467899999999999999999999
Q ss_pred CCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHh
Q 017231 244 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323 (375)
Q Consensus 244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell 323 (375)
-+....++...|.+..-..+.. +.+.+.++++|.+||.+||+.|.++.+|.
T Consensus 320 ~~~~~~~l~~KIvn~pL~fP~~-----------------------------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 320 FDDFELELFDKIVNDPLEFPEN-----------------------------PEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred ccchHHHHHHHHhcCcccCCCc-----------------------------ccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 9999899988888755444332 34678899999999999999999999999
Q ss_pred cCCCCCCC
Q 017231 324 CHPYLAPL 331 (375)
Q Consensus 324 ~~~~f~~~ 331 (375)
.|||...-
T Consensus 371 ~Hpwvt~~ 378 (576)
T KOG0585|consen 371 LHPWVTRD 378 (576)
T ss_pred ecceeccC
Confidence 99999865
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=334.13 Aligned_cols=323 Identities=51% Similarity=0.938 Sum_probs=259.3
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..|.+.++|- +++.||.|++|.||++.++.+++.||+|.+............+..|+.+++.++|||++++++++....
T Consensus 4 ~~~~~~~~y~-~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 82 (328)
T cd07856 4 TVFEITNRYV-DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL 82 (328)
T ss_pred ceeccccceE-EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence 3445555544 799999999999999999999999999988654434444567788999999999999999999885432
Q ss_pred CCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 113 RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
...++++||++++|.+++.. ..+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 83 ----~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 83 ----EDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred ----CcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 45789999998899888764 4589999999999999999999999999999999999999999999999998865
Q ss_pred cCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 193 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 193 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
.... .....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+....+.+++........
T Consensus 158 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 158 QDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred cCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 4332 23345678899999876645688999999999999999999999988877676666777666655444333332
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPS 352 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 352 (375)
.....+...+............+.+++.+.++|++||+.+|++||++++++.|+||+..+....++.++..|.|+++.-.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEEKFDWSFNDAD 315 (328)
T ss_pred hhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCchhhcCCchhccc
Confidence 33333332222222222233345678899999999999999999999999999999999999999999999999999988
Q ss_pred CCHHHHHHHHH
Q 017231 353 FTEENIKELIY 363 (375)
Q Consensus 353 ~~~~~~~~~~~ 363 (375)
+--+.|+-+-|
T Consensus 316 ~~~~~~~~~~~ 326 (328)
T cd07856 316 LPVDTWKVMMY 326 (328)
T ss_pred CCHHHHHHHhc
Confidence 88888876654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=335.15 Aligned_cols=333 Identities=51% Similarity=0.920 Sum_probs=265.7
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
.|++.++|. +++.||+|++|.||++.+..+++.||+|.+............+.+|+.++++++|+||+++++++.....
T Consensus 12 ~~~~~~~y~-~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 12 IWEVPERYQ-NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HhhccCceE-EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 355555554 7999999999999999999999999999987654444445677889999999999999999998864321
Q ss_pred -CCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 114 -ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 114 -~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
......++++++++++|.+++.. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 91 ~~~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 91 LEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ccccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 22345789999998899887765 4699999999999999999999999999999999999999999999999998865
Q ss_pred cCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 193 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 193 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
.... .....++..|+|||.+.+...++.++|||||||++|+|++|..||...+.......+....+..+......+..
T Consensus 170 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred cccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 4332 23446688899999987655688899999999999999999999988887777777777766665555555544
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPS 352 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 352 (375)
.....+...+...+...+.......++++.++|.+||+.||++||++.++++||||++......+++.+. |...+-.-.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~-~~~~~~~~~ 326 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP-YDQSFESRD 326 (345)
T ss_pred HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCCC-ccCcchhcc
Confidence 4444555555544444444444567889999999999999999999999999999999988888777654 332332333
Q ss_pred CCHHHHHHHHHHHHhhcCC
Q 017231 353 FTEENIKELIYRESVKFNP 371 (375)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~ 371 (375)
..-+-++...|.++..|-|
T Consensus 327 ~~~~~~~~~~~~~~~~~~~ 345 (345)
T cd07877 327 LLIDEWKSLTYDEVISFVP 345 (345)
T ss_pred cCHHHHHHHHHHHHHhcCC
Confidence 4557888999999988876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=333.92 Aligned_cols=282 Identities=36% Similarity=0.672 Sum_probs=226.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||+++++.++..||+|.+...... .....+.+|+.++++++|+|++++++++... +..++||
T Consensus 10 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 83 (309)
T cd07872 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSLTLVF 83 (309)
T ss_pred EEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEEEEE
Confidence 799999999999999999999999999998654322 2234567899999999999999999998654 5689999
Q ss_pred eCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
||++++|.+++...+ .++...++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 999999999887654 48999999999999999999999999999999999999999999999999986543322 2233
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+....+....+.+....+.......... ...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 242 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK-NYN 242 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh-hhh
Confidence 4568889999998765678999999999999999999999999988888888888877766655443322211100 011
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.............+.+++++.++|.+||+.||.+|||+.|+++||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 111112222333456889999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=336.63 Aligned_cols=304 Identities=45% Similarity=0.783 Sum_probs=235.8
Q ss_pred CCceEEeceec--CCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHH
Q 017231 10 GDHTIVKGVPT--HGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL 87 (375)
Q Consensus 10 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~ 87 (375)
||||+..|... ...+|. +++.||+|++|.||++.+..+++.||+|.+.+..........+.
T Consensus 1 ~~~~~~~~~~~~~~~~~y~-----------------~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~ 63 (353)
T cd07850 1 QFYSVEVGDSTFTVLKRYQ-----------------NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY 63 (353)
T ss_pred CceeecccchhhhhhcceE-----------------EEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHH
Confidence 67888887743 245666 58999999999999999999999999999876544455566778
Q ss_pred HHHHHHHhcCCCCeeeeceeecCCC-CCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 017231 88 REIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLH 166 (375)
Q Consensus 88 ~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H 166 (375)
.|+.++++++|+|++++++++.... .+.....++||||++++|.+.+... ++...+..++.||+.||.+||+.|++|
T Consensus 64 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H 141 (353)
T cd07850 64 RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIH 141 (353)
T ss_pred HHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 8999999999999999999886543 2233568999999999999988754 899999999999999999999999999
Q ss_pred cCCCCCceEEecCCCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCC
Q 017231 167 RDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK 246 (375)
Q Consensus 167 ~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 246 (375)
+||||+||+++.++.++|+|||.+.............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus 142 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred CCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999876554433344567888999999987 77899999999999999999999999988
Q ss_pred ChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCc-------------cccCCCCCchHHHHHHHhcCcCC
Q 017231 247 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF-------------SARFPNKSPGAVDLLEKMLVFDP 313 (375)
Q Consensus 247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~s~~l~~li~~~L~~dP 313 (375)
+.......+....+.++......+... ...+...........+ .......++.+.++|.+||+.||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 299 (353)
T cd07850 221 DHIDQWNKIIEQLGTPSDEFMSRLQPT-VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDP 299 (353)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHHhhhh-hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCCh
Confidence 877777777666665543322211111 0111111110000000 00012346678999999999999
Q ss_pred CCCCCHHHHhcCCCCCCCCCC
Q 017231 314 NRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 314 ~~Rps~~ell~~~~f~~~~~~ 334 (375)
++|||+.|+|.||||+.-...
T Consensus 300 ~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 300 EKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred hhCcCHHHHhcChhHhhccCC
Confidence 999999999999999864433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=336.24 Aligned_cols=334 Identities=46% Similarity=0.864 Sum_probs=263.0
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
...|++.++|. +.+.||.|++|.||+|.+..+++.||+|.+.+..........+.+|+.+++.++|+||+++++++...
T Consensus 8 ~~~~~~~~~y~-~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 86 (342)
T cd07879 8 KTVWELPERYT-SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSA 86 (342)
T ss_pred hhhhccccceE-EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccc
Confidence 34577777765 79999999999999999999999999999876543343455678999999999999999999988654
Q ss_pred CC-CCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 112 QR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 112 ~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
.. .....+++++||+..+|..++. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 87 VSGDEFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred ccCCCCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 31 1224579999999888877653 46899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 191 RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 191 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
...... .....++..|+|||.+.+...++.++|+|||||++|+|++|+.||...+.......+....+..........
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 165 RHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred cCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 654332 233456788999999876456888999999999999999999999988877777777776655544433333
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEH 350 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~ 350 (375)
.......+....+..+...+...++..++.+.++|.+||+.||++||++.+++.||||+.+.....++ ++..+..+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~-~~~~~~~~~~~ 321 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET-EQQPYDDSLEN 321 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC-CCCcccchhhh
Confidence 33333333333444444444444567888999999999999999999999999999999997655444 45666666656
Q ss_pred CCCCHHHHHHHHHHHHhhcCC
Q 017231 351 PSFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 351 ~~~~~~~~~~~~~~~~~~~~~ 371 (375)
.++..+.+..-.|++.-.|.|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~ 342 (342)
T cd07879 322 EKLSVDEWKKHIYKEVKSFSP 342 (342)
T ss_pred hhCCHHHHHHHhhhhhhccCC
Confidence 568888888888888777765
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=339.97 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=213.1
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|++|.||+++++.+++.||+|++.... ........+..|+.++++++||||+++++.+... +.++
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 94 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----NRVY 94 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----CEEE
Confidence 337999999999999999999999999999986532 2223456788999999999999999999998654 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
+||||+. |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++...... .
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~ 172 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T 172 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence 9999997 699999998888999999999999999999999999999999999999999999999999998765433 2
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 173 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~----------------- 234 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF----------------- 234 (329)
T ss_pred ceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCC-----------------
Confidence 34578999999999987 678999999999999999999999998776555544443211000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPL 331 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~ 331 (375)
...++..+.++|.+||+.||.+||+ ++++++||||++.
T Consensus 235 --------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 235 --------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred --------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 0135788999999999999999997 7999999999875
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=332.02 Aligned_cols=257 Identities=23% Similarity=0.387 Sum_probs=210.1
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc-hHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++++.||+|+||.||++.+..+++.||+|.+...... ......+.+|+.++++++|++++++++.+... +..++
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~~l 77 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DALCL 77 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeEEE
Confidence 3689999999999999999999999999998654322 22334577899999999999999999998554 56899
Q ss_pred EEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 122 VYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
+|||++ |+|.+.+... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 999997 6888877543 4599999999999999999999999999999999999999999999999999876544433
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+........
T Consensus 158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 221 (285)
T cd05631 158 VRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ--------------- 221 (285)
T ss_pred ecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc---------------
Confidence 345678999999999987 6789999999999999999999999987654332222222111100
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH 332 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~ 332 (375)
......+++++.++|++||+.||.+||+ ++++++||||.++.
T Consensus 222 ------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 222 ------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 0011346889999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=332.68 Aligned_cols=318 Identities=58% Similarity=1.000 Sum_probs=256.0
Q ss_pred CCeeeccCCcceEEEEEEeCCC--CcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSET--REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
.+.+.||+|++|.||++.+..+ +..||+|.+............+..|+.+++++ +||||+++++...... .....+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~~~ 81 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFNEL 81 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCCcE
Confidence 3689999999999999999888 89999999865444444456678899999999 5999999998754332 223557
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--
Q 017231 120 YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-- 197 (375)
Q Consensus 120 ~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-- 197 (375)
++++++++++|.+++.....+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 161 (332)
T cd07857 82 YLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGE 161 (332)
T ss_pred EEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccccc
Confidence 899999999999999888889999999999999999999999999999999999999999999999999886543321
Q ss_pred ---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 198 ---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
......++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+.++...........
T Consensus 162 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (332)
T cd07857 162 NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPK 241 (332)
T ss_pred ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhh
Confidence 12234678889999988764568899999999999999999999999988888888888887766654444333333
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFT 354 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (375)
...+...+...+...+....+..+..+.++|.+||+.||.+|||+.+++.||||++..+....+.|..++.+++++-+ +
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 320 (332)
T cd07857 242 AQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFESED-S 320 (332)
T ss_pred HHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccccc-c
Confidence 333333333333333444456678899999999999999999999999999999999999999999999999887653 3
Q ss_pred HHHHHHHH
Q 017231 355 EENIKELI 362 (375)
Q Consensus 355 ~~~~~~~~ 362 (375)
-+-.+.++
T Consensus 321 ~~~~~~~~ 328 (332)
T cd07857 321 MEELRDMI 328 (332)
T ss_pred HHHHHHHH
Confidence 33344443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=339.00 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=215.5
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCC-cEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETR-EEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
+..+.+.+++.||+|+||.||+|.++.++ ..||+|.+.... ........+..|+.+++.++||||+++++++...
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--- 103 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE--- 103 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC---
Confidence 33444557999999999999999876654 689999986532 2233456788999999999999999999998554
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
..+++||||+. |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++...
T Consensus 104 --~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 104 --SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred --CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 56899999996 699999999889999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
... .....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.......
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~----------- 247 (340)
T PTZ00426 182 DTR--TYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF----------- 247 (340)
T ss_pred CCC--cceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC-----------
Confidence 432 235678999999999987 678999999999999999999999998877655555543321111
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
.+.+++.+.++|++||+.||++|+ +++++++||||++++
T Consensus 248 --------------------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 248 --------------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred --------------------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 124678899999999999999995 899999999999874
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=341.57 Aligned_cols=259 Identities=27% Similarity=0.408 Sum_probs=211.0
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||+||+|+++.+++.||+|++.... ........+..|+.++++++|+||+++++.+... ..++
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~~~ 77 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-----DNLY 77 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-----CEEE
Confidence 347999999999999999999999999999996542 2334456788999999999999999999999654 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC---
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET--- 196 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~--- 196 (375)
+||||++ |+|.+++...+.+++..++.++.||+.||.+||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 78 FVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 9999996 699999998888999999999999999999999999999999999999999999999999986432100
Q ss_pred ---------------------------------------------CccccccccccccCchhcccCCCCCccchhHHHHH
Q 017231 197 ---------------------------------------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 231 (375)
Q Consensus 197 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 231 (375)
.......||..|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhh
Confidence 00123468999999999987 67899999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcC-
Q 017231 232 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLV- 310 (375)
Q Consensus 232 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~- 310 (375)
++|+|++|..||...+.......+......... .....+++++.++|.+|+.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~s~~~~dli~~ll~~ 289 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHI---------------------------PPQVKLSPEAVDLITKLCCS 289 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccCC---------------------------CCCCCCCHHHHHHHHHHccC
Confidence 999999999999877655544443321111100 0112468899999999664
Q ss_pred -cCCCCCCCHHHHhcCCCCCCCCC
Q 017231 311 -FDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 311 -~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.+|..|++++++++||||+.+.-
T Consensus 290 ~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 290 AEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred cccccCCCCHHHHhcCcccCCCCh
Confidence 45556999999999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=341.15 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=215.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|++|+||+|.+..+++.||||++..... .......+..|+.++..++|+||+++++.+... ..+++|
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv 79 (350)
T cd05573 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-----EHLYLV 79 (350)
T ss_pred EEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-----CeEEEE
Confidence 79999999999999999999999999999865432 223456788999999999999999999988544 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC----
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---- 197 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---- 197 (375)
|||+. ++|.+++...+.+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 99996 6999999988889999999999999999999999999999999999999999999999999987544332
Q ss_pred --------------------------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH
Q 017231 198 --------------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 251 (375)
Q Consensus 198 --------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 251 (375)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~ 238 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET 238 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence 2234568999999999988 6889999999999999999999999988776555
Q ss_pred HHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-HHHHhcCCCCCC
Q 017231 252 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-VDEALCHPYLAP 330 (375)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-~~ell~~~~f~~ 330 (375)
...+......... .....+++++.++|.+||. ||.+||+ ++++++||||++
T Consensus 239 ~~~i~~~~~~~~~---------------------------p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 239 YNKIINWKESLRF---------------------------PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHhccCCcccC---------------------------CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 5554442111100 0012368899999999998 9999999 999999999998
Q ss_pred CCC
Q 017231 331 LHD 333 (375)
Q Consensus 331 ~~~ 333 (375)
+..
T Consensus 291 ~~~ 293 (350)
T cd05573 291 IDW 293 (350)
T ss_pred CCH
Confidence 743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=335.32 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=211.2
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEe
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 124 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 124 (375)
+.||+|+||.||+++++.+|..||+|++.... ........+..|+.+++.++||||+++++.+... ..+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEe
Confidence 46999999999999999999999999986542 2233455677899999999999999999998554 56899999
Q ss_pred CCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCccccc
Q 017231 125 LMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEY 202 (375)
Q Consensus 125 ~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~~ 202 (375)
|++ |+|..++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..... .......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~ 155 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 155 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccc
Confidence 997 69999998888899999999999999999999999999999999999999999999999998765322 2223345
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
.|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-------------------- 214 (323)
T cd05595 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF-------------------- 214 (323)
T ss_pred cCCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC--------------------
Confidence 68999999999987 678999999999999999999999998877665554443211110
Q ss_pred CCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
...+++++.++|.+||+.||.+|+ ++.++++|+||.+..
T Consensus 215 -----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 215 -----------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred -----------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 024688999999999999999998 899999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=333.60 Aligned_cols=260 Identities=32% Similarity=0.513 Sum_probs=226.6
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
|++.+.||.|.||+||.++++.+|+.+|+|++.+... .......+.+|+.+|+++. |||++.+++.|... ..+
T Consensus 37 Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-----~~~ 111 (382)
T KOG0032|consen 37 YELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-----DSV 111 (382)
T ss_pred EEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-----CeE
Confidence 3378999999999999999999999999999977543 3335677889999999998 99999999999555 679
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC----CCEEEeecccccccC
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN----CDLKIGDFGLARTTS 194 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~----~~i~l~Df~~~~~~~ 194 (375)
++|||++. |.|.+.+... .+++..+..++.||+.++.+||+.|++|+||||+|+++... +.++++|||++....
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999997 6999999877 59999999999999999999999999999999999999543 479999999999888
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
........+||+.|+|||++.. ..++..+|+||+|+++|.|++|..||.+.........+.........
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~---------- 259 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS---------- 259 (382)
T ss_pred CCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC----------
Confidence 7667888999999999999987 78999999999999999999999999998877776655553332222
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
..|+.++..++++|++||..||.+|+|+.++|+|||++......
T Consensus 260 -----------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~ 303 (382)
T KOG0032|consen 260 -----------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT 303 (382)
T ss_pred -----------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence 23467899999999999999999999999999999999764443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.15 Aligned_cols=259 Identities=25% Similarity=0.438 Sum_probs=217.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++++.||+|++|.||+|.+..+++.||+|++..... .......+..|+.++..++||||+++++++... ...++
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~l 78 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-----EYLYL 78 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-----CEEEE
Confidence 379999999999999999999999999999965432 223455678899999999999999999998554 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
||||++ |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++..... ...
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~ 156 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YAN 156 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccC
Confidence 999997 69999999888899999999999999999999999999999999999999999999999999865543 234
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+............
T Consensus 157 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------------- 222 (333)
T cd05600 157 SVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVY------------- 222 (333)
T ss_pred CcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCC-------------
Confidence 5678999999999988 68899999999999999999999999888766665555442211110000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
......+++++.++|.+||..+|.+||++.++++||||+.+.
T Consensus 223 ----------~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 223 ----------DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred ----------CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 000134688999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=307.03 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=230.7
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
++|.+. .+++++.||+|-||.||+|+.+.++..||+|++.++.- .......+.+|+++-+.|+||||++++++|.+.
T Consensus 17 ~~~~l~--dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 17 KTWTLD--DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccchh--hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 344444 45569999999999999999999999999999977542 233446788999999999999999999999887
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~--~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
..+|+++||.. |++...+. ..+.+++...+.++.|++.|+.|+|.++++||||||+|++++.+|.++++|||
T Consensus 95 -----~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfG 169 (281)
T KOG0580|consen 95 -----KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFG 169 (281)
T ss_pred -----ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCC
Confidence 45899999996 89999998 66789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 189 LARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
.+.... .....+.+||..|.+||...+ ..++..+|+|++|++.|+++.|.+||......++.++|.......+
T Consensus 170 wsV~~p-~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----- 242 (281)
T KOG0580|consen 170 WSVHAP-SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----- 242 (281)
T ss_pred ceeecC-CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC-----
Confidence 886665 455688999999999999998 8899999999999999999999999999999999999888655544
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..++...+++|.+||..+|.+|.+..|++.|||+...
T Consensus 243 --------------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 243 --------------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred --------------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 3578899999999999999999999999999999754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=342.72 Aligned_cols=275 Identities=27% Similarity=0.426 Sum_probs=217.9
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++++.||+|+||.||+|+++.+++.||+|++.+.. ........+..|+.++++++|+||+++++.+... ..+++
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~~~l 78 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNLYF 78 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CEEEE
Confidence 37999999999999999999999999999986532 2233456788999999999999999999999654 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC----
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---- 196 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~---- 196 (375)
||||++ |+|.+++.+.+.+++..++.++.||+.||.+||++||+|+||||+||+++.+|.++|+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999997 699999988888999999999999999999999999999999999999999999999999986421100
Q ss_pred --------------------------------------------CccccccccccccCchhcccCCCCCccchhHHHHHH
Q 017231 197 --------------------------------------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 232 (375)
Q Consensus 197 --------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 232 (375)
.......||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvi 237 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVI 237 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechHH
Confidence 00123468999999999987 678999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcC
Q 017231 233 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFD 312 (375)
Q Consensus 233 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 312 (375)
+|+|++|..||...+.......+......... .....+++++.++|.+|+. +
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------p~~~~~s~~~~~li~~l~~-~ 289 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKVINWQTSLHI---------------------------PPQAKLSPEASDLIIKLCR-G 289 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHccCCCcCC---------------------------CCcccCCHHHHHHHHHHcc-C
Confidence 99999999999887765554444332111110 0113568899999999875 9
Q ss_pred CCCCCC---HHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 313 PNRRIT---VDEALCHPYLAPLHDINEEPVCPRPFSFDFEHP 351 (375)
Q Consensus 313 P~~Rps---~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~ 351 (375)
|.+|++ ++++++||||+.+.........+.++.+..+.|
T Consensus 290 p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 331 (382)
T cd05625 290 PEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSAPYIPKITHP 331 (382)
T ss_pred HhHcCCCCCHHHHhcCCCcCCcChHHHHhcCCCCccCcCCCc
Confidence 999997 999999999998754332222333344444333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=335.38 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=210.4
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEe
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 124 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 124 (375)
+.||+|+||.||+++++.+++.||+|++.... ........+..|+.+++.++||||+++++.+... ..+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-----DRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CEEEEEEe
Confidence 46899999999999999999999999996542 2233456778899999999999999999988544 56899999
Q ss_pred CCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCccccc
Q 017231 125 LMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEY 202 (375)
Q Consensus 125 ~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~~ 202 (375)
|++ |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++..... .......
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 155 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF 155 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccc
Confidence 997 69999998888899999999999999999999999999999999999999999999999998865322 2223345
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
.|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 156 ~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~-------------------- 214 (328)
T cd05593 156 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKF-------------------- 214 (328)
T ss_pred cCCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccC--------------------
Confidence 78999999999987 678999999999999999999999998776555444332211000
Q ss_pred CCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
...+++++.++|.+||+.||.+|+ ++.++++|+||....
T Consensus 215 -----------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 258 (328)
T cd05593 215 -----------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258 (328)
T ss_pred -----------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 124688899999999999999997 899999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=338.69 Aligned_cols=257 Identities=21% Similarity=0.356 Sum_probs=211.6
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||+||++.++.+++.||+|++.+.. ........+..|+.++.+++|++|+++++.+... ..++
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-----~~~~ 77 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-----LNLY 77 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CeEE
Confidence 347999999999999999999999999999996532 2233445678899999999999999999998554 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-- 197 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-- 197 (375)
+||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 9999997 6999999988899999999999999999999999999999999999999999999999999886432210
Q ss_pred ----------------------------------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCC
Q 017231 198 ----------------------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 243 (375)
Q Consensus 198 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 243 (375)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0123578999999999987 67899999999999999999999999
Q ss_pred CCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCC---CCCCHH
Q 017231 244 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN---RRITVD 320 (375)
Q Consensus 244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~---~Rps~~ 320 (375)
.+.+.......+........-. ....++++++++|.+|+. +|. .||+++
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p---------------------------~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ 288 (363)
T cd05628 237 CSETPQETYKKVMNWKETLIFP---------------------------PEVPISEKAKDLILRFCC-EWEHRIGAPGVE 288 (363)
T ss_pred CCCCHHHHHHHHHcCcCcccCC---------------------------CcCCCCHHHHHHHHHHcC-ChhhcCCCCCHH
Confidence 8877666666555422111000 012468889999999875 444 468999
Q ss_pred HHhcCCCCCCCC
Q 017231 321 EALCHPYLAPLH 332 (375)
Q Consensus 321 ell~~~~f~~~~ 332 (375)
||++||||++++
T Consensus 289 ei~~hp~f~~~~ 300 (363)
T cd05628 289 EIKTNPFFEGVD 300 (363)
T ss_pred HHhCCCCCCCCC
Confidence 999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=336.58 Aligned_cols=254 Identities=22% Similarity=0.409 Sum_probs=205.0
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||++.++.+++.||+|++.+... .......+..|..++..+ +||||+++++++... ..+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEE
Confidence 468999999999999999999999999976432 233456678899999998 699999999998554 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC-CCCcccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~-~~~~~~~ 201 (375)
||++ |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.... .......
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST 155 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCcccc
Confidence 9997 6999999888899999999999999999999999999999999999999999999999999886422 2223345
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhH-----HHHHHHHHhCCCCcccccccccchhH
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH-----QLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
..|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||....... ....+...
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------------ 216 (329)
T cd05588 156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV------------------ 216 (329)
T ss_pred ccCCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH------------------
Confidence 678999999999987 778999999999999999999999996322100 00000000
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC------HHHHhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT------VDEALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps------~~ell~~~~f~~~~ 332 (375)
....... .-..++.++.++|.+||+.||.+|++ ++++++||||..+.
T Consensus 217 -~~~~~~~--------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 217 -ILEKQIR--------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred -HHcCCCC--------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 0000000 01246888999999999999999997 78999999998764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=332.31 Aligned_cols=247 Identities=30% Similarity=0.484 Sum_probs=209.1
Q ss_pred ccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCC
Q 017231 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 126 (375)
Q Consensus 48 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 126 (375)
||+|+||.||++.++.+++.||+|++.... ........+..|+.++.+++||||+++++.+... ...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-----EKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-----CeEEEEEcCC
Confidence 799999999999999999999999986532 2333456778899999999999999999988544 5689999999
Q ss_pred C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cccccccc
Q 017231 127 D-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVV 204 (375)
Q Consensus 127 ~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~~~~~ 204 (375)
+ |+|.+++...+.+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||++...... .......|
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 155 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG 155 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccC
Confidence 7 699999988888999999999999999999999999999999999999999999999999998653322 22344578
Q ss_pred cccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCC
Q 017231 205 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 284 (375)
Q Consensus 205 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (375)
++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 156 t~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~---------------------- 212 (312)
T cd05585 156 TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRF---------------------- 212 (312)
T ss_pred CcccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCC----------------------
Confidence 999999999987 678999999999999999999999998876655544433211000
Q ss_pred CCCCCccccCCCCCchHHHHHHHhcCcCCCCCC---CHHHHhcCCCCCCC
Q 017231 285 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLAPL 331 (375)
Q Consensus 285 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~ell~~~~f~~~ 331 (375)
...+++++.++|.+||+.||.+|| ++.++++||||...
T Consensus 213 ---------~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 213 ---------PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ---------CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 124688899999999999999997 57999999999986
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=328.25 Aligned_cols=282 Identities=36% Similarity=0.672 Sum_probs=223.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||.|++|.||++.++.+++.||+|.+....... ....+..|+.+++.++||||+++++++... ...++||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~~~lv~ 83 (301)
T cd07873 10 KLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLTLVF 83 (301)
T ss_pred EeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecC-----CeEEEEE
Confidence 7999999999999999999999999999986543222 234567899999999999999999998654 5689999
Q ss_pred eCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
||++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 84 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 84 EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred eccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 99999999988764 568999999999999999999999999999999999999999999999999886543322 1223
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..++..|+|||.+.+...++.++|||||||++|+|++|+.||...+.......+....+.+....+........ .....
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 242 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE-FKSYN 242 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc-ccccc
Confidence 45688899999987756688999999999999999999999998887777777777666554433322111100 00000
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.+...........+.+++.++++|.+||+.||.+|||++|+++||||+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 111111112223356788999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=330.25 Aligned_cols=258 Identities=28% Similarity=0.379 Sum_probs=216.6
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..+++....+.+.+.||+|+||+||.+..+.+ ..||+|++.....+......|.+|+.+|.+++|||||++++++..+.
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~ 112 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP 112 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 55777777777889999999999999987754 23999999776545445788999999999999999999999997763
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCceEEecCC-CEEEeec
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNLLLNANC-DLKIGDF 187 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~Lh~~~-i~H~di~p~NIli~~~~-~i~l~Df 187 (375)
..+++||||++ |+|.+++.. ...++...+..|+.+|+.|+.|||+++ |+|+||||+|||++.++ ++||+||
T Consensus 113 ----~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 113 ----GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred ----CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCC
Confidence 15899999997 799999987 578999999999999999999999999 99999999999999998 9999999
Q ss_pred ccccccCCC-CccccccccccccCchhccc-CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 188 GLARTTSET-DFMTEYVVTRWYRAPELLLN-CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 188 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
|++...... .......||+.|+|||++.+ ...++.++||||||+++|||+||+.||.+.........+......+.-+
T Consensus 189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p 268 (362)
T KOG0192|consen 189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP 268 (362)
T ss_pred ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 999776654 22334788999999999995 2689999999999999999999999999988744443333222211111
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
..+++.+..++.+||+.||++||++.+++.
T Consensus 269 -----------------------------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 269 -----------------------------KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -----------------------------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 126888999999999999999999998876
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=346.15 Aligned_cols=287 Identities=24% Similarity=0.392 Sum_probs=219.6
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCC------CCeeeeceeec
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH------ENIIAIKDIIR 109 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~iv~~~~~~~ 109 (375)
.+....|++++.||+|+||+||++.+..+++.||||++.... ........|+.+++.++| .+++.+++++.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 334444558999999999999999999999999999985421 122334567777776654 45888888875
Q ss_pred CCCCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCC--------
Q 017231 110 PPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANC-------- 180 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~-------- 180 (375)
... .++|+||++++++|.+++...+.+++..++.|+.||+.||.|||+ .||+|+||||+|||++.++
T Consensus 202 ~~~----~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 202 NET----GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred cCC----ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccc
Confidence 432 568999999999999999888889999999999999999999998 5999999999999998765
Q ss_pred --------CEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHH
Q 017231 181 --------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL 252 (375)
Q Consensus 181 --------~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 252 (375)
.++|+|||.+..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred cccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 499999998754322 2345678999999999988 77999999999999999999999999998888888
Q ss_pred HHHHHHhCCCCcccccccccchhHHHhhhCCCCCCC----Ccc-----ccC--CCCCchHHHHHHHhcCcCCCCCCCHHH
Q 017231 253 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ----NFS-----ARF--PNKSPGAVDLLEKMLVFDPNRRITVDE 321 (375)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-----~~~--~~~s~~l~~li~~~L~~dP~~Rps~~e 321 (375)
..+....+..+..............+.......... .+. ... ...++.+.+||.+||..||.+|||++|
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e 434 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ 434 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence 888888887765544322222212222111111000 000 000 012466889999999999999999999
Q ss_pred HhcCCCCCCCC
Q 017231 322 ALCHPYLAPLH 332 (375)
Q Consensus 322 ll~~~~f~~~~ 332 (375)
+|+||||++..
T Consensus 435 ~L~Hp~~~~~~ 445 (467)
T PTZ00284 435 MTTHPYVLKYY 445 (467)
T ss_pred HhcCccccccC
Confidence 99999999753
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=331.07 Aligned_cols=256 Identities=29% Similarity=0.471 Sum_probs=233.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|.|++|.+|++.-+|+.||||++.+...+......+++|++.++.++|||||++|++. .....+|+|+
T Consensus 22 LekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTKlyLiL 96 (864)
T KOG4717|consen 22 LEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTKLYLIL 96 (864)
T ss_pred hhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccceEEEEE
Confidence 68999999999999999999999999999999988888889999999999999999999999998 4447799999
Q ss_pred eCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE-ecCCCEEEeecccccccCCCCccc
Q 017231 124 ELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL-NANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 124 e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli-~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
|+-+ |+|+++|.++ .++++..+.+++.||+.|+.|+|+..++|+||||+||++ .+-|-+||.|||.+..........
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 9997 6999999765 579999999999999999999999999999999999976 567899999999999988888889
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
+.||+..|.|||++.+.....+++||||||+|+|-|.+|+.||...+..+.+-.|+.-....|
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----------------- 239 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----------------- 239 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc-----------------
Confidence 999999999999999977778999999999999999999999999888888877776443332
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
.++|.+++++|..||..||.+|.+.+||..++|++.++...
T Consensus 240 --------------shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 240 --------------SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred --------------hhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 35799999999999999999999999999999999886544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=339.63 Aligned_cols=257 Identities=25% Similarity=0.446 Sum_probs=212.8
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||.||+++++.+++.||||++.... ........+..|+.++..++||||+++++.+... ..++
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~~ 77 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-----NYLY 77 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-----CeEE
Confidence 347999999999999999999999999999996532 2233455678899999999999999999998654 6689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-- 197 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-- 197 (375)
+||||++ |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 9999996 6999999988889999999999999999999999999999999999999999999999999875432110
Q ss_pred -------------------------------------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCC
Q 017231 198 -------------------------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 240 (375)
Q Consensus 198 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 240 (375)
......||+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcCC
Confidence 0112458999999999887 67899999999999999999999
Q ss_pred CCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC--
Q 017231 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-- 318 (375)
Q Consensus 241 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-- 318 (375)
.||...+.......+......... .....+++++.++|.+||. +|.+|++
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~ll~-~p~~R~~~~ 288 (364)
T cd05599 237 PPFCSDNPQETYRKIINWKETLQF---------------------------PDEVPLSPEAKDLIKRLCC-EAERRLGNN 288 (364)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCC---------------------------CCCCCCCHHHHHHHHHHcc-CHhhcCCCC
Confidence 999887766555544332111100 0012468899999999997 9999998
Q ss_pred -HHHHhcCCCCCCCC
Q 017231 319 -VDEALCHPYLAPLH 332 (375)
Q Consensus 319 -~~ell~~~~f~~~~ 332 (375)
+.+++.||||+.+.
T Consensus 289 ~~~~ll~h~~~~~~~ 303 (364)
T cd05599 289 GVNEIKSHPFFKGVD 303 (364)
T ss_pred CHHHHhcCCCcCCCC
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=334.91 Aligned_cols=255 Identities=30% Similarity=0.467 Sum_probs=231.1
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+.+++++|+|+||.+++++++..++.||+|.+..........+...+|+.++++++|||||.+.+.|..++ ..++|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~~l~I 81 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----QLLCI 81 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----ceEEE
Confidence 34799999999999999999999999999999877766667778899999999999999999999996653 23899
Q ss_pred EEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 122 VYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
||+||+ |++.+.+...+ .++++.++.|+.|++.|+.|||+++|.|||||+.|||+++++.|+|+|||+++......
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999997 69999997765 59999999999999999999999999999999999999999999999999999988876
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
...+..||+.|++||.+.+ .+|+.++|||||||++|||++-+.+|...+.......|......+.+
T Consensus 162 ~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp------------- 227 (426)
T KOG0589|consen 162 LASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLP------------- 227 (426)
T ss_pred hhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCC-------------
Confidence 7788999999999999999 89999999999999999999999999999988888888776633322
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..++.+++.+|..||..+|+.||++.+||.+|.++..
T Consensus 228 -----------------~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 228 -----------------SMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred -----------------ccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 2568999999999999999999999999999998854
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=330.40 Aligned_cols=285 Identities=21% Similarity=0.343 Sum_probs=217.5
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
+..+.+++++.||+|++|.||+++++.++..||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 75 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD----- 75 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----
Confidence 34455668999999999999999999999999999986542 233456788999999999999999999998554
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
+..++||||++ ++|.+++.....+++..+..++.|++.||.+||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 56899999997 69999999888899999999999999999999986 69999999999999999999999999886553
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc-----
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF----- 269 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----- 269 (375)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+..............
T Consensus 156 ~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (331)
T cd06649 156 DS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP 233 (331)
T ss_pred cc-ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence 32 2334568899999999987 6789999999999999999999999987765544332221110000000000
Q ss_pred -----------cc---cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 270 -----------LR---SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 270 -----------~~---~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.. ..........+.... ........+++++++||.+||+.||++|||+++|++||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEP--PPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccccchhHHHHHHHHHhCC--CcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00 000000011000000 0011112468899999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=322.66 Aligned_cols=279 Identities=38% Similarity=0.696 Sum_probs=220.1
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|++|.||++.++.++..|++|.+............+..|+.++++++|||++++++++... ...++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v 77 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-----SRLYLI 77 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-----CeEEEE
Confidence 378999999999999999999999999999865443333446678899999999999999999998654 568999
Q ss_pred EeCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 123 YELMDTDLHQIIRSH---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
|||++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 78 FEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred EecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 999999999988653 459999999999999999999999999999999999999999999999999886543321 1
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....+++.|+|||.+.+...++.++|+|||||++|+|++|+.||...........+....+......+..... ...+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 235 (285)
T cd07861 158 YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS--LPDY 235 (285)
T ss_pred ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh--hHHH
Confidence 22335678899999987655678999999999999999999999988776655555555444443332222111 1112
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..................+++++.++|++||+.||++|||+.+|++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 22222222222333345689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=332.81 Aligned_cols=254 Identities=22% Similarity=0.408 Sum_probs=204.1
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||+++++.+++.||+|++.+.. ........+..|+.++.++ +||||+++++++... +.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence 46999999999999999999999999997653 2333455677888888877 799999999998554 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCcccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~ 201 (375)
||++ |+|..++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 155 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcccc
Confidence 9997 69999998888899999999999999999999999999999999999999999999999998865322 222345
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh-----HHHHHHHHHhCCCCcccccccccchhH
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-----HQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...... .....+......
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------------- 219 (329)
T cd05618 156 FCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------------- 219 (329)
T ss_pred ccCCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------------
Confidence 678999999999987 77899999999999999999999999532100 000000000000
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC------HHHHhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT------VDEALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps------~~ell~~~~f~~~~ 332 (375)
.. ......++..+.++|.+||+.||.+||+ +.++++||||+++.
T Consensus 220 ----~~--------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 220 ----KQ--------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred ----CC--------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 00 0001246888999999999999999998 57999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=330.19 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=210.0
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||++.++.+++.||+|++.+.. ........+..|..++..+ +||||+++++++... ..+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEE
Confidence 46999999999999999999999999986542 2223455677888888877 699999999998554 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCcccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~ 201 (375)
||++ |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST 155 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccc
Confidence 9997 69999998888999999999999999999999999999999999999999999999999998765322 222344
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~------------------- 215 (320)
T cd05590 156 FCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY------------------- 215 (320)
T ss_pred cccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCC-------------------
Confidence 578999999999987 678999999999999999999999998887666655543311100
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH------HHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV------DEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~------~ell~~~~f~~~~ 332 (375)
...+++++.++|.+||+.||.+||++ +++++||||+.+.
T Consensus 216 ------------~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 216 ------------PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred ------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 02368889999999999999999998 9999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=332.71 Aligned_cols=250 Identities=27% Similarity=0.427 Sum_probs=209.9
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEe
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 124 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 124 (375)
+.||+|+||.||++.++.++..||+|++.+.. ........+..|+.++..++||||+++++.+... ..+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-----~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-----DRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-----CEEEEEEe
Confidence 46999999999999999999999999997543 2233455677899999999999999999988554 56899999
Q ss_pred CCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEeecccccccCC-CCcccc
Q 017231 125 LMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTE 201 (375)
Q Consensus 125 ~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~ 201 (375)
|++ |+|.+++...+.+++..++.++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 155 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccccc
Confidence 997 6999999888889999999999999999999997 7999999999999999999999999998864322 222334
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~------------------- 215 (325)
T cd05594 156 FCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF------------------- 215 (325)
T ss_pred ccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCC-------------------
Confidence 568999999999987 678999999999999999999999998877655554433211100
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
-..+++++.++|.+||+.||.+|+ ++.++++||||.++.
T Consensus 216 ------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 216 ------------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred ------------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 024688899999999999999997 999999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=330.07 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=209.6
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||+||++.++.+++.||+|++.+.. ........+..|..++..+ +||||+++++++... ..+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-----~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-----DRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence 46999999999999999999999999987542 2233455677888888888 699999999998554 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCcccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~ 201 (375)
||++ |+|...+...+.+++..+..++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccc
Confidence 9997 69999998888899999999999999999999999999999999999999999999999998864322 222334
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..++..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.......
T Consensus 156 ~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~------------------- 215 (318)
T cd05570 156 FCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRY------------------- 215 (318)
T ss_pred eecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence 568999999999987 678999999999999999999999998877655554443211000
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH-----HHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~ 332 (375)
...+++.+.++|++||..||.+||++ .+++.||||+.+.
T Consensus 216 ------------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 216 ------------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred ------------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 02468889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=339.13 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=210.3
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||.||+++++.+++.||+|++.+.. ........+.+|+.++++++|+||+++++.+... +.++
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~~~~ 77 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-----DNLY 77 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CEEE
Confidence 347999999999999999999999999999986532 1223345678899999999999999999998554 6689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC---
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET--- 196 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~--- 196 (375)
+||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||++......
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 9999997 699999998888999999999999999999999999999999999999999999999999986422100
Q ss_pred -----------------------------------------CccccccccccccCchhcccCCCCCccchhHHHHHHHHH
Q 017231 197 -----------------------------------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 235 (375)
Q Consensus 197 -----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 235 (375)
.......||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilye 236 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILYE 236 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceeee
Confidence 00113468999999999987 778999999999999999
Q ss_pred HhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCC
Q 017231 236 IMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 315 (375)
Q Consensus 236 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~ 315 (375)
|++|+.||...+.......+........ ......+++++.++|.+|+. +|.+
T Consensus 237 ll~G~~Pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~l~~-~p~~ 288 (376)
T cd05598 237 MLVGQPPFLADTPAETQLKVINWETTLH---------------------------IPSQAKLSREASDLILRLCC-GAED 288 (376)
T ss_pred hhhCCCCCCCCCHHHHHHHHhccCcccc---------------------------CCCCCCCCHHHHHHHHHHhc-CHhh
Confidence 9999999988775554443322111100 00113568899999999874 9999
Q ss_pred CC---CHHHHhcCCCCCCCC
Q 017231 316 RI---TVDEALCHPYLAPLH 332 (375)
Q Consensus 316 Rp---s~~ell~~~~f~~~~ 332 (375)
|+ ++.++++||||+.+.
T Consensus 289 R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 289 RLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred cCCCCCHHHHhCCCCcCCCC
Confidence 99 999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=330.15 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=211.6
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCC-CCeeeeceeecCCCCCCcCcEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDH-ENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
++++.||+|+||.||+|.++.+++.||+|++.+.. ......+.+..|..++..+.| ++++++++++... +.++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~ 77 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DRLY 77 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CEEE
Confidence 47999999999999999999999999999987542 223345667889999999976 4578888888544 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCc
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDF 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~ 198 (375)
+||||++ |+|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..... ...
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 78 FVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 9999997 69999998888899999999999999999999999999999999999999999999999998764322 222
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+.......
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~---------------- 220 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSY---------------- 220 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC----------------
Confidence 334568999999999987 678999999999999999999999998887666665554321111
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH-----HHHhcCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH 332 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~ 332 (375)
...+++++.++|.+||..||.+|++. .++++||||+.++
T Consensus 221 ---------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 221 ---------------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred ---------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 02468889999999999999999976 8999999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.34 Aligned_cols=291 Identities=39% Similarity=0.659 Sum_probs=226.8
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++++.||.|++|.||++.++.+|+.||+|.+..............+|+.++++++|+|++++++++..... ..+++
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~~~l 85 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL---DSIFL 85 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC---CeEEE
Confidence 447999999999999999999999999999986543332223345679999999999999999999865432 45799
Q ss_pred EEeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cc
Q 017231 122 VYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
||||++++|.+++... ..+++.+++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 165 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCCC
Confidence 9999999999988764 569999999999999999999999999999999999999999999999999887654332 12
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+...++.++|+|||||++|+|++|..||...+.......+....+......+............
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence 22344777999999876566889999999999999999999999998888888888877665544433222111100000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
.........+.......++++.++|.+||+.||++|||++++++||||+.......
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~ 301 (309)
T cd07845 246 -TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCE 301 (309)
T ss_pred -cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCC
Confidence 00111111222233456889999999999999999999999999999997655433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=322.81 Aligned_cols=277 Identities=39% Similarity=0.687 Sum_probs=215.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||.|++|.||++.++.+|+.|++|.+............+..|+.++++++|+|++++++++... ..+++++
T Consensus 4 ~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 78 (284)
T cd07839 4 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLTLVF 78 (284)
T ss_pred eEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceEEEE
Confidence 68999999999999999999999999999865433333345677899999999999999999998654 5689999
Q ss_pred eCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
||++++|.+++.. .+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 9999999998865 4679999999999999999999999999999999999999999999999999886543321 1223
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCC-CCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
..++..|+|||.+.+...++.++|||||||++|+|++|..|+ ...+....++.+....+......+........ + .
T Consensus 159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~ 235 (284)
T cd07839 159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD--Y-K 235 (284)
T ss_pred CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc--c-c
Confidence 456788999999877556789999999999999999998885 55555566666666555443322211110000 0 0
Q ss_pred hCCCCC-CCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 281 MLPQFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 281 ~~~~~~-~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
...... ...+....+.+++++.++|++||+.||.+|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000000 011123345678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=336.43 Aligned_cols=256 Identities=22% Similarity=0.371 Sum_probs=209.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
.+++.||+|+||.||++.++.+++.||||++.+.. ........+..|+.++++++||||+++++.+... ..+|+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~~l 78 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-----QYLYL 78 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-----CeeEE
Confidence 37899999999999999999999999999986532 2233456778899999999999999999999654 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC---
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--- 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--- 197 (375)
||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 79 IMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999996 6999999988889999999999999999999999999999999999999999999999999885221100
Q ss_pred ---------------------------------------------ccccccccccccCchhcccCCCCCccchhHHHHHH
Q 017231 198 ---------------------------------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCI 232 (375)
Q Consensus 198 ---------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i 232 (375)
......||+.|+|||++.+ ..++.++|||||||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvi 237 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLGAI 237 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecchh
Confidence 0012468999999999987 678999999999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcC
Q 017231 233 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFD 312 (375)
Q Consensus 233 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~d 312 (375)
+|+|++|..||...+.......+......... .....+++++.++|.+||. +
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------------------------p~~~~~s~~~~dli~~lL~-~ 289 (377)
T cd05629 238 MFECLIGWPPFCSENSHETYRKIINWRETLYF---------------------------PDDIHLSVEAEDLIRRLIT-N 289 (377)
T ss_pred hhhhhcCCCCCCCCCHHHHHHHHHccCCccCC---------------------------CCCCCCCHHHHHHHHHHhc-C
Confidence 99999999999887765555554432111100 0012468899999999998 6
Q ss_pred CCCC---CCHHHHhcCCCCCCCC
Q 017231 313 PNRR---ITVDEALCHPYLAPLH 332 (375)
Q Consensus 313 P~~R---ps~~ell~~~~f~~~~ 332 (375)
|.+| +++.+++.||||+.+.
T Consensus 290 ~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 290 AENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred HhhcCCCCCHHHHhcCCCcCCCC
Confidence 6665 5999999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=328.06 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=209.8
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||+++++.+++.||+|++.+.. ........+..|..++..+ +||+|+++++++... ..+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence 46999999999999999999999999986542 2233445677888888876 799999999999654 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Ccccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~~ 201 (375)
||++ |+|...+.....+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+...... .....
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT 155 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccc
Confidence 9997 699999988888999999999999999999999999999999999999999999999999988653222 22334
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p------------------ 216 (321)
T cd05591 156 FCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP------------------ 216 (321)
T ss_pred cccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC------------------
Confidence 568999999999987 6789999999999999999999999998877666655543111100
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-------CHHHHhcCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-------TVDEALCHPYLAPL 331 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-------s~~ell~~~~f~~~ 331 (375)
..+++++.++|.+||+.||++|| +++++++||||..+
T Consensus 217 -------------~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 217 -------------VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred -------------CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 23578899999999999999999 99999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=331.05 Aligned_cols=251 Identities=25% Similarity=0.435 Sum_probs=210.3
Q ss_pred eeeccCCcceEEEEEEe---CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 45 IRPVGRGAYGIVCAAMN---SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++.||+|+||.||++.+ +.+|+.||+|++............+..|+.++++++||||+++++.+... +.+++
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-----GKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CEEEE
Confidence 36799999999999986 45789999999976433333445677899999999999999999998554 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Ccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFM 199 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~ 199 (375)
||||++ |+|.+++.....+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+...... ...
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~ 155 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCce
Confidence 999997 699999988888999999999999999999999999999999999999999999999999988654433 223
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.......
T Consensus 156 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~----------------- 217 (318)
T cd05582 156 YSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM----------------- 217 (318)
T ss_pred ecccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCC-----------------
Confidence 34678999999999987 678899999999999999999999998877655554443211110
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~ 332 (375)
...+++.+.++|++||+.||++||+ +.+++.|+||+.+.
T Consensus 218 --------------p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 218 --------------PQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred --------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 0246888999999999999999999 78899999998763
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=327.52 Aligned_cols=250 Identities=27% Similarity=0.429 Sum_probs=206.3
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||+|.+..+++.||+|++..... .......+..|..++..+ +||||+++++.+... ..+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-----EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CEEEEEE
Confidence 469999999999999999999999999875432 222344455666676654 799999999998544 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Ccccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~~ 201 (375)
||++ |+|.+++...+.+++..++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||++...... .....
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~ 155 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST 155 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcccc
Confidence 9996 699999988888999999999999999999999999999999999999999999999999988653322 23345
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------------- 215 (316)
T cd05592 156 FCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHF------------------- 215 (316)
T ss_pred ccCCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------------------
Confidence 678999999999987 678999999999999999999999998887665555443211100
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHH-HHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD-EALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~-ell~~~~f~~~~ 332 (375)
-..+++++.++|.+||+.||++||++. +++.||||..+.
T Consensus 216 ------------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 216 ------------PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred ------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 023578899999999999999999864 899999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=333.10 Aligned_cols=265 Identities=26% Similarity=0.368 Sum_probs=215.7
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
+++....+++++.||+|+||.||+++++.+++.||+|++.+.. ........+..|+.+++.++||||+++++++...
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-- 115 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-- 115 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC--
Confidence 4445555668999999999999999999999999999986532 2223345577899999999999999999988554
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..+++||||++ |+|.+++.. ..+++..+..++.||+.||.+||+.||+|+||||+||+++.++.++|+|||.+..
T Consensus 116 ---~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 116 ---KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred ---CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 56899999997 689988765 4689999999999999999999999999999999999999999999999999866
Q ss_pred cCCCC--ccccccccccccCchhcccC---CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 193 TSETD--FMTEYVVTRWYRAPELLLNC---SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 193 ~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
..... ......|++.|+|||++.+. ..++.++|||||||++|+|++|..||...+.......+........-
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~--- 268 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF--- 268 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCC---
Confidence 54332 22345789999999998652 24788999999999999999999999887766555555432111100
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCC--CCCHHHHhcCCCCCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH 332 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~ 332 (375)
.....+|.++.++|.+||+.+|.+ |++++++++||||+...
T Consensus 269 ------------------------~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 269 ------------------------PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred ------------------------CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 001246899999999999999988 99999999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=326.54 Aligned_cols=302 Identities=49% Similarity=0.912 Sum_probs=240.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.+.||.|++|.||++.+..+++.+++|.+............+..|+.+++++ +||||+++++++..... ...++|
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~---~~~~lv 87 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND---KDIYLV 87 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC---ceEEEE
Confidence 78999999999999999999999999998865444444556677899999999 99999999998865432 457999
Q ss_pred EeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-----
Q 017231 123 YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----- 197 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~----- 197 (375)
|||++++|.+++... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 88 ~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~ 166 (337)
T cd07852 88 FEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166 (337)
T ss_pred ecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccC
Confidence 999999999998775 78999999999999999999999999999999999999999999999999886543322
Q ss_pred -ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 198 -FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 198 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...........+....+................
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (337)
T cd07852 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAA 246 (337)
T ss_pred cchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHH
Confidence 1123456888999999876566789999999999999999999999888777777777666655444333222222222
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFE 349 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~ 349 (375)
..................+.++.++.++|.+||+.||++|||+.++++||||+.......++.....+++-+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (337)
T cd07852 247 TMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319 (337)
T ss_pred HhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc
Confidence 3333333333333344455689999999999999999999999999999999999888777766655554333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=326.72 Aligned_cols=250 Identities=26% Similarity=0.467 Sum_probs=208.4
Q ss_pred eeeccCCcceEEEEEEeC---CCCcEEEEEEecCcc--cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 45 IRPVGRGAYGIVCAAMNS---ETREEVAIKKIGNAF--DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
++.||+|+||.||++.+. .+++.||+|++.... ........+..|+.+++.++||||+++++.+... +.+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeE
Confidence 468999999999999864 478899999986532 1223345677899999999999999999998554 568
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-C
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-D 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~ 197 (375)
++||||++ ++|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++...... .
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999997 599999998888999999999999999999999999999999999999999999999999987643222 2
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
......|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 156 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~--------------- 219 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNL--------------- 219 (323)
T ss_pred cccccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---------------
Confidence 2334568999999999987 678899999999999999999999998877655554443211100
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPL 331 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~ 331 (375)
.+.+++.+.++|.+||+.||++|| +++++++||||...
T Consensus 220 ----------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 220 ----------------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 124688899999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.24 Aligned_cols=250 Identities=22% Similarity=0.411 Sum_probs=205.3
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||++.++.+++.||+|++.+... .......+..|..++.++ +||+|+.+++++... ..+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-----SRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-----CEEEEEE
Confidence 469999999999999999999999999976432 233456678899999888 699999999998544 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC-CCCcccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETDFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~-~~~~~~~ 201 (375)
||++ |+|..++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.... .......
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST 155 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceec
Confidence 9997 6999999888889999999999999999999999999999999999999999999999999886432 2223345
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh------H-HHHHHHHHhCCCCcccccccccch
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV------H-QLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...... . ....+.. ..
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---~~------------ 219 (327)
T cd05617 156 FCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---KP------------ 219 (327)
T ss_pred ccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---CC------------
Confidence 678999999999987 77899999999999999999999999643211 1 1111111 00
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC------HHHHhcCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT------VDEALCHPYLAPLH 332 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps------~~ell~~~~f~~~~ 332 (375)
...-..++..+.++|.+||+.||.+|++ ++++++||||+.+.
T Consensus 220 ----------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 220 ----------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 0001246888999999999999999998 57999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=327.57 Aligned_cols=250 Identities=25% Similarity=0.442 Sum_probs=206.5
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHH-HHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIK-LLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||+||+++++.+|+.||+|++..... .......+..|.. +++.++||||+++++.+... ...++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-----~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-----DKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-----CEEEEEE
Confidence 469999999999999999999999999865321 2223344455544 56778999999999988544 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCcccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~ 201 (375)
||+. |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST 155 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcccc
Confidence 9997 69999999888899999999999999999999999999999999999999999999999998865322 223344
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+.....
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------------------- 213 (323)
T cd05575 156 FCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL--------------------- 213 (323)
T ss_pred ccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---------------------
Confidence 578999999999987 6789999999999999999999999988776555544432110
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH----HHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV----DEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f~~~~ 332 (375)
...+.+++.+.++|.+||+.||.+||++ .++++||||..+.
T Consensus 214 ----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 214 ----------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred ----------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 0113568899999999999999999988 6999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=330.32 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=212.7
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
.+++.||+|+||.||++.++.+++.||+|++..... .......+..|+.+++.++|+||+++++.+... ...++
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-----~~~~l 78 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-----DNLYL 78 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeEEE
Confidence 479999999999999999999999999999976432 233455678899999999999999999988544 56899
Q ss_pred EEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-
Q 017231 122 VYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF- 198 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~- 198 (375)
||||++ |+|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 999996 6999999876 6799999999999999999999999999999999999999999999999999876543322
Q ss_pred -cccccccccccCchhccc-----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 199 -MTEYVVTRWYRAPELLLN-----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 199 -~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
.....+++.|+|||++.. ...++.++|||||||++|+|++|..||...........+........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~--------- 229 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK--------- 229 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC---------
Confidence 223467899999999863 24577899999999999999999999988776655555443211100
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
....+.+++++.++|++||. +|.+||+++++++||||+.+.
T Consensus 230 ------------------~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 230 ------------------FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 00113468899999999998 999999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=319.59 Aligned_cols=257 Identities=33% Similarity=0.554 Sum_probs=212.7
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|++|+||++.++.+++.||+|++...............|+.++++++||||+++++++... ...+++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~v 76 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-----NYLYIV 76 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-----SEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-----cccccc
Confidence 379999999999999999999999999999987755555555556799999999999999999999653 668999
Q ss_pred EeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc-CCCCccc
Q 017231 123 YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT-SETDFMT 200 (375)
Q Consensus 123 ~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~-~~~~~~~ 200 (375)
||++++ +|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+... .......
T Consensus 77 ~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 77 MEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp EEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999986 99999998888999999999999999999999999999999999999999999999999998653 3333445
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||++......+.++|+||||+++++|++|..||...........+..............
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ----------- 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS-----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc-----------
Confidence 667789999999988337899999999999999999999999988744444433333222111110000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....++++.++|.+||+.||++||+++++++||||
T Consensus 226 -------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 226 -------------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -------------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 01123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=318.07 Aligned_cols=281 Identities=32% Similarity=0.642 Sum_probs=214.9
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|++|.||++.++.+++.|++|++..........+.+..|+.++++++|+|++++++++... ...+++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~v 78 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-----RKLHLV 78 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-----CEEEEE
Confidence 368999999999999999999999999999865433333445678999999999999999999998554 568999
Q ss_pred EeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-ccc
Q 017231 123 YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMT 200 (375)
Q Consensus 123 ~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~ 200 (375)
|||+++ .|..++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 999986 555555566679999999999999999999999999999999999999999999999999987654432 222
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+....+....+.........+..........
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 34567889999998765567899999999999999999999998877666655555544433221111110000000000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..............+.++..+.++|.+||+.||++||++.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000000011112235678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=326.12 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=207.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHH---HhcCCCCeeeeceeecCCCCCCcCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLL---RHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l---~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
++++.||+|++|.||++.++.+++.||||++.+.. ......+.+..|..++ +.++||||+++++++... ..
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-----~~ 76 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-----DH 76 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-----CE
Confidence 36899999999999999999999999999996542 2223345566666655 456799999999998554 56
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-C
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-T 196 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~ 196 (375)
.|+||||++ ++|...+.. +.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++..... .
T Consensus 77 ~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 77 VCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 899999997 588777654 5699999999999999999999999999999999999999999999999998764322 2
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
.......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~-------------- 220 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRY-------------- 220 (324)
T ss_pred CcccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------
Confidence 22345678999999999987 678999999999999999999999998887666555443311110
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
...+++.+.++|.+||+.||.+|| ++.++++||||+++.
T Consensus 221 -----------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 221 -----------------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred -----------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 024688899999999999999999 799999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=325.00 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=207.1
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||++.++.+++.||+|++..... ..........|..++..+ .||+++++++.+... +.+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-----EHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-----CEEEEEE
Confidence 469999999999999999999999999865421 122344566777777755 899999999998554 6689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCcccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~ 201 (375)
||+. |+|.+++.....+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+..... ......
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST 155 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceec
Confidence 9997 69999998888899999999999999999999999999999999999999999999999998764322 222345
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~------------------ 216 (316)
T cd05620 156 FCGTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP------------------ 216 (316)
T ss_pred cCCCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------------
Confidence 678999999999987 6789999999999999999999999988776655544432111000
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH-HHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV-DEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~-~ell~~~~f~~~~ 332 (375)
..++.++.++|.+||+.||++||++ +++++||||+.+.
T Consensus 217 -------------~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 217 -------------RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred -------------CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 1357889999999999999999998 5899999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=318.61 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=209.9
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++.+.||+|+||.||++.+..+++.||+|++..... .......+.+|+.+++.++|+||+++++.+... ..+++
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 77 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-----DALCL 77 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-----CeEEE
Confidence 368999999999999999999999999999865322 222334567899999999999999999998554 56899
Q ss_pred EEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 122 VYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
||||++ |+|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999997 6898887653 4599999999999999999999999999999999999999999999999999876544433
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....++..|+|||++.+ ..++.++||||+||++|+|++|..||.+.........+.........
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------- 222 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE-------------- 222 (285)
T ss_pred cccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccc--------------
Confidence 344578899999999987 67899999999999999999999999876654433333222111100
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPL 331 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~ 331 (375)
.....+++.+.++|.+||+.||.+|| +++++++||||+..
T Consensus 223 -------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 223 -------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred -------------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 00124688899999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=328.21 Aligned_cols=258 Identities=22% Similarity=0.367 Sum_probs=206.7
Q ss_pred CCeeeccCCcceEEEEEEeC---CCCcEEEEEEecCcc--cchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNS---ETREEVAIKKIGNAF--DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 116 (375)
++++.||+|+||.||++++. .+++.||+|++.+.. ......+.+..|+.+++.+ +|++|+++++.+...
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----- 77 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE----- 77 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC-----
Confidence 47999999999999999864 478899999986532 1223345678899999999 599999999988544
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
+.+++||||++ |+|.+++.....+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 78 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 78 AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 56899999997 69999998888899999999999999999999999999999999999999999999999999865432
Q ss_pred CC--ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 196 TD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 196 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
.. ......||..|+|||++.+...++.++|||||||++|+|++|..||...........+.........
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------- 228 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP--------- 228 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 21 2234568999999999987456788999999999999999999999654322111111111100000
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
.....+++.+.++|.+||+.||++|| +++++++||||+...
T Consensus 229 ------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 229 ------------------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred ------------------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 00124688899999999999999999 889999999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=332.45 Aligned_cols=257 Identities=23% Similarity=0.398 Sum_probs=212.0
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||.||+++++.+++.||+|++.... ........+..|+.++..++|++++++++.+... ..++
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-----~~~~ 77 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-----RNLY 77 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEEE
Confidence 347899999999999999999999999999986532 2233456778899999999999999999998544 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-- 197 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-- 197 (375)
+||||++ |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 9999997 6999999988889999999999999999999999999999999999999999999999999875432110
Q ss_pred ----------------------------------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCC
Q 017231 198 ----------------------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 243 (375)
Q Consensus 198 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 243 (375)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCCC
Confidence 0113468999999999987 77899999999999999999999999
Q ss_pred CCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC---CHH
Q 017231 244 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVD 320 (375)
Q Consensus 244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~ 320 (375)
...+.......+........- .....++++++++|.+|+. ||.+|+ +++
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~---------------------------p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ 288 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVF---------------------------PPEVPISEKAKDLILRFCT-DSENRIGSNGVE 288 (360)
T ss_pred CCCCHHHHHHHHHcCCCceec---------------------------CCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHH
Confidence 887766655555432111100 0012368889999999875 999998 479
Q ss_pred HHhcCCCCCCCC
Q 017231 321 EALCHPYLAPLH 332 (375)
Q Consensus 321 ell~~~~f~~~~ 332 (375)
++++||||++++
T Consensus 289 ei~~hp~f~~~~ 300 (360)
T cd05627 289 EIKSHPFFEGVD 300 (360)
T ss_pred HHhcCCCCCCCC
Confidence 999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=329.98 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=216.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
..+.||+|.||.||+|.+..+++.||||++..+. .....+.+.+|+.+|.+++++||.++|+.|... ..++++|
T Consensus 17 ~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~LwiiM 90 (467)
T KOG0201|consen 17 KLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKLWIIM 90 (467)
T ss_pred cchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccHHHHH
Confidence 4689999999999999999999999999996543 334567888999999999999999999999776 5589999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
|||+ |++.++++..+.+.+..+..++++++.|+.|||..+.+|+|||+.||++..+|.++|+|||.+....... ...+
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 9997 6999999998888999999999999999999999999999999999999999999999999887655543 3478
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
+.||+.|||||++.. ..|+.++||||||++.+||++|.+|+........+-.|.+
T Consensus 171 fvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk------------------------ 225 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK------------------------ 225 (467)
T ss_pred ccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC------------------------
Confidence 899999999999996 8899999999999999999999999977664332222111
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
...-.+. .+.|+.+++||..||+.||+.||+|.+||+|+|++...
T Consensus 226 ---~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 226 ---SAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred ---CCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 1110111 25689999999999999999999999999999999843
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=316.86 Aligned_cols=279 Identities=41% Similarity=0.734 Sum_probs=221.5
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||.|++|.||++.++.+++.|+||.+............+..|++++++++|||++++++++... ...+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v 77 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLYLV 77 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEEEE
Confidence 478999999999999999999999999999865443343446788999999999999999999998543 568999
Q ss_pred EeCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cc
Q 017231 123 YELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
|||+.++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 78 ~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 157 (284)
T cd07860 78 FEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157 (284)
T ss_pred eeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence 999988999988653 458999999999999999999999999999999999999999999999999886543322 12
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+.......+....+......+..... .....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 235 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--LPDYK 235 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH--HHHHH
Confidence 2334577899999987755568899999999999999999999988877666666666655544332221111 11111
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..........+....+.+++++.++|.+||+.||++||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 2222222333333345678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=316.65 Aligned_cols=252 Identities=25% Similarity=0.414 Sum_probs=202.8
Q ss_pred ccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCC
Q 017231 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 126 (375)
Q Consensus 48 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 126 (375)
||+|+||+||++.++.+++.||+|.+.... ........+..|+.+++.++|+|++++.+.+... ..+++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-----TDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-----CeEEEEEeCC
Confidence 799999999999999999999999986532 2222345677899999999999999999988544 5689999999
Q ss_pred C-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-ccc
Q 017231 127 D-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMT 200 (375)
Q Consensus 127 ~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~ 200 (375)
+ |+|.+.+.. +..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 155 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccc
Confidence 7 688877743 3569999999999999999999999999999999999999999999999999886544332 223
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+.......+
T Consensus 156 ~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------- 217 (280)
T cd05608 156 GYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS----------------- 217 (280)
T ss_pred ccCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-----------------
Confidence 4567899999999987 6789999999999999999999999976543222221111110000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
......+++.+.+++.+||+.||++|| +++++++||||+.+.
T Consensus 218 ----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 218 ----------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred ----------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 001134688999999999999999999 889999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=324.41 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=212.1
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.+++.||+|+||.||+++++.+++.||+|++.+... .......+..|..++..+ +|++++++++++... ..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~ 77 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DRLY 77 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CEEE
Confidence 478999999999999999999999999999875432 222344566788888777 589999999988544 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cc
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DF 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~ 198 (375)
+||||++ |+|.+.+...+.+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++...... ..
T Consensus 78 lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 78 FVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 9999997 699999988888999999999999999999999999999999999999999999999999988653322 22
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.......+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p--------------- 221 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP--------------- 221 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 345678999999999987 7789999999999999999999999998877666655544211111
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH-----HHHhcCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH 332 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~ 332 (375)
..+++++.++|.+||+.||++|++. .++++|+||+.++
T Consensus 222 ----------------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 222 ----------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred ----------------CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 2468889999999999999999984 8999999999775
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=311.64 Aligned_cols=300 Identities=25% Similarity=0.379 Sum_probs=254.2
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
+-.+.-..+..++.||+|.||+|-+++.+.+++.||||+++++. -..........|-++|...+||.+..+-..|...
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~- 240 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ- 240 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC-
Confidence 34455666777999999999999999999999999999998764 4555677788999999999999999988888444
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
+.+|+||||+. |.|.-.+.+...+++...+.+...|+.||.|||+.+|+++|||.+|.++|++|++||.|||+++
T Consensus 241 ----drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCK 316 (516)
T KOG0690|consen 241 ----DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCK 316 (516)
T ss_pred ----ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccch
Confidence 67999999996 6999999888899999999999999999999999999999999999999999999999999987
Q ss_pred c-cCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 192 T-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 192 ~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
. +.......++|||+.|+|||++.. ..|+.++|+|.+|++||||++|+.||.+.+...+...|....-..|
T Consensus 317 E~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP------- 388 (516)
T KOG0690|consen 317 EEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP------- 388 (516)
T ss_pred hcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC-------
Confidence 5 444556788999999999999988 8899999999999999999999999999999998888776443332
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCCC-CCCCCCCCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLHD-INEEPVCPRPF 344 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~~-~~~~~~~~~~~ 344 (375)
..++++.+.++..+|..||.+|. .+.||.+|+||+.++= .....--+.+|
T Consensus 389 ------------------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPf 444 (516)
T KOG0690|consen 389 ------------------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPF 444 (516)
T ss_pred ------------------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCC
Confidence 24799999999999999999998 5789999999999862 22223344557
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 017231 345 SFDFEHPSFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (375)
+++.+.-. ...-+++....+++..+|
T Consensus 445 KPqVtSet-DTryFD~EFT~q~v~lTP 470 (516)
T KOG0690|consen 445 KPQVTSET-DTRYFDEEFTSQPVTLTP 470 (516)
T ss_pred CCCccccc-chhhhhhhhhcceeEecC
Confidence 77666543 233577777788887776
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=330.25 Aligned_cols=264 Identities=24% Similarity=0.345 Sum_probs=213.8
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
.++....+++++.||+|+||.||+++++.+++.||+|++.+.. ........+..|+.+++.++||||+++++.+...
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-- 115 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-- 115 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--
Confidence 4445555668999999999999999999999999999986532 2223345677899999999999999999998554
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..+++||||++ |+|.+++... .+++..+..++.||+.||.+||++||+||||||+||+++.++.++|+|||.+..
T Consensus 116 ---~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 116 ---KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred ---CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 56899999997 6999988654 589999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--ccccccccccccCchhcccCC---CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 193 TSETD--FMTEYVVTRWYRAPELLLNCS---EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 193 ~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
..... ......||+.|+|||++.+.. .++.++|+|||||++|+|++|..||...+.......+..........
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-- 269 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFP-- 269 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCC--
Confidence 54332 223567899999999987522 36789999999999999999999998877666655554322111100
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCC--CCCHHHHhcCCCCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPL 331 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~ 331 (375)
....++..++++|.+||..++.+ |+++.|+++||||+..
T Consensus 270 -------------------------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 270 -------------------------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred -------------------------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 01246888999999999865544 8999999999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=305.45 Aligned_cols=274 Identities=28% Similarity=0.452 Sum_probs=230.9
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPP 111 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 111 (375)
+...|..+|..--++||-|-.|.|..+.++.+++++|+|++.. ..+.++|++.--.. .|||||.++++|...
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs 127 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENS 127 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhh
Confidence 5566778887778999999999999999999999999999843 24456788776666 599999999998654
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC---CCEEEe
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIG 185 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~---~~i~l~ 185 (375)
- .+...+.+|||.++ |.|.+.++..+. +++.++..|++||+.|+.|||+.+|.||||||+|+|...+ ..+||+
T Consensus 128 ~-~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 128 Y-QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred c-cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 3 33366889999997 699999988766 9999999999999999999999999999999999999654 459999
Q ss_pred ecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh----hHHHHHHHHHhCC
Q 017231 186 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY----VHQLRLITELIGS 261 (375)
Q Consensus 186 Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~ 261 (375)
|||.++.........+.+.|++|.|||++.. ..++...|+||||++||-|++|.+||..... ..+.++|....-.
T Consensus 207 DfGFAK~t~~~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~ 285 (400)
T KOG0604|consen 207 DFGFAKETQEPGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYE 285 (400)
T ss_pred ccccccccCCCccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCcc
Confidence 9999998887777888999999999999877 6799999999999999999999999976643 3344455444444
Q ss_pred CCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCC
Q 017231 262 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCP 341 (375)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~ 341 (375)
++.+.| ..+|+..+++|+.+|..+|++|.|+.+++.|||+.+...+..-+.+.
T Consensus 286 FP~pEW---------------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t 338 (400)
T KOG0604|consen 286 FPEPEW---------------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLST 338 (400)
T ss_pred CCChhH---------------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchh
Confidence 444433 46799999999999999999999999999999999988777766644
Q ss_pred C
Q 017231 342 R 342 (375)
Q Consensus 342 ~ 342 (375)
+
T Consensus 339 ~ 339 (400)
T KOG0604|consen 339 S 339 (400)
T ss_pred h
Confidence 3
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=321.35 Aligned_cols=277 Identities=34% Similarity=0.600 Sum_probs=205.8
Q ss_pred eeeccCCcceEEEEEEeC--CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 45 IRPVGRGAYGIVCAAMNS--ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
.++||+|+||+||+|.++ .+++.||+|.+..... ...+.+|+.++++++||||+++++.+..... ..++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHAD---RKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCC---cEEEEE
Confidence 578999999999999966 4678899999865422 2346689999999999999999998865432 568999
Q ss_pred EeCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----ecCCCEEEeeccc
Q 017231 123 YELMDTDLHQIIRSH---------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCDLKIGDFGL 189 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~---------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli----~~~~~i~l~Df~~ 189 (375)
+||++++|.+++... ..+++..++.++.||+.||.|||+.|++|+||||+||++ +.++.++|+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999998887532 248999999999999999999999999999999999999 4567899999999
Q ss_pred ccccCCCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh---------hHHHHHHH
Q 017231 190 ARTTSETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY---------VHQLRLIT 256 (375)
Q Consensus 190 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~i~ 256 (375)
+....... ......+|+.|+|||++.+...++.++|||||||++|+|++|..||..... ...+..+.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 87644321 123456789999999998756689999999999999999999999965432 23455555
Q ss_pred HHhCCCCcccccccccch-----hHHHhhhCC-CCC-CCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 257 ELIGSPDETSLGFLRSDN-----ARRYVRMLP-QFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~-~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
...+.+....+....... ...+..... ... ...+.......+..+.++|++||+.||.+|||++|+|+||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 555544443332211100 000000000 000 000111112345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=317.83 Aligned_cols=283 Identities=38% Similarity=0.691 Sum_probs=221.7
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.+.||.|++|.||+|.++.+++.+++|.++...........+.+|+.++++++|||++++++++.... ....++
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~~l 83 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKIYM 83 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcEEE
Confidence 34789999999999999999999999999998755433333445678999999999999999999886542 256899
Q ss_pred EEeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Ccc
Q 017231 122 VYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFM 199 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~ 199 (375)
++||++++|.+++.... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 163 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence 99999999999987654 4999999999999999999999999999999999999999999999999988765543 223
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+....+.+....+..+........
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 242 (293)
T cd07843 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK- 242 (293)
T ss_pred ccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc-
Confidence 3445678899999987755678999999999999999999999998887777777776665544433322111000000
Q ss_pred hhCCCCCCCCccccCCC--CCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 280 RMLPQFPKQNFSARFPN--KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~--~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..........+...++. +++.+.++|++||+.||++|||+.|++.|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 00001111112222333 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=314.48 Aligned_cols=281 Identities=38% Similarity=0.683 Sum_probs=223.1
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++.+.||.|++|.||+|.+..++..|++|++............+..|+.++++++|||++++++++... ...++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~v 77 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-----SGFVLV 77 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-----CeeEEE
Confidence 378999999999999999999999999999876544444566788999999999999999999998653 568999
Q ss_pred EeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--cc
Q 017231 123 YELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FM 199 (375)
Q Consensus 123 ~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--~~ 199 (375)
+||++++|.+++.. ...+++.+++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 78 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 78 MEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred ecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 99997799999865 4569999999999999999999999999999999999999999999999999887654432 13
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+...++.++||||||+++++|++|.+||...........+....+.+....+...........
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK- 236 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc-
Confidence 3456788899999987656678999999999999999999999988777777776666655544332222111100000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
..........+....+..+..+.++|++||+.||++||+++++++||||.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00011111112233456788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=327.66 Aligned_cols=250 Identities=24% Similarity=0.412 Sum_probs=205.0
Q ss_pred ccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhc---CCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 48 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
||+|+||+||+++++.+++.||+|++.+.. ...........|..++..+ .||+|+++++.+... ..+++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence 799999999999999999999999986432 2222334455666776655 699999999998554 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCcccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~ 201 (375)
||+. |+|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++..... ......
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~ 155 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT 155 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccC
Confidence 9997 69999999888899999999999999999999999999999999999999999999999998865322 223345
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..|+..|+|||++.+...++.++|||||||++|+|++|..||...+.......+.......+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------ 217 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFP------------------ 217 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCC------------------
Confidence 67899999999987655689999999999999999999999988776555544432111100
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC----CHHHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI----TVDEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp----s~~ell~~~~f~~~~ 332 (375)
...+++++.++|++||+.||.+|| ++.++++||||+...
T Consensus 218 ------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 218 ------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred ------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 023588899999999999999998 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=321.81 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=206.8
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||+++++.+++.||+|++..... ..........|..++..+ +||||+++++.+... ..+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence 469999999999999999999999999865421 122334566677777764 899999999998554 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Ccccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~~ 201 (375)
||++ |+|.+++.....+++..+..++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++...... .....
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT 155 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceee
Confidence 9997 699999988888999999999999999999999999999999999999999999999999988643222 22344
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......+
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~------------------ 216 (316)
T cd05619 156 FCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP------------------ 216 (316)
T ss_pred ecCCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC------------------
Confidence 568999999999987 6789999999999999999999999988776555544432110000
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHH-HHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD-EALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~-ell~~~~f~~~~ 332 (375)
..++.++.++|.+||+.||++||++. ++++||||+.+.
T Consensus 217 -------------~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 217 -------------RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred -------------ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 13578899999999999999999996 999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=324.81 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=217.8
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
-..|++.++.+++++.||+|.||.||++..+.+ ..||+|.++.. .-..+.|.+|+++|++|+|++||++++++...
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQ 273 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecC
Confidence 467999999999999999999999999988764 58999988653 22345678999999999999999999999654
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
..++||||||. |+|.++++. ...+...+...++.|||+|++||++++++||||...||||+.+..+||+|||
T Consensus 274 -----~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 274 -----EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred -----CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccc
Confidence 45899999997 999999987 4569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccc--cccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 189 LARTTSETDFMTEY--VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 189 ~~~~~~~~~~~~~~--~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
+++......+.... .....|.|||++.. ..++.+|||||||++||||+| |+.||.+....+.+..+.+...-+.+
T Consensus 349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P- 426 (468)
T KOG0197|consen 349 LARLIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP- 426 (468)
T ss_pred cccccCCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC-
Confidence 99966655443332 33566999999988 779999999999999999998 99999999988888777664332211
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
+.+++++-+++..||..+|++|||++.+..
T Consensus 427 -----------------------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 427 -----------------------------EGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred -----------------------------CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 357999999999999999999999997654
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=316.13 Aligned_cols=285 Identities=41% Similarity=0.686 Sum_probs=222.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc---hHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN---RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++.||.|++|.||++.++.+++.|++|.+...... ......+..|+.++++++|+|++++++++... ...+
T Consensus 4 ~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 78 (298)
T cd07841 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-----SNIN 78 (298)
T ss_pred eeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-----CEEE
Confidence 578999999999999999999999999999765332 22345567899999999999999999998653 5689
Q ss_pred EEEeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 121 IVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
+||||+.++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 999999889999998776 79999999999999999999999999999999999999999999999999887654432 2
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....++..|+|||.+.+...++.++|+|||||++|+|++|..||...+.......+....+.+....+....... .+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 236 (298)
T cd07841 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP--DY 236 (298)
T ss_pred ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc--cc
Confidence 2233457789999998765667899999999999999999988888777666666665544433322221110000 00
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
. .................+..+.++|.+||+.||++|||+.|++.|+||++......
T Consensus 237 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 237 V-EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred c-cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 0 00011111222334566889999999999999999999999999999998766554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=322.11 Aligned_cols=286 Identities=21% Similarity=0.333 Sum_probs=215.5
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
+..+.+++.++||.|+||.||++.++.++..+++|.+.... .......+.+|++++++++|+||+++++++...
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 75 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD----- 75 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----
Confidence 34455668999999999999999999999999999886543 233456788999999999999999999998654
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
+.+++||||+. ++|.+++...+.+++..+..++.+++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 76 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 56899999996 69999999888899999999999999999999975 79999999999999999999999999886543
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhC-CCCccccccccc-
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG-SPDETSLGFLRS- 272 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~- 272 (375)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+..... ............
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 156 DS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred hh-ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 22 2234567889999999987 6788999999999999999999999987654433322211110 000000000000
Q ss_pred ---------------chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 273 ---------------DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 273 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.............. ........++.+++++|.+||+.||++|||+.|++.|+||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEP--PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCC--CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000000000000 00001123578899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=311.90 Aligned_cols=279 Identities=42% Similarity=0.748 Sum_probs=221.6
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||.|++|.||++.++.+|..|++|++............+..|+.+++.++|+|++++++++... ...+++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~iv 76 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYLV 76 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEEE
Confidence 478999999999999999999999999999865543333445678899999999999999999998654 568999
Q ss_pred EeCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cc
Q 017231 123 YELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
+||++++|.+++.... .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 77 FEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred EeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 9999989999998766 69999999999999999999999999999999999999999999999999986543321 11
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+.......+....+.+....+..... ...+.
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 234 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS--LPDYK 234 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh--chhhh
Confidence 2234578899999887645678899999999999999999999988776666666666555444332221111 11112
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
...............+.++..+.++|.+||+.||.+||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 2222222222333346788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=312.13 Aligned_cols=279 Identities=35% Similarity=0.660 Sum_probs=217.5
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++++.||+|++|.||++.++.+++.||+|.+......... .....|+.++.++. |+|++++++++..... +.+++
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~~~~l 77 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKT---GRLAL 77 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCC---CcEEE
Confidence 3689999999999999999999999999998764333322 23457888888885 9999999999865421 46899
Q ss_pred EEeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 122 VYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
|+||++++|.+.+... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++. +.++|+|||.+..........
T Consensus 78 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~ 156 (282)
T cd07831 78 VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYT 156 (282)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcC
Confidence 9999999999988764 56899999999999999999999999999999999999999 999999999987665444444
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||.+.....++.++|+|||||++|+|++|..||...+..+....+....+.................+
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (282)
T cd07831 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY-- 234 (282)
T ss_pred CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc--
Confidence 456788899999876545678899999999999999999999998887777777777666554432111111100000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..+...........+.++.++.++|.+||+.+|++||+++++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 000000111111224568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.56 Aligned_cols=276 Identities=26% Similarity=0.325 Sum_probs=206.4
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++++.||+|++|.||++.+..++..||+|+.... ....|+.++++++|+||+++++++... ...++
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 134 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSG-----AITCM 134 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeC-----CeeEE
Confidence 45899999999999999999999999999985332 124689999999999999999998654 45799
Q ss_pred EEeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 122 VYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 122 v~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
|+|++.++|.+++.. ...+++..++.|+.||+.||.+||++||+|+||||+||+++.++.++|+|||.+..........
T Consensus 135 v~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 135 VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 999999999998865 4569999999999999999999999999999999999999999999999999987544433334
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCC-CCCCCh---------hHHHHHHHHHhCCCCccccccc
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPGKDY---------VHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p-f~~~~~---------~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
...|+..|+|||++.+ ..++.++|||||||++|+|+++..+ |..... ...+..+....+..+.......
T Consensus 215 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 293 (357)
T PHA03209 215 GLAGTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDP 293 (357)
T ss_pred cccccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCC
Confidence 5668999999999987 6789999999999999999985444 443221 1122222232222221111111
Q ss_pred ccchhHHHhhhCCCC--CC-CCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 271 RSDNARRYVRMLPQF--PK-QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~--~~-~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.......+....... +. .........++.++.++|.+||+.||.+|||+.|+|+||||+++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 294 GSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred ccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 111112222111110 00 00111123567888999999999999999999999999999864
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=319.87 Aligned_cols=297 Identities=43% Similarity=0.770 Sum_probs=220.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC---------
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE--------- 114 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--------- 114 (375)
+++.||.|++|.||++.++.+++.|++|.+..... .....+.+|+.++++++|||++++++.+......
T Consensus 9 ~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 9 DLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred EEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 69999999999999999999999999999855432 3456678899999999999999999887654311
Q ss_pred CcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-CCCEEEeeccccccc
Q 017231 115 TFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTT 193 (375)
Q Consensus 115 ~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-~~~i~l~Df~~~~~~ 193 (375)
.....++++||++++|.+++.. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 87 ~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~ 165 (342)
T cd07854 87 ELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165 (342)
T ss_pred ccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceec
Confidence 1235799999999999888864 46999999999999999999999999999999999999974 557899999988654
Q ss_pred CCCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 194 SETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 194 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
.... ......++..|+|||.+.....++.++|||||||++|+|++|..||...+.......+..............
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (342)
T cd07854 166 DPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNE 245 (342)
T ss_pred CCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 3221 112235678899999876546688899999999999999999999988776555554443322211111110
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPF 344 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~ 344 (375)
...... ..................+.++.++.++|.+||+.||.+|||+.+++.||||+.+....+.++...+|
T Consensus 246 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~ 319 (342)
T cd07854 246 LLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPF 319 (342)
T ss_pred hhhhhh-hhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCccccCCCCCc
Confidence 000000 00000001111112223356788999999999999999999999999999999876666555543344
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=320.89 Aligned_cols=250 Identities=24% Similarity=0.432 Sum_probs=204.5
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHH-HHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIK-LLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||+++++.+++.||+|++.+... .......+..|.. +++.++||||+++++.+... ...++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEE
Confidence 469999999999999999999999999865421 2222334445544 67888999999999988554 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCcccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~ 201 (375)
||++ ++|...+...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~ 155 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST 155 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcccc
Confidence 9997 69999998888899999999999999999999999999999999999999999999999998865322 222344
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-------------------- 214 (321)
T cd05603 156 FCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQ-------------------- 214 (321)
T ss_pred ccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCC--------------------
Confidence 568999999999987 67899999999999999999999999887755554443321100
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH----HHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV----DEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f~~~~ 332 (375)
..+..+..+.++|.+||+.||.+||++ .++++|+||..+.
T Consensus 215 -----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 215 -----------LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred -----------CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 013457789999999999999999976 5999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.18 Aligned_cols=250 Identities=24% Similarity=0.447 Sum_probs=205.6
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHH-HHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREI-KLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||+||++.++.+++.||+|++..... .......+..|. .+++.++|+||+++++.+... +.+++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEE
Confidence 469999999999999999999999999865321 112223344444 456788999999999998554 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCcccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~ 201 (375)
||++ |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~ 155 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST 155 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCccc
Confidence 9997 59999998888899999999999999999999999999999999999999999999999998864322 223345
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..|++.|+|||++.+ ..++.++|||||||++|+|++|..||...+..+....+......
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~-------------------- 214 (325)
T cd05602 156 FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ-------------------- 214 (325)
T ss_pred ccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcC--------------------
Confidence 678999999999987 77899999999999999999999999887766655544331110
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHH----HHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD----EALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~----ell~~~~f~~~~ 332 (375)
..+.+++.+.++|.+||+.||.+|+++. ++++|+||..+.
T Consensus 215 -----------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~ 258 (325)
T cd05602 215 -----------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPIN 258 (325)
T ss_pred -----------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence 1135788999999999999999999876 899999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=322.17 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=205.9
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHH-HHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIK-LLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||+||++.++.+|+.||+|++.+.. ........+..|.. +++.++||||+++++.+... +..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-----EKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-----CEEEEEE
Confidence 46999999999999999999999999986542 22223344555554 56778999999999988554 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CCcccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~ 201 (375)
||++ |+|...+.....+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++..... ......
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 155 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCccc
Confidence 9997 69999998888999999999999999999999999999999999999999999999999998864322 223345
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..|+..|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.....
T Consensus 156 ~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~--------------------- 213 (325)
T cd05604 156 FCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL--------------------- 213 (325)
T ss_pred ccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---------------------
Confidence 678999999999987 6789999999999999999999999988776555544432110
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH----HHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV----DEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f~~~~ 332 (375)
...+..+..+.++|++||+.||.+||++ .+++.||||....
T Consensus 214 ----------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 214 ----------VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred ----------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 0113568889999999999999999977 5999999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=325.69 Aligned_cols=265 Identities=24% Similarity=0.331 Sum_probs=213.5
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
.++....+++++.||+|+||.||+++++.+++.||+|++.+.. ........+.+|+.+++.++||||+++++.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-- 115 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-- 115 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC--
Confidence 4444555668999999999999999999999999999986432 2233345577899999999999999999998544
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..+++||||++ |+|.+++.. ..+++..++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||.+..
T Consensus 116 ---~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 116 ---RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred ---CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 56899999997 689888865 4589999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC--ccccccccccccCchhcccCC---CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 193 TSETD--FMTEYVVTRWYRAPELLLNCS---EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 193 ~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
..... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||...+.......+........-
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--- 268 (371)
T cd05622 192 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--- 268 (371)
T ss_pred cCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccC---
Confidence 54332 223567899999999987522 3788999999999999999999999888766666555442211110
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCC--CCCHHHHhcCCCCCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH 332 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~ 332 (375)
.....++..++++|.+||..++.+ |++++++++|+||++..
T Consensus 269 ------------------------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 269 ------------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred ------------------------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 011357889999999999844443 78999999999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=312.44 Aligned_cols=284 Identities=38% Similarity=0.672 Sum_probs=218.5
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++.+.||.|++|.||++.+..+++.||+|.+............+..|+.+++.+. |+|++++++++...........++
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~l 83 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYL 83 (295)
T ss_pred eEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEE
Confidence 3689999999999999999999999999998655433334456788999999995 699999999887654333345899
Q ss_pred EEeCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-CCCEEEeecccccccCC
Q 017231 122 VYELMDTDLHQIIRSH-----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSE 195 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-~~~i~l~Df~~~~~~~~ 195 (375)
+|||++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.++|+|||.+.....
T Consensus 84 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~ 163 (295)
T cd07837 84 VFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI 163 (295)
T ss_pred EeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCC
Confidence 9999999999988653 34899999999999999999999999999999999999998 88999999998865432
Q ss_pred C-CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 196 T-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 196 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
. .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+.+....+.......
T Consensus 164 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T cd07837 164 PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLR 243 (295)
T ss_pred CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhcc
Confidence 2 111223457789999998764667899999999999999999999998877666666665555443332221110000
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
.+. .........+....+.+++++.++|.+||..||.+||+++|++.||||+
T Consensus 244 --~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 244 --DWH-EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred --chh-hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 0111112222233356789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=311.26 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=202.0
Q ss_pred ccCCcceEEEEEEeCCCCcEEEEEEecCcccc-hHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCC
Q 017231 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 126 (375)
Q Consensus 48 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 126 (375)
||+|+||.||++.++.+|+.||+|.+...... ......+..|++++++++||||+++++.+... ..+++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-----~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-----THLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-----CeEEEEEecC
Confidence 79999999999999999999999998643221 12233456799999999999999999988543 5689999999
Q ss_pred C-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccccc
Q 017231 127 D-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 203 (375)
Q Consensus 127 ~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~ 203 (375)
+ ++|.+++.... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.............
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence 7 68988886543 58999999999999999999999999999999999999999999999999887655443334456
Q ss_pred ccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCC
Q 017231 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 283 (375)
Q Consensus 204 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (375)
++..|+|||++.+ ..++.++|+|||||++|+|++|..||...........+.......
T Consensus 156 ~~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 213 (277)
T cd05607 156 GTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED--------------------- 213 (277)
T ss_pred CCCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc---------------------
Confidence 7889999999987 568999999999999999999999997654322211111110000
Q ss_pred CCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH----HHHhcCCCCCCCC
Q 017231 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV----DEALCHPYLAPLH 332 (375)
Q Consensus 284 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f~~~~ 332 (375)
........+++++.++|.+||+.||++||++ ++++.|+||+.+.
T Consensus 214 -----~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 214 -----EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred -----ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 0000112468899999999999999999999 6788999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=318.72 Aligned_cols=290 Identities=37% Similarity=0.623 Sum_probs=227.1
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHH------------HHHHHHHHHHHHhcCCCCee
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRID------------AKRTLREIKLLRHMDHENII 102 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~------------~~~~~~e~~~l~~l~h~~iv 102 (375)
+.+.++|..+.+.||.|++|+||++.++.+++.||+|.+......... ...+.+|+.++++++|+|++
T Consensus 4 ~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 83 (335)
T PTZ00024 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIM 83 (335)
T ss_pred cccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCccee
Confidence 345566665788899999999999999999999999998654222100 12467899999999999999
Q ss_pred eeceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCE
Q 017231 103 AIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 182 (375)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i 182 (375)
++++++... ...+++|||++|+|.+++.....+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.+
T Consensus 84 ~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 84 GLVDVYVEG-----DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred eeeEEEecC-----CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 999998544 568999999999999999888889999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCC---------------CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC
Q 017231 183 KIGDFGLARTTSET---------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 247 (375)
Q Consensus 183 ~l~Df~~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 247 (375)
+|+|||.+...... .......++..|+|||.+.+...++.++|+|||||++|+|++|..||...+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999988654411 111223457789999998775567899999999999999999999999888
Q ss_pred hhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCC
Q 017231 248 YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327 (375)
Q Consensus 248 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~ 327 (375)
....+..+....+.+....+....... .+. .................+.++.++|.+||+.+|++||+++++|.|||
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLP--LYT-EFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcc--ccc-ccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 877777777776665543322110000 000 00001111222233456888999999999999999999999999999
Q ss_pred CCCCC
Q 017231 328 LAPLH 332 (375)
Q Consensus 328 f~~~~ 332 (375)
|+...
T Consensus 316 ~~~~~ 320 (335)
T PTZ00024 316 FKSDP 320 (335)
T ss_pred cCCCC
Confidence 99653
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=311.77 Aligned_cols=283 Identities=40% Similarity=0.736 Sum_probs=221.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||.|++|.||++.++.+++.|++|.+............+..|+.++++++|+|++++++++... ...++||
T Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 80 (294)
T PLN00009 6 KVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-----KRLYLVF 80 (294)
T ss_pred EEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-----CeEEEEE
Confidence 68999999999999999999999999999866543334456678899999999999999999998654 5689999
Q ss_pred eCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-CCCEEEeecccccccCCCC-cc
Q 017231 124 ELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 124 e~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
||++++|.+++..... +++..++.++.||+.||.+||++|++|+||+|+||+++. ++.++|+|||.+....... ..
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 9999899988876544 578899999999999999999999999999999999985 4579999999886543321 12
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+.+....+...... ..+.
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 238 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL--PDYK 238 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc--hhhh
Confidence 23356788999999876556789999999999999999999999887766666666655555444333221111 1111
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
......+........+.+++++.++|.+||+.+|++||++.++++||||..+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 239 SAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred hhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 112222222222334567899999999999999999999999999999997654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=318.46 Aligned_cols=253 Identities=24% Similarity=0.384 Sum_probs=210.7
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
++.+.||+|+||.||+|.++.+++.||+|++.+... .......+..|..++..+. |++++++++++... ..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~~~ 77 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-----DRLY 77 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-----CEEE
Confidence 368899999999999999999999999999865421 2233456778888888885 57788888888544 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
+||||++ |+|.+++...+.+++.+++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 78 lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 9999997 6999999888889999999999999999999999999999999999999999999999999886533222 2
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....|++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.......+
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p--------------- 221 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP--------------- 221 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------------
Confidence 334568999999999987 6789999999999999999999999988876666655544211111
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH 332 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~ 332 (375)
..+++++.+++.+||+.+|.+|++ ..++++||||+.+.
T Consensus 222 ----------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 222 ----------------KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred ----------------ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 245788999999999999999997 57999999999874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=329.58 Aligned_cols=273 Identities=24% Similarity=0.308 Sum_probs=202.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|++|.||++.+..+++.||+|... ...+.+|++++++++|+||+++++++... +..+++|
T Consensus 173 i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~~lv~ 239 (461)
T PHA03211 173 IHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVG-----GLTCLVL 239 (461)
T ss_pred EEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEE
Confidence 6899999999999999999999999999642 12346899999999999999999988554 5579999
Q ss_pred eCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC---cc
Q 017231 124 ELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FM 199 (375)
Q Consensus 124 e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~ 199 (375)
+++.++|.+++... ..+++..++.|+.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 240 e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 240 PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred EccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 99999999988764 469999999999999999999999999999999999999999999999999986543321 12
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCC-CC------hhHHHHHHHHHhCCCCccccccccc
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG-KD------YVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~------~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
....||..|+|||++.+ ..++.++|||||||++|+|++|..++-. .. ....+..+.................
T Consensus 320 ~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred cccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 23568999999999988 6789999999999999999998765422 11 1222333322222111100000000
Q ss_pred chhHHHhhhCC--CCCC--CCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 273 DNARRYVRMLP--QFPK--QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 273 ~~~~~~~~~~~--~~~~--~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
.....+..... ..+. ......+..++..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00111111000 0000 0011122346778999999999999999999999999999975
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=325.73 Aligned_cols=281 Identities=24% Similarity=0.298 Sum_probs=212.9
Q ss_pred cccCCeeeccCCcceEEEEEEeC--CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNS--ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
..+++++.||.|++|.||++... .++..|++|.+... ....+|+.++++++||||+++++.+... .
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~-----~ 159 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWK-----S 159 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeC-----C
Confidence 34558999999999999999754 45678999987543 1235799999999999999999988543 5
Q ss_pred cEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 118 DVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 118 ~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
..+++||++.++|.+++.....+++..++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 160 ~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 68999999999999999877889999999999999999999999999999999999999999999999999986544332
Q ss_pred c---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC---hhHHHHHHHHHhCCCCcccccccc
Q 017231 198 F---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD---YVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 198 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
. .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.. ....+..+....+..+........
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 1 224568999999999987 678999999999999999999999997654 334455555544433222111111
Q ss_pred cchhHHHhhhCCCCCCC-Cc--cccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQ-NF--SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~-~~--~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
......+.......... .. ......++.++.++|.+||..||++|||+.|+|.||||++.+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~ 383 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI 383 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence 11111111111111000 00 0011245778999999999999999999999999999987543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=311.80 Aligned_cols=302 Identities=31% Similarity=0.504 Sum_probs=230.2
Q ss_pred CCCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHH
Q 017231 9 SGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLR 88 (375)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~ 88 (375)
|||||+..|+.+.+|||++ .++||-|.|++||++.|..+.+.||+|+++.. ....+....
T Consensus 64 GGYHpV~IGD~F~~gRY~v-----------------~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlD 123 (590)
T KOG1290|consen 64 GGYHPVRIGDVFNGGRYHV-----------------QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALD 123 (590)
T ss_pred CCCceeeccccccCceEEE-----------------EEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHH
Confidence 7999999999999999995 99999999999999999999999999998543 223455678
Q ss_pred HHHHHHhcC--------CCCeeeeceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHH
Q 017231 89 EIKLLRHMD--------HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKY 158 (375)
Q Consensus 89 e~~~l~~l~--------h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~ 158 (375)
|+.+|++++ ...||++++.|.... .+..++|+|+|+++.+|+.+|... ++++...++.|++||+.||.|
T Consensus 124 EIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdY 202 (590)
T KOG1290|consen 124 EIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDY 202 (590)
T ss_pred HHHHHHHHHhcCCCCCCCceeeeeeccceecC-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHH
Confidence 999999984 247999999998765 444789999999999999999865 569999999999999999999
Q ss_pred HHh-CCccccCCCCCceEEecC----------------------------------------------------------
Q 017231 159 VHS-ANVLHRDLKPSNLLLNAN---------------------------------------------------------- 179 (375)
Q Consensus 159 Lh~-~~i~H~di~p~NIli~~~---------------------------------------------------------- 179 (375)
||+ +||+|.||||+|||+..+
T Consensus 203 LH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~ 282 (590)
T KOG1290|consen 203 LHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAK 282 (590)
T ss_pred HHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhh
Confidence 995 599999999999998210
Q ss_pred ----------------------------C---------------------------------------------------
Q 017231 180 ----------------------------C--------------------------------------------------- 180 (375)
Q Consensus 180 ----------------------------~--------------------------------------------------- 180 (375)
+
T Consensus 283 ~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~ 362 (590)
T KOG1290|consen 283 KLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSD 362 (590)
T ss_pred hhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhccccccccc
Confidence 0
Q ss_pred -----------------------------CEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHH
Q 017231 181 -----------------------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 231 (375)
Q Consensus 181 -----------------------------~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 231 (375)
++||.|||-+.+.... ...-..|..|.|||++.+ ..|+..+||||++|
T Consensus 363 ~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh--FT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC 439 (590)
T KOG1290|consen 363 GSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH--FTEDIQTRQYRAPEVLLG-SGYSTSADIWSTAC 439 (590)
T ss_pred ccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhh--hchhhhhhhccCcceeec-CCCCCchhHHHHHH
Confidence 0112222211111100 011223666999999999 78999999999999
Q ss_pred HHHHHhhCCCCCCCC------ChhHHHHHHHHHhCCCCcccc-------cccccchhHHHhhhCCCCCCCCccccC----
Q 017231 232 ILGEIMTRQPLFPGK------DYVHQLRLITELIGSPDETSL-------GFLRSDNARRYVRMLPQFPKQNFSARF---- 294 (375)
Q Consensus 232 il~~l~~g~~pf~~~------~~~~~~~~i~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 294 (375)
++|||+||...|... ..++.++.|+++++..|.... .+++....-+.++.+..++........
T Consensus 440 ~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s 519 (590)
T KOG1290|consen 440 MAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWS 519 (590)
T ss_pred HHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCC
Confidence 999999999999644 257889999999998775422 222222222333333333322221111
Q ss_pred CCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 295 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 295 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
..-..++.+||.-||+.+|++||||.++|+|||+..+...
T Consensus 520 ~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 520 EEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 1234568999999999999999999999999999988765
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=312.27 Aligned_cols=280 Identities=35% Similarity=0.670 Sum_probs=216.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|++|.||++.++.+++.||+|.+..........+.+..|+.+++.++|||++++++++... ...++|
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 78 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRLYLV 78 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-----CeEEEE
Confidence 368999999999999999999999999999866544443456678899999999999999999998543 568999
Q ss_pred EeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-ccc
Q 017231 123 YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMT 200 (375)
Q Consensus 123 ~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~ 200 (375)
+||+++ .|..+......+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 999986 566665555679999999999999999999999999999999999999999999999999886543332 122
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||.+.+...++.++||||||+++|+|++|..||......+....+....+...................
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM- 237 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc-
Confidence 3456888999999876456788999999999999999999999877766666666655554332211111101000000
Q ss_pred hCCCC-CCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 281 MLPQF-PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 281 ~~~~~-~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..+.. .........+.++..+.+++.+||+.+|++||++.++++|+||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00110 0111122345778999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=318.93 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=208.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++++.||+|+||.||++.++.+++.||+|++.+.. ........+..|+.++..++|+||+++++.+... ..+++
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~l 78 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-----NNLYL 78 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-----CeEEE
Confidence 37999999999999999999999999999986532 2233455678899999999999999999998544 66899
Q ss_pred EEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-
Q 017231 122 VYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF- 198 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~- 198 (375)
||||+. |+|.+++.. ...+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 999996 699999976 45699999999999999999999999999999999999999999999999998865433321
Q ss_pred -cccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 199 -MTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 199 -~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
.....|++.|+|||++.+ ...++.++|||||||++|+|++|..||...+..+....+........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---------- 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ---------- 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc----------
Confidence 123468999999999863 24567899999999999999999999988766555554433211110
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCC--CCCHHHHhcCCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH 332 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~ 332 (375)
+....+.+++.++++|++||..++.+ |++++++++||||..+.
T Consensus 229 ----------------~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 229 ----------------FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred ----------------CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 00111346889999999999765544 88999999999998764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=319.86 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=202.0
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEe-----CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeecee
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMN-----SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDI 107 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 107 (375)
.|++..+.+++++.||.|+||.||+|.+ ..++..||+|++.... .......+..|+.++..+ +||||+++++.
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred CcccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 3777778888999999999999999974 3455789999986432 233456788999999999 89999999998
Q ss_pred ecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC-------------------------------------------------
Q 017231 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSH------------------------------------------------- 137 (375)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------------------------------- 137 (375)
+.... ..++++|||++ |+|.+++...
T Consensus 80 ~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (338)
T cd05102 80 CTKPN----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG 155 (338)
T ss_pred ecCCC----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence 75432 45799999997 7999988653
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC---cccc
Q 017231 138 -------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTE 201 (375)
Q Consensus 138 -------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~ 201 (375)
..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccC
Confidence 237788999999999999999999999999999999999999999999999986543221 1122
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
..++..|+|||++.+ ..++.++|||||||++|+|++ |..||...................
T Consensus 236 ~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~------------------ 296 (338)
T cd05102 236 ARLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM------------------ 296 (338)
T ss_pred CCCCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC------------------
Confidence 344678999999987 678999999999999999997 999998765433222211100000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++.+.++|.+||+.||++|||+.++++
T Consensus 297 -----------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 297 -----------RAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 001246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=320.87 Aligned_cols=258 Identities=26% Similarity=0.355 Sum_probs=203.1
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
..+++++.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++|+||+++++++... +.+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 147 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-----GEI 147 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-----CeE
Confidence 34557899999999999999999999999999986542 233456788999999999999999999998544 568
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-C
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-D 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~ 197 (375)
++||||++ ++|.+. ...++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...... .
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 99999997 566542 34678888999999999999999999999999999999999999999999998764432 2
Q ss_pred ccccccccccccCchhcccC----CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 198 FMTEYVVTRWYRAPELLLNC----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
......|+..|+|||.+... ...+.++|||||||++|+|++|+.||...........+........
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---------- 293 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP---------- 293 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC----------
Confidence 23345789999999987431 2345689999999999999999999974332221111111110000
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
......++.++.++|.+||+.||++||++.|+++||||.+-...
T Consensus 294 -----------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~ 337 (353)
T PLN00034 294 -----------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPG 337 (353)
T ss_pred -----------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcc
Confidence 00113568889999999999999999999999999999986543
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=310.51 Aligned_cols=278 Identities=39% Similarity=0.735 Sum_probs=218.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||.|++|.||++++..+|..||+|.+...... .....+..|+.++++++|+|++++++.+... +..++|
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 76 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLMLV 76 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEEE
Confidence 3789999999999999999999999999998654322 2345567899999999999999999998654 558999
Q ss_pred EeCCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 123 YELMDTDLHQIIRSH---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
|||++++|.+++... ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 156 (284)
T cd07836 77 FEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT 156 (284)
T ss_pred EecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence 999999999988764 358999999999999999999999999999999999999999999999999886543321 1
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....++..|++||.+.+...++.++|+||||+++|+|++|..||.+.+..+....+......+....+..+... ..+
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 234 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQL--PEY 234 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcC--chh
Confidence 223456788999999877556789999999999999999999999988877777776666554433322221100 011
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....+...........+.+++.+.++|.+||+.||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11111111111122234568889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=311.16 Aligned_cols=280 Identities=38% Similarity=0.690 Sum_probs=218.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||.|++|.||++.++.+++.|++|.+............+..|++++++++|+|++++++++... +..++++
T Consensus 5 ~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~iv~ 79 (288)
T cd07833 5 VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-----GRLYLVF 79 (288)
T ss_pred EEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-----CEEEEEE
Confidence 69999999999999999999999999999876544455567788999999999999999999998653 5689999
Q ss_pred eCCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--ccc
Q 017231 124 ELMDTDLHQI-IRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FMT 200 (375)
Q Consensus 124 e~~~g~L~~~-l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--~~~ 200 (375)
||+++++.+. ......+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9998765554 4455669999999999999999999999999999999999999999999999999987655443 233
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||++.+...++.++|+||||+++|+|++|..||...........+....+..+......+.......-..
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 45667889999999874478999999999999999999999998877666666666665554443222221111000000
Q ss_pred hCCCCCCCCccccCCC-CCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 281 MLPQFPKQNFSARFPN-KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~-~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.............++. +++++.++|++||+.+|++||+++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0000001111112223 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=304.85 Aligned_cols=252 Identities=26% Similarity=0.455 Sum_probs=207.5
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc---hHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN---RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+++.+.||+|++|.||.+.+..+++.|++|.+...... ......+.+|+.++++++||||+++++++... ..
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 78 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-----ET 78 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----Ce
Confidence 34789999999999999999999999999998654322 22345678899999999999999999998654 46
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
.++++||++ ++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 899999997 5999999988889999999999999999999999999999999999999999999999999886543321
Q ss_pred cc----ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 198 FM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 198 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
.. ....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+.......
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 226 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP----------- 226 (263)
T ss_pred cccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC-----------
Confidence 11 23456788999999988 668999999999999999999999997665443332221110000
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.....++..+.++|.+||..+|.+||++.++++|+||
T Consensus 227 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 227 ------------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ------------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0012467889999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=312.00 Aligned_cols=284 Identities=36% Similarity=0.598 Sum_probs=216.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC---CCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~~~ 120 (375)
+++.||+|++|.||++.++.+++.||+|.+............+.+|+.++++++|||++++++++..... ......+
T Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 95 (310)
T cd07865 16 KLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFY 95 (310)
T ss_pred EEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEE
Confidence 6899999999999999999999999999886543333333455689999999999999999998765431 1234579
Q ss_pred EEEeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-
Q 017231 121 IVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF- 198 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~- 198 (375)
+||||++++|.+.+.... .+++.+++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 96 lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 175 (310)
T cd07865 96 LVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175 (310)
T ss_pred EEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCccc
Confidence 999999999988887643 699999999999999999999999999999999999999999999999998865433221
Q ss_pred ----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 199 ----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 199 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
.....++..|+|||.+.+...++.++|+||||+++|+|++|..||...+.......+....+..+...........
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (310)
T cd07865 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLE 255 (310)
T ss_pred CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchh
Confidence 1233467789999998774557889999999999999999999999888777777777777665544332221111
Q ss_pred hHHHhhhCCCCCCCCcccc--CCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSAR--FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..... ..+.......... ....++.+.++|.+||..||++|||++++++||||
T Consensus 256 ~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 256 LFKKM-ELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhhc-cCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00000 0000000000000 01236678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=310.38 Aligned_cols=279 Identities=37% Similarity=0.676 Sum_probs=211.0
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||.|++|.||++.++.+++.|++|.+....... ....+.+|+.++++++|+||+++++++... ...++|
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 81 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTK-----KTLTLV 81 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecC-----CeEEEE
Confidence 37899999999999999999999999999986543221 223456899999999999999999998544 568999
Q ss_pred EeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-ccc
Q 017231 123 YELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMT 200 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~ 200 (375)
|||++++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (291)
T cd07844 82 FEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161 (291)
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence 999999999988764 458999999999999999999999999999999999999999999999999876543221 112
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC-hhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
...++..|+|||.+.+...++.++||||||+++|+|++|..||.... ..+....+....+.+....+........ ...
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 240 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE-FKP 240 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc-ccc
Confidence 23457789999998765668899999999999999999999997665 4455555555444433222211110000 000
Q ss_pred hhCCCCCCCCccccCCCCC--chHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKS--PGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s--~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
...............+.++ .++.++|.+||+.+|++|||+++++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0000111111122223344 789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=331.69 Aligned_cols=258 Identities=26% Similarity=0.376 Sum_probs=213.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC---CCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~~~ 120 (375)
+.+.||+|+||+||++.+..+++.||||++............+..|+..+..++|+|++++++.+..... .....++
T Consensus 36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEE
Confidence 5899999999999999999999999999997655555566778899999999999999999887754321 1112468
Q ss_pred EEEeCCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 121 IVYELMD-TDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
+||||+. |+|.+++... ..+++..++.++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~ 195 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA 195 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccc
Confidence 9999997 7999988643 4599999999999999999999999999999999999999999999999999865432
Q ss_pred C---CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 196 T---DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 196 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+......
T Consensus 196 ~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~----------- 263 (496)
T PTZ00283 196 TVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD----------- 263 (496)
T ss_pred cccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-----------
Confidence 2 22345678999999999987 67899999999999999999999999887655544433221100
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
...+.+++++.++|.+||+.||.+||++.++++|||++.+.
T Consensus 264 -------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~ 304 (496)
T PTZ00283 264 -------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFI 304 (496)
T ss_pred -------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhh
Confidence 01135688999999999999999999999999999998754
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=310.92 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=205.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.+.||+|+||.||++.++.+++.||+|.+..... .......+..|+.++++++|++++++++.+... ...++|
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv 78 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DALCLV 78 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEEEEE
Confidence 57889999999999999999999999999865422 222334567899999999999999999988544 568999
Q ss_pred EeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 123 YELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
|||+. ++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 158 (285)
T cd05630 79 LTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI 158 (285)
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence 99997 6898888543 35999999999999999999999999999999999999999999999999988665443333
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.....................
T Consensus 159 ~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------------- 222 (285)
T cd05630 159 KGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE--------------- 222 (285)
T ss_pred cCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhh---------------
Confidence 34578899999999987 67899999999999999999999999765322111111111100000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPL 331 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~ 331 (375)
.....+++++.++|.+||+.||++||| ++|+++||||+.+
T Consensus 223 ------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 223 ------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 001346888999999999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=344.94 Aligned_cols=289 Identities=22% Similarity=0.343 Sum_probs=245.7
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCc-ccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..++..+++.|++.||+|+||.|.+++++.+++.||+|++.+- ........-|+.|-.+|-.-+.+=|+.++..|.+.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~- 147 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE- 147 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc-
Confidence 3456777888999999999999999999999999999998662 12344566788999999998999999999999655
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.++|+||||++ |+|..+|.+..++++..++.++..|+.||..||+.|+|||||||+|||+|..|+++|+|||.+-
T Consensus 148 ----~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 ----RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ----cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 77999999996 7999999999999999999999999999999999999999999999999999999999999887
Q ss_pred ccCCCC--ccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 192 TTSETD--FMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 192 ~~~~~~--~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
.+...+ ......|||-|++||++.. ...|+..+|+||+|+++|||+.|..||...+...+...|+.......-+
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 766443 3456789999999999854 2458899999999999999999999999999889999988863322111
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC---HHHHhcCCCCCCCCCCCCCCCCCC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPYLAPLHDINEEPVCPR 342 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~ell~~~~f~~~~~~~~~~~~~~ 342 (375)
. -..+|+++++||++++. +|+.|.. ++++-.||||.+++= ........
T Consensus 304 ~---------------------------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W-~~iR~~~p 354 (1317)
T KOG0612|consen 304 D---------------------------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW-DNIRESVP 354 (1317)
T ss_pred c---------------------------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh-hhhhhcCC
Confidence 0 13579999999999998 7999998 999999999999865 44555667
Q ss_pred CCCCCCCCCCCCHH
Q 017231 343 PFSFDFEHPSFTEE 356 (375)
Q Consensus 343 ~~~~~~~~~~~~~~ 356 (375)
+|.++++.|+.+++
T Consensus 355 P~vPevssd~DTsn 368 (1317)
T KOG0612|consen 355 PVVPEVSSDDDTSN 368 (1317)
T ss_pred CCCCcCCCCCcccc
Confidence 78888888875553
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=301.51 Aligned_cols=251 Identities=29% Similarity=0.473 Sum_probs=208.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||.|++|.||++.++.+++.|++|.+..........+.+..|+.++++++|+|++++++.+.... ..++++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~lv 78 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGED----GLLYIV 78 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCC----CEEEEE
Confidence 3799999999999999999999999999998765445555667889999999999999999998774322 457999
Q ss_pred EeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 123 YELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
+||++ ++|.+++... ..+++.+++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 99997 6899988763 458999999999999999999999999999999999999999999999999886553322 2
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....+++.|+|||++.+ ..++.++|+||||+++++|++|+.||...+.......+... ..+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~-------------- 221 (257)
T cd08223 159 ASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG--KLPP-------------- 221 (257)
T ss_pred cccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--CCCC--------------
Confidence 234467888999999887 67889999999999999999999999877654443333221 1100
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....+++++.++|.+||+.||++||++.++++||||
T Consensus 222 --------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 222 --------------MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred --------------CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 012467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=316.80 Aligned_cols=260 Identities=23% Similarity=0.391 Sum_probs=209.9
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||.||++.++.+++.||+|++.+.. ........+..|+.++..++|++|+++++.+... ..++
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 77 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-----NNLY 77 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----CEEE
Confidence 347999999999999999999999999999986432 2223344577899999999999999999998544 5689
Q ss_pred EEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 121 IVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
+||||+. |+|.+++.. ...+++..++.++.||+.||.+||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999996 799999977 4679999999999999999999999999999999999999999999999999886543222
Q ss_pred -ccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 198 -FMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 198 -~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
......||+.|+|||++.. ...++.++|||||||++|+|++|+.||...+.......+........
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------- 228 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--------- 228 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc---------
Confidence 1223568999999999863 24578899999999999999999999988776666555543211100
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCC--CCCHHHHhcCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH 332 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~ 332 (375)
+......+++++.++|++||..++.+ |++++++++||||+++.
T Consensus 229 -----------------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 229 -----------------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred -----------------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 01112357899999999999765554 78999999999999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=273.55 Aligned_cols=281 Identities=39% Similarity=0.671 Sum_probs=238.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
-.++||+|.||+||+++++.+++.||+|.+.....++.......+|+.+|+.++|.|||+++++.... ..+.+|+
T Consensus 6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-----kkltlvf 80 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVF 80 (292)
T ss_pred HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-----ceeEEeH
Confidence 46889999999999999999999999999987766666777889999999999999999999998654 6689999
Q ss_pred eCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-ccc
Q 017231 124 ELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTE 201 (375)
Q Consensus 124 e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~-~~~ 201 (375)
|||+.+|..+..+ ++.+..+.++.++.|++.+|.++|++++.|+|+||+|.+|+.+|++||.|||+++..+.... .+.
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 9999999998876 56799999999999999999999999999999999999999999999999999987766532 223
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
..-|..|.+|.++.+-+-|+...|+||.||++.|+.. |.+.|++.+..+++.+|-...+.+.+..|.....-.. +.-
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd--yk~ 238 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD--YKP 238 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC--Ccc
Confidence 4558889999999998889999999999999999975 8888999999999999999999988777654332211 000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
....-....+....+.++..-+++++++|..+|.+|.++++.++||+|...
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 011112234445556777788999999999999999999999999999854
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=312.51 Aligned_cols=278 Identities=35% Similarity=0.599 Sum_probs=203.3
Q ss_pred CeeeccCCcceEEEEEEeCC--CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSE--TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
...+||+|+||.||+|.++. ++..||+|.+..... ...+.+|+.++++++|||++++++++..... ..+++
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~l 77 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSD---RKVWL 77 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCC---CeEEE
Confidence 35689999999999999654 567899998865421 2346789999999999999999998865432 56899
Q ss_pred EEeCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----ecCCCEEEeecc
Q 017231 122 VYELMDTDLHQIIRSH---------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCDLKIGDFG 188 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~---------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli----~~~~~i~l~Df~ 188 (375)
++||++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||++ +.++.++|+|||
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 78 LFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred EEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 9999999998887532 248899999999999999999999999999999999999 566789999999
Q ss_pred cccccCCCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh---------hHHHHHH
Q 017231 189 LARTTSETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY---------VHQLRLI 255 (375)
Q Consensus 189 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~i 255 (375)
++....... ......++..|+|||.+.+...++.++|||||||++|+|++|..||..... ......+
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 987654321 123456788999999987755688999999999999999999999965432 2334444
Q ss_pred HHHhCCCCcccccccccch-----hHHHhhhCCCC--CCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 256 TELIGSPDETSLGFLRSDN-----ARRYVRMLPQF--PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~--~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....+......+....... ...+....... ............+..+.++|.+||+.||.+|||+.|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 4444443333222111000 00000000000 0000011112346678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.91 Aligned_cols=282 Identities=19% Similarity=0.258 Sum_probs=206.4
Q ss_pred CeeeccCC--cceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRG--AYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.||+| ++++||++.++.+|+.||+|.+............+..|+.+++.++||||+++++++... +..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 57889999 678999999999999999999976554455556778899999999999999999998654 56899
Q ss_pred EEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 122 VYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
||||++ |+|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++++||+.........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999997 6999998653 459999999999999999999999999999999999999999999999998643321110
Q ss_pred -------ccccccccccccCchhcccC-CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccc-c
Q 017231 198 -------FMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-G 268 (375)
Q Consensus 198 -------~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-~ 268 (375)
......++..|+|||++.+. ..++.++|||||||++|+|++|..||.............. +..+.... .
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN--GTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhc--CCcccccccc
Confidence 11123456779999998752 3578999999999999999999999976554332222211 11110000 0
Q ss_pred ccccch----------hHHHhh------hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 269 FLRSDN----------ARRYVR------MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 269 ~~~~~~----------~~~~~~------~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
...... ...... ................+++.+.++|.+||+.||++|||++++++||||+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 000000 000000 0000000001111234578899999999999999999999999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=308.04 Aligned_cols=282 Identities=39% Similarity=0.662 Sum_probs=222.2
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||.|++|.||++.+..+++.+++|.+............+..|+.+++.++|+|++++++++.... ....++|
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~lv 78 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYMV 78 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEEE
Confidence 3789999999999999999999999999999766433444566788999999999999999999986542 2568999
Q ss_pred EeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--cc
Q 017231 123 YELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FM 199 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--~~ 199 (375)
+||++++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (287)
T cd07840 79 FEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158 (287)
T ss_pred eccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence 999999999998765 579999999999999999999999999999999999999999999999999887655442 12
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+...++.++||||||+++|+|++|+.||...+.......+....+.+....+............
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (287)
T cd07840 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238 (287)
T ss_pred cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence 33455778999998876456789999999999999999999999988877777777776655544333222111000000
Q ss_pred hhCCCCCCCCccccCCC-CCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 280 RMLPQFPKQNFSARFPN-KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~-~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.. .......+...+.. +++.+.++|++||+.+|++||++++++.||||
T Consensus 239 ~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 239 KP-KKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cc-cccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 00000111122233 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=308.35 Aligned_cols=251 Identities=26% Similarity=0.447 Sum_probs=213.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
.+.+.||.|++|.||++.+..+++.||+|++..... .......+..|+.+++++.||||+++++.+... ...++
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~ 78 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-----SNLYL 78 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CeEEE
Confidence 378999999999999999999999999999865432 233456788999999999999999999998554 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
+|||++ ++|.+++.....+++..+..++.||+.||.+||+.|++|+||+|.||+++.++.++|+|||.+...... ..
T Consensus 79 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~ 156 (290)
T cd05580 79 VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TY 156 (290)
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CC
Confidence 999995 799999998889999999999999999999999999999999999999999999999999988765544 33
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...+++.|+|||.+.+ ...+.++|+||||+++|+|++|..||...+.......+.......
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 217 (290)
T cd05580 157 TLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF------------------ 217 (290)
T ss_pred CCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccC------------------
Confidence 4567889999999877 678899999999999999999999998777544444433211000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
....+..+.++|.+||..||.+|+ +++|+++||||+.+.
T Consensus 218 -------------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 218 -------------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -------------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 023478899999999999999999 999999999999875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=305.87 Aligned_cols=281 Identities=38% Similarity=0.658 Sum_probs=219.2
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc---CCCCeeeeceeecCCCCCCcCcE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
++++.||.|++|.||++.++.+++.||+|.+............+..|+.+++++ +|+|++++++++...........
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 468999999999999999999999999999975444333345566777777666 59999999999877643333458
Q ss_pred EEEEeCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 120 YIVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 120 ~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
+++|||++++|.+++.... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~ 161 (287)
T cd07838 82 TLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM 161 (287)
T ss_pred EEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc
Confidence 9999999999999887654 48999999999999999999999999999999999999999999999999887665444
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||......+....+...........+........
T Consensus 162 ~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 238 (287)
T cd07838 162 ALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR-- 238 (287)
T ss_pred ccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccch--
Confidence 3344456888999999987 6789999999999999999999999998887777777766544432221111000000
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
...............+.+++.+.++|++||+.||++||++++++.||||
T Consensus 239 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 239 --SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred --hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0001111111222234567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=307.19 Aligned_cols=256 Identities=26% Similarity=0.439 Sum_probs=209.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
..+.||.|+||+||++.+..+++.||+|.+..... .......+..|+.++++++|++++++++.+... +..+++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~~lv 78 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-----DALCLV 78 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-----CEEEEE
Confidence 57889999999999999999999999999865322 222344567899999999999999999888554 568999
Q ss_pred EeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 123 YELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
|||+. ++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 158 (285)
T cd05632 79 LTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI 158 (285)
T ss_pred EEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence 99997 5888887653 36999999999999999999999999999999999999999999999999988655443333
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+..........
T Consensus 159 ~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~-------------- 223 (285)
T cd05632 159 RGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV-------------- 223 (285)
T ss_pred cCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc--------------
Confidence 44578999999999987 678999999999999999999999998776544443333322111100
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~ 332 (375)
....+++++.+++.+||+.||++||+ +.+++.|+||+.+.
T Consensus 224 -------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 224 -------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred -------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 01346788999999999999999999 88999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=332.88 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=210.6
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeece-eec
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKD-IIR 109 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~-~~~ 109 (375)
+..|+|..+.++|.+.|.+|||+.||+|++...|..||+|.+... ++.......+|+.++++|+ |+|||.+++ ...
T Consensus 29 G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~ 106 (738)
T KOG1989|consen 29 GQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI 106 (738)
T ss_pred ceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence 578999999999999999999999999999998899999998654 6667788999999999996 999999999 433
Q ss_pred CCCCCC-cCcEEEEEeCCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEecCCCEE
Q 017231 110 PPQRET-FNDVYIVYELMD-TDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLK 183 (375)
Q Consensus 110 ~~~~~~-~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NIli~~~~~i~ 183 (375)
.....+ -..+.|+||||. |+|.|+|.. ..+|++.++++|++++++|+.+||... |+|||||-+||||+.+|..|
T Consensus 107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred cccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEE
Confidence 332222 245789999998 699999974 355999999999999999999999997 99999999999999999999
Q ss_pred EeecccccccCCCC-cc---------ccccccccccCchhcc--cCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH
Q 017231 184 IGDFGLARTTSETD-FM---------TEYVVTRWYRAPELLL--NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 251 (375)
Q Consensus 184 l~Df~~~~~~~~~~-~~---------~~~~~~~~y~aPE~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 251 (375)
|||||++...-... .. -...-|+.|+|||.+. ...+.++|+|||+|||+||-||....||+.......
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI 266 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI 266 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE
Confidence 99999986433221 11 1123489999999974 236789999999999999999999999976532222
Q ss_pred HHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 252 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
+ ...-..| .++.++..+++||+.||+.||++||++.+++.
T Consensus 267 l----ng~Y~~P-----------------------------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 267 L----NGNYSFP-----------------------------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred E----eccccCC-----------------------------CCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 1 1111111 12467899999999999999999999988876
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=306.51 Aligned_cols=278 Identities=42% Similarity=0.743 Sum_probs=225.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|++|.||++.+..+++.|++|.+............+..|+.++++++|+|++++++++... ...++|+
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~v~ 77 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYLVF 77 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEEEe
Confidence 57889999999999999999999999999976543444456678899999999999999999998654 5689999
Q ss_pred eCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
||++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 78 e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (282)
T cd07829 78 EYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157 (282)
T ss_pred cCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCc
Confidence 99999999999876 579999999999999999999999999999999999999999999999999886654432 2223
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..++..|+|||.+.+...++.++|+||||+++++|++|..||...+.......+....+......+....... .+...
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 235 (282)
T cd07829 158 EVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP--DYKPT 235 (282)
T ss_pred cccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc--ccccc
Confidence 4456779999998774478999999999999999999999999888777777777766655444332221111 11112
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.+...........+.++..+.++|.+||..||++||++++++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 22222222233445668899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=305.81 Aligned_cols=280 Identities=46% Similarity=0.798 Sum_probs=222.6
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||.|++|.||++.+..+++.+++|.+............+..|+.++++++|++++++++.+... ...+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v 76 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYLV 76 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEEE
Confidence 368899999999999999999999999999876544444556788899999999999999999998654 568999
Q ss_pred EeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-ccc
Q 017231 123 YELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMT 200 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~ 200 (375)
+||++++|.+.+... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 77 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 77 FEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred EeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 999999998888764 579999999999999999999999999999999999999999999999999886654432 222
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+....+....+......+........ ....
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 235 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR-NYKF 235 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh-hhhh
Confidence 345678899999988744789999999999999999999999988887777777666555543332222211000 0001
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..............+.++.++.++|.+||+.||.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 111111111222335678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=325.45 Aligned_cols=261 Identities=29% Similarity=0.432 Sum_probs=216.8
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
+++.++|+..||.|+||.||+|..+.++-.-|.|++. .......+.+.-|+.+|..+.||+||++++.|... +
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe--tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----n 102 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE--TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----N 102 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc--ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----C
Confidence 4567889999999999999999999998888899883 34566788999999999999999999999987554 6
Q ss_pred cEEEEEeCCCC-CHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc-cC
Q 017231 118 DVYIVYELMDT-DLHQIIR-SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TS 194 (375)
Q Consensus 118 ~~~lv~e~~~g-~L~~~l~-~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~-~~ 194 (375)
.++|+.|||+| -....|. -...+.+.++..+++|++.||.|||+.+|+|+|||..|||++-+|.++|+|||.+.. ..
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~ 182 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS 182 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh
Confidence 69999999985 4444443 346799999999999999999999999999999999999999999999999997643 33
Q ss_pred CCCccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 195 ETDFMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
......++.||++|+|||+.+. ..+|++++||||||+++.+|..+.+|-...+....+-.|.. +.|+....
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK---SePPTLlq-- 257 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLLQ-- 257 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh---cCCCcccC--
Confidence 3344568899999999999853 36899999999999999999999999887776665554443 22211110
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
-..-+..+.+|+.+||..||..||++.+||+||||+++..
T Consensus 258 -----------------------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 258 -----------------------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred -----------------------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 0123677999999999999999999999999999997643
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=308.09 Aligned_cols=288 Identities=39% Similarity=0.644 Sum_probs=222.2
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC-----CC
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-----RE 114 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~ 114 (375)
..+++.+.||.|++|.||++.++.+++.|++|.+............+..|+.++++++|||++++++++.... ..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 3445799999999999999999999999999998654333333456678999999999999999999886643 11
Q ss_pred CcCcEEEEEeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 115 TFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 115 ~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
....+++++||+++++.+.+... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 87 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 166 (302)
T cd07864 87 DKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166 (302)
T ss_pred cCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccc
Confidence 22478999999999888888764 46999999999999999999999999999999999999999999999999988765
Q ss_pred CCCC--ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 194 SETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 194 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
.... ......++..|+|||.+.+...++.++|||||||++++|++|+.||...+....+..+....+......+....
T Consensus 167 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (302)
T cd07864 167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVI 246 (302)
T ss_pred cCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccc
Confidence 4332 11223457779999988764567889999999999999999999999888777787777776665544332221
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
......-.+.... ........+..++..+.++|.+||+.||++||++++++.||||
T Consensus 247 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 247 KLPYFNTMKPKKQ-YRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccc-cccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 1110000000000 0011112234568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=324.51 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=221.0
Q ss_pred cCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCc--ccchHHHHHHHHHHHHHHhcC
Q 017231 20 THGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA--FDNRIDAKRTLREIKLLRHMD 97 (375)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~~e~~~l~~l~ 97 (375)
..+|||++ .-..||+|+|-+||+|.|..+|..||+-.++.. .......++|..|+.+|+.|+
T Consensus 36 ~p~gRy~k----------------~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~ 99 (632)
T KOG0584|consen 36 DPTGRYLK----------------FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK 99 (632)
T ss_pred CCCCceee----------------hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC
Confidence 34789998 678899999999999999999999998876543 345556689999999999999
Q ss_pred CCCeeeeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCce
Q 017231 98 HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNL 174 (375)
Q Consensus 98 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NI 174 (375)
||||+++++.+.+... ..+.+|+|.+. |+|+.+.++.+.++...+..|++||+.||.|||++. |+|||||-+||
T Consensus 100 H~NIirfy~SW~d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNI 176 (632)
T KOG0584|consen 100 HPNIIRFYDSWVDTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNI 176 (632)
T ss_pred CCceeeeeeheecCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceE
Confidence 9999999999987653 56789999996 899999999999999999999999999999999985 99999999999
Q ss_pred EEec-CCCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHH
Q 017231 175 LLNA-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLR 253 (375)
Q Consensus 175 li~~-~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 253 (375)
||+. .|.+||+|+|+|........ ....|||.|||||.+.. .|++.+||||||++|+||.|+..||........+.
T Consensus 177 FinG~~G~VKIGDLGLAtl~r~s~a-ksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY 253 (632)
T KOG0584|consen 177 FVNGNLGEVKIGDLGLATLLRKSHA-KSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY 253 (632)
T ss_pred EEcCCcCceeecchhHHHHhhcccc-ceeccCccccChHHHhh--hcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH
Confidence 9986 48999999999988766643 34899999999999874 79999999999999999999999998876555443
Q ss_pred HHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 254 LITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
+-+.- |..|.... .--.+++++||.+||.. .+.|+|+.|||.||||..-
T Consensus 254 KKV~S-GiKP~sl~---------------------------kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 254 KKVTS-GIKPAALS---------------------------KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHc-CCCHHHhh---------------------------ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 32221 11111111 11278899999999998 9999999999999999974
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=307.87 Aligned_cols=281 Identities=23% Similarity=0.344 Sum_probs=213.0
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.+.||+|++|.||++.+..++..+++|.+.... .......+..|++++++++||||+++++.+... +.+++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 76 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEISI 76 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEEE
Confidence 447999999999999999999999999999986542 233455688999999999999999999998654 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
+|||++ ++|.+++...+.+++..+..++.||+.||.|||+ .+++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 77 v~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~ 155 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA 155 (308)
T ss_pred EeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cc
Confidence 999997 6999999888889999999999999999999997 59999999999999999999999999987654332 22
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccc------ccccc-
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL------GFLRS- 272 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~------~~~~~- 272 (375)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+............ .....
T Consensus 156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 34567889999999877 66889999999999999999999999766533322222111111100000 00000
Q ss_pred ---chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 273 ---DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 273 ---~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.............+ +......++.++.++|.+||..||++||++.++++||||.+...
T Consensus 235 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 235 RPMAIFELLDYIVNEPP---PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred chhhHHHHHHHHhcCCC---ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 00001111111111 11111236788999999999999999999999999999987543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=310.69 Aligned_cols=284 Identities=37% Similarity=0.630 Sum_probs=218.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC---CCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~~~ 120 (375)
+++.||+|++|.||++.++.+++.|++|.+............+.+|+.+++.++|+||+++++++..... .....++
T Consensus 12 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 91 (311)
T cd07866 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91 (311)
T ss_pred EEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEE
Confidence 7999999999999999999999999999886543222223456789999999999999999998765432 2234579
Q ss_pred EEEeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-
Q 017231 121 IVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF- 198 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~- 198 (375)
+++||+++++...+... ..+++..++.++.||++||.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 92 lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 171 (311)
T cd07866 92 MVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171 (311)
T ss_pred EEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcc
Confidence 99999998888877653 4699999999999999999999999999999999999999999999999998865433211
Q ss_pred -----------cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 199 -----------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 199 -----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
.....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.....+.+....+......+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (311)
T cd07866 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW 251 (311)
T ss_pred cccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 112345777999999876456889999999999999999999999988887777777776665544333
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..+........... ...........+..+++.+.++|.+||+.||++|||+.+++.||||
T Consensus 252 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 252 PGWRSLPGCEGVHS-FTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hhhhhccccccccc-CCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 22111100000000 0011112222344567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=340.31 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=209.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||.|+||.||++.++.++..||+|++............+..|+.++++|+||||++++++|..... ..+||||
T Consensus 17 Il~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~---~~lyIVM 93 (1021)
T PTZ00266 17 VIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN---QKLYILM 93 (1021)
T ss_pred EEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC---CEEEEEE
Confidence 6999999999999999999999999999987655555566788999999999999999999998865432 5689999
Q ss_pred eCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCceEEec-------------
Q 017231 124 ELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSA-------NVLHRDLKPSNLLLNA------------- 178 (375)
Q Consensus 124 e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~-------~i~H~di~p~NIli~~------------- 178 (375)
||++ |+|.++|.. ...+++..++.|+.||+.||.|||+. +|+|+||||+|||++.
T Consensus 94 EY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~ 173 (1021)
T PTZ00266 94 EFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173 (1021)
T ss_pred eCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccccc
Confidence 9997 699998865 35699999999999999999999985 4999999999999964
Q ss_pred ----CCCEEEeecccccccCCCCccccccccccccCchhccc-CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHH
Q 017231 179 ----NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN-CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLR 253 (375)
Q Consensus 179 ----~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 253 (375)
.+.++|+|||++.............+|+.|+|||++.+ ...++.++|||||||++|+|++|..||...+....+.
T Consensus 174 n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli 253 (1021)
T PTZ00266 174 NLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI 253 (1021)
T ss_pred ccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHH
Confidence 23489999999876655444455678999999999864 2457889999999999999999999997654333221
Q ss_pred HHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 254 LITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.... ..+. ......+.++.+||..||+.+|.+||++.++|.|+|++.+..
T Consensus 254 ~~lk---~~p~---------------------------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 254 SELK---RGPD---------------------------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred HHHh---cCCC---------------------------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 1111 1000 011345788999999999999999999999999999987643
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=298.76 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=209.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
.+.+.||+|++|.||++.++.+++.|++|.+............+..|+.+++.++|||++++++.+... ...+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 77 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLNIV 77 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEEEE
Confidence 368899999999999999999999999999876544556677889999999999999999999998654 568999
Q ss_pred EeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 123 YELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
+||+. ++|.+++... ..++...++.++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 99996 6999998774 569999999999999999999999999999999999999999999999999887554432 2
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....++..|+|||++.+ ..++.++|+||||+++++|++|..||...+.......+.... .+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~-------------- 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--FPP-------------- 220 (256)
T ss_pred hhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCC--------------
Confidence 233467888999999987 678899999999999999999999998776544443332210 000
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....++..+.++|.+||+.+|++||++.++++|||+
T Consensus 221 --------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 221 --------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred --------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 001457889999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=313.41 Aligned_cols=260 Identities=22% Similarity=0.373 Sum_probs=209.8
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||.||+++++.+++.||+|++.+.. ........+..|..++..++|++|+++++++... +..+
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-----~~~~ 77 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-----NYLY 77 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CEEE
Confidence 347999999999999999999999999999986532 2233445678899999999999999999998544 6689
Q ss_pred EEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 121 IVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
+||||+. |+|.+++.. ...+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||++........
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999996 699999987 46799999999999999999999999999999999999999999999999999865543322
Q ss_pred --cccccccccccCchhcccC----CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 199 --MTEYVVTRWYRAPELLLNC----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 199 --~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
.....|++.|+|||++.+. ..++.++|+|||||++|+|++|+.||...+.......+.......+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------- 228 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ--------- 228 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc---------
Confidence 2235689999999998642 3467899999999999999999999987776555554433211110
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCC--CCCHHHHhcCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH 332 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~ 332 (375)
+......+++++.++|.+||..++.+ |++++++++|+||+.+.
T Consensus 229 -----------------~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 229 -----------------FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred -----------------CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 01112356889999999999876654 56899999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=327.34 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=208.9
Q ss_pred CCeeeccCCcceEEEEEEeCCC-CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSET-REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
.+.+.||+|++|.||+|.+..+ +..||+|.+... .......+..|+.+++.++||||+++++.+... +.+++
T Consensus 70 ~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~l 142 (478)
T PTZ00267 70 VLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLLL 142 (478)
T ss_pred EEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEEE
Confidence 3799999999999999998887 788999977433 333445678899999999999999999998554 66899
Q ss_pred EEeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 122 VYELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
||||++ |+|.+++.. ...+++..+..++.||+.||.+||+.||+||||||+||+++.++.++|+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999996 699887753 346899999999999999999999999999999999999999999999999998765433
Q ss_pred C---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 197 D---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 197 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----------- 290 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP----------- 290 (478)
T ss_pred cccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-----------
Confidence 2 2344568999999999987 678999999999999999999999998877655554443311100
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
....+++++.++|.+||+.||++||++.+++.|+|++.+
T Consensus 291 -------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 291 -------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred -------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 002467889999999999999999999999999998754
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=304.16 Aligned_cols=263 Identities=26% Similarity=0.393 Sum_probs=210.0
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
..++.+++++.||.|++|.||++++..++..|++|.+... .......+..|+.+++.++|+|++++++.+...
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 81 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWD----- 81 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----
Confidence 3445566899999999999999999999999999998643 344567788999999999999999999988543
Q ss_pred CcEEEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 117 NDVYIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
+.+++||||++ ++|..++.. ...+++..++.++.||+.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 56899999997 477777654 4569999999999999999999999999999999999999999999999999875433
Q ss_pred CC-CccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 195 ET-DFMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 195 ~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
.. .......++..|+|||.+.+ ...++.++|+|||||++|+|++|..||...+.......+.. .....
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~---- 234 (292)
T cd06644 162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPT---- 234 (292)
T ss_pred ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCcc----
Confidence 22 12234457888999999852 24567899999999999999999999977654333322211 11000
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
......++.++.++|.+||+.||++||+++++++||||..+...
T Consensus 235 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 235 ---------------------LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred ---------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 00012457789999999999999999999999999999976543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.58 Aligned_cols=252 Identities=30% Similarity=0.488 Sum_probs=211.0
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||.|++|.||++.+..++..|++|.+............+..|+.++++++|+|++++++.+..... ...+++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~~~ 79 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSN---QTLYIV 79 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCC---CEEEEE
Confidence 36899999999999999999999999999987655555566778899999999999999999998765332 557999
Q ss_pred EeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 123 YELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVH-----SANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh-----~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
+||++ ++|.+++.. ...+++..++.++.||+.||.+|| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99997 699999865 356999999999999999999999 88999999999999999999999999999877
Q ss_pred cCCCCc-cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 193 TSETDF-MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 193 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
...... .....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.....+.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 228 (265)
T cd08217 160 LGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR---------- 228 (265)
T ss_pred ccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC----------
Confidence 655432 334567889999999887 66889999999999999999999999887644444333221100
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.....++..+.+++.+||+.+|++||++.+|++|||+
T Consensus 229 --------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 229 --------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred --------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 0012457889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=305.12 Aligned_cols=258 Identities=24% Similarity=0.402 Sum_probs=216.7
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
.-+.++++||+|+||.||++.++.+|+.+|||.+.- +.+..++..|+.++.++..|++|++|+.|.-. ..+
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDL 103 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDL 103 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccC-----Cce
Confidence 345579999999999999999999999999999854 34678889999999999999999999988654 448
Q ss_pred EEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-C
Q 017231 120 YIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-T 196 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~ 196 (375)
++|||||+ |++.+.++. ++.++++++..+.+..+.+|+|||...-+|||||..||+++.+|..||.|||.+..... .
T Consensus 104 WIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred EeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 99999998 899999864 57799999999999999999999999999999999999999999999999999865443 2
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
...++..||+.|+|||++.. -.|+.++||||||++..||..|++||..-.....+-.| ...+++...
T Consensus 184 AKRNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI---PT~PPPTF~--------- 250 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI---PTKPPPTFK--------- 250 (502)
T ss_pred HhhCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec---cCCCCCCCC---------
Confidence 44578899999999999988 78999999999999999999999999765433222111 111111100
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
.+ ..-|.++.+||++||-+.|++|.|+..|++|+|+++.+.++
T Consensus 251 ------------KP----E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~~ 293 (502)
T KOG0574|consen 251 ------------KP----EEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGCD 293 (502)
T ss_pred ------------Ch----HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCccc
Confidence 00 12377899999999999999999999999999999987665
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=302.35 Aligned_cols=258 Identities=27% Similarity=0.414 Sum_probs=208.3
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
.+++++++.||.|++|.||++.+..++..+++|.+... .......+..|+.+++.+.|+|++++++.+... ..
T Consensus 4 ~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~ 76 (282)
T cd06643 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NN 76 (282)
T ss_pred HHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CE
Confidence 34566899999999999999999999999999998543 334456788899999999999999999998654 56
Q ss_pred EEEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 119 VYIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
.++|+||++ ++|..++.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 ~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~ 156 (282)
T cd06643 77 LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 156 (282)
T ss_pred EEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc
Confidence 899999997 577777654 456999999999999999999999999999999999999999999999999987654322
Q ss_pred -CccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 197 -DFMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 197 -~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
.......++..|+|||++.. ...++.++|+|||||++|+|++|..||...+.......+....... .
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~------ 228 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--L------ 228 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC--C------
Confidence 12234567888999999842 2456789999999999999999999998766444333332211100 0
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.....++.++.++|.+||+.||++||++.++++||||+..
T Consensus 229 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 229 --------------------AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred --------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 0012357889999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=301.60 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=210.2
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++.+.||.|++|.||++.+..+++.|++|.+.... .......+..|+.+++.++|+|++++++.+... ...++|
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v 77 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLWII 77 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEEEE
Confidence 37899999999999999999999999999986543 233456678999999999999999999988644 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMT 200 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~ 200 (375)
+||++ ++|.+++... .+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 78 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 78 MEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence 99997 5999998765 7999999999999999999999999999999999999999999999999988765543 2223
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+...... .
T Consensus 157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~--~---------------- 217 (274)
T cd06609 157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPP--S---------------- 217 (274)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCC--C----------------
Confidence 4567788999999987 56899999999999999999999999766543333222221000 0
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
.....++..+.++|.+||..+|++||+++++++||||++....
T Consensus 218 -----------~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 218 -----------LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred -----------CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 0001267889999999999999999999999999999976443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=307.60 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=210.2
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc-hHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++.+.||+|++|.||++.+..+++.||+|.+...... ......+..|+.+++.++|+||+++++.+... ...++
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 78 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-----TYLCL 78 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-----CEEEE
Confidence 3689999999999999999999999999999765333 23556788999999999999999999998543 56899
Q ss_pred EEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 122 VYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
+|||+. ++|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 79 VMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred EEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 999996 5999998764 469999999999999999999999999999999999999999999999999875433221
Q ss_pred -----------------------------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh
Q 017231 198 -----------------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY 248 (375)
Q Consensus 198 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 248 (375)
......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 0112356788999999987 6689999999999999999999999987776
Q ss_pred hHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC----HHHHhc
Q 017231 249 VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT----VDEALC 324 (375)
Q Consensus 249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps----~~ell~ 324 (375)
......+.......+ ....+++.+.++|.+||..||++||+ +++++.
T Consensus 238 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFSNILKKEVTFP-----------------------------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHHhcCCccCC-----------------------------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 554443332110000 01125888999999999999999999 999999
Q ss_pred CCCCCCCC
Q 017231 325 HPYLAPLH 332 (375)
Q Consensus 325 ~~~f~~~~ 332 (375)
||||++..
T Consensus 289 ~~~~~~~~ 296 (316)
T cd05574 289 HPFFRGVN 296 (316)
T ss_pred CchhhcCC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=302.73 Aligned_cols=255 Identities=27% Similarity=0.419 Sum_probs=201.0
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHH-HHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||.||++.++.+|+.||+|.+........ ...+..|+.. ++.++|||++++++.+... +..+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~~ 76 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDVW 76 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcEE
Confidence 3478999999999999999999999999999876543333 2344455554 6667899999999998654 5589
Q ss_pred EEEeCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 121 IVYELMDTDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
++|||++|+|.+++.. ...+++..++.++.||+.||.+||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 9999999998887754 24589999999999999999999997 999999999999999999999999999876544
Q ss_pred CCccccccccccccCchhcccC---CCCCccchhHHHHHHHHHHhhCCCCCCCCC-hhHHHHHHHHHhCCCCcccccccc
Q 017231 196 TDFMTEYVVTRWYRAPELLLNC---SEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
........++..|+|||.+.+. ..++.++|+|||||++|+|++|..||.... ....+..+.. ...+..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~------ 228 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSPQL------ 228 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cCCCCC------
Confidence 3323335678889999988642 346789999999999999999999996532 1222222111 000000
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
....++.++.++|.+||..+|++||++.+++.||||++.
T Consensus 229 ---------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 229 ---------------------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred ---------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 002367889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=300.27 Aligned_cols=252 Identities=24% Similarity=0.467 Sum_probs=209.6
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++.+.||.|++|.||++.+..+++.|++|++..... .......+.+|++++++++|||++++++.+... ...++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 77 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-----ENMYL 77 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-----CeEEE
Confidence 378999999999999999999999999999975432 224567788999999999999999999988544 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
|+||+. ++|.+++.....+++..+..++.||++||.+||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 999997 5999999887789999999999999999999999999999999999999999999999999887665543344
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+................
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------- 219 (258)
T cd05578 158 STSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV----------------- 219 (258)
T ss_pred ccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccc-----------------
Confidence 5667888999999887 6689999999999999999999999987764211111111110000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH--HHHhcCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV--DEALCHPYL 328 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~--~ell~~~~f 328 (375)
......+..+.++|.+||+.||.+||++ .|+++||||
T Consensus 220 -----------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 220 -----------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -----------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0012357889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=308.45 Aligned_cols=282 Identities=37% Similarity=0.659 Sum_probs=210.3
Q ss_pred CeeeccCCcceEEEEEEeCC--CCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSE--TREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++.||+|++|.||+|.++. ++..||+|.+.... ........+..|+.++++++|||++++++++..... ..++
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~~ 80 (316)
T cd07842 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHAD---KSVY 80 (316)
T ss_pred EEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCC---ceEE
Confidence 68899999999999999988 89999999987633 222234567789999999999999999999976522 5689
Q ss_pred EEEeCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec----CCCEEEeeccccc
Q 017231 121 IVYELMDTDLHQIIRSH-----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA----NCDLKIGDFGLAR 191 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~----~~~i~l~Df~~~~ 191 (375)
+||||++++|.+++... ..+++..++.++.||+.||.+||+.+++|+||+|+||+++. ++.++|+|||.+.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 99999998888877532 25899999999999999999999999999999999999999 8999999999887
Q ss_pred ccCCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh---------HHHHHHHHH
Q 017231 192 TTSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV---------HQLRLITEL 258 (375)
Q Consensus 192 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~~~~i~~~ 258 (375)
....... .....++..|+|||.+.+...++.++|+|||||++++|++|..||...... ..+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6443321 223456788999999877566889999999999999999999999765432 233344444
Q ss_pred hCCCCcccccccccch-hHHHhhhCC--CCCCCC---ccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 259 IGSPDETSLGFLRSDN-ARRYVRMLP--QFPKQN---FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 259 ~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~---~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.+......+....... ......... ..+... ........+..+.++|.+||+.||++|||+.|++.||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 4333222221111000 000000000 000000 011112567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=298.72 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=204.0
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc---chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD---NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
.+.+.||+|++|.||++.+..++..|++|.+..... .......+.+|+.++++++|||++++++++..... ..+
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~~ 81 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE---KTL 81 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC---CEE
Confidence 378999999999999999999999999998864322 22344568889999999999999999998865322 567
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
++++||++ ++|.+++...+.+++..++.++.||+.||.+||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 89999997 5999999888889999999999999999999999999999999999999999999999999886543211
Q ss_pred ---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 198 ---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+...... +.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~---------- 229 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN-PQ---------- 229 (266)
T ss_pred cCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC-CC----------
Confidence 1122446788999999987 67899999999999999999999999766543333222111000 00
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
....+++.++++| +||..+|++||+++|+++||||+
T Consensus 230 ------------------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 230 ------------------LPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ------------------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0023577788888 67778999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.07 Aligned_cols=249 Identities=24% Similarity=0.410 Sum_probs=207.0
Q ss_pred ccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCC
Q 017231 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 126 (375)
Q Consensus 48 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 126 (375)
||.|++|.||++.+..+++.|++|++..... .......+..|+.+++.++|||++++++.+... ..+++++||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence 7999999999999999999999999976432 233456788999999999999999999988544 5689999999
Q ss_pred C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccccccc
Q 017231 127 D-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT 205 (375)
Q Consensus 127 ~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~ 205 (375)
+ ++|.+++.+...+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.............++
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 155 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGT 155 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCC
Confidence 7 699999988888999999999999999999999999999999999999999999999999998766554333345678
Q ss_pred ccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC--hhHHHHHHHHHhCCCCcccccccccchhHHHhhhCC
Q 017231 206 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD--YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 283 (375)
Q Consensus 206 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (375)
..|++||.+.+ ..++.++|+||||+++|+|++|..||.... .......+........
T Consensus 156 ~~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------- 214 (262)
T cd05572 156 PEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE-------------------- 214 (262)
T ss_pred cCccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC--------------------
Confidence 88999999877 678899999999999999999999997765 3333332221000000
Q ss_pred CCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCC
Q 017231 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPL 331 (375)
Q Consensus 284 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~ 331 (375)
.-...++++.++|.+||+.+|++||+ +.|+++||||+++
T Consensus 215 ---------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 215 ---------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred ---------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 00123778999999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=300.41 Aligned_cols=254 Identities=28% Similarity=0.380 Sum_probs=204.3
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.+++.+.||+|++|.||+|++..+++.|++|++.... ......+.+|+.+++.++|||++++++.+... ...+
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~ 82 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLW 82 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEE
Confidence 3447999999999999999999999999999986542 23345677899999999999999999988554 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
+++||++ ++|.+++...+.+++.+++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK 162 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc
Confidence 9999997 6999999888899999999999999999999999999999999999999999999999999876543321 2
Q ss_pred cccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 199 MTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
.....++..|+|||.+.. ...++.++|+|||||++|+|++|..||...................+ .
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-~----------- 230 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP-K----------- 230 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC-c-----------
Confidence 234567889999999742 24578899999999999999999999865543222221111000000 0
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~ 327 (375)
......++..+.++|.+||+.+|++||++++|+.|||
T Consensus 231 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 231 --------------LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred --------------ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0001245778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=301.60 Aligned_cols=256 Identities=30% Similarity=0.433 Sum_probs=208.3
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.+++++.||.|++|.||++.+..++..|++|.+... .......+..|+.++++++|+|++++++.+... ...+
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-----NKLW 78 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-----CeEE
Confidence 345899999999999999999999999999998543 344556788999999999999999999998654 5689
Q ss_pred EEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 121 IVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
+||||++ ++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 79 ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred EEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999997 5898888764 569999999999999999999999999999999999999999999999999875543322
Q ss_pred ccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 198 FMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
......++..|+|||.+.. ...++.++|+||||+++|+|++|..||...+.......+... ..+..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~-------- 228 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EPPTL-------- 228 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CCCCc--------
Confidence 2234567888999999752 245678999999999999999999999876544433332211 00000
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.....++.++.++|.+||+.+|.+||++.++++|+||.+.
T Consensus 229 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 229 ------------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ------------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0012467889999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=302.55 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=202.8
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++++.||.|++|.||++.+..+++.||+|.+.... .......+..|+.++++++|||++++++.+... ...++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 76 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISI 76 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEE
Confidence 457899999999999999999999999999986542 233456788999999999999999999998654 55789
Q ss_pred EEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 122 VYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 122 v~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
||||+++ +|..+ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...... ...
T Consensus 77 v~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~ 151 (279)
T cd06619 77 CTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAK 151 (279)
T ss_pred EEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-ccc
Confidence 9999985 66433 35789999999999999999999999999999999999999999999999988654432 233
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH----HHHHHHHhCCCCcccccccccchhH
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ----LRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ...........+
T Consensus 152 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------- 217 (279)
T cd06619 152 TYVGTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP------------- 217 (279)
T ss_pred CCCCChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCC-------------
Confidence 4577889999999987 6789999999999999999999999965321110 000111000000
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
........++++.++|.+||+.+|.+||++++++.||||+....
T Consensus 218 -------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 218 -------------PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred -------------CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 00011236788999999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=297.81 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=208.3
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++++.||.|++|+||++.+..++..+++|++....... ....+.+|+..++.++|+|++++++.+... ...++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~i 76 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVG-----DELWL 76 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-----CEEEE
Confidence 447999999999999999999999999999986543333 567788999999999999999999988544 56899
Q ss_pred EEeCCC-CCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 122 VYELMD-TDLHQIIRSH---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~---~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
++|+++ ++|.+++... ..+++..++.++.||+.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 77 VMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred EEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999997 5899998764 458999999999999999999999999999999999999999999999999876544332
Q ss_pred c-----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 198 F-----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 198 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
. .....++..|+|||.+.....++.++|+||||+++++|++|+.||...+........... .+...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~------ 227 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSL------ 227 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCc------
Confidence 1 233457888999999877447899999999999999999999999776544333322221 00000
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
........+++.+.++|.+||..||++||++.+|+.||||
T Consensus 228 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 228 ----------------ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred ----------------CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000123568889999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=297.83 Aligned_cols=249 Identities=29% Similarity=0.492 Sum_probs=204.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch-------HHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR-------IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
+...||.|++|.||+|.+..+++.|++|.+....... ...+.+..|+.++++++|||++++++.+...
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA----- 78 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----
Confidence 6789999999999999999999999999886542221 2235678899999999999999999988554
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
...++++||++ ++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 79 DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 56799999997 59999998888899999999999999999999999999999999999999999999999998865542
Q ss_pred CC-------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 196 TD-------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 196 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+.... .+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~---- 231 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA--SPE---- 231 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC--CCc----
Confidence 21 1122346788999999887 678899999999999999999999998765433332222210 000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....++..+.++|++||+.||.+||++.++++||||
T Consensus 232 ------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 232 ------------------------IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ------------------------CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 002457889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=297.17 Aligned_cols=253 Identities=30% Similarity=0.414 Sum_probs=205.9
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.+.||.|++|.||++.+..+++.+++|++..... .....+..|+.++++++|||++++++.+... ..+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~l 77 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRR-----DKLWI 77 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeC-----CEEEE
Confidence 4478999999999999999999999999999865422 2467788999999999999999999988554 56899
Q ss_pred EEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 122 VYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
+|||++ ++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 78 ~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence 999998 5899988776 689999999999999999999999999999999999999999999999999886544322 2
Q ss_pred cccccccccccCchhcccC--CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 199 MTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
.....++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...+.......+..........
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKL----------- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccc-----------
Confidence 2334678889999998762 267889999999999999999999998766444333222210000000
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~ 327 (375)
.....++.++.++|.+||..+|..||++.+++.|+|
T Consensus 227 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 227 ---------------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ---------------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 001234678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=294.72 Aligned_cols=249 Identities=29% Similarity=0.471 Sum_probs=211.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||.|++|.||.+++..+++.+++|.+............+.+|+.++++++|+|++++++++... ..++++|
T Consensus 4 ~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~~~ 78 (256)
T cd08221 4 PIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLLIEM 78 (256)
T ss_pred EeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEEEEE
Confidence 69999999999999999999999999999876544555667788999999999999999999999654 5689999
Q ss_pred eCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cc
Q 017231 124 ELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
||++ ++|.+++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 158 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence 9997 6999999775 458999999999999999999999999999999999999999999999999886654433 23
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|.|||.+.+ ..++.++|+||||+++|+|++|..||...+..+....+... ....
T Consensus 159 ~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~~--------------- 220 (256)
T cd08221 159 ETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYTP--------------- 220 (256)
T ss_pred cccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCC---------------
Confidence 34567889999999887 56889999999999999999999999877655555444321 1100
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....++.++.++|.+||+.+|.+||++.++++|+|+
T Consensus 221 -------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 -------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 013468889999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=296.49 Aligned_cols=250 Identities=29% Similarity=0.482 Sum_probs=205.5
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.+++.+.||.|++|.||++.++.++..|++|.+.... ....+.+|+.++++++|+|++++++.+... ...+
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~ 74 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLW 74 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEE
Confidence 3447999999999999999999989999999985432 266788999999999999999999998654 5689
Q ss_pred EEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 121 IVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
+++||++ ++|.+++.. ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 75 l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred EEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999998 599999875 4568999999999999999999999999999999999999999999999999987655433
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.. ....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~------------- 217 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KPPP------------- 217 (256)
T ss_pred ccccccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CCCC-------------
Confidence 2233456888999999887 6789999999999999999999999976554332211111 0000
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.......++..+.++|.+||+.||++|||+.+++.||||
T Consensus 218 ------------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 218 ------------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ------------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 000012457789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=297.48 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=206.5
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc----hHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN----RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+..+.||+|++|.||++.+..+++.|++|++...... ......+..|+.++++++|+|++++++++... +.
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 77 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-----SH 77 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-----Ce
Confidence 3678899999999999999999999999998643311 22356788999999999999999999998544 56
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-CEEEeecccccccCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSET 196 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-~i~l~Df~~~~~~~~~ 196 (375)
+++|+||+. ++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 899999997 59999998888899999999999999999999999999999999999998776 5999999988654432
Q ss_pred C-----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 197 D-----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 197 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
. ......++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 230 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP------ 230 (268)
T ss_pred cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCC------
Confidence 1 1223456888999999877 678899999999999999999999997554333333222211110000
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
.....+++++.+++.+||..+|++||++.++++||||+
T Consensus 231 --------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 231 --------------------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred --------------------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 00124678899999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=315.81 Aligned_cols=277 Identities=20% Similarity=0.283 Sum_probs=229.8
Q ss_pred eEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHH
Q 017231 13 TIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKL 92 (375)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~ 92 (375)
+...+...+.++........+.|+|.-..+.+.+.||+|.||+||.+++-. .||||++.-.....+..+.|.+|+.+
T Consensus 365 ~~s~~e~~~~~~~r~~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~ 441 (678)
T KOG0193|consen 365 RRSPTEDKISGKNRQASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAV 441 (678)
T ss_pred ccCccccccccccccCCccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHH
Confidence 344556666888888889999999999999999999999999999998876 49999998877777789999999999
Q ss_pred HHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 017231 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 170 (375)
Q Consensus 93 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~ 170 (375)
+++-+|.||+-+.+++..+. +.||+.+|+| +|+.+++-. -.+.....+.|++||++|+.|||.++|+|+|||
T Consensus 442 lkkTRH~NIlLFMG~~~~p~------~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLK 515 (678)
T KOG0193|consen 442 LKKTRHENILLFMGACMNPP------LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLK 515 (678)
T ss_pred HhhcchhhheeeehhhcCCc------eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhcc
Confidence 99999999999999997653 4899999997 899988643 359999999999999999999999999999999
Q ss_pred CCceEEecCCCEEEeecccccccCC---CCccccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCC
Q 017231 171 PSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPG 245 (375)
Q Consensus 171 p~NIli~~~~~i~l~Df~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~ 245 (375)
..|||+.+++.|+|+|||++..... ........|...|+|||+++- ..+++..+||||||+++|||++|..||..
T Consensus 516 SnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 516 SNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred ccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 9999999999999999999865332 223445667888999999853 46789999999999999999999999985
Q ss_pred CChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 246 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.+.++.+-.+......+ .......+.++++++|+..||..++++||.+.+||.
T Consensus 596 ~~~dqIifmVGrG~l~p--------------------------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 596 QNRDQIIFMVGRGYLMP--------------------------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CChhheEEEecccccCc--------------------------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 55444332222111111 111222456789999999999999999999999988
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=283.44 Aligned_cols=258 Identities=26% Similarity=0.319 Sum_probs=203.3
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
++.+.|.+.||+|||+.||+++...+++.||+|.+.+.. ....+..++|+...++++|||+++++++.......+...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 333336999999999999999999999999999997764 556788899999999999999999999877665445577
Q ss_pred EEEEEeCCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEecCCCEEEeeccccc
Q 017231 119 VYIVYELMD-TDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.|++++|.. |+|.+.+... ..+++.++..|+.+|+.||.+||+.. ++|+||||.||++...+.++|.|||++.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999996 8999988643 35999999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCcc----------ccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHh
Q 017231 192 TTSETDFM----------TEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 259 (375)
Q Consensus 192 ~~~~~~~~----------~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 259 (375)
........ .....|..|.|||.+.- ....++++|||||||++|.|+.|..||+.. .+.-
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~---------~~~G 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI---------YQQG 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------hhcC
Confidence 65443211 12234888999999853 245689999999999999999999999421 1101
Q ss_pred CCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
++....-. .....+ ..-..+|..+.++|..||++||.+||++.+++.+
T Consensus 249 gSlaLAv~-----------------n~q~s~-P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAVQ-----------------NAQISI-PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEeee-----------------cccccc-CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11000000 000000 0012379999999999999999999999999864
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=296.58 Aligned_cols=254 Identities=29% Similarity=0.459 Sum_probs=212.7
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.+.||.|++|.||++.+..+++.|++|.+...... .....+..|+..+.+++|+|++++++.+... ...++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 76 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEISI 76 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEEE
Confidence 34789999999999999999999999999998665332 4567789999999999999999999998654 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
++||++ ++|.+++.....+++..++.++.||+.|+.+||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 77 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 77 VLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 999998 6999999888889999999999999999999999 99999999999999999999999999988765544322
Q ss_pred -ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh---hHHHHHHHHHhCCCCcccccccccchh
Q 017231 200 -TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY---VHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 200 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ......+.. ....
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~~----------- 221 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPPP----------- 221 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCCC-----------
Confidence 24567888999999887 6788999999999999999999999977642 222222221 1000
Q ss_pred HHHhhhCCCCCCCCccccCCC-CCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPN-KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
..... ++..+.++|++||..+|++||++.++++||||+.++
T Consensus 222 ----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 222 ----------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred ----------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 00112 678899999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=299.68 Aligned_cols=257 Identities=28% Similarity=0.366 Sum_probs=204.4
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
....+++++.||+|++|.||++.+..+++.|++|++.... ......+..|+.++++++|||++++++.+... .
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~ 79 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----E 79 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----C
Confidence 3445668999999999999999999999999999986432 22345677899999999999999999998544 5
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
..++||||++ ++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 80 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 6899999997 699999988888999999999999999999999999999999999999999999999999998754332
Q ss_pred C-ccccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 197 D-FMTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 197 ~-~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
. ......++..|+|||.+.. ...++.++|+|||||++|+|++|..||...........+.......
T Consensus 160 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 228 (267)
T cd06646 160 IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP----------- 228 (267)
T ss_pred ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCC-----------
Confidence 1 2234567888999998742 2446789999999999999999999986543222111110000000
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~ 327 (375)
..+ .....++..+.++|++||+.||++||+++++++|+|
T Consensus 229 --------------~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 229 --------------PKL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --------------CCC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 000 001245788999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=295.34 Aligned_cols=250 Identities=26% Similarity=0.450 Sum_probs=207.9
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||.|++|.+|++.+..+++.|++|.+............+..|+.++++++|+|++++++.+... +..++|
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv 77 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-----GNLYIV 77 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-----CeEEEE
Confidence 368999999999999999999999999999865433444556788999999999999999999998544 568999
Q ss_pred EeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-
Q 017231 123 YELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF- 198 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~- 198 (375)
+||+. ++|.+.+.... .+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 99997 69999887643 589999999999999999999999999999999999999999999999998865544321
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....++..|+|||++.+ ...+.++|+|||||++++|++|..||...+.......+.. +..+.
T Consensus 158 ~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~-------------- 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--GSYPP-------------- 220 (256)
T ss_pred hhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc--CCCCC--------------
Confidence 223456788999999887 6788999999999999999999999987665544433322 11100
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....++.++.++|.+||+.+|++||++.++++||||
T Consensus 221 --------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 221 --------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred --------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 012457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=296.18 Aligned_cols=251 Identities=26% Similarity=0.409 Sum_probs=204.6
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc----chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD----NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
.+.+.||.|+||.||++.+ .+++.+|+|.+..... .......+.+|++++++++|+|++++++.+... ..
T Consensus 3 ~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 76 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----NT 76 (265)
T ss_pred cccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----Ce
Confidence 4789999999999999986 4688999998864321 122345688999999999999999999998654 56
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET- 196 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~- 196 (375)
.++++||++ ++|.+++.+...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 899999997 599999988888999999999999999999999999999999999999999999999999987653221
Q ss_pred ------CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 197 ------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 197 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.......+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 229 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR------ 229 (265)
T ss_pred ccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCC------
Confidence 11223457888999999887 67889999999999999999999999766543333222221111110
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....++.++.++|++||+.+|++||++.++++||||
T Consensus 230 ----------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 230 ----------------------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 113468889999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=300.38 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=204.3
Q ss_pred ccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCC
Q 017231 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 126 (375)
Q Consensus 48 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 126 (375)
||+|+||+||++.++.+|+.|++|.+..... .......+..|+.++++++|||++++++.+... +..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-----DDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-----CeEEEEEecC
Confidence 6999999999999999999999999865432 222345567899999999999999999988544 5689999999
Q ss_pred C-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccccc
Q 017231 127 D-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 203 (375)
Q Consensus 127 ~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~ 203 (375)
+ ++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.............
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence 7 69999997765 69999999999999999999999999999999999999999999999999886654433333455
Q ss_pred ccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCC
Q 017231 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 283 (375)
Q Consensus 204 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (375)
++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+.......
T Consensus 156 ~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------- 213 (277)
T cd05577 156 GTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM--------------------- 213 (277)
T ss_pred CCCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc---------------------
Confidence 6788999999887 558899999999999999999999997665322222221111000
Q ss_pred CCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 284 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
.......+++.+.++|.+||+.||++|| ++.++++||||..+.
T Consensus 214 ------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 214 ------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 0011134688899999999999999999 889999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=300.65 Aligned_cols=259 Identities=25% Similarity=0.439 Sum_probs=208.5
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++++.||+|++|.||++.+..++..||+|.+.... .......+.+|+.++++++|+|++++++.+... +..++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~l 76 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-----GAVYM 76 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-----CeEEE
Confidence 458999999999999999999999999999886542 333456788999999999999999999988654 56899
Q ss_pred EEeCCC-CCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 122 VYELMD-TDLHQIIRSH---QDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~---~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
||||++ ++|.+++... ..+++..+..++.+|+.||.+||+ .|++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 999997 5888887763 369999999999999999999996 59999999999999999999999999988654332
Q ss_pred CccccccccccccCchhcccC-----CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 197 DFMTEYVVTRWYRAPELLLNC-----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
. .....++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||...........+.......+.
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 228 (286)
T cd06622 157 L-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP------- 228 (286)
T ss_pred c-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCC-------
Confidence 2 2334567889999998542 23578999999999999999999999765543333332222111110
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
...+.+++++.++|.+||+.+|++||++.+++.||||......
T Consensus 229 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 229 --------------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred --------------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 0113468889999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.90 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=209.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||.|++|.||++.+..+++.|++|.+..... .....+..|+.+++.++|+|++++++.+... ..+++|+
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 95 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVG-----DELFVVM 95 (296)
T ss_pred EEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecC-----ceEEEEE
Confidence 68999999999999999999999999999864322 2346678899999999999999999998654 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-ccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~-~~~ 201 (375)
||++ ++|.+++.. ..+++.++..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (296)
T cd06655 96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174 (296)
T ss_pred EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence 9997 588887765 4699999999999999999999999999999999999999999999999998765443321 233
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.... . +.
T Consensus 175 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~-~-~~----------------- 234 (296)
T cd06655 175 MVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-T-PE----------------- 234 (296)
T ss_pred cCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-C-cc-----------------
Confidence 467888999999887 678899999999999999999999998776544333222110 0 00
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
......+++.+.++|.+||..||++||++.+++.||||+......
T Consensus 235 ---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~ 279 (296)
T cd06655 235 ---------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLS 279 (296)
T ss_pred ---------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccc
Confidence 001134688899999999999999999999999999999765433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=299.72 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=208.8
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.+.||.|++|.||++.++.+++.|++|.+...... .....+.+|+.++++++|||++++++.+... +..++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~l 76 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDISI 76 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEEE
Confidence 34789999999999999999999999999998765332 4556788999999999999999999988554 56899
Q ss_pred EEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 122 VYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
++||++ ++|.+++... ..+++..++.++.|++.|+.+||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999998 6999999876 779999999999999999999999 9999999999999999999999999998765433221
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh--hHHHHHHHHHhCCCCcccccccccchhH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+. ......+..........
T Consensus 157 -~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 223 (265)
T cd06605 157 -KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR----------- 223 (265)
T ss_pred -hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC-----------
Confidence 22567888999999987 6789999999999999999999999965421 11111111111110000
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.....+++++.++|.+||..||++||++.+++.||||+.+.
T Consensus 224 ---------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 224 ---------------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred ---------------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 00012688899999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=315.29 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=229.7
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+.+++.||+|.|++|.++++..++..||||++.++..+......+.+|+++++.++|||||+++.+.... ..+|+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-----~~lyl 132 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-----ATLYL 132 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-----ceeEE
Confidence 3479999999999999999999999999999999888888888899999999999999999999999544 66999
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
||||+. |.+.+++.+++...+..++.++.|+..|++|||+++|+|+|||++||+++.+.+++|+|||++..........
T Consensus 133 V~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq 212 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ 212 (596)
T ss_pred EEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence 999996 7999999999999999999999999999999999999999999999999999999999999999988888889
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
+.+|++.|.|||++.+.....+.+|+||||+++|.|+.|..||++.+...............+
T Consensus 213 t~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp----------------- 275 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP----------------- 275 (596)
T ss_pred ccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc-----------------
Confidence 999999999999999977778999999999999999999999998774443322222111111
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
-.++-++.++|+++|-.+|.+|++.+++..|.|.......
T Consensus 276 --------------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 276 --------------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred --------------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 2357889999999999999999999999999999987766
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=298.72 Aligned_cols=282 Identities=30% Similarity=0.533 Sum_probs=219.2
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC--CC----CeeeeceeecCC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD--HE----NIIAIKDIIRPP 111 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~----~iv~~~~~~~~~ 111 (375)
.++|. |++.+|+|.||.|-.+.+..++..||+|+++.- ....+..+-|+++|.++. .| -++.+.++|
T Consensus 88 ~~Ry~-i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--- 160 (415)
T KOG0671|consen 88 TNRYE-IVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--- 160 (415)
T ss_pred cccee-hhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh---
Confidence 44444 899999999999999999999999999998542 223455678999999994 22 255666666
Q ss_pred CCCCcCcEEEEEeCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-----------
Q 017231 112 QRETFNDVYIVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA----------- 178 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~----------- 178 (375)
+-.++.|||+|.++.++.+++..++ +++...++.++.||++++++||+.+++|.||||+||++..
T Consensus 161 --dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 161 --DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred --hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCC
Confidence 3347899999999989999998865 5999999999999999999999999999999999999831
Q ss_pred ---------CCCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh
Q 017231 179 ---------NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 249 (375)
Q Consensus 179 ---------~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 249 (375)
+..|+|+|||.++...... .+...|..|.|||++++ -+++..+||||+||||+||++|...|...+..
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 3359999999997765553 66778999999999999 88999999999999999999999999999888
Q ss_pred HHHHHHHHHhCCCCcccccccccc--------------hhHHHhhhCCCCCCCCc-cccCCCCCchHHHHHHHhcCcCCC
Q 017231 250 HQLRLITELIGSPDETSLGFLRSD--------------NARRYVRMLPQFPKQNF-SARFPNKSPGAVDLLEKMLVFDPN 314 (375)
Q Consensus 250 ~~~~~i~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~~li~~~L~~dP~ 314 (375)
+.++.+....|+.|..+...-... ...+............. ...-...-.+|.+||++||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 988888888887766544322100 00000011110000000 011112233589999999999999
Q ss_pred CCCCHHHHhcCCCCCCC
Q 017231 315 RRITVDEALCHPYLAPL 331 (375)
Q Consensus 315 ~Rps~~ell~~~~f~~~ 331 (375)
+|+|+.|+|.||||+..
T Consensus 396 ~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 396 RRITLREALSHPFFARL 412 (415)
T ss_pred ccccHHHHhcCHHhhcC
Confidence 99999999999999865
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=297.72 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=202.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCC-cCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRET-FNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~-~~~~~l 121 (375)
+.+.||.|++|.||++.++.+++.||+|.+..... ....+..|+.+++++ +|+|++++++.+.....++ ...+++
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred HHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 68899999999999999999999999999865422 234677899999998 6999999999987543222 256899
Q ss_pred EEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-C
Q 017231 122 VYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-D 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~ 197 (375)
+|||++ ++|.+++... ..+++..++.++.|++.|+.+||+++++|+||+|+||+++.++.++|+|||++...... .
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~ 166 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 166 (272)
T ss_pred EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccc
Confidence 999997 6999998764 35899999999999999999999999999999999999999999999999998654332 2
Q ss_pred ccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 198 FMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
......++..|+|||++.+ ...++.++|+|||||++|+|++|..||...........+.. ...
T Consensus 167 ~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~---------- 233 (272)
T cd06637 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPA---------- 233 (272)
T ss_pred cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc---CCC----------
Confidence 2334567889999999863 13578899999999999999999999965543322221111 000
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.......++.++.++|.+||..||.+|||+.+++.||||
T Consensus 234 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 234 ----------------PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ----------------CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000112457889999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=299.23 Aligned_cols=254 Identities=21% Similarity=0.211 Sum_probs=204.9
Q ss_pred ecccccCCe--eeccCCcceEEEEEEeCCCCcEEEEEEecCcccch-HHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 37 VSRKYVPPI--RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR-IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 37 ~~~~~~~i~--~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
+....++.. ..||+|+++.||++.. +|+.||+|.+....... ...+.+.+|+.++++++||||+++++++....
T Consensus 15 i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~- 91 (283)
T PHA02988 15 IESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV- 91 (283)
T ss_pred cCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-
Confidence 334444444 6799999999999976 67899999997653332 23467889999999999999999999986521
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEEeeccccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
+....++++|||++ |+|.+++...+.+++.....++.+++.||.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 92 DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEK 171 (283)
T ss_pred cCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHh
Confidence 12256899999997 69999999888899999999999999999999984 99999999999999999999999999987
Q ss_pred ccCCCCccccccccccccCchhcccC-CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 192 TTSETDFMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 192 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
...... ....++..|+|||++.+. ..++.++|||||||++|+|++|..||...+..+....+.......+.
T Consensus 172 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~------ 243 (283)
T PHA02988 172 ILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL------ 243 (283)
T ss_pred hhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC------
Confidence 544322 234578889999998652 46899999999999999999999999887766555544332111110
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
...++++++++|.+||+.||++|||+.|++.
T Consensus 244 -----------------------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 244 -----------------------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -----------------------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0146888999999999999999999999986
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=294.31 Aligned_cols=249 Identities=30% Similarity=0.424 Sum_probs=208.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||.|++|.||++.+..+++.+++|.+............+..|+.+++.++|||++++++.+... ...++|+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~ 78 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALMIVM 78 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEEEEE
Confidence 68999999999999999999999999999876544455567888999999999999999999988543 5689999
Q ss_pred eCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-CEEEeecccccccCCCCcc
Q 017231 124 ELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-~i~l~Df~~~~~~~~~~~~ 199 (375)
||++ ++|.+++... ..+++..++.++.+++.++.+||++|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 9997 5999999764 3489999999999999999999999999999999999998654 5799999998766554434
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......
T Consensus 159 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~------------------ 219 (256)
T cd08220 159 YTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFA------------------ 219 (256)
T ss_pred cccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCC------------------
Confidence 44567888999999887 66889999999999999999999999877654444333221100
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.....+++.+.++|.+||+.+|++|||+.++++||||
T Consensus 220 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 220 ------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 0012367889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=299.07 Aligned_cols=278 Identities=36% Similarity=0.621 Sum_probs=206.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|++|.||++.++.++..|++|.+...... .....+.+|+.+++.++|+|++++++++... ...++|+
T Consensus 9 ~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~~~lv~ 82 (291)
T cd07870 9 NLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTK-----ETLTFVF 82 (291)
T ss_pred EEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-----CeEEEEE
Confidence 689999999999999999999999999998654322 2233567899999999999999999998543 5689999
Q ss_pred eCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
||++++|.+.+... ..+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 99998888887653 458899999999999999999999999999999999999999999999999886543321 1233
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh-hHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY-VHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
..++..|+|||.+.+...++.++|+||||+++|+|++|..||...+. .+.+..+....+.+............. ....
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 241 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN-YKPE 241 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc-ccch
Confidence 45688899999987645678899999999999999999999976543 333444444333322221111100000 0000
Q ss_pred hCCCCCCCCccccCC--CCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 281 MLPQFPKQNFSARFP--NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~--~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.............+. ..++.+.++|.+||..||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 242 WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000000011111111 236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=291.11 Aligned_cols=331 Identities=44% Similarity=0.779 Sum_probs=265.0
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..|.+..+|. -++.+|.|+. .|..|.|...+++|++|.......+....++..+|...+..++|+|+++++.+|....
T Consensus 11 s~ftv~~Ry~-nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~ 88 (369)
T KOG0665|consen 11 STFTVPKRYV-NLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQK 88 (369)
T ss_pred cceeeeeeee-eecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccc
Confidence 4566666666 7899999998 8999999999999999999877777777888899999999999999999999997643
Q ss_pred -CCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 113 -RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 113 -~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
-+.+..+|+|||+|..+|.+.+. -.+.-..+..|..|++.|+.+||+.||+||||||+||+++.+..+||.|||++.
T Consensus 89 ~l~~~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 89 TLEEFQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred cHHHHHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhc
Confidence 23446689999999999999887 457888999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 192 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 192 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
.....-.......+..|.|||++.+ ..+.+.+||||+||++.||++|+..|.+.+..+...++.+..+.+.+.....+.
T Consensus 167 ~e~~~~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 167 TEDTDFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ccCcccccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 7666544556677899999999999 459999999999999999999999999999999999999999988766444333
Q ss_pred cchhHHHhhhCCCCCCCCccccC------------CCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC---CCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARF------------PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA---PLHDINE 336 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~---~~~~~~~ 336 (375)
... ..+.+..++.....+...+ +--+..+.+++.+||-.||++|.+++++|+||+++ .-.+...
T Consensus 246 ~~~-r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~a 324 (369)
T KOG0665|consen 246 PTV-RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEA 324 (369)
T ss_pred HHH-HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccC
Confidence 221 1222222222112222221 12244589999999999999999999999999998 3222222
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 017231 337 EPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (375)
|..+ ...-.+.....+.+-+++..+++...|++
T Consensus 325 -p~pe-~~d~~~d~~~~t~~e~ke~If~ev~~f~~ 357 (369)
T KOG0665|consen 325 -PPPE-IYDKQLDEREHTIEEWKELIFKEVQRFEE 357 (369)
T ss_pred -CCCc-hhhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence 2222 34334444556799999999999999998
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=299.04 Aligned_cols=279 Identities=40% Similarity=0.725 Sum_probs=218.3
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
.+.+.||.|++|+||+|....+++.|+||.+....... ......+|+..++++. |+|++++++++... ...++
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~l 75 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELYF 75 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEEE
Confidence 36889999999999999999999999999986543322 2233456899999998 99999999998653 56899
Q ss_pred EEeCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 122 VYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
||||++|+|.+.+.... .+++..+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (283)
T cd07830 76 VFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY 155 (283)
T ss_pred EEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence 99999989999998765 6899999999999999999999999999999999999999999999999998766554434
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.....++.++|+||||+++++|++|+.||...........+....+.+....+..... ......
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 234 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK-LASKLG 234 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh-hhcccc
Confidence 4456788899999986656688999999999999999999999988887777777666655544322110000 000000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..++...........+..+..+.++|++||+.||++||+++|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0111111111122223457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=301.01 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=205.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||.|++|.||++.+..++..|++|.+..... .....+..|+.+++.+.|+|++++++.+... ...++||
T Consensus 24 ~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~lv~ 96 (296)
T cd06654 24 RFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVM 96 (296)
T ss_pred eEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEEEee
Confidence 68999999999999999999999999999865432 2346688999999999999999999988654 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
||++ ++|.+++.. ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 175 (296)
T cd06654 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (296)
T ss_pred cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence 9997 689998864 458999999999999999999999999999999999999999999999999876543322 1233
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+... .. +.
T Consensus 176 ~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~-~~----------------- 235 (296)
T cd06654 176 MVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GT-PE----------------- 235 (296)
T ss_pred ccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CC-CC-----------------
Confidence 467889999999887 67889999999999999999999999766543322211110 00 00
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
......+++.+.++|.+||..||++||++.++++|+||....
T Consensus 236 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 236 ---------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred ---------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 000124678899999999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=300.56 Aligned_cols=261 Identities=24% Similarity=0.410 Sum_probs=205.1
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
.++..+.||+|++|.||++.+..+++.||+|.+...... .....+..|+.++.++. |+|++++++.+... ...
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~ 78 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDC 78 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcE
Confidence 344688999999999999999999999999998654332 34556788999999996 99999999988553 457
Q ss_pred EEEEeCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 120 YIVYELMDTDLHQIIR-----SHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 120 ~lv~e~~~g~L~~~l~-----~~~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
+++|||+++++.++.. ....+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 8999999877655432 235699999999999999999999975 9999999999999999999999999988654
Q ss_pred CCCCccccccccccccCchhcccC--CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
..........++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.... .....+.......+...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~~----- 231 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPIL----- 231 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCcC-----
Confidence 443333444678889999998773 368899999999999999999999997654 12222222111110000
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.......++.++.++|.+||+.||++|||+++++.||||+...
T Consensus 232 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 232 ------------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred ------------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 0000124688899999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=285.82 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=218.9
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRET 115 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 115 (375)
..-..++++..||+|..|+|++++.+.+|...|||.+.+. .+.++..+++..+.++.+.+ +|+||+.+++|..+.
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--- 164 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--- 164 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc---
Confidence 4455677899999999999999999999999999999776 45556778888888888775 999999999997763
Q ss_pred cCcEEEEEeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 116 FNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 116 ~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
.+++.||.|...+..++++. +++++..+-++...++.||.||.++ ||+|||+||+|||+|..|++||||||.+...
T Consensus 165 --dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 165 --DVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred --hHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 36889999986666666543 5699999999999999999999965 8999999999999999999999999999888
Q ss_pred CCCCccccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCC-hhHHHHHHHHHhCCCCccccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
..+.......|-+.|+|||.+.- ...|+..+||||||+.++||.||..||.+.+ +.+.+-.+.+.. ++....
T Consensus 243 vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e--PP~L~~--- 317 (391)
T KOG0983|consen 243 VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE--PPLLPG--- 317 (391)
T ss_pred ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC--CCCCCc---
Confidence 77777777888999999999853 2467889999999999999999999999854 234444443311 111100
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
-...|+.+.+|+..||..|+.+||...+||+|||++.++...
T Consensus 318 -----------------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 318 -----------------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE 359 (391)
T ss_pred -----------------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence 124799999999999999999999999999999998775443
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=305.34 Aligned_cols=267 Identities=26% Similarity=0.432 Sum_probs=215.2
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecC
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRP 110 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 110 (375)
..++.|.++.|+++++||.||.+.||++..-. ...||+|.+.....+......+..|+..|.+|+ |.+|++++++-..
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 46778999999999999999999999997544 356777777666677888899999999999995 9999999998754
Q ss_pred CCCCCcCcEEEEEeCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 111 PQRETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
. +.+|+|||+-+-+|..+|.+... ++...++.+..||+.|+.++|+.||+|.||||.|+++ -.|.+||+|||.
T Consensus 432 d-----~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGI 505 (677)
T KOG0596|consen 432 D-----GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGI 505 (677)
T ss_pred C-----ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeech
Confidence 3 77999999988899999987655 4446888999999999999999999999999999999 568999999999
Q ss_pred ccccCCCC---ccccccccccccCchhcccC----------CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHH
Q 017231 190 ARTTSETD---FMTEYVVTRWYRAPELLLNC----------SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLIT 256 (375)
Q Consensus 190 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 256 (375)
+..+.... ...+.+||..|++||++... -..++++||||||||+|+|+.|+.||..- ...++++.
T Consensus 506 A~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl~ 583 (677)
T KOG0596|consen 506 ANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKLH 583 (677)
T ss_pred hcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHHH
Confidence 98776653 34567899999999998531 12568999999999999999999999442 12222222
Q ss_pred HHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCc--hHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 257 ELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP--GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
....+.. ...++.+++ ++.++++.||..||.+||++.|||+|||++..+-+
T Consensus 584 aI~~P~~---------------------------~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 584 AITDPNH---------------------------EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP 636 (677)
T ss_pred hhcCCCc---------------------------cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence 2211111 112233332 38999999999999999999999999999975433
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=298.26 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=203.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.+.||+|++|.||++.++.+++.+++|++.... .....+..|+.++.++ +|||++++++++...+.......++|
T Consensus 26 ~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv 102 (291)
T cd06639 26 IIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLV 102 (291)
T ss_pred EEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEE
Confidence 6899999999999999999999999999985432 2234567889999998 79999999999876543333568999
Q ss_pred EeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 123 YELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
+||++ ++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 103 ~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 182 (291)
T cd06639 103 LELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR 182 (291)
T ss_pred EEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhccccc
Confidence 99997 599888753 4569999999999999999999999999999999999999999999999999886544332
Q ss_pred -ccccccccccccCchhcccCC----CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 198 -FMTEYVVTRWYRAPELLLNCS----EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 198 -~~~~~~~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
......++..|+|||.+.... .++.++|+|||||++|+|++|+.||...+.......+..... +..
T Consensus 183 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~------- 253 (291)
T cd06639 183 LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPP--PTL------- 253 (291)
T ss_pred ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCC--CCC-------
Confidence 123345788899999976422 367899999999999999999999977654444333221100 000
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
......+..+.++|.+||+.+|++||++.++++||||+
T Consensus 254 -------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 -------------------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred -------------------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00023466799999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=314.28 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=217.0
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
-...|+|+-+.+.-++.||+|+.|.||+++.+ ++.||||.++. .-..++.-|++|+|+||+.+.++|..
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecC
Confidence 34679999998888999999999999999755 46899998732 22367888999999999999999966
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
. ..+|||||||. |.|.+.++....+.......|..+|+.++.|||.+.|+|||||.-||||..+..|||+|||.
T Consensus 184 s-----PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 184 S-----PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred C-----ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence 5 45899999997 89999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 190 ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
++..........++||..|+|||++.+ .+.++|+||||||++||||+||..||.+.+....+-.+....-..+.+
T Consensus 259 S~e~~~~STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP---- 333 (904)
T KOG4721|consen 259 SKELSDKSTKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP---- 333 (904)
T ss_pred hHhhhhhhhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc----
Confidence 988777777788999999999999999 889999999999999999999999998877554433222211111111
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..+++-++-||++||+..|..||++.++|.|-=+
T Consensus 334 -------------------------stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 334 -------------------------STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred -------------------------ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 2467889999999999999999999999998433
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=300.16 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=209.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++++.||+|++|.||++.++.+++.|++|.+..... .......+..|+.+++.++||||+++++.+... ..+++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~l 78 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-----RHLCM 78 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-----CEEEE
Confidence 478999999999999999999999999999865422 233456788999999999999999999988543 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC---
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--- 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--- 197 (375)
+|||++ ++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 79 VMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999997 5999999888889999999999999999999999999999999999999999999999999875321100
Q ss_pred -------------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 198 -------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 198 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+....+....+.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCC
Confidence 0112346778999999877 67899999999999999999999999876655544443332111110
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC---HHHHhcCCCCCCCC
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPYLAPLH 332 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~ell~~~~f~~~~ 332 (375)
. ...+++++.++|.+||+.||++||+ +.++++||||.+..
T Consensus 238 ~----------------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 238 G----------------------------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred c----------------------------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 0 0246888999999999999999998 79999999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=301.43 Aligned_cols=255 Identities=26% Similarity=0.481 Sum_probs=207.4
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+.....||.|++|.||++.+..++..|+||.+... .....+.+..|+.+++.++|+|++++++.+... +..++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~l 96 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DELWV 96 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeEEE
Confidence 33567799999999999999999999999998543 233456688999999999999999999998654 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
+|||++ ++|.+++.. ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 97 v~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 97 VMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred EEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 999997 578877654 569999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+........
T Consensus 176 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 238 (292)
T cd06658 176 KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV---------------- 238 (292)
T ss_pred ceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc----------------
Confidence 33567888999999877 6788999999999999999999999987665444433322111100
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.....++..+.++|.+||..||.+|||++++++||||+....
T Consensus 239 ------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 239 ------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred ------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 001245788999999999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=292.50 Aligned_cols=251 Identities=29% Similarity=0.469 Sum_probs=207.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc---cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
..+.||.|++|+||++.+..++..|++|.+.... ........+..|+.+++.++|+|++++++.+... ..++
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 78 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-----DNLY 78 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-----CeEE
Confidence 5788999999999999999899999999885432 2233556788999999999999999999988544 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
+++||++ ++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~ 158 (258)
T cd06632 79 IFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFA 158 (258)
T ss_pred EEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccc
Confidence 9999997 599999988888999999999999999999999999999999999999999999999999988765444333
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|++||.+.....++.++|+||||+++|+|++|..||...........+.... ..+
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~---------------- 221 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK-ELP---------------- 221 (258)
T ss_pred cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-cCC----------------
Confidence 455678889999998763338899999999999999999999997765333222221100 000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.....+++.+.+++.+||+.+|++||++.+++.|||+
T Consensus 222 ------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 222 ------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0112467889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=293.48 Aligned_cols=254 Identities=27% Similarity=0.468 Sum_probs=205.0
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc---cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+++.+.||+|++|.||.+.+..++..|++|.+.... ........+..|+.+++++.|+|++++++++..... ..
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~---~~ 80 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME---RT 80 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC---ce
Confidence 347899999999999999999999999999885432 222345678889999999999999999998755421 45
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
++++|||++ ++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 789999997 6999999887889999999999999999999999999999999999999999999999999886543211
Q ss_pred ----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 198 ----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 198 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+. ......
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~-------- 228 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQPTNP-------- 228 (265)
T ss_pred ccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCCCCC--------
Confidence 1223457888999999987 678999999999999999999999997654333332221 111000
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
.....++..+.++|.+||. +|.+||+++++++|||+.
T Consensus 229 ------------------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 229 ------------------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ------------------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0012457789999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=301.96 Aligned_cols=256 Identities=26% Similarity=0.450 Sum_probs=207.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||.|++|.||++.+..+++.|++|.+..... ...+.+..|+.+++.++|+|++++++.+... ...++||
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~ 95 (297)
T cd06656 23 RFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVVM 95 (297)
T ss_pred eeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEEEee
Confidence 68999999999999999999999999999865322 2345678899999999999999999998654 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
||++ ++|.+++.. ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 9997 589888865 458999999999999999999999999999999999999999999999999886544332 1233
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+... +...
T Consensus 175 ~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~-~~~~------------------ 234 (297)
T cd06656 175 MVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE------------------ 234 (297)
T ss_pred ccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC-CCCC------------------
Confidence 467888999999987 67889999999999999999999999765432221111100 0000
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
......+++.+.++|.+||..+|++||++.+++.||||+.......
T Consensus 235 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 280 (297)
T cd06656 235 ---------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS 280 (297)
T ss_pred ---------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence 0001245778999999999999999999999999999997755544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=285.59 Aligned_cols=307 Identities=36% Similarity=0.605 Sum_probs=240.3
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCc----EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETRE----EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
++++++.||+|.||.||+|..+++.. .+|||.++.+....-.....-+|+.+++.++|||++.+..+|...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d---- 100 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD---- 100 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC----
Confidence 45689999999999999996555433 6999999877655555566779999999999999999999998753
Q ss_pred CcEEEEEeCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC----CCEEEeec
Q 017231 117 NDVYIVYELMDTDLHQIIRSH-----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN----CDLKIGDF 187 (375)
Q Consensus 117 ~~~~lv~e~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~----~~i~l~Df 187 (375)
..+++++||.+.+|...++-. +.++...+..|+.||+.|+.|||++=+.||||||.||++..+ |++||+|+
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 679999999999999999643 459999999999999999999999999999999999999888 89999999
Q ss_pred ccccccCCCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC---------hhHHHHH
Q 017231 188 GLARTTSETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD---------YVHQLRL 254 (375)
Q Consensus 188 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~~~~ 254 (375)
|+++.....- ......-|..|.|||.+.+...|+.+.|+|+.|||+.||++-.+.|.+.. ..+++.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9998765442 22345668999999999998999999999999999999999999985432 4567889
Q ss_pred HHHHhCCCCcccccccccchhH-HHhhhCCCCC-----CCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 255 ITELIGSPDETSLGFLRSDNAR-RYVRMLPQFP-----KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
|.+..|.+.+..|..+.....- ..+..++... ...+......-++...+++.+||..||-+|.|+++.|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 9999999988888766544322 2222222111 111122233456779999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 329 APLHDINEEPVCPRPFSFDFEHPSF 353 (375)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (375)
..-+.. ....+..|.+....|..
T Consensus 341 ~~d~lp--p~pt~~~vnf~~~~~~~ 363 (438)
T KOG0666|consen 341 TEDPLP--PLPTSDNVNFEGTTPII 363 (438)
T ss_pred ccCCCC--CCcccceeecccccccC
Confidence 964332 11233444454444443
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=310.79 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=205.6
Q ss_pred eecceeeeecccccCCeeeccCCcceEEEEEEeCCC-----CcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCee
Q 017231 29 NVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSET-----REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENII 102 (375)
Q Consensus 29 ~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 102 (375)
.++...|.+..+.+++++.||+|+||.||++.+... +..||+|.+..... ......+..|+.+++.+ +|+||+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv 105 (374)
T cd05106 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIV 105 (374)
T ss_pred ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCcee
Confidence 455678888888999999999999999999986443 35799999875432 23456788999999999 899999
Q ss_pred eeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC--------------------------------------------
Q 017231 103 AIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-------------------------------------------- 137 (375)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------------------------------------------- 137 (375)
++++.+... ...++||||+. |+|.+++...
T Consensus 106 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (374)
T cd05106 106 NLLGACTHG-----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDT 180 (374)
T ss_pred eEeeEecCC-----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccccccccc
Confidence 999998654 56899999997 7999988542
Q ss_pred --------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 138 --------------------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 138 --------------------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~ 260 (374)
T cd05106 181 YVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260 (374)
T ss_pred ccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeee
Confidence 237888999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 192 TTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 192 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
....... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+........
T Consensus 261 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~---- 335 (374)
T cd05106 261 DIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS---- 335 (374)
T ss_pred eccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc----
Confidence 5433211 112234567999999877 678999999999999999997 9999976554333222221100000
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++++.++|.+||+.||.+||++.++++
T Consensus 336 -------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 336 -------------------------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00235788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=295.81 Aligned_cols=254 Identities=27% Similarity=0.437 Sum_probs=203.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCC-CCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQR-ETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~~l 121 (375)
+++.||.|++|.||+|.++.+++.|++|++..... ....+..|+.+++++ .|+|++++++++..... .....+++
T Consensus 10 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred heeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 69999999999999999999999999999865422 345688999999999 69999999999876542 23366899
Q ss_pred EEeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 122 VYELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
+|||++ ++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 87 VMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred EEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 999998 588888865 356999999999999999999999999999999999999999999999999988654332
Q ss_pred C-ccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 197 D-FMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 197 ~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
. ......++..|+|||.+.. ...++.++||||||+++|+|++|..||...........+... ....
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~------ 237 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PPPT------ 237 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CCCC------
Confidence 2 2234567888999998753 234678999999999999999999999765443333322211 0000
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
......++..+.++|.+||..||++|||+.++++|||+
T Consensus 238 -------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 -------------------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -------------------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00012357789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.23 Aligned_cols=287 Identities=23% Similarity=0.360 Sum_probs=218.4
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCc
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~ 118 (375)
.|.=-.+.||+|+++.|-.+....+|..||||++.+. ......+..+|++++.+++ |+||+.++++|.+. ..
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd-----~~ 150 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD-----TR 150 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc-----ce
Confidence 3333467899999999999999999999999999665 3445778899999999996 99999999999544 67
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC---CEEEeecccccccC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTS 194 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~---~i~l~Df~~~~~~~ 194 (375)
+|+|||-+. |+|...|.+.+.+++.++.+++.+|+.||.|||.+||.|+|+||+||+..... -+|||||.+..-..
T Consensus 151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence 999999996 79999999999999999999999999999999999999999999999986554 38999999875433
Q ss_pred CCC--------ccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCC
Q 017231 195 ETD--------FMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 262 (375)
Q Consensus 195 ~~~--------~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 262 (375)
... ...+.+|+..|||||+..- ...|+.+.|.||||+|+|-|++|.+||.+....+
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d------------ 298 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD------------ 298 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc------------
Confidence 322 1234677888999999732 2457889999999999999999999997653110
Q ss_pred Ccccccccccch-----hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 017231 263 DETSLGFLRSDN-----ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 337 (375)
Q Consensus 263 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~ 337 (375)
..|..+. -......++.-.-.=+...|.++|.+.+++|..+|..|+..|.++.++++|||++......-.
T Consensus 299 -----CGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekal 373 (463)
T KOG0607|consen 299 -----CGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKAL 373 (463)
T ss_pred -----CCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccC
Confidence 0000000 011111111111111233446789999999999999999999999999999999965433221
Q ss_pred CCCCCCCCCCCCCC
Q 017231 338 PVCPRPFSFDFEHP 351 (375)
Q Consensus 338 ~~~~~~~~~~~~~~ 351 (375)
| .+..++-..+.+
T Consensus 374 p-tp~v~~r~~s~~ 386 (463)
T KOG0607|consen 374 P-TPQVLQRNSSTM 386 (463)
T ss_pred C-CCcccccCccch
Confidence 1 333444444444
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=293.11 Aligned_cols=251 Identities=26% Similarity=0.440 Sum_probs=201.9
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHH-HhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLL-RHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||.|++|.||+|.+..+++.||+|++.+... .......+..|..++ ....|+|++++++.+... ..+++++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-----DYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-----CeEEEEE
Confidence 679999999999999999999999999865422 222233344554443 445899999999998544 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 202 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~ 202 (375)
||++ ++|.+++...+.+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+..... ....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~ 153 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKF 153 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccC
Confidence 9997 69999998888899999999999999999999999999999999999999999999999998765433 2334
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
.++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.......+
T Consensus 154 ~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------- 213 (260)
T cd05611 154 VGTPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP------------------- 213 (260)
T ss_pred CCCcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC-------------------
Confidence 57788999999887 5588999999999999999999999987766555444332111100
Q ss_pred CCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH---HHHhcCCCCCCCC
Q 017231 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV---DEALCHPYLAPLH 332 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~---~ell~~~~f~~~~ 332 (375)
......+++.+.++|.+||+.+|++||++ +|++.||||++++
T Consensus 214 --------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 214 --------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred --------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 00112468899999999999999999954 7999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=291.18 Aligned_cols=253 Identities=30% Similarity=0.471 Sum_probs=207.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|++|.||++.+..++..|++|.+............+..|+.+++.++|+||+++++.+... ..+++++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~lv~ 78 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-----EKVYIFM 78 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-----CEEEEEE
Confidence 68999999999999999999999999999876654445677899999999999999999999987443 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc---
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--- 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~--- 199 (375)
||++ ++|.+++.....+++..++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9997 699999988777999999999999999999999999999999999999999999999999988765443221
Q ss_pred --ccccccccccCchhcccCC--CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 200 --TEYVVTRWYRAPELLLNCS--EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 200 --~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
....++..|+|||.+.+.. ..+.++|+||||+++++|++|..||...+........... ...+..
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~---------- 227 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPI---------- 227 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCC----------
Confidence 1245678899999987622 2788999999999999999999999765422222111111 110000
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.....+++.+.++|.+||+.+|++||++.+++.|||+
T Consensus 228 ----------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 228 ----------------PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ----------------CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0112357889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=295.48 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=196.7
Q ss_pred eccCCcceEEEEEEeCCCCcEEEEEEecCcccchH-HHHHHHHHHHHHH---hcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 47 PVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRI-DAKRTLREIKLLR---HMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 47 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~---~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
.||+|+||.||++.+..+++.||+|.+........ ....+..|..+++ ...|++++.+++.+... +..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence 48999999999999999999999999865432211 2222334443333 34799999999988654 458999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 201 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~ 201 (375)
|||++ ++|.+++...+.+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+....... ...
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~ 154 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA 154 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccC
Confidence 99997 6999999888889999999999999999999999999999999999999999999999999886543322 223
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..++..|+|||.+.+...++.++|+||+||++|+|++|..||......... .+........
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~------------------ 215 (279)
T cd05633 155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVN------------------ 215 (279)
T ss_pred cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCC------------------
Confidence 467899999999865356789999999999999999999999754322111 1111100000
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
....+.+++++.++|.+||+.||.+|| ++.++++||||+.+.
T Consensus 216 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 216 ---------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ---------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 001134688899999999999999999 699999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.79 Aligned_cols=255 Identities=29% Similarity=0.473 Sum_probs=203.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc--------chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD--------NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 115 (375)
+.+.||.|++|.||++.+..+++.||+|.+..... .....+.+..|+.+++.++|+|++++++++...
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 80 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE---- 80 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC----
Confidence 68899999999999999999999999998753211 111235678899999999999999999988554
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
...++|+||+. ++|.+++...+.+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 81 -EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred -CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 56899999996 6999999888889999999999999999999999999999999999999999999999999886543
Q ss_pred CCC---ccccccccccccCchhcccCC-CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 195 ETD---FMTEYVVTRWYRAPELLLNCS-EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 195 ~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
... ......++..|+|||.+.+.. .++.++|+||||+++|+|++|..||...+.......+.......
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 231 (272)
T cd06629 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP-------- 231 (272)
T ss_pred ccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC--------
Confidence 221 122345688899999987632 47889999999999999999999996554333222111100000
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.........++.++.++|.+||..||++||+++++++||||
T Consensus 232 -----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 232 -----------------PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred -----------------cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00011123568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=311.53 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=217.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
=++.||+|+||.||.|++..+.+.||||.+..+. .......++..|+..|++++|||.+.+-++|... ...|+|
T Consensus 30 dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~TaWLV 104 (948)
T KOG0577|consen 30 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----HTAWLV 104 (948)
T ss_pred HHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----chHHHH
Confidence 4788999999999999999999999999997764 4455667899999999999999999999999765 457999
Q ss_pred EeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccc
Q 017231 123 YELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 201 (375)
Q Consensus 123 ~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~ 201 (375)
||||=|+-.|++.- .+++.+-++..|+++.+.||.|||+.+.+|+|||..||+++..|.|||+|||++..... .++
T Consensus 105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---Ans 181 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANS 181 (948)
T ss_pred HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc---hhc
Confidence 99998877777754 36799999999999999999999999999999999999999999999999999876654 468
Q ss_pred ccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 202 YVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
+.|||+|+|||++.. ...|+-++||||||++..+|...++|+-+.+....+..|.....+.-..
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs-------------- 247 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS-------------- 247 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCC--------------
Confidence 899999999999853 3568999999999999999999999999988877777776543322111
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
.+-|..+.+||..||++-|.+|||.+++|.|+|+.-
T Consensus 248 ---------------~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 248 ---------------NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred ---------------chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 233778999999999999999999999999999874
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=308.88 Aligned_cols=254 Identities=29% Similarity=0.495 Sum_probs=221.8
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEe
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 124 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 124 (375)
-+.||+|-||+||-+.++.+|+.||||++.+..........+++|+.+|.++.||.||.+--.|... ..+++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEeh
Confidence 3679999999999999999999999999988766666668899999999999999999999999544 66999999
Q ss_pred CCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC---CEEEeecccccccCCCCcc
Q 017231 125 LMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 125 ~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~---~i~l~Df~~~~~~~~~~~~ 199 (375)
-+.|+..+.+.+ .+++++.....++.||+.||.|||.+||+|.||||+||++.... .+||||||.++.++.....
T Consensus 644 Kl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 644 KLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 999988887754 46799999999999999999999999999999999999996543 5999999999999999888
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
.+..||+.|+|||++.+ +.|+...|+||.|+|+|.-++|.+||.... +...+|.+..-..+...
T Consensus 724 rsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~P------------- 787 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNP------------- 787 (888)
T ss_pred hhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCc-------------
Confidence 89999999999999999 899999999999999999999999996542 33334444333333222
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
|..++++..++|..+|++.-.+|.|.++.|.|||++++..
T Consensus 788 --------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~ 827 (888)
T KOG4236|consen 788 --------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQT 827 (888)
T ss_pred --------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchH
Confidence 3578999999999999999999999999999999998754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=297.84 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=197.4
Q ss_pred cccCCeeeccCCcceEEEEEEeCC----------------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeee
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSE----------------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 103 (375)
..+++.+.||+|+||.||++++.. ++..||+|++.... .......+.+|+.++.+++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 334479999999999999998543 34479999986542 3334567889999999999999999
Q ss_pred eceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 017231 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-------------------DLTDDHCRYFLYQLLRGLKYVHSAN 163 (375)
Q Consensus 104 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------------------~l~~~~~~~i~~qi~~al~~Lh~~~ 163 (375)
+++++... ...+++|||++ |+|.+++.... .+++..++.++.||+.||.+||+.|
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 84 LLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred EEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 99998654 45899999997 69999886532 3678889999999999999999999
Q ss_pred ccccCCCCCceEEecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh--
Q 017231 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-- 238 (375)
Q Consensus 164 i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-- 238 (375)
++|+||||+||+++.++.++|+|||.+........ .....++..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHcc
Confidence 99999999999999999999999999865433221 223344678999999877 678999999999999999986
Q ss_pred CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC
Q 017231 239 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 318 (375)
Q Consensus 239 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 318 (375)
+..||...+.......+.......... ......+.++..+.++|.+||+.||++|||
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs 294 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQ-----------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPS 294 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhcccc-----------------------ccccCCCCCCHHHHHHHHHHccCCchhCcC
Confidence 667887766555544433322111000 000011346788999999999999999999
Q ss_pred HHHHhc
Q 017231 319 VDEALC 324 (375)
Q Consensus 319 ~~ell~ 324 (375)
+.+|.+
T Consensus 295 ~~~i~~ 300 (304)
T cd05096 295 FSDIHA 300 (304)
T ss_pred HHHHHH
Confidence 999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=295.04 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=201.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCC-CCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQR-ETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~~l 121 (375)
+.+.||.|+||.||++.+..+++.|++|++... ......+..|+.+++++ +|+|++++++.+..... +....+++
T Consensus 20 ~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 689999999999999999999999999998543 22345677899999998 69999999999864321 22366899
Q ss_pred EEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-C
Q 017231 122 VYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-D 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~ 197 (375)
+|||++ |+|.+++... ..+++..++.++.||+.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~ 176 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 176 (282)
T ss_pred EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc
Confidence 999997 5999988764 34889999999999999999999999999999999999999999999999987654322 1
Q ss_pred ccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 198 FMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
......++..|+|||.+.. ...++.++|+|||||++|+|++|..||...........+.. ...
T Consensus 177 ~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~---------- 243 (282)
T cd06636 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPP---------- 243 (282)
T ss_pred CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh---CCC----------
Confidence 2234567888999999753 24577899999999999999999999966543222221111 000
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.......++.++.++|.+||+.||.+||++.||+.||||
T Consensus 244 ----------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 244 ----------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ----------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000112468889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=293.67 Aligned_cols=251 Identities=21% Similarity=0.309 Sum_probs=201.3
Q ss_pred ecccccCCeeeccCCcceEEEEEEeC---CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNS---ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
+.+..+++.+.||+|+||.||++.++ ..+..||+|.++... .......+.+|+..+++++|||++++++++...
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-- 78 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-- 78 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC--
Confidence 34455668999999999999999765 456689999987543 233456788999999999999999999998644
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
...++||||++ |+|.+++... ..+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++++|||.+.
T Consensus 79 ---~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 79 ---NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred ---CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 56899999997 5888888764 468999999999999999999999999999999999999999999999999765
Q ss_pred ccCCCCccc--cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 192 TTSETDFMT--EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 192 ~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
......... ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~------ 228 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP------ 228 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC------
Confidence 433222111 2233567999999887 778999999999999999775 999998877665555443211100
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....++..+.+++.+||+.+|++||++++|++
T Consensus 229 ------------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 229 ------------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 01346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=294.28 Aligned_cols=255 Identities=26% Similarity=0.494 Sum_probs=208.7
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+...+.||.|++|.||++.+..+++.+++|.+... .......+.+|+.+++.+.|+|++++++.+... +..++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~ 93 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWV 93 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEE
Confidence 33568999999999999999999999999988533 223345678999999999999999999988654 55899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
++||+. ++|.+++.. ..++...++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~ 172 (285)
T cd06648 94 VMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR 172 (285)
T ss_pred EEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccc
Confidence 999996 599998877 679999999999999999999999999999999999999999999999999776443322 12
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.....+.+........
T Consensus 173 ~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---------------- 235 (285)
T cd06648 173 KSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL---------------- 235 (285)
T ss_pred ccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC----------------
Confidence 23457888999999877 6789999999999999999999999977665444443332110000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.....++..+.++|++||+.+|++||++.++++|+||++...
T Consensus 236 ------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 236 ------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred ------------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 001236788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.07 Aligned_cols=261 Identities=22% Similarity=0.356 Sum_probs=210.1
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
..+.+++++.||+|++|+||++.+..+++.|++|++.... .......+..|+++++.++|||++++++.+... .
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~ 76 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----N 76 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----C
Confidence 4455668999999999999999999999999999886542 233456788999999999999999999998654 5
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
.+++|+||++ ++|.+++...+.+++..++.++.+++.||.+||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 77 NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 6899999997 6899998888889999999999999999999997 5899999999999999999999999998754422
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH--------HHHHHHHhCCCCcccc
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ--------LRLITELIGSPDETSL 267 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~i~~~~~~~~~~~~ 267 (375)
. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||........ ...+........
T Consensus 157 ~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 230 (284)
T cd06620 157 S-IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP---- 230 (284)
T ss_pred h-ccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC----
Confidence 2 1234567889999999877 5788999999999999999999999976543211 111111100000
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
. ......++.++.++|.+||+.||++||+++|+++|+||.+..
T Consensus 231 -------------------~---~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 231 -------------------P---RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred -------------------C---CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0 000012577899999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=303.73 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=203.1
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeC-----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeecee
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNS-----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDI 107 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 107 (375)
+|+++++.+++.+.||.|+||.||+|.+. .+++.||+|++.... .......+..|+.++.++ +|+||+++++.
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 48888888889999999999999999743 345789999986543 233456678899999999 79999999998
Q ss_pred ecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC-------------------------------------------------
Q 017231 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSH------------------------------------------------- 137 (375)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------------------------------- 137 (375)
+.... ..+++++||++ ++|.+++...
T Consensus 80 ~~~~~----~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (337)
T cd05054 80 CTKPG----GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD 155 (337)
T ss_pred EecCC----CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh
Confidence 75442 46789999997 6998888542
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC---ccccc
Q 017231 138 ------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEY 202 (375)
Q Consensus 138 ------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~ 202 (375)
..+++..+..++.||+.||.+||++||+|+||||+||+++.++.++|+|||++....... .....
T Consensus 156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCC
Confidence 257899999999999999999999999999999999999999999999999987643221 11223
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
.++..|+|||++.+ ..++.++|||||||++|+|++ |..||......+............
T Consensus 236 ~~~~~y~aPE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 295 (337)
T cd05054 236 RLPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM------------------- 295 (337)
T ss_pred CCCccccCcHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-------------------
Confidence 44677999999987 789999999999999999997 999997654333222211100000
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
......++++.+++.+||+.+|++||++.+++++
T Consensus 296 ----------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 296 ----------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0012357789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=294.93 Aligned_cols=258 Identities=24% Similarity=0.379 Sum_probs=202.1
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCc
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
..+++++.||+|++|.||++.++.+++.+++|+..... .....+..|+.+++.+ +|+|++++++++.....+....
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 33448999999999999999999999999999875431 1234567899999999 6999999999886543334467
Q ss_pred EEEEEeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 119 VYIVYELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
.+++|||++ ++|.+++.. ...+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 899999997 689887753 356899999999999999999999999999999999999999999999999988654
Q ss_pred CCCC-ccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 194 SETD-FMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 194 ~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
.... ......++..|+|||++.. ...++.++|+|||||++|+|++|..||...........+.. .....
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~--- 248 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPR---NPPPT--- 248 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---cCCCc---
Confidence 4322 2233467889999999753 13478899999999999999999999976543222211110 00000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
......++..+.++|.+||+.||++|||+.|+++|+||
T Consensus 249 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 ----------------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ----------------------ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00001246789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=285.15 Aligned_cols=290 Identities=34% Similarity=0.570 Sum_probs=235.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC---CcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE---TFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---~~~~~~ 120 (375)
-..+||+|.||.||+|+.+++|+.|++|++.-+.....-.....+|+.+|..++|+|++.+++++...... ....++
T Consensus 21 k~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~y 100 (376)
T KOG0669|consen 21 KLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFY 100 (376)
T ss_pred HHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceee
Confidence 58899999999999999999999999987633211111234457899999999999999999998764322 224589
Q ss_pred EEEeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 121 IVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
+|+++|+.+|..++... .+++..++..++.+++.+|.|+|+..|+|||+|+.|++|+.+|.++|+|||+++........
T Consensus 101 lVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~ 180 (376)
T KOG0669|consen 101 LVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNV 180 (376)
T ss_pred eeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceeccccc
Confidence 99999999999998765 56999999999999999999999999999999999999999999999999999655443211
Q ss_pred -----ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 200 -----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 200 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
....-|..|.+||.+.+.+.++++.|+|..||++.+|+++.+.+.+.....++..|..++|+....-|..+....
T Consensus 181 ~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lp 260 (376)
T KOG0669|consen 181 VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLP 260 (376)
T ss_pred CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccch
Confidence 123348889999999999999999999999999999999999999999999999999999998777666665555
Q ss_pred hHHHh--hhCCCCCCCCccccCCC--CCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 275 ARRYV--RMLPQFPKQNFSARFPN--KSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 275 ~~~~~--~~~~~~~~~~~~~~~~~--~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.-+.+ ..++.-..+........ -+++..+++.+||..||.+|+.++++|+|.||.+-..
T Consensus 261 L~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~ 323 (376)
T KOG0669|consen 261 LYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPM 323 (376)
T ss_pred HHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCc
Confidence 44444 22333333333322222 2567999999999999999999999999999987443
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.87 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=207.1
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.++.||.|++|.||.+.+..++..||+|.+.... .......+..|+.+++++.|+|++++++.+... ...++|
T Consensus 7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 80 (277)
T cd06640 7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLWII 80 (277)
T ss_pred hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEEEE
Confidence 36889999999999999999999999999986542 233456788999999999999999999998654 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-cc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MT 200 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~-~~ 200 (375)
|||++ ++|.+++.. .++++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 81 MEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence 99997 599998865 5689999999999999999999999999999999999999999999999998866544321 22
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...........+.. ...
T Consensus 160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~------------------ 218 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNP------------------ 218 (277)
T ss_pred cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CCC------------------
Confidence 3456788999999877 6789999999999999999999999976654333322111 000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
......++..+.++|.+||+.+|++||++.++++|+||....
T Consensus 219 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 219 ----------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred ----------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 001123577899999999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=297.43 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=207.2
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+.+.+.||+|++|.||++.+..+++.|++|.+.... ........+.+|+.+++.++|||++++++++... ...+
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~~~ 91 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HTAW 91 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----CeEE
Confidence 447899999999999999999999999999986432 3334456788999999999999999999998654 4579
Q ss_pred EEEeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 121 IVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
+|+||+.|++.+++.. ...+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 9999999999888764 456999999999999999999999999999999999999999999999999988654433
Q ss_pred ccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 200 TEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
....++..|+|||.+.+ ...++.++||||||+++|+|++|..||...+.......+... ..+.
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~~~------------- 233 (307)
T cd06607 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSPT------------- 233 (307)
T ss_pred CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CCCC-------------
Confidence 23456788999998752 245788999999999999999999999776644433322211 0000
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
......+..+.++|.+||+.||++||++.+++.||||...
T Consensus 234 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 234 --------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred --------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 0001247789999999999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=306.63 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=202.0
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEe-----CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeece
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMN-----SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKD 106 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 106 (375)
-.|.+....+++.+.||+|+||.||++++ ..++..||+|+++.... ....+.+.+|+.++..+ +||||+++++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 46777777888999999999999999974 45667899999865432 23456788999999999 8999999999
Q ss_pred eecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-----------------------------------------------
Q 017231 107 IIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----------------------------------------------- 138 (375)
Q Consensus 107 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------------------------------------- 138 (375)
++... ...++||||++ |+|.+++....
T Consensus 107 ~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 181 (375)
T cd05104 107 ACTVG-----GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPT 181 (375)
T ss_pred eeccC-----CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccc
Confidence 98654 45799999997 69998886432
Q ss_pred ----------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 139 ----------------------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 139 ----------------------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
.+++..+..++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a 261 (375)
T cd05104 182 KADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA 261 (375)
T ss_pred ccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccc
Confidence 3678889999999999999999999999999999999999999999999998
Q ss_pred cccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccc
Q 017231 191 RTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETS 266 (375)
Q Consensus 191 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 266 (375)
........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||....................
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--- 337 (375)
T cd05104 262 RDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--- 337 (375)
T ss_pred eeccCcccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC---
Confidence 65443221 112234567999999987 678999999999999999997 8999976543332222211000000
Q ss_pred ccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.....+.++.++|.+||+.||++||++.+|++.
T Consensus 338 --------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 338 --------------------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 002346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=293.55 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=203.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||.|++|.||++.+..+++.|++|.+..... ......+.+|++++++++||||+++++++..... +.+++||
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~ 80 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESS---SSIGIAM 80 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC---CeEEEEE
Confidence 68999999999999999999999999999865432 2345678899999999999999999998865432 5689999
Q ss_pred eCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 124 ELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 124 e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
||++ ++|.+++.. ...+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL- 159 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc-
Confidence 9997 588887643 3458999999999999999999999999999999999999999999999999876543322
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh--hHHHHHHHHHhCCCCcccccccccchhH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... ...................
T Consensus 160 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 229 (287)
T cd06621 160 AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK--------- 229 (287)
T ss_pred cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc---------
Confidence 223456788999999877 6789999999999999999999999976531 1111111111110000000
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.. .......++.+.++|.+||..+|++|||+.|++.||||++.
T Consensus 230 -----------~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 230 -----------DE-PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred -----------cC-CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 00 00001246779999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=291.57 Aligned_cols=249 Identities=30% Similarity=0.481 Sum_probs=206.4
Q ss_pred ccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCC
Q 017231 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 126 (375)
Q Consensus 48 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 126 (375)
||.|++|.||++.+..+++.|++|.+..... .......+..|++++++++|+|++++++.+... ...++++||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-----KNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-----cEEEEEEecC
Confidence 6899999999999999999999999865432 234556788999999999999999999888543 5689999999
Q ss_pred C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--------
Q 017231 127 D-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-------- 197 (375)
Q Consensus 127 ~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-------- 197 (375)
. ++|.+++.+.+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 7 5999999887889999999999999999999999999999999999999999999999999876543321
Q ss_pred -ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 198 -FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 198 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
......++..|+|||...+ ...+.++|+||||+++|+|++|..||...........+.......+.
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 222 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE------------ 222 (265)
T ss_pred ccccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCc------------
Confidence 1223456788999999877 56889999999999999999999999877655554443321100000
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH---HHHhcCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV---DEALCHPYLAPL 331 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~---~ell~~~~f~~~ 331 (375)
...++..+.++|.+||+.+|.+|||+ .++++||||+++
T Consensus 223 -----------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 223 -----------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred -----------------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 01247889999999999999999999 999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=288.62 Aligned_cols=249 Identities=30% Similarity=0.493 Sum_probs=210.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||.|++|.||++.+..++..|++|++............+..|+++++.++|+|++++++.+... ...++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~lv~ 78 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLCIVM 78 (258)
T ss_pred EEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEEEEE
Confidence 68999999999999999999999999999976655555677788999999999999999999988654 5689999
Q ss_pred eCCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 124 ELMD-TDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 124 e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
|+++ ++|.+.+... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9997 5999998764 679999999999999999999999999999999999999999999999999887654443
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
......+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||...+............ ...
T Consensus 159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~------------- 222 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--YPP------------- 222 (258)
T ss_pred eecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--CCC-------------
Confidence 2334567888999999877 668899999999999999999999997776444443322211 000
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....++..+.+++.+||+.+|++||++.++|+||||
T Consensus 223 ---------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 223 ---------------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 012457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=291.08 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=205.4
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|++....+.+.+.||+|++|.||++.++.+++.|++|.+... ......+..|+.++++++|+|++++++++...
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 74 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE--- 74 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCC---
Confidence 566666677899999999999999999999999999998643 22345688999999999999999999988544
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
..++++|||++ ++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 75 --~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 75 --PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred --CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 55799999996 6999998764 358999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccc--cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 192 TTSETDFMT--EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 192 ~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
......... ...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 224 (263)
T cd05052 153 LMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRM------- 224 (263)
T ss_pred ccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC-------
Confidence 654432211 2233567999999877 678899999999999999998 99999877655544443221100
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++++.++|.+||+.||++||++.++++
T Consensus 225 -----------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 225 -----------------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 001346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.81 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=202.7
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCC-----cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETR-----EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
..+++.+.||+|++|.||++.+...+ ..|++|.+.... .......+.+|+..+++++|||++++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE--- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC---
Confidence 45568999999999999999876655 679999886442 333456788999999999999999999998644
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 177 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~ 177 (375)
...+++|||++ ++|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++
T Consensus 81 --~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 81 --QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 45799999997 6999999764 4588899999999999999999999999999999999999
Q ss_pred cCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHH
Q 017231 178 ANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLR 253 (375)
Q Consensus 178 ~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~ 253 (375)
.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE 237 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999886543322 1223455788999999877 678999999999999999998 999998877655544
Q ss_pred HHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 254 LITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.+...... .....+++++.+++.+||+.||.+||++.+|+++
T Consensus 238 ~i~~~~~~------------------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRSRQLL------------------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHcCCcC------------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43321110 0013568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=288.89 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=200.3
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
.+.......||+|++|.||++.+..++..|++|.+... .......+.+|+.++++++|+||+++++++... ..
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 79 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-----GF 79 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----CE
Confidence 33344466899999999999999999999999988644 233456788999999999999999999998654 56
Q ss_pred EEEEEeCCC-CCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-CCCEEEeeccccccc
Q 017231 119 VYIVYELMD-TDLHQIIRSH-QDL--TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTT 193 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~-~~l--~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-~~~i~l~Df~~~~~~ 193 (375)
.++++||++ ++|.+++... ..+ ++..+..++.||+.||.+||+.|++|+||+|+||+++. ++.++|+|||.+...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 899999997 6999998764 445 88999999999999999999999999999999999976 678999999988654
Q ss_pred CCCC-ccccccccccccCchhcccC-CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 194 SETD-FMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 194 ~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
.... ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...................+
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 231 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP-------- 231 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCC--------
Confidence 3322 12234568889999998652 3478899999999999999999999965432111110000000000
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.....+++++.+++.+||+.+|++|||+.+++.||||
T Consensus 232 --------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 232 --------------------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred --------------------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 0012467889999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=297.64 Aligned_cols=256 Identities=25% Similarity=0.459 Sum_probs=207.3
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
++.....||.|+||.||++.+..+++.|++|.+.... ......+.+|+.+++.+.|||++++++.+... ...+
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~ 94 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-----EELW 94 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeC-----CeEE
Confidence 3445678999999999999999999999999985432 22345678899999999999999999988654 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
+++||++ ++|.+++.. ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 95 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~ 173 (297)
T cd06659 95 VLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 173 (297)
T ss_pred EEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence 9999997 578776644 569999999999999999999999999999999999999999999999999876443321 1
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......+... ...
T Consensus 174 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~-------------- 235 (297)
T cd06659 174 RKSLVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP-------------- 235 (297)
T ss_pred ccceecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CCC--------------
Confidence 234567889999999987 67899999999999999999999999776644444332211 000
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.......++..+.++|.+||+.+|++||+++++++||||.+...
T Consensus 236 -----------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 236 -----------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred -----------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 00111346788999999999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=293.10 Aligned_cols=248 Identities=33% Similarity=0.547 Sum_probs=208.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+.+.||+|++|.||++.+..+++.|++|++.... ........+..|+.+++++. |+||+++++.+... ...++
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~l 79 (280)
T cd05581 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----ENLYF 79 (280)
T ss_pred EeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----ceEEE
Confidence 7899999999999999999999999999987643 23334467788999999998 99999999988544 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc--
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-- 198 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~-- 198 (375)
+||++. ++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999995 79999999888899999999999999999999999999999999999999999999999998865443221
Q ss_pred -------------------cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHh
Q 017231 199 -------------------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 259 (375)
Q Consensus 199 -------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 259 (375)
.....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...........+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE 238 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC
Confidence 123356788999999887 668899999999999999999999998876544444333211
Q ss_pred CCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH----HHHhcCCCC
Q 017231 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV----DEALCHPYL 328 (375)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f 328 (375)
...+ ..+++.+.++|++||+.+|++||++ +++++||||
T Consensus 239 ~~~~-------------------------------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 239 YSFP-------------------------------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCC-------------------------------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 1110 2357889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=300.43 Aligned_cols=265 Identities=28% Similarity=0.423 Sum_probs=222.4
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCc-ccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
+-+...++..-+.||+||||.||.++-+.||+.||+|.+.+. ...+......+.|-.+|.+++.+.||.+-..|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf----- 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF----- 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----
Confidence 556777788899999999999999999999999999987542 22333445567899999999999999998888
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
+..+.+|+|+..|. |+|.-.|...+ .+++..++.++.+|+.||++||+.+|++||+||+|||+|..|++.|+|+|++
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLA 334 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLA 334 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceE
Confidence 44477999999997 69988876655 7999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 191 RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 191 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
.............||..|+|||++.+ ..|+...|+|||||++|+|+.|+.||.......-...+.......+...
T Consensus 335 vei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey---- 409 (591)
T KOG0986|consen 335 VEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEY---- 409 (591)
T ss_pred EecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhc----
Confidence 98888877777799999999999999 5699999999999999999999999976543333222222211111110
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
....|++++++.+.+|..||.+|. ++.++-+||||+.++
T Consensus 410 -----------------------~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 410 -----------------------SDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred -----------------------ccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 134699999999999999999998 678999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=288.74 Aligned_cols=304 Identities=21% Similarity=0.371 Sum_probs=252.0
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhc-CCCCeeeeceeec
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIR 109 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~ 109 (375)
...|.+....+.+++.||+|+|++|.+++++++.+.||+|+++++.. +.+..+-...|-.+..+. +||.+|.++.+|.
T Consensus 242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq 321 (593)
T KOG0695|consen 242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ 321 (593)
T ss_pred ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence 35677888888899999999999999999999999999999988653 344555667788888877 6999999999995
Q ss_pred CCCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 110 PPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
.. ..+++|.||++ |+|--.+++...++++.++.+...|+.||.|||+.||+++|||.+|++++..|++||.|+|
T Consensus 322 te-----srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdyg 396 (593)
T KOG0695|consen 322 TE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 396 (593)
T ss_pred cc-----ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccc
Confidence 44 66999999997 6998889999999999999999999999999999999999999999999999999999999
Q ss_pred cccc-cCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCC-------C-hhHHHHHHHHHh
Q 017231 189 LART-TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK-------D-YVHQLRLITELI 259 (375)
Q Consensus 189 ~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-------~-~~~~~~~i~~~~ 259 (375)
.++. ....+..++++||+.|+|||++.+ ..|....|+|+||++|+||+.|+.||+-. + ++-..+.|.+..
T Consensus 397 mcke~l~~gd~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 397 MCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred hhhcCCCCCcccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence 8865 445567889999999999999999 88999999999999999999999999521 1 111222222221
Q ss_pred CCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC------CHHHHhcCCCCCCCC-
Q 017231 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI------TVDEALCHPYLAPLH- 332 (375)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp------s~~ell~~~~f~~~~- 332 (375)
...| ..+|-....+++..|++||.+|. .+.++-.|+||+.++
T Consensus 476 irip-------------------------------rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 476 IRIP-------------------------------RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred cccc-------------------------------ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 1111 12466678899999999999997 568999999999986
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 017231 333 DINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDP 373 (375)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (375)
+.-++.....+|.+..+.. +..++++.+...+.++..||.
T Consensus 525 d~leqk~v~ppf~p~i~~d-~~l~~fd~qft~e~~qltpdd 564 (593)
T KOG0695|consen 525 DLLEQKQVLPPFQPQITDD-YGLDNFDTQFTSEPVQLTPDD 564 (593)
T ss_pred HHHhhcccCCCCCCccccc-cCccccccccccCCcccCCCC
Confidence 4445555666788765544 888899999999999999985
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=292.37 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=205.7
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC---CCCeeeeceeecCCCCCCcCc
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+++++.||.|++|.||++.+..+++.|++|.+.... .......+..|+.+++++. |||++++++.+... ..
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-----~~ 76 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-----PR 76 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-----CE
Confidence 447899999999999999999999999999986542 2234556778999999986 99999999988543 56
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
.+++|||++ ++|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred EEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 899999997 589888865 479999999999999999999999999999999999999999999999999886654432
Q ss_pred -ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 198 -FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 198 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
......++..|+|||.+.+...++.++|+||||+++|+|++|..||...........+.. ..+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~---~~~~------------ 220 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK---SKPP------------ 220 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc---CCCC------------
Confidence 123346788899999987645678999999999999999999999976543222211100 0000
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
......++.++.+++.+||+.||++||++.+++.|+||++..
T Consensus 221 --------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 221 --------------RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred --------------CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 000012578899999999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=296.41 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=205.5
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
.+++.||.|++|.||++.+..++..||+|.+..... ......+..|+.++++++|+|++++++.+... ...++|
T Consensus 7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 80 (277)
T cd06642 7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKLWII 80 (277)
T ss_pred HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----CceEEE
Confidence 368889999999999999999999999999865432 23456788999999999999999999998654 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-cc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MT 200 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~-~~ 200 (375)
+||++ ++|.+++.. ..+++..++.++.||+.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 81 MEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence 99997 588888764 5689999999999999999999999999999999999999999999999998866543321 22
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+... ..
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~~------------------ 218 (277)
T cd06642 160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--SP------------------ 218 (277)
T ss_pred cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC--CC------------------
Confidence 3456888999999887 67889999999999999999999999765433322211100 00
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
......++..+.++|.+||+.+|++||++.++++||||+...
T Consensus 219 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 219 ----------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred ----------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 000123577899999999999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=286.19 Aligned_cols=253 Identities=30% Similarity=0.479 Sum_probs=210.6
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|++|.||++.+..++..|++|++..........+.+.+|+..+++++|+|++++++.+.... ....++++
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~lv~ 80 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLNIFL 80 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEEEEE
Confidence 578999999999999999999999999998765544456778899999999999999999999986542 25689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc---c
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---M 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~---~ 199 (375)
|+++ ++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9995 69999998888999999999999999999999999999999999999999999999999998877665543 3
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+ ...+.++|+||||+++++|++|..||...+. ....+.......
T Consensus 161 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~----------------- 220 (260)
T cd06606 161 GSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGSSG----------------- 220 (260)
T ss_pred cCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccccC-----------------
Confidence 45567888999999887 5689999999999999999999999977651 111111111000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.........+..+.++|.+||+.||++||++.+++.||||
T Consensus 221 ---------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 221 ---------EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ---------CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0000112457889999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=291.12 Aligned_cols=261 Identities=25% Similarity=0.425 Sum_probs=206.2
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeec
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR 109 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 109 (375)
|++..+.+++.+.||+|++|.||++.++. .+..||+|.+..... ......+..|+..++.++|+|++++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 56677777789999999999999997652 345799998865432 233456788999999999999999999986
Q ss_pred CCCCCCcCcEEEEEeCCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec
Q 017231 110 PPQRETFNDVYIVYELMD-TDLHQIIRSH----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 178 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~ 178 (375)
.. ...+++|||++ |+|.+++... ..++...+..++.||+.||.+||++|++|+||||+||+++.
T Consensus 80 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~ 154 (288)
T cd05061 80 KG-----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH 154 (288)
T ss_pred CC-----CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC
Confidence 54 45799999997 7999999753 23567788999999999999999999999999999999999
Q ss_pred CCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHH
Q 017231 179 NCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRL 254 (375)
Q Consensus 179 ~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~ 254 (375)
++.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+..+....
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF 233 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999998865433221 112234667999999877 678999999999999999998 7889987665554433
Q ss_pred HHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc------CCCC
Q 017231 255 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC------HPYL 328 (375)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~------~~~f 328 (375)
+... ... ......++.+.+++.+||+.||++|||+.++++ ||||
T Consensus 234 ~~~~--~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~ 283 (288)
T cd05061 234 VMDG--GYL----------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 283 (288)
T ss_pred HHcC--CCC----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCC
Confidence 3211 000 001234678999999999999999999999987 9999
Q ss_pred CCCC
Q 017231 329 APLH 332 (375)
Q Consensus 329 ~~~~ 332 (375)
..+.
T Consensus 284 ~~~~ 287 (288)
T cd05061 284 PEVS 287 (288)
T ss_pred CCCC
Confidence 8763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=289.29 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=193.3
Q ss_pred Ceee--ccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRP--VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~--lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+.+. ||+|+||.||++.++.++..+++|.+....... .|+.....+ +|+|++++++.+... +..+
T Consensus 18 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~-----~~~~ 85 (267)
T PHA03390 18 IVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTL-----KGHV 85 (267)
T ss_pred cccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecC-----CeeE
Confidence 4444 599999999999999999999999985432111 122222222 799999999999665 4689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-CEEEeecccccccCCCCc
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDF 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-~i~l~Df~~~~~~~~~~~ 198 (375)
+||||++ ++|.+++.....+++.+++.++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 86 iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 9999996 69999998888899999999999999999999999999999999999999998 9999999988655433
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH-HHHHHHHhCCCCcccccccccchhHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ-LRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
....++..|+|||++.+ ..++.++|+||||+++|+|++|..||........ ...+......
T Consensus 164 -~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 225 (267)
T PHA03390 164 -SCYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK---------------- 225 (267)
T ss_pred -ccCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc----------------
Confidence 23457888999999987 6788999999999999999999999975443221 1111111100
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-HHHHhcCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-VDEALCHPYLAP 330 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-~~ell~~~~f~~ 330 (375)
.....+.+++.+.++|.+||+.+|.+||+ ++++|+||||++
T Consensus 226 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 226 ------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 00111357889999999999999999996 699999999974
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=283.53 Aligned_cols=249 Identities=30% Similarity=0.497 Sum_probs=207.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
.+.+.||.|++|.||++.+..+++.+++|++..... .....+.+|+.++++++|++++++++.+... ...+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~ 75 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV 75 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence 468999999999999999999999999999866432 3456788999999999999999999998655 558999
Q ss_pred EeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 123 YELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
+||++ ++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 155 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN 155 (253)
T ss_pred EecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccc
Confidence 99998 6999998776 579999999999999999999999999999999999999999999999999887665543234
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||.+.+ ...+.++|+||||+++++|++|..||...+.......... ...+...
T Consensus 156 ~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~-------------- 218 (253)
T cd05122 156 TMVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPPGLR-------------- 218 (253)
T ss_pred ceecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCCCcC--------------
Confidence 5667888999999887 5688999999999999999999999987654443333222 1000000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~ 327 (375)
....++..+.++|.+||+.||++|||+.+++.|||
T Consensus 219 ------------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 219 ------------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00123778999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=285.89 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=208.6
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++.+.||.|++|.||++.++.+++.+++|.+............+..|+.++++++|+|++++++++... ...++|
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v 77 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLCIV 77 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEEEE
Confidence 368999999999999999999999999999876554555567788999999999999999999988654 568999
Q ss_pred EeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 123 YELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
+||++ ++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99997 589988866 356899999999999999999999999999999999999999999999999988765544
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
......++..|+|||.+.+ ..++.++|+||||+++++|++|+.||...+.......+... ..+
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~~-------------- 219 (256)
T cd08530 157 MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--KYP-------------- 219 (256)
T ss_pred CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCC--------------
Confidence 2334557888999999987 67889999999999999999999999877654433332211 000
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.....++.++.++|.+||+.+|++||++.++++||++
T Consensus 220 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 220 --------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred --------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0012357889999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=293.86 Aligned_cols=270 Identities=23% Similarity=0.361 Sum_probs=210.7
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeec
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIR 109 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~ 109 (375)
..+.|.+..+.+++.+.||+|++|.||++.++.+++.||+|.+...... .....+..|+.++.++. |+|++++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred cceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 3455666777778999999999999999999999999999998654322 23445566777666664 999999999986
Q ss_pred CCCCCCcCcEEEEEeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEeec
Q 017231 110 PPQRETFNDVYIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDF 187 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~Df 187 (375)
.. ...+++|||+++++.+++.. ...+++..+..++.||+.|+.+||+ .|++|+||+|+||+++.++.++|+||
T Consensus 85 ~~-----~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 85 TD-----SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred cC-----CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECcc
Confidence 54 55899999998888887765 4569999999999999999999997 59999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCchhcccC---CCCCccchhHHHHHHHHHHhhCCCCCCCCCh-hHHHHHHHHHhCCCC
Q 017231 188 GLARTTSETDFMTEYVVTRWYRAPELLLNC---SEYTAAIDIWSVGCILGEIMTRQPLFPGKDY-VHQLRLITELIGSPD 263 (375)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~ 263 (375)
|.+.............++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||..... .+.+..+.. ...
T Consensus 160 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~ 236 (296)
T cd06618 160 GISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEP 236 (296)
T ss_pred ccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---CCC
Confidence 988665433333334567789999998752 2378899999999999999999999976432 122221111 100
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
.. . .....++.++.++|.+||+.||++||++++++.|+||+.....
T Consensus 237 ~~-------------------~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 282 (296)
T cd06618 237 PS-------------------L------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA 282 (296)
T ss_pred CC-------------------C------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence 00 0 0001357889999999999999999999999999999975443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=289.84 Aligned_cols=252 Identities=27% Similarity=0.407 Sum_probs=197.1
Q ss_pred eccCCcceEEEEEEeCCCCcEEEEEEecCcccch-HHHHHHHHHH---HHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 47 PVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR-IDAKRTLREI---KLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 47 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~---~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
.||+|++|.||++.+..+++.||+|.+....... ........|. ..++...||+++.+++.+... ..+++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEE
Confidence 4899999999999999999999999986543221 1112233333 344455799999999988654 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 201 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~ 201 (375)
|||+. ++|.+++...+.+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 154 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHA 154 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-CcC
Confidence 99997 6899999888889999999999999999999999999999999999999999999999999886543322 234
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..++..|+|||.+.+...++.++|+||+|+++|+|++|..||....................
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------ 216 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------------------ 216 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCC------------------
Confidence 56889999999987645688999999999999999999999976532211111100000000
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
.....+++++.++|.+||..+|.+|| ++.++++||||+...
T Consensus 217 ----------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 217 ----------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred ----------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 00123588999999999999999999 999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=289.58 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=201.7
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeec
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR 109 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 109 (375)
|.+..+.+++.+.||+|++|+||++.++. ++..||+|.+.... .......+..|+.+++.++|+|++++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 55666777789999999999999998653 45679999885432 2334566889999999999999999999985
Q ss_pred CCCCCCcCcEEEEEeCCC-CCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec
Q 017231 110 PPQRETFNDVYIVYELMD-TDLHQIIRSHQ----------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 178 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~ 178 (375)
.. ...++||||++ ++|.+++.... .++...+..++.|++.||.+||+.|++|+||||+||+++.
T Consensus 80 ~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~ 154 (277)
T cd05062 80 QG-----QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 154 (277)
T ss_pred CC-----CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC
Confidence 44 56899999997 69999986532 2577889999999999999999999999999999999999
Q ss_pred CCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHH
Q 017231 179 NCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRL 254 (375)
Q Consensus 179 ~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~ 254 (375)
++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...........
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~ 233 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999998865433221 112334677999999887 678999999999999999998 7899987765555443
Q ss_pred HHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 255 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
+...... . .....++.+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~--~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 234 VMEGGLL--D----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHcCCcC--C----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3221100 0 012357789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=286.32 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=197.5
Q ss_pred eeccCCcceEEEEEEe--CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMN--SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||++.+ +.++..+|+|++..........+.+..|+.+++.+.|+|++++++++.. ...+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~ 74 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVM 74 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEE
Confidence 3689999999999964 5567899999987655455556788999999999999999999998743 3368999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc---
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--- 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~--- 199 (375)
||++ ++|.+++.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 75 ELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9997 689999988888999999999999999999999999999999999999999999999999998765433211
Q ss_pred -ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 200 -TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 200 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...........+..... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~-~--------------- 217 (257)
T cd05116 155 KTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER-M--------------- 217 (257)
T ss_pred cCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC-C---------------
Confidence 11223567999999876 678889999999999999998 9999987765555444432110 0
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++++.++|.+||+.||++||++.+|..
T Consensus 218 --------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 --------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred --------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 001246889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=283.98 Aligned_cols=250 Identities=32% Similarity=0.506 Sum_probs=210.0
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++.+.||+|++|.||++.+..+++.|++|.+............+..|++++++++|+|++++++++... ...+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v 77 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-----DSLYII 77 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-----CEEEEE
Confidence 368999999999999999999999999999977655445667899999999999999999999988543 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-cc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MT 200 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~-~~ 200 (375)
+|+++ ++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 99997 59999998888899999999999999999999999999999999999999999999999998876554432 23
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||...+ ...+.++|+|+||+++++|++|..||...+.......+.. ...+
T Consensus 158 ~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~----------------- 217 (254)
T cd06627 158 SVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ--DDHP----------------- 217 (254)
T ss_pred ccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--cCCC-----------------
Confidence 4567888999999877 5588999999999999999999999976653332222211 0000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
...+.++..+.++|.+||..+|++||++.+++.||||
T Consensus 218 -----------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 218 -----------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -----------CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0013467889999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=287.13 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=202.9
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|++....+++++.||+|++|.||++.+.. ++.||+|.+..... ....+.+|+.++++++|+|++++++++...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 73 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE--- 73 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecC---
Confidence 56777778899999999999999999754 46899999865422 245678899999999999999999988544
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
+..+++|||++ ++|.+++.... .+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 74 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 74 --EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred --CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 55899999995 79999997654 69999999999999999999999999999999999999999999999999887
Q ss_pred ccCCCCccc--cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 192 TTSETDFMT--EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 192 ~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
......... ....+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.........+...... +
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~----- 224 (261)
T cd05068 152 VIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-P----- 224 (261)
T ss_pred EccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-C-----
Confidence 654322111 1122457999999877 678999999999999999999 99999877655544443321110 0
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+..+.+++.+||+.+|++||++.+++.
T Consensus 225 ------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 225 ------------------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ------------------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 01245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=291.84 Aligned_cols=252 Identities=26% Similarity=0.403 Sum_probs=206.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
..+.||+|++|.||++.+..++..|++|.+.... ........+..|+.+++.++|||++++++++... ...+++
T Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv 99 (313)
T cd06633 25 GLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAWLV 99 (313)
T ss_pred cceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEE
Confidence 5788999999999999999999999999986543 2333446688899999999999999999998654 557999
Q ss_pred EeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccc
Q 017231 123 YELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 201 (375)
Q Consensus 123 ~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~ 201 (375)
|||+.|++.+++.. ...+++..++.++.||+.|+.+||++|++|+||+|+||+++.++.++|+|||.+..... ...
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~ 176 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANS 176 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCC
Confidence 99999999888865 45689999999999999999999999999999999999999999999999998754332 234
Q ss_pred ccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 202 YVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
..++..|+|||.+.. ...++.++|+||||+++|+|++|..||...+.......+.... .+.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~~~--------------- 239 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--SPT--------------- 239 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--CCC---------------
Confidence 567888999999842 2457889999999999999999999997776544443332211 000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.....++..+.++|.+||+.+|.+||++.++++||||+...
T Consensus 240 ------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 240 ------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred ------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 00123567799999999999999999999999999999644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=286.51 Aligned_cols=249 Identities=29% Similarity=0.469 Sum_probs=204.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||.|++|.||++.++.++..|++|.+..........+.+..|+.+++.++|+|++++++.+... ...++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~ 78 (257)
T cd08225 4 IIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-----GRLFIVM 78 (257)
T ss_pred EEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-----CeEEEEE
Confidence 68999999999999999999999999999865433334456778999999999999999999988544 5689999
Q ss_pred eCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC-EEEeecccccccCCCCc-
Q 017231 124 ELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-LKIGDFGLARTTSETDF- 198 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~-i~l~Df~~~~~~~~~~~- 198 (375)
||+. ++|.+++.... .+++..+..++.||+.||.+||+.+++|+||+|+||+++.++. ++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL 158 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence 9997 59999987654 4799999999999999999999999999999999999988865 69999998866543321
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....++..|+|||.+.+ ..++.++|+||||+++++|++|..||...+.......+... ..
T Consensus 159 ~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------------- 219 (257)
T cd08225 159 AYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG--YF---------------- 219 (257)
T ss_pred ccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--cC----------------
Confidence 223457888999999877 66889999999999999999999999776544433322210 00
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....+.++.++.++|.+||..+|++|||+.++++||||
T Consensus 220 ------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 220 ------------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00113467889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=285.89 Aligned_cols=247 Identities=29% Similarity=0.464 Sum_probs=203.7
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++.+.||.|++|.||++.++.++..|++|.+.... .....+.+..|+.+++.++|+|++++++.+... ..++++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 76 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-----GHLYIV 76 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEE
Confidence 36899999999999999999999999999986443 233456778899999999999999999998544 678999
Q ss_pred EeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 123 YELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
+||++ ++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 77 MEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred EeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence 99997 6999988653 458999999999999999999999999999999999999999999999999886554332 2
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|..||...+.......+.......
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---------------- 219 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---------------- 219 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC----------------
Confidence 234567888999999887 678999999999999999999999998776555444332211000
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~ 326 (375)
....++..+.++|.+||+.||++||++.++++--
T Consensus 220 --------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 253 (255)
T cd08219 220 --------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG 253 (255)
T ss_pred --------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence 0123577899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=299.44 Aligned_cols=284 Identities=18% Similarity=0.235 Sum_probs=205.2
Q ss_pred eeeccCC--cceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 45 IRPVGRG--AYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 45 ~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
...||+| ++|+||++.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++... ...+++
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v 77 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVI 77 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEE
Confidence 3566777 899999999999999999999876554455567888999999999999999999999654 558999
Q ss_pred EeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-
Q 017231 123 YELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF- 198 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~- 198 (375)
+||+. ++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++++||+.+........
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99997 6999988764 3589999999999999999999999999999999999999999999999975432211100
Q ss_pred -------cccccccccccCchhcccC-CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 199 -------MTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 199 -------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
.....++..|+|||++.+. ..++.++|+|||||++|+|++|..||...................+. .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 236 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL-DITTF 236 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc-ccccc
Confidence 0111235569999998752 34789999999999999999999999876644433222221110000 00000
Q ss_pred ccchhH------HHhhhCC----------CCCCCC-ccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 271 RSDNAR------RYVRMLP----------QFPKQN-FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 271 ~~~~~~------~~~~~~~----------~~~~~~-~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
...... .....+. ...... .......+++.+.++|++||+.||++|||++++|+|+||+.+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000000 0000000 000000 00111246778999999999999999999999999999998765
Q ss_pred C
Q 017231 334 I 334 (375)
Q Consensus 334 ~ 334 (375)
.
T Consensus 317 ~ 317 (328)
T cd08226 317 Q 317 (328)
T ss_pred h
Confidence 3
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=285.45 Aligned_cols=252 Identities=26% Similarity=0.476 Sum_probs=204.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc---cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
++.+.||+|++|.||++.+..+++.|++|.+.... ........+.+|+.++++++|+|++++++.+..... ..+
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~---~~~ 81 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE---KKL 81 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC---CEE
Confidence 37899999999999999999999999999875321 123345678899999999999999999998865432 457
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
++++||++ ++|.+.+...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 89999997 5999999887889999999999999999999999999999999999999999999999999886543211
Q ss_pred ---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 198 ---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+ .......
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~--------- 228 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQPTKP--------- 228 (264)
T ss_pred cCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCCCCC---------
Confidence 1123457888999999987 66889999999999999999999999766443333222 1111100
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.....+++.+.++|.+||. +|.+||++.+++.|||.
T Consensus 229 -----------------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 -----------------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred -----------------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0013468889999999999 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=288.60 Aligned_cols=253 Identities=24% Similarity=0.435 Sum_probs=204.6
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCC-----cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeec
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETR-----EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR 109 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 109 (375)
|++..+.+.+.+.||+|++|.||++.++..+ ..|++|.+.... .......+.+|+.+++.++|+|++++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 6777788889999999999999999886544 789999985442 2334567889999999999999999999986
Q ss_pred CCCCCCcCcEEEEEeCCC-CCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec
Q 017231 110 PPQRETFNDVYIVYELMD-TDLHQIIRSHQ----------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 178 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~ 178 (375)
.. ...+++|||++ |+|.+++.... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.
T Consensus 80 ~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~ 154 (277)
T cd05032 80 TG-----QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154 (277)
T ss_pred CC-----CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC
Confidence 54 55899999996 79999986532 3678899999999999999999999999999999999999
Q ss_pred CCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHH
Q 017231 179 NCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRL 254 (375)
Q Consensus 179 ~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~ 254 (375)
++.++|+|||.+........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 233 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH
Confidence 99999999998865433321 223345678999999877 678999999999999999998 9999987765555444
Q ss_pred HHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 255 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
+.. +.... .....+.++.++|.+||+.+|++|||+.++++
T Consensus 234 ~~~--~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 234 VID--GGHLD----------------------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred Hhc--CCCCC----------------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 331 11000 01234788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=287.23 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=200.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCc--EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC-CCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETRE--EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~ 120 (375)
+.+.||+|++|.||++++..++. .||+|.++...........+..|+.+++.++|+|++++++++.... .......+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 68899999999999999887775 6999998766555666778899999999999999999999765432 12234578
Q ss_pred EEEeCCC-CCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 121 IVYELMD-TDLHQIIRS------HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~------~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
+++||+. |+|.+++.. ...+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 162 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccccc
Confidence 9999997 699888742 234899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 194 SETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 194 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
..... .....++..|++||.+.+ ..++.++|+|||||++|+|++ |..||...........+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 233 (272)
T cd05075 163 YNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL-------- 233 (272)
T ss_pred CcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC--------
Confidence 43321 112234667999999887 678999999999999999999 88999776544433332221000
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+.++..+.++|.+||+.||++|||+.+|++.
T Consensus 234 ----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 234 ----------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ----------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0013467789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=292.48 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=208.0
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
.+...+.||+|++|.||++.+..++..|++|.+.... ........+..|+.++++++|+|++++++++... ...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeE
Confidence 3457899999999999999999999999999986542 2333456788999999999999999999998654 457
Q ss_pred EEEEeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 120 YIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 120 ~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
++||||+.|+|.+.+.. ...+++.++..++.+|+.|+.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 101 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 101 WLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred EEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 99999999998888754 456999999999999999999999999999999999999999999999999987654332
Q ss_pred cccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 199 MTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
....++..|+|||.+.+ ...++.++|+|||||++|+|++|..||...+.......+........
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 244 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL------------- 244 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC-------------
Confidence 34467888999999742 24578899999999999999999999977654444443332111100
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.....++.+.++|.+||+.+|.+||++.++++|+|+...
T Consensus 245 ----------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 245 ----------------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ----------------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 012357789999999999999999999999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=293.17 Aligned_cols=256 Identities=26% Similarity=0.443 Sum_probs=206.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|++|.||++.+..++..|++|.+... .....+.+..|+.+++.++|||++++++.+... ...++|+
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~ 95 (293)
T cd06647 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELWVVM 95 (293)
T ss_pred eeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEEEEE
Confidence 689999999999999999989999999998543 223356688999999999999999999988654 4589999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
||++ ++|.+++.+ ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred ecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 9997 699988865 458999999999999999999999999999999999999999999999999775543332 2233
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.. ...+.
T Consensus 175 ~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~----------------- 234 (293)
T cd06647 175 MVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT--NGTPE----------------- 234 (293)
T ss_pred ccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc--CCCCC-----------------
Confidence 457788999999877 6788999999999999999999999976553322211110 00000
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
......++..+.++|++||..+|++||++++++.|+||+.......
T Consensus 235 ---------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~ 280 (293)
T cd06647 235 ---------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSS 280 (293)
T ss_pred ---------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccc
Confidence 0011235778999999999999999999999999999998765554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=289.26 Aligned_cols=252 Identities=26% Similarity=0.430 Sum_probs=206.4
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++++.||+|++|.||++.+..++..||+|.+..... ......+.+|+..+++++|||++++++.+... ...++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 79 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWI 79 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEE
Confidence 3478899999999999999999999999998854422 23456788999999999999999999998554 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-c
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-M 199 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~-~ 199 (375)
||||++ ++|.+++.. ..+++..+..++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 80 v~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06641 80 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence 999997 588888764 5689999999999999999999999999999999999999999999999998865443321 2
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+ ...+.++|+|||||++|+|++|..||...........+... ..+
T Consensus 159 ~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~---------------- 219 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NPP---------------- 219 (277)
T ss_pred ccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CCC----------------
Confidence 23456788999999877 67888999999999999999999999765543333322110 000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.....++.++.++|.+||+.+|++||++.++++||||.+.
T Consensus 220 ------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 220 ------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0012457889999999999999999999999999999974
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=290.46 Aligned_cols=244 Identities=28% Similarity=0.455 Sum_probs=195.4
Q ss_pred CeeeccCCcceEEEEEEeC----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAMNS----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+.+.||.|.||.||.|... ..+..|+||.+... ......+.+.+|++.+++++||||+++++++... ...
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~ 76 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPL 76 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccc-----ccc
Confidence 6789999999999999987 45678999999543 3444578899999999999999999999999743 348
Q ss_pred EEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 120 YIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
++|+||+. |+|.+++... ..+++..++.|+.||+.||.|||+++++|++|+++||+++.++.+||+|||........
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999997 7999999887 67999999999999999999999999999999999999999999999999988765322
Q ss_pred C---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 197 D---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 197 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
. ..........|+|||.+.+ ..++.++||||||+++|||++ |..||...+.......+.......
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~---------- 225 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLP---------- 225 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETT----------
T ss_pred ccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccce----------
Confidence 1 1223445778999999987 568999999999999999999 789998887666555553221110
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....++..+.++|.+||+.||++||++.+|++
T Consensus 226 --------------------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 226 --------------------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp --------------------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred --------------------eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01246888999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=289.80 Aligned_cols=248 Identities=27% Similarity=0.398 Sum_probs=200.8
Q ss_pred cccCCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
..+.+.+.||+|++|.||++.+.. ++..||+|.+..... ......+.+|+++++++.|+|++++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEG--- 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence 345579999999999999998753 467899999865432 22456788999999999999999999998654
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ--------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 179 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~--------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~ 179 (375)
...+++|||++ ++|.+++...+ .+++..+..++.||+.|+.+||++|++|+||+|+||+++.+
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 56899999997 69999997643 37899999999999999999999999999999999999999
Q ss_pred CCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHH
Q 017231 180 CDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLI 255 (375)
Q Consensus 180 ~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i 255 (375)
+.++|+|||.+....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred CeEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 999999999886543221 1123344678999999987 678999999999999999998 99999877655554444
Q ss_pred HHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....... ....++..+.+++++||+.||++||++.|+++
T Consensus 238 ~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQGRLLQ------------------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HcCCcCC------------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3211000 01246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=284.11 Aligned_cols=242 Identities=23% Similarity=0.370 Sum_probs=194.3
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeC
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 125 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 125 (375)
+.||+|++|.||+++++.+++.||+|.+.... .......+..|++++++++||||+++++++... ...++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEee
Confidence 46999999999999999999999999876432 233456788999999999999999999998554 558999999
Q ss_pred CC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc---
Q 017231 126 MD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT--- 200 (375)
Q Consensus 126 ~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~--- 200 (375)
++ ++|.+++...+ .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 97 69999987644 58999999999999999999999999999999999999999999999999886543321111
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+......
T Consensus 155 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~------------------ 215 (252)
T cd05084 155 MKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL------------------ 215 (252)
T ss_pred CCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC------------------
Confidence 1122456999999877 668999999999999999997 88889766544333322211000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....++..+.+++.+||+.+|++||++.++++
T Consensus 216 ------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 216 ------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001235788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=291.45 Aligned_cols=255 Identities=26% Similarity=0.495 Sum_probs=207.6
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+....+||+|++|.||++.++.+++.||+|.+... .......+..|+.+++.++|+|++++++.+... ...++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 94 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 94 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEE
Confidence 33457899999999999999999999999988533 233456688999999999999999999998654 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
+|||++ ++|.+++. ...+++..++.++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 95 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 95 VMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred EEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 999997 47877664 4568999999999999999999999999999999999999999999999999876543321 12
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+.......
T Consensus 174 ~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~----------------- 235 (292)
T cd06657 174 KSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK----------------- 235 (292)
T ss_pred cccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-----------------
Confidence 23457888999998876 667899999999999999999999998766554444332211100
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
......+++.+.++|.+||+.||.+||++.++++||||.....
T Consensus 236 -----------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 236 -----------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred -----------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 0011346788999999999999999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=314.59 Aligned_cols=283 Identities=25% Similarity=0.320 Sum_probs=197.1
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCc-EEEEE--------------EecC-cccchHHHHHHHHHHHHHHhcCCCCeeeec
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETRE-EVAIK--------------KIGN-AFDNRIDAKRTLREIKLLRHMDHENIIAIK 105 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~-~vaiK--------------~~~~-~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 105 (375)
|++++.||+|+||+||++..+.... ..+.| .+.+ ..........+.+|+.++++++|+||++++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 4489999999999999987654322 12222 1111 111222345678999999999999999999
Q ss_pred eeecCCCCCCcCcEEEEEeCCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC
Q 017231 106 DIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180 (375)
Q Consensus 106 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-----~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~ 180 (375)
+++... ...+++++++.++|.+++... .......++.++.||+.||.|||++||+|+||||+|||++.++
T Consensus 230 ~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 230 EILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred EEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 998654 457999999998998887543 2245677889999999999999999999999999999999999
Q ss_pred CEEEeecccccccCCCC--ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCC-CCCC--ChhHHHHHH
Q 017231 181 DLKIGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPGK--DYVHQLRLI 255 (375)
Q Consensus 181 ~i~l~Df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p-f~~~--~~~~~~~~i 255 (375)
.++|+|||++....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|..+ +... .....+..+
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999987654332 2234578999999999987 6789999999999999999998754 4322 222333333
Q ss_pred HHHhCCCCcccccccccchhHHHhhhCCCC-CCCCc--cccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 256 TELIGSPDETSLGFLRSDNARRYVRMLPQF-PKQNF--SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
............. . ......++...... ....+ ......++..+.++|.+||+.||.+|||+.|+|.||||....
T Consensus 384 ~~~~~~~~~~~p~-~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 384 IDSLSVCDEEFPD-P-PCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHhcccChhhcCC-c-HHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 3332221111000 0 00001111110000 00000 001123577889999999999999999999999999998753
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=286.08 Aligned_cols=250 Identities=23% Similarity=0.414 Sum_probs=202.5
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|++..+.++++++||+|++|.||++.+. ++..|++|.+... ....+.+..|+.++++++|+|++++++.+...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 73 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE--- 73 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC---
Confidence 6677788889999999999999999865 4567999987543 22356788999999999999999999988544
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
...++++||+. ++|.+++... ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+.
T Consensus 74 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 74 --EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred --CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence 55799999996 6999998653 458999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 192 TTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 192 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
....... .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...........+......
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------- 223 (261)
T cd05072 152 VIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM------- 223 (261)
T ss_pred ecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 6543321 112234567999999877 668889999999999999998 99999776544444333221100
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....++.++.+++.+||+.+|++||+++++++
T Consensus 224 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 224 -----------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 011346788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=301.97 Aligned_cols=260 Identities=25% Similarity=0.347 Sum_probs=205.1
Q ss_pred eecceeeeecccccCCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCee
Q 017231 29 NVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENII 102 (375)
Q Consensus 29 ~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv 102 (375)
.++..+|++.+..+.+++.||+|+||.||++.+.. ++..||+|++.... .....+.+..|+.+++++. ||||+
T Consensus 26 ~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv 104 (400)
T cd05105 26 LPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIV 104 (400)
T ss_pred CCCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCee
Confidence 34557899999999999999999999999998643 33579999986542 2334567889999999996 99999
Q ss_pred eeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC--------------------------------------------
Q 017231 103 AIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-------------------------------------------- 137 (375)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------------------------------------------- 137 (375)
++++++... ...++||||++ |+|.+++...
T Consensus 105 ~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (400)
T cd05105 105 NLLGACTKS-----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMD 179 (400)
T ss_pred eEEEEEccC-----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccc
Confidence 999998554 56899999997 7998887542
Q ss_pred ----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 017231 138 ----------------------------------------------------QDLTDDHCRYFLYQLLRGLKYVHSANVL 165 (375)
Q Consensus 138 ----------------------------------------------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~ 165 (375)
..+++..+..++.||+.||.+||+.|++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv 259 (400)
T cd05105 180 MKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV 259 (400)
T ss_pred cccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 2377888899999999999999999999
Q ss_pred ccCCCCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCC
Q 017231 166 HRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQP 241 (375)
Q Consensus 166 H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~ 241 (375)
|+||||+||+++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..
T Consensus 260 H~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~ 338 (400)
T cd05105 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGT 338 (400)
T ss_pred CCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999986543321 1223345678999999887 678999999999999999997 999
Q ss_pred CCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHH
Q 017231 242 LFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 321 (375)
Q Consensus 242 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~e 321 (375)
||................... .....++.++.+++.+||+.||++||++.+
T Consensus 339 P~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~ 389 (400)
T cd05105 339 PYPGMIVDSTFYNKIKSGYRM-----------------------------AKPDHATQEVYDIMVKCWNSEPEKRPSFLH 389 (400)
T ss_pred CCcccchhHHHHHHHhcCCCC-----------------------------CCCccCCHHHHHHHHHHCccCHhHCcCHHH
Confidence 997654332222111100000 001246788999999999999999999998
Q ss_pred Hhc
Q 017231 322 ALC 324 (375)
Q Consensus 322 ll~ 324 (375)
|.+
T Consensus 390 l~~ 392 (400)
T cd05105 390 LSD 392 (400)
T ss_pred HHH
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=284.58 Aligned_cols=243 Identities=26% Similarity=0.428 Sum_probs=203.6
Q ss_pred eeccCCcceEEEEEEeCCC---CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSET---REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.||+|++|.||++.+... +..|++|.+....... ....+..|+..++.++|+|++++++++... ..++++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEE
Confidence 4699999999999999866 8899999997654333 567788999999999999999999998653 568999
Q ss_pred EeCCC-CCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 123 YELMD-TDLHQIIRSH---------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~---------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
|||++ ++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99995 7999999875 7799999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 193 TSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 193 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------- 226 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL------- 226 (262)
T ss_pred cccccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 65432 2234456788999999887 578999999999999999998 69999887665555444331000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.....+++++.+++.+||+.+|++|||+.+++++
T Consensus 227 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 227 -----------------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -----------------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0012458889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=289.62 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=201.0
Q ss_pred ecccccCCeeeccCCcceEEEEEEeC-----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNS-----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
|.++.+.+.+.||+|++|.||++.+. .++..+++|.+... .......+..|+.++++++|||++++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34555668999999999999999853 34567999988543 333456788999999999999999999998544
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSHQ-------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 177 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~ 177 (375)
...++++||++ ++|.+++...+ .+++..++.++.||+.||.+||++|++|+||||+||+++
T Consensus 80 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~ 154 (288)
T cd05093 80 -----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 154 (288)
T ss_pred -----CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 56899999997 69999987543 389999999999999999999999999999999999999
Q ss_pred cCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHH
Q 017231 178 ANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLR 253 (375)
Q Consensus 178 ~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~ 253 (375)
.++.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||..........
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~ 233 (288)
T cd05093 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233 (288)
T ss_pred cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999875433221 122334677999999887 678999999999999999998 999998776555444
Q ss_pred HHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 254 LITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.+...... . ....++.++.+++.+||+.||.+|||+.+++.
T Consensus 234 ~i~~~~~~--~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 234 CITQGRVL--Q----------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHcCCcC--C----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 44321100 0 01235788999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=290.01 Aligned_cols=252 Identities=31% Similarity=0.498 Sum_probs=209.2
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.+.||.|++|.||++.+..++..|++|++..... ....+..|+..++.++|+|++++++.+... ...++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 92 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWV 92 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEE
Confidence 4478999999999999999998899999999865432 456688999999999999999999998655 56899
Q ss_pred EEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 122 VYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
++||++ ++|.+++...+ .++...++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 999998 69999998876 89999999999999999999999999999999999999999999999999875543321 1
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+...... . .
T Consensus 173 ~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~-~------------- 236 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP-P-L------------- 236 (286)
T ss_pred hccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC-C-C-------------
Confidence 223456788999999877 67899999999999999999999999876654443333221100 0 0
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
.....++..+.++|.+||+.+|.+||++.++++|+||++
T Consensus 237 -------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 237 -------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred -------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 001235788999999999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=283.80 Aligned_cols=245 Identities=22% Similarity=0.356 Sum_probs=197.8
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
..+++.+.||+|+||.||++..+. +..+|+|.+..... ....+..|+.++++++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCE
Confidence 345578999999999999998765 46799998754322 235678899999999999999999998554 558
Q ss_pred EEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 120 YIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
+++|||++ |+|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999997 6999998754 458999999999999999999999999999999999999999999999999886543332
Q ss_pred ccc--cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 198 FMT--EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 ~~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
... ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||...+.......+........
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~----------- 222 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR----------- 222 (256)
T ss_pred eeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC-----------
Confidence 211 2234567999999887 678999999999999999999 8999988776555554433111000
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+..+.+++.+||+.+|++||++.++++
T Consensus 223 -------------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 223 -------------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred -------------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0124677999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=287.25 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=200.0
Q ss_pred cccccCCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
....+.+.+.||+|++|.||++.+.. ++..|++|.+.... .......+..|+.++++++|+|++++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER- 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-
Confidence 34445589999999999999999987 77889999886432 233345688899999999999999999988554
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC---C
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQ-------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---D 181 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~-------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~---~ 181 (375)
...+++|||+. ++|.+++.... .+++..+..++.||+.||.+||+++++|+||+|+||+++.++ .
T Consensus 82 ----~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 82 ----LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred ----CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcc
Confidence 44689999996 69999997653 489999999999999999999999999999999999998765 5
Q ss_pred EEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHH
Q 017231 182 LKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 257 (375)
Q Consensus 182 i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~ 257 (375)
++|+|||.+........ ......+..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 99999999876533221 112233467999999987 678999999999999999997 9999987765544433322
Q ss_pred HhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 258 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
... .. ....++..+.+++.+||+.+|++||++.++++|
T Consensus 237 ~~~-~~-----------------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 GGR-LD-----------------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCc-CC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 100 00 012457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=286.00 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=201.1
Q ss_pred CCeeeccCCcceEEEEEEeCCC---CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC-CCcCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNSET---REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFND 118 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~ 118 (375)
.+.+.||+|+||.||.|.+..+ +..||+|.+............+..|+..++.++|+|++++++.+..... .....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 4789999999999999987653 4789999987655555556788999999999999999999998765432 23345
Q ss_pred EEEEEeCCC-CCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 119 VYIVYELMD-TDLHQIIRSH------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.++++||+. |+|..++... ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+.
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 161 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCcccee
Confidence 799999997 6998887442 358999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 192 TTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 192 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+..... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~---- 234 (273)
T cd05035 162 KIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR--L---- 234 (273)
T ss_pred eccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--C----
Confidence 5543321 112234567999999876 678999999999999999999 8999977665444433322100 0
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.....+++++.+++.+||+.||++||++.+++++
T Consensus 235 ------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 235 ------------------------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred ------------------------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0012467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=282.79 Aligned_cols=244 Identities=29% Similarity=0.509 Sum_probs=204.8
Q ss_pred ccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCC
Q 017231 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM 126 (375)
Q Consensus 48 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 126 (375)
||.|++|.||.+.+..+++.|++|++..... .......+..|+.++++++|+|++++++.+... ...+++||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-----EKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-----CeeEEEEecC
Confidence 6999999999999999999999999866432 233556788999999999999999999988543 5689999999
Q ss_pred C-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cccccccc
Q 017231 127 D-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVV 204 (375)
Q Consensus 127 ~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~~~~~ 204 (375)
+ ++|.+++.....+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+...... .......+
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 155 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG 155 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcC
Confidence 5 799999998888999999999999999999999999999999999999999999999999988765443 22344567
Q ss_pred cccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCC
Q 017231 205 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQ 284 (375)
Q Consensus 205 ~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (375)
+..|+|||...+ ...+.++|+||||+++|+|++|..||...+.....+.+.. ....
T Consensus 156 ~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~--------------------- 211 (250)
T cd05123 156 TPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLR--------------------- 211 (250)
T ss_pred CccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCC---------------------
Confidence 888999999887 5688899999999999999999999977765444333322 0000
Q ss_pred CCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH---HHHhcCCCC
Q 017231 285 FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV---DEALCHPYL 328 (375)
Q Consensus 285 ~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~---~ell~~~~f 328 (375)
.....+..+.++|++||..||++||++ +++++||||
T Consensus 212 --------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 212 --------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred --------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 002347889999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=285.19 Aligned_cols=248 Identities=29% Similarity=0.433 Sum_probs=199.2
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCc-ccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++.+.||+|++|.||+++++.+++.||||.+... .........+..|+.+++.++|||++++++.+... +..++
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~ 79 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NELNI 79 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----CeEEE
Confidence 3789999999999999999999999999987653 23444556788999999999999999999988654 56899
Q ss_pred EEeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 122 VYELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
++||++ ++|.+++.. ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999998 589888753 344899999999999999999999999999999999999999999999999988665433
Q ss_pred Cc-cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh--hHHHHHHHHHhCCCCcccccccccc
Q 017231 197 DF-MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 197 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
.. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ......+.. ...++.
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~--------- 228 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-CDYPPL--------- 228 (267)
T ss_pred hHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhc-CCCCCC---------
Confidence 21 223457788999999887 6788999999999999999999999865432 122211111 111100
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....++..+.++|.+||+.+|++||++.++++.
T Consensus 229 -------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 -------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred -------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 012357789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=283.60 Aligned_cols=245 Identities=20% Similarity=0.350 Sum_probs=196.7
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.+.+++.||+|++|+||++.+.. +..+|+|.+..... ....+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIY 75 (256)
T ss_pred HeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcE
Confidence 34478999999999999998754 45699998864322 235678999999999999999999998554 4579
Q ss_pred EEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 121 IVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
++|||+. |+|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 76 lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999996 6899998764 4689999999999999999999999999999999999999999999999998865433321
Q ss_pred cc--cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 199 MT--EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 199 ~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
.. ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.......
T Consensus 156 ~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 221 (256)
T cd05113 156 TSSVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLY------------- 221 (256)
T ss_pred eecCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC-------------
Confidence 11 2234567999999987 568899999999999999998 999998766554444432211110
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.....++.+.+++.+||+.||++||++.+|+.+
T Consensus 222 -----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 222 -----------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 001347889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=282.25 Aligned_cols=247 Identities=23% Similarity=0.362 Sum_probs=202.5
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|.+....+++.+.||.|++|.||++... ++.|++|.+..... ....+..|+.+++.++|+|++++++++...
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 72 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQG--- 72 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCC---
Confidence 4455667778999999999999999764 78899999865432 456788999999999999999999998653
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
...++||||++ ++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 73 --NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred --CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccc
Confidence 55899999997 69999998765 69999999999999999999999999999999999999999999999999887
Q ss_pred ccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 192 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 192 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
....... ....+..|+|||.+.+ ..++.++|+||||+++++|++ |..||...........+......
T Consensus 151 ~~~~~~~--~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 218 (256)
T cd05039 151 EASQGQD--SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM--------- 218 (256)
T ss_pred ccccccc--cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC---------
Confidence 6533321 2334567999999876 678889999999999999997 99999777654443333221000
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++.+.++|.+||+.+|++||++++++.
T Consensus 219 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 219 ---------------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ---------------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 001245788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=292.96 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=198.8
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcE----EEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREE----VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
...+++.+.||+|+||.||+|.+..++.. ||+|.+... ........+..|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 34455899999999999999998766654 899988643 2333456788999999999999999999988653
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..+++++|+. |+|.+++.... .++...++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 82 ---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 2578999996 79999998754 589999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCcc---ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 193 TSETDFM---TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 193 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
....... .....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+....+... +.......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~---- 232 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS-ILEKGERLPQ---- 232 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHhCCCCCCC----
Confidence 5433221 12233567999999987 678999999999999999997 999998765444322 2221111110
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.+.++..+.+++.+||+.+|++||++.+++.+
T Consensus 233 -------------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 233 -------------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -------------------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12356789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=283.42 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=202.5
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|++.++.++++++||+|++|.||+|..+. ++.||+|.+..... ....+..|+.++++++|+|++++++.+..
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 72 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ---- 72 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc----
Confidence 67888888899999999999999998654 67899999865432 24568889999999999999999988632
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
...+++|||+. ++|.+++... ..++..+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 73 --EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred --CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 34799999996 6999998764 358999999999999999999999999999999999999999999999999886
Q ss_pred ccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 192 TTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 192 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||...+..+....+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------- 222 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM------- 222 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-------
Confidence 6542221 112334567999999876 678899999999999999998 99999877655544443221110
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
......+.++.++|.+||+.+|++||+++++++
T Consensus 223 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 -----------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 001235778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=283.71 Aligned_cols=249 Identities=25% Similarity=0.394 Sum_probs=199.4
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|++....+.+.++||+|++|.||+|.+..+ ..|++|.+..... ....+..|+.++++++|+|++++++.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~---- 72 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE---- 72 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC----
Confidence 455555666899999999999999998766 4699999865332 23467889999999999999999987632
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
...+++|||++ |+|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 73 --EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred --CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCcee
Confidence 33689999997 6999999764 358999999999999999999999999999999999999999999999999886
Q ss_pred ccCCCCcc--ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 192 TTSETDFM--TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 192 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
........ ....++..|+|||...+ ..++.++|+|||||++|+|++ |..||...........+..... .
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~------ 222 (262)
T cd05071 151 LIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-M------ 222 (262)
T ss_pred eccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-C------
Confidence 55433211 12345667999998876 678999999999999999999 8889987665544443322100 0
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....++..+.++|.+||+.||++||++.+++.
T Consensus 223 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 -----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 001246788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=286.26 Aligned_cols=265 Identities=24% Similarity=0.321 Sum_probs=196.9
Q ss_pred ccccCCeeeccCCcceEEEEEE----eCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
++|+++++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.++++++|||++++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG-- 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--
Confidence 4555689999999999998864 44577899999986542 2234566788999999999999999999875432
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
...++++|||+. ++|.+++... .+++.+++.++.|++.||.+||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 80 -~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 80 -GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred -CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 145799999997 6899988764 5999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 194 SETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 194 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+....... ..+. ..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~---~~~~~----~ 227 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF--EEMI---GPKQG----Q 227 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchh--hhhh---ccccc----c
Confidence 43221 112234566999999877 678999999999999999999999986543210 0000 00000 0
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
............... ......++.++.+++.+||+.||++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 228 MTVVRLIELLERGMR------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cchhhhhhhhhcCCC------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000000000000000 0111356789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=300.98 Aligned_cols=265 Identities=23% Similarity=0.336 Sum_probs=224.5
Q ss_pred eEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCc---E-EEEEEecCc-ccchHHHHHHHHHHHHHHhcCCC
Q 017231 25 YVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETRE---E-VAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHE 99 (375)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~---~-vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~ 99 (375)
++..++--+.|++..+.+.+.++||+|+||.||++..+..+. . ||+|..+.+ ........++..|++++++++||
T Consensus 142 ~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~ 221 (474)
T KOG0194|consen 142 FLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHP 221 (474)
T ss_pred eecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCC
Confidence 566777779999999999999999999999999998766422 3 899998863 36677788999999999999999
Q ss_pred CeeeeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe
Q 017231 100 NIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 177 (375)
Q Consensus 100 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~ 177 (375)
|||+++++.... ..+++|||+|. |+|.++|++++. ++..+...++.+.+.||+|||+++++||||-..|+|++
T Consensus 222 NVVr~yGVa~~~-----~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~ 296 (474)
T KOG0194|consen 222 NVVRFYGVAVLE-----EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS 296 (474)
T ss_pred CEEEEEEEEcCC-----CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec
Confidence 999999998665 45899999997 699999999885 99999999999999999999999999999999999999
Q ss_pred cCCCEEEeecccccccCCCCccc-cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHH
Q 017231 178 ANCDLKIGDFGLARTTSETDFMT-EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLI 255 (375)
Q Consensus 178 ~~~~i~l~Df~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i 255 (375)
.++.+||+|||++.......... ...-...|+|||.+.. ..++.++|||||||++||+++ |..||.+....+..+.+
T Consensus 297 ~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI 375 (474)
T KOG0194|consen 297 KKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI 375 (474)
T ss_pred CCCeEEeCccccccCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH
Confidence 99999999999987665332222 2224677999999988 689999999999999999998 88899999988777777
Q ss_pred HHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.......+.+ ...+.++..++.+|+..||++||++.++.+
T Consensus 376 ~~~~~r~~~~-----------------------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 376 VKNGYRMPIP-----------------------------SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HhcCccCCCC-----------------------------CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 4422221111 134778999999999999999999998876
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=289.91 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=204.1
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCC-----CcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeecee
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSET-----REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDI 107 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 107 (375)
.|++.+..+++.+.||+|++|.||++.++.. ...+++|.+..... ......+..|+.+++++ +|+|+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4566666666899999999999999987643 36899999875432 33456688999999999 79999999998
Q ss_pred ecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 017231 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 170 (375)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~ 170 (375)
+... ..++++|||+. |+|.+++... ..+++..++.++.||+.||.+||+.|++|+||+
T Consensus 85 ~~~~-----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 159 (293)
T cd05053 85 CTQE-----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159 (293)
T ss_pred EcCC-----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 8544 55899999996 6999998642 458999999999999999999999999999999
Q ss_pred CCceEEecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCC
Q 017231 171 PSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGK 246 (375)
Q Consensus 171 p~NIli~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~ 246 (375)
|+||+++.++.++|+|||.+........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 9999999999999999999876543321 112233567999999877 678999999999999999997 99999877
Q ss_pred ChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 247 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+....+....... .....+..+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 239 PVEELFKLLKEGYRME------------------------------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CHHHHHHHHHcCCcCC------------------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6555554433211000 012357789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=285.19 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=205.1
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|+.....+.+++.||.|++|.||++.++. +..+++|.+... .......+..|+.+++.++|+|++++++.+...
T Consensus 1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 74 (261)
T cd05148 1 WERPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG--- 74 (261)
T ss_pred CcCcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEecC---
Confidence 34455667789999999999999999988 889999998654 233455688999999999999999999988554
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
...+++|||++ ++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 75 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 75 --EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred --CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchh
Confidence 45899999997 6999999763 458999999999999999999999999999999999999999999999999886
Q ss_pred ccCCCCc-cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 192 TTSETDF-MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 192 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
....... .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~------- 224 (261)
T cd05148 153 LIKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP------- 224 (261)
T ss_pred hcCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC-------
Confidence 6543321 122334667999999877 678899999999999999998 899998777555555444211100
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++.+.+++.+||+.||++|||+.++++
T Consensus 225 -----------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 225 -----------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -----------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=282.68 Aligned_cols=249 Identities=23% Similarity=0.401 Sum_probs=200.6
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|++..+.+++++.||+|++|.||++.+. .+..+++|.+...... ...+.+|+.++++++|++++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~~---- 72 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVSE---- 72 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEECC----
Confidence 6777888889999999999999999876 4567999998654322 3468899999999999999999988733
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
...+++|||++ ++|.+++... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 73 --EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred --CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeee
Confidence 33689999997 6999998764 358999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCcc--ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 192 TTSETDFM--TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 192 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
........ ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------- 222 (260)
T cd05070 151 LIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM------- 222 (260)
T ss_pred eccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 54433211 12234567999999876 678899999999999999999 89999876655544443221000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
......+..+.+++.+||+.+|++|||+.++++
T Consensus 223 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 223 -----------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred -----------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 001245788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=289.23 Aligned_cols=247 Identities=24% Similarity=0.313 Sum_probs=196.1
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCc--EEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCc
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETRE--EVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+++.+.||.|+||.||++.++.++. .+++|.++.. ........+..|+.++.++ +|||++++++.+... +.
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~ 77 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----GY 77 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----Cc
Confidence 4478999999999999999887765 4688877532 2333456788999999999 799999999988554 45
Q ss_pred EEEEEeCCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 181 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~ 181 (375)
+++++||++ ++|.+++.... .+++..++.++.||+.||.+||++|++|+||||+||+++.++.
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe
Confidence 899999997 69999997542 4889999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhC
Q 017231 182 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIG 260 (375)
Q Consensus 182 i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 260 (375)
++|+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.....
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~ 236 (297)
T cd05089 158 SKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236 (297)
T ss_pred EEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC
Confidence 99999998854322211111222456999999876 678999999999999999997 9999987765554443322100
Q ss_pred CCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 261 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
. .....+++.+.++|.+||+.+|.+||+++++++.
T Consensus 237 ~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 237 M------------------------------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred C------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0012467889999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=282.40 Aligned_cols=247 Identities=23% Similarity=0.369 Sum_probs=199.5
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|.+..+.+++.+.||+|++|.||++..+ +..|++|.+... .....+..|+.++++++|++++++++++....
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 72 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-- 72 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCC--
Confidence 4556667778999999999999999764 678999988543 23456889999999999999999998764332
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
...++++||++ ++|.+++...+ .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 73 --GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred --CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccce
Confidence 45799999997 69999987654 38899999999999999999999999999999999999999999999999886
Q ss_pred ccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 192 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 192 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
...... .....+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+.......+......
T Consensus 151 ~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------- 218 (256)
T cd05082 151 EASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--------- 218 (256)
T ss_pred eccccC--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---------
Confidence 543322 22334567999999877 678899999999999999997 99999876654444333221000
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++.+.++|.+||+.+|++|||+.++++
T Consensus 219 ---------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 219 ---------------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011346888999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=290.62 Aligned_cols=249 Identities=24% Similarity=0.314 Sum_probs=196.2
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcE--EEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCc
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREE--VAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 116 (375)
..+++.+.||+|+||.||+|.++.++.. +++|.+... ........+..|+.++.++ +|+|++++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~----- 80 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 80 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----
Confidence 3455789999999999999998887765 577766432 2334456788899999999 899999999998554
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 179 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~ 179 (375)
+.++++|||++ ++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 55899999997 69999987542 47899999999999999999999999999999999999999
Q ss_pred CCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHH
Q 017231 180 CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITEL 258 (375)
Q Consensus 180 ~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 258 (375)
+.++|+|||++..............+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+..+.+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred CcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999999998854322211112233567999998876 668899999999999999998 99999776654443332110
Q ss_pred hCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 259 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
. .. ......++.+.++|.+||+.+|++||++++++..
T Consensus 240 ~--~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 Y--RL----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred C--cC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 00 0002357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=285.43 Aligned_cols=248 Identities=23% Similarity=0.296 Sum_probs=198.7
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCc----EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETRE----EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
...+++++.||.|++|+||+|.+..+++ .||+|++.... .......+..|+.++..++|+|++++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC---
Confidence 4455689999999999999999877766 48999886542 333456788999999999999999999988543
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..+++++|++ |+|.+++... +.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++..
T Consensus 82 ---~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 82 ---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred ---CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 2578999997 7999999764 4699999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCcc---ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 193 TSETDFM---TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 193 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
....... ....++..|+|||...+ ..++.++|||||||++|+|++ |..||...........+.... ..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~----- 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGE-RLP----- 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-cCC-----
Confidence 5433221 12234567999999877 678999999999999999998 899997765444333322210 000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++++.++|.+||+.||++||++.+++.
T Consensus 232 ------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 ------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01246788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=281.42 Aligned_cols=241 Identities=21% Similarity=0.317 Sum_probs=195.9
Q ss_pred eeccCCcceEEEEEEeCCCC---cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETR---EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++||+|++|.||+|....++ ..|++|.+...... .....+..|+.+++++.|+|++++++++.. ...+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEE
Confidence 47999999999999866554 78999998765433 345678899999999999999999998742 346999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc-
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT- 200 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~- 200 (375)
|||+. ++|.+++.....+++..++.++.|++.||.+||..|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99997 6999999988889999999999999999999999999999999999999999999999999887654332111
Q ss_pred ---cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 201 ---EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 201 ---~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--------------- 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL--------------- 217 (257)
T ss_pred cccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---------------
Confidence 1112456999999877 678999999999999999998 99999877655444433221100
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++.+.++|.+||+.+|++||++.++++
T Consensus 218 ---------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 218 ---------------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=286.15 Aligned_cols=251 Identities=21% Similarity=0.353 Sum_probs=199.5
Q ss_pred cccccCCeeeccCCcceEEEEEEe----CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMN----SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
..+.+++.+.||+|+||+||++.. ..++..|++|.+.... .......+.+|+.++++++|||++++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 79 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-- 79 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC--
Confidence 345566899999999999999985 3456789999986542 233446788899999999999999999998554
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSH-----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 175 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~-----------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIl 175 (375)
...+++|||++ ++|.+++... ..+++..+..++.||+.||.+||++|++|+||+|+||+
T Consensus 80 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil 156 (283)
T cd05090 80 ---QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL 156 (283)
T ss_pred ---CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence 45799999997 6999988532 23788999999999999999999999999999999999
Q ss_pred EecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHH
Q 017231 176 LNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQ 251 (375)
Q Consensus 176 i~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~ 251 (375)
++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.+......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 9999999999999987643322 1223344667999999877 668999999999999999998 9999977664444
Q ss_pred HHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 252 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+...... .....+++.+.+++.+||+.||++||++.+|+++
T Consensus 236 ~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVRKRQLL------------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHcCCcC------------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3333221100 0112467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=294.87 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=199.8
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEe-----CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeecee
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMN-----SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDI 107 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 107 (375)
+|++..+.+++++.||.|+||.||+|.+ ..+++.||||++..... ......+..|+.++.++ +|+|++++++.
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 4677777788999999999999999984 35678899999865432 23456788999999999 68999999998
Q ss_pred ecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC-------------------------------------------------
Q 017231 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSH------------------------------------------------- 137 (375)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------------------------------- 137 (375)
+.... ..++++|||++ |+|.+++...
T Consensus 80 ~~~~~----~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (343)
T cd05103 80 CTKPG----GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEE 155 (343)
T ss_pred eecCC----CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCC
Confidence 75432 45789999997 6999988643
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--
Q 017231 138 ------------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-- 197 (375)
Q Consensus 138 ------------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-- 197 (375)
..++...+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 156 KSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred CccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence 136778889999999999999999999999999999999999999999999886543221
Q ss_pred -ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 198 -FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 198 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
......++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||....................
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------ 302 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------------ 302 (343)
T ss_pred hhcCCCCCCcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC------------
Confidence 1112234567999999877 678999999999999999997 9999976543222211111000000
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.....++++.+++.+||+.||++||++.+|++|
T Consensus 303 -----------------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 303 -----------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001246789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=296.02 Aligned_cols=277 Identities=25% Similarity=0.367 Sum_probs=215.8
Q ss_pred eEEeceecCCcceEEEee----cceeeeecccccCCeeeccCCcceEEEEEEeC-----CCCcEEEEEEecCcccchHHH
Q 017231 13 TIVKGVPTHGGRYVQYNV----YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNS-----ETREEVAIKKIGNAFDNRIDA 83 (375)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~ 83 (375)
++..++..++-.|...++ +...|++..+.+.+.+.||+|+||.||++++. .++..||+|++..... ....
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~ 84 (401)
T cd05107 6 KVIESVSSDGHEYIYVDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR-SSEK 84 (401)
T ss_pred EEeeeeccCCceEEEECCCCCCCCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC-hhHH
Confidence 445556666666665543 44679999999999999999999999999854 4556899999975432 2234
Q ss_pred HHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-----------------------
Q 017231 84 KRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----------------------- 138 (375)
Q Consensus 84 ~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------------- 138 (375)
..+..|+.++.++. ||||+++++.+... ...++||||+. |+|.+++..++
T Consensus 85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~~-----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (401)
T cd05107 85 QALMSELKIMSHLGPHLNIVNLLGACTKG-----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGST 159 (401)
T ss_pred HHHHHHHHHHHhcCCCCCeEEEEEEEccC-----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccc
Confidence 56889999999997 99999999998654 45899999997 79999986532
Q ss_pred ---------------------------------------------------------------------------CCCHH
Q 017231 139 ---------------------------------------------------------------------------DLTDD 143 (375)
Q Consensus 139 ---------------------------------------------------------------------------~l~~~ 143 (375)
.++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 239 (401)
T cd05107 160 PLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYM 239 (401)
T ss_pred cccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHH
Confidence 25677
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCC
Q 017231 144 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEY 220 (375)
Q Consensus 144 ~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~ 220 (375)
.++.++.||+.||.|||+.+++|+||||+||+++.++.++|+|||++....... ......++..|+|||.+.+ ..+
T Consensus 240 ~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~ 318 (401)
T cd05107 240 DLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLY 318 (401)
T ss_pred HHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCC
Confidence 888999999999999999999999999999999999999999999986543221 1223455778999999987 678
Q ss_pred CccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCc
Q 017231 221 TAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP 299 (375)
Q Consensus 221 ~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 299 (375)
+.++|+||||+++|+|++ |..||......+............ .....++.
T Consensus 319 ~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~-----------------------------~~p~~~~~ 369 (401)
T cd05107 319 TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM-----------------------------AKPAHASD 369 (401)
T ss_pred CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC-----------------------------CCCCCCCH
Confidence 999999999999999998 889997655433322221100000 00124678
Q ss_pred hHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 300 GAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 300 ~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
++.+++.+||..+|.+||++.+|+..
T Consensus 370 ~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 370 EIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 89999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=290.00 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=205.7
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCc-ccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+...+.||.|++|.||++.++.++..+++|.+... .........+..|+.+++.++|+|++++++++... ...+
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 91 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTAW 91 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----CeeE
Confidence 44688999999999999999999999999998643 22334456778899999999999999999998654 5579
Q ss_pred EEEeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 121 IVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
+|+||+.|++.+++.. ...+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9999999988887754 456899999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 200 TEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
....++..|+|||.+.+ ....+.++|||||||++|+|++|..||...+.......+..... +
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~-------------- 232 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES--P-------------- 232 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC--C--------------
Confidence 23456788999999752 24578899999999999999999999876554333322221100 0
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
......++..+.++|.+||+.+|++||+++++++|+|+...
T Consensus 233 -------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 233 -------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00012467889999999999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=290.33 Aligned_cols=256 Identities=26% Similarity=0.424 Sum_probs=203.5
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCC-------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeee
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE-------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAI 104 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 104 (375)
++|++..+.+.+.+.||+|+||.||++.+.. +...+|+|.+.... .......+..|+.+++.+ +|+|++++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 4667766777789999999999999998643 23569999987542 233456788899999999 79999999
Q ss_pred ceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 017231 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHR 167 (375)
Q Consensus 105 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~ 167 (375)
++.+... +..++||||++ |+|.+++...+ .++..+++.++.||+.||.+||++|++|+
T Consensus 90 ~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 90 LGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred EEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 9998554 55899999997 69999997642 38889999999999999999999999999
Q ss_pred CCCCCceEEecCCCEEEeecccccccCCCCcc---ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCC
Q 017231 168 DLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLF 243 (375)
Q Consensus 168 di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf 243 (375)
||+|+||+++.++.++|+|||.+......... ....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||
T Consensus 165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~ 243 (307)
T cd05098 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPY 243 (307)
T ss_pred cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999988655432211 11223467999999887 678999999999999999998 88999
Q ss_pred CCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHh
Q 017231 244 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323 (375)
Q Consensus 244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell 323 (375)
......+....+...... ......+.++.++|.+||..+|++||++.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 293 (307)
T cd05098 244 PGVPVEELFKLLKEGHRM------------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293 (307)
T ss_pred CcCCHHHHHHHHHcCCCC------------------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 776655444433221100 00124578899999999999999999999998
Q ss_pred cC
Q 017231 324 CH 325 (375)
Q Consensus 324 ~~ 325 (375)
++
T Consensus 294 ~~ 295 (307)
T cd05098 294 ED 295 (307)
T ss_pred HH
Confidence 73
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=291.84 Aligned_cols=276 Identities=22% Similarity=0.255 Sum_probs=200.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.+|. .+.||++++..+++.||+|++............+..|+.+++.++|+||+++++++... ...+++|
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~ 78 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVS 78 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEE
Confidence 3444444 45677777788999999999976544555677899999999999999999999998654 5589999
Q ss_pred eCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC---
Q 017231 124 ELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--- 197 (375)
Q Consensus 124 e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--- 197 (375)
||++ ++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+||+.+.......
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 79 PLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred eccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9997 6899988753 458999999999999999999999999999999999999999999999999775432211
Q ss_pred -----ccccccccccccCchhcccC-CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 198 -----FMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 198 -----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
......++..|+|||++... ..++.++|+|||||++|+|++|..||.........-. ...+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~--- 233 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLDK--- 233 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccCcccccc---
Confidence 11223456779999998652 3578899999999999999999999987654332211 111111100000
Q ss_pred cchhHHHhhhCCC---------CCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 272 SDNARRYVRMLPQ---------FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 272 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.........+.. ............++.++.+++.+||+.||++|||++++|+||||+.+.
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 234 -STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred -CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000000000000 000000011123467789999999999999999999999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=281.55 Aligned_cols=250 Identities=26% Similarity=0.415 Sum_probs=203.5
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|++.++.+.+.+.||+|++|.||++.+.. +..|++|.+..... ....+..|+.++++++|+|++++++++...
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 73 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE--- 73 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecC---
Confidence 66778888899999999999999999764 57799999865332 345688999999999999999999988543
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
...+++|||++ ++|.+++.... .++...+..++.+|+.|+.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 74 --~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 74 --EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred --CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence 45799999997 69999997653 58999999999999999999999999999999999999999999999999886
Q ss_pred ccCCCCcc--ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 192 TTSETDFM--TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 192 ~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
........ .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |+.||.+.........+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 224 (261)
T cd05034 152 LIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP------ 224 (261)
T ss_pred eccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC------
Confidence 65432111 12223567999999887 678999999999999999998 999998776555555443211100
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+.++.+++.+||+.+|++||+++++++
T Consensus 225 ------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 225 ------------------------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00234778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=303.80 Aligned_cols=251 Identities=27% Similarity=0.428 Sum_probs=206.2
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeC
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 125 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 125 (375)
-.||+|.||+||.++|..+...+|||.+... +....+.+..|+..-++|+|.|||++++.+..+ +.+-|.||-
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~sen-----Gf~kIFMEq 653 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSEN-----GFFKIFMEQ 653 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCC-----CeEEEEeec
Confidence 4699999999999999999999999998543 333456788999999999999999999998443 668899999
Q ss_pred CC-CCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe-cCCCEEEeecccccccCCC-Ccc
Q 017231 126 MD-TDLHQIIRSH-QDL--TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSET-DFM 199 (375)
Q Consensus 126 ~~-g~L~~~l~~~-~~l--~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~-~~~~i~l~Df~~~~~~~~~-~~~ 199 (375)
++ |+|.+++.+. +++ ++..+-.+.+||++||.|||++.|+|||||-+||+|+ ..|.+||+|||.++....- .-.
T Consensus 654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 97 6999998764 667 8899999999999999999999999999999999996 4789999999988764443 345
Q ss_pred ccccccccccCchhcc-cCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 200 TEYVVTRWYRAPELLL-NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.++.||..|+|||++. |..+|+.++|||||||++.||.||++||.........--.+.+....|+..
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP------------ 801 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP------------ 801 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc------------
Confidence 6788999999999985 456799999999999999999999999966543222111111111111110
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..+|.+.+.||.+|+.+||.+||+|.++|..||++.-
T Consensus 802 ----------------eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 802 ----------------EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ----------------HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 2457889999999999999999999999999999976
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=282.17 Aligned_cols=249 Identities=24% Similarity=0.384 Sum_probs=199.8
Q ss_pred cccCCeeeccCCcceEEEEEEeCCC---CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSET---REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
..+++.+.||+|+||+||+|.++.+ ...|++|.+.... .......+..|+.++++++|||++++++.+...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 77 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS----- 77 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-----
Confidence 3455899999999999999998654 4579999886543 333456788899999999999999999988544
Q ss_pred CcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
...+++|||++ ++|.+++... +.+++..++.++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 55899999997 6999998764 468999999999999999999999999999999999999999999999999987654
Q ss_pred CCCc-c--ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 195 ETDF-M--TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 195 ~~~~-~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
.... . ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+...... +
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-~------- 228 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL-P------- 228 (266)
T ss_pred ccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-C-------
Confidence 2211 1 11233567999999887 678999999999999999998 99999776655444433221100 0
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....+++.+.+++.+||+.+|++||++.+++++
T Consensus 229 ----------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 229 ----------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ----------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 012457889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=286.63 Aligned_cols=258 Identities=21% Similarity=0.372 Sum_probs=205.2
Q ss_pred CCeeeccCCcceEEEEEEeC---CCCcEEEEEEecCccc--chHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNS---ETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 116 (375)
++.+.||.|++|.||++.+. .+|..||+|++..... .....+.+..|+.+++++ +|++|+++++.+...
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~----- 77 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD----- 77 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC-----
Confidence 47899999999999999875 4788999999865322 222346678899999999 599999999988544
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
..+++|+||++ ++|.+++.....+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 78 TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 56899999997 69999998888899999999999999999999999999999999999999999999999998866543
Q ss_pred CC--ccccccccccccCchhcccC-CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 196 TD--FMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 196 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
.. ......++..|+|||.+.+. ..++.++|+||||+++|+|++|..||...........+..........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~------- 230 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP------- 230 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC-------
Confidence 22 12234578889999998652 346789999999999999999999996543222222222211110000
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
....+++.+.+++++||+.||++|| ++++++.||||+...
T Consensus 231 --------------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 231 --------------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred --------------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 0023678899999999999999997 899999999999875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=287.62 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=204.5
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEe-----CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeece
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMN-----SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKD 106 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 106 (375)
-+|.+..+.+.+.+.||+|++|.||++.+ ..++..||+|.+..... ....+.+..|+.+++++ +|+||+++++
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 46778888888999999999999999975 33556899998865432 33456788999999999 7999999999
Q ss_pred eecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEE
Q 017231 107 IIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 183 (375)
Q Consensus 107 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~ 183 (375)
.+... +..+++|||+. |+|.+++..... +++.++..++.+|+.||.+||+.+++|+||+|+||+++.++.++
T Consensus 107 ~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 107 ACTIG-----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred EEecC-----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEE
Confidence 98554 45899999997 799999976433 89999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHh
Q 017231 184 IGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELI 259 (375)
Q Consensus 184 l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~ 259 (375)
|+|||.+........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||................
T Consensus 182 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~ 260 (302)
T cd05055 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG 260 (302)
T ss_pred ECCCcccccccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC
Confidence 999999875443221 122344677999999887 678999999999999999998 999997765443332222110
Q ss_pred CCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.... .....++++.+++.+||+.+|++||++.+++.
T Consensus 261 ~~~~-----------------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 261 YRMA-----------------------------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CcCC-----------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0000 01235788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=280.77 Aligned_cols=296 Identities=45% Similarity=0.785 Sum_probs=252.0
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
.+++.-+.||-|+||+||.++|..+|+.|++|.+..-..+-...+.+.+|+.+|..++|.|++..+++.....-.-+..+
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 34557789999999999999999999999999998777777778899999999999999999999998876554444557
Q ss_pred EEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-
Q 017231 120 YIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF- 198 (375)
Q Consensus 120 ~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~- 198 (375)
|+++|.+..+|+..+-+...++.+.+.-+..||+.+|.|||+.||.||||||.|.+++.|..+||||||+++..+....
T Consensus 133 YV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~ 212 (449)
T KOG0664|consen 133 YVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL 212 (449)
T ss_pred HHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence 8999999999999999888999999999999999999999999999999999999999999999999999987665532
Q ss_pred -cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 199 -MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 199 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
.....-|.+|.|||++++...|+.+.||||.|||+.||+..+..|...+..+.++.|..+.|.+..+....-+++....
T Consensus 213 hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 213 NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 2334568899999999998999999999999999999999999999999999999999999999888777777766655
Q ss_pred HhhhCCCCCCCC-ccccC--CCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 278 YVRMLPQFPKQN-FSARF--PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 278 ~~~~~~~~~~~~-~~~~~--~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
.++.-..-+... +.... .+...+...++.+||..||++|.+..+.+.|++.....-..
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~r~ 353 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRLRF 353 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccceee
Confidence 555444433222 11111 13345678899999999999999999999999998775433
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=285.80 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=200.8
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCC----------------cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeee
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETR----------------EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 103 (375)
..+++++.||+|+||.||++.+..++ ..|++|.+..... ......+.+|++++.+++|||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34558999999999999999876544 4689999865432 244567889999999999999999
Q ss_pred eceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 017231 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-----------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 171 (375)
Q Consensus 104 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p 171 (375)
+++++... ...++++|++. ++|.+++.... .+++..++.++.|++.||.+||++|++|+||||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 99998554 55799999997 69999997765 689999999999999999999999999999999
Q ss_pred CceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh--CCCCCCCC
Q 017231 172 SNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGK 246 (375)
Q Consensus 172 ~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~--g~~pf~~~ 246 (375)
+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ +..||...
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 99999999999999999886543322 1223345678999999877 678999999999999999998 77888776
Q ss_pred ChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 247 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....++............ ......+.++.++.++|.+||+.||++|||+.+|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 238 TDQQVIENAGHFFRDDGRQ-----------------------IYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred ChHHHHHHHHhcccccccc-----------------------ccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 6555544443321110000 000011345788999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=287.27 Aligned_cols=296 Identities=24% Similarity=0.364 Sum_probs=241.5
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 115 (375)
.-..+..+..||+|+||+|.++..+.+.+.||||++++.. -...+.+--+.|-++|... +-|.+++++.+|..-
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm---- 422 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM---- 422 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh----
Confidence 3344557999999999999999999999999999998753 2233445556677777665 477889999999544
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
+.+|+||||+. |+|--.++.-+.+.+..+..++..|+.||-+||++||++||||.+|||++.+|++||.|||.++..-
T Consensus 423 -DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 423 -DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred -hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 66999999996 6998899999999999999999999999999999999999999999999999999999999986533
Q ss_pred -CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 195 -ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 195 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
......+.+||+.|+|||++.- ++|+.++|+||+|+++|||+.|++||++.+++++.+.|++..-..+
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP---------- 570 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP---------- 570 (683)
T ss_pred cCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----------
Confidence 3345678999999999999987 8999999999999999999999999999999999999988544433
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH-----HHHhcCCCCCCCCCC-CCCCCCCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLHDI-NEEPVCPRPFSFD 347 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~~~-~~~~~~~~~~~~~ 347 (375)
+.+|.+..++....|...|.+|... .+|-.||||+.++=. -+...-..+|++.
T Consensus 571 ---------------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk 629 (683)
T KOG0696|consen 571 ---------------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPK 629 (683)
T ss_pred ---------------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCc
Confidence 3468999999999999999999844 689999999988622 2222233345544
Q ss_pred CCCCCCCHHHHHHHHHHHHhhcCC
Q 017231 348 FEHPSFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~ 371 (375)
.-.. -..+|+++...+..-..+|
T Consensus 630 ~k~~-r~~eNFD~~Ft~~~~~lTP 652 (683)
T KOG0696|consen 630 IKCG-RDAENFDKFFTREPTDLTP 652 (683)
T ss_pred cccC-CchhhhhHHHhcCCCCCCC
Confidence 3222 3467888888777665555
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=282.46 Aligned_cols=247 Identities=28% Similarity=0.400 Sum_probs=198.7
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
.+.+.||.|++|.||+++++.++..|++|.+.... ........+..|+.+++.++|+|++++++.+... +..++
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~~ 79 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NELNI 79 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----CeEEE
Confidence 37899999999999999999999999999876532 3334456788999999999999999999998654 56899
Q ss_pred EEeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 122 VYELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
++||++ ++|.+++.. ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999997 599988863 345899999999999999999999999999999999999999999999999987655433
Q ss_pred Cc-cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh--HHHHHHHHHhCCCCcccccccccc
Q 017231 197 DF-MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV--HQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 197 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
.. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... .....+... ..+
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~---------- 226 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYP---------- 226 (267)
T ss_pred CcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC--CCC----------
Confidence 21 223467888999999877 67889999999999999999999999654321 111111110 000
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
......+++.+.++|.+||+.||++|||+.+|+.
T Consensus 227 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 227 -----------------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----------------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0011246788999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=285.46 Aligned_cols=258 Identities=22% Similarity=0.357 Sum_probs=199.2
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCC--------------CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCee
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSET--------------REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII 102 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 102 (375)
+....+++.+.||+|+||.||++++..+ ...||+|.+.... .......+.+|++++++++|+|++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3445556899999999999999987543 2358999986542 233456788999999999999999
Q ss_pred eeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 017231 103 AIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 169 (375)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di 169 (375)
++++++... ...++||||+. ++|.+++.... .+++..++.++.|++.||.+||++|++|+||
T Consensus 81 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dl 155 (295)
T cd05097 81 RLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDL 155 (295)
T ss_pred eEEEEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecccc
Confidence 999998654 55799999997 69999886432 3688899999999999999999999999999
Q ss_pred CCCceEEecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh--CCCCCC
Q 017231 170 KPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFP 244 (375)
Q Consensus 170 ~p~NIli~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~--g~~pf~ 244 (375)
+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+|||||++|+|++ +..||.
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~ 234 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYS 234 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCc
Confidence 99999999999999999998865432221 122334667999999887 678999999999999999988 677887
Q ss_pred CCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 245 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
..........+.......... ......+.+++.+.+++.+||+.||++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 235 LLSDEQVIENTGEFFRNQGRQ-----------------------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ccChHHHHHHHHHhhhhcccc-----------------------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 766555554443322110000 000011245788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=284.69 Aligned_cols=250 Identities=20% Similarity=0.321 Sum_probs=199.7
Q ss_pred ccccCCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
...+++.+.||.|++|.||++.+.. .+..||+|++.... .......+..|+.++..++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-- 80 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE-- 80 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--
Confidence 3445689999999999999998754 35789999986543 223456688999999999999999999998654
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 176 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli 176 (375)
...++++||+. ++|.+++... ..+++..++.++.|++.||.+||++|++|+||||+||++
T Consensus 81 ---~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~ 157 (283)
T cd05091 81 ---QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157 (283)
T ss_pred ---CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEe
Confidence 45789999997 6898888532 247888999999999999999999999999999999999
Q ss_pred ecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHH
Q 017231 177 NANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQL 252 (375)
Q Consensus 177 ~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 252 (375)
+.++.++|+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+..
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred cCCCceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999998765433221 123344678999999876 668999999999999999998 88898877655554
Q ss_pred HHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 253 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
..+....... ....++..+.+++.+||+.+|.+||++.+|+..
T Consensus 237 ~~i~~~~~~~------------------------------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 237 EMIRNRQVLP------------------------------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHcCCcCC------------------------------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 4443321110 013468889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=313.70 Aligned_cols=247 Identities=29% Similarity=0.372 Sum_probs=195.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|++|.||+|++..+++.||+|++..... ......++.+|+.++++++|||++++++++... +..+++
T Consensus 6 Ii~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~lyLV 80 (932)
T PRK13184 6 IIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DPVYYT 80 (932)
T ss_pred EEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CEEEEE
Confidence 69999999999999999999999999999875432 333456788999999999999999999988554 568999
Q ss_pred EeCCC-CCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 123 YELMD-TDLHQIIRSH-----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~-----------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
|||++ |+|.+++... ..++...++.++.||+.||.+||+.|++||||||+||+++.++.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 99997 5999988642 23567788999999999999999999999999999999999999999999998
Q ss_pred cccCCC-------------------CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH
Q 017231 191 RTTSET-------------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 251 (375)
Q Consensus 191 ~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 251 (375)
...... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||...+....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 654211 00112468999999999987 6789999999999999999999999976543222
Q ss_pred HHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 252 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
... .....+ .. ......+++.+.+++.+||+.||++||+..+.+.
T Consensus 240 ~~~--~~i~~P-~~-------------------------~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYR--DVILSP-IE-------------------------VAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhh--hhccCh-hh-------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 000000 00 0011356888999999999999999987655443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=297.01 Aligned_cols=283 Identities=24% Similarity=0.401 Sum_probs=246.9
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCc-ccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 115 (375)
+.-..++++-.||-||||.|=++..+.....+|+|++++. ..+....+++..|-++|..+..|.||++|..|.+.
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~---- 492 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDS---- 492 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccc----
Confidence 4455677899999999999999987776666999998764 45666778899999999999999999999999766
Q ss_pred cCcEEEEEeCC-CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 116 FNDVYIVYELM-DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 116 ~~~~~lv~e~~-~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
.++|++||-| +|.|...+...+.+....++.++..+++|+.|||++||++|||||+|.+++.+|-+||.|||.++...
T Consensus 493 -kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 493 -KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred -hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 6689999999 68999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
....+.+++||+.|.|||++.+ +..+.++|.||||+++|||++|.+||.+.+...+...|...+....-+
T Consensus 572 ~g~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P--------- 641 (732)
T KOG0614|consen 572 SGRKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP--------- 641 (732)
T ss_pred cCCceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc---------
Confidence 9988999999999999999999 899999999999999999999999999999999988887754432111
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC-CCCCCCCCCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH-DINEEPVCPRPFSFDF 348 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~-~~~~~~~~~~~~~~~~ 348 (375)
..++....++|+++...+|.+|.. +.+|-+|.||.+++ +--....-+++|....
T Consensus 642 --------------------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~v 701 (732)
T KOG0614|consen 642 --------------------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSV 701 (732)
T ss_pred --------------------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccC
Confidence 246788999999999999999985 89999999999986 3334444556677777
Q ss_pred CCCCCC
Q 017231 349 EHPSFT 354 (375)
Q Consensus 349 ~~~~~~ 354 (375)
..|...
T Consensus 702 a~ptD~ 707 (732)
T KOG0614|consen 702 ANPTDV 707 (732)
T ss_pred CCcccc
Confidence 777543
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=279.55 Aligned_cols=245 Identities=19% Similarity=0.318 Sum_probs=196.2
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.+++.+.||+|++|.||++.++. +..+++|++..... ....+..|+.++++++|+|++++++++... ...+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPIF 75 (256)
T ss_pred HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CceE
Confidence 45589999999999999998764 56899999864322 234577899999999999999999988544 5689
Q ss_pred EEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 121 IVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
++|||++ ++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred EEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999996 6899998764 4689999999999999999999999999999999999999999999999998865443221
Q ss_pred cc--cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 199 MT--EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 199 ~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
.. ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+......
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 220 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-------------- 220 (256)
T ss_pred cccCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC--------------
Confidence 11 1123457999999887 678899999999999999998 89999776654444333221100
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.....++.++.+++.+||+.+|++|||+.++++.
T Consensus 221 ----------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 ----------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 0012468889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=279.33 Aligned_cols=249 Identities=24% Similarity=0.393 Sum_probs=197.9
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|++....+.+.+.||+|++|.||++.+..+ ..+++|.+.... ...+.+.+|+.+++++.|+|++++++++..
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 72 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE---- 72 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC----
Confidence 455555556899999999999999988665 469999875432 223567889999999999999999988732
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
...+++|||+. ++|.+++.... .+++..+..++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 73 --EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred --CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccce
Confidence 33689999997 59999997643 48999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 192 TTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 192 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
....... .....++..|+|||...+ ..++.++|+||||+++|+|++ |..||......+....+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 222 (260)
T cd05069 151 LIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM------- 222 (260)
T ss_pred EccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 5433321 112334667999998876 678999999999999999999 99999876655444433221100
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
......+..+.+++.+||+.||++||+++++++
T Consensus 223 -----------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 223 -----------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -----------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 001245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=291.02 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=206.0
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCC-------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeee
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE-------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIA 103 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 103 (375)
...|++....+.+++.||+|+||.||+|++.. .+..|++|.+... ........+..|+.+++++ +||||++
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 36788888888899999999999999998643 2236899987643 2334567788999999999 7999999
Q ss_pred eceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 017231 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLH 166 (375)
Q Consensus 104 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H 166 (375)
+++.+... ...++++||++ |+|.+++.... .++...+..++.||+.||.+||++|++|
T Consensus 83 ~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH 157 (334)
T cd05100 83 LLGACTQD-----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH 157 (334)
T ss_pred eeEEEccC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 99998554 55899999997 69999987532 3788899999999999999999999999
Q ss_pred cCCCCCceEEecCCCEEEeecccccccCCCCcc---ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCC
Q 017231 167 RDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPL 242 (375)
Q Consensus 167 ~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p 242 (375)
+||+|+||+++.++.++|+|||.+......... ....++..|+|||++.+ ..++.++||||||+++|+|++ |..|
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p 236 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSP 236 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCC
Confidence 999999999999999999999988654433211 11223467999999987 678899999999999999998 8899
Q ss_pred CCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHH
Q 017231 243 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 322 (375)
Q Consensus 243 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~el 322 (375)
|...+..+....+...... .....++.++.++|.+||+.+|++||++.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~el 286 (334)
T cd05100 237 YPGIPVEELFKLLKEGHRM------------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQL 286 (334)
T ss_pred CCCCCHHHHHHHHHcCCCC------------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 9877655555443321100 0012457789999999999999999999999
Q ss_pred hcC
Q 017231 323 LCH 325 (375)
Q Consensus 323 l~~ 325 (375)
+.+
T Consensus 287 l~~ 289 (334)
T cd05100 287 VED 289 (334)
T ss_pred HHH
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=283.07 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=198.4
Q ss_pred cccccCCeeeccCCcceEEEEEEeC-----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNS-----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
.++.+.+.++||+|+||.||++... .++..+++|.+... .......+..|+++++.++|+||+++++.+...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG- 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-
Confidence 3445568999999999999999743 35668999987643 334456788999999999999999999988554
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQ---------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 176 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~---------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli 176 (375)
...+++|||++ ++|.+++...+ .+++..++.++.||+.|+.+||+.|++|+||+|+||++
T Consensus 80 ----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~ 155 (280)
T cd05092 80 ----RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155 (280)
T ss_pred ----CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE
Confidence 45799999997 69999987643 48899999999999999999999999999999999999
Q ss_pred ecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHH
Q 017231 177 NANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQL 252 (375)
Q Consensus 177 ~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 252 (375)
+.++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.........
T Consensus 156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 9999999999998864432211 122334677999999887 678999999999999999998 99999776554443
Q ss_pred HHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 253 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
..+...... .....+++.+.++|.+||+.||++||++.+|+.
T Consensus 235 ~~~~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECITQGREL------------------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHcCccC------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 332211000 001246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=284.67 Aligned_cols=245 Identities=27% Similarity=0.395 Sum_probs=196.2
Q ss_pred cCCeeeccCCcceEEEEEEeC-----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 42 VPPIRPVGRGAYGIVCAAMNS-----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
+.+.+.||+|++|.||++.+. .++..+++|.+... .......+.+|+.++++++|+|++++++++...
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDG----- 79 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-----
Confidence 447899999999999999854 34556889987543 233345688999999999999999999998554
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 179 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~ 179 (375)
...++||||++ ++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 55899999997 69999997542 38899999999999999999999999999999999999999
Q ss_pred CCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHH
Q 017231 180 CDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLI 255 (375)
Q Consensus 180 ~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i 255 (375)
+.++|+|||.+....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+..+....+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999886544322 1223445778999999887 678899999999999999998 99999776655544332
Q ss_pred HHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
...... ......+..+.+++.+||+.||++||++.++++
T Consensus 239 ~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 239 TQGRVL------------------------------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hCCCCC------------------------------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 211000 001235778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=308.12 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=219.8
Q ss_pred ecceeeeecccccCCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeee
Q 017231 30 VYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104 (375)
Q Consensus 30 ~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 104 (375)
.-.+..++.+..++.++.||+|+||+||+++-.. ....||||.++.. .+.....+|.+|++++..++|||||++
T Consensus 476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrL 554 (774)
T KOG1026|consen 476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRL 554 (774)
T ss_pred CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEE
Confidence 3456789999999999999999999999997432 3457999988654 334467889999999999999999999
Q ss_pred ceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 017231 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 169 (375)
Q Consensus 105 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di 169 (375)
++++... ..+|+|+|||. |+|.++|... .+++..+.+.|+.||+.|+.||-++.++|+||
T Consensus 555 lGVC~~~-----~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDL 629 (774)
T KOG1026|consen 555 LGVCREG-----DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDL 629 (774)
T ss_pred EEEEccC-----CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccch
Confidence 9999766 55899999998 9999999643 12889999999999999999999999999999
Q ss_pred CCCceEEecCCCEEEeecccccccCCCCcc---ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCC
Q 017231 170 KPSNLLLNANCDLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPG 245 (375)
Q Consensus 170 ~p~NIli~~~~~i~l~Df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~ 245 (375)
-..|.||.++..|||+|||+++..-..++. ...+-..+|||||.++. ..++.++||||+||++||+++ |+.||.+
T Consensus 630 ATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy~g 708 (774)
T KOG1026|consen 630 ATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPYYG 708 (774)
T ss_pred hhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcccc
Confidence 999999999999999999999875555432 23455788999999987 789999999999999999998 9999999
Q ss_pred CChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 246 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+.++.+....- ...-.+++.++.+|+..||+..|.+||++.||=.
T Consensus 709 lSn~EVIe~i~~g~l------------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 709 LSNQEVIECIRAGQL------------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred cchHHHHHHHHcCCc------------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 988888887765211 1222468999999999999999999999999754
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=285.98 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=201.6
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCC-------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeec
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSE-------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIK 105 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 105 (375)
.|.+....+.+.+.||+|++|.||++++.. ....+|+|.+..... ......+..|+.+++++ .||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 455566666689999999999999998632 345699998865432 33456788999999999 699999999
Q ss_pred eeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 017231 106 DIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 168 (375)
Q Consensus 106 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~d 168 (375)
+++... ..++++|||+. |+|.+++... ..++..++..++.||+.||.+||++|++|+|
T Consensus 85 ~~~~~~-----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~d 159 (314)
T cd05099 85 GVCTQE-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRD 159 (314)
T ss_pred EEEccC-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 998543 45899999997 6999999653 3488999999999999999999999999999
Q ss_pred CCCCceEEecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCC
Q 017231 169 LKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFP 244 (375)
Q Consensus 169 i~p~NIli~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~ 244 (375)
|+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred ccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999876543221 111223457999999887 678999999999999999998 899998
Q ss_pred CCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 245 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
..........+..... . .....++.++.++|.+||+.||++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~--~----------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 239 GIPVEELFKLLREGHR--M----------------------------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCHHHHHHHHHcCCC--C----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 7765555544332100 0 001245778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.09 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=197.0
Q ss_pred eeccCCcceEEEEEEeCC-CCc--EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSE-TRE--EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.||+|++|+||++.+.. ++. .|++|.+...... .....+..|+..+++++|+|++++++.+.. ...+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEE
Confidence 468999999999999865 333 6999998765433 556788899999999999999999998854 457999
Q ss_pred EeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--
Q 017231 123 YELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-- 197 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-- 197 (375)
+||++ ++|.+++.... .+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99996 79999998764 68999999999999999999999999999999999999999999999999887654321
Q ss_pred --ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 198 --FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+........
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 221 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE----------- 221 (257)
T ss_pred eecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC-----------
Confidence 1112345677999999877 678999999999999999998 9999987766555544433111000
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+..+.+++.+||+.+|++||++.++++
T Consensus 222 ------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 222 ------------------RPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred ------------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 00235778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=291.90 Aligned_cols=293 Identities=32% Similarity=0.537 Sum_probs=233.6
Q ss_pred CCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHH
Q 017231 10 GDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLRE 89 (375)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e 89 (375)
||..+.+|..+++ ||.+ ....|.|-||+|..|.+..-|..||||++... +.....=+.|
T Consensus 420 GYYrv~igE~LD~-RY~V-----------------~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~E 478 (752)
T KOG0670|consen 420 GYYRVRIGELLDS-RYEV-----------------QGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKE 478 (752)
T ss_pred ceEEEehhhhhcc-eeEE-----------------EeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHH
Confidence 8899999998854 9985 88899999999999999999999999999653 2333445689
Q ss_pred HHHHHhcCC------CCeeeeceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHH
Q 017231 90 IKLLRHMDH------ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVH 160 (375)
Q Consensus 90 ~~~l~~l~h------~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~Lh 160 (375)
+++|++|+. -++++++..|... +++|+|+|-+.-+|.+.+++.+ +|....++.++.|++.||..|.
T Consensus 479 leiLkKL~~AD~Edk~Hclrl~r~F~hk-----nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK 553 (752)
T KOG0670|consen 479 LEILKKLNDADPEDKFHCLRLFRHFKHK-----NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK 553 (752)
T ss_pred HHHHHHhhccCchhhhHHHHHHHHhhhc-----ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH
Confidence 999999963 4788888888544 7899999999999999998754 4999999999999999999999
Q ss_pred hCCccccCCCCCceEEecCC-CEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhC
Q 017231 161 SANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 239 (375)
Q Consensus 161 ~~~i~H~di~p~NIli~~~~-~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 239 (375)
.+|++|.||||+||||++.. .+||||||.+........+ ...-+..|.|||++.| .+|+...|+||.||+||||.||
T Consensus 554 ~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtG 631 (752)
T KOG0670|consen 554 KCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTG 631 (752)
T ss_pred hcCeeecccCccceEeccCcceeeeccCcccccccccccc-HHHHHHhccCcceeec-CcccCCccceeeceeeEEeecc
Confidence 99999999999999998765 5899999999877766533 3344667999999999 8899999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHHHhCCCCcccccc---cccchhHHH---------------hhhCCCCCC-CCcccc------C
Q 017231 240 QPLFPGKDYVHQLRLITELIGSPDETSLGF---LRSDNARRY---------------VRMLPQFPK-QNFSAR------F 294 (375)
Q Consensus 240 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~---~~~~~~~~~---------------~~~~~~~~~-~~~~~~------~ 294 (375)
+..|++.....+++..+.+.|..|..+... ........+ ...+....+ ..+... +
T Consensus 632 kIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~ 711 (752)
T KOG0670|consen 632 KILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRL 711 (752)
T ss_pred ceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCC
Confidence 999999999999999999999987654421 111110000 000111111 111110 1
Q ss_pred C----CCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 295 P----NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 295 ~----~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
+ .+-.++.+||.+||..||++|.|.++.|.||||+.
T Consensus 712 ~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 712 PDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred CchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 1 12335899999999999999999999999999974
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=276.91 Aligned_cols=245 Identities=30% Similarity=0.469 Sum_probs=201.7
Q ss_pred CCeeeccCCcceEEEEEEeCCCC----cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETR----EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
.+++.||.|++|.||.+.+...+ ..||+|.+..... ......+..|+..++.++|+|++++++.+... ..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 75 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP 75 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence 47899999999999999998766 8899999865422 22566788999999999999999999998654 45
Q ss_pred EEEEEeCCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
.+++||++. ++|.+++..... +++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 899999997 699999977654 99999999999999999999999999999999999999999999999999876554
Q ss_pred CCccc--cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 196 TDFMT--EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 196 ~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
..... ...++..|+|||.+.+ ..++.++|+||||+++++|++ |..||...+.......+.......
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---------- 224 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLP---------- 224 (258)
T ss_pred ccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC----------
Confidence 42211 1235678999999866 678999999999999999998 888988766555554443211100
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....++.++.+++.+||+.||++|||+.++++
T Consensus 225 --------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 225 --------------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred --------------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 01236888999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=277.24 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=198.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCc-ccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.+.||.|++|.||++.+..+|+.|++|.++.. .........+.+|+.++++++|++++++++.+... +..+++
T Consensus 6 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~~~lv 80 (267)
T cd08224 6 IEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NELNIV 80 (267)
T ss_pred eeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----CeEEEE
Confidence 689999999999999999999999999988643 23333466788999999999999999999998654 558999
Q ss_pred EeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 123 YELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
|||++ ++|.+++.. ...+++..++.++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 99997 699988864 2448999999999999999999999999999999999999999999999999876544332
Q ss_pred -ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh--HHHHHHHHHhCCCCcccccccccch
Q 017231 198 -FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV--HQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
......++..|.|||.+.+ ..++.++|+||||+++|+|++|..||...... .....+... ..+.
T Consensus 161 ~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~---------- 227 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC--DYPP---------- 227 (267)
T ss_pred cccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC--CCCC----------
Confidence 1233457888999999887 67899999999999999999999999654311 111111110 0000
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....++..+.++|.+||+.+|++||++.+|++
T Consensus 228 -----------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 228 -----------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -----------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 001245778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=285.21 Aligned_cols=255 Identities=26% Similarity=0.428 Sum_probs=204.0
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeC-------CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeec
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNS-------ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIK 105 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 105 (375)
.|++....+.+.+.||+|+||.||++++. ..+..|++|.+.... .......+..|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 46677777778999999999999999752 234579999886542 234456788999999999 799999999
Q ss_pred eeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 017231 106 DIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 168 (375)
Q Consensus 106 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~d 168 (375)
+.+... ...+++|||+. |+|.+++... ..++...+..++.||+.||.+||++|++|+|
T Consensus 88 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~d 162 (304)
T cd05101 88 GACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD 162 (304)
T ss_pred EEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 998554 56899999997 6999998753 2477888999999999999999999999999
Q ss_pred CCCCceEEecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCC
Q 017231 169 LKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFP 244 (375)
Q Consensus 169 i~p~NIli~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~ 244 (375)
|||+||+++.++.++|+|||.+........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred cccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999999999999999999876543321 122234567999999987 678999999999999999998 888998
Q ss_pred CCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 245 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
..........+...... .....++..+.++|.+||+.+|++||++.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 242 GIPVEELFKLLKEGHRM------------------------------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred cCCHHHHHHHHHcCCcC------------------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 77655554443221100 001246788999999999999999999999987
Q ss_pred C
Q 017231 325 H 325 (375)
Q Consensus 325 ~ 325 (375)
.
T Consensus 292 ~ 292 (304)
T cd05101 292 D 292 (304)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=278.41 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=200.5
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCC---CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSET---REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
++.+..+.+.+.||.|++|.||+|.+... ...|++|...... .....+.+..|+.+++++.|+|++++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~- 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN- 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-
Confidence 45555566899999999999999987554 3469999886543 234556788999999999999999999987543
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
..+++|||++ ++|.+++.... .+++..++.++.+|+.||.+||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 80 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 80 -----PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred -----CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence 3589999997 69999997754 5899999999999999999999999999999999999999999999999988
Q ss_pred cccCCCCcc--ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 191 RTTSETDFM--TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 191 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
......... ....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~------ 227 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL------ 227 (270)
T ss_pred eecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC------
Confidence 655433221 12223457999999876 678999999999999999986 99999877655444333221100
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....++..+.++|.+||..+|++|||+.+++.
T Consensus 228 ------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 228 ------------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011346788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=282.16 Aligned_cols=251 Identities=23% Similarity=0.333 Sum_probs=199.0
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
+....+++++.||.|++|.||++.+.. ++..|++|.+.... .......+..|+.+++++.|||++++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 345556689999999999999998753 67789999986543 233446688999999999999999999988654
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSHQ----------------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRD 168 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~d 168 (375)
...++++||++ |+|.+++.... .+++..++.++.||+.||.+||+.|++|+|
T Consensus 81 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~d 155 (288)
T cd05050 81 -----KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRD 155 (288)
T ss_pred -----CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 45799999997 69999997432 378889999999999999999999999999
Q ss_pred CCCCceEEecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCC
Q 017231 169 LKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFP 244 (375)
Q Consensus 169 i~p~NIli~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~ 244 (375)
|+|+||+++.++.++|+|||.+........ ......+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999998765432211 112233566999999877 678999999999999999997 888987
Q ss_pred CCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 245 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
+....+....+...... ......+.++.++|.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 235 GMAHEEVIYYVRDGNVL------------------------------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCHHHHHHHHhcCCCC------------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 76655544333221000 001245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=279.55 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=191.5
Q ss_pred eeccCCcceEEEEEEeCCCCc--EEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETRE--EVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.||+|++|.||+++++.++. .+++|.+... ........+..|+.++.++ +|||++++++++... +..+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEE
Confidence 368999999999999988776 4688877543 2334456788999999999 799999999998554 457999
Q ss_pred EeCCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEe
Q 017231 123 YELMD-TDLHQIIRSHQ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 185 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~ 185 (375)
|||+. |+|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99997 79999987543 47899999999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 186 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 186 Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
|||++..............+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.....+.+......
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~--- 230 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL--- 230 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCC---
Confidence 9998753322111112223556999999876 678999999999999999997 99999776654444332110000
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
......+.++.+++.+||+.||.+|||+.+++.
T Consensus 231 ---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 231 ---------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ---------------------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 001235778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=278.40 Aligned_cols=246 Identities=24% Similarity=0.363 Sum_probs=197.9
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCc---EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETRE---EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+++.+.||+|++|.||+|.++.++. .|++|.+.... .......+..|+.++++++|||++++++++... ..
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-----~~ 79 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----RP 79 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-----Cc
Confidence 4479999999999999999887665 59999986542 344567789999999999999999999998544 45
Q ss_pred EEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
.+++|||++ ++|.+++... +.+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 799999997 5899888764 55899999999999999999999999999999999999999999999999988654332
Q ss_pred Cccc----ccc--ccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 197 DFMT----EYV--VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 197 ~~~~----~~~--~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
.... ... .+..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+...... +
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~-~------ 231 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRL-P------ 231 (269)
T ss_pred ccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcC-C------
Confidence 2111 111 1346999999887 678999999999999999886 99999877655444443211000 0
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....++..+.+++.+||+.+|++||++.+++.
T Consensus 232 -----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 232 -----------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred -----------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01245778999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=277.30 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=199.3
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCc---EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETRE---EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 115 (375)
...+...+.||+|++|.||++.++.++. .+++|.+.... .......+..|+.++++++|+|++++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF---- 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC----
Confidence 3445578999999999999999876655 69999885442 233456788999999999999999999998544
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
...+++|||++ ++|.+++... +.+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 79 -KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred -CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 55799999997 5999988764 56899999999999999999999999999999999999999999999999988654
Q ss_pred CCCCccc----cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 194 SETDFMT----EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 194 ~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
....... ....+..|+|||.+.+ ..++.++|+|||||++|+|++ |..||...+.......+.... ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~----- 230 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-RLP----- 230 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC-CCC-----
Confidence 4322111 1122456999999887 678999999999999999997 999997766555554443211 100
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....++.++.+++.+||+.+|++||++.++++
T Consensus 231 ------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 ------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 01245778999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=279.26 Aligned_cols=264 Identities=23% Similarity=0.390 Sum_probs=195.7
Q ss_pred ccCCeeeccCCcceEEEEEE----eCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 41 YVPPIRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
.+++++.||+|+||.||.+. +..++..|++|.+... .......+..|++++++++|||++++++++.....
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--- 79 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR--- 79 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC---
Confidence 44579999999999999997 4567889999998654 33445678899999999999999999998754322
Q ss_pred CcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
..+++|+||++ ++|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 45899999996 6999999764 458999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcc----ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 195 ETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 195 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
..... ....++..|+|||.+.+ ..++.++|+||||+++++|++|..++...... .. ...+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~----~~~~~~~~~----- 228 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FM----RMMGNDKQG----- 228 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hh----hhccccccc-----
Confidence 33211 11123445999999877 67899999999999999999988766433211 00 000000000
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
..........+... ........++.++.++|.+||+.+|++|||+.+++.
T Consensus 229 -~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 229 -QMIVYHLIELLKNN---GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred -ccchHHHHHHHhcC---CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000000000000 001112456788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=278.55 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=197.2
Q ss_pred CCeeeccCCcceEEEEEEeCCCCc---EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETRE---EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
++.+.||+|+||.||++.++.++. .+++|.+..... ......+..|+.++++++|||++++++++... ...
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 80 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-----KPV 80 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-----Ccc
Confidence 368999999999999999875543 699998865432 33456788999999999999999999998543 558
Q ss_pred EEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 120 YIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
+++|||++ ++|.+++... +.++..+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 99999997 6999999765 458999999999999999999999999999999999999999999999999887654332
Q ss_pred cc----ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 198 FM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 198 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
.. ....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||...........+......
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~----------- 228 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRL----------- 228 (267)
T ss_pred ceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcC-----------
Confidence 11 11122457999999987 678999999999999999886 99999776655444433221100
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++.+.+++.+||+.+|.+||++.++++
T Consensus 229 -------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 -------------------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 001245788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=280.04 Aligned_cols=267 Identities=26% Similarity=0.426 Sum_probs=199.1
Q ss_pred ccccCCeeeccCCcceEEEEEEe----CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMN----SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
++.+++++.||+|++|.||++.. +.++..|++|.+.... .......+.+|+.++++++|||++++++++.....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 80 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG- 80 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC-
Confidence 45566899999999999999973 5678899999986543 23345678899999999999999999998865421
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
...+++|||++ ++|.+++.... .+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 --~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 81 --NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred --CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence 45799999996 69999987653 589999999999999999999999999999999999999999999999998876
Q ss_pred cCCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 193 TSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 193 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|+++..|...... ......+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~--- 229 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQ--- 229 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhccccccc---
Confidence 543321 123345677999999887 6788999999999999999998766533210 000111100000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.........+... ........++..+.++|.+||+.||++||++.++++.
T Consensus 230 ----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 230 ----MTVTRLVRVLEEG---KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ----ccHHHHHHHHHcC---ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0000111111100 0011124578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=279.24 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=194.1
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCc----EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCC
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETRE----EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 115 (375)
..+++++.||.|++|+||++.+..++. .+++|.+... ........+..|+..+.++.||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~----- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG----- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-----
Confidence 344578999999999999999877776 4777776432 222334567788889999999999999998743
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
...++++||+. |+|.+++... +.+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 81 -~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 -ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred -CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 23578999997 7999999764 56899999999999999999999999999999999999999999999999998654
Q ss_pred CCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 194 SETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 194 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
.... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.........+... ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~----- 232 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG-ERLAQ----- 232 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCCC-----
Confidence 3221 1223345677999999877 678999999999999999998 99999876644433332211 00000
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+..+.+++.+||..||++|||+.|+++
T Consensus 233 ------------------------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 233 ------------------------PQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0124567899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=276.05 Aligned_cols=249 Identities=23% Similarity=0.416 Sum_probs=200.1
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|++....+++.+.||+|++|.||++.+.. +..+++|.+... ......+.+|+.++++++|+|++++++.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 72 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK---- 72 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC----
Confidence 67778888899999999999999998654 457999987543 2234678889999999999999999998754
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
...+++|||++ ++|.+++... ..++...++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 73 --~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 73 --EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred --CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence 34689999997 6999999764 347888999999999999999999999999999999999999999999999886
Q ss_pred ccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 192 TTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 192 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
....... .....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||...+.......+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------- 222 (260)
T cd05073 151 VIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM------- 222 (260)
T ss_pred eccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-------
Confidence 5433221 112234566999999877 678899999999999999998 99999877655444433221000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
......+.++.+++.+||+.+|++||++.++++
T Consensus 223 -----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 223 -----------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred -----------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 011346788999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=282.05 Aligned_cols=257 Identities=22% Similarity=0.357 Sum_probs=201.8
Q ss_pred CCeeeccCCcceEEEEEEeC---CCCcEEEEEEecCccc--chHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNS---ETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 116 (375)
++.+.||.|++|.||++++. .++..|++|++.+... .......+..|+.++.++ +|++++++++.+...
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~----- 77 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD----- 77 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC-----
Confidence 36899999999999999864 4678899999865422 122345678899999999 599999999888544
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
...++||||+. ++|.+++.....+++..++.++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 78 TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 56899999997 69999998878899999999999999999999999999999999999999999999999998765433
Q ss_pred CCc--cccccccccccCchhcccCC-CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHH-hCCCCcccccccc
Q 017231 196 TDF--MTEYVVTRWYRAPELLLNCS-EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLR 271 (375)
Q Consensus 196 ~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~ 271 (375)
... .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+... .....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 229 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP-------- 229 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--------
Confidence 321 22345788899999986622 3688999999999999999999999644322111111111 00000
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC---HHHHhcCCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPYLAPLH 332 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps---~~ell~~~~f~~~~ 332 (375)
.....++..+.++|.+||+.||++||| +.++|+||||+.+.
T Consensus 230 --------------------~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 230 --------------------PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred --------------------CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 001235788999999999999999998 56889999999874
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=273.47 Aligned_cols=241 Identities=26% Similarity=0.389 Sum_probs=194.9
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeC
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 125 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 125 (375)
++||.|++|.||++.+.. ++.|++|.+...... .....+..|+.+++++.|+||+++++++... ...++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEc
Confidence 469999999999999888 899999998665333 3566788999999999999999999988544 568999999
Q ss_pred CC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc---c
Q 017231 126 MD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM---T 200 (375)
Q Consensus 126 ~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~---~ 200 (375)
++ ++|.+++... ..++...+..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 96 6899998654 45899999999999999999999999999999999999999999999999988654422111 1
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+...... .
T Consensus 154 ~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~-~---------------- 215 (251)
T cd05041 154 LKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRM-P---------------- 215 (251)
T ss_pred cCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCC-C----------------
Confidence 1223566999999877 678999999999999999998 88899776644433332221000 0
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+.++.+++.+||+.+|.+||++.|+++
T Consensus 216 -------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 216 -------------APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 01245788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=274.19 Aligned_cols=240 Identities=20% Similarity=0.328 Sum_probs=191.1
Q ss_pred eccCCcceEEEEEEeC--CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEe
Q 017231 47 PVGRGAYGIVCAAMNS--ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 124 (375)
Q Consensus 47 ~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 124 (375)
.||+|+||.||++.+. .++..||+|++.... .....+.+.+|+.++++++|+|++++++.+.. ...++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEE
Confidence 4899999999999765 445679999886542 33445678899999999999999999998742 34799999
Q ss_pred CCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc---
Q 017231 125 LMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--- 199 (375)
Q Consensus 125 ~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~--- 199 (375)
|++ ++|.+++.. ...+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+.........
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 997 699998875 456999999999999999999999999999999999999999999999999988654332211
Q ss_pred -ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 200 -TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 200 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||......+....+..... ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~------------- 218 (257)
T cd05115 155 RSAGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR--LD------------- 218 (257)
T ss_pred cCCCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--CC-------------
Confidence 11122467999999877 678999999999999999996 9999987765444333322100 00
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....++++.++|.+||..||++||++.++.+
T Consensus 219 ---------------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 219 ---------------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 01245788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=276.85 Aligned_cols=251 Identities=20% Similarity=0.347 Sum_probs=199.7
Q ss_pred ccccCCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
+..+++++.||.|+||.||+++.+. +.+.|++|.+.... .......+..|++++++++|+|++++++++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 80 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-- 80 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCC--
Confidence 3455689999999999999999754 34579999875432 223456788999999999999999999988554
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEE
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSHQ---------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 183 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~~---------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~ 183 (375)
...++||||++ ++|.+++.... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++
T Consensus 81 ---~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 81 ---EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred ---CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEE
Confidence 45799999997 69999998766 699999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCC--ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhC
Q 017231 184 IGDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIG 260 (375)
Q Consensus 184 l~Df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 260 (375)
++|||.+....... ......++..|+|||.+.+ ...+.++||||||+++|+|++ |..||...........+.....
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 99999876433221 1223455777999999877 568899999999999999998 8889976554444333221100
Q ss_pred CCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 261 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.. .....++..+.+++.+||+.+|++||++.+++..
T Consensus 237 ~~-----------------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 237 EL-----------------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CC-----------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 00 0012467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=279.71 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=195.4
Q ss_pred cccCCeeeccCCcceEEEEEEeCC----------------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeee
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSE----------------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 103 (375)
..+++.+.||+|+||.||++.+.. ++..||+|.+.... .......+..|+.+++.++|+|+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 334589999999999999986432 34569999886442 2334567889999999999999999
Q ss_pred eceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 017231 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-----------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 171 (375)
Q Consensus 104 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p 171 (375)
+++++... ...+++|||++ ++|.+++.... .+++..++.++.||+.||.+||+.|++|+||||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 84 LLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred EEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 99998654 45799999997 69999987642 367789999999999999999999999999999
Q ss_pred CceEEecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh--CCCCCCCC
Q 017231 172 SNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGK 246 (375)
Q Consensus 172 ~NIli~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~--g~~pf~~~ 246 (375)
+||+++.++.++|+|||.+........ ......+..|++||...+ ..++.++|+|||||++|+|++ |..||...
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999999865433221 122233567999998776 678999999999999999998 77888776
Q ss_pred ChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 247 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
+..+............... ........+++.+.+++.+||+.||.+||++.+|++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQ-----------------------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ChHHHHHHHHHHHhhcccc-----------------------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 6544443322211100000 000011245688999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=279.30 Aligned_cols=245 Identities=25% Similarity=0.384 Sum_probs=194.4
Q ss_pred CCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 43 PPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
++.+.||+|+||.||++.+.. ....+++|.+..... ......+..|+.+++.++||||+++++.+... +
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 76 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-----G 76 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----C
Confidence 478999999999999998753 235688888765432 33456788999999999999999999988544 4
Q ss_pred cEEEEEeCCC-CCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 017231 118 DVYIVYELMD-TDLHQIIRSH------------------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPS 172 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~ 172 (375)
..++++||+. ++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 77 PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 5799999997 6999988642 24788999999999999999999999999999999
Q ss_pred ceEEecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCCh
Q 017231 173 NLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDY 248 (375)
Q Consensus 173 NIli~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~ 248 (375)
||+++.++.++|+|||.+........ .....++..|+|||.+.+ ..++.++||||||+++++|++ |..||.+...
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99999999999999999865432211 122334667999999877 678999999999999999998 9999987665
Q ss_pred hHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 249 VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
......+...... .....++.++.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 236 ERLFNLLKTGYRM------------------------------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHHHhCCCCC------------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 4443332211000 001246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=276.16 Aligned_cols=248 Identities=29% Similarity=0.487 Sum_probs=197.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc---cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+.+.||+|++|.||++.+..++..+++|+.+... ........+..|+.++++++|||++++++.+... ...+
T Consensus 4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (260)
T cd08222 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----DAFC 78 (260)
T ss_pred eeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----CceE
Confidence 6899999999999999998887777777765422 1222344567889999999999999999988554 4589
Q ss_pred EEEeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 121 IVYELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
+++||++ ++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+.....
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999997 588887753 356999999999999999999999999999999999999964 6799999998765433
Q ss_pred C-CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 196 T-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 196 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...........+.. +..+.
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~~---------- 224 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPTPS---------- 224 (260)
T ss_pred CcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCCC----------
Confidence 2 22334557888999999876 6788899999999999999999999976554433333221 11100
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....++.++.++|.+||..+|++||++.++++||||
T Consensus 225 ------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 225 ------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ------------------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 012457889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=277.40 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=197.7
Q ss_pred ccCCeeeccCCcceEEEEEEeCC----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSE----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
.+.+.+.||+|+||.||.+.+.. ++..|++|.+... ........+..|+.++++++|+|++++++++....
T Consensus 7 ~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---- 81 (280)
T cd05043 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG---- 81 (280)
T ss_pred heEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC----
Confidence 33468999999999999999876 3578999987643 33445677889999999999999999999875532
Q ss_pred CcEEEEEeCCC-CCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeec
Q 017231 117 NDVYIVYELMD-TDLHQIIRSH--------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 187 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~--------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df 187 (375)
...+++++|++ ++|.+++... ..+++..++.++.||+.||.|||+.+++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 44689999997 7999998653 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 188 GLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 188 ~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
|++........ .....++..|+|||.+.+ ..++.++|||||||++|++++ |+.||...+.......+.... ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~- 238 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-RL- 238 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-CC-
Confidence 99875433221 112334667999999987 678999999999999999998 999997765444332222110 00
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++++.+++.+||..||++|||+.++++
T Consensus 239 ----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 ----------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ----------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001235788999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=270.47 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=192.9
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeC
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYEL 125 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 125 (375)
+.||+|++|.||++... ++..||+|.+..... ......+.+|++++++++|||++++++++... ...++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEEC
Confidence 46899999999999865 578999999865432 23345688999999999999999999998544 457999999
Q ss_pred CC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc--cc
Q 017231 126 MD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TE 201 (375)
Q Consensus 126 ~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~--~~ 201 (375)
++ ++|.+++... ..+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......... ..
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 97 6999988654 45899999999999999999999999999999999999999999999999988654332211 11
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
..++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+......
T Consensus 154 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~------------------- 213 (250)
T cd05085 154 KQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM------------------- 213 (250)
T ss_pred CCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC-------------------
Confidence 233566999999876 678899999999999999998 99999876654443333221000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....++..+.+++.+||+.+|++||++.++++
T Consensus 214 -----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 214 -----------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 001246788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=277.32 Aligned_cols=238 Identities=16% Similarity=0.261 Sum_probs=187.3
Q ss_pred eeccCCcceEEEEEEeCCCCcE-------EEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 46 RPVGRGAYGIVCAAMNSETREE-------VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~-------vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+.||.|+||.||++.++..+.. |++|.+... .....+.+..|+.+++.+.|||++++++.+... ..
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CC
Confidence 4699999999999998665443 888877433 233456788899999999999999999998654 44
Q ss_pred EEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC--------EEEeecc
Q 017231 119 VYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD--------LKIGDFG 188 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~--------i~l~Df~ 188 (375)
.++||||++ |+|.+++...+ .+++..++.++.||+.||.+||++|++|+||||+||+++.++. ++++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 789999997 68999997654 5899999999999999999999999999999999999987765 6999999
Q ss_pred cccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhC-CCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 189 LARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
.+...... ....++..|+|||.+.+...++.++|+||||+++|+|++| ..||...+.......... ....
T Consensus 154 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-~~~~----- 224 (258)
T cd05078 154 ISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED-RHQL----- 224 (258)
T ss_pred cccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc-cccC-----
Confidence 87554332 2345678899999987645678999999999999999998 466655443332221110 0000
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....+.++.++|.+||+.||++|||++++++.
T Consensus 225 --------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 225 --------------------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred --------------------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 01245679999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=275.65 Aligned_cols=246 Identities=25% Similarity=0.342 Sum_probs=197.7
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCc----EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETRE----EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
.+++++.||+|+||.||++.++.+|. .+++|....... ......+.+|+.++.+++|+|++++++++..
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 34478999999999999999877665 589998765432 3455678899999999999999999998854
Q ss_pred CcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
...++++||+. |+|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 34789999997 7999998774 459999999999999999999999999999999999999999999999999887654
Q ss_pred CCCccc---cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 195 ETDFMT---EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 195 ~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
...... ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||......+....+.... ..+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~------ 232 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQ------ 232 (279)
T ss_pred CcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CCCC------
Confidence 332111 1223467999999876 678999999999999999998 999998776555444333211 0000
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+..+.+++.+||..||.+||++.++++
T Consensus 233 -----------------------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 233 -----------------------PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -----------------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0234677999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=272.56 Aligned_cols=243 Identities=24% Similarity=0.376 Sum_probs=188.4
Q ss_pred eeccCCcceEEEEEEeCC---CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSE---TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.||+|+||.||++.+.. .+..||+|.+... ........+..|+.+++.++|||++++++.+...+ +..+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEE
Confidence 468999999999998643 3457999987543 23334567888999999999999999999765432 346899
Q ss_pred EeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC---
Q 017231 123 YELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--- 197 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--- 197 (375)
+||+. ++|.+++... ..++...+..++.||+.||.+||+.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99997 7999998764 347888889999999999999999999999999999999999999999999886543221
Q ss_pred --ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 198 --FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+... ....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~~~---------- 222 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RRLL---------- 222 (262)
T ss_pred ecccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CCCC----------
Confidence 1112344667999999877 678999999999999999999 56677665544333222110 0000
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++.+.+++.+||+.+|++||++.+++.
T Consensus 223 ------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 223 ------------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00234778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=273.39 Aligned_cols=238 Identities=20% Similarity=0.273 Sum_probs=184.8
Q ss_pred eeccCCcceEEEEEEeCC------------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 46 RPVGRGAYGIVCAAMNSE------------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
+.||+|++|+||++.... ....|++|.+... .......+..|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~-- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD-- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 468999999999997432 2335888887543 233445678899999999999999999998654
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC-------EEE
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-------LKI 184 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~-------i~l 184 (375)
...+++|||++ ++|..++.. ...+++..++.++.||+.||.|||+.|++|+||+|+||+++.++. +++
T Consensus 77 ---~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 ---VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred ---CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 44689999998 577777765 356999999999999999999999999999999999999987664 899
Q ss_pred eecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHh-hCCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 185 GDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM-TRQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 185 ~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
+|||.+...... ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||......+....... ..
T Consensus 154 ~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---~~- 226 (262)
T cd05077 154 SDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEG---QC- 226 (262)
T ss_pred CCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhc---Cc-
Confidence 999987554322 23456778999999875467899999999999999997 58888876543322111100 00
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
......++++.++|.+||+.||++||++.+|+++
T Consensus 227 ----------------------------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 227 ----------------------------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ----------------------------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0012235679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=273.31 Aligned_cols=249 Identities=25% Similarity=0.438 Sum_probs=199.9
Q ss_pred cCCeeeccCCcceEEEEEEeCC-CCcEEEEEEecCcc--------cchHHHHHHHHHHHHHHh-cCCCCeeeeceeecCC
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSE-TREEVAIKKIGNAF--------DNRIDAKRTLREIKLLRH-MDHENIIAIKDIIRPP 111 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~ 111 (375)
+.+.+.||+|++|.||++.++. +++.+++|.+.... ........+..|+.++.+ ++|+|++++++.+...
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3478999999999999999988 67889999875321 223344567788888875 6899999999998554
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEe
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIG 185 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~ 185 (375)
+..+++|||++ ++|.+++.. ...+++..++.++.|++.+|.+||+ .|++|+||+|+||+++.++.++|+
T Consensus 82 -----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 82 -----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred -----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEe
Confidence 56899999997 588887743 3469999999999999999999996 689999999999999999999999
Q ss_pred ecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 186 DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 186 Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
|||.+.............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+......+..
T Consensus 157 dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 234 (269)
T cd08528 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP- 234 (269)
T ss_pred cccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC-
Confidence 9999876554433345567888999999987 66899999999999999999999999776655444433321111000
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+++.+.++|.+||+.||++||++.|+..+
T Consensus 235 ----------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 235 ----------------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ----------------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 01357889999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=291.74 Aligned_cols=286 Identities=25% Similarity=0.394 Sum_probs=225.6
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCc-ccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
++-.....++..++.||-|+||.|.+++...|...||+|.+.+. ...+........|-.||.....+-||+++..|.+.
T Consensus 622 kRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 622 KRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred HHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 33445556666899999999999999999999999999998663 34445567778899999999999999999999665
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
+.+|+||+|++ |++-.+|.+.+-+.+..++.++..+..|++..|..|++||||||+|||||.+|+|||.|||++
T Consensus 702 -----dnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLC 776 (1034)
T KOG0608|consen 702 -----DNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLC 776 (1034)
T ss_pred -----CceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeecccc
Confidence 56999999997 699999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccC---------CC----------------------------------CccccccccccccCchhcccCCCCCccchhH
Q 017231 191 RTTS---------ET----------------------------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIW 227 (375)
Q Consensus 191 ~~~~---------~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 227 (375)
+-.. .. .......||+.|+|||++.. ..++..+|+|
T Consensus 777 TGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdww 855 (1034)
T KOG0608|consen 777 TGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWW 855 (1034)
T ss_pred ccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhh
Confidence 4110 00 00123568999999999988 7899999999
Q ss_pred HHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHH
Q 017231 228 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEK 307 (375)
Q Consensus 228 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~ 307 (375)
|.|+|||+|+.|..||-.....++..++.++.....- .-..++|++..++|.+
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~---------------------------~~~~~ls~e~~~li~k 908 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHI---------------------------PYQGNLSKEALDLIQK 908 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCcceeeeeehhhcccc---------------------------ccccccCHHHHHHHHH
Confidence 9999999999999999766544433333322211110 0113679999999998
Q ss_pred hcCcCCCCCC---CHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 308 MLVFDPNRRI---TVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSF 353 (375)
Q Consensus 308 ~L~~dP~~Rp---s~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (375)
+.. +++.|. .+++|-.||||+.++-.+ ..-.+..+-+..++|+.
T Consensus 909 Lc~-sad~RLGkng~d~vKaHpfFkgIDfss-lRkq~ApYIP~ItHptD 955 (1034)
T KOG0608|consen 909 LCC-SADSRLGKNGADQVKAHPFFKGIDFSS-LRKQRAPYIPRITHPTD 955 (1034)
T ss_pred Hhc-ChhhhhcccchhhhhcCccccccchHh-hhhccCCcCccccCCCc
Confidence 876 678887 567899999999997555 33333445555555543
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=278.82 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=196.7
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCc----EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETRE----EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
...+++.+.||+|++|.||++.+..++. .|++|.+.... .......+..|+.+++.++|||++++++.+...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 3445578999999999999999887776 46888875442 233344678999999999999999999988543
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..+++++|++ |+|.+++.... .+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+..
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 2478999997 79999987654 589999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 193 TSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 193 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+.........+.. ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~----- 231 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK-GERLP----- 231 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC-CCCCC-----
Confidence 543221 112334667999999877 678999999999999999997 8999977654333322211 10000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
..+..+..+.+++.+||..+|++||++.++++.
T Consensus 232 ------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 ------------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred ------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012356789999999999999999999998884
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=290.02 Aligned_cols=238 Identities=32% Similarity=0.497 Sum_probs=199.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+...+|.|+|+.|-.+.+..+++.+++|++.+...+ ..+|+.++... +|||++++++.+.+. .+.++|
T Consensus 326 ~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~-----~~~~~v 394 (612)
T KOG0603|consen 326 FREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDG-----KEIYLV 394 (612)
T ss_pred cccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCC-----ceeeee
Confidence 677799999999999999999999999999765222 23566555555 699999999999655 668999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE-ecCCCEEEeecccccccCCCCccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL-NANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli-~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
||.+. +.+.+.+...+.++ .++..|+++|+.|+.+||++|++||||||+|||+ +..|+++|+|||.+...... ..
T Consensus 395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~ 471 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CD 471 (612)
T ss_pred ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hc
Confidence 99997 47777777666566 8888999999999999999999999999999999 68899999999998776655 55
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
+.+.|..|.|||++.. ..+++++||||||+++|+|++|..||...... ..+....+.....
T Consensus 472 tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~s--------------- 532 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKFS--------------- 532 (612)
T ss_pred ccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCccc---------------
Confidence 6677899999999996 89999999999999999999999999776544 2222222222111
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
..+|.++++||+.||+.||.+|+++.+++.||||
T Consensus 533 --------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 --------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 3579999999999999999999999999999999
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=272.08 Aligned_cols=246 Identities=23% Similarity=0.327 Sum_probs=187.2
Q ss_pred eeccCCcceEEEEEEeCC--CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSE--TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||++.... ....+++|.+.... .......+.+|+..++.++|+||+++++.+... ...++||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEE
Confidence 469999999999996433 44578888875432 233445678899999999999999999988654 5589999
Q ss_pred eCCC-CCHHHHHHhCCC-----CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 124 ELMD-TDLHQIIRSHQD-----LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~-----l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
||++ |+|.+++..... .++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9997 699999976532 4678889999999999999999999999999999999999999999999886533221
Q ss_pred c---cccccccccccCchhccc------CCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhC-CCCccc
Q 017231 198 F---MTEYVVTRWYRAPELLLN------CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIG-SPDETS 266 (375)
Q Consensus 198 ~---~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~-~~~~~~ 266 (375)
. .....++..|+|||++.. ...++.++|||||||++|+|++ |..||......+.......... ..+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~- 233 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP- 233 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC-
Confidence 1 122334667999999743 1356789999999999999998 7888877655444433322111 10000
Q ss_pred ccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++.+.+++..|+ .||++||++++|++
T Consensus 234 -------------------------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 234 -------------------------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -------------------------cccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 001246788899999998 59999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.07 Aligned_cols=143 Identities=24% Similarity=0.443 Sum_probs=128.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++||.|+||.||++.+..+++.||||++.... ........+..|+.++..++|+||++++..+... ..+|+|
T Consensus 8 i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~~lV 82 (669)
T cd05610 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-----NNVYLV 82 (669)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-----CEEEEE
Confidence 6899999999999999999999999999996532 3344456788999999999999999999888543 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
|||+. ++|.+++...+.+++..++.++.||+.||.|||.+||+|+||||+|||++.++.++|+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99996 6999999888889999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.53 Aligned_cols=240 Identities=23% Similarity=0.371 Sum_probs=194.0
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
..+++.+.||+|++|.||.+. .+++.|++|.+.... ....+..|+.++++++|||++++++.+... ..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN------GL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------Cc
Confidence 345589999999999999985 567889999985432 345688999999999999999999988543 26
Q ss_pred EEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 120 YIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
+++|||+. ++|.+++.... .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 89999997 69999997653 4899999999999999999999999999999999999999999999999988654322
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+......
T Consensus 154 --~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------- 216 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM-------------- 216 (254)
T ss_pred --CCCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC--------------
Confidence 122233567999999876 678899999999999999997 99999877655443333221000
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++.+.+++.+||+.+|++||++.+++.
T Consensus 217 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 217 ----------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ----------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001246788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=274.27 Aligned_cols=237 Identities=19% Similarity=0.223 Sum_probs=183.8
Q ss_pred eccCCcceEEEEEEeCC------------------------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCee
Q 017231 47 PVGRGAYGIVCAAMNSE------------------------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII 102 (375)
Q Consensus 47 ~lg~G~~g~Vy~~~~~~------------------------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 102 (375)
.||+|+||.||++.... ....|++|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999997432 2235888987543 223345678899999999999999
Q ss_pred eeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC
Q 017231 103 AIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180 (375)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~ 180 (375)
++++++... ...++||||++ |+|..++.. .+.+++..+..++.||+.||.|||++|++|+||||+||+++..+
T Consensus 80 ~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 999998654 45799999997 688888865 45689999999999999999999999999999999999997654
Q ss_pred -------CEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHh-hCCCCCCCCChhHHH
Q 017231 181 -------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM-TRQPLFPGKDYVHQL 252 (375)
Q Consensus 181 -------~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~ 252 (375)
.++++|||.+...... ....++..|+|||.+.+...++.++|+||||+++|+|+ +|..||.........
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 3899999987543222 22345777999999876566899999999999999995 699999766543322
Q ss_pred HHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 253 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...... ... ....++.+.++|.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~-~~~-------------------------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 232 RFYEKK-HRL-------------------------------PEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHhc-cCC-------------------------------CCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 211110 000 01235679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=274.60 Aligned_cols=266 Identities=25% Similarity=0.383 Sum_probs=198.6
Q ss_pred ccccCCeeeccCCcceEEEEEEeC----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNS----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
.+++++.+.||+|++|.||++... .++..||+|.+...... .....+..|+.+++.+.|+|++++++++....
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~-- 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPG-- 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCC--
Confidence 345568899999999999999854 34789999998765433 35677899999999999999999999875532
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
....+++|||++ ++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+..
T Consensus 80 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 80 -GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred -CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 256899999997 69999997755 599999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCcc----ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 193 TSETDFM----TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 193 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
....... ....++..|++||.+.+ ..++.++|+||||+++++|++|..|+......... ..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-----~~~~~~~---- 228 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-----MIGIAQG---- 228 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhcc-----ccccccc----
Confidence 6532111 11233456999999877 57889999999999999999999988654321100 0000000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
..........+.... .......++.++.+++.+||+.+|++||++.|+++
T Consensus 229 ---~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 229 ---QMIVTRLLELLKEGE---RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ---cccHHHHHHHHHcCC---cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 000000000000000 00011235678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=270.16 Aligned_cols=244 Identities=20% Similarity=0.389 Sum_probs=195.6
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.+.||.|++|.||++.+.. +..+++|.+...... ...+..|++++++++||+++++++.+... ...++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 76 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPICL 76 (256)
T ss_pred eEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceEE
Confidence 4478999999999999998864 668999988654322 34578899999999999999999988544 55899
Q ss_pred EEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 122 VYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
++||+. ++|.+++... ..+++..++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999997 6899888764 45899999999999999999999999999999999999999999999999987654332211
Q ss_pred --ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 200 --TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 200 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...........+.......
T Consensus 157 ~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 221 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY-------------- 221 (256)
T ss_pred ccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCC--------------
Confidence 12234567999999887 678899999999999999998 999998766555444432210000
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.....+..+.+++.+||+.+|++||++.++++.
T Consensus 222 ----------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 222 ----------------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ----------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 001247889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=284.18 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=193.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
--..||+|+||.||++..... ..||||.+....... ..+|..|+.++.+++|||+|+++++|.+... ..++|+
T Consensus 79 ~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~~LVY 151 (361)
T KOG1187|consen 79 ESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HRLLVY 151 (361)
T ss_pred hhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eEEEEE
Confidence 457899999999999987664 899999876543332 3449999999999999999999999976531 479999
Q ss_pred eCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceEEecCCCEEEeecccccccCC-C
Q 017231 124 ELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSAN---VLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-T 196 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~---i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~ 196 (375)
||+. |+|.+++.... .++|....+|+.++|.||+|||... |+|||||+.|||+|.+.+.||+|||++..... .
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence 9997 89999997765 7999999999999999999999753 99999999999999999999999999976655 3
Q ss_pred Cccccc-cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh--hHHHHHHH-HHhCCCCccccccccc
Q 017231 197 DFMTEY-VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLIT-ELIGSPDETSLGFLRS 272 (375)
Q Consensus 197 ~~~~~~-~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~-~~~~~~~~~~~~~~~~ 272 (375)
...... .||..|+|||.... ...+.++||||||+++.||++|+.+.+.... ...+..+. .....
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~----------- 299 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE----------- 299 (361)
T ss_pred cceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC-----------
Confidence 333333 78999999999987 7799999999999999999999988765421 11111110 10000
Q ss_pred chhHHHhhhCCCCCCCCcc-ccCC--CCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 273 DNARRYVRMLPQFPKQNFS-ARFP--NKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~-~~~~--~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
. .+....+..+. ..+. ..-..+..+..+|++.+|..||++.+++.
T Consensus 300 ~-------~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 300 G-------KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred c-------chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 0 00011111111 1111 01123678889999999999999999754
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=272.61 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=197.3
Q ss_pred CCeeeccCCcceEEEEEEeCC---CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc-Cc
Q 017231 43 PPIRPVGRGAYGIVCAAMNSE---TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF-ND 118 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~-~~ 118 (375)
.+.+.||+|++|.||+|.++. ++..||||++..........+.+..|+.++++++|||++++++++........ ..
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 368899999999999998643 57889999997765555567778899999999999999999998865432211 23
Q ss_pred EEEEEeCCC-CCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 119 VYIVYELMD-TDLHQIIRSH------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.+++++|+. |+|.+++... ..++...++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccc
Confidence 478899996 7888877432 147899999999999999999999999999999999999999999999999887
Q ss_pred ccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 192 TTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 192 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
....... .....++..|++||.+.+ ..++.++|||||||++|+|++ |..||...+.......+.... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~----- 234 (273)
T cd05074 162 KIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RL----- 234 (273)
T ss_pred cccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cC-----
Confidence 5433221 122234567999999877 678899999999999999999 889997765444333322210 00
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
...+..++.+.+++.+||+.+|++||++.+++.
T Consensus 235 ------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 235 ------------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred ------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001245778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=272.23 Aligned_cols=228 Identities=22% Similarity=0.346 Sum_probs=184.1
Q ss_pred CcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCC-CC
Q 017231 51 GAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TD 129 (375)
Q Consensus 51 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~ 129 (375)
|.+|.||+++++.+++.||+|.+.... ....|...+....|||++++++.+... ...+++|||++ |+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSE-----DSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecC-----CeEEEEEecCCCCC
Confidence 889999999999999999999986542 122344555556799999999988554 56899999997 69
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccccccccccc
Q 017231 130 LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYR 209 (375)
Q Consensus 130 L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~ 209 (375)
|.+++.....+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++++|||.+...... .....++..|+
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCcccc
Confidence 9999988888999999999999999999999999999999999999999999999999977554432 12334566799
Q ss_pred CchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCC
Q 017231 210 APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN 289 (375)
Q Consensus 210 aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
|||.+.+ ..++.++|+||+|+++|+|++|..|+....... .. . . .
T Consensus 150 aPE~~~~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----~~---~-~--------------------~----- 194 (237)
T cd05576 150 APEVGGI-SEETEACDWWSLGAILFELLTGKTLVECHPSGI-----NT---H-T--------------------T----- 194 (237)
T ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----cc---c-c--------------------c-----
Confidence 9999876 668899999999999999999998774321100 00 0 0 0
Q ss_pred ccccCCCCCchHHHHHHHhcCcCCCCCCCH-----HHHhcCCCC
Q 017231 290 FSARFPNKSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYL 328 (375)
Q Consensus 290 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f 328 (375)
+ ..-+.+++.+.++|.+||+.||++||++ +++++||||
T Consensus 195 ~-~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 195 L-NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred c-CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0 0012467889999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=304.68 Aligned_cols=258 Identities=33% Similarity=0.504 Sum_probs=196.0
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC----------
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP---------- 111 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---------- 111 (375)
++.++.||+||||.||+++++-+|..||||.+.... +......+.+|+..|.+|+|||||+++..+.+.
T Consensus 481 FEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~ 559 (1351)
T KOG1035|consen 481 FEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV 559 (1351)
T ss_pred hHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence 557999999999999999999999999999997765 666788899999999999999999998422000
Q ss_pred ---------------------------------------------------------------------------CC---
Q 017231 112 ---------------------------------------------------------------------------QR--- 113 (375)
Q Consensus 112 ---------------------------------------------------------------------------~~--- 113 (375)
..
T Consensus 560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~ 639 (1351)
T KOG1035|consen 560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS 639 (1351)
T ss_pred ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence 00
Q ss_pred ----------------C---C-------cCcEEEEEeCCCCCH-HHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCcc
Q 017231 114 ----------------E---T-------FNDVYIVYELMDTDL-HQIIRSHQDL-TDDHCRYFLYQLLRGLKYVHSANVL 165 (375)
Q Consensus 114 ----------------~---~-------~~~~~lv~e~~~g~L-~~~l~~~~~l-~~~~~~~i~~qi~~al~~Lh~~~i~ 165 (375)
+ + ...+||-||||+.++ .+++..+... ....+|+++++|++||.|+|+.|++
T Consensus 640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giI 719 (1351)
T KOG1035|consen 640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGII 719 (1351)
T ss_pred cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCcee
Confidence 0 0 023588899999655 5555554433 5889999999999999999999999
Q ss_pred ccCCCCCceEEecCCCEEEeecccccccC----C---------------CCccccccccccccCchhcccCC--CCCccc
Q 017231 166 HRDLKPSNLLLNANCDLKIGDFGLARTTS----E---------------TDFMTEYVVTRWYRAPELLLNCS--EYTAAI 224 (375)
Q Consensus 166 H~di~p~NIli~~~~~i~l~Df~~~~~~~----~---------------~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~ 224 (375)
||||||.|||++.++.|||+|||++.... . ........||..|.|||++.+.. .|+.|+
T Consensus 720 HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~Ki 799 (1351)
T KOG1035|consen 720 HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKI 799 (1351)
T ss_pred eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchh
Confidence 99999999999999999999999997511 0 01223467899999999998755 699999
Q ss_pred hhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHH-hCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHH
Q 017231 225 DIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL-IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 303 (375)
Q Consensus 225 Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 303 (375)
|+||||++++||+. ||... .+-...+..+ .+..|.. ..++ .+--+.-..
T Consensus 800 DmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~g~iP~~-~~f~------------------------~~~~~~e~s 849 (1351)
T KOG1035|consen 800 DMYSLGIVLFEMLY---PFGTS--MERASILTNLRKGSIPEP-ADFF------------------------DPEHPEEAS 849 (1351)
T ss_pred hhHHHHHHHHHHhc---cCCch--HHHHHHHHhcccCCCCCC-cccc------------------------cccchHHHH
Confidence 99999999999985 35332 2222222222 1222221 1000 112344678
Q ss_pred HHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 304 LLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 304 li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
+|+.||+.||++||||.|||++.||-.
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 999999999999999999999999983
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=269.72 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=187.1
Q ss_pred eeccCCcceEEEEEEeC--CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNS--ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||++... .++..+++|.+..... ......+.+|+.++++++|||++++++.+... ...++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEE
Confidence 46999999999999754 3556799998865432 23345688899999999999999999988554 4579999
Q ss_pred eCCC-CCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 124 ELMD-TDLHQIIRSHQ-----DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~-----~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
||++ |+|.+++.... ..+...+..++.|++.|+.+||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9997 69999986532 35677888999999999999999999999999999999999999999999886543322
Q ss_pred c---cccccccccccCchhcccC------CCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHh-CCCCccc
Q 017231 198 F---MTEYVVTRWYRAPELLLNC------SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELI-GSPDETS 266 (375)
Q Consensus 198 ~---~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~ 266 (375)
. .....++..|+|||++.+. ..++.++|+||||+++|+|++ |..||......+......... ...+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 233 (269)
T cd05087 155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP- 233 (269)
T ss_pred eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC-
Confidence 1 1234457789999998642 135789999999999999996 999997765444332211110 000000
Q ss_pred ccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
......++.+.+++.+|+ .+|++|||++||+.
T Consensus 234 -------------------------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 -------------------------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -------------------------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 001235777999999999 58999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=275.79 Aligned_cols=254 Identities=15% Similarity=0.147 Sum_probs=187.3
Q ss_pred CeeeccCCcceEEEEEEeCCC---CcEEEEEEecCcccchHHH---------HHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSET---REEVAIKKIGNAFDNRIDA---------KRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
+.+.||+|+||.||+|.+..+ +..+++|+........... .....+...+..+.|+++++++++....
T Consensus 16 i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 95 (294)
T PHA02882 16 IDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFK 95 (294)
T ss_pred EeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEe
Confidence 699999999999999998877 6677888653322111000 1122334455667899999999876443
Q ss_pred CCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 112 QRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.. .....+++++++..++.+.+......++..++.++.|++.||.+||+.+++||||||+||+++.++.++|+|||++.
T Consensus 96 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DFGla~ 174 (294)
T PHA02882 96 RC-RMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174 (294)
T ss_pred cC-CceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEcCCce
Confidence 21 11235788888887888888776667899999999999999999999999999999999999999999999999986
Q ss_pred ccCCCC--------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh-HHHHHHHH-HhCC
Q 017231 192 TTSETD--------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQLRLITE-LIGS 261 (375)
Q Consensus 192 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~-~~~~ 261 (375)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ........ ....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~ 253 (294)
T PHA02882 175 HFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKR 253 (294)
T ss_pred eeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHH
Confidence 543211 1123468999999999887 77899999999999999999999999876322 22211111 1000
Q ss_pred CCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 262 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.... ....+..++++.+++..|++.+|++||++.++++
T Consensus 254 ~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 254 LHEG-------------------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hhhh-------------------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0000 0012345788999999999999999999999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=256.78 Aligned_cols=300 Identities=32% Similarity=0.599 Sum_probs=230.7
Q ss_pred eEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeee
Q 017231 25 YVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIA 103 (375)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~ 103 (375)
|-=|+..--.|.-..+|. +++++|+|-++.||.+....+.++++||+++.. ....+.+|+.+|..|. ||||++
T Consensus 24 YWdYE~~~i~wg~~ddYe-ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~ 97 (338)
T KOG0668|consen 24 YWDYESLVIDWGNQDDYE-IVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIK 97 (338)
T ss_pred hcchhheeeeccccchHH-HHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeee
Confidence 333444445666555555 999999999999999999999999999998543 4567889999999997 999999
Q ss_pred eceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC-CC
Q 017231 104 IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CD 181 (375)
Q Consensus 104 ~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~-~~ 181 (375)
++++..++.. ....+++||++. +...+. +.++..+++..+.+++.||.|+|++||.|+|+||.|++||.. ..
T Consensus 98 L~DiV~Dp~S---ktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rk 171 (338)
T KOG0668|consen 98 LLDIVKDPES---KTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRK 171 (338)
T ss_pred hhhhhcCccc---cCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhce
Confidence 9999988754 456899999974 555554 348999999999999999999999999999999999999865 46
Q ss_pred EEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCC-CCCChhHHHHHHHHHhC
Q 017231 182 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIG 260 (375)
Q Consensus 182 i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~ 260 (375)
++|+|||++.........+-...+..|--||.+...+.++.+.|+|||||++..|+..+.|| .+.+..+++-.|...+|
T Consensus 172 LrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 172 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG 251 (338)
T ss_pred eeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence 99999999987766655555666788999999988888999999999999999999988886 56666777777887777
Q ss_pred CCCcccc-cccccchhHHHhhhCC---CCCCCCccc--cCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 261 SPDETSL-GFLRSDNARRYVRMLP---QFPKQNFSA--RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 261 ~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
....... ..+.-....++...+. ..++..+.. ...-++++..++|.++|..|-++|+|+.|.+.||||..+...
T Consensus 252 t~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 252 TDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred hHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 5322100 0011111222222222 212211111 112357999999999999999999999999999999987554
Q ss_pred CC
Q 017231 335 NE 336 (375)
Q Consensus 335 ~~ 336 (375)
..
T Consensus 332 ~~ 333 (338)
T KOG0668|consen 332 ES 333 (338)
T ss_pred hh
Confidence 44
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=271.21 Aligned_cols=235 Identities=18% Similarity=0.273 Sum_probs=186.2
Q ss_pred eeccCCcceEEEEEEeCCCC----------cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCC
Q 017231 46 RPVGRGAYGIVCAAMNSETR----------EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 115 (375)
+.||+|+||.||++.+..++ ..+++|.+..... ....+.+|+.++++++|||++++++.+..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998776 3578887654321 15678899999999999999999998855
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-------CEEEee
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-------DLKIGD 186 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-------~i~l~D 186 (375)
...++|+||++ |+|.+++.... .++...+..++.||+.||.+||+.|++|+||||+||+++.++ .++|+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 22589999997 69999998766 799999999999999999999999999999999999999888 799999
Q ss_pred cccccccCCCCccccccccccccCchhcccC-CCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 187 FGLARTTSETDFMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 187 f~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
||.+...... ....++..|+|||.+.+. ..++.++|+||||+++|+|++ |..||...+.......... ....
T Consensus 152 fg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~-- 225 (259)
T cd05037 152 PGIPITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRL-- 225 (259)
T ss_pred CCcccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCC--
Confidence 9988764432 233456779999998773 368899999999999999999 5777766542222111110 0000
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.......+.++|.+||..+|++||++.++++
T Consensus 226 -----------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 226 -----------------------------PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -----------------------------CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0011367999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=267.49 Aligned_cols=278 Identities=23% Similarity=0.347 Sum_probs=220.3
Q ss_pred EEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeee
Q 017231 26 VQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAI 104 (375)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 104 (375)
+.+......++...+.++=+..||.|+||+|++..++.+|+..|||.+..... ..+..+++.|.....+- ++||||++
T Consensus 50 l~~p~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkf 128 (361)
T KOG1006|consen 50 LKLPDDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKF 128 (361)
T ss_pred eecCCcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHH
Confidence 44455567778888888889999999999999999999999999999976543 34556777888766665 69999999
Q ss_pred ceeecCCCCCCcCcEEEEEeCCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEec
Q 017231 105 KDIIRPPQRETFNDVYIVYELMDTDLHQIIR-----SHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNA 178 (375)
Q Consensus 105 ~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~-----~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~ 178 (375)
++..... +..++.||+|+-+|..+.+ ....+++..+-.|....+.||.||.. .+|+|||+||+|||++.
T Consensus 129 yGa~F~E-----GdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 129 YGALFSE-----GDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDR 203 (361)
T ss_pred hhhhhcC-----CceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEec
Confidence 9986543 3369999999977655543 34569999999999999999999995 48999999999999999
Q ss_pred CCCEEEeecccccccCCCCccccccccccccCchhcccCC-CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHH
Q 017231 179 NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS-EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 257 (375)
Q Consensus 179 ~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 257 (375)
.|.+||||||.+.....+.....-.|-..|+|||.+.... .++.++|+||||+++||+.||..||..-+. ...++..
T Consensus 204 ~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~ 281 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQ 281 (361)
T ss_pred CCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHH
Confidence 9999999999987766554445556777899999997643 489999999999999999999999976543 3333333
Q ss_pred H-hCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 258 L-IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 258 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
. .+.++... .....-+++..+.++|..||.+|-+.||...+|+.+||++-+...
T Consensus 282 Vv~gdpp~l~-----------------------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 282 VVIGDPPILL-----------------------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred HHcCCCCeec-----------------------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 2 22222111 111113578899999999999999999999999999999976433
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=271.56 Aligned_cols=242 Identities=28% Similarity=0.422 Sum_probs=191.6
Q ss_pred eeccCCcceEEEEEEeCCCC------cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 46 RPVGRGAYGIVCAAMNSETR------EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+.||+|++|.||+++++... ..+++|.+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCe
Confidence 36999999999999876543 679999875432 123456788899999999999999999998654 458
Q ss_pred EEEEeCCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-----CEEEee
Q 017231 120 YIVYELMD-TDLHQIIRSH-------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-----DLKIGD 186 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~-------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-----~i~l~D 186 (375)
+++|||++ ++|.+++... ..+++..+..++.||+.||.+||+++++|+||+|+||+++.++ .++|+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999997 6999998642 3478899999999999999999999999999999999999887 899999
Q ss_pred cccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCC
Q 017231 187 FGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSP 262 (375)
Q Consensus 187 f~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~ 262 (375)
||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+.... ..
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~ 232 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL 232 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc
Confidence 998865433221 122334677999999987 678999999999999999998 999997766544433322100 00
Q ss_pred CcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 263 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....++..+.++|.+||+.+|++||+++++++
T Consensus 233 -----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 233 -----------------------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -----------------------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 001245788999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=302.64 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=210.9
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCCC-----cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETR-----EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
++.+..+...+.||+|+||.||.++-.... ..||+|.+.+. .+.....+|.+|..+++.++|||||++++++..
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 356777888999999999999999855432 24899988654 345567889999999999999999999999987
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCE
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSH-------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 182 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i 182 (375)
. ...+|++|||+ |+|+.+|++. ..++..+...++.+|+.|++||++++++||||...|+|++....+
T Consensus 767 ~-----~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 767 S-----GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred C-----CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcE
Confidence 4 44799999997 7999999875 349999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCccc---cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHH
Q 017231 183 KIGDFGLARTTSETDFMT---EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITEL 258 (375)
Q Consensus 183 ~l~Df~~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 258 (375)
||+|||+++......+.. .......|+|||.+.. ..++.++||||||+++||+++ |..||.+.+..+.+....+.
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~g 920 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEG 920 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhC
Confidence 999999998544433221 1233567999999998 789999999999999999998 99999998877766544442
Q ss_pred hCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 259 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
- ..+.+ +.++..+.+++..||+.+|++||++..|++
T Consensus 921 g-RL~~P-----------------------------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 921 G-RLDPP-----------------------------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred C-ccCCC-----------------------------CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 2 22222 357888999999999999999999999988
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=293.07 Aligned_cols=205 Identities=30% Similarity=0.409 Sum_probs=177.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC-CCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv 122 (375)
.-+.||+||||.||.++++.+|+.||||.+.... .....+....|+++|++++|+|||+++++-.... .-......++
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 4678999999999999999999999999997654 4446777889999999999999999999764432 1112446899
Q ss_pred EeCCC-CCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec--CC--CEEEeecccccccC
Q 017231 123 YELMD-TDLHQIIRSH---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--NC--DLKIGDFGLARTTS 194 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~---~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~--~~--~i~l~Df~~~~~~~ 194 (375)
||||. |+|...+.+. .++++.+++.+..++..||.|||++||+||||||+||++-. +| ..||+|||+++..+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~ 175 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELD 175 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCC
Confidence 99996 7999999753 56999999999999999999999999999999999999732 23 37999999999999
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 249 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 249 (375)
......+..||..|++||.+...+.++..+|.|||||++|++.||..||......
T Consensus 176 d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 176 DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9888999999999999999985578999999999999999999999999765444
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=313.81 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=211.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
-..+||.|.||.||.+.+..+|+..|+|.+............+.+|..++..|+|||+|+++++=... ..++|.|
T Consensus 1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-----ekv~IFM 1313 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-----EKVYIFM 1313 (1509)
T ss_pred cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----HHHHHHH
Confidence 47889999999999999999999999998865444455566778999999999999999999986543 3478999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-----
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----- 197 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~----- 197 (375)
|||+ |+|.+++......++.....+..|++.|+.+||++||+|+||||.||+++.+|-+|++|||++.....+.
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 9996 7999999998889999999999999999999999999999999999999999999999999998766552
Q ss_pred ccccccccccccCchhcccC--CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH-HHHHHHHhCCCCcccccccccch
Q 017231 198 FMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ-LRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
......||+.|+|||++.+. ++...++|||||||++.||+||+.||...+.+=. +..+ ..|..|+..
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V--~~gh~Pq~P-------- 1463 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV--AAGHKPQIP-------- 1463 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH--hccCCCCCc--------
Confidence 23456789999999999764 3567899999999999999999999977653221 1111 122222211
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..+|++..+||..||..||.+|.++.+|+.|.|-+.-
T Consensus 1464 --------------------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1464 --------------------ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred --------------------hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 1368899999999999999999999999999998753
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=262.78 Aligned_cols=246 Identities=19% Similarity=0.260 Sum_probs=186.0
Q ss_pred eeccCCcceEEEEEEeCCC--CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSET--REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.||+|+||.||++....+ ...+++|.+.... .......+.+|+..++.++|||++++++.+... ...++||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~ 74 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVF 74 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEE
Confidence 3699999999999975433 3356677765432 233456788999999999999999999998654 4579999
Q ss_pred eCCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 124 ELMD-TDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 124 e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
||++ |+|.+++... ...+...++.++.||+.||.+||+.+++|+||||+||+++.++.++|+|||.+.......
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 9997 6999999764 346777888999999999999999999999999999999999999999999875422211
Q ss_pred --ccccccccccccCchhccc------CCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCC-CCcccc
Q 017231 198 --FMTEYVVTRWYRAPELLLN------CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGS-PDETSL 267 (375)
Q Consensus 198 --~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~ 267 (375)
......++..|+|||++.. ...++.++||||||+++|+|++ |..||...+..+....+...... ....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 232 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKP-- 232 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCC--
Confidence 1234466788999998753 1235789999999999999996 57788776655544443221110 0000
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++.+.+++..|| .+|++||++.+|++
T Consensus 233 ------------------------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 233 ------------------------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ------------------------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 001236788999999999 58999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=281.23 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=211.4
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCC--CCc--EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE--TRE--EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~--~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
..+++.+..+.+.+.||.|-||.||.+.-.. .|+ .||||+.+..... ...+.|+.|+.+++++.||||+++++++
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 5678899999999999999999999997322 233 5899988765433 3488999999999999999999999999
Q ss_pred cCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEee
Q 017231 109 RPPQRETFNDVYIVYELMD-TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 186 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~D 186 (375)
.+.. .+||||.++ |.|..+++.++. ++......++.||+.||.|||+.+++||||-..||++.....+||+|
T Consensus 461 ~e~P------~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 461 VEQP------MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred eccc------eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecc
Confidence 7653 699999998 999999998764 99999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccc--ccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 187 FGLARTTSETDFMTEYV--VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 187 f~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
||+++......+..... ....|+|||-+.. ..++.++|||.||++|||++. |..||.+....+.+..+.+.
T Consensus 535 FGLSR~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG----- 608 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG----- 608 (974)
T ss_pred cchhhhccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC-----
Confidence 99999888775443333 3566999999876 789999999999999999976 99999876544443333221
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
+....-+.+++.+..++.+||.++|.+||.+.+|..
T Consensus 609 -------------------------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 609 -------------------------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred -------------------------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 111222578999999999999999999999876654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=258.61 Aligned_cols=242 Identities=38% Similarity=0.656 Sum_probs=200.0
Q ss_pred cceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCCC-CH
Q 017231 52 AYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DL 130 (375)
Q Consensus 52 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L 130 (375)
++|.||++.+..+++.+++|++........ ...+..|++.+++++|++++++++.+... ...++++|++++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCH
Confidence 579999999999999999999865433221 67888999999999999999999998654 558999999985 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccccccccccccC
Q 017231 131 HQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 210 (375)
Q Consensus 131 ~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~a 210 (375)
.+++.....++...++.++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.............++..|++
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 154 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMA 154 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCC
Confidence 99998877799999999999999999999999999999999999999999999999999877665544455667888999
Q ss_pred chhcccCCCCCccchhHHHHHHHHHHhhCCCCCCC-CChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCC
Q 017231 211 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQN 289 (375)
Q Consensus 211 PE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (375)
||.+.+ ...+.++|+|+||+++++|++|..||.. .+.......+.........
T Consensus 155 pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------- 208 (244)
T smart00220 155 PEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP------------------------- 208 (244)
T ss_pred HHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-------------------------
Confidence 999886 6678899999999999999999999977 3333333222211111000
Q ss_pred ccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 290 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 290 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....++.++.+++.+||..+|++||++.++++||||
T Consensus 209 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 209 ---PEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---ccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 001167889999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=275.78 Aligned_cols=257 Identities=22% Similarity=0.383 Sum_probs=220.7
Q ss_pred eecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 29 NVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 29 ~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
.+.-.+|++.+..+.+.++||.|-||.||.+.+++-.-.||||.++. +.-..++|+.|+.+++.++|||+|+++++|
T Consensus 256 SPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVC 332 (1157)
T KOG4278|consen 256 SPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 332 (1157)
T ss_pred cCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhh
Confidence 44459999999999999999999999999999999888999998854 344678899999999999999999999999
Q ss_pred cCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEe
Q 017231 109 RPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 185 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~ 185 (375)
... ..+|||+|||. |+|++++....+ ++.-..+.++.||..|++||..++++||||-..|.|+.++..+|+.
T Consensus 333 T~E-----pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 333 THE-----PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred ccC-----CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEee
Confidence 654 45899999996 899999987543 7777888999999999999999999999999999999999999999
Q ss_pred ecccccccCCCCccc--cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCC
Q 017231 186 DFGLARTTSETDFMT--EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSP 262 (375)
Q Consensus 186 Df~~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~ 262 (375)
|||+++.+....+.. .......|.|||-+.- +.++.++|||+||+++||+.| |-.||++.+..+....+.+....-
T Consensus 408 DFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~ 486 (1157)
T KOG4278|consen 408 DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD 486 (1157)
T ss_pred ccchhhhhcCCceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc
Confidence 999999887775432 2334677999999876 789999999999999999998 889999998777766655432211
Q ss_pred CcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 263 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
. -.++++...+|++.||++.|..||++.|+-+
T Consensus 487 ~------------------------------PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 487 G------------------------------PEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred C------------------------------CCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 1 1367999999999999999999999988743
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=285.41 Aligned_cols=262 Identities=24% Similarity=0.405 Sum_probs=212.7
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 117 (375)
.+-++|++.||.|.+|.||++.++.+++..|+|+.......+ +++..|+++|+.. .|||++.++++|.-..-...+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 334457999999999999999999999999999986544333 3456889999988 599999999998765546668
Q ss_pred cEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 118 DVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
.+++|||||+ |+..|+++.. ..+.+..+..|++.++.|+.+||.+.++|+|||-.||+++.++.+||+|||.+....
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 8999999997 7999998765 459999999999999999999999999999999999999999999999999775544
Q ss_pred C-CCccccccccccccCchhcccC----CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 195 E-TDFMTEYVVTRWYRAPELLLNC----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 195 ~-~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
. .....+..||+.|+|||++... ..++..+|+||||++..||.-|.+|+-.......+-.|.. .+++..
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPkL--- 248 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPKL--- 248 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCccc---
Confidence 3 3456788999999999998642 3467789999999999999999999976654433322211 111110
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
...+.-++++.++|..||.+|.++||+..++|.|||++..
T Consensus 249 ----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 249 ----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred ----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 0012237789999999999999999999999999999944
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=271.10 Aligned_cols=269 Identities=25% Similarity=0.428 Sum_probs=212.0
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-----cchHHHHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-----DNRIDAKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
--.+..+|+ ++..||+|||+.||+|.|....+.||+|+-.... ..........+|..+-+.|.||.||++|++|
T Consensus 458 HptLn~RYL-lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 458 HPTLNDRYL-LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred CcchHHHHH-HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 334555565 8999999999999999999999999999864332 1112235667899999999999999999999
Q ss_pred cCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCceEEe---cCCCE
Q 017231 109 RPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA--NVLHRDLKPSNLLLN---ANCDL 182 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~--~i~H~di~p~NIli~---~~~~i 182 (375)
.-.. ..+|-|+|||+| +|.-+++.++.+++.+++.|+.||+.||.||... .|+|-||||.|||+- .-|.+
T Consensus 537 slDt----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 537 SLDT----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eecc----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence 7654 568999999997 7777888888999999999999999999999977 499999999999984 34779
Q ss_pred EEeecccccccCCCC--------ccccccccccccCchhccc---CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH
Q 017231 183 KIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLN---CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 251 (375)
Q Consensus 183 ~l~Df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 251 (375)
||.|||+++.+.... ..+...||..|++||.+.- ....+.++||||.|+|+|..+.|+.||........
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 999999998876553 3355778999999999753 23457899999999999999999999976543222
Q ss_pred HHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 252 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
+ .....-....... -..-+.++.+.+.||++||++--+.|....+|..||+|...
T Consensus 693 I---LqeNTIlkAtEVq----------------------FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 693 I---LQENTILKATEVQ----------------------FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred H---Hhhhchhcceecc----------------------CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 1 1111100000000 01125679999999999999999999999999999999874
Q ss_pred C
Q 017231 332 H 332 (375)
Q Consensus 332 ~ 332 (375)
.
T Consensus 748 ~ 748 (775)
T KOG1151|consen 748 I 748 (775)
T ss_pred h
Confidence 3
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=284.91 Aligned_cols=277 Identities=19% Similarity=0.253 Sum_probs=178.7
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCC----CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC-
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSET----REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ- 112 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 112 (375)
..+.+.+.+.||+|+||.||++.+..+ +..||+|.+..... .+....+ .++...+.++..+...+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 344556899999999999999999998 89999998754211 1111111 122222333333333222211
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQD--------------------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 171 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p 171 (375)
.......++|+||++ ++|.+++..... .....+..++.||+.||.|||+.||+|+||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 133366899999997 689998865421 12345678999999999999999999999999
Q ss_pred CceEEec-CCCEEEeecccccccCCC--CccccccccccccCchhcccCC---------------------CCCccchhH
Q 017231 172 SNLLLNA-NCDLKIGDFGLARTTSET--DFMTEYVVTRWYRAPELLLNCS---------------------EYTAAIDIW 227 (375)
Q Consensus 172 ~NIli~~-~~~i~l~Df~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~Di~ 227 (375)
+|||++. ++.++|+|||++...... .......+++.|+|||.+.... .++.++|||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 9999986 579999999998754322 2234567789999999764311 234567999
Q ss_pred HHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCC---CccccCCCCCchHHHH
Q 017231 228 SVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ---NFSARFPNKSPGAVDL 304 (375)
Q Consensus 228 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~l~~l 304 (375)
||||++|+|+++..++.. .......+....+..... +.......... ..............+|
T Consensus 364 SlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~d~~~~~~~dL 429 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVA------------WRKLVEPRASPDLRRGFEVLDLDGGAGWEL 429 (566)
T ss_pred HHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHH------------HHHhhccccchhhhhhhhhccccchHHHHH
Confidence 999999999997755432 222222222211111000 00000000000 0001111224456799
Q ss_pred HHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 305 LEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 305 i~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
|.+||+.||.+|||+.++|+||||++....
T Consensus 430 i~~mL~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 430 LKSMMRFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred HHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence 999999999999999999999999986543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=282.44 Aligned_cols=260 Identities=24% Similarity=0.378 Sum_probs=222.4
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCc---EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETRE---EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
..||.-.++.|-+.||.|.||.|+.++.+..|+ .||||.++.- ..+.....|+.|+.++-++.||||+++.++...
T Consensus 623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 467888899999999999999999999887775 5999998643 345567889999999999999999999999855
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
. ..+.||+|||+ |+|..+|+.+ +.++.-+...+.+.|+.|+.||-++|++||||-..|||++.+-.+|++|||
T Consensus 702 s-----~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 702 S-----KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred C-----ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccc
Confidence 4 55789999997 8999999876 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-cccccc---ccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 189 LARTTSETD-FMTEYV---VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 189 ~~~~~~~~~-~~~~~~---~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
+++...... ...+.. -...|.|||++.. ..++.++||||+|++|||.++ |..||-.....+.++.|....+-++
T Consensus 777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp 855 (996)
T KOG0196|consen 777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP 855 (996)
T ss_pred ceeecccCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC
Confidence 998765443 111222 2577999999987 889999999999999999886 9999999988888888877655443
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc--CCCCCC
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC--HPYLAP 330 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~--~~~f~~ 330 (375)
+ .+++..|.+|+..||++|-.+||.+.+|++ +..+++
T Consensus 856 P------------------------------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 856 P------------------------------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred C------------------------------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 3 367899999999999999999999988887 344444
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=271.96 Aligned_cols=257 Identities=23% Similarity=0.319 Sum_probs=214.3
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCC-C--cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSET-R--EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~-~--~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
|....+.+.++||+|+||+|+.+.++.. | ..||||.+....... ....|++|+.+|.+|+|+|++++|++..+..
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~qp- 184 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLDQP- 184 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeeccch-
Confidence 4777788999999999999999987753 2 259999986654433 5788999999999999999999999997643
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
+.+|+|++. |+|++.+.+ ...|-......++.||+.|+.||..++++||||-..|+++-....+||+|||+.
T Consensus 185 -----~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 185 -----AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred -----hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccce
Confidence 579999998 899999987 345889999999999999999999999999999999999998889999999999
Q ss_pred cccCCCCcccc----ccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 191 RTTSETDFMTE----YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 191 ~~~~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
+.....+.... ..-...|+|||.+.. ..++.++|+|++|++||||++ |..||.+......++.|-..
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~------- 331 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG------- 331 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc-------
Confidence 87666543222 223566999999988 889999999999999999998 89999999887777766421
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
+...+-+.+++.+.+++..||..+|.+||++..|...-+.+..
T Consensus 332 -----------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 332 -----------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred -----------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 1112225678999999999999999999999999766655543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=262.93 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=210.9
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
.-+.+++-+.++++||+|-||.|.++.-.. +.+||+|..+... .......|.+|+.+|.+|+||||+.++++|...
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-- 607 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-- 607 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecC--
Confidence 446677888899999999999999997543 6899999986542 333457899999999999999999999999665
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
..+++++||++ |+|.+++..+ +.+......+|+.||+.|++||.+.+++||||.+.|+|++.++++||+|||.+
T Consensus 608 ---ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 608 ---DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred ---CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccc
Confidence 45899999997 9999999887 33456667779999999999999999999999999999999999999999998
Q ss_pred cccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHh--hCCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 191 RTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM--TRQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 191 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~--~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
+..-...+ .........|+|+|.+.. ..++.++|+|++|+++||++ +...||.....++..+....+....+..
T Consensus 685 R~lysg~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 685 RNLYSGDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cccccCCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc
Confidence 75433322 223455788999999887 78999999999999999986 4789998887777776666654433221
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
-. ...-+-++..+.+++.+||..|-.+||++++|-.
T Consensus 764 ~~-----------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 764 VV-----------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ee-----------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 11 1111346778999999999999999999999754
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=229.93 Aligned_cols=219 Identities=27% Similarity=0.444 Sum_probs=184.1
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPP 111 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 111 (375)
..|++..+.+..+..||+|++|+|=+.++..+|...|+|.+.-+..+. ...++.+|+.+..+. .+|.+|.+++.+...
T Consensus 39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~re 117 (282)
T KOG0984|consen 39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFRE 117 (282)
T ss_pred CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence 449999999999999999999999999999999999999997665444 445667778876666 699999999977544
Q ss_pred CCCCcCcEEEEEeCCCCCHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEEee
Q 017231 112 QRETFNDVYIVYELMDTDLHQI----IRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGD 186 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~g~L~~~----l~~~~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~D 186 (375)
..+++.||.|+.+|..+ ++..+.+++..+=+|+..++.||.|||++ .++|||+||+|||++.+|++|+||
T Consensus 118 -----gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCD 192 (282)
T KOG0984|consen 118 -----GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICD 192 (282)
T ss_pred -----ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcc
Confidence 55899999999877554 45567799999999999999999999966 899999999999999999999999
Q ss_pred cccccccCCCCccccccccccccCchhccc---CCCCCccchhHHHHHHHHHHhhCCCCCCC-CChhHHHHHHHH
Q 017231 187 FGLARTTSETDFMTEYVVTRWYRAPELLLN---CSEYTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITE 257 (375)
Q Consensus 187 f~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~ 257 (375)
||.+.....+-...-..|-..|+|||.+.. .+.|+.++||||||+.+.||.+++.||+. ..+.++++.+.+
T Consensus 193 FGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 193 FGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred cccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 999977766644444567788999999853 35789999999999999999999999975 345666666655
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=262.79 Aligned_cols=274 Identities=19% Similarity=0.289 Sum_probs=184.0
Q ss_pred cccccCCeeeccCCcceEEEEEEeC----------------CCCcEEEEEEecCcccchH------------HHHHHHHH
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNS----------------ETREEVAIKKIGNAFDNRI------------DAKRTLRE 89 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~----------------~~~~~vaiK~~~~~~~~~~------------~~~~~~~e 89 (375)
..+.+.+.++||+|+||+||++.+. ..++.||||.+........ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3555668999999999999998642 3456799999854321110 11223346
Q ss_pred HHHHHhcCCCCe-----eeeceeecCCCC---CCcCcEEEEEeCCC-CCHHHHHHhC-----------------------
Q 017231 90 IKLLRHMDHENI-----IAIKDIIRPPQR---ETFNDVYIVYELMD-TDLHQIIRSH----------------------- 137 (375)
Q Consensus 90 ~~~l~~l~h~~i-----v~~~~~~~~~~~---~~~~~~~lv~e~~~-g~L~~~l~~~----------------------- 137 (375)
+.++.+++|.++ +++++++..... ...+..++|+||++ ++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766544 566666654211 12245799999997 6998888642
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccc--ccccccccCchhc
Q 017231 138 -QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE--YVVTRWYRAPELL 214 (375)
Q Consensus 138 -~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~--~~~~~~y~aPE~~ 214 (375)
..+++..++.++.|++.+|.+||+.+++|+||||+||+++.++.++|+|||++........... ..+++.|+|||.+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 1245677889999999999999999999999999999999999999999999865433322222 2347889999997
Q ss_pred ccCC---------------------CCCccchhHHHHHHHHHHhhCCC-CCCCCChhHH-HHHHHHHhCCCCcccccccc
Q 017231 215 LNCS---------------------EYTAAIDIWSVGCILGEIMTRQP-LFPGKDYVHQ-LRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 215 ~~~~---------------------~~~~~~Di~slG~il~~l~~g~~-pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 271 (375)
.... ....+.|+||+||++++|++|.. ||........ ......
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~-------------- 448 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDN-------------- 448 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccc--------------
Confidence 5411 11234799999999999999875 6643221110 000000
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCC---CCCCCHHHHhcCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDP---NRRITVDEALCHPYLAP 330 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP---~~Rps~~ell~~~~f~~ 330 (375)
....+.. ... .... ...+...++...+++.+||..+| .+|+|+.|+|+||||..
T Consensus 449 --~~~~~r~-~~~-~~~~-~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 449 --DLNRWRM-YKG-QKYD-FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred --hHHHHHh-hcc-cCCC-cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0000000 000 0000 11234568899999999999766 68999999999999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=272.83 Aligned_cols=245 Identities=29% Similarity=0.367 Sum_probs=187.4
Q ss_pred CeeeccCCcceE-EEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRGAYGI-VCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~-Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
-.+.+|.|+.|+ ||.+. -.|+.||||.+-.+ -..-..+|+..|+.- .||||++++..-.+. ...||
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~-----qF~YI 580 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGV--YEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDR-----QFLYI 580 (903)
T ss_pred cHHHcccCCCCcEEEEEe--eCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCC-----ceEEE
Confidence 456789999885 59985 45779999987433 234567899999988 599999998765433 56899
Q ss_pred EEeCCCCCHHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec---C--CCEEEeecccccc
Q 017231 122 VYELMDTDLHQIIRSHQD----LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---N--CDLKIGDFGLART 192 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~~~----l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~---~--~~i~l~Df~~~~~ 192 (375)
+.|.|..+|.+++..... ......+.+..|++.||+|||+.+|+||||||+||||.. + .+++|+|||+++.
T Consensus 581 alELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 581 ALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred EehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 999999999999987411 222456788999999999999999999999999999976 3 4699999999987
Q ss_pred cCCCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhC-CCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 193 TSETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 193 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
..... ......||..|+|||.+.. ...+.++|||||||++|+.++| ..||...-..+. .|........
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~---- 733 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLV---- 733 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCcccee----
Confidence 65542 3456788999999999988 5567799999999999999985 899965532221 1111100000
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.+ .+....+..++|.+|+++||..||+|.+||.||||=..
T Consensus 734 ----------------~L--------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 734 ----------------HL--------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred ----------------ee--------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 00 00111178999999999999999999999999999653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-32 Score=266.26 Aligned_cols=257 Identities=28% Similarity=0.439 Sum_probs=210.4
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEeC----C---CCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCee
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNS----E---TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENII 102 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~----~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 102 (375)
+...|++.+..+.+.+.||+|+||.|+++.-. . ....||+|..+..... ...+.+..|+.+++.+ .|+|++
T Consensus 287 ~~~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv 365 (609)
T KOG0200|consen 287 EDPKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIV 365 (609)
T ss_pred cCCceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchh
Confidence 33499999999999999999999999999733 1 1457999998766544 6788899999999999 599999
Q ss_pred eeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 017231 103 AIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----------------DLTDDHCRYFLYQLLRGLKYVHSANVL 165 (375)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~Lh~~~i~ 165 (375)
.+++.+... +.+++|+||+. |+|.++++..+ .++..+.+.++.||+.|++||++.+++
T Consensus 366 ~llG~~t~~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 366 NLLGACTQD-----GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred hheeeeccC-----CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 999999662 66899999997 89999998766 389999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCEEEeecccccccCCCCccc--ccc--ccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CC
Q 017231 166 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT--EYV--VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQ 240 (375)
Q Consensus 166 H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~--~~~--~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~ 240 (375)
||||-..||++..+..+|++|||+++......... ... -...|+|||.+.. ..++.++||||+|+++||+++ |.
T Consensus 441 HRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~ 519 (609)
T KOG0200|consen 441 HRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGG 519 (609)
T ss_pred chhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCC
Confidence 99999999999999999999999998655443222 112 2455999999998 889999999999999999998 89
Q ss_pred CCCCCCC-hhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH
Q 017231 241 PLFPGKD-YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 319 (375)
Q Consensus 241 ~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~ 319 (375)
.||.+.. ..+....+..... .. .-..+++++.++++.||+.+|++||++
T Consensus 520 ~PYp~~~~~~~l~~~l~~G~r-~~-----------------------------~P~~c~~eiY~iM~~CW~~~p~~RP~F 569 (609)
T KOG0200|consen 520 TPYPGIPPTEELLEFLKEGNR-ME-----------------------------QPEHCSDEIYDLMKSCWNADPEDRPTF 569 (609)
T ss_pred CCCCCCCcHHHHHHHHhcCCC-CC-----------------------------CCCCCCHHHHHHHHHHhCCCcccCCCH
Confidence 9998754 3333332222111 00 013468889999999999999999999
Q ss_pred HHHhc
Q 017231 320 DEALC 324 (375)
Q Consensus 320 ~ell~ 324 (375)
.++..
T Consensus 570 ~~~~~ 574 (609)
T KOG0200|consen 570 SECVE 574 (609)
T ss_pred HHHHH
Confidence 98775
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=256.49 Aligned_cols=198 Identities=28% Similarity=0.431 Sum_probs=174.7
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc--cchHH----HHHHHHHHHHHHhcC---CCCeeeeceeecCCC
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF--DNRID----AKRTLREIKLLRHMD---HENIIAIKDIIRPPQ 112 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~----~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~ 112 (375)
+..++.+|.|+||.|++|.++.+...|+||.+.++. .+... .-....|+++|..++ |+||++++++|.+
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd-- 640 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED-- 640 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec--
Confidence 347999999999999999999999999999997653 11111 122457999999997 9999999999944
Q ss_pred CCCcCcEEEEEeCCC-C-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 113 RETFNDVYIVYELMD-T-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
.+++|++||..+ | +|.+++...+.+++.++..|+.||+.|+++||+.||+|||||-+||.++.+|-++|+|||++
T Consensus 641 ---dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 641 ---DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred ---CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 477999999986 6 99999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCC
Q 017231 191 RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 245 (375)
Q Consensus 191 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 245 (375)
..... .+...+.||..|.|||++.+.+..+..-|||+||+++|.+.....||.+
T Consensus 718 a~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 66554 3567889999999999999977778999999999999999999999854
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.29 Aligned_cols=282 Identities=30% Similarity=0.466 Sum_probs=210.7
Q ss_pred cccCCeeeccCCcceEEEEEEeCC---CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCC
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSE---TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRET 115 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 115 (375)
.++.++++||.|.|++||++.+.. ..+.||+|.+... ....++..|+++|..+. +.||+++.+++..+
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn---- 107 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN---- 107 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhhccC----
Confidence 344489999999999999999887 7889999998543 23456889999999995 99999999999665
Q ss_pred cCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-CCCEEEeeccccccc
Q 017231 116 FNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTT 193 (375)
Q Consensus 116 ~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-~~~i~l~Df~~~~~~ 193 (375)
++.++|+||++. .-.++... ++..+++.+++.++.||.++|.+||+|+||||+|++.+. .++-.|+|||++...
T Consensus 108 -d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~ 183 (418)
T KOG1167|consen 108 -DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY 183 (418)
T ss_pred -CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHH
Confidence 568999999984 66776654 789999999999999999999999999999999999975 467999999998610
Q ss_pred CCC--------------C-------------------------------ccccccccccccCchhcccCCCCCccchhHH
Q 017231 194 SET--------------D-------------------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWS 228 (375)
Q Consensus 194 ~~~--------------~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 228 (375)
... . ......||+.|.|||++..+...+.++||||
T Consensus 184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws 263 (418)
T KOG1167|consen 184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS 263 (418)
T ss_pred HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence 000 0 0012357999999999999888899999999
Q ss_pred HHHHHHHHhhCCCCC-CCCChhHHHHHHHHHhCCCCcc-----ccc--ccc-c--ch----hHHHhhh-CCCCCC-----
Q 017231 229 VGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPDET-----SLG--FLR-S--DN----ARRYVRM-LPQFPK----- 287 (375)
Q Consensus 229 lG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~-----~~~--~~~-~--~~----~~~~~~~-~~~~~~----- 287 (375)
.|+|+..++++..|| ...+....+..+....|...-. ... .+. + .. ...|... ......
T Consensus 264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n 343 (418)
T KOG1167|consen 264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN 343 (418)
T ss_pred ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence 999999999999997 4455556666666655532110 000 111 0 01 1111111 011111
Q ss_pred CCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 288 QNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 288 ~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
..........+..+.+++.+||..||.+|.|+++.|.||||...++
T Consensus 344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 1222233445668999999999999999999999999999996543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=280.97 Aligned_cols=250 Identities=18% Similarity=0.258 Sum_probs=181.3
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
...+.||+|+||.||+|.++.++..||+|.+...... ...|+..+++++||||+++++++... ...++|
T Consensus 693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv 761 (968)
T PLN00113 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLI 761 (968)
T ss_pred CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEE
Confidence 3567899999999999999999999999998643211 12458889999999999999999654 447999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH---SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh---~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
|||++ |+|.+++. .+++..+..++.+|+.|+.||| +.+++|+||||+||+++.++..++. ++.......
T Consensus 762 ~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred EeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99997 79999986 3899999999999999999999 6699999999999999998887775 554332211
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh-hHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY-VHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ............... ....
T Consensus 835 ~~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~ 903 (968)
T PLN00113 835 DTKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC----------HLDM 903 (968)
T ss_pred CCCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc----------chhh
Confidence 123356888999999887 7799999999999999999999999853211 111111111100000 0000
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
+.+... .. .. ........++.+++.+||+.||++||++.|+++.
T Consensus 904 ~~~~~~--~~-~~-~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 904 WIDPSI--RG-DV-SVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred eeCccc--cC-CC-CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000000 00 00 0000112357789999999999999999999875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=238.88 Aligned_cols=248 Identities=22% Similarity=0.294 Sum_probs=183.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHh--cCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH--MDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.||+|.||.||.+.++ |+.||||++... +...+.+|.++... |+|+||+.+++.-.... ..-..+++
T Consensus 215 L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwL 286 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWL 286 (513)
T ss_pred EEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEE
Confidence 8999999999999999776 679999999432 34456677777665 48999999998755443 33367999
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEecCCCEEEeecccccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA--------NVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~--------~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
|++|.+ |+|.|++.+ ..++.....+++..++.||+|||-. .|.|||||..||+|.++|.+-|+|+|++..
T Consensus 287 vTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~ 365 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 365 (513)
T ss_pred eeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence 999998 999999988 5699999999999999999999943 399999999999999999999999999866
Q ss_pred cCCC-----CccccccccccccCchhcccCCCC-----CccchhHHHHHHHHHHhhC----------CCCCCCC----Ch
Q 017231 193 TSET-----DFMTEYVVTRWYRAPELLLNCSEY-----TAAIDIWSVGCILGEIMTR----------QPLFPGK----DY 248 (375)
Q Consensus 193 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~-----~~~~Di~slG~il~~l~~g----------~~pf~~~----~~ 248 (375)
.... ...+...||..|+|||++...... -..+||||||.++||++.. ..||.+. ..
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 5443 234567899999999999763221 2468999999999999742 4666432 12
Q ss_pred hHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHh
Q 017231 249 VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323 (375)
Q Consensus 249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell 323 (375)
.+.++.+......-|..+..+.. ...-..+..+++.||..+|.-|.|+--+-
T Consensus 446 ~eeMrkVVCv~~~RP~ipnrW~s-----------------------~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 446 FEEMRKVVCVQKLRPNIPNRWKS-----------------------DPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred HHHHhcceeecccCCCCCccccc-----------------------CHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 22233332222211111110000 01122367889999999999999886543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-33 Score=259.62 Aligned_cols=261 Identities=26% Similarity=0.380 Sum_probs=213.6
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
+++.++.+..+|+|.+|.||+++++.+++..|+|+++....+ +..-+..|+-+++..+||||+.+++.|... .
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~-----d 85 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRR-----D 85 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhh-----c
Confidence 345556999999999999999999999999999999765333 355677899999999999999999999665 4
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
.++++||||+ |+|.+...-.+++++.++..+++..+++++|||+.|-+|||||-.||+++..|.++|.|||.+......
T Consensus 86 klwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred CcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 5899999997 699998888899999999999999999999999999999999999999999999999999987554433
Q ss_pred -CccccccccccccCchhcc--cCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 197 -DFMTEYVVTRWYRAPELLL--NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 197 -~~~~~~~~~~~y~aPE~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
.....+.||++|+|||+-. ....|+..+|+|++|+...|+-.-++|.-..-....+..+..-...++.....
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk----- 240 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDK----- 240 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCC-----
Confidence 3456788999999999952 22578999999999999999988777765544444444333322222211111
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..-++.+-+|++.+|.++|.+||+++.+|.|||...-
T Consensus 241 ---------------------~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 241 ---------------------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ---------------------ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 1236779999999999999999999999999998753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=251.57 Aligned_cols=245 Identities=24% Similarity=0.328 Sum_probs=200.8
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCc----EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETRE----EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
.+-.++||+|+||+||++.+--.|+ +||||++... .......+++.|+.++.++.|||++++++++..+.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence 3357899999999999998765555 5777876443 34445678999999999999999999999997653
Q ss_pred cEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 118 DVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
+.||++|++ |+|.++++.+ .++-.+..+.|..||++|+.|||.++++||||-..||||..-..+|+.|||++.....
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 578999998 8999999876 4599999999999999999999999999999999999999999999999999987655
Q ss_pred CCccc---cccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 196 TDFMT---EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 196 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
..... ...-.+.|+|-|.+.. ..++.++||||+|+++||++| |..|+.+...++.-..+..... .+++
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-LsqP------ 922 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LSQP------ 922 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CCCC------
Confidence 53222 1223566999999887 889999999999999999998 9999998876665544433211 1111
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
+..+.++-.++.+||..|+..||+++++..
T Consensus 923 -----------------------piCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 923 -----------------------PICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -----------------------CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 346778999999999999999999988765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=235.07 Aligned_cols=191 Identities=26% Similarity=0.358 Sum_probs=156.7
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc--CCCCeeeeceeecCCCCCCcCcE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM--DHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++.+.||+|.||.||+|+.. ++.||||++. ....+.+..|-.+.+.. +|+||++++..-...... ...+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~--~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~ey 283 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEY 283 (534)
T ss_pred hhhHHHhhcCccceeehhhcc--CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccce
Confidence 347899999999999999654 5899999983 34566677777777654 799999999876554422 3568
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceEEecCCCEEEeeccc
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA---------NVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~---------~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
++|++|.+ |+|.+++..+ .+++....+|+..++.||+|||+- .|+|||||..||||..+++..|+|||+
T Consensus 284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999997 8999999874 499999999999999999999953 499999999999999999999999999
Q ss_pred ccccCCCC---ccccccccccccCchhcccCCCCC-----ccchhHHHHHHHHHHhhCCC
Q 017231 190 ARTTSETD---FMTEYVVTRWYRAPELLLNCSEYT-----AAIDIWSVGCILGEIMTRQP 241 (375)
Q Consensus 190 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~-----~~~Di~slG~il~~l~~g~~ 241 (375)
+....... ......||.+|+|||++.+--.+. .+.||||+|.++|||++...
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~ 422 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCT 422 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcc
Confidence 97655432 223468899999999997733333 47899999999999998643
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=216.78 Aligned_cols=211 Identities=37% Similarity=0.643 Sum_probs=181.6
Q ss_pred ccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCC
Q 017231 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 127 (375)
Q Consensus 48 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~ 127 (375)
||+|.+|.||++.+..+++.+++|++....... ....+.+|++.++.+.|++++++++++... ...++++|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCC
Confidence 689999999999998889999999986543222 356788999999999999999999998654 55899999998
Q ss_pred -CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-CCCEEEeecccccccCCCC-cccccc
Q 017231 128 -TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETD-FMTEYV 203 (375)
Q Consensus 128 -g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-~~~i~l~Df~~~~~~~~~~-~~~~~~ 203 (375)
++|.+++... ..++...++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+||+.+....... ......
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 6999998876 57999999999999999999999999999999999999999 8999999999886554432 123345
Q ss_pred ccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCC
Q 017231 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 283 (375)
Q Consensus 204 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (375)
+...|++||.+......+.+.|+|+||+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 677899999987733788999999999999999
Q ss_pred CCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCC
Q 017231 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326 (375)
Q Consensus 284 ~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~ 326 (375)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 ---------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1267999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=213.49 Aligned_cols=197 Identities=36% Similarity=0.623 Sum_probs=170.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
.+.+.||.|++|.||++.+..+++.+++|.+...... .....+..|+..+++++|+|++++++.+... ...+++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV 75 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence 3688999999999999999998999999999764332 2466788999999999999999999988554 557999
Q ss_pred EeCCCC-CHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--c
Q 017231 123 YELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--F 198 (375)
Q Consensus 123 ~e~~~g-~L~~~l~~~~~-l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--~ 198 (375)
+|++++ +|.+++..... +++..++.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+....... .
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred EeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 999985 99999988777 8999999999999999999999999999999999999999999999999887655442 2
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCC
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 245 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 245 (375)
.....++..|++||.+.....++.++|+|+||+++++|++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 34456678899999983336778899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=215.04 Aligned_cols=274 Identities=20% Similarity=0.283 Sum_probs=203.6
Q ss_pred CcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCC
Q 017231 22 GGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHEN 100 (375)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~ 100 (375)
|.+..+-....++..+.+.|- |.+.||+|.||.+.+++++.+...+++|.+... .....+|.+|..---.| .|.|
T Consensus 7 g~ih~I~~~el~kv~l~d~y~-I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~h 82 (378)
T KOG1345|consen 7 GQIHLIPMEELKKVDLEDVYT-INKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQH 82 (378)
T ss_pred Ccccccccccccccchhhhhh-HHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchh
Confidence 444555555557777777777 999999999999999999999999999998664 23456788888766666 4999
Q ss_pred eeeeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-
Q 017231 101 IIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA- 178 (375)
Q Consensus 101 iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~- 178 (375)
|+.-|+.-. +..+.+++++||++ |+|.+-+.. .++-+.....++.|++.||.|+|+++++|||||.+||||-.
T Consensus 83 Ii~tY~vaF----qt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~ 157 (378)
T KOG1345|consen 83 IIDTYEVAF----QTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA 157 (378)
T ss_pred hhHHHHHHh----hcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC
Confidence 998887643 22356889999998 899988876 45889999999999999999999999999999999999943
Q ss_pred -CCCEEEeecccccccCCCCccccccccccccCchhcccC----CCCCccchhHHHHHHHHHHhhCCCCCCCCChh-HHH
Q 017231 179 -NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQL 252 (375)
Q Consensus 179 -~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~ 252 (375)
..++||||||.....+..- ...-.+..|.+||+.... -...+.+|+|.||+++|.+++|.+|+...... ...
T Consensus 158 df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y 235 (378)
T KOG1345|consen 158 DFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY 235 (378)
T ss_pred CccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH
Confidence 3479999999886554321 122236679999987542 23467899999999999999999999743221 112
Q ss_pred HHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCC---CCHHHHhcCCCCC
Q 017231 253 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR---ITVDEALCHPYLA 329 (375)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R---ps~~ell~~~~f~ 329 (375)
...+...+.... .....+...++.+.++.++-|..+|++| .++.+.....|..
T Consensus 236 ~~~~~w~~rk~~------------------------~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 236 WEWEQWLKRKNP------------------------ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred HHHHHHhcccCc------------------------cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 222222221100 1112234578889999999999999999 6666666666654
Q ss_pred C
Q 017231 330 P 330 (375)
Q Consensus 330 ~ 330 (375)
.
T Consensus 292 ~ 292 (378)
T KOG1345|consen 292 K 292 (378)
T ss_pred h
Confidence 3
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=258.40 Aligned_cols=205 Identities=15% Similarity=0.209 Sum_probs=145.8
Q ss_pred hcCC-CCeeeeceeecCCCC--CCcCcEEEEEeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 017231 95 HMDH-ENIIAIKDIIRPPQR--ETFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK 170 (375)
Q Consensus 95 ~l~h-~~iv~~~~~~~~~~~--~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~ 170 (375)
.++| +||+++++.+..... .....+++++|+++++|.+++... ..+++.+++.++.||+.||.|||++||+|+|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 577777777633221 112357788999999999999753 459999999999999999999999999999999
Q ss_pred CCceEEecCCCE-------------------EEeecccccccCCCC-----------------ccccccccccccCchhc
Q 017231 171 PSNLLLNANCDL-------------------KIGDFGLARTTSETD-----------------FMTEYVVTRWYRAPELL 214 (375)
Q Consensus 171 p~NIli~~~~~i-------------------~l~Df~~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~ 214 (375)
|+|||++..+.+ +++|||++....... ......+|+.|+|||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999665554 455555443211000 00113468889999998
Q ss_pred ccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccC
Q 017231 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 294 (375)
Q Consensus 215 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.+ ..++.++|||||||++|||++|..|+.... .....+..... +.. .
T Consensus 188 ~~-~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~----------------------------~ 234 (793)
T PLN00181 188 NG-SSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQ----------------------------I 234 (793)
T ss_pred cc-CCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Chh----------------------------h
Confidence 87 678999999999999999999988764321 11111111100 000 0
Q ss_pred CCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 295 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 295 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
....+...+++.+||+.+|.+||++.|+++||||....
T Consensus 235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 01134567899999999999999999999999998754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=216.61 Aligned_cols=254 Identities=20% Similarity=0.283 Sum_probs=202.0
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCC-----CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeec
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSET-----REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR 109 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 109 (375)
..+.+..++..-.+-+|.||.||.+.++.. .+.|.+|.++.. .+......+..|.-.+..+.|||+..+.++..
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 445566677778899999999999965542 334677776543 34456677889999999999999999999876
Q ss_pred CCCCCCcCcEEEEEeCCC-CCHHHHHHh-----C---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC
Q 017231 110 PPQRETFNDVYIVYELMD-TDLHQIIRS-----H---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~-----~---~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~ 180 (375)
+.. ...++++.+++ |+|..++.. . ..++..+...++.|++.|++|||+.|++|.||-..|.+|++.-
T Consensus 358 e~~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 358 EDY----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred ecc----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe
Confidence 532 45688999998 899999972 1 2388889999999999999999999999999999999999999
Q ss_pred CEEEeecccccccCCCCcc---ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHH
Q 017231 181 DLKIGDFGLARTTSETDFM---TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLIT 256 (375)
Q Consensus 181 ~i~l~Df~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~ 256 (375)
++||+|-.+++..-..++. ........|++||.+.+ ..++.++|+||||+++|||+| |+.|+..-++.++..-+.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk 512 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK 512 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence 9999998887654443321 12223556999999998 889999999999999999998 999998888777655444
Q ss_pred HHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 257 ELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....- .++ -++++++..++.-||..+|++||+++++..
T Consensus 513 dGyRl-aQP-----------------------------~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 513 DGYRL-AQP-----------------------------FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cccee-cCC-----------------------------CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 32111 000 257999999999999999999999999876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=198.70 Aligned_cols=166 Identities=22% Similarity=0.282 Sum_probs=127.9
Q ss_pred CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccccccccc
Q 017231 128 TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 206 (375)
Q Consensus 128 g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~ 206 (375)
|+|.+++... ..+++.+++.++.||+.||.|||+.+ ||+||+++.++.+++ ||.+....... ..+++
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence 6899999874 56999999999999999999999998 999999999999999 99886654432 25789
Q ss_pred cccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh-HHHHHHHHHhCCCCcccccccccchhHHHhhhCCCC
Q 017231 207 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 285 (375)
Q Consensus 207 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (375)
.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+............
T Consensus 69 ~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------ 129 (176)
T smart00750 69 YFMAPEVIQG-QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDR------------------ 129 (176)
T ss_pred cccChHHhcC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcccc------------------
Confidence 9999999988 77899999999999999999999999765432 222222221111100000
Q ss_pred CCCCccccCCCCCc--hHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 286 PKQNFSARFPNKSP--GAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 286 ~~~~~~~~~~~~s~--~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
.....++. ++.++|.+||+.+|.+||++.+++.|+|+..
T Consensus 130 ------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 130 ------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00011222 6999999999999999999999999998763
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=234.45 Aligned_cols=277 Identities=27% Similarity=0.303 Sum_probs=209.2
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEec----CcccchHHHHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIG----NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~----~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
....+...|-.....+|.|++|.|+.+......+.+..|.+. ...........+..|+.+-..+.|+|++..+..+
T Consensus 311 ~~~~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~ 390 (601)
T KOG0590|consen 311 SPIGFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIV 390 (601)
T ss_pred CccccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHH
Confidence 334444556668899999999999999887777767776553 2222222222367788888899999998887777
Q ss_pred cCCCCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 109 RPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
.... ...-.||||+++|..++.....++..++..++.|++.|+.|+|+.|+.|+|+|++|+++..+|.++++|||
T Consensus 391 ~~~~-----~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 391 QEID-----GILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred hhcc-----cchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecC
Confidence 5543 12233999988999999988889999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC-----CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHH-HHHHHhCCC
Q 017231 189 LARTTSET-----DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLR-LITELIGSP 262 (375)
Q Consensus 189 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~i~~~~~~~ 262 (375)
.+...... .......|+..|.|||++.+........||||.|+++..|.+|+.||......+... ....
T Consensus 466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~----- 540 (601)
T KOG0590|consen 466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY----- 540 (601)
T ss_pred cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc-----
Confidence 88654433 233467889999999999884444678999999999999999999996543222111 0000
Q ss_pred CcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 017231 263 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 337 (375)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~ 337 (375)
.. ...........+..++...+.+|.+||+.||.+|.|+++|++.+||+.+.++...
T Consensus 541 ---~~---------------~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v~ 597 (601)
T KOG0590|consen 541 ---SD---------------QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHVD 597 (601)
T ss_pred ---cc---------------ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEec
Confidence 00 0000111122223456778899999999999999999999999999999877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=192.66 Aligned_cols=226 Identities=18% Similarity=0.244 Sum_probs=182.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++||.|.||+++++.+.-++++||||.-... ..+..+..|.+..+.|. .++|+.++.+..++ -+-.+|
T Consensus 32 VGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG-----~~NiLV 102 (449)
T KOG1165|consen 32 VGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG-----KYNILV 102 (449)
T ss_pred eccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeecccc-----chhhhh
Confidence 699999999999999999999999999975332 34566888999999884 89999888776444 344799
Q ss_pred EeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-----CEEEeecccccccCCC
Q 017231 123 YELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-----DLKIGDFGLARTTSET 196 (375)
Q Consensus 123 ~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-----~i~l~Df~~~~~~~~~ 196 (375)
+|+++.+|.|+..- ...++...+..++.|++.-++++|++.+++|||||+|+||..-+ .|.++|||+++.....
T Consensus 103 idLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 103 IDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred hhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 99999999998864 45699999999999999999999999999999999999996543 4999999999865544
Q ss_pred C--------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 197 D--------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 197 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
. ...+..||-.|++-....+ +..+...|+-|||-++++.+-|..||.+......-.+....-......+..
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~ 261 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE 261 (449)
T ss_pred cccccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence 2 2345678999999999988 889999999999999999999999998877655555444443344444455
Q ss_pred ccccchhHHHh
Q 017231 269 FLRSDNARRYV 279 (375)
Q Consensus 269 ~~~~~~~~~~~ 279 (375)
.++.+...+|.
T Consensus 262 ~Lc~g~P~efa 272 (449)
T KOG1165|consen 262 VLCEGFPEEFA 272 (449)
T ss_pred HHHhcCHHHHH
Confidence 55555544443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-24 Score=194.51 Aligned_cols=248 Identities=19% Similarity=0.195 Sum_probs=186.2
Q ss_pred CeeeccCCcceEEEEEEeCCCC-cEEEEEEecCcccchHHHHHHHHHHHHHHhcC----CCCeeeeceeec-CCCCCCcC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETR-EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD----HENIIAIKDIIR-PPQRETFN 117 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~~~~~~~-~~~~~~~~ 117 (375)
+.+.||+|+||.||++.+..++ ..+|+|.......... ..+..|..++..+. .+++..+++.+. .. .
T Consensus 22 i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~-----~ 94 (322)
T KOG1164|consen 22 LGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE-----D 94 (322)
T ss_pred EeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC-----c
Confidence 6999999999999999988875 6789998755422221 14667888888886 368888888874 22 4
Q ss_pred cEEEEEeCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC-----CCEEEeecccc
Q 017231 118 DVYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-----CDLKIGDFGLA 190 (375)
Q Consensus 118 ~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~-----~~i~l~Df~~~ 190 (375)
.-++||+.++.+|.++.... +.++...+..|+.|++.+|.+||+.|++||||||+|+.+... ..++|.|||++
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 46999999999999988655 469999999999999999999999999999999999999765 35999999999
Q ss_pred c--ccC-CC-------Cc-cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHh
Q 017231 191 R--TTS-ET-------DF-MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 259 (375)
Q Consensus 191 ~--~~~-~~-------~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 259 (375)
. ... .. .. .....||..|+++.+..+ ...+.+.|+||+++++.+|+.|..|+................
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 7 311 11 11 123458999999999988 789999999999999999999999997655333333222221
Q ss_pred CCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....... .....+.++..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDR--------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhcccc--------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 1110000 012234567777777777888889988776554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=180.23 Aligned_cols=205 Identities=24% Similarity=0.320 Sum_probs=168.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++||+|+||.+|++....+|+.||||+-... .....+..|..+.+.|+ ...|+.+..+..+. .+-.+|
T Consensus 19 lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~----a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~-----~ynvlV 89 (341)
T KOG1163|consen 19 LVRKIGSGSFGDIYLGISITSGEEVAIKLESSK----AKHPQLLYESKVYRILQGGVGIPHIRHYGTEK-----DYNVLV 89 (341)
T ss_pred EEEeecCCchhheeeeeeccCCceEEEEeeccc----CCCcchhHHHHHHHHhccCCCCchhhhhcccc-----ccceee
Confidence 799999999999999999999999999986332 23445778999999996 57777777776444 445899
Q ss_pred EeCCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC---CCEEEeecccccccCCCC-
Q 017231 123 YELMDTDLHQIIR-SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 123 ~e~~~g~L~~~l~-~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~---~~i~l~Df~~~~~~~~~~- 197 (375)
|+..+.+|.+++. ....++...++.++-|++.-++++|.++++|+||||+|+++.-+ ..+.|+|||+++......
T Consensus 90 MdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 90 MDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred eeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 9999999999885 35679999999999999999999999999999999999998543 469999999997654432
Q ss_pred -------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHH
Q 017231 198 -------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL 258 (375)
Q Consensus 198 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 258 (375)
......||..|.+-.+..+ ...+...|+-|+|.++.+..-|..||.+.......++....
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI 236 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKI 236 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHH
Confidence 1234678999999988877 67889999999999999999999999987655544444333
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=187.76 Aligned_cols=236 Identities=22% Similarity=0.285 Sum_probs=152.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcC----------CCCeeeeceeecCC-
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMD----------HENIIAIKDIIRPP- 111 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~----------h~~iv~~~~~~~~~- 111 (375)
..+.||.|+++.||.++|..+++.+++|++.... ......+.+.+|......+. |-.++..++.....
T Consensus 16 ~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 16 RGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred EccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 6899999999999999999999999999985432 33335566666665555532 22333333333211
Q ss_pred --------CCCCcC---cEEEEEeCCCCCHHHHHH---hCCC----CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 017231 112 --------QRETFN---DVYIVYELMDTDLHQIIR---SHQD----LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSN 173 (375)
Q Consensus 112 --------~~~~~~---~~~lv~e~~~g~L~~~l~---~~~~----l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~N 173 (375)
...... +.+++|+-+.++|.+++. .... +.......+..|++..+++||..|++|+||+|+|
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~n 175 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPEN 175 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGG
T ss_pred CCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceee
Confidence 000111 247788888888877764 2222 3334445566999999999999999999999999
Q ss_pred eEEecCCCEEEeecccccccCCCCccccccccccccCchhcccC-------CCCCccchhHHHHHHHHHHhhCCCCCCCC
Q 017231 174 LLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-------SEYTAAIDIWSVGCILGEIMTRQPLFPGK 246 (375)
Q Consensus 174 Ili~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~ 246 (375)
++++.+|.++|+||+.....+..... ...+..|.+||..... ..++.+.|.|+||+++|.|+++..||...
T Consensus 176 fll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 176 FLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp EEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred EEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 99999999999999877655543322 3345678899976431 24688999999999999999999999765
Q ss_pred ChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCC
Q 017231 247 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316 (375)
Q Consensus 247 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 316 (375)
....... ..+..+. ++++.++.+|+.+|+.+|.+|
T Consensus 254 ~~~~~~~----------------------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 254 SPEADPE----------------------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp GGGSTSG----------------------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred Ccccccc----------------------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 4211100 0223333 789999999999999999987
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-22 Score=182.58 Aligned_cols=263 Identities=32% Similarity=0.522 Sum_probs=205.1
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchH-HHHHHHHHHHHHHhcCCC-CeeeeceeecCCCCCCcCcEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRI-DAKRTLREIKLLRHMDHE-NIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.+.+.||.|+|+.||.+.+. ..+++|.+........ ....+.+|+..+..+.|+ +++++.+.+... ...+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~ 74 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSLY 74 (384)
T ss_pred eeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEEE
Confidence 36889999999999999887 7899999877654443 567788999999999988 799999999433 3379
Q ss_pred EEEeCCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-CEEEeecccccccCC
Q 017231 121 IVYELMD-TDLHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSE 195 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-~i~l~Df~~~~~~~~ 195 (375)
++++++. +++.+++.... .++...+..++.|++.++.++|+.+++|+|+||+||+++..+ .++++|||.+.....
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999997 58887777664 799999999999999999999999999999999999999998 799999999875443
Q ss_pred CC-------ccccccccccccCchhcccC--CCCCccchhHHHHHHHHHHhhCCCCCCCCCh----hHHHHHHHHHhCC-
Q 017231 196 TD-------FMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDY----VHQLRLITELIGS- 261 (375)
Q Consensus 196 ~~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~- 261 (375)
.. ......++..|.+||.+.+. .......|+|++|++++++++|..||..... ......+......
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 32 23567889999999999874 4788999999999999999999999876653 2333333222211
Q ss_pred CCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 262 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
......... . ......+.+++..++..+|..|.+..+...++|.........
T Consensus 235 ~~~~~~~~~-------------------~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~ 286 (384)
T COG0515 235 LASPLSPSN-------------------P----ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKES 286 (384)
T ss_pred cccccCccc-------------------c----chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcccccc
Confidence 000000000 0 112356889999999999999999999999877776544444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=187.53 Aligned_cols=157 Identities=18% Similarity=0.239 Sum_probs=120.2
Q ss_pred CeeeccCCcceEEEEEEeCC-CCcEEEEEEecCccc---chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAMNSE-TREEVAIKKIGNAFD---NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+.+.||+|+||+||+|+++. +++.||||....... .......+.+|+.+|++++|+|+++.+..+ +..
T Consensus 22 ~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--------~~~ 93 (365)
T PRK09188 22 ETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--------GKD 93 (365)
T ss_pred EccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--------CCc
Confidence 69999999999999999876 677789998653211 223456688999999999999998533222 236
Q ss_pred EEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceEEecCCCEEEeecccccccCCCC
Q 017231 120 YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL-KPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 120 ~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di-~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
++||||++| +|. .+.. .. ...++.+++.+|.+||+.||+|||| ||+||+++.+++++|+|||++.......
T Consensus 94 ~LVmE~~~G~~L~-~~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~ 166 (365)
T PRK09188 94 GLVRGWTEGVPLH-LARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRG 166 (365)
T ss_pred EEEEEccCCCCHH-HhCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCc
Confidence 999999985 665 2211 11 1467899999999999999999999 9999999999999999999987554332
Q ss_pred cc---------ccccccccccCchhcc
Q 017231 198 FM---------TEYVVTRWYRAPELLL 215 (375)
Q Consensus 198 ~~---------~~~~~~~~y~aPE~~~ 215 (375)
.. ....++..|.|||.+.
T Consensus 167 ~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 167 ALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred chhhhhhhhhhhhhhccCccCCcccCC
Confidence 11 2345677789999875
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.8e-24 Score=207.93 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=178.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc--hHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN--RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
..+.||++.|=+|.++++.+. .|+||++-+.... -....+...|++ ...+++||++++.-... .....|+
T Consensus 27 ~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~-----t~kAAyl 98 (1431)
T KOG1240|consen 27 YVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLV-----TDKAAYL 98 (1431)
T ss_pred eecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHH-----hhHHHHH
Confidence 688999999999999987663 4999998654322 112233334444 55568999999877652 2245689
Q ss_pred EEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc--cCCCCc-
Q 017231 122 VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART--TSETDF- 198 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~--~~~~~~- 198 (375)
|-+|...+|+|.+...+-+..-+.+.|+.||+.||..+|..||+|||||.+||||+.=+=+.|+||..-+. ....++
T Consensus 99 vRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 99999999999999999999999999999999999999999999999999999999888899999976432 111111
Q ss_pred -----cccccccccccCchhcccC---------CC-CCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCC
Q 017231 199 -----MTEYVVTRWYRAPELLLNC---------SE-YTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSP 262 (375)
Q Consensus 199 -----~~~~~~~~~y~aPE~~~~~---------~~-~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~ 262 (375)
..+.....+|+|||.+... .+ .+++.||||+||++.||++ |.+||..... .....+.
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL------~aYr~~~- 251 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL------LAYRSGN- 251 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH------HhHhccC-
Confidence 1222335669999998541 12 5789999999999999987 7888842211 1110000
Q ss_pred CcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 263 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
+...++.++.++ +..++++|..|++.||++|.++++.|+.
T Consensus 252 ---------~~~~e~~Le~Ie--------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 252 ---------ADDPEQLLEKIE--------------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ---------ccCHHHHHHhCc--------------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111222222222 3458999999999999999999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-24 Score=202.60 Aligned_cols=242 Identities=22% Similarity=0.342 Sum_probs=197.3
Q ss_pred eccCCcceEEEEEEe---CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEE
Q 017231 47 PVGRGAYGIVCAAMN---SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 47 ~lg~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
.+|.|++|.|++++. ...+..|++|+.++.............|..++..++ ||.+++++..+... +..+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~-----~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTD-----GKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccc-----cchhHh
Confidence 379999999998863 345677999988764322222225567888888886 99999999998544 668999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 201 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~ 201 (375)
+++.. |.|...+.....+.+.........++.|+.++|+.+++|+|+|++||+++.+|.+++.|||.++..-.....
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 99996 589998888888999999999999999999999999999999999999999999999999998765544322
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
+||..|+|||++. ....+.|.||+|+++++|++|..||.. +....|....-..+
T Consensus 154 -cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p------------------ 207 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP------------------ 207 (612)
T ss_pred -ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc------------------
Confidence 8999999999987 468899999999999999999999977 44444444222211
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH-----HHHhcCCCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLHDI 334 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~~~ 334 (375)
...+..+++++..++..+|..|... .|+++|+||+.+.-.
T Consensus 208 -------------~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 208 -------------RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred -------------hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 2357778999999999999999855 799999999988533
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=171.40 Aligned_cols=142 Identities=19% Similarity=0.204 Sum_probs=109.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHH------------------------HHHHHHHHHHHHhcCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRID------------------------AKRTLREIKLLRHMDHE 99 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~ 99 (375)
+.+.||+|++|.||.|.+. +|+.||+|+++........ ......|+..+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 1 INGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 3578999999999999987 8999999998654221111 11234599999999887
Q ss_pred CeeeeceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCceEEe
Q 017231 100 NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV-HSANVLHRDLKPSNLLLN 177 (375)
Q Consensus 100 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~L-h~~~i~H~di~p~NIli~ 177 (375)
++.....+.. ...++||||++| ++...+.....++...+..++.|++.+|.++ |+.|++|+||||+||+++
T Consensus 80 ~v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~ 152 (190)
T cd05147 80 GIPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE
Confidence 7644333221 112799999986 5544444556799999999999999999999 799999999999999998
Q ss_pred cCCCEEEeecccccccC
Q 017231 178 ANCDLKIGDFGLARTTS 194 (375)
Q Consensus 178 ~~~~i~l~Df~~~~~~~ 194 (375)
++.++|+|||++....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 5889999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=174.04 Aligned_cols=173 Identities=14% Similarity=0.162 Sum_probs=129.4
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHH-HHH------HHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRID-AKR------TLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~------~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
+++++.||.|+||.||++.+ ++..+|+|++......... ... +.+|++.+.+++|++|..+.+++......
T Consensus 33 y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~ 110 (232)
T PRK10359 33 IKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERK 110 (232)
T ss_pred eEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccc
Confidence 34799999999999999765 4668999999755433322 222 57899999999999999998886644211
Q ss_pred ---CcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 115 ---TFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 115 ---~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
..+..+++|||++| +|.++. .+++ ....+++.++..+|+.|++|+|++|+||+++.+| ++|+|||..
T Consensus 111 ~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~~ 181 (232)
T PRK10359 111 TLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSGK 181 (232)
T ss_pred cccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCCc
Confidence 12457999999997 787763 2333 2456999999999999999999999999999988 999999987
Q ss_pred cccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHh
Q 017231 191 RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 237 (375)
Q Consensus 191 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 237 (375)
.......... ..+.. ..+..++|+|+||+++..+.
T Consensus 182 ~~~~e~~a~d-----------~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 182 RCTAQRKAKD-----------RIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccccchhhHH-----------HHHHH-hHhcccccccceeEeehHHH
Confidence 5543322111 12333 45668999999999877653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-22 Score=196.62 Aligned_cols=222 Identities=28% Similarity=0.397 Sum_probs=173.1
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.+..||.|..|++|-||+++|+.+.+++|+|+-+.. .+++. |..+.+ ..+
T Consensus 84 df~~IklisngAygavylvrh~~trqrfa~kiNkq~--------------lilRn-----ilt~a~-----------npf 133 (1205)
T KOG0606|consen 84 DFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN--------------LILRN-----ILTFAG-----------NPF 133 (1205)
T ss_pred ccceeEeeccCCCCceeeeeccccccchhhcccccc--------------hhhhc-----cccccC-----------Ccc
Confidence 344799999999999999999999999999653221 11111 222211 123
Q ss_pred EEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC---
Q 017231 121 IVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--- 197 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--- 197 (375)
+| |+-...++..+.++.+. +.|++|||+-||+|+|+||+|.+|+.-|++|+.|||+.+......
T Consensus 134 vv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 134 VV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 33 55556666555555554 778999999999999999999999999999999999986533221
Q ss_pred -------------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 198 -------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 198 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
.....+||+.|+|||++.. +.|...+|+|+||+|+|+.+-|..||.+...++++..........++
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 279 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence 1124589999999999987 78999999999999999999999999999888888877775555444
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC---CHHHHhcCCCCCCCCCC
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---TVDEALCHPYLAPLHDI 334 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp---s~~ell~~~~f~~~~~~ 334 (375)
.. ..+.++++++|.++|..+|..|. .+-++.+|+||+.++.-
T Consensus 280 ~d----------------------------ea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 280 ED----------------------------EALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cC----------------------------cCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 42 34688999999999999999997 56789999999988654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=163.44 Aligned_cols=143 Identities=16% Similarity=0.142 Sum_probs=111.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch------------------------HHHHHHHHHHHHHHhcCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR------------------------IDAKRTLREIKLLRHMDHE 99 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------------------------~~~~~~~~e~~~l~~l~h~ 99 (375)
+.+.||+|++|+||+|.+. +|+.||||++....... .....+..|...+.++.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999987542110 0012235789999999998
Q ss_pred CeeeeceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEe
Q 017231 100 NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLN 177 (375)
Q Consensus 100 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~ 177 (375)
++.....+... ..++||||++| ++.........++...+..++.|++.++.++|+ .|++|+||||+||+++
T Consensus 80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 87544433321 13899999986 343333344668899999999999999999999 9999999999999998
Q ss_pred cCCCEEEeecccccccCC
Q 017231 178 ANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 178 ~~~~i~l~Df~~~~~~~~ 195 (375)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 89999999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=195.65 Aligned_cols=196 Identities=21% Similarity=0.287 Sum_probs=158.1
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC---CCCeeeeceeec
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAIKDIIR 109 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~ 109 (375)
.-+++.+..+.|-+.||.|+||+||.|.+.+ |+.||+|+-+.. ...+|.-=.+++.+|+ -+.|..+...+.
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~-----~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPP-----NPWEFYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCC-----CceeeeehHHHHHhhchhhhcchHHHHHHHc
Confidence 4567777777789999999999999999877 999999986443 1223333344555554 344445544443
Q ss_pred CCCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-------CCC
Q 017231 110 PPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-------NCD 181 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-------~~~ 181 (375)
.. +.-++|+||.+ |+|.+++..++.+++..++.++.|++..+.+||..+|+||||||+|+++.. ..-
T Consensus 765 ~~-----~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 765 FQ-----NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred cC-----CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccc
Confidence 33 33589999998 999999999999999999999999999999999999999999999999943 234
Q ss_pred EEEeecccccccCC---CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCC
Q 017231 182 LKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 240 (375)
Q Consensus 182 i~l~Df~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 240 (375)
++|+|||.+..+.. .......++|..+-.+|...| ++|++..|.|.|+.+++.|+.|+
T Consensus 840 l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred eEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHH
Confidence 99999998865332 334556778999999999999 89999999999999999999997
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=171.19 Aligned_cols=208 Identities=23% Similarity=0.284 Sum_probs=148.5
Q ss_pred CCCCeeeeceeecCC----------------------CCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHH
Q 017231 97 DHENIIAIKDIIRPP----------------------QRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLR 154 (375)
Q Consensus 97 ~h~~iv~~~~~~~~~----------------------~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~ 154 (375)
+|||||++...|.+. .......+|+||.-++.+|++++..+. .+......++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~-~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH-RSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC-CchHHHHHHHHHHHH
Confidence 599999998766432 112234589999999999999998744 778888889999999
Q ss_pred HHHHHHhCCccccCCCCCceEEecCC----CEEEeecccccccCCCC-------ccccccccccccCchhcccCCC----
Q 017231 155 GLKYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLARTTSETD-------FMTEYVVTRWYRAPELLLNCSE---- 219 (375)
Q Consensus 155 al~~Lh~~~i~H~di~p~NIli~~~~----~i~l~Df~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~---- 219 (375)
|+.|||++|+.|+|+|.+||++.-+. .++|+|||++-.-.... ......|.-..+|||+......
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence 99999999999999999999995432 38999999885433321 1233456777999999764222
Q ss_pred -CCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCC
Q 017231 220 -YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS 298 (375)
Q Consensus 220 -~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 298 (375)
.-.++|.|+.|.+.||+++...||....... +........+.+ ..-..++
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe~qLP----------------------------alp~~vp 483 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQESQLP----------------------------ALPSRVP 483 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhhhhCC----------------------------CCcccCC
Confidence 1358999999999999999999997643211 111111001111 1113468
Q ss_pred chHHHHHHHhcCcCCCCCCCHH---HHhc------CCCCCCCCCC
Q 017231 299 PGAVDLLEKMLVFDPNRRITVD---EALC------HPYLAPLHDI 334 (375)
Q Consensus 299 ~~l~~li~~~L~~dP~~Rps~~---ell~------~~~f~~~~~~ 334 (375)
+.+++++..+|+.||++|++++ .+|+ |.|++...+.
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~~ 528 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMMEK 528 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhccc
Confidence 8899999999999999999874 4444 5566655443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-20 Score=154.38 Aligned_cols=185 Identities=15% Similarity=0.070 Sum_probs=135.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc--chHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+...|++|+||+|+++.. .+.+++.+.+..... .......+.+|+++|++|. ++++++++++. ..+
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~ 74 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH 74 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence 578899999999998854 567888777654432 1111235789999999995 58888888752 258
Q ss_pred EEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceEEecCCCEEEeecccccccCCCCc
Q 017231 121 IVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL-KPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 121 lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di-~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
++|+|+.| +|...+.. . ...++.|++.+|.++|+.|++|+|| +|+||+++.++.++|+|||++........
T Consensus 75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999986 66543211 1 2357889999999999999999999 79999999999999999999975443321
Q ss_pred c--------------ccccccccccCchhcccCCCCC-ccchhHHHHHHHHHHhhCCCCCCCC
Q 017231 199 M--------------TEYVVTRWYRAPELLLNCSEYT-AAIDIWSVGCILGEIMTRQPLFPGK 246 (375)
Q Consensus 199 ~--------------~~~~~~~~y~aPE~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~ 246 (375)
. .....++.+++|+...-....+ ...++++.|+-+|.++|+..+.-+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 1 0112356677777654322333 5678888999999999999886443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=8e-21 Score=161.09 Aligned_cols=242 Identities=18% Similarity=0.226 Sum_probs=181.4
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
..+.++-+|.....|..|.+++.. ..++.|++.-........+.|..|.-.|+-+.||||+++++.+..+ .++
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnl 262 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNL 262 (448)
T ss_pred hhhhhhhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCc
Confidence 344568889999999999997764 4688888765444444456788999999999999999999999665 568
Q ss_pred EEEEeCCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEecCCCEEEe--ecccccc
Q 017231 120 YIVYELMD-TDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIG--DFGLART 192 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NIli~~~~~i~l~--Df~~~~~ 192 (375)
.++..||+ |+|...+..... +...++.+++.+|+.++.|||+.. |.--.|+...++||++.+.+|+ |-..+..
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee
Confidence 99999998 899999987644 788899999999999999999985 4444788999999998876653 3222111
Q ss_pred cCCCCccccccccccccCchhcccCCC--CCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 193 TSETDFMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 193 ~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
.......+.|++||.+..... .-.++|+|||++++|||.|...||......+---++.- .+-
T Consensus 343 ------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-egl--------- 406 (448)
T KOG0195|consen 343 ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-EGL--------- 406 (448)
T ss_pred ------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-ccc---------
Confidence 112233678999999976222 23589999999999999999999977664332111110 000
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHh
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell 323 (375)
....-+++++.+..++.-|++.||.+||.++.++
T Consensus 407 -------------------rv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 407 -------------------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred -------------------cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 0112257899999999999999999999987654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.4e-19 Score=150.77 Aligned_cols=136 Identities=24% Similarity=0.308 Sum_probs=106.1
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-----CCCCeeeeceeecCCCCCCcCcE
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-----DHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
.+.||+|++|.||. ++.++.. +||++..... ...+.+.+|+.+++.+ .||||+++++++..+.+ .+.+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g--~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG--TGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC--CeEE
Confidence 57799999999995 7777666 6998865322 2346689999999999 57999999999976532 2333
Q ss_pred E-EEEeCCC---CCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCceEEecC----CCEEEee-ccc
Q 017231 120 Y-IVYELMD---TDLHQIIRSHQDLTDDHCRYFLYQLLRGL-KYVHSANVLHRDLKPSNLLLNAN----CDLKIGD-FGL 189 (375)
Q Consensus 120 ~-lv~e~~~---g~L~~~l~~~~~l~~~~~~~i~~qi~~al-~~Lh~~~i~H~di~p~NIli~~~----~~i~l~D-f~~ 189 (375)
+ +|+||++ |+|.+++... .+++. ..++.+++.++ .|||+++|+|+||||+||+++.+ ++++|+| ||.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 3 7899954 6999999764 46666 35678888777 99999999999999999999753 3799999 554
Q ss_pred c
Q 017231 190 A 190 (375)
Q Consensus 190 ~ 190 (375)
.
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 3
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=155.72 Aligned_cols=143 Identities=13% Similarity=0.093 Sum_probs=110.7
Q ss_pred cCCeeeccCCcceEEEEEE-eCCCCcEEEEEEecCcccch----------------------HHHHHHHHHHHHHHhcCC
Q 017231 42 VPPIRPVGRGAYGIVCAAM-NSETREEVAIKKIGNAFDNR----------------------IDAKRTLREIKLLRHMDH 98 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~-~~~~~~~vaiK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~h 98 (375)
+.+.+.||.|++|.||+|. +..+|+.||+|++....... .....+..|+..+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4489999999999999998 77789999999986432110 011235689999999975
Q ss_pred CC--eeeeceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCce
Q 017231 99 EN--IIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-VLHRDLKPSNL 174 (375)
Q Consensus 99 ~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~-i~H~di~p~NI 174 (375)
.. ++++++. . ..++||||++| +|.........+....+..++.||+.++.+||+.| ++|+||||+||
T Consensus 110 ~~i~~p~~~~~---~------~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVPKPIAW---R------RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI 180 (237)
T ss_pred cCCCCCeeeEe---c------CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence 32 3344432 1 13799999987 56555544556777788899999999999999999 99999999999
Q ss_pred EEecCCCEEEeecccccccC
Q 017231 175 LLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 175 li~~~~~i~l~Df~~~~~~~ 194 (375)
+++ +++++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999875443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.3e-19 Score=163.79 Aligned_cols=175 Identities=28% Similarity=0.496 Sum_probs=134.1
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
.+++|.|++|. .+|.+|+.... ..+......++.|++.|+.| +|.+|+|++|.||+...+..++|+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 45789999997 79999997543 37888899999999999999 9999999999999999999999999999876
Q ss_pred cCCCC-------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhC-CCCCCCCChhHHHHHHHHH-hCCCC
Q 017231 193 TSETD-------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITEL-IGSPD 263 (375)
Q Consensus 193 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~i~~~-~~~~~ 263 (375)
..... ......||..|++||.+.+ ..++.++||||||++++||+.. .-.+ +..+..... .+..+
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLIQFSTQF------ERIATLTDIRDGIIP 478 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHHHhccHH------HHHHhhhhhhcCCCC
Confidence 55544 3455678999999999998 8899999999999999999872 1111 111111110 01111
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
+. +..-.++-..|+++||...|.+||++.+.-.|.|.+
T Consensus 479 ~~----------------------------~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 479 PE----------------------------FLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred hH----------------------------HhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 11 111234456899999999999999888887787753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-17 Score=142.34 Aligned_cols=136 Identities=24% Similarity=0.281 Sum_probs=109.1
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc------hHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN------RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
++.||+|++|.||++.+ .|..+++|+....... ......+..|+.++..+.|++++.+..++... ..
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----EN 73 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CC
Confidence 36799999999999986 6678999986533211 11234577899999999999887666655433 34
Q ss_pred EEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 119 VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 119 ~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
.+++|||++| +|.+++..... ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 6899999975 89888865432 8889999999999999999999999999999998 88999999998855
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-17 Score=156.94 Aligned_cols=203 Identities=24% Similarity=0.338 Sum_probs=151.7
Q ss_pred HHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCC
Q 017231 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANV-LHRDL 169 (375)
Q Consensus 93 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i-~H~di 169 (375)
|+.+.|.|+.++++.+... ...++|.+||. |+|.|.+.. .-.++......++++|+.+|.|||...| +||.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 3568899999999999776 55899999997 899999987 4468899999999999999999998865 99999
Q ss_pred CCCceEEecCCCEEEeecccccccCCC---CccccccccccccCchhcccCC------CCCccchhHHHHHHHHHHhhCC
Q 017231 170 KPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCS------EYTAAIDIWSVGCILGEIMTRQ 240 (375)
Q Consensus 170 ~p~NIli~~~~~i~l~Df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~------~~~~~~Di~slG~il~~l~~g~ 240 (375)
++.|.+++..-.+||+|||+....... ..........-|.|||.+.+.. ..+.+.|+||+|++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999988765421 1112223355699999997621 1467899999999999999999
Q ss_pred CCCCCCCh--h--HHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCC
Q 017231 241 PLFPGKDY--V--HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316 (375)
Q Consensus 241 ~pf~~~~~--~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 316 (375)
.||..... . +....+......+..+.. .......+++..++++||..+|.+|
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i------------------------~~~~e~~~~l~~l~~~cw~e~P~~r 211 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKKGGSNPFRPSI------------------------ELLNELPPELLLLVARCWEEIPEKR 211 (484)
T ss_pred CccccccccCChHHHHHHHHhcCCCCcCcch------------------------hhhhhcchHHHHHHHHhcccChhhC
Confidence 99976432 1 222222220000000000 0001335579999999999999999
Q ss_pred CCHHHHhc
Q 017231 317 ITVDEALC 324 (375)
Q Consensus 317 ps~~ell~ 324 (375)
|+++.+-.
T Consensus 212 Ps~~~i~~ 219 (484)
T KOG1023|consen 212 PSIEQIRS 219 (484)
T ss_pred ccHHHHHh
Confidence 99988755
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.3e-17 Score=137.56 Aligned_cols=136 Identities=19% Similarity=0.181 Sum_probs=103.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchH--------------------HHHHHHHHHHHHHhcCCCC--e
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRI--------------------DAKRTLREIKLLRHMDHEN--I 101 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~h~~--i 101 (375)
+.+.||+|++|.||++... +|+.||||++........ .......|..++..+.+++ +
T Consensus 19 ~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v 97 (198)
T cd05144 19 LGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV 97 (198)
T ss_pred cCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence 6899999999999999875 789999998754321100 1123567888888887764 3
Q ss_pred eeeceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC
Q 017231 102 IAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180 (375)
Q Consensus 102 v~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~ 180 (375)
+.+++. ...+++|||++| +|..... ......++.+++.++..+|+.|++|+||+|+||+++.++
T Consensus 98 ~~~~~~---------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 98 PKPIDW---------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred Cceeec---------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 333321 234899999986 6655432 145667899999999999999999999999999999999
Q ss_pred CEEEeecccccccCC
Q 017231 181 DLKIGDFGLARTTSE 195 (375)
Q Consensus 181 ~i~l~Df~~~~~~~~ 195 (375)
.++|+|||.+.....
T Consensus 163 ~~~liDfg~~~~~~~ 177 (198)
T cd05144 163 KIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEEECCccccCCC
Confidence 999999998855443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=136.99 Aligned_cols=131 Identities=25% Similarity=0.327 Sum_probs=101.1
Q ss_pred eccCCcceEEEEEEeCCCCcEEEEEEecCcc-cc-----hHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 47 PVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DN-----RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 47 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~-----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.||+|++|.||++.. ++..+++|...... .. ......+..|+.++..+.++++.....++... ...+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence 389999999999984 56789999864321 11 11235677899999999887654443333222 3358
Q ss_pred EEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 121 IVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 121 lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
++|||++| +|.+++..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999975 88887754321 7899999999999999999999999999999 89999999998755
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.1e-16 Score=133.04 Aligned_cols=139 Identities=21% Similarity=0.247 Sum_probs=97.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHH----------------------HHHHHHHHhcCCCC-
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT----------------------LREIKLLRHMDHEN- 100 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~----------------------~~e~~~l~~l~h~~- 100 (375)
+.+.||+|++|.||++.+. +++.||||++............. ..|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3678999999999999987 78999999986543221111111 34566666664332
Q ss_pred -eeeeceeecCCCCCCcCcEEEEEeCCCC-CHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEE
Q 017231 101 -IIAIKDIIRPPQRETFNDVYIVYELMDT-DLH-QIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLL 176 (375)
Q Consensus 101 -iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~-~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli 176 (375)
+++++.. ...+++|||++| .+. ..+.... . ...++.++.+++.++.++|. .|++|+||+|+||++
T Consensus 80 ~~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili 148 (187)
T cd05119 80 PVPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV 148 (187)
T ss_pred CCCceEec---------CCCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE
Confidence 3333332 124899999986 221 1111111 1 16788999999999999999 999999999999999
Q ss_pred ecCCCEEEeecccccccCC
Q 017231 177 NANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 177 ~~~~~i~l~Df~~~~~~~~ 195 (375)
+ ++.++|+|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 89999999999855443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.2e-18 Score=165.45 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=198.7
Q ss_pred CCeeeccCCcceEEEEEEeCCC-CcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSET-REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
++.+.||+|+++.|-++....+ ...++.|.+...............|..+-+.+. |.|++.+++..... ...+
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~-----~~~~ 97 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSP-----RSYL 97 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCC-----cccc
Confidence 3688899999999998876443 334666666544333444555667888888887 99999999988665 4478
Q ss_pred EEEeCCC-CCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEEecCC-CEEEeecccccccCC
Q 017231 121 IVYELMD-TDLHQII-RSHQ-DLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSE 195 (375)
Q Consensus 121 lv~e~~~-g~L~~~l-~~~~-~l~~~~~~~i~~qi~~al~~Lh-~~~i~H~di~p~NIli~~~~-~i~l~Df~~~~~~~~ 195 (375)
+++++.. +++.+.+ .... ..+...+..++.|+..++.|+| ..++.|+||+|+|.+++..+ .+++.|||++.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 9999986 5888877 5554 6888899999999999999999 99999999999999999999 999999999977655
Q ss_pred -C---Cccccccc-cccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHH-HHHHHHhCCCCcccccc
Q 017231 196 -T---DFMTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL-RLITELIGSPDETSLGF 269 (375)
Q Consensus 196 -~---~~~~~~~~-~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~ 269 (375)
. ......+| ++.|.|||...+.....+..|+||+|+++.-+++|..|+......... ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~----------- 246 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN----------- 246 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc-----------
Confidence 2 23345677 999999999887556688999999999999999999998665432200 000000
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
...--...+..++....+++.+++..+|+.|.+.+++-.++|+..
T Consensus 247 ----------------~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 247 ----------------KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ----------------ccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 000012234567888999999999999999999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-17 Score=145.21 Aligned_cols=249 Identities=21% Similarity=0.233 Sum_probs=173.2
Q ss_pred eEEEEEEeCCCCcEEEEEEecCcc-cch-HHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCC-CCH
Q 017231 54 GIVCAAMNSETREEVAIKKIGNAF-DNR-IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDL 130 (375)
Q Consensus 54 g~Vy~~~~~~~~~~vaiK~~~~~~-~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L 130 (375)
-.||++.++..|.+|++..+.... .+. ...+....-..-|.++-|.|+++++.++.+...++.....+++||+. |++
T Consensus 80 d~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 80 DDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 467999999999998887764321 111 11222333344556667999999999998887667778899999997 899
Q ss_pred HHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEecCCCEEEeecccccccCCCC-----cc
Q 017231 131 HQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-----FM 199 (375)
Q Consensus 131 ~~~l~~~----~~l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-----~~ 199 (375)
.++|++. +.+......+|+.||+.||.|||+.. |+|+++..+.|++..+|-++++.---........ ..
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek 239 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEK 239 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhh
Confidence 9999764 34889999999999999999999984 9999999999999988888875322111111000 11
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCC-CChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
....+.+.|.+||.-.. ...+-++|||++|+...+|..+..--.+ .+.-..-..+.+...
T Consensus 240 ~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~------------------ 300 (458)
T KOG1266|consen 240 SVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII------------------ 300 (458)
T ss_pred hccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee------------------
Confidence 12344667899987544 4567799999999999999887643211 111111111111100
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 337 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~ 337 (375)
.+. ..--+.+|.+||+..|..||++.+++.||.+-+++-.+..
T Consensus 301 --~le--------------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkll 343 (458)
T KOG1266|consen 301 --GLE--------------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKLL 343 (458)
T ss_pred --ecc--------------CccccCcCcccccCCCCCCcchhhhhcCceeeecchHHHH
Confidence 000 1112378999999999999999999999999998766643
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-15 Score=149.86 Aligned_cols=134 Identities=22% Similarity=0.323 Sum_probs=104.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEec-Cccc-----chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIG-NAFD-----NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~~~~-----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
..+.||+|++|.||++..... .+++|... +... .......+..|+++++.++|++++.+..+.... .
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~ 409 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-----E 409 (535)
T ss_pred ccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-----C
Confidence 489999999999999976543 44444322 1111 112345678999999999999988776555433 2
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
..++||||++ ++|.+++. ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||++...
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 3589999997 58888775 356789999999999999999999999999999 6789999999998553
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=8.1e-15 Score=128.74 Aligned_cols=140 Identities=18% Similarity=0.251 Sum_probs=104.0
Q ss_pred eeecc-CCcceEEEEEEeCCCCcEEEEEEecCcc------c-----chHHHHHHHHHHHHHHhcCCCCe--eeeceeecC
Q 017231 45 IRPVG-RGAYGIVCAAMNSETREEVAIKKIGNAF------D-----NRIDAKRTLREIKLLRHMDHENI--IAIKDIIRP 110 (375)
Q Consensus 45 ~~~lg-~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~-----~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~ 110 (375)
...|| .||.|+||.+... +..+++|.+.... . .......+.+|+.++.+|.|+++ +.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45687 8999999999764 6789999874311 0 11233567889999999988775 556665432
Q ss_pred CCCCCcCcEEEEEeCCCC--CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 111 PQRETFNDVYIVYELMDT--DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~g--~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
.. ......++|||+++| +|.+++.. ..+++.. +.+|+.++.+||+.||+|+||+|.|||++.++.++|+|||
T Consensus 114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 114 RH-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred ec-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 21 111234699999985 78888765 3455543 5789999999999999999999999999999999999999
Q ss_pred cccc
Q 017231 189 LART 192 (375)
Q Consensus 189 ~~~~ 192 (375)
.+..
T Consensus 188 ~~~~ 191 (239)
T PRK01723 188 RGEL 191 (239)
T ss_pred Cccc
Confidence 8754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.5e-15 Score=141.58 Aligned_cols=262 Identities=27% Similarity=0.278 Sum_probs=196.2
Q ss_pred cccccCCeeeccC--CcceEEEEEEe--CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCC
Q 017231 38 SRKYVPPIRPVGR--GAYGIVCAAMN--SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQ 112 (375)
Q Consensus 38 ~~~~~~i~~~lg~--G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 112 (375)
...-..+.+.+|. |.+|.||.+.. ..++..+|+|.-+...........=.+|+...+.+. |++.++.+..+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~---- 187 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW---- 187 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc----
Confidence 3344557888999 99999999998 889999999985433332223333345666666664 89998866666
Q ss_pred CCCcCcEEEEEeCCCCCHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCceEEecC-CCEEEee
Q 017231 113 RETFNDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLR----GLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGD 186 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~g~L~~~l~~~~~-l~~~~~~~i~~qi~~----al~~Lh~~~i~H~di~p~NIli~~~-~~i~l~D 186 (375)
++.+..++-+|+++.+|.++...... ++...++....+... |+.++|..+++|-|++|.||++..+ ...+++|
T Consensus 188 -e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 188 -EGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred -ccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCC
Confidence 34467899999999999998887666 999999999999999 9999999999999999999999999 8899999
Q ss_pred cccccccCCCCcccc------ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhC
Q 017231 187 FGLARTTSETDFMTE------YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 260 (375)
Q Consensus 187 f~~~~~~~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 260 (375)
||+...+........ ..+...|++||...+ .++..+|+|+||.++.+..++..+......
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------------ 332 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKN------------ 332 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCC------------
Confidence 999887766542221 245677999999876 578999999999999999887655533200
Q ss_pred CCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 261 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
..|..+.. .....+-..+.+.++...+..|++.+|-.|+++..++.++++........
T Consensus 333 ----~~W~~~r~--------------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~ 390 (524)
T KOG0601|consen 333 ----SSWSQLRQ--------------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHL 390 (524)
T ss_pred ----CCcccccc--------------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcc
Confidence 00000000 00011112345677788999999999999999999999999986544443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.7e-14 Score=117.46 Aligned_cols=131 Identities=19% Similarity=0.220 Sum_probs=106.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCC--CCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH--ENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.||+|.++.||++.... ..+++|.+..... ...+..|+..++.+++ ..+++++..+... +..++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEE
Confidence 57889999999999998754 6899999855432 4567889999999976 5888887776433 45799
Q ss_pred EEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceEEecCCCEEEeecccccc
Q 017231 122 VYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA---NVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 122 v~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~---~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
++||++| .+..+ +......++.+++.++..+|.. +++|+|++|.||+++..+.++++||+.+..
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999986 34332 5567778899999999999985 699999999999999989999999998743
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.5e-14 Score=132.98 Aligned_cols=178 Identities=18% Similarity=0.334 Sum_probs=134.4
Q ss_pred ccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCC
Q 017231 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD 127 (375)
Q Consensus 48 lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~ 127 (375)
.+-++.+..-.+..+.++.+|.+...+.+.. .......+.+..|+.++||+|+++++.+... +++|+|+|-+.
T Consensus 20 ~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~-----~~~ylvTErV~ 92 (690)
T KOG1243|consen 20 TAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEE-----GTLYLVTERVR 92 (690)
T ss_pred ccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhccc-----CceEEEeeccc
Confidence 3334433222567788899999998876533 4556678889999999999999999998444 67999999985
Q ss_pred CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-ccccccc
Q 017231 128 TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVT 205 (375)
Q Consensus 128 g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh-~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~-~~~~~~~ 205 (375)
.|...++. +....+...+.||+.||.||| +.+++|+||.-+.|+|+..|+.+|++|.++........ ......-
T Consensus 93 -Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~ 168 (690)
T KOG1243|consen 93 -PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLI 168 (690)
T ss_pred -cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhh
Confidence 35555554 347788889999999999997 67899999999999999999999999998755444321 1222223
Q ss_pred ccccCchhcccCCCCCccchhHHHHHHHHHHhhC
Q 017231 206 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 239 (375)
Q Consensus 206 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 239 (375)
..|..|+.... -.-..|.|.|||++++++.|
T Consensus 169 ~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 169 ESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 34666765433 12467999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=5.9e-13 Score=112.02 Aligned_cols=141 Identities=18% Similarity=0.218 Sum_probs=100.6
Q ss_pred eeeccCCcceEEEEEEeCC------CCcEEEEEEecCccc-----------c---------hHHHHHH----HHHHHHHH
Q 017231 45 IRPVGRGAYGIVCAAMNSE------TREEVAIKKIGNAFD-----------N---------RIDAKRT----LREIKLLR 94 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~-----------~---------~~~~~~~----~~e~~~l~ 94 (375)
...||.|--+.||.|.... .+..+|||+.+-+.. + ......+ .+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999997654 357899998732100 0 0112223 37999999
Q ss_pred hcC--CCCeeeeceeecCCCCCCcCcEEEEEeCCCCC-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCC
Q 017231 95 HMD--HENIIAIKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYV-HSANVLHRDLK 170 (375)
Q Consensus 95 ~l~--h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~-L~~~l~~~~~l~~~~~~~i~~qi~~al~~L-h~~~i~H~di~ 170 (375)
++. .-+++.++++. .-++||||++++ +..-..+...++..++..+..+++.++..| |+.|++||||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 995 34566666542 137999999852 322112223466677788899999999998 89999999999
Q ss_pred CCceEEecCCCEEEeecccccccCC
Q 017231 171 PSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 171 p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
+.||+++ ++.+.|+||+.+.....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999996 57899999998865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.3e-14 Score=139.54 Aligned_cols=264 Identities=22% Similarity=0.232 Sum_probs=194.9
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
.-+...+++.+-+|.++.++.+.-..+|...++|+...... .....+..+.+-.++-.-.+|.++....-+. ..
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-----~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-----CR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-----CC
Confidence 44555578899999999999998888887777776533211 1111222222323332233455554433321 12
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
...+++++|.+ ++|...++..+..+..-++..+..+..++++||...+.|+|++|.|+++..+|...+.||+.......
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 45789999996 69999998888889999999999999999999999999999999999999999999999974321110
Q ss_pred C--------------------------------CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCC
Q 017231 196 T--------------------------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 243 (375)
Q Consensus 196 ~--------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 243 (375)
. .......+|+.|.+||...+ ......+|+|+.|+++++.++|..||
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 01123457889999999998 77899999999999999999999999
Q ss_pred CCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHH---
Q 017231 244 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD--- 320 (375)
Q Consensus 244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~--- 320 (375)
.........+.|.......+... ...+.+.++++.+.|..+|.+|..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~----------------------------~~~s~~aq~~~~~ll~~~~~qr~~a~~~~ 1087 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGP----------------------------EEGSYEAQDLINRLLTEEPTQRLGAKGAA 1087 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCc----------------------------cccChhhhhhhhhhhccCchhccCccccc
Confidence 88877666655544333322211 23578899999999999999999988
Q ss_pred HHhcCCCCCCCCCCC
Q 017231 321 EALCHPYLAPLHDIN 335 (375)
Q Consensus 321 ell~~~~f~~~~~~~ 335 (375)
++-.|+||+.+.-..
T Consensus 1088 e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1088 EVKGHPFFQDVDWEN 1102 (1205)
T ss_pred ccccCCccCCCCccc
Confidence 999999999886444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.9e-12 Score=123.45 Aligned_cols=142 Identities=20% Similarity=0.272 Sum_probs=95.8
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHH--------------------------------------HHHHH
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRID--------------------------------------AKRTL 87 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~--------------------------------------~~~~~ 87 (375)
+.||+|+.|+||+|+.+ +|+.||||+........-. .-.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999875 6899999998543111000 00234
Q ss_pred HHHHHHHhc----CCCCeeeeceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHH
Q 017231 88 REIKLLRHM----DHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLR-GLKYVH 160 (375)
Q Consensus 88 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qi~~-al~~Lh 160 (375)
.|+..+.++ ++.+-+.+..++..-. +..++||||++| +|.+..... ... ....++..++. .+..+|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH
Confidence 455555555 2333344444443221 235899999986 776665432 122 23345566655 467889
Q ss_pred hCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 161 ~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
..|++|+|++|.||+++.+++++++|||++.....
T Consensus 275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999999866543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-12 Score=109.10 Aligned_cols=127 Identities=20% Similarity=0.184 Sum_probs=92.4
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe-eeeceeecCCCCCCcCcEEEEE
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~ 123 (375)
++.|+.|..+.||.++.. +..|++|+...... ....+..|+.+++.+.+.++ ++++..... ..++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~-------~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDPE-------TGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeCC-------CCeEEE
Confidence 678999999999999864 67899998754321 12235678888888865444 344443311 137999
Q ss_pred eCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCceEEecCCCEEEeecccccc
Q 017231 124 ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV-----LHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 124 e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i-----~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
|+++| ++.+. ......++.+++.+|..||..++ +|+|++|.||+++ ++.++++||+.+..
T Consensus 71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 99986 44332 11123456899999999999885 9999999999998 67899999998743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-11 Score=114.27 Aligned_cols=169 Identities=14% Similarity=0.217 Sum_probs=130.9
Q ss_pred cceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCC--CC
Q 017231 52 AYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD--TD 129 (375)
Q Consensus 52 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~--g~ 129 (375)
--.+.|+++...+|..|++|.++..... .......-+++.+++.|+|+|++.++|.... -+...+++|++|.+ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCch
Confidence 3457899999999999999999543211 1122345678899999999999999998433 33477999999997 48
Q ss_pred HHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 130 LHQIIRS---------------HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 130 L~~~l~~---------------~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
|.++.-. +...++..+|.++.||..||..+|+.|+...-|.|.+|+++.+.+++|+..|......
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 8887632 2347889999999999999999999999999999999999999999998776654433
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCC
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 240 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 240 (375)
... . +.+. -..+.|.-.||.+++.|.+|.
T Consensus 445 ~d~-----------~--~~le----~~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 445 EDP-----------T--EPLE----SQQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CCC-----------C--cchh----HHhhhhHHHHHHHHHHHhhcc
Confidence 331 0 1121 234789999999999999996
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.5e-12 Score=122.46 Aligned_cols=139 Identities=17% Similarity=0.283 Sum_probs=93.1
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcccc----------------------------h----HHHH------HHH
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN----------------------------R----IDAK------RTL 87 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------------------------~----~~~~------~~~ 87 (375)
+.||+|+.|+||.|+.+.+|+.||||+....... . +-.. .+.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 7899999999999999988999999998643110 0 0011 133
Q ss_pred HHHHHHHhcC----CCCeeeeceeecCCCCCCcCcEEEEEeCCCC-CHHHH--HHhCC----CCCHHHHHHHHHHHHHHH
Q 017231 88 REIKLLRHMD----HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQI--IRSHQ----DLTDDHCRYFLYQLLRGL 156 (375)
Q Consensus 88 ~e~~~l~~l~----h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~--l~~~~----~l~~~~~~~i~~qi~~al 156 (375)
.|+..+.++. +...+.+..++.+-. +.-++||||++| .+.+. +...+ .+.+..+..++.|++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s----t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--- 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYC----SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--- 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccC----CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH---
Confidence 4554444442 444445545553321 335899999986 77653 33322 144444444445543
Q ss_pred HHHHhCCccccCCCCCceEEecCC----CEEEeecccccccCC
Q 017231 157 KYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLARTTSE 195 (375)
Q Consensus 157 ~~Lh~~~i~H~di~p~NIli~~~~----~i~l~Df~~~~~~~~ 195 (375)
..|++|+|++|.||+++.+| +++++|||++...+.
T Consensus 278 ----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999988 999999999866544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-11 Score=100.15 Aligned_cols=132 Identities=22% Similarity=0.282 Sum_probs=94.3
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEec-Cc-----ccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIG-NA-----FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
..+++|+-+.+|.+... |.++++|.-. +. .+..-...+..+|+.++.++.--.+....-+..++ ...
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~-----~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDP-----DNG 74 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCC
Confidence 45789999999999653 4457777542 22 22233345667899999999654443333333332 224
Q ss_pred EEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 120 YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 120 ~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
.|+|||++| .|.+.+... ...++..+-..+.-||..||+||||.++||++... ++.++|||++..
T Consensus 75 ~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred EEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 799999997 677787765 24566777777888999999999999999999665 499999999854
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.8e-11 Score=107.74 Aligned_cols=258 Identities=13% Similarity=0.120 Sum_probs=163.0
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCC----eeeeceeecCCCCC
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHEN----IIAIKDIIRPPQRE 114 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~----iv~~~~~~~~~~~~ 114 (375)
.-+...+.||+|+.+.+|.+-.-. ..+.|++........ . .-+..|-.. .||- ++...+.....+.
T Consensus 11 e~i~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~--a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~- 81 (637)
T COG4248 11 EPIPPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ--A---QKVAELAATPDAPLLNYRVAWPQATLHGGRR- 81 (637)
T ss_pred cccCCCccccCCccceeeecchhh---chhheeecCCCchHH--H---HHHHHhccCCCCcchhhhhcccHHHhhCCCc-
Confidence 334568889999999999884433 356788765422211 1 112222222 3443 2333333333221
Q ss_pred CcCcEEEEEeCCCC--CHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEee
Q 017231 115 TFNDVYIVYELMDT--DLHQIIRS------HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 186 (375)
Q Consensus 115 ~~~~~~lv~e~~~g--~L~~~l~~------~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~D 186 (375)
+ ...-+.|..+.| .+..++.. .+...++...+.++.|+.+...||..|.+-||++++|+|+..++.+.|.|
T Consensus 82 ~-~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 82 G-KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred c-ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEc
Confidence 1 226688888875 56666532 24588999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhC-CCCCCCCChhHHHHHHHHHhCC
Q 017231 187 FGLARTTSETDFMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGS 261 (375)
Q Consensus 187 f~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~ 261 (375)
-+.-.............|...|++||.-.- ...-+..+|.|.||+++++|+.| +.||.+-... +.
T Consensus 161 sDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~----------~~ 230 (637)
T COG4248 161 SDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI----------SD 230 (637)
T ss_pred ccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc----------CC
Confidence 776655555544555678889999998641 13456789999999999999886 9999764200 00
Q ss_pred CCcccccccccchhHHHhhhCCC---CCCCCccccCCCCCchHHHHHHHhcCc--CCCCCCCHH
Q 017231 262 PDETSLGFLRSDNARRYVRMLPQ---FPKQNFSARFPNKSPGAVDLLEKMLVF--DPNRRITVD 320 (375)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~l~~li~~~L~~--dP~~Rps~~ 320 (375)
-+.......... .|.+.-.+ .........+.-+++.++.+..+|+.. .++-|||++
T Consensus 231 ap~p~E~~Ia~g---~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 231 APNPLETDIAHG---RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred CCCcchhhhhcc---eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 000000000000 00100000 111112223345788999999999863 367899874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5e-11 Score=96.71 Aligned_cols=143 Identities=24% Similarity=0.293 Sum_probs=105.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEec-C-----cccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIG-N-----AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~-~-----~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
.+..|-+|+-+.|+.+. -.|+.++||.-. + ..+..-...+..+|++.|.++.--.|.-..-++.+. .
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~-----~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT-----Y 83 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec-----C
Confidence 46778899999999985 557888888532 1 123333456677899999998644554333334333 1
Q ss_pred cEEEEEeCCCC--CHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC---EEEeecccc
Q 017231 118 DVYIVYELMDT--DLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLA 190 (375)
Q Consensus 118 ~~~lv~e~~~g--~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~---i~l~Df~~~ 190 (375)
.-+|+|||++| ++.+++..... ........++..|-+.+.-||..+++||||..+||++..++. +.++|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 23799999998 88998876533 333444788999999999999999999999999999977653 589999998
Q ss_pred ccc
Q 017231 191 RTT 193 (375)
Q Consensus 191 ~~~ 193 (375)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.4e-12 Score=118.32 Aligned_cols=246 Identities=22% Similarity=0.212 Sum_probs=175.5
Q ss_pred CCeeeccCCcceEEEEEEeC-CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNS-ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
..+..||.|.++.|+.+.-+ .++..|++|...+.......-..-..|+.+...+ .|.+++.....+... .+.+
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-----r~~~ 342 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-----RQGY 342 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-----cccc
Confidence 36899999999999987644 6778899998876655544444445667766666 488888877776544 3356
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC-CCEEEeecccccccCCCCc
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~-~~i~l~Df~~~~~~~~~~~ 198 (375)
+=.|||+ +++...+.....+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..+++||++.......
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-- 420 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-- 420 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee--
Confidence 8889996 4554444444458899999999999999999999999999999999999776 78899999988642221
Q ss_pred ccccccccccc-CchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 199 MTEYVVTRWYR-APELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 199 ~~~~~~~~~y~-aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
.........+. .+|++.....+..+.|+++||.-+.+..++...-.....-..+
T Consensus 421 ~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i------------------------- 475 (524)
T KOG0601|consen 421 SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTI------------------------- 475 (524)
T ss_pred cccccccccccccchhhccccccccccccccccccccccccCcccCcccccceee-------------------------
Confidence 11222233333 3566655578899999999999999999987543322110000
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
........+....+++.+.+.+...|+..||++.++..|.=|.
T Consensus 476 ---------~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 476 ---------RSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---------ecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0011122234456788999999999999999999998876543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.7e-10 Score=98.37 Aligned_cols=134 Identities=13% Similarity=0.083 Sum_probs=93.7
Q ss_pred EEEEEeCCCCcEEEEEEecCcccch---------HHHHHHHHHHHHHHhcCCCCee--eeceeecCCCCCCcCcEEEEEe
Q 017231 56 VCAAMNSETREEVAIKKIGNAFDNR---------IDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVYIVYE 124 (375)
Q Consensus 56 Vy~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~lv~e 124 (375)
|..+. -.|+.|.||......... .....+.+|...+.+|...+|. .++.+............++|||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 44553 346789999764322111 0111367888888888544443 3344443222122244689999
Q ss_pred CCCC--CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-------CCCEEEeeccccc
Q 017231 125 LMDT--DLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-------NCDLKIGDFGLAR 191 (375)
Q Consensus 125 ~~~g--~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-------~~~i~l~Df~~~~ 191 (375)
++++ +|.+++.. ....+......++.+++..+..||..|++|+|+++.||+++. +..+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9986 78888764 345677788899999999999999999999999999999975 4679999999774
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.4e-11 Score=118.05 Aligned_cols=151 Identities=23% Similarity=0.361 Sum_probs=109.9
Q ss_pred HHHHHHHHhC-CccccCCCCCceEEecCCCEEEeecccccccCCC-C-----cc--c--cccccccccCchhcccCCCCC
Q 017231 153 LRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-D-----FM--T--EYVVTRWYRAPELLLNCSEYT 221 (375)
Q Consensus 153 ~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~-----~~--~--~~~~~~~y~aPE~~~~~~~~~ 221 (375)
+.|+.++|.. +++|++|.|++|+++.+|.+||+.|+.+...... + +. . -......|.|||.+.+ ...+
T Consensus 109 ~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~~~ 187 (700)
T KOG2137|consen 109 ADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TTNT 187 (700)
T ss_pred cchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cccc
Confidence 3899999955 8999999999999999999999999987654441 1 00 0 1123566999999988 7789
Q ss_pred ccchhHHHHHHHHHHh-hCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCch
Q 017231 222 AAIDIWSVGCILGEIM-TRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 300 (375)
Q Consensus 222 ~~~Di~slG~il~~l~-~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 300 (375)
.++|+||||+++|.+. .|+..+...........-...... .. ......++.+
T Consensus 188 ~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~-~~--------------------------~~~s~~~p~e 240 (700)
T KOG2137|consen 188 PASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNA-GA--------------------------FGYSNNLPSE 240 (700)
T ss_pred ccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccc-cc--------------------------ccccccCcHH
Confidence 9999999999999999 555555443221111111110000 00 0001467899
Q ss_pred HHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 301 AVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 301 l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
+++=|.++|..++..||++.+++..+||...
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 9999999999999999999999999999865
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.9e-10 Score=98.05 Aligned_cols=143 Identities=17% Similarity=0.258 Sum_probs=100.1
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCC--CeeeeceeecCCCCCCcCcEEEE
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE--NIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++.|+.|..+.+|++.... |..+++|........ .....+..|+.+++.+.+. .+++++.+..... ..+..+++
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v 78 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYV 78 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEE
Confidence 4678999999999998644 678999987543221 1345678899999999753 3566666554321 11346899
Q ss_pred EeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 017231 123 YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS---------------------------------------- 161 (375)
Q Consensus 123 ~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~---------------------------------------- 161 (375)
||+++| ++.+.+.. ..++..+...++.+++.+|..||+
T Consensus 79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999986 55443321 345666666666777777766663
Q ss_pred ----------------CCccccCCCCCceEEec--CCCEEEeecccccc
Q 017231 162 ----------------ANVLHRDLKPSNLLLNA--NCDLKIGDFGLART 192 (375)
Q Consensus 162 ----------------~~i~H~di~p~NIli~~--~~~i~l~Df~~~~~ 192 (375)
..++|+|++|+||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999988 56689999997744
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.6e-10 Score=95.02 Aligned_cols=147 Identities=18% Similarity=0.198 Sum_probs=107.2
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecC------------------cccc--hHHHHHHHHHHHHHH
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGN------------------AFDN--RIDAKRTLREIKLLR 94 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~------------------~~~~--~~~~~~~~~e~~~l~ 94 (375)
+........++.+||-|--|.||.+.+. .|.+++||+-.. ...+ ........+|..+|.
T Consensus 86 l~~r~~ve~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~ 164 (304)
T COG0478 86 LVKRGIVEAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQ 164 (304)
T ss_pred HHHcChHHhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHH
Confidence 3334445668999999999999999987 578999996411 0011 122344568999999
Q ss_pred hcCCC--CeeeeceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 017231 95 HMDHE--NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 171 (375)
Q Consensus 95 ~l~h~--~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p 171 (375)
+|... .+++.++. +.-++|||+++| .|... +++......++..|++-+..+-..|++|||+++
T Consensus 165 ~L~~~G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSe 230 (304)
T COG0478 165 RLYPEGVKVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSE 230 (304)
T ss_pred HhhhcCCCCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCch
Confidence 98644 66666654 334799999998 33332 124566666777788777777799999999999
Q ss_pred CceEEecCCCEEEeecccccccCCC
Q 017231 172 SNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 172 ~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
-||+++.+|.+.++||-.+......
T Consensus 231 fNIlV~~dg~~~vIDwPQ~v~~~hp 255 (304)
T COG0478 231 FNILVTEDGDIVVIDWPQAVPISHP 255 (304)
T ss_pred heEEEecCCCEEEEeCcccccCCCC
Confidence 9999999999999999877554433
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.1e-10 Score=92.72 Aligned_cols=128 Identities=23% Similarity=0.271 Sum_probs=81.0
Q ss_pred EEEEEEeCCCCcEEEEEEecCc------------------------ccchHHHHHHHHHHHHHHhcCCC--Ceeeeceee
Q 017231 55 IVCAAMNSETREEVAIKKIGNA------------------------FDNRIDAKRTLREIKLLRHMDHE--NIIAIKDII 108 (375)
Q Consensus 55 ~Vy~~~~~~~~~~vaiK~~~~~------------------------~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~ 108 (375)
.||.|... +|..+|+|+.... ...........+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888764 4679999987321 01111234557899999999755 456666543
Q ss_pred cCCCCCCcCcEEEEEeCCC--CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCceEEecCCCEEEe
Q 017231 109 RPPQRETFNDVYIVYELMD--TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY-VHSANVLHRDLKPSNLLLNANCDLKIG 185 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~-Lh~~~i~H~di~p~NIli~~~~~i~l~ 185 (375)
.-+|||||++ |.....+... .++......++.+++..+.. +|..|++|||+++.||+++.+ .+.++
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---------CCEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 1279999998 6322323221 12245566777888885555 679999999999999999877 99999
Q ss_pred ecccccccC
Q 017231 186 DFGLARTTS 194 (375)
Q Consensus 186 Df~~~~~~~ 194 (375)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999875544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.6e-09 Score=91.86 Aligned_cols=109 Identities=22% Similarity=0.317 Sum_probs=85.1
Q ss_pred HHHHHHHHHHHHhcCCCC--eeeeceeecCCCCCCcCcEEEEEeCCCC--CHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 017231 83 AKRTLREIKLLRHMDHEN--IIAIKDIIRPPQRETFNDVYIVYELMDT--DLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158 (375)
Q Consensus 83 ~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv~e~~~g--~L~~~l~~~~~l~~~~~~~i~~qi~~al~~ 158 (375)
.....+|...+..|..-+ .+.++++........ ...++|+|+++| +|.+++......+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 345677888888775333 344455443322122 456899999986 799999876668888899999999999999
Q ss_pred HHhCCccccCCCCCceEEecCC---CEEEeecccccc
Q 017231 159 VHSANVLHRDLKPSNLLLNANC---DLKIGDFGLART 192 (375)
Q Consensus 159 Lh~~~i~H~di~p~NIli~~~~---~i~l~Df~~~~~ 192 (375)
||+.|++|+|+++.|||++.++ .+.|+||+-+..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999999887 899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=5.6e-09 Score=88.21 Aligned_cols=141 Identities=14% Similarity=0.165 Sum_probs=103.6
Q ss_pred cCCcceEEEEEEeCCCCcEEEEEEecC----cccchHHHHHHHHHHHHHHhcCCCC--eeeeceeecCCCCCCcCcEEEE
Q 017231 49 GRGAYGIVCAAMNSETREEVAIKKIGN----AFDNRIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 49 g~G~~g~Vy~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv 122 (375)
|+||-|.|+..... |+.+-+|.... +.........+.+|...+.+|..-+ ++++. ++...........+||
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 45888999988643 34688887642 1111224567889999999996433 44444 3322222333557899
Q ss_pred EeCCCC--CHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC--EEEeecccccc
Q 017231 123 YELMDT--DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD--LKIGDFGLART 192 (375)
Q Consensus 123 ~e~~~g--~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~--i~l~Df~~~~~ 192 (375)
+|-++| +|.+++... .+.+......++.+++.++.-||+.|+.|+|+.+.||+++.+|. +.++||.-+..
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998874 899988663 34688888999999999999999999999999999999987777 99999987643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1e-07 Score=81.75 Aligned_cols=140 Identities=16% Similarity=0.140 Sum_probs=98.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc--------------------hH--HHHHHHHHHHHHHhcC--CC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN--------------------RI--DAKRTLREIKLLRHMD--HE 99 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--------------------~~--~~~~~~~e~~~l~~l~--h~ 99 (375)
+...|++|-.+.||+|.. .++..+|+|++.-+... .. ...-..+|...|+++. +-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 455889999999999975 45789999998432111 11 1112356888888885 44
Q ss_pred CeeeeceeecCCCCCCcCcEEEEEeCCCCC--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEE
Q 017231 100 NIIAIKDIIRPPQRETFNDVYIVYELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLL 176 (375)
Q Consensus 100 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~--L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli 176 (375)
.+++.+.+.. -.+||||++.. -.-.|+. -++...++..+..++++.+.-|-. .+++|+||+.-|||+
T Consensus 131 rvP~Pi~~~~---------nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~ 200 (268)
T COG1718 131 RVPEPIAFRN---------NVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV 200 (268)
T ss_pred CCCCceeecC---------CeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE
Confidence 5555555441 27999999732 1111111 124444788889999999988887 899999999999999
Q ss_pred ecCCCEEEeecccccccCC
Q 017231 177 NANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 177 ~~~~~i~l~Df~~~~~~~~ 195 (375)
. ++.+.++||+.+.....
T Consensus 201 ~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 201 H-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred E-CCeEEEEECccccccCC
Confidence 8 88999999998866553
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.77 E-value=6.6e-08 Score=82.07 Aligned_cols=138 Identities=14% Similarity=0.129 Sum_probs=79.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHH-HH------HHHHHHHHHHhcC---CCCeeeeceeecCCC
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRID-AK------RTLREIKLLRHMD---HENIIAIKDIIRPPQ 112 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~------~~~~e~~~l~~l~---h~~iv~~~~~~~~~~ 112 (375)
++++.+-......|.+. ..+|..+++|.........+. .. ...+.+..+.++. ......++.+..-..
T Consensus 34 ~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~ 111 (229)
T PF06176_consen 34 KIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI 111 (229)
T ss_pred eEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence 35566666655555555 456788999987543211110 00 1122333333332 222223222221111
Q ss_pred CCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 113 RETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
..--...+++|||++| .|.+... +++ .+...|.+++.-||+.|++|||.+|.|+++..+ .++++|++...
T Consensus 112 ~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 112 FRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred ccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECcccc
Confidence 1111345689999998 5554421 222 244667788999999999999999999999754 59999997653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2e-07 Score=75.74 Aligned_cols=138 Identities=20% Similarity=0.187 Sum_probs=98.6
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeee-eceeecCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKDIIRPP 111 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~ 111 (375)
-+++....-+++.+.|++|.+|.||++..+ |..+|+|+-... .....+..|+++|..++..++-+ ++.+.
T Consensus 15 ~~~~~~~~~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d----s~r~~l~kEakiLeil~g~~~~p~vy~yg--- 85 (201)
T COG2112 15 LNVEEGKYELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD----SPRRNLEKEAKILEILAGEGVTPEVYFYG--- 85 (201)
T ss_pred eeeeccchhhhhhhhhhcccccEEEEeecc--CceEEEEEecCC----cchhhHHHHHHHHHHhhhcCCCceEEEec---
Confidence 355666666778999999999999999765 458999986433 33556789999999998666643 44332
Q ss_pred CCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCceEEecCCCEEEeeccc
Q 017231 112 QRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLK-PSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~-p~NIli~~~~~i~l~Df~~ 189 (375)
.-++.|||+.| +|.++.... . .+-+..++++.--|-..||-|+.|+ |..+++-.++++.|+||..
T Consensus 86 ------~~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~ 152 (201)
T COG2112 86 ------EDFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDS 152 (201)
T ss_pred ------hhhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccc
Confidence 12467999987 776654321 1 2344566666666888899999997 5555555666999999999
Q ss_pred ccc
Q 017231 190 ART 192 (375)
Q Consensus 190 ~~~ 192 (375)
++.
T Consensus 153 At~ 155 (201)
T COG2112 153 ATF 155 (201)
T ss_pred hhh
Confidence 864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.8e-07 Score=92.89 Aligned_cols=209 Identities=20% Similarity=0.250 Sum_probs=146.7
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Q 017231 81 IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159 (375)
Q Consensus 81 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~L 159 (375)
........|...+.++.|+|++.++.+-......+ ....+..+++.+ ++...+..-..++....+.+..++.+++.++
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~ 302 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYL 302 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHH
Confidence 44555667888888999999999988865543211 123345677864 8899998888999999999999999999999
Q ss_pred HhCCccccCCCCC---ceEEecCCCEEEe--ecccccccCCCCccccccccccccCchhcccCCCC--CccchhHHHHHH
Q 017231 160 HSANVLHRDLKPS---NLLLNANCDLKIG--DFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY--TAAIDIWSVGCI 232 (375)
Q Consensus 160 h~~~i~H~di~p~---NIli~~~~~i~l~--Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~Di~slG~i 232 (375)
|+....|.-+..+ +.-++..+.+..+ ||+................+..+.++|.... +.. ....|+|++|..
T Consensus 303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHH
Confidence 9986555544444 3334455556665 8887776666554444455666778887765 333 345799999999
Q ss_pred HHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCC-chHHHHHHHhcCc
Q 017231 233 LGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS-PGAVDLLEKMLVF 311 (375)
Q Consensus 233 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s-~~l~~li~~~L~~ 311 (375)
...+..|..+-.... ...... +..+ ..+.+.+.+|+.-
T Consensus 382 ~~~~~~~~~i~~~~~------~~~~~l-----------------------------------~~~~~~~~~d~~~~~~~~ 420 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSA------VPVSLL-----------------------------------DVLSTSELLDALPKCLDE 420 (1351)
T ss_pred HhhhhhcCccccccc------chhhhh-----------------------------------ccccchhhhhhhhhhcch
Confidence 999988764321110 000000 0111 1578999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCC
Q 017231 312 DPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 312 dP~~Rps~~ell~~~~f~~~~ 332 (375)
++++|+++.+++.|+|.+.-.
T Consensus 421 ~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 421 DSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred hhhhccchhhhhhchhccccc
Confidence 999999999999999998643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.4e-06 Score=84.20 Aligned_cols=143 Identities=17% Similarity=0.245 Sum_probs=91.2
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCccc----------------------------chHHHH----------HHH
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD----------------------------NRIDAK----------RTL 87 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----------------------------~~~~~~----------~~~ 87 (375)
+.|+.++-|+||.|+.+. |+.||||+...... -....+ .+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 789999999999999876 89999998732110 001111 123
Q ss_pred HHHHHHHhc----CCCCeeeeceeecCCCCCCcCcEEEEEeCCCC-CHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 017231 88 REIKLLRHM----DHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQI--IRSHQDLTDDHCRYFLYQLLRGLKYVH 160 (375)
Q Consensus 88 ~e~~~l~~l----~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~--l~~~~~l~~~~~~~i~~qi~~al~~Lh 160 (375)
.|...+.++ ++..-+.+-.+|.+-. +.-+++|||++| .+.+. ++. .+.+...+.....++. +..+=
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t----~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYT----TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLL 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhcc----CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHH
Confidence 455555554 2333345555554321 234899999998 55554 444 4455444333222222 22233
Q ss_pred hCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 161 ~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
..|++|.|.+|.||+++.+|++.+.|||.....+..
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 479999999999999999999999999998665543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=4e-06 Score=73.03 Aligned_cols=133 Identities=19% Similarity=0.214 Sum_probs=78.9
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe--eeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI--IAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~ 123 (375)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-.+ ++++++.... +...++|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~-----~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDG-----GRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecC-----Ceeeeee
Confidence 57899999999984 24568899875422 23446789999998864433 5556655333 3357899
Q ss_pred eCCCCC--HHHHH---------------------HhC--CCCCHHHHH-HHHHH----------HHH-HHHHHH----hC
Q 017231 124 ELMDTD--LHQII---------------------RSH--QDLTDDHCR-YFLYQ----------LLR-GLKYVH----SA 162 (375)
Q Consensus 124 e~~~g~--L~~~l---------------------~~~--~~l~~~~~~-~i~~q----------i~~-al~~Lh----~~ 162 (375)
|+++|. +...+ +.- ......... .+..+ +.. ...+|. ..
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999873 11111 000 011111110 01000 111 112222 12
Q ss_pred CccccCCCCCceEEecCCCEEEeecccccc
Q 017231 163 NVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
.++|||++|.||+++.++ +.++||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 478999999999999888 99999997743
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.39 E-value=5.9e-06 Score=72.19 Aligned_cols=80 Identities=20% Similarity=0.231 Sum_probs=53.8
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCC--CeeeeceeecCCCCCCcCcEEEE
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE--NIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++.|+.|..+.||.+.... ..+++|..... .....+..|..+++.+... .+++++...... ......+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5789999999999998766 48999987433 3456677888888888533 345555533222 222347899
Q ss_pred EeCCCC-CHHH
Q 017231 123 YELMDT-DLHQ 132 (375)
Q Consensus 123 ~e~~~g-~L~~ 132 (375)
|++++| .+..
T Consensus 74 ~~~i~g~~~~~ 84 (239)
T PF01636_consen 74 MEYIPGRPLDD 84 (239)
T ss_dssp EEEESSEEHHH
T ss_pred EEEeccccccc
Confidence 999987 4444
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=7.9e-06 Score=78.79 Aligned_cols=142 Identities=18% Similarity=0.239 Sum_probs=89.0
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCcccch-----------------------------HHHH------HHHHHH
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR-----------------------------IDAK------RTLREI 90 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----------------------------~~~~------~~~~e~ 90 (375)
+.||.-+.|+|+.|+.+. |+.||||+-+...... +-.+ .|..|+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 789999999999999877 9999999863321111 0000 122344
Q ss_pred HHHHhc----CCCC---eeeeceeecCCCCCCcCcEEEEEeCCCC---CHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-H
Q 017231 91 KLLRHM----DHEN---IIAIKDIIRPPQRETFNDVYIVYELMDT---DLHQIIRSHQDLTDDHCRYFLYQLLRGLKY-V 159 (375)
Q Consensus 91 ~~l~~l----~h~~---iv~~~~~~~~~~~~~~~~~~lv~e~~~g---~L~~~l~~~~~l~~~~~~~i~~qi~~al~~-L 159 (375)
+...++ .|-+ -|.+-.+|.+-. ..-+++||||+| +=.+.|.+.+ ++... ++..+.++... +
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s----t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~---i~~~l~~~~~~qI 317 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS----TKRVLTMEYVDGIKINDLDAIDKRG-ISPHD---ILNKLVEAYLEQI 317 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC----cceEEEEEecCCccCCCHHHHHHcC-CCHHH---HHHHHHHHHHHHH
Confidence 433333 3444 223334443321 235899999986 3345565544 55554 33444444333 3
Q ss_pred HhCCccccCCCCCceEEec----CCCEEEeecccccccCCC
Q 017231 160 HSANVLHRDLKPSNLLLNA----NCDLKIGDFGLARTTSET 196 (375)
Q Consensus 160 h~~~i~H~di~p~NIli~~----~~~i~l~Df~~~~~~~~~ 196 (375)
=..|++|+|-+|.||+++. ++++.+.|||+.......
T Consensus 318 f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 318 FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 3568999999999999984 668999999998666544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.5e-05 Score=69.05 Aligned_cols=74 Identities=12% Similarity=0.065 Sum_probs=48.1
Q ss_pred eeccCCcc-eEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAY-GIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~-g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
..|..|.. +.||.+... +..+++|+..... ...+..|+.+++.+. +-.+++++...... +..++||
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~ 71 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLT 71 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEE
Confidence 34555665 788999653 3688999874432 234667888888884 44455666655332 3458999
Q ss_pred eCCCC-CHH
Q 017231 124 ELMDT-DLH 131 (375)
Q Consensus 124 e~~~g-~L~ 131 (375)
++++| ++.
T Consensus 72 e~i~G~~l~ 80 (244)
T cd05150 72 SAVPGVPAA 80 (244)
T ss_pred EeeCCccHh
Confidence 99987 443
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.7e-05 Score=65.51 Aligned_cols=158 Identities=18% Similarity=0.187 Sum_probs=100.8
Q ss_pred CCCCCCCCCCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcc-eEEEEEEeCCCCcEEEEEEecC---cc
Q 017231 2 SGESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAY-GIVCAAMNSETREEVAIKKIGN---AF 77 (375)
Q Consensus 2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~-g~Vy~~~~~~~~~~vaiK~~~~---~~ 77 (375)
+..+....-..|-..|+++ ++|.- ....++.++.||.|.. |.||+++ -.|+.||+|++.. ..
T Consensus 11 ~~~~~~~~~plp~~~gPKL--~~F~~----------h~~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~ 76 (207)
T PF13095_consen 11 DQPPRKPPKPLPQCPGPKL--EPFTH----------HGDDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTE 76 (207)
T ss_pred cCCCCCCCcccccCCCCCc--CCcCC----------CCCcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCC
Confidence 3444444445555666665 22221 2255668999999999 9999996 4567999999311 10
Q ss_pred c--------c-h-------HHHHHHHHHHHHHHhcC---CCCe--eeeceeecCCC-C------------CCcCcEEEEE
Q 017231 78 D--------N-R-------IDAKRTLREIKLLRHMD---HENI--IAIKDIIRPPQ-R------------ETFNDVYIVY 123 (375)
Q Consensus 78 ~--------~-~-------~~~~~~~~e~~~l~~l~---h~~i--v~~~~~~~~~~-~------------~~~~~~~lv~ 123 (375)
. . . .....|..|-+...+|+ +.++ ++++++..-.. . .......||-
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVK 156 (207)
T PF13095_consen 77 PDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVK 156 (207)
T ss_pred CccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEE
Confidence 0 0 0 12345777888877774 4455 88888874331 0 1112346788
Q ss_pred eCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 124 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 124 e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
||+...- .++... +.+|..-+..+|..||+-+|+++.|.. .-+|+|||.+
T Consensus 157 D~v~~~~--------~~~~~~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 157 DFVPDDP--------PLQIRD----IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred eecCCcc--------ccchhH----HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 8886422 233333 456666677899999999999999985 4578899864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.5e-05 Score=67.71 Aligned_cols=73 Identities=16% Similarity=0.208 Sum_probs=43.9
Q ss_pred eeeccCCcce-EEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCC---CeeeeceeecCCCCCCcCcEE
Q 017231 45 IRPVGRGAYG-IVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE---NIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 45 ~~~lg~G~~g-~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~ 120 (375)
++.|+.|+.. .||.+ +..+++|+.... .....+..|..++..+... .++.+++..... +.....+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~--~~~~~~~ 70 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAA----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPG--EGYPWPW 70 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCcc----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCc--cCCCcce
Confidence 4677877766 48987 235788876432 1244678899999888532 233333322221 1123357
Q ss_pred EEEeCCCC
Q 017231 121 IVYELMDT 128 (375)
Q Consensus 121 lv~e~~~g 128 (375)
++|++++|
T Consensus 71 ~l~~~i~G 78 (235)
T cd05155 71 SVYRWLEG 78 (235)
T ss_pred EEEEeecC
Confidence 89999876
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.07 E-value=7.1e-05 Score=77.71 Aligned_cols=83 Identities=12% Similarity=0.171 Sum_probs=56.2
Q ss_pred CeeeccCCcceEEEEEEeCCCC--cEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCe--eeeceeecCCCCCCcCc
Q 017231 44 PIRPVGRGAYGIVCAAMNSETR--EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENI--IAIKDIIRPPQRETFND 118 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~ 118 (375)
-++.|+.|....+|++.....+ ..+++|+....... .....+.+|+.+++.+. |.++ ++++.++.+. ...+.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3788999999999999765433 46888876432211 12345779999999995 6665 5666665443 22245
Q ss_pred EEEEEeCCCCC
Q 017231 119 VYIVYELMDTD 129 (375)
Q Consensus 119 ~~lv~e~~~g~ 129 (375)
.|+|||+++|.
T Consensus 119 ~flVME~v~G~ 129 (822)
T PLN02876 119 AFYIMEYLEGR 129 (822)
T ss_pred ceEEEEecCCc
Confidence 68999999873
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.3e-07 Score=86.51 Aligned_cols=183 Identities=17% Similarity=0.129 Sum_probs=132.6
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCC-eeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN-IIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~~~~~~lv 122 (375)
..+-+++|+++++++.+...+...+ .+++... ....-++++|.+++||| .+..++-+ +.....++.
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~ 312 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIP 312 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchh
Confidence 5667889999999999887775555 7776433 33457889999999999 33333333 444778999
Q ss_pred EeCCCCC--HHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 123 YELMDTD--LHQIIR-SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 123 ~e~~~g~--L~~~l~-~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
++++++. ....+. ..-.+...+...+.+.-+.+++++|+.--+|+| ||+.. ++..++.||+...........
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc-ccccccccccCCcccCccccc
Confidence 9999742 222211 112245556666777778889999988767887 66664 478899999987665555445
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCC
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 245 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 245 (375)
.+..+++.++|||+... ..+..+.|.|++|.-..+|.-|.+|-..
T Consensus 388 ~t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCCC
Confidence 66788999999998877 6788999999999887888878777644
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.05 E-value=8.5e-05 Score=65.18 Aligned_cols=72 Identities=14% Similarity=0.278 Sum_probs=45.5
Q ss_pred eeeccCCcceEEEEEEeCC-CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe-eeeceeecCCCCCCcCcEEEE
Q 017231 45 IRPVGRGAYGIVCAAMNSE-TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv 122 (375)
++.|..|-...+|++.... .+..|++|+....... ......|+.+++.+...++ ++++.... . .++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~--------~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---IIDRERELRIHKLLSKHGLAPKLYATFQ-N--------GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---eecHHHHHHHHHHHHhCCCCCeEEEEeC-C--------cEE
Confidence 5778899999999997543 3568999977432111 1122368888888853333 44443321 1 379
Q ss_pred EeCCCC
Q 017231 123 YELMDT 128 (375)
Q Consensus 123 ~e~~~g 128 (375)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999976
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00023 Score=60.39 Aligned_cols=133 Identities=18% Similarity=0.284 Sum_probs=89.0
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcc--------------cchHHHHHHHHHHHHHHhcC------CCCeeee
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF--------------DNRIDAKRTLREIKLLRHMD------HENIIAI 104 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~~iv~~ 104 (375)
...||+|+.-.||.- +.+ ...+||+..... ..........+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P~d-p~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDD-PNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--CCC-CCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 456999999999986 332 457899886553 01112344555555555554 8899999
Q ss_pred ceeecCCCCCCcCcEEEEEeCC---CC----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe
Q 017231 105 KDIIRPPQRETFNDVYIVYELM---DT----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 177 (375)
Q Consensus 105 ~~~~~~~~~~~~~~~~lv~e~~---~g----~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~ 177 (375)
++....+ -..-+|+|.+ +| +|.+++.. +.++. ... ..+-+-..+|-+.+|+.+|++|.||++.
T Consensus 83 ~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 83 YGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred eEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEE
Confidence 9998655 3456777765 23 68888854 44666 333 3444556678899999999999999996
Q ss_pred cCC----CEEEee-cccc
Q 017231 178 ANC----DLKIGD-FGLA 190 (375)
Q Consensus 178 ~~~----~i~l~D-f~~~ 190 (375)
.+. .++|+| ||..
T Consensus 153 ~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred ecCCCceEEEEEeCCCCc
Confidence 543 578887 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00045 Score=64.97 Aligned_cols=84 Identities=15% Similarity=0.166 Sum_probs=56.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc----cc-hHHHHHHHHHHHHHHhcC---CCCeeeeceeecCCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF----DN-RIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRET 115 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~-~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 115 (375)
-++.||.|....||.+.+...++.++||...... .. ....++...|...|..+. -.++++++.+-.
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~------ 103 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE------ 103 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC------
Confidence 3678999999999999987554689999853211 11 124566777888888873 245666666532
Q ss_pred cCcEEEEEeCCCC--CHHHHH
Q 017231 116 FNDVYIVYELMDT--DLHQII 134 (375)
Q Consensus 116 ~~~~~lv~e~~~g--~L~~~l 134 (375)
...++|||++++ .+.+.+
T Consensus 104 -~~~~lVME~L~~~~~lr~~L 123 (401)
T PRK09550 104 -ELAVTVMEDLSDHKILRKGL 123 (401)
T ss_pred -CCCEEEEecCCCccHHHHHH
Confidence 224899999974 344443
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00011 Score=66.96 Aligned_cols=143 Identities=20% Similarity=0.213 Sum_probs=98.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-----------------------cchHH-HHHHHHHHHHHHhcCC
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-----------------------DNRID-AKRTLREIKLLRHMDH 98 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----------------------~~~~~-~~~~~~e~~~l~~l~h 98 (375)
.|-..|..|--+.||.|.. .+|..+|||+++-+. ..+.. .--...|++-|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3567788999999999985 557789999873221 11111 1123468899999987
Q ss_pred CCeeeeceeecCCCCCCcCcEEEEEeCCC--CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceE
Q 017231 99 ENIIAIKDIIRPPQRETFNDVYIVYELMD--TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH-SANVLHRDLKPSNLL 175 (375)
Q Consensus 99 ~~iv~~~~~~~~~~~~~~~~~~lv~e~~~--g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh-~~~i~H~di~p~NIl 175 (375)
..|+-.--+..-. -+|||++++ |--...|+ ...++...+..+-.+++.-+.-|- .++++|.||+--|+|
T Consensus 226 aGIP~PePIlLk~-------hVLVM~FlGrdgw~aPkLK-d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 226 AGIPCPEPILLKN-------HVLVMEFLGRDGWAAPKLK-DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL 297 (520)
T ss_pred cCCCCCCceeeec-------ceEeeeeccCCCCcCcccc-cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence 7754333333222 379999997 32222222 245788888888888888777765 569999999999999
Q ss_pred EecCCCEEEeecccccccCC
Q 017231 176 LNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 176 i~~~~~i~l~Df~~~~~~~~ 195 (375)
+ -+|.++++|.+.+.....
T Consensus 298 y-hdG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 298 Y-HDGKLYIIDVSQSVEHDH 316 (520)
T ss_pred E-ECCEEEEEEccccccCCC
Confidence 9 568999999987755443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=4.1e-05 Score=68.43 Aligned_cols=137 Identities=15% Similarity=0.178 Sum_probs=93.3
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecC-----------------cc-cc--hHHHHHHHHHHHHHHhcCC-C-
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGN-----------------AF-DN--RIDAKRTLREIKLLRHMDH-E- 99 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-----------------~~-~~--~~~~~~~~~e~~~l~~l~h-~- 99 (375)
..++++||-|--+.||++-+.. |.+.++|+-.. .. .+ .-..-...+|...|+.|.. .
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4579999999999999998654 67888885310 00 00 1111223567788887743 2
Q ss_pred CeeeeceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec
Q 017231 100 NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 178 (375)
Q Consensus 100 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~ 178 (375)
-+++.+++ +.-++|||++.| .|...-+ ...+..+...++..+..|-.+|++|||.+--||+++.
T Consensus 173 pVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PVPKPIDH---------NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCcccc---------cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence 23344443 345899999986 5554321 2223345566666677889999999999999999999
Q ss_pred CCCEEEeecccccccC
Q 017231 179 NCDLKIGDFGLARTTS 194 (375)
Q Consensus 179 ~~~i~l~Df~~~~~~~ 194 (375)
++.++++||-.....+
T Consensus 238 d~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVSTS 253 (465)
T ss_pred CCCEEEeechHhhccC
Confidence 9999999998654433
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00021 Score=63.57 Aligned_cols=134 Identities=16% Similarity=0.168 Sum_probs=75.3
Q ss_pred eccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe-eeeceeecCCCCCCcCcEEEEEeC
Q 017231 47 PVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRETFNDVYIVYEL 125 (375)
Q Consensus 47 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~e~ 125 (375)
.+..|-...+|++. .++..+++|......... .-....|..+++.+....+ ++++... . -++|+||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~-------~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--E-------HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--C-------CEEEEEe
Confidence 46678888999996 456789999764321111 0123578888888854333 3333332 1 1589999
Q ss_pred CCC-CHH--------------HHHH---hC----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcc
Q 017231 126 MDT-DLH--------------QIIR---SH----QDLTDD-HCRYFLYQL---------LRGLKYVHS--------ANVL 165 (375)
Q Consensus 126 ~~g-~L~--------------~~l~---~~----~~l~~~-~~~~i~~qi---------~~al~~Lh~--------~~i~ 165 (375)
++| .+. +.+. .. .+++.. .+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 976 321 1111 11 111211 111211111 111222221 2489
Q ss_pred ccCCCCCceEEecCCCEEEeecccccccC
Q 017231 166 HRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 166 H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
|+|+.|.||+++.++ +.|+||+.+....
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~gd 177 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASDGD 177 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCcCC
Confidence 999999999998877 7899999875433
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00032 Score=59.15 Aligned_cols=98 Identities=18% Similarity=0.135 Sum_probs=77.1
Q ss_pred HHHHHHHHhcCC-CCeeeeceeecCCCCCCcCcEEEEEeCCC-CCHHH---HHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 017231 87 LREIKLLRHMDH-ENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQ---IIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161 (375)
Q Consensus 87 ~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~---~l~~~~~l~~~~~~~i~~qi~~al~~Lh~ 161 (375)
..|.-++..+++ ++++++++.+ ++ +++.||.+ +++.. .+...-..++..+.+|+.++++.+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--------G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--------GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--------CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 358888888875 6999999988 22 57889987 44432 11222347999999999999999999997
Q ss_pred C---CccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 162 A---NVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 162 ~---~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
. .+.-.|++++|+.++.+|+++++|.+.+...
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 3 4777899999999999999999999977544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00046 Score=62.82 Aligned_cols=140 Identities=14% Similarity=0.065 Sum_probs=79.7
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCC--eeeeceeecCCC-CCCcCcEEE
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQ-RETFNDVYI 121 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~-~~~~~~~~l 121 (375)
++.|..|....+|.+.. .+..+++|+... .....+..|+.++..+...+ +++++....... ....+..++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 77888898889999864 335799998753 12344667788887774333 344433211000 011244688
Q ss_pred EEeCCCC-CHH-----------HHH---Hh-CCCC----------CHHHH----------HHHHHHHHHHHHHHHh----
Q 017231 122 VYELMDT-DLH-----------QII---RS-HQDL----------TDDHC----------RYFLYQLLRGLKYVHS---- 161 (375)
Q Consensus 122 v~e~~~g-~L~-----------~~l---~~-~~~l----------~~~~~----------~~i~~qi~~al~~Lh~---- 161 (375)
++++++| .+. ..+ +. ...+ ..... ......+..++..+.+
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9999976 210 001 00 0000 00000 0011112333444443
Q ss_pred ---CCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 162 ---ANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 162 ---~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.+++|+|++|.||+++.++.+.|+||+.+.
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 369999999999999987777899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.56 E-value=1.8e-05 Score=83.02 Aligned_cols=158 Identities=19% Similarity=0.143 Sum_probs=112.8
Q ss_pred HHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHH
Q 017231 82 DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----QDLTDDHCRYFLYQLLRGL 156 (375)
Q Consensus 82 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qi~~al 156 (375)
..+....|...++...|+++...+.-...... ...+..++++. |.+.+.+.++ ..+...-+.....+.+.+.
T Consensus 1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s---~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~ 1348 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSES---TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNR 1348 (2724)
T ss_pred HHHhhhhhhhhhhhhhceeeecccccCCCCCC---hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhcc
Confidence 34445556666667789998877665544322 44678999996 7999888654 2233333333333335566
Q ss_pred HHHHhC-C----ccccCCCCCceEEecCCCEEEeeccccc-ccCCCCccccccccccccCchhcccCCCCCccchhHHHH
Q 017231 157 KYVHSA-N----VLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVG 230 (375)
Q Consensus 157 ~~Lh~~-~----i~H~di~p~NIli~~~~~i~l~Df~~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 230 (375)
.-+|+. + .+|.++++-|.+|..+.+++++++|+.+ ............+++.|+.|+.... -.++.++|+|..|
T Consensus 1349 ~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1349 NVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRS 1427 (2724)
T ss_pred chhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHH
Confidence 666644 2 7889999999999999999999999998 3333344556677888888887765 5677779999999
Q ss_pred HHHHHHhhCCCCC
Q 017231 231 CILGEIMTRQPLF 243 (375)
Q Consensus 231 ~il~~l~~g~~pf 243 (375)
+.+|.+..|..+|
T Consensus 1428 ~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHhcccHHH
Confidence 9999999888777
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0021 Score=59.22 Aligned_cols=29 Identities=31% Similarity=0.337 Sum_probs=25.0
Q ss_pred CccccCCCCCceEEecCCCEEEeeccccc
Q 017231 163 NVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
+++|+|++|+||+++.+...-++||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 79999999999999866556899999763
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00025 Score=67.16 Aligned_cols=175 Identities=22% Similarity=0.266 Sum_probs=111.6
Q ss_pred HHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 017231 83 AKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162 (375)
Q Consensus 83 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~ 162 (375)
...+.-..++++.+.|++...++++-.... ....+|+|+++-+|.+.+.... +-..... .+
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~~--------------~~ 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESLL--------------AH 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhhc--------------cc
Confidence 344566788999999999999988765442 3378999999999999887654 2111111 11
Q ss_pred CccccCCCCCceEEecCCCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCC
Q 017231 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 242 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 242 (375)
|+.| .| .++.+| ..... | | .+..+++|||++|.++.++.-|...
T Consensus 87 ~~~~-----~~-------~~~~td-~~~t~---------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l 130 (725)
T KOG1093|consen 87 GVLH-----LN-------IIYITD-HFLTK---------------Y--P------SPIGPKSDVWSLGFIILELYLGISL 130 (725)
T ss_pred ccce-----eh-------hhhccc-ccccc---------------C--C------CCCCcchhhhhHHHHHHHHHHhhHH
Confidence 2111 12 223333 11100 0 1 1112499999999999999999988
Q ss_pred CCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHH
Q 017231 243 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 322 (375)
Q Consensus 243 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~el 322 (375)
+......+....+....... .......... .....++.....++.+|+-..|..||...++
T Consensus 131 ~~~~~~s~~l~~i~k~~~~d-~~~~~~a~e~------------------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 131 EAELTESEYLEILLKYYTDD-QELLSTAMEH------------------LIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHHHHHHHHHHHHhccCc-hhHHHHHHHH------------------HHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 87776666666665543221 1111110000 0012346668899999999999999999999
Q ss_pred hcCCCCCCC
Q 017231 323 LCHPYLAPL 331 (375)
Q Consensus 323 l~~~~f~~~ 331 (375)
.+++-|.++
T Consensus 192 ~k~~i~~ev 200 (725)
T KOG1093|consen 192 SKRCSFTEV 200 (725)
T ss_pred hcCccHHHH
Confidence 999999877
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0013 Score=60.14 Aligned_cols=142 Identities=13% Similarity=0.126 Sum_probs=79.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCC--eeeeceeecCCC-CCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQ-RETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~-~~~~~~~~ 120 (375)
.++.++.|....+|.+... +..+++|+..... ....+..|+.++..|...+ +++++....... ....+..+
T Consensus 26 ~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred eccccCCccccceEEEEeC--CCcEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 4778888888899998642 3368899874421 1233456677777774333 334433211100 01124578
Q ss_pred EEEeCCCCC-H----HH-------HH---Hh-CCCCC-------HHHHHH----------------HHHHHHHHHHHHHh
Q 017231 121 IVYELMDTD-L----HQ-------II---RS-HQDLT-------DDHCRY----------------FLYQLLRGLKYVHS 161 (375)
Q Consensus 121 lv~e~~~g~-L----~~-------~l---~~-~~~l~-------~~~~~~----------------i~~qi~~al~~Lh~ 161 (375)
++++|++|. + .+ .+ +. ...++ ....+. ....+...+.++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999762 1 11 11 10 01110 001000 01122334444432
Q ss_pred -------CCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 162 -------ANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 162 -------~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.+++|+|+++.||+++.++...|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 579999999999999988777899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0017 Score=59.34 Aligned_cols=72 Identities=13% Similarity=0.203 Sum_probs=44.7
Q ss_pred eeeccCCcceEEEEEEeCC------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe-eeeceeecCCCCCCcC
Q 017231 45 IRPVGRGAYGIVCAAMNSE------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRETFN 117 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~ 117 (375)
++.|..|-...+|++.... .++.|++|+...... .......|..++..+...++ ++++..+..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~------- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE---LLIDRERELVVFARLSERNLGPKLYGIFPN------- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc---ceechHHHHHHHHHHHhCCCCCceEEEeCC-------
Confidence 5667788888999997543 257899999754321 12234578888887753333 344444421
Q ss_pred cEEEEEeCCCC
Q 017231 118 DVYIVYELMDT 128 (375)
Q Consensus 118 ~~~lv~e~~~g 128 (375)
.+|++|++|
T Consensus 73 --~~v~e~i~G 81 (302)
T cd05156 73 --GRIEEFIPS 81 (302)
T ss_pred --CchhheeCC
Confidence 257888765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0021 Score=59.33 Aligned_cols=83 Identities=14% Similarity=0.055 Sum_probs=52.7
Q ss_pred eeccCCcceEEEEEEeCCCCcEEEEEEecCc----c-cchHHHHHHHHHHHHHHhcC--CCC-eeeeceeecCCCCCCcC
Q 017231 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNA----F-DNRIDAKRTLREIKLLRHMD--HEN-IIAIKDIIRPPQRETFN 117 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~-~~~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~~~ 117 (375)
+.||.|....||.+.+...++.|+||.-..- . .-.....+...|...|+... .|. +++++.+-. .
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~-------e 73 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDT-------E 73 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEcc-------c
Confidence 3589999999999998654468999975321 1 11334556667888887763 453 444444331 2
Q ss_pred cEEEEEeCCCC--CHHHHHH
Q 017231 118 DVYIVYELMDT--DLHQIIR 135 (375)
Q Consensus 118 ~~~lv~e~~~g--~L~~~l~ 135 (375)
...+|||+++. .|++.+.
T Consensus 74 ~~~~vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 74 MAVTVMEDLSHHKIARKGLI 93 (370)
T ss_pred cceehHhhCccchHHHHHHH
Confidence 24689999963 5555553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0039 Score=56.73 Aligned_cols=147 Identities=12% Similarity=0.144 Sum_probs=84.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCee--eeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII--AIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv--~~~~~~~~~~~~~~~~~~l 121 (375)
+++.+..|.-..+|...+. ++.++++ ...............+|+.+++.+.---+. ..++++... . .+..+.
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~--~-~g~pf~ 102 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEG--Y-LGTPFY 102 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccC--C-CCCceE
Confidence 4555555555555666544 7789998 332223334456667888888887533333 334444332 2 356799
Q ss_pred EEeCCCC-C------------------HHHHHHh---C-----------CCCCHHHHHHHHHHH--------------HH
Q 017231 122 VYELMDT-D------------------LHQIIRS---H-----------QDLTDDHCRYFLYQL--------------LR 154 (375)
Q Consensus 122 v~e~~~g-~------------------L~~~l~~---~-----------~~l~~~~~~~i~~qi--------------~~ 154 (375)
||++++| . |-+.|.. - ......++..+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 9999977 1 1111110 0 001122222222222 22
Q ss_pred HHHHHHhC--------CccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 155 GLKYVHSA--------NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 155 al~~Lh~~--------~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
...+++.+ .++|||+++.|++++..+.+-++||+.+......
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 34455533 4899999999999999999999999998765544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0049 Score=57.33 Aligned_cols=137 Identities=16% Similarity=0.187 Sum_probs=77.4
Q ss_pred CeeeccCCcceEEEEEEeCC----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe-eeeceeecCCCCCCcCc
Q 017231 44 PIRPVGRGAYGIVCAAMNSE----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRETFND 118 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~ 118 (375)
-++.|..|-...+|++.... .++.|++|+....... ... -..|..+++.+...++ +++++.+..
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~--~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-------- 108 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVEL--FFD-RDDEIRTFECMSRHGQGPRLLGRFPN-------- 108 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCe--eec-hHHHHHHHHHHHHcCCCCceEEEECC--------
Confidence 46777788899999997432 3468999987543211 111 2568888888854433 344555421
Q ss_pred EEEEEeCCCC-CHHH----------H----HH---hCC----C-C-CHHHHHHHHHHH-----------------HHHHH
Q 017231 119 VYIVYELMDT-DLHQ----------I----IR---SHQ----D-L-TDDHCRYFLYQL-----------------LRGLK 157 (375)
Q Consensus 119 ~~lv~e~~~g-~L~~----------~----l~---~~~----~-l-~~~~~~~i~~qi-----------------~~al~ 157 (375)
..|.+|++| ++.. . +. ... . . ....+..+..++ ...+.
T Consensus 109 -g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 109 -GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred -ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 147788764 3211 0 11 100 0 1 112222222111 11122
Q ss_pred HHH--------hCCccccCCCCCceEEec-CCCEEEeecccccc
Q 017231 158 YVH--------SANVLHRDLKPSNLLLNA-NCDLKIGDFGLART 192 (375)
Q Consensus 158 ~Lh--------~~~i~H~di~p~NIli~~-~~~i~l~Df~~~~~ 192 (375)
.|. ...++|+|+++.||+++. ++.+.++||..+..
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 221 225899999999999986 46799999998743
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0029 Score=59.19 Aligned_cols=85 Identities=15% Similarity=0.187 Sum_probs=55.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCc---ccc-hHHHHHHHHHHHHHHhcC--CCC-eeeeceeecCCCCCCc
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA---FDN-RIDAKRTLREIKLLRHMD--HEN-IIAIKDIIRPPQRETF 116 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~---~~~-~~~~~~~~~e~~~l~~l~--h~~-iv~~~~~~~~~~~~~~ 116 (375)
.++.||.|.-.-||.+.+...++.|+||.-..- ..+ ....++...|...|+... .|. +++++.+-.
T Consensus 33 ~~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~------- 105 (409)
T PRK12396 33 QCKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDS------- 105 (409)
T ss_pred eeeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECc-------
Confidence 378899999999999998544567999975321 111 334567778888888774 454 444544321
Q ss_pred CcEEEEEeCCCC--CHHHHHH
Q 017231 117 NDVYIVYELMDT--DLHQIIR 135 (375)
Q Consensus 117 ~~~~lv~e~~~g--~L~~~l~ 135 (375)
....+|||+++. .|++.+.
T Consensus 106 e~~~~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 106 VMNCCVMEDLSDHTILRTALI 126 (409)
T ss_pred HHhhHHHHhCcccHHHHHHHH
Confidence 223688998863 4555553
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0057 Score=55.01 Aligned_cols=31 Identities=23% Similarity=0.468 Sum_probs=25.6
Q ss_pred CccccCCCCCceEEecCCC-EEEeeccccccc
Q 017231 163 NVLHRDLKPSNLLLNANCD-LKIGDFGLARTT 193 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~-i~l~Df~~~~~~ 193 (375)
.++|||++|.||+++.+++ .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999987566 469999987443
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0043 Score=57.40 Aligned_cols=73 Identities=10% Similarity=0.226 Sum_probs=44.3
Q ss_pred CeeeccCCcceEEEEEEeCCC---CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe-eeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAMNSET---REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~ 119 (375)
-++.|..|-...+|++..... +..|++|+....... .-.-..|..+++.+..-++ +++++.+. +
T Consensus 18 ~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~---~IdR~~E~~il~~l~~~gl~P~~l~~~~-~-------- 85 (330)
T PLN02421 18 SVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY---VIDRERELQAIKYLSAAGFGAKLLGVFG-N-------- 85 (330)
T ss_pred EEEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe---EechHHHHHHHHHHHhcCCCCceeEEeC-C--------
Confidence 467777788889999975432 348999987543211 1122468888888864444 34554442 1
Q ss_pred EEEEeCCCC
Q 017231 120 YIVYELMDT 128 (375)
Q Consensus 120 ~lv~e~~~g 128 (375)
.+|.+|++|
T Consensus 86 G~i~~fi~g 94 (330)
T PLN02421 86 GMIQSFINA 94 (330)
T ss_pred cEeehhhcC
Confidence 147777764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.019 Score=54.12 Aligned_cols=76 Identities=18% Similarity=0.237 Sum_probs=50.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc--cch---HHHHHHHHHHHHHHhcC---CCCeeeeceeecCCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF--DNR---IDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRET 115 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~---~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~ 115 (375)
-++.||.|....||.+.+. +..++||.-..-. ... ....+...|+..|+.+. -..+++++.+..+.
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~---- 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM---- 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC----
Confidence 4788999999999999873 4569999864211 111 13444455677777663 24677777776432
Q ss_pred cCcEEEEEeCCCC
Q 017231 116 FNDVYIVYELMDT 128 (375)
Q Consensus 116 ~~~~~lv~e~~~g 128 (375)
.+++||++++
T Consensus 110 ---~vlvME~L~~ 119 (418)
T PLN02756 110 ---ALIGMRYLEP 119 (418)
T ss_pred ---CEEEEeecCC
Confidence 3788999965
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.031 Score=51.13 Aligned_cols=28 Identities=25% Similarity=0.400 Sum_probs=25.0
Q ss_pred CCccccCCCCCceEEecCCCEEEeecccc
Q 017231 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 162 ~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
.+++|||+++.||+++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47899999999999987 67899999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.017 Score=52.86 Aligned_cols=30 Identities=20% Similarity=0.169 Sum_probs=27.3
Q ss_pred CccccCCCCCceEEecCCCEEEeecccccc
Q 017231 163 NVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
+++|+|+.++||+++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 699999999999999999999999987643
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.026 Score=53.13 Aligned_cols=73 Identities=15% Similarity=0.170 Sum_probs=43.5
Q ss_pred CeeeccCCcceEEEEEEeCCC-Cc-----EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe-eeeceeecCCCCCCc
Q 017231 44 PIRPVGRGAYGIVCAAMNSET-RE-----EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRETF 116 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~-~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~ 116 (375)
.++.|..|-...+|++..... +. .|+++..... ....-.-..|+.+++.+...++ +++++.+..
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~---~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------ 124 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY---NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------ 124 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC---CceEeccHHHHHHHHHHHhCCCCCeEEEecCC------
Confidence 567787899999999975432 12 2444443111 1111122468889999865544 455665521
Q ss_pred CcEEEEEeCCCC
Q 017231 117 NDVYIVYELMDT 128 (375)
Q Consensus 117 ~~~~lv~e~~~g 128 (375)
+++.||++|
T Consensus 125 ---g~l~efIeG 133 (383)
T PTZ00384 125 ---FTIQEWVEG 133 (383)
T ss_pred ---EEEEEEecc
Confidence 589999976
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.021 Score=51.97 Aligned_cols=108 Identities=11% Similarity=0.090 Sum_probs=72.4
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCC---CCeeeeceeecCCCCCCcCc
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH---ENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~iv~~~~~~~~~~~~~~~~ 118 (375)
+.-++.||+|..+.||...... ..+++|..+.. .....+..|...|+.|.. -.++++++.+.... ..+.
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~--~~~~~k~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~ 87 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ--GNPMPLMARSF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGP 87 (297)
T ss_pred hheeeecCCccceeEEEEEcCC--CCEEEEEeccc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCC
Confidence 3357889999999999996433 25777875321 123467789999998853 35677777665431 1244
Q ss_pred EEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 017231 119 VYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162 (375)
Q Consensus 119 ~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~ 162 (375)
.++|||+++| ++.+. ..+......+..+++.+|..||+.
T Consensus 88 ~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 88 DVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 7999999986 45431 133445566777888888888874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.022 Score=52.25 Aligned_cols=108 Identities=17% Similarity=0.249 Sum_probs=74.7
Q ss_pred CcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 117 NDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 117 ~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
-+.|++|++-++++.-. +.....++..++.+.+..+.-+... ..-|+|+..+||+|+ +|+|.|+||.+++....
T Consensus 299 ~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~ 373 (488)
T COG5072 299 LYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS 373 (488)
T ss_pred eEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccC
Confidence 45678888887655322 2356778888888888887777754 799999999999999 99999999999975433
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHH
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGE 235 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 235 (375)
... ......-.|-.+.| .-+..-+||-+--.+.-
T Consensus 374 q~~----isy~rldhp~lF~G--~dd~QFeIYrlMr~l~~ 407 (488)
T COG5072 374 QGI----ISYNRLDHPDLFNG--VDDYQFEIYRLMRRLLK 407 (488)
T ss_pred Cce----eeccccCchhhhcC--ccceeeeHHHHHHHHhc
Confidence 321 11222345555655 33778888876544433
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.026 Score=50.96 Aligned_cols=73 Identities=12% Similarity=0.109 Sum_probs=45.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC---CCCeeeeceeecCCCCCCcCcE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+-++.|+.|....+|.+. .+++.+.+|+-. ......+..|..-|+.|. .-.+++++.+....+ ..
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~-----~~ 87 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD-----DA 87 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS-----CC
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC-----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC-----Cc
Confidence 346789999999999996 677899999864 223345678888888883 445667777764432 23
Q ss_pred EEEEeCCC
Q 017231 120 YIVYELMD 127 (375)
Q Consensus 120 ~lv~e~~~ 127 (375)
+++|||++
T Consensus 88 fLlle~l~ 95 (288)
T PF03881_consen 88 FLLLEFLE 95 (288)
T ss_dssp EEEEE---
T ss_pred eEEEEeec
Confidence 89999986
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.05 Score=46.73 Aligned_cols=28 Identities=39% Similarity=0.673 Sum_probs=20.5
Q ss_pred CccccCCCCCceEE-ecCCCEEEeecccc
Q 017231 163 NVLHRDLKPSNLLL-NANCDLKIGDFGLA 190 (375)
Q Consensus 163 ~i~H~di~p~NIli-~~~~~i~l~Df~~~ 190 (375)
.++|+|+.+.||++ +.++.++|+||..+
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya 172 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYA 172 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHH
Confidence 49999999999999 88999999999877
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.079 Score=50.94 Aligned_cols=78 Identities=14% Similarity=0.163 Sum_probs=46.7
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCC--------CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe-eeeceee
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSET--------REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDII 108 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~ 108 (375)
....+ -++.|..|-.-.+|++..... ++.|++++.......- -.-..|..+++.+...++ .++++.+
T Consensus 104 ~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l---IdR~~E~~v~~~ls~~gi~P~l~~~f 179 (442)
T PTZ00296 104 TEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL---YNPISEFEVYKTMSKYRIAPQLLNTF 179 (442)
T ss_pred CcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce---eCHHHHHHHHHHHHHCCCCCceEEEe
Confidence 33445 678888888889999975422 5689999874422111 122357777777653333 2445544
Q ss_pred cCCCCCCcCcEEEEEeCCCC
Q 017231 109 RPPQRETFNDVYIVYELMDT 128 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~g 128 (375)
. + ..+.+|++|
T Consensus 180 ~-g--------g~I~efi~g 190 (442)
T PTZ00296 180 S-G--------GRIEEWLYG 190 (442)
T ss_pred C-C--------CEEEEeeCC
Confidence 2 1 357888875
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.25 Score=42.67 Aligned_cols=73 Identities=12% Similarity=0.100 Sum_probs=49.0
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCC---CeeeeceeecCCCCCCcCcE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE---NIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~ 119 (375)
+-.+.+..|.--..|.+.+- ..+|.+|+- .......+..|+.-|+.|.-. .+.+++.... ..++.
T Consensus 19 ~er~~v~gG~inea~~v~dg--~~~~FvK~n-----~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~-----~~~~s 86 (286)
T COG3001 19 KEREEVSGGDINEAWRLRDG--TDPFFVKCN-----QREQLSMFTAEADGLELLARSNTITVPKVIAVGA-----SRDHS 86 (286)
T ss_pred hcccccCCccccceeEeecC--CcceEEEec-----chhhHHHHHHHHHHHHHHHhcCCccccceEEecC-----CCCee
Confidence 34567777777777888543 357888875 233456677888888877544 4555555543 33678
Q ss_pred EEEEeCCC
Q 017231 120 YIVYELMD 127 (375)
Q Consensus 120 ~lv~e~~~ 127 (375)
|+|+||.+
T Consensus 87 ylVle~L~ 94 (286)
T COG3001 87 YLVLEYLP 94 (286)
T ss_pred EEEEeecc
Confidence 99999996
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.95 Score=41.76 Aligned_cols=27 Identities=30% Similarity=0.351 Sum_probs=23.2
Q ss_pred CCccccCCCCCceEEecCCCEEEeecccc
Q 017231 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 162 ~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
.+++|+|+.++||+++ + .+.++||+.+
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~ 222 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDA 222 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCC
Confidence 3689999999999995 4 5889999976
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.90 E-value=0.98 Score=48.41 Aligned_cols=31 Identities=35% Similarity=0.523 Sum_probs=25.9
Q ss_pred CCccccCCCCCceEEecCC--CEE-Eeecccccc
Q 017231 162 ANVLHRDLKPSNLLLNANC--DLK-IGDFGLART 192 (375)
Q Consensus 162 ~~i~H~di~p~NIli~~~~--~i~-l~Df~~~~~ 192 (375)
.+++|+|++++||+++.++ ++. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999998875 555 999997743
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.21 Score=42.88 Aligned_cols=84 Identities=19% Similarity=0.270 Sum_probs=56.0
Q ss_pred HHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 017231 85 RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA- 162 (375)
Q Consensus 85 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~- 162 (375)
-+..+.+++.++. .|+++.. .....+-++.|.|-. ... ...++..=+.+|..+|+.
T Consensus 104 ~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~-------------~~N~i~agi~~L~~fH~~~ 161 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKIN-------------FSNFITAGIKDLMDFHSEN 161 (308)
T ss_pred hhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccc-------------hhHHHHHhHHHHHHhhccC
Confidence 3466778877763 4555541 122447799999953 110 011222224667788844
Q ss_pred -CccccCCCCCceEEecCCCEEEeecccc
Q 017231 163 -NVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 163 -~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
+..|||-.|+|||-|+.|.+||.|-++.
T Consensus 162 ~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 162 QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred CCeecCCCChhheeecCCCCEEecChhhh
Confidence 6999999999999999999999997754
|
The function of this family is unknown. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.061 Score=45.02 Aligned_cols=31 Identities=29% Similarity=0.401 Sum_probs=26.3
Q ss_pred CccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
-.+|+|+.|.||++..+| ++|+||+.+...+
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gD 108 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDGD 108 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccCCC
Confidence 379999999999998776 9999999885443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 375 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-99 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-99 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-99 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-98 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-98 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-98 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-98 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-98 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-98 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-98 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-98 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-98 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-98 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-98 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-98 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-98 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-97 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-97 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-97 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-97 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-97 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-97 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-97 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-97 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-96 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-96 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-95 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-95 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-95 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-95 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-95 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-95 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-95 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-95 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-95 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-95 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-95 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-95 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-95 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-95 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-95 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-95 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-95 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-95 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-95 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-95 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-95 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-95 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-95 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-95 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-95 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-95 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-95 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-95 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-95 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-95 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-95 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-95 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-95 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-95 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-95 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-95 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-94 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-94 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-94 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-94 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-94 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-94 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-94 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-94 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-94 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-94 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-94 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-94 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-94 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-94 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-94 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-94 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-94 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-94 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-94 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-94 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-94 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-94 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-93 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-93 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-93 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-92 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-89 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-88 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-88 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-86 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-86 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-84 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-74 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-74 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-72 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-72 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-72 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-72 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-72 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-72 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-72 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-72 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-72 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-72 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-72 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-72 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-72 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-72 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-71 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-71 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-71 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-71 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-71 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-71 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-71 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-71 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-70 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-70 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-70 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-70 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-70 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-69 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-69 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-68 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-67 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-67 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-63 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-61 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-60 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-59 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-59 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-54 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-53 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-53 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-53 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-53 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-53 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-53 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-53 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-53 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-53 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-53 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-53 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-53 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-53 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-53 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-53 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-53 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-53 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-53 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-53 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-53 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-53 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-53 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-53 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-53 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-53 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-53 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-53 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-53 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-53 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-53 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-53 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-53 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-52 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-52 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-50 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-50 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-48 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-47 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-47 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-47 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-46 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-46 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-46 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-45 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-44 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-44 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-43 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-43 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-42 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-42 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-42 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 9e-42 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-41 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-41 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-41 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-41 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-41 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-41 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-41 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-41 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-41 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-41 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-41 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-41 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-41 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-40 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-40 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-40 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-40 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-40 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-40 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-40 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-40 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-40 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-40 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-40 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-40 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-39 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-39 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-39 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-39 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-37 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-34 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-31 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-31 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-31 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 9e-31 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-30 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-30 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-30 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-29 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-29 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-29 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-29 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-29 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-29 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-29 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-29 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-29 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-29 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-29 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-29 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-28 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-28 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-28 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-28 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-28 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-28 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-28 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-28 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-28 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-28 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-28 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-28 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-28 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-27 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-27 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-27 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-26 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-26 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-26 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-26 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-26 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-26 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-26 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-26 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-26 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-26 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-26 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-26 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-26 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-25 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-24 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-23 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-23 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-23 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-23 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-23 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-23 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-23 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-23 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-23 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-23 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 9e-23 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-23 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-22 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-22 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-22 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-22 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-22 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-22 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-22 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-22 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-22 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-21 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-21 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-21 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-21 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-21 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-21 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-21 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-21 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-21 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-21 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-21 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-21 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-20 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-20 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-20 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-20 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-20 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-20 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-20 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-20 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-20 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-20 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-20 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-20 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-20 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 9e-20 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-19 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-19 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-19 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-19 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-19 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-19 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-19 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-19 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-19 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-19 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-19 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-19 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-19 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-19 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-19 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-19 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-19 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-19 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-19 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-19 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-19 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-19 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-19 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-19 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-19 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-19 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-19 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-18 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-18 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-18 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-18 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-18 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-18 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-18 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-18 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-18 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-18 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-18 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-18 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-18 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-18 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-18 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-18 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-18 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-18 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-18 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-18 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-18 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-18 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-18 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-17 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-17 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-17 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-17 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-17 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-16 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-16 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-16 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-16 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-16 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-16 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-16 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-16 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-15 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-15 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-15 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-15 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-15 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-15 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-15 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-15 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-15 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-15 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 8e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-15 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 9e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-15 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-14 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-14 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-14 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-14 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-14 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-14 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-14 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-14 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-14 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-14 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-14 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-14 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-14 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-14 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-14 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-14 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-14 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-14 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-14 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-14 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-14 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-14 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-14 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-14 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-14 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-14 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-14 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-13 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-13 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-13 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-13 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 8e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-13 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-13 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 8e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-13 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 9e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-12 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-12 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-11 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-11 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-10 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-10 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-09 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 375 | |||
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 0.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 0.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 0.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 0.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 0.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 0.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 0.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 0.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 0.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 0.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 0.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 0.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 0.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 1e-176 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 1e-174 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 1e-173 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-170 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-136 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-122 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 1e-111 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-111 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-110 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-110 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-109 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-109 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-109 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-107 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-107 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-107 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 1e-106 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 7e-94 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-64 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-64 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 9e-64 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-62 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-62 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-61 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-61 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 8e-61 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-60 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-60 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-60 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 3e-60 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 3e-60 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 5e-60 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 9e-60 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 1e-59 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-59 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 6e-59 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-59 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 9e-59 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-58 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-58 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-58 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-58 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-58 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-57 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-57 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 8e-57 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-56 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-56 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 2e-56 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 2e-56 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 3e-56 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 6e-56 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 7e-56 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-55 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-55 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-55 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 5e-55 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-55 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-54 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 5e-54 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 9e-54 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-53 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 1e-53 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-53 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-53 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 4e-53 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 7e-53 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-51 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 2e-51 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-51 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 2e-51 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-51 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 9e-51 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-50 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-50 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-50 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-50 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-49 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 6e-49 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 8e-49 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-48 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 8e-48 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-47 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-47 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 2e-47 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-47 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-47 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 1e-46 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-46 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-46 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-46 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-46 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 9e-46 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 1e-45 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 5e-45 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 5e-45 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 8e-45 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-44 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-43 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-42 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 4e-42 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-41 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 8e-40 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 6e-39 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-37 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-37 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 3e-37 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 4e-37 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 5e-37 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 7e-37 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 2e-36 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-36 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-36 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-36 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-36 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 8e-36 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-35 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 4e-35 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 4e-35 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-35 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 9e-35 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-34 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-34 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 1e-34 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-33 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-33 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-33 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-31 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-31 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-31 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-31 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 5e-31 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 9e-31 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-30 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-30 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-29 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-29 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 2e-29 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-29 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 9e-29 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 1e-28 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-28 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-28 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-28 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 4e-28 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 4e-28 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-28 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 7e-28 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 8e-28 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 9e-28 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-27 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-27 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-27 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-27 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-27 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-27 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-27 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-27 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 4e-27 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-27 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 7e-27 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 9e-27 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-26 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-26 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-26 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-26 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-26 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-26 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 8e-26 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-25 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-25 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-25 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-25 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-25 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-25 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-25 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 5e-25 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 6e-25 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-25 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 8e-25 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-24 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-24 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-24 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 8e-24 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 8e-23 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 9e-23 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-22 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-22 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 3e-22 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 5e-22 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-22 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 9e-22 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-21 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-21 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 2e-21 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-21 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-21 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 9e-21 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 9e-21 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-20 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-20 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 2e-20 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-20 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 2e-20 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-20 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-20 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 5e-20 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 5e-20 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 7e-20 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 7e-20 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-19 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-16 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-15 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-14 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-13 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 4e-12 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 4e-12 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 8e-12 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 8e-12 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 3e-11 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 5e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-06 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 2e-05 |
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 621 bits (1604), Expect = 0.0
Identities = 179/351 (50%), Positives = 241/351 (68%), Gaps = 7/351 (1%)
Query: 26 VQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR 85
V G +F+V +Y + +G GAYG+VC+A ++ + VAIKKI + F+++ +R
Sbjct: 14 GPEMVRGQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQR 71
Query: 86 TLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHC 145
TLREIK+L HENII I DIIR P E DVYIV +LM+TDL++++++ Q L++DH
Sbjct: 72 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHI 130
Query: 146 RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS----ETDFMTE 201
YFLYQ+LRGLKY+HSANVLHRDLKPSNLLLN CDLKI DFGLAR T F+TE
Sbjct: 131 CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190
Query: 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 261
YV TRWYRAPE++LN YT +IDIWSVGCIL E+++ +P+FPGK Y+ QL I ++GS
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 250
Query: 262 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 321
P + L + + AR Y+ LP K ++ FPN A+DLL+KML F+P++RI V++
Sbjct: 251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 310
Query: 322 ALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPD 372
AL HPYL +D ++EP+ PF FD E +E +KELI+ E+ +F P
Sbjct: 311 ALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG 361
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 615 bits (1589), Expect = 0.0
Identities = 128/362 (35%), Positives = 191/362 (52%), Gaps = 14/362 (3%)
Query: 20 THGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA--- 76
G ++ L + Y R + G+YG VCA ++SE VAIK++ N
Sbjct: 3 QAKGEAAMRDLIAELHAMQSPYTV-QRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVSD 60
Query: 77 ------FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDL 130
+ KR LREI+LL H H NI+ ++DI + + +Y+V ELM TDL
Sbjct: 61 GRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDL 120
Query: 131 HQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189
Q+I + ++ H +YF+Y +L GL +H A V+HRDL P N+LL N D+ I DF L
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180
Query: 190 ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 249
AR + T YV RWYRAPEL++ +T +D+WS GC++ E+ R+ LF G +
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240
Query: 250 HQLRLITELIGSPDETSLGFLRSDNARRYVR-MLPQFPKQNFSARFPNKSPGAVDLLEKM 308
+QL I E++G+P + S +AR Y+R L P + ++A P P A+DL+ KM
Sbjct: 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300
Query: 309 LVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVK 368
L F+P RRI+ ++AL HPY L D + F F+ ++ ++ E +
Sbjct: 301 LEFNPQRRISTEQALRHPYFESLFDPLDLTEGL-SERFHFDESVTDVYDMHKIFTAEVER 359
Query: 369 FN 370
FN
Sbjct: 360 FN 361
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 611 bits (1577), Expect = 0.0
Identities = 155/353 (43%), Positives = 217/353 (61%), Gaps = 6/353 (1%)
Query: 20 THGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN 79
+ + +V +E+ + YV VG GAYG VC+A++ + E+VAIKK+ F +
Sbjct: 5 IRKKGFYKQDVNKTAWELPKTYVS-PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS 63
Query: 80 RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQ 138
I AKR RE+ LL+HM HEN+I + D+ P F D Y+V M TDL +I+
Sbjct: 64 EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--L 121
Query: 139 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198
+++ +Y +YQ+L+GLKY+HSA V+HRDLKP NL +N +C+LKI DFGLAR
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AE 179
Query: 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL 258
MT YVVTRWYRAPE++L+ Y +DIWSVGCI+ E++T + LF GKDY+ QL I ++
Sbjct: 180 MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 239
Query: 259 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 318
G P + L A+ Y++ LPQ P+++F+ FP SP A DLLEKML D ++R+T
Sbjct: 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 299
Query: 319 VDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
+AL HP+ P D EE +PF EH T + K+ IY+E V F+P
Sbjct: 300 AAQALTHPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 608 bits (1570), Expect = 0.0
Identities = 171/347 (49%), Positives = 229/347 (65%), Gaps = 19/347 (5%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
+ +S + +G GAYG+VC+A + T E VAIKKI FD + A RTLREIK+L+
Sbjct: 7 YNISSDFQL-KSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKILK 64
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLR 154
H HENII I +I RP E FN+VYI+ ELM TDLH++I + Q L+DDH +YF+YQ LR
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLR 123
Query: 155 GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-----------TSETDFMTEYV 203
+K +H +NV+HRDLKPSNLL+N+NCDLK+ DFGLAR T + M E+V
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP- 262
TRWYRAPE++L ++Y+ A+D+WS GCIL E+ R+P+FPG+DY HQL LI +IG+P
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243
Query: 263 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 322
+ L + S AR Y++ LP +P FP +P +DLL++MLVFDP +RIT EA
Sbjct: 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEA 303
Query: 323 LCHPYLAPLHDINEEPVC----PRPFSFDFEHPSFTEENIKELIYRE 365
L HPYL HD N+EP P F FD + T +++K+LI+ E
Sbjct: 304 LEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNE 350
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 611 bits (1577), Expect = 0.0
Identities = 137/403 (33%), Positives = 205/403 (50%), Gaps = 53/403 (13%)
Query: 22 GGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRI 81
GR Y V Y+ +GRG+YG V A + T + VAIKK+ F++ I
Sbjct: 9 SGRENLYFQGIKNVHVPDNYII-KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI 67
Query: 82 DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLT 141
D KR LREI +L + + II + D+I P F+++YIV E+ D+DL ++ ++ LT
Sbjct: 68 DCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT 127
Query: 142 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS------- 194
++H + LY LL G ++H + ++HRDLKP+N LLN +C +K+ DFGLART +
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 195 ----------------ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
+T +VVTRWYRAPEL+L YT +IDIWS GCI E++
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
Query: 239 -----------RQPLFPG-----------------KDYVHQLRLITELIGSPDETSLGFL 270
R PLFPG K QL +I +IG+P E L +
Sbjct: 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307
Query: 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330
+Y+++ P N ++P+ S ++LLE ML F+PN+RIT+D+AL HPYL
Sbjct: 308 NKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367
Query: 331 LHDINEEPVCPRPFSFDFE-HPSFTEENIKELIYRESVKFNPD 372
+ E + F+ +E ++ + +E F+P+
Sbjct: 368 VRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPE 410
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 608 bits (1569), Expect = 0.0
Identities = 171/350 (48%), Positives = 234/350 (66%), Gaps = 6/350 (1%)
Query: 25 YVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK 84
+ + + ++EV +Y + PVG GAYG VCAA +++T VA+KK+ F + I AK
Sbjct: 15 FYRQELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 73
Query: 85 RTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDD 143
RT RE++LL+HM HEN+I + D+ P + E FNDVY+V LM DL+ I++ Q LTDD
Sbjct: 74 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDD 132
Query: 144 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 203
H ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +C+LKI DFGLAR T+ D MT YV
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYV 190
Query: 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263
TRWYRAPE++LN Y +DIWSVGCI+ E++T + LFPG D++ QL+LI L+G+P
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250
Query: 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
L + S++AR Y++ L Q PK NF+ F +P AVDLLEKMLV D ++RIT +AL
Sbjct: 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310
Query: 324 CHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDP 373
H Y A HD ++EPV P+ E + K L Y E + F P P
Sbjct: 311 AHAYFAQYHDPDDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPPP 359
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 607 bits (1567), Expect = 0.0
Identities = 153/356 (42%), Positives = 226/356 (63%), Gaps = 7/356 (1%)
Query: 19 PTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD 78
P G + + V +EV Y ++PVG GAYG VC+A++ T +VAIKK+ F
Sbjct: 6 PARSG-FYRQEVTKTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 63
Query: 79 NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMDTDLHQIIRSH 137
+ + AKR RE++LL+HM HEN+I + D+ P + + F D Y+V M TDL ++++
Sbjct: 64 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH- 122
Query: 138 QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197
+ L +D ++ +YQ+L+GL+Y+H+A ++HRDLKP NL +N +C+LKI DFGLAR
Sbjct: 123 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--S 180
Query: 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 257
MT YVVTRWYRAPE++LN YT +DIWSVGCI+ E++T + LF G D++ QL+ I +
Sbjct: 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 240
Query: 258 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 317
+ G+P + L+SD A+ Y++ LP+ K++F++ N SP AV+LLEKMLV D +R+
Sbjct: 241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 300
Query: 318 TVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDP 373
T EAL HPY LHD +EP + F+ T + K + Y+E + F P
Sbjct: 301 TAGEALAHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPPR 355
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 597 bits (1542), Expect = 0.0
Identities = 139/431 (32%), Positives = 218/431 (50%), Gaps = 61/431 (14%)
Query: 2 SGESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMN 61
+ + SGS + + +++ +Y +G G+YG VC A +
Sbjct: 16 TQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEI-RHLIGTGSYGHVCEAYD 74
Query: 62 SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121
+ VAIKKI F++ ID KR LREI +L ++H++++ + DI+ P E F+++Y+
Sbjct: 75 KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134
Query: 122 VYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 181
V E+ D+D ++ R+ LT+ H + LY LL G+KYVHSA +LHRDLKP+N L+N +C
Sbjct: 135 VLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS 194
Query: 182 LKIGDFGLARTTSETD----------------------------FMTEYVVTRWYRAPEL 213
+K+ DFGLART + +T +VVTRWYRAPEL
Sbjct: 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL 254
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMT-----------RQPLFPGKDYV------------- 249
+L YT AID+WS+GCI E++ R PLFPG
Sbjct: 255 ILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFK 314
Query: 250 -------HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAV 302
QL +I ++G+P E + L ++A+RY+R+ P+ + + RFP S A+
Sbjct: 315 FHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAI 374
Query: 303 DLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFE-HPSFTEENIKEL 361
LL++MLVF+PN+RIT++E L HP+ + E F + E ++
Sbjct: 375 HLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYA 434
Query: 362 IYRESVKFNPD 372
+E +++P+
Sbjct: 435 FVKEIQRYHPE 445
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 583 bits (1505), Expect = 0.0
Identities = 137/378 (36%), Positives = 219/378 (57%), Gaps = 45/378 (11%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
V RKY ++ +G+GAYGIV +++ T E VA+KKI +AF N DA+RT REI +L
Sbjct: 5 RHVLRKYEL-VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63
Query: 95 HM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLL 153
+ HENI+ + +++R DVY+V++ M+TDLH +IR+ L H +Y +YQL+
Sbjct: 64 ELSGHENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLI 119
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART--------------------- 192
+ +KY+HS +LHRD+KPSN+LLNA C +K+ DFGL+R+
Sbjct: 120 KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179
Query: 193 -TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 251
+ +T+YV TRWYRAPE+LL ++YT ID+WS+GCILGEI+ +P+FPG ++Q
Sbjct: 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239
Query: 252 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF----------------P 295
L I +I P + ++S A+ + L + + S +
Sbjct: 240 LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKA 299
Query: 296 NKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDF-EHPSFT 354
+ + A+DLL+K+L F+PN+RI+ ++AL HP+++ H+ NEEP C + ++ +
Sbjct: 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHS 359
Query: 355 EENIKELIYRESVKFNPD 372
++ + L+Y E + +
Sbjct: 360 IDDYRNLVYSEISRRKRE 377
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 575 bits (1483), Expect = 0.0
Identities = 148/366 (40%), Positives = 215/366 (58%), Gaps = 19/366 (5%)
Query: 24 RYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDA 83
+ + + F V ++Y ++P+G GA GIVCAA ++ VAIKK+ F N+ A
Sbjct: 10 NFYSVEIGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHA 68
Query: 84 KRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMDTDLHQIIRSHQDLTD 142
KR RE+ L++ ++H+NII + ++ P + E F DVYIV ELMD +L Q+I+ +L
Sbjct: 69 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDH 126
Query: 143 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 202
+ Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART + MT Y
Sbjct: 127 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 186
Query: 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 262
VVTR+YRAPE++L Y +DIWSVGCI+GE++ LFPG D++ Q + E +G+P
Sbjct: 187 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 245
Query: 263 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN------------KSPGAVDLLEKMLV 310
+ L R YV P++ +F FP+ K+ A DLL KMLV
Sbjct: 246 CPEFMKKL-QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304
Query: 311 FDPNRRITVDEALCHPYLAPLHDINEEPVC-PRPFSFDFEHPSFTEENIKELIYRESVKF 369
D ++RI+VDEAL HPY+ +D +E P+ + T E KELIY+E +
Sbjct: 305 IDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDL 364
Query: 370 NPDPTH 375
H
Sbjct: 365 EHHHHH 370
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 574 bits (1481), Expect = 0.0
Identities = 148/363 (40%), Positives = 217/363 (59%), Gaps = 19/363 (5%)
Query: 23 GRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRID 82
++ V + F V ++Y ++P+G GA GIVCAA ++ VAIKK+ F N+
Sbjct: 46 NQFYSVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 104
Query: 83 AKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMDTDLHQIIRSHQDLT 141
AKR RE+ L++ ++H+NII++ ++ P + E F DVY+V ELMD +L Q+I+ +L
Sbjct: 105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELD 162
Query: 142 DDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 201
+ Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART + MT
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222
Query: 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 261
YVVTR+YRAPE++L Y +DIWSVGCI+GE++ + LFPG+DY+ Q + E +G+
Sbjct: 223 YVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281
Query: 262 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN------------KSPGAVDLLEKML 309
P + L R YV P++ F FP+ K+ A DLL KML
Sbjct: 282 PCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340
Query: 310 VFDPNRRITVDEALCHPYLAPLHDIN-EEPVCPRPFSFDFEHPSFTEENIKELIYRESVK 368
V DP +RI+VD+AL HPY+ +D E P+ + + T E KELIY+E +
Sbjct: 341 VIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMN 400
Query: 369 FNP 371
Sbjct: 401 SEE 403
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 558 bits (1440), Expect = 0.0
Identities = 132/326 (40%), Positives = 193/326 (59%), Gaps = 21/326 (6%)
Query: 28 YNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL 87
N++G F++ +Y+ ++P+G G G+V +A++++ + VAIKKI + K L
Sbjct: 2 MNIHG--FDLGSRYMD-LKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHAL 56
Query: 88 REIKLLRHMDHENIIAIKDIIRPPQR---------ETFNDVYIVYELMDTDLHQIIRSHQ 138
REIK++R +DH+NI+ + +I+ P N VYIV E M+TDL ++
Sbjct: 57 REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-G 115
Query: 139 DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTS--- 194
L ++H R F+YQLLRGLKY+HSANVLHRDLKP+NL +N + LKIGDFGLAR
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 195 -ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLR 253
++E +VT+WYR+P LLL+ + YT AID+W+ GCI E++T + LF G + Q++
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ 235
Query: 254 LITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDP 313
LI E I E L S Y+R P + + P S AVD LE++L F P
Sbjct: 236 LILESIPVVHEEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSP 294
Query: 314 NRRITVDEALCHPYLAPLHDINEEPV 339
R+T +EAL HPY++ +EP+
Sbjct: 295 MDRLTAEEALSHPYMSIYSFPMDEPI 320
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 518 bits (1336), Expect = 0.0
Identities = 111/362 (30%), Positives = 164/362 (45%), Gaps = 21/362 (5%)
Query: 22 GGRYVQYNVYGNLFEVSRKYVP---PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD 78
G + N E SRK + R G+G +G V T VAIKK+
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQ 58
Query: 79 NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY--IVYELMDTDLHQIIRS 136
+ R L+ ++ L + H NI+ ++ D+Y +V E + LH+ R+
Sbjct: 59 DPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRN 118
Query: 137 H----QDLTDDHCRYFLYQLLRGLKYVH--SANVLHRDLKPSNLLLN-ANCDLKIGDFGL 189
+ + FL+QL+R + +H S NV HRD+KP N+L+N A+ LK+ DFG
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 190 ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 249
A+ S ++ Y+ +R+YRAPEL+ YT A+DIWSVGCI E+M +P+F G +
Sbjct: 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 250 HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP-KQNFSARFPNKSPGAVDLLEKM 308
QL I ++G P L L + + P FS + A DLL +
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298
Query: 309 LVFDPNRRITVDEALCHPYLAPLHDINEE-----PVCPRPFSFDFEHPSFTEENIKELIY 363
L + P R+ EALCHPY LHD + + F F E K +
Sbjct: 299 LQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV 358
Query: 364 RE 365
R+
Sbjct: 359 RK 360
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 495 bits (1275), Expect = e-176
Identities = 102/389 (26%), Positives = 182/389 (46%), Gaps = 61/389 (15%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
E S K + +G G++GIVC + E+ + A+KK+ D + RE+ +++
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV------LQDPRYKNRELDIMK 55
Query: 95 HMDHENIIAIKDIIR---------------------------------PPQRETFNDVYI 121
+DH NII + D + +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 122 VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN 177
+ E + LH++++ S + + + ++YQL R + ++HS + HRD+KP NLL+N
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN 175
Query: 178 ANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 236
+ + LK+ DFG A+ ++ Y+ +R+YRAPEL+L +EYT +ID+WS+GC+ GE+
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL 235
Query: 237 MTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN 296
+ +PLF G+ + QL I +++G+P + + + P +++ P
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVR---FPTLKAKDWRKILPE 292
Query: 297 KSP-GAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC-------------PR 342
+P A+DLLE++L ++P+ RI EA+ HP+ L + E V P+
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQ 352
Query: 343 PFSFDFEHPSFTEENIKELIYRESVKFNP 371
F+F S N+ I ++ N
Sbjct: 353 LFNFSPYELSIIPGNVLNRILPKNFSPNY 381
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 490 bits (1263), Expect = e-174
Identities = 107/373 (28%), Positives = 179/373 (47%), Gaps = 28/373 (7%)
Query: 1 MSGESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAM 60
S D + V V G+ G Y + +G G++G+V A
Sbjct: 23 FGSMKVSRDKDGSKVTTVVATPGQ-------GPDRPQEVSYTD-TKVIGNGSFGVVYQAK 74
Query: 61 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP-QRETFNDV 119
++ E VAIKK+ D + RE++++R +DH NI+ ++ +++ +
Sbjct: 75 LCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 120 YIVYELMDTDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 175
+V + + ++++ R + Q L + + ++YQL R L Y+HS + HRD+KP NLL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 188
Query: 176 LNANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 234
L+ + LK+ DFG A+ + Y+ +R+YRAPEL+ ++YT++ID+WS GC+L
Sbjct: 189 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248
Query: 235 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 294
E++ QP+FPG V QL I +++G+P +R N PQ ++ F
Sbjct: 249 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE---QIREMNPNYTEFKFPQIKAHPWTKVF 305
Query: 295 -PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRP----FSFDFE 349
P P A+ L ++L + P R+T EA H + L D N + R F+F +
Sbjct: 306 RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQ 365
Query: 350 HPSFTEENIKELI 362
S LI
Sbjct: 366 ELSSNPPLATILI 378
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 487 bits (1256), Expect = e-173
Identities = 109/377 (28%), Positives = 182/377 (48%), Gaps = 23/377 (6%)
Query: 2 SGESSSGSGDHTIVKGVPTHGG-RYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAM 60
S S+ + + + V + + Y + +G G++G+V A
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTN-CKVIGNGSFGVVFQAK 60
Query: 61 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP-QRETFNDV 119
E+ E VAIKK+ D + RE++++R + H N++ +K ++ +
Sbjct: 61 LVESDE-VAIKKV------LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113
Query: 120 YIVYELMDTDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLL 175
+V E + +++ R + Q + + ++YQLLR L Y+HS + HRD+KP NLL
Sbjct: 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLL 173
Query: 176 LNANCD-LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILG 234
L+ LK+ DFG A+ + Y+ +R+YRAPEL+ + YT IDIWS GC++
Sbjct: 174 LDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA 233
Query: 235 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 294
E+M QPLFPG+ + QL I +++G+P +++ N PQ FS F
Sbjct: 234 ELMQGQPLFPGESGIDQLVEIIKVLGTPSRE---QIKTMNPNYMEHKFPQIRPHPFSKVF 290
Query: 295 -PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE----PVCPRPFSFDFE 349
P P A+DL+ ++L + P+ R+T EALCHP+ L P F++ E
Sbjct: 291 RPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKE 350
Query: 350 HPSFTEENIKELIYRES 366
S + I L+ + +
Sbjct: 351 ELSVRPDLISRLVPQHA 367
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 476 bits (1228), Expect = e-170
Identities = 91/318 (28%), Positives = 164/318 (51%), Gaps = 20/318 (6%)
Query: 25 YVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK 84
Y Y + + Y +R +GRG Y V A+N E+V +K + + K
Sbjct: 22 YWDYESHVVEWGNQDDYQL-VRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKK 75
Query: 85 RTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDD 143
+ REIK+L ++ NII + DI++ P + + + +TD Q+ Q LTD
Sbjct: 76 KIKREIKILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDY 130
Query: 144 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEY 202
R+++Y++L+ L Y HS ++HRD+KP N++++ + L++ D+GLA
Sbjct: 131 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR 190
Query: 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGS 261
V +R+++ PELL++ Y ++D+WS+GC+L ++ R +P F G D QL I +++G+
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250
Query: 262 PDETS-LGFLRSDNARRYVRMLPQFPKQNFSARFPNK-----SPGAVDLLEKMLVFDPNR 315
D + + R+ +L + ++ + ++ SP A+D L+K+L +D
Sbjct: 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 310
Query: 316 RITVDEALCHPYLAPLHD 333
R+T EA+ HPY +
Sbjct: 311 RLTAREAMEHPYFYTVVK 328
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 389 bits (1001), Expect = e-136
Identities = 92/308 (29%), Positives = 164/308 (53%), Gaps = 8/308 (2%)
Query: 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE 99
KY I +G G+YG+V N +T + VAIKK + D+ + K LREI++L+ + H
Sbjct: 4 KYEK-IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKY 158
N++ + ++ R +++V+E D + + + + + + + +Q L+ + +
Sbjct: 63 NLVNLLEVFR-----RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 217
H N +HRD+KP N+L+ + +K+ DFG AR T +D+ + V TRWYR+PELL+
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGD 177
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
++Y +D+W++GC+ E+++ PL+PGK V QL LI + +G ++
Sbjct: 178 TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237
Query: 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 337
V++ + +FPN S A+ LL+ L DP R+T ++ L HPY + +I +
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDL 297
Query: 338 PVCPRPFS 345
+
Sbjct: 298 AKEHDKPA 305
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 354 bits (912), Expect = e-122
Identities = 96/297 (32%), Positives = 161/297 (54%), Gaps = 12/297 (4%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
F+ KY + VG G+YG+V N +T VAIKK + D+++ K +REIKLL+
Sbjct: 21 FQSMEKYEN-LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLK 79
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLL 153
+ HEN++ + ++ + Y+V+E +D + + L + +L+Q++
Sbjct: 80 QLRHENLVNLLEVCK-----KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQII 134
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPE 212
G+ + HS N++HRD+KP N+L++ + +K+ DFG ART + + + V TRWYRAPE
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLR 271
LL+ +Y A+D+W++GC++ E+ +PLFPG + QL I +G+ F
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF-- 252
Query: 272 SDNARRYVRMLPQF-PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+ N LP+ ++ R+P S +DL +K L DP++R E L H +
Sbjct: 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = e-111
Identities = 110/335 (32%), Positives = 168/335 (50%), Gaps = 26/335 (7%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK-----RTLREIKLLRHMDHE 99
+ +G G Y V + T VA+K+I R++ + +RE+ LL+ + H
Sbjct: 7 LDKLGEGTYATVYKGKSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKY 158
NI+ + DII T + +V+E +D DL Q + + + + FL+QLLRGL Y
Sbjct: 61 NIVTLHDIIH-----TEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNC 217
H VLHRDLKP NLL+N +LK+ DFGLAR + T VVT WYR P++LL
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGS 175
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNAR 276
++Y+ ID+W VGCI E+ T +PLFPG QL I ++G+P E + G L ++ +
Sbjct: 176 TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336
Y P++ + + P DLL K+L F+ RI+ ++A+ HP+ L +
Sbjct: 236 TY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293
Query: 337 EPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
+ P S + KE R + +
Sbjct: 294 KL--PDTTS---IFALKEIQLQKEASLRSAHHHHH 323
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-110
Identities = 108/297 (36%), Positives = 152/297 (51%), Gaps = 34/297 (11%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDH 98
+ +G G YG+V A N E A+KKI R++ + T+REI +L+ + H
Sbjct: 7 LEKIGEGTYGVVYKAQN-NYGETFALKKI------RLEKEDEGIPSTTIREISILKELKH 59
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLK 157
NI+ + D+I T + +V+E +D DL +++ L + FL QLL G+
Sbjct: 60 SNIVKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 216
Y H VLHRDLKP NLL+N +LKI DFGLAR T +VT WYRAP++L+
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE------TSLGFL 270
+Y+ IDIWSVGCI E++ PLFPG QL I ++G+P+ T L
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL--- 231
Query: 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+Y + + + +DLL KML DPN+RIT +AL H Y
Sbjct: 232 -----PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 324 bits (834), Expect = e-110
Identities = 107/288 (37%), Positives = 154/288 (53%), Gaps = 19/288 (6%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR-----TLREIKLLRHMDHENII 102
+G G + V A + T + VAIKKI +R +AK LREIKLL+ + H NII
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHS 161
+ D +++ +V++ M+TDL II+ + LT H + ++ L+GL+Y+H
Sbjct: 76 GLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEY 220
+LHRDLKP+NLLL+ N LK+ DFGLA++ S T VVTRWYRAPELL Y
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 190
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNARRYV 279
+D+W+VGCIL E++ R P PG + QL I E +G+P E + +
Sbjct: 191 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF- 249
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
FP F +DL++ + +F+P RIT +AL Y
Sbjct: 250 ---KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-109
Identities = 109/296 (36%), Positives = 166/296 (56%), Gaps = 23/296 (7%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDH 98
+ VG G YG+V A +S VA+K+I R+DA+ +REI LL+ + H
Sbjct: 26 LEKVGEGTYGVVYKAKDS-QGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHH 78
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLK 157
NI+++ D+I + + +V+E M+ DL +++ + L D + +LYQLLRG+
Sbjct: 79 PNIVSLIDVIH-----SERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 216
+ H +LHRDLKP NLL+N++ LK+ DFGLAR T VVT WYRAP++L+
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNA 275
+Y+ ++DIWS+GCI E++T +PLFPG QL I ++G+P+
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW 253
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331
++ F K+ +S+ P +DLL ML FDPN+RI+ +A+ HPY L
Sbjct: 254 KQRT--FQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-109
Identities = 98/291 (33%), Positives = 145/291 (49%), Gaps = 19/291 (6%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR-----TLREIKLLRHM---DHE 99
+G GAYG V A + + VA+K + N T+RE+ LLR + +H
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV--RVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLK 157
N++ + D+ + + V +V+E +D DL + L + + + Q LRGL
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD 134
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217
++H+ ++HRDLKP N+L+ + +K+ DFGLAR S +T VVT WYRAPE+LL
Sbjct: 135 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ- 193
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDNAR 276
S Y +D+WSVGCI E+ R+PLF G QL I +LIG P E +
Sbjct: 194 STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA 253
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
P + + P LL +ML F+P++RI+ AL H Y
Sbjct: 254 -----FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 321 bits (826), Expect = e-109
Identities = 106/311 (34%), Positives = 162/311 (52%), Gaps = 34/311 (10%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDH 98
I +G G YG V A+++ T E VAIK+I R++ + +RE+ LL+ + H
Sbjct: 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLLKELQH 92
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
NII +K +I + +++++E + DL + + + D++ + FLYQL+ G+ +
Sbjct: 93 RNIIELKSVIH-----HNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNF 147
Query: 159 VHSANVLHRDLKPSNLLLNANCD-----LKIGDFGLART-TSETDFMTEYVVTRWYRAPE 212
HS LHRDLKP NLLL+ + LKIGDFGLAR T ++T WYR PE
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPE 207
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLR 271
+LL Y+ ++DIWS+ CI E++ + PLFPG + QL I E++G PD+T+ G
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA 267
Query: 272 SDNARRYVRMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330
+ + + P+F + +DLL ML DP +RI+ AL HPY
Sbjct: 268 LPD---WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF-- 322
Query: 331 LHDINEEPVCP 341
+ P
Sbjct: 323 ----SHNDFDP 329
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = e-107
Identities = 110/294 (37%), Positives = 160/294 (54%), Gaps = 26/294 (8%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDH 98
+ +G G YG V A N ET E VA+K++ R+D LREI LL+ + H
Sbjct: 7 LEKIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKH 60
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLK 157
+NI+ + D++ + + +V+E D DL + S DL + + FL+QLL+GL
Sbjct: 61 KNIVRLHDVLH-----SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 216
+ HS NVLHRDLKP NLL+N N +LK+ +FGLAR + VVT WYR P++L
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 217 CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDN 274
Y+ +ID+WS GCI E+ +PLFPG D QL+ I L+G+P E + +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 275 ARRYVRMLPQFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+ Y P +P + P + DLL+ +L +P +RI+ +EAL HPY
Sbjct: 236 YKPY----PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-107
Identities = 103/322 (31%), Positives = 154/322 (47%), Gaps = 31/322 (9%)
Query: 48 VGRGAYGIVCAAMNS-ETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHM---D 97
+G GAYG V A + VA+K++ R+ T+RE+ +LRH+ +
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 98 HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRG 155
H N++ + D+ + + + +V+E +D DL + + + + + ++QLLRG
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRG 132
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 215
L ++HS V+HRDLKP N+L+ ++ +K+ DFGLAR S +T VVT WYRAPE+LL
Sbjct: 133 LDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLRSDN 274
S Y +D+WSVGCI E+ R+PLF G V QL I ++IG P E +
Sbjct: 193 Q-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 251
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334
Q + DLL K L F+P +RI+ AL HPY
Sbjct: 252 QA-----FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF------ 300
Query: 335 NEEPVCPRPFSFDFEHPSFTEE 356
+ C T E
Sbjct: 301 QDLERCKENLDSHLPPSQNTSE 322
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-107
Identities = 108/330 (32%), Positives = 168/330 (50%), Gaps = 47/330 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR-----TLREIKLLRHMDHE 99
+ +G G Y V +N T VA+K++ ++D++ +REI L++ + HE
Sbjct: 10 LEKLGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKELKHE 63
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH------QDLTDDHCRYFLYQLL 153
NI+ + D+I T N + +V+E MD DL + + S + L + +YF +QLL
Sbjct: 64 NIVRLYDVIH-----TENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPE 212
+GL + H +LHRDLKP NLL+N LK+GDFGLAR + + VVT WYRAP+
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE------TS 266
+L+ Y+ +IDIWS GCIL E++T +PLFPG + QL+LI +++G+P+E T
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238
Query: 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNK-----SPGAVDLLEKMLVFDPNRRITVDE 321
L +Y + Q P ++ +D L +L +P+ R++ +
Sbjct: 239 L--------PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQ 290
Query: 322 ALCHPYLAPLHDINEEPVCPRPFSFDFEHP 351
AL HP+ A S H
Sbjct: 291 ALHHPWFA-----EYYHHASMGGSRSHHHH 315
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = e-106
Identities = 102/325 (31%), Positives = 165/325 (50%), Gaps = 29/325 (8%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR------TLREIKLLRHMDHENI 101
+G+G +G V A + +T ++VA+KK+ ++ ++ LREIK+L+ + HEN+
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV------LMENEKEGFPITALREIKILQLLKHENV 78
Query: 102 IAIKDII---RPPQRETFNDVYIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLK 157
+ + +I P +Y+V++ + DL ++ + T + + LL GL
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPE 212
Y+H +LHRD+K +N+L+ + LK+ DFGLAR S+ + T VVT WYR PE
Sbjct: 139 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 198
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL-GFLR 271
LLL +Y ID+W GCI+ E+ TR P+ G HQL LI++L GS
Sbjct: 199 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 258
Query: 272 SDNARRYVRMLPQFPKQNFSARFPN--KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL- 328
+ + L + K+ R + P A+DL++K+LV DP +RI D+AL H +
Sbjct: 259 YELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316
Query: 329 -APL-HDINEEPVCPRPFSFDFEHP 351
P+ D+ F++ P
Sbjct: 317 SDPMPSDLKGMLSTHLTSMFEYLAP 341
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 7e-94
Identities = 100/344 (29%), Positives = 156/344 (45%), Gaps = 62/344 (18%)
Query: 48 VGRGAYGIVCAAMN--SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
VGRG YG V A + ++ A+K+I + REI LLR + H N+I+++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMS--ACREIALLRELKHPNVISLQ 84
Query: 106 DIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD---------LTDDHCRYFLYQLLRGL 156
+ V+++++ + DL II+ H+ L + LYQ+L G+
Sbjct: 85 KVFLSH---ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 157 KYVHSANVLHRDLKPSNLLLNANCD----LKIGDFGLARTTSE-----TDFMTEYVVTRW 207
Y+H+ VLHRDLKP+N+L+ +KI D G AR + D VVT W
Sbjct: 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV-VVTFW 200
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD---------YVHQLRLITEL 258
YRAPELLL YT AIDIW++GCI E++T +P+F + + QL I +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260
Query: 259 IGSPDE------TSLGFLRSDNARRYVRMLPQFPKQNFS---------ARFPNKSPGAVD 303
+G P + + + ++ F + ++ A
Sbjct: 261 MGFPADKDWEDIKKM--------PEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 312
Query: 304 LLEKMLVFDPNRRITVDEALCHPYL--APLHDINEEPVCPRPFS 345
LL+K+L DP +RIT ++A+ PY PL + C P+
Sbjct: 313 LLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYP 356
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 1e-64
Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 50/304 (16%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH--ENII 102
++ +G G V +N E ++ AIK + + EI L + + II
Sbjct: 33 LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ D T +Y+V E + DL+ ++ + + + + +L + +H
Sbjct: 92 RLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 146
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCS- 218
++H DLKP+N L+ + LK+ DFG+A + V T Y PE + + S
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 219 ---------EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269
+ + D+WS+GCIL + + F ++Q+ + +I E
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHE----- 258
Query: 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
+FP D+L+ L DP +RI++ E L HPY+
Sbjct: 259 -------------IEFP--------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297
Query: 330 PLHD 333
Sbjct: 298 IQTH 301
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 3e-64
Identities = 77/327 (23%), Positives = 128/327 (39%), Gaps = 64/327 (19%)
Query: 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREI 90
Y + FE I +G+GA+G V A N+ AIKKI + L E+
Sbjct: 4 YASDFEE-------IAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEV 53
Query: 91 KLLRHMDHENIIAIKD--------IIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLT 141
LL ++H+ ++ + + + ++I E + L+ +I S
Sbjct: 54 MLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ 113
Query: 142 D-DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---- 196
D Q+L L Y+HS ++HRDLKP N+ ++ + ++KIGDFGLA+ +
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 197 -----------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 245
D +T + T Y A E+L Y ID++S+G I E++ P G
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTG 231
Query: 246 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 305
+ V+ L+ + + P F NK ++
Sbjct: 232 MERVNILKKLR-------------------SVSIEFPPDFDD--------NKMKVEKKII 264
Query: 306 EKMLVFDPNRRITVDEALCHPYLAPLH 332
++ DPN+R L +L H
Sbjct: 265 RLLIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 9e-64
Identities = 86/325 (26%), Positives = 156/325 (48%), Gaps = 55/325 (16%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM------DH 98
++ +G+G++G V A + + + VA+K + N + ++ EI++L H+ +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 99 ENIIAIKDIIRPPQRETF---NDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLL 153
N+I + + F N + + +EL+ +L+++I+ ++ + R F + +L
Sbjct: 159 MNVIHMLE--------NFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 154 RGLKYVHSANVLHRDLKPSNLLLN--ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 211
+ L +H ++H DLKP N+LL +K+ DFG + E + Y+ +R+YRAP
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAP 268
Query: 212 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE------- 264
E++L Y ID+WS+GCIL E++T PL PG+D QL + EL+G P +
Sbjct: 269 EVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 265 ------TSLGFLRSDNA-----RRYVRMLPQFPKQNFSARFPNKSPGA----------VD 303
+S G+ R V + + ++ G +D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 304 LLEKMLVFDPNRRITVDEALCHPYL 328
L++ L +DP R+T +AL HP+L
Sbjct: 388 FLKQCLEWDPAVRMTPGQALRHPWL 412
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 204 bits (519), Expect = 1e-62
Identities = 50/318 (15%), Positives = 88/318 (27%), Gaps = 54/318 (16%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
P+ G +V + E E+ A+K A ++R + +R + E+
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 105 KDIIR---------------------PPQRETFNDVYIVYELMDTDLHQIIR-------S 136
+D R + ++ DL +
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 137 HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196
D QL+R + S ++H P NL + + L +GD
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR 247
Query: 197 DFMTEYVVTRWYRAPELL-LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 255
V Y E L + + +T A++ W +G + + F +
Sbjct: 248 --GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK 305
Query: 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 315
+ P SL F L+ + L FD R
Sbjct: 306 RPSLRVPGTDSLAF----------------------GSCTPLPDFVKTLIGRFLNFDRRR 343
Query: 316 RITVDEALCHPYLAPLHD 333
R+ EA+ P L +
Sbjct: 344 RLLPLEAMETPEFLQLQN 361
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-62
Identities = 66/311 (21%), Positives = 117/311 (37%), Gaps = 54/311 (17%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH--ENII 102
++ +G G V +N E ++ AIK + + EI L + + II
Sbjct: 14 LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ D T +Y+V E + DL+ ++ + + + + +L + +H
Sbjct: 73 RLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLN--- 216
++H DLKP+N L+ + LK+ DFG+A + V T Y PE + +
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 217 -------CSEYTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSPDETSLG 268
S+ + D+WS+GCIL + + F + + +L I
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------------ 234
Query: 269 FLRSDNARRYVRMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
N FP+ D+L+ L DP +RI++ E L HPY
Sbjct: 235 ------------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276
Query: 328 LAPLHDINEEP 338
+ +
Sbjct: 277 VQIQTHPVNQM 287
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-61
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 50/309 (16%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH--ENII 102
++ +G G V +N E ++ AIK + + EI L + + II
Sbjct: 61 LKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 119
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ D T +Y+V E + DL+ ++ + + + + +L + +H
Sbjct: 120 RLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCS- 218
++H DLKP+N L+ + LK+ DFG+A + V Y PE + + S
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 219 ---------EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269
+ + D+WS+GCIL + + F ++Q+ + +I E
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--QIINQISKLHAIIDPNHE----- 286
Query: 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
+FP D+L+ L DP +RI++ E L HPY+
Sbjct: 287 -------------IEFP--------DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325
Query: 330 PLHDINEEP 338
+
Sbjct: 326 IQTHPVNQM 334
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 4e-61
Identities = 92/310 (29%), Positives = 146/310 (47%), Gaps = 53/310 (17%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKI------GNAFDNRIDAKRTLRE 89
+ +Y+ + +G GA G V A +T ++VAIK I + A E
Sbjct: 7 ALRDEYIM-SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYF 148
I++L+ ++H II IK+ + D YIV ELM+ +L + ++ L + C+ +
Sbjct: 66 IEILKKLNHPCIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 119
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVT 205
YQ+L ++Y+H ++HRDLKP N+LL++ +C +KI DFG ++ ET M T
Sbjct: 120 FYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 179
Query: 206 RWYRAPELLLNCSE--YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP- 262
Y APE+L++ Y A+D WS+G IL ++ L G P
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVIL--------------FI--C-----LSGYPP 218
Query: 263 ---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 319
T + + +Y F + S A+DL++K+LV DP R T
Sbjct: 219 FSEHRTQVSLKDQITSGKY-----NFI----PEVWAEVSEKALDLVKKLLVVDPKARFTT 269
Query: 320 DEALCHPYLA 329
+EAL HP+L
Sbjct: 270 EEALRHPWLQ 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 8e-61
Identities = 66/300 (22%), Positives = 109/300 (36%), Gaps = 56/300 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I +G G +G V A + + IK++ + + ++ RE+K L +DH NI+
Sbjct: 16 IELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVKALAKLDHVNIVHY 69
Query: 105 KD-----------IIRPPQRETFNDVYIVYELMDT-DLHQII--RSHQDLTDDHCRYFLY 150
+ R ++I E D L Q I R + L
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 210
Q+ +G+ Y+HS +++RDLKPSN+ L +KIGDFGL + T T Y +
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 189
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270
PE + + +Y +D++++G IL E++ + +
Sbjct: 190 PEQISS-QDYGKEVDLYALGLILAELLH--VCDTAFETSKFFTDL--------------- 231
Query: 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330
S F LL+K+L P R E L +
Sbjct: 232 ---------------RDGIISDIF---DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-60
Identities = 90/300 (30%), Positives = 142/300 (47%), Gaps = 52/300 (17%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKI------GNAFDNRIDAKRTLREIKLLRHMDHE 99
+ +G GA G V A +T ++VAI+ I + A EI++L+ ++H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
II IK+ + D YIV ELM+ +L + ++ L + C+ + YQ+L ++Y
Sbjct: 201 CIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 159 VHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 215
+H ++HRDLKP N+LL++ +C +KI DFG ++ ET M T Y APE+L+
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 314
Query: 216 NCSE--YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP----DETSLGF 269
+ Y A+D WS+G IL ++ L G P T +
Sbjct: 315 SVGTAGYNRAVDCWSLGVIL--------------FI--C-----LSGYPPFSEHRTQVSL 353
Query: 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
+ +Y F + S A+DL++K+LV DP R T +EAL HP+L
Sbjct: 354 KDQITSGKY-----NFI----PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-60
Identities = 89/375 (23%), Positives = 145/375 (38%), Gaps = 65/375 (17%)
Query: 10 GDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVA 69
G H KG P RY + +R +G G + V A + VA
Sbjct: 6 GYHPAFKGEPYKDARY----------IL-------VRKLGWGHFSTVWLAKDMVNNTHVA 48
Query: 70 IKKIGNAFDNRIDAKRTLREIKLLR-----------HMDHENIIAIKD--IIRPPQRETF 116
+K + +++ + EIKLL+ M +I+ + D + P
Sbjct: 49 MKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV-- 103
Query: 117 NDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSN 173
V +V+E++ +L +I+ ++ + + + QLL GL Y+H ++H D+KP N
Sbjct: 104 -HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 162
Query: 174 LLLNANCD------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIW 227
+L+ +KI D G A E T + TR YR+PE+LL + DIW
Sbjct: 163 VLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIW 219
Query: 228 SVGCILGEIMTRQPLFPGKDY------VHQLRLITELIGSPD-------ETSLGFLRSDN 274
S C++ E++T LF + + I EL+G + + F S
Sbjct: 220 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRG 279
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGA----VDLLEKMLVFDPNRRITVDEALCHPYLAP 330
R + L +P ++ S D L ML DP +R + HP+L
Sbjct: 280 LLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
Query: 331 LHDINEEPVCPRPFS 345
+ E V R
Sbjct: 340 TLGMEEIRVPDRELY 354
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-60
Identities = 68/286 (23%), Positives = 102/286 (35%), Gaps = 41/286 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIA 103
+ +G G+YG V + E A+K+ + F D R L E+ + H +
Sbjct: 62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 104 IKDIIRPPQRETFNDVYIVYELMDTDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
++ E +Y+ EL L Q L + +L L L ++HS
Sbjct: 122 LEQAW-----EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA 222
++H D+KP+N+ L K+GDFGL Y APELL Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGT 234
Query: 223 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282
A D++S+G + E+ L G + QLR +
Sbjct: 235 AADVFSLGLTILEVACNMELPHGGEGWQQLRQG------------------------YLP 270
Query: 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+F S +L ML DP R T + L P L
Sbjct: 271 PEFT--------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 3e-60
Identities = 56/299 (18%), Positives = 113/299 (37%), Gaps = 27/299 (9%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G+GA V + +T + AIK N R +RE ++L+ ++H+NI+ +
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLF 73
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHS 161
I + T ++ E L+ ++ L + L ++ G+ ++
Sbjct: 74 AIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 162 ANVLHRDLKPSNLLLNANCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL--- 214
++HR++KP N++ D K+ DFG AR + + T Y P++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 215 ----LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI--GSPDETSLG 268
+ +Y A +D+WS+G T F + + + + I G P G
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 269 FLRSDNAR-RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
+++N + +P + + +L +L D + D+
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGLQVLLT-----PVLANILEADQEKCWGFDQFFAET 304
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-60
Identities = 85/310 (27%), Positives = 136/310 (43%), Gaps = 53/310 (17%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKI-------GNAFDNRIDAKRTLR 88
Y P +GRG +V ++ T +E A+K I +A + + + TL+
Sbjct: 14 GFYENYEP-KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 89 EIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR 146
E+ +LR + H NII +KD ET ++V++LM +L + L++ R
Sbjct: 73 EVDILRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 206
+ LL + +H N++HRDLKP N+LL+ + ++K+ DFG + + + E T
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP 187
Query: 207 WYRAPELLLNCSE-----YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 261
Y APE++ Y +D+WS G I+ Y L L GS
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM--------------YT----L---LAGS 226
Query: 262 P---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 318
P + LR + Y QF S + + S DL+ + LV P +R T
Sbjct: 227 PPFWHRKQMLMLRMIMSGNY-----QFG----SPEWDDYSDTVKDLVSRFLVVQPQKRYT 277
Query: 319 VDEALCHPYL 328
+EAL HP+
Sbjct: 278 AEEALAHPFF 287
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-60
Identities = 84/326 (25%), Positives = 147/326 (45%), Gaps = 50/326 (15%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+G+G++G V A + +E VAIK I N + + E++LL M+ +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 105 KDIIRPPQRETF---NDVYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYV 159
I+ + F N + +V+E++ +L+ ++R+ + ++ + R F Q+ L ++
Sbjct: 116 YYIVHL--KRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 160 HS--ANVLHRDLKPSNLLL--NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 215
+ +++H DLKP N+LL +KI DFG + + +Y+ +R+YR+PE+LL
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLL 231
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE----------- 264
Y AID+WS+GCIL E+ T +PLF G + V Q+ I E++G P
Sbjct: 232 GMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARK 290
Query: 265 -------TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGA---------------V 302
+ ++ + +R + N G
Sbjct: 291 FFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFK 350
Query: 303 DLLEKMLVFDPNRRITVDEALCHPYL 328
DL+ +ML +DP RI AL H +
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 9e-60
Identities = 74/315 (23%), Positives = 135/315 (42%), Gaps = 41/315 (13%)
Query: 20 THGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN 79
H V F+ KYV ++ +G G++G ++E + IK+I + +
Sbjct: 5 HHHSSGVDLGTENLYFQSMEKYVR-LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS 63
Query: 80 RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ 138
+ + + RE+ +L +M H NI+ ++ E +YIV + + DL + I + +
Sbjct: 64 SKEREESRREVAVLANMKHPNIVQYRESF-----EENGSLYIVMDYCEGGDLFKRINAQK 118
Query: 139 D--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196
+D + Q+ LK+VH +LHRD+K N+ L + +++GDFG+AR + T
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178
Query: 197 DFMTEYVV-TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 255
+ + T +Y +PE+ N Y DIW++GC+L E+ T + F + + I
Sbjct: 179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237
Query: 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 315
GS SL + S L+ ++ +P
Sbjct: 238 IS--GSFPPVSLHY----------------------------SYDLRSLVSQLFKRNPRD 267
Query: 316 RITVDEALCHPYLAP 330
R +V+ L ++A
Sbjct: 268 RPSVNSILEKGFIAK 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-59
Identities = 79/288 (27%), Positives = 135/288 (46%), Gaps = 43/288 (14%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G+GA+ +V ++ T E A K I + D ++ RE ++ R + H NI+ +
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
D I + + Y+V++L+ +L + I + + ++ + + Q+L + Y HS +
Sbjct: 72 DSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 165 LHRDLKPSNLLLNANCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+HR+LKP NLLL + +K+ DFGLA ++++ + T Y +PE +L Y+
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYS 185
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRY 278
+DIW+ G IL Y+ L L+G P DE A Y
Sbjct: 186 KPVDIWACGVIL--------------YI--L-----LVGYPPFWDEDQHRLYAQIKAGAY 224
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
+P S + +P A L++ ML +P +RIT D+AL P
Sbjct: 225 -----DYP----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-59
Identities = 81/301 (26%), Positives = 136/301 (45%), Gaps = 39/301 (12%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
R +G+G++G V + T +E A+K I + D + LRE++LL+ +DH NI+ +
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
+ E Y+V E+ +L I S + ++ + Q+L G+ Y+H
Sbjct: 92 YEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 164 VLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY 220
++HRDLKP NLLL + + +++I DFGL+ + M + + T +Y APE+L Y
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--Y 204
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
D+WS G IL +++ P F G + L+ + G
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV--EKGKYT----------------- 245
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC 340
F ++ S A DL+ KML + P+ RI+ +AL H ++
Sbjct: 246 ----FE----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDV 297
Query: 341 P 341
P
Sbjct: 298 P 298
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 6e-59
Identities = 81/307 (26%), Positives = 137/307 (44%), Gaps = 52/307 (16%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKI------GNAFDNRIDAKRTLRE 89
E +KY P +GRG +V ++ T E A+K + + + T RE
Sbjct: 91 EFYQKYDP-KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 90 IKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY 147
+LR + H +II + D E+ + +++V++LM +L + L++ R
Sbjct: 150 THILRQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS 204
Query: 148 FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW 207
+ LL + ++H+ N++HRDLKP N+LL+ N +++ DFG + + + E T
Sbjct: 205 IMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPG 264
Query: 208 YRAPELLLNCSE-----YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 262
Y APE+L + Y +D+W+ G IL + L L GSP
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVIL--------------FT--L-----LAGSP 303
Query: 263 ---DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 319
+ LR +Y QF S + ++S DL+ ++L DP R+T
Sbjct: 304 PFWHRRQILMLRMIMEGQY-----QFS----SPEWDDRSSTVKDLISRLLQVDPEARLTA 354
Query: 320 DEALCHP 326
++AL HP
Sbjct: 355 EQALQHP 361
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 7e-59
Identities = 88/287 (30%), Positives = 129/287 (44%), Gaps = 38/287 (13%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+ +G GAYG V + T E AIK I + + L E+ +L+ +DH NI+ +
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 106 DIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
D E + Y+V E +L I + + Q+L G+ Y+H N+
Sbjct: 103 DFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 165 LHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+HRDLKP NLLL + +KI DFGL+ M E + T +Y APE+L Y
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK--YD 215
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281
D+WS+G IL ++ P F G+ LR + G
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV--EKGKYT------------------ 255
Query: 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
F S + N S GA DL+++ML FD RRI+ +AL HP++
Sbjct: 256 ---FD----SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 9e-59
Identities = 70/293 (23%), Positives = 110/293 (37%), Gaps = 51/293 (17%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDI 107
G GA G + +VA+K+I + D RE++LLR D H N+I
Sbjct: 33 GHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHPNVIRYFCT 86
Query: 108 IRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLH 166
+ YI EL L + + L Q GL ++HS N++H
Sbjct: 87 E-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVH 141
Query: 167 RDLKPSNLLL-----NANCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNC 217
RDLKP N+L+ + I DFGL + + T + APE+L
Sbjct: 142 RDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201
Query: 218 SE--YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+ T +DI+S GC+ +++ GK Q L+G+
Sbjct: 202 CKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN---ILLGACS------------ 246
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ ++ A +L+EKM+ DP +R + L HP+
Sbjct: 247 ------------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 1e-58
Identities = 76/297 (25%), Positives = 123/297 (41%), Gaps = 45/297 (15%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G G+YG + + K++ + + + E+ LLR + H NI+
Sbjct: 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD----LTDDHCRYFLYQLLRGLKYV 159
D I T +YIV E + DL +I L ++ + QL LK
Sbjct: 71 YDRI---IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 127
Query: 160 HSAN-----VLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 213
H + VLHRDLKP+N+ L+ ++K+GDFGLAR +T F +V T +Y +PE
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQ 187
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
+ S Y DIWS+GC+L E+ P F I E
Sbjct: 188 MNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---------------- 230
Query: 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330
++ R+ ++ S +++ +ML R +V+E L +P +
Sbjct: 231 --GKFRRIPYRY------------SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-58
Identities = 88/288 (30%), Positives = 135/288 (46%), Gaps = 44/288 (15%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G+G++G V + T++E A+K I A D LRE++LL+ +DH NI+ +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
+I+ E + YIV EL +L I + ++ + Q+ G+ Y+H N+
Sbjct: 88 EIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 165 LHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+HRDLKP N+LL +CD+KI DFGL+ + M + + T +Y APE+L Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YD 200
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRY 278
D+WS G IL Y+ L L G+P + L+ +Y
Sbjct: 201 EKCDVWSAGVIL--------------YI----L---LSGTPPFYGKNEYDILKRVETGKY 239
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
F ++ S A DL+ KML F P+ RIT + L HP
Sbjct: 240 -----AFD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 191 bits (486), Expect = 2e-58
Identities = 68/323 (21%), Positives = 122/323 (37%), Gaps = 58/323 (17%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
PI+ +GRG +G+V A N AIK+I + + ++ +RE+K L ++H I+
Sbjct: 9 PIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 104 IKD-------IIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLT---DDHCRYFLYQL 152
+ + +YI +L +L + + C + Q+
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM------------- 199
++++HS ++HRDLKPSN+ + +K+GDFGL + +
Sbjct: 128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 259
T V T+ Y +PE + + Y+ +DI+S+G IL E++ P + V L +
Sbjct: 188 TGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--PFSTQMERVRTLTDVR--- 241
Query: 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 319
F F K P +++ ML P R
Sbjct: 242 ---------------------------NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA 274
Query: 320 DEALCHPYLAPLHDINEEPVCPR 342
+ + L + + R
Sbjct: 275 INIIENAVFEDLDFPGKTVLRQR 297
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 4e-58
Identities = 87/287 (30%), Positives = 137/287 (47%), Gaps = 38/287 (13%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G+G++G V + T++E A+K I A D LRE++LL+ +DH NI+ +
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 106 DIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
+I+ E + YIV EL +L I + ++ + Q+ G+ Y+H N+
Sbjct: 88 EIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 165 LHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+HRDLKP N+LL +CD+KI DFGL+ + M + + T +Y APE+L Y
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT--YD 200
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281
D+WS G IL +++ P F GK+ L+ + G
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV--ETGKYA------------------ 240
Query: 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
F ++ S A DL+ KML F P+ RIT + L HP++
Sbjct: 241 ---FD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 6e-58
Identities = 79/288 (27%), Positives = 135/288 (46%), Gaps = 43/288 (14%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G+GA+ +V ++ T E A K I + D ++ RE ++ R + H NI+ +
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
D I + + Y+V++L+ +L + I + + ++ + + Q+L + Y HS +
Sbjct: 95 DSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149
Query: 165 LHRDLKPSNLLLNANCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+HR+LKP NLLL + +K+ DFGLA ++++ + T Y +PE +L Y+
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE-VLKKDPYS 208
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRY 278
+DIW+ G IL Y+ L L+G P DE A Y
Sbjct: 209 KPVDIWACGVIL--------------YI--L-----LVGYPPFWDEDQHRLYAQIKAGAY 247
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
+P S + +P A L++ ML +P +RIT D+AL P
Sbjct: 248 -----DYP----SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 286
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-57
Identities = 73/335 (21%), Positives = 136/335 (40%), Gaps = 23/335 (6%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+G G +G V ++ +T E+VAIK+ + + +R EI++++ ++H N+++
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK-NRERWCLEIQIMKKLNHPNVVSA 77
Query: 105 KDIIRPPQRETFND-VYIVYELMDT-DLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYV 159
+++ Q+ ND + E + DL + + ++ L + R L + L+Y+
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 160 HSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 216
H ++HRDLKP N++L KI D G A+ + + TE+V T Y APELL
Sbjct: 138 HENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ 197
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
YT +D WS G + E +T F Q +E + + A
Sbjct: 198 KK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR--EKSNEHIVVYDDLTGAV 254
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336
++ +LP + L+ ML++ +R T + L I
Sbjct: 255 KFSSVLPTPNH-----LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309
Query: 337 EPV------CPRPFSFDFEHPSFTEENIKELIYRE 365
+ + +N+K + ++
Sbjct: 310 LKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQD 344
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-57
Identities = 67/345 (19%), Positives = 128/345 (37%), Gaps = 40/345 (11%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G+GA V + +T + AIK N R +RE ++L+ ++H+NI+ +
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLF 73
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHS 161
I + T ++ E L+ ++ L + L ++ G+ ++
Sbjct: 74 AIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 162 ANVLHRDLKPSNLLLNANCD----LKIGDFGLARTTSETDFMTEYVVTRWYRAPELL--- 214
++HR++KP N++ D K+ DFG AR + + T Y P++
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERA 190
Query: 215 ----LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI--GSPDETSLG 268
+ +Y A +D+WS+G T F + + + + I G P G
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISG 250
Query: 269 FLRSDNAR-RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+++N + +P + +L +L D + D+ +
Sbjct: 251 VQKAENGPIDWSGDMPVSCSLSRGL-----QVLLTPVLANILEADQEKCWGFDQ-----F 300
Query: 328 LAPLHDINEEPVCPRPFSFD-------FEHPSFTEENIKELIYRE 365
A DI V FS + H T EL+Y++
Sbjct: 301 FAETSDILHRMVI-HVFSLQQMTAHKIYIHSYNTATIFHELVYKQ 344
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 8e-57
Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 46/288 (15%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+GRG++G V A+ TR A KKI D R +EI++++ +DH NII +
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKY--FVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
+ E D+Y+V EL +L + + + + + +L + Y H NV
Sbjct: 73 ETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 165 LHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
HRDLKP N L + + LK+ DFGLA M V T +Y +P++L Y
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL--YG 185
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRY 278
D WS G ++ YV L L G P T + +
Sbjct: 186 PECDEWSAGVMM--------------YV----L---LCGYPPFSAPTDSEVMLKIREGTF 224
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
FP + N SP A L+ ++L P +RIT +AL H
Sbjct: 225 -----TFP----EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHE 263
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-56
Identities = 84/305 (27%), Positives = 131/305 (42%), Gaps = 48/305 (15%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHENI 101
+G G + IV T +E A K I ++ + + RE+ +LR + H NI
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
I + DI E DV ++ EL+ +L + + LT+D FL Q+L G+ Y+H
Sbjct: 71 ITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 161 SANVLHRDLKPSNLLL----NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 216
S + H DLKP N++L N +K+ DFG+A + T + APE ++N
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE-IVN 184
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSD 273
D+WS+G I Y+ L L G+ ET L +
Sbjct: 185 YEPLGLEADMWSIGVIT--------------YI--L-----LSGASPFLGETKQETLTNI 223
Query: 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333
+A Y F F N S A D + ++LV DP RR+T+ ++L H ++ +
Sbjct: 224 SAVNY-----DFD----EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRR 274
Query: 334 INEEP 338
N
Sbjct: 275 RNVRG 279
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-56
Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 50/292 (17%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
R +G GA+G V + E IK I N +++ ++ EI++L+ +DH NII I
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 106 DIIRPPQRETFNDVYIVYELMD-----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
++ E ++++YIV E + + + L++ + + Q++ L Y H
Sbjct: 87 EVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 161 SANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217
S +V+H+DLKP N+L + + +KI DFGLA + T T Y APE+
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF--K 199
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDN 274
+ T DIWS G ++ Y L L G + +
Sbjct: 200 RDVTFKCDIWSAGVVM--------------YF--L-----LTGCLPFTGTSLEEVQQKAT 238
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
+ N++ +P AVDLL++ML DP RR + + L H
Sbjct: 239 YKEP----------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-56
Identities = 70/334 (20%), Positives = 133/334 (39%), Gaps = 64/334 (19%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-----DHE 99
IR +G G +G V + + ++ A+K + N AK E +L+ + ++
Sbjct: 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNN 96
Query: 100 NIIAIKDIIRPPQRETF---NDVYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLR 154
NI+ F + + +++E + L++II + + + + ++L+
Sbjct: 97 NIVKYHG--------KFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILK 148
Query: 155 GLKYVHSANVLHRDLKPSNLLLN-------------------------ANCDLKIGDFGL 189
L Y+ ++ H DLKP N+LL+ + +K+ DFG
Sbjct: 149 ALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 190 ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 249
A T ++D+ + TR YRAPE++LN + + D+WS GC+L E+ T LF +++
Sbjct: 209 A--TFKSDYHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 250 HQLRLITELIGSPDE--------TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKS--- 298
L ++ +I + T+ + + + +
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325
Query: 299 ----PGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
D L +L DP R + E L H +L
Sbjct: 326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-56
Identities = 81/328 (24%), Positives = 140/328 (42%), Gaps = 48/328 (14%)
Query: 45 IRPVGRGAYGIVCAAM-NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
+ +G G +G V + ++ + +VA+K I N R A+ EI +L+ + ++
Sbjct: 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKEN 80
Query: 104 IKDIIRPPQRETF---NDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKY 158
+ + F + I +EL+ + + ++ + H R+ YQL L++
Sbjct: 81 KFLCVL--MSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 159 VHSANVLHRDLKPSNLLLN-------------------ANCDLKIGDFGLARTTSETDFM 199
+H + H DLKP N+L N +++ DFG A T + +
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHH 196
Query: 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 259
T V TR YR PE++L + D+WS+GCIL E LF + L ++ +++
Sbjct: 197 TTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255
Query: 260 GSPD--------------ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 305
G + L + + + RYV+ + K + DL+
Sbjct: 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSL-EHVQLFDLM 314
Query: 306 EKMLVFDPNRRITVDEALCHPYLAPLHD 333
+ML FDP +RIT+ EAL HP+ A L
Sbjct: 315 RRMLEFDPAQRITLAEALLHPFFAGLTP 342
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 3e-56
Identities = 87/326 (26%), Positives = 145/326 (44%), Gaps = 48/326 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSET-REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
+ +G GA+G V ++ + VA+K + N A+ EI++L H++ + +
Sbjct: 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNS 75
Query: 104 IKDIIRPPQRETF---NDVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKY 158
++ E F + IV+EL+ + I+ + DH R YQ+ + + +
Sbjct: 76 TFRCVQ--MLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 159 VHSANVLHRDLKPSNLLLN-------------------ANCDLKIGDFGLARTTSETDFM 199
+HS + H DLKP N+L N D+K+ DFG A T + +
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHH 191
Query: 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 259
+ V TR YRAPE++L ++ D+WS+GCIL E +FP D L ++ ++
Sbjct: 192 STLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250
Query: 260 GSP--------------DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 305
G L + +A RYV + K+ ++ DL+
Sbjct: 251 GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH-ERLFDLI 309
Query: 306 EKMLVFDPNRRITVDEALCHPYLAPL 331
+KML +DP +RIT+ EAL HP+ L
Sbjct: 310 QKMLEYDPAKRITLREALKHPFFDLL 335
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 6e-56
Identities = 79/308 (25%), Positives = 133/308 (43%), Gaps = 49/308 (15%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKI-----------GNAFDNRIDAKRTLREIKLLR 94
R +G GAYG V E AIK I + + + EI LL+
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLL 153
+DH NII + D+ E Y+V E + +L + I + + + Q+L
Sbjct: 102 SLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 154 RGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 210
G+ Y+H N++HRD+KP N+LL N+ ++KI DFGL+ S+ + + + T +Y A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270
PE+L +Y D+WS G I+ ++ P F G++ ++ +
Sbjct: 217 PEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE-------------- 260
Query: 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330
+ F + N S A +L++ ML +D N+R T +EAL ++
Sbjct: 261 ---------KGKYYFD----FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK 307
Query: 331 LHDINEEP 338
+ +
Sbjct: 308 YANNINKS 315
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 7e-56
Identities = 67/305 (21%), Positives = 126/305 (41%), Gaps = 46/305 (15%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH 95
+ Y+ + +GRG + +V ++ T +E A K + + L EI +L
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 96 MDH-ENIIAIKDIIRPPQRETFNDVYIVYELMDT-DL-HQII-RSHQDLTDDHCRYFLYQ 151
+I + ++ E +++ ++ E ++ + + ++++ + Q
Sbjct: 85 AKSCPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWY 208
+L G+ Y+H N++H DLKP N+LL D+KI DFG++R + E + T Y
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY 199
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DET 265
APE +LN T A D+W++G I Y+ L L + E
Sbjct: 200 LAPE-ILNYDPITTATDMWNIGIIA--------------YM--L-----LTHTSPFVGED 237
Query: 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325
+ + + + F + S A D ++ +LV +P +R T + L H
Sbjct: 238 NQETYLNISQVNV-----DYS----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288
Query: 326 PYLAP 330
+L
Sbjct: 289 SWLQQ 293
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-55
Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 42/292 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENII 102
+ +GRG + V A VA+KK+ + D + ++EI LL+ ++H N+I
Sbjct: 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHPNVI 95
Query: 103 AIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD----LTDDHCRYFLYQLLRGLK 157
N++ IV EL D DL ++I+ + + + + QL L+
Sbjct: 96 KYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLN 216
++HS V+HRD+KP+N+ + A +K+GD GL R +S+T V T +Y +PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
+ Y DIWS+GC+L E+ Q F G D ++ L ++
Sbjct: 211 -NGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCD-------------- 254
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P P ++ S L+ + DP +R V
Sbjct: 255 -----YPPLPSDHY-------SEELRQLVNMCINPDPEKRPDVTYVYDVAKR 294
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-55
Identities = 77/297 (25%), Positives = 127/297 (42%), Gaps = 48/297 (16%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
G G + IV T E A K I A + + RE+ +LR + H N+I +
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
D+ E DV ++ EL+ +L + + L+++ F+ Q+L G+ Y+H+
Sbjct: 81 HDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 164 VLHRDLKPSNLLL----NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
+ H DLKP N++L +K+ DFGLA + T + APE ++N
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEP 194
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNAR 276
D+WS+G I Y+ L L G+ +T L + +
Sbjct: 195 LGLEADMWSIGVIT--------------YI--L-----LSGASPFLGDTKQETLANITSV 233
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333
Y F F + S A D + K+LV + +R+T+ EAL HP++ P+ +
Sbjct: 234 SY-----DFD----EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-55
Identities = 87/291 (29%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+GRGA IV T++ A+K + +D K EI +L + H NII +K
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
+I ET ++ +V EL+ +L I ++ + Q+L + Y+H +
Sbjct: 115 EIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 165 LHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+HRDLKP NLL + LKI DFGL++ M T Y APE+L C+ Y
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCA-YG 228
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRY 278
+D+WSVG I Y+ L L G DE F+ RR
Sbjct: 229 PEVDMWSVGIIT--------------YI--L-----LCGFEPFYDERGDQFM----FRRI 263
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
+ F S + S A DL+ K++V DP +R+T +AL HP++
Sbjct: 264 LNCEYYFI----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-55
Identities = 77/294 (26%), Positives = 128/294 (43%), Gaps = 48/294 (16%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
G G + +V T + A K I + + + RE+ +L+ + H N+I +
Sbjct: 20 GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79
Query: 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
++ E DV ++ EL+ +L + + LT++ FL Q+L G+ Y+HS
Sbjct: 80 HEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 164 VLHRDLKPSNLLL----NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
+ H DLKP N++L +KI DFGLA + T + APE ++N
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE-IVNYEP 193
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNAR 276
D+WS+G I Y+ L L G+ +T L + +A
Sbjct: 194 LGLEADMWSIGVIT--------------YI--L-----LSGASPFLGDTKQETLANVSAV 232
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330
Y +F F N S A D + ++LV DP +R+T+ ++L HP++ P
Sbjct: 233 NY-----EFE----DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 8e-55
Identities = 79/302 (26%), Positives = 125/302 (41%), Gaps = 48/302 (15%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
G G + IV T E A K I A + + RE+ +LR + H NII +
Sbjct: 21 GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
D+ E DV ++ EL+ +L + + L+++ F+ Q+L G+ Y+H+
Sbjct: 81 HDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 164 VLHRDLKPSNLLL----NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
+ H DLKP N++L +K+ DFGLA + T + APE ++N
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE-IVNYEP 194
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNAR 276
D+WS+G I Y+ L L G+ +T L + A
Sbjct: 195 LGLEADMWSIGVIT--------------YI--L-----LSGASPFLGDTKQETLANITAV 233
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336
Y F F S A D + K+LV + +R+T+ EAL HP++ P+
Sbjct: 234 SY-----DFD----EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQA 284
Query: 337 EP 338
Sbjct: 285 MV 286
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-54
Identities = 81/366 (22%), Positives = 135/366 (36%), Gaps = 85/366 (23%)
Query: 20 THGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKI---GNA 76
GR Y G+L E+ +KY +G+G+YG+V A+ ++TR AIK +
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHL-KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 77 FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM---------- 126
N D +R E++L++ + H NI + ++ E + +V EL
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLN 120
Query: 127 -------------------------------DTDLHQIIRSHQDLTDDHCRYFLYQLLRG 155
+ + + Q+
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 156 LKYVHSANVLHRDLKPSNLLL--NANCDLKIGDFGLAR-----TTSETDFMTEYVVTRWY 208
L Y+H+ + HRD+KP N L N + ++K+ DFGL++ E MT T ++
Sbjct: 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF 240
Query: 209 RAPELLLNCSE-YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267
APE+L +E Y D WS G +L ++ FPG + + + L
Sbjct: 241 VAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV--LNKKLC---- 294
Query: 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
F + + SP A DLL +L + + R AL HP+
Sbjct: 295 -----------------FE----NPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPW 333
Query: 328 LAPLHD 333
++ D
Sbjct: 334 ISQFSD 339
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 5e-54
Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 44/301 (14%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G+GA+ +V + +E A I + D ++ RE ++ R + H NI+ +
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 106 DIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
D I Y++++L+ +L + I + + ++ + + Q+L + + H V
Sbjct: 77 DSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131
Query: 165 LHRDLKPSNLLL---NANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEY 220
+HR+LKP NLLL +K+ DFGLA E + T Y +PE+L Y
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-RKDPY 190
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARR 277
+D+W+ G IL Y+ L L+G P DE + A
Sbjct: 191 GKPVDLWACGVIL--------------YI----L---LVGYPPFWDEDQHRLYQQIKAGA 229
Query: 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 337
Y FP S + +P A DL+ KML +P++RIT EAL HP+++ +
Sbjct: 230 Y-----DFP----SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASC 280
Query: 338 P 338
Sbjct: 281 M 281
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 9e-54
Identities = 69/304 (22%), Positives = 129/304 (42%), Gaps = 46/304 (15%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+GRG +GIV + + +++ K + +++ K+ EI +L H NI+ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHLH 67
Query: 106 DIIRPPQRETFNDVYIVYELMD-TDLH-QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
+ E+ ++ +++E + D+ +I S +L + +++Q+ L+++HS N
Sbjct: 68 ESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 164 VLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+ H D++P N++ + +KI +FG AR D Y APE + +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE-VHQHDVVS 181
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRY 278
A D+WS+G ++ YV L L G ET+ + + Y
Sbjct: 182 TATDMWSLGTLV--------------YV--L-----LSGINPFLAETNQQIIENIMNAEY 220
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 338
F F S A+D ++++LV + R+T EAL HP+L +
Sbjct: 221 -----TFD----EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271
Query: 339 VCPR 342
V
Sbjct: 272 VIRT 275
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-53
Identities = 83/322 (25%), Positives = 138/322 (42%), Gaps = 44/322 (13%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
R +G+G + +++T+E A K + + ++ EI + R + H++++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
E + V++V EL L ++ + + LT+ RY+L Q++ G +Y+H
Sbjct: 107 HGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCSEYT 221
V+HRDLK NL LN + ++KIGDFGLA T E D + V+ T Y APE+L ++
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEVLSK-KGHS 219
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281
+D+WS+GCI+ ++ +P F I + Y
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------------------NEY--- 258
Query: 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL--APLHDINEEPV 339
P + +P A L++KML DP R T++E L + +
Sbjct: 259 --SIP--------KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITC 308
Query: 340 CPRPFSFDFEHPSFTEENIKEL 361
P F S N K L
Sbjct: 309 LTIPPRFSIAPSSLDPSNRKPL 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 1e-53
Identities = 77/285 (27%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
R +G+G + +++T+E A K + + ++ EI + R + H++++
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
E + V++V EL L ++ + + LT+ RY+L Q++ G +Y+H
Sbjct: 81 HGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCSEYT 221
V+HRDLK NL LN + ++KIGDFGLA T E D + V+ T Y APE+L ++
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKVLCGTPNYIAPEVLSK-KGHS 193
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281
+D+WS+GCI+ ++ +P F I + Y
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK------------------NEY--- 232
Query: 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
P + +P A L++KML DP R T++E L
Sbjct: 233 --SIP--------KHINPVAASLIQKMLQTDPTARPTINELLNDE 267
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-53
Identities = 74/307 (24%), Positives = 133/307 (43%), Gaps = 50/307 (16%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIG-NAFDNR--IDAKRTLREIKLLRHMDHENII 102
+G+G + +V +N ET ++ A+K + F + + + RE + + H +I+
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 103 AIKDIIRPPQRETFNDVYIVYELMD-TDL-HQIIR---SHQDLTDDHCRYFLYQLLRGLK 157
+ + + +Y+V+E MD DL +I++ + ++ +++ Q+L L+
Sbjct: 90 ELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 158 YVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPEL 213
Y H N++HRD+KP +LL + +K+G FG+A E+ V T + APE
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE- 203
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP--DETSLGFLR 271
++ Y +D+W G IL ++ L L G T
Sbjct: 204 VVKREPYGKPVDVWGCGVIL--------------FI--L-----LSGCLPFYGTKERLFE 242
Query: 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331
+Y + ++ + S A DL+ +ML+ DP RITV EAL HP+L
Sbjct: 243 GIIKGKY-----KMN----PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293
Query: 332 HDINEEP 338
+
Sbjct: 294 DRYAYKI 300
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-53
Identities = 81/291 (27%), Positives = 124/291 (42%), Gaps = 46/291 (15%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G GA+ V T + A+K I + EI +L+ + HENI+ ++
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
DI E+ Y+V +L+ +L I T+ + Q+L +KY+H +
Sbjct: 73 DIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGI 127
Query: 165 LHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+HRDLKP NLL N + I DFGL++ + M+ T Y APE +L Y+
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSK-MEQNGIMSTACGTPGYVAPE-VLAQKPYS 185
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRY 278
A+D WS+G I Y+ L L G P +ET Y
Sbjct: 186 KAVDCWSIGVIT--------------YI--L-----LCGYPPFYEETESKLFEKIKEGYY 224
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
+F S + + S A D + +L DPN R T ++AL HP++
Sbjct: 225 -----EFE----SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-53
Identities = 78/325 (24%), Positives = 123/325 (37%), Gaps = 69/325 (21%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH 95
+ V + +G G+ G V S VA+K++ F + EIKLL
Sbjct: 12 SLKNLVVSE-KILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIAL-----MEIKLLTE 64
Query: 96 MD-HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQD-------LTDDHCRY 147
D H N+I T +YI EL + +L ++ S + +
Sbjct: 65 SDDHPNVIRYYCSE-----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 148 FLYQLLRGLKYVHSANVLHRDLKPSNLLL-------------NANCDLKIGDFGLART-- 192
L Q+ G+ ++HS ++HRDLKP N+L+ N + I DFGL +
Sbjct: 120 LLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179
Query: 193 ---TSETDFMTEYVVTRWYRAPELLLNCSE------YTAAIDIWSVGCILGEIMTRQPLF 243
+S + T +RAPELL + T +IDI+S+GC+ I+++
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239
Query: 244 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVD 303
G Y R N R + L + + A D
Sbjct: 240 FGDKY---------------------SRESNIIRGIFSLDEMK----CLHDRSLIAEATD 274
Query: 304 LLEKMLVFDPNRRITVDEALCHPYL 328
L+ +M+ DP +R T + L HP
Sbjct: 275 LISQMIDHDPLKRPTAMKVLRHPLF 299
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 7e-53
Identities = 67/301 (22%), Positives = 123/301 (40%), Gaps = 45/301 (14%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G GA+G+V + T K I +D EI ++ + H +I +
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHPKLINLH 114
Query: 106 DIIRPPQRETFNDVYIVYELMD-TDLH-QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
D E ++ ++ E + +L +I +++ ++ Q GLK++H +
Sbjct: 115 DAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 164 VLHRDLKPSNLLL--NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
++H D+KP N++ +KI DFGLA + + + T + APE +++
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-IVDREPVG 228
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRY 278
D+W++G + YV L L G E L L++ +
Sbjct: 229 FYTDMWAIGVLG--------------YV--L-----LSGLSPFAGEDDLETLQNVKRCDW 267
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 338
+F F + SP A D ++ +L +P +R+TV +AL HP+L H
Sbjct: 268 -----EFD----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318
Query: 339 V 339
+
Sbjct: 319 I 319
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-51
Identities = 79/304 (25%), Positives = 133/304 (43%), Gaps = 43/304 (14%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAI 104
+G G+Y + ++ T E A+K I ++ D EI++L H NII +
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIID---KSKRDPTE---EIEILLRYGQHPNIITL 81
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
KD+ + VY+V ELM +L I + ++ L+ + + ++Y+H+
Sbjct: 82 KDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG 136
Query: 164 VLHRDLKPSNLLLNANCD----LKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCS 218
V+HRDLKPSN+L ++I DFG A+ +E + T + APE +L
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE-VLERQ 195
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278
Y AA DIWS+G +L ++T F PD+T L + ++
Sbjct: 196 GYDAACDIWSLGVLLYTMLTGYTPF---------------ANGPDDTPEEILARIGSGKF 240
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 338
+ + S A DL+ KML DP++R+T L HP++ + +
Sbjct: 241 -----SLS----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQ 291
Query: 339 VCPR 342
+ +
Sbjct: 292 LNRQ 295
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 83/336 (24%), Positives = 136/336 (40%), Gaps = 46/336 (13%)
Query: 2 SGESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKY-VPPIRPVGRGAYGIVCAAM 60
+ +P + V V+ Y V +G G +G V
Sbjct: 50 ERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCE 109
Query: 61 NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120
+ T ++A K I D + EI ++ +DH N+I + D E+ ND+
Sbjct: 110 ETATGLKLAAKII--KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKNDIV 162
Query: 121 IVYELMDT-DLH-QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL-- 176
+V E +D +L +II +LT+ F+ Q+ G++++H +LH DLKP N+L
Sbjct: 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222
Query: 177 NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 236
+KI DFGLAR + + T + APE ++N + D+WSVG I
Sbjct: 223 RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIA--- 278
Query: 237 MTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRYVRMLPQFPKQNFSAR 293
Y+ L L G + L + A R+
Sbjct: 279 -----------YM--L-----LSGLSPFLGDNDAETLNNILACRW-----DLE----DEE 311
Query: 294 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
F + S A + + K+L+ + + RI+ EAL HP+L+
Sbjct: 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 45/292 (15%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+G GA+G+V T A K + + D + +EI+ + + H ++ +
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFV--MTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 106 DIIRPPQRETFNDVYIVYELMD-TDL-HQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
D E N++ ++YE M +L ++ H +++D ++ Q+ +GL ++H N
Sbjct: 221 DAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 164 VLHRDLKPSNLLL--NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+H DLKP N++ + +LK+ DFGL + T + APE +
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVG 334
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRY 278
D+WSVG + Y+ L L G E LR+ + +
Sbjct: 335 YYTDMWSVGVLS--------------YI--L-----LSGLSPFGGENDDETLRNVKSCDW 373
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330
+ F S D + K+L+ DPN R+T+ +AL HP+L P
Sbjct: 374 -----NMD----DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 416
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-51
Identities = 61/311 (19%), Positives = 105/311 (33%), Gaps = 66/311 (21%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIA 103
+ +G G +G V + AIK+ +D + LRE+ + H +++
Sbjct: 16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD----LTDDHCRYFLYQLLRGLKY 158
+ + I E + L I + + + L Q+ RGL+Y
Sbjct: 76 YFSAW-----AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 159 VHSANVLHRDLKPSNLLLNAN-------------------CDLKIGDFGLARTTSETDFM 199
+HS +++H D+KPSN+ ++ KIGD G S
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190
Query: 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 259
+ A E+L + DI+++ + +PL D H++R
Sbjct: 191 ---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIR-----Q 242
Query: 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 319
G P+ P Q S F +LL+ M+ DP RR +
Sbjct: 243 GRL--------------------PRIP-QVLSQEF-------TELLKVMIHPDPERRPSA 274
Query: 320 DEALCHPYLAP 330
+ H L
Sbjct: 275 MALVKHSVLLS 285
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-51
Identities = 66/312 (21%), Positives = 113/312 (36%), Gaps = 48/312 (15%)
Query: 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK 91
G++ + K+ I+ +G G + V A+K+I + D + RE
Sbjct: 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI--LCHEQQDREEAQREAD 78
Query: 92 LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD----LTDDHCR 146
+ R +H NI+ + +R ++ +++ L I +D LT+D
Sbjct: 79 MHRLFNHPNILRLVAYCLR-ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART------TSETDFMT 200
+ L + RGL+ +H+ HRDLKP+N+LL + D G S
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 201 EYVVTR----WYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRL 254
+ + YRAPEL D+WS+GC+L +M + +
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV-------- 249
Query: 255 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN 314
F + D+ V+ P+ P S LL M+ DP+
Sbjct: 250 --------------FQKGDSVALAVQNQLSIPQ------SPRHSSALWQLLNSMMTVDPH 289
Query: 315 RRITVDEALCHP 326
+R + L
Sbjct: 290 QRPHIPLLLSQL 301
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-51
Identities = 73/305 (23%), Positives = 135/305 (44%), Gaps = 37/305 (12%)
Query: 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-H 98
+P+G G++ I ++ ++ + A+K I ++ T +EI L+ + H
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII-----SKRMEANTQKEITALKLCEGH 65
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
NI+ + ++ ++V EL++ +L + I+ + ++ Y + +L+ +
Sbjct: 66 PNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS 120
Query: 158 YVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPEL 213
++H V+HRDLKP NLL N N ++KI DFG AR + + T Y APE
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE- 179
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
LLN + Y + D+WS+G IL +++ Q F D E+
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEI--------------- 224
Query: 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333
++ + F + N S A DL++ +L DPN+R+ + + +L
Sbjct: 225 -MKKIKKGDFSFE----GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279
Query: 334 INEEP 338
++ P
Sbjct: 280 LSSNP 284
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-50
Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 49/289 (16%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+G+G++ V A + T EVAIK I A +R E+K+ + H +I+ +
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 105 KDIIRPPQRETFNDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+ E N VY+V E+ + + +++ R+F++Q++ G+ Y
Sbjct: 77 YNYF-----EDSNYVYLVLEMCHNGEMNR----YLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLA-RTTSETDFMTEYVVTRWYRAPELLLNC 217
+HS +LHRDL SNLLL N ++KI DFGLA + + T Y +PE+
Sbjct: 128 LHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR- 186
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
S + D+WS+GC+ ++ +P F + L +
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV------------------LAD 228
Query: 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
Y + P S A DL+ ++L +P R+++ L HP
Sbjct: 229 Y-----EMP--------SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-50
Identities = 69/297 (23%), Positives = 121/297 (40%), Gaps = 40/297 (13%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH-MDHENIIAIKDI 107
G G G V + T ++ A+K + D+ + +E+ +I+ I D+
Sbjct: 38 GLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCILDV 90
Query: 108 IRPPQRETFNDVYIVYELMDTD--LHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
+ I+ E M+ +I R Q T+ + + ++++HS N+
Sbjct: 91 YENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 165 LHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
HRD+KP NLL + LK+ DFG A+ T++ T T +Y APE+L Y
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVLGPEK-YD 207
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281
+ D+WS+G I+ ++ P F + S G R +Y
Sbjct: 208 KSCDMWSLGVIMYILLCGFPPFYSN--------------TGQAISPGMKRRIRLGQY--- 250
Query: 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 338
FP + + S A L+ +L DP R+T+ + + HP++ + + P
Sbjct: 251 --GFP----NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-50
Identities = 73/302 (24%), Positives = 125/302 (41%), Gaps = 43/302 (14%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAI 104
+ +G G G V N T+E+ A+K + D + RE++L +I+ I
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 120
Query: 105 KDIIRPPQRETFNDVYIVYELMD--TDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHS 161
D+ + IV E +D +I R Q T+ + + ++Y+HS
Sbjct: 121 VDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 162 ANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 218
N+ HRD+KP NLL N LK+ DFG A+ T+ + +T T +Y APE+L
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 239
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI--GSPDETSLGFLRSDNAR 276
Y + D+WS+G I+ ++ P F + + I G +
Sbjct: 240 -YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE------------- 285
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336
FP + + S L+ +L +P +R+T+ E + HP++ + +
Sbjct: 286 --------FP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 333
Query: 337 EP 338
P
Sbjct: 334 TP 335
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 4e-50
Identities = 73/317 (23%), Positives = 136/317 (42%), Gaps = 75/317 (23%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI------------------------GNAFDNR 80
+G+G+YG+V A N A+K + G R
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 81 IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE------LMDTDLHQII 134
++ +EI +L+ +DH N++ + +++ P + +Y+V+E +M+ +
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVME------V 128
Query: 135 RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194
+ + L++D R++ L++G++Y+H ++HRD+KPSNLL+ + +KI DFG++
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 195 ETDFMTEYVV-TRWYRAPELLLNCS-EYT-AAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 251
+D + V T + APE L ++ A+D+W++G L Y
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL--------------YC-- 232
Query: 252 LRLITELIGS-P-DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKML 309
+ G P + + L + +FP P+ + DL+ +ML
Sbjct: 233 --FVF---GQCPFMDERIMCLH----SKIKSQALEFP------DQPDIAEDLKDLITRML 277
Query: 310 VFDPNRRITVDEALCHP 326
+P RI V E HP
Sbjct: 278 DKNPESRIVVPEIKLHP 294
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-49
Identities = 66/291 (22%), Positives = 123/291 (42%), Gaps = 56/291 (19%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDA----KRTLREIKLLRHMDHENI 101
RP+G+G +G V A +++ +A+K + F +++ + RE+++ H+ H NI
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVL---FKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
+ + VY++ E +++ ++ + ++ +L L Y H
Sbjct: 72 LRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPELLL 215
S V+HRD+KP NLLL + +LKI DFG + + +Y+ PE++
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPEMIE 180
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+ +D+WS+G + E + +P F Y + I
Sbjct: 181 G-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------------------- 219
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
R+ FP + GA DL+ ++L +P++R + E L HP
Sbjct: 220 ---SRVEFTFP--------DFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 6e-49
Identities = 59/286 (20%), Positives = 121/286 (42%), Gaps = 36/286 (12%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+GRG++ V +++ET EVA ++ + + + +R E ++L+ + H NI+ D
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 108 IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN--V 164
+ + +V ELM + L ++ + + R + Q+L+GL+++H+ +
Sbjct: 94 WESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 165 LHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAA 223
+HRDLK N+ + +KIGD GLA + F + T + APE+ +Y +
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDES 209
Query: 224 IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 283
+D+++ G + E+ T + + Q+ P
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------------------A 249
Query: 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
F K P +++E + + + R ++ + L H +
Sbjct: 250 SFDK--------VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 8e-49
Identities = 70/311 (22%), Positives = 118/311 (37%), Gaps = 55/311 (17%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI------GNAFDNRIDAKRTLREIKLLRHMDH 98
+ P+G GA+G V A++ E +EV +K I + + + EI +L ++H
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMDT--DLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
NII + DI E +V E + DL I H L + Y QL+ +
Sbjct: 89 ANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAV 143
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN 216
Y+ +++HRD+K N+++ + +K+ DFG A + T Y APE+L+
Sbjct: 144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203
Query: 217 CSEYT-AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+ Y +++WS+G L Y L+
Sbjct: 204 -NPYRGPELEMWSLGVTL--------------YT----LVF-----------EENPFCEL 233
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL---APLH 332
V P S + L+ +L P RR T+++ + P++ L
Sbjct: 234 EETVEAAIHPP--------YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLA 285
Query: 333 DINEEPVCPRP 343
D E V
Sbjct: 286 DYTWEEVFRVN 296
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-48
Identities = 88/328 (26%), Positives = 147/328 (44%), Gaps = 47/328 (14%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
G G++G V A + +T+++VA+K I R REI L+ + H +II + D+
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 108 IRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHR 167
I T D+ +V E +L I + +T+D R F Q++ ++Y H ++HR
Sbjct: 78 I-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHR 132
Query: 168 DLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT-AAIDI 226
DLKP NLLL+ N ++KI DFGL+ ++ +F+ + Y APE++ Y +D+
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-KLYAGPEVDV 191
Query: 227 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 286
WS G +L ++ + F + + + + +P F
Sbjct: 192 WSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS----------CVYV----------MPDFL 231
Query: 287 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP--------YLAPLHDINEEP 338
SPGA L+ +M+V DP +RIT+ E P YL P+ ++
Sbjct: 232 -----------SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 280
Query: 339 VCPRPFSFDFEHPSFTEENIKELIYRES 366
R S E F+E+ I E + +
Sbjct: 281 ADSRIVSKLGEAMGFSEDYIVEALRSDE 308
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 8e-48
Identities = 69/315 (21%), Positives = 136/315 (43%), Gaps = 45/315 (14%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108
G+G + V A + T EVAIK I N ++ RE+++++ ++H NI+ + ++I
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 109 RPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHR 167
ET +Y++ E ++ + +H + + R Q++ ++Y H ++HR
Sbjct: 84 -----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHR 138
Query: 168 DLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT-AAIDI 226
DLK NLLL+A+ ++KI DFG + + + + Y APEL +Y +D+
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG-KKYDGPEVDV 197
Query: 227 WSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP 286
WS+G IL +++ F G++ + G R +P +
Sbjct: 198 WSLGVILYTLVSGSLPFDGQNLKELRERVLR----------GKYR----------IPFYM 237
Query: 287 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSF 346
S +LL++ LV +P +R T+++ + ++ N F
Sbjct: 238 -----------STDCENLLKRFLVLNPIKRGTLEQIMKDRWI------NAGHEEDELKPF 280
Query: 347 DFEHPSFTEENIKEL 361
+++ ++
Sbjct: 281 VEPELDISDQKRIDI 295
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-47
Identities = 72/303 (23%), Positives = 119/303 (39%), Gaps = 46/303 (15%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH-MDHENIIAIKDI 107
G GA+ V +N T +E A+K I R RE+++L H N++ + +
Sbjct: 22 GEGAHARVQTCINLITSQEYAVKII--EKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 108 IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLH 166
E + Y+V+E M + I + + + + L ++H+ + H
Sbjct: 80 F-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAH 134
Query: 167 RDLKPSNLLL---NANCDLKIGDFGLAR--------TTSETDFMTEYVVTRWYRAPELLL 215
RDLKP N+L N +KI DF L + T + + Y APE++
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194
Query: 216 NCSE----YTAAIDIWSVGCIL-----GEIMTRQPLFPGKDYVHQLRLITELIGSPDETS 266
SE Y D+WS+G IL G P F G+ + +
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSG-----YPPFVGR---CGSDCGWDRGEACPACQ 246
Query: 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
S +Y +FP + + S A DL+ K+LV D +R++ + L HP
Sbjct: 247 NMLFESIQEGKY-----EFP----DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP 297
Query: 327 YLA 329
++
Sbjct: 298 WVQ 300
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 161 bits (411), Expect = 2e-47
Identities = 67/291 (23%), Positives = 122/291 (41%), Gaps = 56/291 (19%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDA----KRTLREIKLLRHMDHENI 101
RP+G+G +G V A + + +A+K + F ++++ + REI++ H+ H NI
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVL---FKSQLEKEGVEHQLRREIEIQSHLRHPNI 76
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
+ + + +Y++ E +L++ ++ H + F+ +L L Y H
Sbjct: 77 LRMYNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-----EYVVTRWYRAPELLL 215
V+HRD+KP NLL+ +LKI DFG + T +Y+ PE++
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPEMIE 185
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+ +D+W G + E + P F + R I
Sbjct: 186 G-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI-------------------- 224
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
V + +FP P S G+ DL+ K+L + P +R+ + + HP
Sbjct: 225 ---VNVDLKFP--------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-47
Identities = 67/331 (20%), Positives = 127/331 (38%), Gaps = 64/331 (19%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI---------------GNAFDNRIDAKRTLRE 89
IR + +G + + + + A+KK + + E
Sbjct: 36 IRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE 93
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDL-------- 140
++++ + +E + + II +++VYI+YE M+ + + L
Sbjct: 94 LQIITDIKNEYCLTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 141 TDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199
+ + +L Y+H+ N+ HRD+KPSN+L++ N +K+ DFG + +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 200 T-----EYVVTRWYRAPELLLNCSEY-TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL- 252
E++ PE N S Y A +DIWS+G L + F K + +L
Sbjct: 209 GSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262
Query: 253 -RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVF 311
+ T+ I P + + L + + S +D L+ L
Sbjct: 263 NNIRTKNIEYPLDRN-------------HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRK 309
Query: 312 DPNRRITVDEALCHP-----YLAPLHDINEE 337
+P RIT ++AL H + L + ++E
Sbjct: 310 NPAERITSEDALKHEWLADTNIEDLREFSKE 340
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-47
Identities = 66/315 (20%), Positives = 118/315 (37%), Gaps = 60/315 (19%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIG----NAFDNRIDAKRTLREIKLLRHMDHE- 99
+G G +G V + + VAIK + + + + R E+ LL+ +
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 100 -NIIAIKDIIRPPQRETFNDVYIVYELMDT--DLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
+I + D E + ++ E + DL I L ++ R F +Q+L +
Sbjct: 108 SGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162
Query: 157 KYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 215
++ H+ VLHRD+K N+L++ N +LK+ DFG +T + + TR Y PE +
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIR 221
Query: 216 NCSEYTAA-IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
Y +WS+G +L Y ++ G + ++
Sbjct: 222 Y-HRYHGRSAAVWSLGILL--------------YD----MVC-----------GDIPFEH 251
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL------ 328
+R F S L+ L P+ R T +E HP++
Sbjct: 252 DEEIIRGQVFFR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303
Query: 329 APLHDINEEPVCPRP 343
+I+ + P P
Sbjct: 304 QETAEIHLHSLSPGP 318
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-47
Identities = 66/290 (22%), Positives = 121/290 (41%), Gaps = 49/290 (16%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
VGRG++G V + +T + A+KK+ R++ R + E+ + I+ +
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFR-VEELVACAGLSSPRIVPLYGA 118
Query: 108 IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLH 166
+R V I EL++ L Q+I+ L +D Y+L Q L GL+Y+H+ +LH
Sbjct: 119 VR-----EGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILH 173
Query: 167 RDLKPSNLLLNAN-CDLKIGDFGLAR-----TTSETDFMTEYVV-TRWYRAPELLLNCSE 219
D+K N+LL+++ + DFG A ++ +Y+ T + APE+++
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KP 232
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
A +DIWS C++ ++ P Y + L ++ P
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGCH--PWTQY-FRGPLCLKIASEPPPI-------------- 275
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
+ P P+ +P +++ L +P R + E A
Sbjct: 276 ---REIP--------PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-46
Identities = 73/288 (25%), Positives = 120/288 (41%), Gaps = 42/288 (14%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G YGIV A + + +AIK+I EI L +H+ H+NI+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLKHKNIVQYLGS 87
Query: 108 IRPPQRETFNDVYIVYELMDTD-LHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHSAN 163
+ I E + L ++RS + ++ Q+L GLKY+H
Sbjct: 88 FS-----ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 164 VLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETDFMTEYVV-TRWYRAPELLLNCSE-Y 220
++HRD+K N+L+N + LKI DFG ++ + + TE T Y APE++ Y
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
A DIWS+GC + E+ T +P P + + +G
Sbjct: 203 GKAADIWSLGCTIIEMATGKP--PFYELGEPQAAMF-KVGMFKVH--------------- 244
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+ P+ + S A + K DP++R ++ L +L
Sbjct: 245 --PEIPE--------SMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-46
Identities = 85/333 (25%), Positives = 140/333 (42%), Gaps = 48/333 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +G G +G+ + T+E VA+K I + REI R + H NI+
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIER---GAAIDENVQREIINHRSLRHPNIVRF 81
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
K++I T + I+ E +L++ I + ++D R+F QLL G+ Y HS
Sbjct: 82 KEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 164 VLHRDLKPSNLLL--NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+ HRDLK N LL + LKI DFG ++++ V T Y APE+LL EY
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR-QEYD 195
Query: 222 -AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
D+WS G L YV L+G + F + R Y +
Sbjct: 196 GKIADVWSCGVTL--------------YVM-------LVG-----AYPFEDPEEPRDYRK 229
Query: 281 MLPQFPKQNFSARFPNK---SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 337
+ + + P+ SP L+ ++ V DP RI++ E H + L ++ +
Sbjct: 230 TIQRILSVKY--SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF--LKNLPAD 285
Query: 338 PVCPRPFSFDFEHPSFTEENIKEL--IYRESVK 368
+ F+ P +++ + I E+
Sbjct: 286 LMNESNTGSQFQEPEQPMQSLDTIMQIISEATI 318
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 49/321 (15%), Positives = 96/321 (29%), Gaps = 78/321 (24%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLRE----IKLLRHMDHENI 101
+G+ A + ET E + +A + ++E ++LLR + ++
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 102 I-------AIKDIIRPPQ-------RETFND-----VYIVYELMDTD-------LHQIIR 135
D+++ PQ R D + +Y M ++ L
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 136 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195
+H+ L Q++R L +H ++H L+P +++L+ + + F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 196 TDFMTEYVVTRWYRAPELLLNC----------SEYTAAIDIWSVGCILGEIMTRQPLFPG 245
V+R + PEL + T + D W++G ++ I
Sbjct: 259 R---VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 246 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 305
+ I R P LL
Sbjct: 316 DAALGGSEWI-----------------------FRSCKNIP------------QPVRALL 340
Query: 306 EKMLVFDPNRRITVDEALCHP 326
E L + R+ +A+ P
Sbjct: 341 EGFLRYPKEDRLLPLQAMETP 361
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-46
Identities = 70/314 (22%), Positives = 118/314 (37%), Gaps = 59/314 (18%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIG----NAFDNRIDAKRTLREIKLLRHMD----HEN 100
G+G +G V A R +VAIK I + D+ E+ LL + H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMDT--DLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+I + D ET +V E DL I L + R F Q++ +++
Sbjct: 100 VIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 159 VHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217
HS V+HRD+K N+L++ K+ DFG + + + TR Y PE +
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWISR- 212
Query: 218 SEYTAA-IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
+Y A +WS+G +L Y ++ G + + +
Sbjct: 213 HQYHALPATVWSLGILL--------------YD----MVC-----------GDIPFERDQ 243
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL---APLHD 333
+ FP + SP L+ + L P+ R +++E L P++ A
Sbjct: 244 EILEAELHFP--------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP 295
Query: 334 INEEPVCPRPFSFD 347
+N P P ++
Sbjct: 296 LNPSKGGPAPLAWS 309
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 9e-46
Identities = 75/294 (25%), Positives = 119/294 (40%), Gaps = 62/294 (21%)
Query: 49 GRGAYGIVCAAMNSETREEVAIK-----KIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
G GAYG V A+N T E VA+K + + + +EI + + ++HEN++
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD------CPENIKKEICINKMLNHENVVK 69
Query: 104 IKDIIRPPQRETFNDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
N Y+ Y EL D I + + + F +QL+ G+
Sbjct: 70 FYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELL 214
Y+H + HRD+KP NLLL+ +LKI DFGLA R + + + T Y APELL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 215 LNCSEYTAA-IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
E+ A +D+WS G +L ++ G L D
Sbjct: 180 KR-REFHAEPVDVWSCGIVL--------------TA----MLA-----------GELPWD 209
Query: 274 NARRYVRMLPQFPKQNFSA-RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
+ + ++ + + LL K+LV +P+ RIT+ +
Sbjct: 210 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR 263
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 1e-45
Identities = 76/313 (24%), Positives = 124/313 (39%), Gaps = 47/313 (15%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHENIIAIKD 106
G G+YG V ++SET A+K + +EI+LLR + H+N+I + D
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 107 IIRPPQRETFNDVYIVYELM---DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
++ E +Y+V E ++ + + + QL+ GL+Y+HS
Sbjct: 74 VLYN---EEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG 129
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTT---SETDFMTEYVVTRWYRAPELLLNCSEY 220
++H+D+KP NLLL LKI G+A + D + ++ PE+ +
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 221 T-AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
+ +DIWS G L I T F G + I
Sbjct: 190 SGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG----------------------- 226
Query: 280 RMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 338
K ++ P P DLL+ ML ++P +R ++ + H + H E P
Sbjct: 227 -------KGSY--AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAP 277
Query: 339 VCPRPFSFDFEHP 351
V P P S D +
Sbjct: 278 V-PIPPSPDTKDR 289
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-45
Identities = 76/287 (26%), Positives = 118/287 (41%), Gaps = 46/287 (16%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+G G +G V + T +VA+K + + + REI+ L+ H +II +
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
+I T D ++V E + +L I H + + R Q+L + Y H
Sbjct: 77 YQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT-A 222
V+HRDLKP N+LL+A+ + KI DFGL+ S+ +F+ + Y APE++ Y
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGP 190
Query: 223 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282
+DIWS G IL Y L+ G L D+ +
Sbjct: 191 EVDIWSCGVIL--------------YA----LLC-----------GTLPFDDEH-----V 216
Query: 283 PQFPKQNFSARF---PNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
P K+ F + LL ML DP +R T+ + H
Sbjct: 217 PTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHE 263
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 5e-45
Identities = 69/346 (19%), Positives = 126/346 (36%), Gaps = 60/346 (17%)
Query: 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK 91
G E+ + R + G + V A + + E A+K++ + + ++E+
Sbjct: 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVC 77
Query: 92 LLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD----TDLHQII--RSHQDLTDDH 144
++ + H NI+ + E+ L + + + S L+ D
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 145 CRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIGDFGLART---------T 193
YQ R ++++H ++HRDLK NLLL+ +K+ DFG A T +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
Query: 194 SETDFMTEYVVTR----WYRAPEL--LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 247
++ + E +TR YR PE+ L + DIW++GCIL + RQ F
Sbjct: 198 AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG- 256
Query: 248 YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEK 307
LR N +Y P + L+
Sbjct: 257 --------------------AKLRIVNG-KY-----SIPP------HDTQYTVFHSLIRA 284
Query: 308 MLVFDPNRRITVDEALCHPY-LAPLHDINEEPVCPRPFSFDFEHPS 352
ML +P R+++ E + +A ++N + + + S
Sbjct: 285 MLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGS 330
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-45
Identities = 79/341 (23%), Positives = 128/341 (37%), Gaps = 62/341 (18%)
Query: 49 GRGAYGIVCAAMNSETREEVAIK-----KIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
G GAYG V A+N T E VA+K + + + +EI + + ++HEN++
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD------CPENIKKEICINKMLNHENVVK 69
Query: 104 IKDIIRPPQRETFNDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
N Y+ Y EL D I + + + F +QL+ G+
Sbjct: 70 FYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA---RTTSETDFMTEYVVTRWYRAPELL 214
Y+H + HRD+KP NLLL+ +LKI DFGLA R + + + T Y APELL
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 215 LNCSEYTAA-IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
E+ A +D+WS G +L ++ G L D
Sbjct: 180 KR-REFHAEPVDVWSCGIVL--------------TA----MLA-----------GELPWD 209
Query: 274 NARRYVRMLPQ-FPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332
+ K+ + + + LL K+LV +P+ RIT+ + +
Sbjct: 210 QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269
Query: 333 DINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDP 373
+ F++ L + + P
Sbjct: 270 KKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTP 310
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-44
Identities = 66/302 (21%), Positives = 113/302 (37%), Gaps = 64/302 (21%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAI 104
+ +G G G V N T+E+ A+K + D + RE++L +I+ I
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 76
Query: 105 KDIIRPPQRETFNDVYIVYELMDTD--LHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHS 161
D+ + IV E +D +I R Q T+ + + ++Y+HS
Sbjct: 77 VDVYENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135
Query: 162 ANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 218
N+ HRD+KP NLL N LK+ DFG A E
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTG--E 173
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI--GSPDETSLGFLRSDNAR 276
+Y + D+WS+G I+ ++ P F + + I G +
Sbjct: 174 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE------------- 220
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336
FP + + S L+ +L +P +R+T+ E + HP++ + +
Sbjct: 221 --------FP----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ 268
Query: 337 EP 338
P
Sbjct: 269 TP 270
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 155 bits (392), Expect = 1e-43
Identities = 49/322 (15%), Positives = 93/322 (28%), Gaps = 71/322 (22%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLRE----IKLLRH------ 95
+G+ A + ET E + +A + ++E ++LLR
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 96 -MDHENIIAIKDIIRPPQRETFNDV------------YIVYELMDTDLHQIIRS------ 136
H I D+++ PQ++ V + +Y M ++L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 137 -HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195
H+ L Q++R L +H ++H L+P +++L+ + + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 196 TDFM--TEYVVTRWYRAPELLL----NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 249
+ A +L + + T A D W++G + I +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323
Query: 250 HQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKML 309
I R P LLE L
Sbjct: 324 GGSEWI-----------------------FRSCKNIP------------QPVRALLEGFL 348
Query: 310 VFDPNRRITVDEALCHPYLAPL 331
+ R+ +A+ P L
Sbjct: 349 RYPKEDRLLPLQAMETPEYEQL 370
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-42
Identities = 78/284 (27%), Positives = 123/284 (43%), Gaps = 46/284 (16%)
Query: 49 GRGAYGIVCAAMNSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
G G +G V + T +VA+K + + + REI+ L+ H +II + +
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 108 IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLH 166
I T +D+++V E + +L I + L + R Q+L G+ Y H V+H
Sbjct: 85 I-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVH 139
Query: 167 RDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT-AAID 225
RDLKP N+LL+A+ + KI DFGL+ S+ +F+ + Y APE++ Y +D
Sbjct: 140 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-RLYAGPEVD 198
Query: 226 IWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQF 285
IWS G IL Y L+ G L D+ +P
Sbjct: 199 IWSSGVIL--------------YA----LLC-----------GTLPFDDDH-----VPTL 224
Query: 286 PKQNFSARF---PNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
K+ F +P + LL+ ML DP +R T+ + H
Sbjct: 225 FKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHE 268
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 4e-42
Identities = 66/357 (18%), Positives = 118/357 (33%), Gaps = 103/357 (28%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
PI+ +GRG +G+V A N AIK+I + + ++ +RE+K L ++H I+
Sbjct: 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHPGIVR 68
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT-------------DLHQIIRSHQDLTDDHCRYF-- 148
+ E + + L D IR + +
Sbjct: 69 YFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQ 128
Query: 149 -------------------LYQLLR----------------------GLKYVHSANVLHR 167
L + ++++HS ++HR
Sbjct: 129 PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHR 188
Query: 168 DLKPSNLLLNANCDLKIGDFGLARTTSETDF-------------MTEYVVTRWYRAPELL 214
DLKPSN+ + +K+GDFGL + + T V T+ Y +PE +
Sbjct: 189 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248
Query: 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
+ Y+ +DI+S+G IL E++ + V + +
Sbjct: 249 HG-NNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDVRN----------------- 288
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331
+FP F K P +++ ML P R + + + L
Sbjct: 289 --------LKFPLL-----FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-41
Identities = 82/308 (26%), Positives = 135/308 (43%), Gaps = 53/308 (17%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK-LL 93
EV + PI +GRGAYG+V + + + +A+K+I A N + KR L ++ +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISM 60
Query: 94 RHMDHENIIA-----IKDIIRPPQRETFNDVYIVYELMDT----DLHQIIRSHQDLTDDH 144
R +D + ++ DV+I ELMDT Q+I Q + +D
Sbjct: 61 RTVDCPFTVTFYGALFRE----------GDVWICMELMDTSLDKFYKQVIDKGQTIPEDI 110
Query: 145 CRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 203
+++ L+++HS +V+HRD+KPSN+L+NA +K+ DFG++ +
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 204 VTRWYRAPE---LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 260
+ Y APE LN Y+ DIWS+G + E+ + FP + + + +++
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVE 228
Query: 261 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD 320
P PQ P FSA F VD + L + R T
Sbjct: 229 EPS-------------------PQLPADKFSAEF-------VDFTSQCLKKNSKERPTYP 262
Query: 321 EALCHPYL 328
E + HP+
Sbjct: 263 ELMQHPFF 270
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-39
Identities = 65/324 (20%), Positives = 126/324 (38%), Gaps = 47/324 (14%)
Query: 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK 91
+ E+ I +G G G+V + + +A K I + + +RE++
Sbjct: 25 QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQ 83
Query: 92 LLRHMDHENIIA-----IKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQDLTDDHC 145
+L + I+ D ++ I E MD L Q+++ + +
Sbjct: 84 VLHECNSPYIVGFYGAFYSD----------GEISICMEHMDGGSLDQVLKKAGRIPEQIL 133
Query: 146 RYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV 204
+++GL Y+ ++HRD+KPSN+L+N+ ++K+ DFG++ ++ + +V
Sbjct: 134 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVG 192
Query: 205 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 264
TR Y +PE L + Y+ DIWS+G L E+ + P D + +
Sbjct: 193 TRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 251
Query: 265 TSLGFLRSDNARRYVRML--------------------PQFPKQNFSARFPNKSPGAVDL 304
+ R+ + P+ P FS F D
Sbjct: 252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF-------QDF 304
Query: 305 LEKMLVFDPNRRITVDEALCHPYL 328
+ K L+ +P R + + + H ++
Sbjct: 305 VNKCLIKNPAERADLKQLMVHAFI 328
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 72/293 (24%), Positives = 132/293 (45%), Gaps = 53/293 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+G+GA G V AM+ T +EVAI+++ + + + EI ++R + NI+
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI--INEILVMRENKNPNIVNY 82
Query: 105 KDIIRPPQRETF---NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
D ++ +++++V E + TD + + + + + L+ L+
Sbjct: 83 LD--------SYLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALE 130
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLN 216
++HS V+HRD+K N+LL + +K+ DFG A+ T E + V T ++ APE++
Sbjct: 131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
Y +DIWS+G + E++ +P P + + LR + +L + N
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEP--PYLN-ENPLRAL-------------YLIATNGT 233
Query: 277 RYVRMLPQFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+ + SA F D L + L D +R + E L H +L
Sbjct: 234 ------PELQNPEKLSAIF-------RDFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 61/323 (18%), Positives = 111/323 (34%), Gaps = 54/323 (16%)
Query: 45 IRPVGRGA--YGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII 102
+ +G+G V A T E V +++I + E+ + + +H NI+
Sbjct: 30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89
Query: 103 AIKDIIRPPQRETF---NDVYIVYELMDT-DLHQIIRSHQD--LTDDHCRYFLYQLLRGL 156
+ TF N++++V M +I +H + + Y L +L+ L
Sbjct: 90 PYRA--------TFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA--------RTTSETDFMTEYVVTRWY 208
Y+H +HR +K S++L++ + + + R DF V +
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 209 RAPELLL-NCSEYTAAIDIWSVGC-------------------ILGEIMTRQP--LFPGK 246
+PE+L N Y A DI+SVG +L E + L
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTS 261
Query: 247 DYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ-NFSARFPNKSPGAVDLL 305
+ ++ + L + R P P FS F +
Sbjct: 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF-------HHFV 314
Query: 306 EKMLVFDPNRRITVDEALCHPYL 328
E+ L +P+ R + L H +
Sbjct: 315 EQCLQRNPDARPSASTLLNHSFF 337
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-37
Identities = 68/293 (23%), Positives = 129/293 (44%), Gaps = 51/293 (17%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHENIIA 103
+R +G G++G V A + E VAIKK+ + + + + +E++ L+ + H N I
Sbjct: 59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 104 IKDIIRPPQRETF---NDVYIVYELMDTDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYV 159
+ + + ++V E ++ H+ L + + L+GL Y+
Sbjct: 119 YRG--------CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC-- 217
HS N++HRD+K N+LL+ +K+GDFG A + + V T ++ APE++L
Sbjct: 171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDE 227
Query: 218 SEYTAAIDIWSVG--CILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+Y +D+WS+G CI E+ R+P P + ++ + + + + N
Sbjct: 228 GQYDGKVDVWSLGITCI--ELAERKP--PLFN-MNAMSAL-------------YHIAQNE 269
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P ++S F + ++ L P R T + L H ++
Sbjct: 270 S------PALQSGHWSEYF-------RNFVDSCLQKIPQDRPTSEVLLKHRFV 309
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-37
Identities = 66/313 (21%), Positives = 134/313 (42%), Gaps = 53/313 (16%)
Query: 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK 91
++ + + + + +GRGAYG V ++ + + +A+K+I + + + K+ L ++
Sbjct: 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLD 72
Query: 92 -LLRHMDHENIIA-----IKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-----HQDL 140
++R D I+ ++ D +I ELM T + + +
Sbjct: 73 VVMRSSDCPYIVQFYGALFRE----------GDCWICMELMSTSFDKFYKYVYSVLDDVI 122
Query: 141 TDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199
++ ++ L ++ ++HRD+KPSN+LL+ + ++K+ DFG++ ++
Sbjct: 123 PEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182
Query: 200 TEYVVTRWYRAPELL---LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH-QLRLI 255
T R Y APE + + Y D+WS+G L E+ T + +P + V QL +
Sbjct: 183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV 242
Query: 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR 315
+ G P + L ++ FS F ++ + L D ++
Sbjct: 243 VK--GDPPQ-----------------LSNSEEREFSPSF-------INFVNLCLTKDESK 276
Query: 316 RITVDEALCHPYL 328
R E L HP++
Sbjct: 277 RPKYKELLKHPFI 289
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-37
Identities = 51/213 (23%), Positives = 94/213 (44%), Gaps = 16/213 (7%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK 105
+ +G G++G V +VA+K + + E+ +LR H NI+
Sbjct: 30 QRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSAN 163
PQ + IV + + L+ + + + Q RG+ Y+H+ +
Sbjct: 87 GYSTAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCSE- 219
++HRDLK +N+ L+ + +KIGDFGLA S + + + + APE++
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 220 -YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 251
Y+ D+++ G +L E+MT Q + + Q
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-37
Identities = 70/293 (23%), Positives = 125/293 (42%), Gaps = 53/293 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+G G+ GIVC A + +VA+K + R + E+ ++R H N++ +
Sbjct: 50 YVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE--LLFNEVVIMRDYQHFNVVEM 107
Query: 105 KDIIRPPQRETF---NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
++ +++++ E + TD I S L ++ +L+ L
Sbjct: 108 YK--------SYLVGEELWVLMEFLQGGALTD----IVSQVRLNEEQIATVCEAVLQALA 155
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLN 216
Y+H+ V+HRD+K ++LL + +K+ DFG A+ + + V T ++ APE++
Sbjct: 156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR 215
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
S Y +DIWS+G ++ E++ +P P ++ + D+
Sbjct: 216 -SLYATEVDIWSLGIMVIEMVDGEP--PYFS-DSPVQAM-------------KRLRDSPP 258
Query: 277 RYVRMLPQFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P+ S D LE+MLV DP R T E L HP+L
Sbjct: 259 ------PKLKNSHKVSPVL-------RDFLERMLVRDPQERATAQELLDHPFL 298
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 26/231 (11%)
Query: 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKI--GNAFDNRIDAKRTLREIK 91
L E+ + +G G +G V A EVA+K D + +E K
Sbjct: 1 LLEIDFAELTLEEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAK 58
Query: 92 LLRHMDHENIIAIKDI-IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFL 149
L + H NIIA++ + ++ P ++ +V E L++++ + + D +
Sbjct: 59 LFAMLKHPNIIALRGVCLKEP------NLCLVMEFARGGPLNRVLSGKR-IPPDILVNWA 111
Query: 150 YQLLRGLKYVHSAN---VLHRDLKPSNLLLN--------ANCDLKIGDFGLARTTSETDF 198
Q+ RG+ Y+H ++HRDLK SN+L+ +N LKI DFGLAR T
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK 171
Query: 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 249
M+ W APE++ S ++ D+WS G +L E++T + F G D +
Sbjct: 172 MSAAGAYAW-MAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKI-GNAFDNRIDAKRTL----REIKLLRHMDHENII 102
+G+G +G+V + + VAIK + + + RE+ ++ +++H NI+
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 103 AIKDI-IRPPQRETFNDVYIVYELMDT-DLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYV 159
+ + PP +V E + DL+ + + + + G++Y+
Sbjct: 87 KLYGLMHNPP--------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 160 HSAN--VLHRDLKPSNLLL-----NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 212
+ N ++HRDL+ N+ L NA K+ DFGL++ + + ++ + + APE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPE 196
Query: 213 LLLNCSE-YTAAIDIWSVGCILGEIMTRQPLFPGKDYVH 250
+ E YT D +S IL I+T + F Y
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 64/298 (21%), Positives = 112/298 (37%), Gaps = 54/298 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK-LLRHMDHENIIA 103
+ +G G G V +T +A+K++ + + + KR L ++ +L+ D I+
Sbjct: 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQ 88
Query: 104 -----IKDIIRPPQRETFNDVYIVYELMDTDLHQII-RSHQDLTDDHCRYFLYQLLRGLK 157
I + DV+I ELM T ++ R + + +++ L
Sbjct: 89 CFGTFITN----------TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALY 138
Query: 158 YVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE---- 212
Y+ V+HRD+KPSN+LL+ +K+ DFG++ + Y APE
Sbjct: 139 YLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDP 198
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271
+Y D+WS+G L E+ T + P K L + + P
Sbjct: 199 PDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP--------- 247
Query: 272 SDNARRYVRMLPQFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P P FS F ++ L D +R ++ L H ++
Sbjct: 248 -----------PLLPGHMGFSGDF-------QSFVKDCLTKDHRKRPKYNKLLEHSFI 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 68/227 (29%), Positives = 106/227 (46%), Gaps = 24/227 (10%)
Query: 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKL 92
+L + K + VGRGA+G+VC A +VAIK+I ++ + K + E++
Sbjct: 1 SLHMIDYKEIEVEEVVGRGAFGVVCKAKWRAK--DVAIKQI----ESESERKAFIVELRQ 54
Query: 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ---DLTDDHCRYF 148
L ++H NI+ + N V +V E + L+ ++ + T H +
Sbjct: 55 LSRVNHPNIVKLYGA-------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 107
Query: 149 LYQLLRGLKYVHSAN---VLHRDLKPSNLLLNANCD-LKIGDFGLARTTSETDFMTEYVV 204
Q +G+ Y+HS ++HRDLKP NLLL A LKI DFG A MT
Sbjct: 108 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKG 165
Query: 205 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 251
+ + APE + S Y+ D++S G IL E++TR+ F
Sbjct: 166 SAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-36
Identities = 75/293 (25%), Positives = 132/293 (45%), Gaps = 53/293 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G G+YG V A++ ET + VAIK++ D + ++EI +++ D +++
Sbjct: 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCDSPHVVKY 89
Query: 105 KDIIRPPQRETF---NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
++ D++IV E +D+ ++ ++ LT+D L L+GL+
Sbjct: 90 YG--------SYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLE 139
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLN 216
Y+H +HRD+K N+LLN K+ DFG+ + T + T ++ APE++
Sbjct: 140 YLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
Y DIWS+G E+ +P P D +H +R I F+ N
Sbjct: 200 -IGYNCVADIWSLGITAIEMAEGKP--PYAD-IHPMRAI-------------FMIPTNPP 242
Query: 277 RYVRMLPQFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P F + +S F D +++ LV P +R T + L HP++
Sbjct: 243 ------PTFRKPELWSDNF-------TDFVKQCLVKSPEQRATATQLLQHPFV 282
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-36
Identities = 53/210 (25%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKD 106
+G G++G V A + +VA+K + + LRE+ +++ + H NI+ +
Sbjct: 45 IGAGSFGTVHRAEWHGS--DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 107 IIRPPQRETFNDVYIVYELMD-TDLHQIIR---SHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ +PP + IV E + L++++ + + L + Y + +G+ Y+H+
Sbjct: 103 VTQPPN------LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 163 N--VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCSE 219
N ++HR+LK NLL++ +K+ DFGL+R + T T + APE +L
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE-VLRDEP 215
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYV 249
D++S G IL E+ T Q + +
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPWGNLNPA 245
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 52/219 (23%), Positives = 93/219 (42%), Gaps = 27/219 (12%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-I 104
+G+G +G V EVAI+ I DN K RE+ R HEN++ +
Sbjct: 39 ELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSA 162
+ PP + I+ L L+ ++R + L + R ++++G+ Y+H+
Sbjct: 96 GACMSPPH------LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK 149
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY----VVTRWYR--APELLLN 216
+LH+DLK N+ + N + I DFGL + + W APE++
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 217 CSE--------YTAAIDIWSVGCILGEIMTRQPLFPGKD 247
S ++ D++++G I E+ R+ F +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP 247
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 82/366 (22%), Positives = 140/366 (38%), Gaps = 94/366 (25%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-----DHE 99
IR +G G + V + + + ++ VA+K + + ++ + L EI+LL+ + +
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTET--ALDEIRLLKSVRNSDPNDP 98
Query: 100 NIIAIKDIIRPPQRETFND-------VYIVYELMDTDLHQIIRS--HQDLTDDHCRYFLY 150
N ++++ + F + +V+E++ L + I +Q L + +
Sbjct: 99 N----REMVVQL-LDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 151 QLLRGLKYVHS-ANVLHRDLKPSNLLLNAN------------------------------ 179
Q+L+GL Y+H+ ++H D+KP N+LL+ N
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 180 -------------------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY 220
+KI D G A + TE + TR YR+ E+L+ Y
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF--TEDIQTRQYRSLEVLIGS-GY 270
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPG-------KDYVHQLRLITELIGSPD-------ETS 266
DIWS C+ E+ T LF +D H + LI EL+G + S
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH-IALIIELLGKVPRKLIVAGKYS 329
Query: 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSP----GAVDLLEKMLVFDPNRRITVDEA 322
F +++ L + S G D L ML P +R T E
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
Query: 323 LCHPYL 328
L HP+L
Sbjct: 390 LRHPWL 395
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 69/302 (22%), Positives = 121/302 (40%), Gaps = 54/302 (17%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA---- 103
+G GA +V AA + +E+VAIK+I N + L+EI+ + H NI++
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 104 -IKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQD-----LTDDHCRYFLYQLL 153
+ +++++V +L+ D+ + I + + L + L ++L
Sbjct: 82 FVVK----------DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE------YVVTRW 207
GL+Y+H +HRD+K N+LL + ++I DFG++ + +T +V T
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267
+ APE++ Y DIWS G E+ T P Y ++++
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKY-PPMKVL------------ 236
Query: 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRITVDEALCHP 326
L N P K ++ L DP +R T E L H
Sbjct: 237 -MLTLQNDP------PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHK 289
Query: 327 YL 328
+
Sbjct: 290 FF 291
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-35
Identities = 72/295 (24%), Positives = 129/295 (43%), Gaps = 44/295 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIA 103
+ VG G YG V + +T + AIK + D + K+ EI +L+ H NI
Sbjct: 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHHRNIAT 85
Query: 104 IKDI-IRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
I+ + +++V E TDL + + + L ++ Y ++LRGL +
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICREILRGLSH 144
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNC 217
+H V+HRD+K N+LL N ++K+ DFG++ T ++ T ++ APE++
Sbjct: 145 LHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 218 ----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
+ Y D+WS+G E+ P P D +H +R + FL
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAP--PLCD-MHPMRAL-------------FLIPR 248
Query: 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
N P+ + +S +F +E LV + ++R ++ + HP++
Sbjct: 249 NPA------PRLKSKKWSKKF-------QSFIESCLVKNHSQRPATEQLMKHPFI 290
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-35
Identities = 65/297 (21%), Positives = 122/297 (41%), Gaps = 54/297 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G GA+G V A N ET A K I + ++ + EI++L DH I+ +
Sbjct: 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED--YIVEIEILATCDHPYIVKL 81
Query: 105 KDIIRPPQRETF---NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
+ ++I+ E + + LT+ + Q+L L
Sbjct: 82 LG--------AYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALN 131
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGL-ARTTSETDFMTEYVVTRWYRAPELLLN 216
++HS ++HRDLK N+L+ D+++ DFG+ A+ ++ T ++ APE+++
Sbjct: 132 FLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMC 191
Query: 217 C----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272
+ Y DIWS+G L E+ +P P + ++ +R++ +
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMAQIEP--PHHE-LNPMRVL-------------LKIA 235
Query: 273 DNARRYVRMLPQFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ P +S F D L+ L +P R + + L HP++
Sbjct: 236 KSDP------PTLLTPSKWSVEF-------RDFLKIALDKNPETRPSAAQLLEHPFV 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 1e-34
Identities = 36/228 (15%), Positives = 77/228 (33%), Gaps = 33/228 (14%)
Query: 45 IRPVGRGAYGIVCAAM-----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE 99
+G GA+ V A +++ +++ +K A N + + ++ L+
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQH 127
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-----QDLTDDHCRYFLYQLL 153
+ N +V EL L I + + + F ++L
Sbjct: 128 MFMKFYSAH-----LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 154 RGLKYVHSANVLHRDLKPSNLLLN-----------ANCDLKIGDFGLARTTS---ETDFM 199
++ VH ++H D+KP N +L + L + D G + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD 247
T T ++ E+L N + ID + V + ++ + +
Sbjct: 243 TAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNE 289
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 29/217 (13%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT-LREIKLLRHMDHENIIA-IK 105
+G+G +G + ET E + +K++ + + +RT L+E+K++R ++H N++ I
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 106 DIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSAN 163
+ + + + + E + L II+S F + G+ Y+HS N
Sbjct: 75 VLYKDKR------LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN 128
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---------------MTEYVVTRWY 208
++HRDL N L+ N ++ + DFGLAR + V ++
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 245
APE++ Y +D++S G +L EI+ R P
Sbjct: 189 MAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 69/295 (23%), Positives = 111/295 (37%), Gaps = 39/295 (13%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA- 103
++ +G+G YG V E+VA+K F + EI M HENI+
Sbjct: 42 VKQIGKGRYGEVWMGKWRG--EKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
I I+ T +Y++ + + L+ ++S L Y + GL ++H+
Sbjct: 97 IAADIKGTGSWT--QLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLHTE 153
Query: 163 N--------VLHRDLKPSNLLLNANCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYR 209
+ HRDLK N+L+ N I D GLA T V T+ Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 210 APELL-----LNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPD 263
PE+L N + D++S G IL E+ R ++Y + P
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV-----PS 268
Query: 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 318
+ S +R + +R P FP + S L+ + +P R+T
Sbjct: 269 DPSYEDMREIVCIKKLR--PSFPNRWSSDECL---RQMGKLMTECWAHNPASRLT 318
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-33
Identities = 32/206 (15%), Positives = 72/206 (34%), Gaps = 18/206 (8%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+ G + ++ +K + + ++ E LR H N++ +
Sbjct: 18 LNENHSGELWKGRWQGN--DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 108 -IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRY--FLYQLLRGLKYVHSAN 163
PP ++ M L+ ++ + D + F + RG+ ++H+
Sbjct: 76 CQSPPA----PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE 131
Query: 164 --VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--CSE 219
+ L +++++ + +I + + M W APE L
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP---AWV-APEALQKKPEDT 187
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPG 245
+ D+WS +L E++TR+ F
Sbjct: 188 NRRSADMWSFAVLLWELVTREVPFAD 213
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 70/293 (23%), Positives = 131/293 (44%), Gaps = 54/293 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL-REIKLLRHMDHENIIA 103
+ +G+G++G V +++ T++ VAIK I + D + +EI +L D +
Sbjct: 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 104 IKDIIRPPQRETF---NDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
++ ++I+ E + DL + L + L ++L+GL
Sbjct: 85 YYG--------SYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGL 132
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLL 215
Y+HS +HRD+K +N+LL+ + ++K+ DFG+A ++T +V T ++ APE++
Sbjct: 133 DYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK 192
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
S Y + DIWS+G E+ +P P + H ++++ FL N
Sbjct: 193 Q-SAYDSKADIWSLGITAIELARGEP--PHSEL-HPMKVL-------------FLIPKNN 235
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
P + N+S + +E L +P+ R T E L H ++
Sbjct: 236 -------PPTLEGNYSKPL-------KEFVEACLNKEPSFRPTAKELLKHKFI 274
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 59/259 (22%), Positives = 115/259 (44%), Gaps = 26/259 (10%)
Query: 21 HGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAA----MNSETREEVAIKKI-GN 75
H + Q + +++ I +G+G +G V + T VA+K++ +
Sbjct: 4 HHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS 63
Query: 76 AFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQII 134
D + D REI++L+ + + I+ + + P R++ + +V E + + L +
Sbjct: 64 GPDQQRD---FQREIQILKALHSDFIVKYRGVSYGPGRQS---LRLVMEYLPSGCLRDFL 117
Query: 135 RSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193
+ H+ L + Q+ +G++Y+ S +HRDL N+L+ + +KI DFGLA+
Sbjct: 118 QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177
Query: 194 SETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFP 244
YVV WY APE L + ++ D+WS G +L E+ T + P
Sbjct: 178 PLDK--DYYVVREPGQSPIFWY-APESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSP 233
Query: 245 GKDYVHQLRLITELIGSPD 263
+++ + ++
Sbjct: 234 SAEFLRMMGCERDVPALSR 252
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 62/242 (25%), Positives = 109/242 (45%), Gaps = 30/242 (12%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM----NSETREEVAIK--KIGNAFDNRIDAKRTLRE 89
++++ IR +G G +G V T E+VA+K K + ++ D +E
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---LKKE 73
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRY 147
I++LR++ HENI+ K I + ++ E + + L + + +++ +
Sbjct: 74 IEILRNLYHENIVKYKGICTEDGGNG---IKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 148 FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-- 205
+ Q+ +G+ Y+ S +HRDL N+L+ + +KIGDFGL + Y V
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK--EYYTVKDD 188
Query: 206 -----RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 260
WY APE L S++ A D+WS G L E++T + L ++IG
Sbjct: 189 RDSPVFWY-APE-CLMQSKFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIG 241
Query: 261 SP 262
Sbjct: 242 PT 243
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 32/214 (14%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLRE--IKLLRHMDHENIIA-I 104
VG+G YG V E VA+K + D K RE + + HENI+ I
Sbjct: 16 VGKGRYGEVWRGSWQG--ENVAVKIF-----SSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA- 162
+ T ++++ + L+ ++ L C + + GL ++H
Sbjct: 69 ASDMTSRHSST--QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 163 -------NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRA 210
+ HRDLK N+L+ N I D GLA S++ + T+ Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 211 PELL-----LNCSEYTAAIDIWSVGCILGEIMTR 239
PE+L ++C + +DIW+ G +L E+ R
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 4e-31
Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA----MNSETREEVAIKKI-GNAFDNRIDAKRTLREI 90
+ +++ ++ +G+G +G V + T E VA+KK+ + ++ D REI
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---FEREI 62
Query: 91 KLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYF 148
++L+ + H+NI+ K + R + ++ E + L ++ H++ + +
Sbjct: 63 EILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT--- 205
Q+ +G++Y+ + +HRDL N+L+ +KIGDFGL + + + V
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EFFKVKEPG 177
Query: 206 ----RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
WY APE L S+++ A D+WS G +L E+ T
Sbjct: 178 ESPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-31
Identities = 55/216 (25%), Positives = 106/216 (49%), Gaps = 22/216 (10%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA----MNSETREEVAIKKIGNAFDNRIDAKRTLREIK 91
+ +++ ++ +G+G +G V + T E VA+KK+ ++ + + REI+
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE--HLRDFEREIE 94
Query: 92 LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFL 149
+L+ + H+NI+ K + R + ++ E + L ++ H++ + +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 150 YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---- 205
Q+ +G++Y+ + +HRDL N+L+ +KIGDFGL + + Y V
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EYYKVKEPGE 209
Query: 206 ---RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
WY APE L S+++ A D+WS G +L E+ T
Sbjct: 210 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 69/241 (28%), Positives = 101/241 (41%), Gaps = 30/241 (12%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM----NSETREEVAIK--KIGNAFDNRIDAKRTLRE 89
++Y+ IR +G G +G V N T E VA+K K +R +E
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQE 83
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYF 148
I +LR + HE+II K + + +V E + L + H + F
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAAS---LQLVMEYVPLGSLRDYLPRHS-IGLAQLLLF 139
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT--- 205
Q+ G+ Y+H+ + +HRDL N+LL+ + +KIGDFGLA+ E Y V
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EYYRVREDG 197
Query: 206 ----RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 261
WY APE L + A D+WS G L E++T ELIG
Sbjct: 198 DSPVFWY-APECLKEYK-FYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGI 250
Query: 262 P 262
Sbjct: 251 A 251
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-30
Identities = 58/291 (19%), Positives = 101/291 (34%), Gaps = 37/291 (12%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKD 106
+G+G +G V EEVA+K + EI + HENI+ I
Sbjct: 50 IGKGRFGEVWRGKWRG--EEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 107 IIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA--- 162
+ T +++V + + L + + +T + GL ++H
Sbjct: 105 DNKDNGTWT--QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 163 -----NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV-----TRWYRAPE 212
+ HRDLK N+L+ N I D GLA + T+ Y APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 213 LL-----LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267
+L + E DI+++G + EI R + + +QL + P +
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED-YQLPYYDLVPSDPSVEEM 280
Query: 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 318
+ + R P P + S ++ + + R+T
Sbjct: 281 RKVVCEQKLR-----PNIPNRWQSCEAL---RVMAKIMRECWYANGAARLT 323
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 34/228 (14%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVC---AAMNSETREEVAIK--KIGNAFDNRIDAKRTLRE 89
+E+ R+ + R +G G +G V VAIK K + R L+E
Sbjct: 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF---LQE 66
Query: 90 IKLLRHMDHENIIAIKDII-RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCR 146
+R DH +I+ + +I P V+I+ EL +L ++ + L
Sbjct: 67 ALTMRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLI 119
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT- 205
+ YQL L Y+ S +HRD+ N+L+++N +K+GDFGL+R ++ Y
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 175
Query: 206 ------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W APE +N +T+A D+W G + EI+ +P F G
Sbjct: 176 KGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQG 220
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 55/222 (24%), Positives = 96/222 (43%), Gaps = 25/222 (11%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIK--KIGNAFDNRIDAKRTLREIKLL 93
++ + + +GRG +G V + VA+K + D + L+E ++L
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF---LQEARIL 166
Query: 94 RHMDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRSH-QDLTDDHCRYFL 149
+ H NI+ + + + P +YIV EL+ D +R+ L +
Sbjct: 167 KQYSHPNIVRLIGVCTQKQP-------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219
Query: 150 YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---- 205
G++Y+ S +HRDL N L+ LKI DFG++R ++ + +
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 206 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W APE LN Y++ D+WS G +L E + P +P
Sbjct: 280 KWT-APE-ALNYGRYSSESDVWSFGILLWETFSLGASP-YPN 318
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 62/290 (21%), Positives = 106/290 (36%), Gaps = 35/290 (12%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKD 106
RG +G V A E VA+K + + E+ L M HENI+ I
Sbjct: 32 KARGRFGCVWKAQLLN--EYVAVKIF---PIQDKQSWQNEYEVYSLPGMKHENILQFIGA 86
Query: 107 IIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA--- 162
R + D++++ + L ++++ ++ + + + RGL Y+H
Sbjct: 87 EKRGTSVDV--DLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARGLAYLHEDIPG 143
Query: 163 -------NVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPE 212
+ HRD+K N+LL N I DFGLA V TR Y APE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 213 LL----LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268
+L + ID++++G +L E+ +R G + L E+ P +
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ 263
Query: 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 318
+ +R P + +E+ D R++
Sbjct: 264 EVVVHKKKR-----PVLRDYWQKHAGM---AMLCETIEECWDHDAEARLS 305
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 61/295 (20%), Positives = 133/295 (45%), Gaps = 44/295 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR-TLREIKLLRHMDHENIIA 103
+R +G+G++G VC ++T++ A+K + + R +E+++++ ++H ++
Sbjct: 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 104 IKDIIRPPQRETF---NDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
+ +F D+++V +L+ DL ++ + ++ + F+ +L+ L Y+
Sbjct: 80 LWY--------SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYL 131
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN--C 217
+ ++HRD+KP N+LL+ + + I DF +A +T T+ Y APE+ +
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG 191
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
+ Y+ A+D WS+G E++ + + + S E F +
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-----------TSSKEIVHTFETTV---- 236
Query: 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-TVDEALCHPYLAPL 331
+P S V LL+K+L +P++R + + PY+ +
Sbjct: 237 -----VTYP--------SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-29
Identities = 69/281 (24%), Positives = 118/281 (41%), Gaps = 48/281 (17%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIA 103
+ +G G++ V A T E AIK + RE ++ +DH +
Sbjct: 35 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
+ TF D +Y + +L + IR + R++ +++ L+Y+
Sbjct: 95 LYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLN 216
H ++HRDLKP N+LLN + ++I DFG A+ S+ +V T Y +PELL
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206
Query: 217 CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
+ D+W++GCI+ +++ P F + LI + I ++ +
Sbjct: 207 -KSACKSSDLWALGCIIYQLVAGLPPFRAGNE----YLIFQKI----------IKLE--- 248
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 317
FP P A DL+EK+LV D +R+
Sbjct: 249 ------YDFP--------EKFFPKARDLVEKLLVLDATKRL 275
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 54/240 (22%), Positives = 96/240 (40%), Gaps = 17/240 (7%)
Query: 45 IRPVGRGAYGIVCAA--MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENII 102
+ G G + A N R V +K + ++ D + E + L + H +I+
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRP-VVLKGLVHSGD-AEAQAMAMAERQFLAEVVHPSIV 142
Query: 103 AIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
I + + R YIV E + L + L +L ++L L Y+HS
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPALSYLHS 200
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
+++ DLKP N++L LK+ D G + ++ T ++APE++ + T
Sbjct: 201 IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIVR--TGPT 254
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP---DETSLGFLRSDNARRY 278
A DI++VG L + P G YV L ++ + + D +R+
Sbjct: 255 VATDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRF 313
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 78/340 (22%), Positives = 135/340 (39%), Gaps = 63/340 (18%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIA 103
R +G+G +G VCA T + A KK+ R L E ++L ++ +++
Sbjct: 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT-DL-HQIIRSHQD-LTDDHCRYFLYQLLRGLKYVH 160
+ ET + + +V LM+ DL I Q + ++ ++ GL+ +H
Sbjct: 249 LAYAY-----ETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY 220
+++RDLKP N+LL+ + ++I D GLA E + V T Y APE++ N Y
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN-ERY 362
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
T + D W++GC+L E++ Q F + + + L+
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV--------------------- 401
Query: 281 MLPQFPKQNFSARFPNK-SPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLHDI 334
+ + + SP A L ++L DP R+ + E HP +
Sbjct: 402 -------KEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK---KL 451
Query: 335 N---------EEPVCPRPFS------FDFEHPSFTEENIK 359
N E P P P + D E T + ++
Sbjct: 452 NFKRLGAGMLEPPFKPDPQAIYCKDVLDIE-QFSTVKGVE 490
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 49/213 (23%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 46 RPVGRGAYGIVCAAM--NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
+ +G G +G V + + VA+K + N ++ L E +++ +D+ I+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 104 IKDII-RPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
+ I +V E+ + L++ ++ ++ + D + ++Q+ G+KY+
Sbjct: 83 MIGICEAES-------WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELL 214
+N +HRDL N+LL KI DFGL++ + Y +WY APE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVKWY-APE-C 191
Query: 215 LNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+N ++++ D+WS G ++ E + ++P + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP-YRG 223
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 56/228 (24%), Positives = 105/228 (46%), Gaps = 34/228 (14%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAA---MNSETREEVAIK--KIGNAFDNRIDAKRTLRE 89
+ ++R+ V R +G G +G V + + VA+K K DN+ + E
Sbjct: 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSE 63
Query: 90 IKLLRHMDHENIIAIKDII-RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCR 146
+++++DH +I+ + II P +I+ EL +L + +++ L
Sbjct: 64 AVIMKNLDHPHIVKLIGIIEEEP-------TWIIMELYPYGELGHYLERNKNSLKVLTLV 116
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT- 205
+ Q+ + + Y+ S N +HRD+ N+L+ + +K+GDFGL+R + D Y
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKAS 172
Query: 206 ------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W +PE +N +T A D+W + EI++ +QP F
Sbjct: 173 VTRLPIKWM-SPE-SINFRRFTTASDVWMFAVCMWEILSFGKQP-FFW 217
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 29/234 (12%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAM---NSETREEVAIK--KIGNAFDNRIDAKRTLRE 89
+ R + + +G G +G V T +VA+K K+ N+ + + L E
Sbjct: 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSE 86
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH------QDLTD 142
++ H N+I + + + ++ M DLH + + +
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 143 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 202
F+ + G++Y+ + N LHRDL N +L + + + DFGL++ D Y
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YY 203
Query: 203 VVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR--QPLFPGKD 247
+W A E L + YT+ D+W+ G + EI TR P +PG
Sbjct: 204 RQGRIAKMPVKWI-AIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTP-YPGVQ 254
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-28
Identities = 48/224 (21%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
E+ R+ + ++ +G G +G+V + VA+K I + + +E + +
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYD--VAVKMIK---EGSMSEDEFFQEAQTMM 58
Query: 95 HMDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLY 150
+ H ++ + P +YIV E + L +RSH + L Y
Sbjct: 59 KLSHPKLVKFYGVCSKEYP-------IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCY 111
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----- 205
+ G+ ++ S +HRDL N L++ + +K+ DFG+ R + +YV +
Sbjct: 112 DVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTKF 167
Query: 206 --RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W APE + + +Y++ D+W+ G ++ E+ + + P +
Sbjct: 168 PVKWS-APE-VFHYFKYSSKSDVWAFGILMWEVFSLGKMP-YDL 208
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-28
Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 29/220 (13%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT--LREIKLL 93
++ K + ++ +G+G +G V + VA+K I + DA L E ++
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCI------KNDATAQAFLAEASVM 68
Query: 94 RHMDHENIIAIKDII---RPPQRETFNDVYIVYELMDT-DLHQIIRSH--QDLTDDHCRY 147
+ H N++ + +I + +YIV E M L +RS L D
Sbjct: 69 TQLRHSNLVQLLGVIVEEKGG-------LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121
Query: 148 FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW 207
F + ++Y+ N +HRDL N+L++ + K+ DFGL + S T + V +W
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KW 180
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
APE L +++ D+WS G +L EI + R P +P
Sbjct: 181 T-APE-ALREKKFSTKSDVWSFGILLWEIYSFGRVP-YPR 217
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-28
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 21/225 (9%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVC---AAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKL 92
S V +GRG +G V N + A+K + D + + L E +
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGII 79
Query: 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ-DLTDDHCRYFLY 150
++ H N++++ I + +V M DL IR+ + T F
Sbjct: 80 MKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 135
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----- 205
Q+ +G+KY+ S +HRDL N +L+ +K+ DFGLAR + ++ + + T
Sbjct: 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195
Query: 206 -RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR--QPLFPGKD 247
+W A E L ++T D+WS G +L E+MTR P +P +
Sbjct: 196 VKWM-ALE-SLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVN 237
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-28
Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA---MNSETREEVAIKKI-GNAFDNRIDAKRTLREIK 91
+ K + + +G G++G+V S VA+K + + +RE+
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 92 LLRHMDHENIIAIKDII-RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYF 148
+ +DH N+I + ++ PP + +V EL L +R HQ +
Sbjct: 74 AMHSLDHRNLIRLYGVVLTPP-------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT--- 205
Q+ G+ Y+ S +HRDL NLLL +KIGDFGL R + D YV+
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND--DHYVMQEHR 184
Query: 206 ----RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
W APE L ++ A D W G L E+ T ++P + G
Sbjct: 185 KVPFAWC-APE-SLKTRTFSHASDTWMFGVTLWEMFTYGQEP-WIG 227
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 31/224 (13%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH 95
E+ R + +G G YG V + + VA+K + ++ ++ + L+E +++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKE 65
Query: 96 MDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRSH--QDLTDDHCRYFLY 150
+ H N++ + + PP YI+ E M +L +R Q+++ Y
Sbjct: 66 IKHPNLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----- 205
Q+ ++Y+ N +HRDL N L+ N +K+ DFGL+R D Y
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGD---TYTAHAGAKF 174
Query: 206 --RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W APE L ++++ D+W+ G +L EI T P +PG
Sbjct: 175 PIKWT-APE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPG 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 45 IRPVGRGAYGIVCAAM----NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDH 98
I+ +G GA+G V + + + VAIK + + + L E ++ +D+
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE---ILDEAYVMASVDN 76
Query: 99 ENIIAIKDII-RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRG 155
++ + I V ++ +LM L +R H+D + + + Q+ +G
Sbjct: 77 PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT------RWYR 209
+ Y+ ++HRDL N+L+ +KI DFGLA+ + EY +W
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM- 186
Query: 210 APELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
A E + YT D+WS G + E+MT +P + G
Sbjct: 187 ALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDG 222
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 26/233 (11%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAM---NSETREEVAIKKIGNAFDNRIDAKRTLREIK 91
+ + R +G+G +G V A + +VA+K + D + LRE
Sbjct: 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAA 77
Query: 92 LLRHMDHENIIAIKDI-IRPPQRETFNDVYIVYELMDT-DLHQIIRSH------QDLTDD 143
++ DH ++ + + +R + ++ M DLH + + +L
Sbjct: 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 144 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 203
F+ + G++Y+ S N +HRDL N +L + + + DFGL+R D Y
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYR 194
Query: 204 VT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR--QPLFPGKD 247
+W A E L + + YT D+W+ G + EIMTR P + G +
Sbjct: 195 QGCASKLPVKWL-ALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTP-YAGIE 244
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 67/281 (23%), Positives = 125/281 (44%), Gaps = 47/281 (16%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE-NIIA 103
R +GRG +G V ++T + A+K + K+ ++ + +E +++
Sbjct: 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCL---------DKKRIKMKQGETLALNERIMLS 244
Query: 104 IKDIIRPP-------QRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRG 155
+ P T + + + +LM+ DLH + H ++ R++ +++ G
Sbjct: 245 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG 304
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 215
L+++H+ V++RDLKP+N+LL+ + ++I D GLA S+ V T Y APE+L
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGTHGYMAPEVLQ 363
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
Y ++ D +S+GC+L +++ F H+ + E+
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPF----RQHKTKDKHEID---------------- 403
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
R + M + P + SP LLE +L D NRR
Sbjct: 404 RMTLTMAVELP--------DSFSPELRSLLEGLLQRDVNRR 436
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 45/224 (20%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
+ + ++ +G G +G+V ++ + VAIK I + + + + E +++
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDK--VAIKTIR---EGAMSEEDFIEEAEVMM 58
Query: 95 HMDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLY 150
+ H ++ + + + P + +V E M+ L +R+ + +
Sbjct: 59 KLSHPKLVQLYGVCLEQAP-------ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL 111
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----- 205
+ G+ Y+ A V+HRDL N L+ N +K+ DFG+ R + +Y +
Sbjct: 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKF 167
Query: 206 --RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W +PE + + S Y++ D+WS G ++ E+ + + P +
Sbjct: 168 PVKWA-SPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKIP-YEN 208
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 32/228 (14%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM----NSETREEVAIK--KIGNAFDNRIDAKRTLRE 89
E+ V + +G G +G V M + + VAIK K G R+D L E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF---LGE 96
Query: 90 IKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHC 145
++ H NII ++ +I P + I+ E M+ L + +R +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKP-------MMIITEYMENGALDKFLREKDGEFSVLQL 149
Query: 146 RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT 205
L + G+KY+ + N +HRDL N+L+N+N K+ DFGL+R E D Y +
Sbjct: 150 VGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTS 208
Query: 206 ------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
RW APE ++ ++T+A D+WS G ++ E+MT +P +
Sbjct: 209 GGKIPIRWT-APE-AISYRKFTSASDVWSFGIVMWEVMTYGERP-YWE 253
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 64/279 (22%), Positives = 121/279 (43%), Gaps = 40/279 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIA 103
R +GRG +G V A T + A KK+ R + + E K+L + I++
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 104 IKDIIRPPQRETFNDVYIVYELMD-----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+ ET D+ +V +M+ ++ + + + ++ Q++ GL++
Sbjct: 250 LAYAF-----ETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNC 217
+H N+++RDLKP N+LL+ + +++I D GLA T+ Y T + APELLL
Sbjct: 305 LHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG- 363
Query: 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
EY ++D +++G L E++ + F + + + + + +
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV------------------ 405
Query: 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
+ +P SP + D E +L DP +R
Sbjct: 406 -LEQAVTYP--------DKFSPASKDFCEALLQKDPEKR 435
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 34/228 (14%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVC---AAMNSETREEVAIK--KIGNAFDNRIDAKRTLRE 89
+E+ R+ + R +G G +G V VAIK K + R L+E
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK---FLQE 441
Query: 90 IKLLRHMDHENIIAIKDII-RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCR 146
+R DH +I+ + +I P V+I+ EL +L ++ + L
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLI 494
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT- 205
+ YQL L Y+ S +HRD+ N+L+++N +K+GDFGL+R ++ Y
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKAS 550
Query: 206 ------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W APE +N +T+A D+W G + EI+ +P F G
Sbjct: 551 KGKLPIKWM-APE-SINFRRFTSASDVWMFGVCMWEILMHGVKP-FQG 595
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 68/227 (29%), Positives = 104/227 (45%), Gaps = 31/227 (13%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-NSETREE--VAIK--KIGNAFDNRIDAKRTLREI 90
E+ + + VG G +G VC+ +++E VAIK K+G R D L E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD---FLGEA 97
Query: 91 KLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCR 146
++ DH NII ++ ++ P V IV E M+ L +R H T
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT- 205
L + G+KY+ +HRDL N+L+N+N K+ DFGL R E D Y
Sbjct: 151 GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRG 209
Query: 206 -----RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
RW +PE + ++T+A D+WS G +L E+M+ +P +
Sbjct: 210 GKIPIRWT-SPE-AIAYRKFTSASDVWSYGIVLWEVMSYGERP-YWE 253
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 52/224 (23%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
E+ K + ++ +G G +G+V + +VAIK I + + + E K++
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQY--DVAIKMIK---EGSMSEDEFIEEAKVMM 74
Query: 95 HMDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLY 150
++ HE ++ + + + P ++I+ E M L +R +
Sbjct: 75 NLSHEKLVQLYGVCTKQRP-------IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 127
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----- 205
+ ++Y+ S LHRDL N L+N +K+ DFGL+R + EY +
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKF 183
Query: 206 --RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
RW PE +L S++++ DIW+ G ++ EI + + P +
Sbjct: 184 PVRWS-PPE-VLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-YER 224
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 62/244 (25%), Positives = 107/244 (43%), Gaps = 29/244 (11%)
Query: 12 HTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIK 71
++K G Q Y + + ++ K + ++ +G+G +G V + VA+K
Sbjct: 165 TRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVK 222
Query: 72 KIGNAFDNRIDAKRT--LREIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVYELM 126
I + DA L E ++ + H N++ + +I + +YIV E M
Sbjct: 223 CI------KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG-------LYIVTEYM 269
Query: 127 DT-DLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 183
L +RS L D F + ++Y+ N +HRDL N+L++ + K
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 329
Query: 184 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQP 241
+ DFGL + S T + V +W APE L +++ D+WS G +L EI + R P
Sbjct: 330 VSDFGLTKEASSTQDTGKLPV-KWT-APE-ALREKKFSTKSDVWSFGILLWEIYSFGRVP 386
Query: 242 LFPG 245
+P
Sbjct: 387 -YPR 389
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 31/227 (13%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA---MNSETREEVAIK--KIGNAFDNRIDAKRTLREI 90
E+ + + +G G G VC + + VAIK K G R D L E
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF---LSEA 101
Query: 91 KLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCR 146
++ DH NII ++ ++ IV E M+ L +R+H T
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRL-------AMIVTEYMENGSLDTFLRTHDGQFTIMQLV 154
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT- 205
L + G++Y+ +HRDL N+L+++N K+ DFGL+R E D Y T
Sbjct: 155 GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTG 213
Query: 206 -----RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
RW APE + +++A D+WS G ++ E++ +P +
Sbjct: 214 GKIPIRWT-APE-AIAFRTFSSASDVWSFGVVMWEVLAYGERP-YWN 257
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-27
Identities = 51/212 (24%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 49 GRGAYGIVCAAM--NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
G G +G V + + + +VAIK K G + + +RE +++ +D+ I+ +
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPYIVRL 75
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSA 162
+ + +V E+ LH+ + ++ + + L+Q+ G+KY+
Sbjct: 76 IGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLL 215
N +HRDL N+LL KI DFGL++ D + Y +WY APE +
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-CI 185
Query: 216 NCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
N ++++ D+WS G + E ++ ++P +
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKP-YKK 216
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 21/225 (9%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVC---AAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKL 92
S V +GRG +G V N + A+K + D + + L E +
Sbjct: 85 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG-EVSQFLTEGII 143
Query: 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQ-DLTDDHCRYFLY 150
++ H N++++ I + +V M DL IR+ + T F
Sbjct: 144 MKDFSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----- 205
Q+ +G+K++ S +HRDL N +L+ +K+ DFGLAR + +F + + T
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259
Query: 206 -RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR--QPLFPGKD 247
+W A E L ++T D+WS G +L E+MTR P +P +
Sbjct: 260 VKWM-ALE-SLQTQKFTTKSDVWSFGVLLWELMTRGAPP-YPDVN 301
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 10/205 (4%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIA 103
R VGRG G V A ++ VA+K + + + R RE + + +++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
I D E +Y+ L++ DL ++R L + Q+ L H+A
Sbjct: 99 IHD-----FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-MTEYVV-TRWYRAPELLLNCSEY 220
HRD+KP N+L++A+ + DFG+A T++ V T +Y APE S
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHA 212
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPG 245
T DI+++ C+L E +T P + G
Sbjct: 213 TYRADIYALTCVLYECLTGSPPYQG 237
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 60/220 (27%), Positives = 105/220 (47%), Gaps = 25/220 (11%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
EV R+ + + +G G +G V N T+ VA+K + + L E L++
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTK--VAVKSLK---QGSMSPDAFLAEANLMK 63
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH--QDLTDDHCRYFLYQ 151
+ H+ ++ + ++ T +YI+ E M+ L +++ LT + Q
Sbjct: 64 QLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----RW 207
+ G+ ++ N +HRDL+ +N+L++ KI DFGLAR + ++ T +W
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKW 176
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
APE +N +T D+WS G +L EI+T R P +PG
Sbjct: 177 T-APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 45/226 (19%), Positives = 92/226 (40%), Gaps = 30/226 (13%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIK 91
+ ++ +G G +G V + + V IK I R + +
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHML 67
Query: 92 LLRHMDHENIIAIKDII-RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYF 148
+ +DH +I+ + + + +V + + L +R H+ L +
Sbjct: 68 AIGSLDHAHIVRLLGLCPGSS-------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT--- 205
Q+ +G+ Y+ ++HR+L N+LL + +++ DFG+A D + ++
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD---KQLLYSEA 177
Query: 206 ----RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W A E ++ +YT D+WS G + E+MT +P + G
Sbjct: 178 KTPIKWM-ALE-SIHFGKYTHQSDVWSYGVTVWELMTFGAEP-YAG 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 31/226 (13%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH 95
E+ R + +G G YG V + + VA+K + ++ ++ + L+E +++
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKE 272
Query: 96 MDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRSH--QDLTDDHCRYFLY 150
+ H N++ + + PP YI+ E M +L +R Q+++ Y
Sbjct: 273 IKHPNLVQLLGVCTREPP-------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----- 205
Q+ ++Y+ N +HR+L N L+ N +K+ DFGL+R + Y
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG----DTYTAHAGAKF 381
Query: 206 --RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKD 247
+W APE L ++++ D+W+ G +L EI T P +PG D
Sbjct: 382 PIKWT-APE-SLAYNKFSIKSDVWAFGVLLWEIATYGMSP-YPGID 424
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 38/235 (16%), Positives = 83/235 (35%), Gaps = 34/235 (14%)
Query: 34 LFEVSRKYVPPIRPVGRGAYGIVCAAM-------NSETREEVAIKKIGNAFDNRIDAKRT 86
++ + + +G+G + + + EV +K + A N ++
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN--YSESF 59
Query: 87 LREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTD 142
++ + H++++ + +V E + L ++ +++ +
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDE-------NILVQEFVKFGSLDTYLKKNKNCINI 112
Query: 143 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL--------KIGDFGLARTTS 194
QL + ++ ++H ++ N+LL D K+ D G++ T
Sbjct: 113 LWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL 172
Query: 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKD 247
D + E + W PE + N A D WS G L EI + +P D
Sbjct: 173 PKDILQERI--PWV-PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALD 223
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 10/205 (4%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIA 103
+ +G G V A ++ +VAIK I + KR RE+ + H+NI++
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ D E + Y+V E ++ L + I SH L+ D F Q+L G+K+ H
Sbjct: 76 MID-----VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCSEY 220
++HRD+KP N+L+++N LKI DFG+A+ SET V T Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG-EAT 189
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPG 245
DI+S+G +L E++ +P F G
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 23/219 (10%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
E+ R+ + +G+G +G V N TR VAIK + + + L+E ++++
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMK 234
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQ 151
+ HE ++ + ++ + +YIV E M L ++ + L Q
Sbjct: 235 KLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 288
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWY 208
+ G+ YV N +HRDL+ +N+L+ N K+ DFGLAR + ++ +W
Sbjct: 289 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 348
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
APE +T D+WS G +L E+ T R P +PG
Sbjct: 349 -APE-AALYGRFTIKSDVWSFGILLTELTTKGRVP-YPG 384
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 60/240 (25%), Positives = 105/240 (43%), Gaps = 47/240 (19%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIK--KIGNAFDNRIDAKRTLR 88
EV+R+ + R +G+G++G+V + E VAIK + RI+ L
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE---FLN 77
Query: 89 EIKLLRHMDHENIIAIKDII---RPPQRETFNDVYIVYELMDT-DLHQIIRSH------- 137
E +++ + +++ + ++ +P ++ ELM DL +RS
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPT--------LVIMELMTRGDLKSYLRSLRPAMANN 129
Query: 138 ---QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194
+ ++ G+ Y+++ +HRDL N ++ + +KIGDFG+ R
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 195 ETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
ETD+ Y RW +PE L + +T D+WS G +L EI T QP + G
Sbjct: 190 ETDY---YRKGGKGLLPVRWM-SPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQP-YQG 243
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 45 IRPVGRGAYGIVCAAM----NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDH 98
I+ +G GA+G V + + + VAIK + + + L E ++ +D+
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE---ILDEAYVMASVDN 76
Query: 99 ENIIAIKDII-RPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRG 155
++ + I V ++ +LM L +R H+D + + + Q+ +G
Sbjct: 77 PHVCRLLGICLTST-------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT------RWYR 209
+ Y+ ++HRDL N+L+ +KI DFGLA+ + EY +W
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKWM- 186
Query: 210 APELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
A E + YT D+WS G + E+MT +P + G
Sbjct: 187 ALE-SILHRIYTHQSDVWSYGVTVWELMTFGSKP-YDG 222
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 31/223 (13%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
E+ R+ + + +G G +G V A N T+ VA+K + + + L E +++
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTK--VAVKTMK---PGSMSVEAFLAEANVMK 238
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH--QDLTDDHCRYFLYQ 151
+ H+ ++ + ++ T +YI+ E M L ++S F Q
Sbjct: 239 TLQHDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ 292
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT------ 205
+ G+ ++ N +HRDL+ +N+L++A+ KI DFGLAR + EY
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFP 348
Query: 206 -RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+W APE +N +T D+WS G +L EI+T R P +PG
Sbjct: 349 IKWT-APE-AINFGSFTIKSDVWSFGILLMEIVTYGRIP-YPG 388
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 50/212 (23%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 49 GRGAYGIVCAAM--NSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
G G +G V + + + +VAIK K G + + +RE +++ +D+ I+ +
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM---MREAQIMHQLDNPYIVRL 401
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSA 162
+ + +V E+ LH+ + ++ + + L+Q+ G+KY+
Sbjct: 402 IGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLL 215
N +HR+L N+LL KI DFGL++ D + Y +WY APE +
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLKWY-APE-CI 511
Query: 216 NCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
N ++++ D+WS G + E ++ ++P +
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKP-YKK 542
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 57/300 (19%), Positives = 110/300 (36%), Gaps = 52/300 (17%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIA 103
++ +GRGA+ V +T + A+K + R + E +L + D I
Sbjct: 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125
Query: 104 IKDIIRPPQRETFNDVYIVYELMD----TDL-HQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+ F D +Y +M+ DL + + + + + R++L +++ +
Sbjct: 126 LH--------FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELLLN 216
VH +HRD+KP N+LL+ +++ DFG + ++ + V T Y +PE+L
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 217 ------CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270
Y D W++G E+ Q F ET
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--------------TAET----- 278
Query: 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPY 327
Y +++ + A D ++++L P R+ + HP+
Sbjct: 279 -------YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 25/225 (11%)
Query: 38 SRKYVPPIRPVGRGAYGIVC---AAMNSETREEVAIK--KIGNAFDNRIDAKRTLREIKL 92
R R +G+G +G+V ++ R + AIK LRE L
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA---FLREGLL 75
Query: 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH-QDLTDDHCRYFLY 150
+R ++H N++A+ I+ PP+ +++ M DL Q IRS ++ T F
Sbjct: 76 MRGLNHPNVLALIGIMLPPE----GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT----- 205
Q+ RG++Y+ +HRDL N +L+ + +K+ DFGLAR + ++ +
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191
Query: 206 -RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPGKD 247
+W A E L +T D+WS G +L E++T P + D
Sbjct: 192 VKWT-ALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPP-YRHID 233
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 77/332 (23%), Positives = 116/332 (34%), Gaps = 45/332 (13%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA-IKD 106
+GRG YG V E VA+K + I + M+H+NI I
Sbjct: 21 IGRGRYGAVYKGSLDE--RPVAVKVF---SFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 107 IIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA--- 162
R +V E L + + H CR + + RGL Y+H+
Sbjct: 76 DERVTADGRME-YLLVMEYYPNGSLXKYLSLHTSDWVSSCR-LAHSVTRGLAYLHTELPR 133
Query: 163 ------NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---------MTEYVVTRW 207
+ HRDL N+L+ + I DFGL+ + V T
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIR 193
Query: 208 YRAPELL------LNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYV-HQLRLITELI 259
Y APE+L + +D++++G I EI R LFPG+ +Q+ TE+
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVG 253
Query: 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 319
P + L S +R P+FP+ + +E D R+T
Sbjct: 254 NHPTFEDMQVLVSREKQR-----PKFPEAWKE--NSLAVRSLKETIEDCWDQDAEARLTA 306
Query: 320 DEALCHPYLAPLHDINEEPVCPRPFS-FDFEH 350
A +A L I E P + H
Sbjct: 307 QXAE--ERMAELMMIWERNKSVSPTAHHHHHH 336
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 73/276 (26%), Positives = 116/276 (42%), Gaps = 49/276 (17%)
Query: 3 GESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAA--- 59
G SS S G+ H QY + + R+ + +G GA+G V A
Sbjct: 4 GSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECH 63
Query: 60 --MNSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDII--RPPQRE 114
+ + + VA+K + A ++ R D RE +LL + H++I+ + P
Sbjct: 64 NLLPEQDKMLVAVKALKEASESARQD---FQREAELLTMLQHQHIVRFFGVCTEGRP--- 117
Query: 115 TFNDVYIVYELMDT-DLHQIIRSH---------------QDLTDDHCRYFLYQLLRGLKY 158
+ +V+E M DL++ +RSH L Q+ G+ Y
Sbjct: 118 ----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAP 211
+ + +HRDL N L+ +KIGDFG++R TD+ Y V RW P
Sbjct: 174 LAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWM-PP 229
Query: 212 ELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
E +L ++T D+WS G +L EI T +QP +
Sbjct: 230 ESILY-RKFTTESDVWSFGVVLWEIFTYGKQP-WYQ 263
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 23/219 (10%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
E+ R+ + +G+G +G V N TR VAIK + + + L+E ++++
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTR--VAIKTLK---PGTMSPEAFLQEAQVMK 317
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQ 151
+ HE ++ + ++ + +YIV E M L ++ + L Q
Sbjct: 318 KLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 371
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT---RWY 208
+ G+ YV N +HRDL+ +N+L+ N K+ DFGLAR + ++ +W
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 431
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
APE +T D+WS G +L E+ T R P +PG
Sbjct: 432 -APE-AALYGRFTIKSDVWSFGILLTELTTKGRVP-YPG 467
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 60/285 (21%), Positives = 121/285 (42%), Gaps = 61/285 (21%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR----TLREIKLLRHMDHEN 100
I+ +G G++G V + E+ A+K + ++ + TL E ++L+ ++
Sbjct: 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQ---KVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMDT----DLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
++ ++ +F D +Y +M+ ++ +R ++ H R++ Q++
Sbjct: 103 LVKLEF--------SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 157 KYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPE 212
+Y+HS ++++RDLKP NLL++ +++ DFG A+ + E + APE
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL------APE 208
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272
++L+ Y A+D W++G ++ E+ P F + I G +R
Sbjct: 209 IILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS----------GKVR- 256
Query: 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 317
FP + S DLL +L D +R
Sbjct: 257 ------------FP--------SHFSSDLKDLLRNLLQVDLTKRF 281
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 57/249 (22%), Positives = 99/249 (39%), Gaps = 51/249 (20%)
Query: 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIK--KIGNAFDNRIDAK 84
G L E+S V + +G +G V E + VAIK K R +
Sbjct: 1 GKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-- 58
Query: 85 RTLREIKLLRHMDHENIIAIKDII--RPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLT 141
E L + H N++ + ++ P + +++ DLH+ + +
Sbjct: 59 -FRHEAMLRARLQHPNVVCLLGVVTKDQP-------LSMIFSYCSHGDLHEFLVMRSPHS 110
Query: 142 DDHCR----------------YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 185
D + + Q+ G++Y+ S +V+H+DL N+L+ ++KI
Sbjct: 111 DVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKIS 170
Query: 186 DFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
D GL R D Y + RW APE ++ +++ DIWS G +L E+ +
Sbjct: 171 DLGLFREVYAAD---YYKLLGNSLLPIRWM-APEAIMY-GKFSIDSDIWSYGVVLWEVFS 225
Query: 239 --RQPLFPG 245
QP + G
Sbjct: 226 YGLQP-YCG 233
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 67/295 (22%), Positives = 117/295 (39%), Gaps = 50/295 (16%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIA 103
++ +GRGA+G V + TR+ A+K + R D+ E ++ + ++
Sbjct: 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133
Query: 104 IKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
+ F D +Y +M+ DL ++ ++ D+ + R++ +++ L +
Sbjct: 134 LF--------YAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAI 184
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELLLNC 217
HS +HRD+KP N+LL+ + LK+ DFG + E + V T Y +PE+L +
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244
Query: 218 ---SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
Y D WSVG L E++ F V I N
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM-----------------N 287
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHP 326
+ + FP + S A +L+ L D R+ V+E H
Sbjct: 288 HKNSLT----FP------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHL 331
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 60/296 (20%), Positives = 119/296 (40%), Gaps = 48/296 (16%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIG-NAFDNRIDAKRTLREIKLLRHMDHENIIA 103
++ +GRGA+G V + A+K + R + E +L + D + I
Sbjct: 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 104 IKDIIRPPQRETFNDVYIVYELMD----TDL-HQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+ F D +Y +MD DL + + L ++ R++L +++ +
Sbjct: 139 LH--------YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLA-RTTSETDFMTEYVV-TRWYRAPELLLN 216
VH + +HRD+KP N+L++ N +++ DFG + + + V T Y +PE+L
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 217 CSE----YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272
Y D WS+G + E++ + F + ET
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------------LVET------- 289
Query: 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHP 326
Y +++ + F + + S A DL+ +++ +R + +++ HP
Sbjct: 290 -----YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP 340
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-24
Identities = 67/245 (27%), Positives = 109/245 (44%), Gaps = 52/245 (21%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIKKIGNAFDN-RIDAKRTLRE 89
+ R+ + R +G GA+G V A ++ + VA+K + + R D RE
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD---FQRE 67
Query: 90 IKLLRHMDHENII---AIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHC 145
+LL ++ HE+I+ + P + +V+E M DL++ +R+H
Sbjct: 68 AELLTNLQHEHIVKFYGVCGDGDP--------LIMVFEYMKHGDLNKFLRAHGPDAMILV 119
Query: 146 R----------------YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189
+ Q+ G+ Y+ S + +HRDL N L+ AN +KIGDFG+
Sbjct: 120 DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
Query: 190 ARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQ 240
+R TD+ Y V RW PE ++ ++T D+WS G IL EI T +Q
Sbjct: 180 SRDVYSTDY---YRVGGHTMLPIRWM-PPESIMY-RKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 241 PLFPG 245
P +
Sbjct: 235 P-WFQ 238
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-23
Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 45/239 (18%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIK--KIGNAFDNRIDAKRTLR 88
EV RK + IR +G GA+G V N + +VA+K + + +D L
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD---FLM 82
Query: 89 EIKLLRHMDHENIIAIKDI--IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHC 145
E ++ +H+NI+ + P +I+ ELM DL +R +
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLP-------RFILMELMAGGDLKSFLRETRPRPSQPS 135
Query: 146 RYFLYQLL-------RGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSE 195
+ LL G +Y+ + +HRD+ N LL KIGDFG+AR
Sbjct: 136 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
Query: 196 TDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+ Y +W PE + +T+ D WS G +L EI + P +P
Sbjct: 196 ASY---YRKGGCAMLPVKWM-PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMP-YPS 248
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 9e-23
Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 63/285 (22%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLRHMDHENII 102
+R +G G++G V + A+K K + + T E +L + H II
Sbjct: 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIVTHPFII 69
Query: 103 AIKDIIRPPQRETFNDVYIVYELMD----TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+ TF D ++ +MD +L ++R Q + +++ ++ L+Y
Sbjct: 70 RMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM----TEYVVTRWYRAPELL 214
+HS ++++RDLKP N+LL+ N +KI DFG A+ + + +Y+ APE++
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI------APEVV 175
Query: 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
Y +ID WS G ++ E++ F + +T
Sbjct: 176 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------------TMKT--------- 211
Query: 275 ARRYVRML---PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
Y ++L +FP P + DLL +++ D ++R
Sbjct: 212 ---YEKILNAELRFP--------PFFNEDVKDLLSRLITRDLSQR 245
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-22
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIA 103
+G G V A + +VA+K + + R RE + ++H I+A
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ D + YIV E +D L I+ + +T + + L + H
Sbjct: 77 VYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVV-TRWYRAPELLLNCS 218
++HRD+KP+N++++A +K+ DFG+AR +++ T V+ T Y +PE
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-D 194
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPG 245
A D++S+GC+L E++T +P F G
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 67/255 (26%), Positives = 107/255 (41%), Gaps = 55/255 (21%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-----NSETREEVAIK--KIGNAFDNRIDAKRTLR 88
E R + +P+GRGA+G V A + T VA+K K G +
Sbjct: 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA---LMS 79
Query: 89 EIKLLRHMD-HENII----AIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH----- 137
E+K+L H+ H N++ A P + ++ E +L +RS
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGP--------LMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 138 -----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 186
LT +H + +Q+ +G++++ S +HRDL N+LL+ +KI D
Sbjct: 132 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 187 FGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 238
FGLAR + +YV +W APE + + YT D+WS G +L EI +
Sbjct: 192 FGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIFSL 246
Query: 239 -RQPLFPGKDYVHQL 252
P +PG +
Sbjct: 247 GASP-YPGVKIDEEF 260
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 61/239 (25%), Positives = 95/239 (39%), Gaps = 45/239 (18%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIK--KIGNAFDNRIDAKRTLR 88
EV RK + IR +G GA+G V N + +VA+K + + +D L
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD---FLM 123
Query: 89 EIKLLRHMDHENIIAIKDI--IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHC 145
E ++ +H+NI+ + P +I+ ELM DL +R +
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLP-------RFILLELMAGGDLKSFLRETRPRPSQPS 176
Query: 146 RYFLYQLL-------RGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSE 195
+ LL G +Y+ + +HRD+ N LL KIGDFG+AR
Sbjct: 177 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 236
Query: 196 TDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPLFPG 245
+ Y +W PE + +T+ D WS G +L EI + P +P
Sbjct: 237 AGY---YRKGGCAMLPVKWM-PPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMP-YPS 289
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-22
Identities = 63/243 (25%), Positives = 93/243 (38%), Gaps = 52/243 (21%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM--NSETREEVAIK--KIGNAFDNRIDAKRTLREIK 91
+ + +G G +G V A R + AIK K + D+ D E++
Sbjct: 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD---FAGELE 77
Query: 92 LLRHM-DHENIIAIKDI--IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCR- 146
+L + H NII + R +Y+ E +L +R + L D
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGY-------LYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 147 ---------------YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191
+F + RG+ Y+ +HRDL N+L+ N KI DFGL+R
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
Query: 192 TTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT--RQPL 242
YV RW A E LN S YT D+WS G +L EI++ P
Sbjct: 191 GQE------VYVKKTMGRLPVRWM-AIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTP- 241
Query: 243 FPG 245
+ G
Sbjct: 242 YCG 244
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-22
Identities = 68/255 (26%), Positives = 101/255 (39%), Gaps = 54/255 (21%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIK--KIGNAFDNRIDAKRTLR 88
E R + + +G GA+G V A + S+ VA+K K R +
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA---LMS 75
Query: 89 EIKLLRHM-DHENIIAIKDI--IRPPQRETFNDVYIVYELM-DTDLHQIIRSHQDLTDDH 144
E+K+L ++ +H NI+ + I P ++ E DL +R +D
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGP-------TLVITEYCCYGDLLNFLRRKRDSFICS 128
Query: 145 CRY------------------FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 186
F YQ+ +G+ ++ S N +HRDL N+LL KI D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 187 FGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 238
FGLAR YVV +W APE + NC YT D+WS G L E+ +
Sbjct: 189 FGLARDIKNDS---NYVVKGNARLPVKWM-APESIFNC-VYTFESDVWSYGIFLWELFSL 243
Query: 239 -RQPLFPGKDYVHQL 252
P +PG +
Sbjct: 244 GSSP-YPGMPVDSKF 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 9e-22
Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 56/247 (22%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-----NSETREEVAIK--KIGNAFDNRIDAKRTLR 88
E R + + +G GA+G V A + +VA+K K D + +
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA---LMS 98
Query: 89 EIKLLRHMD-HENIIAI-----KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH---- 137
E+K++ H+ HENI+ + P V ++ E DL +R
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHG--GP--------VLVITEYCCYGDLLNFLRRKSRVL 148
Query: 138 ----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 187
+ +F Q+ +G+ ++ S N +HRD+ N+LL KIGDF
Sbjct: 149 ETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 188 GLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-- 238
GLAR Y+V +W APE + +C YT D+WS G +L EI +
Sbjct: 209 GLARDIMNDS---NYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLG 263
Query: 239 RQPLFPG 245
P +PG
Sbjct: 264 LNP-YPG 269
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 64/282 (22%), Positives = 120/282 (42%), Gaps = 60/282 (21%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKD 106
+G+G +G V T A+K + + + T+ E ++L++ H + A+K
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 107 IIRPPQRETFNDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
+ R + V Y EL + R T++ R++ +++ L+Y+H
Sbjct: 73 AFQTHDR-----LCFVMEYANGGELF----FHLSRERV-FTEERARFYGAEIVSALEYLH 122
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW------YRAPELL 214
S +V++RD+K NL+L+ + +KI DFGL + + +++ + Y APE+L
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVL 177
Query: 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
+ ++Y A+D W +G ++ E+M + F +D + L +
Sbjct: 178 ED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------------HERLFELILMEE- 221
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
+FP SP A LL +L DP +R
Sbjct: 222 --------IRFP--------RTLSPEAKSLLAGLLKKDPKQR 247
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 68/298 (22%), Positives = 125/298 (41%), Gaps = 82/298 (27%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH-ENIIA 103
+R +G+G YG V +K+ A +I A + L++ ++R+ + A
Sbjct: 22 LRVLGKGGYGKVFQV-----------RKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA 70
Query: 104 IKDI---IRPP---------QRETFNDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHC 145
++I ++ P Q T +Y++ Y EL Q+ R +D
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQ--TGGKLYLILEYLSGGELF----MQLEREGI-FMEDTA 123
Query: 146 RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT----- 200
++L ++ L ++H +++RDLKP N++LN +K+ DFGL + + +T
Sbjct: 124 CFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 201 --EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL 258
EY+ APE+L+ S + A+D WS+G ++ +++T P F G++
Sbjct: 184 TIEYM------APEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN----------- 225
Query: 259 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
+T L+ P P + A DLL+K+L + R
Sbjct: 226 ---RKKTIDKILKCK---------LNLP--------PYLTQEARDLLKKLLKRNAASR 263
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 64/256 (25%), Positives = 97/256 (37%), Gaps = 65/256 (25%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIK--KIGNAFDNRIDAKRTLR 88
E R + +R +G GA+G V A + E VA+K K + D + D R
Sbjct: 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD---FQR 99
Query: 89 EIKLLRHMDHENIIAI-----KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTD 142
E L+ D+ NI+ + +P +++E M DL++ +RS T
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVG--KPM--------CLLFEYMAYGDLNEFLRSMSPHTV 149
Query: 143 DHCR------------------------YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 178
Q+ G+ Y+ +HRDL N L+
Sbjct: 150 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE 209
Query: 179 NCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGC 231
N +KI DFGL+R D Y RW PE + + YT D+W+ G
Sbjct: 210 NMVVKIADFGLSRNIYSAD---YYKADGNDAIPIRWM-PPESIFY-NRYTTESDVWAYGV 264
Query: 232 ILGEIMT--RQPLFPG 245
+L EI + QP + G
Sbjct: 265 VLWEIFSYGLQP-YYG 279
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 72/308 (23%), Positives = 125/308 (40%), Gaps = 74/308 (24%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G+G++G V A +T + AIK L++ +L D E +
Sbjct: 22 HKMLGKGSFGKVFLAEFKKTNQFFAIK--------------ALKKDVVLMDDDVECTMVE 67
Query: 105 KDI----IRPP---------QRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLY 150
K + P Q T +++ V E ++ DL I+S ++
Sbjct: 68 KRVLSLAWEHPFLTHMFCTFQ--TKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW--- 207
+++ GL+++HS +++RDLK N+LL+ + +KI DFG+ + + M T
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCG 180
Query: 208 ---YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 264
Y APE+LL +Y ++D WS G +L E++ Q F G+D +E
Sbjct: 181 TPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------------EEE 225
Query: 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324
+ P +P A DLL K+ V +P +R+ V +
Sbjct: 226 LFHSIRMDN---------PFYP--------RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268
Query: 325 -HPYLAPL 331
HP +
Sbjct: 269 QHPLFREI 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 63/256 (24%), Positives = 99/256 (38%), Gaps = 65/256 (25%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIK--KIGNAFDNRIDAKRTLR 88
E RK + + +G G +G V A VA+K K + D L
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD---LLS 75
Query: 89 EIKLLRHMDHENIIAI-----KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSH----- 137
E +L+ ++H ++I + +D P ++ E L +R
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQD--GPL--------LLIVEYAKYGSLRGFLRESRKVGP 125
Query: 138 -------------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 178
+ LT F +Q+ +G++Y+ ++HRDL N+L+
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE 185
Query: 179 NCDLKIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGC 231
+KI DFGL+R E D YV +W A E L + YT D+WS G
Sbjct: 186 GRKMKISDFGLSRDVYEED---SYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGV 240
Query: 232 ILGEIMT--RQPLFPG 245
+L EI+T P +PG
Sbjct: 241 LLWEIVTLGGNP-YPG 255
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-21
Identities = 61/297 (20%), Positives = 113/297 (38%), Gaps = 83/297 (27%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
IR +G+G++G V A ET + A+K L++ +L+ D E +
Sbjct: 28 IRVLGKGSFGKVMLARVKETGDLYAVK--------------VLKKDVILQDDDVECTMTE 73
Query: 105 KDI----IRPP---------QRETFNDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHC 145
K I P Q T + ++ V + +LM I +S + +
Sbjct: 74 KRILSLARNHPFLTQLFCCFQ--TPDRLFFVMEFVNGGDLM----FHIQKSRR-FDEARA 126
Query: 146 RYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVT 205
R++ +++ L ++H +++RDLK N+LL+ K+ DFG+ + + + V T
Sbjct: 127 RFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-----EGICNGVTT 181
Query: 206 RW------YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 259
Y APE+L Y A+D W++G +L E++ F ++
Sbjct: 182 ATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN------------ 228
Query: 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
D+ L + +P A +L+ + +P R
Sbjct: 229 --EDDLFEAILNDE---------VVYP--------TWLHEDATGILKSFMTKNPTMR 266
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 9e-21
Identities = 65/291 (22%), Positives = 121/291 (41%), Gaps = 70/291 (24%)
Query: 45 IRPVGRGAYGIVCAA---MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI 101
++ +G+G++G V S+ R+ A+K + A D RT E +L ++H I
Sbjct: 29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 102 IAIKDIIRPPQRETF---NDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYFLYQL 152
+ + F +Y++ + +L ++ + T++ +++L +L
Sbjct: 89 VKLH--------YAFQTEGKLYLILDFLRGGDLF----TRLSKEVM-FTEEDVKFYLAEL 135
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-------EYVVT 205
L ++HS +++RDLKP N+LL+ +K+ DFGL++ + + + EY+
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYM-- 193
Query: 206 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 265
APE++ +T + D WS G ++ E++T F GKD ET
Sbjct: 194 ----APEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------------RKET 234
Query: 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
L++ P SP A LL + +P R
Sbjct: 235 MTMILKAK---------LGMP--------QFLSPEAQSLLRMLFKRNPANR 268
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 82/338 (24%), Positives = 136/338 (40%), Gaps = 77/338 (22%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKD 106
+G+G +G V T A+K + + + TL E ++L++ H + A+K
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 107 IIRPPQRETFNDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
+ R + V Y EL + R ++D R++ +++ L Y+H
Sbjct: 216 SFQTHDR-----LCFVMEYANGGELF----FHLSRERV-FSEDRARFYGAEIVSALDYLH 265
Query: 161 SA-NVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCS 218
S NV++RDLK NL+L+ + +KI DFGL + + M + T Y APE+L + +
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-N 324
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278
+Y A+D W +G ++ E+M + F +D+ LI L +
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--------------LMEE----- 365
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLHD 333
+FP P A LL +L DP +R+ E + H + A
Sbjct: 366 ----IRFP--------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA---G 410
Query: 334 INEEPV----CPRPFS-----------FDFEHPSFTEE 356
I + V PF FD E FT +
Sbjct: 411 IVWQHVYEKKLSPPFKPQVTSETDTRYFDEE---FTAQ 445
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 54/248 (21%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-------NSETREEVAIK--KIGNAFDNRIDAKRT 86
E R + +P+G GA+G V A + VA+K K + D
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---L 87
Query: 87 LREIKLLRHM-DHENIIAIKDI--IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTD 142
+ E+++++ + H+NII + P +Y++ E +L + +R+ +
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGM 140
Query: 143 DHCR----------------YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 186
++ YQL RG++Y+ S +HRDL N+L+ N +KI D
Sbjct: 141 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 187 FGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 238
FGLAR + D Y T +W APE L + YT D+WS G ++ EI T
Sbjct: 201 FGLARDINNID---YYKKTTNGRLPVKWM-APEALFDR-VYTHQSDVWSFGVLMWEIFTL 255
Query: 239 -RQPLFPG 245
P +PG
Sbjct: 256 GGSP-YPG 262
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 55/298 (18%), Positives = 126/298 (42%), Gaps = 74/298 (24%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH-ENIIA 103
++ +G GAYG V +KI ++ A + L++ +++ E+
Sbjct: 59 LKVLGTGAYGKVFLV-----------RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 107
Query: 104 IKDIIRPPQRETF-----------NDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCR 146
+ ++ ++ F ++++ Y EL + + + T+ +
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELF----THLSQRER-FTEHEVQ 162
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 206
++ +++ L+++H +++RD+K N+LL++N + + DFGL++ +F+ +
Sbjct: 163 IYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-----EFVADETERA 217
Query: 207 W-------YRAPELLLNCSE-YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL 258
+ Y AP+++ + A+D WS+G ++ E++T F + I+
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277
Query: 259 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
I L+S+ P +P S A DL++++L+ DP +R
Sbjct: 278 I----------LKSE---------PPYP--------QEMSALAKDLIQRLLMKDPKKR 308
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 78/355 (21%), Positives = 139/355 (39%), Gaps = 106/355 (29%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G++G V A + A+K L++ +L+ + ++I++ +++
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVK--------------VLQKKAILKKKEEKHIMSERNV 91
Query: 108 ----IRPP---------QRETFNDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYF 148
++ P Q T + +Y V Y EL + + R + R++
Sbjct: 92 LLKNVKHPFLVGLHFSFQ--TADKLYFVLDYINGGELF----YHLQRERC-FLEPRARFY 144
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-------E 201
++ L Y+HS N+++RDLKP N+LL++ + + DFGL + E + T E
Sbjct: 145 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE 204
Query: 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 261
Y+ APE+L Y +D W +G +L E++ P F ++
Sbjct: 205 YL------APEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-------------- 243
Query: 262 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI---- 317
E L Q PN + A LLE +L D +R+
Sbjct: 244 TAEMYDNILNKP---------LQLK--------PNITNSARHLLEGLLQKDRTKRLGAKD 286
Query: 318 TVDEALCHPYLAPL--HDINEEPVCPRPFS-----------FDFEHPSFTEENIK 359
E H + + + D+ + + P PF+ FD P FTEE +
Sbjct: 287 DFMEIKSHVFFSLINWDDLINKKITP-PFNPNVSGPNDLRHFD---PEFTEEPVP 337
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 63/259 (24%), Positives = 102/259 (39%), Gaps = 57/259 (22%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIK--KIGNAFDNRIDAKRTLR 88
E R+ + + +G GA+G V A + +VA+K K R +
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA---LMS 97
Query: 89 EIKLLRHM-DHENII------AIKD---II----------------RPPQRETFNDVYIV 122
E+K++ + HENI+ + +I R E +
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 123 YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 182
L + + ++ + +DL F YQ+ +G++++ + +HRDL N+L+ +
Sbjct: 158 KRLEEEEDLNVL-TFEDLLC-----FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 211
Query: 183 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGE 235
KI DFGLAR YVV +W APE L YT D+WS G +L E
Sbjct: 212 KICDFGLARDIMSDS---NYVVRGNARLPVKWM-APESLFEG-IYTIKSDVWSYGILLWE 266
Query: 236 IMT--RQPLFPGKDYVHQL 252
I + P +PG
Sbjct: 267 IFSLGVNP-YPGIPVDANF 284
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 59/292 (20%), Positives = 113/292 (38%), Gaps = 64/292 (21%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+R +GRG+Y V +T A+K +++ + D + +
Sbjct: 14 LRVIGRGSYAKVLLVRLKKTDRIYAMK--------------VVKKELVNDDEDIDWVQTE 59
Query: 105 KDI----IRPP---------QRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLY 150
K + P Q T + ++ V E ++ DL ++ + L ++H R++
Sbjct: 60 KHVFEQASNHPFLVGLHSCFQ--TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 117
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW--- 207
++ L Y+H +++RDLK N+LL++ +K+ D+G+ + + + T
Sbjct: 118 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCG 172
Query: 208 ---YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 264
Y APE+L +Y ++D W++G ++ E+M + F TE D
Sbjct: 173 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE-----DY 226
Query: 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
L + P + S A +L+ L DP R
Sbjct: 227 LFQVILEKQ---------IRIP--------RSLSVKAASVLKSFLNKDPKER 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 60/295 (20%), Positives = 117/295 (39%), Gaps = 85/295 (28%)
Query: 48 VGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107
+G+G++G V + T E A+K L++ +++ D E + K +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVK--------------ILKKDVVIQDDDVECTMVEKRV 73
Query: 108 ----IRPP---------QRETFNDVYIV--Y----ELMDTDLHQIIRSHQDLTDDHCRYF 148
+PP Q T + +Y V Y +LM + I + + + H ++
Sbjct: 74 LALPGKPPFLTQLHSCFQ--TMDRLYFVMEYVNGGDLM----YHIQQVGR-FKEPHAVFY 126
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-------E 201
++ GL ++ S +++RDLK N++L++ +KI DFG+ + T +
Sbjct: 127 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 186
Query: 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 261
Y+ APE++ Y ++D W+ G +L E++ Q F G+D
Sbjct: 187 YI------APEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-------------- 225
Query: 262 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
DE + + +P + S AV + + ++ P +R
Sbjct: 226 EDELFQSIMEHN---------VAYP--------KSMSKEAVAICKGLMTKHPGKR 263
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 65/248 (26%), Positives = 105/248 (42%), Gaps = 54/248 (21%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-------NSETREEVAIK--KIGNAFDNRIDAKRT 86
E R + +P+G G +G V A + VA+K K + D
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---L 133
Query: 87 LREIKLLRHM-DHENIIAIKDI--IRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTD 142
+ E+++++ + H+NII + P +Y++ E +L + +R+ +
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGM 186
Query: 143 DHCR----------------YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 186
++ YQL RG++Y+ S +HRDL N+L+ N +KI D
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 246
Query: 187 FGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 238
FGLAR + D Y T +W APE L + YT D+WS G ++ EI T
Sbjct: 247 FGLARDINNID---YYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLMWEIFTL 301
Query: 239 -RQPLFPG 245
P +PG
Sbjct: 302 GGSP-YPG 308
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 5e-20
Identities = 41/315 (13%), Positives = 79/315 (25%), Gaps = 77/315 (24%)
Query: 4 ESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE 63
ESS+ D +V G GRY + + G A+++
Sbjct: 12 ESSAPPDDVQLVPGARIANGRY----------RL-------LIFHGGVPPLQFWQALDTA 54
Query: 64 TREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122
+VA+ + + TL L +D + + D++ T +V
Sbjct: 55 LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTRAGGLVV 109
Query: 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 181
E + L ++ + + + L H A V PS + ++ + D
Sbjct: 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD 167
Query: 182 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 241
+ + DI +G L ++ +
Sbjct: 168 VVLAYPATMPDA---------------------------NPQDDIRGIGASLYALLVNRW 200
Query: 242 LFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGA 301
P L A R P P + +
Sbjct: 201 PLPEAGVRSGLAP--------------------AERDTAGQPIEP----ADIDRDIPFQI 236
Query: 302 VDLLEKMLVFDPNRR 316
+ + + D R
Sbjct: 237 SAVAARSVQGDGGIR 251
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-20
Identities = 58/292 (19%), Positives = 113/292 (38%), Gaps = 64/292 (21%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+R +GRG+Y V +T A++ +++ + D + +
Sbjct: 57 LRVIGRGSYAKVLLVRLKKTDRIYAMR--------------VVKKELVNDDEDIDWVQTE 102
Query: 105 KDI----IRPP---------QRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLY 150
K + P Q T + ++ V E ++ DL ++ + L ++H R++
Sbjct: 103 KHVFEQASNHPFLVGLHSCFQ--TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 160
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW--- 207
++ L Y+H +++RDLK N+LL++ +K+ D+G+ + + + T
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-----EGLRPGDTTSTFCG 215
Query: 208 ---YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 264
Y APE+L +Y ++D W++G ++ E+M + F TE D
Sbjct: 216 TPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE-----DY 269
Query: 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
L + P + S A +L+ L DP R
Sbjct: 270 LFQVILEKQ---------IRIP--------RSLSVKAASVLKSFLNKDPKER 304
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 55/288 (19%), Positives = 111/288 (38%), Gaps = 65/288 (22%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENI 101
+ +G+G++G V + T E A+K + D+ ++ + + L +
Sbjct: 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFL 404
Query: 102 IAIKDIIRPPQRETFNDVYIVYE------LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRG 155
+ + R +Y V E LM + I + + + H ++ ++ G
Sbjct: 405 TQLHSCFQTMDR-----LYFVMEYVNGGDLM----YHIQQVGR-FKEPHAVFYAAEIAIG 454
Query: 156 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT-------EYVVTRWY 208
L ++ S +++RDLK N++L++ +KI DFG+ + T +Y+
Sbjct: 455 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYI----- 509
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268
APE++ Y ++D W+ G +L E++ Q F G+D + I E
Sbjct: 510 -APEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-----HN---- 558
Query: 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316
+P + S AV + + ++ P +R
Sbjct: 559 --------------VAYP--------KSMSKEAVAICKGLMTKHPGKR 584
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 65/248 (26%), Positives = 106/248 (42%), Gaps = 54/248 (21%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAM-------NSETREEVAIK--KIGNAFDNRIDAKRT 86
E+ R + +P+G GA+G V A +VA+K K + D
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD---L 121
Query: 87 LREIKLLRHM-DHENIIAIKDI--IRPPQRETFNDVYIVYELMDT-DLHQIIRSH----- 137
+ E+++++ + H+NII + P +Y++ E +L + +++
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGL 174
Query: 138 -----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 186
+ L+ YQ+ RG++Y+ S +HRDL N+L+ + +KI D
Sbjct: 175 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 187 FGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 238
FGLAR D Y T +W APE L + YT D+WS G +L EI T
Sbjct: 235 FGLARDIHHID---YYKKTTNGRLPVKWM-APEALFDR-IYTHQSDVWSFGVLLWEIFTL 289
Query: 239 -RQPLFPG 245
P +PG
Sbjct: 290 GGSP-YPG 296
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 20/139 (14%)
Query: 123 YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 182
E DL++ + + L + +Q+ +G++++ S +HRDL N+LL+ +
Sbjct: 178 EEEAPEDLYKDFLTLEHLIC-----YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232
Query: 183 KIGDFGLARTTSETDFMTEYVVT-------RWYRAPELLLNCSEYTAAIDIWSVGCILGE 235
KI DFGLAR + +YV +W APE + + YT D+WS G +L E
Sbjct: 233 KICDFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDR-VYTIQSDVWSFGVLLWE 287
Query: 236 IMT--RQPLFPGKDYVHQL 252
I + P +PG +
Sbjct: 288 IFSLGASP-YPGVKIDEEF 305
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 3e-15
Identities = 45/332 (13%), Positives = 85/332 (25%), Gaps = 70/332 (21%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI---------------GNAFDNRIDAKRTLRE 89
+G G +G V + VAIK I I + L
Sbjct: 25 CEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL 82
Query: 90 IKLLRHMDHENIIAIKDII-------------------------RPPQRETFNDVYIVYE 124
+ E I + + P + ++IV E
Sbjct: 83 LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142
Query: 125 LMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLK 183
+ + + + L+QL L ++ HRDL N+LL K
Sbjct: 143 FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKK 202
Query: 184 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF 243
+ ++++ L ++ +YT + + ++ + LF
Sbjct: 203 LHYTLNGKSSTIPSC-------------GLQVSIIDYTLSRLERDGIVVFCDVSMDEDLF 249
Query: 244 PGKDYVHQLRLITELIGSPDETSL-GFLRSDNA------RRYVRMLPQFPKQNFSARFPN 296
G I L+ + + N + F + +
Sbjct: 250 TGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQ 307
Query: 297 KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ ML F + + LC L
Sbjct: 308 IKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 4e-14
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 208
G+ ++H + +HRD+K +N+LL+ KI DFGLAR + + + +R Y
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAY 201
Query: 209 RAPELLLNCSEYTAAIDIWSVGCILGEIMT 238
APE L E T DI+S G +L EI+T
Sbjct: 202 MAPEALRG--EITPKSDIYSFGVVLLEIIT 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 45/176 (25%), Positives = 71/176 (40%), Gaps = 37/176 (21%)
Query: 30 VYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL-R 88
+ G F V +K +G G +G + N T E VAIK + L
Sbjct: 6 MVGPNFRVGKK-------IGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHL 53
Query: 89 EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYF 148
E + + + + I + +N +V EL+ L +DL D R F
Sbjct: 54 EYRFYKQLG--SGDGIPQVYYFGPCGKYN--AMVLELLGPSL-------EDLFDLCDRTF 102
Query: 149 --------LYQLLRGLKYVHSANVLHRDLKPSNLLL--NANCDLKIG---DFGLAR 191
QL+ ++YVHS N+++RD+KP N L+ N ++ DF LA+
Sbjct: 103 SLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 4e-12
Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 16/95 (16%)
Query: 154 RGLKYVH---SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW--- 207
RGL Y+H ++HRD+K +N+LL+ + +GDFGLA+ D +V T
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTAVRGT 198
Query: 208 --YRAPELLLN--CSEYTAAIDIWSVGCILGEIMT 238
+ APE L SE T D++ G +L E++T
Sbjct: 199 IGHIAPEYLSTGKSSEKT---DVFGYGVMLLELIT 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 42/166 (25%), Positives = 70/166 (42%), Gaps = 23/166 (13%)
Query: 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT--LRE 89
GN + + RK +G G++G + + EEVAIK + K E
Sbjct: 8 GNRYRLGRK-------IGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLHIE 54
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRS-HQDLTDDHCRYF 148
K+ + M + + I I +N +V EL+ L + + +
Sbjct: 55 SKIYKMM--QGGVGIPTIRWCGAEGDYN--VMVMELLGPSLEDLFNFCSRKFSLKTVLLL 110
Query: 149 LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLAR 191
Q++ ++Y+HS N +HRD+KP N L+ + I DFGLA+
Sbjct: 111 ADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 8e-12
Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 21/106 (19%)
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRW-----Y 208
RGL Y+H+ ++HRD+K N+LL+ N KI DFG+++ +E D ++ T Y
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD--QTHLSTVVKGTLGY 207
Query: 209 RAPELLLNCSEY------TAAIDIWSVGCILGEIMT-RQPLFPGKD 247
P EY T D++S G +L E++ R +
Sbjct: 208 IDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 37/178 (20%), Positives = 70/178 (39%), Gaps = 39/178 (21%)
Query: 29 NVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL- 87
NV G ++V R+ +G G++G++ N ++VAIK +
Sbjct: 6 NVVGVHYKVGRR-------IGEGSFGVIFEGTNLLNNQQVAIK------FEPRRSDAPQL 52
Query: 88 -REIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCR 146
E + + + I ++ Q N +V +L+ L +DL D R
Sbjct: 53 RDEYRTYKLLA--GCTGIPNVYYFGQEGLHN--VLVIDLLGPSL-------EDLLDLCGR 101
Query: 147 YF--------LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK-----IGDFGLAR 191
F Q+L ++ +H ++++RD+KP N L+ + DFG+ +
Sbjct: 102 KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 37/173 (21%)
Query: 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT--LRE 89
GN F + RK +G G++G + N +T EEVAIK + K L E
Sbjct: 6 GNKFRLGRK-------IGSGSFGEIYLGTNIQTNEEVAIKL------ENVKTKHPQLLYE 52
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYF- 148
K+ R + + I ++ +N +V +L+ L +DL + R
Sbjct: 53 SKIYRIL--QGGTGIPNVRWFGVEGDYN--VLVMDLLGPSL-------EDLFNFCSRKLS 101
Query: 149 -------LYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLAR 191
Q++ +++VHS + LHRD+KP N L+ + I DFGLA+
Sbjct: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 33/173 (19%), Positives = 65/173 (37%), Gaps = 24/173 (13%)
Query: 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIK--KIGNAFDNRIDAKRTLREIKLLR 94
++V + +G G +G++ A + E+ A K+ + E+K +
Sbjct: 35 EGNQWVL-GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQ-----ENGPLFSELKFYQ 88
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVY--------------IVYELMDTDLHQIIRSHQDL 140
+ ++ I + Y +V E + DL +I +
Sbjct: 89 RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTF 148
Query: 141 TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCD-LKIGDFGLAR 191
++L L+Y+H +H D+K +NLLL N D + + D+GL+
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 35/181 (19%), Positives = 66/181 (36%), Gaps = 37/181 (20%)
Query: 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM 96
+ + P+G+G +G + A + + E V D E+K +
Sbjct: 33 AAAAWKV-GLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90
Query: 97 DHENIIAIKDIIRPP----------------QRETFNDVYIVYELMDTDLHQIIRSHQDL 140
I R +++ +++ + +DL Q +
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR--FMIMDRFGSDL-------QKI 141
Query: 141 TDDHCRYF--------LYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCD-LKIGDFGLA 190
+ + + F ++L L+Y+H +H D+K SNLLLN N D + + D+GLA
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 191 R 191
Sbjct: 202 Y 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 5e-09
Identities = 24/174 (13%), Positives = 53/174 (30%), Gaps = 38/174 (21%)
Query: 45 IRPVGRGAYGIVCAAMNSETR--------EEVAIK--------KIGNAFDNRIDAKRTLR 88
R GI+ A + T ++ ++K F R +
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 89 EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYF 148
+ K L I ++ + ++V + L Q D ++
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGV--HQDKYR--FLVLPSLGRSL-------QSALDVSPKHV 155
Query: 149 L---------YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI--GDFGLAR 191
L +LL L+++H +H ++ N+ ++ ++ +G A
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 3e-06
Identities = 64/414 (15%), Positives = 118/414 (28%), Gaps = 136/414 (32%)
Query: 53 YGIVCAAMNSETREEVAIKKI-----------GNAFD----NRIDAKRTLREIKLLRHMD 97
Y + + + +E R+ + ++ F +R+ LR+ LL
Sbjct: 91 YKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQ-ALLELRP 149
Query: 98 HENII---------------AIKDIIRPPQRETFNDVY-----------IVYELMDTDLH 131
+N++ Q + ++ V E++ L+
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLS--YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 132 QIIRSHQDLTDDHCRY---------FLYQLLRGLKYVHSANVLHRDLKPSNLL--LNANC 180
QI + +D L +LL+ Y + VL +++ + N +C
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL-LNVQNAKAWNAFNLSC 266
Query: 181 DLKIGDFGLA--RTTSETDFMTEYVVTRWY-----------RAPELLLNCSEYTAAIDIW 227
KI L R TDF++ T LLL +D
Sbjct: 267 --KI----LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY------LDC- 313
Query: 228 SVGCILGEIMTRQPL-----------FPGK-DYVHQLRL--ITELIGSPDETSLGFLRSD 273
+ E++T P D + +T +I E+SL L
Sbjct: 314 RPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII----ESSLNVLEPA 369
Query: 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLE----KMLVFDPNRRITVDE------AL 323
R+ L FP SA P LL ++ D + V++
Sbjct: 370 EYRKMFDRLSVFPP---SAHIPTI------LLSLIWFDVIKSDV--MVVVNKLHKYSLVE 418
Query: 324 CHP--YLAPLHDINEEPVCPRPFSFDFEHPSFTEENI-KELI--YRESVKFNPD 372
P + I + + E + + ++ Y F+ D
Sbjct: 419 KQPKESTISIPSI----------YLELKVKLENEYALHRSIVDHYNIPKTFDSD 462
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 27/120 (22%), Positives = 49/120 (40%), Gaps = 18/120 (15%)
Query: 78 DNRIDAKRTLREIKLLRHMDHENIIA--IKDIIRPPQRETFNDVYIVYELMDTDLHQIIR 135
D I RT RE + L + I A I D+ + N ++ + +I
Sbjct: 378 DENIRKSRTAREARYLALVKDFGIPAPYIFDV------DLDNKRIMMSYINGKLAKDVIE 431
Query: 136 SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195
+ D Y++ + +H +V+H DL SN + + + + I DFGL + ++
Sbjct: 432 DNLD--------IAYKIGEIVGKLHKNDVIHNDLTTSNFIFDKDLYI-I-DFGLGKISNL 481
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 375 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.7 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.07 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.75 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.58 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.32 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.28 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.14 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.09 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.04 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.89 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.85 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.76 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.66 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.43 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.41 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.37 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.27 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.06 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.96 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.88 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.83 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.83 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.37 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.06 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 87.08 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-64 Score=471.22 Aligned_cols=339 Identities=53% Similarity=0.934 Sum_probs=295.8
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
+...|++.++|. +++.||+|+||+||+|+++.+|+.||||++.+..........+.+|+.+|++++|||||++++++..
T Consensus 46 ~~~~~~i~~~Y~-~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 124 (398)
T 4b99_A 46 FDVTFDVGDEYE-IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRP 124 (398)
T ss_dssp --CCCCCCSSEE-EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred cCCCCCCCCCeE-EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeec
Confidence 345567776665 8999999999999999999999999999998776666667788999999999999999999999875
Q ss_pred CC-CCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 111 PQ-RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 111 ~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
.. ......+|||||||+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 125 ~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 125 TVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp SSCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecce
Confidence 42 23446799999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC-----CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 190 ARTTSET-----DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 190 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
+...... ....+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+++..|....+.++.
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9764332 23456789999999999988667899999999999999999999999999999999999999999888
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPF 344 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~ 344 (375)
..+..........+...++......+...++.+++++.+||.+||..||.+|||+.|+|+||||+++.+..++|.+..+|
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~~~ 364 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAPPF 364 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSSCC
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCCCC
Confidence 77777666667777777777666667777888999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHhhcC
Q 017231 345 SFDFEHPSFTEENIKELIYRESVKFN 370 (375)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (375)
.+++....++.+++++..+.+...|+
T Consensus 365 ~~~~~~~~~~~~~~k~~i~~ei~~~~ 390 (398)
T 4b99_A 365 DFAFDREALTRERIKEAIVAEIEDFH 390 (398)
T ss_dssp CCHHHHSCCCHHHHHHHHHHHHHHHH
T ss_pred CCccchhhcCHHHHHHHHHHHHHHHH
Confidence 98888888899999999988888775
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-61 Score=426.47 Aligned_cols=251 Identities=28% Similarity=0.506 Sum_probs=206.6
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.++++++||||+++++++... +.+|+|
T Consensus 17 i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~iv 91 (275)
T 3hyh_A 17 IVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-----DEIIMV 91 (275)
T ss_dssp EEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEEEEE
Confidence 59999999999999999999999999999976542 233456788999999999999999999999654 669999
Q ss_pred EeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccccc
Q 017231 123 YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 202 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~ 202 (375)
|||++|+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++..........+.
T Consensus 92 mEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 171 (275)
T 3hyh_A 92 IEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS 171 (275)
T ss_dssp EECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------------
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCe
Confidence 99999999999999999999999999999999999999999999999999999999999999999999877666666678
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.....+.+.......+
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p------------------- 232 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP------------------- 232 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC-------------------
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC-------------------
Confidence 9999999999998844456899999999999999999999999887777776655322111
Q ss_pred CCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
..+|++++++|.+||+.||++|||++|+++||||+.
T Consensus 233 ------------~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 233 ------------KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ------------CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 246899999999999999999999999999999974
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-60 Score=428.07 Aligned_cols=255 Identities=26% Similarity=0.434 Sum_probs=224.4
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
.|++++.||+|+||+||+|+++.+++.||||++.+.. ........+.+|+.+|++++|||||+++++|.+. +.+
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 107 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EKL 107 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEE
Confidence 3458999999999999999999999999999996542 2233456789999999999999999999999654 679
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC--
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-- 196 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-- 196 (375)
|+|||||+ |+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999997 699999999999999999999999999999999999999999999999999999999999999865432
Q ss_pred -CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 197 -DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 197 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
....+.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p------------ 254 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP------------ 254 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------------
T ss_pred cccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC------------
Confidence 23456789999999999988 7899999999999999999999999999888888877766322111
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHH------HhcCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE------ALCHPYLAPLH 332 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~e------ll~~~~f~~~~ 332 (375)
..+|+++++||.+||+.||++|||++| |++||||++++
T Consensus 255 -------------------~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 255 -------------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp -------------------TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred -------------------cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 246899999999999999999999988 58999999875
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-59 Score=417.66 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=214.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.++||+|+||+||+|.++.++..||+|++..........+.+.+|+.++++++|||||+++++|.... .....+++||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lvm 108 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLVT 108 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEEE
Confidence 678899999999999999999999999999776666667788999999999999999999999986432 1225689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEec-CCCEEEeecccccccCCCCcc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NIli~~-~~~i~l~Df~~~~~~~~~~~~ 199 (375)
|||+ |+|.+++.+.+.+++..++.|+.||+.||.|||++| |+||||||+|||++. +|.+||+|||++..... ...
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~ 187 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFA 187 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSB
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-Ccc
Confidence 9997 699999999899999999999999999999999998 999999999999974 79999999999975443 334
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHH-HHHHHHhCCCCcccccccccchhHHH
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL-RLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.+.+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+ +.+... ..+..
T Consensus 188 ~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~--~~~~~------------- 250 (290)
T 3fpq_A 188 KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKPAS------------- 250 (290)
T ss_dssp EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CCCGG-------------
T ss_pred CCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC--CCCCC-------------
Confidence 56789999999999875 5899999999999999999999999775543333 222211 11100
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
.....++++++||.+||+.||++|||+.|+|+||||++
T Consensus 251 --------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 251 --------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 01246788999999999999999999999999999985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-59 Score=429.02 Aligned_cols=252 Identities=25% Similarity=0.437 Sum_probs=216.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.++++|+|||||++++++.+. +.+||||
T Consensus 28 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~~yiVm 102 (350)
T 4b9d_A 28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----GSLYIVM 102 (350)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEEEEEE
Confidence 79999999999999999999999999999987666666778899999999999999999999999654 6799999
Q ss_pred eCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cc
Q 017231 124 ELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
|||+ |+|.+++...+ .+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... ..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 9997 69999997653 47999999999999999999999999999999999999999999999999998765432 23
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 183 ~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~----------------- 244 (350)
T 4b9d_A 183 RACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP----------------- 244 (350)
T ss_dssp HHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC-----------------
T ss_pred cccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------------
Confidence 45689999999999988 789999999999999999999999999988887777766532110
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
....+|+++++||.+||+.||++|||++|+|+||||++-
T Consensus 245 -------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 245 -------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred -------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 113578999999999999999999999999999999753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-59 Score=426.80 Aligned_cols=256 Identities=26% Similarity=0.491 Sum_probs=221.8
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
.+++++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|++++|||||+++++|... +.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DEL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence 4566899999999999999999999999999999654322 245578999999999999999999999654 669
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-C
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-D 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~ 197 (375)
|||||||+ |+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999997 699998876 56999999999999999999999999999999999999999999999999999765443 3
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
...+.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 226 ~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~-------------- 290 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL-------------- 290 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC--------------
T ss_pred cccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC--------------
Confidence 4567899999999999987 7899999999999999999999999999888777777655321111
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
..+..+|+++++||.+||+.||++|||++|+|+||||++..
T Consensus 291 --------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 291 --------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp --------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 01135789999999999999999999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-59 Score=420.94 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=215.3
Q ss_pred ccCCeeeccCCcceEEEEEEeC---CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNS---ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
.|++++.||+|+||+||+|++. .+++.||||++.+..........+.+|+.++++++|||||++++++... +
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 99 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-----G 99 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-----T
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----C
Confidence 3458999999999999999874 4678999999976543333344678899999999999999999999654 6
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE- 195 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~- 195 (375)
.+|+|||||+ |+|.+++.+.+.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 7999999997 69999999999999999999999999999999999999999999999999999999999999976433
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
.....+.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p------------ 246 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP------------ 246 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred CccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC------------
Confidence 334556789999999999988 7899999999999999999999999999988888777765321111
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH 332 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~ 332 (375)
..+|+++++||.+||+.||++||| ++|+++||||++++
T Consensus 247 -------------------~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 247 -------------------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp -------------------TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -------------------CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 247899999999999999999998 58999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=428.47 Aligned_cols=257 Identities=26% Similarity=0.495 Sum_probs=222.8
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
..+|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|++++|||||+++++|... +.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~ 222 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DE 222 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CE
Confidence 35566899999999999999999999999999999654322 245678999999999999999999999654 66
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET- 196 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~- 196 (375)
+|||||||+ |+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 223 ~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999997 699998865 56999999999999999999999999999999999999999999999999999765443
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
....+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+....+..+........
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~------------- 367 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL------------- 367 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------
T ss_pred ccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-------------
Confidence 34567899999999999987 7899999999999999999999999999888777777655321110
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.....+|+++++||.+||..||++|||+.|+|+||||++..
T Consensus 368 ---------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 368 ---------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp ---------------SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ---------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 11245799999999999999999999999999999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-57 Score=413.12 Aligned_cols=257 Identities=23% Similarity=0.313 Sum_probs=216.6
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
...+++++.++||+|+||+||+|+++.+|+.||||++...... .+|+.++++++|||||++++++...
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~----- 122 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREG----- 122 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEET-----
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence 3445666899999999999999999999999999999654322 3699999999999999999999654
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-CEEEeecccccccC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTS 194 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-~i~l~Df~~~~~~~ 194 (375)
+.+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+| ++||+|||++....
T Consensus 123 ~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 123 PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred CEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 66899999997 69999999989999999999999999999999999999999999999999988 69999999997654
Q ss_pred CCCc------cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 195 ETDF------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 195 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
.... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~------ 275 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPI------ 275 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGG------
T ss_pred CCCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCc------
Confidence 3321 234579999999999998 789999999999999999999999998877666666555421110
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHH-------------hcCCCCCCCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA-------------LCHPYLAPLHDI 334 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~el-------------l~~~~f~~~~~~ 334 (375)
....+.+++++.++|.+||+.||.+|||+.|| |+|||++.+.++
T Consensus 276 ----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 276 ----------------------REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp ----------------------GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred ----------------------hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 01124679999999999999999999999998 579999977544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-55 Score=417.04 Aligned_cols=341 Identities=39% Similarity=0.738 Sum_probs=291.9
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
+.|++.++|. +++.||+|+||.||+|+++.+++.||||++............+.+|+.++++++||||+++++++....
T Consensus 20 ~~~~i~~~y~-~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~ 98 (432)
T 3n9x_A 20 KNVHVPDNYI-IKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDD 98 (432)
T ss_dssp GGCCCCTTEE-EEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CcceecCCEE-EEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 3455555555 799999999999999999999999999999877666777788999999999999999999999998765
Q ss_pred CCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 113 RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
......+|+||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 99 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 99 LLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp TTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 45556799999999999999999988899999999999999999999999999999999999999999999999999976
Q ss_pred cCCCC-----------------------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-----------
Q 017231 193 TSETD-----------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT----------- 238 (375)
Q Consensus 193 ~~~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~----------- 238 (375)
..... ......||+.|+|||++.....++.++|||||||++|+|++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 54332 12456789999999997655779999999999999999998
Q ss_pred CCCCCCCCC-----------------hhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchH
Q 017231 239 RQPLFPGKD-----------------YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGA 301 (375)
Q Consensus 239 g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l 301 (375)
|.++|.+.+ ....+..+....+.++..............+...+.......+...++.+++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 445554443 367788889999999888877777777888888888777777777788999999
Q ss_pred HHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHhhcCCCCC
Q 017231 302 VDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHP-SFTEENIKELIYRESVKFNPDPT 374 (375)
Q Consensus 302 ~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 374 (375)
.+||.+||..||.+|||++|+|+||||+++.....++.+...+.+.+... .++.+.++.+.+++...|.|+.+
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 412 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFLKEVQSFHPELV 412 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHHHHHHHHCTTCC
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHHHHHHHhCcccc
Confidence 99999999999999999999999999999999999998888888887764 58899999999999999999753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-55 Score=407.79 Aligned_cols=339 Identities=45% Similarity=0.834 Sum_probs=284.3
Q ss_pred eecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 29 NVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 29 ~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
......|++.++|. +++.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~~~~~~~~y~-~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 93 (367)
T 1cm8_A 15 EVTKTAWEVRAVYR-DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVF 93 (367)
T ss_dssp ECSSSEECCBSSEE-EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEE
T ss_pred EecCceeeecceEE-EeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeE
Confidence 34455666766665 89999999999999999999999999999977666666677899999999999999999999998
Q ss_pred cCCC-CCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeec
Q 017231 109 RPPQ-RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 187 (375)
Q Consensus 109 ~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df 187 (375)
.... ......+++||||++++|.+++.. ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+||
T Consensus 94 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 94 TPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred ecCCccccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEee
Confidence 7653 223356799999998899999877 56999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 188 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
|++...... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.++....
T Consensus 173 g~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 173 GLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp TTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 999765433 345577999999999887667899999999999999999999999999999999999999999888877
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFD 347 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~ 347 (375)
..+.......+...++......+...++..++.+.++|.+||..||.+|||+.++|+||||+.+.....++.+. .|.++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~-~~~~~ 329 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ-KYDDS 329 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC-CCCCC
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC-CCCCC
Confidence 77777778888888888888888888889999999999999999999999999999999999999888887766 67777
Q ss_pred CCCCCCCHHHHHHHHHHHHhhcCCC
Q 017231 348 FEHPSFTEENIKELIYRESVKFNPD 372 (375)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (375)
+.......+.++...+.+...|+|.
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (367)
T 1cm8_A 330 FDDVDRTLDEWKRVTYKEVLSFKPP 354 (367)
T ss_dssp -----CCHHHHHHHHHHHHHTCCC-
T ss_pred hhhhcCCHHHHHHHHHHHHHHhccc
Confidence 7777788899999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=420.13 Aligned_cols=340 Identities=40% Similarity=0.776 Sum_probs=284.9
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..|++.++|. +++.||+|+||+||+|+++.+++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 47 ~~~~~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 125 (458)
T 3rp9_A 47 SDWQIPDRYE-IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKD 125 (458)
T ss_dssp SSCCSCTTEE-ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred CcCccCCCeE-EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence 4566766666 899999999999999999999999999999876666777788999999999999999999999997765
Q ss_pred CCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 113 RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
.+....+|+||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 126 ~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 126 VEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 55567799999999999999999988899999999999999999999999999999999999999999999999999976
Q ss_pred cCCCC----------------------------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh------
Q 017231 193 TSETD----------------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT------ 238 (375)
Q Consensus 193 ~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~------ 238 (375)
..... ......||+.|+|||++.....++.++|||||||++|+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 54221 12345679999999987654779999999999999999998
Q ss_pred -----CCCCCCCCC--------------------hhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCcccc
Q 017231 239 -----RQPLFPGKD--------------------YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSAR 293 (375)
Q Consensus 239 -----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (375)
|.++|.+.+ ....+..+....+.+...............+...+.......+...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 777776654 2567788888899988888877777778888888888777888888
Q ss_pred CCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHhhcCCC
Q 017231 294 FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDFEHP-SFTEENIKELIYRESVKFNPD 372 (375)
Q Consensus 294 ~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 372 (375)
++..++++.+||.+||..||.+|||++|+|+||||+++.....++.+...+.+.+... ++..+.+++..+.+...|+|+
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 445 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCHHHHHHHHHHHHTTTCTT
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhCcc
Confidence 8999999999999999999999999999999999999998888888877777776653 588889999999999999986
Q ss_pred C
Q 017231 373 P 373 (375)
Q Consensus 373 ~ 373 (375)
-
T Consensus 446 ~ 446 (458)
T 3rp9_A 446 I 446 (458)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-55 Score=407.48 Aligned_cols=346 Identities=49% Similarity=0.897 Sum_probs=288.0
Q ss_pred ceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeee
Q 017231 24 RYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103 (375)
Q Consensus 24 ~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 103 (375)
+-.++......|++..+|. +++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~~~~~~~~y~-~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~ 92 (367)
T 2fst_X 14 TFYRQELNKTIWEVPERYQ-NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92 (367)
T ss_dssp CEEEEEETTEEEEEETTEE-EEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcceEeecCcccCCCCceE-EeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 3444556778888888877 999999999999999999999999999999776666667788899999999999999999
Q ss_pred eceeecCCC-CCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCE
Q 017231 104 IKDIIRPPQ-RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 182 (375)
Q Consensus 104 ~~~~~~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i 182 (375)
+++++.... .+....+++++|+++++|.+++.. ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.+
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 93 LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp CSEEECSCSSGGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred EEEEEecCCccccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCE
Confidence 999987642 223356899999999899888876 579999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCC
Q 017231 183 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 262 (375)
Q Consensus 183 ~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 262 (375)
+|+|||++...... .....+|..|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+.+
T Consensus 172 kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 172 KILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp EECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred EEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999998765433 3456789999999998875678999999999999999999999999999999999999999998
Q ss_pred CcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCC
Q 017231 263 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPR 342 (375)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~ 342 (375)
...............+...+...+...+...++..++.+.+||.+||..||.+|||+.++|+||||+.+....+++.+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~- 328 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD- 328 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCC-
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCC-
Confidence 8887777777778888888887777777777888999999999999999999999999999999999999888888776
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHhhcCCCCC
Q 017231 343 PFSFDFEHPSFTEENIKELIYRESVKFNPDPT 374 (375)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (375)
+|.+++.......+.+++..+.+...|.|.+.
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~ 360 (367)
T 2fst_X 329 PYDQSLESRDLLIDEWKSLTYDEVISFVPPPL 360 (367)
T ss_dssp CCCGGGSSCCCCHHHHHHHHHHHHHHCCCCC-
T ss_pred CCCcchhhccCCHHHHHHHHHHHHHHhccCcc
Confidence 78888888788999999999999999999763
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=399.99 Aligned_cols=348 Identities=51% Similarity=0.917 Sum_probs=291.8
Q ss_pred CCCCCCceEEeceecC-CcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHH
Q 017231 6 SSGSGDHTIVKGVPTH-GGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK 84 (375)
Q Consensus 6 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~ 84 (375)
+..+++.....|...+ ++||. +++.||+|+||.||++.+..++..||||++... .......
T Consensus 9 ~~~~~~~~~~~g~~~~~~~~y~-----------------~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~ 70 (364)
T 3qyz_A 9 AAAAAGPEMVRGQVFDVGPRYT-----------------NLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQ 70 (364)
T ss_dssp ------CCBCC-CBCCCTTTEE-----------------EEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHH
T ss_pred HHhhcceEEEccEeccccccEE-----------------EEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHH
Confidence 3446777777777776 56787 599999999999999999999999999998653 2344557
Q ss_pred HHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 017231 85 RTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164 (375)
Q Consensus 85 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i 164 (375)
.+.+|+.++++++||||+++++++.....+.....++|||+++|+|.+++.. ..+++..++.++.||+.||.+||++|+
T Consensus 71 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i 149 (364)
T 3qyz_A 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANV 149 (364)
T ss_dssp HHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 7889999999999999999999997765455567899999999999999876 469999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCEEEeecccccccCCCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCC
Q 017231 165 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ 240 (375)
Q Consensus 165 ~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 240 (375)
+|+||||+||+++.++.++|+|||.+....... ......||+.|+|||++.+...++.++|||||||++|+|++|.
T Consensus 150 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 229 (364)
T 3qyz_A 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229 (364)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred ecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCC
Confidence 999999999999999999999999987654332 1234578999999999876567899999999999999999999
Q ss_pred CCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHH
Q 017231 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD 320 (375)
Q Consensus 241 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ 320 (375)
.||.+.+..+.+..+....+.+...............+...........+....+.+++++.++|.+||+.||++|||+.
T Consensus 230 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 309 (364)
T 3qyz_A 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309 (364)
T ss_dssp CSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 99999999999999999988887776665555555666666665555555566678899999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 017231 321 EALCHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPD 372 (375)
Q Consensus 321 ell~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (375)
|+|+||||+.......++....+|.++....++..+++++....++..|+|.
T Consensus 310 e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 361 (364)
T 3qyz_A 310 QALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG 361 (364)
T ss_dssp HHHTSGGGTTTCCGGGSCCCSSCCCCC-----CCHHHHHHHHHHHTGGGCC-
T ss_pred HHhcCcchhhccCcccccCCCCcCCcccccccCCHHHHHHHHHHHHHHhhhh
Confidence 9999999999988888999999999999999999999999999999999986
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=396.21 Aligned_cols=345 Identities=45% Similarity=0.838 Sum_probs=300.6
Q ss_pred CcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe
Q 017231 22 GGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI 101 (375)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 101 (375)
...|.........|++.++|. +++.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||
T Consensus 25 ~~g~~~~~~~~~~~~l~~~y~-~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 103 (371)
T 4exu_A 25 KKGFYKQDVNKTAWELPKTYV-SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 103 (371)
T ss_dssp CTTEEEEEETTEEEEEETTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccceeeeeccceecccccEE-EEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCc
Confidence 444555788889999999987 8999999999999999999999999999998766666667888999999999999999
Q ss_pred eeeceeecCCCC-CCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC
Q 017231 102 IAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180 (375)
Q Consensus 102 v~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~ 180 (375)
+++++++..... .....+++||||++++|.+.+. ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++
T Consensus 104 v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~ 181 (371)
T 4exu_A 104 IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC 181 (371)
T ss_dssp CCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC
T ss_pred hhhhhheeccCCcccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC
Confidence 999999976532 1223359999999999988874 4599999999999999999999999999999999999999999
Q ss_pred CEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhC
Q 017231 181 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 260 (375)
Q Consensus 181 ~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 260 (375)
.++|+|||.+...... .....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+
T Consensus 182 ~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 259 (371)
T 4exu_A 182 ELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTG 259 (371)
T ss_dssp CEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred CEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999999998765433 34557799999999998756789999999999999999999999999999999999999999
Q ss_pred CCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 017231 261 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC 340 (375)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~ 340 (375)
.++......+.......+...+.......+....+.+++++.+||.+||+.||++|||+.|+|+||||+.+.....+...
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~ 339 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEA 339 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCC
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccccc
Confidence 88887777777777777777777777777777778899999999999999999999999999999999999888888888
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 017231 341 PRPFSFDFEHPSFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (375)
..+|...........+.+++..+++.+.|.|
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 340 QQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp SSCCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred ccCcCcchhhcccchHHHHHHHHHHHHhccc
Confidence 8889888888888999999999999999987
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=389.76 Aligned_cols=260 Identities=21% Similarity=0.292 Sum_probs=211.7
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
-...|+|..+.+++.++||+|+||+||+|+++. .||||+++.........+.+.+|+.++++++|||||++++++..
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC
Confidence 345799999999999999999999999998654 59999997666666677889999999999999999999998743
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
+.++||||||+ |+|.+++... ..+++.++..|+.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 104 ------~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 104 ------DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp ------SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred ------CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeecc
Confidence 34799999997 7999999764 569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC---CccccccccccccCchhcccC--CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 189 LARTTSET---DFMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 189 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
++...... .......||+.|+|||++.+. ..++.++|||||||++|||+||+.||.+.+....+..+.......+
T Consensus 178 la~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p 257 (307)
T 3omv_A 178 LATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP 257 (307)
T ss_dssp SCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC
T ss_pred CceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC
Confidence 99765432 223456899999999998642 4589999999999999999999999988765554444433211111
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
. +.....++++++.++|.+||+.||++|||+.||++
T Consensus 258 ~-------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 258 D-------------------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp C-------------------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred C-------------------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1 11112467899999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-55 Score=394.25 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=197.7
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC-------C
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-------E 114 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-------~ 114 (375)
+++++.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.++++++|||||++++++..... .
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 447999999999999999999999999999986543 33455678999999999999999999999865431 1
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~~---l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
....+|+|||||+ |+|.+++..... .+...++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccc
Confidence 1235799999997 699999987655 445678999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-------------cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHH
Q 017231 191 RTTSETDF-------------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 257 (375)
Q Consensus 191 ~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 257 (375)
+....... ..+.+||+.|+|||++.+ ..++.++|||||||++|+|++ ||.... +....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~~~~ 239 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRTLTD 239 (299)
T ss_dssp --------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHHHHH
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHHHHH
Confidence 76544321 234579999999999988 789999999999999999996 775432 22222222
Q ss_pred HhC-CCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 258 LIG-SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 258 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
... ..+.. ++..++.+.+||.+||+.||.+|||+.|+|+||||++++.
T Consensus 240 ~~~~~~p~~----------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 240 VRNLKFPPL----------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHTTCCCHH----------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HhcCCCCCC----------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 211 11111 1123667889999999999999999999999999998743
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-53 Score=405.46 Aligned_cols=345 Identities=43% Similarity=0.776 Sum_probs=264.4
Q ss_pred CcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe
Q 017231 22 GGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI 101 (375)
Q Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 101 (375)
.+.|.........|.+.++|. +++.||+|+||+||+|++..+++.||||++............+.+|+.+++.++||||
T Consensus 45 ~~~~~~~~~~~~~~~~~~~y~-~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 123 (464)
T 3ttj_A 45 DNQFYSVEVGDSTFTVLKRYQ-NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123 (464)
T ss_dssp -CCEEEEEC--CEEEEETTEE-EEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred cccceeeecCCcceeecCCeE-EEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCC
Confidence 345555556666777777776 8999999999999999999999999999998766666677889999999999999999
Q ss_pred eeeceeecCCCC-CCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC
Q 017231 102 IAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC 180 (375)
Q Consensus 102 v~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~ 180 (375)
+++++++..... +....+++||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 124 v~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~ 201 (464)
T 3ttj_A 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201 (464)
T ss_dssp CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred CcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC
Confidence 999999976532 34467899999999988888754 499999999999999999999999999999999999999999
Q ss_pred CEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhC
Q 017231 181 DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 260 (375)
Q Consensus 181 ~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 260 (375)
.++|+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+....+
T Consensus 202 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg 280 (464)
T 3ttj_A 202 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280 (464)
T ss_dssp CEEECCCCCC-----CCCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999999987766555566788999999999988 6899999999999999999999999999999999999999998
Q ss_pred CCCcccccccccchhHHHhhhCCCCCCCCccccCCC------------CCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 261 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN------------KSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.+......... .....+....+......+...++. .++++.+||.+||..||++|||++|+|+||||
T Consensus 281 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 281 TPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp SCCHHHHTTSC-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred CCCHHHHHHcc-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 87766554443 223333333333222222222211 15679999999999999999999999999999
Q ss_pred CCCCCCCCC-CCCCCCCCCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 017231 329 APLHDINEE-PVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 329 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (375)
+...+..+. +.++..+..++...+...+.+++..+.+...+++
T Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 403 (464)
T 3ttj_A 360 NVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEE 403 (464)
T ss_dssp GGGCCHHHHSCCC-----------CCCHHHHHHHHHHHHHC---
T ss_pred hhccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHHHHhhh
Confidence 987655432 3345556777777778888999999988887764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=400.83 Aligned_cols=324 Identities=41% Similarity=0.772 Sum_probs=258.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||.||+|.++.+++.||||++............+.+|+.+++.+. ||||+++++++..... ..+|+|
T Consensus 13 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~---~~~~lv 89 (388)
T 3oz6_A 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND---RDVYLV 89 (388)
T ss_dssp EEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS---SCEEEE
T ss_pred EEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC---CEEEEE
Confidence 699999999999999999999999999999776666777788899999999997 9999999999875432 568999
Q ss_pred EeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-------
Q 017231 123 YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE------- 195 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~------- 195 (375)
|||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 90 ~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 168 (388)
T 3oz6_A 90 FDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168 (388)
T ss_dssp EECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCC
T ss_pred ecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccccc
Confidence 99999999999876 5799999999999999999999999999999999999999999999999999865432
Q ss_pred ---------------CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhC
Q 017231 196 ---------------TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG 260 (375)
Q Consensus 196 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 260 (375)
........||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 248 (388)
T 3oz6_A 169 IPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID 248 (388)
T ss_dssp GGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 11123457899999999998766789999999999999999999999999999999999999888
Q ss_pred CCCcccccccccchhHHHhhhCCCCC---CCCccc-------------cCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 261 SPDETSLGFLRSDNARRYVRMLPQFP---KQNFSA-------------RFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------------~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.+...............+...+.... ...+.. ....+++++.+||.+||+.||++|||++|+|+
T Consensus 249 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence 87766554444433333332221110 111111 11367899999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHhhcCC
Q 017231 325 HPYLAPLHDINEEPVCPRPFSFDFEHP-SFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 325 ~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 371 (375)
||||+.+.....++.+...+.+.+... ....+.+++..+.+...|+|
T Consensus 329 Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 376 (388)
T 3oz6_A 329 HPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKR 376 (388)
T ss_dssp STTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhhh
Confidence 999999999999999999998888753 46778999999988887765
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-53 Score=395.56 Aligned_cols=283 Identities=27% Similarity=0.449 Sum_probs=215.6
Q ss_pred ecccccCCeeeccCCcceEEEEEEeC---CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNS---ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQ 112 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~ 112 (375)
+.++|. ++++||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+.+|+.+ +||||++++++|...
T Consensus 19 l~~~Y~-i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~- 92 (361)
T 4f9c_A 19 LSNVFK-IEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN- 92 (361)
T ss_dssp GGGTCE-EEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET-
T ss_pred ccCcEE-EEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC-
Confidence 344443 7999999999999999875 467899999986542 234577899999998 699999999999554
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC-CCEEEeecccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLA 190 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~-~~i~l~Df~~~ 190 (375)
+++|+||||++ |+|.+++. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++
T Consensus 93 ----~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 93 ----DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp ----TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ----CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 67999999997 69999884 59999999999999999999999999999999999999887 79999999998
Q ss_pred cccCCCC-----------------------------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCC
Q 017231 191 RTTSETD-----------------------------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 241 (375)
Q Consensus 191 ~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 241 (375)
....... ...+.+||+.|+|||++.+...++.++||||+||++|+|++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 6433221 12345799999999999885678999999999999999999999
Q ss_pred CCC-CCChhHHHHHHHHHhCCCCcccc-----------cccccchhHHHhhhCCCC------------CCCCccccCCCC
Q 017231 242 LFP-GKDYVHQLRLITELIGSPDETSL-----------GFLRSDNARRYVRMLPQF------------PKQNFSARFPNK 297 (375)
Q Consensus 242 pf~-~~~~~~~~~~i~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~ 297 (375)
||. +.+..+.+..|....+....... ..............+... ........+..+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 984 55677788888777664321110 000011111111111000 001112335678
Q ss_pred CchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 298 SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 298 s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
|+++++||.+||..||.+|||++|+|+||||++++
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999999999764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=388.01 Aligned_cols=255 Identities=24% Similarity=0.372 Sum_probs=209.8
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeC-----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeecee
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNS-----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 107 (375)
..+++..+.+.+.++||+|+||+||+|+++ .++..||||+++.. +....+.|.+|+.++++++|||||+++++
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 456778888889999999999999999865 46889999999653 44556789999999999999999999999
Q ss_pred ecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 017231 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSH---------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 171 (375)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~---------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p 171 (375)
+... ..+++|||||+ |+|.+++... .++++.+++.|+.||+.||.|||+++|+||||||
T Consensus 112 ~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp 186 (329)
T 4aoj_A 112 CTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLAT 186 (329)
T ss_dssp ECSS-----SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred EEEC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccH
Confidence 9654 56899999997 7999999754 3589999999999999999999999999999999
Q ss_pred CceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCC
Q 017231 172 SNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKD 247 (375)
Q Consensus 172 ~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~ 247 (375)
+|||++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||...+
T Consensus 187 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp GGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC
T ss_pred hhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999997654332 2334678999999999988 789999999999999999998 899999888
Q ss_pred hhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 248 YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 248 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
..+.+..+....... ....+++++.+++.+||+.||++|||+.||+++
T Consensus 266 ~~~~~~~i~~g~~~~------------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 266 NTEAIDCITQGRELE------------------------------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHHTCCCC------------------------------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCC------------------------------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 777766665421110 013578999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=384.71 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=213.4
Q ss_pred eecccccCCeeeccCCcceEEEEEEeC-----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNS-----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
+|.++.+.+.++||+|+||+||+|++. .++..||||+++.. .....+.+.+|+.++++++|||||++++++..
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 566777779999999999999999865 36788999999654 44456789999999999999999999999965
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSH-------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 176 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~-------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli 176 (375)
. +.+++|||||+ |+|.+++... ..+++.+++.|+.||+.||.|||+++|+||||||+|||+
T Consensus 87 ~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl 161 (299)
T 4asz_A 87 G-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 161 (299)
T ss_dssp S-----SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred C-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence 4 56899999997 7999999764 359999999999999999999999999999999999999
Q ss_pred ecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHH
Q 017231 177 NANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQL 252 (375)
Q Consensus 177 ~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 252 (375)
+.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||.+.+..+..
T Consensus 162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 240 (299)
T 4asz_A 162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240 (299)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9999999999999975443322 234568999999999988 789999999999999999998 89999998877777
Q ss_pred HHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 253 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..+........ ...+++++.+++.+||+.||++|||+.+|+ +|++++
T Consensus 241 ~~i~~~~~~~~------------------------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~ 287 (299)
T 4asz_A 241 ECITQGRVLQR------------------------------PRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL 287 (299)
T ss_dssp HHHHHTCCCCC------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred HHHHcCCCCCC------------------------------CccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence 66654221100 135788999999999999999999999994 455543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-52 Score=386.21 Aligned_cols=342 Identities=45% Similarity=0.846 Sum_probs=291.4
Q ss_pred eEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeee
Q 017231 25 YVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104 (375)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 104 (375)
|...+.....|++.++|. +.+.||+|+||.||+|.++.+|+.||||++............+.+|+.+++.++||||+++
T Consensus 10 ~~~~~~~~~~~~l~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 88 (353)
T 3coi_A 10 FYKQDVNKTAWELPKTYV-SPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGL 88 (353)
T ss_dssp EEEEEETTEEEEEETTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred cEEEeecCcccccCceEE-EeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccH
Confidence 444456667788888877 8999999999999999999999999999997766666667788999999999999999999
Q ss_pred ceeecCCCC-CCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEE
Q 017231 105 KDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 183 (375)
Q Consensus 105 ~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~ 183 (375)
++++..... .....+++||||++++|.+++. ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 89 LDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp SEEECSCSSGGGCCCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEE
T ss_pred hheEecccccccceeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEE
Confidence 999876532 1223469999999998888764 3599999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 184 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 184 l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
|+|||.+...... .....+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+.++
T Consensus 167 l~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 167 ILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp ECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred EeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999998765433 23457799999999988756789999999999999999999999999998888999988888887
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCC
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRP 343 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~ 343 (375)
......+.......+...++..+...+....+.+++++.++|.+||+.||++|||+.++++||||+.+.....++....+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~ 324 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP 324 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSC
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCC
Confidence 77666666666666666666655555666667889999999999999999999999999999999999888888888888
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 017231 344 FSFDFEHPSFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (375)
|.........+.+.++...+++.++|.|
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 325 FDDSLEHEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp CCCTTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred CccchhhccCCHHHHHHHHHHHHHhhcc
Confidence 9888888889999999999999999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=412.86 Aligned_cols=259 Identities=26% Similarity=0.445 Sum_probs=227.4
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
|++++.||+|+||+||+|+++.+|+.||+|++... .....+.+.+|+.+|+.++||||++++++|... ..+|+
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-----~~~~i 231 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMVM 231 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-----SEEEE
T ss_pred cEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEE
Confidence 44899999999999999999999999999998654 334466788999999999999999999999654 67999
Q ss_pred EEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC--CCEEEeecccccccCCCC
Q 017231 122 VYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN--CDLKIGDFGLARTTSETD 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~--~~i~l~Df~~~~~~~~~~ 197 (375)
|||||+ |+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.......
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 999997 699999864 4579999999999999999999999999999999999999854 899999999998877776
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+..
T Consensus 312 ~~~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------ 378 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS------------ 378 (573)
T ss_dssp EEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG------------
T ss_pred ceeeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc------------
Confidence 6677889999999999988 789999999999999999999999999998888887776543332222
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
.++.+|+++++||.+||+.||.+|||+.|+|+||||+..+...
T Consensus 379 ---------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 379 ---------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp ---------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred ---------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 1246799999999999999999999999999999999765543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=413.52 Aligned_cols=260 Identities=26% Similarity=0.391 Sum_probs=215.1
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc----cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF----DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
.+.-+.+++++.||+|+||+||+|+++.+|+.||||++.+.. ...........++.+++.++|||||++++.|.+.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 344455678999999999999999999999999999996532 1111222333456677788999999999999655
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
..+|+|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 265 -----~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 265 -----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp -----SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred -----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEeccccee
Confidence 67999999997 699999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhH---HHHHHHHHhCCCCcccc
Q 017231 191 RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH---QLRLITELIGSPDETSL 267 (375)
Q Consensus 191 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~ 267 (375)
....... ..+.+||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+... ....+.......
T Consensus 340 ~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~----- 413 (689)
T 3v5w_A 340 CDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL----- 413 (689)
T ss_dssp EECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC-----
T ss_pred eecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC-----
Confidence 7665443 4567999999999999754679999999999999999999999997643322 222222211110
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH 332 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~ 332 (375)
...+|+++++||.+||+.||.+|++ ++||++||||++++
T Consensus 414 --------------------------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 414 --------------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp --------------------------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred --------------------------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 1357999999999999999999998 79999999999885
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=381.24 Aligned_cols=255 Identities=21% Similarity=0.328 Sum_probs=212.8
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeC-----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNS-----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
..++....++++++||+|+||+||+|+.. .+++.||||+++... .....+.|.+|+.++++++|||||++++++
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 45677777889999999999999999853 467889999986543 233457799999999999999999999999
Q ss_pred cCCCCCCcCcEEEEEeCCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 017231 109 RPPQRETFNDVYIVYELMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 171 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p 171 (375)
... ..+++|||||+ |+|.+++... ..+++.++..|+.||+.||.|||+++|+||||||
T Consensus 99 ~~~-----~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~ 173 (308)
T 4gt4_A 99 TKD-----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLAT 173 (308)
T ss_dssp CSS-----SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEC-----CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 654 45799999997 7999999653 3489999999999999999999999999999999
Q ss_pred CceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCC
Q 017231 172 SNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKD 247 (375)
Q Consensus 172 ~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~ 247 (375)
+|||++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.+
T Consensus 174 ~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp GGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred cceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999987643332 2345678999999999988 789999999999999999998 899999988
Q ss_pred hhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 248 YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 248 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
..+....+......+ ....+++++.+++.+||+.||++|||+.||+++
T Consensus 253 ~~~~~~~i~~~~~~~------------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 253 NQDVVEMIRNRQVLP------------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHHTTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCC------------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 777666554321110 013578899999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=386.37 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=215.1
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCC-----CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCC-CCeeeec
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSET-----REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH-ENIIAIK 105 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~ 105 (375)
.++|++..+.+++++.||+|+||+||+|.+..+ ++.||||.+.... .....+.+.+|+.+|.++.| ||||+++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 368999999999999999999999999987653 4679999986543 33456779999999999965 9999999
Q ss_pred eeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 017231 106 DIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 168 (375)
Q Consensus 106 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~d 168 (375)
+++.... ..+++|||||+ |+|.+++... ..+++..+..++.||+.||.|||+++|+|||
T Consensus 135 g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRD 210 (353)
T 4ase_A 135 GACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 210 (353)
T ss_dssp EEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCc
Confidence 9986542 45799999997 7999999753 3489999999999999999999999999999
Q ss_pred CCCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCC
Q 017231 169 LKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFP 244 (375)
Q Consensus 169 i~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~ 244 (375)
|||+|||++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+| |..||.
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999997654332 2345678999999999988 789999999999999999998 999998
Q ss_pred CCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 245 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
+.+....+..+......++. -..+++++.++|.+||+.||++|||+.||++
T Consensus 290 ~~~~~~~~~~~i~~g~~~~~-----------------------------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~ 340 (353)
T 4ase_A 290 GVKIDEEFCRRLKEGTRMRA-----------------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 340 (353)
T ss_dssp TCCCSHHHHHHHHHTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCCCC-----------------------------CccCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 87654443333322111110 0246889999999999999999999999998
Q ss_pred C
Q 017231 325 H 325 (375)
Q Consensus 325 ~ 325 (375)
|
T Consensus 341 ~ 341 (353)
T 4ase_A 341 H 341 (353)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=374.19 Aligned_cols=304 Identities=36% Similarity=0.645 Sum_probs=237.0
Q ss_pred CCCCCCCCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHH
Q 017231 4 ESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDA 83 (375)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~ 83 (375)
++++.+++.+...+..+ .++|. +++.||+|+||+||++++.. ++.||+|++..........
T Consensus 3 ~~~~~~~~~~~~~~q~l-~~~y~-----------------~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~ 63 (311)
T 3niz_A 3 HHHHHSSGRENLYFQGL-MEKYQ-----------------KLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIP 63 (311)
T ss_dssp ------------CEECS-SCEEE-----------------EEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHH
T ss_pred ccccccccccceeecch-HhhhH-----------------hhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhh
Confidence 45667778888877777 55888 49999999999999999864 8999999997655455456
Q ss_pred HHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 017231 84 KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSA 162 (375)
Q Consensus 84 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~ 162 (375)
..+.+|+.++++++||||+++++++... ..+++||||++++|.+.+.... .+++..++.++.||+.||.+||++
T Consensus 64 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 138 (311)
T 3niz_A 64 STAIREISLLKELHHPNIVSLIDVIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138 (311)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECCS-----SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHcCCCCEeeeeeEEccC-----CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 7788999999999999999999999654 5689999999999999887754 499999999999999999999999
Q ss_pred CccccCCCCCceEEecCCCEEEeecccccccCCC-CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCC
Q 017231 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 241 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 241 (375)
|++|+||||+||+++.++.++|+|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..
T Consensus 139 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 218 (311)
T 3niz_A 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218 (311)
T ss_dssp TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999998765433 223445779999999999875678999999999999999999999
Q ss_pred CCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHH
Q 017231 242 LFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 321 (375)
Q Consensus 242 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~e 321 (375)
||.+.........+....+.+....+........ .............+....+.+++++.++|.+||+.||++|||++|
T Consensus 219 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 297 (311)
T 3niz_A 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPL-WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297 (311)
T ss_dssp SCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHH-HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCCCCChHHHHHHHHHHHCCCChHHhhhhhccch-hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH
Confidence 9999988888888888888766554443322111 111112222223334445678999999999999999999999999
Q ss_pred HhcCCCCCCCC
Q 017231 322 ALCHPYLAPLH 332 (375)
Q Consensus 322 ll~~~~f~~~~ 332 (375)
+|+||||++++
T Consensus 298 ll~hp~f~~~~ 308 (311)
T 3niz_A 298 AMNHPYFKDLD 308 (311)
T ss_dssp HHTSGGGTTSC
T ss_pred HhcCcccccCC
Confidence 99999999874
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=373.40 Aligned_cols=257 Identities=25% Similarity=0.439 Sum_probs=226.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||+|++..+|+.||||++............+.+|+.+++.++||||+++++++... ..+++||
T Consensus 19 ~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~lv~ 93 (328)
T 3fe3_A 19 LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-----KTLYLIM 93 (328)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEE
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEEEEE
Confidence 69999999999999999999999999999977666666778889999999999999999999998544 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 202 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~ 202 (375)
||++ |+|.+++...+.+++..++.++.||+.||.+||++|++||||||+||+++.++.++|+|||++............
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 173 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF 173 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTT
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccc
Confidence 9996 699999998889999999999999999999999999999999999999999999999999999876666556677
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 174 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p------------------- 234 (328)
T 3fe3_A 174 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP------------------- 234 (328)
T ss_dssp SSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------------
T ss_pred cCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------------------
Confidence 8999999999998844446899999999999999999999999887777666654221111
Q ss_pred CCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
..+++++.++|.+||+.||.+|||++|+++||||+.......
T Consensus 235 ------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~ 276 (328)
T 3fe3_A 235 ------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276 (328)
T ss_dssp ------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTCC
T ss_pred ------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcccc
Confidence 236889999999999999999999999999999998765443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=382.88 Aligned_cols=350 Identities=43% Similarity=0.743 Sum_probs=258.0
Q ss_pred CCCCCCCCCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHH
Q 017231 3 GESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRID 82 (375)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~ 82 (375)
..+.+.++++++..|... +.+.++|. +++.||+|+||.||+|.+..+++.||||++.........
T Consensus 3 ~~~~~~~~~~~~~~~~~~--------------~~~~~~y~-~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~ 67 (371)
T 2xrw_A 3 SRSKRDNNFYSVEIGDST--------------FTVLKRYQ-NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH 67 (371)
T ss_dssp CSGGGGGGEEEEEETTEE--------------EEEETTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHH
T ss_pred ccccccCcceEeecCCcc--------------cchhhhee-EeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHH
Confidence 344455667777766532 22223332 699999999999999999999999999999776556666
Q ss_pred HHHHHHHHHHHHhcCCCCeeeeceeecCCC-CCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 017231 83 AKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161 (375)
Q Consensus 83 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~ 161 (375)
...+.+|+.+++.++||||+++++++.... .+.....++||||++++|.+.+. ..+++..++.++.||+.||.+||+
T Consensus 68 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~ 145 (371)
T 2xrw_A 68 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS 145 (371)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHH
Confidence 778899999999999999999999987653 22335789999999999999886 459999999999999999999999
Q ss_pred CCccccCCCCCceEEecCCCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCC
Q 017231 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 241 (375)
Q Consensus 162 ~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 241 (375)
+|++|+||||+||+++.++.++|+|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 146 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~ 224 (371)
T 2xrw_A 146 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGV 224 (371)
T ss_dssp TTCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999999977655544456678999999999988 678999999999999999999999
Q ss_pred CCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCC------------CCCchHHHHHHHhc
Q 017231 242 LFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP------------NKSPGAVDLLEKML 309 (375)
Q Consensus 242 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~s~~l~~li~~~L 309 (375)
||.+.+.......+....+.+.......... ....+....+......+...++ ..++++.+||.+||
T Consensus 225 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 303 (371)
T 2xrw_A 225 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP-TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303 (371)
T ss_dssp SSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH-HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh-HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHC
Confidence 9999988888887777666554433322211 1111121111111111111111 12567999999999
Q ss_pred CcCCCCCCCHHHHhcCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 017231 310 VFDPNRRITVDEALCHPYLAPLHDINE-EPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 310 ~~dP~~Rps~~ell~~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (375)
..||++|||++|+|+||||+....... ....+.....+..+....-+.++++.+++..+|+-
T Consensus 304 ~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 366 (371)
T 2xrw_A 304 VIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEH 366 (371)
T ss_dssp CSSGGGSCCHHHHHHSHHHHTTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHHHHCC
T ss_pred cCChhhCCCHHHHhCCcchhhhcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHHHHHhh
Confidence 999999999999999999997654332 22233334455666667888999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=369.65 Aligned_cols=322 Identities=52% Similarity=0.926 Sum_probs=265.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||++.+..+|+.||||++... ........+.+|+.++++++||||+++++++.....+.....++||
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 93 (353)
T 2b9h_A 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQ 93 (353)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEE
T ss_pred EeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEE
Confidence 799999999999999999999999999998643 2344556788999999999999999999998765444557789999
Q ss_pred eCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-----
Q 017231 124 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF----- 198 (375)
Q Consensus 124 e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~----- 198 (375)
||++++|.+++.. ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++........
T Consensus 94 e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 172 (353)
T 2b9h_A 94 ELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEP 172 (353)
T ss_dssp CCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---------
T ss_pred eccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCc
Confidence 9999999999876 5699999999999999999999999999999999999999999999999999876543211
Q ss_pred ------cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcc-cccccc
Q 017231 199 ------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET-SLGFLR 271 (375)
Q Consensus 199 ------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~ 271 (375)
.....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+.+... ......
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (353)
T 2b9h_A 173 TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIE 252 (353)
T ss_dssp -------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCC
T ss_pred cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccc
Confidence 1234679999999998765678999999999999999999999999999888888888877765532 222223
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC----CCCCCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE----EPVCPRPFSFD 347 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~----~~~~~~~~~~~ 347 (375)
......+...+...+...+....+.+++++.++|.+||+.||++|||+.++++||||+....... ++..+..|.++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (353)
T 2b9h_A 253 SPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEPIPPSFFEFD 332 (353)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCCCCGGGGGGG
T ss_pred cchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCCCCcceeeec
Confidence 33344455555555444555556788999999999999999999999999999999999875543 34455668888
Q ss_pred CCCCCCCHHHHHHHHHHHHh
Q 017231 348 FEHPSFTEENIKELIYRESV 367 (375)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~ 367 (375)
+....++++.+++...++..
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 333 HYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCSSCCCHHHHHHHHHHHHT
T ss_pred chhhcCCHHHHHHHHHHHhh
Confidence 88888999999999988764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=364.45 Aligned_cols=284 Identities=35% Similarity=0.584 Sum_probs=229.6
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc---chHHHHHHHHHHHHHHhc---CCCCeeeeceeecCCCCCCcC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD---NRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~ 117 (375)
+++.||+|+||+||+|+++.+++.||+|++..... .......+.+|+.+++++ +||||+++++++.........
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~ 92 (308)
T 3g33_A 13 PVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92 (308)
T ss_dssp EEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEE
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCce
Confidence 69999999999999999999999999999864321 111123455666666665 599999999998765433334
Q ss_pred cEEEEEeCCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 118 DVYIVYELMDTDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 118 ~~~lv~e~~~g~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
.++++||+++++|.+++..... +++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 93 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 172 (308)
T 3g33_A 93 KVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY 172 (308)
T ss_dssp EEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTT
T ss_pred eEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCC
Confidence 6899999999999999988755 99999999999999999999999999999999999999999999999999987766
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+....+..+...+........
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (308)
T 3g33_A 173 QMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR 251 (308)
T ss_dssp CCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCG
T ss_pred CcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 655666788999999999987 6789999999999999999999999999999999999988888766554432211111
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
...............+.+++++.++|.+||+.||++|||+.|+|+||||++..
T Consensus 252 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 252 ----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp ----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred ----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 11111222233344567899999999999999999999999999999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=360.82 Aligned_cols=281 Identities=37% Similarity=0.651 Sum_probs=230.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||+||+|+++.+++.||+|++............+.+|+.++++++||||+++++++... ..+++||
T Consensus 6 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 80 (292)
T 3o0g_A 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVF 80 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred eeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEEEEEE
Confidence 69999999999999999999999999999987665666667888999999999999999999998654 5689999
Q ss_pred eCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Ccccc
Q 017231 124 ELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTE 201 (375)
Q Consensus 124 e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~~ 201 (375)
||+++++.+.+.. .+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+...... .....
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 9999988887765 567999999999999999999999999999999999999999999999999999765433 23345
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCC-CCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL-FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
..+|+.|+|||++.+...++.++|||||||++|+|++|..| |...+....+..+....+.+....+........ +..
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~--~~~ 238 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD--YKP 238 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT--CCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc--ccc
Confidence 67799999999998755589999999999999999987766 677777888888888887766554433221110 000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..............+.+++++.++|.+||+.||++|||++|+|+||||+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 000011122233345689999999999999999999999999999999975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=375.85 Aligned_cols=273 Identities=22% Similarity=0.350 Sum_probs=218.2
Q ss_pred CCCCCCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHH
Q 017231 6 SSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAK 84 (375)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~ 84 (375)
+..+...+...+.+..-++|. +++.||+|+||.||+|+++.+++.||||++.+.. .......
T Consensus 6 ~~~~~~~~~~~~~~~~~~~y~-----------------~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~ 68 (353)
T 3txo_A 6 SKEGNGIGVNSSNRLGIDNFE-----------------FIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVE 68 (353)
T ss_dssp -----------------CCEE-----------------EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHH
T ss_pred CcCCCCCCCCCcCCCchhheE-----------------EEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHH
Confidence 334445555555556566666 5999999999999999999999999999996542 2233456
Q ss_pred HHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 017231 85 RTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162 (375)
Q Consensus 85 ~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~ 162 (375)
.+..|..+++.+ +||||+++++++... ..+++||||++ |+|.+++...+.+++..++.++.||+.||.+||++
T Consensus 69 ~~~~E~~il~~~~~hp~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 143 (353)
T 3txo_A 69 CTMTEKRILSLARNHPFLTQLFCCFQTP-----DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK 143 (353)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHhccCCCceeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 678899999988 699999999999654 56899999997 69999999988999999999999999999999999
Q ss_pred CccccCCCCCceEEecCCCEEEeecccccccCC-CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCC
Q 017231 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 241 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 241 (375)
||+||||||+||+++.+|.++|+|||++..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..
T Consensus 144 givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~ 222 (353)
T 3txo_A 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHA 222 (353)
T ss_dssp TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCC
Confidence 999999999999999999999999999875332 233456789999999999987 678999999999999999999999
Q ss_pred CCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH--
Q 017231 242 LFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV-- 319 (375)
Q Consensus 242 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~-- 319 (375)
||...+.......+.......+ ..+++++.++|.+||+.||.+||++
T Consensus 223 Pf~~~~~~~~~~~i~~~~~~~p-------------------------------~~~~~~~~~li~~lL~~dP~~R~~~~~ 271 (353)
T 3txo_A 223 PFEAENEDDLFEAILNDEVVYP-------------------------------TWLHEDATGILKSFMTKNPTMRLGSLT 271 (353)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCC-------------------------------TTSCHHHHHHHHHHTCSSGGGSTTSGG
T ss_pred CCCCCCHHHHHHHHHcCCCCCC-------------------------------CCCCHHHHHHHHHHhhhCHHHccCCcc
Confidence 9999988887777765322111 2368889999999999999999999
Q ss_pred ----HHHhcCCCCCCCC
Q 017231 320 ----DEALCHPYLAPLH 332 (375)
Q Consensus 320 ----~ell~~~~f~~~~ 332 (375)
+++++||||++++
T Consensus 272 ~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 272 QGGEHAILRHPFFKEID 288 (353)
T ss_dssp GTCTHHHHTSGGGTTCC
T ss_pred cCCHHHHhhCCcccCCC
Confidence 8999999999874
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=370.79 Aligned_cols=256 Identities=29% Similarity=0.463 Sum_probs=222.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch----HHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++.||+|+||+||++.++.+|+.||+|++.+..... ...+.+.+|+.++++++||||+++++++... ..+
T Consensus 16 ~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~ 90 (361)
T 2yab_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-----TDV 90 (361)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred EeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-----CEE
Confidence 7999999999999999999999999999997643221 1356788999999999999999999999554 668
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC----CEEEeecccccccC
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLARTTS 194 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~----~i~l~Df~~~~~~~ 194 (375)
++||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+|+||||+||+++.++ .++|+|||++....
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999996 79999998888899999999999999999999999999999999999998877 79999999998766
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
.........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+...
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------- 241 (361)
T 2yab_A 171 DGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF-------- 241 (361)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH--------
T ss_pred CCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchh--------
Confidence 6555566789999999999987 6789999999999999999999999998887777766655332222111
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
+..++++++++|.+||..||.+|||+.|+++||||+.+.
T Consensus 242 -------------------~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 242 -------------------FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp -------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred -------------------ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 245789999999999999999999999999999999654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=362.71 Aligned_cols=288 Identities=32% Similarity=0.624 Sum_probs=226.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|++|.||+|.+..+|+.||+|++............+.+|+.++++++||||+++++++... ...++||
T Consensus 7 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 81 (311)
T 4agu_A 7 KIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRLHLVF 81 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred EeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeEEEEE
Confidence 69999999999999999999999999999977666666677888999999999999999999998544 5689999
Q ss_pred eCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Ccccc
Q 017231 124 ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTE 201 (375)
Q Consensus 124 e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~~ 201 (375)
||+++ +|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+...... .....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 99985 67777777788999999999999999999999999999999999999999999999999998765533 23345
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..++..|+|||++.+...++.++||||||+++|+|++|..||.+.+.......+....+.........+...........
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI 241 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCC
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcC
Confidence 67899999999998756789999999999999999999999999988888888877776654432221111110000000
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
............++.+++++.++|.+||+.||++|||++++++||||+++....+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~ 296 (311)
T 4agu_A 242 PDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIED 296 (311)
T ss_dssp CCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC----
T ss_pred CCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHHH
Confidence 0001111223334678999999999999999999999999999999999876654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=362.34 Aligned_cols=256 Identities=25% Similarity=0.416 Sum_probs=220.7
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
..+++++.||+|+||.||+|+++.+|+.||+|++.+.. ........+..|+.+++.++||||+++++++... ..
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----SE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----CE
Confidence 34447999999999999999999999999999996542 1223456788999999999999999999999654 56
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC-CC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ET 196 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~-~~ 196 (375)
+++||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+||||||+||+++.+|.++|+|||++.... ..
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 899999997 6999999988899999999999999999999999999999999999999999999999999987533 23
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.......+
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------- 225 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP------------- 225 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-------------
T ss_pred CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-------------
Confidence 34456789999999999987 7789999999999999999999999998887776666554211111
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
..+++++.++|.+||+.||.+|| +++|+++||||++++
T Consensus 226 ------------------~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 226 ------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp ------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ------------------CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 24689999999999999999999 999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=374.92 Aligned_cols=298 Identities=22% Similarity=0.379 Sum_probs=233.4
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 114 (375)
+.-..+++++.||+|+||+||+|+++.+++.||+|++.+... .......+..|..++.++ +||||+++++++...
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--- 125 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE--- 125 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS---
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC---
Confidence 444555689999999999999999999999999999976532 233345677899999887 899999999999654
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc-
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART- 192 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~- 192 (375)
..+++||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+||||||+||+++.+|.++|+|||++..
T Consensus 126 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 126 --SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred --CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 56899999997 69999999888999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh---------hHHHHHHHHHhCCCC
Q 017231 193 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY---------VHQLRLITELIGSPD 263 (375)
Q Consensus 193 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~i~~~~~~~~ 263 (375)
..........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+.......
T Consensus 204 ~~~~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~- 281 (396)
T 4dc2_A 204 LRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI- 281 (396)
T ss_dssp CCTTCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC-
T ss_pred ccCCCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC-
Confidence 333344567789999999999988 7889999999999999999999999964321 11222222211000
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH------HHHhcCCCCCCCCCCC-C
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV------DEALCHPYLAPLHDIN-E 336 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~------~ell~~~~f~~~~~~~-~ 336 (375)
...+++++.++|++||+.||.+||++ +|+++||||++++-.. .
T Consensus 282 ------------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~ 331 (396)
T 4dc2_A 282 ------------------------------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMME 331 (396)
T ss_dssp ------------------------------CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHH
T ss_pred ------------------------------CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 12468899999999999999999985 7999999999875111 1
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHhhcCCC
Q 017231 337 EPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPD 372 (375)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (375)
...-..+|.+....+ +...++++....+.+...|+
T Consensus 332 ~~~~~pp~~p~~~~~-~d~~~fd~~~~~~~~~~~~~ 366 (396)
T 4dc2_A 332 QKQVVPPFKPNISGE-FGLDNFDSQFTNEPVQLTPD 366 (396)
T ss_dssp TTCSCCSCCCCCCSS-TTGGGSCHHHHTSCCCCCCC
T ss_pred cCCCCCCCcCCCCCc-cchhhcChhhccCCCccCCC
Confidence 112233466655544 44455555566666666665
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=359.47 Aligned_cols=280 Identities=37% Similarity=0.654 Sum_probs=225.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||+|++ .+++.||+|++............+.+|+.++++++||||+++++++... ...++||
T Consensus 6 ~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 79 (288)
T 1ob3_A 6 GLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLVLVF 79 (288)
T ss_dssp EEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEEEEE
T ss_pred hhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEEEEE
Confidence 699999999999999998 6789999999976544444456788999999999999999999999654 5689999
Q ss_pred eCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Ccccc
Q 017231 124 ELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMTE 201 (375)
Q Consensus 124 e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~~ 201 (375)
||++++|.+++... +.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+...... .....
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence 99999999999864 67999999999999999999999999999999999999999999999999998654432 22334
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..+|+.|+|||++.+...++.++|||||||++|+|++|..||...+.......+....+......+....... .+...
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 237 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP--KYDPN 237 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--TCCTT
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc--ccccc
Confidence 5679999999999775668999999999999999999999999998888888888877766554433221110 00111
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
........+......+++++.++|.+||+.||++|||+.|+++||||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 11111122233345689999999999999999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=364.49 Aligned_cols=324 Identities=38% Similarity=0.710 Sum_probs=252.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc---------chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD---------NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
+++.||+|+||.||++.+.. +..||||++..... .......+.+|+.++++++||||+++++++......
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (362)
T 3pg1_A 26 VQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104 (362)
T ss_dssp EEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTT
T ss_pred EeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCC
Confidence 69999999999999999866 89999999865322 223347789999999999999999999998665444
Q ss_pred CcCcEEEEEeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 115 TFNDVYIVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 115 ~~~~~~lv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
....+++||||++|+|.+.+.... .+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 105 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (362)
T 3pg1_A 105 AMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARED 184 (362)
T ss_dssp TCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC----
T ss_pred CcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCccccc
Confidence 456789999999999999987654 6999999999999999999999999999999999999999999999999999765
Q ss_pred CCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
..........+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+.+...........
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 264 (362)
T 3pg1_A 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSP 264 (362)
T ss_dssp -----------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCH
T ss_pred ccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccch
Confidence 55555556678999999999887567899999999999999999999999999999999999988887765544433333
Q ss_pred hhHHHh-hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCC-CCCCCCCCCCCC
Q 017231 274 NARRYV-RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV-CPRPFSFDFEHP 351 (375)
Q Consensus 274 ~~~~~~-~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~-~~~~~~~~~~~~ 351 (375)
....+. ......+...+....+..++.+.++|.+||+.||++|||+.|+++||||+.+....+... ....+ .+...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~--~~~~~ 342 (362)
T 3pg1_A 265 SARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERF--HFDES 342 (362)
T ss_dssp HHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTCCCCC--CCCTT
T ss_pred hhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccccccccc--Chhhh
Confidence 333333 223333444455556778999999999999999999999999999999999865544332 22333 34444
Q ss_pred CCCHHHHHHHHHHHHhhcC
Q 017231 352 SFTEENIKELIYRESVKFN 370 (375)
Q Consensus 352 ~~~~~~~~~~~~~~~~~~~ 370 (375)
.....+++.....+...||
T Consensus 343 ~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 343 VTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp CCCHHHHHHHHHHHHHHHC
T ss_pred hhhHHHHHHHHHHHHHHhc
Confidence 4566788888888887765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=364.19 Aligned_cols=292 Identities=22% Similarity=0.398 Sum_probs=227.7
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++++.||+|+||.||+|+++.+++.||+|++.+.. ........+..|..+++++ +||||+++++++... ..+
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----~~~ 85 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRL 85 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEE
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-----CEE
Confidence 347999999999999999999999999999997653 3444566788999999988 899999999999554 568
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC-CCC
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-ETD 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~-~~~ 197 (375)
++||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+|+||||+||+++.+|.++|+|||++.... ...
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999997 6999999988889999999999999999999999999999999999999999999999999987533 233
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC---------hhHHHHHHHHHhCCCCccccc
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD---------YVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~~~~i~~~~~~~~~~~~~ 268 (375)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.... .......+......
T Consensus 166 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------- 237 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------- 237 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-------
T ss_pred cccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-------
Confidence 4456789999999999988 778999999999999999999999996532 11122222211000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH------HHHhcCCCCCCCCC-CCCCCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV------DEALCHPYLAPLHD-INEEPVCP 341 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~------~ell~~~~f~~~~~-~~~~~~~~ 341 (375)
. -..+++++.++|.+||+.||.+||++ +++++||||++++- .-......
T Consensus 238 ----------------~--------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~ 293 (345)
T 3a8x_A 238 ----------------I--------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVV 293 (345)
T ss_dssp ----------------C--------CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred ----------------C--------CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCC
Confidence 0 02468899999999999999999995 89999999998751 11112222
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 017231 342 RPFSFDFEHPSFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (375)
.+|.+....+ ....++++....+++.+.|
T Consensus 294 ~p~~p~~~~~-~~~~~~~~~~~~~~~~~~~ 322 (345)
T 3a8x_A 294 PPFKPNISGE-FGLDNFDSQFTNEPVQLTP 322 (345)
T ss_dssp CSCCCCCCTT-TCGGGSCHHHHTSCSSCCC
T ss_pred CCcCCCCCCc-chhhhcCcccccCcccCCC
Confidence 3455554443 2333444444444444433
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=367.54 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=222.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||++.++.+++.||+|++............+.+|+.++++++||||+++++++... ...++||
T Consensus 33 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~lv~ 107 (362)
T 2bdw_A 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVF 107 (362)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEE
T ss_pred EeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEEE
Confidence 79999999999999999999999999999977655566677899999999999999999999999654 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC---CEEEeecccccccCCCCcc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~---~i~l~Df~~~~~~~~~~~~ 199 (375)
||+. |+|.+.+.....+++..++.++.||+.||.|||++||+|+||||+||+++.++ .++|+|||++.........
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~ 187 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCccc
Confidence 9997 59999998888899999999999999999999999999999999999998654 5999999999877655555
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......+...
T Consensus 188 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------- 253 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE------------- 253 (362)
T ss_dssp CCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG-------------
T ss_pred ccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc-------------
Confidence 56789999999999987 6789999999999999999999999998887777666655332222111
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
+..+++++.++|.+||+.||++||++.++|+||||+..
T Consensus 254 --------------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 254 --------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp --------------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred --------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 23568899999999999999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=364.63 Aligned_cols=282 Identities=37% Similarity=0.655 Sum_probs=219.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||++++..+++.||||++............+.+|+.++++++||||+++++++... ..+++||
T Consensus 38 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 112 (329)
T 3gbz_A 38 RITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-----HRLHLIF 112 (329)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred EEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----CEEEEEE
Confidence 59999999999999999999999999999976655555566778999999999999999999998654 5689999
Q ss_pred eCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe-----cCCCEEEeecccccccCCC-C
Q 017231 124 ELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-----ANCDLKIGDFGLARTTSET-D 197 (375)
Q Consensus 124 e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~-----~~~~i~l~Df~~~~~~~~~-~ 197 (375)
||++|+|.+++...+.+++..++.++.||+.||.+||++||+|+||||+||+++ .++.++|+|||++...... .
T Consensus 113 e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 192 (329)
T 3gbz_A 113 EYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192 (329)
T ss_dssp ECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC----
T ss_pred ecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc
Confidence 999999999999999999999999999999999999999999999999999995 4455999999998765432 2
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
......+|+.|+|||++.+...++.++|||||||++|+|++|..||...+....+..+....+.+....+....... .
T Consensus 193 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 270 (329)
T 3gbz_A 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP--D 270 (329)
T ss_dssp -------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST--T
T ss_pred ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh--h
Confidence 23445679999999999875668999999999999999999999999999888888888887766554433221110 0
Q ss_pred HhhhCCCCCCCCcccc-CCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSAR-FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
+...........+... ...+++++.+||.+||+.||.+|||+.|+|+||||++.+
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 271 WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326 (329)
T ss_dssp CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence 0011111111111110 112688999999999999999999999999999999763
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=360.78 Aligned_cols=286 Identities=36% Similarity=0.667 Sum_probs=218.9
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++++.||+|+||.||+|.++.+++.||+|++.... .......+.+|+.++++++||||+++++++... +.+++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~l 80 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTE-----NKLTL 80 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-----TEEEE
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-----CeEEE
Confidence 337999999999999999999999999999986543 222345677899999999999999999999654 56899
Q ss_pred EEeCCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 122 VYELMDTDLHQIIRSH------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 122 v~e~~~g~L~~~l~~~------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
||||++|+|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 v~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 81 VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 9999999999998754 3599999999999999999999999999999999999999999999999999876543
Q ss_pred C-CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 196 T-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 196 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
. .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+.+....+.......
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 3 223455789999999999875678999999999999999999999999999888888888887776554433221110
Q ss_pred hHHHhhhCCCCCCCCc-----cccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNF-----SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~-----~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
.+...........+ ......+++++.++|.+||+.||++|||+.|+|+||||++.....
T Consensus 241 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 241 --KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp --TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred --hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 00000000000000 111235788999999999999999999999999999999875443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=362.76 Aligned_cols=286 Identities=35% Similarity=0.655 Sum_probs=228.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||++.++.+++.||+|++...... .....+.+|+.++++++||||+++++++... ...++||
T Consensus 6 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 79 (324)
T 3mtl_A 6 KLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLTLVF 79 (324)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEEEEE
T ss_pred EEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEEEEe
Confidence 699999999999999999999999999998654211 1112345799999999999999999998654 5689999
Q ss_pred eCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
||++|+|.+++...+ .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 80 EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred cccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 999999999988754 59999999999999999999999999999999999999999999999999986554332 2334
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+.+....+.......... ...
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~ 238 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK-TYN 238 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH-HTC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc-ccc
Confidence 5679999999999875678999999999999999999999999999999999999988887666554332221111 111
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
.............+.+++++.+||.+||+.||.+|||++|+|+||||.++.....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 293 (324)
T 3mtl_A 239 YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIH 293 (324)
T ss_dssp CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTS
T ss_pred cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccc
Confidence 2222233334445678999999999999999999999999999999999865443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=359.20 Aligned_cols=257 Identities=27% Similarity=0.462 Sum_probs=221.2
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch----HHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
++.+.||+|+||.||++.++.+++.||+|++....... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 88 (326)
T 2y0a_A 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-----TD 88 (326)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred EeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CE
Confidence 37999999999999999999999999999986543221 2356788999999999999999999999654 56
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC----CEEEeeccccccc
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLARTT 193 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~----~i~l~Df~~~~~~ 193 (375)
.++||||++ ++|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 899999996 69999998888899999999999999999999999999999999999998887 8999999999876
Q ss_pred CCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......+..
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 239 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE-------- 239 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHH--------
T ss_pred CCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcc--------
Confidence 65544556778999999999987 678999999999999999999999998887777666665533222211
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.+..+++.+.++|.+||+.||.+|||+.++|+||||+...
T Consensus 240 -------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 240 -------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp -------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred -------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 1135688999999999999999999999999999998653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=370.73 Aligned_cols=255 Identities=27% Similarity=0.449 Sum_probs=221.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||+||++.++.+|+.||+|++............+.+|+.++++++||||+++++++... +..++||
T Consensus 15 i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~~lv~ 89 (444)
T 3soa_A 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-----GHHYLIF 89 (444)
T ss_dssp EEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-----SEEEEEE
T ss_pred EEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-----CEEEEEE
Confidence 79999999999999999999999999999977665566677889999999999999999999999544 6689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe---cCCCEEEeecccccccCCCC-c
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN---ANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~---~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
||+. |+|.+.+...+.+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++....... .
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~ 169 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence 9996 69999999989999999999999999999999999999999999999998 45789999999997655432 2
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+..
T Consensus 170 ~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~------------- 235 (444)
T 3soa_A 170 WFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP------------- 235 (444)
T ss_dssp CCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT-------------
T ss_pred eecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc-------------
Confidence 345678999999999987 678999999999999999999999999888777777766543332221
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.+..+++++.++|.+||+.||.+|||+.|+|+||||+..
T Consensus 236 --------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 236 --------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp --------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred --------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 124678999999999999999999999999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=363.22 Aligned_cols=290 Identities=21% Similarity=0.324 Sum_probs=232.9
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcC
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 117 (375)
..+++++.||+|+||.||+|+++.+++.||+|++.+... .......+..|..++..+ +||+|+++++++... .
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-----~ 94 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----D 94 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-----S
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-----C
Confidence 344479999999999999999999999999999865421 223456678899999988 799999999999654 5
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC-C
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-E 195 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~-~ 195 (375)
.+|+||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+||||||+||+++.+|.++|+|||++.... .
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 6899999997 6999999988889999999999999999999999999999999999999999999999999987533 2
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p------------ 241 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP------------ 241 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence 233456789999999999987 7789999999999999999999999999887777777665221111
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCCCCC-CCCCCCCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLHDIN-EEPVCPRPFSFDFE 349 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~~~~-~~~~~~~~~~~~~~ 349 (375)
..+++++.++|.+||+.||.+||+ ++++++||||+.++-.. ....-..+|.+...
T Consensus 242 -------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~ 302 (353)
T 2i0e_A 242 -------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAC 302 (353)
T ss_dssp -------------------TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred -------------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCC
Confidence 246889999999999999999994 69999999999874211 11112234555554
Q ss_pred CCCCCHHHHHHHHHHHHhh
Q 017231 350 HPSFTEENIKELIYRESVK 368 (375)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~ 368 (375)
.+ ...++++...+....
T Consensus 303 ~~--~~~~f~~~~~~~~~~ 319 (353)
T 2i0e_A 303 GR--NAENFDRFFTRHPPV 319 (353)
T ss_dssp CC----CHHHHHHHHSCCC
T ss_pred Cc--chhhccchhccCCcc
Confidence 44 344666554444433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=356.06 Aligned_cols=252 Identities=23% Similarity=0.407 Sum_probs=219.3
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||.||+|+++.+|+.||+|++.+... .....+.+.+|..+++.++||||+++++++... ..++
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-----~~~~ 82 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQIF 82 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-----CEEE
Confidence 4479999999999999999999999999999865421 122356678899999999999999999999654 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
+||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+|+||||+||+++.+|.++|+|||++...... .
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~ 160 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--T 160 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--B
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--c
Confidence 9999997 699999999889999999999999999999999999999999999999999999999999998765433 3
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
...+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.......+
T Consensus 161 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p---------------- 223 (318)
T 1fot_A 161 YTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP---------------- 223 (318)
T ss_dssp CCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----------------
T ss_pred ccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----------------
Confidence 45688999999999987 7789999999999999999999999998887777666655221111
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
+.+++++.++|.+||..||.+|| +++++++||||+++.
T Consensus 224 ---------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 224 ---------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ---------------CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 24688999999999999999999 999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=358.46 Aligned_cols=252 Identities=24% Similarity=0.422 Sum_probs=219.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||++.++.+++.||+|++... ......+.+|+.+++.++||||+++++++... ..+++||
T Consensus 9 ~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~ 80 (321)
T 1tki_A 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESM-----EELVMIF 80 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred eeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEEEEEE
Confidence 799999999999999999999999999998643 23455688999999999999999999999554 5689999
Q ss_pred eCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec--CCCEEEeecccccccCCCCcc
Q 017231 124 ELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~--~~~i~l~Df~~~~~~~~~~~~ 199 (375)
||++ |+|.+++.... .+++..++.++.||+.||.+||++|++|+||||+||+++. ++.++|+|||++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 9997 59999997654 6999999999999999999999999999999999999987 789999999999877665555
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......+..
T Consensus 161 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-------------- 225 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE-------------- 225 (321)
T ss_dssp EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHH--------------
T ss_pred ccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChh--------------
Confidence 66778999999999987 678999999999999999999999999888777777766543332221
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.++.+++++.++|.+||..||.+|||+.|+|+||||++.
T Consensus 226 -------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 226 -------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp -------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred -------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 124678999999999999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=363.30 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=218.6
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++++.||+|+||.||+|+++.+++.||||++.+.. ........+..|..++..+ +||||+++++++... ..+
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-----~~~ 93 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----ENL 93 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-----CEE
Confidence 337999999999999999999999999999996542 1122345677899999887 899999999999654 568
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-CC
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE-TD 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~-~~ 197 (375)
++||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+||||||+||+++.+|.++|+|||++..... ..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 173 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 173 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence 99999996 69999999888899999999999999999999999999999999999999999999999999875432 23
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
.....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+.......+.......+
T Consensus 174 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p-------------- 238 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP-------------- 238 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred cccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence 3456789999999999988 6789999999999999999999999998887777766654211110
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHH-HHhcCCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD-EALCHPYLAPLH 332 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~-ell~~~~f~~~~ 332 (375)
..+++++.++|.+||..||++||++. ++++||||++++
T Consensus 239 -----------------~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 239 -----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred -----------------cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 24688999999999999999999998 999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=350.95 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=216.0
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.+++++.||+|+||+||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++... ..++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 93 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 93 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence 344899999999999999999999999999998654322 345688999999999999999999998654 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-c
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-F 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~ 198 (375)
+||||++ |+|.+++... .+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc
Confidence 9999996 6999998764 69999999999999999999999999999999999999999999999999886654432 3
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+..........
T Consensus 173 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------- 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN------------- 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSC-------------
T ss_pred cCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC-------------
Confidence 345678999999999988 778999999999999999999999998887666555544432211100
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
...+++.+.++|.+||+.||++|||+.|+++||||+...
T Consensus 239 ---------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 239 ---------------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp ---------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ---------------ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 124688899999999999999999999999999999653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-49 Score=361.67 Aligned_cols=252 Identities=30% Similarity=0.484 Sum_probs=213.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc-hHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN-RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++... ...++|
T Consensus 13 i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~lv 87 (336)
T 3h4j_B 13 IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-----TDIVMV 87 (336)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEE
Confidence 699999999999999999999999999998643211 12235688999999999999999999999654 568999
Q ss_pred EeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccccc
Q 017231 123 YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 202 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~ 202 (375)
|||++|+|.+++...+.+++.+++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++............
T Consensus 88 ~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~ 167 (336)
T 3h4j_B 88 IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167 (336)
T ss_dssp ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCC
T ss_pred EECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999877666666677
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
+||+.|+|||++.+....+.++|||||||++|+|++|..||...........+
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--------------------------- 220 (336)
T 3h4j_B 168 CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--------------------------- 220 (336)
T ss_dssp TTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC---------------------------
T ss_pred cCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH---------------------------
Confidence 89999999999987433478999999999999999999999765422111000
Q ss_pred CCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..........+++++.++|++||+.||.+|||++|+++||||+..
T Consensus 221 ----~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 221 ----NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ----CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ----HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000011113478999999999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=347.55 Aligned_cols=260 Identities=28% Similarity=0.470 Sum_probs=226.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|++|.||++.++.+++.||+|++............+.+|+.++++++||||+++++++... ...++||
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~ 84 (284)
T 3kk8_A 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SFHYLVF 84 (284)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEE
T ss_pred hhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-----CEEEEEE
Confidence 69999999999999999999999999999977665666677889999999999999999999998544 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC---EEEeecccccccCCCCcc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSETDFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~---i~l~Df~~~~~~~~~~~~ 199 (375)
||++ ++|.+.+.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++. ++|+|||.+.........
T Consensus 85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (284)
T 3kk8_A 85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164 (284)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccc
Confidence 9997 599999988888999999999999999999999999999999999999987665 999999999776666555
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.......+..
T Consensus 165 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------- 229 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP-------------- 229 (284)
T ss_dssp CCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT--------------
T ss_pred cCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch--------------
Confidence 56788999999999987 678999999999999999999999999888777666665533222211
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
.+..+++++.++|.+||+.||++|||+.|+++||||++......
T Consensus 230 -------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 230 -------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 273 (284)
T ss_dssp -------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGG
T ss_pred -------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHh
Confidence 12457899999999999999999999999999999998755544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=363.85 Aligned_cols=265 Identities=22% Similarity=0.444 Sum_probs=219.7
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
..+....+++++.||+|+||.||+|+++.+++.||+|++.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-- 87 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-- 87 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC--
Confidence 3344444557999999999999999999999999999986532 2223456788999999999999999999999654
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..+++||||+. |+|.+++.....+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++..
T Consensus 88 ---~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 164 (384)
T 4fr4_A 88 ---EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAM 164 (384)
T ss_dssp ---SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ---CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence 56899999996 69999999988999999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccccccccccCchhcccC--CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 193 TSETDFMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 193 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
..........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+.........
T Consensus 165 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------ 238 (384)
T 4fr4_A 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT------ 238 (384)
T ss_dssp CCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC------
T ss_pred ccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC------
Confidence 7666666678899999999998742 45889999999999999999999999754432222222111111000
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-HHHHhcCCCCCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-VDEALCHPYLAPLH 332 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-~~ell~~~~f~~~~ 332 (375)
....+++++.++|.+||+.||.+||+ ++++++||||++++
T Consensus 239 ----------------------~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 239 ----------------------YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred ----------------------CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 01246889999999999999999998 89999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=359.53 Aligned_cols=268 Identities=28% Similarity=0.414 Sum_probs=204.7
Q ss_pred eEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHH
Q 017231 13 TIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKL 92 (375)
Q Consensus 13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~ 92 (375)
|.........+||. +++.||+|+||+||+++++.+++.||+|++...... ...+.+|+.+
T Consensus 10 p~~~~~~~~~~~y~-----------------~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~ 69 (361)
T 3uc3_A 10 PLDMPIMHDSDRYD-----------------FVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIIN 69 (361)
T ss_dssp -CCCCCCCCTTTEE-----------------EEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHH
T ss_pred CCCccCCCCCCcEE-----------------EEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHH
Confidence 33444445567888 599999999999999999999999999999654322 2457799999
Q ss_pred HHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q 017231 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKP 171 (375)
Q Consensus 93 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p 171 (375)
++.++||||+++++++... ..+++||||++ |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||
T Consensus 70 l~~l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp 144 (361)
T 3uc3_A 70 HRSLRHPNIVRFKEVILTP-----THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKL 144 (361)
T ss_dssp HHHCCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCG
T ss_pred HHhCCCCCCCcEEEEEeeC-----CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 9999999999999999654 56899999996 69999998888999999999999999999999999999999999
Q ss_pred CceEEecCCC--EEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh
Q 017231 172 SNLLLNANCD--LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV 249 (375)
Q Consensus 172 ~NIli~~~~~--i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 249 (375)
+||+++.++. ++|+|||++.............||+.|+|||++.+....+.++|||||||++|+|++|..||......
T Consensus 145 ~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 145 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp GGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C
T ss_pred HHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH
Confidence 9999987765 99999999875544444456678999999999987333345599999999999999999999875432
Q ss_pred HHHHHHHH-HhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 250 HQLRLITE-LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 250 ~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
.....+.. ........ .....+++++.++|.+||+.||.+|||+.|+++||||
T Consensus 225 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f 278 (361)
T 3uc3_A 225 RDYRKTIQRILSVKYSI--------------------------PDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278 (361)
T ss_dssp CCHHHHHHHHHTTCCCC--------------------------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHHHHhcCCCCC--------------------------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence 22222211 11110000 0012468999999999999999999999999999999
Q ss_pred CCC
Q 017231 329 APL 331 (375)
Q Consensus 329 ~~~ 331 (375)
.+.
T Consensus 279 ~~~ 281 (361)
T 3uc3_A 279 LKN 281 (361)
T ss_dssp HTT
T ss_pred hcC
Confidence 654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=358.93 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=220.1
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
.+++++.||+|+||.||+++++.+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++... ..+
T Consensus 42 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 116 (350)
T 1rdq_E 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SNL 116 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEE
T ss_pred HCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-----CEE
Confidence 3447999999999999999999999999999986532 1223456788999999999999999999999654 568
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
++||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+||||||+||+++.+|.++|+|||++......
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 99999996 699999998889999999999999999999999999999999999999999999999999999765443
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......+
T Consensus 195 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--------------- 258 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP--------------- 258 (350)
T ss_dssp BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------------
T ss_pred cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC---------------
Confidence 345688999999999987 6789999999999999999999999998887777766655221111
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH 332 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~ 332 (375)
..+++++.++|.+||+.||.+||+ ++++++||||+.++
T Consensus 259 ----------------~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 259 ----------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp ----------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred ----------------CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 246889999999999999999998 99999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=363.17 Aligned_cols=277 Identities=27% Similarity=0.445 Sum_probs=214.6
Q ss_pred CCCCCCCCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc---cch
Q 017231 4 ESSSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF---DNR 80 (375)
Q Consensus 4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~ 80 (375)
.+...||..+...+...-.++|. +++.||+|+||+||++.++.+++.||||++.... ...
T Consensus 5 ~~~~~g~~~~~~~~~~~~~~~y~-----------------~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~ 67 (351)
T 3c0i_A 5 ISGGGGGILDMADDDVLFEDVYE-----------------LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPG 67 (351)
T ss_dssp ---------------CCHHHHEE-----------------EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSS
T ss_pred CCCCCcccccccCCCCccccceE-----------------EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccccc
Confidence 34444566666666555556666 5999999999999999999999999999985421 111
Q ss_pred HHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHH
Q 017231 81 IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----QDLTDDHCRYFLYQLLRG 155 (375)
Q Consensus 81 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qi~~a 155 (375)
...+.+.+|+.+++.++||||+++++++... ..+++||||++ ++|.+.+... ..+++..++.++.||+.|
T Consensus 68 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~a 142 (351)
T 3c0i_A 68 LSTEDLKREASICHMLKHPHIVELLETYSSD-----GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142 (351)
T ss_dssp CCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHH
Confidence 2356788999999999999999999998554 56899999997 6998877543 358999999999999999
Q ss_pred HHHHHhCCccccCCCCCceEEecCCC---EEEeecccccccCCCCc-cccccccccccCchhcccCCCCCccchhHHHHH
Q 017231 156 LKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSETDF-MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGC 231 (375)
Q Consensus 156 l~~Lh~~~i~H~di~p~NIli~~~~~---i~l~Df~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 231 (375)
|.|||++||+|+||||+||+++.++. ++|+|||++........ .....||+.|+|||++.+ ..++.++|||||||
T Consensus 143 l~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~ 221 (351)
T 3c0i_A 143 LRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGV 221 (351)
T ss_dssp HHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHH
T ss_pred HHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHH
Confidence 99999999999999999999987665 99999999876554432 345678999999999987 67899999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCc
Q 017231 232 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVF 311 (375)
Q Consensus 232 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 311 (375)
++|+|++|..||.+.. ......+......... ..+..+++++.++|.+||+.
T Consensus 222 il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~ 273 (351)
T 3c0i_A 222 ILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP---------------------------RQWSHISESAKDLVRRMLML 273 (351)
T ss_dssp HHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH---------------------------HHHTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc---------------------------cccccCCHHHHHHHHHHCCC
Confidence 9999999999998754 3333333332111111 11235789999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCC
Q 017231 312 DPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 312 dP~~Rps~~ell~~~~f~~~ 331 (375)
||++|||+.++|+||||+..
T Consensus 274 dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 274 DPAERITVYEALNHPWLKER 293 (351)
T ss_dssp STTTSCCHHHHHTSHHHHTH
T ss_pred ChhHCcCHHHHhcChhhcCC
Confidence 99999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=357.96 Aligned_cols=292 Identities=33% Similarity=0.569 Sum_probs=230.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC---CCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~~~ 120 (375)
+++.||+|+||.||+|+++.+|+.||+|++............+.+|+.+++.++||||+++++++..... ...+.++
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 100 (351)
T 3mi9_A 21 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 100 (351)
T ss_dssp EEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEE
T ss_pred EEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEE
Confidence 7999999999999999999999999999987655444445667899999999999999999999866421 1135689
Q ss_pred EEEeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC---
Q 017231 121 IVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET--- 196 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~--- 196 (375)
+||||++++|.+.+... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++......
T Consensus 101 lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (351)
T 3mi9_A 101 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180 (351)
T ss_dssp EEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSS
T ss_pred EEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccc
Confidence 99999999998888764 56999999999999999999999999999999999999999999999999998654422
Q ss_pred --CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 197 --DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 197 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
.......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+..+...+.......
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 260 (351)
T 3mi9_A 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 260 (351)
T ss_dssp SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCG
T ss_pred cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccch
Confidence 223345679999999999875678999999999999999999999999999999999999888877665544332211
Q ss_pred hHHHhhhCCCCCCCCccccC--CCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARF--PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
........... ........ ...++.+.++|.+||+.||.+|||++|+|+||||+.......
T Consensus 261 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 261 LYEKLELVKGQ-KRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp GGTSSCCCSSC-CCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred hhccccccccc-ccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 10000000000 00000000 013678999999999999999999999999999997655443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=357.67 Aligned_cols=283 Identities=33% Similarity=0.607 Sum_probs=225.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|++|.||++++..+++.||+|++............+.+|+.++++++||||+++++++... ...++|
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv 102 (331)
T 4aaa_A 28 ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----KRWYLV 102 (331)
T ss_dssp EEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred eeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-----CEEEEE
Confidence 379999999999999999999999999999977666666677788999999999999999999998544 568999
Q ss_pred EeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cccc
Q 017231 123 YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMT 200 (375)
Q Consensus 123 ~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~ 200 (375)
|||+++ +|.+++.....+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+...... ....
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence 999986 56666666778999999999999999999999999999999999999999999999999998764433 2234
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||++.+...++.++|||||||++|+|++|..||...+.......+....+.........+.........
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 261 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV- 261 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC-
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc-
Confidence 5578999999999987557899999999999999999999999999888888888777766544332221111100000
Q ss_pred hCCCC-CCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 281 MLPQF-PKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 281 ~~~~~-~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.++.. .........+.+++.+.++|.+||+.||.+|||+.|+|+||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 01111 1122233346789999999999999999999999999999999853
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=367.97 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=220.0
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
++....+++++.||+|+||.||+|+++.+++.||+|++.+.. ........+..|+.+++.++||||+++++++...
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--- 141 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--- 141 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC---
Confidence 344455668999999999999999999999999999986421 1111233477899999999999999999999654
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
..+++||||++ |+|.+++.. ..+++..++.++.||+.||.+||++||+||||||+||+++.+|.++|+|||++...
T Consensus 142 --~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 142 --RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp --SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred --CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 66899999996 699998876 46999999999999999999999999999999999999999999999999999765
Q ss_pred CCCC--ccccccccccccCchhcccCCC---CCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 194 SETD--FMTEYVVTRWYRAPELLLNCSE---YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 194 ~~~~--~~~~~~~~~~y~aPE~~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
.... .....+||+.|+|||++.+... ++.++|||||||++|+|++|..||.+.+.......+........-.
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p--- 295 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP--- 295 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC---
Confidence 5443 2346789999999999986221 7789999999999999999999999988887777776532111000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCC--CCCHHHHhcCCCCCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLH 332 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~ 332 (375)
....++++++++|.+||..+|.+ ||+++||++||||++++
T Consensus 296 ------------------------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 296 ------------------------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp ------------------------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred ------------------------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 01357899999999999999988 99999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=354.87 Aligned_cols=285 Identities=37% Similarity=0.623 Sum_probs=227.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch---HHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR---IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++.||+|+||.||++.++.+|+.||+|++....... .....+.+|+.++++++||||+++++++... ...+
T Consensus 14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 88 (346)
T 1ua2_A 14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNIS 88 (346)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCE
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-----CceE
Confidence 6999999999999999999999999999986532221 1224677999999999999999999999554 5589
Q ss_pred EEEeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cc
Q 017231 121 IVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DF 198 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~ 198 (375)
+||||++++|.+++.... .+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++...... ..
T Consensus 89 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 168 (346)
T 1ua2_A 89 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 168 (346)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred EEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCccc
Confidence 999999999999887654 5999999999999999999999999999999999999999999999999998765433 23
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+.+....+.........
T Consensus 169 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-- 246 (346)
T 1ua2_A 169 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY-- 246 (346)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC--
T ss_pred CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccc--
Confidence 345678999999999977566899999999999999999999999999988888888887777655544332211100
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
. .....+...+...+..+++++.++|.+||+.||++|||+.|+|+||||++......
T Consensus 247 ~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 247 V-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp C-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred c-cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 0 00011111122233567899999999999999999999999999999998765443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=349.43 Aligned_cols=287 Identities=35% Similarity=0.585 Sum_probs=229.2
Q ss_pred CeeeccCCcceEEEEEEeC-CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc---CCCCeeeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAMNS-ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++.||+|+||.||++++. .+++.||+|++............+.+|+.+++.+ +||||+++++++...........
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 94 (326)
T 1blx_A 15 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 94 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEE
T ss_pred eeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceE
Confidence 6999999999999999995 6788999999865433222223455666666665 89999999999864322334678
Q ss_pred EEEEeCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 120 YIVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 120 ~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
++||||++|+|.+++.... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 95 ~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (326)
T 1blx_A 95 TLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM 174 (326)
T ss_dssp EEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG
T ss_pred EEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCC
Confidence 9999999999999998754 49999999999999999999999999999999999999999999999999987766554
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+....+.+....+.........
T Consensus 175 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~- 252 (326)
T 1blx_A 175 ALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ- 252 (326)
T ss_dssp GGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGG-
T ss_pred CccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchh-
Confidence 4456678999999999987 67899999999999999999999999999888888888887776655443321111110
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
..............+.+++.+.++|.+||+.||++|||+.++++||||+.+....
T Consensus 253 ---~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 253 ---AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp ---GSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred ---hhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 0111111222333467899999999999999999999999999999999876544
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=359.63 Aligned_cols=287 Identities=34% Similarity=0.617 Sum_probs=227.6
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC-CCcCcE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDV 119 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~ 119 (375)
.|.+++.||+|+||+||+|++..++. ||+|.+...... ..+|+.+++.++||||+++++++..... .....+
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 34479999999999999999988776 888877543211 1269999999999999999999865432 233457
Q ss_pred EEEEeCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe-cCCCEEEeecccccccC
Q 017231 120 YIVYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTTS 194 (375)
Q Consensus 120 ~lv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~-~~~~i~l~Df~~~~~~~ 194 (375)
++||||+++++...+. ....+++..++.++.||+.||.|||++||+||||||+||+++ .++.++|+|||++....
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 8999999987766554 356799999999999999999999999999999999999999 79999999999998765
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
.........+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+.+............
T Consensus 194 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 194 AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 55555667789999999999875678999999999999999999999999999999999998888876654332211100
Q ss_pred hHHHhhhCCCCCCCCccccC-CCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARF-PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 337 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~ 337 (375)
....++......+...+ +.+++++.++|.+||+.||.+|||+.|+++||||+++......
T Consensus 274 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 274 ---MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp ---SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCC
T ss_pred ---hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccccc
Confidence 00111111222222222 3478999999999999999999999999999999998665443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=351.36 Aligned_cols=256 Identities=29% Similarity=0.468 Sum_probs=220.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch----HHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++.||+|+||.||+++++.+++.||+|++....... ...+.+.+|+.++++++||||+++++++... ...
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 90 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-----TDV 90 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-----CEE
Confidence 7999999999999999999999999999986543221 1356788999999999999999999998554 568
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC----CEEEeecccccccC
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLARTTS 194 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~----~i~l~Df~~~~~~~ 194 (375)
++||||++ ++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~ 170 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence 99999996 69999999888899999999999999999999999999999999999999888 79999999997766
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
.........+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........+.......+..
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~--------- 240 (321)
T 2a2a_A 171 DGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEE--------- 240 (321)
T ss_dssp TTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH---------
T ss_pred ccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChh---------
Confidence 5544556678999999999987 678999999999999999999999998887766666554432221111
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
....+++.+.++|.+||+.||++|||+.++++||||+.+.
T Consensus 241 ------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 241 ------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp ------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred ------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 1135688999999999999999999999999999998764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=374.99 Aligned_cols=255 Identities=33% Similarity=0.569 Sum_probs=219.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||+||+|.++.+++.||||++............+.+|+.++++++||||+++++++... ..+++||
T Consensus 26 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv~ 100 (486)
T 3mwu_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVG 100 (486)
T ss_dssp EEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEE
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-----CEEEEEE
Confidence 59999999999999999999999999999865443334467788999999999999999999999654 6689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe---cCCCEEEeecccccccCCCCcc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN---ANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~---~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
||+. |+|.+.+...+.+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++.........
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 180 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCcc
Confidence 9997 69999998888999999999999999999999999999999999999995 4567999999999876665555
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.......+...
T Consensus 181 ~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------- 245 (486)
T 3mwu_A 181 KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ------------- 245 (486)
T ss_dssp -CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGG-------------
T ss_pred CCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcc-------------
Confidence 66789999999999876 489999999999999999999999999888777777665433222111
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
+..++++++++|.+||+.||.+|||+.++|+||||++..
T Consensus 246 --------------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 246 --------------WRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp --------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred --------------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 235689999999999999999999999999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=362.49 Aligned_cols=281 Identities=31% Similarity=0.634 Sum_probs=224.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC----------
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---------- 113 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---------- 113 (375)
+++.||+|+||+||+|++..+|+.||||++...... ..+|+.+++.++||||+++++++.....
T Consensus 11 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 11 LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp EEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred EEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 699999999999999999999999999998654221 2369999999999999999999854321
Q ss_pred -----------------------CCcCcEEEEEeCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 017231 114 -----------------------ETFNDVYIVYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLH 166 (375)
Q Consensus 114 -----------------------~~~~~~~lv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H 166 (375)
.....+++||||++|+|.+.+. ....+++..++.++.||+.||.|||++||+|
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H 164 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICH 164 (383)
T ss_dssp -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCcc
Confidence 2234588999999988777665 3567999999999999999999999999999
Q ss_pred cCCCCCceEEe-cCCCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCC
Q 017231 167 RDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG 245 (375)
Q Consensus 167 ~di~p~NIli~-~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 245 (375)
+||||+||+++ .++.++|+|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|..||.+
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 99999999998 68899999999998766655556677899999999988756689999999999999999999999999
Q ss_pred CChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccC-CCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 246 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF-PNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.+..+.+..+....+.+............. ....+......+...+ ..+++++.++|.+||+.||++|||+.|+|+
T Consensus 245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYT---EVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHHCTTC-----CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHhCcccc---cccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999999999988888765443221110000 0001111111122222 347889999999999999999999999999
Q ss_pred CCCCCCCCC
Q 017231 325 HPYLAPLHD 333 (375)
Q Consensus 325 ~~~f~~~~~ 333 (375)
||||+.+..
T Consensus 322 hp~f~~~~~ 330 (383)
T 3eb0_A 322 HPFFDHLRN 330 (383)
T ss_dssp SGGGHHHHH
T ss_pred CHHHHHHHh
Confidence 999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=358.95 Aligned_cols=257 Identities=25% Similarity=0.463 Sum_probs=219.6
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.+++++.||+|+||.||+|.++.+++.||+|++.... ......+.+|+.++++++||||+++++++... ..++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~ 124 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMV 124 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEE
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-----CEEE
Confidence 3448999999999999999999999999999986542 33455788999999999999999999999554 5689
Q ss_pred EEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec--CCCEEEeecccccccCCC
Q 017231 121 IVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSET 196 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~--~~~i~l~Df~~~~~~~~~ 196 (375)
+||||++ |+|.+++.... .+++..++.++.||+.||.+||++|++|+||||+||+++. ++.++|+|||++......
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999997 69999987654 6999999999999999999999999999999999999974 477999999999876665
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+.
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~------------ 271 (387)
T 1kob_A 205 EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------------ 271 (387)
T ss_dssp SCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS------------
T ss_pred cceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc------------
Confidence 55556678999999999987 77899999999999999999999999988877666665543221111
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
..+..+++++.++|.+||+.||.+|||+.++|+||||+...
T Consensus 272 ---------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 272 ---------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp ---------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ---------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 11245789999999999999999999999999999999753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=368.59 Aligned_cols=283 Identities=22% Similarity=0.357 Sum_probs=227.5
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
++..+.+++++.||+|+||+||+++++.+++.||+|++.+.. ........+..|..++..++||||+++++++...
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--- 146 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD--- 146 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS---
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC---
Confidence 445556668999999999999999999999999999986431 1111223478899999999999999999999654
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..+++||||++ |+|.+++.. .+.+++..++.++.||+.||.+||++||+||||||+||+++.++.++|+|||++..
T Consensus 147 --~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 147 --NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp --SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred --CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 56899999996 799999987 46799999999999999999999999999999999999999999999999999866
Q ss_pred cCCCCc--cccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccc
Q 017231 193 TSETDF--MTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS 266 (375)
Q Consensus 193 ~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 266 (375)
...... ....+||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+....+........-
T Consensus 225 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-- 302 (437)
T 4aw2_A 225 LMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF-- 302 (437)
T ss_dssp CCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC--
T ss_pred cccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC--
Confidence 544322 234679999999999872 356899999999999999999999999998887777777543211100
Q ss_pred ccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCC--CCCHHHHhcCCCCCCCCCCCCCCCCCCCC
Q 017231 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNR--RITVDEALCHPYLAPLHDINEEPVCPRPF 344 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~--Rps~~ell~~~~f~~~~~~~~~~~~~~~~ 344 (375)
......+++++++||++||..+|++ ||+++|+++||||++++-..- .....+|
T Consensus 303 ------------------------p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l-~~~~~p~ 357 (437)
T 4aw2_A 303 ------------------------PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI-RNCEAPY 357 (437)
T ss_dssp ------------------------CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG-GGSCCSC
T ss_pred ------------------------CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH-hhCCCCC
Confidence 0111357999999999999988888 999999999999998853332 2233344
Q ss_pred CCCCCC
Q 017231 345 SFDFEH 350 (375)
Q Consensus 345 ~~~~~~ 350 (375)
.+....
T Consensus 358 ~P~~~~ 363 (437)
T 4aw2_A 358 IPEVSS 363 (437)
T ss_dssp CCCCSS
T ss_pred CCcCCC
Confidence 444433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=350.18 Aligned_cols=248 Identities=25% Similarity=0.336 Sum_probs=202.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++||+|+||+||+|+++.+++.||||++...............|+..+.++ +|+||+++++++... ..+++|
T Consensus 61 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~~~~lv 135 (311)
T 3p1a_A 61 RLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----GILYLQ 135 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred eeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----CEEEEE
Confidence 69999999999999999999999999999876655555555666666666666 899999999998544 668999
Q ss_pred EeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccc
Q 017231 123 YELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 201 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~ 201 (375)
|||++++|.+++...+ .+++..++.++.||+.||.+||+.||+|+||||+||+++.++.++|+|||++...........
T Consensus 136 ~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 215 (311)
T 3p1a_A 136 TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV 215 (311)
T ss_dssp EECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------C
T ss_pred EeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcc
Confidence 9999999999887654 599999999999999999999999999999999999999999999999999877665555556
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..||+.|+|||++.+ .++.++|||||||++|+|++|..|+..... ...+.. +..+.
T Consensus 216 ~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~--~~~~~----------------- 271 (311)
T 3p1a_A 216 QEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQ--GYLPP----------------- 271 (311)
T ss_dssp CCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTT--TCCCH-----------------
T ss_pred cCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhc--cCCCc-----------------
Confidence 678999999999876 589999999999999999999766644321 111111 00000
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
.....+++++.++|.+||+.||++|||+.|+|+||||++
T Consensus 272 ----------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 ----------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ----------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 011356899999999999999999999999999999985
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=352.94 Aligned_cols=255 Identities=27% Similarity=0.379 Sum_probs=208.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||++.++.+++.||+|++..... ....+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 11 i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~ 84 (323)
T 3tki_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLFL 84 (323)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEE
T ss_pred eeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeEEEEE
Confidence 69999999999999999999999999999854322 22335678999999999999999999998654 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC---Ccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~---~~~ 199 (375)
||++ |+|.+++.....+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9997 599999988888999999999999999999999999999999999999999999999999998654322 223
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....||+.|+|||++.+....+.++|||||||++|+|++|..||...+...............
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----------------- 227 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----------------- 227 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-----------------
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-----------------
Confidence 456789999999999874445789999999999999999999997765432221111111000
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
...+..+++.+.++|.+||+.||++|||+.|+++||||++..
T Consensus 228 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 228 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -----------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 011234688999999999999999999999999999998753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=351.86 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=207.6
Q ss_pred CCeeeccCCcceEEEEEEeC---CCCcEEEEEEecCccc--chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 43 PPIRPVGRGAYGIVCAAMNS---ETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
++++.||+|+||.||++++. .+++.||+|++.+... .......+.+|+.+++.++||||+++++++... +
T Consensus 20 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~ 94 (327)
T 3a62_A 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-----G 94 (327)
T ss_dssp EEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred EEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-----C
Confidence 36999999999999999985 6889999999976532 223445678899999999999999999999654 5
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
.+++||||++ ++|.+++...+.+++..++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||++......
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 6899999997 699999998888999999999999999999999999999999999999999999999999998653322
Q ss_pred -CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 197 -DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 197 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......+
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p------------ 241 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP------------ 241 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC------------
T ss_pred CccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC------------
Confidence 23345678999999999987 6789999999999999999999999998887777666655321111
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
+.+++++.++|.+||+.||.+|| ++.++++||||+.+.
T Consensus 242 -------------------~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 242 -------------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp -------------------TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred -------------------CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 24688999999999999999999 889999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=354.05 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=216.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
..+.||+|+||.||++.++.+++.||+|++............+.+|+.+++.+. ||||+++++++... ...++|
T Consensus 33 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-----~~~~lv 107 (327)
T 3lm5_A 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-----SEIILI 107 (327)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEE
T ss_pred ccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-----CeEEEE
Confidence 348999999999999999999999999999776555555677889999999995 79999999999544 568999
Q ss_pred EeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec---CCCEEEeecccccccCCC
Q 017231 123 YELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSET 196 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~---~~~i~l~Df~~~~~~~~~ 196 (375)
|||+. |+|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++. ++.++|+|||++......
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 99997 5999888553 66999999999999999999999999999999999999988 789999999999876655
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
.......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.......+.
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~------------ 254 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE------------ 254 (327)
T ss_dssp ------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT------------
T ss_pred cccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc------------
Confidence 55556778999999999987 67899999999999999999999999988877776666554332221
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
.....+++.+.++|.+||+.||.+|||++++|+||||++..-.
T Consensus 255 ---------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 255 ---------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp ---------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred ---------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 1124578899999999999999999999999999999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=358.04 Aligned_cols=256 Identities=23% Similarity=0.409 Sum_probs=211.6
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHH-HHhcCCCCeeeeceeecCCCCCCcC
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKL-LRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~-l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
..+++++.||+|+||.||+++++.+++.||+|++.+... .......+..|..+ ++.++||||+++++++... .
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-----~ 112 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----D 112 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-----S
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-----C
Confidence 344479999999999999999999999999999976532 23334556667776 4678999999999999654 5
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC-C
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS-E 195 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~-~ 195 (375)
.+|+||||++ |+|.+++...+.+++..++.++.||+.||.+||++||+||||||+||+++.+|.++|+|||++.... .
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 6899999997 5999999988899999999999999999999999999999999999999999999999999987532 3
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
.......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.......
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~------------- 258 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQL------------- 258 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC-------------
T ss_pred CCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCC-------------
Confidence 334556789999999999987 779999999999999999999999999888777777665521111
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH----HHHhcCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV----DEALCHPYLAPLH 332 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~----~ell~~~~f~~~~ 332 (375)
.+.+++++.++|.+||+.||.+||++ .++++||||+.++
T Consensus 259 ------------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 259 ------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp ------------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred ------------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 13568899999999999999999987 6999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=366.26 Aligned_cols=259 Identities=26% Similarity=0.415 Sum_probs=212.3
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 115 (375)
+....+++++.||+|+||.||++.++.+++.||||++.... ........+..|+.+++.++||||+++++++...
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~---- 220 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH---- 220 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET----
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC----
Confidence 33444558999999999999999999999999999986542 2333456678899999999999999999999654
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
+.+++||||++ |+|.+++...+.+++..++.++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++...
T Consensus 221 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 221 -DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp -TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred -CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 56899999997 5999999988899999999999999999999998 99999999999999999999999999998753
Q ss_pred CC-CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 194 SE-TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 194 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......+
T Consensus 300 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p--------- 369 (446)
T 4ejn_A 300 IKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP--------- 369 (446)
T ss_dssp CC-----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred cCCCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence 32 233456788999999999987 7799999999999999999999999998887777766654221111
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
..+++++.++|.+||+.||.+|| +++|+++||||+++.
T Consensus 370 ----------------------~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 370 ----------------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp ----------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ----------------------ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 24688999999999999999999 999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=342.31 Aligned_cols=251 Identities=31% Similarity=0.452 Sum_probs=206.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|+||.||++.++.++..||+|++..... ....+.+.+|+.++++++||||+++++++... ...++||
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~ 99 (285)
T 3is5_A 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-----HNMYIVM 99 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEE
T ss_pred ecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecC-----CeEEEEE
Confidence 59999999999999999999999999999866432 22356788999999999999999999999544 5689999
Q ss_pred eCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ecCCCEEEeecccccccCC
Q 017231 124 ELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 124 e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli---~~~~~i~l~Df~~~~~~~~ 195 (375)
||++ |+|.+.+.. ...+++..++.++.||+.||.+||+.|++|+||||+||++ +.++.++|+|||++.....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 9997 599988854 3679999999999999999999999999999999999999 4567899999999977665
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
........+++.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+........
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 245 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA------------ 245 (285)
T ss_dssp -------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred cccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc------------
Confidence 555566778999999999864 688999999999999999999999998876665544433211111
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
.....+++++.++|.+||+.||++|||+.|+|+||||++
T Consensus 246 ----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 ----------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ----------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 111346889999999999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=372.83 Aligned_cols=255 Identities=33% Similarity=0.541 Sum_probs=217.2
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|+||+||+|+++.++..||+|++............+.+|+.+++.++||||+++++++... ..+++|
T Consensus 40 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv 114 (494)
T 3lij_A 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-----RNYYLV 114 (494)
T ss_dssp EEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEE
T ss_pred EEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CEEEEE
Confidence 379999999999999999999999999999976544444466788999999999999999999999654 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC---CCEEEeecccccccCCCCc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~---~~i~l~Df~~~~~~~~~~~ 198 (375)
|||+. |+|.+.+.....+++..++.++.||+.||.|||++||+|+||||+||+++.. +.++|+|||++........
T Consensus 115 ~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 99997 6999999888899999999999999999999999999999999999999764 4599999999977666555
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.......+...
T Consensus 195 ~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~------------ 260 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE------------ 260 (494)
T ss_dssp BCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG------------
T ss_pred ccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh------------
Confidence 566789999999999864 589999999999999999999999999888777777766433322221
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
+..+++.+.++|.+||+.||.+|||+.++|+||||+..
T Consensus 261 ---------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 261 ---------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp ---------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ---------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 24678999999999999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=350.76 Aligned_cols=263 Identities=20% Similarity=0.201 Sum_probs=185.6
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.++||+|+||+||+|++ +|+.||||++.... ........|+..+.+++|||||++++++.... .....++|||
T Consensus 7 L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV~ 80 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp EEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEEe
Confidence 889999999999999987 47899999985431 11222335666677889999999999987543 1224589999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA--------NVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~--------~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
|||+ |+|.+++.. .++++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 81 Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp ECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred cCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 9997 799999976 4699999999999999999999987 89999999999999999999999999987654
Q ss_pred CCC-----ccccccccccccCchhcccCC-----CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 195 ETD-----FMTEYVVTRWYRAPELLLNCS-----EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 195 ~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
... ......||+.|+|||++.+.. .++.++|||||||++|||+||..||........ +.
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~-----------p~ 228 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL-----------PY 228 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC-----------TT
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc-----------cc
Confidence 332 123457999999999997621 356799999999999999999887743321000 00
Q ss_pred ccccccccchhHHHhhhCC--CCCCCCcc-ccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 265 TSLGFLRSDNARRYVRMLP--QFPKQNFS-ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
... .............+. ..+..-+. ......++.+.+++.+||+.||++|||+.||++.
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 229 YDL-VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTT-SCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hhc-ccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000 000000000000000 00000000 0001223468899999999999999999999863
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=352.94 Aligned_cols=255 Identities=31% Similarity=0.459 Sum_probs=199.2
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+.+++.+.||+|+||.||+++++.+++.||+|++.... ..+.+.+|+.++++++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 123 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEI 123 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecC-----CeE
Confidence 33448999999999999999999999999999986542 345677899999999999999999999654 568
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec---CCCEEEeecccccccCC
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSE 195 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~---~~~i~l~Df~~~~~~~~ 195 (375)
++||||++ ++|.+++...+.+++.+++.++.||+.||.+||+.|++|+||||+||+++. ++.++|+|||++.....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999997 699999998888999999999999999999999999999999999999975 88999999999877665
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhH-HHHHHHHHhCCCCcccccccccch
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH-QLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+........
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~----------- 271 (349)
T 2w4o_A 204 QVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI----------- 271 (349)
T ss_dssp ---------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC-----------
T ss_pred ccccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC-----------
Confidence 544556778999999999987 678999999999999999999999997765443 3333322111110
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
...+..++.++.++|.+||+.||++|||+.++|+||||+..
T Consensus 272 ----------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 272 ----------------SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp ----------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred ----------------CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 11124678999999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=362.63 Aligned_cols=268 Identities=21% Similarity=0.297 Sum_probs=221.0
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
.++..+.+++++.||+|+||.||+++++.+++.||+|++.+.. ........+..|..++..++||||+++++++...
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-- 133 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE-- 133 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS--
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--
Confidence 3455566678999999999999999999999999999986532 1222334578899999999999999999999654
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
..+|+||||++ |+|.+++... ..+++..++.++.||+.||.+||++||+||||||+||+++.+|.++|+|||++.
T Consensus 134 ---~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 134 ---NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp ---SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ---CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 66899999996 7999999875 479999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCc--cccccccccccCchhccc------CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 192 TTSETDF--MTEYVVTRWYRAPELLLN------CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 192 ~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
....... ....+||+.|+|||++.. ...++.++|||||||++|+|++|..||...+..+....+........
T Consensus 211 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 211 KLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp ECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 6554332 234689999999999873 25689999999999999999999999999887777776654221110
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCC---CCHHHHhcCCCCCCCCCC
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR---ITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R---ps~~ell~~~~f~~~~~~ 334 (375)
.. .....++++++++|++||. +|.+| |+++|+++||||++++-.
T Consensus 291 ~p--------------------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 291 LP--------------------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp CC------------------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred CC--------------------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 00 0013578999999999999 99998 599999999999988533
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=341.57 Aligned_cols=253 Identities=30% Similarity=0.467 Sum_probs=220.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|+||.||++.++.++..||+|.+...... ..+.+.+|+.++++++||||+++++++... ...++||
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 85 (277)
T 3f3z_A 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDN-----TDIYLVM 85 (277)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEE
T ss_pred eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CeEEEEE
Confidence 799999999999999999999999999998654322 356788999999999999999999999654 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ecCCCEEEeecccccccCCCCcc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli---~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
||++ ++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 9997 5999999988889999999999999999999999999999999999999 78899999999999776665555
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....+++.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+.......+...
T Consensus 166 ~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------- 230 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKD------------- 230 (277)
T ss_dssp CCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHH-------------
T ss_pred hccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchh-------------
Confidence 66788999999999876 489999999999999999999999998887777666655333322221
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
+..+++.+.++|.+||+.||.+|||+.++|+||||++..
T Consensus 231 --------------~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 231 --------------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp --------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred --------------hhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 135688999999999999999999999999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=357.60 Aligned_cols=288 Identities=19% Similarity=0.242 Sum_probs=213.8
Q ss_pred CeeeccCC--cceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRG--AYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G--~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.||+| ++|.||+++++.+++.||||++............+.+|+.+++.++||||+++++++... +.+++
T Consensus 29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 103 (389)
T 3gni_B 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 103 (389)
T ss_dssp EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred EEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-----CEEEE
Confidence 69999999 999999999999999999999987665666677888999999999999999999999654 56899
Q ss_pred EEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC--
Q 017231 122 VYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-- 196 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-- 196 (375)
||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||.+......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 999997 6999999876 67999999999999999999999999999999999999999999999999987533211
Q ss_pred ------CccccccccccccCchhcccC-CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCC-Ccc---
Q 017231 197 ------DFMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP-DET--- 265 (375)
Q Consensus 197 ------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~-~~~--- 265 (375)
.......||..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+.......+....... ...
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTI 263 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccc
Confidence 112234678889999998763 468999999999999999999999998776555443332211100 000
Q ss_pred -cccccccch----hHHHhhhCC------CCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 266 -SLGFLRSDN----ARRYVRMLP------QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 266 -~~~~~~~~~----~~~~~~~~~------~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
......... ......... .............+++++.+||.+||+.||++|||+.|+|+||||+.+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 264 PAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 343 (389)
T ss_dssp ------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---
T ss_pred ccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhc
Confidence 000000000 000000000 000000111234578999999999999999999999999999999988654
Q ss_pred CC
Q 017231 335 NE 336 (375)
Q Consensus 335 ~~ 336 (375)
..
T Consensus 344 ~~ 345 (389)
T 3gni_B 344 AS 345 (389)
T ss_dssp CC
T ss_pred ch
Confidence 43
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=345.10 Aligned_cols=263 Identities=26% Similarity=0.367 Sum_probs=202.1
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
+++..+.+++++.||+|+||.||++.+..+++.||+|++............+..+...++.++||||+++++++...
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~--- 78 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE--- 78 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS---
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc---
Confidence 45556666689999999999999999999999999999976654444455556666678888999999999999654
Q ss_pred CcCcEEEEEeCCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEEeeccc
Q 017231 115 TFNDVYIVYELMDTDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 115 ~~~~~~lv~e~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
...++||||++|+|.+++.. ...+++..++.++.||+.||.+||++ |++|+||||+||+++.++.++|+|||.
T Consensus 79 --~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T 3fme_A 79 --GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156 (290)
T ss_dssp --SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred --CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence 56899999999988777753 56799999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCchhcc---cCCCCCccchhHHHHHHHHHHhhCCCCCCCCC-hhHHHHHHHHHhCCCCcc
Q 017231 190 ARTTSETDFMTEYVVTRWYRAPELLL---NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDET 265 (375)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~ 265 (375)
+.............+++.|+|||++. ....++.++|||||||++|+|++|..||.... ...............
T Consensus 157 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 233 (290)
T 3fme_A 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ--- 233 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC---
T ss_pred cccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC---
Confidence 97766555555567899999999972 33678899999999999999999999997643 222232222211100
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.....+++++.++|.+||+.||++|||+.++++||||+..
T Consensus 234 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 234 --------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp --------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred --------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 0013468899999999999999999999999999999854
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=346.50 Aligned_cols=291 Identities=44% Similarity=0.747 Sum_probs=219.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC---------CC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ---------RE 114 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---------~~ 114 (375)
+++.||+|++|.||++.+..+++.||+|++... .......+.+|+.++++++||||+++++++.... ..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 15 DLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred EEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 699999999999999999999999999998643 4455677889999999999999999999875432 12
Q ss_pred CcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe-cCCCEEEeeccccccc
Q 017231 115 TFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTT 193 (375)
Q Consensus 115 ~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~-~~~~i~l~Df~~~~~~ 193 (375)
.....++||||++|+|.+++.. +.+++..++.++.||+.||.+||++|++|+||||+||+++ .++.++|+|||.+...
T Consensus 93 ~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~ 171 (320)
T 2i6l_A 93 ELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171 (320)
T ss_dssp SCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC
T ss_pred ccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcccccc
Confidence 3367899999999999998865 5699999999999999999999999999999999999997 5678999999998765
Q ss_pred CCC----CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 194 SET----DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 194 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
... .......++..|+|||++.+...++.++|||||||++|+|++|..||...+.......+..............
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (320)
T 2i6l_A 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQE 251 (320)
T ss_dssp --------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHH
T ss_pred CCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhh
Confidence 432 1223456688899999987656789999999999999999999999999888777777766554433222111
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 338 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~ 338 (375)
...... .+.......+...+....+.+++++.++|.+||+.||++|||+.++|+||||+.......+|
T Consensus 252 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~~~ 319 (320)
T 2i6l_A 252 LLSVIP-VYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEP 319 (320)
T ss_dssp HHTTSC-HHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-----
T ss_pred hhhcCc-ccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccCCC
Confidence 100000 00000001111222233456899999999999999999999999999999999876665544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=340.77 Aligned_cols=259 Identities=22% Similarity=0.372 Sum_probs=214.5
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++++.+.||+|+||.||+|.+..++..||+|++............+.+|+.++++++||||+++++++.... .....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence 3334799999999999999999999999999999876666667788999999999999999999999886432 223568
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEe-cCCCEEEeecccccccCC
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NIli~-~~~~i~l~Df~~~~~~~~ 195 (375)
++||||++ ++|.+++...+.+++..++.++.||+.||.+||+.| ++|+||+|+||+++ .++.++|+|||++.....
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999997 599999998888999999999999999999999999 99999999999997 789999999999865443
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
. ......+++.|+|||++.+ .++.++||||||+++|+|++|..||....................
T Consensus 185 ~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------ 249 (290)
T 1t4h_A 185 S-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA------------ 249 (290)
T ss_dssp T-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG------------
T ss_pred c-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc------------
Confidence 3 2345568999999998875 589999999999999999999999987554333322211110000
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
......++++.++|.+||+.||.+|||+.++++||||++
T Consensus 250 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 250 ----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 001245788999999999999999999999999999985
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=365.61 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=218.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++... ..+++|
T Consensus 20 l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-----~~~~lv 94 (476)
T 2y94_A 20 LGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-----SDIFMV 94 (476)
T ss_dssp EEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEE
Confidence 69999999999999999999999999999865321 122356788999999999999999999998654 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 201 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~ 201 (375)
|||++ |+|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++...........
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 174 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccc
Confidence 99996 69999999888899999999999999999999999999999999999999999999999999987766555667
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
.+||+.|+|||++.+....+.++|||||||++|+|++|..||...+.......+.......+
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p------------------ 236 (476)
T 2y94_A 175 SCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP------------------ 236 (476)
T ss_dssp CCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC------------------
T ss_pred cCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC------------------
Confidence 78999999999998844457899999999999999999999998877666665543211110
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..+++++.++|.+||+.||.+|||+.++++||||+..
T Consensus 237 -------------~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 237 -------------QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp -------------TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred -------------ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 2468899999999999999999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=358.22 Aligned_cols=286 Identities=32% Similarity=0.602 Sum_probs=225.0
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC-CCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~ 120 (375)
|++++.||+|+||+||+++++.+++.||||++..... ...+|+.+++.++||||+++++++.... ......++
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4479999999999999999999999999999865321 1236999999999999999999885432 12234578
Q ss_pred EEEeCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC-CCEEEeecccccccCC
Q 017231 121 IVYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSE 195 (375)
Q Consensus 121 lv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~-~~i~l~Df~~~~~~~~ 195 (375)
+||||++++|.+.+. ....+++..++.++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||++.....
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 999999988877664 34679999999999999999999999999999999999999965 5689999999987655
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
........+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+........
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~ 289 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 289 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 54455667899999999998756789999999999999999999999999998888888888777655432211100000
Q ss_pred HHHhhhCCCCCCCCccccC-CCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARF-PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
...++......+...+ +.+++++.+||.+||..||.+||++.|+++||||+.+.....
T Consensus 290 ---~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 290 ---EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp ---CCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred ---hhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence 0001111111111111 356889999999999999999999999999999998865543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=346.40 Aligned_cols=253 Identities=27% Similarity=0.501 Sum_probs=204.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc------------------------hHHHHHHHHHHHHHHhcCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN------------------------RIDAKRTLREIKLLRHMDHE 99 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~~~e~~~l~~l~h~ 99 (375)
+++.||+|+||.||+|+++.+++.||+|++...... ....+.+.+|+.++++++||
T Consensus 17 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 96 (298)
T 2zv2_A 17 LKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHP 96 (298)
T ss_dssp EEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCT
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCC
Confidence 599999999999999999999999999998654211 11235688999999999999
Q ss_pred CeeeeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec
Q 017231 100 NIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 178 (375)
Q Consensus 100 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~ 178 (375)
||+++++++.... ...+++||||++ ++|.+++ ....+++..++.++.||+.||.+||++|++|+||||+||+++.
T Consensus 97 ~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 172 (298)
T 2zv2_A 97 NVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172 (298)
T ss_dssp TBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred CCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECC
Confidence 9999999987532 256899999997 5776643 3467999999999999999999999999999999999999999
Q ss_pred CCCEEEeecccccccCCCC-ccccccccccccCchhcccCCC--CCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHH
Q 017231 179 NCDLKIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCSE--YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLI 255 (375)
Q Consensus 179 ~~~i~l~Df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~--~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i 255 (375)
++.++|+|||++....... ......||+.|+|||++.+... .+.++|||||||++|+|++|..||...+.......+
T Consensus 173 ~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~ 252 (298)
T 2zv2_A 173 DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKI 252 (298)
T ss_dssp TSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHH
Confidence 9999999999987654432 2345678999999999876322 477899999999999999999999887765555444
Q ss_pred HHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
.......+ ..+.+++++.++|.+||+.||++|||+.|+++||||+
T Consensus 253 ~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 253 KSQALEFP-----------------------------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHCCCCCC-----------------------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred hcccCCCC-----------------------------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 33211111 1135789999999999999999999999999999986
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=343.06 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=216.5
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
..+++++.||+|++|.||++.++.++..||+|++..... .......+.+|+.++++++||||+++++++... ..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 83 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TR 83 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----CE
Confidence 334479999999999999999999999999999855322 222345688999999999999999999999554 56
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
.++||||++ ++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 899999997 6999999988889999999999999999999999999999999999999999999999999885544332
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.......+
T Consensus 164 -~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------- 227 (279)
T 3fdn_A 164 -RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP-------------- 227 (279)
T ss_dssp -----CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC--------------
T ss_pred -ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC--------------
Confidence 345578999999999987 6789999999999999999999999998887777666655322211
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
..+++.+.++|.+||+.||.+|||++|+++||||+......
T Consensus 228 -----------------~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 228 -----------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp -----------------TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred -----------------CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence 23688899999999999999999999999999999765433
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=368.22 Aligned_cols=255 Identities=30% Similarity=0.484 Sum_probs=218.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch-----------HHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR-----------IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
+++.||+|+||+||+|.++.+++.||+|++....... ...+.+.+|+.++++++||||+++++++...
T Consensus 40 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~- 118 (504)
T 3q5i_A 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK- 118 (504)
T ss_dssp EEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred EEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-
Confidence 7999999999999999999999999999987543221 2356788999999999999999999999654
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC---CEEEeecc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFG 188 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~---~i~l~Df~ 188 (375)
..+++||||++ |+|.+.+...+.+++..++.++.||+.||.+||++||+|+||||+||+++.++ .++|+|||
T Consensus 119 ----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 194 (504)
T 3q5i_A 119 ----KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194 (504)
T ss_dssp ----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred ----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence 66899999997 69999998888999999999999999999999999999999999999998876 69999999
Q ss_pred cccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 189 LARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.......+..
T Consensus 195 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--- 269 (504)
T 3q5i_A 195 LSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN--- 269 (504)
T ss_dssp TCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH---
T ss_pred CCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc---
Confidence 9987766555566789999999999875 58999999999999999999999999988887777766533222211
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.+..+++++.++|.+||+.||.+|||+.|+|+||||++..
T Consensus 270 ------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 270 ------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp ------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred ------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 1246789999999999999999999999999999998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=358.08 Aligned_cols=293 Identities=32% Similarity=0.549 Sum_probs=214.3
Q ss_pred ecccccCCeeeccCCcceEEEEEEeC--CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNS--ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
+.+.|....++||+|+||.||+|+++ .+++.||||++..... ...+.+|+.++++++||||+++++++....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-- 91 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHA-- 91 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETT--
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCC--
Confidence 33444435778999999999999966 5688999999965432 235678999999999999999999985432
Q ss_pred CcCcEEEEEeCCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----ecCCC
Q 017231 115 TFNDVYIVYELMDTDLHQIIRSH---------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCD 181 (375)
Q Consensus 115 ~~~~~~lv~e~~~g~L~~~l~~~---------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli----~~~~~ 181 (375)
...+++||||++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||++ +.++.
T Consensus 92 -~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 92 -DRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp -TTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTC
T ss_pred -CCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCc
Confidence 2568999999999999888632 249999999999999999999999999999999999999 67789
Q ss_pred EEEeecccccccCCC----CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh---------
Q 017231 182 LKIGDFGLARTTSET----DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY--------- 248 (375)
Q Consensus 182 i~l~Df~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------- 248 (375)
++|+|||++...... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.....
T Consensus 171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 999999999765432 2234567899999999998756689999999999999999999999976553
Q ss_pred hHHHHHHHHHhCCCCcccccccccchh-HHHhhhCCCCCCC------CccccCCCCCchHHHHHHHhcCcCCCCCCCHHH
Q 017231 249 VHQLRLITELIGSPDETSLGFLRSDNA-RRYVRMLPQFPKQ------NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 321 (375)
Q Consensus 249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~e 321 (375)
...+..+....+.+....+........ ............. .........++.+.+||.+||+.||.+|||++|
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 467788888888777665544332211 1111111100000 001111234788999999999999999999999
Q ss_pred HhcCCCCCCCCCCCC
Q 017231 322 ALCHPYLAPLHDINE 336 (375)
Q Consensus 322 ll~~~~f~~~~~~~~ 336 (375)
+|+||||++......
T Consensus 331 ~L~hp~f~~~~~~~~ 345 (405)
T 3rgf_A 331 AMQDPYFLEDPLPTS 345 (405)
T ss_dssp HHTSGGGTSSSCCCS
T ss_pred HhcChhhccCCCCcc
Confidence 999999998654443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=348.98 Aligned_cols=253 Identities=27% Similarity=0.484 Sum_probs=190.4
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
.+.||+|+||.||++.++.+++.||+|++... ....+.+|+.+++.+. ||||+++++++... ...++||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-----~~~~lv~ 85 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQ-----LHTFLVM 85 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SEEEEEE
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-----CEEEEEE
Confidence 47899999999999999999999999998543 3456778999999997 99999999999654 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC---CEEEeecccccccCCC-Cc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTSET-DF 198 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~---~i~l~Df~~~~~~~~~-~~ 198 (375)
||++ |+|.+++...+.+++.+++.++.||+.||.+||++|++|+||||+||+++.++ .++|+|||++...... ..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~ 165 (325)
T 3kn6_A 86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165 (325)
T ss_dssp CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence 9997 59999999999999999999999999999999999999999999999998766 7999999998754433 23
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh-------HHHHHHHHHhCCCCcccccccc
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-------HQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.. .....+.......
T Consensus 166 ~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--------- 235 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--------- 235 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC---------
T ss_pred ccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC---------
Confidence 345677999999999987 77899999999999999999999999765421 1222211110000
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
....+..+++++.++|.+||+.||.+|||+.++++||||++.....
T Consensus 236 ------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~ 281 (325)
T 3kn6_A 236 ------------------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLS 281 (325)
T ss_dssp ------------------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCC
T ss_pred ------------------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCC
Confidence 0111235789999999999999999999999999999999754443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=338.71 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=220.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||.||++.++.+++.||+|++.... ......+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv 93 (294)
T 2rku_A 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----DFVFVV 93 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEE
T ss_pred EEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-----CEEEEE
Confidence 5999999999999999999999999999986543 3344567788999999999999999999998654 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMT 200 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~ 200 (375)
|||++ ++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173 (294)
T ss_dssp EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccc
Confidence 99997 699999988888999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+.......
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 234 (294)
T 2rku_A 174 VLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI------------------ 234 (294)
T ss_dssp CCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC------------------
T ss_pred cccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCC------------------
Confidence 4568999999999987 678999999999999999999999998877655544433211100
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC 340 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~ 340 (375)
...+++.+.++|.+||+.||++|||++++++||||+........+..
T Consensus 235 -------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~~ 281 (294)
T 2rku_A 235 -------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPIT 281 (294)
T ss_dssp -------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGG
T ss_pred -------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCCcc
Confidence 12468889999999999999999999999999999987666655443
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=355.33 Aligned_cols=275 Identities=30% Similarity=0.574 Sum_probs=221.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc------CCCCeeeeceeecCCCCCCcC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM------DHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~iv~~~~~~~~~~~~~~~ 117 (375)
+++.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.+ +|+||+++++.+... .
T Consensus 101 ~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-----~ 172 (429)
T 3kvw_A 101 VLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-----N 172 (429)
T ss_dssp EEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-----T
T ss_pred EEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-----C
Confidence 699999999999999999999999999999653 23345667788888777 577999999998554 5
Q ss_pred cEEEEEeCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC--EEEeeccccccc
Q 017231 118 DVYIVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD--LKIGDFGLARTT 193 (375)
Q Consensus 118 ~~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~--i~l~Df~~~~~~ 193 (375)
.+++||||++++|.+++.... .+++..++.++.||+.||.+||+.||+|+||||+||+++.++. ++|+|||++...
T Consensus 173 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 173 HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred eEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 689999999999999998764 4999999999999999999999999999999999999999987 999999998654
Q ss_pred CCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.++.........
T Consensus 253 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~- 328 (429)
T 3kvw_A 253 HQR--VYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKR- 328 (429)
T ss_dssp TCC--CCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTT-
T ss_pred CCc--ccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhh-
Confidence 433 345678999999999988 6789999999999999999999999999999999999999888776554322111
Q ss_pred hhHHHhhhCCC-----------------------------CCCCCccccC-CCCCchHHHHHHHhcCcCCCCCCCHHHHh
Q 017231 274 NARRYVRMLPQ-----------------------------FPKQNFSARF-PNKSPGAVDLLEKMLVFDPNRRITVDEAL 323 (375)
Q Consensus 274 ~~~~~~~~~~~-----------------------------~~~~~~~~~~-~~~s~~l~~li~~~L~~dP~~Rps~~ell 323 (375)
...+...-.. .....+.... ...++++.+||.+||+.||++|||+.|+|
T Consensus 329 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 329 -AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp -HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred -hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 1111110000 0000011111 23477899999999999999999999999
Q ss_pred cCCCCCCC
Q 017231 324 CHPYLAPL 331 (375)
Q Consensus 324 ~~~~f~~~ 331 (375)
+||||+..
T Consensus 408 ~Hpw~~~~ 415 (429)
T 3kvw_A 408 RHPWLRRR 415 (429)
T ss_dssp TSTTTC--
T ss_pred CChhhccC
Confidence 99999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=352.78 Aligned_cols=297 Identities=33% Similarity=0.522 Sum_probs=220.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC--CCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR--ETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~~~l 121 (375)
+++.||+|+||.||+++++.+++.||||++...... ......++..+..++||||+++++++..... .....+++
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 27 VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp EC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 699999999999999999999999999988553222 2345677888889999999999999865321 22234789
Q ss_pred EEeCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceEEec-CCCEEEeecccccccC
Q 017231 122 VYELMDTDLHQIIR----SHQDLTDDHCRYFLYQLLRGLKYVH--SANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTS 194 (375)
Q Consensus 122 v~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~al~~Lh--~~~i~H~di~p~NIli~~-~~~i~l~Df~~~~~~~ 194 (375)
||||++++|...+. ....+++..++.++.||+.||.+|| +.||+|+||||+||+++. ++.++|+|||++....
T Consensus 104 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~ 183 (360)
T 3e3p_A 104 VMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183 (360)
T ss_dssp EEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCC
T ss_pred EeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecC
Confidence 99999988766554 4567999999999999999999999 999999999999999997 8999999999998776
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
.........+|+.|+|||++.+...++.++|||||||++|+|++|..||...+....+..+....+.++...........
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3e3p_A 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSH 263 (360)
T ss_dssp TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC
T ss_pred CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccch
Confidence 66555667789999999999775668999999999999999999999999999888998888887776544332211110
Q ss_pred hHHHhhhCCCCC-CCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCC
Q 017231 275 ARRYVRMLPQFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRP 343 (375)
Q Consensus 275 ~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~ 343 (375)
...-.......+ ...+.......++++.++|.+||+.||.+|||+.|+|+||||+++............
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~ 333 (360)
T 3e3p_A 264 TDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKD 333 (360)
T ss_dssp CCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCC
T ss_pred hhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCC
Confidence 000000000000 000011112357889999999999999999999999999999998776654433333
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=351.48 Aligned_cols=275 Identities=26% Similarity=0.447 Sum_probs=219.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-----CCCeeeeceeecCCCCCCcCc
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-----HENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+++.||+|+||.||+|++..+++.||||++... ......+..|+.+++.+. ||||+++++++... ..
T Consensus 39 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-----~~ 110 (360)
T 3llt_A 39 VIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-----DH 110 (360)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----TE
T ss_pred EEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----Ce
Confidence 699999999999999999999999999998642 334556778999999996 99999999998654 56
Q ss_pred EEEEEeCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec------------------
Q 017231 119 VYIVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA------------------ 178 (375)
Q Consensus 119 ~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~------------------ 178 (375)
.++||||++++|.+++.... .+++..++.++.||+.||.+||++||+|+||||+||+++.
T Consensus 111 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 111 MCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred eEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 89999999889999998764 5999999999999999999999999999999999999975
Q ss_pred -------CCCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH
Q 017231 179 -------NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 251 (375)
Q Consensus 179 -------~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 251 (375)
++.++|+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+....
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 267 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH 267 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH
Confidence 789999999999764433 345678999999999988 6799999999999999999999999999998888
Q ss_pred HHHHHHHhCCCCcccccccccchhHHHhhhCC---CCCCCC------------ccccCCCCCchHHHHHHHhcCcCCCCC
Q 017231 252 LRLITELIGSPDETSLGFLRSDNARRYVRMLP---QFPKQN------------FSARFPNKSPGAVDLLEKMLVFDPNRR 316 (375)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~------------~~~~~~~~s~~l~~li~~~L~~dP~~R 316 (375)
...+....+..+..............+..... ..+... ........++.+.+||.+||+.||.+|
T Consensus 268 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 347 (360)
T 3llt_A 268 LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLR 347 (360)
T ss_dssp HHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhC
Confidence 88888887776643322111111000000000 000000 000001235778899999999999999
Q ss_pred CCHHHHhcCCCCC
Q 017231 317 ITVDEALCHPYLA 329 (375)
Q Consensus 317 ps~~ell~~~~f~ 329 (375)
||+.|+|+||||+
T Consensus 348 pta~elL~hp~f~ 360 (360)
T 3llt_A 348 PSPAELLKHKFLE 360 (360)
T ss_dssp CCHHHHTTSGGGC
T ss_pred CCHHHHhcCcccC
Confidence 9999999999996
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=369.01 Aligned_cols=255 Identities=30% Similarity=0.524 Sum_probs=222.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||.||++.++.+++.||||++.... ........+.+|+.++++++||||+++++++... ..+++|
T Consensus 30 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~lv 104 (484)
T 3nyv_A 30 GQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-----GYFYLV 104 (484)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEE
T ss_pred EeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----CEEEEE
Confidence 7999999999999999999999999999986543 2234567788999999999999999999999654 668999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ecCCCEEEeecccccccCCCCc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli---~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
|||+. |+|.+.+...+.+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 99997 6999999998999999999999999999999999999999999999999 5678999999999877666555
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+.......+..
T Consensus 185 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~------------- 249 (484)
T 3nyv_A 185 MKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP------------- 249 (484)
T ss_dssp HHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG-------------
T ss_pred cccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc-------------
Confidence 566789999999999876 58999999999999999999999999988877777766533222211
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.+..++++++++|.+||+.||.+|||+.++|+||||+...
T Consensus 250 --------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 250 --------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp --------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred --------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 1235789999999999999999999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=379.78 Aligned_cols=260 Identities=22% Similarity=0.353 Sum_probs=222.4
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQR 113 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 113 (375)
.+.-..+++++.||+|+||.||+++++.+++.||||++.+.. ........+..|..++..+ +||+|+.+++++...
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~-- 414 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-- 414 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS--
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC--
Confidence 344455668999999999999999999999999999986532 1223456678899999988 699999999999554
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..
T Consensus 415 ---~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 415 ---DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp ---SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred ---CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 56899999997 69999999888999999999999999999999999999999999999999999999999999875
Q ss_pred cC-CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 193 TS-ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 193 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
.. ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 492 ~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p-------- 562 (674)
T 3pfq_A 492 NIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP-------- 562 (674)
T ss_dssp CCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC--------
T ss_pred cccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC--------
Confidence 32 2334556789999999999987 7899999999999999999999999999888777777655221111
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH-----HHHhcCCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPLH 332 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~-----~ell~~~~f~~~~ 332 (375)
..+++++.+||.+||+.||++||++ +||++||||+.++
T Consensus 563 -----------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 563 -----------------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp -----------------------TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred -----------------------ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 2468999999999999999999998 9999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=343.02 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=222.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||.||++++..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++... ...++|
T Consensus 45 ~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv 119 (335)
T 2owb_A 45 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----DFVFVV 119 (335)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEE
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----CeEEEE
Confidence 6999999999999999999999999999986543 3344567788999999999999999999999654 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMT 200 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~ 200 (375)
|||++ ++|.+++.....+++.+++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 120 ~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 199 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199 (335)
T ss_dssp ECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccccc
Confidence 99997 699999988888999999999999999999999999999999999999999999999999998765432 2234
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...++..|+|||++.+ ..++.++||||||+++|+|++|..||...........+.......
T Consensus 200 ~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------ 260 (335)
T 2owb_A 200 VLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSI------------------ 260 (335)
T ss_dssp CCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC------------------
T ss_pred ccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCC------------------
Confidence 4678999999999987 678999999999999999999999998877666555444321111
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC 340 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~ 340 (375)
...+++.+.++|.+||+.||++|||++++++|+||+........+..
T Consensus 261 -------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~~~~ 307 (335)
T 2owb_A 261 -------------PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPIT 307 (335)
T ss_dssp -------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGG
T ss_pred -------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccCCcc
Confidence 02468889999999999999999999999999999987766655544
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=342.07 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=201.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
..+.||+|+||.||++.+..+++.||||++.... ......+.+|+.++.++ +||||+++++++... +.+++|
T Consensus 17 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~~~lv 89 (316)
T 2ac3_A 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DRFYLV 89 (316)
T ss_dssp CCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred cCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CEEEEE
Confidence 4588999999999999999999999999996542 23356788999999985 799999999998654 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC---EEEeecccccccCCCC-
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSETD- 197 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~---i~l~Df~~~~~~~~~~- 197 (375)
|||++ ++|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++. ++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 99997 699999998888999999999999999999999999999999999999988776 9999999886543221
Q ss_pred -------ccccccccccccCchhcccC----CCCCccchhHHHHHHHHHHhhCCCCCCCCChh---------------HH
Q 017231 198 -------FMTEYVVTRWYRAPELLLNC----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV---------------HQ 251 (375)
Q Consensus 198 -------~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------------~~ 251 (375)
......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 12234589999999998641 34788999999999999999999999765421 11
Q ss_pred HHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 252 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
...+.......+ ...+..+++++.++|.+||+.||.+|||+.|+++||||++.
T Consensus 250 ~~~i~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 250 FESIQEGKYEFP---------------------------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp HHHHHHCCCCCC---------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred HHHHhccCcccC---------------------------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 222211111111 11123578899999999999999999999999999999976
Q ss_pred CC
Q 017231 332 HD 333 (375)
Q Consensus 332 ~~ 333 (375)
..
T Consensus 303 ~~ 304 (316)
T 2ac3_A 303 AP 304 (316)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=354.64 Aligned_cols=297 Identities=29% Similarity=0.444 Sum_probs=228.1
Q ss_pred CCCCCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHH
Q 017231 7 SGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRT 86 (375)
Q Consensus 7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~ 86 (375)
..+|++++..|..+ .++|. +++.||+|+||+||+|++..+++.||||++... ......+
T Consensus 22 ~~~~~~~~~~g~~~-~~~y~-----------------~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~ 80 (397)
T 1wak_A 22 CKGGYHLVKIGDLF-NGRYH-----------------VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETA 80 (397)
T ss_dssp CC--CCSSCTTCEE-TTTEE-----------------EEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHH
T ss_pred CCCCceEEehhhhc-CCeEE-----------------EEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHH
Confidence 44789999999988 56898 499999999999999999999999999998643 3345678
Q ss_pred HHHHHHHHhcC--------CCCeeeeceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHH
Q 017231 87 LREIKLLRHMD--------HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGL 156 (375)
Q Consensus 87 ~~e~~~l~~l~--------h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~al 156 (375)
.+|+.+++.++ |+||+++++.+.... .....+++||||++++|.+.+... ..+++..++.++.||+.||
T Consensus 81 ~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL 159 (397)
T 1wak_A 81 LDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159 (397)
T ss_dssp HHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence 89999999985 788999999886322 122568999999998998888765 4699999999999999999
Q ss_pred HHHHhC-CccccCCCCCceEEecCC-------------------------------------------------CEEEee
Q 017231 157 KYVHSA-NVLHRDLKPSNLLLNANC-------------------------------------------------DLKIGD 186 (375)
Q Consensus 157 ~~Lh~~-~i~H~di~p~NIli~~~~-------------------------------------------------~i~l~D 186 (375)
.+||++ ||+|+||||+||+++.++ .++|+|
T Consensus 160 ~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~D 239 (397)
T 1wak_A 160 DYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239 (397)
T ss_dssp HHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECC
T ss_pred HHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecc
Confidence 999998 999999999999998775 799999
Q ss_pred cccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC------hhHHHHHHHHHhC
Q 017231 187 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD------YVHQLRLITELIG 260 (375)
Q Consensus 187 f~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~ 260 (375)
||.+...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+ ....+..+....+
T Consensus 240 fG~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 316 (397)
T 1wak_A 240 LGNACWVHKH--FTEDIQTRQYRSLEVLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316 (397)
T ss_dssp GGGCEETTBC--SCSCCSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHC
T ss_pred cccccccccc--CccCCCCCcccCChhhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcC
Confidence 9998765433 345578999999999988 678999999999999999999999997654 4456667777777
Q ss_pred CCCcccccccccchhHHHhhhC---CCCCCCCc----------cccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCC
Q 017231 261 SPDETSLGFLRSDNARRYVRML---PQFPKQNF----------SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327 (375)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----------~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~ 327 (375)
..+......... ...+.... ........ .......++.+.+||.+||+.||++|||+.|+|+|||
T Consensus 317 ~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 317 KVPRKLIVAGKY--SKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp SCCHHHHHHCTT--GGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred CCChHHhhcccc--cccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 655432210000 00000000 00000000 0000123567889999999999999999999999999
Q ss_pred CCC
Q 017231 328 LAP 330 (375)
Q Consensus 328 f~~ 330 (375)
|++
T Consensus 395 ~~~ 397 (397)
T 1wak_A 395 LNS 397 (397)
T ss_dssp GGC
T ss_pred ccC
Confidence 974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=369.53 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=217.8
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 115 (375)
+....+++++.||+|+||.||+++++.+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~---- 256 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK---- 256 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC----
Confidence 45555668999999999999999999999999999986532 1222345678999999999999999999999554
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..+++||||++ |+|.+++...+. +++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++..
T Consensus 257 -~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 257 -DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp -SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred -CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 56899999996 699999987544 99999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh----hHHHHHHHHHhCCCCccccc
Q 017231 193 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY----VHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 193 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~ 268 (375)
...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+.......
T Consensus 336 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~------ 408 (576)
T 2acx_A 336 VPEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY------ 408 (576)
T ss_dssp CCTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC------
T ss_pred cccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC------
Confidence 665555556789999999999987 6789999999999999999999999987542 22222222211000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
...+++++.++|.+||+.||.+|| +++|+++||||++++
T Consensus 409 -------------------------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 409 -------------------------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp -------------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred -------------------------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 134689999999999999999999 899999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=337.40 Aligned_cols=258 Identities=29% Similarity=0.477 Sum_probs=218.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-------chHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-------NRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRET 115 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 115 (375)
+.+.||+|++|.||++.++.+++.||+|++..... .....+.+.+|+.+++++. ||||+++++++...
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---- 96 (298)
T 1phk_A 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN---- 96 (298)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS----
T ss_pred eeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC----
Confidence 69999999999999999999999999999865421 1223456789999999995 99999999998544
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
...++||||++ ++|.+++.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....
T Consensus 97 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 97 -TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp -SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred -CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 66899999997 6999999988889999999999999999999999999999999999999999999999999987766
Q ss_pred CCCccccccccccccCchhccc-----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 195 ETDFMTEYVVTRWYRAPELLLN-----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
.........+++.|+|||++.+ ...++.++||||||+++|+|++|..||...+.......+.......+..
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 251 (298)
T 1phk_A 176 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP---- 251 (298)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----
T ss_pred CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcc----
Confidence 5555556678999999999852 2567889999999999999999999998887666666555432221111
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.+..+++.+.++|.+||+.||.+|||+.++++||||++...
T Consensus 252 -----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 252 -----------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp -----------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred -----------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 11346889999999999999999999999999999997643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=340.80 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=215.5
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch----HHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
++++.||+|+||.||+++++.+++.||+|++....... ...+.+.+|+.++++++||||+++++++... ..
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~ 82 (283)
T 3bhy_A 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-----TD 82 (283)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred hhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-----Ce
Confidence 37999999999999999999999999999986543221 2356788999999999999999999998654 56
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC----CEEEeeccccccc
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLARTT 193 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~----~i~l~Df~~~~~~ 193 (375)
.++||||++ ++|.+++.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 899999996 69999998888899999999999999999999999999999999999998877 8999999998776
Q ss_pred CCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
..........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.......+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------- 232 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE--------- 232 (283)
T ss_dssp C--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH---------
T ss_pred cCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc---------
Confidence 55544455678999999999987 67899999999999999999999999888766655554432211111
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
.....+++.+.++|.+||+.||++|||+.++++||||+.+...
T Consensus 233 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 233 ------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp ------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred ------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 1113568889999999999999999999999999999987543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=346.82 Aligned_cols=257 Identities=28% Similarity=0.508 Sum_probs=217.9
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc------hHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCC
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN------RIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 114 (375)
+++.+.||+|++|+||+|.++.+|+.||||++...... ....+.+..|+.+++++ +||||+++++++...
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--- 172 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS--- 172 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS---
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC---
Confidence 44789999999999999999999999999998654311 12245678999999999 799999999998544
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
...++||||++ ++|.+++.....+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++...
T Consensus 173 --~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 173 --SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp --SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred --CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 56899999997 599999998888999999999999999999999999999999999999999999999999998776
Q ss_pred CCCCccccccccccccCchhccc-----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLLN-----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
..........||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+...........
T Consensus 251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-- 328 (365)
T 2y7j_A 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPE-- 328 (365)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHH--
T ss_pred CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcc--
Confidence 65555566788999999999864 13578899999999999999999999988776666666554322221111
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
+..+++.+.++|.+||+.||++|||+.++|+||||+.
T Consensus 329 -------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 329 -------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp -------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred -------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 1356888999999999999999999999999999973
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=352.04 Aligned_cols=252 Identities=29% Similarity=0.426 Sum_probs=212.2
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEe
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYE 124 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e 124 (375)
.+.||+|+||.||++.+..+|+.||+|++... .....+.+.+|+.++++++||||+++++++... ..+++|||
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E 166 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVME 166 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEe
Confidence 57899999999999999999999999998654 234566788999999999999999999999654 56899999
Q ss_pred CCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE--ecCCCEEEeecccccccCCCCccc
Q 017231 125 LMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL--NANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 125 ~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli--~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
|++ ++|.+++... ..+++..++.++.||+.||.+||+.||+|+||||+||++ +.++.++|+|||++..........
T Consensus 167 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~ 246 (373)
T 2x4f_A 167 YVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246 (373)
T ss_dssp CCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCC
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccc
Confidence 997 6898888654 469999999999999999999999999999999999999 456789999999998766655555
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+.......+.
T Consensus 247 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~---------------- 309 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED---------------- 309 (373)
T ss_dssp CCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS----------------
T ss_pred cccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh----------------
Confidence 6678999999999977 67899999999999999999999999988877777666553222211
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..+..+++++.++|.+||+.||.+|||+.|+|+||||+..
T Consensus 310 -----------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 310 -----------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp -----------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred -----------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 1124678999999999999999999999999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=349.14 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=210.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch------HHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR------IDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
+++.||+|+||.||+++++.+++.||+|++....... .....+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-----~ 102 (335)
T 3dls_A 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-----G 102 (335)
T ss_dssp EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC-----C
Confidence 6999999999999999999999999999997643211 1334566899999999999999999999554 5
Q ss_pred cEEEEEeCCC-C-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 118 DVYIVYELMD-T-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 118 ~~~lv~e~~~-g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
.+++||||+. | +|.+++...+.+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 6899999985 5 9999999988999999999999999999999999999999999999999999999999999987766
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
........||+.|+|||++.+....+.++|||||||++|+|++|..||....... ..
T Consensus 183 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------~~-------------- 239 (335)
T 3dls_A 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------EA-------------- 239 (335)
T ss_dssp TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------TT--------------
T ss_pred CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------hh--------------
Confidence 6555667889999999999874444889999999999999999999996532100 00
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.......+++++.++|.+||+.||.+|||+.++++||||+...
T Consensus 240 --------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 240 --------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp --------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred --------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 0000124688999999999999999999999999999998753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=349.62 Aligned_cols=306 Identities=27% Similarity=0.433 Sum_probs=232.2
Q ss_pred CCCCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHH
Q 017231 8 GSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL 87 (375)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~ 87 (375)
.||++|...|..+..++|.+ ++.||+|+||.||+|.+..+++.||||++... ......+.
T Consensus 4 ~~~~~p~~~~~~~~~~~y~~-----------------~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~ 63 (373)
T 1q8y_A 4 PGGYHPAFKGEPYKDARYIL-----------------VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAE 63 (373)
T ss_dssp ---CCCCCTTCEETTTTEEE-----------------EEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHH
T ss_pred CCCceeeecCCcccCCeEEE-----------------EEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhh
Confidence 47899999999999999995 99999999999999999999999999998643 23455677
Q ss_pred HHHHHHHhcC-----------CCCeeeeceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHH
Q 017231 88 REIKLLRHMD-----------HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLR 154 (375)
Q Consensus 88 ~e~~~l~~l~-----------h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~ 154 (375)
+|+.++++++ |+||+++++++.... .....++++||+++++|.+++... ..+++..++.++.||+.
T Consensus 64 ~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~ 142 (373)
T 1q8y_A 64 DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 142 (373)
T ss_dssp HHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhcccccchhccccchHHHHHHHhhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHH
Confidence 8999988886 799999999986542 122468999999988999999874 45999999999999999
Q ss_pred HHHHHHhC-CccccCCCCCceEEecC------CCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhH
Q 017231 155 GLKYVHSA-NVLHRDLKPSNLLLNAN------CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIW 227 (375)
Q Consensus 155 al~~Lh~~-~i~H~di~p~NIli~~~------~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 227 (375)
||.+||++ ||+|+||||+||+++.+ +.++|+|||++...... .....+|+.|+|||++.+ ..++.++|||
T Consensus 143 aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~Di~ 219 (373)
T 1q8y_A 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-APWGCGADIW 219 (373)
T ss_dssp HHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CCCCTHHHHH
T ss_pred HHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhC-CCCCchHhHH
Confidence 99999998 99999999999999543 37999999998765433 334578999999999988 6789999999
Q ss_pred HHHHHHHHHhhCCCCCCCCC------hhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCC---Cc--------
Q 017231 228 SVGCILGEIMTRQPLFPGKD------YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQ---NF-------- 290 (375)
Q Consensus 228 slG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-------- 290 (375)
||||++|+|++|..||...+ ....+..+....+..+......... ...+.......... ..
T Consensus 220 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (373)
T 1q8y_A 220 STACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY--TRTFFNSRGLLRNISKLKFWPLEDVLT 297 (373)
T ss_dssp HHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTT--HHHHBCC--CBSSCCCCCBCCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccch--hhhhcCCcchhcccccccccchhhhhh
Confidence 99999999999999997654 4556667777777665533211100 00000000000000 00
Q ss_pred --cccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCC
Q 017231 291 --SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 339 (375)
Q Consensus 291 --~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~ 339 (375)
......+++++.+||.+||+.||++|||+.|+|+||||++.........
T Consensus 298 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~ 348 (373)
T 1q8y_A 298 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRV 348 (373)
T ss_dssp HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCC
T ss_pred hcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCcccccC
Confidence 0000134677899999999999999999999999999998765554433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=345.50 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=208.9
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCC--CCeeeeceeecCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH--ENIIAIKDIIRPP 111 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~~~~~~~~~ 111 (375)
+.++..+.|++++.||+|+||.||++.+. +++.||+|++............+.+|+.++++++| +||+++++++...
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 34455555558999999999999999985 58899999997766666667889999999999976 9999999998654
Q ss_pred CCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 112 QRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
..+++|||+.+++|.+++...+.+++.+++.++.||+.||.+||+.||+|+||||+||+++ ++.++|+|||++.
T Consensus 82 -----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 82 -----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp -----SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred -----CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 5689999987889999999999999999999999999999999999999999999999996 6889999999997
Q ss_pred ccCCCC---ccccccccccccCchhccc----------CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHH
Q 017231 192 TTSETD---FMTEYVVTRWYRAPELLLN----------CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL 258 (375)
Q Consensus 192 ~~~~~~---~~~~~~~~~~y~aPE~~~~----------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 258 (375)
...... ......||+.|+|||++.+ ...++.++|||||||++|+|++|..||...... ...+...
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~ 233 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHAI 233 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHH
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHHH
Confidence 654432 2235678999999999864 246788999999999999999999999764321 1112221
Q ss_pred hCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 259 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
........ .....++++.++|.+||+.||.+|||+.++|+||||+..
T Consensus 234 ~~~~~~~~--------------------------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 234 IDPNHEIE--------------------------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp HCTTSCCC--------------------------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred hcCCcccC--------------------------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 11111000 002346789999999999999999999999999999854
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=345.96 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=214.6
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
.+++++.||+|+||.||+|++..+++.||||++.... ........+.+|+.++++++||||+++++++... ...
T Consensus 55 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 129 (348)
T 1u5q_A 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA 129 (348)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred heeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CeE
Confidence 3457899999999999999999999999999987543 3344456788999999999999999999998654 568
Q ss_pred EEEEeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 120 YIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 120 ~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
++||||+.|+|.+++.. ...+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++......
T Consensus 130 ~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 130 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 99999999999988854 567999999999999999999999999999999999999999999999999998765433
Q ss_pred cccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 199 MTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
....||+.|+|||++.+ ...++.++|||||||++|+|++|..||...+.......+.......
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 272 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA-------------- 272 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--------------
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC--------------
Confidence 34578999999999853 2568899999999999999999999998877665555443321110
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.....+++.+.++|.+||+.||++|||++++++||||...
T Consensus 273 ---------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 273 ---------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp ---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ---------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 0013468889999999999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=342.33 Aligned_cols=254 Identities=26% Similarity=0.429 Sum_probs=202.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC----------
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---------- 113 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---------- 113 (375)
+++.||+|+||.||+|+++.+++.||||++.... .....+.+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~ 88 (332)
T 3qd2_B 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEI 88 (332)
T ss_dssp EEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-
T ss_pred eeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhh
Confidence 7999999999999999999999999999996543 33356778999999999999999999998754321
Q ss_pred ------------------------------------------CCcCcEEEEEeCCC-CCHHHHHHhCCC---CCHHHHHH
Q 017231 114 ------------------------------------------ETFNDVYIVYELMD-TDLHQIIRSHQD---LTDDHCRY 147 (375)
Q Consensus 114 ------------------------------------------~~~~~~~lv~e~~~-g~L~~~l~~~~~---l~~~~~~~ 147 (375)
.....+++||||++ ++|.+++..... .++..++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ 168 (332)
T 3qd2_B 89 WLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168 (332)
T ss_dssp -------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHH
T ss_pred hhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHH
Confidence 11234899999997 599999987654 56667899
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-------------ccccccccccccCchhc
Q 017231 148 FLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-------------FMTEYVVTRWYRAPELL 214 (375)
Q Consensus 148 i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~ 214 (375)
++.||+.||.+||++|++|+||||+||+++.++.++|+|||++....... ......||+.|+|||++
T Consensus 169 i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 248 (332)
T 3qd2_B 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQI 248 (332)
T ss_dssp HHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHH
T ss_pred HHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHh
Confidence 99999999999999999999999999999999999999999987655432 22345689999999999
Q ss_pred ccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccC
Q 017231 215 LNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARF 294 (375)
Q Consensus 215 ~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (375)
.+ ..++.++|||||||++|+|++|..|+. .....+.......... ..
T Consensus 249 ~~-~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~---------------------------~~ 295 (332)
T 3qd2_B 249 HG-NNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPL---------------------------LF 295 (332)
T ss_dssp HC-CCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCH---------------------------HH
T ss_pred cC-CCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCc---------------------------cc
Confidence 87 678999999999999999999876652 2222222211111000 01
Q ss_pred CCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 295 PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 295 ~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
...++++.++|.+||+.||.+|||+.|+++||||+++
T Consensus 296 ~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 1246778999999999999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=338.66 Aligned_cols=254 Identities=29% Similarity=0.451 Sum_probs=214.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|++|.||+++++.+|+.||+|++.... ......+.+|+.++++++||||+++++++... ...++||
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 85 (304)
T 2jam_A 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYEST-----THYYLVM 85 (304)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEEEEE
T ss_pred eeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccC-----CEEEEEE
Confidence 7999999999999999999999999999997542 22345678999999999999999999998554 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ecCCCEEEeecccccccCCCCcc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli---~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
||++ ++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||++ +.++.++|+|||.+...... ..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~ 164 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IM 164 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TT
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-cc
Confidence 9997 6999999888889999999999999999999999999999999999999 78899999999998654433 23
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+.......+.
T Consensus 165 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~--------------- 228 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFES--------------- 228 (304)
T ss_dssp HHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCT---------------
T ss_pred ccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCc---------------
Confidence 44568999999999987 67899999999999999999999999888776666665543221111
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.....+++++.++|.+||+.||++|||+.++++||||++...
T Consensus 229 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 229 ------------PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp ------------TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred ------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 112457899999999999999999999999999999987543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=336.48 Aligned_cols=252 Identities=27% Similarity=0.403 Sum_probs=206.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.+.||+|++|.||++.++.+++.||+|++.... ........+.+|+.+++.++||||+++++++... ...++|
T Consensus 15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 89 (276)
T 2h6d_A 15 LGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-----TDFFMV 89 (276)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEE
T ss_pred EEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----CeEEEE
Confidence 6999999999999999999999999999986432 1222345788999999999999999999998654 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE 201 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~ 201 (375)
|||++ ++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 169 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceec
Confidence 99997 69999999888899999999999999999999999999999999999999999999999999877665544556
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..+++.|+|||.+.+....+.++||||||+++|+|++|..||...........+.......
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------- 230 (276)
T 2h6d_A 170 SCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYI------------------- 230 (276)
T ss_dssp -------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------------------
T ss_pred ccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccC-------------------
Confidence 6789999999999874334689999999999999999999998877666555544321111
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
...+++.+.++|.+||+.||++|||+.++++||||++.
T Consensus 231 ------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 231 ------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 02457889999999999999999999999999999853
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=345.87 Aligned_cols=251 Identities=30% Similarity=0.465 Sum_probs=207.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||.||++.++.+++.||+|++.+.... ..+|+.++.++ +||||+++++++... ..+++|
T Consensus 26 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv 94 (342)
T 2qr7_A 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDG-----KYVYVV 94 (342)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECS-----SEEEEE
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcC-----CEEEEE
Confidence 799999999999999999999999999999665322 34688888888 799999999999554 668999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC----CCEEEeecccccccCCC-
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN----CDLKIGDFGLARTTSET- 196 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~----~~i~l~Df~~~~~~~~~- 196 (375)
|||++ |+|.+.+...+.+++..++.++.||+.||.+||++||+|+||||+||++..+ +.++|+|||++......
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99997 6999999998899999999999999999999999999999999999998443 34999999998765433
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCC---ChhHHHHHHHHHhCCCCcccccccccc
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK---DYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
......++|+.|+|||++.+ ..++.++|||||||++|+|++|..||... ........+.......+
T Consensus 175 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~---------- 243 (342)
T 2qr7_A 175 GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS---------- 243 (342)
T ss_dssp CCBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC----------
T ss_pred CceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC----------
Confidence 33456678999999999987 66889999999999999999999999763 23333433333111111
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
...+..+++++.++|.+||..||++|||+.++++||||.+...
T Consensus 244 -----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 244 -----------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp -----------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred -----------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 1112467999999999999999999999999999999976543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=336.46 Aligned_cols=253 Identities=25% Similarity=0.424 Sum_probs=215.5
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++++.||+|++|.||++.+..++..||+|++..... .......+.+|+.++++++||||+++++++... ...++
T Consensus 17 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 91 (284)
T 2vgo_A 17 DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-----KRIYL 91 (284)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEE
T ss_pred eeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-----CEEEE
Confidence 379999999999999999999999999999864321 122345688999999999999999999998654 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
||||++ ++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 170 (284)
T 2vgo_A 92 MLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR-RR 170 (284)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-BC
T ss_pred EEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc-cc
Confidence 999997 5999999988889999999999999999999999999999999999999999999999999886544332 34
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.......
T Consensus 171 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------ 231 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF------------------ 231 (284)
T ss_dssp CCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC------------------
T ss_pred cccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC------------------
Confidence 5678999999999987 678999999999999999999999998877666555443321110
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
...+++.+.++|.+||+.||.+||+++++++||||+....
T Consensus 232 -------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 232 -------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp -------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred -------------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 0346889999999999999999999999999999996543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=341.42 Aligned_cols=278 Identities=31% Similarity=0.595 Sum_probs=214.6
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||.||+|++..+++.||+|++... ....+.+|+.++++++ ||||+++++++..... ...++|
T Consensus 40 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~---~~~~lv 111 (330)
T 3nsz_A 40 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVS---RTPALV 111 (330)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT---CCEEEE
T ss_pred EEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC---CceEEE
Confidence 799999999999999999999999999998643 2456889999999997 9999999999876432 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-CEEEeecccccccCCCCccc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-~i~l~Df~~~~~~~~~~~~~ 200 (375)
|||++ ++|.+++.. +++..++.++.||+.||.+||++|++|+||||+||+++.++ .++|+|||++..........
T Consensus 112 ~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp EECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred EeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence 99997 688888753 89999999999999999999999999999999999999777 89999999997766555556
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCC-CChhHHHHHHHHHhCCCCcccc-cccccchhHHH
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPG-KDYVHQLRLITELIGSPDETSL-GFLRSDNARRY 278 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~ 278 (375)
...++..|+|||++.+...++.++|||||||++|+|++|..||.. .+....+..+....+....... ..........+
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRF 268 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHH
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccch
Confidence 677899999999998766789999999999999999999999954 4444455544444332110000 00000000001
Q ss_pred hhhCCCCCCCCccc-----cCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSA-----RFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 279 ~~~~~~~~~~~~~~-----~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
...........+.. ....+++++.+||.+||+.||.+|||++|+|+||||+.+.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 269 NDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11111111111111 1123789999999999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=339.02 Aligned_cols=253 Identities=26% Similarity=0.461 Sum_probs=212.9
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+...+.||+|+||.||+|+++.+|+.||||++..... ...+.+.+|+.++++++||||+++++++... ...++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 119 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWV 119 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEE
Confidence 3467899999999999999999999999999865432 2356688999999999999999999998654 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
||||++ ++|.+++.. ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 120 v~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (321)
T 2c30_A 120 LMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198 (321)
T ss_dssp EECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred EEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccc
Confidence 999997 588888764 569999999999999999999999999999999999999999999999999887654432 23
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.........
T Consensus 199 ~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 262 (321)
T 2c30_A 199 KSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK--------------- 262 (321)
T ss_dssp CCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCT---------------
T ss_pred ccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcC---------------
Confidence 45678999999999987 67899999999999999999999999887766665554432111100
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
....+++.+.++|.+||+.||++|||+.++++||||+..
T Consensus 263 -------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 263 -------------NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp -------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred -------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 012468889999999999999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=336.66 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=214.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc--chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.||+|+||.||++.+..+++.||+|++..... .......+.+|+.++++++||||+++++++.... ....++
T Consensus 9 i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~~~l 85 (305)
T 2wtk_C 9 MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE---KQKMYM 85 (305)
T ss_dssp CCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC------CEEE
T ss_pred EeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC---CCeEEE
Confidence 89999999999999999999999999999965421 1234567889999999999999999999985432 256899
Q ss_pred EEeCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC---
Q 017231 122 VYELMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET--- 196 (375)
Q Consensus 122 v~e~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~--- 196 (375)
||||++++|.+++.. ...+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 86 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 165 (305)
T 2wtk_C 86 VMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165 (305)
T ss_dssp EEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSS
T ss_pred EehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccccc
Confidence 999999888888876 356999999999999999999999999999999999999999999999999998765422
Q ss_pred CccccccccccccCchhcccCC-CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 197 DFMTEYVVTRWYRAPELLLNCS-EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
.......+++.|+|||++.+.. ..+.++||||||+++|+|++|..||...+.......+.......
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~------------- 232 (305)
T 2wtk_C 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAI------------- 232 (305)
T ss_dssp CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC-------------
T ss_pred cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCC-------------
Confidence 2233456899999999987622 24779999999999999999999999877666655554321110
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 338 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~ 338 (375)
...+++.+.++|.+||+.||.+|||+.++++||||++.......+
T Consensus 233 ------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~ 277 (305)
T 2wtk_C 233 ------------------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAP 277 (305)
T ss_dssp ------------------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CCC
T ss_pred ------------------CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCCC
Confidence 124688899999999999999999999999999999876554433
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=342.84 Aligned_cols=292 Identities=30% Similarity=0.512 Sum_probs=228.4
Q ss_pred CCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEe-CCCCcEEEEEEecCcccchHHHHHHHH
Q 017231 10 GDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMN-SETREEVAIKKIGNAFDNRIDAKRTLR 88 (375)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~ 88 (375)
|.+....|..+ ++||. +++.||+|+||.||++.+ +.+++.||+|++... ......+.+
T Consensus 2 ~~~~~~~g~~~-~~~y~-----------------~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~ 60 (339)
T 1z57_A 2 MHLICQSGDVL-SARYE-----------------IVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARS 60 (339)
T ss_dssp GGGTCSTTCEE-TTTEE-----------------EEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHH
T ss_pred CceeeecCCCc-cCceE-----------------EEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHH
Confidence 34455556666 45777 599999999999999998 568899999998643 234566788
Q ss_pred HHHHHHhcCCC------CeeeeceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH
Q 017231 89 EIKLLRHMDHE------NIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVH 160 (375)
Q Consensus 89 e~~~l~~l~h~------~iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh 160 (375)
|+.+++.++|+ +++++++++... +..++||||++++|.+++...+ .+++..++.++.||+.||.+||
T Consensus 61 e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH 135 (339)
T 1z57_A 61 EIQVLEHLNTTDPNSTFRCVQMLEWFEHH-----GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135 (339)
T ss_dssp HHHHHHHHHHHCTTCTTCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhhhcCCCCceeeEeeecccccC-----CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH
Confidence 99999988655 489999988544 5689999999989999998765 6899999999999999999999
Q ss_pred hCCccccCCCCCceEEec-------------------CCCEEEeecccccccCCCCccccccccccccCchhcccCCCCC
Q 017231 161 SANVLHRDLKPSNLLLNA-------------------NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221 (375)
Q Consensus 161 ~~~i~H~di~p~NIli~~-------------------~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 221 (375)
++|++|+||||+||+++. ++.++|+|||.+...... .....+|+.|+|||++.+ ..++
T Consensus 136 ~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~ 212 (339)
T 1z57_A 136 SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA-LGWS 212 (339)
T ss_dssp HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT-SCCC
T ss_pred HCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC-CCCC
Confidence 999999999999999987 678999999998764433 345678999999999987 6789
Q ss_pred ccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc--------------chhHHHhh-hCCCCC
Q 017231 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS--------------DNARRYVR-MLPQFP 286 (375)
Q Consensus 222 ~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--------------~~~~~~~~-~~~~~~ 286 (375)
.++|||||||++|+|++|..||...+.......+....+..+......... ........ ....
T Consensus 213 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 290 (339)
T 1z57_A 213 QPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP-- 290 (339)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC--
T ss_pred cchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc--
Confidence 999999999999999999999999988888888888777665533211110 00001110 0000
Q ss_pred CCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 287 KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 287 ~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
...........++++.++|.+||+.||.+|||+.|+++||||+.+.
T Consensus 291 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 291 LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred hhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence 0001111123467799999999999999999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=352.72 Aligned_cols=264 Identities=26% Similarity=0.399 Sum_probs=204.5
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHh-cCCCCeeeeceeecCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH-MDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~~~~~~~~~~ 112 (375)
...+.++|..+.+.||.|+||+||++.++.+++.||||++... ..+.+|+.++.+ .+||||+++++++....
T Consensus 56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 3445556663458999999999999999999999999998532 345678887754 48999999999885421
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec---CCCEEEee
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGD 186 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~---~~~i~l~D 186 (375)
.....+++||||++ |+|.+++...+ .+++..++.++.||+.||.|||++||+|+||||+||+++. ++.++|+|
T Consensus 129 -~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 129 -AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp -TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred -cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence 12256899999997 59999998754 4999999999999999999999999999999999999988 78899999
Q ss_pred cccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhH----HHHHHHHHhCCC
Q 017231 187 FGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH----QLRLITELIGSP 262 (375)
Q Consensus 187 f~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~ 262 (375)
||++............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+.......
T Consensus 208 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~ 286 (400)
T 1nxk_A 208 FGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286 (400)
T ss_dssp CTTCEECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCC
T ss_pred cccccccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccC
Confidence 999987665555566788999999999977 779999999999999999999999997654321 222222211111
Q ss_pred CcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 263 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
+ ...+..+++++.+||.+||+.||++|||+.++++||||.....
T Consensus 287 ~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 287 P---------------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp C---------------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred C---------------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 1 1123467999999999999999999999999999999986543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=336.66 Aligned_cols=255 Identities=33% Similarity=0.552 Sum_probs=218.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|++|.||++.++.+++.||+|++............+.+|+.++++++||||+++++++... ...++||
T Consensus 26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 100 (287)
T 2wei_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-----SSFYIVG 100 (287)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SEEEEEE
T ss_pred eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-----CeEEEEE
Confidence 59999999999999999999999999999976554445567788999999999999999999998654 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC---CEEEeecccccccCCCCcc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~---~i~l~Df~~~~~~~~~~~~ 199 (375)
|++. ++|.+.+...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~ 180 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc
Confidence 9996 69999998888899999999999999999999999999999999999997644 6999999998776655444
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+.......+.
T Consensus 181 ~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------- 243 (287)
T 2wei_A 181 KDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--------------- 243 (287)
T ss_dssp SCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS---------------
T ss_pred ccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---------------
Confidence 55678999999999876 4889999999999999999999999988776666555442211111
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
..+..+++++.++|.+||+.||++|||+.++++||||++..
T Consensus 244 ------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 244 ------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp ------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred ------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 11245789999999999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=347.96 Aligned_cols=258 Identities=27% Similarity=0.443 Sum_probs=210.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc---cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF---DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++.||+|+||.||++.++.++..||+|++.... ......+.+.+|+.++++++||||+++++++... ...+
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~~ 104 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE-----QYIC 104 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEEE
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC-----CeEE
Confidence 7999999999999999999999999999986532 1334567789999999999999999999999554 5689
Q ss_pred EEEeCCC-CCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 017231 121 IVYELMD-TDLHQIIRS----------------------------------------HQDLTDDHCRYFLYQLLRGLKYV 159 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qi~~al~~L 159 (375)
+||||++ |+|.+++.. ...+++..++.++.||+.||.+|
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999996 699998842 11246788999999999999999
Q ss_pred HhCCccccCCCCCceEEecCC--CEEEeecccccccCCCC-----ccccccccccccCchhcccC-CCCCccchhHHHHH
Q 017231 160 HSANVLHRDLKPSNLLLNANC--DLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGC 231 (375)
Q Consensus 160 h~~~i~H~di~p~NIli~~~~--~i~l~Df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ 231 (375)
|+.|++|+||||+||+++.++ .++|+|||++....... ......+|+.|+|||++.+. ..++.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998776 89999999987543211 23456789999999998642 56789999999999
Q ss_pred HHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCc
Q 017231 232 ILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVF 311 (375)
Q Consensus 232 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~ 311 (375)
++|+|++|..||...+.......+.......+... +..+++++.++|.+||+.
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~li~~~l~~ 317 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN---------------------------YNVLSPLARDLLSNLLNR 317 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGG---------------------------GGGSCHHHHHHHHHHSCS
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcc---------------------------cccCCHHHHHHHHHHcCC
Confidence 99999999999998887777766655332222111 124688999999999999
Q ss_pred CCCCCCCHHHHhcCCCCCCCCC
Q 017231 312 DPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 312 dP~~Rps~~ell~~~~f~~~~~ 333 (375)
||.+||++.++|+||||+++..
T Consensus 318 ~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 318 NVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp CTTTSCCHHHHHHSHHHHTTSS
T ss_pred ChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=347.19 Aligned_cols=264 Identities=24% Similarity=0.369 Sum_probs=211.9
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC--CCCeeeeceeecC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD--HENIIAIKDIIRP 110 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~ 110 (375)
.+..+..+.|++++.||+|+||.||++.+.. ++.||||++............+.+|+.++++++ ||||+++++++..
T Consensus 49 ~~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~ 127 (390)
T 2zmd_A 49 ECISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 127 (390)
T ss_dssp CCEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccccccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec
Confidence 3455556666689999999999999999876 889999999776556667788999999999996 5999999999865
Q ss_pred CCCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 111 PQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
. ..+++|||+.+++|.+++.....+++.+++.++.||+.||.|||+.||+|+||||+||+++ ++.++|+|||++
T Consensus 128 ~-----~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a 201 (390)
T 2zmd_A 128 D-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 201 (390)
T ss_dssp S-----SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred C-----CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCcc
Confidence 4 5589999977789999999988999999999999999999999999999999999999995 689999999999
Q ss_pred cccCCCC---ccccccccccccCchhcccC----------CCCCccchhHHHHHHHHHHhhCCCCCCCCChh-HHHHHHH
Q 017231 191 RTTSETD---FMTEYVVTRWYRAPELLLNC----------SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQLRLIT 256 (375)
Q Consensus 191 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~ 256 (375)
....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...... ..+..+
T Consensus 202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~- 280 (390)
T 2zmd_A 202 NQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI- 280 (390)
T ss_dssp CCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH-
T ss_pred ccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH-
Confidence 7654332 23456789999999998651 35888999999999999999999999765322 222222
Q ss_pred HHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 257 ELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
......... ....++++.++|.+||+.||.+|||+.|+|+||||+...
T Consensus 281 --~~~~~~~~~--------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 281 --IDPNHEIEF--------------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp --HCTTSCCCC--------------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred --hCccccCCC--------------------------CccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 111100000 012367899999999999999999999999999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=341.63 Aligned_cols=296 Identities=28% Similarity=0.488 Sum_probs=233.4
Q ss_pred CCCCCCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCC-cEEEEEEecCcccchHHHH
Q 017231 6 SSGSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETR-EEVAIKKIGNAFDNRIDAK 84 (375)
Q Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~-~~vaiK~~~~~~~~~~~~~ 84 (375)
+..+|+.+...|..+ .++|.+ ++.||+|+||.||++.+..++ ..||+|++... .....
T Consensus 3 ~~~~~~~~~~~g~~~-~~~y~~-----------------~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~ 61 (355)
T 2eu9_A 3 DDKEGHLVCRIGDWL-QERYEI-----------------VGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYRE 61 (355)
T ss_dssp BCTTSCBCCCTTCEE-TTTEEE-----------------EEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHH
T ss_pred cccCCCcccccCcee-cccEEE-----------------EEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchh
Confidence 456788888888888 568884 999999999999999998877 68999998643 23456
Q ss_pred HHHHHHHHHHhcCCCC------eeeeceeecCCCCCCcCcEEEEEeCCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHH
Q 017231 85 RTLREIKLLRHMDHEN------IIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQ--DLTDDHCRYFLYQLLRGL 156 (375)
Q Consensus 85 ~~~~e~~~l~~l~h~~------iv~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~al 156 (375)
.+..|+.++++++|++ ++.+++++... ...++||||++++|.+.+.... .+++..++.++.||+.||
T Consensus 62 ~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L 136 (355)
T 2eu9_A 62 AARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-----GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136 (355)
T ss_dssp HHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-----CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 6788999999987655 78888877543 5689999999999999887654 699999999999999999
Q ss_pred HHHHhCCccccCCCCCceEE-------------------ecCCCEEEeecccccccCCCCccccccccccccCchhcccC
Q 017231 157 KYVHSANVLHRDLKPSNLLL-------------------NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217 (375)
Q Consensus 157 ~~Lh~~~i~H~di~p~NIli-------------------~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 217 (375)
.+||++||+|+||||+||++ +.++.++|+|||++...... .....+|+.|+|||++.+
T Consensus 137 ~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~- 213 (355)
T 2eu9_A 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE- 213 (355)
T ss_dssp HHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT-
T ss_pred HHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec-
Confidence 99999999999999999999 67889999999998764433 345678999999999987
Q ss_pred CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc--------------hhHHHh-hhC
Q 017231 218 SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD--------------NARRYV-RML 282 (375)
Q Consensus 218 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--------------~~~~~~-~~~ 282 (375)
..++.++|||||||++|+|++|..||...+.......+....+..+.......... ....+. ...
T Consensus 214 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (355)
T 2eu9_A 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293 (355)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccC
Confidence 67899999999999999999999999999888888888888777665432111100 000000 000
Q ss_pred CCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 283 ~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
... ..........++++.++|.+||+.||++|||+.|+|+||||+++.
T Consensus 294 ~~~--~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 294 KPL--KSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp CCG--GGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred Ccc--cccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 000 000011112355799999999999999999999999999999874
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=341.75 Aligned_cols=261 Identities=23% Similarity=0.324 Sum_probs=212.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||.||++++..+++.||+|++.... ........+.+|+.++++++||||+++++++..... .....++|
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~~~~~lv 94 (311)
T 3ork_A 16 LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGPLPYIV 94 (311)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TEEEEEEE
T ss_pred EEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CCcccEEE
Confidence 6999999999999999999999999999997653 334455678899999999999999999999865431 11345999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC----
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---- 197 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---- 197 (375)
|||++ ++|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 95 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~ 174 (311)
T 3ork_A 95 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174 (311)
T ss_dssp EECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccc
Confidence 99997 6999999988899999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.......+.
T Consensus 175 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 240 (311)
T 3ork_A 175 QTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS------------- 240 (311)
T ss_dssp -------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH-------------
T ss_pred cccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc-------------
Confidence 2234568999999999987 67899999999999999999999999888766655444332111110
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.....+++++.++|.+||+.||++||++.+++.|+|++....
T Consensus 241 --------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 241 --------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp --------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred --------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 112457899999999999999999999999999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=354.22 Aligned_cols=258 Identities=34% Similarity=0.521 Sum_probs=201.9
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc------chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD------NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
.+.+.+.||+|+||.||+|.++.+++.||+|++..... .......+.+|+.++++++||||+++++++..
T Consensus 136 ~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~---- 211 (419)
T 3i6u_A 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA---- 211 (419)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES----
T ss_pred cEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec----
Confidence 34589999999999999999999999999999865321 11122357899999999999999999999743
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC---CEEEeecccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC---DLKIGDFGLA 190 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~---~i~l~Df~~~ 190 (375)
...++||||++ |+|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 212 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 212 --EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp --SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred --CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 33789999997 69999998888999999999999999999999999999999999999997654 4999999999
Q ss_pred cccCCCCccccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHH-HHHHHHhCCCCcccc
Q 017231 191 RTTSETDFMTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL-RLITELIGSPDETSL 267 (375)
Q Consensus 191 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~ 267 (375)
.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||........+ ..+........
T Consensus 290 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~---- 365 (419)
T 3i6u_A 290 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI---- 365 (419)
T ss_dssp TSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC----
T ss_pred eecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC----
Confidence 87766655566789999999999853 356788999999999999999999999765433222 22222111110
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
...+..+++.+.++|.+||+.||.+|||++++|+||||++.
T Consensus 366 -----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 366 -----------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp -----------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred -----------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 11124578999999999999999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=358.80 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=215.2
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 115 (375)
+..+.+++++.||+|+||.||+++++.+|+.||+|++.+... .......+..|+.++++++||||+++++++...
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~---- 257 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK---- 257 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC----
Confidence 344555589999999999999999999999999999965421 122346788999999999999999999998554
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
..+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.+|.++|+|||++
T Consensus 258 -~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 258 -TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp -SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred -CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence 56899999997 6999998764 36999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh----hHHHHHHHHHhCCCCcc
Q 017231 191 RTTSETDF-MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY----VHQLRLITELIGSPDET 265 (375)
Q Consensus 191 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~~ 265 (375)
........ ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+.......
T Consensus 337 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~--- 412 (543)
T 3c4z_A 337 VELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTY--- 412 (543)
T ss_dssp EECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCC---
T ss_pred eeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCC---
Confidence 76554432 344589999999999988 7899999999999999999999999977532 23333332211110
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH 332 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~ 332 (375)
...+++++.++|.+||+.||++||+ ++++++||||+.++
T Consensus 413 ----------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 413 ----------------------------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp ----------------------------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred ----------------------------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 0356899999999999999999996 58999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=334.11 Aligned_cols=265 Identities=22% Similarity=0.344 Sum_probs=210.7
Q ss_pred eecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 29 NVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 29 ~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
..-...+++....+++++.||+|+||+||++++ ++..||+|++............+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 103 (309)
T 3p86_A 26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103 (309)
T ss_dssp ------CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 444567778888888999999999999999976 478899999987666666677899999999999999999999999
Q ss_pred cCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEecCCCE
Q 017231 109 RPPQRETFNDVYIVYELMD-TDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDL 182 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~---l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NIli~~~~~i 182 (375)
... ..+++||||++ |+|.+++...+. +++..++.++.||+.||.+||+.| ++|+||||+||+++.++.+
T Consensus 104 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~ 178 (309)
T 3p86_A 104 TQP-----PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTV 178 (309)
T ss_dssp CST-----TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCE
T ss_pred EEC-----CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcE
Confidence 654 45799999997 599999987654 999999999999999999999999 9999999999999999999
Q ss_pred EEeecccccccCCCC-ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCC
Q 017231 183 KIGDFGLARTTSETD-FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 261 (375)
Q Consensus 183 ~l~Df~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 261 (375)
+|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+......
T Consensus 179 kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 257 (309)
T 3p86_A 179 KVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR 257 (309)
T ss_dssp EECCCC-----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCC
T ss_pred EECCCCCCccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCC
Confidence 999999986544332 2345678999999999988 67899999999999999999999999888766655544332211
Q ss_pred CCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc--CCCCCC
Q 017231 262 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC--HPYLAP 330 (375)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~--~~~f~~ 330 (375)
.. ....+++++.++|.+||+.||.+|||+.++++ .++++.
T Consensus 258 ~~-----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 258 LE-----------------------------IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CC-----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CC-----------------------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 11357889999999999999999999999998 566654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=333.32 Aligned_cols=252 Identities=27% Similarity=0.442 Sum_probs=187.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.+.||+|++|.||++.+..+++.||+|++..... .......+.+|+.++++++||||+++++++... ...++|
T Consensus 15 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 89 (278)
T 3cok_A 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-----NYVYLV 89 (278)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-----SEEEEE
T ss_pred eeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-----CeEEEE
Confidence 79999999999999999999999999999854321 112246788999999999999999999998654 568999
Q ss_pred EeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cc
Q 017231 123 YELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FM 199 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~ 199 (375)
|||++ ++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 99997 5999999875 569999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...........+..
T Consensus 170 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------------- 226 (278)
T 3cok_A 170 YTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL---------------------- 226 (278)
T ss_dssp -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS----------------------
T ss_pred eeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh----------------------
Confidence 34568999999999887 6789999999999999999999999977654332221100
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.. ......++.++.++|.+||+.||++|||++++++||||....
T Consensus 227 --------~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 227 --------AD-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp --------SC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred --------cc-cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 00 001134688999999999999999999999999999998653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=329.57 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=210.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|++|.||++.++.+++.||+|++..... ....+.+.+|+.+++.++||||+++++++... ...++||
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 84 (276)
T 2yex_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLFL 84 (276)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred EEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEEEEEE
Confidence 69999999999999999999999999999865432 23456788999999999999999999998544 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC---Ccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~---~~~ 199 (375)
||++ ++|.+++.....+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...... ...
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9997 599999988788999999999999999999999999999999999999999999999999998654322 123
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhH-HHHHHHHHhCCCCcccccccccchhHHH
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH-QLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
....+++.|+|||++.+....+.++||||||+++|+|++|..||....... ....+......
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 227 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----------------- 227 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT-----------------
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc-----------------
Confidence 456789999999999874444789999999999999999999997765332 22221110000
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
......+++.+.++|.+||+.||++|||++++++||||+...
T Consensus 228 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 228 ------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp ------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ------------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 001134688999999999999999999999999999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=356.11 Aligned_cols=260 Identities=17% Similarity=0.200 Sum_probs=202.5
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHH---HHHHhcCCCCeeeec-----
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREI---KLLRHMDHENIIAIK----- 105 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~---~~l~~l~h~~iv~~~----- 105 (375)
|....+.+++++.||+|+||+||+|+++.+|+.||||++.... ......+.+.+|+ ..+++++||||++++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 3344455668999999999999999999999999999997542 3344567788999 455555799999998
Q ss_pred --eeecCCCC---------CCc---CcEEEEEeCCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCc
Q 017231 106 --DIIRPPQR---------ETF---NDVYIVYELMDTDLHQIIRSHQDLTD-------DHCRYFLYQLLRGLKYVHSANV 164 (375)
Q Consensus 106 --~~~~~~~~---------~~~---~~~~lv~e~~~g~L~~~l~~~~~l~~-------~~~~~i~~qi~~al~~Lh~~~i 164 (375)
+++..... +.. ...+++|||++|+|.+++...+.+++ ..++.|+.||+.||.|||++||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44332210 000 13789999999999999987655665 8888899999999999999999
Q ss_pred cccCCCCCceEEecCCCEEEeecccccccCCCCccccccccccccCchhcccC----------CCCCccchhHHHHHHHH
Q 017231 165 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC----------SEYTAAIDIWSVGCILG 234 (375)
Q Consensus 165 ~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~Di~slG~il~ 234 (375)
+|+||||+||+++.++.++|+|||++..... ......| +.|+|||++.+. ..++.++|||||||++|
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 9999999999999999999999999875433 2345566 899999999873 17899999999999999
Q ss_pred HHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCC
Q 017231 235 EIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN 314 (375)
Q Consensus 235 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~ 314 (375)
+|++|..||...+...... ........+++++.++|.+||+.||+
T Consensus 305 elltg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 305 WIWCADLPITKDAALGGSE-----------------------------------WIFRSCKNIPQPVRALLEGFLRYPKE 349 (377)
T ss_dssp HHHHSSCCC------CCSG-----------------------------------GGGSSCCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHCCCCCcccccccchh-----------------------------------hhhhhccCCCHHHHHHHHHHcCCCch
Confidence 9999999996543211100 00111246789999999999999999
Q ss_pred CCCCHHHHhcCCCCCCCC
Q 017231 315 RRITVDEALCHPYLAPLH 332 (375)
Q Consensus 315 ~Rps~~ell~~~~f~~~~ 332 (375)
+|||+.++++||||+.+.
T Consensus 350 ~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 350 DRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp GCCCHHHHHTSHHHHHHH
T ss_pred hCCCHHHHhhChHHHHHH
Confidence 999999999999998653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=338.20 Aligned_cols=255 Identities=35% Similarity=0.534 Sum_probs=206.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc------chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD------NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
+++.||+|+||.||++.++.+++.||||++..... .......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------ 87 (322)
T 2ycf_A 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE------ 87 (322)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC------
Confidence 79999999999999999999999999999865421 112234578999999999999999999998543
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC---EEEeeccccccc
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD---LKIGDFGLARTT 193 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~---i~l~Df~~~~~~ 193 (375)
..++||||++ ++|.+++.....+++..++.++.||+.||.+||++|++|+||||+||+++.++. ++|+|||++...
T Consensus 88 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 88 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 2799999997 599999988889999999999999999999999999999999999999987665 999999999776
Q ss_pred CCCCccccccccccccCchhcc--cCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh-HHHHHHHHHhCCCCccccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLL--NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV-HQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~ 270 (375)
..........+++.|+|||++. +...++.++|||||||++|+|++|..||...... .....+........
T Consensus 168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------- 240 (322)
T 2ycf_A 168 GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI------- 240 (322)
T ss_dssp CCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC-------
T ss_pred ccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC-------
Confidence 5554444567899999999974 2356889999999999999999999999765433 22222222111100
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
...+..+++.+.++|.+||+.||++||++.++++||||+..
T Consensus 241 --------------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 241 --------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp --------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred --------------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 01123568899999999999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=340.24 Aligned_cols=276 Identities=32% Similarity=0.535 Sum_probs=217.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CC-----CeeeeceeecCCCCCCcC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HE-----NIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~iv~~~~~~~~~~~~~~~ 117 (375)
+++.||+|+||+||+|.++.+++.||||++... ......+..|+.+++.++ |+ +++++++.+... .
T Consensus 58 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-----~ 129 (382)
T 2vx3_A 58 IDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-----N 129 (382)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-----T
T ss_pred EEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-----C
Confidence 799999999999999999999999999999643 233456778888888885 55 488888888544 5
Q ss_pred cEEEEEeCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceEEe--cCCCEEEeeccccc
Q 017231 118 DVYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVH--SANVLHRDLKPSNLLLN--ANCDLKIGDFGLAR 191 (375)
Q Consensus 118 ~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh--~~~i~H~di~p~NIli~--~~~~i~l~Df~~~~ 191 (375)
..++||||++++|.+++... ..+++..++.++.||+.||.+|| +.||+|+||||+||+++ .++.++|+|||++.
T Consensus 130 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 68999999999999999876 45999999999999999999999 57999999999999994 47789999999987
Q ss_pred ccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 192 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 192 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+....+.++........
T Consensus 210 ~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 286 (382)
T 2vx3_A 210 QLGQR--IYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAP 286 (382)
T ss_dssp ETTCC--CCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCT
T ss_pred ecccc--cccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhH
Confidence 65433 345678999999999988 678999999999999999999999999999989999998888776654432211
Q ss_pred cchhHHHhhhCCCCCC-----------------CCc-----------cccCCC-------CCchHHHHHHHhcCcCCCCC
Q 017231 272 SDNARRYVRMLPQFPK-----------------QNF-----------SARFPN-------KSPGAVDLLEKMLVFDPNRR 316 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~-----------------~~~-----------~~~~~~-------~s~~l~~li~~~L~~dP~~R 316 (375)
....+...++.... ..+ ...... .++++.+||.+||+.||++|
T Consensus 287 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 364 (382)
T 2vx3_A 287 --KARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364 (382)
T ss_dssp --THHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTS
T ss_pred --HHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhC
Confidence 11112221111000 000 000000 01368999999999999999
Q ss_pred CCHHHHhcCCCCCCCC
Q 017231 317 ITVDEALCHPYLAPLH 332 (375)
Q Consensus 317 ps~~ell~~~~f~~~~ 332 (375)
||+.|+|+||||++..
T Consensus 365 pta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 365 IQPYYALQHSFFKKTA 380 (382)
T ss_dssp CCHHHHTTSGGGCC--
T ss_pred CCHHHHhcCcccccCC
Confidence 9999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=329.04 Aligned_cols=247 Identities=23% Similarity=0.312 Sum_probs=204.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|++|.||++.++.+++.||+|++............+.+|+..+..+ +||||+++++++... ...++|
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~~~~lv 89 (289)
T 1x8b_A 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----DHMLIQ 89 (289)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----TEEEEE
T ss_pred hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----CeEEEE
Confidence 79999999999999999999999999999987655556677888999999999 899999999998554 568999
Q ss_pred EeCCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC------------------
Q 017231 123 YELMD-TDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN------------------ 179 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~------------------ 179 (375)
|||++ ++|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99997 5999999765 669999999999999999999999999999999999999844
Q ss_pred -CCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHH
Q 017231 180 -CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL 258 (375)
Q Consensus 180 -~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 258 (375)
..++|+|||.+....... ...+++.|+|||++.+...++.++|||||||++|+|++|..++..... ...+..
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~- 242 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQ- 242 (289)
T ss_dssp CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHT-
T ss_pred ceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHc-
Confidence 479999999987665432 345899999999998745677899999999999999999987754422 111111
Q ss_pred hCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 259 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
+..+ .....+++++.++|.+||+.||++|||+.++++||||++.
T Consensus 243 -~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 243 -GRLP----------------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp -TCCC----------------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred -CCCC----------------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 0000 0113578999999999999999999999999999999964
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=338.96 Aligned_cols=270 Identities=24% Similarity=0.403 Sum_probs=195.0
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHH-HHHhcCCCCeeeeceeecC
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK-LLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~ 110 (375)
.+.|++....+++++.||+|+||.||++.++.+++.||||++....... ....+..|+. +++.++||||+++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK-EQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH-HHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch-HHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 4667777777779999999999999999999999999999997653333 3344555555 7777899999999999865
Q ss_pred CCCCCcCcEEEEEeCCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEE
Q 017231 111 PQRETFNDVYIVYELMDTDLHQIIRS-----HQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKI 184 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~g~L~~~l~~-----~~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l 184 (375)
. +..++||||++++|.+++.. ...+++..++.++.|++.||.+||+. |++|+||||+||+++.++.++|
T Consensus 93 ~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 93 E-----GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp S-----SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred C-----CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 4 56899999999999888864 56799999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCccccccccccccCchhcc---cCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCC
Q 017231 185 GDFGLARTTSETDFMTEYVVTRWYRAPELLL---NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 261 (375)
Q Consensus 185 ~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 261 (375)
+|||.+.............+++.|+|||++. ....++.++|||||||++|+|++|..||....... ..+...
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~--- 242 (327)
T 3aln_A 168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQV--- 242 (327)
T ss_dssp CCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC---
T ss_pred ccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHH---
Confidence 9999997765554444557899999999983 22568899999999999999999999997643210 000000
Q ss_pred CCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 262 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.......-.......+++.+.++|.+||+.||++|||+.++++||||....
T Consensus 243 --------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 243 --------------------VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp --------------------CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred --------------------hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 000000001111245789999999999999999999999999999998654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=336.86 Aligned_cols=272 Identities=24% Similarity=0.374 Sum_probs=191.7
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|.+..+.+++++.||+|++|.||++.+..+++.||+|++..... ......+.+|+.++++++||||+++++++...
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 85 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK--- 85 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESS---
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec---
Confidence 44444445579999999999999999999999999999865422 23456688999999999999999999998654
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEe
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRS--------HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIG 185 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~--------~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~ 185 (375)
...++||||++ ++|.+++.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+
T Consensus 86 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 86 --DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp --SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred --CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEE
Confidence 45899999996 699999874 4569999999999999999999999999999999999999999999999
Q ss_pred ecccccccCCC------CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHh
Q 017231 186 DFGLARTTSET------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELI 259 (375)
Q Consensus 186 Df~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 259 (375)
|||.+...... .......+++.|+|||++.+...++.++||||||+++|+|++|..||..............
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-- 241 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ-- 241 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--
Confidence 99987654322 1123456899999999987545688999999999999999999999987765544332221
Q ss_pred CCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 260 GSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
...+.... ..........+++++.++|.+||+.||.+||++.++++||||++...
T Consensus 242 ~~~~~~~~-------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 242 NDPPSLET-------------------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp SSCCCTTC------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred cCCCcccc-------------------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 11100000 00001122467889999999999999999999999999999997644
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=343.86 Aligned_cols=263 Identities=21% Similarity=0.363 Sum_probs=209.0
Q ss_pred ecccccCCeeeccCCcceEEEEEEeC---CCCcEEEEEEecCccc--chHHHHHHHHHHHHHHhc-CCCCeeeeceeecC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNS---ETREEVAIKKIGNAFD--NRIDAKRTLREIKLLRHM-DHENIIAIKDIIRP 110 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 110 (375)
+....+++++.||+|+||.||++++. .+++.||||++..... .......+..|+.+++++ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34355668999999999999999984 5889999999865321 122334566899999999 69999999999854
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
. ..+++||||++ ++|.+++.....+++..++.++.||+.||.+||++||+|+||||+||+++.++.++|+|||+
T Consensus 131 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 131 E-----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp T-----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred C-----ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 4 56899999997 69999999888899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC--ccccccccccccCchhcccC-CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHH-hCCCCcc
Q 017231 190 ARTTSETD--FMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITEL-IGSPDET 265 (375)
Q Consensus 190 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~~~~ 265 (375)
+....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||...........+... ....+.
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 284 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP- 284 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC-
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC-
Confidence 86543322 23345789999999998752 45788999999999999999999999754322211111111 000000
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
....+++.+.++|.+||+.||.+|| +++++++||||+++.
T Consensus 285 ---------------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 285 ---------------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp ---------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred ---------------------------CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 0134688899999999999999999 999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=333.73 Aligned_cols=256 Identities=24% Similarity=0.400 Sum_probs=204.6
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCC-CCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQR-ETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~-~~~~~~~l 121 (375)
+++.||+|++|.||++.+..+++.||+|++..... ....+.+|+.+++++ +||||+++++++..... .....+++
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 28 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 69999999999999999999999999999865432 235678999999999 79999999999875421 11356899
Q ss_pred EEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-C
Q 017231 122 VYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-D 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~ 197 (375)
||||++ ++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 184 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG 184 (326)
T ss_dssp EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------
T ss_pred EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc
Confidence 999997 5999999865 46999999999999999999999999999999999999999999999999998765432 2
Q ss_pred ccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 198 FMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
......+++.|+|||++.. ...++.++|||||||++|+|++|..||...+.......+...... .
T Consensus 185 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~--------- 253 (326)
T 2x7f_A 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP--R--------- 253 (326)
T ss_dssp ------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--C---------
T ss_pred ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc--c---------
Confidence 2344578999999999862 256889999999999999999999999887765554443321110 0
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.....+++.+.++|.+||..||.+||++.++++||||+..
T Consensus 254 ------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 254 ------------------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp ------------------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred ------------------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 0113568899999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=329.51 Aligned_cols=254 Identities=29% Similarity=0.427 Sum_probs=213.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|++|.||++.++.+++.||+|++..........+.+.+|+.++++++||||+++++++.... ...+++||
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~~~lv~ 86 (279)
T 2w5a_A 10 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTTLYIVM 86 (279)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---GTEEEEEE
T ss_pred eehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---CceEEEEE
Confidence 699999999999999999999999999999776556666788999999999999999999999875432 25689999
Q ss_pred eCCC-CCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 124 ELMD-TDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYVHSAN-----VLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 124 e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qi~~al~~Lh~~~-----i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
||++ ++|.+++... ..+++..++.++.||+.||.+||+.| ++|+||+|+||+++.++.++|+|||.+...
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~ 166 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 166 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheee
Confidence 9997 5999999753 34999999999999999999999999 999999999999999999999999998665
Q ss_pred CCCC-ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 194 SETD-FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 194 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
.... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.......
T Consensus 167 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---------- 235 (279)
T 2w5a_A 167 NHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---------- 235 (279)
T ss_dssp ---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC----------
T ss_pred ccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc----------
Confidence 4332 2234567899999999987 678999999999999999999999998887665555544421110
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
....+++++.++|.+||+.||++||++.+|++|+|+..-
T Consensus 236 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 236 --------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred --------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 012468899999999999999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=342.77 Aligned_cols=287 Identities=21% Similarity=0.321 Sum_probs=217.3
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 115 (375)
++....+++++.||+|+||.||++.+..++..||+|++.... .......+.+|+.++++++||||+++++++...
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 103 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD---- 103 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET----
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC----
Confidence 344455557999999999999999999999999999987653 344567789999999999999999999998654
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
...++||||++ ++|.+++...+.+++..++.++.||+.||.+||+. |++|+||||+||+++.++.++|+|||++...
T Consensus 104 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 104 -GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp -TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred -CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 56899999997 59999999888999999999999999999999986 9999999999999999999999999988543
Q ss_pred CCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcc-ccc----
Q 017231 194 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET-SLG---- 268 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~---- 268 (375)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+.......... ...
T Consensus 183 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 183 IDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp HHH-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ccc-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 222 2234578999999999987 678999999999999999999999998877555433322111100000 000
Q ss_pred ----------ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 269 ----------FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 269 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.................. ........+++++.+||.+||+.||++|||+.++|+||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp -------------CCCHHHHHHHHHHSC--CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccC--CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 000000000000000000 00111134688999999999999999999999999999999754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=330.03 Aligned_cols=256 Identities=27% Similarity=0.352 Sum_probs=206.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||.||++++..++..||+|++.... ........+.+|+.++++++||||+++++++... +.+++|
T Consensus 15 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv 89 (294)
T 4eqm_A 15 IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-----DCYYLV 89 (294)
T ss_dssp EEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-----SEEEEE
T ss_pred EEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-----CeEEEE
Confidence 5999999999999999999999999999986543 3445567889999999999999999999998544 668999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--cc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FM 199 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--~~ 199 (375)
|||++ ++|.+++...+.+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++....... ..
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 169 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence 99997 5999999988899999999999999999999999999999999999999999999999999987654432 22
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+............ ...+..
T Consensus 170 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~~-------------- 232 (294)
T 4eqm_A 170 NHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ--DSVPNV-------------- 232 (294)
T ss_dssp -----CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS--SCCCCH--------------
T ss_pred CccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh--ccCCCc--------------
Confidence 34568999999999988 6789999999999999999999999988765444322221 111110
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.....+.+++.+.++|.+||+.||.+||+..+.+.+.|..-+
T Consensus 233 ----------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 233 ----------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ----------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ----------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 011124678999999999999999999966666666555433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=338.50 Aligned_cols=273 Identities=18% Similarity=0.263 Sum_probs=207.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||+|+++.+++.||||++..... ....+.+.+|+.++++++||||+++++++..... ...++||
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~lv~ 88 (319)
T 4euu_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---RHKVLIM 88 (319)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCEEEEE
T ss_pred EEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC---ceEEEEE
Confidence 69999999999999999999999999999865432 2235667899999999999999999999865432 4689999
Q ss_pred eCCC-CCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----ecCCCEEEeecccccccCC
Q 017231 124 ELMD-TDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~---l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli----~~~~~i~l~Df~~~~~~~~ 195 (375)
||++ ++|.+++..... +++..++.++.||+.||.+||+.|++|+||||+||++ +.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~ 168 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCT
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCC
Confidence 9997 699999976543 9999999999999999999999999999999999999 7777899999999987766
Q ss_pred CCccccccccccccCchhccc-------CCCCCccchhHHHHHHHHHHhhCCCCCCCCCh----hHHHHHHHHHhCCCCc
Q 017231 196 TDFMTEYVVTRWYRAPELLLN-------CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY----VHQLRLITELIGSPDE 264 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~i~~~~~~~~~ 264 (375)
........+|+.|+|||++.. ...++.++|||||||++|+|++|..||..... ...+..+.... +.
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---p~ 245 (319)
T 4euu_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK---PS 245 (319)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC---CT
T ss_pred CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC---Cc
Confidence 655566778999999999862 26788999999999999999999999965432 23333333221 11
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCC
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~ 326 (375)
............. .......+ ........+++.+.++|.+||+.||++|||++|+|+||
T Consensus 246 ~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 246 GAISGVQKAENGP-IDWSGDMP--VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp TCCEEEECSTTCC-EEEESSCC--TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred ccchhhhcccCCc-cccCccCC--cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 1111100000000 00000000 00011123456789999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=329.32 Aligned_cols=254 Identities=25% Similarity=0.395 Sum_probs=206.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|++|.||++.++.+++.||+|++... .......+..|+.+++.++||||+++++++... ...++||
T Consensus 23 i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 95 (302)
T 2j7t_A 23 IVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKLWIMI 95 (302)
T ss_dssp EEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEEEEE
T ss_pred ecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeEEEEE
Confidence 799999999999999999999999999998654 223456788999999999999999999998654 5689999
Q ss_pred eCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cccc
Q 017231 124 ELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFMT 200 (375)
Q Consensus 124 e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~~ 200 (375)
||++ ++|.+++.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (302)
T 2j7t_A 96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175 (302)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC--
T ss_pred EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccc
Confidence 9997 589888865 466999999999999999999999999999999999999999999999999986432111 1123
Q ss_pred cccccccccCchhcc----cCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 201 EYVVTRWYRAPELLL----NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~----~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
...++..|+|||++. ....++.++||||||+++|+|++|..||...+.......+........
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------- 242 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL------------- 242 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-------------
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-------------
Confidence 456789999999984 236688999999999999999999999988776655544433211100
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.....++..+.++|.+||+.||.+|||+.++++||||+.+.
T Consensus 243 ---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 243 ---------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp ---------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ---------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 00124578899999999999999999999999999999764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=329.28 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=212.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|++|.||++.+..+++.||+|++..... ......+.+|+.++++++||||+++++++... ...++||
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 99 (303)
T 3a7i_A 26 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWIIM 99 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred HhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEEE
Confidence 69999999999999999999999999999865432 23467788999999999999999999998654 5689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
||++ ++|.+++.. +.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 9997 599998865 569999999999999999999999999999999999999999999999999986654432 2345
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+..... +
T Consensus 179 ~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~------------------ 237 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP--P------------------ 237 (303)
T ss_dssp CCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--C------------------
T ss_pred cCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC--C------------------
Confidence 578999999999987 6788999999999999999999999988766555444332110 0
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.....+++.+.++|.+||+.||.+|||+.++++||||...
T Consensus 238 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 238 ----------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ----------CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ----------CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0113568889999999999999999999999999999753
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=331.76 Aligned_cols=263 Identities=20% Similarity=0.276 Sum_probs=196.3
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
+.-..+++++.||+|+||.||++.++.+++.||||++............+..+..+++.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~----- 96 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN----- 96 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----
Confidence 344555589999999999999999999999999999976644444445555666678888999999999999654
Q ss_pred CcEEEEEeCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 117 NDVYIVYELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSA-NVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 117 ~~~~lv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~-~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
...++||||+++.+..+... ...+++..++.++.||+.||.+||+. |++|+||+|+||+++.++.++|+|||.+....
T Consensus 97 ~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 97 TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp SEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 56899999997666666654 46799999999999999999999995 99999999999999999999999999987665
Q ss_pred CCCccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCC-hhHHHHHHHHHhCCCCcccccc
Q 017231 195 ETDFMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
.........+++.|+|||++.+ ...++.++||||||+++|+|++|..||.... .......+.......
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 249 (318)
T 2dyl_A 177 DDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL------- 249 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC-------
T ss_pred CCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC-------
Confidence 5544455678999999999852 2567889999999999999999999998643 333333332211100
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
......+++++.++|.+||+.||.+||++.++++||||+...
T Consensus 250 ---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 250 ---------------------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp ---------------------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred ---------------------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 001135688999999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=336.49 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=214.3
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEE-----eCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeec
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAM-----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIK 105 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 105 (375)
...|++..+.+++++.||+|+||.||+++ +..+++.||||++.... .....+.+.+|+.++.++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 46788888888899999999999999998 66778999999996542 334567789999999999 799999999
Q ss_pred eeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCC---------------------------------------------
Q 017231 106 DIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--------------------------------------------- 139 (375)
Q Consensus 106 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--------------------------------------------- 139 (375)
+++.... ..+++||||++ |+|.+++.....
T Consensus 93 ~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (359)
T 3vhe_A 93 GACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168 (359)
T ss_dssp EEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred eeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence 9986543 44799999997 599999986543
Q ss_pred ---------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 140 ---------------------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 140 ---------------------l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 8999999999999999999999999999999999999999999999999987653332
Q ss_pred --ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 198 --FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+...................
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~---------- 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---------- 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC----------
T ss_pred chhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC----------
Confidence 2234567888999999987 778999999999999999998 99999887654444333332211110
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+++++.++|.+||+.||++|||+.++++|
T Consensus 318 -------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 318 -------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 12468899999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=329.87 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=209.0
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
..+.+++++.||+|++|.||++.++.+|+.||+|++.... ....+.+|+.++++++||||+++++++... +
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----T 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----C
Confidence 3444558999999999999999999999999999986542 235678999999999999999999998654 5
Q ss_pred cEEEEEeCCC-CCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 118 DVYIVYELMD-TDLHQIIR-SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~-~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
..++||||++ ++|.+++. ....+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 6899999997 59999987 456799999999999999999999999999999999999999999999999999865443
Q ss_pred C-CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 196 T-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 196 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
. .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+........
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------- 245 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF----------- 245 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-----------
T ss_pred hccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCccc-----------
Confidence 3 22344568999999999987 6789999999999999999999999987765544433322111000
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.....+++.+.++|.+||+.||.+|||+.++++||||+....
T Consensus 246 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 246 -----------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp -----------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred -----------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 001235788999999999999999999999999999997643
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=345.40 Aligned_cols=267 Identities=16% Similarity=0.151 Sum_probs=192.8
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhc--CCCCeeeecee-------ecCC
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHM--DHENIIAIKDI-------IRPP 111 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~-------~~~~ 111 (375)
+++++.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.+++.+ +|||+++++.. +...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 4489999999999999999999999999999977543 344556677885544444 69998875533 3221
Q ss_pred CCC------------CcCcEEEEEeCCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhCCccccCCCCC
Q 017231 112 QRE------------TFNDVYIVYELMDTDLHQIIRSH-QDLTDDHC------RYFLYQLLRGLKYVHSANVLHRDLKPS 172 (375)
Q Consensus 112 ~~~------------~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~------~~i~~qi~~al~~Lh~~~i~H~di~p~ 172 (375)
... ....+++||||++|+|.+++... ..++...+ ..++.||+.||.|||++||+|+||||+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~ 223 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPD 223 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHH
Confidence 110 01448999999999999999864 34555555 677899999999999999999999999
Q ss_pred ceEEecCCCEEEeecccccccCCCCccccccccccccCchhccc-CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH
Q 017231 173 NLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLN-CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ 251 (375)
Q Consensus 173 NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 251 (375)
||+++.++.++|+|||++...... .....+++.|+|||++.+ ...++.++|||||||++|+|++|..||........
T Consensus 224 NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~ 301 (371)
T 3q60_A 224 NLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301 (371)
T ss_dssp GEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT
T ss_pred HEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc
Confidence 999999999999999999765433 224556799999999864 24689999999999999999999999976532100
Q ss_pred HHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 252 LRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 252 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
. .... . ...............+.+++.+.++|.+||+.||++|||+.++|+||||+++
T Consensus 302 ~-------------~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 302 G-------------SWKR---P------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp T-------------CCCB---C------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred c-------------chhh---h------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 0 0000 0 0000000011112234789999999999999999999999999999999875
Q ss_pred C
Q 017231 332 H 332 (375)
Q Consensus 332 ~ 332 (375)
.
T Consensus 360 ~ 360 (371)
T 3q60_A 360 Q 360 (371)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=320.93 Aligned_cols=253 Identities=19% Similarity=0.326 Sum_probs=210.6
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..|.+..+.+++++.||+|+||.||++.+.. +..||+|++...... .+.+.+|+.++++++||||+++++++...
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 77 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ- 77 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 4577777788899999999999999999874 678999999765333 35688999999999999999999998654
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
...++||||++ ++|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++
T Consensus 78 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 78 ----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp ----SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred ----CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccc
Confidence 55899999997 5999999764 45999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCC--ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 191 RTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 191 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 228 (269)
T 4hcu_A 154 RFVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---- 228 (269)
T ss_dssp GGBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC----
T ss_pred ccccccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC----
Confidence 7654332 1223455778999999987 678999999999999999999 9999998877666655543211110
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+++.+.++|.+||+.||++|||+.+++++
T Consensus 229 --------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 229 --------------------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp --------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 12358889999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=334.93 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=212.6
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeC-------CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeee
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNS-------ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAI 104 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 104 (375)
..|++..+.+++++.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+++++ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 456777788889999999999999999864 356689999997652 344567889999999999 89999999
Q ss_pred ceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 017231 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHR 167 (375)
Q Consensus 105 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~ 167 (375)
++++... +.+++||||++ |+|.+++.... .+++.+++.++.||+.||.|||++||+|+
T Consensus 153 ~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr 227 (370)
T 2psq_A 153 LGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 227 (370)
T ss_dssp EEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred EEEEccC-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 9998654 55899999997 69999998653 48999999999999999999999999999
Q ss_pred CCCCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCC
Q 017231 168 DLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLF 243 (375)
Q Consensus 168 di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf 243 (375)
||||+||+++.++.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |..||
T Consensus 228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~ 306 (370)
T 2psq_A 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY 306 (370)
T ss_dssp CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999987544332 1233456788999999987 779999999999999999999 99999
Q ss_pred CCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHh
Q 017231 244 PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323 (375)
Q Consensus 244 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell 323 (375)
...+.......+...... .....+++++.++|.+||+.||.+||++.|++
T Consensus 307 ~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell 356 (370)
T 2psq_A 307 PGIPVEELFKLLKEGHRM------------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLV 356 (370)
T ss_dssp TTCCGGGHHHHHHTTCCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHhcCCCC------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 887766655544332110 00134688999999999999999999999998
Q ss_pred cC
Q 017231 324 CH 325 (375)
Q Consensus 324 ~~ 325 (375)
++
T Consensus 357 ~~ 358 (370)
T 2psq_A 357 ED 358 (370)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=331.79 Aligned_cols=267 Identities=22% Similarity=0.335 Sum_probs=197.1
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCc---EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETRE---EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
.+.+....+++++.||+|+||.||+|+++.++. .||+|++..........+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 344555556689999999999999999888775 89999997665555567889999999999999999999999876
Q ss_pred CCCC-CcCcEEEEEeCCC-CCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCE
Q 017231 111 PQRE-TFNDVYIVYELMD-TDLHQIIRSHQ------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 182 (375)
Q Consensus 111 ~~~~-~~~~~~lv~e~~~-g~L~~~l~~~~------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i 182 (375)
.... .....++||||+. |+|.+++.... .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 5321 1123589999997 59999986543 59999999999999999999999999999999999999999999
Q ss_pred EEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHH
Q 017231 183 KIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITEL 258 (375)
Q Consensus 183 ~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~ 258 (375)
+|+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||...+.......+...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence 9999999876544322 223445778999999987 678999999999999999999 99999887766665554332
Q ss_pred hCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-------HHHHhcCCCCCCC
Q 017231 259 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-------VDEALCHPYLAPL 331 (375)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-------~~ell~~~~f~~~ 331 (375)
.... ..+.+++++.++|.+||+.||++||| +++++.|+|+...
T Consensus 256 ~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 256 NRLK------------------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp CCCC------------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred CCCC------------------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 1110 11356889999999999999999999 7888899999964
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=326.99 Aligned_cols=268 Identities=24% Similarity=0.360 Sum_probs=211.5
Q ss_pred eecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC--CCCeeeece
Q 017231 29 NVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD--HENIIAIKD 106 (375)
Q Consensus 29 ~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~ 106 (375)
+.+.+...+..+.+++++.||+|+||.||++.+.. ++.||+|++............+.+|+.++++++ |+||+++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 34456677777777799999999999999999864 889999999766556667788999999999997 599999999
Q ss_pred eecCCCCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEee
Q 017231 107 IIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 186 (375)
Q Consensus 107 ~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~D 186 (375)
++... ...+++||+.+++|.+++.....+++..++.++.||+.||.+||+.|++|+||+|+||+++ ++.++|+|
T Consensus 96 ~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~D 169 (313)
T 3cek_A 96 YEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLID 169 (313)
T ss_dssp EEECS-----SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECC
T ss_pred EeecC-----CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEee
Confidence 98654 5689999977789999999988999999999999999999999999999999999999996 58999999
Q ss_pred cccccccCCCC---ccccccccccccCchhcccC----------CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHH
Q 017231 187 FGLARTTSETD---FMTEYVVTRWYRAPELLLNC----------SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLR 253 (375)
Q Consensus 187 f~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 253 (375)
||++....... ......+++.|+|||++.+. ..++.++||||||+++|+|++|..||....... .
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~ 247 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--S 247 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH--H
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH--H
Confidence 99987654332 12345689999999998651 357889999999999999999999997653221 1
Q ss_pred HHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 254 LITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.+.......... ......++++.++|.+||+.||.+||++.++++||||+..
T Consensus 248 ~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 248 KLHAIIDPNHEI--------------------------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHHCTTSCC--------------------------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHHhccccc--------------------------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 111111110000 0012347789999999999999999999999999999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=324.60 Aligned_cols=260 Identities=25% Similarity=0.349 Sum_probs=215.2
Q ss_pred ecceeeeecccccCCeeeccCCcceEEEEEEe-----CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeee
Q 017231 30 VYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMN-----SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIA 103 (375)
Q Consensus 30 ~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 103 (375)
++...|++....+++++.||+|+||.||++.+ ..+++.||+|++.... .....+.+.+|+.+++++ +||||++
T Consensus 13 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~ 91 (313)
T 1t46_A 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVN 91 (313)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeee
Confidence 35567888888888999999999999999984 5678899999997543 334567789999999999 8999999
Q ss_pred eceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 017231 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ------------------DLTDDHCRYFLYQLLRGLKYVHSANV 164 (375)
Q Consensus 104 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------------~l~~~~~~~i~~qi~~al~~Lh~~~i 164 (375)
+++++... ...++||||++ |+|.+++.... .+++..++.++.||+.||.+||++|+
T Consensus 92 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 166 (313)
T 1t46_A 92 LLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166 (313)
T ss_dssp EEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 99999654 45799999997 59999998754 48999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CC
Q 017231 165 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQ 240 (375)
Q Consensus 165 ~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~ 240 (375)
+|+||||+||+++.++.++|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |.
T Consensus 167 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~ 245 (313)
T 1t46_A 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGS 245 (313)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred ecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999876554422 233456788999999987 678999999999999999998 99
Q ss_pred CCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHH
Q 017231 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD 320 (375)
Q Consensus 241 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ 320 (375)
.||.................... ....+++.+.++|.+||+.||.+|||+.
T Consensus 246 ~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ 296 (313)
T 1t46_A 246 SPYPGMPVDSKFYKMIKEGFRML-----------------------------SPEHAPAEMYDIMKTCWDADPLKRPTFK 296 (313)
T ss_dssp CSSTTCCSSHHHHHHHHHTCCCC-----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCcccchhHHHHHhccCCCCC-----------------------------CcccCCHHHHHHHHHHcCCCchhCcCHH
Confidence 99987765444443333211110 0134688999999999999999999999
Q ss_pred HHhcC
Q 017231 321 EALCH 325 (375)
Q Consensus 321 ell~~ 325 (375)
+++++
T Consensus 297 ell~~ 301 (313)
T 1t46_A 297 QIVQL 301 (313)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99874
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=321.07 Aligned_cols=248 Identities=23% Similarity=0.375 Sum_probs=202.3
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.+.+.+.||+|+||.||++.++.+++.||+|.+... .......+.+|+.++++++||||+++++++... ...+
T Consensus 11 ~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 83 (310)
T 3s95_A 11 DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN 83 (310)
T ss_dssp GEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred HeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence 333799999999999999999999999999988543 455667899999999999999999999998654 5689
Q ss_pred EEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 121 IVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
+||||++ |+|.+++.. ...+++.+++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+........
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999997 599999987 56799999999999999999999999999999999999999999999999999876543321
Q ss_pred c---------------ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 199 M---------------TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 199 ~---------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
. ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~----------- 231 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD----------- 231 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT-----------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH-----------
Confidence 1 14568999999999988 77899999999999999999999998654211100
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
. ........... ..+.+++.+.++|.+||+.||++|||+.++++
T Consensus 232 ------~-~~~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 232 ------F-GLNVRGFLDRY----------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp ------S-SBCHHHHHHHT----------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------H-hhhhhcccccc----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 00000000000 01357889999999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=320.45 Aligned_cols=254 Identities=27% Similarity=0.422 Sum_probs=203.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
....||+|++|.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++++... +..++||
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~ 98 (295)
T 2clq_A 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIKIFM 98 (295)
T ss_dssp SBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred CcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEEEEE
Confidence 466899999999999999999999999998654 233456788999999999999999999998544 5689999
Q ss_pred eCCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-CCCEEEeecccccccCCCC-
Q 017231 124 ELMD-TDLHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-~~~i~l~Df~~~~~~~~~~- 197 (375)
||++ ++|.+++.... .+++..++.++.||+.||.+||+.|++|+||+|+||+++. ++.++|+|||.+.......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9997 69999997652 4679999999999999999999999999999999999988 8999999999987654322
Q ss_pred ccccccccccccCchhcccC-CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 198 FMTEYVVTRWYRAPELLLNC-SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
......+++.|+|||++.+. ..++.++||||||+++|+|++|..||...................+.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------ 246 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPE------------ 246 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCC------------
T ss_pred cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccc------------
Confidence 23455789999999998752 23789999999999999999999999754432221111111111100
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
....+++++.++|.+||+.||++||++.++++||||+...
T Consensus 247 ----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 247 ----------------IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp ----------------CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred ----------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 0135688999999999999999999999999999999654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=334.72 Aligned_cols=269 Identities=23% Similarity=0.349 Sum_probs=183.6
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 115 (375)
.+.++|..+.+.||+|+||.||++.++.+++.||+|++.... .........++.+.|||++++++++.... ..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~ 97 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMH-HG 97 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CC
Confidence 334444424567999999999999999999999999985431 11222333456678999999999986532 12
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC---CCEEEeeccc
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN---CDLKIGDFGL 189 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~---~~i~l~Df~~ 189 (375)
...+++||||++ |+|.+++.... .+++..++.++.||+.||.+||++|++|+||||+||+++.+ +.++|+|||+
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 255899999997 59999998764 59999999999999999999999999999999999999764 4599999999
Q ss_pred ccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 190 ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
+...... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||..................
T Consensus 178 ~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 247 (336)
T 3fhr_A 178 AKETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-------- 247 (336)
T ss_dssp CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred ceecccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc--------
Confidence 8765433 2345677999999999876 67889999999999999999999999765433221111110000
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
.........+..+++++.++|.+||+.||.+|||+.++++||||+.......
T Consensus 248 ---------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 299 (336)
T 3fhr_A 248 ---------------GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299 (336)
T ss_dssp ------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred ---------------cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence 0000011223467999999999999999999999999999999997644333
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=327.30 Aligned_cols=253 Identities=22% Similarity=0.327 Sum_probs=207.9
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCc---EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETRE---EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
.++....+++.+.||+|+||.||++.++.++. .||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 34555666689999999999999999986555 49999996543 344567789999999999999999999998544
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
...++||||++ |+|.+++... ..+++..++.++.||+.||.+||+.||+|+||||+||+++.++.++|+|||+
T Consensus 123 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 123 -----RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp -----GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred -----CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 55799999996 5999999765 5799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 190 ARTTSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 190 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
+........ .....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+.......
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~-- 274 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP-- 274 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC--
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC--
Confidence 876544321 122344678999999987 678999999999999999999 999998887766665554321111
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++.+.++|.+||+.||.+|||+.++++
T Consensus 275 ----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 ----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01356889999999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=335.02 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=212.5
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEE-----eCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeecee
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAM-----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 107 (375)
...++..+.+++++.||+|+||.||+|+ +..++..||||++.... .......+.+|+.++++++||||++++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4456777778899999999999999999 45677899999986542 33445678899999999999999999999
Q ss_pred ecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC
Q 017231 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 179 (375)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~ 179 (375)
+... ...++||||++ |+|.+++.... .+++.+++.++.||+.||.+||++||+||||||+||+++.+
T Consensus 143 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 217 (367)
T 3l9p_A 143 SLQS-----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP 217 (367)
T ss_dssp ECSS-----SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred EecC-----CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecC
Confidence 8654 45699999996 69999997653 49999999999999999999999999999999999999965
Q ss_pred C---CEEEeecccccccCC---CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHH
Q 017231 180 C---DLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQL 252 (375)
Q Consensus 180 ~---~i~l~Df~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 252 (375)
+ .++|+|||++..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||...+.....
T Consensus 218 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~ 296 (367)
T 3l9p_A 218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296 (367)
T ss_dssp STTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred CCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 5 499999999864321 122334567889999999987 679999999999999999998 99999988776666
Q ss_pred HHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 253 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
..+........ ...+++.+.++|.+||+.||.+|||+.+|+++.++.
T Consensus 297 ~~i~~~~~~~~------------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 297 EFVTSGGRMDP------------------------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHTTCCCCC------------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCC------------------------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 55543221110 135688899999999999999999999999986654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=323.66 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=198.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC--------CCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ--------RET 115 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--------~~~ 115 (375)
+++.||+|+||.||+|++..+++.||+|++.. .......+.+|+.++++++||||+++++++.... ...
T Consensus 10 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (303)
T 1zy4_A 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86 (303)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred hhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence 79999999999999999999999999999854 2344567889999999999999999999875431 122
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
....++||||++ ++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 166 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCT
T ss_pred CCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhc
Confidence 366899999997 59999998654 5889999999999999999999999999999999999999999999999998765
Q ss_pred CCC---------------CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC-hhHHHHHHHH
Q 017231 194 SET---------------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITE 257 (375)
Q Consensus 194 ~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~ 257 (375)
... .......+++.|+|||++.+...++.++|||||||++|+|++ ||.... .......+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~ 243 (303)
T 1zy4_A 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS 243 (303)
T ss_dssp TC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHS
T ss_pred ccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccc
Confidence 422 122345678999999999875578999999999999999998 453321 1222222211
Q ss_pred HhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 258 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.....+. ......++.+.++|.+||+.||.+|||+.++++||||+..
T Consensus 244 ~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 244 VSIEFPP---------------------------DFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp TTCCCCT---------------------------TCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred cccccCc---------------------------cccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 1111000 0113457789999999999999999999999999999853
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=320.09 Aligned_cols=253 Identities=20% Similarity=0.324 Sum_probs=207.9
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..|++..+.+++++.||+|+||.||++.+. ++..||+|++...... ...+.+|+.++++++||||+++++++...
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 91 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ- 91 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEEecC-
Confidence 456677777778999999999999999876 5678999999764333 35678999999999999999999999554
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
...++||||++ ++|.+++.. ...+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+
T Consensus 92 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 92 ----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp ----SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred ----CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccc
Confidence 56899999996 699999976 467999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 191 RTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 191 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.......+........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---- 242 (283)
T 3gen_A 168 RYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---- 242 (283)
T ss_dssp GGBCCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC----
T ss_pred ccccccccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC----
Confidence 76543321 223345778999999987 678999999999999999998 9999988876666655544221111
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....++.+.++|.+||+.||.+|||+.+++++
T Consensus 243 --------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 243 --------------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp --------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 12457889999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=335.20 Aligned_cols=271 Identities=24% Similarity=0.344 Sum_probs=211.0
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchH---------------HHHHHHHHHHHHHhcCCCCeeeec
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRI---------------DAKRTLREIKLLRHMDHENIIAIK 105 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---------------~~~~~~~e~~~l~~l~h~~iv~~~ 105 (375)
.+++++.||+|++|.||++.+ +++.||+|++........ ....+.+|+.++++++||||++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred ceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 344799999999999999998 889999999864321111 126788999999999999999999
Q ss_pred eeecCCCCCCcCcEEEEEeCCCC-CHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceE
Q 017231 106 DIIRPPQRETFNDVYIVYELMDT-DLHQI------IRS--HQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLL 175 (375)
Q Consensus 106 ~~~~~~~~~~~~~~~lv~e~~~g-~L~~~------l~~--~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIl 175 (375)
+++... ...++||||+++ +|.++ +.. ...+++..++.++.||+.||.+||+ .|++|+||+|+||+
T Consensus 110 ~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 110 GIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp EEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred EEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 998654 568999999974 99988 655 5679999999999999999999999 99999999999999
Q ss_pred EecCCCEEEeecccccccCCCCccccccccccccCchhcccCCCCCc-cchhHHHHHHHHHHhhCCCCCCCCCh-hHHHH
Q 017231 176 LNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA-AIDIWSVGCILGEIMTRQPLFPGKDY-VHQLR 253 (375)
Q Consensus 176 i~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~ 253 (375)
++.++.++|+|||.+...... ......++..|+|||++.+...++. ++|||||||++|+|++|..||..... .....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred EcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 999999999999998765443 3445678999999999987435655 99999999999999999999987765 44444
Q ss_pred HHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 254 LITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 254 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.+.......+....... ..............+++++.++|.+||+.||.+|||+.|+++||||++.
T Consensus 264 ~i~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 264 NIRTKNIEYPLDRNHFL------------YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHTSCCCCCCCSSSSST------------TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHhccCcCCccchhhhh------------ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 43322111111100000 0000011111224678999999999999999999999999999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.19 Aligned_cols=256 Identities=24% Similarity=0.374 Sum_probs=212.9
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEe-----CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeecee
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMN-----SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 107 (375)
..|++..+.+.+.+.||+|+||.||++.+ +.++..||+|++.... .......+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 45677777777999999999999999987 3456889999987543 34456778999999999999999999999
Q ss_pred ecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHhC
Q 017231 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD------------------------LTDDHCRYFLYQLLRGLKYVHSA 162 (375)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~------------------------l~~~~~~~i~~qi~~al~~Lh~~ 162 (375)
+... ...++||||++ ++|.+++..... +++..++.++.||+.||.+||++
T Consensus 95 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 169 (314)
T 2ivs_A 95 CSQD-----GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM 169 (314)
T ss_dssp ECSS-----SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT
T ss_pred EecC-----CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 8654 55899999997 699999987543 89999999999999999999999
Q ss_pred CccccCCCCCceEEecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-
Q 017231 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT- 238 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~- 238 (375)
|++|+||||+||+++.++.++|+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTT
T ss_pred CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999875543321 223456788999999987 678999999999999999999
Q ss_pred CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC
Q 017231 239 RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 318 (375)
Q Consensus 239 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 318 (375)
|..||...........+...... .....+++++.++|.+||+.||++||+
T Consensus 249 g~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps 298 (314)
T 2ivs_A 249 GGNPYPGIPPERLFNLLKTGHRM------------------------------ERPDNCSEEMYRLMLQCWKQEPDKRPV 298 (314)
T ss_dssp SCCSSTTCCGGGHHHHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCCCHHHHHHHhhcCCcC------------------------------CCCccCCHHHHHHHHHHccCChhhCcC
Confidence 99999887766655444331110 011356889999999999999999999
Q ss_pred HHHHhcC
Q 017231 319 VDEALCH 325 (375)
Q Consensus 319 ~~ell~~ 325 (375)
+.+++++
T Consensus 299 ~~~l~~~ 305 (314)
T 2ivs_A 299 FADISKD 305 (314)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=332.30 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=215.3
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCC-------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeee
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE-------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIA 103 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 103 (375)
...|++..+.+.+.+.||+|+||.||+|++.. .+..||+|++... ........+.+|+.+++++ +||||++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 35678888888899999999999999999653 3457999998765 3444567889999999999 8999999
Q ss_pred eceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 017231 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLH 166 (375)
Q Consensus 104 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H 166 (375)
+++++... +..++||||++ |+|.+++.... .+++..++.++.||+.||.+||+.|++|
T Consensus 140 ~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 214 (382)
T 3tt0_A 140 LLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 214 (382)
T ss_dssp EEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred heeeeccC-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 99999654 55799999997 59999998754 4999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCC
Q 017231 167 RDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPL 242 (375)
Q Consensus 167 ~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p 242 (375)
+||||+||+++.++.++|+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..|
T Consensus 215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p 293 (382)
T 3tt0_A 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSP 293 (382)
T ss_dssp SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999997654432 2233456788999999987 778999999999999999999 9999
Q ss_pred CCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHH
Q 017231 243 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 322 (375)
Q Consensus 243 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~el 322 (375)
|...+.......+....... ....+++++.++|.+||+.||++|||+.++
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~el 343 (382)
T 3tt0_A 294 YPGVPVEELFKLLKEGHRMD------------------------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQL 343 (382)
T ss_dssp STTCCHHHHHHHHHTTCCCC------------------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCC------------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 98887666655544321110 013568899999999999999999999999
Q ss_pred hcC
Q 017231 323 LCH 325 (375)
Q Consensus 323 l~~ 325 (375)
+++
T Consensus 344 l~~ 346 (382)
T 3tt0_A 344 VED 346 (382)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=317.10 Aligned_cols=251 Identities=19% Similarity=0.320 Sum_probs=207.8
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
+++..+.+++++.||+|+||.||++.++. +..||+|++...... ...+.+|+.++++++||||+++++++...
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 75 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMS---EDEFFQEAQTMMKLSHPKLVKFYGVCSKE--- 75 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred eEechhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCc---HHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 45666667789999999999999998764 678999999754332 35588999999999999999999998544
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
...++||||++ ++|.+++...+ .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+..
T Consensus 76 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 76 --YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp --SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred --CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence 56899999997 68999997754 499999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 193 TSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 193 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+.......+........
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 226 (268)
T 3sxs_A 154 VLDDQYVSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR------ 226 (268)
T ss_dssp CCTTCEEECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC------
T ss_pred cchhhhhcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC------
Confidence 544432 223345677999999987 678999999999999999998 9999988776665554433211110
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....++.+.++|.+||+.||++|||+.+++++
T Consensus 227 ------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 227 ------------------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ------------------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12357889999999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=328.92 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=211.2
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEe-----CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeee
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMN-----SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAI 104 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 104 (375)
+...|++..+.+++++.||+|+||.||+|.+ ..++..||+|++.... .......+.+|+.+++++ +||||+++
T Consensus 36 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 114 (344)
T 1rjb_A 36 YDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNL 114 (344)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 3457889999999999999999999999997 3466789999997542 233456788999999999 89999999
Q ss_pred ceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHH
Q 017231 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-----------------------DLTDDHCRYFLYQLLRGLKYVH 160 (375)
Q Consensus 105 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~al~~Lh 160 (375)
++++... +..++||||++ |+|.+++.... .+++..++.++.||+.||.+||
T Consensus 115 ~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 189 (344)
T 1rjb_A 115 LGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 189 (344)
T ss_dssp EEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeeC-----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 9998654 45899999997 69999997653 2799999999999999999999
Q ss_pred hCCccccCCCCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHh
Q 017231 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 237 (375)
Q Consensus 161 ~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 237 (375)
+.|++|+||||+||+++.++.++|+|||++....... ......+++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 190 ~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~ 268 (344)
T 1rjb_A 190 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIF 268 (344)
T ss_dssp HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHT
T ss_pred hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHH
Confidence 9999999999999999999999999999987654332 1234456788999999987 67899999999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCC
Q 017231 238 T-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316 (375)
Q Consensus 238 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 316 (375)
+ |..||...........+........ ....+++++.++|.+||+.||.+|
T Consensus 269 t~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~R 319 (344)
T 1rjb_A 269 SLGVNPYPGIPVDANFYKLIQNGFKMD-----------------------------QPFYATEEIYIIMQSCWAFDSRKR 319 (344)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred cCCCCCcccCCcHHHHHHHHhcCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCCchhC
Confidence 8 9999988765544443333111110 012468899999999999999999
Q ss_pred CCHHHHhcC
Q 017231 317 ITVDEALCH 325 (375)
Q Consensus 317 ps~~ell~~ 325 (375)
||+.+++++
T Consensus 320 ps~~~l~~~ 328 (344)
T 1rjb_A 320 PSFPNLTSF 328 (344)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=335.97 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=213.5
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
....|++..+.+.+.+.||+|+||.||++.++.+++.||+|++.... .......+.+|+.++++++||||+++++++..
T Consensus 105 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 183 (377)
T 3cbl_A 105 PKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183 (377)
T ss_dssp CCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence 34678888888889999999999999999999999999999986542 33345678899999999999999999999955
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
. ..+++||||++ |+|.+++...+ .+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||
T Consensus 184 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 184 K-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred C-----CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCC
Confidence 4 45799999997 79999997654 59999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcc---ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 189 LARTTSETDFM---TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 189 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
++......... ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+..... .+
T Consensus 259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~- 335 (377)
T 3cbl_A 259 MSREEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGR-LP- 335 (377)
T ss_dssp GCEECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCC-CC-
T ss_pred CceecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CC-
Confidence 98754433211 12235678999999987 678999999999999999998 9999988776555444332111 00
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++++.++|.+||+.||++|||+.++++
T Consensus 336 ----------------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 336 ----------------------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 01246888999999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=324.25 Aligned_cols=263 Identities=19% Similarity=0.260 Sum_probs=205.3
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCC---CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE---TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
...+.+....+.+.+.||+|+||.||+|.+.. ++..||+|++..........+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 35566667777789999999999999998765 566899999976655666677899999999999999999999998
Q ss_pred cCCCCCCcCcEEEEEeCCC-CCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC
Q 017231 109 RPPQRETFNDVYIVYELMD-TDLHQIIRS------HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 181 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~------~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~ 181 (375)
...........++||||++ ++|.+++.. ...+++..++.++.||+.||.+||++|++|+||||+||+++.++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc
Confidence 7765433446799999997 699999843 356999999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHH
Q 017231 182 LKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITE 257 (375)
Q Consensus 182 i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~ 257 (375)
++|+|||.+....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...........+..
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 264 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc
Confidence 9999999987654332 1223456778999999987 778999999999999999999 9999988776665554433
Q ss_pred HhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 258 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
..... ....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 265 GHRLK------------------------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TCCCC------------------------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCC------------------------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 21110 013568899999999999999999999999874
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=315.76 Aligned_cols=243 Identities=22% Similarity=0.349 Sum_probs=198.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHH-----HHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDA-----KRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+.+.||+|+||.||++++..+++.||+|++.......... ..+.+|+.++++++||||+++++++....
T Consensus 23 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------ 96 (287)
T 4f0f_A 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP------ 96 (287)
T ss_dssp EEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT------
T ss_pred ehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC------
Confidence 5999999999999999999999999999986543222111 67889999999999999999999985542
Q ss_pred EEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEecCCC-----EEEeeccc
Q 017231 119 VYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCD-----LKIGDFGL 189 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NIli~~~~~-----i~l~Df~~ 189 (375)
++||||++ |+|.+.+... ..+++..++.++.||+.||.+||+.| ++|+||||+||+++.++. ++|+|||.
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~ 175 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTT
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCc
Confidence 69999997 7998888654 46999999999999999999999999 999999999999988876 99999999
Q ss_pred ccccCCCCccccccccccccCchhccc-CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH--HHHHHHHhCCCCccc
Q 017231 190 ARTTSETDFMTEYVVTRWYRAPELLLN-CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ--LRLITELIGSPDETS 266 (375)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 266 (375)
+...... .....+++.|+|||++.+ ...++.++|||||||++|+|++|..||........ ...+.. ....+
T Consensus 176 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~--- 249 (287)
T 4f0f_A 176 SQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EGLRP--- 249 (287)
T ss_dssp CBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SCCCC---
T ss_pred ccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cCCCC---
Confidence 8754432 345678999999999843 24578899999999999999999999987654333 222211 11100
Q ss_pred ccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++++.++|.+||+.||.+|||++++++
T Consensus 250 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 250 -------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp -------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011356889999999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=317.57 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=200.2
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCC---CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeec
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSET---REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR 109 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 109 (375)
..|++....+++++.||+|+||.||++.+..+ +..||+|++... ......+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 44666666777899999999999999998654 456999998654 23445677899999999999999999999984
Q ss_pred CCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeec
Q 017231 110 PPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 187 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df 187 (375)
. +..++||||++ ++|.+++...+ .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+||
T Consensus 87 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 87 E------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp S------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred c------CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcc
Confidence 3 34689999998 59999998654 6999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 188 GLARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 188 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
|++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~--- 236 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL--- 236 (281)
T ss_dssp ------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred ccccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCC---
Confidence 99876544322 223345778999999987 678999999999999999996 99999887766655554331110
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+.+++.+.++|.+||+.||++|||+.+++++
T Consensus 237 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 237 ---------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0113578899999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=319.38 Aligned_cols=254 Identities=23% Similarity=0.396 Sum_probs=215.5
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
.+.|++....+++.+.||+|++|.||++.++.++..||+|++... ....+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 357888888888999999999999999999999999999998653 23456788999999999999999999998554
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
...++||||++ ++|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||
T Consensus 82 -----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 82 -----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp -----SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred -----CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCc
Confidence 55899999998 6999999874 349999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 189 LARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 189 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
.+........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |..||...+.......+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~--- 232 (288)
T 3kfa_A 157 LSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME--- 232 (288)
T ss_dssp GGGTSCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---
T ss_pred cceeccCCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCC---
Confidence 9876554432 233456778999999987 678999999999999999999 999998887666555443321110
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++.+.++|.+||+.||.+|||+.++++
T Consensus 233 ---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 233 ---------------------------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 11356889999999999999999999999976
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=322.28 Aligned_cols=268 Identities=21% Similarity=0.360 Sum_probs=201.3
Q ss_pred ecccccCCeeeccCCcceEEEEEE----eCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
+..+.+++++.||+|+||.||+++ +..+++.||+|++... .......+.+|+.++++++||||+++++++....
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 344445579999999999999998 6778999999998654 4445677899999999999999999999885432
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
. ..+++||||++ |+|.+++...+ .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++
T Consensus 85 ~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 85 R---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp H---TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred C---CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 1 45799999996 69999998765 4999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccc
Q 017231 191 RTTSETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS 266 (375)
Q Consensus 191 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 266 (375)
....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..|+...... .....+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~ 235 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQGQ 235 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCCTH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccccc
Confidence 7654432 1223446777999999987 67899999999999999999999988654211 111111111000
Q ss_pred ccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.........+... ........+++++.++|.+||+.||++|||+.++++
T Consensus 236 ------~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 ------MIVFHLIELLKNN---GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp ------HHHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ------hhHHHHHHHHhcc---CcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0000000000000 001112457899999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=317.11 Aligned_cols=247 Identities=22% Similarity=0.317 Sum_probs=193.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|+||.||++.+.. .||+|++............+.+|+.++++++||||++++++... ...++||
T Consensus 28 ~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~lv~ 98 (289)
T 3og7_A 28 VGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQLAIVT 98 (289)
T ss_dssp EEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SSCEEEE
T ss_pred eeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------CccEEEE
Confidence 59999999999999997654 59999998776667777889999999999999999999996533 3469999
Q ss_pred eCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC---Cc
Q 017231 124 ELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DF 198 (375)
Q Consensus 124 e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~---~~ 198 (375)
||++ ++|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++...... ..
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence 9998 6999998643 56999999999999999999999999999999999999999999999999998654432 22
Q ss_pred cccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 199 MTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
.....+++.|+|||++.. ...++.++||||||+++|+|++|..||...................+.
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 246 (289)
T 3og7_A 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD------------ 246 (289)
T ss_dssp -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC------------
T ss_pred ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc------------
Confidence 334568999999999862 256788999999999999999999999886655544443332211111
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
+......+++.+.++|.+||+.||.+|||+.++++
T Consensus 247 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 -------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11112457889999999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=314.18 Aligned_cols=252 Identities=15% Similarity=0.205 Sum_probs=209.0
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
.+++....+++.+.||+|++|.||++++. +..||+|++..........+.+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 34555556668999999999999999985 7889999998766666667789999999999999999999999866532
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEecCCCEEEeecc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
...++||||++ |+|.+++.... .+++..++.++.||+.||.+||++| ++|+||||+||+++.++.++|+||+
T Consensus 82 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~ 158 (271)
T 3kmu_A 82 ---PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMAD 158 (271)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGG
T ss_pred ---CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecc
Confidence 56799999997 69999998765 4899999999999999999999999 9999999999999999999999998
Q ss_pred cccccCCCCccccccccccccCchhcccCCCCC---ccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 189 LARTTSETDFMTEYVVTRWYRAPELLLNCSEYT---AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
.+..... ....+|+.|+|||.+.+ ...+ .++|||||||++|+|++|..||...+.......+........
T Consensus 159 ~~~~~~~----~~~~~t~~y~aPE~~~~-~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 231 (271)
T 3kmu_A 159 VKFSFQS----PGRMYAPAWVAPEALQK-KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT-- 231 (271)
T ss_dssp SCCTTSC----TTCBSCGGGSCHHHHHS-CGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC--
T ss_pred ceeeecc----cCccCCccccChhhhcc-CCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC--
Confidence 7654332 24567899999999986 3333 379999999999999999999988776655544433211110
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++++.++|.+||+.||++|||++++++
T Consensus 232 ---------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 232 ---------------------------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11357889999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=331.86 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=205.7
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch----HHHHHHHHHHHHHHhcC--CCCeeeeceeecCCCCCCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHMD--HENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~ 116 (375)
++++.||+|+||.||++.+..+++.||||++....... .....+..|+.++++++ |+|++++++++...
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~----- 120 (320)
T 3a99_A 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP----- 120 (320)
T ss_dssp EEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-----
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-----
Confidence 37999999999999999999999999999986543221 12234567999999996 59999999999654
Q ss_pred CcEEEEEeCCC--CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe-cCCCEEEeeccccccc
Q 017231 117 NDVYIVYELMD--TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLARTT 193 (375)
Q Consensus 117 ~~~~lv~e~~~--g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~-~~~~i~l~Df~~~~~~ 193 (375)
...++|+|++. ++|.+++...+.+++..++.++.||+.||.+||+.|++|+||||+||+++ .++.++|+|||++...
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 56899999996 69999999888999999999999999999999999999999999999999 7889999999998765
Q ss_pred CCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
.... .....+++.|+|||++.+....+.++||||||+++|+|++|..||..... +.. ...
T Consensus 201 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~~----------- 260 (320)
T 3a99_A 201 KDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQV----------- 260 (320)
T ss_dssp CSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CCC-----------
T ss_pred cccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--ccc-----------
Confidence 5432 34457899999999988744457899999999999999999999965321 111 000
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.....+++++.++|.+||+.||++|||++++++||||++..
T Consensus 261 ------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 261 ------------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ------------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 00135688999999999999999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=327.05 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=211.5
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeC-----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNS-----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
.+++....+++++.||+|+||.||++++. .+++.||+|++.... .......+.+|+.++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 46777778889999999999999999987 456899999987543 334567789999999999999999999998
Q ss_pred cCCCCCCcCcEEEEEeCCC-CCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 017231 109 RPPQRETFNDVYIVYELMD-TDLHQIIRSH------------------------QDLTDDHCRYFLYQLLRGLKYVHSAN 163 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~al~~Lh~~~ 163 (375)
... ...++||||++ |+|.+++... ..+++.+++.++.||+.||.+||++|
T Consensus 120 ~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 120 AVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp CSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccC-----CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 654 55899999997 5999999764 56999999999999999999999999
Q ss_pred ccccCCCCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-C
Q 017231 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-R 239 (375)
Q Consensus 164 i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g 239 (375)
++|+||||+||+++.++.++|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcC
Confidence 9999999999999999999999999986543321 2234566888999999987 678999999999999999999 9
Q ss_pred CCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCH
Q 017231 240 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV 319 (375)
Q Consensus 240 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~ 319 (375)
..||...+.......+...... .....+++.+.++|.+||+.||++||++
T Consensus 274 ~~p~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~ 323 (343)
T 1luf_A 274 LQPYYGMAHEEVIYYVRDGNIL------------------------------ACPENCPLELYNLMRLCWSKLPADRPSF 323 (343)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCcCCCCChHHHHHHHhCCCcC------------------------------CCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 9999887766655544331110 0013568899999999999999999999
Q ss_pred HHHhcC
Q 017231 320 DEALCH 325 (375)
Q Consensus 320 ~ell~~ 325 (375)
.+++++
T Consensus 324 ~~~~~~ 329 (343)
T 1luf_A 324 CSIHRI 329 (343)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999863
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=317.34 Aligned_cols=254 Identities=20% Similarity=0.304 Sum_probs=205.7
Q ss_pred eeeecccccCCee-eccCCcceEEEEE--EeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 34 LFEVSRKYVPPIR-PVGRGAYGIVCAA--MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 34 ~~~~~~~~~~i~~-~lg~G~~g~Vy~~--~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
.+.+..+.+.+.+ .||+|+||.||++ .+..+++.||+|++..........+.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 89 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 89 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC
Confidence 3444455555677 9999999999999 456778899999997665555557789999999999999999999999832
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
...++||||++ ++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||+
T Consensus 90 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 163 (291)
T 1xbb_A 90 ------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163 (291)
T ss_dssp ------SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ------CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence 44799999997 69999999988899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 190 ARTTSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 190 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||...+.......+......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--- 239 (291)
T 1xbb_A 164 SKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--- 239 (291)
T ss_dssp CEECCTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---
T ss_pred ceeeccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---
Confidence 876544322 122335678999999987 678899999999999999999 99999888766555444321100
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++.+.++|.+||+.||.+||++.++++
T Consensus 240 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 240 ---------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 001356889999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=313.26 Aligned_cols=252 Identities=19% Similarity=0.320 Sum_probs=209.5
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
.|.+..+.+++++.||+|++|.||++.+. ++..||+|++...... .+.+.+|+.++++++||||+++++++...
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 75 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-- 75 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSS--
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence 46777777779999999999999999986 5678999999765333 35688999999999999999999998654
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
+..+++|||++ ++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.
T Consensus 76 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 76 ---APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp ---SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred ---CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccc
Confidence 45799999997 6999999875 459999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC--ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 192 TTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 192 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
...... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||...+.......+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~------ 225 (267)
T 3t9t_A 153 FVLDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY------ 225 (267)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC------
T ss_pred ccccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC------
Confidence 654321 1223455778999999987 678999999999999999999 899998877666555543321110
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....+++.+.++|.+||+.||++||++.+++++
T Consensus 226 ------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 226 ------------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 012458889999999999999999999999863
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=320.88 Aligned_cols=259 Identities=25% Similarity=0.412 Sum_probs=211.9
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEe-----CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeec
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMN-----SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIK 105 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~ 105 (375)
...|++..+.+++++.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.+++++ +||||++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 356777777777999999999999999984 4677899999997543 334556788999999999 699999999
Q ss_pred eeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 017231 106 DIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD----------------LTDDHCRYFLYQLLRGLKYVHSANVLHRD 168 (375)
Q Consensus 106 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~----------------l~~~~~~~i~~qi~~al~~Lh~~~i~H~d 168 (375)
+++.... ..+++||||++ ++|.+++..... +++..++.++.||+.||.+||+.|++|+|
T Consensus 98 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d 173 (316)
T 2xir_A 98 GACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173 (316)
T ss_dssp EEECCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 9986542 44799999997 599999987654 89999999999999999999999999999
Q ss_pred CCCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCC
Q 017231 169 LKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFP 244 (375)
Q Consensus 169 i~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~ 244 (375)
|||+||+++.++.++|+|||.+....... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 99999999999999999999987654332 1234556888999999987 778999999999999999998 999998
Q ss_pred CCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 245 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
................... ....+++.+.++|.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 303 (316)
T 2xir_A 253 GVKIDEEFCRRLKEGTRMR-----------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303 (316)
T ss_dssp TCCCSHHHHHHHHHTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHHHhccCccCC-----------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7664443332222111110 01246889999999999999999999999997
Q ss_pred C
Q 017231 325 H 325 (375)
Q Consensus 325 ~ 325 (375)
|
T Consensus 304 ~ 304 (316)
T 2xir_A 304 H 304 (316)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=324.41 Aligned_cols=244 Identities=19% Similarity=0.186 Sum_probs=199.6
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||.||++.+..+++.||||++..... ...+..|+.+++++ +||||+++++++... ...++|
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~~~lv 83 (330)
T 2izr_A 13 VGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KYNAMV 83 (330)
T ss_dssp EEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TEEEEE
T ss_pred EEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----CccEEE
Confidence 69999999999999999999999999999864422 23477899999999 899999999998654 568999
Q ss_pred EeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC-----EEEeecccccccCCC
Q 017231 123 YELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-----LKIGDFGLARTTSET 196 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~-----i~l~Df~~~~~~~~~ 196 (375)
|||++++|.+++... +.+++..++.++.||+.||.+||+.|++|+||||+||+++.++. ++|+|||++......
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 84 LELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred EEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 999988999999874 67999999999999999999999999999999999999998887 999999999764433
Q ss_pred Cc--------cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhH---HHHHHHHHhCCCCcc
Q 017231 197 DF--------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH---QLRLITELIGSPDET 265 (375)
Q Consensus 197 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 265 (375)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+... ....+.......+..
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 21 245678999999999988 778999999999999999999999998754333 333332221111110
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
. .....+ ++.++|..||+.||.+||++++|++
T Consensus 243 ~--------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 243 V--------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp H--------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred H--------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 001234 8999999999999999999988876
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=325.58 Aligned_cols=259 Identities=23% Similarity=0.342 Sum_probs=191.8
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPP 111 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~ 111 (375)
+.+++....+++++.||+|+||.||++++..+++.||+|++... .......+.+|+.+++++. ||||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 44555555666899999999999999999999999999988543 3445667889999999996 99999999988432
Q ss_pred C---CCCcCcEEEEEeCCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEecCCCEE
Q 017231 112 Q---RETFNDVYIVYELMDTDLHQIIRS---HQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLNANCDLK 183 (375)
Q Consensus 112 ~---~~~~~~~~lv~e~~~g~L~~~l~~---~~~l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NIli~~~~~i~ 183 (375)
. ......++++|||++|+|.+++.. .+.+++..++.++.||+.||.+||+.| ++|+||||+||+++.++.++
T Consensus 99 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 1 123356899999999999998865 456999999999999999999999999 99999999999999999999
Q ss_pred EeecccccccCCCCcc-------------ccccccccccCchhcc--cCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh
Q 017231 184 IGDFGLARTTSETDFM-------------TEYVVTRWYRAPELLL--NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY 248 (375)
Q Consensus 184 l~Df~~~~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 248 (375)
|+|||++......... ....+++.|+|||++. ....++.++|||||||++|+|++|..||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 9999998765543211 1345789999999983 225678999999999999999999999965443
Q ss_pred hHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCC
Q 017231 249 VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326 (375)
Q Consensus 249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~ 326 (375)
...... ... .......++.+.++|.+||+.||.+|||+.|++++-
T Consensus 259 ~~~~~~----~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 259 LRIVNG----KYS-----------------------------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp -----------CC-----------------------------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HHhhcC----ccc-----------------------------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 221110 000 001134577899999999999999999999999863
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=317.77 Aligned_cols=247 Identities=17% Similarity=0.256 Sum_probs=201.8
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCC-------cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeec
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETR-------EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR 109 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 109 (375)
+..+.+.+.+.||+|+||.||++.++.++ ..||+|++... .....+.+.+|+.++++++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 44555558999999999999999998877 47999998654 3344577899999999999999999999996
Q ss_pred CCCCCCcCcEEEEEeCCC-CCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC------
Q 017231 110 PPQRETFNDVYIVYELMD-TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD------ 181 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~------ 181 (375)
.. ...++||||++ |+|.+++...+. +++..++.++.||+.||.+||++|++|+||||+||+++.++.
T Consensus 83 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 83 CG-----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp CT-----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred eC-----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc
Confidence 54 45799999997 699999987665 999999999999999999999999999999999999999887
Q ss_pred --EEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhC-CCCCCCCChhHHHHHHHHH
Q 017231 182 --LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITEL 258 (375)
Q Consensus 182 --i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~i~~~ 258 (375)
++|+|||.+...... ....++..|+|||++.+...++.++|||||||++|+|++| ..||...+........ ..
T Consensus 158 ~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~-~~ 233 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY-ED 233 (289)
T ss_dssp CEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH-HT
T ss_pred ceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh-hc
Confidence 999999998654332 3445788899999998756789999999999999999995 4555554433332222 11
Q ss_pred hCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 259 IGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.... ....++++.++|.+||+.||.+|||+.+++++
T Consensus 234 ~~~~-------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 RHQL-------------------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp TCCC-------------------------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCC-------------------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1110 12357789999999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=322.82 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=213.7
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEeC-------CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCee
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNS-------ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENII 102 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv 102 (375)
-...|++..+.+++++.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++++ +||||+
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv 104 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNII 104 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEe
Confidence 34678888888889999999999999999975 467789999987543 344567788999999999 899999
Q ss_pred eeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 017231 103 AIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ----------------DLTDDHCRYFLYQLLRGLKYVHSANVL 165 (375)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~Lh~~~i~ 165 (375)
++++++... +.+++||||++ |+|.+++.... .+++..++.++.||+.||.+||+.|++
T Consensus 105 ~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 179 (334)
T 2pvf_A 105 NLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI 179 (334)
T ss_dssp CEEEEECSS-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred eEEEEEccC-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 999998654 55899999997 59999998654 389999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCC
Q 017231 166 HRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQP 241 (375)
Q Consensus 166 H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~ 241 (375)
|+||||+||+++.++.++|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..
T Consensus 180 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~ 258 (334)
T 2pvf_A 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGS 258 (334)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999876544321 223455788999999987 678999999999999999999 999
Q ss_pred CCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHH
Q 017231 242 LFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 321 (375)
Q Consensus 242 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~e 321 (375)
||.+.........+....... ....+++++.++|.+||+.||.+|||+.+
T Consensus 259 p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e 308 (334)
T 2pvf_A 259 PYPGIPVEELFKLLKEGHRMD------------------------------KPANCTNELYMMMRDCWHAVPSQRPTFKQ 308 (334)
T ss_dssp SSTTCCHHHHHHHHHHTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CcCcCCHHHHHHHHhcCCCCC------------------------------CCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 998887666655544421110 01356889999999999999999999999
Q ss_pred HhcC
Q 017231 322 ALCH 325 (375)
Q Consensus 322 ll~~ 325 (375)
++++
T Consensus 309 ll~~ 312 (334)
T 2pvf_A 309 LVED 312 (334)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=318.54 Aligned_cols=245 Identities=16% Similarity=0.164 Sum_probs=201.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|++|.||++.+..+++.||+|++..... ...+.+|+.+++.+ +|++++++++++... ...++|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~lv 84 (298)
T 1csn_A 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHNVLV 84 (298)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEEEEE
T ss_pred EEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCC-----ceeEEE
Confidence 69999999999999999999999999999864322 23467899999999 799999999988543 568999
Q ss_pred EeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC-----EEEeecccccccCCC
Q 017231 123 YELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD-----LKIGDFGLARTTSET 196 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~-----i~l~Df~~~~~~~~~ 196 (375)
|||++++|.+++...+ .+++..++.++.||+.||.+||++|++|+||||+||+++.++. ++|+|||++......
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 9999889999998754 5999999999999999999999999999999999999988776 999999998765443
Q ss_pred C--------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh---hHHHHHHHHHhCCCCcc
Q 017231 197 D--------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY---VHQLRLITELIGSPDET 265 (375)
Q Consensus 197 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~ 265 (375)
. ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||...+. ......+.......+..
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred cccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH
Confidence 2 1244568999999999987 6789999999999999999999999987542 23333332221111110
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
...+.+++++.++|.+||+.||++||++++|++
T Consensus 244 --------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 244 --------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp --------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 111357899999999999999999999999987
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=317.52 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=197.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|++|.||++++..+++.||+|++..... .......+.+|+.++++++||||+++++++... +..+++
T Consensus 38 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv 112 (309)
T 2h34_A 38 LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----GQLYVD 112 (309)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred EEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----CeEEEE
Confidence 69999999999999999999999999999976533 334457788999999999999999999998554 568999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC--cc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD--FM 199 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~--~~ 199 (375)
|||++ ++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence 99997 5999999988889999999999999999999999999999999999999999999999999986654432 22
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....+++.|+|||++.+ ..++.++||||||+++|+|++|..||...+.......+.. ..+.
T Consensus 193 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~~~~--------------- 253 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ---AIPR--------------- 253 (309)
T ss_dssp ----CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHS---CCCC---------------
T ss_pred cccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhcc---CCCC---------------
Confidence 34568899999999987 6789999999999999999999999987664432222211 1100
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-CHHHHhc
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-TVDEALC 324 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-s~~ell~ 324 (375)
.....+.+++++.++|.+||+.||++|| +++++++
T Consensus 254 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 ----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 0111246789999999999999999999 8888876
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=353.05 Aligned_cols=299 Identities=24% Similarity=0.327 Sum_probs=214.0
Q ss_pred CCCCceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHH
Q 017231 8 GSGDHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTL 87 (375)
Q Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~ 87 (375)
+||++|...|... ++|. +.+.||+|+||.||++.++.+|+.||||++... ......+.+.
T Consensus 1 GGG~~p~~pg~~~--grY~-----------------i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~ 60 (676)
T 3qa8_A 1 GGGRSPSLPTQTC--GPWE-----------------MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWC 60 (676)
T ss_dssp ------------------C-----------------CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHH
T ss_pred CCCCCCCCCCCCC--CCeE-----------------EEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHH
Confidence 5789998888776 5787 699999999999999999999999999998654 2444567789
Q ss_pred HHHHHHHhcCCCCeeeeceeecCCC-CCCcCcEEEEEeCCC-CCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhC
Q 017231 88 REIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIVYELMD-TDLHQIIRSHQ---DLTDDHCRYFLYQLLRGLKYVHSA 162 (375)
Q Consensus 88 ~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qi~~al~~Lh~~ 162 (375)
+|+.++++++||||+++++++.... .......++||||++ |+|.+++.... .+++..++.++.||+.||.+||+.
T Consensus 61 ~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~ 140 (676)
T 3qa8_A 61 LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140 (676)
T ss_dssp HHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9999999999999999999876522 122366799999996 69999998754 599999999999999999999999
Q ss_pred CccccCCCCCceEEecCCC---EEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhC
Q 017231 163 NVLHRDLKPSNLLLNANCD---LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 239 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~---i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 239 (375)
|++|+||+|+||+++.++. ++|+|||.+.............+++.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 141 gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG 219 (676)
T 3qa8_A 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITG 219 (676)
T ss_dssp TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSS
T ss_pred CCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHC
Confidence 9999999999999997775 99999999987766655566788999999999987 7889999999999999999999
Q ss_pred CCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCC--CCCccccCCCCCchHHHHHHHhcCcCCCCCC
Q 017231 240 QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFP--KQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 317 (375)
Q Consensus 240 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp 317 (375)
..||......... ................ . ........ ..........+++.+.++|.+||..||++||
T Consensus 220 ~~Pf~~~~~~~~~------~~~i~~~~~~~~~~~~--~-l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP 290 (676)
T 3qa8_A 220 FRPFLPNWQPVQW------HGKVREKSNEHIVVYD--D-LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG 290 (676)
T ss_dssp CSSCCSSCHHHHS------STTCC------CCSCC--C-CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---
T ss_pred CCCCCcccchhhh------hhhhhcccchhhhhhh--h-hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCc
Confidence 9999765422211 0000000000000000 0 00000000 0001112234578899999999999999999
Q ss_pred CHHHHhcCCCCCCCCCCCC
Q 017231 318 TVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 318 s~~ell~~~~f~~~~~~~~ 336 (375)
|+.++++||||+.+.....
T Consensus 291 Ta~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 291 TDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCTTCCCCTTHHHHHHHHC
T ss_pred CHHHHhcCHHHHHHHHHHh
Confidence 9999999999998754443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=321.76 Aligned_cols=258 Identities=24% Similarity=0.367 Sum_probs=212.3
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEeCCCCc-----EEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeee
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETRE-----EVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAI 104 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 104 (375)
+...|++....+++.+.||+|+||.||++.+..++. .||+|.+.... .......+.+|+.+++++ +||||+++
T Consensus 37 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~ 115 (333)
T 2i1m_A 37 YNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNL 115 (333)
T ss_dssp CCGGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 345688888888899999999999999999877665 79999986543 334567789999999999 89999999
Q ss_pred ceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 017231 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH--------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 169 (375)
Q Consensus 105 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~--------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di 169 (375)
++++... +..++||||++ |+|.+++... ..+++..++.++.||+.||.+||+.|++|+||
T Consensus 116 ~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 190 (333)
T 2i1m_A 116 LGACTHG-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDV 190 (333)
T ss_dssp EEEECSS-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred EEEEecC-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCc
Confidence 9998654 45899999997 5999998653 35899999999999999999999999999999
Q ss_pred CCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCC
Q 017231 170 KPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPG 245 (375)
Q Consensus 170 ~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~ 245 (375)
||+||+++.++.++|+|||++....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus 191 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 191 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp SGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred ccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999999999999987543332 1233456788999999987 678999999999999999998 9999987
Q ss_pred CChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 246 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.........+......... ....++.+.++|.+||+.||.+|||+.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 270 ILVNSKFYKLVKDGYQMAQ-----------------------------PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp CCSSHHHHHHHHHTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchhHHHHHHHhcCCCCCC-----------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 7655444443332211110 1235788999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=322.64 Aligned_cols=246 Identities=25% Similarity=0.356 Sum_probs=199.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch----HHHHHHHHHHHHHHhc----CCCCeeeeceeecCCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHM----DHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~~iv~~~~~~~~~~~~~ 115 (375)
+++.||+|+||.||++.++.+++.||+|++....... .....+..|+.+++++ +|+||+++++++...
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~---- 110 (312)
T 2iwi_A 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ---- 110 (312)
T ss_dssp EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-------
T ss_pred EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC----
Confidence 7999999999999999999999999999996543221 1223455799999998 899999999998554
Q ss_pred cCcEEEEEeC-CC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe-cCCCEEEeecccccc
Q 017231 116 FNDVYIVYEL-MD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN-ANCDLKIGDFGLART 192 (375)
Q Consensus 116 ~~~~~lv~e~-~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~-~~~~i~l~Df~~~~~ 192 (375)
...++|+|+ +. ++|.+++...+.+++..++.++.||+.||.+||+.|++|+||+|+||+++ .++.++|+|||.+..
T Consensus 111 -~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~ 189 (312)
T 2iwi_A 111 -EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL 189 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEE
T ss_pred -CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhh
Confidence 457899998 55 69999999888899999999999999999999999999999999999999 889999999999876
Q ss_pred cCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 193 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 193 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
..... .....++..|+|||++.+....+.++||||||+++|+|++|..||.... .+......
T Consensus 190 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~----------- 251 (312)
T 2iwi_A 190 LHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELH----------- 251 (312)
T ss_dssp CCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCC-----------
T ss_pred cccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccC-----------
Confidence 55432 3455689999999998774444568999999999999999999996532 11110000
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
....+++.+.++|.+||+.||++|||++++++||||+...
T Consensus 252 --------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 252 --------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp --------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred --------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 0135688999999999999999999999999999999764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=313.09 Aligned_cols=254 Identities=23% Similarity=0.395 Sum_probs=211.7
Q ss_pred ecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeec
Q 017231 30 VYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR 109 (375)
Q Consensus 30 ~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 109 (375)
-|...|++..+.+++++.||+|++|.||++.+. ++..||+|.+..... ..+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 356789999999999999999999999999976 467899999865432 2456889999999999999999999885
Q ss_pred CCCCCCcCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEee
Q 017231 110 PPQRETFNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 186 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~D 186 (375)
. ...++||||++ ++|.+++.... .+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|
T Consensus 79 ~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 79 Q------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp S------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECC
T ss_pred C------CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECC
Confidence 3 33689999996 69999987543 699999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 187 FGLARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 187 f~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
||.+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||......+....+.......
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~- 230 (279)
T 1qpc_A 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV- 230 (279)
T ss_dssp CTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-
T ss_pred CcccccccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC-
Confidence 999876554322 223445778999999987 678999999999999999999 999998877666555443311100
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++++.++|.+||+.||++|||++++++
T Consensus 231 -----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 231 -----------------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01356889999999999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=320.07 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=211.7
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeC-----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeecee
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNS-----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 107 (375)
..|++....+++.+.||+|+||.||+|.++ .+++.||+|++.... .......+.+|+.++++++||||++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 556777777778999999999999999876 467889999987542 33445678899999999999999999999
Q ss_pred ecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 017231 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSH----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 176 (375)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli 176 (375)
+... ...++||||++ |+|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||++
T Consensus 97 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 97 VSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171 (322)
T ss_dssp ECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred EccC-----CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence 8554 45799999997 6999998753 457999999999999999999999999999999999999
Q ss_pred ecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHH
Q 017231 177 NANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQL 252 (375)
Q Consensus 177 ~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~ 252 (375)
+.++.++|+|||++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...+.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH
Confidence 999999999999987544332 1223456788999999987 678999999999999999999 89999887766655
Q ss_pred HHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 253 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
..+...... .....+++.+.++|.+||+.||++|||+.+++++
T Consensus 251 ~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 251 RFVMEGGLL------------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCcC------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 544331110 0113568899999999999999999999999985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=326.64 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=199.9
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeC---CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNS---ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
..++....+.+.+.||+|+||.||+++++ .++..||||++.... .......+.+|+.++++++||||+++++++..
T Consensus 39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 34666777889999999999999999887 467789999986543 34456789999999999999999999999965
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
. ...++||||++ |+|.+++...+ .+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||
T Consensus 118 ~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 118 S-----KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred C-----CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence 4 55799999996 69999998754 69999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 189 LARTTSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 189 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+.......+.......
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~- 270 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP- 270 (373)
T ss_dssp ---------------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC-
T ss_pred cccccccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 9876543321 112234677999999987 678999999999999999997 999998877665555443221110
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....++..+.++|.+||+.||.+||++.++++
T Consensus 271 -----------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 -----------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -----------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 01246788999999999999999999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=312.01 Aligned_cols=253 Identities=22% Similarity=0.377 Sum_probs=204.1
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCC---CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSE---TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
+.+....+++.+.||+|++|.||++.+.. ++..||+|++.... .....+.+.+|+.++++++||||+++++++...
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 85 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE 85 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC
Confidence 34445555579999999999999998643 44569999987643 334567789999999999999999999998543
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
..++||||++ ++|.+++...+ .+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.
T Consensus 86 ------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 86 ------PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp ------SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred ------CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCC
Confidence 3589999997 69999997654 599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccc
Q 017231 190 ARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETS 266 (375)
Q Consensus 190 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 266 (375)
+........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...........+........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~--- 235 (281)
T 3cc6_A 160 SRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK--- 235 (281)
T ss_dssp GGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---
T ss_pred CcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---
Confidence 876544321 223455778999999987 678999999999999999998 9999987766665554443211110
Q ss_pred ccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+++.+.++|.+||+.||++||++.+++++
T Consensus 236 ---------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 236 ---------------------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ---------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 12468889999999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=333.75 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=207.5
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..|++..+.+++++.||+|+||.||++.++ ++.||||+++... ..+.+.+|+.++++++||||+++++++....
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 457888888889999999999999999875 6799999996542 3467889999999999999999999876542
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
..+++||||++ |+|.+++...+. +++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus 260 ----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 260 ----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp ----SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ----CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 35899999997 699999987654 79999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 190 ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
+...... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 336 a~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~------- 405 (450)
T 1k9a_A 336 TKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM------- 405 (450)
T ss_dssp CEECC--------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCC-------
T ss_pred ccccccc--ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 8754332 223356788999999987 779999999999999999998 99999887665555444321110
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++++.++|.+||+.||.+|||+.++++
T Consensus 406 -----------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 406 -----------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 001357899999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=338.07 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=214.9
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
...|++....+++.+.||+|+||.||++.++.++..||||++..... ..+.+.+|+.++++++||||+++++++...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 35688998889999999999999999999999999999999875432 356788999999999999999999999654
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
..+++||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||
T Consensus 289 -----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 363 (495)
T 1opk_A 289 -----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 363 (495)
T ss_dssp -----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred -----CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecc
Confidence 45799999997 7999999864 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 189 LARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 189 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.......+......
T Consensus 364 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---- 438 (495)
T 1opk_A 364 LSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---- 438 (495)
T ss_dssp CEECCTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC----
T ss_pred cceeccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 9876544322 223345678999999987 678999999999999999999 99999888766655444321110
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++++.++|.+||+.||++|||+.+|++
T Consensus 439 --------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 439 --------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 011356889999999999999999999999987
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=311.99 Aligned_cols=250 Identities=26% Similarity=0.353 Sum_probs=193.1
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc--hHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN--RIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
+....+++.+.||+|+||.||++.+. ++.||+|++...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 78 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE--- 78 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC---
Confidence 33444457999999999999999875 789999998654322 23356788999999999999999999998654
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceEEec--------CCCE
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN---VLHRDLKPSNLLLNA--------NCDL 182 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~---i~H~di~p~NIli~~--------~~~i 182 (375)
...++||||++ ++|.+++. ...+++..++.++.||+.||.+||+.| ++|+||||+||+++. ++.+
T Consensus 79 --~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 79 --PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp ----CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred --CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 45799999997 58888775 467999999999999999999999999 899999999999986 7789
Q ss_pred EEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCC
Q 017231 183 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 262 (375)
Q Consensus 183 ~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 262 (375)
+|+|||.+....... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+.......
T Consensus 156 kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3dtc_A 156 KITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233 (271)
T ss_dssp EECCCCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCC
T ss_pred EEccCCccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCC
Confidence 999999987654432 234578999999999987 678999999999999999999999998877555444332211110
Q ss_pred CcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 263 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
+ ....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 234 ~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 234 P-----------------------------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp C-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-----------------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0 113568899999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=315.42 Aligned_cols=266 Identities=25% Similarity=0.425 Sum_probs=201.9
Q ss_pred ccccCCeeeccCCcceEEEEEE----eCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
.+++++++.||+|+||.||+++ +..+++.||+|++.... .......+.+|+.++++++||||+++++++.....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG- 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC-
Confidence 4445579999999999999998 67789999999997543 22345678899999999999999999999876432
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..+++||||++ ++|.+++.. ...+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++..
T Consensus 98 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 98 --NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccc
Confidence 55899999997 599999954 45699999999999999999999999999999999999999999999999999876
Q ss_pred cCCCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 193 TSETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 193 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
..... ......++..|+|||++.+ ..++.++||||||+++|+|++|..|+... ...............
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~-- 247 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPTHGQM-- 247 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSCCGGG--
T ss_pred ccCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCccccc--
Confidence 55442 2234556788999999987 67889999999999999999999886432 111222222111100
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
........+... ........+++++.++|.+||+.||.+|||+.++++
T Consensus 248 -----~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 248 -----TVTRLVNTLKEG---KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp -----HHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred -----CHHHHHHHHhcc---CCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 001111110000 001112467899999999999999999999999985
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=320.73 Aligned_cols=244 Identities=24% Similarity=0.353 Sum_probs=194.5
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEE----EEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEV----AIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++.||+|+||.||+|++..+++.+ |+|.+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~ 91 (327)
T 3poz_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS------TV 91 (327)
T ss_dssp EEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS------SE
T ss_pred cceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC------Ce
Confidence 6999999999999999998887765 777664332 233456788999999999999999999998653 26
Q ss_pred EEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 120 YIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
+++++++. |+|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 171 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence 78999996 7999999874 569999999999999999999999999999999999999999999999999987654332
Q ss_pred c---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 198 F---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 198 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
. .....+|..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.......
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~----------- 239 (327)
T 3poz_A 172 KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP----------- 239 (327)
T ss_dssp C-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----------
T ss_pred ccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC-----------
Confidence 2 223345778999999988 778999999999999999999 999998877665544433211110
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....++.++.++|.+||+.||.+||++.+++++
T Consensus 240 -------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 -------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 013467889999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=331.33 Aligned_cols=259 Identities=22% Similarity=0.398 Sum_probs=215.4
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
...|++....+++.+.||+|+||.||++.++. +..||||++..... ..+.+.+|+.++++++||||+++++++..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~~- 254 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVTK- 254 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEeC-
Confidence 35688888999999999999999999999864 57899999975432 35678999999999999999999999852
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
...++||||+. |+|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||
T Consensus 255 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG 329 (454)
T 1qcf_A 255 -----EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFG 329 (454)
T ss_dssp -----SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred -----CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence 34799999997 6999999754 368999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 189 LARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 189 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
++........ .....++..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+........
T Consensus 330 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-- 406 (454)
T 1qcf_A 330 LARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-- 406 (454)
T ss_dssp GGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC--
T ss_pred CceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence 9976543321 123345778999999987 678999999999999999999 9999998877766665544211110
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc--CCCCCCC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC--HPYLAPL 331 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~--~~~f~~~ 331 (375)
...+++++.++|.+||+.||++|||+++|++ ..++...
T Consensus 407 ----------------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 407 ----------------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp ----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred ----------------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 1346889999999999999999999999987 4555543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=319.77 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=205.2
Q ss_pred eeecccccCCeeeccCCcceEEEEEE-----eCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeec
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAM-----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR 109 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 109 (375)
.++....+++++.||+|+||.||+++ +..++..||+|++.... .......+.+|+.++++++||||+++++++.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 34555556689999999999999999 55678899999986442 3445567889999999999999999999986
Q ss_pred CCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC--
Q 017231 110 PPQRETFNDVYIVYELMD-TDLHQIIRSHQ-------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-- 179 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~-- 179 (375)
.. ...++||||++ ++|.+++.... .+++..++.++.||+.||.+||+.|++|+||+|+||+++.+
T Consensus 104 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~ 178 (327)
T 2yfx_A 104 QS-----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 178 (327)
T ss_dssp SS-----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred CC-----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence 54 45799999996 69999998753 48999999999999999999999999999999999999854
Q ss_pred -CCEEEeecccccccCCC---CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHH
Q 017231 180 -CDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRL 254 (375)
Q Consensus 180 -~~i~l~Df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~ 254 (375)
..++|+|||.+...... .......+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 257 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257 (327)
T ss_dssp TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred cceEEECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH
Confidence 45999999988643222 12234566888999999987 678999999999999999998 9999988776655544
Q ss_pred HHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 255 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 255 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
+....... ....+++.+.++|.+||+.||.+||++.+++++.|+.
T Consensus 258 ~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 258 VTSGGRMD------------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HHTTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCC------------------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 43321110 0135688999999999999999999999999987764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=311.34 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=206.5
Q ss_pred eeecccccCCee-eccCCcceEEEEEEeC--CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 35 FEVSRKYVPPIR-PVGRGAYGIVCAAMNS--ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 35 ~~~~~~~~~i~~-~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
+.+.++.+.+++ .||+|+||.||++.++ .++..||+|++... ......+.+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 81 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 81 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-
Confidence 444444444666 9999999999999854 46788999999764 234456788999999999999999999999832
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
...++||||++ ++|.+++... ..+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 82 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 82 -----EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp -----SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred -----CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccc
Confidence 34799999997 5999998654 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 190 ARTTSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 190 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
+........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||...........+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~--- 232 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM--- 232 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC---
T ss_pred eeeeccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC---
Confidence 876543321 223345788999999987 678999999999999999998 99999887766655444331100
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+.+++++.++|.+||+.||++||++.+++++
T Consensus 233 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 233 ---------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0113578999999999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=321.96 Aligned_cols=247 Identities=24% Similarity=0.324 Sum_probs=200.6
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEE--EEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCc
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEV--AIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+++.+.||+|+||.||+++++.++..+ ++|.+... ........+.+|+.+++++ +||||+++++++... ..
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~~ 100 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GY 100 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----TE
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-----Cc
Confidence 347999999999999999999888865 99988643 2233456788999999999 899999999998544 56
Q ss_pred EEEEEeCCC-CCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSHQ----------------DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCD 181 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~ 181 (375)
.++||||++ ++|.+++...+ .+++..++.++.||+.||.+||++|++|+||||+||+++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 899999996 69999997654 6999999999999999999999999999999999999999999
Q ss_pred EEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhC
Q 017231 182 LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIG 260 (375)
Q Consensus 182 i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~ 260 (375)
++|+|||++.............+++.|+|||++.+ ..++.++|||||||++|+|++ |..||...+.......+.....
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 259 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCC
Confidence 99999999865443333334456788999999987 678999999999999999998 9999988776554443322100
Q ss_pred CCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 261 SPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
. .....+++.+.++|.+||+.||.+|||+.+++++
T Consensus 260 ~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 260 L------------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp C------------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C------------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 0012468899999999999999999999999984
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=319.19 Aligned_cols=264 Identities=21% Similarity=0.325 Sum_probs=203.4
Q ss_pred ccCCeeeccCCcceEEEEEE----eCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 41 YVPPIRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
.+++++.||+|+||.||+++ +..+++.||+|++... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 98 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG---R 98 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---S
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC---C
Confidence 33479999999999999999 6778999999999654 3445667899999999999999999999886533 2
Q ss_pred CcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
..+++||||++ ++|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 56899999996 6999999774 569999999999999999999999999999999999999999999999999987654
Q ss_pred CCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 195 ETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 195 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||......... .......
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~~------ 246 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGCERD------ 246 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC----------
T ss_pred cCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hcccccc------
Confidence 432 2233456788999999987 67899999999999999999999998654322111 0000000
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
..........+... ........+++.+.++|.+||+.||.+|||+.+++++
T Consensus 247 -~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 247 -VPALSRLLELLEEG---QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp -CCHHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -cccHHHHHHHhhcc---cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00000000000000 0011124678999999999999999999999999763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=312.93 Aligned_cols=246 Identities=20% Similarity=0.181 Sum_probs=198.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|++|.||++++..+++.||+|++..... ...+..|+.+++.++|++++..+..+... ....++||
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv~ 84 (296)
T 3uzp_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM 84 (296)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred EEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCC----CCceEEEE
Confidence 69999999999999999999999999999865432 23477899999999988877766655332 25679999
Q ss_pred eCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ecCCCEEEeecccccccCCCCc-
Q 017231 124 ELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDF- 198 (375)
Q Consensus 124 e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli---~~~~~i~l~Df~~~~~~~~~~~- 198 (375)
||++++|.+++.. ...+++..++.++.||+.||.+||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred EecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 9998899999974 4579999999999999999999999999999999999999 4889999999999876544322
Q ss_pred -------cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh---hHHHHHHHHHhCCCCccccc
Q 017231 199 -------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY---VHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 199 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~ 268 (375)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+.......+..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 240 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE--- 240 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH---
T ss_pred cccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH---
Confidence 235578999999999988 6789999999999999999999999976432 22233222211111100
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++++.++|.+||+.||++|||+.++++
T Consensus 241 -----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 241 -----------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -----------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -----------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 011356889999999999999999999999887
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=317.83 Aligned_cols=251 Identities=24% Similarity=0.321 Sum_probs=197.2
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++++.||+|++|.||++.++.+++.||+|++... .......+.+|+.+++.++||||+++++++.... ......++
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l 107 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL 107 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence 33699999999999999999999999999988543 4455677889999999999999999999986421 12256899
Q ss_pred EEeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 122 VYELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
||||+. |+|.+++.. ...+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 187 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH 187 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence 999997 599999876 466999999999999999999999999999999999999999999999999987654322
Q ss_pred Cc----------cccccccccccCchhcccCC--CCCccchhHHHHHHHHHHhhCCCCCCCCCh--hHHHHHHHHHhCCC
Q 017231 197 DF----------MTEYVVTRWYRAPELLLNCS--EYTAAIDIWSVGCILGEIMTRQPLFPGKDY--VHQLRLITELIGSP 262 (375)
Q Consensus 197 ~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~~~~ 262 (375)
.. .....+++.|+|||++.+.. .++.++||||||+++|+|++|..||..... ......+.. ...
T Consensus 188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~- 265 (317)
T 2buj_A 188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLS- 265 (317)
T ss_dssp EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C---
T ss_pred cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cCC-
Confidence 11 11234688999999987522 368899999999999999999999943110 000000000 000
Q ss_pred CcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 263 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....+.+++++.++|.+||+.||.+|||+.+++++
T Consensus 266 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 266 ----------------------------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00113568899999999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=312.32 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=198.2
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..|.+..+.+++++.||+|++|.||++.+. ++.||+|++.... ..+.+.+|+.++++++||||+++++++....
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 445666666668999999999999999874 7899999986432 4567889999999999999999999875432
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
...++||||++ ++|.+++..... +++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.
T Consensus 88 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 88 ----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp -----CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred ----CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccc
Confidence 45799999997 499999977544 89999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 190 ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
+...... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...+.......+......
T Consensus 164 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~------- 233 (278)
T 1byg_A 164 TKEASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM------- 233 (278)
T ss_dssp --------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC-------
T ss_pred ccccccc--ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC-------
Confidence 8654433 223456788999999987 678999999999999999998 99999877665554433221000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++.+.++|.+||+.||.+||++.++++
T Consensus 234 -----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 234 -----------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 011356889999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=321.57 Aligned_cols=246 Identities=21% Similarity=0.306 Sum_probs=198.8
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcE----EEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREE----VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
+++++.||+|+||.||+|.+..+++. |++|.+.... .......+.+|+.++++++||||+++++++.. .
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~ 87 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------S 87 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------S
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------C
Confidence 33699999999999999999888876 7777664332 12223456689999999999999999998842 3
Q ss_pred cEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 118 DVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
..++||||+. |+|.+++... +.+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 4789999997 7999999775 5699999999999999999999999999999999999999999999999999976544
Q ss_pred CC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 196 TD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 196 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
.. ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||...........+........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------- 238 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ-------- 238 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC--------
T ss_pred ccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC--------
Confidence 32 2234556778999999987 678999999999999999999 9999988776655544433111100
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+++++.++|.+||+.||.+||++.+++++
T Consensus 239 ----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 239 ----------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ----------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ----------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 12357789999999999999999999999985
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=316.47 Aligned_cols=243 Identities=24% Similarity=0.357 Sum_probs=195.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEE----EEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEV----AIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++.||+|+||.||++++..+++.| ++|.+.... .......+.+|+.++++++||||+++++++... ..
T Consensus 19 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~------~~ 91 (327)
T 3lzb_A 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS------TV 91 (327)
T ss_dssp EEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS------SE
T ss_pred EEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC------Cc
Confidence 6999999999999999998888765 666554332 233456788999999999999999999998654 26
Q ss_pred EEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 120 YIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
+++++++. |+|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 92 ~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 88999986 6999999774 569999999999999999999999999999999999999999999999999997654332
Q ss_pred c---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccc
Q 017231 198 F---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 198 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...........+.......
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 239 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP----------- 239 (327)
T ss_dssp --------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-----------
T ss_pred ccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-----------
Confidence 2 223345778999999987 778999999999999999999 999998877666554443321111
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++++.++|.+||+.||.+||++.++++
T Consensus 240 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 240 -------------------QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01346888999999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=321.77 Aligned_cols=272 Identities=21% Similarity=0.240 Sum_probs=198.1
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
+.+....+++++.||+|+||.||++++. ++.||||++... .........|+.++++++||||+++++++.... .
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~ 92 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-S 92 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-S
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-C
Confidence 3344555558999999999999999876 689999998543 223344566899999999999999999987643 1
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCCceEEecCCCEE
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA----------NVLHRDLKPSNLLLNANCDLK 183 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~----------~i~H~di~p~NIli~~~~~i~ 183 (375)
....+++||||++ |+|.+++... .+++..++.++.||+.||.|||+. |++|+||||+||+++.++.++
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred CCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 1245899999997 5999999764 599999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCC---ccccccccccccCchhcccC----CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHH
Q 017231 184 IGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNC----SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLIT 256 (375)
Q Consensus 184 l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 256 (375)
|+|||++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+...........
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 99999996544332 22345789999999998762 245668899999999999999999997653211100000
Q ss_pred HHhCCCCcccccccccchhHHHhhhCC-CCCCCCcccc--CCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 257 ELIGSPDETSLGFLRSDNARRYVRMLP-QFPKQNFSAR--FPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
...... .......... ......+... ....++++.++|.+||+.||++|||+.++++
T Consensus 252 ~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHP-----------SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSC-----------CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCC-----------chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000000 0000000000 0000000000 0112445999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=315.39 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=203.1
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCC----cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETR----EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
.++....+.+.+.||+|+||.||+|.++.++ ..||+|++.... .......+.+|+.++++++||||+++++++..
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 4667777778999999999999999877553 459999986543 33455678899999999999999999999854
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
. ...++||||++ ++|.+++... ..+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||
T Consensus 118 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 118 Y-----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp S-----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred C-----CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence 3 56899999997 5999999765 569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 189 LARTTSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 189 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
.+........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...+.......+.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~- 270 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP- 270 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-
T ss_pred cchhhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCC-
Confidence 9876543321 122345778999999987 678999999999999999998 999998877665555443311110
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....+++.+.++|.+||+.||++||++.+++++
T Consensus 271 -----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 271 -----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 012468889999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=322.40 Aligned_cols=260 Identities=14% Similarity=0.128 Sum_probs=197.4
Q ss_pred cCCeeeccCCcceEEEEEEeCC---CCcEEEEEEecCcccchH---------HHHHHHHHHHHHHhcCCCCeeeeceeec
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSE---TREEVAIKKIGNAFDNRI---------DAKRTLREIKLLRHMDHENIIAIKDIIR 109 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 109 (375)
+++++.||+|+||.||+|.+.. ++..||+|++........ ....+.+|+..++.++||||+++++++.
T Consensus 39 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~ 118 (345)
T 2v62_A 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGL 118 (345)
T ss_dssp EEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEE
T ss_pred EEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccc
Confidence 3379999999999999999987 888999999865432111 1123567888999999999999999986
Q ss_pred CCCCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC--CEEEeec
Q 017231 110 PPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC--DLKIGDF 187 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~--~i~l~Df 187 (375)
... ......++||||++++|.+++...+.+++..++.++.||+.||.+||+.|++|+||||+||+++.++ .++|+||
T Consensus 119 ~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Df 197 (345)
T 2v62_A 119 TEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADY 197 (345)
T ss_dssp EES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCC
T ss_pred ccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeC
Confidence 632 2236789999999779999998888899999999999999999999999999999999999999887 9999999
Q ss_pred ccccccCCCC--------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCC--ChhHHHHHHHH
Q 017231 188 GLARTTSETD--------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGK--DYVHQLRLITE 257 (375)
Q Consensus 188 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~i~~ 257 (375)
|++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||... +..........
T Consensus 198 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 276 (345)
T 2v62_A 198 GLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTN 276 (345)
T ss_dssp TTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHH
T ss_pred CCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHh
Confidence 9986543221 1234578999999999988 67899999999999999999999999652 22222222222
Q ss_pred HhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 258 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.....+..... ... ...+++++.++|.+||+.||++||++++|++.
T Consensus 277 ~~~~~~~~~~~------------~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 277 LLDELPQSVLK------------WAP----------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHTTTHHHHH------------HSC----------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred hcccccHHHHh------------hcc----------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 22222111100 000 02578899999999999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=331.35 Aligned_cols=251 Identities=27% Similarity=0.352 Sum_probs=190.1
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+.+.+.||+|+||+|+. ....+++.||||++...... .+.+|+.+++.+ +||||+++++++... ...+
T Consensus 26 y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~-----~~~~ 94 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDR-----QFQY 94 (432)
T ss_dssp EEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEET-----TEEE
T ss_pred EecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecC-----CEEE
Confidence 33699999999999764 34567899999998654322 245799999999 799999999988544 5689
Q ss_pred EEEeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-----CCCEEEeecccccccC
Q 017231 121 IVYELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-----NCDLKIGDFGLARTTS 194 (375)
Q Consensus 121 lv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-----~~~i~l~Df~~~~~~~ 194 (375)
+||||++|+|.+++.... .+++..++.++.||+.||.|||++||+|+||||+||+++. ...++|+|||++....
T Consensus 95 lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 95 IAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp EEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred EEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 999999999999998764 3666678899999999999999999999999999999953 2358899999987654
Q ss_pred CCC----ccccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 195 ETD----FMTEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 195 ~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
... ......||+.|+|||++.+ ...++.++|||||||++|+|++ |..||........... ........
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~----~~~~~~~~- 249 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL----LGACSLDC- 249 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH----TTCCCCTT-
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH----hccCCccc-
Confidence 331 2334678999999999874 2456789999999999999999 9999965543322111 11100000
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.......+..+.++|.+||+.||.+|||+.++++||||..+
T Consensus 250 -----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 250 -----------------------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp -----------------------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred -----------------------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 00001234568899999999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=332.21 Aligned_cols=269 Identities=18% Similarity=0.281 Sum_probs=203.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|+||.||+|+++.+++.||||++..... ....+.+.+|+.++++++||||+++++++..... ...++||
T Consensus 13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---~~~~lv~ 88 (396)
T 4eut_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT---RHKVLIM 88 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT---CCEEEEE
T ss_pred EEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC---CeeEEEE
Confidence 69999999999999999999999999999965422 2235667899999999999999999999865432 4689999
Q ss_pred eCCC-CCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----ecCCCEEEeecccccccCC
Q 017231 124 ELMD-TDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL----NANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~---l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli----~~~~~i~l~Df~~~~~~~~ 195 (375)
||++ |+|.+++..... +++..++.++.||+.||.+||+.||+|+||||+||++ +.++.++|+|||++.....
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~ 168 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCC
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccC
Confidence 9997 699999976433 9999999999999999999999999999999999999 7777899999999987666
Q ss_pred CCccccccccccccCchhcccC-------CCCCccchhHHHHHHHHHHhhCCCCCCCCC----hhHHHHHHHHHhCCCCc
Q 017231 196 TDFMTEYVVTRWYRAPELLLNC-------SEYTAAIDIWSVGCILGEIMTRQPLFPGKD----YVHQLRLITELIGSPDE 264 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~~~ 264 (375)
........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.... ..+.+..+.. ..+.
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~---~~p~ 245 (396)
T 4eut_A 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT---GKPS 245 (396)
T ss_dssp GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH---SCCT
T ss_pred CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc---CCCc
Confidence 5555567789999999998641 356789999999999999999999996432 2233333332 2221
Q ss_pred ccccccccchh--HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 265 TSLGFLRSDNA--RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 265 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
........... ..+...++ ........+++.+.++|++||+.||++||+++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 246 GAISGVQKAENGPIDWSGDMP-----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp TCCEEEECSTTCCEEEESSCC-----TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred ccchhheeccCCCcccCccCC-----cccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 11111100000 00000000 000111234567899999999999999999999855
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=316.60 Aligned_cols=246 Identities=20% Similarity=0.184 Sum_probs=197.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||++++..+++.||+|++..... ...+..|+.+++.++|++++..+..+... ....++||
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv~ 84 (296)
T 4hgt_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM 84 (296)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred EeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceEEEE
Confidence 69999999999999999999999999998654322 23467899999999988877776665432 25679999
Q ss_pred eCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ecCCCEEEeecccccccCCCCc-
Q 017231 124 ELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDF- 198 (375)
Q Consensus 124 e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli---~~~~~i~l~Df~~~~~~~~~~~- 198 (375)
||++++|.+++.. ...+++..++.++.||+.||.+||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp ECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred EccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 9998899999985 4579999999999999999999999999999999999999 7899999999999876544321
Q ss_pred -------cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh---HHHHHHHHHhCCCCccccc
Q 017231 199 -------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV---HQLRLITELIGSPDETSLG 268 (375)
Q Consensus 199 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~ 268 (375)
.....+|+.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.. .....+.......+.
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---- 239 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI---- 239 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH----
T ss_pred ccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh----
Confidence 234578999999999988 67899999999999999999999999764322 222222221111110
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
......+++++.++|.+||+.||++|||+.++++
T Consensus 240 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 240 ----------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp ----------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ----------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 0111356889999999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=310.18 Aligned_cols=246 Identities=28% Similarity=0.410 Sum_probs=190.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCc-ccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNA-FDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.+.||+|++|.||++.+..+++.||+|++... .........+.+|+.++++++||||+++++++... ...++|
T Consensus 36 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 110 (310)
T 2wqm_A 36 IEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NELNIV 110 (310)
T ss_dssp EEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred EEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----CcEEEE
Confidence 799999999999999999999999999999753 23455667889999999999999999999998654 568999
Q ss_pred EeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 123 YELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
|||++ ++|.+++.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 99997 599998864 4569999999999999999999999999999999999999999999999999987654332
Q ss_pred -ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChh--HHHHHHHHHhCCCCcccccccccch
Q 017231 198 -FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYV--HQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+.... .....+... ..+.
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~---------- 257 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC--DYPP---------- 257 (310)
T ss_dssp --------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT--CSCC----------
T ss_pred ccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc--cCCC----------
Confidence 2234567899999999987 67899999999999999999999999754321 222221110 0000
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++++.++|.+||+.||.+|||+.++++
T Consensus 258 -----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 258 -----------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -----------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 001356889999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=327.87 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=210.7
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
...|++..+.+++.+.||+|+||.||++.++.+ ..||||++..... ..+.+.+|+.++++++||||+++++++..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 250 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 250 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence 356888888899999999999999999998764 6799999875432 24568899999999999999999999854
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
...++||||++ |+|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||
T Consensus 251 -----~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 -----EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp -----SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred -----CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCc
Confidence 34699999997 6999999743 569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 189 LARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 189 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
++........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.+....+....+.......
T Consensus 326 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--- 401 (452)
T 1fmk_A 326 LARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--- 401 (452)
T ss_dssp TTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---
T ss_pred cceecCCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 9976543321 223345778999999987 678999999999999999999 999998887666655543311110
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc--CCCCCCC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC--HPYLAPL 331 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~--~~~f~~~ 331 (375)
....+++.+.++|.+||+.||++|||+++|++ ..++...
T Consensus 402 ---------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 402 ---------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ---------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 01356888999999999999999999999998 4677654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=315.48 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=198.2
Q ss_pred CeeeccCCcceEEEEEE----eCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++.||+|+||.||++. +..+++.||+|++... ........+.+|+.++++++||||+++++++..... ..+
T Consensus 35 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~ 110 (318)
T 3lxp_A 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA---ASL 110 (318)
T ss_dssp EEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT---TEE
T ss_pred hhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC---ceE
Confidence 79999999999998774 4558899999999765 334456778999999999999999999999876432 568
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
++||||++ |+|.+++... .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||.+.......
T Consensus 111 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 99999997 5999998765 49999999999999999999999999999999999999999999999999987655432
Q ss_pred ---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 198 ---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||....... .......... .....
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-----~~~~~~~~~~----~~~~~ 259 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-----LELIGIAQGQ----MTVLR 259 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-----HHHHCSCCHH----HHHHH
T ss_pred ccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-----hhhhcccccc----hhHHH
Confidence 1233456788999999987 678899999999999999999999996542111 0000000000 00000
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
......... .......+++++.++|.+||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 260 LTELLERGE------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccc------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000000000 01112457899999999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=309.87 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=202.0
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC-----------
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ----------- 112 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----------- 112 (375)
+++.||+|++|.||++.+..+++.||+|++.... ..+.+|+.++++++||||+++++++....
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 88 (284)
T 2a19_B 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS 88 (284)
T ss_dssp EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence 6999999999999999999999999999986542 24568999999999999999999874311
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
......+++||||++ ++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 168 (284)
T 2a19_B 89 RSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGL 168 (284)
T ss_dssp CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred ccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchh
Confidence 012355899999998 5999999754 5799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 190 ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
+.............+++.|+|||++.+ ..++.++||||||+++|+|++|..|+.... .... ......
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~---~~~~~~------- 235 (284)
T 2a19_B 169 VTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS--KFFT---DLRDGI------- 235 (284)
T ss_dssp CEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHH---HHHTTC-------
T ss_pred heeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHH---Hhhccc-------
Confidence 877665544555678999999999987 678999999999999999999998873211 1111 110000
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
....+++.+.++|.+||+.||.+|||+.+++++.+.-.
T Consensus 236 -----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 236 -----------------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred -----------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 01246888999999999999999999999999876553
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=340.07 Aligned_cols=254 Identities=20% Similarity=0.308 Sum_probs=208.0
Q ss_pred eeeecccccCCe-eeccCCcceEEEEEE--eCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 34 LFEVSRKYVPPI-RPVGRGAYGIVCAAM--NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 34 ~~~~~~~~~~i~-~~lg~G~~g~Vy~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
.+++....+.+. +.||+|+||.||++. .+.+++.||||+++.........+.+.+|+.++++++||||+++++++..
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 345555555443 479999999999994 45677899999998765555567889999999999999999999998843
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
...++||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||+
T Consensus 442 ------~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGl 515 (635)
T 4fl3_A 442 ------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515 (635)
T ss_dssp ------SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred ------CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence 33789999997 69999999988999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 190 ARTTSETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 190 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
+....... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.......
T Consensus 516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~-- 592 (635)
T 4fl3_A 516 SKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-- 592 (635)
T ss_dssp HHHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--
T ss_pred ccccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence 87654332 1223345778999999987 779999999999999999998 999999888766665554321110
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++++.++|.+||+.||++||++.+|++
T Consensus 593 ----------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 593 ----------------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------------CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 01356889999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=309.38 Aligned_cols=245 Identities=25% Similarity=0.350 Sum_probs=192.6
Q ss_pred CeeeccCCcceEEEEEEeCC-CCc--EEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAMNSE-TRE--EVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~-~~~--~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++.||+|++|.||++.+.. ++. .||+|++.... ......+.+.+|+.++++++||||+++++++.... .
T Consensus 22 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~ 95 (291)
T 1u46_A 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP------M 95 (291)
T ss_dssp EEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS------C
T ss_pred eeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC------c
Confidence 69999999999999998643 333 69999986543 23345678899999999999999999999986542 6
Q ss_pred EEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 120 YIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
++|+||+. ++|.+++... ..+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccccc
Confidence 89999997 6999998764 569999999999999999999999999999999999999999999999999987654432
Q ss_pred c----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 198 F----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 198 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
. .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||...+.......+.......+
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 245 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--------- 245 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC---------
T ss_pred cchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC---------
Confidence 1 223456778999999987 678999999999999999999 9999988876665554433211111
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++++.++|.+||+.||++|||+.++++
T Consensus 246 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 246 --------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11357889999999999999999999999987
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=320.69 Aligned_cols=259 Identities=14% Similarity=0.138 Sum_probs=196.0
Q ss_pred CCeeeccCCcceEEEEEEeCCC-----CcEEEEEEecCcccchHH---------HHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 43 PPIRPVGRGAYGIVCAAMNSET-----REEVAIKKIGNAFDNRID---------AKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
++++.||+|+||.||+|.++.+ ++.||+|++......... ......|+..++.++||||+++++++
T Consensus 38 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~ 117 (364)
T 3op5_A 38 KVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSG 117 (364)
T ss_dssp EEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEE
T ss_pred EEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeee
Confidence 3699999999999999998775 578999998654211111 11233456667778899999999998
Q ss_pred cCCCCCCcCcEEEEEeCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe--cCCCEEEe
Q 017231 109 RPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN--ANCDLKIG 185 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~--~~~~i~l~ 185 (375)
.... .+....++||||++++|.+++... +.+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+
T Consensus 118 ~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~ 196 (364)
T 3op5_A 118 LHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLV 196 (364)
T ss_dssp EEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEEC
T ss_pred eecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEE
Confidence 6542 223558999999977999999876 6799999999999999999999999999999999999999 88999999
Q ss_pred ecccccccCCCCc--------cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHH
Q 017231 186 DFGLARTTSETDF--------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 257 (375)
Q Consensus 186 Df~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 257 (375)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+............
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~ 275 (364)
T 3op5_A 197 DYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSK 275 (364)
T ss_dssp CCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHH
T ss_pred ECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHH
Confidence 9999965443221 123458999999999988 6789999999999999999999999985432222211111
Q ss_pred HhCCCCcccccccccchhHHHh-hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 258 LIGSPDETSLGFLRSDNARRYV-RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
..... ...... ..+. ...+++++.++|..||+.||.+||++.+|++
T Consensus 276 ~~~~~-----------~~~~~~~~~~~----------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 276 IRYRE-----------NIASLMDKCFP----------AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHH-----------CHHHHHHHHSC----------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhh-----------hHHHHHHHhcc----------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 10000 000000 0110 1357889999999999999999999999887
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=305.86 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=198.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCc---EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETRE---EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+.+.||+|+||.||+|.+..++. .||+|.+... ......+.+.+|+.++++++||||+++++++.... ...+
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~ 99 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----GLPH 99 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SCCE
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----CCcE
Confidence 57999999999999999655444 7999998653 33445678899999999999999999999986543 3348
Q ss_pred EEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-
Q 017231 121 IVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD- 197 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~- 197 (375)
++|||+. |+|.+++.. ...+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 9999996 799999977 4569999999999999999999999999999999999999999999999999987543321
Q ss_pred ----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhC-CCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 198 ----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 198 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
......++..|+|||.+.+ ..++.++||||||+++|+|++| .+||...+.......+.......
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---------- 248 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---------- 248 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC----------
T ss_pred cccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC----------
Confidence 2234566888999999987 6789999999999999999995 55565555554444433321110
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++.+.++|.+||+.||.+|||+.++++
T Consensus 249 --------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 249 --------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp --------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01346888999999999999999999999887
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=319.38 Aligned_cols=247 Identities=11% Similarity=0.102 Sum_probs=195.8
Q ss_pred CeeeccCCcceEEEEEEeCCC--------CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeec----------
Q 017231 44 PIRPVGRGAYGIVCAAMNSET--------REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIK---------- 105 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~---------- 105 (375)
+++.||+|+||.||+|+++.+ ++.||+|++... ..+.+|+.++++++|||+++++
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 118 (352)
T 2jii_A 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA 118 (352)
T ss_dssp EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence 699999999999999999884 889999998543 3467899999999999998844
Q ss_pred -----eeecCCCCCCcCcEEEEEeCCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec
Q 017231 106 -----DIIRPPQRETFNDVYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 178 (375)
Q Consensus 106 -----~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~ 178 (375)
+++... ....++||||++++|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++.
T Consensus 119 i~~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 119 IPTCMGFGVHQ----DKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CCCCCEEEEET----TTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred ccchhhccccC----CcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 333221 2568999999988999999886 77999999999999999999999999999999999999999
Q ss_pred CC--CEEEeecccccccCCCC--------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC-
Q 017231 179 NC--DLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD- 247 (375)
Q Consensus 179 ~~--~i~l~Df~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~- 247 (375)
++ .++|+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 98 89999999996654322 1234478999999999987 678999999999999999999999997653
Q ss_pred -hhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 248 -YVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 248 -~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.................... ....+..+++++.++|.+||+.||++||+++++++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKPGPFVG----------------------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CHHHHHHHHHHHHHSCCCEEC----------------------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHhccCChhhhhh----------------------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 23333332222222111100 00111356899999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=329.06 Aligned_cols=250 Identities=30% Similarity=0.381 Sum_probs=188.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++++ +||||+++++++... ..+++|
T Consensus 19 ~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----~~~~lv 87 (434)
T 2rio_A 19 SEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTD-----RFLYIA 87 (434)
T ss_dssp EEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECS-----SEEEEE
T ss_pred ccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecC-----CeEEEE
Confidence 68899999999998754 567899999998543 234567899999887 899999999988544 568999
Q ss_pred EeCCCCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC-------------CCE
Q 017231 123 YELMDTDLHQIIRSHQDL-------TDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-------------CDL 182 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~~l-------~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~-------------~~i 182 (375)
|||++|+|.+++...... ++..++.++.||+.||.|||++||+|+||||+||+++.+ +.+
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 999999999999876443 233457899999999999999999999999999999754 479
Q ss_pred EEeecccccccCCCC-----ccccccccccccCchhccc------CCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhH
Q 017231 183 KIGDFGLARTTSETD-----FMTEYVVTRWYRAPELLLN------CSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVH 250 (375)
Q Consensus 183 ~l~Df~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~------~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~ 250 (375)
+|+|||++....... ......||+.|+|||++.+ ...++.++|||||||++|+|++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999987655432 1234578999999999865 2467899999999999999998 999997654332
Q ss_pred HHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 251 QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 251 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
..+.......+.. . ......+++++.++|.+||+.||.+|||+.++++||||..
T Consensus 248 --~~i~~~~~~~~~~--~----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 --SNIIRGIFSLDEM--K----------------------CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp --HHHHHTCCCCCCC--T----------------------TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred --HHHhcCCCCcccc--c----------------------ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 1222211111000 0 0000124578999999999999999999999999999974
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=311.61 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=189.3
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHh--cCCCCeeeeceeecCCCCCCcCcE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH--MDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++++.||+|+||.||++.+ +++.||+|++... ....+..|.+++.. ++||||+++++++.... .....+
T Consensus 10 y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~ 81 (301)
T 3q4u_A 10 ITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQL 81 (301)
T ss_dssp CEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEE
T ss_pred EEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCcee
Confidence 33799999999999999987 5789999998543 23445566666666 78999999999865432 223568
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH--------SANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh--------~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
++||||++ |+|.+++.. ..+++..++.++.||+.||.+|| +.|++|+||||+||+++.++.++|+|||++
T Consensus 82 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999997 699999954 57999999999999999999999 999999999999999999999999999998
Q ss_pred cccCCCCc-----cccccccccccCchhcccCC-----CCCccchhHHHHHHHHHHhhC----------CCCCCCCCh--
Q 017231 191 RTTSETDF-----MTEYVVTRWYRAPELLLNCS-----EYTAAIDIWSVGCILGEIMTR----------QPLFPGKDY-- 248 (375)
Q Consensus 191 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~l~~g----------~~pf~~~~~-- 248 (375)
........ .....||+.|+|||++.+.. .++.++|||||||++|+|++| ..||.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 65443321 22347899999999997732 345799999999999999999 777754321
Q ss_pred --hHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 249 --VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 249 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
..............+..... ......++++.++|.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRPNIPNR-----------------------WFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGG-----------------------GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cchhhhhHHHhccCCCCCCChh-----------------------hccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 11111111111111100000 000124567999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=306.02 Aligned_cols=245 Identities=23% Similarity=0.342 Sum_probs=197.8
Q ss_pred CeeeccCCcceEEEEEEeCCC---CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSET---REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+.+.||+|+||.||+|.+..+ +..|++|.+... ........+.+|+.++++++||||+++++++.... +..+
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~~ 103 (298)
T 3f66_A 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPL 103 (298)
T ss_dssp EEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SCCE
T ss_pred hcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCC----CceE
Confidence 689999999999999996543 345899988653 34445677899999999999999999999865432 4578
Q ss_pred EEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc
Q 017231 121 IVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~ 198 (375)
+||||++ |+|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||.+........
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 9999997 5999999764 4599999999999999999999999999999999999999999999999999876544321
Q ss_pred -----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 199 -----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 199 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
.....+++.|+|||.+.+ ..++.++||||||+++|+|++ |.+||...+.......+........
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 253 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ--------- 253 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC---------
T ss_pred hccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCC---------
Confidence 223456788999999987 678999999999999999999 6777776665554444333111110
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
...+++.+.++|.+||+.||.+|||+.++++
T Consensus 254 ---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 254 ---------------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ---------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1246788999999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=316.96 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=200.9
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
...+++.+.||+|+||.||++.++ +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++... +.
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~ 109 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDER-----NE 109 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-----TC
T ss_pred HhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----Ce
Confidence 344558999999999999999965 58899999886542 33466788999999999999999999998554 55
Q ss_pred EEEEEeCCC-CCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 119 VYIVYELMD-TDLHQIIRSHQ----DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~----~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
.++||||++ |+|.+++.... .+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++...
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 799999997 69999886543 4999999999999999999999999999999999999999999999999998654
Q ss_pred CCC---CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHH---HHhCCCCcccc
Q 017231 194 SET---DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLIT---ELIGSPDETSL 267 (375)
Q Consensus 194 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~---~~~~~~~~~~~ 267 (375)
... .......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||............. .....
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 262 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN------ 262 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT------
T ss_pred ccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc------
Confidence 322 12234568999999999987 678999999999999999999999997654222111110 00000
Q ss_pred cccccchhHHHhhhCCCCCCCCc-cccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNF-SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
..+........ ....+..+..+.+++.+||+.||++|||+.+++++
T Consensus 263 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 263 ------------GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp ------------TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000000000 01112345678999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=305.75 Aligned_cols=252 Identities=29% Similarity=0.416 Sum_probs=195.5
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
..+.+++.+.||+|+||.||++.+. ++.||+|.+... .....+.+|+.++++++||||+++++++..
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------- 72 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN------- 72 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------
Confidence 3344557999999999999999875 678999998542 345678899999999999999999998753
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCceEEecCCC-EEEeeccc
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQD---LTDDHCRYFLYQLLRGLKYVHS---ANVLHRDLKPSNLLLNANCD-LKIGDFGL 189 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~---l~~~~~~~i~~qi~~al~~Lh~---~~i~H~di~p~NIli~~~~~-i~l~Df~~ 189 (375)
..++||||++ |+|.+++..... ++...++.++.||+.||.+||+ +|++|+||||+||+++.++. ++|+|||.
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 2589999997 699999987653 7899999999999999999999 89999999999999999887 79999999
Q ss_pred ccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 190 ARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
+...... .....|++.|+|||++.+ ..++.++||||||+++|+|++|..||................+..+
T Consensus 153 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 223 (307)
T 2eva_A 153 ACDIQTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP------ 223 (307)
T ss_dssp --------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC------
T ss_pred ccccccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC------
Confidence 8654432 234468999999999987 6789999999999999999999999976433221111111111110
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc-----CCCCCCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC-----HPYLAPLHD 333 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~-----~~~f~~~~~ 333 (375)
.....+++.+.++|.+||+.||++|||+.++++ ..++.....
T Consensus 224 ----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 224 ----------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp ----------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred ----------------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 111357889999999999999999999999998 455554433
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=330.29 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=215.1
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
...|++..+.+++.+.||+|+||.||++.++.+ ..||||++..... ..+.+.+|+.++++++|+||+++++++..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 356888888899999999999999999998764 6799999975432 24568899999999999999999999854
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
..+++||||++ |+|.+++... ..+++.+++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||
T Consensus 334 -----~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 408 (535)
T 2h8h_A 334 -----EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 408 (535)
T ss_dssp -----SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred -----ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence 34799999997 6999999753 569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 189 LARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 189 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....+....+.......
T Consensus 409 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--- 484 (535)
T 2h8h_A 409 LARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--- 484 (535)
T ss_dssp STTTCCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCC---
T ss_pred cceecCCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---
Confidence 9976543321 123345678999999987 678999999999999999999 999998887666655543311100
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC--CCCCCCC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH--PYLAPLH 332 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~--~~f~~~~ 332 (375)
....+++.+.++|.+||+.||++|||+++|++. .+|....
T Consensus 485 ---------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 485 ---------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred ---------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 013568889999999999999999999999883 6666543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=314.16 Aligned_cols=258 Identities=21% Similarity=0.292 Sum_probs=207.0
Q ss_pred eecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 29 NVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 29 ~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
....+.|++....+++++.||+|++|.||++.+.. .|++|++..........+.+.+|+.++++++||||+++++++
T Consensus 22 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred ccccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 34557788888888899999999999999998764 499999876544444445577899999999999999999998
Q ss_pred cCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEee
Q 017231 109 RPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGD 186 (375)
Q Consensus 109 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~D 186 (375)
... ..++++|||++ ++|.+++...+ .+++..++.++.||+.||.+||+.|++|+||+|+||+++ ++.++|+|
T Consensus 99 ~~~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~D 172 (319)
T 2y4i_B 99 MSP-----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITD 172 (319)
T ss_dssp ECS-----SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECC
T ss_pred ecC-----CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEee
Confidence 654 45899999997 69999997755 699999999999999999999999999999999999998 78999999
Q ss_pred cccccccCCC------CccccccccccccCchhccc--------CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHH
Q 017231 187 FGLARTTSET------DFMTEYVVTRWYRAPELLLN--------CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL 252 (375)
Q Consensus 187 f~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 252 (375)
||++...... .......++..|+|||++.+ ...++.++||||||+++|+|++|..||.........
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 252 (319)
T 2y4i_B 173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII 252 (319)
T ss_dssp CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9987654321 12234457899999999874 235788999999999999999999999887766555
Q ss_pred HHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 253 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
..+....... .....+++++.++|.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 253 WQMGTGMKPN-----------------------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHTTCCCC-----------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHhccCCCCC-----------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4443211110 001246888999999999999999999999997
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=309.43 Aligned_cols=269 Identities=21% Similarity=0.350 Sum_probs=203.3
Q ss_pred eecccccCCeeeccCCcceEEEEEE----eCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAM----NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
.+..+.+++++.||+|++|.||+++ +..+++.||+|++... .......+.+|+.++++++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 3445555589999999999999998 5678999999998654 344567789999999999999999999988654
Q ss_pred CCCCcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 112 QRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
.. ..+++||||++ ++|.+++...+ .+++..++.++.||+.||.+||+.|++|+||||+||+++.++.++|+|||+
T Consensus 115 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 115 GR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp ------CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CC---CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence 32 45799999997 59999998764 599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 190 ARTTSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 190 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+..... ......+.....
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~~~ 265 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQG 265 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTCCT
T ss_pred hhhccccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhccccch
Confidence 876554321 223445777999999987 6789999999999999999999998854321 111111111000
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.. ...........-.. ......+++++.++|.+||+.||++|||+.++++
T Consensus 266 ~~---~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 266 QM---IVFHLIELLKNNGR------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HH---HHHHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hh---hHHHHHHHhhcCCC------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 00000000000000 0112457899999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=316.25 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=192.4
Q ss_pred cCCeeeccCCcceEEEEEEeCCC---CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSET---REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
+.+.+.||+|+||.||++.+..+ +..||+|.+... ........+.+|+.++++++||||+++++++.... +.
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----~~ 165 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GS 165 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCS----SC
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC----CC
Confidence 34689999999999999987543 346899988653 33445678899999999999999999999875432 45
Q ss_pred EEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 119 VYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
.++||||++ |+|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++......
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 789999997 5999999765 45899999999999999999999999999999999999999999999999998754332
Q ss_pred Cc-----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 197 DF-----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 197 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+.......
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~-------- 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL-------- 316 (373)
T ss_dssp ------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCC--------
T ss_pred ccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 21 123455778999999987 778999999999999999999 788887765544443332211000
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....+++.+.++|.+||+.||++|||+.+++++
T Consensus 317 ----------------------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 ----------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 013468889999999999999999999999873
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=306.85 Aligned_cols=257 Identities=25% Similarity=0.349 Sum_probs=199.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc--cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF--DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
..+.||+|++|.||++.+ +++.||+|++.... ........+.+|+.++++++||||+++++++... ...++
T Consensus 35 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 107 (307)
T 2nru_A 35 GGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDG-----DDLCL 107 (307)
T ss_dssp TCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred cCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecC-----CceEE
Confidence 679999999999999986 57899999986542 2344567789999999999999999999998654 45799
Q ss_pred EEeCCC-CCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 122 VYELMD-TDLHQIIRS---HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~---~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
||||++ ++|.+++.. ...+++..++.++.||+.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 108 VYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187 (307)
T ss_dssp EEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCS
T ss_pred EEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccc
Confidence 999996 699999874 3469999999999999999999999999999999999999999999999999986544322
Q ss_pred ---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 198 ---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
......|++.|+|||++.+ .++.++||||||+++|+|++|..||...........+..........
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 256 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT--------- 256 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC---------
T ss_pred ccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh---------
Confidence 1234568999999999875 47899999999999999999999998765433332222211111000
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+. .. .........++.+.++|.+||+.||.+|||+.+++++
T Consensus 257 ~~~~~---~~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 257 IEDYI---DK----KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHS---CS----SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred hhhhc---cc----cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000 00 0000111235678999999999999999999999863
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.59 Aligned_cols=273 Identities=22% Similarity=0.301 Sum_probs=204.3
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..+++....+++.+.||+|+||.||++.+. +++.||+|++....... ....+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~- 99 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTP- 99 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCS-
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecC-
Confidence 445566666779999999999999999854 58899999986543221 223578999999999999999999999654
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceEEecCCCEEE
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQ----DLTDDHCRYFLYQLLRGLKYVHSA---NVLHRDLKPSNLLLNANCDLKI 184 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~----~l~~~~~~~i~~qi~~al~~Lh~~---~i~H~di~p~NIli~~~~~i~l 184 (375)
...++||||++ |+|.+++.... .+++..++.++.||+.||.+||+. |++|+||||+||+++.++.++|
T Consensus 100 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 100 ----TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ----SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred ----CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 45799999997 59999997653 399999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCC--ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC-----hhHHHHHHHH
Q 017231 185 GDFGLARTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-----YVHQLRLITE 257 (375)
Q Consensus 185 ~Df~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~i~~ 257 (375)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+..
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 9999997654332 2334558999999999987 678999999999999999999999995211 0011110000
Q ss_pred HhCCCCcccccccccchhHHHhhhCCCCCCCCc-cccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 258 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNF-SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
... ... +........ .......++.+.+++.+||+.||.+|||+.+++++-.-..+
T Consensus 255 ~~~---~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 255 LLK---EKK---------------LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTS---SCC---------------STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred Hhh---chh---------------hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 000 000 000000000 00011234679999999999999999999999997654433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=323.75 Aligned_cols=246 Identities=21% Similarity=0.225 Sum_probs=195.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||++.+..+++.||||++...... ..+..|+.+++.++|.+.+..+..+... ....++||
T Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~----~~~~~lvm 82 (483)
T 3sv0_A 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVE----GDYNVLVM 82 (483)
T ss_dssp CCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred EEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEee----CCEEEEEE
Confidence 799999999999999999999999999987644322 2367899999999875544444433221 25679999
Q ss_pred eCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ecCCCEEEeecccccccCCCCc-
Q 017231 124 ELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDF- 198 (375)
Q Consensus 124 e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli---~~~~~i~l~Df~~~~~~~~~~~- 198 (375)
||++++|.+++.. ...+++..++.|+.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++........
T Consensus 83 e~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (483)
T 3sv0_A 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162 (483)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred ECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence 9998899999985 5679999999999999999999999999999999999999 6889999999999876544321
Q ss_pred -------cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH---HHHHHHHhCCCCccccc
Q 017231 199 -------MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ---LRLITELIGSPDETSLG 268 (375)
Q Consensus 199 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 268 (375)
.....||..|+|||++.+ ..++.++|||||||++|+|++|..||........ +..+........
T Consensus 163 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~----- 236 (483)
T 3sv0_A 163 QHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS----- 236 (483)
T ss_dssp CBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC-----
T ss_pred cccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc-----
Confidence 225678999999999988 6789999999999999999999999987554322 222222110000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.......+++++.++|..||+.||++||++.+|++
T Consensus 237 ---------------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 237 ---------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp ---------------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ---------------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00111356889999999999999999999988765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.88 Aligned_cols=253 Identities=20% Similarity=0.321 Sum_probs=203.0
Q ss_pred eeeecccccCCee-eccCCcceEEEEEEeC--CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 34 LFEVSRKYVPPIR-PVGRGAYGIVCAAMNS--ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 34 ~~~~~~~~~~i~~-~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
.+.+....+.+.+ .||+|+||.||++.++ .++..||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 3445555554555 8999999999999775 456679999997642 23356778999999999999999999999854
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
..+++||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||
T Consensus 408 ------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 408 ------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp ------SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred ------CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeecc
Confidence 33799999997 6999998754 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 189 LARTTSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 189 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||...+..+....+.......
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~- 559 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME- 559 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC-
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence 9976543321 112334678999999987 679999999999999999998 999999887766665544321100
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++++.++|.+||+.||++||++.+|++
T Consensus 560 -----------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 560 -----------------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -----------------------------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -----------------------------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01357899999999999999999999999865
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=306.23 Aligned_cols=242 Identities=25% Similarity=0.409 Sum_probs=186.4
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHH-HhcCCCCeeeeceeecCCCCCCcC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLL-RHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
++|..+.+.||+|++|.||++.++.+++.||+|++... ..+.+|+.++ +.++||||+++++++.... ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~ 88 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AGRK 88 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCc
Confidence 33332458899999999999999999999999998532 3456788887 5558999999999885421 1235
Q ss_pred cEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec---CCCEEEeeccccc
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLAR 191 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~---~~~i~l~Df~~~~ 191 (375)
.+++||||++ |+|.+++.... .+++..++.++.||+.||.+||++|++|+||||+||+++. ++.++|+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 6899999997 59999998764 5999999999999999999999999999999999999998 7889999999874
Q ss_pred ccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 192 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 192 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
... + ..++.++|||||||++|+|++|..||...........+..
T Consensus 169 ~~~---------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-------------- 212 (299)
T 3m2w_A 169 ETT---------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------------- 212 (299)
T ss_dssp ECT---------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--------------
T ss_pred ccc---------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--------------
Confidence 322 1 3567899999999999999999999976543221100000
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
.............+..+++++.++|.+||+.||++|||+.|+++||||++...
T Consensus 213 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 213 ---------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp ---------SSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred ---------HHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 00000000011112467899999999999999999999999999999997543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=328.63 Aligned_cols=255 Identities=17% Similarity=0.153 Sum_probs=194.6
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCC-CCeeee---------cee-
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDH-ENIIAI---------KDI- 107 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~~iv~~---------~~~- 107 (375)
+.+.+.+.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.+++.+.| ++...+ .+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 33447899999999999999999999999999987432 233345678899999999976 322111 111
Q ss_pred -----------ecCCCCCCcCcEEEEEeCCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 017231 108 -----------IRPPQRETFNDVYIVYELMDTDLHQIIRS-------HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 169 (375)
Q Consensus 108 -----------~~~~~~~~~~~~~lv~e~~~g~L~~~l~~-------~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di 169 (375)
+..........++++|+++.++|.+++.. ...+++..++.++.||+.||.|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11111111244788999999999988841 234788899999999999999999999999999
Q ss_pred CCCceEEecCCCEEEeecccccccCCCCccccccccccccCchhcc---------cCCCCCccchhHHHHHHHHHHhhCC
Q 017231 170 KPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL---------NCSEYTAAIDIWSVGCILGEIMTRQ 240 (375)
Q Consensus 170 ~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~Di~slG~il~~l~~g~ 240 (375)
||+||+++.++.+||+|||++...... .....| +.|+|||++. ....++.++|||||||++|+|++|+
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~ 314 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSS
T ss_pred ccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCC
Confidence 999999999999999999998665443 345567 8999999983 2256788999999999999999999
Q ss_pred CCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHH
Q 017231 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD 320 (375)
Q Consensus 241 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ 320 (375)
.||...+....... .......+++++.++|.+||+.||++||++.
T Consensus 315 ~Pf~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 359 (413)
T 3dzo_A 315 LPNTDDAALGGSEW-----------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPL 359 (413)
T ss_dssp CCCCTTGGGSCSGG-----------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCcchhhhHHH-----------------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCHH
Confidence 99976542211100 0111235789999999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 017231 321 EALCHPYLAPLH 332 (375)
Q Consensus 321 ell~~~~f~~~~ 332 (375)
++++||||+.+.
T Consensus 360 ~~l~~~~~~~~~ 371 (413)
T 3dzo_A 360 QAMETPEYEQLR 371 (413)
T ss_dssp HHTTSHHHHHHH
T ss_pred HHHhCHHHHHHH
Confidence 999999998763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=313.04 Aligned_cols=246 Identities=17% Similarity=0.195 Sum_probs=195.5
Q ss_pred eeeeecccccCCeeeccCCcceEEEEE-----EeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC---CCCeeee
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAI 104 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~ 104 (375)
..+++..+.+.+.+.||+|+||.||+| .+..+++.||+|++... ....+..|+.+++.++ |+|++.+
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 567777888889999999999999999 46778999999998653 2345677888888886 9999999
Q ss_pred ceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec
Q 017231 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRS-----HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 178 (375)
Q Consensus 105 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~-----~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~ 178 (375)
++.+... +..++||||++ |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 133 ~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~ 207 (365)
T 3e7e_A 133 YSAHLFQ-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207 (365)
T ss_dssp EEEEECS-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECG
T ss_pred heeeecC-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecc
Confidence 9998654 55799999997 799999974 466999999999999999999999999999999999999998
Q ss_pred -----------CCCEEEeecccccccC---CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCC
Q 017231 179 -----------NCDLKIGDFGLARTTS---ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 244 (375)
Q Consensus 179 -----------~~~i~l~Df~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 244 (375)
++.++|+|||++.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 208 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 208 GFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp GGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred cccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccc
Confidence 8999999999995432 2333455678999999999988 679999999999999999999999984
Q ss_pred CCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 245 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
...... .. +.. ... ....++.+.+++..||+.+|.+|++..+.+.
T Consensus 287 ~~~~~~--------------~~---------------~~~-----~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 287 KNEGGE--------------CK---------------PEG-----LFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp EEETTE--------------EE---------------ECS-----CCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred cCCCCc--------------ee---------------ech-----hcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 432100 00 000 000 0123667999999999999999976544444
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=306.50 Aligned_cols=276 Identities=21% Similarity=0.214 Sum_probs=189.2
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHH--HHHhcCCCCeeeeceeecCCCCCCcCc
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK--LLRHMDHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~--~l~~l~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
.+++++.||+|+||.||++.+ +++.||||++... ....+..|.. .+..++||||+++++.+......+...
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred HhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 333699999999999999976 5789999998543 2233333444 445579999999998654433344456
Q ss_pred EEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceEEecCCCEEEeecc
Q 017231 119 VYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA---------NVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 119 ~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~---------~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
+++||||++ |+|.+++.... .++..++.++.||+.||.+||+. |++|+||||+||+++.++.++|+|||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 899999996 69999997654 59999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCC---------ccccccccccccCchhcccC------CCCCccchhHHHHHHHHHHhhCCCCCCCCC-hhHHH
Q 017231 189 LARTTSETD---------FMTEYVVTRWYRAPELLLNC------SEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQL 252 (375)
Q Consensus 189 ~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~ 252 (375)
++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.... .....
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 997654321 12245689999999998762 245678999999999999999977663322 11100
Q ss_pred HHHHHHhCCCCcccccccccchhHHHhhhCCCCC-CCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc------C
Q 017231 253 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFP-KQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC------H 325 (375)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~------~ 325 (375)
..+....+..+.. .............+ ..........+++++.++|.+||+.||++|||+.|+++ +
T Consensus 246 ~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 246 MAFQTEVGNHPTF-------EDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CTTHHHHCSSCCH-------HHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhhhcccCCCchH-------HHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 0000000000000 00000000000000 00000001123457999999999999999999999954 7
Q ss_pred CCCCCC
Q 017231 326 PYLAPL 331 (375)
Q Consensus 326 ~~f~~~ 331 (375)
+|-++-
T Consensus 319 ~~~~~~ 324 (336)
T 3g2f_A 319 IWERNK 324 (336)
T ss_dssp CCCC--
T ss_pred HHHhcc
Confidence 887764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=307.09 Aligned_cols=249 Identities=23% Similarity=0.285 Sum_probs=184.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc--CCCCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM--DHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++.||+|+||.||++.+. ++.||+|++... .......|.+++..+ +||||+++++++.... .....+++
T Consensus 41 ~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 112 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYL 112 (337)
T ss_dssp EEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEE
T ss_pred EEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEE
Confidence 6999999999999999875 789999998433 223344555555554 8999999999986543 22256899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEecCCCEEEeecccccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA--------NVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~--------~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
||||++ |+|.+++... .+++..++.++.||+.||.+||+. |++|+||||+||+++.++.++|+|||++..
T Consensus 113 v~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~ 191 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191 (337)
T ss_dssp EECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCcee
Confidence 999997 5999999764 699999999999999999999998 999999999999999999999999999865
Q ss_pred cCCCCc-----cccccccccccCchhcccCCCCCc------cchhHHHHHHHHHHhhC----------CCCCCCCCh---
Q 017231 193 TSETDF-----MTEYVVTRWYRAPELLLNCSEYTA------AIDIWSVGCILGEIMTR----------QPLFPGKDY--- 248 (375)
Q Consensus 193 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~------~~Di~slG~il~~l~~g----------~~pf~~~~~--- 248 (375)
...... .....||+.|+|||++.+ ..... ++|||||||++|+|++| ..||.....
T Consensus 192 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 270 (337)
T 3mdy_A 192 FISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270 (337)
T ss_dssp CC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence 443321 124578999999999977 34444 39999999999999999 555543211
Q ss_pred -hHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 249 -VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 249 -~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
..............+... .......+++++.++|.+||+.||.+|||+.+++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 271 SYEDMREIVCIKKLRPSFP-----------------------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CHHHHHHHHTTSCCCCCCC-----------------------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred chhhhHHHHhhhccCcccc-----------------------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 111111111000000000 000012346679999999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.13 Aligned_cols=254 Identities=27% Similarity=0.428 Sum_probs=209.2
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCC---CcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeec
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSET---REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIR 109 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 109 (375)
..+++....+++++.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 45677778888999999999999999998654 457999988653 23445677899999999999999999999984
Q ss_pred CCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeec
Q 017231 110 PPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 187 (375)
Q Consensus 110 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df 187 (375)
. +..++||||++ |+|.+++...+ .+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+||
T Consensus 462 ~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DF 535 (656)
T 2j0j_A 462 E------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 535 (656)
T ss_dssp S------SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred c------CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEec
Confidence 3 34699999997 69999998654 6999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 188 GLARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 188 ~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
|++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.......
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~-- 612 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-- 612 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC--
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC--
Confidence 99976544322 223445778999999987 678999999999999999997 999999887776666554421110
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
..+.+++.+.++|.+||+.||++|||+.++++
T Consensus 613 ----------------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 613 ----------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01356889999999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=304.10 Aligned_cols=250 Identities=21% Similarity=0.266 Sum_probs=190.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHh--cCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH--MDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+.+.||+|+||.||++.+ +++.||+|++... ....+..|.+++.. ++||||+++++++.... ......++
T Consensus 46 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~l 117 (342)
T 1b6c_B 46 LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 117 (342)
T ss_dssp EEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEE
T ss_pred EEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEE
Confidence 599999999999999987 4789999998543 34556788888887 68999999999987653 12236899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH--------SANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh--------~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
||||++ |+|.+++.. ..+++..++.++.||+.||.+|| +.|++|+||||+||+++.++.++|+|||++..
T Consensus 118 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 196 (342)
T 1b6c_B 118 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196 (342)
T ss_dssp EECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCcee
Confidence 999997 599999976 46999999999999999999999 89999999999999999999999999999866
Q ss_pred cCCCC-----ccccccccccccCchhcccCC-----CCCccchhHHHHHHHHHHhhC----------CCCCCCCChh-HH
Q 017231 193 TSETD-----FMTEYVVTRWYRAPELLLNCS-----EYTAAIDIWSVGCILGEIMTR----------QPLFPGKDYV-HQ 251 (375)
Q Consensus 193 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~l~~g----------~~pf~~~~~~-~~ 251 (375)
..... ......+++.|+|||++.+.. .++.++|||||||++|+|++| ..||...... ..
T Consensus 197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 276 (342)
T 1b6c_B 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276 (342)
T ss_dssp EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence 54432 123457899999999987632 223689999999999999999 6777554211 01
Q ss_pred HHHHHHHhC-C--CCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 252 LRLITELIG-S--PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 252 ~~~i~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+..... . .+..... ......++.+.++|.+||+.||++|||+.+++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 277 VEEMRKVVCEQKLRPNIPNR-----------------------WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHHTTSCCCCCCCGG-----------------------GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCccc-----------------------ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 111111110 0 0000000 0001234578999999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=295.91 Aligned_cols=239 Identities=14% Similarity=0.071 Sum_probs=189.5
Q ss_pred CceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHH
Q 017231 11 DHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLRE 89 (375)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e 89 (375)
..++..|.++.++||.+ .+.||+|+||.||++++..+++.||||++..... .......+.+|
T Consensus 19 ~~~~~~g~~~~~~~y~i-----------------~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e 81 (286)
T 3uqc_A 19 DVQLVPGARIANGRYRL-----------------LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSR 81 (286)
T ss_dssp -CCCCTTCEETTTTEEE-----------------EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHH
T ss_pred CCcCCCCCEEecCcEEE-----------------EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHH
Confidence 44566777666789985 8999999999999999999999999999976543 34456788999
Q ss_pred HHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 017231 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRD 168 (375)
Q Consensus 90 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~d 168 (375)
+.++.+++||||+++++++... +..|+||||++ ++|.+++... ....++..++.||+.||.+||++||+|+|
T Consensus 82 ~~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~D 154 (286)
T 3uqc_A 82 TLRLSRIDKPGVARVLDVVHTR-----AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSI 154 (286)
T ss_dssp HHHHHTCCCTTBCCEEEEEEET-----TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHhcCCCCCcceeeEEEEEC-----CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence 9999999999999999998554 56899999997 5999998543 46678899999999999999999999999
Q ss_pred CCCCceEEecCCCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCCh
Q 017231 169 LKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY 248 (375)
Q Consensus 169 i~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 248 (375)
|||+||+++.+|.++|++++. ++ .++.++|||||||++|+|++|+.||.+.+.
T Consensus 155 ikp~NIll~~~g~~kl~~~~~-------------------~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~ 207 (286)
T 3uqc_A 155 DHPSRVRVSIDGDVVLAYPAT-------------------MP--------DANPQDDIRGIGASLYALLVNRWPLPEAGV 207 (286)
T ss_dssp CSGGGEEEETTSCEEECSCCC-------------------CT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred CCcccEEEcCCCCEEEEeccc-------------------cC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 999999999999999984432 22 367899999999999999999999977542
Q ss_pred hHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 249 VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 249 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+... ... . ...........+.+++++.++|.+||+.||.+| |+.|+++.
T Consensus 208 ~~~~~~~-----------~~~------------~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 208 RSGLAPA-----------ERD------------T-AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CCCSEEC-----------CBC------------T-TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred chhhHHH-----------HHH------------h-ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 2110000 000 0 000001112235678999999999999999999 99999873
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=308.61 Aligned_cols=252 Identities=17% Similarity=0.189 Sum_probs=186.1
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc------chHHHHHHHHHHHHHHhcC---------CCCeeee
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD------NRIDAKRTLREIKLLRHMD---------HENIIAI 104 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~~iv~~ 104 (375)
..+++++.||+|+||+||+|++ +|+.||||++..... .....+.+.+|+.+++.++ |||++++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 3444899999999999999988 679999999975432 2223467788999988886 5555555
Q ss_pred ce-----------------eecCCC--------CCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 017231 105 KD-----------------IIRPPQ--------RETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158 (375)
Q Consensus 105 ~~-----------------~~~~~~--------~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~ 158 (375)
.+ ++.... ......+++||||++ |++.+.+.. +.+++..++.++.||+.||.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence 44 443210 011367999999996 556666544 568999999999999999999
Q ss_pred HH-hCCccccCCCCCceEEecCC--------------------CEEEeecccccccCCCCccccccccccccCchhcccC
Q 017231 159 VH-SANVLHRDLKPSNLLLNANC--------------------DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNC 217 (375)
Q Consensus 159 Lh-~~~i~H~di~p~NIli~~~~--------------------~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 217 (375)
|| ++||+||||||+|||++.++ .+||+|||++...... ...||+.|+|||++.+
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g- 251 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG- 251 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC-
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC-
Confidence 99 99999999999999999987 8999999999765432 4578999999999987
Q ss_pred CCCCccchhHHHHHH-HHHHhhCCCCCCCCChhH-HHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCC
Q 017231 218 SEYTAAIDIWSVGCI-LGEIMTRQPLFPGKDYVH-QLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 295 (375)
Q Consensus 218 ~~~~~~~Di~slG~i-l~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (375)
.. +.++||||||++ .+++++|..||....... ....+......... ......+
T Consensus 252 ~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~ 306 (336)
T 2vuw_A 252 DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTK------------------------CNTPAMK 306 (336)
T ss_dssp CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSC------------------------CCSHHHH
T ss_pred CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcc------------------------cchhhhh
Confidence 33 889999998776 777889999984422111 11122111110000 0001112
Q ss_pred CCCchHHHHHHHhcCcCCCCCCCHHHHh-cCCCCC
Q 017231 296 NKSPGAVDLLEKMLVFDPNRRITVDEAL-CHPYLA 329 (375)
Q Consensus 296 ~~s~~l~~li~~~L~~dP~~Rps~~ell-~~~~f~ 329 (375)
.+++++.+||++||+.| |+.|+| +||||+
T Consensus 307 ~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 45788999999999976 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=327.20 Aligned_cols=242 Identities=22% Similarity=0.308 Sum_probs=194.4
Q ss_pred CCeeeccCCcceEEEEEEeCC-CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSE-TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
++++.||+|+||.||++.+.. +++.||||++... ........+..|+.++++++||||+++++++......+....|+
T Consensus 83 ~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~l 161 (681)
T 2pzi_A 83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYI 161 (681)
T ss_dssp EEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEE
Confidence 379999999999999999976 7899999998653 23345567889999999999999999999987654322233699
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMT 200 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~ 200 (375)
||||++ ++|.+++.. .+++..++.++.||+.||.|||++||+|+||||+||+++.+ .++|+|||++...... .
T Consensus 162 v~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---~ 235 (681)
T 2pzi_A 162 VMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---G 235 (681)
T ss_dssp EEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---S
T ss_pred EEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC---C
Confidence 999997 588887654 79999999999999999999999999999999999999875 9999999998765543 4
Q ss_pred cccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 201 EYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 201 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
...||+.|+|||++.+ . ++.++|||||||++|+|++|..||.+..... .+.
T Consensus 236 ~~~gt~~y~aPE~~~~-~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~~---------------- 286 (681)
T 2pzi_A 236 YLYGTPGFQAPEIVRT-G-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LPE---------------- 286 (681)
T ss_dssp CCCCCTTTSCTTHHHH-C-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CCT----------------
T ss_pred ccCCCccccCHHHHcC-C-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------ccc----------------
Confidence 5678999999999876 3 4889999999999999999998886432100 000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
. ......++.+.++|.+||+.||.+||+..+.+.++|+.-
T Consensus 287 -------~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 287 -------D---DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -------T---CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -------c---ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 000113577999999999999999999999999888754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=261.84 Aligned_cols=188 Identities=17% Similarity=0.107 Sum_probs=135.5
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcc--------cchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCC
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF--------DNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 115 (375)
-...+.|+.|....++....|+.|++|++.+.. ......+.+.+|+.+|+++ .|+||+++++++.+.
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~---- 314 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA---- 314 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS----
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC----
Confidence 345678888888888888899999999996542 1223456789999999999 699999999999544
Q ss_pred cCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 116 FNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 116 ~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
..+||||||++| +|.+++...+++++. .|+.||+.||.|+|++||+||||||+|||++.+|++||+|||+++...
T Consensus 315 -~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 315 -QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp -SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred -CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 679999999985 999999998888875 478999999999999999999999999999999999999999987654
Q ss_pred CC-CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCC
Q 017231 195 ET-DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPL 242 (375)
Q Consensus 195 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 242 (375)
.. ....+.+||+.|+|||++.+ .+..++|+|++|+++++|.++..+
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred CCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccch
Confidence 43 33456789999999999986 367789999999999988776543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=218.94 Aligned_cols=183 Identities=22% Similarity=0.245 Sum_probs=138.6
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc------chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD------NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
..+.||+|+||.||++ ...+..+++|....... .....+.+.+|+.++++++||||+++..++... .
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~ 412 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-----D 412 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----T
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----C
Confidence 4678999999999999 44567899998643221 112245678999999999999999554444322 3
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
..++||||++ ++|.+++.. +..++.||+.||.+||++||+|+||||+||+++. +++|+|||++......
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 3599999997 699999875 6689999999999999999999999999999988 9999999999876554
Q ss_pred Cc--------cccccccccccCchhccc-CCCCCccchhHHHHHHHHHHhhCCCCC
Q 017231 197 DF--------MTEYVVTRWYRAPELLLN-CSEYTAAIDIWSVGCILGEIMTRQPLF 243 (375)
Q Consensus 197 ~~--------~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf 243 (375)
.. .....||+.|+|||++.. ...|+..+|+|+..+-..+.+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 21 235678999999999865 234677889999988888877766555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=181.90 Aligned_cols=146 Identities=18% Similarity=0.190 Sum_probs=114.5
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch----------------HHHHHHHHHHHHHHhcCCCCeee
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR----------------IDAKRTLREIKLLRHMDHENIIA 103 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~~iv~ 103 (375)
..+.+++.||+|++|.||+|.+ .+|+.||+|++....... .....+.+|+.++++++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 3344679999999999999999 889999999986432111 23566889999999998 4 66
Q ss_pred eceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCE
Q 017231 104 IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDL 182 (375)
Q Consensus 104 ~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i 182 (375)
+++++.. +..++||||++| +|.+ + .......++.||+.||.+||++|++|+||||+||+++ ++.+
T Consensus 166 v~~~~~~------~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYAW------EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEEE------ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred cCeEEec------cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 6665532 335999999974 8877 3 2234557999999999999999999999999999999 9999
Q ss_pred EEeecccccccCCCCccccccccccccCchhcc
Q 017231 183 KIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 215 (375)
Q Consensus 183 ~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 215 (375)
+|+|||++.. +..+.|||.+.
T Consensus 232 kl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 232 WIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp EECCCTTCEE------------TTSTTHHHHHH
T ss_pred EEEECCCCeE------------CCCCCHHHHHH
Confidence 9999998843 33357788774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3e-20 Score=164.71 Aligned_cols=137 Identities=16% Similarity=0.119 Sum_probs=106.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcE--EEEEEecCcccc----------------------hHHHHHHHHHHHHHHhcCC
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREE--VAIKKIGNAFDN----------------------RIDAKRTLREIKLLRHMDH 98 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~----------------------~~~~~~~~~e~~~l~~l~h 98 (375)
++.+.||+|++|.||+|.+..+|+. ||||++...... ......+.+|+.++.++.|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 3789999999999999998778888 999987543211 0112357889999999988
Q ss_pred CCe--eeeceeecCCCCCCcCcEEEEEeCCC--C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCC
Q 017231 99 ENI--IAIKDIIRPPQRETFNDVYIVYELMD--T----DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH-SANVLHRDL 169 (375)
Q Consensus 99 ~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~--g----~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh-~~~i~H~di 169 (375)
+++ +.++.. ...++||||++ | +|.+.... .++..+..++.||+.+|.+|| +.|++|+||
T Consensus 130 ~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 130 AGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp TTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred CCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 764 333332 23489999995 3 67766432 345678899999999999999 999999999
Q ss_pred CCCceEEecCCCEEEeeccccccc
Q 017231 170 KPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 170 ~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
||+|||++. .++|+|||++...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999988 9999999998554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.4e-17 Score=152.20 Aligned_cols=137 Identities=13% Similarity=0.106 Sum_probs=97.9
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc---------------hHH-----HHHHHHHHHHHHhcCCCCe
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN---------------RID-----AKRTLREIKLLRHMDHENI 101 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------------~~~-----~~~~~~e~~~l~~l~h~~i 101 (375)
+++.+.||.|++|.||+|.+. +|+.||||+++..... ... ......|...|.++.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 558999999999999999985 5899999987532110 000 0112356777777754443
Q ss_pred e--eeceeecCCCCCCcCcEEEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec
Q 017231 102 I--AIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA 178 (375)
Q Consensus 102 v--~~~~~~~~~~~~~~~~~~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~ 178 (375)
. .+++.. ..++||||++| +|..+ ........++.||+.+|.+||+.|++||||||.|||++.
T Consensus 176 ~vp~p~~~~---------~~~LVME~i~G~~L~~l------~~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIAQS---------RHTIVMSLVDALPMRQV------SSVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEEEE---------TTEEEEECCSCEEGGGC------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred CCCeeeecc---------CceEEEEecCCccHhhh------cccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence 2 222221 12799999986 55433 223345678999999999999999999999999999988
Q ss_pred CCC----------EEEeecccccccC
Q 017231 179 NCD----------LKIGDFGLARTTS 194 (375)
Q Consensus 179 ~~~----------i~l~Df~~~~~~~ 194 (375)
+|. +.|+||+.+....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCcccccccccceEEEEeCCcccCC
Confidence 873 8999999875543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=2.9e-11 Score=106.83 Aligned_cols=133 Identities=12% Similarity=0.092 Sum_probs=100.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+...++.|+.+.||.+... +..+++|+...... .....+..|+.+++.+. +..++++++++... +..++|
T Consensus 18 ~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv 88 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-----GWSNLL 88 (263)
T ss_dssp EEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEE
T ss_pred eEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-----CceEEE
Confidence 5777888888999999743 67899999854211 11234778999999884 66677888777433 557999
Q ss_pred EeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 017231 123 YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS---------------------------------------- 161 (375)
Q Consensus 123 ~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~---------------------------------------- 161 (375)
||+++| +|.+.+. +......++.+++.++..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 999987 7766521 223345788999999999998
Q ss_pred -------------------CCccccCCCCCceEEecCCCEEEeecccc
Q 017231 162 -------------------ANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 162 -------------------~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
..++|||++|.||+++.++.+.|+||+.+
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 34899999999999987555679999876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=6.8e-10 Score=102.72 Aligned_cols=142 Identities=11% Similarity=0.184 Sum_probs=102.7
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEec--CcccchHHHHHHHHHHHHHHhcC--CCCeeeeceeecCCCCCCcCcE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIG--NAFDNRIDAKRTLREIKLLRHMD--HENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
-++.|+.|..+.||++... +..+++|+.. ... .......+..|+.+++.+. +..+++++..+.... ..+..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSC
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCe
Confidence 4788999999999999754 4689999875 221 1112346778999999997 445677777765442 12456
Q ss_pred EEEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 017231 120 YIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS------------------------------------- 161 (375)
Q Consensus 120 ~lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~------------------------------------- 161 (375)
++|||+++| .+.+. ....++..+...++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 899999987 44321 12347888889999999999999997
Q ss_pred ---------------------CCccccCCCCCceEEecCCC--EEEeecccccc
Q 017231 162 ---------------------ANVLHRDLKPSNLLLNANCD--LKIGDFGLART 192 (375)
Q Consensus 162 ---------------------~~i~H~di~p~NIli~~~~~--i~l~Df~~~~~ 192 (375)
..++|||+++.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987764 68999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.07 E-value=2.2e-10 Score=103.50 Aligned_cols=187 Identities=17% Similarity=0.190 Sum_probs=119.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCe--eeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENI--IAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--v~~~~~~~~~~~~~~~~~~ 120 (375)
-++.++.|....||.+. ..+++|+.... .....+..|..+++.+. +..+ +.++...... ......|
T Consensus 24 ~i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~ 92 (304)
T 3sg8_A 24 TIEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSF 92 (304)
T ss_dssp CCCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSC
T ss_pred eeEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcce
Confidence 35679999999999983 46999986432 34567889999998884 4333 3333332221 2223458
Q ss_pred EEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 017231 121 IVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-------------------------------------- 161 (375)
Q Consensus 121 lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-------------------------------------- 161 (375)
+||++++| ++.+... ..++..+...++.+++..+..||+
T Consensus 93 ~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp EEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred EEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 89999987 5543222 347788888888888888888885
Q ss_pred --------------------CCccccCCCCCceEEec--CCCEEEeecccccccCCCCccccccccccccCchhcc----
Q 017231 162 --------------------ANVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL---- 215 (375)
Q Consensus 162 --------------------~~i~H~di~p~NIli~~--~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~---- 215 (375)
..++|+|++|.||+++. .+.+.|+||+.+.......-.........-..|+...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 13799999999999998 4567899999876543221000000000001222111
Q ss_pred cCCC---------CCccchhHHHHHHHHHHhhCCCCC
Q 017231 216 NCSE---------YTAAIDIWSVGCILGEIMTRQPLF 243 (375)
Q Consensus 216 ~~~~---------~~~~~Di~slG~il~~l~~g~~pf 243 (375)
.... .....+.|+++.++|.+.+|..+|
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1000 112358999999999999998666
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.06 E-value=2.9e-10 Score=99.99 Aligned_cols=126 Identities=13% Similarity=0.096 Sum_probs=88.6
Q ss_pred eecc-CCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCC--eeeeceeecCCCCCCcCcEEEE
Q 017231 46 RPVG-RGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 46 ~~lg-~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~~~~~~~~lv 122 (375)
..++ .|..+.||.+.. .+|..+++|+.... ....+..|+.+++.+.+.+ +++++...... +..++|
T Consensus 25 ~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~~~~~v 93 (264)
T 1nd4_A 25 AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLL 93 (264)
T ss_dssp EECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEE
T ss_pred EecccCCCCceEEEEec-CCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----CCCEEE
Confidence 4454 556699999964 45678999997543 1234668888888885434 45577766433 447999
Q ss_pred EeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 017231 123 YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN-------------------------------------- 163 (375)
Q Consensus 123 ~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~-------------------------------------- 163 (375)
||+++| +| + . ...+ ...++.+++.+|..||+..
T Consensus 94 ~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 999987 55 3 1 1122 2356677777788887643
Q ss_pred --------------------ccccCCCCCceEEecCCCEEEeecccc
Q 017231 164 --------------------VLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 164 --------------------i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
++|+|++|.||+++.++.+.|+||+.+
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 999999999999987655679999976
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=7.1e-07 Score=80.43 Aligned_cols=136 Identities=21% Similarity=0.209 Sum_probs=92.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCC---CeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE---NIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~ 120 (375)
-++.++.|....||.+ +..+++|+... ......+..|..+|+.+.+. .+++++.+.... .+..+
T Consensus 23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----~g~~~ 89 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----DGNPF 89 (306)
T ss_dssp CEEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT----TSCEE
T ss_pred eeeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC----CCceE
Confidence 4677889999999999 56799998532 23456788999999999642 244555444321 24568
Q ss_pred EEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 017231 121 IVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA------------------------------------- 162 (375)
Q Consensus 121 lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~------------------------------------- 162 (375)
++|++++| ++.+... ..++..+...++.++...|..||+.
T Consensus 90 ~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~ 167 (306)
T 3tdw_A 90 VGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES 167 (306)
T ss_dssp EEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred EEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence 99999987 5544211 2245555555555555555555532
Q ss_pred -----------------------CccccCCCCCceEEec---CCCE-EEeecccccccC
Q 017231 163 -----------------------NVLHRDLKPSNLLLNA---NCDL-KIGDFGLARTTS 194 (375)
Q Consensus 163 -----------------------~i~H~di~p~NIli~~---~~~i-~l~Df~~~~~~~ 194 (375)
.++|+|+++.||+++. ++.+ .|+||+.+....
T Consensus 168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3589999999999987 4665 899999875543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.54 E-value=1.4e-06 Score=76.94 Aligned_cols=130 Identities=20% Similarity=0.234 Sum_probs=88.9
Q ss_pred ccCCcce-EEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEEEeC
Q 017231 48 VGRGAYG-IVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIVYEL 125 (375)
Q Consensus 48 lg~G~~g-~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 125 (375)
+..|..+ .||.+.....+..+++|+... .....+..|...|+.+. +-.+++++.+.... +..++|||+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~ 101 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTA 101 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEEC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEe
Confidence 4444444 689998888888899998632 23556788999999884 33355666665433 457999999
Q ss_pred CCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 017231 126 MDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA------------------------------------------ 162 (375)
Q Consensus 126 ~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~------------------------------------------ 162 (375)
++| ++.+.... .......+..++...|..||+.
T Consensus 102 l~G~~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 102 IPGKTAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp CCSEEHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred eCCccccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 987 66555432 1222334555555555555531
Q ss_pred ----------------CccccCCCCCceEEecCCCEEEeeccccc
Q 017231 163 ----------------NVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 163 ----------------~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.++|||+++.||+++.++.+-|+||+.+.
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 17899999999999887767799998763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=4.4e-06 Score=78.06 Aligned_cols=78 Identities=14% Similarity=0.096 Sum_probs=47.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc--c---hHHHHHHHHHHHHHHhcCC--CC-eeeeceeecCCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD--N---RIDAKRTLREIKLLRHMDH--EN-IIAIKDIIRPPQRET 115 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h--~~-iv~~~~~~~~~~~~~ 115 (375)
-++.||.|..+.||.+....++..+++|....... . ......+..|..+++.+.. +. +++++.+. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~---- 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--T---- 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--T----
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--C----
Confidence 36789999999999998766678899998643211 0 0122345678888887732 33 34454432 1
Q ss_pred cCcEEEEEeCCCC
Q 017231 116 FNDVYIVYELMDT 128 (375)
Q Consensus 116 ~~~~~lv~e~~~g 128 (375)
...++|||+++|
T Consensus 108 -~~~~lvmE~l~g 119 (397)
T 2olc_A 108 -EMAVTVMEDLSH 119 (397)
T ss_dssp -TTTEEEECCCTT
T ss_pred -CccEEEEEeCCC
Confidence 123799999975
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=2.4e-05 Score=71.16 Aligned_cols=29 Identities=28% Similarity=0.370 Sum_probs=26.7
Q ss_pred CCccccCCCCCceEEecCCCEEEeecccc
Q 017231 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 162 ~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
..++|||+++.||+++.++.+.|+||+.+
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 57999999999999988889999999976
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.04 E-value=4.8e-05 Score=63.67 Aligned_cols=99 Identities=16% Similarity=0.121 Sum_probs=67.3
Q ss_pred CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEeecccccccCCCCccccccccc
Q 017231 129 DLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTR 206 (375)
Q Consensus 129 ~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~ 206 (375)
+|.+.+.. +.+++++++|.++.|.+.+|..+-. ..-...=+.|..|++..+|.|.+.+ ..+. ....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~ 101 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP 101 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence 79998876 4679999999999999999887632 2222334557899999999998874 1110 1122
Q ss_pred cccCchhcccCCCCCccchhHHHHHHHHHHhhCCC
Q 017231 207 WYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP 241 (375)
Q Consensus 207 ~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~ 241 (375)
.+.|||... ...+.+.=|||||+++|.-+-...
T Consensus 102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp -----CCSS--SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCC
Confidence 356888763 356788899999999999886543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.89 E-value=0.0001 Score=65.91 Aligned_cols=68 Identities=10% Similarity=0.079 Sum_probs=41.6
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe-eeeceeecCCCCCCcCcEEEEE
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv~ 123 (375)
++.|+.|....+|++ ..+++|+........ .....|+.+++.+...++ ++++...... -++++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~~~~~-------~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHVDPAT-------GVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEECTTT-------CCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEEECCC-------CEEEE
Confidence 788999999999999 468999875421111 112357777776642222 4555443221 26899
Q ss_pred eCC-CC
Q 017231 124 ELM-DT 128 (375)
Q Consensus 124 e~~-~g 128 (375)
||+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=4.4e-05 Score=70.09 Aligned_cols=83 Identities=8% Similarity=0.096 Sum_probs=51.2
Q ss_pred Ceeec-cCCcceEEEEEEeC---C---CCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcC-C--CCeeeeceeecCCC
Q 017231 44 PIRPV-GRGAYGIVCAAMNS---E---TREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMD-H--ENIIAIKDIIRPPQ 112 (375)
Q Consensus 44 i~~~l-g~G~~g~Vy~~~~~---~---~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~ 112 (375)
.++.| +.|....+|.+... . ++..+++|+...... .......+..|+.+++.+. + -.+++++.......
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~ 103 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD 103 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence 35778 88989999998653 1 256899998643210 0000134567888888774 2 34566776654331
Q ss_pred CCCcCcEEEEEeCCCC
Q 017231 113 RETFNDVYIVYELMDT 128 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~g 128 (375)
..+..++|||+++|
T Consensus 104 --~~g~~~~v~e~l~G 117 (357)
T 3ats_A 104 --VLGTPFFLMDYVEG 117 (357)
T ss_dssp --TTSSCEEEEECCCC
T ss_pred --ccCCceEEEEecCC
Confidence 11345899999976
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00027 Score=66.40 Aligned_cols=78 Identities=9% Similarity=-0.005 Sum_probs=45.8
Q ss_pred hCCccccCCCCCceEEecCCCEEEeecccccccCCCCccccccc--cccccCchhcccCC--CCCccchhHHHHHHHHHH
Q 017231 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV--TRWYRAPELLLNCS--EYTAAIDIWSVGCILGEI 236 (375)
Q Consensus 161 ~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~--~~~~~~Di~slG~il~~l 236 (375)
...++|||+++.||+++.++ +.++||+.+.......-...... ...|++|+...... .......+..+...+|..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 45799999999999998776 99999998865442211111111 23355555443100 011234445667777776
Q ss_pred hhC
Q 017231 237 MTR 239 (375)
Q Consensus 237 ~~g 239 (375)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00074 Score=60.63 Aligned_cols=73 Identities=11% Similarity=0.071 Sum_probs=54.1
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC---CCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD---HENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
-++.|+.|....+|.+.. .+..+++|+.... ....+..|+..|+.|. ...+++++...... +..+
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~ 107 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSF 107 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceE
Confidence 367899999999999975 4678999987432 3556778988888884 35566777665432 4579
Q ss_pred EEEeCCCC
Q 017231 121 IVYELMDT 128 (375)
Q Consensus 121 lv~e~~~g 128 (375)
+|||+++|
T Consensus 108 lvme~l~G 115 (312)
T 3jr1_A 108 LLLEALNK 115 (312)
T ss_dssp EEEECCCC
T ss_pred EEEEeccC
Confidence 99999975
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0006 Score=60.45 Aligned_cols=72 Identities=10% Similarity=-0.008 Sum_probs=49.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCC---CeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE---NIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~iv~~~~~~~~~~~~~~~~~~ 120 (375)
-++.+|.|..+.||+++. .+|+.|++|+...... .....+..|+..|+.|... .+++++... .-+
T Consensus 19 ~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~ 86 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT 86 (288)
T ss_dssp EEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred EEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence 588899999999999985 4578999998654321 1223467899999888422 233444332 127
Q ss_pred EEEeCCC
Q 017231 121 IVYELMD 127 (375)
Q Consensus 121 lv~e~~~ 127 (375)
++||+++
T Consensus 87 lv~e~l~ 93 (288)
T 3f7w_A 87 LAMEWVD 93 (288)
T ss_dssp EEEECCC
T ss_pred EEEEeec
Confidence 8999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00048 Score=63.62 Aligned_cols=136 Identities=14% Similarity=0.188 Sum_probs=79.9
Q ss_pred CeeeccCCcceEEEEEEeCC-------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSE-------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRET 115 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 115 (375)
-++.|..|-...+|++.... ++..|++|+..... .......+|..+++.|. +.-.++++..+..
T Consensus 54 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----- 125 (379)
T 3feg_A 54 RVYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----- 125 (379)
T ss_dssp CCEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-----
T ss_pred EEEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-----
Confidence 46788889999999998643 35789999863321 12344558888888884 3223556655521
Q ss_pred cCcEEEEEeCCCC-CHH--------------HHH---HhC-----CCCC--HHHHHHHHHHHHH----------------
Q 017231 116 FNDVYIVYELMDT-DLH--------------QII---RSH-----QDLT--DDHCRYFLYQLLR---------------- 154 (375)
Q Consensus 116 ~~~~~lv~e~~~g-~L~--------------~~l---~~~-----~~l~--~~~~~~i~~qi~~---------------- 154 (375)
.+|+||++| +|. +.+ ... +... ..++..+..++..
T Consensus 126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 289999976 211 111 111 1111 3455555544422
Q ss_pred ---HHHHHH----hC----CccccCCCCCceEEecC----CCEEEeeccccc
Q 017231 155 ---GLKYVH----SA----NVLHRDLKPSNLLLNAN----CDLKIGDFGLAR 191 (375)
Q Consensus 155 ---al~~Lh----~~----~i~H~di~p~NIli~~~----~~i~l~Df~~~~ 191 (375)
.+..|. .. .++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 223332 22 49999999999999876 789999999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00079 Score=63.37 Aligned_cols=72 Identities=13% Similarity=0.150 Sum_probs=48.3
Q ss_pred CeeeccCCcceEEEEEEeCC-------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe-eeeceeecCCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSE-------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRET 115 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~ 115 (375)
-++.|+.|....+|++.... .+..+++|+.... .. ...+..|..+++.+...++ +++++.+..
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC-----
Confidence 36788999999999998653 2578999988432 11 1344578888888853333 556655421
Q ss_pred cCcEEEEEeCCCC
Q 017231 116 FNDVYIVYELMDT 128 (375)
Q Consensus 116 ~~~~~lv~e~~~g 128 (375)
.+|++|++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 388999875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00072 Score=60.84 Aligned_cols=141 Identities=12% Similarity=0.115 Sum_probs=74.2
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCC--eeeeceeecCCC-CCCcCcEEE
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQ-RETFNDVYI 121 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~-~~~~~~~~l 121 (375)
++.|+.|....+|.+.... ..+++|+..... ....+..|+.++..+...+ +++++....... ....+..++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~--g~~vlk~~~~~~----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTK--DPLILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEECC---EEEEEEEESS--CCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eeccCCCcccceEEEEeCC--ccEEEEEeCCCC----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 6778889889999997543 368999885421 1233456777777664222 233332110000 001134689
Q ss_pred EEeCCCC-CH-----H------HH---HHh-CCC--------CCHHHHHH---------------HHHHHHHHHHHHHh-
Q 017231 122 VYELMDT-DL-----H------QI---IRS-HQD--------LTDDHCRY---------------FLYQLLRGLKYVHS- 161 (375)
Q Consensus 122 v~e~~~g-~L-----~------~~---l~~-~~~--------l~~~~~~~---------------i~~qi~~al~~Lh~- 161 (375)
++++++| .+ . .. ++. ... ........ +...+...+..+..
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 9999976 21 0 00 111 011 11110000 00113344455542
Q ss_pred ------CCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 162 ------ANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 162 ------~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 369999999999999876556899998763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0044 Score=58.71 Aligned_cols=73 Identities=21% Similarity=0.207 Sum_probs=46.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe-eeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI-IAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~~~~~~lv 122 (375)
-++.|+.|....+|++.....+..+++|+.......... -..|+.+++.|...++ +++++.+. + .+|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id---R~~E~~vl~~L~~~gl~P~ll~~~~-~--------G~v 179 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN---REREKKISCILYNKNIAKKIYVFFT-N--------GRI 179 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC---HHHHHHHHHHHTTSSSBCCEEEEET-T--------EEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC---HHHHHHHHHHHHhcCCCCCEEEEeC-C--------eEE
Confidence 367889999999999987654578999987432111111 1478888888864444 45666552 1 259
Q ss_pred EeCCCC
Q 017231 123 YELMDT 128 (375)
Q Consensus 123 ~e~~~g 128 (375)
+||++|
T Consensus 180 ~e~I~G 185 (458)
T 2qg7_A 180 EEFMDG 185 (458)
T ss_dssp EECCCS
T ss_pred EEeeCC
Confidence 999975
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0021 Score=58.14 Aligned_cols=33 Identities=27% Similarity=0.360 Sum_probs=27.7
Q ss_pred CCccccCCCCCceEEecC----CCEEEeecccccccC
Q 017231 162 ANVLHRDLKPSNLLLNAN----CDLKIGDFGLARTTS 194 (375)
Q Consensus 162 ~~i~H~di~p~NIli~~~----~~i~l~Df~~~~~~~ 194 (375)
..++|||+++.||+++.+ +.+.|+||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 369999999999999874 679999999875543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.014 Score=52.41 Aligned_cols=77 Identities=13% Similarity=0.113 Sum_probs=45.6
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCC--eeeeceeecCCCC--CCcCcEE
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN--IIAIKDIIRPPQR--ETFNDVY 120 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--iv~~~~~~~~~~~--~~~~~~~ 120 (375)
+..|+ |....||.+... +|+.+++|+...... ....+..|..+++.+.... +++++.. .+.. ...+..+
T Consensus 31 ~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~ 103 (328)
T 1zyl_A 31 LTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYF 103 (328)
T ss_dssp CEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEE
T ss_pred EEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEE
Confidence 45566 778899988543 456799999853211 2344566788877774222 3444433 1110 0124467
Q ss_pred EEEeCCCC
Q 017231 121 IVYELMDT 128 (375)
Q Consensus 121 lv~e~~~g 128 (375)
+++++++|
T Consensus 104 ~l~~~i~G 111 (328)
T 1zyl_A 104 AVFPSVGG 111 (328)
T ss_dssp EEEECCCC
T ss_pred EEEEecCC
Confidence 89999986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.005 Score=56.51 Aligned_cols=73 Identities=14% Similarity=0.165 Sum_probs=42.2
Q ss_pred CeeeccCCcceEEEEEEeCC--------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCC-eeeeceeecCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSE--------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN-IIAIKDIIRPPQRE 114 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~ 114 (375)
-++.|+.|....+|++.... .+..+++|+...... .......|..+++.+...+ .++++... .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T---
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---ceecHHHHHHHHHHHHhcCCCCceEEec--C---
Confidence 36778889889999997643 136899998744211 1112346777777774223 34555443 1
Q ss_pred CcCcEEEEEeCCCC
Q 017231 115 TFNDVYIVYELMDT 128 (375)
Q Consensus 115 ~~~~~~lv~e~~~g 128 (375)
+ ++|++|++|
T Consensus 109 --~--~~v~e~i~G 118 (369)
T 3c5i_A 109 --G--GRIEEWLYG 118 (369)
T ss_dssp --T--EEEEECCCS
T ss_pred --C--cEEEEEecC
Confidence 1 589999976
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0064 Score=55.17 Aligned_cols=30 Identities=20% Similarity=0.287 Sum_probs=26.9
Q ss_pred CccccCCCCCceEEecCCCEEEeecccccc
Q 017231 163 NVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
.++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 599999999999999888999999987644
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.37 E-value=0.0093 Score=55.78 Aligned_cols=73 Identities=10% Similarity=0.074 Sum_probs=46.0
Q ss_pred CeeeccCCcceEEEEEEeCCC-------CcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSET-------REEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRET 115 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 115 (375)
-++.|..|-...+|++..... +..|++|+....... .-...+|..+++.+. +.-.+++++.+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~~------ 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADFP------ 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEET------
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEcC------
Confidence 467888888999999987531 578999986432111 111236777777774 222345554331
Q ss_pred cCcEEEEEeCCCC
Q 017231 116 FNDVYIVYELMDT 128 (375)
Q Consensus 116 ~~~~~lv~e~~~g 128 (375)
-+.|++|++|
T Consensus 145 ---~~~I~efI~G 154 (424)
T 3mes_A 145 ---EGRIEEFIDG 154 (424)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CCEEEEEeCC
Confidence 1689999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.06 E-value=0.03 Score=51.98 Aligned_cols=28 Identities=29% Similarity=0.437 Sum_probs=24.3
Q ss_pred ccccCCCCCceEE------ecCCCEEEeeccccc
Q 017231 164 VLHRDLKPSNLLL------NANCDLKIGDFGLAR 191 (375)
Q Consensus 164 i~H~di~p~NIli------~~~~~i~l~Df~~~~ 191 (375)
++|+|+.+.||++ +.++.+.++||..+.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 7899999999999 346679999999874
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=87.08 E-value=0.065 Score=50.72 Aligned_cols=62 Identities=13% Similarity=0.057 Sum_probs=16.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEE------EEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceee
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAI------KKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDII 108 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vai------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 108 (375)
+.+.|| ||.||.+....+..+||+ |..+...........+.+|..+.+.++|+|+++.+.+.
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 456776 999999988765567888 66544333344455678888999999999999887754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 375 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-101 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-99 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-96 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-84 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-79 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-77 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-75 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-74 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-74 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-71 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-70 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-69 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-69 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-69 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-68 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-67 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-67 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-66 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-66 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-66 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-65 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-65 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-65 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-65 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-61 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-61 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-56 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-56 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-55 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-53 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-52 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-51 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-50 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-49 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-46 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-45 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-43 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-37 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-22 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 300 bits (769), Expect = e-101
Identities = 175/345 (50%), Positives = 236/345 (68%), Gaps = 7/345 (2%)
Query: 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK 91
G +F+V +Y + +G GAYG+VC+A ++ + VAIKKI + F+++ +RTLREIK
Sbjct: 1 GQVFDVGPRYTN-LSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIK 58
Query: 92 LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQ 151
+L HENII I DIIR P E DVY+V LM DL++++++ L++DH YFLYQ
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR----TTSETDFMTEYVVTRW 207
+LRGLKY+HSANVLHRDLKPSNLLLN CDLKI DFGLAR T F+TEYV TRW
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267
YRAPE++LN YT +IDIWSVGCIL E+++ +P+FPGK Y+ QL I ++GSP + L
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237
Query: 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPY 327
+ + AR Y+ LP K ++ FPN A+DLL+KML F+P++RI V++AL HPY
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297
Query: 328 LAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPD 372
L +D ++EP+ PF FD E +E +KELI+ E+ +F P
Sbjct: 298 LEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPG 342
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 296 bits (757), Expect = 4e-99
Identities = 171/350 (48%), Positives = 234/350 (66%), Gaps = 6/350 (1%)
Query: 25 YVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK 84
+ + + ++EV +Y + PVG GAYG VCAA +++T VA+KK+ F + I AK
Sbjct: 4 FYRQELNKTIWEVPERYQN-LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 85 RTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDD 143
RT RE++LL+HM HEN+I + D+ P + E FNDVY+V LM DL+ I++ Q LTDD
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDD 121
Query: 144 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 203
H ++ +YQ+LRGLKY+HSA+++HRDLKPSNL +N +C+LKI DFGLAR T + MT YV
Sbjct: 122 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYV 179
Query: 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263
TRWYRAPE++LN Y +DIWSVGCI+ E++T + LFPG D++ QL+LI L+G+P
Sbjct: 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
L + S++AR Y++ L Q PK NF+ F +P AVDLLEKMLV D ++RIT +AL
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299
Query: 324 CHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDP 373
H Y A HD ++EPV P+ FE + K L Y E + F P P
Sbjct: 300 AHAYFAQYHDPDDEPVAD-PYDQSFESRDLLIDEWKSLTYDEVISFVPPP 348
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 289 bits (740), Expect = 2e-96
Identities = 152/348 (43%), Positives = 225/348 (64%), Gaps = 6/348 (1%)
Query: 25 YVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK 84
+ + V +EV Y ++PVG GAYG VC+A++ T +VAIKK+ F + + AK
Sbjct: 4 FYRQEVTKTAWEVRAVYRD-LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK 62
Query: 85 RTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDD 143
R RE++LL+HM HEN+I + D+ P + + F D Y+V M TDL ++++ H+ L +D
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGED 121
Query: 144 HCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYV 203
++ +YQ+L+GL+Y+H+A ++HRDLKP NL +N +C+LKI DFGLAR MT YV
Sbjct: 122 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYV 179
Query: 204 VTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263
VTRWYRAPE++LN YT +DIWSVGCI+ E++T + LF G D++ QL+ I ++ G+P
Sbjct: 180 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239
Query: 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
+ L+SD A+ Y++ LP+ K++F++ N SP AV+LLEKMLV D +R+T EAL
Sbjct: 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299
Query: 324 CHPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371
HPY LHD +EP + F+ T + K + Y+E + F P
Sbjct: 300 AHPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (658), Expect = 3e-84
Identities = 148/358 (41%), Positives = 217/358 (60%), Gaps = 19/358 (5%)
Query: 24 RYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDA 83
++ V + F V ++Y ++P+G GA GIVCAA ++ VAIKK+ F N+ A
Sbjct: 2 QFYSVEVGDSTFTVLKRYQN-LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 60
Query: 84 KRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTD 142
KR RE+ L++ ++H+NII++ ++ P + E F DVY+V ELMD +L Q+I+ D
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--H 118
Query: 143 DHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 202
+ Y LYQ+L G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLART + MT Y
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178
Query: 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSP 262
VVTR+YRAPE++L Y +DIWSVGCI+GE++ + LFPG+DY+ Q + E +G+P
Sbjct: 179 VVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 263 DETSLGFLRSDNARRYVRMLPQFPKQNFSARFPN------------KSPGAVDLLEKMLV 310
+ L+ R YV P++ F FP+ K+ A DLL KMLV
Sbjct: 238 CPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 311 FDPNRRITVDEALCHPYLAPLHDINEEPVC-PRPFSFDFEHPSFTEENIKELIYRESV 367
DP +RI+VD+AL HPY+ +D E P+ + + T E KELIY+E +
Sbjct: 297 IDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (626), Expect = 2e-79
Identities = 100/329 (30%), Positives = 170/329 (51%), Gaps = 20/329 (6%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G G++G+V A ++ E VAIKK+ D + RE++++R +DH NI+ +
Sbjct: 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRKLDHCNIVRL 78
Query: 105 KDIIRPP-QRETFNDVYIVYELMDTDLHQIIRSH----QDLTDDHCRYFLYQLLRGLKYV 159
+ +++ + +V + + ++++ R + Q L + + ++YQL R L Y+
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 160 HSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 218
HS + HRD+KP NLLL+ + LK+ DFG A+ + Y+ +R+YRAPEL+ +
Sbjct: 139 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278
+YT++ID+WS GC+L E++ QP+FPG V QL I +++G+P +R N
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE---QIREMNPNYT 255
Query: 279 VRMLPQFPKQNFSARF-PNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEE 337
PQ ++ F P P A+ L ++L + P R+T EA H + L D N +
Sbjct: 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVK 315
Query: 338 ----PVCPRPFSFDFEHPSFTEENIKELI 362
P F+F + S LI
Sbjct: 316 LPNGRDTPALFNFTTQELSSNPPLATILI 344
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 2e-77
Identities = 106/304 (34%), Positives = 153/304 (50%), Gaps = 13/304 (4%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRID---AKRTLREIKLLRHMDHENI 101
+ +G G + V A + T + VAIKKI + + LREIKLL+ + H NI
Sbjct: 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVH 160
I + D +++ +V++ M+TD I + LT H + ++ L+GL+Y+H
Sbjct: 63 IGLLDA-----FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSE 219
+LHRDLKP+NLLL+ N LK+ DFGLA++ S T VVTRWYRAPELL
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
Y +D+W+VGCIL E++ R P PG + QL I E +G+P E + S
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT- 236
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPV 339
FP F +DL++ + +F+P RIT +AL Y +
Sbjct: 237 --FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294
Query: 340 CPRP 343
PRP
Sbjct: 295 LPRP 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 2e-75
Identities = 96/294 (32%), Positives = 155/294 (52%), Gaps = 10/294 (3%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G+G +G V A + +T ++VA+KK+ + LREIK+L+ + HEN++ +
Sbjct: 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74
Query: 105 KDIIR---PPQRETFNDVYIVYELMDTDLHQI-IRSHQDLTDDHCRYFLYQLLRGLKYVH 160
+I R P +Y+V++ + DL + T + + LL GL Y+H
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134
Query: 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLAR-----TTSETDFMTEYVVTRWYRAPELLL 215
+LHRD+K +N+L+ + LK+ DFGLAR S+ + T VVT WYR PELLL
Sbjct: 135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLL 194
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+Y ID+W GCI+ E+ TR P+ G HQL LI++L GS + +
Sbjct: 195 GERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254
Query: 276 RRYVRMLPQFPKQ-NFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ ++ ++ + + P A+DL++K+LV DP +RI D+AL H +
Sbjct: 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 1e-74
Identities = 112/292 (38%), Positives = 162/292 (55%), Gaps = 10/292 (3%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G G YG+V A N T E VA+KKI + +REI LL+ ++H NI+ +
Sbjct: 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSA 162
D+ T N +Y+V+E + DL + + + + + +L+QLL+GL + HS
Sbjct: 67 LDV-----IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPELLLNCSEYT 221
VLHRDLKP NLL+N +K+ DFGLAR T VVT WYRAPE+LL C Y+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 222 AAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281
A+DIWS+GCI E++TR+ LFPG + QL I +G+PDE + + Y
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV--WPGVTSMPDYKPS 239
Query: 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333
P++ +Q+FS P LL +ML +DPN+RI+ AL HP+ +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 2e-74
Identities = 64/299 (21%), Positives = 126/299 (42%), Gaps = 23/299 (7%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
I +G G G+V + + +A K I + + +RE+++L + I+
Sbjct: 11 ISELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHECNSPYIVGF 69
Query: 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
+ ++ I E MD L Q+++ + + +++GL Y+ +
Sbjct: 70 YGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 164 -VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA 222
++HRD+KPSN+L+N+ ++K+ DFG++ ++ +V TR Y +PE L + Y+
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG-THYSV 182
Query: 223 AIDIWSVGCILGEIMTRQPLFPGKDY-VHQLRLITELIGSPDETS----------LGFLR 271
DIWS+G L E+ + P D +L ++ G ET +
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242
Query: 272 SDNARRYVRMLPQFPKQNFSARFPNK--SPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ L + + P+ S D + K L+ +P R + + + H ++
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 2e-71
Identities = 99/298 (33%), Positives = 150/298 (50%), Gaps = 11/298 (3%)
Query: 45 IRPVGRGAYGIVCAAMNSETR-EEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHEN 100
+ +G GAYG V A + + VA+K++ T+RE+ +LRH+ +H N
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELM--DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
++ + D+ + + + +V+E + D + + + + ++QLLRGL +
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 218
+HS V+HRDLKP N+L+ ++ +K+ DFGLAR S +T VVT WYRAPE+LL S
Sbjct: 132 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-S 190
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278
Y +D+WSVGCI E+ R+PLF G V QL I ++IG P E +
Sbjct: 191 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDVALP 246
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336
+ Q + DLL K L F+P +RI+ AL HPY L E
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 222 bits (568), Expect = 3e-71
Identities = 69/327 (21%), Positives = 133/327 (40%), Gaps = 42/327 (12%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
+R +G G++G V A + E VAIKK+ + + + ++E++ L+ + H N I
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ + ++V E + + + L + + L+GL Y+HS
Sbjct: 80 YRGCY-----LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE--Y 220
N++HRD+K N+LL+ +K+GDFG A + +V T ++ APE++L E Y
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQY 191
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
+D+WS+G E+ R+P + + L I +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ----------------------N 229
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN-EEPV 339
P ++ S + ++ L P R T + L H ++ +
Sbjct: 230 ESPALQSGHW-------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDL 282
Query: 340 CPRPFSFDFEHPSFTEENIKELIYRES 366
R E + +K+++++E+
Sbjct: 283 IQRTKDAVRELDNLQYRKMKKILFQEA 309
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 218 bits (556), Expect = 8e-70
Identities = 102/286 (35%), Positives = 147/286 (51%), Gaps = 10/286 (3%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G G YG+V A N+ E A+KKI ++ T+REI +L+ + H NI+ +
Sbjct: 7 LEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
D+I +R + +V+E +D + L + FL QLL G+ Y H
Sbjct: 66 YDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTE-YVVTRWYRAPELLLNCSEYTA 222
VLHRDLKP NLL+N +LKI DFGLAR +VT WYRAP++L+ +Y+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 223 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282
IDIWSVGCI E++ PLFPG QL I ++G+P+ + + +Y
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN--WPNVTELPKYDPNF 238
Query: 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ + + +DLL KML DPN+RIT +AL H Y
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 1e-69
Identities = 67/286 (23%), Positives = 122/286 (42%), Gaps = 40/286 (13%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
RP+G+G +G V A +++ +A+K + + + RE+++ H+ H NI+
Sbjct: 11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILR 70
Query: 104 IKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ VY++ E +++ ++ + ++ +L L Y HS
Sbjct: 71 LYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA 222
V+HRD+KP NLLL + +LKI DFG + + T T Y PE++ +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEG-RMHDE 183
Query: 223 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282
+D+WS+G + E + +P F Y + I R+
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-----------------------SRVE 220
Query: 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
FP + GA DL+ ++L +P++R + E L HP++
Sbjct: 221 FTFP--------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 219 bits (560), Expect = 2e-69
Identities = 68/311 (21%), Positives = 126/311 (40%), Gaps = 39/311 (12%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+G GA+G+V T A K + ++ D + +EI+ + + H ++ +
Sbjct: 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES--DKETVRKEIQTMSVLRHPTLVNL 88
Query: 105 KDIIRPPQRETFNDVYIVYELMDTD--LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
D E N++ ++YE M ++ H +++D ++ Q+ +GL ++H
Sbjct: 89 HDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 163 NVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY 220
N +H DLKP N++ + +LK+ DFGL + T + APE+
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KPV 202
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
D+WSVG + +++ F G++ LR + + D++
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS--------------- 247
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVC 340
F S D + K+L+ DPN R+T+ +AL HP+L P + +
Sbjct: 248 ------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295
Query: 341 PRPFSFDFEHP 351
P
Sbjct: 296 PSSRYTKIRDS 306
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 3e-69
Identities = 102/291 (35%), Positives = 148/291 (50%), Gaps = 8/291 (2%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G G YG V A N ET E VA+K++ D+ LREI LL+ + H+NI+ +
Sbjct: 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164
D++ + + DL + + FL+QLL+GL + HS NV
Sbjct: 67 HDVLH----SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122
Query: 165 LHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEYTAA 223
LHRDLKP NLL+N N +LK+ +FGLAR + VVT WYR P++L Y+ +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 224 IDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282
ID+WS GCI E+ +PLFPG D QL+ I L+G+P E + + M
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242
Query: 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333
P + P + DLL+ +L +P +RI+ +EAL HPY +
Sbjct: 243 P--ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 3e-68
Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 38/288 (13%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +G GAYG V A+N T E VA+K + + + +EI + + ++HEN++
Sbjct: 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLH-QIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
R N Y+ E I + + + F +QL+ G+ Y+H
Sbjct: 69 YGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLAR---TTSETDFMTEYVVTRWYRAPELLLNCSEY 220
+ HRD+KP NLLL+ +LKI DFGLA + + + T Y APELL +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
+D+WS G +L ++ + + Q +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---------------------- 221
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
K+ + + + LL K+LV +P+ RIT+ + +
Sbjct: 222 ------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 212 bits (541), Expect = 5e-67
Identities = 88/303 (29%), Positives = 165/303 (54%), Gaps = 24/303 (7%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIA 103
+R +GRG Y V A+N E+V +K + + K+ REIK+L ++ NII
Sbjct: 40 VRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIIT 94
Query: 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ DI++ P T +V+E ++ TD Q+ ++ LTD R+++Y++L+ L Y HS
Sbjct: 95 LADIVKDPVSRTP---ALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSM 148
Query: 163 NVLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYT 221
++HRD+KP N++++ + L++ D+GLA V +R+++ PELL++ Y
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 222 AAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSP-DETSLGFLRSDNARRYV 279
++D+WS+GC+L ++ ++P F G D QL I +++G+ + + R+
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 280 RMLPQFPKQNFSARFPNK-----SPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334
+L + ++ + ++ SP A+D L+K+L +D R+T EA+ HPY + +
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY---FYTV 325
Query: 335 NEE 337
++
Sbjct: 326 VKD 328
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 8e-67
Identities = 77/295 (26%), Positives = 120/295 (40%), Gaps = 45/295 (15%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G G+YG + + K++ + + + E+ LLR + H NI+
Sbjct: 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68
Query: 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQII----RSHQDLTDDHCRYFLYQLLRGLKYV 159
D I T +YIV E + DL +I + Q L ++ + QL LK
Sbjct: 69 YDRI---IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 160 H-----SANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAPEL 213
H VLHRDLKP+N+ L+ ++K+GDFGLAR +T F +V T +Y +PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPE- 184
Query: 214 LLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSD 273
+N Y DIWS+GC+L E+ P F I E
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---------------- 228
Query: 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ P S +++ +ML R +V+E L +P +
Sbjct: 229 ------GKFRRIP--------YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (537), Expect = 1e-66
Identities = 73/321 (22%), Positives = 129/321 (40%), Gaps = 53/321 (16%)
Query: 35 FEVSRKYVPP------IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLR 88
+E + + P I +G GA+G V A N ET A K I + + + +
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMV 58
Query: 89 EIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDL--HQIIRSHQDLTDDHCR 146
EI +L DH NI+ + D N+++I+ E ++ + LT+ +
Sbjct: 59 EIDILASCDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQ 113
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVT 205
Q L L Y+H ++HRDLK N+L + D+K+ DFG++ T ++ T
Sbjct: 114 VVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGT 173
Query: 206 RWYRAPELLLNCS----EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGS 261
++ APE+++ + Y D+WS+G L E+ +P + + L I +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK---- 229
Query: 262 PDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE 321
+ A+ S D L+K L + + R T +
Sbjct: 230 ------------------------SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ 265
Query: 322 ALCHPYL-----APLHDINEE 337
L HP++ P+ ++ E
Sbjct: 266 LLQHPFVTVDSNKPIRELIAE 286
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 1e-66
Identities = 70/297 (23%), Positives = 130/297 (43%), Gaps = 38/297 (12%)
Query: 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKL 92
++ + +KY +G+GA G V AM+ T +EVAI+++ + + + EI +
Sbjct: 14 SVGDPKKKYTR-FEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILV 70
Query: 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQL 152
+R + NI+ D +++++V E + + + + + +
Sbjct: 71 MRENKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCREC 125
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART-TSETDFMTEYVVTRWYRAP 211
L+ L+++HS V+HRD+K N+LL + +K+ DFG T E + V T ++ AP
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 212 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271
E++ Y +DIWS+G + E++ +P + ++ + L LI G+P+
Sbjct: 186 EVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE-------- 235
Query: 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
Q P S D L + L D +R + E L H +L
Sbjct: 236 -----------LQNP--------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 211 bits (539), Expect = 3e-66
Identities = 64/293 (21%), Positives = 122/293 (41%), Gaps = 39/293 (13%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+ +G GA+G+V + T K I +D EI ++ + H +I +
Sbjct: 34 LEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD-LTDDHCRYFLYQLLRGLKYVHSA 162
D E ++ ++ E + +L I + +++ ++ Q GLK++H
Sbjct: 92 HDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 163 NVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY 220
+++H D+KP N++ +KI DFGLA + + + T + APE++
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPV 205
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
D+W++G + +++ F G+D + L+ + DE
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED--------------- 250
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333
F + SP A D ++ +L +P +R+TV +AL HP+L H
Sbjct: 251 ------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-65
Identities = 77/333 (23%), Positives = 136/333 (40%), Gaps = 40/333 (12%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIK-LLRHMDHENIIAI 104
+ +G G G V N T+E+ A+K + D + RE++ R +I+ I
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRI 70
Query: 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--LTDDHCRYFLYQLLRGLKYVHS 161
D+ + IV E +D +L I+ D T+ + + ++Y+HS
Sbjct: 71 VDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 162 ANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCS 218
N+ HRD+KP NLL + N LK+ DFG A+ T+ + +T T +Y APE +L
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VLGPE 188
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278
+Y + D+WS+G I+ ++ P F + + I
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ--------------- 233
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEP 338
+FP + S L+ +L +P +R+T+ E + HP++ + + P
Sbjct: 234 ----YEFPNP----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 285
Query: 339 VC-PRPFSFDFEHPSFTEENIKELIYRESVKFN 370
+ R D E +E + + V +
Sbjct: 286 LHTSRVLKEDKERWEDVKEEMTSALATMRVDYE 318
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 207 bits (527), Expect = 2e-65
Identities = 81/299 (27%), Positives = 133/299 (44%), Gaps = 46/299 (15%)
Query: 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK-------RTLREIKLLRHM 96
P +GRG +V ++ T +E A+K I A+ TL+E+ +LR +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 97 -DHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLR 154
H NII +KD ET ++V++LM +L + L++ R + LL
Sbjct: 67 SGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121
Query: 155 GLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELL 214
+ +H N++HRDLKP N+LL+ + ++K+ DFG + + + E T Y APE++
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181
Query: 215 L-----NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269
N Y +D+WS G I+ ++ P F + + LR+I
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-------------- 227
Query: 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
+ QF S + + S DL+ + LV P +R T +EAL HP+
Sbjct: 228 ---------MSGNYQFG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-65
Identities = 67/325 (20%), Positives = 135/325 (41%), Gaps = 41/325 (12%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH 95
E+ KY+ +GRG +GIV + + +++ K + D +EI +L
Sbjct: 2 ELYEKYMI-AEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNI 57
Query: 96 MDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLL 153
H NI+ + + E+ ++ +++E + D+ + I + +L + +++Q+
Sbjct: 58 ARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 154 RGLKYVHSANVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAP 211
L+++HS N+ H D++P N++ + +KI +FG AR D Y AP
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
Query: 212 ELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271
E+ + + A D+WS+G ++ +++ F + + I + DE +
Sbjct: 173 EVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA----- 226
Query: 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331
F S A+D ++++LV + R+T EAL HP+L
Sbjct: 227 ----------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264
Query: 332 HDINEEPVCPRPFSFDFEHPSFTEE 356
+ V + H ++
Sbjct: 265 IERVSTKVIRTLKHRRYYHTLIKKD 289
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 206 bits (525), Expect = 9e-65
Identities = 75/289 (25%), Positives = 126/289 (43%), Gaps = 38/289 (13%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+G GA+ V A + T++ VAIK I + EI +L + H NI+A+
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE-GSMENEIAVLHKIKHPNIVAL 72
Query: 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
DI E+ +Y++ +L+ +L I T+ ++Q+L +KY+H
Sbjct: 73 DDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 164 VLHRDLKPSNLLL---NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEY 220
++HRDLKP NLL + + + I DFGL++ ++ T Y APE+L Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPY 186
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
+ A+D WS+G I ++ P F ++ I + D
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD----------------- 229
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329
S + + S A D + ++ DP +R T ++AL HP++A
Sbjct: 230 ----------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-62
Identities = 59/293 (20%), Positives = 125/293 (42%), Gaps = 36/293 (12%)
Query: 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE 99
+++ +GRG++ V +++ET EVA ++ + + + +R E ++L+ + H
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
NI+ D + + +V ELM + L ++ + + R + Q+L+GL++
Sbjct: 69 NIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 159 VHSAN--VLHRDLKPSNLLLNA-NCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 215
+H+ ++HRDLK N+ + +KIGD GLA F + T + APE+
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYE 186
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+Y ++D+++ G + E+ T + + Q+
Sbjct: 187 E--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI----------------------- 221
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
Y R+ +F P +++E + + + R ++ + L H +
Sbjct: 222 --YRRVTSGVKPASFD---KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-61
Identities = 66/289 (22%), Positives = 117/289 (40%), Gaps = 42/289 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
+ +G G++ V A T E AIK + RE ++ +DH +
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ + +Y +L + IR + R++ +++ L+Y+H
Sbjct: 73 LYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLART---TSETDFMTEYVVTRWYRAPELLLNCSE 219
++HRDLKP N+LLN + ++I DFG A+ S+ +V T Y +PELL
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE-KS 186
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
+ D+W++GCI+ +++ P F + + I +
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI-----------------------I 223
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328
++ FP P A DL+EK+LV D +R+ +E + L
Sbjct: 224 KLEYDFP--------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-61
Identities = 75/318 (23%), Positives = 131/318 (41%), Gaps = 49/318 (15%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHEN 100
+G G + +V T + A K I + + + RE+ +L+ + H N
Sbjct: 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 74
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
+I + ++ E DV ++ EL+ L + + LT++ FL Q+L G+ Y+
Sbjct: 75 VITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 160 HSANVLHRDLKPSNLLLN----ANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 215
HS + H DLKP N++L +KI DFGLA + T + APE++
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV- 188
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
N D+WS+G I +++ F G L ++ + ++
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE---------- 238
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335
F N S A D + ++LV DP +R+T+ ++L HP++ P +
Sbjct: 239 -----------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP---KD 278
Query: 336 EEPVCPRPFSFDFEHPSF 353
+ +S HP F
Sbjct: 279 TQQALSSAWS----HPQF 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 186 bits (472), Expect = 3e-56
Identities = 77/338 (22%), Positives = 137/338 (40%), Gaps = 56/338 (16%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMDHEN 100
R +GRG +G V ++T + A+K + A + L+ D
Sbjct: 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
I+ + T + + + +LM+ DLH + H ++ R++ +++ GL+++
Sbjct: 69 IVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSE 219
H+ V++RDLKP+N+LL+ + ++I D GLA S+ V T Y APE+L
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVA 182
Query: 220 YTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
Y ++ D +S+GC+L +++ F + + R +
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------------RMTL 222
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV-----DEALCHPYLAPL--H 332
M + P + SP LLE +L D NRR+ E P+ L
Sbjct: 223 TMAVELP--------DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274
Query: 333 DINEEPVCPRPF---------SFDFEHPSFTEENIKEL 361
+ + P P + F+ SF EE+ K +
Sbjct: 275 MVFLQKYPP-PLIPPRGEVNAADAFDIGSFDEEDTKGI 311
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-56
Identities = 56/298 (18%), Positives = 114/298 (38%), Gaps = 41/298 (13%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
+E+ + + +G G++G V + +VA+K + + E+ +LR
Sbjct: 3 WEIPDGQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD-LTDDHCRYFLYQL 152
H NI+ T + IV + + + L+ + + Q
Sbjct: 60 KTRHVNILLFMGY------STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYR 209
+G+ Y+H+ +++HRDLK +N+ L+ + +KIGDFGLA S + + + +
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 210 APELLL--NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267
APE++ + + Y+ D+++ G +L E+MT Q + + Q+ +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR--------- 224
Query: 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325
+ + S N L+ + L + R + L
Sbjct: 225 ----------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-55
Identities = 62/303 (20%), Positives = 116/303 (38%), Gaps = 52/303 (17%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI----GNAFDNRIDAKRTLREIKLLRHMD--H 98
+G G +G V + + VAIK + + + + R E+ LL+ +
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 99 ENIIAIKDIIRPPQRETFNDVYIVYELMD--TDLHQIIRSHQDLTDDHCRYFLYQLLRGL 156
+I + D P + ++ E + DL I L ++ R F +Q+L +
Sbjct: 69 SGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 157 KYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLL 215
++ H+ VLHRD+K N+L++ N +LK+ DFG +T T++ TR Y PE +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIR 182
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
+ + +WS+G +L +++ F + + + ++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF-------------------- 222
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335
F S L+ L P+ R T +E HP++ +
Sbjct: 223 ---------FR--------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265
Query: 336 EEP 338
E
Sbjct: 266 ETA 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-55
Identities = 75/337 (22%), Positives = 141/337 (41%), Gaps = 46/337 (13%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRH-MDHENII 102
+ +G+G++G V A +T + AIK + + D + T+ E ++L +H +
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 103 AIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS 161
+ +T +++ V E ++ DL I+S ++ +++ GL+++HS
Sbjct: 67 HMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 162 ANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRAPELLLNCSEY 220
+++RDLK N+LL+ + +KI DFG+ + + T Y APE+LL +Y
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG-QKY 180
Query: 221 TAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280
++D WS G +L E++ Q F G+D I
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-----------------------RM 217
Query: 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITV-DEALCHPYLAPLH--DINEE 337
P +P+ A DLL K+ V +P +R+ V + HP ++ ++ +
Sbjct: 218 DNPFYPR--------WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERK 269
Query: 338 PVCPRPFSFDFEHPSFTEENIKELIYRESVKFNPDPT 374
+ P PF + P N + E + +
Sbjct: 270 EIDP-PFRPKVKSPFDC-SNFDKEFLNEKPRLSFADR 304
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 176 bits (446), Expect = 2e-53
Identities = 65/288 (22%), Positives = 111/288 (38%), Gaps = 35/288 (12%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
+G G V A + +VA+K + + + R RE + ++H I+A
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ D + YIV E +D L I+ + +T + + L + H
Sbjct: 72 VYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 130
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCS 218
++HRD+KP+N++++A +K+ DFG+AR + + + T Y +PE
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-D 189
Query: 219 EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278
A D++S+GC+L E++T +P F G V
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH----------------------- 226
Query: 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHP 326
VR P P SAR S ++ K L +P R +
Sbjct: 227 VREDPIPP----SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 5e-52
Identities = 61/292 (20%), Positives = 120/292 (41%), Gaps = 43/292 (14%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
++ +G+G +G V T A+K + + + T+ E ++L++ H + A
Sbjct: 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 104 IKDIIRPPQRETFNDVYIVYELMDTD-LHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+K + R + V E + L + + T++ R++ +++ L+Y+HS
Sbjct: 70 LKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA 222
+V++RD+K NL+L+ + +KI DFGL + + +L ++Y
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGR 184
Query: 223 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282
A+D W +G ++ E+M + F +D+ LI +
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI-----------------------LMEE 221
Query: 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLA 329
+FP+ SP A LL +L DP +R+ E + H +
Sbjct: 222 IRFPR--------TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (435), Expect = 2e-51
Identities = 66/342 (19%), Positives = 133/342 (38%), Gaps = 61/342 (17%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
+R +G G++G V + A+K + + T E +L + H II
Sbjct: 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68
Query: 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ + ++++ + ++ +L ++R Q + +++ ++ L+Y+HS
Sbjct: 69 MWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTA 222
++++RDLKP N+LL+ N +KI DFG A+ + T Y APE +++ Y
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPE-VVSTKPYNK 180
Query: 223 AIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282
+ID WS G ++ E++ F + + I +
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-----------------------LNAE 217
Query: 283 PQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLHDINEE 337
+FP P + DLL +++ D ++R+ ++ HP+ ++ E
Sbjct: 218 LRFP--------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW---FKEVVWE 266
Query: 338 ---------PVCPRPFSFDFEH---PSFTEENIKELIYRESV 367
P P + + EE+I + E
Sbjct: 267 KLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDINYGVQGEDP 308
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 9e-51
Identities = 59/294 (20%), Positives = 109/294 (37%), Gaps = 47/294 (15%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRH 95
++ K + ++ +G+G +G V +VA+K I N A+ L E ++
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI----KNDATAQAFLAEASVMTQ 56
Query: 96 MDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--LTDDHCRYFLYQL 152
+ H N++ + +I E +YIV E M L +RS L D F +
Sbjct: 57 LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 153 LRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPE 212
++Y+ N +HRDL N+L++ + K+ DFGL + S T + + APE
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPE 170
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271
L +++ D+WS G +L EI + + +P + + +
Sbjct: 171 ALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------------- 215
Query: 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325
P P ++++ D R + +
Sbjct: 216 --------GYKMDAP--------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 3e-50
Identities = 69/339 (20%), Positives = 135/339 (39%), Gaps = 54/339 (15%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
I+ +G G++G V + E+ A+K + + TL E ++L+ ++ ++
Sbjct: 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 104 IKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
++ ++ N ++ + ++ +R ++ H R++ Q++ +Y+HS +
Sbjct: 106 LEF----SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 164 VLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAA 223
+++RDLKP NLL++ +++ DFG A+ T APE++L+ Y A
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-KGYNKA 218
Query: 224 IDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLP 283
+D W++G ++ E+ P F + I
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV-----------------------SGKV 255
Query: 284 QFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPL--HDINE 336
+FP + S DLL +L D +R V++ H + A I +
Sbjct: 256 RFP--------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQ 307
Query: 337 EPVCPRPFSFDFEHP-------SFTEENIKELIYRESVK 368
V PF F+ P + EE I+ I + K
Sbjct: 308 RKVEA-PFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGK 345
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (421), Expect = 6e-49
Identities = 76/349 (21%), Positives = 129/349 (36%), Gaps = 43/349 (12%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+R +G G + V A + VA+K + +++ + EIKLL+ ++ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 105 KDIIRP------------PQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQL 152
+ + + H+ + + + QL
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 153 LRGLKYVH-SANVLHRDLKPSNLLLNAN------CDLKIGDFGLARTTSETDFMTEYVVT 205
L GL Y+H ++H D+KP N+L+ +KI D G A E + T
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--SIQT 192
Query: 206 RWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDY------VHQLRLITELI 259
R YR+PE+LL + + DIWS C++ E++T LF + + I EL+
Sbjct: 193 REYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 260 GSPDETSL-------GFLRSDNARRYVRMLPQFPKQNFSAR----FPNKSPGAVDLLEKM 308
G L F S R + L +P ++ +++ D L M
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 309 LVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSF-DFEHPSFTEE 356
L DP +R + HP+L + E V R + P + EE
Sbjct: 312 LQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWFEE 360
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-48
Identities = 54/302 (17%), Positives = 123/302 (40%), Gaps = 45/302 (14%)
Query: 45 IRPVGRGAYGIVCAAM---NSETREEVAIKKI--GNAFDNRIDAKRTLREIKLLRHMDHE 99
++ +G GAYG V +T + A+K + + T E ++L H+
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 100 NIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+ + +T ++++ + ++ +L + + T+ + ++ +++ L++
Sbjct: 89 PFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE---TDFMTEYVVTRWYRAPELLL 215
+H +++RD+K N+LL++N + + DFGL++ + +
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275
S + A+D WS+G ++ E++T F + I +
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------------------S 245
Query: 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAP 330
RR ++ P +P S A DL++++L+ DP +R+ DE H +
Sbjct: 246 RRILKSEPPYP--------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
Query: 331 LH 332
++
Sbjct: 298 IN 299
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 4e-48
Identities = 54/293 (18%), Positives = 110/293 (37%), Gaps = 48/293 (16%)
Query: 46 RPVGRGAYGIVCAAM--NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIA 103
+ +G G +G V + + VA+K + N ++ L E +++ +D+ I+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ I +V E+ + L++ ++ ++ + D + ++Q+ G+KY+ +
Sbjct: 73 MIGICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES 126
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLLNCS 218
N +HRDL N+LL KI DFGL++ + T + APE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-Y 185
Query: 219 EYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277
++++ D+WS G ++ E + Q + G ++ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------------- 225
Query: 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPY 327
P DL+ +D R V+ L + Y
Sbjct: 226 --GERMGCP--------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-47
Identities = 60/295 (20%), Positives = 109/295 (36%), Gaps = 47/295 (15%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
+EV R+ + + +G G +G V + + VA+K + + L E L++
Sbjct: 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSL---KQGSMSPDAFLAEANLMK 63
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDL---HQIIRSHQDLTDDHCRYFLYQ 151
+ H+ ++ + ++ T +YI+ E M+ S LT + Q
Sbjct: 64 QLQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYR 209
+ G+ ++ N +HRDL+ +N+L++ KI DFGLAR + ++ +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 210 APELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLG 268
APE +N +T D+WS G +L EI+T + +PG ++ +
Sbjct: 178 APE-AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP---- 232
Query: 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
N L+ P R T D
Sbjct: 233 --------------------------DNCPEELYQLMRLCWKERPEDRPTFDYLR 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 6e-47
Identities = 64/303 (21%), Positives = 114/303 (37%), Gaps = 49/303 (16%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
+E+ R+ + +G+G +G V + T VAIK + + + L+E ++++
Sbjct: 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTL---KPGTMSPEAFLQEAQVMK 67
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMD---TDLHQIIRSHQDLTDDHCRYFLYQ 151
+ HE ++ + ++ + +YIV E M + + L Q
Sbjct: 68 KLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYR 209
+ G+ YV N +HRDL+ +N+L+ N K+ DFGLAR + ++ +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 210 APELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLG 268
APE L +T D+WS G +L E+ T+ + +PG L + P
Sbjct: 182 APEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---- 236
Query: 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE--ALCHP 326
P DL+ + +P R T + A
Sbjct: 237 --------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
Query: 327 YLA 329
Y
Sbjct: 271 YFT 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 8e-46
Identities = 64/330 (19%), Positives = 118/330 (35%), Gaps = 70/330 (21%)
Query: 30 VYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETRE-----EVAIKKIGNAFDNRIDAK 84
Y +E R+ + + +G GA+G V A + +VA+K + D+ + +
Sbjct: 27 EYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-ERE 85
Query: 85 RTLREIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--- 139
+ E+K++ + HENI+ + +Y+++E DL +RS ++
Sbjct: 86 ALMSELKMMTQLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFS 140
Query: 140 --------------------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN 179
LT + F YQ+ +G++++ + +HRDL N+L+
Sbjct: 141 EDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG 200
Query: 180 CDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEI 236
+KI DFGLAR + + APE L YT D+WS G +L EI
Sbjct: 201 KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEI 259
Query: 237 MTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFP 295
+ +PG + + D+
Sbjct: 260 FSLGVNPYPGIPVDANFYKLIQNGFKMDQP-----------------------------F 290
Query: 296 NKSPGAVDLLEKMLVFDPNRRITVDEALCH 325
+ +++ FD +R +
Sbjct: 291 YATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 7e-45
Identities = 55/293 (18%), Positives = 112/293 (38%), Gaps = 50/293 (17%)
Query: 49 GRGAYGIVCAAMNSETRE--EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKD 106
G G +G V + ++ +VAIK + + D + +RE +++ +D+ I+ +
Sbjct: 18 GCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 107 IIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANV 164
+ + + +V E+ LH+ + +++ + L+Q+ G+KY+ N
Sbjct: 77 VCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 165 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETD----FMTEYVVTRWYRAPELLLNCSEY 220
+HRDL N+LL KI DFGL++ D + + APE +N ++
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE-CINFRKF 189
Query: 221 TAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
++ D+WS G + E ++ Q + + I +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------------------- 227
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT---VDEALCHPYLA 329
+ P P P L+ ++ R V++ + Y +
Sbjct: 228 GKRMECP--------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 7e-45
Identities = 58/289 (20%), Positives = 101/289 (34%), Gaps = 45/289 (15%)
Query: 45 IRPVGRGAYGIVCAA---MNSETREEVAIKKI-GNAFDNRIDAKRTLREIKLLRHMDHEN 100
+ +G G++G+V S VA+K + + +RE+ + +DH N
Sbjct: 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMD--TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+I + ++ + +V EL + L ++ + + Q+ G+ Y
Sbjct: 73 LIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLL 215
+ S +HRDL NLLL +KIGDFGL R + D M E+ + L
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 216 NCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
++ A D W G L E+ T Q + G + L I
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------------------- 227
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
+ + P R + +++ + P R T
Sbjct: 228 ----DKEGERLP------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-44
Identities = 62/306 (20%), Positives = 108/306 (35%), Gaps = 36/306 (11%)
Query: 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM 96
++R V +G+G +G V EEVA+K + + + EI +
Sbjct: 1 IARTIVL-QESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREA---EIYQTVML 54
Query: 97 DHENIIAIKDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRG 155
HENI+ T+ +++V + + L + + +T + G
Sbjct: 55 RHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASG 112
Query: 156 LKYVHSA--------NVLHRDLKPSNLLLNANCDLKIGDFGLAR-----TTSETDFMTEY 202
L ++H + HRDLK N+L+ N I D GLA T +
Sbjct: 113 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172
Query: 203 VVTRWYRAPELLLNCS-----EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITE 257
V T+ Y APE+L + E DI+++G + EI R + G +QL
Sbjct: 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDL 231
Query: 258 LIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI 317
+ P + + + R P P + S ++ + + R+
Sbjct: 232 VPSDPSVEEMRKVVCEQKLR-----PNIPNRWQSCEALRV---MAKIMRECWYANGAARL 283
Query: 318 TVDEAL 323
T
Sbjct: 284 TALRIK 289
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 48/286 (16%), Positives = 101/286 (35%), Gaps = 45/286 (15%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +G G +G+V + +VAIK I + + + E K++ ++ HE ++ +
Sbjct: 9 LKELGTGQFGVVKYGKW-RGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 105 KDIIRPPQRETFNDVYIVYELM--DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSA 162
+ ++I+ E M L+ + + ++Y+ S
Sbjct: 65 YGVC-----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF--MTEYVVTRWYRAPELLLNCSEY 220
LHRDL N L+N +K+ DFGL+R + ++ + PE+L+ S++
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 221 TAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
++ DIW+ G ++ EI + + + I + +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP--------------- 223
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325
S ++ + R T L +
Sbjct: 224 ---------------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (384), Expect = 4e-44
Identities = 55/294 (18%), Positives = 110/294 (37%), Gaps = 43/294 (14%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLR 94
+E+ R + +G G YG V + + VA+K + ++ ++ + L+E +++
Sbjct: 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMK 68
Query: 95 HMDHENIIAIKDIIRPPQRETFNDVYIVYELMD---TDLHQIIRSHQDLTDDHCRYFLYQ 151
+ H N++ + + YI+ E M + + Q+++ Y Q
Sbjct: 69 EIKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 152 LLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR-TTSETDFMTEYVVTRWYRA 210
+ ++Y+ N +HRDL N L+ N +K+ DFGL+R T +T
Sbjct: 124 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183
Query: 211 PELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGF 269
L ++++ D+W+ G +L EI T +PG D L+ +
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 231
Query: 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
+ P +L+ ++P+ R + E
Sbjct: 232 ----------DYRMERP--------EGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-43
Identities = 48/286 (16%), Positives = 102/286 (35%), Gaps = 45/286 (15%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
++ +G G +G+V +++VAIK I + + + + E +++ + H ++ +
Sbjct: 10 VQEIGSGQFGLVHLGYW-LNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 105 KDIIRPPQRETFNDVYIVYELMDT-DLHQIIRSHQDLTD-DHCRYFLYQLLRGLKYVHSA 162
+ + +V+E M+ L +R+ + L + + G+ Y+ A
Sbjct: 66 YGVC-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLAR--TTSETDFMTEYVVTRWYRAPELLLNCSEY 220
V+HRDL N L+ N +K+ DFG+ R + T + +PE+ S Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 221 TAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279
++ D+WS G ++ E+ + + + + + I+
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP--------------- 224
Query: 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325
S ++ P R L
Sbjct: 225 ---------------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 5e-43
Identities = 70/299 (23%), Positives = 118/299 (39%), Gaps = 46/299 (15%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREE---VAIKKIGNAFDNRIDAKRTLREIK 91
+E+ R+ + R +G G +G V + VAIK N + + ++ L+E
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV-REKFLQEAL 60
Query: 92 LLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELM--DTDLHQIIRSHQDLTDDHCRYFL 149
+R DH +I+ + +I T N V+I+ EL + L +
Sbjct: 61 TMRQFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 150 YQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM--TEYVVTRW 207
YQL L Y+ S +HRD+ N+L+++N +K+GDFGL+R ++ + ++ +
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 208 YRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETS 266
+ APE +N +T+A D+W G + EI+ F G + I
Sbjct: 175 WMAPE-SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--------- 224
Query: 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325
P PN P L+ K +DP+RR E
Sbjct: 225 -------------GERLPMP--------PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (375), Expect = 1e-42
Identities = 57/299 (19%), Positives = 106/299 (35%), Gaps = 47/299 (15%)
Query: 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREE---VAIKKIGNAFDNRIDAKRTLREIKL 92
E+ V + +G G +G VC+ + VAIK + + + + + L E +
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEK-QRRDFLSEASI 80
Query: 93 LRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQII--RSHQDLTDDHCRYFLY 150
+ DH N+I ++ ++ V I+ E M+ ++ T L
Sbjct: 81 MGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLR 135
Query: 151 QLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRA 210
+ G+KY+ N +HRDL N+L+N+N K+ DFGL+R + Y +
Sbjct: 136 GIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 195
Query: 211 PELLL-----NCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDE 264
P ++T+A D+WS G ++ E+M+ + + + I + P
Sbjct: 196 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP 255
Query: 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
+ L+ D N R + +
Sbjct: 256 ------------------------------MDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-42
Identities = 64/335 (19%), Positives = 123/335 (36%), Gaps = 55/335 (16%)
Query: 45 IRPVGRGAYGIVCAAMNSETREE----VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHEN 100
I+ +G GA+G V + E+ VAIK++ A + + K L E ++ +D+ +
Sbjct: 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYVMASVDNPH 72
Query: 101 IIAIKDIIRPPQRETFNDVYIVYELMD--TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKY 158
+ + I V ++ +LM L + ++ + + Q+ +G+ Y
Sbjct: 73 VCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 159 VHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLL 215
+ ++HRDL N+L+ +KI DFGLA+ + V + A E +L
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 216 NCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274
+ YT D+WS G + E+MT + G ++ +
Sbjct: 187 H-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK----------------- 228
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH-------PY 327
P P + ++ K + D + R E + P
Sbjct: 229 -----GERLPQP--------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275
Query: 328 LAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELI 362
+ +E P P +F EE++ +++
Sbjct: 276 RYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVV 310
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (370), Expect = 6e-42
Identities = 52/316 (16%), Positives = 94/316 (29%), Gaps = 53/316 (16%)
Query: 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
R +G G++G + + EEVAIK + + E K+ + M I
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 105 KDIIRPPQRETFNDVYIVYELMDTDLHQI-IRSHQDLTDDHCRYFLYQLLRGLKYVHSAN 163
+ +V EL+ L + + + Q++ ++Y+HS N
Sbjct: 68 IRWCG----AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 164 VLHRDLKPSNLL---LNANCDLKIGDFGLARTTSETD--------FMTEYVVTRWYRAPE 212
+HRD+KP N L + I DFGLA+ + T Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 213 LLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272
L E + D+ S+G +L + G +
Sbjct: 184 THLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-------------------- 222
Query: 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332
++Y R+ + L + + L
Sbjct: 223 ---QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY---------LR 270
Query: 333 DINEEPVCPRPFSFDF 348
+ + FS+D+
Sbjct: 271 QLFRNLFHRQGFSYDY 286
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-41
Identities = 65/314 (20%), Positives = 109/314 (34%), Gaps = 63/314 (20%)
Query: 45 IRPVGRGAYGIVCAAMNSET--REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENI 101
+G G +G V A + R + AIK++ + ++ D + E+++L + H NI
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 102 IAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----------------QDLTDDH 144
I + +Y+ E +L +R L+
Sbjct: 74 INLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 145 CRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVV 204
+F + RG+ Y+ +HRDL N+L+ N KI DFGL+R T +
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 188
Query: 205 TRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPD 263
+ A E LN S YT D+WS G +L EI++ + G + +
Sbjct: 189 PVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ------ 241
Query: 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
+ P N DL+ + P R + + L
Sbjct: 242 ----------------GYRLEKP--------LNCDDEVYDLMRQCWREKPYERPSFAQIL 277
Query: 324 CHPYLAPLHDINEE 337
L+ + EE
Sbjct: 278 VS-----LNRMLEE 286
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (365), Expect = 3e-41
Identities = 60/323 (18%), Positives = 105/323 (32%), Gaps = 71/323 (21%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIKKIGNAFDNRIDAKRTLRE 89
E R + +R +G GA+G V A + E VA+K + + RE
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ-ADFQRE 66
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--------- 139
L+ D+ NI+ + + + +++E M DL++ +RS
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 121
Query: 140 ---------------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKI 184
L+ Q+ G+ Y+ +HRDL N L+ N +KI
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 181
Query: 185 GDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ- 240
DFGL+R D+ + + PE + YT D+W+ G +L EI +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGL 240
Query: 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPG 300
+ G + + + + + P N
Sbjct: 241 QPYYGMAHEEVIYYVRD----------------------GNILACP--------ENCPLE 270
Query: 301 AVDLLEKMLVFDPNRRITVDEAL 323
+L+ P R +
Sbjct: 271 LYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-40
Identities = 69/319 (21%), Positives = 117/319 (36%), Gaps = 67/319 (21%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAA-----MNSETREEVAIKKIGNAFDNRIDAKRTLRE 89
+E R + + +G GA+G V A + S+ VA+K + + + + + E
Sbjct: 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSE 76
Query: 90 IKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD-------- 139
+K+L ++ +H NI+ + ++ E DL +R +D
Sbjct: 77 LKVLSYLGNHMNIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 140 ----------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189
L + F YQ+ +G+ ++ S N +HRDL N+LL KI DFGL
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 190 AR---TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPG 245
AR S + + APE + NC YT D+WS G L E+ + +PG
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 246 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK-SPGAVDL 304
+ + K+ F P D+
Sbjct: 251 MPVDSKFYKMI------------------------------KEGFRMLSPEHAPAEMYDI 280
Query: 305 LEKMLVFDPNRRITVDEAL 323
++ DP +R T + +
Sbjct: 281 MKTCWDADPLKRPTFKQIV 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (355), Expect = 8e-40
Identities = 48/296 (16%), Positives = 100/296 (33%), Gaps = 34/296 (11%)
Query: 29 NVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLR 88
NV G ++V R +G G++G++ N ++VAIK R DA +
Sbjct: 1 NVVGVHYKV-------GRRIGEGSFGVIFEGTNLLNNQQVAIKFE----PRRSDAPQLRD 49
Query: 89 EIKLLRHMDHENIIA-IKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSH-QDLTDDHCR 146
E + + + I + + +V +L+ L ++ + +
Sbjct: 50 EYRTYKLLAGCTGIPNVYYFG-----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVA 104
Query: 147 YFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-----DLKIGDFGLAR--------TT 193
Q+L ++ +H ++++RD+KP N L+ + + DFG+ +
Sbjct: 105 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164
Query: 194 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLR 253
T Y + E + D+ ++G + + + G +
Sbjct: 165 IPYREKKNLSGTARYMSIN-THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223
Query: 254 LITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKML 309
+ T L L + + + + F A P+ L K+L
Sbjct: 224 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT-PDYD-YLQGLFSKVL 277
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-39
Identities = 62/289 (21%), Positives = 110/289 (38%), Gaps = 47/289 (16%)
Query: 48 VGRGAYGIVCAAM---NSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104
+GRG +G V N + A+K + N + + + L E +++ H N++++
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSA 162
I + +V M DL IR+ + T F Q+ +G+K++ S
Sbjct: 94 LGICL----RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF-----MTEYVVTRWYRAPELLLNC 217
+HRDL N +L+ +K+ DFGLAR + +F T + + A E L
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT- 208
Query: 218 SEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276
++T D+WS G +L E+MTR P +P + + + R
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-----------------GR 251
Query: 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325
R P+ +++ K R + E +
Sbjct: 252 R-----LLQPE--------YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 6e-39
Identities = 64/309 (20%), Positives = 122/309 (39%), Gaps = 57/309 (18%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMN-----SETREEVAIKKIGNAFDNRIDAKRTLRE 89
+EV+R+ + R +G+G++G+V + E VAIK + A R + L E
Sbjct: 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR-ERIEFLNE 73
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--------- 139
+++ + +++ + ++ ++ ELM DL +RS +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128
Query: 140 -LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF 198
+ ++ G+ Y+++ +HRDL N ++ + +KIGDFG+ R ETD+
Sbjct: 129 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188
Query: 199 ---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRL 254
+ ++ + +PE L + +T D+WS G +L EI T + + G LR
Sbjct: 189 YRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247
Query: 255 ITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPN 314
+ E L P N +L+ ++P
Sbjct: 248 VME----------------------GGLLDKP--------DNCPDMLFELMRMCWQYNPK 277
Query: 315 RRITVDEAL 323
R + E +
Sbjct: 278 MRPSFLEII 286
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-38
Identities = 56/289 (19%), Positives = 106/289 (36%), Gaps = 48/289 (16%)
Query: 46 RPVGRGAYGIVCAAMNSETREE----VAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI 101
+ +G G +G V M + + VAIK + + + L E ++ H NI
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK-QRVDFLGEAGIMGQFSHHNI 71
Query: 102 IAIKDIIRPPQRETFNDVYIVYELM--DTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYV 159
I ++ +I + + I+ E M + + + L + G+KY+
Sbjct: 72 IRLEGVIS-----KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 160 HSANVLHRDLKPSNLLLNANCDLKIGDFGLAR----TTSETDFMTEYVVTRWYRAPELLL 215
+ N +HRDL N+L+N+N K+ DFGL+R T + + + APE +
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 216 NCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQL-RLITELIGSPDETSLGFLRSDN 274
+A+ D+WS G ++ E+MT + H++ + I +
Sbjct: 187 YRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND----------------- 228
Query: 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL 323
P + L+ + + RR + +
Sbjct: 229 -----GFRLPTP--------MDCPSAIYQLMMQCWQQERARRPKFADIV 264
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 5e-38
Identities = 66/318 (20%), Positives = 123/318 (38%), Gaps = 66/318 (20%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREE-------VAIKKIGNAFDNRIDAKRTL 87
+E+ R + +P+G GA+G V A ++ VA+K + + + D +
Sbjct: 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK-DLSDLI 66
Query: 88 REIKLLRHM-DHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH-------- 137
E+++++ + H+NII + +Y++ E +L + +++
Sbjct: 67 SEMEMMKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 138 --------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189
+ L+ YQ+ RG++Y+ S +HRDL N+L+ + +KI DFGL
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 190 ARTTSETDFMTE---YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPG 245
AR D+ + + + APE L + YT D+WS G +L EI T +PG
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPG 240
Query: 246 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLL 305
+L+ E P N + ++
Sbjct: 241 VPVEELFKLLKE----------------------GHRMDKP--------SNCTNELYMMM 270
Query: 306 EKMLVFDPNRRITVDEAL 323
P++R T + +
Sbjct: 271 RDCWHAVPSQRPTFKQLV 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-37
Identities = 67/318 (21%), Positives = 123/318 (38%), Gaps = 62/318 (19%)
Query: 35 FEVSRKYVPPIRPVGRGAYGIVCAAM-----NSETREEVAIKKIGNAFDNRIDAKRTLRE 89
+E R + +P+GRGA+G V A + T VA+K + + + + + E
Sbjct: 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS-EHRALMSE 66
Query: 90 IKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQD--------- 139
+K+L H+ H + + + ++ E +L +RS ++
Sbjct: 67 LKILIHIGHHLNVVNLLGA---CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 123
Query: 140 -------LTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192
LT +H + +Q+ +G++++ S +HRDL N+LL+ +KI DFGLAR
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 183
Query: 193 TSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDY 248
+ + + + APE + + YT D+WS G +L EI + +PG
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242
Query: 249 VHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNK-SPGAVDLLEK 307
+ K+ R P+ +P +
Sbjct: 243 DEEFCRRL------------------------------KEGTRMRAPDYTTPEMYQTMLD 272
Query: 308 MLVFDPNRRITVDEALCH 325
+P++R T E + H
Sbjct: 273 CWHGEPSQRPTFSELVEH 290
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.2 bits (228), Expect = 1e-22
Identities = 27/198 (13%), Positives = 56/198 (28%), Gaps = 30/198 (15%)
Query: 46 RPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAK--------RTLREIKLLRHMD 97
+ +G G V + E E +K + K +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 98 HENIIAIKDIIRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLK 157
+ ++ + P + ++ EL+D +R + L +L +
Sbjct: 65 FRALQKLQGLAVPKVYA-WEGNAVLMELIDAKELYRVRVE------NPDEVLDMILEEVA 117
Query: 158 YVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-----FMTEYVVTRWYRAPE 212
+ ++H DL N+L++ + I DF + E + ++
Sbjct: 118 KFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS--- 173
Query: 213 LLLNCSEYTAAIDIWSVG 230
Y DI S
Sbjct: 174 -----RTYRTEKDINSAI 186
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 375 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.89 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.26 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.13 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.71 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.39 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.32 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.52 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-59 Score=431.71 Aligned_cols=343 Identities=44% Similarity=0.808 Sum_probs=284.4
Q ss_pred CCCCceEEeceec--CCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHH
Q 017231 8 GSGDHTIVKGVPT--HGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKR 85 (375)
Q Consensus 8 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~ 85 (375)
++||++...+... -..||. +++.||+|+||+||+|.++.+|+.||||++..........+.
T Consensus 1 ~~~~~~~~~~~~~~~~~~~Y~-----------------~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~ 63 (346)
T d1cm8a_ 1 RSGFYRQEVTKTAWEVRAVYR-----------------DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63 (346)
T ss_dssp CCSBCCEECSSSEECCBSSEE-----------------EEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHH
T ss_pred CCCcEEEeccCceeecCCcEE-----------------EEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHH
Confidence 4678888777652 134665 699999999999999999999999999999876666667788
Q ss_pred HHHHHHHHHhcCCCCeeeeceeecCCCC-CCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 017231 86 TLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANV 164 (375)
Q Consensus 86 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i 164 (375)
+.+|+.+|++++||||++++++|..... .....+|+||||++.+|..++.. ..+++..++.++.||+.||.|||++||
T Consensus 64 ~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~I 142 (346)
T d1cm8a_ 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGI 142 (346)
T ss_dssp HHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999976542 23356899999998788777654 579999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCC
Q 017231 165 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFP 244 (375)
Q Consensus 165 ~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 244 (375)
+||||||+|||++.++.++|+|||.+...... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.
T Consensus 143 iHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~ 220 (346)
T d1cm8a_ 143 IHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220 (346)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccccCcchhhcccccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCC
Confidence 99999999999999999999999999766544 3456789999999999876678999999999999999999999999
Q ss_pred CCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 245 GKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 245 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
+.+....+..+....+.++..................+.......+....+.+++++.+||.+||..||++|||+.|+|+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 99999999999999998888777777777777777778777777777778899999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHhhcCC
Q 017231 325 HPYLAPLHDINEEPVCPRPFSFDFEHPSFTEENIKELIYRESVKFNP 371 (375)
Q Consensus 325 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 371 (375)
||||+.+....++|.+. .+..++...+-..+.++...+++...|+|
T Consensus 301 Hp~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 301 HPYFESLHDTEDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp SGGGTTTC------CCC-CCCCC-----CCHHHHHHHHHHHHHTCCC
T ss_pred ChhhCcCCCccccccCC-CCCCchhhhhcCHHHHHHHHHHHhhcCCC
Confidence 99999998777776654 57777777777889999999999999998
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-59 Score=431.59 Aligned_cols=344 Identities=50% Similarity=0.910 Sum_probs=296.1
Q ss_pred eEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeee
Q 017231 25 YVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAI 104 (375)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 104 (375)
|.........|+++++|. +++.||+|+||+||+|+++.+|+.||||++.+...+......+.+|+.+|++++|||++++
T Consensus 4 ~~~~~~~~~~~~~~~rY~-i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~ 82 (348)
T d2gfsa1 4 FYRQELNKTIWEVPERYQ-NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82 (348)
T ss_dssp EEEEECSSSEEEEETTEE-EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred cEEEecCCccccCCCCeE-EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeE
Confidence 444455667788888876 9999999999999999999999999999998776667777889999999999999999999
Q ss_pred ceeecCCCC-CCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEE
Q 017231 105 KDIIRPPQR-ETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLK 183 (375)
Q Consensus 105 ~~~~~~~~~-~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~ 183 (375)
++++..... +....+++++++++|+|.+++.. +++++.+++.++.||+.||.|||++||+||||||+||+++.+|.++
T Consensus 83 ~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~k 161 (348)
T d2gfsa1 83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELK 161 (348)
T ss_dssp SEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred EEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccccc
Confidence 999876532 22344566666656899998854 5799999999999999999999999999999999999999999999
Q ss_pred EeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 184 IGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 184 l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
++|||.+...... .....|++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+....+...
T Consensus 162 l~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~ 239 (348)
T d2gfsa1 162 ILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239 (348)
T ss_dssp ECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccchhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999998665433 35567899999999988756678999999999999999999999999999999999999888877
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCC
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRP 343 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~ 343 (375)
..................+.......+...+..+++++.+||.+||..||.+|||+.|+|+||||+++.+...++++. +
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~-~ 318 (348)
T d2gfsa1 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVAD-P 318 (348)
T ss_dssp HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCC-C
T ss_pred hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCC-C
Confidence 776666666667777777777777777777788999999999999999999999999999999999999888888765 7
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHhhcCCCC
Q 017231 344 FSFDFEHPSFTEENIKELIYRESVKFNPDP 373 (375)
Q Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (375)
+..+++..+...++++++.+.++++|+|.|
T Consensus 319 ~~~~~~~~~~~~~~~k~~~~~e~~~~~p~~ 348 (348)
T d2gfsa1 319 YDQSFESRDLLIDEWKSLTYDEVISFVPPP 348 (348)
T ss_dssp CCCGGGGCCCCHHHHHHHHHHHHHTCCCCC
T ss_pred CCCcccchhcCHHHHHHHHHHHhhccCCCC
Confidence 888888899999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=425.12 Aligned_cols=339 Identities=51% Similarity=0.925 Sum_probs=278.4
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCC
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPP 111 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 111 (375)
+++|++..+|. +++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|++++|||++++++++...
T Consensus 1 ~~~~~i~~rY~-~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 1 GQVFDVGPRYT-NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78 (345)
T ss_dssp CCCCCCCTTEE-EEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred CCccCcCCCeE-EEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence 35677877765 8999999999999999999999999999996543 344566789999999999999999999999776
Q ss_pred CCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 112 QRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 112 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
.......+++++++++|+|.+++.. .++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+.
T Consensus 79 ~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 79 TIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp STTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 5444456788888778899999976 469999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccc
Q 017231 192 TTSETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSL 267 (375)
Q Consensus 192 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 267 (375)
...... ......||+.|+|||++.....++.++||||+||++|+|++|+.||...+..............+.....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 543332 2345678999999999876577899999999999999999999999999888888888777777665544
Q ss_pred cccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 268 GFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFD 347 (375)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~ 347 (375)
......................+...++.+++++.+||.+||+.||.+|||++|+|+||||+......+++.....++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~~~~~ 317 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFD 317 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSCC---
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCccCCC
Confidence 44444444455555555555555566778899999999999999999999999999999999999988999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHhhcCCCC
Q 017231 348 FEHPSFTEENIKELIYRESVKFNPDP 373 (375)
Q Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 373 (375)
....++..+++++....+.++|+|+-
T Consensus 318 ~~~~~~~~~~l~~l~~~e~~~~~~~~ 343 (345)
T d1pmea_ 318 MELDDLPKEKLKELIFEETARFQPGY 343 (345)
T ss_dssp -----CCHHHHHHHHHHHSGGGSTTT
T ss_pred hhhhhCCHHHHHHHHHHHHHhcCCCC
Confidence 88888999999999999999999973
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-58 Score=409.26 Aligned_cols=257 Identities=25% Similarity=0.444 Sum_probs=222.1
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
.|.+. .+++++.||+|+||+||+|+++.+++.||+|++.+.. ........+.+|+.++++++||||+++++++.+.
T Consensus 2 ~~~l~--dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~- 78 (263)
T d2j4za1 2 QWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA- 78 (263)
T ss_dssp CCCGG--GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-
T ss_pred Ccchh--HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-
Confidence 35543 2448999999999999999999999999999986543 2223356788999999999999999999999654
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
+.+++|||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 79 ----~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~ 154 (263)
T d2j4za1 79 ----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV 154 (263)
T ss_dssp ----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred ----CEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceee
Confidence 56899999997 6999999998899999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccc
Q 017231 192 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLR 271 (375)
Q Consensus 192 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 271 (375)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......+
T Consensus 155 ~~~~~~-~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p-------- 224 (263)
T d2j4za1 155 HAPSSR-RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP-------- 224 (263)
T ss_dssp CCCCCC-CEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--------
T ss_pred ecCCCc-ccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--------
Confidence 665443 345689999999999998 7789999999999999999999999998887777666544221111
Q ss_pred cchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 272 SDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
..+|++++++|.+||+.||++|||++|+|+||||++
T Consensus 225 -----------------------~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 225 -----------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----------------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 246899999999999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=402.70 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=213.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.++||+|+||+||+|+++.++..||+|.+..........+.+.+|++++++++||||+++++++.... .+...+++||
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~ivm 91 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLVT 91 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEEE
Confidence 677899999999999999999999999999776556666778999999999999999999999986532 2235689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEe-cCCCEEEeecccccccCCCCcc
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSAN--VLHRDLKPSNLLLN-ANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~--i~H~di~p~NIli~-~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
||++ |+|.+++.+...+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++...... ..
T Consensus 92 E~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~ 170 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FA 170 (270)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SB
T ss_pred eCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-cc
Confidence 9997 699999999889999999999999999999999998 99999999999996 5789999999999764433 34
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHH-HHHHHHHhCCCCcccccccccchhHHH
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQ-LRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
....||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ .+.+... ..+..
T Consensus 171 ~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~--~~~~~------------- 233 (270)
T d1t4ha_ 171 KAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG--VKPAS------------- 233 (270)
T ss_dssp EESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT--CCCGG-------------
T ss_pred CCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcC--CCCcc-------------
Confidence 56789999999999875 589999999999999999999999976554333 3332221 11100
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLA 329 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~ 329 (375)
.....+++++++|.+||+.||++|||++|+|+||||+
T Consensus 234 --------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 --------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp --------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred --------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 0124688999999999999999999999999999996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-58 Score=406.66 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=210.0
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+.++++++||||+++++++... +.+++|
T Consensus 8 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~~iv 81 (271)
T d1nvra_ 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQYLF 81 (271)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----ceeEEE
Confidence 379999999999999999999999999999865432 22345688999999999999999999999654 668999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC---Cc
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DF 198 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~---~~ 198 (375)
|||++ |+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99997 699999988888999999999999999999999999999999999999999999999999999765432 23
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....||+.|+|||++.+...++.++|||||||++|+|++|+.||...................
T Consensus 162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---------------- 225 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------------- 225 (271)
T ss_dssp BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT----------------
T ss_pred ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC----------------
Confidence 4456899999999999873445688999999999999999999997665433222222111110
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
...+..+|+++.++|.+||+.||++|||++|+|+||||++
T Consensus 226 ------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 ------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0112356899999999999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-57 Score=408.15 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=203.9
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
|++++.||+|+||+||+|+++.+++.||||++.+..... ....+.+|+.++++++||||+++++++... +.+|+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~~l 84 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESG-----GHLYL 84 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECS-----SEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence 448999999999999999999999999999997653322 235677899999999999999999999654 66899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe---cCCCEEEeecccccccCCCC
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN---ANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~---~~~~i~l~Df~~~~~~~~~~ 197 (375)
|||||+ |+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||++. .++.+||+|||++.......
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 999997 69999999988999999999999999999999999999999999999994 57899999999998776666
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
...+..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......+.
T Consensus 165 ~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~------------- 230 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS------------- 230 (307)
T ss_dssp --------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCT-------------
T ss_pred eeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCC-------------
Confidence 6667789999999999988 77999999999999999999999999988877766665543222111
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
...+.+|+++.+||.+||+.||++|||++|+++||||++
T Consensus 231 --------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 231 --------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp --------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred --------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 112467999999999999999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-56 Score=402.42 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=216.9
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.++++++||||+++++++... +.+|+
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i 94 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV 94 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEE
Confidence 44899999999999999999999999999998654322 356788999999999999999999999654 56899
Q ss_pred EEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Ccc
Q 017231 122 VYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFM 199 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~ 199 (375)
|||||+ |+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++...... ...
T Consensus 95 vmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~ 173 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173 (293)
T ss_dssp EEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccc
Confidence 999997 689887765 56999999999999999999999999999999999999999999999999999765433 344
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..+..........
T Consensus 174 ~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-------------- 238 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN-------------- 238 (293)
T ss_dssp CCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSS--------------
T ss_pred cccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCC--------------
Confidence 56789999999999988 778999999999999999999999998887766666554432211100
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
.+.+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 239 --------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 239 --------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp --------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred --------------cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 1246899999999999999999999999999999984
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=405.18 Aligned_cols=259 Identities=27% Similarity=0.455 Sum_probs=223.4
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc----chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD----NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.++++++||||+++++++... .
T Consensus 12 Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~ 86 (293)
T d1jksa_ 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-----T 86 (293)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----S
T ss_pred EEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----C
Confidence 3479999999999999999999999999999865422 222457788999999999999999999999654 6
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC----CEEEeecccccc
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC----DLKIGDFGLART 192 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~----~i~l~Df~~~~~ 192 (375)
.+++|||||+ |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.++ .+||+|||++..
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 7899999997 69999999888999999999999999999999999999999999999998876 499999999987
Q ss_pred cCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 193 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 193 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
...........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+..
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~------- 238 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE------- 238 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHH-------
T ss_pred cCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCch-------
Confidence 766666667788999999999987 778999999999999999999999999988777777665533222211
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
..+.+|+++++||.+||+.||++|||++|+|+||||+..+.
T Consensus 239 --------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 239 --------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp --------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred --------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 11457899999999999999999999999999999997643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=398.99 Aligned_cols=253 Identities=29% Similarity=0.438 Sum_probs=208.0
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
+++++.||+|+||+||+|+++.+|+.||+|++..........+.+.+|+.++++++||||+++++++.+... +.+|+
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~---~~~~i 82 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN---TTLYI 82 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC---CEEEE
Confidence 448999999999999999999999999999998776666677889999999999999999999998865322 56899
Q ss_pred EEeCCC-CCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceEEecCCCEEEeeccccc
Q 017231 122 VYELMD-TDLHQIIRS----HQDLTDDHCRYFLYQLLRGLKYVHSAN-----VLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qi~~al~~Lh~~~-----i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
|||||+ |+|.+++.. ...+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||+|||++.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999997 699998864 467999999999999999999999876 9999999999999999999999999997
Q ss_pred ccCCCC-ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 192 TTSETD-FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 192 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~-------- 233 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-------- 233 (269)
T ss_dssp HC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------
T ss_pred ecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence 655432 3446788999999999987 779999999999999999999999999888777766665421110
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYL 328 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f 328 (375)
....+|+++.++|.+||+.||.+|||++|+|+|||+
T Consensus 234 ----------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 234 ----------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ----------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 013478999999999999999999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.2e-56 Score=409.00 Aligned_cols=257 Identities=26% Similarity=0.452 Sum_probs=225.1
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.++++++||||+++++++... +.+++|
T Consensus 29 ~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~iv 101 (350)
T d1koaa2 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMVMI 101 (350)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEEEEE
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEE
Confidence 3799999999999999999999999999999654 334567788999999999999999999999654 679999
Q ss_pred EeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec--CCCEEEeecccccccCCCCc
Q 017231 123 YELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA--NCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~--~~~i~l~Df~~~~~~~~~~~ 198 (375)
||||+ |+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++........
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 99997 699999854 457999999999999999999999999999999999999954 67899999999988777666
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+...
T Consensus 182 ~~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------------ 248 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA------------ 248 (350)
T ss_dssp EEEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG------------
T ss_pred cceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc------------
Confidence 677889999999999988 7789999999999999999999999999888888877766443332221
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDI 334 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~ 334 (375)
.+.+|+++++||.+||+.||++|||++|+|+||||+.....
T Consensus 249 ---------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp ---------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred ---------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 13578999999999999999999999999999999976543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=402.68 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=217.8
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||+||+|+++.+++.||||++.+.. ......+.+.+|+.++++++||||+++++++... +.+|
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~ 84 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----EKLY 84 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-----SEEE
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-----CEEE
Confidence 448999999999999999999999999999986532 2233456788999999999999999999999654 6689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC---
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET--- 196 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~--- 196 (375)
+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999997 699999999999999999999999999999999999999999999999999999999999999765433
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p------------- 230 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP------------- 230 (288)
T ss_dssp -----CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC-------------
T ss_pred cccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC-------------
Confidence 22345679999999999988 7899999999999999999999999998887777766654211111
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHH------HhcCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE------ALCHPYLAPLH 332 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~e------ll~~~~f~~~~ 332 (375)
..+++++++||.+||+.||++|||++| +++||||++++
T Consensus 231 ------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 231 ------------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp ------------------TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred ------------------ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 246899999999999999999999988 58899999874
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-56 Score=402.33 Aligned_cols=285 Identities=36% Similarity=0.607 Sum_probs=228.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchH---HHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRI---DAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
.++.||+|+||+||+|+++.+|+.||||++........ ....+.+|+.++++++||||+++++++... ++++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Ccee
Confidence 47899999999999999999999999999865432221 234678999999999999999999999655 5689
Q ss_pred EEEeCCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Cc
Q 017231 121 IVYELMDTDLHQ-IIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DF 198 (375)
Q Consensus 121 lv~e~~~g~L~~-~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~ 198 (375)
+||||+.|.+.. +......+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||.+...... ..
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 999999865544 4444567999999999999999999999999999999999999999999999999999765543 23
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+.........
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~-- 234 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY-- 234 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC--
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchh--
Confidence 445678999999999877567899999999999999999999999999999999999988887665544322211110
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
......+...+....+.+++++.+||.+||+.||++|||++|+|+||||++.+....
T Consensus 235 -~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~ 291 (299)
T d1ua2a_ 235 -VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291 (299)
T ss_dssp -CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred -hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence 011122222333445678999999999999999999999999999999997655433
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.2e-56 Score=408.81 Aligned_cols=254 Identities=24% Similarity=0.451 Sum_probs=223.4
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.++++++||||++++++|... ..+|+|
T Consensus 32 ~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~iv 104 (352)
T d1koba_ 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-----YEMVLI 104 (352)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-----SEEEEE
T ss_pred EEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEEE
Confidence 37999999999999999999999999999986542 33456788999999999999999999999654 668999
Q ss_pred EeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEe--cCCCEEEeecccccccCCCCc
Q 017231 123 YELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLN--ANCDLKIGDFGLARTTSETDF 198 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~--~~~~i~l~Df~~~~~~~~~~~ 198 (375)
||||+ |+|.+.+...+ ++++.+++.|+.||+.||.|||++||+||||||+|||++ .++.++|+|||++........
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence 99997 69998876654 699999999999999999999999999999999999997 578999999999988777766
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRY 278 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 278 (375)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.......+..
T Consensus 185 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~------------- 250 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED------------- 250 (352)
T ss_dssp EEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS-------------
T ss_pred eeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-------------
Confidence 677889999999999988 789999999999999999999999999988888877776643332221
Q ss_pred hhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 279 VRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
.++.+|+++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 251 --------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 --------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp --------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred --------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 124679999999999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=403.57 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=224.8
Q ss_pred ccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcC
Q 017231 39 RKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 39 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 117 (375)
-+.+++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|++++||||+++++++.+. .
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----c
Confidence 344558999999999999999999999999999997542 2233456788999999999999999999999654 6
Q ss_pred cEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC-
Q 017231 118 DVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE- 195 (375)
Q Consensus 118 ~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~- 195 (375)
.+|+||||++ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 7999999997 69999999999999999999999999999999999999999999999999999999999999976543
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.......+
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p------------ 225 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP------------ 225 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------
T ss_pred CcccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC------------
Confidence 344566789999999999988 7899999999999999999999999999988777766655322111
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH 332 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~ 332 (375)
..+|+++++||.+||+.||.+|++ ++|+++||||++++
T Consensus 226 -------------------~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 226 -------------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp -------------------TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -------------------ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 357899999999999999999994 89999999999863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=399.89 Aligned_cols=256 Identities=27% Similarity=0.413 Sum_probs=216.0
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+.|++++.||+|+||+||+|+++.+++.||+|++... .....+.+.+|+.++++++||||+++++++... +.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeE
Confidence 3455899999999999999999999999999998654 233456788999999999999999999999654 568
Q ss_pred EEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-
Q 017231 120 YIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET- 196 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~- 196 (375)
++|||||+ |+|.+++.. .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999997 699998765 456999999999999999999999999999999999999999999999999998654332
Q ss_pred CccccccccccccCchhccc----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 197 DFMTEYVVTRWYRAPELLLN----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
.......||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~-------- 236 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-------- 236 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS--------
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--------
Confidence 22345678999999999852 256789999999999999999999999988877776666542211100
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
....+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 237 --------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 237 --------------------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------------------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 01346899999999999999999999999999999973
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-55 Score=399.93 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=215.8
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
++++++||+|+||+||+|+++.+++.||||++.... ......+.+.+|+.++++++||||+++++++... +.++
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~~ 91 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTAW 91 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CEEE
Confidence 457999999999999999999999999999997654 3344556789999999999999999999999654 5689
Q ss_pred EEEeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 121 IVYELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 121 lv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
+|||||.| +|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 99999985 66666677788999999999999999999999999999999999999999999999999999765443
Q ss_pred ccccccccccCchhccc--CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 200 TEYVVTRWYRAPELLLN--CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
....||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+.+....+..+........
T Consensus 169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------- 234 (309)
T d1u5ra_ 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL-------------- 234 (309)
T ss_dssp CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--------------
T ss_pred CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--------------
Confidence 45679999999999864 24588999999999999999999999988877666665554221111
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
....+|+++.+||.+||+.||++|||++|+|+||||+.
T Consensus 235 ---------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 235 ---------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp ---------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ---------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 01356899999999999999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=398.07 Aligned_cols=289 Identities=35% Similarity=0.590 Sum_probs=232.9
Q ss_pred CCeeeccCCcceEEEEEEeCCC-CcEEEEEEecCcccchHHHHHHHHHHHHHHhc---CCCCeeeeceeecCCCCCCcCc
Q 017231 43 PPIRPVGRGAYGIVCAAMNSET-REEVAIKKIGNAFDNRIDAKRTLREIKLLRHM---DHENIIAIKDIIRPPQRETFND 118 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~~~~~~~~~~~~~~~~ 118 (375)
++++.||+|+||+||+|++..+ ++.||||++............+.+|+.+++.| +||||+++++++.....+....
T Consensus 10 ~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~ 89 (305)
T d1blxa_ 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK 89 (305)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEE
T ss_pred EEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCce
Confidence 3799999999999999999765 66799999865433333333455667666655 7999999999987554444577
Q ss_pred EEEEEeCCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC
Q 017231 119 VYIVYELMDTDLHQIIR--SHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET 196 (375)
Q Consensus 119 ~~lv~e~~~g~L~~~l~--~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~ 196 (375)
++++||++++.+..+.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||.+......
T Consensus 90 ~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~ 169 (305)
T d1blxa_ 90 LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 169 (305)
T ss_dssp EEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG
T ss_pred EEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhccc
Confidence 89999999976655443 3356999999999999999999999999999999999999999999999999999877666
Q ss_pred CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhH
Q 017231 197 DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNAR 276 (375)
Q Consensus 197 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 276 (375)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+....+.+....+.........
T Consensus 170 ~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 248 (305)
T d1blxa_ 170 MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248 (305)
T ss_dssp GGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGG
T ss_pred ccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhh
Confidence 66677889999999999988 78999999999999999999999999999999999999998887766554332221111
Q ss_pred HHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCC
Q 017231 277 RYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINE 336 (375)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~ 336 (375)
. ...............+++.+.+||.+||+.||++|||++|+|+||||++++.+.+
T Consensus 249 ~----~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ke 304 (305)
T d1blxa_ 249 A----FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304 (305)
T ss_dssp G----SCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred h----hccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchhhCC
Confidence 1 1111122223334578999999999999999999999999999999999876554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.3e-55 Score=390.45 Aligned_cols=257 Identities=29% Similarity=0.488 Sum_probs=222.3
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc-------hHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCC
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN-------RIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRE 114 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~ 114 (375)
++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 6 ~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--- 82 (277)
T d1phka_ 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN--- 82 (277)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS---
T ss_pred EEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC---
Confidence 4799999999999999999999999999998654322 122346789999999997 99999999999654
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
+.+|+||||++ |+|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 83 --~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 --TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp --SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred --cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 67999999997 699999999899999999999999999999999999999999999999999999999999999877
Q ss_pred CCCCccccccccccccCchhccc-----CCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccc
Q 017231 194 SETDFMTEYVVTRWYRAPELLLN-----CSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLG 268 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 268 (375)
..........||+.|.|||.+.+ ...++.++||||+||++|+|++|+.||.+.+.......+.......+..
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 237 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP--- 237 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc---
Confidence 66555566789999999999863 2456889999999999999999999999988777777666533222111
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..+.+|++++++|.+||+.||++|||++|+|+||||+++
T Consensus 238 ------------------------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 238 ------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp ------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ------------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 123579999999999999999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=397.29 Aligned_cols=284 Identities=40% Similarity=0.718 Sum_probs=231.8
Q ss_pred CCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 43 PPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 43 ~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
++++.||+|+||+||+|.++.+|+.||||++............+.+|++++++++||||+++++++... +.+|+|
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~~iv 79 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLYLV 79 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred EeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cceeEE
Confidence 379999999999999999999999999999976544444456788999999999999999999999654 668999
Q ss_pred EeCCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-Ccc
Q 017231 123 YELMDTDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-DFM 199 (375)
Q Consensus 123 ~e~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~~~ 199 (375)
|||+++++.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||.+...... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 99999887777654 356999999999999999999999999999999999999999999999999998765443 344
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+....+..+....+.+.+..+..... .....
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~ 237 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS--MPDYK 237 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG--STTCC
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc--ccccc
Confidence 5567899999999988756678999999999999999999999999988888888888777765544432211 11112
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
...............+.+++++.+||.+||+.||++|||++|+|+||||+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 222222233334455678999999999999999999999999999999998744
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-56 Score=406.60 Aligned_cols=287 Identities=22% Similarity=0.335 Sum_probs=217.6
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRET 115 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 115 (375)
+|.++.|++++.||+|+||+||+|+++.+|+.||+|++.... .......+.+|+.+|++++||||++++++|...
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 76 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD---- 76 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS----
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC----
Confidence 455566668999999999999999999999999999997643 233456788999999999999999999999654
Q ss_pred cCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEecCCCEEEeeccccccc
Q 017231 116 FNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS-ANVLHRDLKPSNLLLNANCDLKIGDFGLARTT 193 (375)
Q Consensus 116 ~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~-~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~ 193 (375)
+.+++||||++ |+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||++...
T Consensus 77 -~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 77 -GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp -SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred -CEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 56899999997 5999999988899999999999999999999997 59999999999999999999999999998754
Q ss_pred CCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHH-HHHHhCCCCccccc----
Q 017231 194 SETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRL-ITELIGSPDETSLG---- 268 (375)
Q Consensus 194 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~---- 268 (375)
... ...+..||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....... +....+........
T Consensus 156 ~~~-~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 156 IDS-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HHH-TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CCC-ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 332 2345689999999999998 7899999999999999999999999987664332111 11111111000000
Q ss_pred ----------ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 269 ----------FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 269 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
................... .......+|+++.+||.+||..||.+|||++|+|+||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCC--CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccccccchhHHHHHhhhhccCC--ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0000000000110000000 0011123688999999999999999999999999999998643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-55 Score=398.32 Aligned_cols=252 Identities=23% Similarity=0.407 Sum_probs=222.1
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+.++++++||||+++++++... ..+|
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ 80 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQIF 80 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SEEE
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----Ceee
Confidence 458999999999999999999999999999996543 2233456788999999999999999999999654 6689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
+||||++ |+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~ 158 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--T 158 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--B
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--c
Confidence 9999997 589999999999999999999999999999999999999999999999999999999999999776544 3
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
.+..||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 159 ~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p---------------- 221 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP---------------- 221 (316)
T ss_dssp CCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----------------
T ss_pred ccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----------------
Confidence 46789999999999987 7789999999999999999999999999888777777665322111
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
+.+++++.++|.+||..||.+|+ |++++++||||+++.
T Consensus 222 ---------------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 222 ---------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp ---------------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ---------------CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 34689999999999999999996 999999999999874
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=399.73 Aligned_cols=320 Identities=44% Similarity=0.790 Sum_probs=242.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC-CCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR-ETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~~lv 122 (375)
++++||+|+||+||+|+++.+|+.||||++.....+......+.+|+.++++++||||++++++|..... +...++|+|
T Consensus 21 i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv 100 (355)
T d2b1pa1 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 100 (355)
T ss_dssp EEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEE
T ss_pred EEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEE
Confidence 6999999999999999999999999999998776666677789999999999999999999999976432 344789999
Q ss_pred EeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCccccc
Q 017231 123 YELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFMTEY 202 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~~~~ 202 (375)
|||+.|++.+.+. ..+++..++.++.||+.||.+||++||+|+||||+||+++.++.++++|||.+............
T Consensus 101 ~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~ 178 (355)
T d2b1pa1 101 MELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 178 (355)
T ss_dssp EECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------------
T ss_pred EeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccccccccc
Confidence 9999988877764 56999999999999999999999999999999999999999999999999998877776666677
Q ss_pred cccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhC
Q 017231 203 VVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRML 282 (375)
Q Consensus 203 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (375)
.+|+.|+|||++.+ ..++.++||||+||++++|++|+.||.+.+.......+......+....+....... ..+....
T Consensus 179 ~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~ 256 (355)
T d2b1pa1 179 VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV-RNYVENR 256 (355)
T ss_dssp --CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHH-HHHHHTS
T ss_pred cccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhH-HHHhhcC
Confidence 88999999999988 789999999999999999999999999999888888888777765554443322211 2222222
Q ss_pred CCCCCCCcc------------ccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC-CCCCCCCCCCCCCC
Q 017231 283 PQFPKQNFS------------ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN-EEPVCPRPFSFDFE 349 (375)
Q Consensus 283 ~~~~~~~~~------------~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~-~~~~~~~~~~~~~~ 349 (375)
......... ......++++.+||++||..||++|||++|+|+||||+...+.. .+..++..+..++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~~~~~~~~~~ 336 (355)
T d2b1pa1 257 PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLD 336 (355)
T ss_dssp CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCCC-------C
T ss_pred ccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCCCCCCCcchh
Confidence 111111100 00112467789999999999999999999999999999864322 33446667777777
Q ss_pred CCCCCHHHHHHHHHHHHh
Q 017231 350 HPSFTEENIKELIYRESV 367 (375)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~ 367 (375)
+-+...+.+++..+++..
T Consensus 337 ~~~~~~~~~~~~~~~~~~ 354 (355)
T d2b1pa1 337 EREHTIEEWKELIYKEVM 354 (355)
T ss_dssp CCCCCHHHHHHHHHHHHH
T ss_pred hhhcCHHHHHHHHHHHhc
Confidence 778888899999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-55 Score=401.42 Aligned_cols=252 Identities=23% Similarity=0.406 Sum_probs=221.4
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVY 120 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 120 (375)
+++++.||+|+||+||+|+++.+|+.||||++.+.. ......+.+.+|+.+++.++||||+++++++... ..++
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~ 117 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SNLY 117 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEE
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cccc
Confidence 447999999999999999999999999999986532 2223456788999999999999999999999655 5689
Q ss_pred EEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCcc
Q 017231 121 IVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDFM 199 (375)
Q Consensus 121 lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~~ 199 (375)
+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... .
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~ 195 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--c
Confidence 9999997 699999999899999999999999999999999999999999999999999999999999999776543 3
Q ss_pred ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHh
Q 017231 200 TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYV 279 (375)
Q Consensus 200 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 279 (375)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.......+
T Consensus 196 ~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p---------------- 258 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP---------------- 258 (350)
T ss_dssp CCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----------------
T ss_pred ccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----------------
Confidence 46789999999999988 7889999999999999999999999999887777777655322211
Q ss_pred hhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 280 RMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
..+++++.++|++||+.||.+|+ |++++++||||++++
T Consensus 259 ---------------~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 259 ---------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp ---------------TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred ---------------ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 35789999999999999999995 999999999999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=396.03 Aligned_cols=257 Identities=25% Similarity=0.430 Sum_probs=223.8
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
|.++|. +++.||+|+||+||+|+++.+++.||||++.... .....+.+|+.+|++++||||+++++++.+.
T Consensus 3 ~~~rY~-i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~----- 73 (321)
T d1tkia_ 3 LYEKYM-IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESM----- 73 (321)
T ss_dssp CTTTEE-EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----
T ss_pred CccceE-EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----
Confidence 445554 7999999999999999999999999999997642 2334578999999999999999999999554
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC--CCEEEeecccccc
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN--CDLKIGDFGLART 192 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~--~~i~l~Df~~~~~ 192 (375)
+.+|+|||||+ |+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+||+++.+ +.++|+|||.+..
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 67999999997 59999998765 69999999999999999999999999999999999999854 4799999999987
Q ss_pred cCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccccc
Q 017231 193 TSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRS 272 (375)
Q Consensus 193 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 272 (375)
...........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+....+.......+...
T Consensus 154 ~~~~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------ 226 (321)
T d1tkia_ 154 LKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------ 226 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------
T ss_pred cccCCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh------
Confidence 766666667788999999999987 7789999999999999999999999999988888887776443333221
Q ss_pred chhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 273 DNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
++.+|+++++||.+||..||++|||++|+|+||||++
T Consensus 227 ---------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 227 ---------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 2457999999999999999999999999999999975
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9e-54 Score=396.32 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=212.5
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc----chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD----NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
.|++++.||+|+||.||+|+++.+|+.||||++.+... ..........++.+++.++||||+++++++...
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~----- 79 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP----- 79 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-----
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-----
Confidence 34479999999999999999999999999999864321 111222233457777788899999999999654
Q ss_pred CcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSE 195 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~ 195 (375)
+.+|+||||++ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 56899999997 69999999999999999999999999999999999999999999999999999999999999976654
Q ss_pred CCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchh
Q 017231 196 TDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNA 275 (375)
Q Consensus 196 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 275 (375)
.. .....||+.|+|||++.+...++.++|||||||++|+|++|+.||...+................
T Consensus 160 ~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~------------ 226 (364)
T d1omwa3 160 KK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV------------ 226 (364)
T ss_dssp SC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC------------
T ss_pred Cc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC------------
Confidence 43 34568999999999997646789999999999999999999999987654433322222111111
Q ss_pred HHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC-----HHHHhcCCCCCCCC
Q 017231 276 RRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT-----VDEALCHPYLAPLH 332 (375)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps-----~~ell~~~~f~~~~ 332 (375)
.....+|+++.+||.+||+.||.+||| ++|+++||||++++
T Consensus 227 ----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 227 ----------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp ----------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred ----------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 011357999999999999999999999 79999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=391.12 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=218.2
Q ss_pred cCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcc-cchHHHHHHHHHHHHHH-hcCCCCeeeeceeecCCCCCCcCcE
Q 017231 42 VPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF-DNRIDAKRTLREIKLLR-HMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 42 ~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+++++.||+|+||+||+|.++.+++.||||++.+.. ......+.+..|..++. .++||||+++++++... +.+
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~~~ 78 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----ENL 78 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----SEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----Cce
Confidence 337999999999999999999999999999996532 12233455667777665 68999999999999665 668
Q ss_pred EEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC-C
Q 017231 120 YIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET-D 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~-~ 197 (375)
|+||||++ |+|.+++.....+++.+++.++.||+.||.|||++|++||||||+|||++.+++++|+|||.+...... .
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence 99999997 699999999999999999999999999999999999999999999999999999999999999765443 3
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.......+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p-------------- 223 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP-------------- 223 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC--------------
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC--------------
Confidence 3445688999999999998 7899999999999999999999999999888877777654211111
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHH-HHhcCCCCCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD-EALCHPYLAPLH 332 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~-ell~~~~f~~~~ 332 (375)
..+|+++.+||++||+.||++||++. ++++||||++++
T Consensus 224 -----------------~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 224 -----------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp -----------------TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred -----------------ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 24689999999999999999999996 899999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.1e-53 Score=382.65 Aligned_cols=279 Identities=37% Similarity=0.658 Sum_probs=226.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
++++||+|+||+||+|+++ +|+.||||++............+.+|+.++++++||||+++++.+... +..++++
T Consensus 6 ~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~i~~ 79 (286)
T d1ob3a_ 6 GLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLVLVF 79 (286)
T ss_dssp EEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEEEEE
T ss_pred eccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----CceeEEE
Confidence 6999999999999999986 679999999977655554567889999999999999999999999655 5689999
Q ss_pred eCCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMDTDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~g~L~~~l-~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
+++.+.+...+ ...+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||.+....... ....
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence 99987655555 556779999999999999999999999999999999999999999999999999987654432 2344
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRM 281 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (375)
..+++.|.|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+...... ......
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~--~~~~~~ 237 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL--PKYDPN 237 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--TTCCTT
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh--hhcccc
Confidence 567899999999987677899999999999999999999999999988888888888877665544322111 111111
Q ss_pred CCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCC
Q 017231 282 LPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAP 330 (375)
Q Consensus 282 ~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~ 330 (375)
.............+.+++.+.+||.+||+.||++|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 2222222334445678999999999999999999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-53 Score=389.75 Aligned_cols=283 Identities=32% Similarity=0.596 Sum_probs=228.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC-CCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ-RETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~~lv 122 (375)
.+++||+|+||+||+|+++.+|+.||||++...... ..+|+.+|++++||||++++++|.... .....++++|
T Consensus 24 ~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred eeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 589999999999999999999999999999654322 237999999999999999999986543 2334568999
Q ss_pred EeCCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-CEEEeecccccccCCCC
Q 017231 123 YELMDTDLHQII----RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLARTTSETD 197 (375)
Q Consensus 123 ~e~~~g~L~~~l----~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-~i~l~Df~~~~~~~~~~ 197 (375)
|||+++++.+.+ .....+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus 98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 999997665554 3456799999999999999999999999999999999999999875 89999999998776666
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
...+..|+..|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+....+......+........
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~-- 255 (350)
T d1q5ka_ 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT-- 255 (350)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-----
T ss_pred ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh--
Confidence 666778999999999988767899999999999999999999999999998888888888888766544322211110
Q ss_pred HhhhCCCCCCCCc-cccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCC
Q 017231 278 YVRMLPQFPKQNF-SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDIN 335 (375)
Q Consensus 278 ~~~~~~~~~~~~~-~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~ 335 (375)
...........+ ....+..++++.+||.+||..||++|||+.|+|+||||+++....
T Consensus 256 -~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 313 (350)
T d1q5ka_ 256 -EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 313 (350)
T ss_dssp -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred -hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCC
Confidence 001111111111 122356799999999999999999999999999999999886544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=373.55 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=211.3
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR 113 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 113 (375)
.||+....+++++.||+|+||+||+|+.+ ..||||++..........+.+.+|+.++++++||||+++++++..
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--- 75 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--- 75 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---
Confidence 58999988899999999999999999754 359999997766566677889999999999999999999998743
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
..+++||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 76 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 76 ---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp ---SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred ---cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence 34799999998 6999999765 569999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC---ccccccccccccCchhcccC--CCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccc
Q 017231 192 TTSETD---FMTEYVVTRWYRAPELLLNC--SEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETS 266 (375)
Q Consensus 192 ~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 266 (375)
...... ......||+.|+|||++.+. ..++.++|||||||++|||++|+.||.+.+...............+.
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-- 230 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-- 230 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC--
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc--
Confidence 654322 23456789999999998652 35789999999999999999999999887655554444332221111
Q ss_pred ccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
+......+++++.++|.+||+.||++|||+.+|+++
T Consensus 231 -----------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 -----------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -----------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111124578999999999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=381.34 Aligned_cols=289 Identities=33% Similarity=0.563 Sum_probs=223.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCC---CCcCcEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQR---ETFNDVY 120 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~~~ 120 (375)
++++||+|+||+||+|+++.+|+.||||++............+.+|+.+|++++|||++++++++..... ...+.++
T Consensus 14 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~ 93 (318)
T d3blha1 14 KLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIY 93 (318)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEE
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEE
Confidence 6999999999999999999999999999987665555556678899999999999999999998865321 2235689
Q ss_pred EEEeCCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC---
Q 017231 121 IVYELMDTDLHQII-RSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET--- 196 (375)
Q Consensus 121 lv~e~~~g~L~~~l-~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~--- 196 (375)
++|||+++.+.... .....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 94 iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~ 173 (318)
T d3blha1 94 LVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 173 (318)
T ss_dssp EEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC----
T ss_pred EEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccccccc
Confidence 99999986665554 44567999999999999999999999999999999999999999999999999998654432
Q ss_pred --CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 197 --DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 197 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
.......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+....+..............
T Consensus 174 ~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 253 (318)
T d3blha1 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253 (318)
T ss_dssp -CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhh
Confidence 223345789999999999876678999999999999999999999999999899999999988877665544433222
Q ss_pred hHHHhhhCCCCCCCCcccc--CCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSAR--FPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHD 333 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~--~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~ 333 (375)
............ ...... ....++++.+||.+||+.||++|||++|+|+||||+..+.
T Consensus 254 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 254 LYEKLELVKGQK-RKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp ------CCSSCC-BCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred hhhhhccccccc-ccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 211111111100 000000 0123678899999999999999999999999999996533
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=376.48 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=205.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccch----HHHHHHHHHHHHHHhcC--CCCeeeeceeecCCCCCCcC
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNR----IDAKRTLREIKLLRHMD--HENIIAIKDIIRPPQRETFN 117 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~iv~~~~~~~~~~~~~~~ 117 (375)
+.+.||+|+||+||+|+++.+|+.||||++.+..... .....+.+|+.++++++ ||||+++++++... +
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-----~ 82 (273)
T d1xwsa_ 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-----D 82 (273)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-----S
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-----C
Confidence 6999999999999999999999999999986532111 12233568999999996 89999999999654 6
Q ss_pred cEEEEEeCCC--CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecC-CCEEEeecccccccC
Q 017231 118 DVYIVYELMD--TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNAN-CDLKIGDFGLARTTS 194 (375)
Q Consensus 118 ~~~lv~e~~~--g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~-~~i~l~Df~~~~~~~ 194 (375)
.+++||||+. +++.+++.....+++.+++.++.||+.||.|||++||+||||||+||+++.+ +.++|+|||++....
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 6899999996 4888999888899999999999999999999999999999999999999855 789999999997654
Q ss_pred CCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 195 ETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 195 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
.. ...+..||+.|+|||++.+...++.++|||||||++|+|++|+.||...+ .+......
T Consensus 163 ~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~------------- 222 (273)
T d1xwsa_ 163 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVF------------- 222 (273)
T ss_dssp SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCC-------------
T ss_pred cc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccC-------------
Confidence 43 34567899999999999874555788999999999999999999996532 11110000
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
....+|++++++|.+||+.||++|||++|+|+||||+++.
T Consensus 223 ------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 223 ------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ------------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 0135799999999999999999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-52 Score=372.89 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=212.0
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
..||+..+.+++.+.||+|+||+||+|+++.+++.||||++..... ..+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~- 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE- 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeC-
Confidence 5689999999999999999999999999999999999999865433 345688999999999999999999999654
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGL 189 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~ 189 (375)
+.+++||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 86 ----~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~ 161 (287)
T d1opja_ 86 ----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 161 (287)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCC
T ss_pred ----CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccc
Confidence 55799999997 7999998764 5689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCC-CCCChhHHHHHHHHHhCCCCccc
Q 017231 190 ARTTSETDF--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPDETS 266 (375)
Q Consensus 190 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~ 266 (375)
+........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|..|| ...+.....+.+.... .+
T Consensus 162 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~-~~---- 235 (287)
T d1opja_ 162 SRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-RM---- 235 (287)
T ss_dssp TTTCCSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CC----
T ss_pred eeecCCCCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC-CC----
Confidence 987654432 233457889999999988 77999999999999999999966554 4555444433332211 00
Q ss_pred ccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 267 LGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.....+++++.+||.+||+.||++|||+.+|++
T Consensus 236 -------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 -------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 011357899999999999999999999999976
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=387.37 Aligned_cols=262 Identities=26% Similarity=0.414 Sum_probs=208.4
Q ss_pred cccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCCCCc
Q 017231 38 SRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 38 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 116 (375)
-++|..+.+.||+|+||+||+|+++.+++.||||++... ..+.+|+.++.++ +||||++++++|.... ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCC
Confidence 344431345699999999999999999999999998542 3466899887655 8999999999986422 123
Q ss_pred CcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec---CCCEEEeecccc
Q 017231 117 NDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLA 190 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~---~~~i~l~Df~~~ 190 (375)
..+|+|||||+ |+|.+++... ..+++.+++.++.||+.||.|||++||+||||||+||+++. .+.+||+|||++
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 66899999997 6999999874 36999999999999999999999999999999999999975 457999999999
Q ss_pred cccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 191 RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 191 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+........
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~------- 233 (335)
T d2ozaa1 162 KETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ------- 233 (335)
T ss_dssp EECCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS-------
T ss_pred eeccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC-------
Confidence 87766666677889999999999987 7799999999999999999999999977654444333322211100
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPL 331 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~ 331 (375)
..-+...+..+|+++.+||++||+.||++|||+.|+++||||++.
T Consensus 234 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 234 ----------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ----------------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ----------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 000011123478999999999999999999999999999999754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=370.75 Aligned_cols=282 Identities=36% Similarity=0.611 Sum_probs=230.6
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
++++||+|+||+||+|+++.+++.||||+++...........+.+|+.+++.++||||+++++++... ...++++
T Consensus 6 ~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~~iv~ 80 (292)
T d1unla_ 6 KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKLTLVF 80 (292)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEE
T ss_pred eeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-----cceeEEe
Confidence 69999999999999999999999999999977665666678899999999999999999999999665 5689999
Q ss_pred eCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC-cccc
Q 017231 124 ELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD-FMTE 201 (375)
Q Consensus 124 e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~-~~~~ 201 (375)
+++.| .|..++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 99985 777777888889999999999999999999999999999999999999999999999999997765443 3334
Q ss_pred ccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCC-CCCChhHHHHHHHHHhCCCCcccccccccchhHHHhh
Q 017231 202 YVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLF-PGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVR 280 (375)
Q Consensus 202 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (375)
..++..|.|||++.+...++.++|||||||++|+|++|+.|| .+.+..+....+....+......+........ ...
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 238 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD--YKP 238 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT--CCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc--ccc
Confidence 456788999999887566799999999999999999999884 66677777888888777765544332211110 000
Q ss_pred hCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 281 MLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 281 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
..............+.+++.+.+||.+||+.||.+|||++|+|+||||+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 0001112233344467889999999999999999999999999999999764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=380.02 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=213.8
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEeCCCCc-----EEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeee
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETRE-----EVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAI 104 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~ 104 (375)
|..+|++..+.+++++.||+|+||+||+|+++.+++ .||+|.+.... .......+.+|+.+++++ +|||||++
T Consensus 28 ~~~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l 106 (325)
T d1rjba_ 28 YDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNL 106 (325)
T ss_dssp CCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence 446789999999999999999999999999876543 69999886543 233456788999999998 89999999
Q ss_pred ceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHH
Q 017231 105 KDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ-----------------------DLTDDHCRYFLYQLLRGLKYVH 160 (375)
Q Consensus 105 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~al~~Lh 160 (375)
++++... +.+++|||||+ |+|.+++.... .+++..++.++.||+.||.|||
T Consensus 107 ~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH 181 (325)
T d1rjba_ 107 LGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE 181 (325)
T ss_dssp EEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeeC-----CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999655 56899999997 79999997642 4899999999999999999999
Q ss_pred hCCccccCCCCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHh
Q 017231 161 SANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIM 237 (375)
Q Consensus 161 ~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 237 (375)
++||+||||||+||+++.++.+||+|||+++...... ......+|+.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 182 ~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~eml 260 (325)
T d1rjba_ 182 FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIF 260 (325)
T ss_dssp HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHT
T ss_pred hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHH
Confidence 9999999999999999999999999999997654433 2235567999999999987 78999999999999999999
Q ss_pred h-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCC
Q 017231 238 T-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRR 316 (375)
Q Consensus 238 ~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~R 316 (375)
+ |..||.+.+....+..+......++. ...+++++.+||.+||+.||++|
T Consensus 261 t~g~~Pf~~~~~~~~~~~~~~~~~~~~~-----------------------------p~~~~~~l~~li~~cl~~dP~~R 311 (325)
T d1rjba_ 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQ-----------------------------PFYATEEIYIIMQSCWAFDSRKR 311 (325)
T ss_dssp TTSCCSSTTCCCSHHHHHHHHTTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hCCCCCCCCCCHHHHHHHHHhcCCCCCC-----------------------------CCcCCHHHHHHHHHHcCCChhHC
Confidence 7 89999887766665555442211110 13568899999999999999999
Q ss_pred CCHHHHhcC
Q 017231 317 ITVDEALCH 325 (375)
Q Consensus 317 ps~~ell~~ 325 (375)
||++||++|
T Consensus 312 Pt~~ei~~~ 320 (325)
T d1rjba_ 312 PSFPNLTSF 320 (325)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=370.56 Aligned_cols=259 Identities=23% Similarity=0.388 Sum_probs=215.0
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
|...|++..+.+++++.||+|+||.||+|+++ ++..||||++..... ..+.+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 67889999999999999999999999999986 467899999965432 24568999999999999999999998754
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeec
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSH--QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 187 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df 187 (375)
+ .+++||||++ |+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 80 ~------~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 80 E------PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp S------SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred C------CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccc
Confidence 3 3689999997 7998877543 35999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC--ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhC-CCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 188 GLARTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 188 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
|++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|+|| .+||...+..+....+.......
T Consensus 154 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~-- 230 (272)
T d1qpca_ 154 GLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-- 230 (272)
T ss_dssp TTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--
T ss_pred cceEEccCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--
Confidence 9998765443 2334567899999999987 6789999999999999999995 55566666555555543311110
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc--CCCCCC
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC--HPYLAP 330 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~--~~~f~~ 330 (375)
....+++++.++|.+||+.||++|||+++|++ ++||..
T Consensus 231 ----------------------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 ----------------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 01356889999999999999999999999998 777753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.9e-51 Score=366.77 Aligned_cols=255 Identities=25% Similarity=0.340 Sum_probs=206.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCccc-chHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFD-NRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||+||+|+++.+|+.||||++..... +......+.+|+.+++.++||||+++++++.... .....+|+|
T Consensus 11 i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~~~~lv 89 (277)
T d1o6ya_ 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGPLPYIV 89 (277)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCceEEEE
Confidence 69999999999999999999999999999976543 3445667899999999999999999999986543 222458999
Q ss_pred EeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCC----C
Q 017231 123 YELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET----D 197 (375)
Q Consensus 123 ~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~----~ 197 (375)
|||++ ++|.+++...+.+++.+++.++.||+.||.+||++||+||||||+||+++.++.++++|||.+...... .
T Consensus 90 mE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~ 169 (277)
T d1o6ya_ 90 MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 169 (277)
T ss_dssp EECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-------
T ss_pred EECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccccccc
Confidence 99998 599999999899999999999999999999999999999999999999999999999999987543332 2
Q ss_pred ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 198 FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 198 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+.......+
T Consensus 170 ~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 234 (277)
T d1o6ya_ 170 QTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP-------------- 234 (277)
T ss_dssp ---------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG--------------
T ss_pred ccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC--------------
Confidence 3345678999999999987 6789999999999999999999999998877666655544221111
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-CHHHHhcCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-TVDEALCHPYL 328 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-s~~ell~~~~f 328 (375)
....+.+|+++.++|.+||+.||.+|| |+++++ |+|.
T Consensus 235 -------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~ 272 (277)
T d1o6ya_ 235 -------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMR-ADLV 272 (277)
T ss_dssp -------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHHH
T ss_pred -------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHHH
Confidence 112246799999999999999999999 566554 4443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=368.47 Aligned_cols=246 Identities=21% Similarity=0.324 Sum_probs=202.5
Q ss_pred eeccCCcceEEEEEEeC--CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 46 RPVGRGAYGIVCAAMNS--ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 46 ~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
++||+|+||+||+|.++ .+++.||||+++....+....+.+.+|+.++++++||||+++++++.. ...++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence 46999999999999754 456789999997665555566789999999999999999999999843 2368999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc----
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF---- 198 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~---- 198 (375)
||++ |+|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 87 E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp ECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred EcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 9997 69999999999999999999999999999999999999999999999999999999999999976543321
Q ss_pred cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccchhHH
Q 017231 199 MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARR 277 (375)
Q Consensus 199 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 277 (375)
.....||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+...... .
T Consensus 167 ~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~--~------------- 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM--G------------- 230 (277)
T ss_dssp ----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC--C-------------
T ss_pred ccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC--C-------------
Confidence 223567899999999987 678999999999999999997 89999988776665555431110 0
Q ss_pred HhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHh---cCCCC
Q 017231 278 YVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEAL---CHPYL 328 (375)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell---~~~~f 328 (375)
....+++++.++|.+||+.||++|||+.+|+ +|+|+
T Consensus 231 ---------------~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 231 ---------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ---------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------------CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 0135689999999999999999999999984 55554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-50 Score=366.28 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=199.8
Q ss_pred eecccccCCeeeccCCcceEEEEEEeCCCCc---EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 36 EVSRKYVPPIRPVGRGAYGIVCAAMNSETRE---EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 36 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
++...++++.+.||+|+||+||+|+++.+++ .||||.+.... .....+.+.+|+.++++++|||||++++++...
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS- 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-
Confidence 4555666689999999999999999987765 58888876543 344567799999999999999999999999654
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
+.+++|||||+ |+|.+++... +.+++.++..++.||+.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus 100 ----~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 100 ----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred ----CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence 55899999997 6999988774 46999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcc------ccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 191 RTTSETDFM------TEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 191 ~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
......... ....+|+.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+....+........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~ 254 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP 254 (299)
T ss_dssp --------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 765443211 12356889999999987 789999999999999999998 8999998887766655543211110
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+++++.++|.+||+.||++|||+.+|++.
T Consensus 255 ------------------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 255 ------------------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ------------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 13568899999999999999999999998864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.3e-51 Score=374.04 Aligned_cols=287 Identities=31% Similarity=0.561 Sum_probs=218.4
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQ 112 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~ 112 (375)
.|...++ ++++++||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+|++++ ||||+++++++....
T Consensus 30 ~~~~~d~-y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~ 103 (328)
T d3bqca1 30 EWGNQDD-YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPV 103 (328)
T ss_dssp CCCCGGG-EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT
T ss_pred CCCCCcC-eEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecC
Confidence 3443344 44899999999999999999999999999998653 2456789999999995 999999999986543
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCC-CEEEeecccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANC-DLKIGDFGLA 190 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~-~i~l~Df~~~ 190 (375)
. ..+++||||++ ++|... .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .++|+|||++
T Consensus 104 ~---~~~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a 177 (328)
T d3bqca1 104 S---RTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 177 (328)
T ss_dssp T---CSEEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGC
T ss_pred C---CceeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccc
Confidence 2 56899999998 466554 35699999999999999999999999999999999999999765 5999999999
Q ss_pred cccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC-hhHHHHHHHHHhCCCCccccc-
Q 017231 191 RTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLG- 268 (375)
Q Consensus 191 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~- 268 (375)
.............+|+.|+|||.+.+...++.++|||||||++|+|++|..||.... .......+....+.+......
T Consensus 178 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~ 257 (328)
T d3bqca1 178 EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 257 (328)
T ss_dssp EECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred eeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence 877666666677889999999998876678999999999999999999999997654 344444454444422111000
Q ss_pred ccccchhHHHhhhCCCCCCCCc-----cccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNF-----SARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLH 332 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~ 332 (375)
.........+...........+ ......+++++.+||++||..||.+|||++|+|+||||+.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 0000001111111111111111 112234788999999999999999999999999999999763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=359.70 Aligned_cols=246 Identities=19% Similarity=0.343 Sum_probs=196.8
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+.+++++.||+|+||.||+|.++. ++.||||++...... .+.+.+|+.++++++||||+++++++... +.+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~ 75 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----API 75 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccC-----Cce
Confidence 344579999999999999999864 578999998754332 35688999999999999999999999654 457
Q ss_pred EEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 120 YIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
++||||++ |+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||++.......
T Consensus 76 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 76 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred EEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999997 7999988765 558999999999999999999999999999999999999999999999999987655443
Q ss_pred c--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 198 F--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
. .....||+.|+|||++.+ ..++.++|||||||++|||++ |.+||...+..+....+........
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~----------- 223 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK----------- 223 (263)
T ss_dssp ---------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC-----------
T ss_pred ceeecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC-----------
Confidence 2 233567899999999987 679999999999999999999 5777777776666666554211110
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....++++.++|.+||+.||++|||+++|+++
T Consensus 224 -------------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 224 -------------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 02457889999999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=355.85 Aligned_cols=246 Identities=20% Similarity=0.322 Sum_probs=208.5
Q ss_pred cccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcE
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDV 119 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 119 (375)
+.++++++||+|+||+||+++++ ++..||||+++..... .+.+.+|+.++++++||||+++++++... +.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~ 74 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPI 74 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC---HHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC---HHHHHHHHHHHHhcCCCceeeEEEEEeeC-----Cce
Confidence 45568999999999999999985 6789999999764333 35688999999999999999999999654 568
Q ss_pred EEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCC
Q 017231 120 YIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETD 197 (375)
Q Consensus 120 ~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~ 197 (375)
++||||++ |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 75 ~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp EEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred EEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999997 788888655 4569999999999999999999999999999999999999999999999999997654433
Q ss_pred c--cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcccccccccch
Q 017231 198 F--MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFLRSDN 274 (375)
Q Consensus 198 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 274 (375)
. .....+|+.|+|||.+.+ ..++.++|||||||++|+|+| |+.||...+..+....+........
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~----------- 222 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR----------- 222 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-----------
T ss_pred ceeecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC-----------
Confidence 2 224567899999999987 779999999999999999998 8999999887777766654221111
Q ss_pred hHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 275 ARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
....++++.++|.+||+.||++|||+++|++|
T Consensus 223 -------------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 223 -------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 02457889999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=360.41 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=211.2
Q ss_pred cceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 31 YGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 31 ~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
..+.|+|..+.+++++.||+|+||+||+|+++.+ ..||||++...... .+.+.+|+.++++++|||||++++++..
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 3467889889999999999999999999998776 57999999755333 3568899999999999999999999854
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeec
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRS--HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 187 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df 187 (375)
. .+++||||++ |+|..++.. .+.+++.+++.++.||+.||.|||+.|++||||||+||+++.++.+||+||
T Consensus 84 ~------~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~Df 157 (285)
T d1fmka3 84 E------PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF 157 (285)
T ss_dssp S------SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred C------CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEccc
Confidence 2 3689999997 688888754 356999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC--ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCC-CCCCCCChhHHHHHHHHHhCCCCc
Q 017231 188 GLARTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ-PLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 188 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
|++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|. +|+......+.+..+.......
T Consensus 158 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~-- 234 (285)
T d1fmka3 158 GLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-- 234 (285)
T ss_dssp CTTC--------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC--
T ss_pred chhhhccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC--
Confidence 9997654332 2234567999999999987 77899999999999999999965 5556666555555544321110
Q ss_pred ccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc--CCCCCCCC
Q 017231 265 TSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC--HPYLAPLH 332 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~--~~~f~~~~ 332 (375)
....++++++++|.+||+.||++|||+++|+. ++||.+..
T Consensus 235 ----------------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 235 ----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp ----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ----------------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 11357889999999999999999999999998 89998753
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=360.83 Aligned_cols=258 Identities=21% Similarity=0.328 Sum_probs=211.9
Q ss_pred eeeecccccCCee-eccCCcceEEEEEEeCC--CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 34 LFEVSRKYVPPIR-PVGRGAYGIVCAAMNSE--TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 34 ~~~~~~~~~~i~~-~lg~G~~g~Vy~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
.+-+.++.+.+.+ +||+|+||+||+|.++. ++..||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 3456666666777 49999999999998764 44579999987543 44456789999999999999999999998853
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
..+++||||++ |+|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 81 ------~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFG 154 (285)
T d1u59a_ 81 ------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 154 (285)
T ss_dssp ------SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred ------CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccch
Confidence 23799999998 6999988654 569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCC
Q 017231 189 LARTTSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPD 263 (375)
Q Consensus 189 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~ 263 (375)
++........ .....||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+......
T Consensus 155 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~-- 231 (285)
T d1u59a_ 155 LSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-- 231 (285)
T ss_dssp TCEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC--
T ss_pred hhhcccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC--
Confidence 9976554322 234567899999999987 679999999999999999998 99999988766666555431111
Q ss_pred cccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHH---hcCCCCC
Q 017231 264 ETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA---LCHPYLA 329 (375)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~el---l~~~~f~ 329 (375)
...+.+++++.++|.+||+.||++|||+.+| |+++|+.
T Consensus 232 ----------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 232 ----------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 0113578999999999999999999999888 5577764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-50 Score=357.24 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=203.5
Q ss_pred eeeecccccCCeeeccCCcceEEEEEEeCCCC---cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecC
Q 017231 34 LFEVSRKYVPPIRPVGRGAYGIVCAAMNSETR---EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRP 110 (375)
Q Consensus 34 ~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 110 (375)
.|||.++.+++++.||+|+||+||+|.+..++ ..||||.+... ......+.+.+|+.++++++||||+++++++..
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 38899888889999999999999999986543 46889988543 234456779999999999999999999999853
Q ss_pred CCCCCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecc
Q 017231 111 PQRETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFG 188 (375)
Q Consensus 111 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~ 188 (375)
+.+++||||++ |+|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 80 ------~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 80 ------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp ------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred ------CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence 34799999997 6898887654 569999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC--ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 189 LARTTSETD--FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 189 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||...+..+....+......
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---- 228 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---- 228 (273)
T ss_dssp -----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC----
T ss_pred hheeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC----
Confidence 987654432 2234567899999999987 789999999999999999987 89999988877776665442111
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...+.+++++.++|.+||+.||++|||++||+++
T Consensus 229 --------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 229 --------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0124578999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=357.29 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=202.9
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeece
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKD 106 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~ 106 (375)
.+|++..+.+++++.||+|+||.||+|++.. +++.||||++.... .....+.+..|...+.++ +|+||+.+++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 7899999888899999999999999999654 45789999986543 333456677788888777 6899999999
Q ss_pred eecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 017231 107 IIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDL 169 (375)
Q Consensus 107 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di 169 (375)
.+.... ..+++|||||+ |+|.+++... ..+++.+++.++.||+.||.|||++||+||||
T Consensus 85 ~~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDl 160 (299)
T d1ywna1 85 ACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 160 (299)
T ss_dssp EECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred eeccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcC
Confidence 876543 45799999997 7999999653 24899999999999999999999999999999
Q ss_pred CCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhC-CCCCCC
Q 017231 170 KPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPG 245 (375)
Q Consensus 170 ~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~ 245 (375)
||+|||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++| ..||.+
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999997544332 2345678999999999988 7899999999999999999986 568877
Q ss_pred CChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 246 KDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 246 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.+..............+.. ...+++++.++|.+||+.||++|||++||++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 240 VKIDEEFCRRLKEGTRMRA-----------------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCCSHHHHHHHHHTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCCC-----------------------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6655544433332111110 13468899999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=352.12 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=202.1
Q ss_pred eeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCC
Q 017231 35 FEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRE 114 (375)
Q Consensus 35 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 114 (375)
|++..+.+++++.||+|+||.||+|+++ |..||||+++.+. ..+.+.+|+.++++++||||+++++++....
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-- 73 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK-- 73 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC---
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecC--
Confidence 7888888999999999999999999874 6789999996542 3466889999999999999999999886542
Q ss_pred CcCcEEEEEeCCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeeccccc
Q 017231 115 TFNDVYIVYELMD-TDLHQIIRSHQ--DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLAR 191 (375)
Q Consensus 115 ~~~~~~lv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~ 191 (375)
+.+++||||++ |+|.+++.... .+++..++.|+.||+.||.|||+.+++||||+|+||+++.++.++|+|||.+.
T Consensus 74 --~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 74 --GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp ---CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred --CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccce
Confidence 44799999997 79999986543 49999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 192 TTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 192 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
..... .....++..|+|||++.+ ..++.++|||||||++|||++ |..||...+..+....+.+....
T Consensus 152 ~~~~~--~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~--------- 219 (262)
T d1byga_ 152 EASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM--------- 219 (262)
T ss_dssp ------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---------
T ss_pred ecCCC--CccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 65443 344567889999999988 679999999999999999998 78888887766666555331110
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.....+++++.++|.+||+.||.+|||+.+|+++
T Consensus 220 ---------------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 220 ---------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0113468899999999999999999999999873
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=364.92 Aligned_cols=261 Identities=21% Similarity=0.370 Sum_probs=212.6
Q ss_pred cccCCeeeccCCcceEEEEEEe---CCCCcEEEEEEecCcc--cchHHHHHHHHHHHHHHhcCC-CCeeeeceeecCCCC
Q 017231 40 KYVPPIRPVGRGAYGIVCAAMN---SETREEVAIKKIGNAF--DNRIDAKRTLREIKLLRHMDH-ENIIAIKDIIRPPQR 113 (375)
Q Consensus 40 ~~~~i~~~lg~G~~g~Vy~~~~---~~~~~~vaiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 113 (375)
+.|++++.||+|+||+||+|.+ +.+|+.||||++.+.. .+....+.+.+|+.++++++| |||+++++++...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 3355799999999999999987 4578999999987542 222334567899999999966 8999999998554
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccc
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLART 192 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~ 192 (375)
..++++|||+. |+|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 102 ---~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 102 ---TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp ---TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ---CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 56899999997 69999999999999999999999999999999999999999999999999999999999999875
Q ss_pred cCCC--CccccccccccccCchhcccCC-CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCcccccc
Q 017231 193 TSET--DFMTEYVVTRWYRAPELLLNCS-EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDETSLGF 269 (375)
Q Consensus 193 ~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 269 (375)
.... .......|++.|+|||.+.+.. .++.++|||||||++|+|++|+.||...+.......+..........
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~---- 254 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP---- 254 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC----
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC----
Confidence 4433 2344567899999999987633 46789999999999999999999998765444444333321110000
Q ss_pred cccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCC-----CHHHHhcCCCCCCCC
Q 017231 270 LRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRI-----TVDEALCHPYLAPLH 332 (375)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rp-----s~~ell~~~~f~~~~ 332 (375)
....+++++.+||.+||+.||++|| |++|+++||||+.++
T Consensus 255 -----------------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 255 -----------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp -----------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -----------------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 0135789999999999999999999 589999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=349.25 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=196.0
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCC----cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETR----EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
|....+++.+.||+|+||.||+|.++.++ ..||||++.... .......+.+|+.++++++||||+++++++...
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~- 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY- 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-
Confidence 44444557899999999999999877654 469999986543 333456788999999999999999999999654
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
...++||||+. +++.+.+... +.+++.++..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 82 ----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 82 ----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp ----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred ----CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchh
Confidence 55899999997 5788877654 56999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC----ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCC-CCCCCChhHHHHHHHHHhCCCCcc
Q 017231 191 RTTSETD----FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQP-LFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 191 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~-pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|.. |+...+..+..+.+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~--- 233 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP--- 233 (283)
T ss_dssp ----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---
T ss_pred hcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCC---
Confidence 7654332 1223467899999999987 789999999999999999999654 455555555544443211110
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++++.++|.+||+.||++|||+.||++
T Consensus 234 ---------------------------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 234 ---------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ---------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------------------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 01246788999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=350.97 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=208.8
Q ss_pred ceeeeecccccCCeeeccCCcceEEEEEEeCCCC-------cEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeee
Q 017231 32 GNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETR-------EEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIA 103 (375)
Q Consensus 32 ~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 103 (375)
..+|+|..+.+++++.||+|+||.||+|++..++ ..||||++.... .......+.+|...+.++ +||||++
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 4569999999999999999999999999876543 479999987653 334566788899999888 7999999
Q ss_pred eceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 017231 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLH 166 (375)
Q Consensus 104 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H 166 (375)
+++++... ..+++||||++ |+|.+++... ..+++.+++.++.||+.||+|||+.|++|
T Consensus 84 ~~~~~~~~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivH 158 (299)
T d1fgka_ 84 LLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIH 158 (299)
T ss_dssp EEEEECSS-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred cccccccC-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEe
Confidence 99999654 55899999997 7999999654 34899999999999999999999999999
Q ss_pred cCCCCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCC
Q 017231 167 RDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPL 242 (375)
Q Consensus 167 ~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~p 242 (375)
|||||+|||++.++.+||+|||.+....... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |..|
T Consensus 159 rDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p 237 (299)
T d1fgka_ 159 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSP 237 (299)
T ss_dssp SCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred eeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCC
Confidence 9999999999999999999999987654432 2334667899999999988 789999999999999999998 7999
Q ss_pred CCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHH
Q 017231 243 FPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEA 322 (375)
Q Consensus 243 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~el 322 (375)
|...+.......+.... .++ . ...+++++.++|.+||+.||++|||+.||
T Consensus 238 ~~~~~~~~~~~~i~~~~-~~~-~----------------------------p~~~~~~l~~li~~cl~~dP~~Rps~~ei 287 (299)
T d1fgka_ 238 YPGVPVEELFKLLKEGH-RMD-K----------------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQL 287 (299)
T ss_dssp STTCCHHHHHHHHHTTC-CCC-C----------------------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCHHHHHHHHHcCC-CCC-C----------------------------CccchHHHHHHHHHHccCCHhHCcCHHHH
Confidence 98887666555443211 110 0 13568899999999999999999999999
Q ss_pred hc
Q 017231 323 LC 324 (375)
Q Consensus 323 l~ 324 (375)
++
T Consensus 288 l~ 289 (299)
T d1fgka_ 288 VE 289 (299)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=354.86 Aligned_cols=247 Identities=24% Similarity=0.341 Sum_probs=199.4
Q ss_pred ccCCeeeccCCcceEEEEEEeCCCCc----EEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCc
Q 017231 41 YVPPIRPVGRGAYGIVCAAMNSETRE----EVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 41 ~~~i~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 116 (375)
.+++++.||+|+||+||+|.+..+|+ +||+|.+.... .....+.+.+|+.++++++||||+++++++...
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 35589999999999999999988876 57888775432 233456789999999999999999999998654
Q ss_pred CcEEEEEeCCC-CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 117 NDVYIVYELMD-TDLHQIIRSH-QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 117 ~~~~lv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
..+++++++. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 2567778775 7898877664 569999999999999999999999999999999999999999999999999987654
Q ss_pred CCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCccccccc
Q 017231 195 ETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDETSLGFL 270 (375)
Q Consensus 195 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 270 (375)
.... .....||+.|+|||++.+ ..++.++|||||||++|||+| |..||.+.+..+....+........
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~------- 234 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------- 234 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC-------
T ss_pred cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-------
Confidence 4322 233457899999999988 679999999999999999998 8999988877666655544211100
Q ss_pred ccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 271 RSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.+.+++++.++|.+||+.||++|||+.||+.|
T Consensus 235 -----------------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 235 -----------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp -----------------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 13468899999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-48 Score=351.56 Aligned_cols=255 Identities=23% Similarity=0.304 Sum_probs=211.6
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeC-----CCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeecee
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNS-----ETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 107 (375)
..+|++++.+++++.||+|+||+||+|+.+ .+++.||||++.... .......+.+|+.++++++|||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 347788888889999999999999999865 356789999986543 33456678999999999999999999999
Q ss_pred ecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 017231 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ------------------------DLTDDHCRYFLYQLLRGLKYVHSA 162 (375)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------------------~l~~~~~~~i~~qi~~al~~Lh~~ 162 (375)
+... ...+++|||++ |+|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 85 ~~~~-----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~ 159 (301)
T d1lufa_ 85 CAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 159 (301)
T ss_dssp ECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eccC-----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC
Confidence 9654 55799999997 79999986432 389999999999999999999999
Q ss_pred CccccCCCCCceEEecCCCEEEeecccccccCCC---CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhC
Q 017231 163 NVLHRDLKPSNLLLNANCDLKIGDFGLARTTSET---DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR 239 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 239 (375)
|++||||||+||+++.++.+||+|||++...... .......+++.|+|||.+.+ ..++.++|||||||++|||++|
T Consensus 160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTT
T ss_pred CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHcc
Confidence 9999999999999999999999999998654332 22335677899999999988 7899999999999999999998
Q ss_pred C-CCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCC
Q 017231 240 Q-PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRIT 318 (375)
Q Consensus 240 ~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps 318 (375)
. .||.+.+..+....+...... .....+++++.++|.+||+.||++|||
T Consensus 239 ~~~p~~~~~~~e~~~~v~~~~~~------------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 239 GLQPYYGMAHEEVIYYVRDGNIL------------------------------ACPENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp TCCTTTTSCHHHHHHHHHTTCCC------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCCCHHHHHHHHHcCCCC------------------------------CCCccchHHHHHHHHHHcCCChhHCcC
Confidence 5 678888877776665432111 011357889999999999999999999
Q ss_pred HHHHhc
Q 017231 319 VDEALC 324 (375)
Q Consensus 319 ~~ell~ 324 (375)
+.||++
T Consensus 289 ~~ev~~ 294 (301)
T d1lufa_ 289 FCSIHR 294 (301)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999965
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=347.96 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=197.5
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCC-CC--cEEEEEEecCcc-cchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSE-TR--EEVAIKKIGNAF-DNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQ 112 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~-~~--~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 112 (375)
|..+.+++++.||+|+||.||+|+... ++ ..||||++.+.. ......+.+.+|+.++++++||||+++++++..+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 344556689999999999999998543 33 368999987643 2334457899999999999999999999999543
Q ss_pred CCCcCcEEEEEeCCC-CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccc
Q 017231 113 RETFNDVYIVYELMD-TDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 113 ~~~~~~~~lv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
.+++||||++ |++.+.+.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 84 -----~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 84 -----PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp -----SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred -----chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence 3589999997 688887655 456999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CCCCCCCCChhHHHHHHHHHhCCCCcc
Q 017231 191 RTTSETDF----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQPLFPGKDYVHQLRLITELIGSPDET 265 (375)
Q Consensus 191 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 265 (375)
........ .....++..|+|||++.+ ..++.++|||||||++|||++ |..||.+.+..+....+......++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~-- 235 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP-- 235 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--
Confidence 86544322 223456788999999988 789999999999999999998 8999999888877766654221111
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+++++.++|.+||+.||++|||+.+|++
T Consensus 236 ---------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 236 ---------------------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11457899999999999999999999999863
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=347.07 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=215.5
Q ss_pred ecceeeeecccccCCeeeccCCcceEEEEEEe-----CCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeee
Q 017231 30 VYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMN-----SETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIA 103 (375)
Q Consensus 30 ~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~ 103 (375)
++...|++..+.+++++.||+|+||.||+|++ ..+++.||||+++... .......+.+|+.+++++ +||||++
T Consensus 13 ~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~ 91 (311)
T d1t46a_ 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVN 91 (311)
T ss_dssp CCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEE
Confidence 35568999989999999999999999999985 3567789999997653 344566789999999999 6999999
Q ss_pred eceeecCCCCCCcCcEEEEEeCCC-CCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 017231 104 IKDIIRPPQRETFNDVYIVYELMD-TDLHQIIRSHQ------------------DLTDDHCRYFLYQLLRGLKYVHSANV 164 (375)
Q Consensus 104 ~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~------------------~l~~~~~~~i~~qi~~al~~Lh~~~i 164 (375)
+++++... ..++++||||+ |+|.+++.... .+++..+..++.||+.||.|||++|+
T Consensus 92 ~~g~~~~~-----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~i 166 (311)
T d1t46a_ 92 LLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166 (311)
T ss_dssp EEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEEEeeC-----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 99999654 45799999997 69999987543 48999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCEEEeecccccccCCCC---ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhh-CC
Q 017231 165 LHRDLKPSNLLLNANCDLKIGDFGLARTTSETD---FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMT-RQ 240 (375)
Q Consensus 165 ~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-g~ 240 (375)
+||||||+||+++.++.++++|||.+....... ......+|+.|+|||.+.+ ..++.++|||||||++|+|++ |.
T Consensus 167 vHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~ 245 (311)
T d1t46a_ 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGS 245 (311)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCC
Confidence 999999999999999999999999998655432 2234678999999999987 789999999999999999998 67
Q ss_pred CCCCCCChhHHHHHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHH
Q 017231 241 PLFPGKDYVHQLRLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVD 320 (375)
Q Consensus 241 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ 320 (375)
+||...+....+..+......+.. ....++++.+||.+||+.||.+|||++
T Consensus 246 p~~~~~~~~~~~~~~i~~~~~~~~-----------------------------~~~~~~~l~~Li~~cl~~dP~~RPs~~ 296 (311)
T d1t46a_ 246 SPYPGMPVDSKFYKMIKEGFRMLS-----------------------------PEHAPAEMYDIMKTCWDADPLKRPTFK 296 (311)
T ss_dssp CSSTTCCSSHHHHHHHHHTCCCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCC-----------------------------cccccHHHHHHHHHHcCCChhHCcCHH
Confidence 777776665555554432211111 024688999999999999999999999
Q ss_pred HHhc
Q 017231 321 EALC 324 (375)
Q Consensus 321 ell~ 324 (375)
+|++
T Consensus 297 ~il~ 300 (311)
T d1t46a_ 297 QIVQ 300 (311)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9985
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-48 Score=349.41 Aligned_cols=261 Identities=23% Similarity=0.396 Sum_probs=218.2
Q ss_pred eeeeecccccCCeeeccCCcceEEEEEEeCC-----CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeecee
Q 017231 33 NLFEVSRKYVPPIRPVGRGAYGIVCAAMNSE-----TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDI 107 (375)
Q Consensus 33 ~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 107 (375)
..|++..+.+++++.||+|+||.||+|.++. ++..||||++.... .......+.+|+.++++++||||++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 5699999999999999999999999998753 45789999997543 44456678999999999999999999999
Q ss_pred ecCCCCCCcCcEEEEEeCCC-CCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 017231 108 IRPPQRETFNDVYIVYELMD-TDLHQIIRSH----------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 176 (375)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~----------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli 176 (375)
+... ...++||||++ |+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 92 ~~~~-----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 92 VSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 166 (308)
T ss_dssp ECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred EecC-----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence 9654 45799999997 7999988543 347899999999999999999999999999999999999
Q ss_pred ecCCCEEEeecccccccCCCCc---cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhC-CCCCCCCChhHHH
Q 017231 177 NANCDLKIGDFGLARTTSETDF---MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTR-QPLFPGKDYVHQL 252 (375)
Q Consensus 177 ~~~~~i~l~Df~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~ 252 (375)
+.++++||+|||++........ .....+++.|+|||.+.+ ..++.++|||||||++|||++| ..||.+.+..+..
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999876544322 234467999999999988 7789999999999999999998 5888888877777
Q ss_pred HHHHHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc------CC
Q 017231 253 RLITELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC------HP 326 (375)
Q Consensus 253 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~------~~ 326 (375)
..+....... ....+++.+.++|.+||+.||++|||+++|++ +|
T Consensus 246 ~~i~~~~~~~------------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 246 RFVMEGGLLD------------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHHHTTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHhCCCCC------------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 6654421110 01346889999999999999999999999998 66
Q ss_pred CCCC
Q 017231 327 YLAP 330 (375)
Q Consensus 327 ~f~~ 330 (375)
+|++
T Consensus 296 ~~~~ 299 (308)
T d1p4oa_ 296 GFRE 299 (308)
T ss_dssp THHH
T ss_pred CCcC
Confidence 6654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=351.02 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=205.4
Q ss_pred ecccccCCeeeccCCcceEEEEEEeCCCCcE--EEEEEecCcccchHHHHHHHHHHHHHHhc-CCCCeeeeceeecCCCC
Q 017231 37 VSRKYVPPIRPVGRGAYGIVCAAMNSETREE--VAIKKIGNAFDNRIDAKRTLREIKLLRHM-DHENIIAIKDIIRPPQR 113 (375)
Q Consensus 37 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 113 (375)
|.-+.+++.+.||+|+||+||+|+++.++.. ||||.+.... .....+.+.+|+.+++++ +||||+++++++...
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-- 83 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-- 83 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--
Confidence 4445666899999999999999999888774 6777764332 233456789999999999 799999999999654
Q ss_pred CCcCcEEEEEeCCC-CCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q 017231 114 ETFNDVYIVYELMD-TDLHQIIRSH----------------QDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLL 176 (375)
Q Consensus 114 ~~~~~~~lv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli 176 (375)
+.+++||||++ |+|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||+
T Consensus 84 ---~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 84 ---GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 160 (309)
T ss_dssp ---TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ---CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE
Confidence 56899999997 7999999654 569999999999999999999999999999999999999
Q ss_pred ecCCCEEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCC-CCCCCCChhHHHHHH
Q 017231 177 NANCDLKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQ-PLFPGKDYVHQLRLI 255 (375)
Q Consensus 177 ~~~~~i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~~~~~i 255 (375)
+.++.+||+|||++.............+|..|+|||.+.+ ..++.++|||||||++|+|++|. +||.+.+..+....+
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred cCCCceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999999999876665554556678999999999987 77899999999999999999965 678887766665554
Q ss_pred HHHhCCCCcccccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 256 TELIGSPDETSLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
...... .....+++++.+||.+||+.||++|||++||+++
T Consensus 240 ~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQGYRL------------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGTCCC------------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCC------------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 331110 0113568899999999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.8e-47 Score=351.42 Aligned_cols=310 Identities=27% Similarity=0.391 Sum_probs=226.9
Q ss_pred CceEEeceecCCcceEEEeecceeeeecccccCCeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHH
Q 017231 11 DHTIVKGVPTHGGRYVQYNVYGNLFEVSRKYVPPIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREI 90 (375)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~ 90 (375)
|||+.+|+.+.+|||. ++++||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+
T Consensus 1 ~~p~~~g~~~~~~rY~-----------------i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei 60 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYI-----------------LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEI 60 (362)
T ss_dssp CCCCCTTCEETTTTEE-----------------EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHH
T ss_pred CCCCCCCCCccCCcEE-----------------EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHH
Confidence 7999999999999998 4999999999999999999999999999996542 2345667888
Q ss_pred HHHHhcC-----------CCCeeeeceeecCCCCCCcCcEEEEEeCC--CCCHHHHH--HhCCCCCHHHHHHHHHHHHHH
Q 017231 91 KLLRHMD-----------HENIIAIKDIIRPPQRETFNDVYIVYELM--DTDLHQII--RSHQDLTDDHCRYFLYQLLRG 155 (375)
Q Consensus 91 ~~l~~l~-----------h~~iv~~~~~~~~~~~~~~~~~~lv~e~~--~g~L~~~l--~~~~~l~~~~~~~i~~qi~~a 155 (375)
.+++.++ |+||+++++++.... ....++++.++ .+...... .....+++..++.++.||+.|
T Consensus 61 ~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~a 137 (362)
T d1q8ya_ 61 KLLQRVNDADNTKEDSMGANHILKLLDHFNHKG---PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137 (362)
T ss_dssp HHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE---TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcchhhhhhhhcCcCceEEEEEEeeecc---ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHH
Confidence 8888875 578999998875432 13345555555 34433333 334569999999999999999
Q ss_pred HHHHHh-CCccccCCCCCceEEecCCC------EEEeecccccccCCCCccccccccccccCchhcccCCCCCccchhHH
Q 017231 156 LKYVHS-ANVLHRDLKPSNLLLNANCD------LKIGDFGLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWS 228 (375)
Q Consensus 156 l~~Lh~-~~i~H~di~p~NIli~~~~~------i~l~Df~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 228 (375)
|.+||+ .||+||||||+|||++.++. ++++|||.+...... .....+|+.|+|||++.+ ..++.++|+||
T Consensus 138 l~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS 214 (362)
T d1q8ya_ 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG-APWGCGADIWS 214 (362)
T ss_dssp HHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT-CCCCTHHHHHH
T ss_pred HHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhhccc-cCCCccccccc
Confidence 999997 89999999999999987764 999999998654433 356778999999999987 77899999999
Q ss_pred HHHHHHHHhhCCCCCCCCC------hhHHHHHHHHHhCCCCcccccccccchhHHHhh------hCCCCCCCC-------
Q 017231 229 VGCILGEIMTRQPLFPGKD------YVHQLRLITELIGSPDETSLGFLRSDNARRYVR------MLPQFPKQN------- 289 (375)
Q Consensus 229 lG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~------- 289 (375)
+||++++|++|+.||...+ ....+.......+..+........ ....+.. .........
T Consensus 215 lG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (362)
T d1q8ya_ 215 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK--YTRTFFNSRGLLRNISKLKFWPLEDVLTE 292 (362)
T ss_dssp HHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCT--THHHHBCC--CBSSCCCCCBCCHHHHHHH
T ss_pred hHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhccc--ccccccccchhhhccccccCCchhhhccc
Confidence 9999999999999996543 234455566666665443321111 0000100 000000000
Q ss_pred ccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcCCCCCCCCCCCCCCCCCCCCCCCC
Q 017231 290 FSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCHPYLAPLHDINEEPVCPRPFSFDF 348 (375)
Q Consensus 290 ~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~~~f~~~~~~~~~~~~~~~~~~~~ 348 (375)
........++++.+||.+||..||++|||++|+|+||||+++....+...+..+...+.
T Consensus 293 ~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~~~~ 351 (362)
T d1q8ya_ 293 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSG 351 (362)
T ss_dssp TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCTTCCCTTSCTTCBS
T ss_pred ccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCCcccCCCCCcccCCCC
Confidence 00011234678999999999999999999999999999998876666666555555443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=336.73 Aligned_cols=245 Identities=22% Similarity=0.306 Sum_probs=195.4
Q ss_pred eeeccCCcceEEEEEEeCCCC---cEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEE
Q 017231 45 IRPVGRGAYGIVCAAMNSETR---EEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYI 121 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 121 (375)
.++||+|+||+||+|++..++ ..||||.+... .+....+.+.+|+.++++++||||+++++++...+ +..++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~l 106 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLV 106 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEE
Confidence 578999999999999986643 36899998653 34556788999999999999999999999875432 45899
Q ss_pred EEeCCC-CCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeecccccccCCCCc-
Q 017231 122 VYELMD-TDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTTSETDF- 198 (375)
Q Consensus 122 v~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~~~~~- 198 (375)
|||||+ |+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 107 v~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999997 69999887543 588889999999999999999999999999999999999999999999999976544321
Q ss_pred ----cccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCC-hhHHHHHHHHHhCCCCcccccccccc
Q 017231 199 ----MTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKD-YVHQLRLITELIGSPDETSLGFLRSD 273 (375)
Q Consensus 199 ----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~ 273 (375)
.....||..|+|||.+.+ ..++.++||||||+++|||++|..||.... ..+....+... ..+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~~~~--------- 254 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RRLL--------- 254 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--CCCC---------
T ss_pred cceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--CCCC---------
Confidence 223467899999999987 678999999999999999999877775432 22222222111 1000
Q ss_pred hhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhcC
Q 017231 274 NARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALCH 325 (375)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~~ 325 (375)
.-+.+++++.++|.+||+.||++||++.||+++
T Consensus 255 -------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 255 -------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 013468899999999999999999999999997
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7e-46 Score=335.45 Aligned_cols=252 Identities=19% Similarity=0.186 Sum_probs=194.9
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+++.||+|+||.||+|+++.+|+.||||++...... ..+..|+++++.++|++++..+..+... ....++||
T Consensus 11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~ivm 82 (299)
T d1ckia_ 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM 82 (299)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEEE
Confidence 699999999999999999999999999987654322 3467899999999877765554443322 25678999
Q ss_pred eCCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec---CCCEEEeecccccccCCCC--
Q 017231 124 ELMDTDLHQIIRS-HQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA---NCDLKIGDFGLARTTSETD-- 197 (375)
Q Consensus 124 e~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~---~~~i~l~Df~~~~~~~~~~-- 197 (375)
||++++|.+.+.. .+.+++..+..++.|++.||++||++||+||||||+||+++. +..++|+|||++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 9999888777755 457999999999999999999999999999999999999864 4579999999997654332
Q ss_pred ------ccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhC---CCCccccc
Q 017231 198 ------FMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIG---SPDETSLG 268 (375)
Q Consensus 198 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~ 268 (375)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........+..... ..+
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~----- 236 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP----- 236 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-----
T ss_pred cceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-----
Confidence 2235578999999999988 7799999999999999999999999987654443332221110 000
Q ss_pred ccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHH---HhcCCCCCC
Q 017231 269 FLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDE---ALCHPYLAP 330 (375)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~e---ll~~~~f~~ 330 (375)
.......+|+++.++|.+||+.||++||++++ +|+++|.+.
T Consensus 237 ---------------------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 237 ---------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ---------------------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---------------------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 01112467899999999999999999999874 567776543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.6e-46 Score=333.15 Aligned_cols=245 Identities=16% Similarity=0.163 Sum_probs=197.8
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCC-CCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDH-ENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
+++.||+|+||+||+|+++.+|+.||||++..... ...+..|++.++.++| +|++.+++++... ...++|
T Consensus 9 i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~~~~~v 79 (293)
T d1csna_ 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEG-----LHNVLV 79 (293)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEET-----TEEEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----cHHHHHHHHHHHHhcCCCCCCEEEEEeecC-----CccEEE
Confidence 69999999999999999999999999998855422 2346688899999964 8999999988544 668999
Q ss_pred EeCCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEec-----CCCEEEeecccccccCCC
Q 017231 123 YELMDTDLHQIIRSHQ-DLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNA-----NCDLKIGDFGLARTTSET 196 (375)
Q Consensus 123 ~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~-----~~~i~l~Df~~~~~~~~~ 196 (375)
|||++++|.+++...+ .++...+..++.|++.||.+||++||+||||||+||+++. ++.++|+|||++......
T Consensus 80 me~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 80 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 9999999999997754 6999999999999999999999999999999999999964 578999999999764432
Q ss_pred --------CccccccccccccCchhcccCCCCCccchhHHHHHHHHHHhhCCCCCCCCChhH---HHHHHHHHhCCCCcc
Q 017231 197 --------DFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCILGEIMTRQPLFPGKDYVH---QLRLITELIGSPDET 265 (375)
Q Consensus 197 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 265 (375)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... ....+.......+.
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~- 237 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL- 237 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH-
T ss_pred ccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh-
Confidence 12334678999999999988 789999999999999999999999997654332 22222221111110
Q ss_pred cccccccchhHHHhhhCCCCCCCCccccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 266 SLGFLRSDNARRYVRMLPQFPKQNFSARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
....+.+++++.+++..|++.+|++||+.+.+.+
T Consensus 238 -------------------------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 238 -------------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp -------------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred -------------------------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0112457889999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-45 Score=328.04 Aligned_cols=262 Identities=20% Similarity=0.195 Sum_probs=185.4
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCeeeeceeecCCCCCCcCcEEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENIIAIKDIIRPPQRETFNDVYIVY 123 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 123 (375)
+.+.||+|+||.||+|+. +|+.||||++.... ........|+..+.+++||||+++++++.... .....+++||
T Consensus 7 l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv~ 80 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLVS 80 (303)
T ss_dssp EEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEEE
T ss_pred EEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEEE
Confidence 789999999999999986 57899999985432 11222334555666789999999999987653 2224689999
Q ss_pred eCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCceEEecCCCEEEeecccccccC
Q 017231 124 ELMD-TDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS--------ANVLHRDLKPSNLLLNANCDLKIGDFGLARTTS 194 (375)
Q Consensus 124 e~~~-g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~--------~~i~H~di~p~NIli~~~~~i~l~Df~~~~~~~ 194 (375)
||++ |+|.+++.+. .+++..++.++.+++.||.+||+ +||+||||||+|||++.++.+||+|||++....
T Consensus 81 Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~ 159 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred ecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccccc
Confidence 9997 7999999875 69999999999999999999996 599999999999999999999999999987654
Q ss_pred CCC-----ccccccccccccCchhcccCC-----CCCccchhHHHHHHHHHHhhCCCCCCCCChhHHHHHHHHHhCCCCc
Q 017231 195 ETD-----FMTEYVVTRWYRAPELLLNCS-----EYTAAIDIWSVGCILGEIMTRQPLFPGKDYVHQLRLITELIGSPDE 264 (375)
Q Consensus 195 ~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 264 (375)
... ......||+.|+|||++.+.. .++.++|||||||++|||++|..||......... .
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-----------~ 228 (303)
T d1vjya_ 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-----------Y 228 (303)
T ss_dssp TTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-----------T
T ss_pred CCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-----------h
Confidence 332 223467899999999987522 2567899999999999999998887432211000 0
Q ss_pred ccccccccchhHHHhhhCC--CCCCCCcc-ccCCCCCchHHHHHHHhcCcCCCCCCCHHHHhc
Q 017231 265 TSLGFLRSDNARRYVRMLP--QFPKQNFS-ARFPNKSPGAVDLLEKMLVFDPNRRITVDEALC 324 (375)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~s~~l~~li~~~L~~dP~~Rps~~ell~ 324 (375)
.... .............. ..++.-.. .........+.+++.+||+.||.+|||+.||++
T Consensus 229 ~~~~-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 229 YDLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTS-CSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hhcc-cccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0000 00000000000000 00000000 000112345889999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.89 E-value=8.4e-24 Score=176.98 Aligned_cols=170 Identities=15% Similarity=0.139 Sum_probs=120.2
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccc----------------hHHHHHHHHHHHHHHhcCCCCeeeecee
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDN----------------RIDAKRTLREIKLLRHMDHENIIAIKDI 107 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 107 (375)
+.++||+|+||+||+|.+. +|+.||||+++..... .........|...+.++.|.+++..++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 6899999999999999985 5889999987532110 1112344568889999999999888765
Q ss_pred ecCCCCCCcCcEEEEEeCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEecCCCEEEeec
Q 017231 108 IRPPQRETFNDVYIVYELMDTDLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHSANVLHRDLKPSNLLLNANCDLKIGDF 187 (375)
Q Consensus 108 ~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~~~i~H~di~p~NIli~~~~~i~l~Df 187 (375)
.. .+++||++++... ..++...+..++.||+.++.+||++||+|+||||+|||++.+ .++|+||
T Consensus 83 ~~---------~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 EG---------NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp ET---------TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred cC---------CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 31 2799999986221 235667778899999999999999999999999999999865 5999999
Q ss_pred ccccccCCCCccccccccccccCchhcccCCCCCccchhHHHHHHH
Q 017231 188 GLARTTSETDFMTEYVVTRWYRAPELLLNCSEYTAAIDIWSVGCIL 233 (375)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 233 (375)
|.+......... .........-.+.+ . +.++.++|+||+.--+
T Consensus 147 G~a~~~~~~~~~-~~l~rd~~~~~~~f-~-r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR-EILERDVRNIITYF-S-RTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH-HHHHHHHHHHHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH-HHHHHHHHHHHHHH-c-CCCCCcccHHHHHHHH
Confidence 998665433211 10000000001222 2 5678899999975443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.26 E-value=1.8e-06 Score=73.67 Aligned_cols=133 Identities=12% Similarity=0.092 Sum_probs=80.3
Q ss_pred CeeeccCCcceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCCcCcEEEE
Q 017231 44 PIRPVGRGAYGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRETFNDVYIV 122 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv 122 (375)
.++..+.++.+.||.+. .++..+++|....... .....+..|...+..+. +-.+++++.+.... +..++|
T Consensus 18 ~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-----~~~~lv 88 (263)
T d1j7la_ 18 CVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-----GWSNLL 88 (263)
T ss_dssp EEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEE
T ss_pred EEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--cchhhHHHHHHHHHHHhccCCCCcEEEEEecC-----CceEEE
Confidence 34555555567899985 4556788898754321 12334567888887774 33355666655332 457899
Q ss_pred EeCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 017231 123 YELMDT-DLHQIIRSHQDLTDDHCRYFLYQLLRGLKYVHS---------------------------------------- 161 (375)
Q Consensus 123 ~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qi~~al~~Lh~---------------------------------------- 161 (375)
|++++| ++.+.... ......++.+++..+..||+
T Consensus 89 ~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 999987 55433211 11111223333333333331
Q ss_pred -------------C------CccccCCCCCceEEecCCCEEEeecccc
Q 017231 162 -------------A------NVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 162 -------------~------~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
. .++|+|+.|.||+++.++.+-|+||+.+
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a 211 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhc
Confidence 1 2789999999999987666679999876
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.13 E-value=5.8e-06 Score=74.91 Aligned_cols=77 Identities=16% Similarity=0.092 Sum_probs=46.8
Q ss_pred eeeccCCcceEEEEEEeCCCCcEEEEEEecCcc----c-chHHHHHHHHHHHHHHhcC-C--CCeeeeceeecCCCCCCc
Q 017231 45 IRPVGRGAYGIVCAAMNSETREEVAIKKIGNAF----D-NRIDAKRTLREIKLLRHMD-H--ENIIAIKDIIRPPQRETF 116 (375)
Q Consensus 45 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~-~~~~~~~~~~e~~~l~~l~-h--~~iv~~~~~~~~~~~~~~ 116 (375)
++.||.|....||.+.+..+++.|++|...... . -.....+...|+..|+.+. + ..+++++.+...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~------ 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE------ 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT------
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC------
Confidence 678999999999999988888899999753211 0 0112334556788777663 2 234455543321
Q ss_pred CcEEEEEeCCCC
Q 017231 117 NDVYIVYELMDT 128 (375)
Q Consensus 117 ~~~~lv~e~~~g 128 (375)
..++|||++++
T Consensus 105 -~~~lvmE~L~~ 115 (392)
T d2pula1 105 -MAVTVMEDLSH 115 (392)
T ss_dssp -TTEEEECCCTT
T ss_pred -CCEEEEeccCC
Confidence 23789999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.71 E-value=0.00013 Score=61.28 Aligned_cols=70 Identities=11% Similarity=0.051 Sum_probs=43.9
Q ss_pred ccCCc-ceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCC--CeeeeceeecCCCCCCcCcEEEEEe
Q 017231 48 VGRGA-YGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHE--NIIAIKDIIRPPQRETFNDVYIVYE 124 (375)
Q Consensus 48 lg~G~-~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~--~iv~~~~~~~~~~~~~~~~~~lv~e 124 (375)
+..|. .+.||.+.. ..+..+++|....... ..+..|...++.+... .+++++...... +..++||+
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-----~~~~~v~~ 86 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEA-----GRDWLLLG 86 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----SCEEEEEE
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccc-----cceEEEEE
Confidence 44554 367899875 3466789998754322 2355677777776432 345556554333 45789999
Q ss_pred CCCC
Q 017231 125 LMDT 128 (375)
Q Consensus 125 ~~~g 128 (375)
+++|
T Consensus 87 ~i~G 90 (255)
T d1nd4a_ 87 EVPG 90 (255)
T ss_dssp CCSS
T ss_pred eeec
Confidence 9976
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.39 E-value=0.00026 Score=63.75 Aligned_cols=72 Identities=13% Similarity=0.098 Sum_probs=49.0
Q ss_pred CeeeccCCcceEEEEEEeCC-------CCcEEEEEEecCcccchHHHHHHHHHHHHHHhcC-CCCeeeeceeecCCCCCC
Q 017231 44 PIRPVGRGAYGIVCAAMNSE-------TREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMD-HENIIAIKDIIRPPQRET 115 (375)
Q Consensus 44 i~~~lg~G~~g~Vy~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 115 (375)
-++.|+.|-.-.+|++.... .++.|++++.-.. .. .....+|..+++.+. +.-.+++++.+..
T Consensus 46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----- 116 (395)
T d1nw1a_ 46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----- 116 (395)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----
Confidence 46889999999999998653 3467888887532 12 223447888888885 4334567776631
Q ss_pred cCcEEEEEeCCCC
Q 017231 116 FNDVYIVYELMDT 128 (375)
Q Consensus 116 ~~~~~lv~e~~~g 128 (375)
.+|+||++|
T Consensus 117 ----g~I~efi~g 125 (395)
T d1nw1a_ 117 ----GRLEEYIPS 125 (395)
T ss_dssp ----EEEECCCCE
T ss_pred ----ceEEEEecc
Confidence 588999876
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.32 E-value=0.00065 Score=59.26 Aligned_cols=72 Identities=14% Similarity=0.104 Sum_probs=42.1
Q ss_pred ceEEEEEEeCCCCcEEEEEEecCcccchHHHHHHHHHHHHHHhcCCCCe--eeeceeecCCCCCCcCcEEEEEeCCCC
Q 017231 53 YGIVCAAMNSETREEVAIKKIGNAFDNRIDAKRTLREIKLLRHMDHENI--IAIKDIIRPPQRETFNDVYIVYELMDT 128 (375)
Q Consensus 53 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--v~~~~~~~~~~~~~~~~~~lv~e~~~g 128 (375)
.-.||.++. .+|..|++|+.... ....+.+..|...+..|....+ +.....-........+..+.++++++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 357999975 45788999997543 2234556678888887753332 222221111111223557788998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.52 E-value=0.0062 Score=52.34 Aligned_cols=28 Identities=29% Similarity=0.325 Sum_probs=25.7
Q ss_pred CccccCCCCCceEEecCCCEEEeecccc
Q 017231 163 NVLHRDLKPSNLLLNANCDLKIGDFGLA 190 (375)
Q Consensus 163 ~i~H~di~p~NIli~~~~~i~l~Df~~~ 190 (375)
|++|+|+.++||+++.+...-|+||+.+
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred ccccCCcchhhhhcccccceeEeccccc
Confidence 7999999999999998877789999976
|